{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/Connoroverbay/DS-4002-Project1/blob/main/Project_1_Code.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "#Project 1 Code: Group 3"
      ],
      "metadata": {
        "id": "B6PqPiEhorKt"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "import numpy as np\n",
        "import seaborn as sns\n",
        "import matplotlib.pyplot as plt\n",
        "import sklearn as sk"
      ],
      "metadata": {
        "id": "bNa5tpHVowy3"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "HjRdECtm7ch2",
        "outputId": "4e159a5c-ef37-41b6-c76d-eb71dc28d737",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 776
        }
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "  ----------------------------------------------------------------------------------------------------------------  \\\n",
              "0                                   Search Criteria:                                                                 \n",
              "1                                  Fiscal Year: 2024                                                                 \n",
              "2                                         Admin: Yes                                                                 \n",
              "3                       Agency/Institute/Center: NCI                                                                 \n",
              "4                                    Award Type: New                                                                 \n",
              "5  ----------------------------------------------...                                                                 \n",
              "6                        NIH Spending Categorization                                                                 \n",
              "7                          No NIH Category available                                                                 \n",
              "8                          No NIH Category available                                                                 \n",
              "9                          No NIH Category available                                                                 \n",
              "\n",
              "                                          Unnamed: 1        Unnamed: 2  \\\n",
              "0                                                NaN               NaN   \n",
              "1                                                NaN               NaN   \n",
              "2                                                NaN               NaN   \n",
              "3                                                NaN               NaN   \n",
              "4                                                NaN               NaN   \n",
              "5                                                NaN               NaN   \n",
              "6                                      Project Title  Administering IC   \n",
              "7  eDyNAmiC (extrachromosomal DNA in Cancer) - Un...               NCI   \n",
              "8  SCH: Individualized learning and prediction fo...               NCI   \n",
              "9  SCH: Individualized learning and prediction fo...               NCI   \n",
              "\n",
              "       Unnamed: 3                    Unnamed: 4          Unnamed: 5  \\\n",
              "0             NaN                           NaN                 NaN   \n",
              "1             NaN                           NaN                 NaN   \n",
              "2             NaN                           NaN                 NaN   \n",
              "3             NaN                           NaN                 NaN   \n",
              "4             NaN                           NaN                 NaN   \n",
              "5             NaN                           NaN                 NaN   \n",
              "6  Application ID  Program Official Information  Project Start Date   \n",
              "7        11128010              FINGERMAN, IAN M       6/1/2024 0:00   \n",
              "8        11064395          WOLFF-HUGHES, DANA L       7/1/2024 0:00   \n",
              "9        11064395          WOLFF-HUGHES, DANA L       7/1/2024 0:00   \n",
              "\n",
              "         Unnamed: 6                                Unnamed: 7  \\\n",
              "0               NaN                                       NaN   \n",
              "1               NaN                                       NaN   \n",
              "2               NaN                                       NaN   \n",
              "3               NaN                                       NaN   \n",
              "4               NaN                                       NaN   \n",
              "5               NaN                                       NaN   \n",
              "6  Project End Date                             Study Section   \n",
              "7    5/31/2025 0:00                              ZCA1-SRC(99)   \n",
              "8    6/30/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "9    6/30/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "\n",
              "             Unnamed: 8                   Unnamed: 9  ...     Unnamed: 23  \\\n",
              "0                   NaN                          NaN  ...             NaN   \n",
              "1                   NaN                          NaN  ...             NaN   \n",
              "2                   NaN                          NaN  ...             NaN   \n",
              "3                   NaN                          NaN  ...             NaN   \n",
              "4                   NaN                          NaN  ...             NaN   \n",
              "5                   NaN                          NaN  ...             NaN   \n",
              "6  Contact PI Person ID  Contact PI / Project Leader  ...  ARRA Indicator   \n",
              "7               9811494             VENTURA, ANDREA   ...               N   \n",
              "8               9839722                   QU, ANNIE   ...               N   \n",
              "9               9839722                   QU, ANNIE   ...               N   \n",
              "\n",
              "  Unnamed: 24        Unnamed: 25  Unnamed: 26 Unnamed: 27  \\\n",
              "0         NaN                NaN          NaN         NaN   \n",
              "1         NaN                NaN          NaN         NaN   \n",
              "2         NaN                NaN          NaN         NaN   \n",
              "3         NaN                NaN          NaN         NaN   \n",
              "4         NaN                NaN          NaN         NaN   \n",
              "5         NaN                NaN          NaN         NaN   \n",
              "6   CFDA Code  Funding Mechanism  Fiscal Year  Total Cost   \n",
              "7         393              Other         2024      166232   \n",
              "8         393      Non-SBIR/STTR         2024      299988   \n",
              "9         393      Non-SBIR/STTR         2024      299988   \n",
              "\n",
              "                 Unnamed: 28    Unnamed: 29     Unnamed: 30       Unnamed: 31  \\\n",
              "0                        NaN            NaN             NaN               NaN   \n",
              "1                        NaN            NaN             NaN               NaN   \n",
              "2                        NaN            NaN             NaN               NaN   \n",
              "3                        NaN            NaN             NaN               NaN   \n",
              "4                        NaN            NaN             NaN               NaN   \n",
              "5                        NaN            NaN             NaN               NaN   \n",
              "6  Total Cost (Sub Projects)  Funding IC(s)  Direct Cost IC  InDirect Cost IC   \n",
              "7                                       NCI           94450             71782   \n",
              "8                                        OD           66234             33766   \n",
              "9                                       NCI          132459             67529   \n",
              "\n",
              "     Unnamed: 32  \n",
              "0            NaN  \n",
              "1            NaN  \n",
              "2            NaN  \n",
              "3            NaN  \n",
              "4            NaN  \n",
              "5            NaN  \n",
              "6  Total Cost IC  \n",
              "7         166232  \n",
              "8         100000  \n",
              "9         199988  \n",
              "\n",
              "[10 rows x 33 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-363bb3fc-e9ce-4485-b587-1ef5be463210\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>----------------------------------------------------------------------------------------------------------------</th>\n",
              "      <th>Unnamed: 1</th>\n",
              "      <th>Unnamed: 2</th>\n",
              "      <th>Unnamed: 3</th>\n",
              "      <th>Unnamed: 4</th>\n",
              "      <th>Unnamed: 5</th>\n",
              "      <th>Unnamed: 6</th>\n",
              "      <th>Unnamed: 7</th>\n",
              "      <th>Unnamed: 8</th>\n",
              "      <th>Unnamed: 9</th>\n",
              "      <th>...</th>\n",
              "      <th>Unnamed: 23</th>\n",
              "      <th>Unnamed: 24</th>\n",
              "      <th>Unnamed: 25</th>\n",
              "      <th>Unnamed: 26</th>\n",
              "      <th>Unnamed: 27</th>\n",
              "      <th>Unnamed: 28</th>\n",
              "      <th>Unnamed: 29</th>\n",
              "      <th>Unnamed: 30</th>\n",
              "      <th>Unnamed: 31</th>\n",
              "      <th>Unnamed: 32</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Search Criteria:</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Fiscal Year: 2024</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Admin: Yes</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Agency/Institute/Center: NCI</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Award Type: New</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>----------------------------------------------...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>NIH Spending Categorization</td>\n",
              "      <td>Project Title</td>\n",
              "      <td>Administering IC</td>\n",
              "      <td>Application ID</td>\n",
              "      <td>Program Official Information</td>\n",
              "      <td>Project Start Date</td>\n",
              "      <td>Project End Date</td>\n",
              "      <td>Study Section</td>\n",
              "      <td>Contact PI Person ID</td>\n",
              "      <td>Contact PI / Project Leader</td>\n",
              "      <td>...</td>\n",
              "      <td>ARRA Indicator</td>\n",
              "      <td>CFDA Code</td>\n",
              "      <td>Funding Mechanism</td>\n",
              "      <td>Fiscal Year</td>\n",
              "      <td>Total Cost</td>\n",
              "      <td>Total Cost (Sub Projects)</td>\n",
              "      <td>Funding IC(s)</td>\n",
              "      <td>Direct Cost IC</td>\n",
              "      <td>InDirect Cost IC</td>\n",
              "      <td>Total Cost IC</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>eDyNAmiC (extrachromosomal DNA in Cancer) - Un...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11128010</td>\n",
              "      <td>FINGERMAN, IAN M</td>\n",
              "      <td>6/1/2024 0:00</td>\n",
              "      <td>5/31/2025 0:00</td>\n",
              "      <td>ZCA1-SRC(99)</td>\n",
              "      <td>9811494</td>\n",
              "      <td>VENTURA, ANDREA</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Other</td>\n",
              "      <td>2024</td>\n",
              "      <td>166232</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>94450</td>\n",
              "      <td>71782</td>\n",
              "      <td>166232</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Individualized learning and prediction fo...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11064395</td>\n",
              "      <td>WOLFF-HUGHES, DANA L</td>\n",
              "      <td>7/1/2024 0:00</td>\n",
              "      <td>6/30/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>9839722</td>\n",
              "      <td>QU, ANNIE</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>299988</td>\n",
              "      <td></td>\n",
              "      <td>OD</td>\n",
              "      <td>66234</td>\n",
              "      <td>33766</td>\n",
              "      <td>100000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Individualized learning and prediction fo...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11064395</td>\n",
              "      <td>WOLFF-HUGHES, DANA L</td>\n",
              "      <td>7/1/2024 0:00</td>\n",
              "      <td>6/30/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>9839722</td>\n",
              "      <td>QU, ANNIE</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>299988</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>132459</td>\n",
              "      <td>67529</td>\n",
              "      <td>199988</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>10 rows × 33 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-363bb3fc-e9ce-4485-b587-1ef5be463210')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-363bb3fc-e9ce-4485-b587-1ef5be463210 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-363bb3fc-e9ce-4485-b587-1ef5be463210');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-8f9ec99d-08e1-4cc9-8c38-ae2637f0d8ea\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-8f9ec99d-08e1-4cc9-8c38-ae2637f0d8ea')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-8f9ec99d-08e1-4cc9-8c38-ae2637f0d8ea button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df"
            }
          },
          "metadata": {},
          "execution_count": 2
        }
      ],
      "source": [
        "df = pd.read_csv(\"/content/Cancer Research Grants.csv\")\n",
        "df.head(10)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: drop first 5 rows\n",
        "\n",
        "df1 = df.iloc[6:]\n",
        "df1.head(5)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 741
        },
        "id": "fcyOeGjrpqU5",
        "outputId": "e5d97647-2d39-4e56-c66c-418a77efdd8a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   ----------------------------------------------------------------------------------------------------------------  \\\n",
              "6                         NIH Spending Categorization                                                                 \n",
              "7                           No NIH Category available                                                                 \n",
              "8                           No NIH Category available                                                                 \n",
              "9                           No NIH Category available                                                                 \n",
              "10                          No NIH Category available                                                                 \n",
              "\n",
              "                                           Unnamed: 1        Unnamed: 2  \\\n",
              "6                                       Project Title  Administering IC   \n",
              "7   eDyNAmiC (extrachromosomal DNA in Cancer) - Un...               NCI   \n",
              "8   SCH: Individualized learning and prediction fo...               NCI   \n",
              "9   SCH: Individualized learning and prediction fo...               NCI   \n",
              "10  SCH: Robust Multimodal Longitudinal AI for Enh...               NCI   \n",
              "\n",
              "        Unnamed: 3                    Unnamed: 4          Unnamed: 5  \\\n",
              "6   Application ID  Program Official Information  Project Start Date   \n",
              "7         11128010              FINGERMAN, IAN M       6/1/2024 0:00   \n",
              "8         11064395          WOLFF-HUGHES, DANA L       7/1/2024 0:00   \n",
              "9         11064395          WOLFF-HUGHES, DANA L       7/1/2024 0:00   \n",
              "10        11063443         SKARLUPKA, AMANDA LEE       8/1/2024 0:00   \n",
              "\n",
              "          Unnamed: 6                                Unnamed: 7  \\\n",
              "6   Project End Date                             Study Section   \n",
              "7     5/31/2025 0:00                              ZCA1-SRC(99)   \n",
              "8     6/30/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "9     6/30/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "10    7/31/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "\n",
              "              Unnamed: 8                   Unnamed: 9  ...     Unnamed: 23  \\\n",
              "6   Contact PI Person ID  Contact PI / Project Leader  ...  ARRA Indicator   \n",
              "7                9811494             VENTURA, ANDREA   ...               N   \n",
              "8                9839722                   QU, ANNIE   ...               N   \n",
              "9                9839722                   QU, ANNIE   ...               N   \n",
              "10              10641231              NABAVI, SHEIDA   ...               N   \n",
              "\n",
              "   Unnamed: 24        Unnamed: 25  Unnamed: 26 Unnamed: 27  \\\n",
              "6    CFDA Code  Funding Mechanism  Fiscal Year  Total Cost   \n",
              "7          393              Other         2024      166232   \n",
              "8          393      Non-SBIR/STTR         2024      299988   \n",
              "9          393      Non-SBIR/STTR         2024      299988   \n",
              "10         394      Non-SBIR/STTR         2024      310317   \n",
              "\n",
              "                  Unnamed: 28    Unnamed: 29     Unnamed: 30  \\\n",
              "6   Total Cost (Sub Projects)  Funding IC(s)  Direct Cost IC   \n",
              "7                                        NCI           94450   \n",
              "8                                         OD           66234   \n",
              "9                                        NCI          132459   \n",
              "10                                        OD           34720   \n",
              "\n",
              "         Unnamed: 31    Unnamed: 32  \n",
              "6   InDirect Cost IC  Total Cost IC  \n",
              "7              71782         166232  \n",
              "8              33766         100000  \n",
              "9              67529         199988  \n",
              "10             15280          50000  \n",
              "\n",
              "[5 rows x 33 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-9a31d920-119f-4197-a10f-eae4af04b46a\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>----------------------------------------------------------------------------------------------------------------</th>\n",
              "      <th>Unnamed: 1</th>\n",
              "      <th>Unnamed: 2</th>\n",
              "      <th>Unnamed: 3</th>\n",
              "      <th>Unnamed: 4</th>\n",
              "      <th>Unnamed: 5</th>\n",
              "      <th>Unnamed: 6</th>\n",
              "      <th>Unnamed: 7</th>\n",
              "      <th>Unnamed: 8</th>\n",
              "      <th>Unnamed: 9</th>\n",
              "      <th>...</th>\n",
              "      <th>Unnamed: 23</th>\n",
              "      <th>Unnamed: 24</th>\n",
              "      <th>Unnamed: 25</th>\n",
              "      <th>Unnamed: 26</th>\n",
              "      <th>Unnamed: 27</th>\n",
              "      <th>Unnamed: 28</th>\n",
              "      <th>Unnamed: 29</th>\n",
              "      <th>Unnamed: 30</th>\n",
              "      <th>Unnamed: 31</th>\n",
              "      <th>Unnamed: 32</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>NIH Spending Categorization</td>\n",
              "      <td>Project Title</td>\n",
              "      <td>Administering IC</td>\n",
              "      <td>Application ID</td>\n",
              "      <td>Program Official Information</td>\n",
              "      <td>Project Start Date</td>\n",
              "      <td>Project End Date</td>\n",
              "      <td>Study Section</td>\n",
              "      <td>Contact PI Person ID</td>\n",
              "      <td>Contact PI / Project Leader</td>\n",
              "      <td>...</td>\n",
              "      <td>ARRA Indicator</td>\n",
              "      <td>CFDA Code</td>\n",
              "      <td>Funding Mechanism</td>\n",
              "      <td>Fiscal Year</td>\n",
              "      <td>Total Cost</td>\n",
              "      <td>Total Cost (Sub Projects)</td>\n",
              "      <td>Funding IC(s)</td>\n",
              "      <td>Direct Cost IC</td>\n",
              "      <td>InDirect Cost IC</td>\n",
              "      <td>Total Cost IC</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>eDyNAmiC (extrachromosomal DNA in Cancer) - Un...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11128010</td>\n",
              "      <td>FINGERMAN, IAN M</td>\n",
              "      <td>6/1/2024 0:00</td>\n",
              "      <td>5/31/2025 0:00</td>\n",
              "      <td>ZCA1-SRC(99)</td>\n",
              "      <td>9811494</td>\n",
              "      <td>VENTURA, ANDREA</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Other</td>\n",
              "      <td>2024</td>\n",
              "      <td>166232</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>94450</td>\n",
              "      <td>71782</td>\n",
              "      <td>166232</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Individualized learning and prediction fo...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11064395</td>\n",
              "      <td>WOLFF-HUGHES, DANA L</td>\n",
              "      <td>7/1/2024 0:00</td>\n",
              "      <td>6/30/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>9839722</td>\n",
              "      <td>QU, ANNIE</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>299988</td>\n",
              "      <td></td>\n",
              "      <td>OD</td>\n",
              "      <td>66234</td>\n",
              "      <td>33766</td>\n",
              "      <td>100000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Individualized learning and prediction fo...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11064395</td>\n",
              "      <td>WOLFF-HUGHES, DANA L</td>\n",
              "      <td>7/1/2024 0:00</td>\n",
              "      <td>6/30/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>9839722</td>\n",
              "      <td>QU, ANNIE</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>299988</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>132459</td>\n",
              "      <td>67529</td>\n",
              "      <td>199988</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>10</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Robust Multimodal Longitudinal AI for Enh...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11063443</td>\n",
              "      <td>SKARLUPKA, AMANDA LEE</td>\n",
              "      <td>8/1/2024 0:00</td>\n",
              "      <td>7/31/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>10641231</td>\n",
              "      <td>NABAVI, SHEIDA</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>394</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>310317</td>\n",
              "      <td></td>\n",
              "      <td>OD</td>\n",
              "      <td>34720</td>\n",
              "      <td>15280</td>\n",
              "      <td>50000</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 33 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-9a31d920-119f-4197-a10f-eae4af04b46a')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-9a31d920-119f-4197-a10f-eae4af04b46a button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-9a31d920-119f-4197-a10f-eae4af04b46a');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-7a40c9a4-168f-454f-a80b-fd13446db0d8\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-7a40c9a4-168f-454f-a80b-fd13446db0d8')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-7a40c9a4-168f-454f-a80b-fd13446db0d8 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df1"
            }
          },
          "metadata": {},
          "execution_count": 3
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: reindex row 6 as the column headers\n",
        "\n",
        "df1 = df1.rename(columns=df1.iloc[0])\n",
        "df2 = df1[1:]\n",
        "df2.head()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 637
        },
        "id": "IHvBVaPeqVLz",
        "outputId": "30ed304a-3be4-477d-c843-94fdd3ae7f9d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   NIH Spending Categorization  \\\n",
              "7    No NIH Category available   \n",
              "8    No NIH Category available   \n",
              "9    No NIH Category available   \n",
              "10   No NIH Category available   \n",
              "11   No NIH Category available   \n",
              "\n",
              "                                        Project Title Administering IC  \\\n",
              "7   eDyNAmiC (extrachromosomal DNA in Cancer) - Un...              NCI   \n",
              "8   SCH: Individualized learning and prediction fo...              NCI   \n",
              "9   SCH: Individualized learning and prediction fo...              NCI   \n",
              "10  SCH: Robust Multimodal Longitudinal AI for Enh...              NCI   \n",
              "11  SCH: Robust Multimodal Longitudinal AI for Enh...              NCI   \n",
              "\n",
              "   Application ID Program Official Information Project Start Date  \\\n",
              "7        11128010             FINGERMAN, IAN M      6/1/2024 0:00   \n",
              "8        11064395         WOLFF-HUGHES, DANA L      7/1/2024 0:00   \n",
              "9        11064395         WOLFF-HUGHES, DANA L      7/1/2024 0:00   \n",
              "10       11063443        SKARLUPKA, AMANDA LEE      8/1/2024 0:00   \n",
              "11       11063443        SKARLUPKA, AMANDA LEE      8/1/2024 0:00   \n",
              "\n",
              "   Project End Date                             Study Section  \\\n",
              "7    5/31/2025 0:00                              ZCA1-SRC(99)   \n",
              "8    6/30/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "9    6/30/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "10   7/31/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "11   7/31/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "\n",
              "   Contact PI Person ID Contact PI / Project Leader  ... ARRA Indicator  \\\n",
              "7               9811494            VENTURA, ANDREA   ...              N   \n",
              "8               9839722                  QU, ANNIE   ...              N   \n",
              "9               9839722                  QU, ANNIE   ...              N   \n",
              "10             10641231             NABAVI, SHEIDA   ...              N   \n",
              "11             10641231             NABAVI, SHEIDA   ...              N   \n",
              "\n",
              "   CFDA Code Funding Mechanism Fiscal Year Total Cost  \\\n",
              "7        393             Other        2024     166232   \n",
              "8        393     Non-SBIR/STTR        2024     299988   \n",
              "9        393     Non-SBIR/STTR        2024     299988   \n",
              "10       394     Non-SBIR/STTR        2024     310317   \n",
              "11       394     Non-SBIR/STTR        2024     310317   \n",
              "\n",
              "   Total Cost (Sub Projects) Funding IC(s) Direct Cost IC InDirect Cost IC  \\\n",
              "7                                      NCI          94450            71782   \n",
              "8                                       OD          66234            33766   \n",
              "9                                      NCI         132459            67529   \n",
              "10                                      OD          34720            15280   \n",
              "11                                     NCI         180763            79554   \n",
              "\n",
              "   Total Cost IC  \n",
              "7         166232  \n",
              "8         100000  \n",
              "9         199988  \n",
              "10         50000  \n",
              "11        260317  \n",
              "\n",
              "[5 rows x 33 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-2d52dfec-8760-4b99-ab13-2aa01f8da54d\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>NIH Spending Categorization</th>\n",
              "      <th>Project Title</th>\n",
              "      <th>Administering IC</th>\n",
              "      <th>Application ID</th>\n",
              "      <th>Program Official Information</th>\n",
              "      <th>Project Start Date</th>\n",
              "      <th>Project End Date</th>\n",
              "      <th>Study Section</th>\n",
              "      <th>Contact PI Person ID</th>\n",
              "      <th>Contact PI / Project Leader</th>\n",
              "      <th>...</th>\n",
              "      <th>ARRA Indicator</th>\n",
              "      <th>CFDA Code</th>\n",
              "      <th>Funding Mechanism</th>\n",
              "      <th>Fiscal Year</th>\n",
              "      <th>Total Cost</th>\n",
              "      <th>Total Cost (Sub Projects)</th>\n",
              "      <th>Funding IC(s)</th>\n",
              "      <th>Direct Cost IC</th>\n",
              "      <th>InDirect Cost IC</th>\n",
              "      <th>Total Cost IC</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>eDyNAmiC (extrachromosomal DNA in Cancer) - Un...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11128010</td>\n",
              "      <td>FINGERMAN, IAN M</td>\n",
              "      <td>6/1/2024 0:00</td>\n",
              "      <td>5/31/2025 0:00</td>\n",
              "      <td>ZCA1-SRC(99)</td>\n",
              "      <td>9811494</td>\n",
              "      <td>VENTURA, ANDREA</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Other</td>\n",
              "      <td>2024</td>\n",
              "      <td>166232</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>94450</td>\n",
              "      <td>71782</td>\n",
              "      <td>166232</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Individualized learning and prediction fo...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11064395</td>\n",
              "      <td>WOLFF-HUGHES, DANA L</td>\n",
              "      <td>7/1/2024 0:00</td>\n",
              "      <td>6/30/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>9839722</td>\n",
              "      <td>QU, ANNIE</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>299988</td>\n",
              "      <td></td>\n",
              "      <td>OD</td>\n",
              "      <td>66234</td>\n",
              "      <td>33766</td>\n",
              "      <td>100000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Individualized learning and prediction fo...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11064395</td>\n",
              "      <td>WOLFF-HUGHES, DANA L</td>\n",
              "      <td>7/1/2024 0:00</td>\n",
              "      <td>6/30/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>9839722</td>\n",
              "      <td>QU, ANNIE</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>299988</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>132459</td>\n",
              "      <td>67529</td>\n",
              "      <td>199988</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>10</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Robust Multimodal Longitudinal AI for Enh...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11063443</td>\n",
              "      <td>SKARLUPKA, AMANDA LEE</td>\n",
              "      <td>8/1/2024 0:00</td>\n",
              "      <td>7/31/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>10641231</td>\n",
              "      <td>NABAVI, SHEIDA</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>394</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>310317</td>\n",
              "      <td></td>\n",
              "      <td>OD</td>\n",
              "      <td>34720</td>\n",
              "      <td>15280</td>\n",
              "      <td>50000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>11</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Robust Multimodal Longitudinal AI for Enh...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11063443</td>\n",
              "      <td>SKARLUPKA, AMANDA LEE</td>\n",
              "      <td>8/1/2024 0:00</td>\n",
              "      <td>7/31/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>10641231</td>\n",
              "      <td>NABAVI, SHEIDA</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>394</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>310317</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>180763</td>\n",
              "      <td>79554</td>\n",
              "      <td>260317</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 33 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-2d52dfec-8760-4b99-ab13-2aa01f8da54d')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-2d52dfec-8760-4b99-ab13-2aa01f8da54d button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-2d52dfec-8760-4b99-ab13-2aa01f8da54d');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-08567962-a6ec-47ac-b392-9f0776aca590\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-08567962-a6ec-47ac-b392-9f0776aca590')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-08567962-a6ec-47ac-b392-9f0776aca590 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df2"
            }
          },
          "metadata": {},
          "execution_count": 4
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: drop rows with Funding IC(s) not = \"NCI\"\n",
        "\n",
        "df_nci = df2[df2['Funding IC(s)'] == 'NCI']\n",
        "df_nci.head()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 637
        },
        "id": "ljRdVATzrda6",
        "outputId": "a8b9474f-6531-4e02-ada3-4642676c4c39"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   NIH Spending Categorization  \\\n",
              "7    No NIH Category available   \n",
              "9    No NIH Category available   \n",
              "11   No NIH Category available   \n",
              "12   No NIH Category available   \n",
              "15   No NIH Category available   \n",
              "\n",
              "                                        Project Title Administering IC  \\\n",
              "7   eDyNAmiC (extrachromosomal DNA in Cancer) - Un...              NCI   \n",
              "9   SCH: Individualized learning and prediction fo...              NCI   \n",
              "11  SCH: Robust Multimodal Longitudinal AI for Enh...              NCI   \n",
              "12  SCH: Synchronous Dyadic Physiological Monitori...              NCI   \n",
              "15  SCH: Topological Methods for Breast Tissue Qua...              NCI   \n",
              "\n",
              "   Application ID Program Official Information Project Start Date  \\\n",
              "7        11128010             FINGERMAN, IAN M      6/1/2024 0:00   \n",
              "9        11064395         WOLFF-HUGHES, DANA L      7/1/2024 0:00   \n",
              "11       11063443        SKARLUPKA, AMANDA LEE      8/1/2024 0:00   \n",
              "12       11063434         WOLFF-HUGHES, DANA L      8/1/2024 0:00   \n",
              "15       11062792              MILLER, DAVID J      8/1/2024 0:00   \n",
              "\n",
              "   Project End Date                             Study Section  \\\n",
              "7    5/31/2025 0:00                              ZCA1-SRC(99)   \n",
              "9    6/30/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "11   7/31/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "12   7/31/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "15   7/31/2028 0:00  Special Emphasis Panel[ZRG1-IVBH-N(50)R]   \n",
              "\n",
              "   Contact PI Person ID Contact PI / Project Leader  ... ARRA Indicator  \\\n",
              "7               9811494            VENTURA, ANDREA   ...              N   \n",
              "9               9839722                  QU, ANNIE   ...              N   \n",
              "11             10641231             NABAVI, SHEIDA   ...              N   \n",
              "12             78467322            ROBERTS, DAVID L  ...              N   \n",
              "15             14901305                 CHEN, CHAO   ...              N   \n",
              "\n",
              "   CFDA Code Funding Mechanism Fiscal Year Total Cost  \\\n",
              "7        393             Other        2024     166232   \n",
              "9        393     Non-SBIR/STTR        2024     299988   \n",
              "11       394     Non-SBIR/STTR        2024     310317   \n",
              "12       393     Non-SBIR/STTR        2024     299950   \n",
              "15       393     Non-SBIR/STTR        2024     300000   \n",
              "\n",
              "   Total Cost (Sub Projects) Funding IC(s) Direct Cost IC InDirect Cost IC  \\\n",
              "7                                      NCI          94450            71782   \n",
              "9                                      NCI         132459            67529   \n",
              "11                                     NCI         180763            79554   \n",
              "12                                     NCI         111281            38669   \n",
              "15                                     NCI          97207            52793   \n",
              "\n",
              "   Total Cost IC  \n",
              "7         166232  \n",
              "9         199988  \n",
              "11        260317  \n",
              "12        149950  \n",
              "15        150000  \n",
              "\n",
              "[5 rows x 33 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-e60ec5e7-b840-4fd8-9cc2-ebfadff8cc8b\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>NIH Spending Categorization</th>\n",
              "      <th>Project Title</th>\n",
              "      <th>Administering IC</th>\n",
              "      <th>Application ID</th>\n",
              "      <th>Program Official Information</th>\n",
              "      <th>Project Start Date</th>\n",
              "      <th>Project End Date</th>\n",
              "      <th>Study Section</th>\n",
              "      <th>Contact PI Person ID</th>\n",
              "      <th>Contact PI / Project Leader</th>\n",
              "      <th>...</th>\n",
              "      <th>ARRA Indicator</th>\n",
              "      <th>CFDA Code</th>\n",
              "      <th>Funding Mechanism</th>\n",
              "      <th>Fiscal Year</th>\n",
              "      <th>Total Cost</th>\n",
              "      <th>Total Cost (Sub Projects)</th>\n",
              "      <th>Funding IC(s)</th>\n",
              "      <th>Direct Cost IC</th>\n",
              "      <th>InDirect Cost IC</th>\n",
              "      <th>Total Cost IC</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>eDyNAmiC (extrachromosomal DNA in Cancer) - Un...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11128010</td>\n",
              "      <td>FINGERMAN, IAN M</td>\n",
              "      <td>6/1/2024 0:00</td>\n",
              "      <td>5/31/2025 0:00</td>\n",
              "      <td>ZCA1-SRC(99)</td>\n",
              "      <td>9811494</td>\n",
              "      <td>VENTURA, ANDREA</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Other</td>\n",
              "      <td>2024</td>\n",
              "      <td>166232</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>94450</td>\n",
              "      <td>71782</td>\n",
              "      <td>166232</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Individualized learning and prediction fo...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11064395</td>\n",
              "      <td>WOLFF-HUGHES, DANA L</td>\n",
              "      <td>7/1/2024 0:00</td>\n",
              "      <td>6/30/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>9839722</td>\n",
              "      <td>QU, ANNIE</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>299988</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>132459</td>\n",
              "      <td>67529</td>\n",
              "      <td>199988</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>11</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Robust Multimodal Longitudinal AI for Enh...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11063443</td>\n",
              "      <td>SKARLUPKA, AMANDA LEE</td>\n",
              "      <td>8/1/2024 0:00</td>\n",
              "      <td>7/31/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>10641231</td>\n",
              "      <td>NABAVI, SHEIDA</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>394</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>310317</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>180763</td>\n",
              "      <td>79554</td>\n",
              "      <td>260317</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>12</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Synchronous Dyadic Physiological Monitori...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11063434</td>\n",
              "      <td>WOLFF-HUGHES, DANA L</td>\n",
              "      <td>8/1/2024 0:00</td>\n",
              "      <td>7/31/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>78467322</td>\n",
              "      <td>ROBERTS, DAVID L</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>299950</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>111281</td>\n",
              "      <td>38669</td>\n",
              "      <td>149950</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>15</th>\n",
              "      <td>No NIH Category available</td>\n",
              "      <td>SCH: Topological Methods for Breast Tissue Qua...</td>\n",
              "      <td>NCI</td>\n",
              "      <td>11062792</td>\n",
              "      <td>MILLER, DAVID J</td>\n",
              "      <td>8/1/2024 0:00</td>\n",
              "      <td>7/31/2028 0:00</td>\n",
              "      <td>Special Emphasis Panel[ZRG1-IVBH-N(50)R]</td>\n",
              "      <td>14901305</td>\n",
              "      <td>CHEN, CHAO</td>\n",
              "      <td>...</td>\n",
              "      <td>N</td>\n",
              "      <td>393</td>\n",
              "      <td>Non-SBIR/STTR</td>\n",
              "      <td>2024</td>\n",
              "      <td>300000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>97207</td>\n",
              "      <td>52793</td>\n",
              "      <td>150000</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 33 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-e60ec5e7-b840-4fd8-9cc2-ebfadff8cc8b')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-e60ec5e7-b840-4fd8-9cc2-ebfadff8cc8b button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-e60ec5e7-b840-4fd8-9cc2-ebfadff8cc8b');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-f0d21114-8167-4331-a07b-c2b6c3d208b7\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-f0d21114-8167-4331-a07b-c2b6c3d208b7')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-f0d21114-8167-4331-a07b-c2b6c3d208b7 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df_nci"
            }
          },
          "metadata": {},
          "execution_count": 5
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_nci['Funding IC(s)'].describe()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 209
        },
        "id": "IlC2IuOgrwZf",
        "outputId": "95c63ed1-a3ff-441d-b57f-ae34681e9df5"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "count     1468\n",
              "unique       1\n",
              "top        NCI\n",
              "freq      1468\n",
              "Name: Funding IC(s), dtype: object"
            ],
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Funding IC(s)</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>count</th>\n",
              "      <td>1468</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>unique</th>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>top</th>\n",
              "      <td>NCI</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>freq</th>\n",
              "      <td>1468</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div><br><label><b>dtype:</b> object</label>"
            ]
          },
          "metadata": {},
          "execution_count": 6
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: drop columns named\n",
        "\n",
        "df2 = df_nci.drop(columns=['NIH Spending Categorization',\n",
        "                           'Administering IC',\n",
        "                           'Application ID',\n",
        "                           'Program Official Information',\n",
        "                           'Program Official Information',\n",
        "                           'Project Start Date',\n",
        "                           'Project End Date',\n",
        "                           'Study Section',\n",
        "                           'Other PI or Project Leader(s)',\n",
        "                           'Primary DUNS',\n",
        "                           'Primary UEI',\n",
        "                           'Organization Zip',\n",
        "                           'ARRA Indicator',\n",
        "                           'CFDA Code',\n",
        "                           'Funding Mechanism',\n",
        "                           'Fiscal Year'])\n",
        "df2.head()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 590
        },
        "id": "8mj1UIaA6HJW",
        "outputId": "a83ef11f-e97f-4611-f808-0e0f5128f1dc"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                        Project Title Contact PI Person ID  \\\n",
              "7   eDyNAmiC (extrachromosomal DNA in Cancer) - Un...              9811494   \n",
              "9   SCH: Individualized learning and prediction fo...              9839722   \n",
              "11  SCH: Robust Multimodal Longitudinal AI for Enh...             10641231   \n",
              "12  SCH: Synchronous Dyadic Physiological Monitori...             78467322   \n",
              "15  SCH: Topological Methods for Breast Tissue Qua...             14901305   \n",
              "\n",
              "   Contact PI / Project Leader  \\\n",
              "7             VENTURA, ANDREA    \n",
              "9                   QU, ANNIE    \n",
              "11             NABAVI, SHEIDA    \n",
              "12            ROBERTS, DAVID L   \n",
              "15                 CHEN, CHAO    \n",
              "\n",
              "                                     Project Abstract  \\\n",
              "7   Abstract: eDyNAmiC (extrachromosomal DNA in Ca...   \n",
              "9   Recent technological advances in mobile health...   \n",
              "11  The overarching objective of this project is t...   \n",
              "12  Animal-Assisted Interventions (AAIs) are goal-...   \n",
              "15  To better understand breast cancer and its res...   \n",
              "\n",
              "                              Public Health Relevance  \\\n",
              "7                                                 NaN   \n",
              "9   The proposed project will have potentially pro...   \n",
              "11                                                NaN   \n",
              "12                                                NaN   \n",
              "15                                                NaN   \n",
              "\n",
              "                        Department Organization ID (IPF)  \\\n",
              "7                      Unavailable               5079202   \n",
              "9   BIOSTATISTICS & OTHER MATH SCI                577504   \n",
              "11         ENGINEERING (ALL TYPES)               1506602   \n",
              "12  BIOSTATISTICS & OTHER MATH SCI                578204   \n",
              "15         ENGINEERING (ALL TYPES)               5992612   \n",
              "\n",
              "                          Organization Name Organization City  \\\n",
              "7         SLOAN-KETTERING INST CAN RESEARCH          NEW YORK   \n",
              "9           UNIVERSITY OF CALIFORNIA-IRVINE            IRVINE   \n",
              "11         UNIVERSITY OF CONNECTICUT STORRS  STORRS-MANSFIELD   \n",
              "12  NORTH CAROLINA STATE UNIVERSITY RALEIGH           RALEIGH   \n",
              "15    STATE UNIVERSITY NEW YORK STONY BROOK       STONY BROOK   \n",
              "\n",
              "   Organization State              Organization Type Organization Country  \\\n",
              "7                  NY            Research Institutes        UNITED STATES   \n",
              "9                  CA                COMPUTER CENTER        UNITED STATES   \n",
              "11                 CT  BIOMED ENGR/COL ENGR/ENGR STA        UNITED STATES   \n",
              "12                 NC  BIOMED ENGR/COL ENGR/ENGR STA        UNITED STATES   \n",
              "15                 NY  BIOMED ENGR/COL ENGR/ENGR STA        UNITED STATES   \n",
              "\n",
              "   Total Cost Total Cost (Sub Projects) Funding IC(s) Direct Cost IC  \\\n",
              "7      166232                                     NCI          94450   \n",
              "9      299988                                     NCI         132459   \n",
              "11     310317                                     NCI         180763   \n",
              "12     299950                                     NCI         111281   \n",
              "15     300000                                     NCI          97207   \n",
              "\n",
              "   InDirect Cost IC Total Cost IC  \n",
              "7             71782        166232  \n",
              "9             67529        199988  \n",
              "11            79554        260317  \n",
              "12            38669        149950  \n",
              "15            52793        150000  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-82c220a1-25f5-460d-8c87-1ec30bf98962\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Project Title</th>\n",
              "      <th>Contact PI Person ID</th>\n",
              "      <th>Contact PI / Project Leader</th>\n",
              "      <th>Project Abstract</th>\n",
              "      <th>Public Health Relevance</th>\n",
              "      <th>Department</th>\n",
              "      <th>Organization ID (IPF)</th>\n",
              "      <th>Organization Name</th>\n",
              "      <th>Organization City</th>\n",
              "      <th>Organization State</th>\n",
              "      <th>Organization Type</th>\n",
              "      <th>Organization Country</th>\n",
              "      <th>Total Cost</th>\n",
              "      <th>Total Cost (Sub Projects)</th>\n",
              "      <th>Funding IC(s)</th>\n",
              "      <th>Direct Cost IC</th>\n",
              "      <th>InDirect Cost IC</th>\n",
              "      <th>Total Cost IC</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>eDyNAmiC (extrachromosomal DNA in Cancer) - Un...</td>\n",
              "      <td>9811494</td>\n",
              "      <td>VENTURA, ANDREA</td>\n",
              "      <td>Abstract: eDyNAmiC (extrachromosomal DNA in Ca...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>5079202</td>\n",
              "      <td>SLOAN-KETTERING INST CAN RESEARCH</td>\n",
              "      <td>NEW YORK</td>\n",
              "      <td>NY</td>\n",
              "      <td>Research Institutes</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>166232</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>94450</td>\n",
              "      <td>71782</td>\n",
              "      <td>166232</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>SCH: Individualized learning and prediction fo...</td>\n",
              "      <td>9839722</td>\n",
              "      <td>QU, ANNIE</td>\n",
              "      <td>Recent technological advances in mobile health...</td>\n",
              "      <td>The proposed project will have potentially pro...</td>\n",
              "      <td>BIOSTATISTICS &amp; OTHER MATH SCI</td>\n",
              "      <td>577504</td>\n",
              "      <td>UNIVERSITY OF CALIFORNIA-IRVINE</td>\n",
              "      <td>IRVINE</td>\n",
              "      <td>CA</td>\n",
              "      <td>COMPUTER CENTER</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>299988</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>132459</td>\n",
              "      <td>67529</td>\n",
              "      <td>199988</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>11</th>\n",
              "      <td>SCH: Robust Multimodal Longitudinal AI for Enh...</td>\n",
              "      <td>10641231</td>\n",
              "      <td>NABAVI, SHEIDA</td>\n",
              "      <td>The overarching objective of this project is t...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>ENGINEERING (ALL TYPES)</td>\n",
              "      <td>1506602</td>\n",
              "      <td>UNIVERSITY OF CONNECTICUT STORRS</td>\n",
              "      <td>STORRS-MANSFIELD</td>\n",
              "      <td>CT</td>\n",
              "      <td>BIOMED ENGR/COL ENGR/ENGR STA</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>310317</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>180763</td>\n",
              "      <td>79554</td>\n",
              "      <td>260317</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>12</th>\n",
              "      <td>SCH: Synchronous Dyadic Physiological Monitori...</td>\n",
              "      <td>78467322</td>\n",
              "      <td>ROBERTS, DAVID L</td>\n",
              "      <td>Animal-Assisted Interventions (AAIs) are goal-...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>BIOSTATISTICS &amp; OTHER MATH SCI</td>\n",
              "      <td>578204</td>\n",
              "      <td>NORTH CAROLINA STATE UNIVERSITY RALEIGH</td>\n",
              "      <td>RALEIGH</td>\n",
              "      <td>NC</td>\n",
              "      <td>BIOMED ENGR/COL ENGR/ENGR STA</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>299950</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>111281</td>\n",
              "      <td>38669</td>\n",
              "      <td>149950</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>15</th>\n",
              "      <td>SCH: Topological Methods for Breast Tissue Qua...</td>\n",
              "      <td>14901305</td>\n",
              "      <td>CHEN, CHAO</td>\n",
              "      <td>To better understand breast cancer and its res...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>ENGINEERING (ALL TYPES)</td>\n",
              "      <td>5992612</td>\n",
              "      <td>STATE UNIVERSITY NEW YORK STONY BROOK</td>\n",
              "      <td>STONY BROOK</td>\n",
              "      <td>NY</td>\n",
              "      <td>BIOMED ENGR/COL ENGR/ENGR STA</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>300000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>97207</td>\n",
              "      <td>52793</td>\n",
              "      <td>150000</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-82c220a1-25f5-460d-8c87-1ec30bf98962')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-82c220a1-25f5-460d-8c87-1ec30bf98962 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-82c220a1-25f5-460d-8c87-1ec30bf98962');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-461cd5b2-ee6f-4afa-9b93-2bc63b5bc600\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-461cd5b2-ee6f-4afa-9b93-2bc63b5bc600')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-461cd5b2-ee6f-4afa-9b93-2bc63b5bc600 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df2",
              "summary": "{\n  \"name\": \"df2\",\n  \"rows\": 1468,\n  \"fields\": [\n    {\n      \"column\": \"Project Title\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1459,\n        \"samples\": [\n          \"Development of an Efficient 18F labeling technology based on tetrazine trans-cyclooctene ligation\",\n          \"The role of UbcH7 in male breast cancer\",\n          \"Investigating a Novel Inhibitory Receptor in Regulating CAR-T Cell Persistence and Function\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Contact PI Person ID\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1402,\n        \"samples\": [\n          \"10335210\",\n          \"9614628\",\n          \"12334483\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Contact PI / Project Leader\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1401,\n        \"samples\": [\n          \"DELLACECCA, EMILIA R\",\n          \"LIANG, CHENGYU \",\n          \"ABRAMOV, VASILIY \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Project Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1448,\n        \"samples\": [\n          \"PROJECT SUMMARYWilms tumor (WT) is the second most common solid pediatric cancer that usually develops in young childrenbefore age 5. WT encompass three main cell types: epithelium stroma and blasterma. WT are typicallytreated with a combination of surgery chemotherapy and radiotherapy. Although the survival rate for WTpatients is generally favorable prognosis for patients with blastema dominant histology remain poor. Patientswith blastema dominant histology are more resistance to chemotherapy and have higher rate of cancerrecurrence therefore there is unmet clinical need to improve therapy. The major obstacle for developingnovel therapies is the lack of cell lines and animal models representing high-risk blastemal WT. Becauseblastemal WT represents aberrant ESCs we reprogrammed WiT49 WT cells of epithelial origin into inducedpluripotent stem cells (iPSCs) and transplanted iPSCs into kidneys of mice. The tumors metastasized to theliver and lung. Thus WiT49-iPSCs represent the first blastemal WT model suitable for mechanistic studies tounderstand the molecular changes distinguishing epithelial and blastemal types of WT and can be used toscreen FDA-approved drugs to find better treatments for children with aggressive WT. Because WiT49-iPSCsacquire stem cell markers as well as metastatic traits as compared to WiT49 we hypothesize that WiT49-iPSCs serve as a blastemal WT model suitable for mechanistic studies and drug screening to develop noveltherapies for metastatic blastemal WT. In this proposed study we will (1) reprogram WiT49-iPSCs andperform the teratoma assay to determine stem cell potency. (2) identify the epigenetic and chromatinsignatures distinguishing the blastemal and epithelial types of WT. (3) develop novel therapeutic strategiesfor the treatment of WT. We will screen WiT49 and WiT49-iPSC cells against FDA-approved drugs andepigenetic compounds to identify drugs effective against WiT49-iPSCs versus WiT-49 cells. Successfulcompletion of this project is expected to have a great impact on understanding the biology of kidney cancerand establishing the invaluable experimental platform for the development of safer and more effectivetherapies for Wilms tumors.\",\n          \"ABSTRACT:Breast cancer in Uganda presents a pressing public health challenge characterized by late-stagediagnoses and high mortality rates particularly among women residing in rural and semi-urban areas. Thisproposal addresses this critical issue by optimizing validating and deploying a point-of-care diagnostic kittailored for primary care clinics in Uganda where most women access care. The proposed diagnostic kitcombines (1) an FDA-cleared automated AI-enabled whole breast ultrasound and (2) a smartphone-enabled AI-powered device that performs brightfield imaging of basic cytology preparations andincorporates a self-contained immunodiagnostic chip to quantify breast tumor biomarkers. Our approachinvolves a two-fold validation strategy. First we will validate the diagnostic performance of the proposeddiagnostic kit in a U.S. clinical setting comparing it to standard-of-care methods such as ultrasoundmammography tissue sampling and pathology (aim 1). Utilizing quality improvement cycles and feedbackfrom end-users we will refine the kit's performance and usability. Next we will validate the kit at theUganda Cancer Institute tailoring it to Uganda's healthcare landscape considering factors likeinfrastructure health workers expertise and accessibility (aim 2). Following validation and guided by aUgandan Community Advisory Board we will implement a cluster randomized controlled trial involvingeight community health centers (CHCs) across two health districts in Uganda (aim 3). A mobile breastcancer detection clinic will deliver the diagnostic kit to CHCs during bi-monthly Breast Health Days forN=1000 patients referred for diagnostic evaluation at 4 CHCs. We will compare the effectiveness of thediagnostic kit with women receiving care at control CHCs who will be referred for standard-of-careultrasound at Regional Hospitals (N=1000). Our collaboration draws upon expertise in engineering andbiomedical device development breast cancer research and global health positioning us to significantlyimpact breast cancer outcomes in Uganda. This initiative aligns with the RFA-CA-24-005 mission todevelop cancer-relevant technologies suitable for use in low- and middle-income countries. By validatingand deploying a practical cost-effective and user-friendly detection and diagnostic technology we aim toempower healthcare providers in Uganda and ultimately improve patient outcomes. If successful thisinnovation stands to enhance access to timely breast cancer detection and diagnosis in resource-constrained settings.\",\n          \"ABSTRACTUrothelial bladder cancer represents a significant global public health burden accounting for some 200000deaths each year. Among the many environmental risk factors for bladder cancer drinking water contaminatedby inorganic arsenic (iAS) represents a common cause especially among rural populations. This mechanismappears especially relevant here in the rural state of New Hampshire which suffers from the single highestincidence of bladder cancer among the fifty states. Despite longstanding knowledge that iAs exposure representsa highly preventable cause of bladder cancer the precise mechanism by which iAs increases bladder cancerrisk remains uncertain leading to an absence of post-exposure risk mitigation strategies. To address this issuewe now propose to develop an entirely novel zebrafish model of urinary bladder cancer allowing us to leveragethe many advantages of the zebrafish model organism including facile gene targeting and a long history ofproductive use in environmental toxicology research. Our group has recently demonstrated that adult zebrafishharbor a mammalian-like contractile urinary bladder with single cell (sc) RNA-Seq identifying both basal andluminal urothelial cell types similar to those observed in mouse and human. Based on these findings we nowpropose to test the following central hypotheses: First that urothelial-specific oncogene activation combinedwith tp53 kdm6a and stag2 inactivation will induce zebrafish urothelial neoplasia; second that arsenic exposurewill alter the transcriptional landscape and cell composition of zebrafish bladder; and third that a combination ofoncogenic stimuli and arsenic exposure will accelerate these changes in both pre-malignant and neoplasticzebrafish urothelium. To test these hypotheses the following Specific Aims will be pursued: 1) To examine theability of urothelial-specific oncogene activation and tumor suppressor gene inactivation to induce neoplastictransformation in zebrafish urinary bladder; and 2) To determine the effects of iAs on transcriptional landscapesand cell composition in normal pre-neoplastic and/or neoplastic zebrafish urinary bladder. These studies willbe enabled by our broadly inter-disciplinary multi-institutional research team comprised of experts in zebrafishcancer modeling (Leach) bladder cancer molecular genetics (Real) and arsenic toxicology and single celltranscriptional profiling (Goodale) allowing us to pursue a variety of highly innovative strategies. Together thestudies proposed in this R21 application will determine the effects of combined oncogene activation and tumorsuppressor gene inactivation in zebrafish urothelium potentially leading to a valuable new zebrafish model ofurinary bladder cancer. In addition these studies will provide the very first glimpse of how inorganic arsenic altersthe transcriptional landscape of urothelial and non-urothelial cells in vivo and at single cell resolution informingfuture strategies for the effective prevention of arsenic-induced bladder cancer.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Public Health Relevance\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1422,\n        \"samples\": [\n          \"PROJECT NARRATIVEThe effectiveness of immune checkpoint blockades (ICBs) in treating triple-negative breast cancer (TNBC) ishindered by poor immune response and low antigen presentation of the cancer cells. This project aims to addressthe knowledge gap by investigating the role of PIK3C2A in tumor antigen presentation and its impact on anti-tumor immunity within the tumor microenvironment. Identification of PIK3C2A as a key target for tumor antigenpresentation is a critical step towards designing small molecule inhibitors to enhance the efficacy of ICBs inTNBC treatment.\",\n          \"Project NarrativeLeptomeningeal disease (LMD) is a metastatic cancer of the brain that impacts up to 30% of allpatients with a primary tumor of advanced stage most commonly from breast lung or skincancer. Treatment options and prognosis for these patients are poor with survival ranging from3-6 months depending on the location of the primary tumor. The device proposed in this projectwill deliver chemotherapy more effectively by controlling the flow of CSF in an effort to improvepatient outcomes.\",\n          \"This project seeks to characterize the novel regulatory perspectives of the CD73/A2AR adenosinesignaling pathway where the GSH/Gpx4 axis plays a key role in T cell differentiation and survivalby regulating its effector vs. exhaustion phenotype and metabolic commitment that shouldsignificantly forward the field of ACT for rapid translational implications.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Department\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 45,\n        \"samples\": [\n          \"OPHTHALMOLOGY\",\n          \"BIOLOGY\",\n          \"CHEMISTRY\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization ID (IPF)\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 308,\n        \"samples\": [\n          \"578209\",\n          \"1514803\",\n          \"10053556\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization Name\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 308,\n        \"samples\": [\n          \"EAST CAROLINA UNIVERSITY\",\n          \"WEILL MEDICAL COLL OF CORNELL UNIV\",\n          \"ALBERT EINSTEIN COLLEGE OF MEDICINE\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization City\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 204,\n        \"samples\": [\n          \"OSLO\",\n          \"CAMBRIDGE\",\n          \"SPRINGFIELD\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization State\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 49,\n        \"samples\": [\n          \"IL\",\n          \"NM\",\n          \"VT\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization Type\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 28,\n        \"samples\": [\n          \"Domestic For-Profits\",\n          \"SCHOOL OF MEDICINE & DENTISTRY\",\n          \"SCHOOLS OF PUBLIC HEALTH\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization Country\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 11,\n        \"samples\": [\n          \"NETHERLANDS\",\n          \"UNITED STATES\",\n          \"BELGIUM\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Total Cost\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1325,\n        \"samples\": [\n          \"699080\",\n          \"695464\",\n          \"1027816\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Total Cost (Sub Projects)\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \" \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Funding IC(s)\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \"NCI\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Direct Cost IC\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1108,\n        \"samples\": [\n          \"535769\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"InDirect Cost IC\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1203,\n        \"samples\": [\n          \"63603\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Total Cost IC\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1325,\n        \"samples\": [\n          \"474760\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 7
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: list columns in df2\n",
        "\n",
        "print(df2.columns)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "c_7WoFag7H7i",
        "outputId": "756391fe-04a1-4c34-928d-f45da585ef73"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Index(['Project Title', 'Contact PI Person ID', 'Contact PI / Project Leader',\n",
            "       'Project Abstract', 'Public Health Relevance', 'Department',\n",
            "       'Organization ID (IPF)', 'Organization Name', 'Organization City',\n",
            "       'Organization State', 'Organization Type', 'Organization Country',\n",
            "       'Total Cost', 'Total Cost (Sub Projects)', 'Funding IC(s)',\n",
            "       'Direct Cost IC', 'InDirect Cost IC', 'Total Cost IC'],\n",
            "      dtype='object')\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: export df2 as a csv\n",
        "\n",
        "df2.to_csv('df2.csv', index=False)\n"
      ],
      "metadata": {
        "id": "287L7yO875FX"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: sort df2 by project title\n",
        "\n",
        "df2_sorted = df2.sort_values(by=['Project Title'])\n",
        "df2_sorted.head(20)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "kVGD37a59Isx",
        "outputId": "4fe3e4fd-a01f-4266-d3cf-489e0c0dedb3"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                          Project Title Contact PI Person ID  \\\n",
              "929   \"SMART\" nanoparticle delivery of veratridine o...             10847048   \n",
              "1179              2023 SoCal Genome Stability Symposium             10556025   \n",
              "693   2024 Annual Conference Grant: American Society...              3056913   \n",
              "689   2024 Annual Meeting of the American Society fo...             15646248   \n",
              "735           2024 BTEC conference (5/14/24 to 5/17/24)             11264850   \n",
              "761   2024 Chromatin Structure and Function Gordon R...              8025133   \n",
              "1250  2024 DNA Damage Mutation and Cancer Gordon Res...              8326184   \n",
              "754   2024 Intrinsically Disordered Proteins Gordon ...             10831685   \n",
              "691   2024 Mutagenesis Gordon Research Conference an...             10118578   \n",
              "682   2024 Radionuclide Theranostics for the Managem...             15487881   \n",
              "82    21st International Conference of the Society f...             10568482   \n",
              "674                   23rd Midwest DNA Repair Symposium              1880454   \n",
              "1446  3' RNA modification enzymes regulate tumor ang...              9776729   \n",
              "1331  33rd International Workshop on Retroviral Path...              1866427   \n",
              "1126      3D In vivo dosimetry for FLASH proton therapy             14424291   \n",
              "655   3D Proteomics at Single Cell Resolution with C...              6611541   \n",
              "178   3D Spatial Multi-Omics Profiling of Ovarian Ca...              1899826   \n",
              "363   3D bioengineered microfluidic platform for res...              6763712   \n",
              "523   3D genome reorganization drives cancer develop...             11474116   \n",
              "539   3D wearable NIR spectral tomography for early ...              7735441   \n",
              "\n",
              "     Contact PI / Project Leader  \\\n",
              "929      REZVANI, KHOSROW SAMUEL   \n",
              "1179             CHIOLO, IRENE E   \n",
              "693             KINNEY, ANITA Y.   \n",
              "689           COLEMAN, WILLIAM B   \n",
              "735              OSTROM, QUINN T   \n",
              "761            NARLIKAR, GEETA J   \n",
              "1250       STARK, JEREMY MICHAEL   \n",
              "754               MITTAG, TANJA    \n",
              "691              MERRIKH, HOURA    \n",
              "682                  ZAN, ELCIN    \n",
              "82                LEE, RICHARD T   \n",
              "674        STATES, J CHRISTOPHER   \n",
              "1446         TAKYAR, SEYEDTAGHI    \n",
              "1331          GREEN, PATRICK LEE   \n",
              "1126     XIANG, LIANGZHONG SHAWN   \n",
              "655            YATES III, JOHN R   \n",
              "178                MOK, SAMUEL C   \n",
              "363         KITLINSKA, JOANNA B.   \n",
              "523      MUZUMDAR, MANDAR DEEPAK   \n",
              "539              JIANG, SHUDONG    \n",
              "\n",
              "                                       Project Abstract  \\\n",
              "929   Project SummaryColorectal cancer (CRC) has a h...   \n",
              "1179  ABSTRACTThe 2023 SoCal Genome Stability Sympos...   \n",
              "693   ABSTRACTThe mission of the American Society of...   \n",
              "689   The 2024 Annual Meeting of the American Societ...   \n",
              "735   ABSTRACT/SUMMARYBrain tumors (malignant and be...   \n",
              "761   Project SummaryThis proposal requests support ...   \n",
              "1250  SUMMARY. The DNA Damage Mutation and Cancer Go...   \n",
              "754   Project Summary/AbstractThe 2022 Gordon Resear...   \n",
              "691   Project SummaryThe 2024 Gordon Research Confer...   \n",
              "682   Project Summary/AbstractThe Gordon Research Co...   \n",
              "82    PROJECT SUMMARY/ABSTRACTThe Society for Integr...   \n",
              "674   AbstractThe 23rd Midwest DNA Repair Symposium ...   \n",
              "1446  Lung cancer is the leading cause of cancer-rel...   \n",
              "1331  Project Summary/AbstractThe International Work...   \n",
              "1126  ABSTRACT: This U01 application aims to (1) dev...   \n",
              "655   Project Summary/AbstractSomatic mutations alte...   \n",
              "178   Research Summary:High-grade serous ovarian can...   \n",
              "363   Ewing sarcoma (ES) is a pediatric malignancy w...   \n",
              "523   PROJECT SUMMARY/ABSTRACTThe three-dimensional ...   \n",
              "539   Prediction of Residual Cancer Burden (RCB) ear...   \n",
              "\n",
              "                                Public Health Relevance  \\\n",
              "929   Public Health RelevanceThis study will develop...   \n",
              "1179  PROJECT NARRATIVEMany novel cancer therapies h...   \n",
              "693   Project Narrative - Public Health RelevanceThe...   \n",
              "689   The Annual Meeting of the American Society for...   \n",
              "735   PROJECT NARRATIVEWe propose a 2024 conference ...   \n",
              "761   Project NarrativeThe organization of the eukar...   \n",
              "1250  NARRATIVE. Several cancer treatment modalities...   \n",
              "754   Project NarrativeIntrinsically disordered prot...   \n",
              "691   Project NarrativeMutagenesis changes in the DN...   \n",
              "682   Project NarrativeCancer is an increasing threa...   \n",
              "82    Project NarrativeThe Society for Integrative O...   \n",
              "674   Project NarrativeDNA damage contributes to the...   \n",
              "1446  Vascular cells inside the tumor or tumor endot...   \n",
              "1331  Project NarrativeRetroviruses have long been r...   \n",
              "1126  The field of FLASH radiotherapy has experience...   \n",
              "655   Project narrativeSomatic mutations that alter ...   \n",
              "178   Project Narrative The proposed study seeks to ...   \n",
              "363   Ewing Sarcoma (ES) is an aggressive tumor ofte...   \n",
              "523   PROJECT NARRATIVEThe three-dimensional (3D) ge...   \n",
              "539   PROJECT NARRATIVEOur project aims to refine a ...   \n",
              "\n",
              "                         Department Organization ID (IPF)  \\\n",
              "929            OTHER BASIC SCIENCES               7596201   \n",
              "1179                   BIOCHEMISTRY               7636101   \n",
              "693                     Unavailable              10061137   \n",
              "689                     Unavailable              10004881   \n",
              "735                    NEUROSURGERY               2221101   \n",
              "761                     Unavailable               2988701   \n",
              "1250                    Unavailable               2988701   \n",
              "754                     Unavailable               2988701   \n",
              "691                     Unavailable               2988701   \n",
              "682                     Unavailable               2988701   \n",
              "82                      Unavailable               3058203   \n",
              "674                    PHARMACOLOGY               4679701   \n",
              "1446     INTERNAL MEDICINE/MEDICINE               9420201   \n",
              "1331                           NONE               6218701   \n",
              "1126  RADIATION-DIAGNOSTIC/ONCOLOGY                577504   \n",
              "655                     Unavailable               7375802   \n",
              "178         OBSTETRICS & GYNECOLOGY                578407   \n",
              "363                    BIOCHEMISTRY               2869001   \n",
              "523                        GENETICS               9420201   \n",
              "539         ENGINEERING (ALL TYPES)               2021601   \n",
              "\n",
              "                                  Organization Name Organization City  \\\n",
              "929                      UNIVERSITY OF SOUTH DAKOTA        VERMILLION   \n",
              "1179              UNIVERSITY OF SOUTHERN CALIFORNIA       Los Angeles   \n",
              "693   AMERICAN SOCIETY OF PREVENTIVE ONCOLOGY, INC.      INDIANAPOLIS   \n",
              "689        AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY         ROCKVILLE   \n",
              "735                                 DUKE UNIVERSITY            DURHAM   \n",
              "761                     GORDON RESEARCH CONFERENCES    East Greenwich   \n",
              "1250                    GORDON RESEARCH CONFERENCES    East Greenwich   \n",
              "754                     GORDON RESEARCH CONFERENCES    East Greenwich   \n",
              "691                     GORDON RESEARCH CONFERENCES    East Greenwich   \n",
              "682                     GORDON RESEARCH CONFERENCES    East Greenwich   \n",
              "82          BECKMAN RESEARCH INSTITUTE/CITY OF HOPE            DUARTE   \n",
              "674                        UNIVERSITY OF LOUISVILLE        LOUISVILLE   \n",
              "1446                                YALE UNIVERSITY         NEW HAVEN   \n",
              "1331                          OHIO STATE UNIVERSITY          COLUMBUS   \n",
              "1126                UNIVERSITY OF CALIFORNIA-IRVINE            IRVINE   \n",
              "655                 SCRIPPS RESEARCH INSTITUTE, THE          LA JOLLA   \n",
              "178            UNIVERSITY OF TX MD ANDERSON CAN CTR           HOUSTON   \n",
              "363                           GEORGETOWN UNIVERSITY        WASHINGTON   \n",
              "523                                 YALE UNIVERSITY         NEW HAVEN   \n",
              "539                               DARTMOUTH COLLEGE           HANOVER   \n",
              "\n",
              "     Organization State              Organization Type Organization Country  \\\n",
              "929                  SD            SCHOOLS OF MEDICINE        UNITED STATES   \n",
              "1179                 CA               GRADUATE SCHOOLS        UNITED STATES   \n",
              "693                  IN     Other Domestic Non-Profits        UNITED STATES   \n",
              "689                  MD     Other Domestic Non-Profits        UNITED STATES   \n",
              "735                  NC            SCHOOLS OF MEDICINE        UNITED STATES   \n",
              "761                  RI           Domestic For-Profits        UNITED STATES   \n",
              "1250                 RI           Domestic For-Profits        UNITED STATES   \n",
              "754                  RI           Domestic For-Profits        UNITED STATES   \n",
              "691                  RI           Domestic For-Profits        UNITED STATES   \n",
              "682                  RI           Domestic For-Profits        UNITED STATES   \n",
              "82                   CA            Research Institutes        UNITED STATES   \n",
              "674                  KY            SCHOOLS OF MEDICINE        UNITED STATES   \n",
              "1446                 CT            SCHOOLS OF MEDICINE        UNITED STATES   \n",
              "1331                 OH       ORGANIZED RESEARCH UNITS        UNITED STATES   \n",
              "1126                 CA            SCHOOLS OF MEDICINE        UNITED STATES   \n",
              "655                  CA     Other Domestic Non-Profits        UNITED STATES   \n",
              "178                  TX                      HOSPITALS        UNITED STATES   \n",
              "363                  DC            SCHOOLS OF MEDICINE        UNITED STATES   \n",
              "523                  CT            SCHOOLS OF MEDICINE        UNITED STATES   \n",
              "539                  NH  BIOMED ENGR/COL ENGR/ENGR STA        UNITED STATES   \n",
              "\n",
              "     Total Cost Total Cost (Sub Projects) Funding IC(s) Direct Cost IC  \\\n",
              "929       74750                                     NCI          50000   \n",
              "1179       7000                                     NCI           5000   \n",
              "693       40000                                     NCI          40000   \n",
              "689       15000                                     NCI          15000   \n",
              "735       16317                                     NCI          16317   \n",
              "761       15000                                     NCI          15000   \n",
              "1250      15000                                     NCI          15000   \n",
              "754       20000                                     NCI          15000   \n",
              "691       25000                                     NCI          18000   \n",
              "682        5000                                     NCI           5000   \n",
              "82        10000                                     NCI          10000   \n",
              "674       15000                                     NCI          15000   \n",
              "1446     430684                                     NCI         257125   \n",
              "1331      10000                                     NCI           5000   \n",
              "1126     641155                                     NCI         510313   \n",
              "655      240092                                     NCI         130485   \n",
              "178     1004570                                     NCI         713019   \n",
              "363      401115                                     NCI         257125   \n",
              "523      695123                                     NCI         414999   \n",
              "539      549536                                     NCI         348942   \n",
              "\n",
              "     InDirect Cost IC Total Cost IC  \n",
              "929             24750         74750  \n",
              "1179                0          5000  \n",
              "693                 0         40000  \n",
              "689                 0         15000  \n",
              "735                 0         16317  \n",
              "761                 0         15000  \n",
              "1250                0         15000  \n",
              "754                 0         15000  \n",
              "691                 0         18000  \n",
              "682                 0          5000  \n",
              "82                  0         10000  \n",
              "674                 0         15000  \n",
              "1446           173559        430684  \n",
              "1331                0          5000  \n",
              "1126           130842        641155  \n",
              "655            109607        240092  \n",
              "178            291551       1004570  \n",
              "363            143990        401115  \n",
              "523            280124        695123  \n",
              "539            200594        549536  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-bb79704c-285e-4c6d-b6e6-ea207209e8ae\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Project Title</th>\n",
              "      <th>Contact PI Person ID</th>\n",
              "      <th>Contact PI / Project Leader</th>\n",
              "      <th>Project Abstract</th>\n",
              "      <th>Public Health Relevance</th>\n",
              "      <th>Department</th>\n",
              "      <th>Organization ID (IPF)</th>\n",
              "      <th>Organization Name</th>\n",
              "      <th>Organization City</th>\n",
              "      <th>Organization State</th>\n",
              "      <th>Organization Type</th>\n",
              "      <th>Organization Country</th>\n",
              "      <th>Total Cost</th>\n",
              "      <th>Total Cost (Sub Projects)</th>\n",
              "      <th>Funding IC(s)</th>\n",
              "      <th>Direct Cost IC</th>\n",
              "      <th>InDirect Cost IC</th>\n",
              "      <th>Total Cost IC</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>929</th>\n",
              "      <td>\"SMART\" nanoparticle delivery of veratridine o...</td>\n",
              "      <td>10847048</td>\n",
              "      <td>REZVANI, KHOSROW SAMUEL</td>\n",
              "      <td>Project SummaryColorectal cancer (CRC) has a h...</td>\n",
              "      <td>Public Health RelevanceThis study will develop...</td>\n",
              "      <td>OTHER BASIC SCIENCES</td>\n",
              "      <td>7596201</td>\n",
              "      <td>UNIVERSITY OF SOUTH DAKOTA</td>\n",
              "      <td>VERMILLION</td>\n",
              "      <td>SD</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>74750</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>50000</td>\n",
              "      <td>24750</td>\n",
              "      <td>74750</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1179</th>\n",
              "      <td>2023 SoCal Genome Stability Symposium</td>\n",
              "      <td>10556025</td>\n",
              "      <td>CHIOLO, IRENE E</td>\n",
              "      <td>ABSTRACTThe 2023 SoCal Genome Stability Sympos...</td>\n",
              "      <td>PROJECT NARRATIVEMany novel cancer therapies h...</td>\n",
              "      <td>BIOCHEMISTRY</td>\n",
              "      <td>7636101</td>\n",
              "      <td>UNIVERSITY OF SOUTHERN CALIFORNIA</td>\n",
              "      <td>Los Angeles</td>\n",
              "      <td>CA</td>\n",
              "      <td>GRADUATE SCHOOLS</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>7000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>5000</td>\n",
              "      <td>0</td>\n",
              "      <td>5000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>693</th>\n",
              "      <td>2024 Annual Conference Grant: American Society...</td>\n",
              "      <td>3056913</td>\n",
              "      <td>KINNEY, ANITA Y.</td>\n",
              "      <td>ABSTRACTThe mission of the American Society of...</td>\n",
              "      <td>Project Narrative - Public Health RelevanceThe...</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>10061137</td>\n",
              "      <td>AMERICAN SOCIETY OF PREVENTIVE ONCOLOGY, INC.</td>\n",
              "      <td>INDIANAPOLIS</td>\n",
              "      <td>IN</td>\n",
              "      <td>Other Domestic Non-Profits</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>40000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>40000</td>\n",
              "      <td>0</td>\n",
              "      <td>40000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>689</th>\n",
              "      <td>2024 Annual Meeting of the American Society fo...</td>\n",
              "      <td>15646248</td>\n",
              "      <td>COLEMAN, WILLIAM B</td>\n",
              "      <td>The 2024 Annual Meeting of the American Societ...</td>\n",
              "      <td>The Annual Meeting of the American Society for...</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>10004881</td>\n",
              "      <td>AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY</td>\n",
              "      <td>ROCKVILLE</td>\n",
              "      <td>MD</td>\n",
              "      <td>Other Domestic Non-Profits</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>15000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>15000</td>\n",
              "      <td>0</td>\n",
              "      <td>15000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>735</th>\n",
              "      <td>2024 BTEC conference (5/14/24 to 5/17/24)</td>\n",
              "      <td>11264850</td>\n",
              "      <td>OSTROM, QUINN T</td>\n",
              "      <td>ABSTRACT/SUMMARYBrain tumors (malignant and be...</td>\n",
              "      <td>PROJECT NARRATIVEWe propose a 2024 conference ...</td>\n",
              "      <td>NEUROSURGERY</td>\n",
              "      <td>2221101</td>\n",
              "      <td>DUKE UNIVERSITY</td>\n",
              "      <td>DURHAM</td>\n",
              "      <td>NC</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>16317</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>16317</td>\n",
              "      <td>0</td>\n",
              "      <td>16317</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>761</th>\n",
              "      <td>2024 Chromatin Structure and Function Gordon R...</td>\n",
              "      <td>8025133</td>\n",
              "      <td>NARLIKAR, GEETA J</td>\n",
              "      <td>Project SummaryThis proposal requests support ...</td>\n",
              "      <td>Project NarrativeThe organization of the eukar...</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>2988701</td>\n",
              "      <td>GORDON RESEARCH CONFERENCES</td>\n",
              "      <td>East Greenwich</td>\n",
              "      <td>RI</td>\n",
              "      <td>Domestic For-Profits</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>15000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>15000</td>\n",
              "      <td>0</td>\n",
              "      <td>15000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1250</th>\n",
              "      <td>2024 DNA Damage Mutation and Cancer Gordon Res...</td>\n",
              "      <td>8326184</td>\n",
              "      <td>STARK, JEREMY MICHAEL</td>\n",
              "      <td>SUMMARY. The DNA Damage Mutation and Cancer Go...</td>\n",
              "      <td>NARRATIVE. Several cancer treatment modalities...</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>2988701</td>\n",
              "      <td>GORDON RESEARCH CONFERENCES</td>\n",
              "      <td>East Greenwich</td>\n",
              "      <td>RI</td>\n",
              "      <td>Domestic For-Profits</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>15000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>15000</td>\n",
              "      <td>0</td>\n",
              "      <td>15000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>754</th>\n",
              "      <td>2024 Intrinsically Disordered Proteins Gordon ...</td>\n",
              "      <td>10831685</td>\n",
              "      <td>MITTAG, TANJA</td>\n",
              "      <td>Project Summary/AbstractThe 2022 Gordon Resear...</td>\n",
              "      <td>Project NarrativeIntrinsically disordered prot...</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>2988701</td>\n",
              "      <td>GORDON RESEARCH CONFERENCES</td>\n",
              "      <td>East Greenwich</td>\n",
              "      <td>RI</td>\n",
              "      <td>Domestic For-Profits</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>20000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>15000</td>\n",
              "      <td>0</td>\n",
              "      <td>15000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>691</th>\n",
              "      <td>2024 Mutagenesis Gordon Research Conference an...</td>\n",
              "      <td>10118578</td>\n",
              "      <td>MERRIKH, HOURA</td>\n",
              "      <td>Project SummaryThe 2024 Gordon Research Confer...</td>\n",
              "      <td>Project NarrativeMutagenesis changes in the DN...</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>2988701</td>\n",
              "      <td>GORDON RESEARCH CONFERENCES</td>\n",
              "      <td>East Greenwich</td>\n",
              "      <td>RI</td>\n",
              "      <td>Domestic For-Profits</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>25000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>18000</td>\n",
              "      <td>0</td>\n",
              "      <td>18000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>682</th>\n",
              "      <td>2024 Radionuclide Theranostics for the Managem...</td>\n",
              "      <td>15487881</td>\n",
              "      <td>ZAN, ELCIN</td>\n",
              "      <td>Project Summary/AbstractThe Gordon Research Co...</td>\n",
              "      <td>Project NarrativeCancer is an increasing threa...</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>2988701</td>\n",
              "      <td>GORDON RESEARCH CONFERENCES</td>\n",
              "      <td>East Greenwich</td>\n",
              "      <td>RI</td>\n",
              "      <td>Domestic For-Profits</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>5000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>5000</td>\n",
              "      <td>0</td>\n",
              "      <td>5000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>82</th>\n",
              "      <td>21st International Conference of the Society f...</td>\n",
              "      <td>10568482</td>\n",
              "      <td>LEE, RICHARD T</td>\n",
              "      <td>PROJECT SUMMARY/ABSTRACTThe Society for Integr...</td>\n",
              "      <td>Project NarrativeThe Society for Integrative O...</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>3058203</td>\n",
              "      <td>BECKMAN RESEARCH INSTITUTE/CITY OF HOPE</td>\n",
              "      <td>DUARTE</td>\n",
              "      <td>CA</td>\n",
              "      <td>Research Institutes</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>10000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>10000</td>\n",
              "      <td>0</td>\n",
              "      <td>10000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>674</th>\n",
              "      <td>23rd Midwest DNA Repair Symposium</td>\n",
              "      <td>1880454</td>\n",
              "      <td>STATES, J CHRISTOPHER</td>\n",
              "      <td>AbstractThe 23rd Midwest DNA Repair Symposium ...</td>\n",
              "      <td>Project NarrativeDNA damage contributes to the...</td>\n",
              "      <td>PHARMACOLOGY</td>\n",
              "      <td>4679701</td>\n",
              "      <td>UNIVERSITY OF LOUISVILLE</td>\n",
              "      <td>LOUISVILLE</td>\n",
              "      <td>KY</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>15000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>15000</td>\n",
              "      <td>0</td>\n",
              "      <td>15000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1446</th>\n",
              "      <td>3' RNA modification enzymes regulate tumor ang...</td>\n",
              "      <td>9776729</td>\n",
              "      <td>TAKYAR, SEYEDTAGHI</td>\n",
              "      <td>Lung cancer is the leading cause of cancer-rel...</td>\n",
              "      <td>Vascular cells inside the tumor or tumor endot...</td>\n",
              "      <td>INTERNAL MEDICINE/MEDICINE</td>\n",
              "      <td>9420201</td>\n",
              "      <td>YALE UNIVERSITY</td>\n",
              "      <td>NEW HAVEN</td>\n",
              "      <td>CT</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>430684</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>257125</td>\n",
              "      <td>173559</td>\n",
              "      <td>430684</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1331</th>\n",
              "      <td>33rd International Workshop on Retroviral Path...</td>\n",
              "      <td>1866427</td>\n",
              "      <td>GREEN, PATRICK LEE</td>\n",
              "      <td>Project Summary/AbstractThe International Work...</td>\n",
              "      <td>Project NarrativeRetroviruses have long been r...</td>\n",
              "      <td>NONE</td>\n",
              "      <td>6218701</td>\n",
              "      <td>OHIO STATE UNIVERSITY</td>\n",
              "      <td>COLUMBUS</td>\n",
              "      <td>OH</td>\n",
              "      <td>ORGANIZED RESEARCH UNITS</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>10000</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>5000</td>\n",
              "      <td>0</td>\n",
              "      <td>5000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1126</th>\n",
              "      <td>3D In vivo dosimetry for FLASH proton therapy</td>\n",
              "      <td>14424291</td>\n",
              "      <td>XIANG, LIANGZHONG SHAWN</td>\n",
              "      <td>ABSTRACT: This U01 application aims to (1) dev...</td>\n",
              "      <td>The field of FLASH radiotherapy has experience...</td>\n",
              "      <td>RADIATION-DIAGNOSTIC/ONCOLOGY</td>\n",
              "      <td>577504</td>\n",
              "      <td>UNIVERSITY OF CALIFORNIA-IRVINE</td>\n",
              "      <td>IRVINE</td>\n",
              "      <td>CA</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>641155</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>510313</td>\n",
              "      <td>130842</td>\n",
              "      <td>641155</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>655</th>\n",
              "      <td>3D Proteomics at Single Cell Resolution with C...</td>\n",
              "      <td>6611541</td>\n",
              "      <td>YATES III, JOHN R</td>\n",
              "      <td>Project Summary/AbstractSomatic mutations alte...</td>\n",
              "      <td>Project narrativeSomatic mutations that alter ...</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>7375802</td>\n",
              "      <td>SCRIPPS RESEARCH INSTITUTE, THE</td>\n",
              "      <td>LA JOLLA</td>\n",
              "      <td>CA</td>\n",
              "      <td>Other Domestic Non-Profits</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>240092</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>130485</td>\n",
              "      <td>109607</td>\n",
              "      <td>240092</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>178</th>\n",
              "      <td>3D Spatial Multi-Omics Profiling of Ovarian Ca...</td>\n",
              "      <td>1899826</td>\n",
              "      <td>MOK, SAMUEL C</td>\n",
              "      <td>Research Summary:High-grade serous ovarian can...</td>\n",
              "      <td>Project Narrative The proposed study seeks to ...</td>\n",
              "      <td>OBSTETRICS &amp; GYNECOLOGY</td>\n",
              "      <td>578407</td>\n",
              "      <td>UNIVERSITY OF TX MD ANDERSON CAN CTR</td>\n",
              "      <td>HOUSTON</td>\n",
              "      <td>TX</td>\n",
              "      <td>HOSPITALS</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>1004570</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>713019</td>\n",
              "      <td>291551</td>\n",
              "      <td>1004570</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>363</th>\n",
              "      <td>3D bioengineered microfluidic platform for res...</td>\n",
              "      <td>6763712</td>\n",
              "      <td>KITLINSKA, JOANNA B.</td>\n",
              "      <td>Ewing sarcoma (ES) is a pediatric malignancy w...</td>\n",
              "      <td>Ewing Sarcoma (ES) is an aggressive tumor ofte...</td>\n",
              "      <td>BIOCHEMISTRY</td>\n",
              "      <td>2869001</td>\n",
              "      <td>GEORGETOWN UNIVERSITY</td>\n",
              "      <td>WASHINGTON</td>\n",
              "      <td>DC</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>401115</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>257125</td>\n",
              "      <td>143990</td>\n",
              "      <td>401115</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>523</th>\n",
              "      <td>3D genome reorganization drives cancer develop...</td>\n",
              "      <td>11474116</td>\n",
              "      <td>MUZUMDAR, MANDAR DEEPAK</td>\n",
              "      <td>PROJECT SUMMARY/ABSTRACTThe three-dimensional ...</td>\n",
              "      <td>PROJECT NARRATIVEThe three-dimensional (3D) ge...</td>\n",
              "      <td>GENETICS</td>\n",
              "      <td>9420201</td>\n",
              "      <td>YALE UNIVERSITY</td>\n",
              "      <td>NEW HAVEN</td>\n",
              "      <td>CT</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>695123</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>414999</td>\n",
              "      <td>280124</td>\n",
              "      <td>695123</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>539</th>\n",
              "      <td>3D wearable NIR spectral tomography for early ...</td>\n",
              "      <td>7735441</td>\n",
              "      <td>JIANG, SHUDONG</td>\n",
              "      <td>Prediction of Residual Cancer Burden (RCB) ear...</td>\n",
              "      <td>PROJECT NARRATIVEOur project aims to refine a ...</td>\n",
              "      <td>ENGINEERING (ALL TYPES)</td>\n",
              "      <td>2021601</td>\n",
              "      <td>DARTMOUTH COLLEGE</td>\n",
              "      <td>HANOVER</td>\n",
              "      <td>NH</td>\n",
              "      <td>BIOMED ENGR/COL ENGR/ENGR STA</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>549536</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>348942</td>\n",
              "      <td>200594</td>\n",
              "      <td>549536</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-bb79704c-285e-4c6d-b6e6-ea207209e8ae')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-bb79704c-285e-4c6d-b6e6-ea207209e8ae button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-bb79704c-285e-4c6d-b6e6-ea207209e8ae');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-ab2c61d1-be23-4767-af8b-3af5222f5758\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-ab2c61d1-be23-4767-af8b-3af5222f5758')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-ab2c61d1-be23-4767-af8b-3af5222f5758 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df2_sorted",
              "summary": "{\n  \"name\": \"df2_sorted\",\n  \"rows\": 1468,\n  \"fields\": [\n    {\n      \"column\": \"Project Title\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1459,\n        \"samples\": [\n          \"The Personalized Remote Radiation Tracking Portable Organ Dosimetry Devise (PRRT PODD)\",\n          \"MIZ1 Activation in Triple-negative Breast Cancer Racial Disparities\",\n          \"Diet-mediated regulation of fatty acid saturation impacts cancer progression and therapy responses.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Contact PI Person ID\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1402,\n        \"samples\": [\n          \"14397153\",\n          \"9231962\",\n          \"10726280\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Contact PI / Project Leader\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1401,\n        \"samples\": [\n          \"PATEL, AYUSHI \",\n          \"MAHER, CHRISTOPHER A\",\n          \"FURLAN, SCOTT NICHOLAS\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Project Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1448,\n        \"samples\": [\n          \"PROJECT SUMMARY/ABSTRACTApproximately 40% of U.S. adults have obesity (BMI>30) and excess body weight is associated with at least 13different cancers and 5% and 11% of cancer cases in men and women respectively. Obesity disproportionatelyimpacts racial/ethnic minority low socioeconomic status (SES) and rural populations and plays a critical rolein cancer inequities. Evidence-Based Interventions (EBIs) that address excess body weight physical inactivityand poor diet are effective in promoting weight loss and reducing cancer risk but are grossly underutilized andthere are substantial disparities in access among historically marginalized populations. Digital EBI deliverymodalities have yielded outcomes comparable to in-person programs. As such the long-term objective ofSMARTLife Utah is to increase the reach of existing digital EBIs for obesity among racial/ethnic minority lowSES and rural populations in low resource healthcare settings. SMARTLife Utah will be conducted in 11Community Health Center (CHC) systems consisting of 38 primary care clinics. SMARTLife Utah is a hybridtype III effectiveness  implementation design using a pragmatic multilevel three phase Sequential MultipleAssignment Randomized Trial (SMART). SMARTLife Utah leverages ubiquitous health information technology(HIT)/telehealth for both the implementation strategies and EBI delivery in order to address barriers forengaging in EBIs. Implementation strategies target two different levels to increase the reach of EBIs: 1) a cliniclevel HIT implementation strategy that includes enhanced system supports at point of care; and 2) patientlevel implementation strategies that provide repeated opportunities to enroll in EBIs as well asmotivation/practical problem solving to facilitate enrollment. The scientific premise of SMARTLife Utah isbased on: 1) Evidence that EBIs for obesity are effective but underutilized 2) Recommendations to scale upEBI reach and reduce inequities utilizing technology based programs 3) Data demonstrating that HITimplementation strategies can dramatically increase engagement with EBIs and fit within existing clinicalsystems 4) Data indicating that text messaging can increase the reach of EBIs and 5) Prior researchhighlighting the effectiveness of telehealth-based patient navigation in improving the reach of EBIs.SMARTLife Utah will provide critical data regarding the impact of pragmatic and scalable multilevelimplementation strategies designed to increase the uptake of EBIs for obesity among historically marginalizedpopulations low resource healthcare settings. It will also advance the field of dissemination andimplementation science by testing key constructs hypothesized to influence implementation and effectivenessusing a comprehensive conceptual framework.\",\n          \"AbstractTargeted protein degradation by chimeric molecules has emerged as a novel therapeutic modality. Thebifunctional chimeric molecules usually have one end binding to the protein of interest (POI) and the other enddirecting the ternary complex towards the degradation in proteasome or lysosome. The PROteolysis TArgetingChimera (PROTAC) received the most attention to date. PROTACs contain an E3 ubiquitin ligase ligand todirect the POI for ubiquitination and route it to the proteasome for degradation. Because of this PROTACs areonly capable of depleting intracellular proteins. About 40% of the proteome are extracellular secreted andmembrane proteins and many of them are related to cancers. To broaden the scope of targets to includeextracellular proteins the LYsosome TArgeting Chimeras (LYTAC) were recently reported by us and others.LYTACs are created by conjugating a ligand of a lysosome targeting receptor (LTR) on the cell surface with aligand that can bind to the extracellular POI. The first two LTRs employed for LYTACs are lectins orcarbohydrate binding proteins: cation-independent mannose 6-phosphate receptor (CIM6PR) andasialoglycoprotein receptor (ASGPR). The receptor-ligand interaction triggers the internalization of theextracellular proteins through receptor-mediated endocytosis further inducing the degradation of the targets inthe lysosome. However CIM6PR is ubiquitously expressed in most types of cells while ASGPR is mainlyexpressed on liver. It would be ideal to recruit a LTR that is overexpressed on cancer cells to degradeextracellular POIs associated with cancers to achieve high efficiency and selectivity. After examining a seriesof cell surface receptors that are overexpressed on cancers we found that chimeric molecules that recruitfolate receptor (FR) could degrade extracellular POIs on cancer cells highly effectively. In this application wewill demonstrate for the first time that the conjugation of FR ligand folate (FA) to binders of POI on themembrane of cancer cells can create degraders that are capable of selectively degrading the endogenousmembrane POI on cancers. We propose to exploit the potential of this strategy to develop novel FA-antibodyconjugates that can degrade check point inhibitors such as programmed death ligand 1 (PD-L1) for thetreatment of various cancers with a focus on head neck cancers (HNC). In Aim 1 we will synthesize variousFA-antibody conjugates and test their degradation activity in cells. In Aim 2 we will evaluate the in-vivodegradation activity and anti-tumor efficacy of the PD-L1 degrader in syngeneic and humanized mouse modelswith a focus on HNC. In Aim 3 we propose to study the mechanism of the FR-mediated degradation of PD-L1and the underlying principle for improved anti-tumor efficacy. These studies will facilitate the establishment of ageneral platform for the development of efficient and tissue-selective degraders for cancer associatedextracellular POIs which will lead to effective therapeutics for the treatment of many types of cancers.\",\n          \"Project SummaryOral squamous cell carcinoma (OSCC) is the sixth most common epithelial cancer worldwide with 50000 newcases/year in US. Despite being less frequent survival rates are relative lower. Clinically OSCC presents as anecrotic lesion with stiffened borders; surgical resection requires significant tissue loss up to 2 cm surround thelesion owing to the fact that these tumors are poorly margined and require significant resection to ensure allmetastatic disease is removed. Even with aggressive surgical approaches significant morbidity and mortality isassociated with OSCC and this dramatically reduces patient quality of life. While stiffened borders are a hallmarkof the disease it is unclear to what extent microenvironmental properties e.g. mechanical changes inextracellular matrix (ECM) stiffness contribute to tumor progression and invasion. The role of stiffness has beenwell established in other epithelial tumors e.g. breast but our understanding in OSCC is relatively nascent; lessthan 10 studies have even peripherally addressed the issue. Preliminary data from our groups is the first todemonstrate that a stiffer environment induces epithelial-to-mesenchymal transition (EMT) of oral epithelial cellsand that they adopt a more aggressive behavior of invasive OSCC (Matte et al 2019; Moon et al 2023). EMT ofthese oral tissues might contribute to frequent tumor recurrence observed in patients with excessively stiff tumormargins. Since OSCC is exceedingly invasive learned behaviors within the stiffened tumor must be rememberedand recalled once in softer adjacent oral tissues to facilitate the establishment of secondary disease. Thus wehypothesize that tumor stiffness induces the acquisition and consolidation of mechanical memory i.e. EMT andmigration which can be recalled later when the resulting OSCC cells disseminate and contribute to tumormetastasis invasion and recurrence. To test this hypothesis we propose the following specific aims:Specific Aim 1: Elucidate the mechanisms involved in mechanical sensing leading to memory acquisition andrecallSpecific Aim 2: Determine to what extent epigenetic changes in OSCC induce memory consolidation\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Public Health Relevance\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1422,\n        \"samples\": [\n          \"PROJECT NARRATIVE EZH2 is a well-known histone lysine methyltransferase and an oncogene upregulated in many types ofcancer including prostate cancer. In this project we will investigate the novel noncanonical Polycomb-repressive complex-independent role for EZH2 in A-to-I RNA editing via ADAR. Successful completion of thisproject will provide novel mechanistic insights EZH2s novel functions beyond its lysine methyltransferase andtranscription repressor activities.\",\n          \"PROJECT NARRATIVE The co-use of cigarettes and cannabis is common and has been shown to negatively affect treatment andother clinical outcomes yet no treatment recommendations exist to address co-use. The overall goal of thisrandomized controlled trial is to evaluate varenicline versus placebo paired with an evidence-basedpsychosocial intervention on cigarette abstinence and cannabis use reduction or abstinence (based onparticipant treatment goals) among adults who co-use. There is an urgent need to evaluate promising co-usetreatment interventions and the proposed study is supported by rigorous prior literature including our own workand utilizes a decentralized study design and remote intervention delivery to support scalability of thisintervention to address co-occurring tobacco and cannabis use.\",\n          \"PROJECT NARRATIVE Cancer typically takes years to go from one abnormal cell to a life-threatening tumor but work in mousemodels suggest that the kind of cell from which a tumor arises can have long-lasting effects on the behavior ofthe disease. In this study we aim to develop methods to determine the so-called cells of origin of pancreaticand liver cancers and determine if the clinical behavior of human cancers is also determined by features ofthose cells. We will use genetic information from human cancer samples to identify these cells and theirrelationship to tumor types and patient outcomes with an ultimate goal of using these data as prognosticbiomarkers in a clinical setting.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Department\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 45,\n        \"samples\": [\n          \"DERMATOLOGY\",\n          \"MISCELLANEOUS\",\n          \"PEDIATRICS\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization ID (IPF)\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 308,\n        \"samples\": [\n          \"6644301\",\n          \"6218701\",\n          \"9021205\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization Name\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 308,\n        \"samples\": [\n          \"RUSH UNIVERSITY MEDICAL CENTER\",\n          \"OHIO STATE UNIVERSITY\",\n          \"WAKE FOREST UNIVERSITY HEALTH SCIENCES\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization City\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 204,\n        \"samples\": [\n          \"NEW YORK\",\n          \"COLUMBUS\",\n          \"AUGUSTA\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization State\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 49,\n        \"samples\": [\n          \"WA\",\n          \"KS\",\n          \"VT\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization Type\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 28,\n        \"samples\": [\n          \"SCHOOLS OF ARTS AND SCIENCES\",\n          \"SCHOOLS OF SOCIAL WELFARE/WORK\",\n          \"SCH ALLIED HEALTH PROFESSIONS\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Organization Country\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 11,\n        \"samples\": [\n          \"NORWAY\",\n          \"UNITED STATES\",\n          \"SOUTH AFRICA\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Total Cost\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1325,\n        \"samples\": [\n          \"676063\",\n          \"182325\",\n          \"411206\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Total Cost (Sub Projects)\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \" \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Funding IC(s)\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \"NCI\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Direct Cost IC\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1108,\n        \"samples\": [\n          \"414787\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"InDirect Cost IC\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1203,\n        \"samples\": [\n          \"76866\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Total Cost IC\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1325,\n        \"samples\": [\n          \"483591\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 9
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: bar graph by count of Organization Country\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "# Count the occurrences of each country\n",
        "country_counts = df2['Organization Name'].value_counts()\n",
        "\n",
        "# Create the bar graph\n",
        "plt.figure(figsize=(10, 6))  # Adjust figure size if needed\n",
        "country_counts.plot(kind='bar')\n",
        "plt.xlabel('Organization Name')\n",
        "plt.ylabel('Count')\n",
        "plt.title('Organizaiton Name')\n",
        "plt.xticks(rotation=45, ha='right')  # Rotate x-axis labels for better readability\n",
        "plt.tight_layout()  # Adjust layout to prevent labels from overlapping\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 607
        },
        "id": "enWNL-CP9q0X",
        "outputId": "7a448cb7-e29a-46f6-bc2a-732062033b3d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: create this graph again with only more than 10\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "# Count the occurrences of each country\n",
        "country_counts = df2['Organization Name'].value_counts()\n",
        "\n",
        "# Filter out countries with less than or equal to 10 occurrences\n",
        "country_counts_filtered = country_counts[country_counts > 20]\n",
        "\n",
        "# Create the bar graph\n",
        "plt.figure(figsize=(10, 6))  # Adjust figure size if needed\n",
        "country_counts_filtered.plot(kind='bar')\n",
        "plt.xlabel('Organization Name')\n",
        "plt.ylabel('Count')\n",
        "plt.title('Organizaiton Name (More than 10 occurrences)')\n",
        "plt.xticks(rotation=45, ha='right')  # Rotate x-axis labels for better readability\n",
        "plt.tight_layout()  # Adjust layout to prevent labels from overlapping\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 607
        },
        "id": "fVyt_GAYftpg",
        "outputId": "a38b2fe5-787e-4bae-80d9-10dd106be587"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from collections import Counter\n",
        "\n",
        "def count_words(text):\n",
        "    skips = [\".\", \", \", \":\", \";\", \"'\", '\"', \"and\", \"of\", \"the\", \"in\", \"a\", \"will\", \"for\", \"is\", \"that\",\"re\", \" \", \"to\", \"with\", \"tht\", \"by\", \"as\", \"on\", \"at\", \"from\", \"or\", \"it\", \"this\", \"its\", \"has\", \"have\", \"be\", \"but\", \"s\", \"an\", \"its\"]\n",
        "    for ch in skips:\n",
        "        text = text.replace(ch, \"\")\n",
        "    word_counts = Counter(text.split(\" \"))\n",
        "    return word_counts\n",
        "\n",
        "text = ' '.join(df2['Project Abstract'].astype(str).tolist())\n",
        "counts = count_words(text)\n",
        "print(counts.most_common(10))"
      ],
      "metadata": {
        "id": "GYeUCYWF99eR",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "438a526a-64b0-4890-d200-1fb0aaedf6d1"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[('AbtrcteDyNAmiC(extrchromoomlDNACncer)Humngenerrnged23pirchromoomecncertumour-promotggenecnfemelvechromoomeloctecirculrextrchromoomlpieceDNA(ecDNA)TheeecDNAdotfollownmlrulechromoomlhernceenblgtumourchievefrhigherlevelcncer-cugcogenethnwouldwepoiblelicengcncerwyevolvechngeirgenomeevdettmenttrtewouldunthkblehumncellTheltedcirculrrchectuecDNAlochngewycncer-cuggenegultedexpedfurrctrigggivetumourgrowthTheeuniquefetumkeecDNA-ctgcncerepecillyggivedifficultttCncerptientwhoetumourhrbourecDNAhvemrkedlyhterurvivlDepegfirteenoverfiftyyergocriclimptnceecDNAhlycentlycomelightcleproblemubtntilecDNApentnerlyhlfllhumncncertypepotentillyup-thirdllcncerptientThecollectivecurntundertghowecDNAmhowyfunctihowymoveroundcellhowyevolvetttmenthowyimpctimmuneytemhowycneffectivelytrgetedlckgWebrggernterntillycognizedpieergterdciplrytemcncerbiologtgenetictcomputercienttevolutirybiologtmmticinclicinptientdvocteboldlyctenovelightourceprovidetrnmtiveolutieCncerGrChllengeAcotemexperiencedproductiveecDNAvetigrwknewvetigrecDNAcncerfieldbrgcompletelynewperpectivepprochethduntgchllengeBybridggcuttg-edgediverepprocheightcncergenomicyetgeneticepigenomicrtificilgenomeynlgudlptienttrckgcombrilmchelernglghmmmticlmodellgimmunobiologynovtivechemtrywedevelopnewundertgroleecDNAcncerwefdnewwydrugundruggbleThboldprogrmmewhichct7wkpckgecommtedterntilfrtructugenertenewunuulcollbtiwouldimplyimpoibleundernytypefundgmechnmOurprogrmmeendevourfoterboldnovtiveolutiehrdetproblemcnceregtetchllengefcgcncerptientRecenttechnologicldvncemobilehelthhvectlyzedrpidgrowthlrgevolumediglhelthdtduepotentilcientificimpcthelthlevncegenerlpopultiThgrowthimpoeuniquechllengemchelerngcomputtimticiencedueheervolumehighfquencielgudlmeumentovertimeWhilemchelerngprticulrlydeeplernghledmjdvncecrovrioudttypepplictimodelgtimeeriehelthdtdevelopmrterhelthcytemmchllenggltivelylowdoptil-wldhelthcettgPrimryechllengelieirgulrmulti-olutihelthdtcollecteddivereubjectwhodplyignificntvriirhvipediffentttmentNeglectgpopultidiveryctrieignificntlyhelthdpriepoliciedecitendgrdmrglizedmygroupThpropolprovidefundmentlrigouolutiddechllengecomplexheterogenoudtprticulrfocumobilehelthdtMopecificllyourerchpidocildetermnthelth(SDoH)impcthelthdpriemgwomenUSugtwoethnicllydiverewomenhelthdtetwhedtpenthighheterogeneymulti-olutifetuovertimeWeimflexiblyextrcteentilmtiheterogeneouignlcrohigh-dimenilomni-chnnelovertimetegrtemtimulti-olutivribleenhncepdictipcerptbilyWefurrtrgenleequentilpolicyoptimiztiproviden-viveterventtmentovertimemximizedividulhelthoutcomeccdgirheterogeneyInummryourerchim(1)Developdeepneurlmodelundertgpdictgdividulhelthovertimewhilelernghdptterncromultipledividulenhnceterptbilyult(2)Ctenoveldttegrtechniquemulti-olutimobilehelthdtccommodtgirgulrtimetervldiveremplgrtemeumentvrimgubject(3)Implementcementlerngpltmfdubject-pecificoptimlpolicieunderpopultilheterogeney(4)Applypropoedmethodidentifybiopychoocilfcrffectgwomenhelthenblgdevelopmenterlypventerventitrtegieenhnceoverllwell-gwomenTheoverrchgobjectivethprojectoptimizeperlizebtcncercengdvncgrtificiltelligence(AI)lghmBtcncermjgloblhelthccernErlydignokeyducgdeeburdenmtlymkgbtcncerefewcncergulrlycenedympmticwomenAccdglyAmericnCncerSocietycommendnnulcengwomenge40olderledgubtntilnumrcncductedyerlyMmmogrphynetimted39millinnulcengUSprimrybtcncercengmethodDiglBtTomoyn(DBT)3Dmmmogrphyhcomeroutecengmethod3DtueviewimprovgcncerdetectiHowevercomplexymmmogrmhighrdiologtwklodlowpvlencebtcncercengexmtichllengerdiologtpermncecerkflepoivemeddignoeComputer-ideddetecti(CAD)ytemhveentroducedtrdiologtufferhighflepoivetrghelthcytemcugneedlewryptientRecentdvncementdeeplerng(DL)ubfieldAIhveenbleddevelopmentnewCAD(AI-CAD)ytemcntrnmclicldeci-mkgHoweverAI-CADfcelimtiwhendelgDBTimgeCurntDLmodeltenlyjutcurntcnlckl-wldgenerlizbilytrugglehigh-olutiDICOMmtcomplexyDBTimgeToenhncebtcncercengwepropoemolticAI-CADytemwhichmimicrdiologtpprochbtcncercengcomprgcurntprimmmogrmcptgcliclrkfcrccountgimgecfigurtivriFurrmoweciderprcticlimplementtiuchytemcliclueThprojectimchievemobjectivethroughthepecificgoli)chieverobutexplbleefficientpenttiDBTimgecnceridentifictiemploygelfttentigrphlerngmodelii)developmultimodllgudllerngmodeltegrtghryimgecliclmtictgmohumn-liketelligenceCADytemimprovebtcncerdetectilocliztiiii)prcticllyimplementAI-CADcliclueutilizgexpert---loopctullerngenumodeldptivychngeprcticenlghm-hrdwcodeignmodelcompienucomputtilfeibilyFurrmoprojectprovidecompheniveDBTdtbeInthprojectbothpubliclyvilble-houeDBTimgeuedtrevlutevlidtepropoedmodelDuewidepduemmmogrphycriclimptnceerlydetectiptienturvivluccefulcomplethprojectprovidementrnmbtcncerdignothroughgterccurcyimprovgptienutcomeducghelthccotThenovtivedevelopedlghmctriedvncgDLepecillybiomediclimgenlyecnuednlyzg3DbiomediclimgeuchCTcnbrMRIAniml-AtedInterventi(AAI)gol-ientedprogrmtentillycptenimluchdogrpeuticnefAAIwidelyuedvrietyettgepecillycncerptientwellveternPot-TrumticStDder(PTSD)AAIhprovenprovidephyiologiclpychologiclympmnefThepoiveeffectAAIpoedprtduedynmichumn-nimlbd(HAB)DepeAAIpopulryneircompheniveAAIementmethodntkeholder-medtrdizedAAIprocolextcludgctiviecriclundertgAAImechnmctiroleHABmechnmwhichHABmedmtedOuroverllobjectivedeveloptetevlutenternetthgtwhrdwytemdydicphyiologiclmirghumnnimlAAIettgnovtenlyticmethodterptgdtThewkimptntcfulytemticyieldnovelcpbiliemtiAAIoutcomeementterventidevelopmentOurtemhdevelopedtetednnovtivepltmcptewerblewileenimultneoulygrphyiologicldt(iectivyhertrte/vribilypirryrteelectrodermlctivy)bothhumndogvolvedAAIThnovelytemcomdpychologicl(iedtwell-g)ympmdt(iepftigue)collectedptientdoghlerTkcludequltivemethod(iefocugroup)elucidtefirttkeholder-medtrdizedAAIprocolCductgfocugroupcludgptienthlerproviderprovidemtioptimizetructudAAIprocolcndelivedhighlevelterventifidelyledneficilptienutcomeprovidectrolledettgobjectivectuoumeumentbothptientdogphyiologyhviThwkctrienewcpbilievivotudyhumn-nimlbdAAIepecillycologyPTSDettgnewknowledgebouttypeterctipromoteulttrgerhumn-nimlbdroleyplyrpeuticoutcomeThepopultilrgeUShhd13M-18Mnewcncerptienteveryyerce1999etimted23%27MveternufferPTSDThecpbilieknowledgederivedthprojectfdnewwydictlyimprovelivemilliAmericnRELEVANCE(Seetructi)ThepropoederchlevntNCIctrienewknowledgeolillumteenblenoveltudyroleAniml-AtedInterventi(AAI)cologyttmentExtgknowledgetrglyuggetAAIcnimprovewellgcologyptienttructurgAAIeipromoteimprovedoutcomehenprocetril--errThenovelolpropoedheenblenewcpbiliecumizgAAIcologyttmentqunttivelyevlutgoutcomeTotterundertbtcncerpettmentkeyundertbttuerchectuModifictituerchectudictcequencerrngementfe-gdtructuuchfibroglulrtueveelbroughtbouteventcludgnotlimedngiogenettmentuchrdirpyChngebttructurlpologyhpotentilfluencecncerrkprognottmentpehoweverthhnotenextenivelytudiednquntifiedExtgwklimedlynlyfetuuchrdiomicThprojectundertkenmulti-dciplrytemcomprgpologtcomputercienttimggmticexpertclicinimdevelopdvncedmethodpologiclmodelggprimryhypoelghmcncertwekengtuerchectuimggThcnhelpidentifyghigh-rkceprecncermnifetticncercurnceSpecificllyprojectpropoedevelopTopoQuntueTopologyDtAnly(TDA)-driventechniqueextrctgterptgfe-gdpologiclmtibtpnchymbedboth2D3DbtimggTopoQuntgenertehigh-qulynnottibttueproducedvncedpologicldecriprchrcterizebttuecomplexlernpology-medpdictimodelugepologiclfetuwellprovideclicllytuivevuliztilevntpologiclfetuThepropoedwkdvncebothTDAcncererchctenewTDAmethodologieextrctnlyzerichtructurlmtibtimggThchievedthrough(1)Developgnovelpologicllghmeffectivelycptutructurldiverybtpnchym(2)Addgchllengelimeddtvilbilydevg2D3Dmppgmethodologieyieldhighlyctiblepologiclmtievenwhenvilbledtpretricted(3)Developglghmco-hrnepowerfullerngbilyblck-boxdeepnetwkbiologiclly-groundedgl-boxpologicldecripr(4)CtructgterptbleTDAfrmewkpecificllytilodegcncerrkrdtmentpebttueOurlghmvelpologiclightbttuetructuenblgclicinercherttercomphendplnevluteeffectivenettmentbtcncerptientRELEVANCE(Seetructi)TheerchenhnceourundertgbtcncerpotentillyimprovgerlydetecttmentnefgwomenhelthqulylifeThenovelmethodnlyzgrdiologycnhveignificntimplicticromultipledciplecludgneurociencebiologypromotecro-dciplrycollbtiAlghmdevelopedhdcientificcommunytegrteddiffentpltmAccurtedignocncerhgehpthologiclementttmentpivotguptummphologiclclifictiAImodelepecillydeeplerng(DL)modelhvehowngtpromeccurtelyclifygtumhpthologiclimge(tenddilgenomicmti)UnliketypiclmediclimgefeturgmllcriclhpthologiclimgetexturllevnttextupnngentiimgemkgchllenggexplDLpdictiloctgnimgeSuchlckexplbily(terptbily)evelylimDLpotentilvlubleolpthologtThucriclneedytemticllyexplDLhpthologiclmodelydmelocliztiubtntillyimproveAI-tedcncerdignopthologtThprojectimdevelopprcipledfrmewkytemticllyexplDLhpthologiclmodelugcounterfctulexplntiThertilewhiletextufetunotmenbleloclizti-bedexplntimethodecnexplmodelkgcounterfctulquetiuchwhthpthologiclimgecouldhvehiftedmodelpdictin-ggivetumggivetumSpecificllythprojectcenterroundfourtk(1)Dtet-LevelGenertiveExplntiDevelopgdtet-levelgenertiveexplerfrmewkexplnygivenDLhpthologiclmodelgenertgpectrumhpthologiclimgecnlednocedpectrumdiffentpdicti(egn-ggivethroughggivehighlyggive)expledDLmodel(2)Intnce-LevelCounterfctulExplntiDevelopgprcipledtnce-levelcounterfctulexplerfrmewkgenertetnce-pecificcounterfctulexplntipecifichpthologiclimge(3)FtCounterfctulExplntiDevelopgftcounterfctulexplerfrmewkenblel-timegenerticounterfctulhpthologiclimge(4)FromExplntiSubtypeDcoveryDevelopgubtypgcounterfctulexplerfrmewkgoeydexplntidcovernovelcncerubtype(phenotype)RELEVANCE(Seetructi)AccurtedignocncerhgehpthologiclementttmentpivotguptummphologiclclifictiAImodelcntenccurtelyclifytumhpthologiclimgeirlckterptbilyevelyhderirdeploymentcliclcenrioThprojectdevelopprcipledfrmewkytemticllyexplAIhpthologiclmodelugcounterfctulexplntiubtntillyimprovgAI-tedcncerdignopthologtTlePROTECTHrnegPROTEdegrdtiAdvncedChildhoodTumAbtrctBckgroundSurvivlrtechildnolidtumcludgbrhvelrgelyplteuedoverptthedecdemkgmmotcommcuedee-ltedmtlythgegroupAfterdecdeoptimizgchempyrdipyprocolhighercurtechildhoodolidtumnolgerchievedmomeRrcuquinovtiveterventipecificllytrgetuniquebiologyetumwhichtendrivencogenicfuipedric-pecificcoprotehricllycideddifficultdrugtrgetWhdvncetrgetedprotedegrdtichemiclterventihibprote-proteterctihcentlycometrctbletrgeteprotepvioulythoughtundruggbleMooverundfunctilcengpprocheuchCRISPR-C9hvevelednewpedriccncerynticlethllibilieneedtrgetedhibirAimWeimledtrnmtideliverguchpecificttmentouryoungptienthrnegpowerhighlyterdciplrycollbtivetemwld-ledgexpertpedriccologytrgetedprotedegrdtihigh-throughputchemiclcengmediclchemtrytructurlbiologytumbiologypclicldrugtetgclicltrilcomplementedtrn-AtlnticgroupenggedptientpenttiveMethodAboldplnpuruedptfolioprojectblnceveryhigh-rkeftnergcliclimplementtiWefocudriver/trgetfollowgdeeEwgrcomneuroblmynovilrcomependymomhigh-grdegliomWeexplodiffentpprochetrgeteyetundruggedpedricdriver/dependencieovercometncevilbletrgetedhibirimproveefficcyrpeuticwdowCAR-TttmentHowultuedThepirtiourtemetblhutblepltmpeteddevelopmentlcyclepedric-pecificdrugdevelopmentemerggtrgetcludgviblefncilmodelde-rkuchdevelopmentuchrpedrictumdictnefiurptientSpecificllywenticipteuccethrough(i)delivergtleneoptimedprotedegrderpplictierly-pheclicltril(ii)enblgdruggbilypvioulyundruggbletrget(iii)providgmechnticightdeenoveltrgetrpytncemechnmwytcklemABSTRACTOurviunrvelultimtelyveretrictenetwkculfcrthroughoutlifecouredruptbiologiclhomeotpromotecoloctlcncer(CRC)mgdividulyoungerthnge50yerUngledgcientificmderly-etcoloctlcncer(EOCRC)erchcomplementryfieldwehveembrceddruptivetrndciplrypprochepnngcelldividulpopultiddcoGrChllengeDetermewhycidenceerly-etcncerrgglobllyWeddpecificquetimechnmlkglifetimeexpoucnceripromotifocugEOCRCnidelmodelerly-etcncerduevilbilywell-chrcterizednimlmodelwell-etblhedpvlentpcurleidenomupolyp(denom)ferguniqueopptunyterceptipventiOurwktrnmfielddictlyddgouroverrchggolidentifyundertproceethroughwhichdiffentbiologiclenvirmentlfcrcueerly-etcncervereburdentimelyeffectivefeiblecluivefhiOurtembothwkgdependentlycollbtihuncovedeverlrkfcrlikelydriverrgcidenceEOCRCWenowuniquelypoiedtrnlteetiologicundertgctiblepventiidentifygnovelfcrcludgenvirmentlocildetermntdeepengourundertgoverlookeddimeniexpouthroughoutlifecoureTheunpcedentedcopecleourpropolcnlyupptedthroughCncerGrChllengeceourhigh-rkdruptivepprochquideepterctitweenwkpckge(WP)ledlederdiveredcipleThenblecptifhperpectivemoveydtrdilrk-fcrepidemiologywrdntegrtedmechnticlly-medmodelpopulticlecellulrolutimultiplecumultivehpromoteEOCRCmdevelopmentctiblepventiOurnovtiterectepidemiologymllmoleculedcoverygenomictemcellbiologyimmunologycomputtilbiologyekeyfetu1)hrmiztidiverecohtdtbiopecimencollectedcrolifecoure2)novtiveliblenlymllmoleculedetectnovelexpou3)high-olutechnologienlytrgettue4)modelytemcpbleterrogtgccumultgexpoucrolifepnirimpcncellulrecoytem5)pventhroughrkementphrmcologic/lifetyleterventiCollectivelyourwkervenexemplrtrnmgercherly-etcncereRAASSISTNCIPROTECTTlePROTECTHrnegPROTEdegrdtiAdvncedChildhoodTumAbtrctBckgroundSurvivlrtechildnolidtumcludgbrhvelrgelyplteuedoverptthedecdemkgmmotcommcuedee-ltedmtlythgegroupAfterdecdeoptimizgchempyrdipyprocolhighercurtechildhoodolidtumnolgerchievedmomeRrcuquinovtiveterventipecificllytrgetuniquebiologyetumwhichtendrivencogenicfuipedric-pecificcoprotehricllycideddifficultdrugtrgetWhdvncetrgetedprotedegrdtichemiclterventihibprote-proteterctihcentlycometrctbletrgeteprotepvioulythoughtundruggbleMooverundfunctilcengpprocheuchCRISPR-C9hvevelednewpedriccncerynticlethllibilieneedtrgetedhibirAimWeimledtrnmtideliverguchpecificttmentouryoungptienthrnegpowerhighlyterdciplrycollbtivetemwld-ledgexpertpedriccologytrgetedprotedegrdtihigh-throughputchemiclcengmediclchemtrytructurlbiologytumbiologypclicldrugtetgclicltrilcomplementedtrn-AtlnticgroupenggedptientpenttiveMethodAboldplnpuruedptfolioprojectblnceveryhigh-rkeftnergcliclimplementtiWefocudriver/trgetfollowgdeeEwgrcomneuroblmynovilrcomependymomhigh-grdegliomWeexplodiffentpprochetrgeteyetundruggedpedricdriver/dependencieovercometncevilbletrgetedhibirimproveefficcyrpeuticwdowCAR-TttmentHowultuedThepirtiourtemetblhutblepltmpeteddevelopmentlcyclepedric-pecificdrugdevelopmentemerggtrgetcludgviblefncilmodelde-rkuchdevelopmentuchrpedrictumdictnefiurptientSpecificllywenticipteuccethrough(i)delivergtleneoptimedprotedegrderpplictierly-pheclicltril(ii)enblgdruggbilypvioulyundruggbletrget(iii)providgmechnticightdeenoveltrgetrpytncemechnmwytcklemSAMBAISocietlAncetryMoleculrBiologiclAnlyeInequlieReerchAbtrctBckgroundProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidenceWetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunder-pentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelf-ptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglgdht/deepultr-lowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloud-bedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunder-ourcedenvirmentlrge-clecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpcnthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiSAMBAISocietlAncetryMoleculrBiologiclAnlyeInequlieReerchAbtrctNewYkGenomeCenterBckgroundProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidenceWetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunder-pentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelf-ptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglgdht/deepultr-lowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloud-bedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunder-ourcedenvirmentlrge-clecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpcnthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiABSTRACTOurviunrvelultimtelyveretrictenetwkculfcrthroughoutlifecouredruptbiologiclhomeotpromotecoloctlcncer(CRC)mgdividulyoungerthnge50yerUngledgcientificmderly-etcoloctlcncer(EOCRC)erchcomplementryfieldwehveembrceddruptivetrndciplrypprochepnngcelldividulpopultiddcoGrChllengeDetermewhycidenceerly-etcncerrgglobllyWeddpecificquetimechnmlkglifetimeexpoucnceripromotifocugEOCRCnidelmodelerly-etcncerduevilbilywell-chrcterizednimlmodelwell-etblhedpvlentpcurleidenomupolyp(denom)ferguniqueopptunyterceptipventiOurwktrnmfielddictlyddgouroverrchggolidentifyundertproceethroughwhichdiffentbiologiclenvirmentlfcrcueerly-etcncervereburdentimelyeffectivefeiblecluivefhiOurtembothwkgdependentlycollbtihuncovedeverlrkfcrlikelydriverrgcidenceEOCRCWenowuniquelypoiedtrnlteetiologicundertgctiblepventiidentifygnovelfcrcludgenvirmentlocildetermntdeepengourundertgoverlookeddimeniexpouthroughoutlifecoureTheunpcedentedcopecleourpropolcnlyupptedthroughCncerGrChllengeceourhigh-rkdruptivepprochquideepterctitweenwkpckge(WP)ledlederdiveredcipleThenblecptifhperpectivemoveydtrdilrk-fcrepidemiologywrdntegrtedmechnticlly-medmodelpopulticlecellulrolutimultiplecumultivehpromoteEOCRCmdevelopmentctiblepventiOurnovtiterectepidemiologymllmoleculedcoverygenomictemcellbiologyimmunologycomputtilbiologyekeyfetu1)hrmiztidiverecohtdtbiopecimencollectedcrolifecoure2)novtiveliblenlymllmoleculedetectnovelexpou3)high-olutechnologienlytrgettue4)modelytemcpbleterrogtgccumultgexpoucrolifepnirimpcncellulrecoytem5)pventhroughrkementphrmcologic/lifetyleterventiCollectivelyourwkervenexemplrtrnmgercherly-etcncerABSTRACTOurviunrvelultimtelyveretrictenetwkculfcrthroughoutlifecouredruptbiologiclhomeotpromotecoloctlcncer(CRC)mgdividulyoungerthnge50yerUngledgcientificmderly-etcoloctlcncer(EOCRC)erchcomplementryfieldwehveembrceddruptivetrndciplrypprochepnngcelldividulpopultiddcoGrChllengeDetermewhycidenceerly-etcncerrgglobllyWeddpecificquetimechnmlkglifetimeexpoucnceripromotifocugEOCRCnidelmodelerly-etcncerduevilbilywell-chrcterizednimlmodelwell-etblhedpvlentpcurleidenomupolyp(denom)ferguniqueopptunyterceptipventiOurwktrnmfielddictlyddgouroverrchggolidentifyundertproceethroughwhichdiffentbiologiclenvirmentlfcrcueerly-etcncervereburdentimelyeffectivefeiblecluivefhiOurtembothwkgdependentlycollbtihuncovedeverlrkfcrlikelydriverrgcidenceEOCRCWenowuniquelypoiedtrnlteetiologicundertgctiblepventiidentifygnovelfcrcludgenvirmentlocildetermntdeepengourundertgoverlookeddimeniexpouthroughoutlifecoureTheunpcedentedcopecleourpropolcnlyupptedthroughCncerGrChllengeceourhigh-rkdruptivepprochquideepterctitweenwkpckge(WP)ledlederdiveredcipleThenblecptifhperpectivemoveydtrdilrk-fcrepidemiologywrdntegrtedmechnticlly-medmodelpopulticlecellulrolutimultiplecumultivehpromoteEOCRCmdevelopmentctiblepventiOurnovtiterectepidemiologymllmoleculedcoverygenomictemcellbiologyimmunologycomputtilbiologyekeyfetu1)hrmiztidiverecohtdtbiopecimencollectedcrolifecoure2)novtiveliblenlymllmoleculedetectnovelexpou3)high-olutechnologienlytrgettue4)modelytemcpbleterrogtgccumultgexpoucrolifepnirimpcncellulrecoytem5)pventhroughrkementphrmcologic/lifetyleterventiCollectivelyourwkervenexemplrtrnmgercherly-etcncerABSTRACTOurviunrvelultimtelyveretrictenetwkculfcrthroughoutlifecouredruptbiologiclhomeotpromotecoloctlcncer(CRC)mgdividulyoungerthnge50yerUngledgcientificmderly-etcoloctlcncer(EOCRC)erchcomplementryfieldwehveembrceddruptivetrndciplrypprochepnngcelldividulpopultiddcoGrChllengeDetermewhycidenceerly-etcncerrgglobllyWeddpecificquetimechnmlkglifetimeexpoucnceripromotifocugEOCRCnidelmodelerly-etcncerduevilbilywell-chrcterizednimlmodelwell-etblhedpvlentpcurleidenomupolyp(denom)ferguniqueopptunyterceptipventiOurwktrnmfielddictlyddgouroverrchggolidentifyundertproceethroughwhichdiffentbiologiclenvirmentlfcrcueerly-etcncervereburdentimelyeffectivefeiblecluivefhiOurtembothwkgdependentlycollbtihuncovedeverlrkfcrlikelydriverrgcidenceEOCRCWenowuniquelypoiedtrnlteetiologicundertgctiblepventiidentifygnovelfcrcludgenvirmentlocildetermntdeepengourundertgoverlookeddimeniexpouthroughoutlifecoureTheunpcedentedcopecleourpropolcnlyupptedthroughCncerGrChllengeceourhigh-rkdruptivepprochquideepterctitweenwkpckge(WP)ledlederdiveredcipleThenblecptifhperpectivemoveydtrdilrk-fcrepidemiologywrdntegrtedmechnticlly-medmodelpopulticlecellulrolutimultiplecumultivehpromoteEOCRCmdevelopmentctiblepventiOurnovtiterectepidemiologymllmoleculedcoverygenomictemcellbiologyimmunologycomputtilbiologyekeyfetu1)hrmiztidiverecohtdtbiopecimencollectedcrolifecoure2)novtiveliblenlymllmoleculedetectnovelexpou3)high-olutechnologienlytrgettue4)modelytemcpbleterrogtgccumultgexpoucrolifepnirimpcncellulrecoytem5)pventhroughrkementphrmcologic/lifetyleterventiCollectivelyourwkervenexemplrtrnmgercherly-etcncerAbtrctUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztiSAMBAISocietlAncetryMoleculrBiologiclAnlyeInequlieReerchAbtrctBckgroundProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidenceWetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunder-pentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelf-ptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglgdht/deepultr-lowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloud-bedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunder-ourcedenvirmentlrge-clecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpcnthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiAbtrctBckgroundSurvivlrtechildnolidtumcludgbrhvelrgelyplteuedoverptthedecdemkgmmotcommcuedee-ltedmtlythgegroupAfterdecdeoptimizgchempyrdipyprocolhighercurtechildhoodolidtumnolgerchievedmomeRrcuquinovtiveterventipecificllytrgetuniquebiologyetumwhichtendrivencogenicfuipedric-pecificcoprotehricllycideddifficultdrugtrgetWhdvncetrgetedprotedegrdtichemiclterventihibprote-proteterctihcentlycometrctbletrgeteprotepvioulythoughtundruggbleMooverundfunctilcengpprocheuchCRISPR-C9hvevelednewpedriccncerynticlethllibilieneedtrgetedhibirAimWeimledtrnmtideliverguchpecificttmentouryoungptienthrnegpowerhighlyterdciplrycollbtivetemwld-ledgexpertpedriccologytrgetedprotedegrdtihigh-throughputchemiclcengmediclchemtrytructurlbiologytumbiologypclicldrugtetgclicltrilcomplementedtrn-AtlnticgroupenggedptientpenttiveMethodAboldplnpuruedptfolioprojectblnceveryhigh-rkeftnergcliclimplementtiWefocudriver/trgetfollowgdeeEwgrcomneuroblmynovilrcomependymomhigh-grdegliomWeexplodiffentpprochetrgeteyetundruggedpedricdriver/dependencieovercometncevilbletrgetedhibirimproveefficcyrpeuticwdowCAR-TttmentHowultuedThepirtiourtemetblhutblepltmpeteddevelopmentlcyclepedric-pecificdrugdevelopmentemerggtrgetcludgviblefncilmodelde-rkuchdevelopmentuchrpedrictumdictnefiurptientSpecificllywenticipteuccethrough(i)delivergtleneoptimedprotedegrderpplictierly-pheclicltril(ii)enblgdruggbilypvioulyundruggbletrget(iii)providgmechnticightdeenoveltrgetrpytncemechnmwytcklemABSTRACTOurviunrvelultimtelyveretrictenetwkculfcrthroughoutlifecouredruptbiologiclhomeotpromotecoloctlcncer(CRC)mgdividulyoungerthnge50yerUngledgcientificmderly-etcoloctlcncer(EOCRC)erchcomplementryfieldwehveembrceddruptivetrndciplrypprochepnngcelldividulpopultiddcoGrChllengeDetermewhycidenceerly-etcncerrgglobllyWeddpecificquetimechnmlkglifetimeexpoucnceripromotifocugEOCRCnidelmodelerly-etcncerduevilbilywell-chrcterizednimlmodelwell-etblhedpvlentpcurleidenomupolyp(denom)ferguniqueopptunyterceptipventiOurwktrnmfielddictlyddgouroverrchggolidentifyundertproceethroughwhichdiffentbiologiclenvirmentlfcrcueerly-etcncervereburdentimelyeffectivefeiblecluivefhiOurtembothwkgdependentlycollbtihuncovedeverlrkfcrlikelydriverrgcidenceEOCRCWenowuniquelypoiedtrnlteetiologicundertgctiblepventiidentifygnovelfcrcludgenvirmentlocildetermntdeepengourundertgoverlookeddimeniexpouthroughoutlifecoureTheunpcedentedcopecleourpropolcnlyupptedthroughCncerGrChllengeceourhigh-rkdruptivepprochquideepterctitweenwkpckge(WP)ledlederdiveredcipleThenblecptifhperpectivemoveydtrdilrk-fcrepidemiologywrdntegrtedmechnticlly-medmodelpopulticlecellulrolutimultiplecumultivehpromoteEOCRCmdevelopmentctiblepventiOurnovtiterectepidemiologymllmoleculedcoverygenomictemcellbiologyimmunologycomputtilbiologyekeyfetu1)hrmiztidiverecohtdtbiopecimencollectedcrolifecoure2)novtiveliblenlymllmoleculedetectnovelexpou3)high-olutechnologienlytrgettue4)modelytemcpbleterrogtgccumultgexpoucrolifepnirimpcncellulrecoytem5)pventhroughrkementphrmcologic/lifetyleterventiCollectivelyourwkervenexemplrtrnmgercherly-etcncerSAMBAISocietlAncetryMoleculrBiologiclAnlyeInequlieReerchAbtrctBckgroundProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidenceWetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunder-pentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelf-ptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglgdht/deepultr-lowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloud-bedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunder-ourcedenvirmentlrge-clecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpcnthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiTlePROTECTHrnegPROTEdegrdtiAdvncedChildhoodTumAbtrctBckgroundSurvivlrtechildnolidtumcludgbrhvelrgelyplteuedoverptthedecdemkgmmotcommcuedee-ltedmtlythgegroupAfterdecdeoptimizgchempyrdipyprocolhighercurtechildhoodolidtumnolgerchievedmomeRrcuquinovtiveterventipecificllytrgetuniquebiologyetumwhichtendrivencogenicfuipedric-pecificcoprotehricllycideddifficultdrugtrgetWhdvncetrgetedprotedegrdtichemiclterventihibprote-proteterctihcentlycometrctbletrgeteprotepvioulythoughtundruggbleMooverundfunctilcengpprocheuchCRISPR-C9hvevelednewpedriccncerynticlethllibilieneedtrgetedhibirAimWeimledtrnmtideliverguchpecificttmentouryoungptienthrnegpowerhighlyterdciplrycollbtivetemwld-ledgexpertpedriccologytrgetedprotedegrdtihigh-throughputchemiclcengmediclchemtrytructurlbiologytumbiologypclicldrugtetgclicltrilcomplementedtrn-AtlnticgroupenggedptientpenttiveMethodAboldplnpuruedptfolioprojectblnceveryhigh-rkeftnergcliclimplementtiWefocudriver/trgetfollowgdeeEwgrcomneuroblmynovilrcomependymomhigh-grdegliomWeexplodiffentpprochetrgeteyetundruggedpedricdriver/dependencieovercometncevilbletrgetedhibirimproveefficcyrpeuticwdowCAR-TttmentHowultuedThepirtiourtemetblhutblepltmpeteddevelopmentlcyclepedric-pecificdrugdevelopmentemerggtrgetcludgviblefncilmodelde-rkuchdevelopmentuchrpedrictumdictnefiurptientSpecificllywenticipteuccethrough(i)delivergtleneoptimedprotedegrderpplictierly-pheclicltril(ii)enblgdruggbilypvioulyundruggbletrget(iii)providgmechnticightdeenoveltrgetrpytncemechnmwytcklemSAMBAISocietlAncetryMoleculrBiologiclAnlyeInequlieReerchAbtrctBckgroundProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidenceWetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunderpentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelfptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglgdht/deepultrlowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloudbedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunderourcedenvirmentlrgeclecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpcnthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiSAMBAISocietlAncetryMoleculrBiologiclAnlyeInequlieReerchAbtrctBckgroundProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidenceWetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunder-pentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelf-ptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglgdht/deepultr-lowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloud-bedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunder-ourcedenvirmentlrge-clecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpcnthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiAbtrctUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztiAbtrctUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztiAbtrctUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztieRAASSISTNCIPROTECTTlePROTECTHrnegPROTEdegrdtiAdvncedChildhoodTumAbtrctBckgroundSurvivlrtechildnolidtumcludgbrhvelrgelyplteuedoverptthedecdemkgmmotcommcuedee-ltedmtlythgegroupAfterdecdeoptimizgchempyrdipyprocolhighercurtechildhoodolidtumnolgerchievedmomeRrcuquinovtiveterventipecificllytrgetuniquebiologyetumwhichtendrivencogenicfuipedric-pecificcoprotehricllycideddifficultdrugtrgetWhdvncetrgetedprotedegrdtichemiclterventihibprote-proteterctihcentlycometrctbletrgeteprotepvioulythoughtundruggbleMooverundfunctilcengpprocheuchCRISPR-C9hvevelednewpedriccncerynticlethllibilieneedtrgetedhibirAimWeimledtrnmtideliverguchpecificttmentouryoungptienthrnegpowerhighlyterdciplrycollbtivetemwld-ledgexpertpedriccologytrgetedprotedegrdtihigh-throughputchemiclcengmediclchemtrytructurlbiologytumbiologypclicldrugtetgclicltrilcomplementedtrn-AtlnticgroupenggedptientpenttiveMethodAboldplnpuruedptfolioprojectblnceveryhigh-rkeftnergcliclimplementtiWefocudriver/trgetfollowgdeeEwgrcomneuroblmynovilrcomependymomhigh-grdegliomWeexplodiffentpprochetrgeteyetundruggedpedricdriver/dependencieovercometncevilbletrgetedhibirimproveefficcyrpeuticwdowCAR-TttmentHowultuedThepirtiourtemetblhutblepltmpeteddevelopmentlcyclepedric-pecificdrugdevelopmentemerggtrgetcludgviblefncilmodelde-rkuchdevelopmentuchrpedrictumdictnefiurptientSpecificllywenticipteuccethrough(i)delivergtleneoptimedprotedegrderpplictierly-pheclicltril(ii)enblgdruggbilypvioulyundruggbletrget(iii)providgmechnticightdeenoveltrgetrpytncemechnmwytcklemSAMBAISocietlAncetryMoleculrBiologiclAnlyeInequlieReerchAbtrctBckgroundProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidenceWetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunder-pentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelf-ptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglgdht/deepultr-lowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloud-bedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunder-ourcedenvirmentlrge-clecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpcnthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiSAMBAISocietlAncetryMoleculrBiologiclAnlyeInequlieReerchAbtrctBckgroundProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidenceWetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunder-pentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelf-ptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglgdht/deepultr-lowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloud-bedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunder-ourcedenvirmentlrge-clecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpcnthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiOverllAbtrctProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidencewetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunder-pentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelf-ptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglg-dht/deepultr-lowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloud-bedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunder-ourcedenvirmentlrgeclecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpctthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiABSTRACTBckgroundSurvivlrtechildnolidtumcludgbrhvelrgelyplteuedoverptthedecdemkgmmotcommcuedee-ltedmtlythgegroupAfterdecdeopmizgchempyrdipyprocolhighercurtechildhoodolidtumnolgerchievedmomeRrcuquinovvetervenpecificllytrgetuniquebiologyetumwhichtendrivencogenicfuipedric-pecificcoprotehricllycideddifficultdrugtrgetWhdvncetrgetedprotedegrdchemicltervenhibprote-proteterchcentlycometrctbletrgeteprotepvioulythoughtundruggbleMooverundfunclcengpprocheuchCRISPRC9hvevelednewpedriccncerynclethllibilieneedtrgetedhibirAimWeimledtrnmdeliverguchpecificttmentouryoungpenthrnegpowerhighlyterdciplrycollbvetemwld-ledgexpertpedriccologytrgetedprotedegrdhigh-throughputchemiclcengmediclchemtrytructurlbiologytumbiologypclicldrugtengclicltrilcomplementedtrn-AtlncgroupenggedpentpentveMethodAboldplnpuruedptiolioprojectblnceveryhigh-rkeftnergcliclimplemennWefocudriver/trgetfollowgdeeEwgrcomneuroblmynovilrcomependymomhigh-grdegliomWeexplodiffentpprochetrgeteyetundruggedpedricdriver/dependencieovercometncevilbletrgetedhibirimproveefficcyrpeucwdowCAR-TttmentHowultuedThepirourtemetblhutblepltimpeteddevelopmentlcyclepedricpecificdrugdevelopmentemerggtrgetcludgviblefncilmodelde-rkuchdevelopmentuchrpedrictumdictnefiurpentSpecificllywencipteuccethrough(i)delivergtleneopmedprotedegrderpplicerly-pheclicltril(ii)enblgdruggbilypvioulyundruggbletrget(iii)providgmechncightdeenoveltrgetrpytncemechnmwytcklemSAMBAISocietlAncetryMoleculrBiologiclAnlyeInequlieReerchAbtrctBckgroundProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidenceWetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunder-pentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelf-ptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglgdht/deepultr-lowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloud-bedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunder-ourcedenvirmentlrge-clecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpcnthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiAbtrctUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztiAbtrctUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztiSAMBAISocietlAncetryMoleculrBiologiclAnlyeInequlieReerchAbtrctBckgroundProttebtpncticcncerllhvedproptelyhigherrteggivetumgrdeerlyetBlckptientcentpikehighcidenceWetAfricnnticompdAfricngiThegeneticbckgroundcltiimplictepdpoiMemrourSAMBAItemvetigrhvepieedgenomiccncerdprieerchoverpttwodecdewehveuncovedcompellgevidencedtctimmunologiclmechnmocedgeneticncetryOurSAMBAItemmemrhvedevelopedmethodquntifyenvirmentlexpouterrogtelivedexperiencemrglizedpopulticludgepigeneticpercmAimWeprtnercienttcroUSAfricUKbuildnunpcedentedourceSAMBAIBiobnkDtRepoiryCncerEquyReerchWegenertecompheniveccurtelevntmeumentocilenvirmentlgeneticimmunologiclfcrcompletentegrtedetnlyedefeculvmodifierltihipdprteoutcomedivereunderervedpopultiWeetblhutblefrmewktemciencepprocheunder-pentedprtneretblhtprcticecodtgcncerequyerchgloblcleMethodWepropoeutilizemultiplemethodcroourdiffentwkpckgeSocilDetermntcludeelf-ptgurveydtbebtrctiExpoomeutilizempectrometryplmGenomicutilizetheequencgmethodgermletumtuecludglgdht/deepultr-lowpwholegenomeequencgLtlyimmunologiclprilemeudptiltrncripmiccircultgmultipleximmunoyTheedtquinovelcomputtilfrmewkcludgcloud-bedvirtuliztiuemchelerngtechnologieidentifynovelocicrotrtocilptildtelementcroourdiveregeogrphicncetrlSAMBAIcohtUtilyImpctWeimproveerchcpcyunder-ourcedenvirmentlrge-clecncererchequbleccedtequblefeibilyimprovettmenutcomeWedefeterctienvirmentlexpouocildetermntgeneticncetrydetermeimmunologicllcpeprimrytum/circultgimmunologiclprileptientAfricndecentOurprojectctriedtpoiry100Kfetu/ptient40000ptientTheimpcnthpopulticludenoveltrildeigncollbtiourptientdvoccyprtnerenupecificgenomicimmunologiclfetuweuncovercomeprttrgetedpcicologyrgnoticoptiABSTRACTUCSFUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztiABSTRACTTlePROTECTHrnegPROTEdegrdtiAdvncedChildhoodTumBckgroundSurvivlrtechildnolidtumcludgbrhvelrgelyplteuedoverptthedecdemkgmmotcommcuedee-ltedmtlythgegroupAfterdecdeoptimizgchempyrdipyprocolhighercurtechildhoodolidtumnolgerchievedmomeRrcuquinovtiveterventipecificllytrgetuniquebiologyetumwhichtendrivencogenicfuipedric-pecificcoprotehricllycideddifficultdrugtrgetWhdvncetrgetedprotedegrdtichemiclterventihibprote-proteterctihcentlycometrctbletrgeteprotepvioulythoughtundruggbleMooverundfunctilcengpprocheuchCRISPR-C9hvevelednewpedriccncerynticlethllibilieneedtrgetedhibirAimWeimledtrnmtideliverguchpecificttmentouryoungptienthrnegpowerhighlyterdciplrycollbtivetemwld-ledgexpertpedriccologytrgetedprotedegrdtihigh-throughputchemiclcengmediclchemtrytructurlbiologytumbiologypclicldrugtetgclicltrilcomplementedtrn-AtlnticgroupenggedptientpenttiveMethodAboldplnpuruedptfolioprojectblnceveryhigh?rkeftnergcliclimplementtiWefocudriver/trgetfollowgdeeEwgrcomneuroblmynovilrcomependymomhigh-grdegliomWeexplodiffentpprochetrgeteyetundruggedpedricdriver/dependencieovercometncevilbletrgetedhibirimproveefficcyrpeuticwdowCAR-TttmentHowultuedThepirtiourtemetblhutblepltmpeteddevelopmentlcyclepedric-pecificdrugdevelopmentemerggtrgetcludgviblefncilmodelde-rkuchdevelopmentuchrpedrictumdictnefiurptientSpecificllywenticipteuccethrough(i)delivergtleneoptimedprotedegrderpplictierly-pheclicltril(ii)enblgdruggbilypvioulyundruggbletrget(iii)providgmechnticightdeenoveltrgetrpytncemechnmwytcklemABSTRACTOurviunrvelultimtelyveretrictenetwkculfcrthroughoutlifecouredruptbiologiclhomeotpromotecoloctlcncer(CRC)mgdividulyoungerthnge50yerUngledgcientificmderly-etcoloctlcncer(EOCRC)erchcomplementryfieldwehveembrceddruptivetrndciplrypprochepnngcelldividulpopultiddcoGrChllengeDetermewhycidenceerly-etcncerrgglobllyWeddpecificquetimechnmlkglifetimeexpoucnceripromotifocugEOCRCnidelmodelerly-etcncerduevilbilywell-chrcterizednimlmodelwell-etblhedpvlentpcurleidenomupolyp(denom)ferguniqueopptunyterceptipventiOurwktrnmfielddictlyddgouroverrchggolidentifyundertproceethroughwhichdiffentbiologiclenvirmentlfcrcueerly-etcncervereburdentimelyeffectivefeiblecluivefhiOurtembothwkgdependentlycollbtihuncovedeverlrkfcrlikelydriverrgcidenceEOCRCWenowuniquelypoiedtrnlteetiologicundertgctiblepventiidentifygnovelfcrcludgenvirmentlocildetermntdeepengourundertgoverlookeddimeniexpouthroughoutlifecoureTheunpcedentedcopecleourpropolcnlyupptedthroughCncerGrChllengeceourhigh-rkdruptivepprochquideepterctitweenwkpckge(WP)ledlederdiveredcipleThenblecptifhperpectivemoveydtrdilrk-fcrepidemiologywrdntegrtedmechnticlly-medmodelpopulticlecellulrolutimultiplecumultivehpromoteEOCRCmdevelopmentctiblepventiOurnovtiterectepidemiologymllmoleculedcoverygenomictemcellbiologyimmunologycomputtilbiologyekeyfetu1)hrmiztidiverecohtdtbiopecimencollectedcrolifecoure2)novtiveliblenlymllmoleculedetectnovelexpou3)high-olutechnologienlytrgettue4)modelytemcpbleterrogtgccumultgexpoucrolifepnirimpcncellulrecoytem5)pventhroughrkementphrmcologic/lifetyleterventiCollectivelyourwkervenexemplrtrnmgercherly-etcncerAbtrctUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztiAbtrctUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztiABSTRACTBckgroundSurvivlrtechildnolidtumcludgbrhvelrgelyplteuedoverptthedecdemkgmmotcommcuedee-ltedmtlythgegroupAfterdecdeoptimizgchempyrdipyprocolhighercurtechildhoodolidtumnolgerchievedmomeRrcuquinovtiveterventipecificllytrgetuniquebiologyetumwhichtendrivencogenicfuipedric-pecificcoprotehricllycideddifficultdrugtrgetWhdvncetrgetedprotedegrdtichemiclterventihibprote-proteterctihcentlycometrctbletrgeteprotepvioulythoughtundruggbleMooverundfunctilcengpprocheuchCRISPR-C9hvevelednewpedriccncerynticlethllibilieneedtrgetedhibirAimWeimledtrnmtideliverguchpecificttmentouryoungptienthrnegpowerhighlyterdciplrycollbtivetemwld-ledgexpertpedriccologytrgetedprotedegrdtihigh-throughputchemiclcengmediclchemtrytructurlbiologytumbiologypclicldrugtetgclicltrilcomplementedtrn-AtlnticgroupenggedptientpenttiveMethodAboldplnpuruedptfolioprojectblnceveryhigh-rkeftnergcliclimplementtiWefocudriver/trgetfollowgdeeEwgrcomneuroblmynovilrcomependymomhigh-grdegliomWeexplodiffentpprochetrgeteyetundruggedpedricdriver/dependencieovercometncevilbletrgetedhibirimproveefficcyrpeuticwdowCAR-TttmentHowultuedThepirtiourtemetblhutblepltmpeteddevelopmentlcyclepedric-pecificdrugdevelopmentemerggtrgetcludgviblefncilmodelde-rkuchdevelopmentuchrpedrictumdictnefiurptientSpecificllywenticipteuccethrough(i)delivergtleneoptimedprotedegrderpplictierly-pheclicltril(ii)enblgdruggbilypvioulyundruggbletrget(iii)providgmechnticightdeenoveltrgetrpytncemechnmwytcklemAbtrctUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztiABSTRACTOurviunrvelultimtelyveretrictenetwkculfcrthroughoutlifecouredruptbiologiclhomeotpromotecoloctlcncer(CRC)mgdividulyoungerthnge50yerUngledgcientificmderly-etcoloctlcncer(EOCRC)erchcomplementryfieldwehveembrceddruptivetrndciplrypprochepnngcelldividulpopultiddcoGrChllengeDetermewhycidenceerly-etcncerrgglobllyWeddpecificquetimechnmlkglifetimeexpoucnceripromotifocugEOCRCnidelmodelerly-etcncerduevilbilywell-chrcterizednimlmodelwell-etblhedpvlentpcurleidenomupolyp(denom)ferguniqueopptunyterceptipventiOurwktrnmfielddictlyddgouroverrchggolidentifyundertproceethroughwhichdiffentbiologiclenvirmentlfcrcueerly-etcncervereburdentimelyeffectivefeiblecluivefhiOurtembothwkgdependentlycollbtihuncovedeverlrkfcrlikelydriverrgcidenceEOCRCWenowuniquelypoiedtrnlteetiologicundertgctiblepventiidentifygnovelfcrcludgenvirmentlocildetermntdeepengourundertgoverlookeddimeniexpouthroughoutlifecoureTheunpcedentedcopecleourpropolcnlyupptedthroughCncerGrChllengeceourhigh-rkdruptivepprochquideepterctitweenwkpckge(WP)ledlederdiveredcipleThenblecptifhperpectivemoveydtrdilrk-fcrepidemiologywrdntegrtedmechnticlly-medmodelpopulticlecellulrolutimultiplecumultivehpromoteEOCRCmdevelopmentctiblepventiOurnovtiterectepidemiologymllmoleculedcoverygenomictemcellbiologyimmunologycomputtilbiologyekeyfetu1)hrmiztidiverecohtdtbiopecimencollectedcrolifecoure2)novtiveliblenlymllmoleculedetectnovelexpou3)high-olutechnologienlytrgettue4)modelytemcpbleterrogtgccumultgexpoucrolifepnirimpcncellulcoytem5)pventhroughrkementphrmcologic/lifetyleterventiCollectivelyourwkervenexemplrtrnmgercherly-etcncerAbtrctUndertghowTcellcepr(TCR)eetumntigenpentedMHCneceryfullyunderthowimmuneytemcognizetumntigenpfullpotentilntigen-pecificimmunpyTochievethgolquntumlepwrdquidwhichvolutirydvncemchelerngcomdlrgevolumetructufunctidnmtchedTCR-pMHCpirThedevelopmentccurtepdicrTCR-ntigencognidependennctegrtiequencg-beddtethigh-throughputtructurlfunctilightOurpropolubmtedCRUK/NCIGrChllengetem(MATCHMAKERS)comercherexperteimmunologymethoddevelopmenttructurlbiologycomputtienblegenerlizedpdictideignTCRcogniThwkpdcrofourWkPckge(WP)WP1Lrge-clegenertiTCR-pMHCpirnturllyoccurrgourceWebuilddtetnturllyoccurrgTCR-pMHCpirOurtemuenrrypprochecollectedtethumnmouemodelctextbothcncerimmunymogenerllyWP2Ultr-highthroughputTCR-pMHCmtchgugmoleculrengeergEftctegenerlmodelquibroderrrydtthnfeiblecollectnturlTCRytemWeuenrryynticpprochedevelopedourtemcomphenivelymtchTCRpMHCtrcomputtilmodelWP3Lrge-cletructurlbiochemiclnlyeTCR-pMHCterctiAkeyourtemvimtchterctidtethighthroughputtructurlfunctilightAdeepundertghowTCRctctMHChelicectrolfunctiienttieentiltrgtetgcomputtilmodelWP4AI-bedpdictideignTCR-pMHCterctiWetegrteourdttrnext-genertilghmcpblegenerllypdictgdeigngTCR-pMHCterctiTheepdictiproceedthroughertivetetgfeedbckcircufurrmodeloptimiztiAbtrctVirueetiologiclgentnumrdiffenthumncncerEpte-Brrviru(EBV)ubiquiupthogenfectgover95%humnpopultiwldwideEBVetiologiclgenteverlmlignnciecludgHodgklymphom(HL)multipletypen-Hodgklymphom(NHL)cludgpot-trnplntlymphoprolifertivedee(PTLD)diffuelrgeBcelllymphom(DLBCL)TcelllymphomNK/Tcelllymphom(NKTL)Burktlymphom(BL)InddiEBVloocednophryngelcrcom(NPC)gtriccncerThencedcidenceEBV-ocedNHLHIV-fectedptientHIV-poivedividulhve1020%lifetimerkdevelopgBurktlymphomEBV-poiveNKTLeencedfquencyHIVfectiwelltrnplntcipientHIV-fectedEBV-poiveNKTLptientlothigherrkdethwhencompdNKTLptientoutHIVWepropoeunderthowEBVocedmultipletypeNHLHIV-fectedpopultiEBVpentecheverylymphomcellwhichimplieEBVctrieidevelopmentmtenncetumSeverleEBV-ocedlymphomegNKTLBLhighlyggiveNKTLhowtncechempeuticHencenewrpieneededtrgeteNHLWehvefoundEBV-ocedNHLdplyhighexpicellcyclewhoeexpiupgultedfollowgEBVfectinveBcellWehypoizeEBVctivtethkedrivetumgrowthurvivlInthpropolweimidentifyhowEBVupgultethkevirlgenemypiblethphenomenWevetigtemechnmwhichEBVculgenthumncncermodultecellulrproceectrieerlyeventcrcogeneEBV-ocedlymphomWelodetermewherhibgthkecnhderEBV-drivenlymphomgenevrovivowevetigtewherhibirthkecnfunctinovelrpeutictrgethderdevelopmentpthologyEBV-drivenlymphomTheidentifictinovelrpeutictrgethelpovercomembidymtlyEBV-ocedlymphomroundglomylolevntn-virlcncerPROJECTSUMMARY30leProtekectlyzeelectivetimelyprotephophyltieentilnmlfunctillcellUngultedkectivydictlyocedhunddhumndeecludgcncernetimted30%llnewdrugdevelopmentfocuergetclUntuntelylthoughprotekevlidteddrugtrgetkehibirpentpromgttmentdeechllengemllmoleculedrugdcoverydevelopmentcurntkeymethodefficientcommlylywkunderlimedcdiAignificntbrrierprogcenterolppliedyprotekethroughoutdrugdcoverypipeleAlthoughmnyypltmextevelimtivriouengmechnmledubtntildcnectdcoveryproceultglewell-vlidtedcliclcidtetenlimedefficcyttgdeeThepropoederchexploAQTPhophoSenpltmkeypurifiedenzymeueenpeptidefeturgke-cogniequenceulfmido-oxefluophocjugtedcytee(CSox)proximl(Ser/Thr/Tyr)phophyltieynticenpeptidepnphophyltivichelti-enhncedfluocence(ChEF)time-dependentmnnerThePhophoSenmtddelimtikeyglepltmThDictPheIIpropollevergeAQTPhophoSenKSightTM(highthroughputkeprilgpltmbedPhophoSen)etblhgcommercilPhophoSenLyteproductFbroddoptinewymutddrngephyiologicllyrpeuticllycriclkecomptiblecomplexcelltuelytempletrightwrdpplyqunttiverpidproducibledilyruntrdlbrymicropltederAim1focuemigen-ctivtedproteke(MAPK)whichplycriclrolecellignlgcludgpeprolifertiflmmryignldrivetumphenotypeAQTcommercilizelyte-comptibleenpeptideERK1/2bedPhe1productAQT0491SenpeptideeighrMAPKdevelopedvlidtedfollowgMilenetep1-3biochemiclvlidtideploymentenpeptidettetetetgcomplexmple(egcelltuelyte)AQTfeenpeptideneededecommercilproductleeAim2focueddilcology-centrickeLyte-comptibleenpeptidePIM1/3GSK3/commercilizedbedPhe1productAQT0473AQT0157pectivelyAQTdevelopdt-drivenpprochepriizetletixddilproteketrgetenpeptidedevelopmentcommerciliztifollowgpprocheoutledAim1HelthcdprieUSultlrgeegmentpopultioutccerdirpy(RT)ThmnifetelfEternKentuckyApplchiwheimpctexcerbtedhighcidencemokg-ltedcncerRTneffectivecompentttmenttrtegyeptientAdvncedtechniqueuchtenymodultedrdirpy(IMRT)imge-guidedRT(IGRT)teotcticbodyRT(SBRT)teotcticrdiourgery(SRS)improveoutcomedelivedugmedicllerccelerr(ielc)SBRTepecillyppelgeettggivenpcettmentdelived1-5dilyttmentfrctioppoed20-40frctiquidcventiltechniqueProvidgSBRTrurlettgcnimproveccedmtergepcebbvedttmentptientwhohvedifficultytrvelglrgegilmediclcenterThequlyurnce(QA)mediclphyictprovidecriclfettmentyethtgequlifiedmediclphyict(QMP)bothUSglobllyAtmetimemocentertroducgmoderntechniquemopcetricllyhvemkduehighdoegeometricpciquidThewidepdncomplincedutrytrdQAprocolUSterntillyExtgQAdevicehvenotevolvedufficientlyprovidepcivertilyefficiencyneededhighpciRTGiveneexcerbtedfetyrkmrketneedprdigmhifthowQApermedmodernRTWildDogPhyic(WDP)propoedeigntetnew-genertiQAdeviceddeeunmetmediclneedWehvetrdemrkedthdeviceRetrieverTMWhencompletemopceefficientcomphenivethnnyQAoluticurntlymrketThepropoedprojecteekdevelopcliclprotypetetedRdiTherpyclictUniveryKentuckywellprtnergniztiloctedrurlunderervedHvgprovenfeibilyourfeibilytudyweeekdvncethnovticommercilvibilyPhe2throughthepecificim1)hrdwfementllowmeumentmchepermncemetric05mm1%ltivedoe2)twdevelopmentllowl-timedtnlyl-timecomplinceementnlyticlolcnmirlg-termtndbrupthiftter-mcheter-tutilcompr3)clicltetgvlidteenivypecificyRetrieverhiftmchechrcterticWewkkeycdemiccliclprtnerdeigntetgphecludgQulifiedMediclPhyict(QMP)ervgprelypopultedlowourceettgUSWhenuccefulthimptntnovtihelpbrgccurtette---rtrdirpyttmentptientwhomighrwenotceivemAbtrctMotdrugdmtedytemicllypdthroughoutbodyDuelckpecificypthologiclehighdoequidchieveeffectiverpeuticccentrticugxicydveredrugeffect(ADE)tebodywheynotneededEchyerpproximtely12milliptADEUSlepentgover5%llhoplizedptientADEloctrie90%filurtedrugcidteduebilychieverpeuticccentrtittrgetelerbleideeffectthuledghighdrugdevelopmentcotpriceToxicyADEextmelycommchempeuticcompounddmtedytemicllyuchextecnpotenthibirpoomereIWhileecompoundexhibpotentnti-tumctivyirueefficcyhdedevedoe-limgxiciecludgneutropeniliverdyfunctiHoweverevenpecifictrgetgddintibodycjugtiedrug(ntibody-drugcjugteADC)uchTrtuzumb-deruxtecn(nextecnnlogue)hvemultiplelimticludgytemicleechempypylodpopenetrtiolidtumlimedternliztumcellAddilfcruchlowceprcopynumrquidternliztipylodctivtiefficientubcellulrtrffickglyoomellfurrlimpotentildevelopmentnewADCShqidevelopgpltmctivtedrugtpecificebodythuenhncgirefficcywhilemimizgytemicxicydveredrugevent(ADE)Shqmodulrclickctivtedprodrug(CAP)pltmddecriclneedbrodcommercilopptunynewtechnologiecpbleefficientctivtirpeuticptiotemplctrolmkgdrugmoefficcioucgtrgeteccentrtiwhileloimprovgfetyducgytemicexpouThpltmlohpotentilenblevetigtipurpogdrugcidtemyhvepvioulyenhelvedduehighlevelxicyTochieveimthDictPheIItudyShqifirtchrcterizetetnovelHER2-trgetedctivtggentcjugtettenutedextecnderuxtecnprodrugHER2+xenogrftmouemodelgtriccncerThenefficcypltmcfirmedchllengedlowexpgHER2+cncermodelthopicmodelphrmcoketicevlutednvertFllyn-GLPxicologytudieelectedextecnderuxtecncjugtenvertpermedprifltepGLPmnufcturgflcjugteprodrugdvnceIND-enblgxicologytudieTheboveidentifynovelntigen-trgetedtructuueShqGen2CAPdvncenilproductwrdclicwhichcouldlouedfutudevelope-dictedttmentdicticludgntibiotice-pecificfectiuimmunyloclizednti-flmmrypmngementPROJECTSUMMARYBrcncerledgcuedee-lteddethchildndultunderge40yeroldEvenggivettmentcludemximlurgiclectiteotcticrdiourgerywhole-brrdirpychempymoleculrlytrgetedrpeuticimmunpiecurncertemnybrcncernerly100%DepehunddclicltrilcombtirpietetedmtlyrtehvelylightlydecedAccdgAmericnCncerSocietyetimtedover24000dultchildnprimrybrcncerUS2023novilblemedicticnveredrugtntbrcncercurnceWhenecdrybrmetteprimrycncerlikebtmelnomlungcludedetimtedover300000ptientecdrybrmettethyerUSTheeptientcfrtedmixedbleglgerilttmenturvivlncedcidenceecdrydrugtntbrtumMuchlikeprimrybrcncerwhencncermettizebrylmotlwylethlNewrpiecntrgetdultpedricdrugtntcurntprimryecdrybrcncerbdlyneededCtiveBioTherpeutichdcovedcurntdrugtntcncerup-gulteurvivlpthwyultgexpiectinextrcellulrGlucoe-RegultedProte78(ecGRP78)tummicroenvirmentOurerchhowecGRP78imptntdrugimmunetncewellgliomtemcellmtiCellurfceboundecGRP78henfoundbtlungovrinprottemelnommultiplemyelomcolpedricdultbrtumnnmlcellWehvefoundecGRP78tbilizeeentilcetlproteROR1CriplgcheckpotprotePD-L1tumimmunecellurfceducgccdeeventcedrugtnceimmuneuppicncertemcellmtiAuchwedeigneddevelopedeverlnti-cncerrpiepecificllyblockN-termldomecGRP78bdgtbilizgepro-tumigenicprotetumurfceoutdruptgnmlcellfunctiWecnnowhowthurledhibirCBT300vrocn)ducepopdrugtnttumcellb)elimtedrugimmunetncehowgynergticeffectchempyimmunpyc)decemountchempyneededthulowergxicideeffectOurvivoulthumnhighgrdegliomtummicettedeourecGRP78hibirdplyedncepthologiclcompletepeover65%ncemedinurvivl12dynetimted2yerhumnptientnoobervblexicyAn-xicrpeuticlterntiveeffectivegtcurntbrtumbrmettcedoverllurvivlcompletepewouldproveprdigmltergAbtrctRelpedfrcryT-cellcutelymphoblticleukemi(T-ALL)T-celllymphom(TCL)ggivehemlogicmlignncielimedrpeuticopti3-yerurvivlrtelow20percentWhiledevelopmentchimericntigencepr(CAR)-TcellrpiehvehownpromeB-cellcncertrgetgT-cellmlignnciehenhdedhdntigenpcetweenhelthymlignntcellledgCARTcellelf-trgetgheightenedrkT-cellpliCD5CD7keyurfcemrkerT-ALL/TCLbout90%T-cellmlignncieexpgebothmrkerTheulogouCD5CAR-TCD7CAR-TcellrpiedevelopedtBylCollegeMedicelicenedMrchBiociencehowfetyfeibilyigndurbleefficcyPhe1clicltrilT-cellmlignncieHoweveretrilhvefcedmnufcturgchllengemnyptientnefhveenbrogtedntigenicllyheterogenoutumToovercomeelimtienhncenti-tumctivygtT-cellcncerMrchBiociencepropoedevelopprtilly-mtchedd-deriveddul-pecificCAR-Tcell(CD5/CD7CAR-Tcell)TheeCD5/CD7CAR-TcelluniquelyengeedfrtricidetnceproducedhploidenticlCD45RA-depleteddT-cell(RAD-T)mimizerkgrftveruhotdeeugrpidcurntgoodmnufcturgprctice(cGMP)complintproceSfetyctrollbilyfurrugmentedtegrtgdrug-duciblecpe9(iC9)ytemllowgpcevivoctrolCAR-Tcellpot-fuiThprojectimdevelopCD5/CD7CARRAD-TcellhighetctivygtmlignntT-cellvrygntigenexpibothvrovivomodeldemtrtectrolledCAR-Tcellelimtictivtgcpe9-ducedpopTotmleCAR-TcellproductiducecotoptimlclbilyMrchBiocienceoptimizgcGMPproceccelertemnufcturgCD5/CD7CARRAD-TcellBytrnigrpidcloed-circuytemMrchBiocienceeekcolidteT-celltimultrnductiexpnigleveelover4dyThetrgettlproductimele9dycluiveflleetetgthuenurgpotentrpidlyvilbleproductptientggivedeeUpcomplethprojectMrchBiociencehveelectedledcidteflizedcGMP-dyprocemnufcturgdul-trgetgCAR-TenblgubequentclicltetgPhe1/2trilptientfrcrylpedT-cellmlignncieProjectAbtrctSignificnceThedevtgoutcomeglioblm(GBM)ptientmdepedvncecncerrpyImprovedGBMrpycriclunmetneedquinewterventicpbilielikelytegrtinovtiveGBMterventipropoedtherchThepmethprojectthnechllengeimprovgGBMptientlivecnovercomecedrpeuticcovergeGBMtumugnnovtivecvectienhnceddelivery(CED)cterInnovtiThepropoedSBIRDictPheIIerchfernovti(1)improvedGBMrpeuticgentdeliveryobtedCEDPouBrInfuiCter(PBIC)whencomdmoccurteMoleculrFlowSimulti(MFS)twPBICSytem(2)novelpprochevluteCEDdrugdeliverycterromizedctrolledtrilPlimryDtPBIChdemtrtedpcliclvivocedvolumefuedbrdtriiTheMFSfuiplnngtwhdemtrtedrobutcltictulimultedhumnbrtumfuihobtedFDA510kmrketgclernceComprtiveGBMtumfuiimultiugFDAcledMFStwdictePBICcncerpeuticcovergeGBMtumHypoThePBIChveequivlenrimprovedfetyprileignificntlygterpercentgeenhncgtumcovergethnnendptCEDcterOverllProjectObjectiveAccelerteCEDerchcliclfetyfuidtriievlutiPBICSytemAim1erchSpecificAim1Firt-In-HumntudyevlutePBICfetycurntGBMtumfuidtriiefficcyCoSlumnufctuPBICtetdeviceprovidephyicinplcementtrgDukevetigrThertxupptevlutePBICttcurntWHOgrde34mlignntgliom(rGBM)ptientugnextgDukeclicltriltrtumlrpeuticfuiviCEDD2C7-IT2141-V11(NCT04547777IND151390)Atl24ptient(12ptientperctergroup)romizedeirPBICcurntDukeCEDendptcterSfetynlybedcterlteddvereeventInfuidtriienhncgtumevlutedco-fuedPETimggtrcer(124I-humnerumlbum(HSA))meuedpriDukeBrTumCenterThertxCEDdtriitudieAim1MileneCompdctrolendptcterPBICdemtrte()equivlenrtterfety(b)ignificntlyimproved(p<05)124I-HSAdtriienhncgtumReerchImpctImproveddrugdtriiugcterpecificllydeignedCEDimproveGBMbrdee/juryptienutcomeProjectSummryNnopo-bedequencghnumeroudvntgeoverequencg--yn(SBScurntgoldtrdccurcy)cludgbilydetectgenomicvri(glemoleculeb)providelg-dwidergenomicctextcffoldAddillylowcotimpletrumenttimennnopoequencgcnenblecceibleroutecliclcncercengfutucomphenivedee-pecificydevelopedHoweverderupplntSBSnnopo-bedequencgtechniquemuteeimprovementmethodologyceccurcythprticulrlytruegenomicpetwhichpentignificntunder-tudiedgigenomeInfctpetiveDNAequencecomplmot50%humngenometillquechllenggchrcterizecueimpoiblecfidentlylign/dermllfrgmentpetDNApetneeddctuoulycompletely(end--end)SBStechnologypecificllylimedcombtiequencebpolymere/ynerrfiluccumultedurgequencgproceultimtelylimtechniquehtdlengthThucuemotccurteequencgmethodmrket(SBS)cnnotequenceegiirroledeeprogilrgelyunknownHowevevidencedtehowDNApethvemrkblequntyequencevri()nmlvdeedcellfunctideeprogiFurredee-cltedvrihveloenfounddicterpyucceUntuntelymethoduedetudieprimrilycdemicntulygcomplexqultivemethoddottrnfercliclettgTobridgeechnologygpDrEricPeterledElectricBioScienceInc(EBS)nnopotechnologyexpertdevelopgnovelpprochnnopo-ctrolledequencgyieldtte---rtccurcydlengthcpbleegDNApetDurgthprogrmEBSdemtrtefunctilypprochfullyewkflow/methodologycludgccurcygtcurnttrdpprocheToillychrcterizefeibilyprcticlypropoedpprochEBSlohowbilymultiplexmeumentelfmllclewhichpoechnologyextenivemultiplexgdurgfollow-eftcriclciderticommercildoptbilyThecpbilyequencepetiveequencehighccurcypciidentifyirvriignifymjdvncementcncergenomicpvgwyimproveddignoticprognoticrpeuticwhichledtteroutcomecncercMedulloblm(MB)motcommmlignntbrtumchildnFdecdehvenotenignificntdvncettmentMBwhichtillcludeurgeryrdichempyUntuntelyettmentcncueeveideeffectcludglifelgcognivedeficiencieendocdyfunctineurologicldefectemotilocilproblemecdrytumSuchttment-ocedxicieprticulrlyevechildnirbrtillgrowgThemotggiveftlMBhvehighlevelknowncogeneMYChighlydependennMYCgrowthprogiMYCwelletblhedcricldrivermnytypecncertrncriptifcrhprovenverydifficulttrgetrpeuticllyWehvehownMYCexpiprotetbilyMBgultedEYA2throughuniquetyroephophte(TyrPte)ctivyWeidentifiedclpotentelectivemll-moleculellotericEYA2TyrPtehibirhvehownpenttivecompoundelectivelyduceMYClevelhibMBcelllegrowlowubmicromolrccentrtiefficientlycroebloodbrbrriervimultipleroutedmtrtihibMBgrowthntrcrnilmouemodelwhendelivedlgvgeWeimprovedctivy/electivydrug-likepropertieilcompoundthroughcomphenivemediclchemtryhveledcompoundSD3-146fvbleCNSPKpropertieplimrynlyeInthPheISTTRprojectwetethypofeibledevelopSD3-146highlyefficcioulexicrpeutichibMYCthuMYC-MBgrowthThefirtAimoptimizecleupynSD3-146mothoughlyevlutedrugmetbolmphrmcoketic(DMPK)propertiepotentilxicieodetermeoptimldogetimgdeliveryvivoTheecdAimverify-trgeteffect(phrmcodynmicPD)efficcymoueMBmodelWhuccefulcompletieimweexpecthveufficientdtmGO/NOGOdeckeourledcompoundthroughnSTTRPheIIprojectfurrp-clicldevelopmentBecueEYA2henhowngulteMYClevelcncercludgbtcncerglioblmdrugwedevelopmyhvebrodpplicbilyttgeverldifficult--ttcncerThupropoederchcouldettgetrgetgundruggbleuper-ctrollerMYCthroughEYA2multipletumtypeABSTRACTTrnltilfetytudienovelnerveimgggentrdiclprottecmieInwo-yerpropolwecompleteIND-enblgtudieNerveLightnerveimgggentWepplygledoeNerveLighttertilly(piclly)tr-opertively~15mtgngrdiclprottecmienwhexceThenomrketedolublen-devicenerveimgggentNerveLightcompdNerInfrRed(NIR)dyefluoce800gtchedcombnthumnNerveGrowthFcr(rhNGF)Inplimrycnetudiewehvehowndyecndetectedcliclytemdeignedimgedocynegen(ICG)ItknownrhNGFbdelectivelytropomyokeA(TrkA)highffyceprexpedtdtlendnervetueWhenNGF/TrkAcomplexendocyeddyettchedrhNGFmovednervecellbodieIneprtepetdoedyerhNGFwhengiveneyedropfeWepvioulyhowedNerveLightcn(i)vulizedelectivellrttudie(n=103)(ii)whichn=46werdiclprottecmie(iii)completedn-GLPdoe-rngefdgtudiertttticlignificncertProjectMileneTheProjectMilenecfirmfetyexpouNerveLightxicyexpoutue-perFDAGuidncetwopeciertdog-GLPncliclIND-enblgtudieHypoSpecificAimWehypoizefetycfirmedGLPxicologyvrofetyphrmcologytudiertdogWetethypofollowgSpecificAimSpecificAim1InAim11ugmeimggurgiclprocolpvioulywecductn-GLPpilotdoe-rngefdgtudienetizedmledultn-neutednvedognopenprocedu(cuten-urvivl)InAim12fterciNerveLightppliedwhednprottet-rknervetuehrvetednn-GLPimggmoleculrhlogydeSuccecreriAim1(i)determecnedoevibptivuliztiDye-Adduct-Rtio(DAR2)vrintdetermedrt(ii)ueco-loclizticfirmgenttrgetnerveSpecificAim2InAim21wecductGLPxicologyfetyphrmcologyrtdogperetblhedtrnltilnclicldeignSuccecrerillultfll10%vluehemlogybiochemtryknownbothpecieInAim22weuemeetblhedhlogymethodAim12heGLPttticlignificncegugco-loclizticfirmgenttrgetnerveNexttepPrigngthProjectwehveelectednot-novelimggytemwhichNerveLightcndetected(nofundgqueted)UpcompletinINDwetettheSgleAcendgDoeNerveLightcliclPhe1tudymenundergogrdiclprottecmieMnznexpertcjugtichemtrynlyticrhNGFcienceneurologygulryffirAbtrctSolidtumuchn-mllcelllungcncermelnomfflictmothn250000AmericnperyerWhileimmunpieuchcheckpothibir(CPI)hveimprovedcncercurteylyeffective20-40%ptienthenceignificntunmetneedimproveolidtumttmenutcomeRegulryT(Tg)cellclicllydefedCD4+CD25+FoxP3+Tcellkeytrgetcncerimmunpieceyhibnti-tumTeffecrpepromotetumprogicltepottmenutcomeReducgtum-ocedTgwouldenhncententi-tumimmunepewouldlolikelyimprovectivyCPIimmunpieIndeedTg-depletgimmunpyOntkwhichtrgetCD25molecule(bundnnTg)wmrket1999-2011cricldrwbckcludg25%rtevculrlekyndrome(VLS)ignificntmnufcturgctencieledmovlmrketAclenerveriOntkddilpurifictitepRemirowpprovedhumnueJpnMrch2021tillhowhighlevelVLSTheneedfeeffectiventi-cncergenttrgetgTgcellmToddthneeddvncefieldTg-depletgimmunpySovldevelopgecd-genertiveriOntkclledSON-211BymodifygkeyVLS-ducgdomOntkSovlhvirtullyelimtedVLSSON-211whilefullcyxicpotencygtTgtedSovlloholdIPnovelproductimethodolveprimnufcturgproblemInPheIequivlentultSON-211demtrtedpotentnti-tumofficcympyhowedignificntnti-tumynergywhenuedgerCPImumodelolidtum(melnomcolcrcomnlcellcrcom)RecentlyourtemmemrDrDwPrdollhowedmothighlyimmunouppiveTgubethumntum(OX40hiGITRhi)trglyexpeCD25(dicttrgetSON-211Ontk)whilenTgubet(TtIFNG)hprdoxiclntumeffectveryweklyexpeCD25TheedtuggetSON-211trgetgCD25myelectivelyelimtebdOX40hiGITRhiTgubetperveneficilTtIFNGTgubetBuildgthtrghighlyencourggplimrydtSovllevergeekeynewfdgchrcterizebilySON-211electively-blnceTgubettumwrdpotentflmmrynti-tumpopultiSpecificAimthDictPheIIproject1)DetermeeffectSON-211mpyvnpyblnceTgubetTME2)CompeffectdulrpySON-211plunAnti-PD1CPITgubet3)OptimizeexpiSON-211producti/purificti4)DemtrtenbilymnufctuSON-211tcle5)Permp-INDdoe-fdgxicologytudieSON-211SprgueDwleyrtABSTRACTPncticcncer(PC)nphndee5-yerltiveurvivl115%ltiveurvivlmettticPCly31%Althoughurgiclectiprovidetcurtiveopti<20%PCptienteligibleurgerytdignoFrt-lechempyttmentFOLFIRINOXultmedinoverllurvivl(mOS)ly111mthocedevexicielimptientttmentOverllnewrpieurgentlyneededfulfillthunmetmediclneedextendOSyd11mthDepeuccehemlogicmlignncieimmunpyhnotyetignificntlyimprovedclicloutcomePCduecdiurroundgolidtumMrkerhypoizebedclicltrildtechempycnmodifytummicroenvirmentpromoteTcellfiltrtiTcellctivtumcellkillgMrkerpropoeMT-601novelTcellrpyimultneoulytrget6tum-ocedntigen(TAA)highlyexpedPCmimizgtumecpeMnufctudptientownphemterilMT-601cognizetrgetcellvintive(n-engeed)Tcellcepr(TCR)terctgbothclIIIMHC(CD4+CD8+Tcell)ledgkillgcellexpgTAAwellctivtiimmunecellInvrotudiehowMT-601wfruperictrollggrowthPANC1pncticcncercellveructrolcdiMoimptntlyplimryclicldtMrkerTACTOPStrilpncticcncerptientdemtrtedignlefficcycludg1CompleteRepe(CR)3PrtilRepe(PR)out13PCptientttedEpipepdgwobervedlikelyledgmodurblepethncellulrrpieTodtemultipleTAA(mTAA)-pecificTcellhveenhownfe>200ptientvrioucncertypeTheeMrkerTherpeuticpropoeueMT-601nimprovedmTAA-pecificTcellproductPCderimproveptienutcomeCombgMT-601frt-leFOLFIRINOXchempymyovercomecurntlimtiimmunpyPCThgrntpropoePhe1open-lltudyevlutefetyefficcyMT-601comdfrt-lechempymettticPCptientSpecificAim1eeprimryecdryfetyefficcyoutcomePCptientttedfrt-lechempy(FOLFIRINOX)combtiMT-601SpecificAim2cltebiologiclchrcterticproductprilecliclfetyefficcyoutcomeSuccefulcomplethgrntprovidecliclprocceptMT-601ttmentPCptientupptfutuclicltrilledgfutuBLAfilgcommercilpprovlMT-601SUMMARYMettticdeepible~90%cncerdethprimrydetermntlife-limgpectcncerOnevlidteddrivermettmiRNA-10bn-codgRNAocedmettticproginumeroupclicl>100clicltudieTrncodehdevelopednovelrpeuticgent(termedMN-nti-miR10bcommercillydevelopedTTX-MC138)liepecificerdictimetttictumcellMN-nti-miR10bctntgomirgtmiRNA-10bcjugteduniquedeliverypltmclledTTXwhichoptimizedtrgetgprimrymetttictumcellTrncodeproprietryptentedtechnologyllowelectivetrgetgmicroRNA-10bmettticcelldependentirtypeprimrytumigNumeroupclicltudiecductedTrncodehvehownMN-nti-miR10bmedeignificntmiR-10bhibivivoelicgmrkeddurblegilymphnodedtntmettemouemodelbtcncernoevidenceytemicxicySpecificllyfewfourixweeklyttmentMN-nti-miR10bcombtilowdoechempyledcompletegidetectblemetteOfcriclimptncefollowgelimtimettefollowgdctutirpynoevidencewfounduggetcurnceovermgnturllifepnnimlInddiimilrtudiemouemodelpncticcncerwecductedcompletepedefedcompleteginodeecurnceFllyilevidencefetyrpeuticctivywcfirmedcompnictptneoumettticbtcncerTrnCodehcompletedcriclexplryINDenblgtudiertdogn-humnprimterdiolledMN-nti-miR10bSpecificllymtigenertedultedFDAuthiztiupptngogmicrodogPhe0clicltrilptientdvncedmettticcncerAtthpotTrnCodehcductediltudieptientdemtrtgdeliverydrugmettticleiThePhe0trilvolveglejectimicrodoeCu-64lledMN-nti-miR10bwhichllowdictvuliztivivoviPET-MRimggprimryendpotdetermg%ID/ccrpeuticdelivedmettticleiBedoutcomemlpINDcommunictiFDAOfficeOncologicDeecurntpplictiupptfullIND-enblgtudiegenertifilgnINDpplicti(Aim1)wellPheIdoe-ecltrilptientdvncedolidcncer(Aim2)TheefundccelerteprogrmwrdcommerciliztienblgfetytudiepotentillyobtgefficcyignlcouldenbleFDApprovlfirt--clrpeuticgtmettticcncerdivereprimrydeeigPROJECTSUMMARYKpoSrcom-ocedherpeviru(KSHV)cueAIDS-defgcncerKpoSrcom(KS)HowKSHVfecticueKSpolyunderodprimrilyduelckrigoulydefedprimryhumncellcultumodelcpultetrnmedfetuKSHV-fectedtumcellKSKStumcellmotlikelyigtemicrovculrlymphticendolilcell(LEC)LECepentphyiologicllylevntmodeltudieKSWehvedevelopedprocolKSHVfectiprimryhumnLECllowumeuKSHV-ducedloctcthibiproliferti(CIP)LoCIPfetucogenictrnmtiolidtumBededurcentrlhypoKSHV-mededdegulticellulrgeneexpriggercogenictrnmtiLECwhichcpulteKSHV-mededcogeneKSThpropoleimidentifyKSHV-ducedgenepromoteKSHV-ducedloCIPKLECWeloimdetermeifKSHV-fectedLEC(KLEC)fullytrnmedmxenogrfttumimmunodeficientmiceToteurhypochieveourobjectivewepropoetwoSpecificAimInSpecificAim1wecductub-genomicCRISPRcenidentifywhichKSHV-ducedhumngenepromoteKSHV-ducedloCIPKLECSpecificAim2determewherKLECfullytrnmedcnmxenogrfttumimmunodeficientmiceupubcutneouubnlimplnttiWeeultgtumexpivirlcellulrmrkerKSdetermehowcloelyKLECtummodelKSThepropoedtudynovtivecueourmodelprovideetrigoulydefedexperimentlettgenblecogenicchngefterKSHVfectiprimryhumncelltypelevntKSThwkignificntcueidentifyKSHV-ducedcellulrgenepromoteechngeetblhwherKSHV-fectedLECfullytrnmedtumigenicmiceFurrmoultimpctfulcueymyenblemechnticightprovideprocceptKLECundergocogenictrnmtiReultwouldloetblhwell-trdizedprimryhumncell-bedmodelKSvrolikelyvivoSuchmodelwouldenblecountletudierolevirlcellulrgeneKSHV-mededtumigeneidentifictiKSbiomrkerp-clicltetgrpeuticpprochePciEpigenomicIncUniveryArizCncerCenterDeprtmentPthologypoutimglunchmoleculrdignotictetcncerptientTheproductthSBIRSentel-MPEliquidbiopyywhichmulti-cncerdetectetOurSentel-MPEtetcnidentifyovertwentydiffentcncertypeHewepplySentel-MPEtetdiffentildignopleurleffuiIncliclprcticemchllengedtguhtweenmlignntpleurleffui(MPE)nignpleurleffui(BPE)CylogymgoldtrddetectimlignntcellpleurleffuiHoweverenivylimedBecuelimticventilcylogymethodnurgentneeddevelopmoccurteeffectivemethodefficientdignoMPEIncollbtiUniveryArizPciEpigenomichgenertedignificntfeibilycliclutilydtugpleurleffuiOurpilottudiedictethurSentel-MPEtethpotentilneffectivecomplimentryolcylogyprocediffentildignoTheimthprojectcductmulti-ecliclvlidtitudyetblhSentel-MPEtetnewcommercilmoleculrtetdignoMPETheimthproject1)ToetblhdignoticvlueSentel-MPEliquidbiopyyidentifycncerpleurleffui2)TovlidteSentel-MPEliquidbiopyycncerdetectipleurleffuiThelg-termgolthprojectbrgfieldpthologynewdignoticoldignomlignntpleurleffuiPROJECTSUMMARYKpoircom-ocedherpeviru(KSHV)ncogenicvirucueKpoircom(KS)emotcommmlignnciepeoplelivgHIVwldwideKSHVlocueprimryeffuilymphom(PEL)multicentricCtlemndee(KSHV-MCD)Infecticommub-ShrnAfrictenoccurerlychildhoodwhileweternhemphefectirgenerlpopultimofquentmenwhohveexmenAvccepventKSHVfecti/ocedmbidymtlypentcriclunmetneedHowevertypeimmunepevccewouldneedelichvenotenwelldefedHeweeekidentifylevntntigenictrgetpecificepipetrgetedKSHV-neutrlizgntibodieetblhbilyneutrlizgntibodieprotectgtKSHVfectimllnimlmodelTodothwelevergelrgep-collectedpoiryerumPBMCmpleKSHV+prticipntoutKSdeechrcterizeneutrlizgntibodypeKSHVWeproducecombntKSHVglycoproteueddepleteerumbdgntibodieeirctriipolycllerumneutrlizgpeInprllelweolteneutrlizgmocllntibodieKSHV+PBMCmplecrryout-depthtructu-functinlyeidentifycriclevulnerbilyKSHVglycoproteLtlyweevlutebilyneutrlizgKSHVmocllntibodiepventfectihumnizedmouemodelKSHVfectiOurtudiedefelevntntigenepipetrgetedneutrlizgntibodienturlKSHVfecthumdeigndevelopmentKSHVvcceMoovervivoprotectiKSHVfectietblhcriclprocceptKSHVvccehouldeekelicneutrlizgntibodieSUMMARYTheoverllgolthU01pplictwo-foldFirtvetigtetwopotentilKSHVtrgetetructurlen-tructurldetermeifetwotrgetcpbleprotectgvcctednimlfectiAndecdcomptwovccetrtegietimulteimmunepeKSHVntigenThefirtpprochutilizemRNA-lipidnnoprticle(mRNA-LNP)vccewidelyuedvccetrtegyhprovencpbleducgprotectiveimmunygtSARS-CoV2TheecdpprochemploynovelvccetrtegytrgetCD180ll-likecepr(TLR)expedntigenpentgcell(APC)cntimulterobutimmunepecjugtedntigenevenctextimmuneuppiToccomplhegolweutilizerheumcquerhdoviru(RRV)/rheumcque(RM)modelKSHV-likefectievluteKSHVtrgetcompimmunepeducedmRNA-LNPtrgetedCD180vccepltmThenovtitngththpplictieverlcludecollbtimedmgtprciplvetigrco-vetigrbiotechnologyecr(AbcuBiocience)whoecompnyfocunoveltrgetedCD180vccepltm(nti-CD180)cpbleducgrobutimmunepecjugtedntigenrodentnhumnprimte(NHP)cdemicco-vetigrwhoeexpertechrcteriztiprimtentibody-mededfunctiImptntlydtpentedplimrytudieectiupptthpplicti1)CD180expedmultipleBcelllegedendriccellmocyteimilrhownhumn2)fuinntigengtnti-CD180ntibody(CD180)provideimultneountigendeliveryctivtiAPCultgpotentntigen-pecificIgGproductiexpnictivtedntigen-pecificTcellimmunocompetentimmuneuppedniml3)wehveuccefullyexpedtwocombntCD180-KSHVntigencomplexe(CD180-K81ecdomCD180-KSHVvIL6)evlutevrovivo4)wehveetblhednlchllengemodelRRVfectiultvirufecti5)wehvectednecerychimericKSHV/RRVcombntpeudotypedKSHVglycoproteK81combntRRVencodgKSHVvIL-6plceRRVvIL-6TheechimericRRVcombntcnfectetblhltentfectiRMidenticlwild-typeRRVThuoverllgolcomptte---rtmRNA-LNPnovelnti-CD180pltmtimultennti-K81nti-vIL6immunepeimmunecompetentSIV-fectedRMprilRRVchllenge/fectiTheoverllhypoimmuniztrgetgKSHVprotedevelopcellhumlimmunepegtvirlntigenThdicthed--hedcomprervenecerypqueevlutgeirvccepltmRMpricliclevlutihumnPROJECTSUMMARYThegolthSTTRPheIpplictietblhfeibilycommercilizgperlizedmulti-trgeteddoptiveTcellrpy(ATCT)glioblm(GBM)GBMmotcommprimrybrtumdmlprognoltivefive-yerurvivlrte75%ThehennoignificntimprovemenutcomeeptienttwodecdeInpethurgentneednovelrpieGBMptientwehvedevelopedperlizedulogouATCTtrgetgmultiplentigenGBMuniqueechptientWeenvidmtergATCTndjuvntrpydictlytumdthroughnOmmyervoirftertrd--curgeryOurtrtegygenertgGBM-pecificATCTvolvepplygPruinbluennoprticle-bedphmlrpy(PBNP-PTT)GBMcellexvivoDurgPBNP-PTTPBNPdmtedGBMcellhveenexcedviurgerynerfrdlerhemixtuexvivogenertghetUndercertcdiPBNP-PTTdeliverrmldoeelicimmunogeniccelldeth(ICD)GBMcellfcilteleeGBM-pecificntigenuniqueechptientThePBNP-PTT-ttedGBMcellnco-cultudulogoudendriccell(DC)TcellexpGBM-pecificTcellubequentfuibckptientImptntlythpltmdeigneddevelopmulti-trgetedTcellnntigen-gnoticmnnerScethpprochueptientowntumourceTcelltrgetdoenotquipriichoenntigenOurpublheddtillutrtefeibilyournovelATCTdevelopmentpltmugPBNP-PTTgenertepotentfunctilGBM-pecificTcellgttwoGBMcellleU87SNB19ughelthydPBMCHLA-mtchedtumcellleInnpublhedtudyugnthopicU87xenogrftmodelwehvedemtrtedthurATCTmoeffectivegenertgvivotumgilg-termurvivlltivelterntivectrolATCTBuildgepublhedultthSTTRPheItudyweeeketblhfeibilydevelopgulogouGBM-pecificTcellourPBNP-PTT-bedpltmugbloodGBMtummpleptientOuroverllhypoPBNP-PTT-ttedGBMcellfciltegenertipotentperlizedGBM-pecificTcellnntigen-gnoticmnnerexertpecificcyxicygtulogouptient-derivedGBMcellvrovivoInAim1weevlutewherPBNP-PTT-mededexvivoexpnigenertepotenteffectiveptient-derivedGBM-pecificTcelldefemechnmdrivgobervedpeInAim2wetetefficcyPBNP-PTT-derivedTcellGBMptient-derivedxenogrft(PDX)modelvivocompdTcellpproche(egB7-H3CARTcell)Succefulcompletietudiedemtrtefeibilymnufcturgulogouptient-derivedGBM-pecificTcellugPBNP-PTTirueATCTPROJECTSUMMARYTobccouemledgmodifiblerkfcrpventgcncerglobllyprticulrlymgpeopleHIV(PWH)InLoPeopleDemocrticRepublic(Lo)61%80%mlePWH3%10%femlePWHmokecigttePWHwhomokeLocurntlyhvenooticllyempiricllybedmokgcetiupptThuimplementgutbleevidence-bedmokgceterventiPWHLocricllyneededTheubtntilevidencemobilehelth(mHelth)-bedmokgceterventieffectivecot-effectivefdbleWedevelopedclblefdblemHelth-bedumtedttmentprogrm(MAP)upptLoCmbodinmokerqumokgTheMAPvolveterctivetilodperlizedctent(textmegephovideo)delivedvimrtpheppAlgeffectivecettmentimpertiveimplementproceduidentifyptientwhomokefciltecnectittmentOneuchpprochpieedourtemAk-Adve-Cnect(AACkgptientboutmokgteveryvbrieflydvgthoewhomokequcnectgmttment)whichhowedgtimpcurUStudieThepurpoethpplicticomp2mokgcetiimplementtitrtegie8ntrovirlrpy(ART)clic5motpopulouprovce/gicroLoughybridtype-2prgmticeffectivene-implementtitudyprllelcluterromizedtrildeignSpecificllywecompnAACpprochpidourpvioulydevelopedMAP(AA-MAP)nAACpprochpidleourceteniveprtedelf-helpmteril(AA-SH)ToguideourimplementtiwkweuePrcticlRobutImplementtiSutbilyModel(PRISM)whichexpRE-AIM(RechEffectiveneAdoptiImplementtiMtennce)frmewkcludemokeymultilevelctextulfcrlevntprogrmimplementtiAim1evlutecheffectiveneAA-MAPveruAA-SHRechproptiPWHwhomokegmkequttemptenrollttmentEffectiveneproptienrolledprticipnt(n=1200)whochievebiochemicllycfirmedpotpvlencebtence6mthfterenrollmentWehypoizecompdAA-SHAA-MAPhvelowerchmoeffectiveWeloetimtel-wldimpct(impct=cheffectivene)echterventiAim2evlutemulti-levelimplementtioutcome(egdoptiimplementtifidelyutbily)AA-MAPAA-SHARTclicettgugmixedmethodAim3cductcompheniveementourceuecotimplementgAA-MAPAA-SHclculteboluteltivecoteffectivene2terventitrtegieTheprojecthpotentiltrnmHIVcdeliverythroughoutcountryducebcco-ltedcncermbidieABSTRACTInub-ShrnAfric(SSA)humnppillomviru(HPV)HIVctedulburdendeecueignificntmbidymtlymcerviclcncer(CC)WomenlivgHIV(WLWH)hveix-foldhigherrkdevelopgpcncerouleipertprogCCwhichledgcuecncermtlymgwomenKenySignificntupptGoFurrcmpignpentedduchPidentEmergencyPlnAIDSRelief(PEPFAR)GegeWBuhIntuteUNAIDSMerckRochetegrteCCcengHIVclicpentnexceptilopptunycleCCimpctcroSSAbunlyifimplementticienceevidencevilblemtrtegyCurntlyimpctGoFurrhenundermedfrctudlkgecenivecengmethodKenylethn2%WLWHcenedhveceivedpproprettmentImplementticiencetudieneededtterunderturmountbrriertegrtedcpubliclyfundedHIVclicSpecificllyweneedexplovtetrtegieovercomeptient-provider-ytem-levelbrrierimplementgCCcengferrlguidelelkWLWHwhoquifurrdignotictetg/ttmenteffectivecceiblecdocumenterviceccountbilyqulyimprovementInthpropolourtempplyouxteniveimplementticienceexperteprtnerhipKenyMtryHelth(MOH)dpttetevidence-bedtrtegie(egHPVelf-tetgcnvigrWEMAmHelthpp[tetedcledTnzni])ddkeymulti-levelbrrieridentifiedthroughmtivetkeholder-enggederchpheUgEPISfrmewkguideourprojectweAim1)Explo(enggemulti-dciplrytkeholderdvybdco-deignterventipckgepriizeimplementtitrtegielignloclcpcyopptuniemotivtiAim1b)Pp(developoltngncpcytclicimplementtrtegieAim2)Implementevlutepckgeimplementtitrtegievicluter-romizedteppedwedgetril9clic(egimplementti[proviCCcengHPVelf-tetg]effectivene[proptiHPV-poiveWLWHwhoceiveubequentdignotictrige/ttment]overmth0-12Aim3)eSutbily(cotcot-effectivenetrnferdeliverytudylocltffovermth13-18TheoverllgolthtudyemployrigouempiriclmethoddpttetimplementtitrtegieexpcopeHIVccentterlypcncerouCCleiutbleclblewyThroughprtnergKenyMOHthprojecthvecricltutilupptdemticpbilydictlympublichelthprcticepolicyferghighlikelihoodutblecncerimpctmgWLWHcndoptedcroSSAProjectSummryF>18yerMkeJohnHopkuniveriehveprtnedUgchrcterizeepidemiologyheptB(HBV)HIVco-fectidefeubequentequelecludghepcellulrcrcom(HCC)dvncecliclmngementThroughnNCI-upptedU54progrmwecductedelrgetwell-chrcterizedtudieHCCAfriccrugbothcentrlurbnnrnrurlgiUgMooverwehvepermedmixed-methoderchidentifyknowledgecliclbrrierimplementtiHBVcengdignoHIVcettgRecentlyourcollbtivetemuccefullycompleteddemtrtiprojectfocuedtegrtgHBVdignoticttmenterviceHIVcWetNilegilolunchednimplementtiementntentlccengdeliveryHepBbirthdoevcctmultipleecroUgImptntlyburdenlethlyHCCcnuccefullymeledimplementtievidence-bedctextullypproprepventicengdignoticttmentterventiHoweveremeuhvenotencomphenivelyimplementedroutecettgUghighHCCburdengiub-ShrnAfricLeverggthlg-tgwkUgourpropoedbundleterventiLiverCncerCompheniveCtrol(LC3)pckgecptedignotictetgttmentHBVprimrypventhroughvcctiuceptibledultferrlliverdeetggctiveurveillnceerlyHCCdetectimgt-rkpopultiWetegrteLC3pckgeextgHIVcdeliverypltmmgdultlivgHIVUgOuroverrchggoldemtrtecheffectivenemtenncedelivergLC3erviceHIVcettgSuccefulimplementtiLC3UgervemodeltegrtgcomplexcncerctrolterventipckgeextgHIVcdeliveryytemcroimilrcountrieub-ShrnAfricPROJECTSUMMARYCerviclcncerpventbleyetmemotcommcuecncer-lteddethwomenlow-middle-comecountrie(LMIC)Fewdeeflectgloblequiemuchcerviclcncercidencemtlyrte2-3timehigherLMICcompdrichercountrieFurrwomenlivgHIV(WLH)ixtimemolikelydevelopcerviclcncercompdwomenwhoHIV-negtiveRechgWLHwhothighrkdevelopgcerviclcncerquitegrtipventivecengttmentervicebothdee(cerviclcncerHIV)ceefficienciemximizeimpctFmothntwodecdeercherhvevetigtedlterntivepprochecerviclcncercengmximizeirimpctLMICculmtgtrgendementhumnppillomviru(HPV)tetgprimrycengcurntWldHelthOrgnizti(WHO)guideleImptntlyWLHmgwhomHPVco-fectiexceptillyhighpprocheknownScenTrigeTt(iSTAR)hveendemtrtedfeeffectiveTheScenTrigeTtpprochdeignedimplementtiglevducettriuehelthcpernelexperteoptimllymximlefficiencyInpeRFA-CA-23-033ourtudyeekidentifyundertdeveloptrtegieddbrrierdoptegrtiutbilyevidence-bedcncerctrolterventimgperHIVLMICToendwepropoeuebundletrtegie(mHelthclicldeciupptolprcticefciltiptienteductimteril)implementWHO-endediSTARpprochcerviclcncercengWLHLRomnDomicnRepublic(DR)TheextgcerviclcncercengprogrmDRefficienteffectiveultgehighetdeeburdenwldInpethneedclicltemtClnicdeFmilipprochedexpertcerviclcncerctrolHIVmticimplementticiencetColumbiUniveryemblemultidciplrytemovercomecurntchllengeprovidgcerviclcncercengwomenttendgirclicTheoverllgolthprojectutimplementtievidence-bediSTARpprochcerviclcncercengWLHgenertenewdtmeffectiveequbleimplementtiwiderclePROJECTABSTRACTEchyermothn500000womendignoedcerviclcncer(CxC)pventblecncercuedhumnppillomviru(HPV)dproptelyburdenlow-middle-comecountrie(LMIC)WomenlivgHIV(WLHIV)upixtimemolikelydevelopCxCmkgmnepecillyimptnttrgetpopultipventictroleftInEthiopintilCxCcengprogrmwetblhed2016cengguideleWLHIVhvecentlyenupdtedhiftvulpecticeticcid(VIA)humnppillomviru(HPV)DNAtetgThelimeddnproviderfcilydhencecen-trige-ttguidelelghmHPVtetgUp30%WLHIVcenpoiveHPVproptipproprelytrigedVIAttedifneededcurntlyunknownImplementtichllengeCxCcengptedhelthprovidercludehighvribilyprcticetweencengeufficienttrgmirgevlutiWeeekexploddechllengethroughnimplementticiencetudypot--cHPVelf-mplgtegrtedrouteHIVcntrovirlrpy(ART)clichoplleverggetblhedHIVcfrtructuimprovedcncerctrolWLHIVAmixedmethodutilnlycducteddecriextgtegrtiCxCcengHIVchoplidentifyopptunieoptimiztegrtederviceefcilydeimproveccdecProjectECHOfciltedvirtullernercommunyhelthpiluedpromoteexperiencehrgtweenfivehoplwhichtwolow-permgeceivetenivetechnicltncecepropticen-poivedividulpproprelytrigedttedAcceptbilypproprenefeibily(implementtioutcome)eedECHO(1)prticipti(2)tfcti(3)impcnknowledge(4)impcncfidence(5)impcnpilprcticeFllycotgimevlutecot-nefProjectECHOtechniclupptmdeci-mkgroundutbilythpprochimprovedcncerctrolpeoplelivgHIVThtudyctentgolRFA-CA-23-033FOAImplementtiScienceCncerCtrolPeopleLivgHIVLow-Middle-IncomeCountrieidentifygddguniquepublichelthneedLMICpopulthroughutilnlydemtrtgpotentilbroderimplementtegrtedCxCcengptient-centedHPVelf-mplgWLHIVLMIClow-ourceettgcidergcle-uputbilytermtrigettmentcovergeimplementticotBycidergenticengccdethtudygenerteimptntightgoydcenguptkedvnceCxCctrolWLHIVLMICmoveneedleelimtinlmotentilypventblecncerunjutlyimpctub-ShrnAfricABSTRACTOver69000womenlivgHIV(WLWH)Ghnhveix-foldcedrkdevelopgcerviclcncer1quierlyfquentcerviclcncerceng(CCS)2-4HowevervilbledtGhnhowCCSrtemgeligiblewomenlow27%noevidenceWLWHcenthigherrte5InpeneedceuptkeCCSmgWLWHourtemdevelopedHome-bedelf-mplgcerviclcncerPventiEducti(HOPE)terventiHOPEctHPVelf-mplgcomd3R(RefrmgRepriizgRemg)communictimodelpromotgCCSInromizedctrolledtril(RCT)GhnwedemtrtedHOPEignificntlycedCCSmgWLWH(100%)vrouteclic-bedceng(1464%)8Prticiptgwomenfoundelf-mplg3Rcommunictimodelcceptbleculturllyppropre8High-impctimplementtitrtegieneededtegrtecleupHPVelf-mplgwomenhelthcGhnWepropoedevelop/dptimplementtitrtegiemximizeucceHOPEterventicghelthytemdoptiptientuptkeutmentCCSmgWLWHOurpropoedhybridtype2effectivene-implementtiRCTtrillevergeextgltihipecdry-levelhelthfcilieGhnWeelectfourecdry-levelhelthfciliecomprblefrtructuWLWHptientenrollmentUgExpltiPprtiImplementtiSutment(EPIS)frmewk1011weddfollowgpecificimAim1Todevelopculturllyppropreevidence-bedhelthytemimplementtiplnprovidertrgctentuccefulHOPEimplementti(Pprtiphe)Throughnomlgrouptechniqueweupptenggedtkeholderelectgpriizgdptgculturllyppropreimplementtiuppttrtegie(ISS)HOPEAim2AeeffectiveneHOPE20terventiucceimplementtiplnhybridtype2tril(Implementtiphe)Wecducthybridtype2effectivene-implementtiRCTevluteimpctimplementtitrtegieFourHIVecdry-levelcliccluter-romized11two-rmRCTHelthcproviderterventigroup(IGArm1)ceiveevidence-bedtrgvlidtedAim1AftertrgtdprovidercruWLWH(n=576)irHIVfcilieimplementHOPEProviderctrolgroup(CGArm2)whottdourISSmterilcruWLWH(n=576)implementHOPEirclicAim3AeimpctimplementtiplnutmentHOPEterventtudye(Sutmentphe)WeeimpctHOPEWLWHcenghviimpcttrtegymterilproviderelf-efficcyimplementgHOPEcrotudyrmProjectSummry/AbtrctHumnppillomviru(HPV)vccticriclcncerctrolterventiprticulrlyource-ctdhelthytemlimedccecengttmenterviceMlwilikemnyAfricncountriehtroducedntilHPVvcceprogrmtrgetgpdolecentgirlcovergemverylowClicincommendtiHPVvcctihighlyeffectiveevidence-bedterventicguptkevcceltlemtihowencourgeclicinlow-middle-comecountriedeliverthcommendtiTheKupewproject(pventChichew)im(A)identifyoptimlimplementtitrtegiecgclicincommendtiHPVvcctigirlyoungwomenged9-24wholivgHIVMlwi(B)fetheptimizedtrtegiecludgmtibouttrtegieimplementbily(C)ultimtelyidentifyettrtegieeffectiveimplementblehowutedeffect18mthfterterventiendThetudymedTheoticlDomFrmewkWldHelthOrgniztiBehviourlSocilDriver(BeSD)vcctifrmewkToourknowledgethwouldmgfirtpplictiterventioptimiztilgideimplementticiencemgfirtcductedlow-comecountryTheprojectlevergerobuterchprtnerhiptweentutihighly-qulifiedvetigrMlwiUSwggementprtnerMlwiMtryHelthllphecceptuliztitudyexecutiultterpttidemtiClicin-fcgimplementtitrtegiepromotevccticommendtilow-middle-comecountrieundertudiedurgentlyneededccelerteHPVvcctiprogrmglobllyThtudyprovidemuch-neededightwypromoteclicincommendtiHPVvcctihighet-rkgirlyoungwomencountryecd-highetburdencerviclcncerglobllyPROJECTSUMMARYANDABSTRACTEveryyerpproximtely300000womendiecerviclcncerover90%thoedethoccurrglow-middle-comecountrie(LMIC)1Themjycerviclcncerpventblethroughvcctigthigh-rktypehumnppillomviru(HPV)virucuenerlyllcerviclcncercengttmentpcncerouleimgwomenldyfectedHPVIn2021WHOcommendedHPVtetgmgwomenged25-49yerllcerviclcncercengprogrmwldwide3DepethcommendticcefdbleHPVtetgmbrrierdtelimedfieldexperienceHPVtetgcroub-ShrnAfric(SSA)HPVelf-mplgholdgtpromeimprovgccecengpromotgequycgctroloverwhewhenhowwomencenedPlimrydttwocenttudiecductedMDAnderMozmbiquehvehowncerviclcncercengHPVDNAtetgfeibleMozmbiqueprticipnttudypferdelf-collectipproche1112GuidedKnowledge--Acticceptulfrmewkwhichwdeignedenhnceuptkeevidence-bedprcticecliclcwepropoehybridtypeIIIeffectiveneimplementtriltetimplementtitprcticedeploygScen&Ttpprochcerviclcncercengutilizgelf-collectedHPVDNAtetgHIVcttmentelecthelthfcilieThpropoldictlyddebilyfelycle-upScen&TtpprochcerviclcncercengWepropoecplizepoolcen-eligiblewomenccegroutectrgetedHIVcttmenterviceTheprimryoutcometetnumrwomencenednumrcen-poivewomenundergogttmentSecdryoutcomefocuimplementtioutcomeifuccefulutilizedmfutuerchtkethpprochclecroMozmbiqueABSTRACTRISEUP(RevolutiizgInvetigtiLkScengExperimentlTherpeuticUpendPrognoBtCncer)brgnterdciplrypventi-focuedpprochchllengeelimtgbtcncermtlyWeimlevergewhtweknowbouttrgetedbtcncerttmentdevelopnovelwypprochbtcncerpventiThecfencebrggernterntilgroupexpertmnybckgrounddciplecludg(notlimed!)phyicincrowomenhelthpeciltie(cologtgynecologtrdiologtprimrycprovider)biccienttdvocteentpneurpolicymkergulrvetmentlederWepplythvriedexpertethemfocu1)combggrowgknowledgeboutnewbtcncerubtypettmentuccefullyelimtetumerly-tgeettgtrtegieubtypepecificpventi2)explghowtpplytrildeignugerlyendpotccelertelerngfundgFDApprovlcengpventi3)tegrtgknowledgebtcncerttmentpventipprochehmlcyclectrolUltimtelywehopeueourknowledgeboutbtcncermultehmlctrolproductmilliwomentkeducebtcncercidenceTheeventcttlkpotereifotercrodciplrylernghighlighterchprkidectiGenerleideignedeductettendeeboupptunieimprovehelthwell-gwomenpventtmentbtcncerwellmngementcyclectrolctrceptimenopueexulhelthOurgolbridgecriclgpknowledgebtpeciltgynecologtmkebtcncermngementtterenggegynecologicprimryccommunyimprovementbtcncercengpventhkhmlctrolcroctuumwomnlifeneyewrdbtcncerpventiThecfencedeignedfoterqueticollbtioverllgenertinewidewythkgboutbtcncerThenooverlppgeiollttendeecomeoutcommetknowledgebilyimproveirprcticeupendwywethkboutbtcncerpventiThecfenceheldNovemr1-32024tHotelNikkoSnFrnccoWehopeentpneurilpirSilicVlleyenergizettendeechllengettuquoctThnotiideimplementtibuiltcfenceweholdcompeticptebtcncerpventihme-bedcwomenldyceive--prizewkgByAbiotechledermkeidelyPROJECTSUMMARY/ABSTRACTTheSocietyIntegrtiveOncology(SIO)21tInterntilCfenceFullCircleTrnltilIntegrtiveOncologyBedideBenchBck-Thetrnmtivepowercliclobervtiignecientificdcoveryoptimizeptienutcomeimencourgecientificcliclcollbticrogloblter-pilboundriedvnceknowledgerpiecdeliveryultimtelyimprovequlylifeclicloutcomedividulfmilielivgcncerroundwldThyercfenceSIO2024focudemtgimptntprcticlfdgtegrtivecologyerchhvepotentiltrnmcncercThthe-dymeetgheldOrngeCountyCAOcr25Ocr272024hotedCyHope(COH)SIO2024fetuthekeynotelectuhighlightcfenceme1)noverviewnewetimmune-cologypprochefocuCART-cellrpy2)nturlproductdrugdcoverynticncerrpy3)terectipirulytegrtivecologyThecfencecludethemodertedplenrypnelfocucurntttecience1)nturlproductimmunpy2)nutrimetbolomic3)pplygrtificiltelligence/mchelerngtegrtivecologyThecfencelocludeeveneductileiwkhopfiveccurnrlbtrcteitheluncheifocugnutrimd-bodymedicedivery&equytegrtivecologywellptientdvoccyte/newvetigrtrckWeolictlet75lup150poterpenttiiglerchmemrntilterntilerchcommunyThecfencepecificim1)ctenterntilumwhichercherclicinteptientdvoctenemphdiverycludgwomenmiecnlernboutdcucurntevidenceterplytegrtivecologyerchcliclpplictienhnceirundertgdvntgechllengethfield2)fotercricldiloguecollbtiopptuniemgercherhelthpilptientdvoctetngntrnltilpotentilclicllevncefutuerchtegrtivecology3)uppttrgerlyvetigrptientdvocteterptdemtedevelopevidence-bedtegrtivecologyerchUltimtelywehopeSIO2024improveoutcomecncercptientcommunieroundwldPROJECTSUMMARYThePuerRicoCncerReerchMeetg(PRCRM)hotedUniveriddCentrldelCriSchoolMedice(UCC-SOM)imbridgegpcncererchddgchllengefcedloclcientttudentduegeogrphicllimtiAecdledgcuedethPuerRicocombtgcncermtlyrtecomecrucilLimedcceourcetrictopptunietudentercherttendntilcientificmeetgThe-dynnulcfenceneentilpltmfciltecro-dciplryexchngemgunderpentedvetigrteptientdvoctecncerurvivItcompdivereeicludgplenrylectudtguhederchercncer/urvivdvoccytlktehttlkeipoternetwkgeiwellUCCgrduteprogrmmtieiWhprimryemphpromotgdiverycluhmeetgtrgetunderpentedcientttudentdiverebckgroundFmerttendeeptPRCRMedinowctrigpotdocrlfellowerchteidenteteemedloclntiltutiThemeetgpecificim1)TopromotedemtibiccienceltetcliclerchcncerpventirpytncenovtivettmentmetthelthdprieudiencePuerRico2)ToempowerunderpentedtebiomediclwkcePuerRicoprticiptgprtnertutiprovidgpieergcientificumgivgmignificntntilvenuehirerchwk3)TotngnnetwkgcollbtiveefttweenloclntiltutifotergdiverecluivetemwkgenvirmenttefcultycncerurvivAnticiptedoutcomePRCRMcludetimultinewerchcollbtidevelopmentgrntpropoltedvncedceropptunieignificntdvncementcncererchThivehpotentilignificntlycediverybiomediclwkceervemodelcountriemechllengePROJECTSUMMARYThemgolRUNX1ReerchProgrm8thAnnulScientificCfencePtientMeetgctedynmiccvengderfotercollbtiprovideopptunieknowledgedthrgmgdivereetercherclicinptientirfmilierdeeclledRUNX1fmililplteletdderpdpoihemlogicmlignncie(RUNX1-FPDFPDMM)Individuldderhve35-50%lifetimerkdevelopghemlogicmlignncyOfthoewhodevelopmlignncyover50%dignoedAMLInlycvengkdctuenimptntprtdcoveryfuturpiedderwellnopptunyerlycervetigrpotgrdutetudentpentirerchCfenceprticiptihgrownechyerWehdover181ttendeevirtulcfence2021In2022wehd130dividul-40ptient90cienttclicingeneticcounel-whottended-perPrcenNJDueNCATS/NIHfundgweweblewrdfive(5)deervgyoungvetigrtrvelcholrhipttendcfence2022penttpotereiIn2023weturnedvirtulmt397gtrnt219prticipntWelocegheldpotereifour(4)youngvetigr-thewhichwewomenewAfricn-AmericnInpviouyerover50%erchttendeewewomen30%ttendeewepot-docgrdutetudent15%dependentvetigrwe5yerleirfirtfcultypoiWeplnctueenggedivereudiencevetigrRRPcommtedengggptientclicin/ercherunderpentedrcilethnicgroupbrodenprticiptiecommunieurcfenceydThegendcludeerch-pecificeiopenlltkeholderwelltrckdedictedRUNX1-FPDptientfmilymemrTheobjectivepromotedriveptient-enggederchwrddictptientputdevelopmentplnngeiviour23-memrReerchGuidedPtientCommtee(RGPC)TheerchfocuedptimeetgbrggerexpertfieldhemlogyimmunologycologycellrpybicciencewhocommteduncovergmechnmunderlygpthogeneRUNX1-FPDgoldevelopgrpeuticterventiimpctbothbleedguemotimptntlypdpoimlignncyTheudiencecludevetigrdevotedtudygRUNX1leukemiprogicllhempoiegeneedghempoietictemcelltrnplntIthcomecglyclerthroughNHGRI-podnturlhrytudyRUNX1-FPDimmunedyfunctiflmmryddercommRUNX1-FPDcludeuniqueptientpopultiwhemynexutweenimmunologycologybedentilyctivyglemtergulrRUNX1Abtrct/SummryProtephophteplykeyrolecellulrignlgpthwyoppogkectivydynmicllyblnceprotephophyltiDepeircriclrolecellignlgymundertudiedcompdprotekeWeubmtgnpplictiquetguppt2024ediFedertiAmericnSocietieExperimentlBiology(FASEB)ScienceReerchCfenceProtePhophteFover34yerthcfencehexplodroleprotephophtenmlphyiologypthologiclcdiRecenterchhexpedourundertgfunctigultimothn1000mecomplexenzymeidentifygmtegrlcellulrhomeotAuchrolepecificphophteirocednewlyidentifiedmuttifoundculvrietyhumndeectueelucidtedbictrnltilcliclerchercrocdemidutrywkdeciphercomplexiephopho-gultedpthwyidentifynovelrpeutictrgetThProtePhophtecfenceneffectivefocuedumhelpeductenewcomerdemtetegrtecentdvncethrpidlygrowgchnggfieldHighlightgcriclrolecientificcommunythcfence17thedicurrgeriebi-nnulFASEBmeetgheldctuoulyce1990ctueolemeetgNthAmericthpicWeplnng2024cfencectuemerger(ecdtime)tweentwolget-tgwldprotephophtecfenceFASEBprotephophtecfenceJpneeAociProtePhophteReerch(JAPPR)cfenceTheSpecificAim2024FASEB-JAPPRCfenceProtePhophte1)pentdcumotcurntwktructugultifunctiprotephophte2)highlightmjchievementnewpprochefueltetdutrilcdemicgroupdrugggphophte3)fhnewfieldthroughenggementdevelopmenterlycervetigr(ECI)underpenteddividul(URI)cludgwomenThpplictiquetlimedfncilupptprticulrlyvtiECIURIttendctriethjotcfenceheldPlmSprgCliniDecemr2024PROJECTSUMMARYPncticductldenocrcom(PDAC)emotggivemcncerknownproundimmuneuppitncemotrpieOnetrtegyovercomeebrrierlevergeeffecttrd--cchempyceextrcellulrATPpromotenti-tumflmmtiHoweverPDACexphighlevelecnucleotideENPP1CD39CD73quicklycvertextrcellulrATPleeddygtumcellimmunouppivedenoeIncentPheIA/1BclicltriltUCLAptientBderleReectblePDAC(NCT03970252)neodjuvntFOLFIRINOXchempyPD-1hibiproducedchngemopermiventi-tumimmunemicroenvirment(TME)wocedexcellenverllurvivlHowevercompenrydenoeignlgcedpot-ttmenttumpotentillyhdergnti-tumimmunyTotrtegicllyddthproblemfollow-upPhe1/2tril(NCT05688215)wedtUCLAcollbtiArcuBiociencetroducemllmoleculehibirCD73neodjuvntFOLFIRINOXPD-1hibilimdenoePDACTMEThpropolimextenivelyevlutep-pot-ttmentptientpecimenrildefeimpctCD73hibumdenoemetbolmignlg-mededimmunouppi(Aim1)PdicrpetnceCD73hibiidentifiedInAim2uchthoutummodelimplntblemodelmetthumntumexplntueddeferoleENPP1CD39gulrATPbkdownwherycooperteCD73genertedenoeInddiATPecnucleotideENPP1degrdenturlSTINGligcGAMPloleedtumcellfterDNAdmggchempyfurrducenti-tumflmmtiTheepropoedtudieAim3buildnovelplimrydthowgdenoedictlyhibSTINGctivtimyeloidcellexplowherENPP1hibicooperteCD73hibir-mededdenoedepletienhnceSTINGignlgTMETheeexperimentdrwnewlydevelopednti-humnENPP1ntibodyENPP1humnizedmouemodelAtrndciplrytemexpertePDACbiologytumimmunologyclicltrilbiomticbiottticmpectrometrytrgtrckcdwkggerhenembledcompletepropoedtudieThprojectnlyprovidecompheniveundertgATPdenoemetbolmPDACTMEloidentifyimmunologiccequenceechngeOverllhpotentildvncettmenutcomeptientthchllenggcncertypeeffectivelyvergdenoe-mededimmunouppiunlehfullpotencychemo-immunpyPROJECTSUMMARY/ABSTRACTThepropoedtudyeekdetermeifDNAmethyltrnferememrmicrobiotctriebcterilpthodpttumnichedictxenogeneicepi-modifictihumngenomecnexploedrpeutictrgetcncerpventi/ttmentWhptienttummlignntcellurroundedcomplexmicroenvirmentencompgrngen-trnmedcelllodiverecollectimicrognmFexmpleFuobcteriumnucletum(Fn)ignificntlyenrichedcoloctldenocrcomcompddjcentnmltueAlthoughcellulrnimlmodelhveupptedrolethbcteriumcnceriprogiwetillhveltlemtihowydictlyctriecncerInpublhedwkourgrouphdemtrtedFnwhichuullyprrlmicrobiomenotfoundlowergtrotetltrctnvivetrcellulrbcteriumeffectivelycolizecoloctlcncer(CRC)nicheInplimrytudieweoltedchrcterizedgenomeepigenome>150FntrCRCtumlcvydcovedFnubpecieFnubpnimltwodtctcldedifferirenrichmentCRCwhichwenmedFnl-cldeFnCRC-cldeWehowFnCRC-cldelyFngroupignificntlyenrichedhumntumfeclpecimenOfmnydiffencetweenetwocldeperhpemottrikgirdtctDNAmethylomeigntuCRC-cldeuniquelyhrbgGm6ANTCmethyl-modifictiWeehypoizeDNAmethyl-modifygenzyme(MFnI)piblem6AmethyltthmotifctrieFnCRC-cldevirulencedurgcrcogeneWepropoetetthhypouggeneticllyengeedCRC-cldeclicloltecellcultunimlmodelexperimentdetermeifMFnIgultebcterilgeneexpipromoteirpthodptti(Aim1)AddillywepeculteMFnIcnctnucleomoduldictlyterfehumnhotepigenomegenegultiWevetigtethpoibilythroughecpicexpiMFnIhumnCRCcelllep-cncergnoidmodeldeletenucleomodulpotentil(Aim2)FllyweeekdevelopchemiclpropecificMFnIiduntictgrpeutictrgetCRCpventiprogi(Aim3)WhilewefocuheglepthogengledeeuccefulcompletieimprovidefundmentlknowledgerolemicrobilepigeneticytemtumcolizgmicroFurrthwkhpotentilvelhiddenprdigmhotmicro-epigeneticcrotlkunderlygcogenicprocebcteril-colizedhypermethyltedtumAuchifourcohypotruethwkcouldhvefr-chgimpctydCRCABSTRACTThcfencegrntpplictiquetfundhelpuppt2024InterntilCfenceEBV&KSHVThecfenceheldtBonPrkPlzHotelThjotcfenceuniquenovtivecomInterntilWkhopKpoSrcom-AocedHerpeviru(KSHV)ReltedAgentInterntilSympoiumEpte-BrrViru(EBV)AocedDeeThefunduedducecfencegtrticotouttgp-pot-docrltehricllyunder-pentedmiecludgthoeunderervedThegolemeetgctentmittementNIHNCINIAIDNIDCRnmelydvncepromotepceerchfectiocedhumncncerdeecludgettgHIV-AIDSThejotEBV&KSHVMeetgheldJune29thJuly3rd2024AllmgcotecfencedgtrtifeepidcfeectriifoundtiphrmceuticlbiotechnologycompnieThemfocuEBV&KSHVmeetgbiologycogenicherpevirueocedhumndeepecificemphvirlpthogenevirlltencyctivtivirlgeneexpiplictihotpefectiuimmunyepidemiologyvccedevelopmentrpeuticterventiInddiEBVKSHVtudieltedHerpeviruimirimuherpeviru-68rheurhdovirurheulymphocrypvirupentedThecomdEBV/KSHVcfencehnotenheldce2018optimizepotentilynergticterctimgcfeepotentilnewcollbtiPROJECTSUMMARY/ABSTRACTProttecncer(PC)clicllymoleculrheterogenoudeedtctubtypeTheeubtypeocedchrcterticgenomicltertigeneexpiprilettmentpeimplygtrulydtctbiologyWehvedefedeuchmoleculrubclPCchrcterizedcurntmenemuttiubiquligeSPOP--pentgbout10-15%PCbothprimrymettticdeeTheeSPOPmutntcncerdplydtctbiologyperpieHoweverkeyplyerSPOPpthwyfluencgctiPCbroderbilypecificllytrgetthxptientnefmcompletelyunderodPlimrydtgenertedourmultidciplrycollbtivegrouphvedefednovelelementSPOPignlgpthwycludguptmgulrG3BP1uggetubclPCdefeddegultiSPOPignlgpfentillytrgetblenovelrpeuticterventiTheoverllobjectivethpropoldefemechnticbiologiclrpeuticcequenceltertiSPOPignlgpthwycludguptmgulrG3BP1UgnovelmodelhumnprottecncermpleourplimrydtdemtrtenovelendogenouhibirSPOPubiquligeG3BP1cnpotentillyphenocopycogeniceffectSPOPmuttimodultheffectmllmoleculehibircnviblerpeutictrtegyFurrmowehowmodultgSPOPctivyprogrmrogencepr(AR)functhroughkeydowntmubtrteltergchromtcceibilytrncriptidrivenARmkgecncerhighlylinnARctivyThprojectelucidtemoleculrdetilunderlygephenomenthroughfollowgAim1)deferoleG3BP1-drivgprottetumigenemodelytemhumnprottecncerbilytrgetthuptmx2)etblhrpeuticpotentiltrgetgSPOPxmodultgtrgetbledowntmignlgnodeToccomplhthwelevergeuniquebiologicllyclicllylevntmodelytemnovelmllmoleculehibirnovtivepprochemodultgubiquligeignlgdthumnprottecncermpleThprojectdefecricldependenciepecificubtypeprottecncerbroderpplicbilyttmentpeprovidefoundtipciclicltrilnoveltrtegiettckthubclcncerPROJECTSUMMARYPltumdruguchcpltervemtycncerrpytncelimircurtivepotentilThroughkome-wideRNAicenweidentifiedmicrotubule-ocede/theke1(MAST1)mcplttncedriverhumncnceridentifiedleturtibpromgMAST1hibirMAST1wfoundctivteMEK1pthwycferrgcplttnceHoweverwedotknowhowthpivotlfcrMAST1ctivtedexpedocedcogenicmuttiThroughproteomictudymuttilnlyweidentifiedurkeB(AURKB)nuptmkephophylteMAST1tS1258criclMAST1ctivtiOurtrncriptifcrtudyveledtrncriptifcrCEBPbpibleMAST1geneexpiwildtypep53hibctivyCEBPbduceMAST1InlethobervtiTCGAnlyveledMAST1expihighlungcncerptientmutntp53TheedtuggetAURKBp53/CEBPbmygulteMAST1trncripti-dependent-dependentmnnerRecentlycncerhendictedmetbolicdeelteduniquemetbolicpropertiecncercellmkecncermetbolmnttrctivetrgetttgcncerHoweverlktweenMAST1cellulrmetbolmhneverenexplodThroughl-timecellmetbolicnlymetbolomicprilgwefoundMAST1elevteglucoeuptkectroldoxmetbolmwhencellexpoedcpltWenoticedMAST1volvedgeneductiglucoetrnpter1(GLUT1)peroxidox2(PRX2)FurrmoMAST1dictlyphophyltec-myctS62mytbilizec-mycpotentiltrncriptigulrGLUT1PRX2TheeplimrydtuggetMAST1myplycriclrolemetbolicprogrmmgcncercellTofurrnefMAST1rpywepermedkehibirynergycenidentifiedcombtileturtibptibnoptimlcombriltrtegyovercomecplttnceMooverleturtibBAY-876(GLUT1hibir)ynergticllyenhncedcpltenivyvrioucncercellOurcentrlhypoMAST1modultedAURKBCEBPbprovidemetbolicdvntgecncercellcfercplttnceMAST1ignlgxlkedAURKB/CEBPbGLUT1/PRX2pentpromgcplt-enizgtrgetThepecificimpropoed(1)TodetermehowMAST1gultedAURKBp53/CEBPb(2)TodeciphermechnmhowMAST1-c-myc-GLUT1PRX2ignlgcfermetbolicdvntge(3)ToevluteoptimlMAST1-bedcombriltrtegyttgcplt-tntcncerProjectSummry/AbtrctThecriclneedmoeffectivedurbleprottecncerttmentProttecncer(PC)motfquentlydignoedcncermgmenecdledgcuemlecncerdethUSThedevelopmentprogicurncePCdependennAndrogenRecepr(AR)Thhleduenti-rogenrpieduceendogenouteroidhmeproductiwellueARntgtUntuntelynerlyllptientceivgthrogendeprivtirpy(ADT)developtnceprogctrtitntPC(CRPC)TheprognoCRPCpomedinurvivl~3yertmediclrpyInhtCRPChpottmenptiprognofterpentgclerignificntneednewttmentLigctivtedtrncriptifcr(TF)ideTFhvetrdillyenviewedundruggblelthoughthprdigmrpidlyhiftgThetrgetgTFdrugdevelopmenthtmendoupotentilbedirwell-documentedrolecncertemneimmuneeviugulrydrivercircudrugtnceThetrncriptifcrERGpdomnttrgetchromoomltrnloctiTMPRSS2egenefuioberved~50%prottecncerptientAexpiTMPRSS2ARgultedthgenefuiultARdrivenover-expiERGeprottecncerMultiplemodelytemhvecfirmeddriverntuERGprottecncerfirmlyetblhgERGvlidtedrpeutictrgetPCToendwepropogfurrdeveloplgtrnltilpipelenovelmllmoleculehibirtrncriptifcrERGnewpprochttmentPCWepropogtwoAimthgrntAim1OptimiztimllmoleculehibirERGWedevelopedhibirERG-DNAbdghighnnomolrMcellulrefficcypecificyvihetero-bivlenthibircomfrgmenttbilizeuhibiERGfrgmentcovlentlyctERGInAim1wefurroptimizeehibirpotencypecificyTheyevlutedpotencyelectivyEtfmilyugbiochemiclycellulrpecificyugmpecbedchemoproteomicpprocheAim2PcliclevlutiERGhibirWeprileeffecthibirprottecncercellle(prolifertipopcellcyclemigrti)EffectgeneexpiERGoccupncywell-vlidtedtrgetgeneevlutedddigenomewideprilggeneexpiERGoccupncygenomepeERGhibiInhibirtetedugnexvivoprottecncerptienttuemodelptientderivedxenogrftPROJECTSUMMARYTheoverllgolthpropolobtfundguppterly-cerercher(iePhDtudentpotdocrlfellow)junifcultyttend2024FASEBScientificReerchCfenceHippopthwyBiologyDeeheldtCrownePlzMelbourne-OcenfrtMelbourneFlidtweenNovemr10-142024TheHippopthwyfunctinumerouphyiologiclproceefquentlydygultedhumndeecludgcncerWecvenenouttgdiveregroupcienttwkgtefrtHippofieldgnewightHippopthwybrodbiologicleventltertictrigcncerhumndeenewcceptdrugdevelopmenttrgetgHippopthwyTochieveegolcfencefocumultiplepicltedHippopthwyerchwhichcludenotlimedmechnmHippoignlgHippopthwytemcelldevelopmentHippopthwycncerHippopthwyimmunologycncerimmunyHippo-beddrugdevelopmentTwocerdevelopmentwkhopeMeetExperteiplnnederly-cerercherjunifcultydurgcfenceThrougheexcgprogrmweim1)identifyknowledgegpopptuniecienttclicinnprdutryprtnerhdcucuttg-edgeerchHippopthwygultifunctirpy2)trnextgenerticientificlederprovidgnetwkgpildevelopmentlopptunieerly-cerercherjunifculty3)promoteprticiptipublicpenttiwomenunderpentedmieprovidgopptunieplenrytlktrvelgwrdpoter/wkhopdcui4)demteltetHippoignlgdcoveriepublhgproceedgcfencebootgnewcollbtiwrgco-uthodviewWecommtedbrggdiverecienttgerdcucientificdvncehcuttg-edgeerchfecluiveenvirmentThveryfirtFASEBHippocfencehvemjimpcnfieldccelertgtemcienceprovidguniqueopptunycro-fertiliztinewidetrgnextgenerticientificledercncererchPROJECTSUMMARYCellcommunictierchgrowgfieldcomplimentrydtcttrdilignltrn-ductifieldThemerggfieldemphizeptiotemplpectcellcommunictiqunttiveundertghowmtrnmiprocegoccurAcentrlfocufieldunder-texctlywhtdtguhenmldeecellignlghvermptiltempldetilThetlet80lbwldwideuelivecellimgggeneticllyencodedbioencompu-ttilimgenlymmticlmodeldetermemodernqunttivecceptcellcommuni-ctiHowevernotcurntlyextghomecfencebiomediclcienttwkgthfieldlimgcro-fertiliztihdhigher-levelcceptcromnypthwytudiedfieldcludgimmuneignlgcepr-mededignltrnductigeneexpicellcyclemetbolicignlgpthwyTheenurgentneedcfencewhichcnbrggerdiverygroupcellcommunictifieldhidedevelopmentwkfocughowcellcommunictioccurnmllyperturddeeToddthneedwefciltgnewcfence2024DynmicEncodgCellSignlgFASEBScientificReerchCfenceFfirttimewebrgger-pernterntilcommunycellcommunictifieldToccomplhthweim(1)providetructunemerggerchfieldetblhgbuildgltihipcollb-titweenenicientterlycerercherthroughnetwkgopptuniepekerleupcludgbotherlycerercheretblhedlederThclude20tetlkovercourecfenceLightengtlkhighlighttepoterencourgeterctinetwk-gtpotereitweenteetblhedvetigrWeim(2)provideteknowledgenetwkmenrceropptuniethroughmeetgnetwkgopptuniewtblhedercherbothdutrycdemiThfirtertimeetgim(3)ctenewmodelcnectgerchertetedltedcceptcrobiologicllydiffentignlggulryytemprovidgopptunieercherthkoutidetypiclboundrieirwkfdnewightcollegueprllelfieldWeloim(4)promoteccenewimgenlymodelgtechnologieemphizgltettechnicldvnceeThecfer-encelohighlightdiveryfieldouur31vedpeker13women10tutioutideUnedStteAlgerDynmicEncodgCellSignlgFASEBScientificReerchCfenceprovidemuchneededexcgumcellcommunictifielden-blecro-dciplrycollbtiightcellfunctihvinotcurntlypoiblePROJECTSUMMARY/ABSTRACTCncer-ltedcogniveimpirment(CRCI)commdtgmgcncerurvivAnundertudiedimpcttrgetedrpienewgenerticncerrpyTyroekehibir(TKI)mgfirtmotprolificmotuccefulcletrgetedrpyTKIrpidlyexpgover40FDA-pprovedTKIcncerWepropoetudyimpcttrgetedrpyCRCImgptientbouttrtTKIchricmyeloidleukemi(CML)chriclymphocyticleukemi(CLL)TheeidelmodeltudyimpcttrgetedrpyCRCIcueTKIuullyfirt-lerpyptientCMLCLLptienthemlogiccncerhveenundertudiedCRCIerchourplimrydtuggetCRCIignificntproblemptientCMLCLLeptientlohveexcellenturvivlWepropoefirtlrge-clepropectivetudyexmeimpctTKICRCIcludgpotentilrkfcrmechnmWenotethenovtivectriifieldCRCIFirtweexmebothubjectiveobjectiveCRCIugbothneuropychologiclmeu(CANTAB)uedourprintiwidetudieecologiclmomentryement(EMA)EMAimprovelibilyenivyobjectiveCRCIEMAttereeubjectivecognivelpeSecdcncercncerttmentpromoteccelertibiologiclggwhichocedcogniveimpirmentWeevlutewherccelertedepigeneticggltedvribilyCRCIThirdwepropoeidentifymodifiblehvilmodifiblerkfcrThwkmdevelopmentfututerventipvenrduceCRCIWecductfirttudyubjectiveobjectiveCRCImgTKIcipientCMLptientCLLWecru200ptientboutgTKICMLCML200ctrolmtchedgeexeductinohrycncerPrticipntcruedprtnerhipUniveryRocheterCncerCenterNCICommunyOncologyReerchProgrm(NCORP)ReerchBe30ntiwideffilettglrgepopultiCML/CLLptientTKIperyerAementoccurpritrtgTKI612mthltercludeCANTABbtterycogniveEMAvmrtpheptient-ptedoutcomewrt-wnctigrphyeleepcircdinfunctilivmpleWeimchrcterizediffenceobjectiveubjectivecncer-ltedcogniveimpirment(CRCI)tp-ttmentlgudllymgptientceivgTKICMLCLLWeloidentifyrkfcrCRCIedurgTKIrpyLtlyweidentifybiohvilmechnmunderlygeffectTKICRCIProjectSummryPloidyvricncerhllmrkfquentlyocedpoprognohigh-grdecncerSuchvricncludencechromoomeet(polyploidy)diffencechromoomeet(neuploidy)gilploidychngecopynumrvri(CNV)Genome-widetudiemultiplecncerpecimenhvehownwholegenomedoublgemotcommmoleculrbnmliehumncncercloelylkedcopynumrltertiHoweverhowexctlypolyploidyctrietumgrowthprogimlignncymlrgelyunclerUgimplehighlyproducibleDroophiltummodelwhenctivemNotch(NICD)drivetumigenenepililtrnize(TZ)ourplimrytudiedictetumprogidrivenoccurncepolyploidmiendoplictiploidyductidiviBothpolyploidmidepolyploidiztierr-precnledchromoomebnmlieuchCNVpolyneuploidyultgtrtumlheterogeneyDNAploidyComprtiveRNA-SeqnlyeveledDNAdmgepe(DDR)geneupgultedeNICD-TZtumGeneticepttudiehvefurrhownomeeDDRgenequidploidyductidiviAddillyetumhowexuldimphmgrdgtumgrowthprogiBedefdgwehypoizepolyploidyocedcell-cyclevrintcriclctuedtumgrowthcedtum-cellgenometbilydurgtumprogiTotetthhypowecrryouttudiepropoedfollowgtwoim(1)determehowpolyploidcelldivictrietumgrowthprogi(2)chrcterizeexuldimphmNICD-TZtummodelTheuccefulexecutipropoedtudieledtterundertgtrtumploidyheterogeneycncerevolutiwellimprovedtrtegiecncerpventtmentex-dependentmnnerPROJECTSUMMARYWepentnterdciplrytrgetdcoveryT-cellcepr(TCR)rpydevelopmentprogrmfocuedpltum-tnthigh-grdeerouovrincrcom(HGSOC)highlylethldeenoeffectivelg-termttmenttrgetedrpieNerlyllptientdignoedHGSOClpefterilttmentDeecurnce6mthpltumttmentctegizedpltum-tntHGSOCwhichhighlyftlOurtrtegydevelopTCR-bedrpiepltum-tnvrincncerlieunmkghiddendiverycncerproteomeproducedRNAdygultimRNAmvriRNAdygulticncercellcnproducenewepipethroughgenertinovelmRNAprotemcedcncerpecificyToidentifyufficientlycncer-pecificpeptidetrgetimmunpydevelopmenurpropoedtrtegyexpydtrgetdcoveryomticmuttileInprticulrlg-dRNAequencg(RNA-eq)powerfulpprochmnlytumntigendcoveryWepropoeexplomRNAmvriourcehdtumntigenpltum-tnvrincncerWefirtdefelcpefull-lengthmRNAmpltum-tnvrincncergenertgnlyzglg-dnnopoRNA-eqdtetcrobrodcohtptientthdeeWecouplethnlybigdtexmtilg-ht-dtrncripmeprilelrgepneltumnmltueecncerpecificySecdwedictlyypeptidepentedimmuneytemimmunopeptidomicexmentigenheterogeneygle-celllg-dnnopoRNA-eqIntegrtgemultiplem-omicnlyette---rtcomputtilepipepdictiwectehighlyprivilegedetpotentilTCRtrgetFllyweutilizenovelvrohumnrtificilthymicgnoid(ATO)cultu-bedTCRdcoverypltmrpidlycteelectctiveTCRTcellgenertedthroughdicteddiffentipluripotenttemcellAntigen-pecificTCRpclicllyevlutedrpeuticllylevntgentvrodoptiveTCR-Tcellrpyptient-derivedxenogrft(PDX)modelpltum-tnvrincncerWehveembledmulti-dciplrytemexperttUCLAChildnHoplPhildelphiexperteovrincncerbiologyttment(Memrzdeh)RNAgenomiccomputtilimmuno-cology(Xg)tumbiologyimmunology(MemrzdehSeetWte)T-celldevelopmentlbiology(Seet)OurercheekdcovernewclntigenircognteTCRpltum-tnvrincnceretblhirilefficcypcliclmodelPROJECTSUMMARYGtroeophgeldenocrcom(GEA)4thledgcuecncerdethwldwidemedinurvivl62mthptientwhopentmettticdeeUp10%GEAptienthowctivtifibrobltgrowthfcr2(FGFR2)ignlgdueFGFR2genemplificti/fuiFGFR2ovexpiocedlowerpechempypoprognoClicltriltrgetgFGFR2GEAcludeuebothntibodiemllmoleculeAPhe2clicltrilcombgtrd--cchempynnti-FGFR2mocllntibody(mruzumb)howedmengfulnotyetttticllyignificntimprovementprogi-feurvivlRecentclicldtdemtrteignificntimprovementprogi-feurvivlGEAptientttednFGFR2electivetyroekehibir(TKI)RLY4008HowevertnceTKIemergerpidlywehveidentified-trgettncemuttiFGFR2kedomGEAptientwhoprogRLY4008OnepprochovercomeTKItncemuttithroughcombtirpyntibodydrugcjugte(ADC)StrdntibodiecludgmruzumbdotignificntlyttenuteFGFR2ignlglikelyduebivlentntuntibodiemtceprdimerbenceligBiprpicntibodie(BipAb)howevercognizetwodtctepipemeproteledgenhncedphrmcologicctivyThuwected15BipAbcombti6FGFR2ntibodietrgetgextrcellulrdomFGFR2whichtedbothFGFR2mplifiedFGFR2fui-poiveGEATwoourFGFR2BipAbhowmrkedlycedvidyceprdegrdtimededlyoomlpthwyvrovivoctivygtFGFR2-fuiFurrmoilexperimenthowetwobipAbctiveGEAcellleADCTheignificntcliclctivyADCtrtuzumb-deruxtecnHER2+GEAuggetthlker-pylodcombtrgetgFGFR2houldtetedFGFR2+GEAInthpropolwe1)utilizenovelimmunecompetentmouemodelFGFR2mplifiedGEAFGFR2fui-poiveGEAdeveloptethighlyefficciouFGFR2bipAbntibody-drugcjugtelecombtiimmunecheckpothibir2)developcombtitrtegieFGFR2bipAbTKIundertgmechnmtnceFGFR2electiveTKIWehypoizebothpprocheledenhncedpeFGFR2TKIdelyemergenceTKItnceProjectSummry/AbtrctCpe-8primryprotedriveextricpopticpthwyfquentlymuttedctpolymphmdowngultedvrioucncerThroughlertumnypvioufdgourlbwehveidentifiedpotentilpopticn-popticrolecpe-8modultgTcellkillgflmmryignlgFurrmyplimrydtidentifiediffenceTcelleffecrmrker/functiwellpotentilmcrophgecykeignlgTkengerefdgimplicteCpe-8terferpemcrophgecykeproductiTcelleffecrfunctillwhichhveknownimptncenti-cncerimmunyHoweverdepedowngultiCpe-8vrioucncerwidepdflmmryfunctipopticn-popticignlgpthwyrolepromotghibgnticncerimmunyffectgimmunpiehvenotenexplodThutwopropoedprojectimeekterrogteroleCpe-8tumcellwelltummicroenvirmentfocupotentilrolenticncerimmunyCAR-TcellfunctiThegolAim1eekundertroleCpe-8cncercellwhichfluencenti-cncerimmunySpecificllythimcomplevntmucncercelloutCpe-8identifydiffence(1)prolifertiflmmryignlg(2)tnceCAR-Tcellducedkillg(3)vivogrowthimmunecellfiltrtiThegolAim2eekundertroleCpe-8tummicroenvirment(TME)cludgimmunecelltromlcellwhichfluencenticncerimmunySpecificllythimcomphowcpe-8TMElter(1)mcrophgepolriztivivotumgrowthimmunefiltrti(2)bilyCAR-TcellducedethlevntmucncercellThetrgplnfocueextendgmypviouexperiencecncerbiologycurntexperiencefieldcelldethfieldimmunologyexpogmedvncedtechniquefieldimmuno-cologyFrompentgtdeprtmentljournlclublbmeetgemrtutilterntilcfenceIimprovemypenttikillThroughK99pplictimnucriptpprtiIctuemtmywrgkillFllythroughdvncedcourewkhdowgIcemyknowledgeexperiencefieldimmunpieclicltrilThetrgenvirmenttStJudebotnumeroucowhichtmouewkgeneedgwhileImmunologydeprtmentelfbotflowcymetryImmunologicImggcopecificllydeignteddeprtmentInddimnycoStJudehotnumerouympoiumprovidefundgpotdocrlfellowceiveddiltrgvicourecfenceOvrincncerptientburdenedlckeffectiverpeuticoptiultglowurvivlrteduechempytncecurncemettTheoverllgolpropoedprojectetblhnovtiventi-cncerdrugtrgetmppgmechniclgulrovrincncerprogiCncermettquicelldemmigrtethroughcfedpceTourvivecncercellmutenephyiclcedptmtcellulrnuclermechniclhomeotIfwecouldmpmechniclgulrcncercellmoleculectrolcelldembilymigrthwouldenbleudefenovelcomplementryttmenttrtegieToidentifynovelmechniclgulrwedevelopedhighthroughputdembilycentetedeffect1280compound(LibrryPhrmcologicllyActiveCompound)dembilyhumnhigh-grdeerouovrincncer(OVCAR5)cellOurcenveleddrugcompoundducedcelldembilyAmet-nlycropdrughveledNUDT5pdictedgulrcellulrmechniclhviNUDT5memrNudix(nucleoidediphophtelkedmoietyX)hydroleuperfmilyOurplimrynlyeveledNUDT5highlyexpedvrioucncertypecompdnmltueMyplimrydthowNUDT5gultecelltiffnemphologymigrtiOVCAR5cellThegolmyprojecttethypoNUDT5driveovrincncerprogigultgcncercellmechniclhviInAim1IehowNUDT5lteovrincncerprogimeurgNUDT5expilocliztdiffentdeetgedtcthlogiclubtypecludghigh-grdeerou(HGSOC)clercell(OCCC)crcomtumugptienttuemicrryIloexmevrohowNUDT5gultePARPhibirtnceovrincncercellhviuchprolifertimigrtipheroidmtiviInAim2IdetermeroleNUDT5ctivyctlyzgATPproductictcykeletlnuclermodelgfollowgcfedmigrtiUndertghowNUDT5gultecncercellmechniclhviguidefutucliclttmenttrtegieimproveptienturvivlAbtrctGlioblmmultime(GBM)nggiveprimrybrtummedinurvivlpproximtely15mthCurntlytrdcrpycludeectifollowedchempy/rdipyTheettmentlimedcompletetumectiporpeuticdeliverydueblood-tumblood-brbrrierGenerpyhemergedpotentilrpeutictrtegyttmentGBMInfctclicltrilhveexploddeliverycolyticvirueuicidegenep53genehowevererpielolrgelychllengedpodeliveryNnoprticle(NP)typicllyemployedgenerpieprotectnucleicciddegrdtiimprovetueccumultipenetrtiHoweverNPgenedeliverypltmtenlypiveccumultumfciltedlekyvcultu(ieenhncedpermebilytenti(EPR)effect)whichtr-tertumllyheterogeneoulyllowmllfrctiNPccumultetumTheepropoedtudieimimprovetumlrpeuticccumultidevelopgnoveln-virlgenedeliverypltmGBMBrpenetrtgNP(BPN)cldenelyPEGyltedpolyethyleneime(PEI)NPhvedemtrtedenhncedtumtrgetgcompdcventillyPEGyltedPEINPInourtudiewehvemodifiedBPN(SH-BPN)trgetexcilthiolovexpedtumcellduedygultedproteyntummicroenvirmentFirtwevetigtetum-tropmtrnfectichrcterticSH-BPNcompdBPNvwodiffentdmtrtiroutetrtumljectiytemicdeliveryNextwefurroptimizegenedeliveryugfocuedultround(FUS)ttmentgimenenhncerpeuticdeliveryToddchllengeEPReffectercherhveemployedFUSenhncedeliveryvriourpeuticgentcludgNPcrovrioubiologiclbrrierWevetigteSH-BPNdeliverytvrioutimepotltiveFUSttmentWhilemotFUS-mededdeliveryNPvolvetrvenoudmtrtimicrobubble(MB)followedNPtudiehvehowncouplgtwocteNP-MBctructimprovetrnfectiefficcyWeloexploeffectSH-BPNcjugtiMB(SH-BPN-MB)OverllthtudyctriedevelopmenttrgetedgenerpytrtegieGBMddgdeliverychllengeenhncgrpeuticpotentilnucleiccid-bedttmentPROJECTSUMMARY/ABSTRACTNturlkiller(NK)cellenggerpromgnticncerrpypotentlylevergeimmuneytemwhileprovidgnexceptilfetyprileTrpecifickillercellengger(TriKE)NKcellenggermedeNKcellkillgtumcellthroughmultpecificbdgTriKEcttumbdgdomnIL-15cykeCD16enggerTheIL-15CD16enggertimulterobutNKcellctivtumcellkillgwhiletumbdgdomtrgetrpytummicroenvirmentExpniTriKEpltmtrgetnewtum-ocedntigenquitegrtinovelTriKEtumbdgdomThprocebottleneckeddifficultiepervgTriKEfunctilydevelopbily(ieufficienttbilygggticombntyieldrpeuticue)upddinewtumbdgdomThprojecttrnmTriKEdcoveryproceterrogtgimpctpecifictumbdgdompropertieultntTriKEfunctilydevelopbilycludguenovtivehypertblemiproteSpecificllyAim1vetigteimpcttumbdercffoldrchectucomprgpermnceeverldiffentcffoldTriKEcludgntibodyfrgmenthmiproteAim2vetigteimpctpemptivelyoptimizgtumbdertbilycombntyieldeertiTriKEThccomplhedytemticllyvrygtumbdertbilycombntyieldquntifygimpcnTriKEfunctilydevelopbilyTheevetigtivolveproductichrcteriztiexperimentltumbdgdomTriKEtrgetgB7-H3netblhedtum-ocedntigenTheprimrygolthwkmdeignTriKEtumtrgetgdomtmlgexpnipltmnewrpeutictrgetFurrmothprojectdvncedevelopmentTriKErpeuticoptiB7-H3poivecncerTITLEComdImggRNAAnlyeDevelopCerviclCncerBiomrkerABSTRACTDepeignificntdvncedeepventicengcerviclcncerctuenimptntwldwidepublichelthproblemTtgcerviclcncerptientperlizedtrtegiecnpotentillyimprovechnceurvivlPdictgerlyttmentwhertumlikelypiveemotchllenggyetimptnttktrtifygcerviclcncerptientupptgperlizedttmenttrtegieimprovecncerptientcVriouunimodldtcludgribucleiccid(RNA)rdiologichlogicimggclicopthologicdthveenemployedpdictgcerviclcncerttmentpeptienutcomeEchtypeunimodldtnlyzetumphenotypediffentpotviewprovidevlublewhilelimedprognoticmtiWehvehownRNApromgbiomrkerplycriclgulryrolecerviclcncerRdiologicimggbiomrkerhvehownprometrtifygptientfvbleunfvbleprognomultipletumeTheirn-vivechrcterticlollowcvenientlgudlmirgtumprogiheterogeneoupedurgttmentcoureMooverhlogicimgeprovidekeymtiboutmicrocopictructucelltuegnmRecentptourplimrytudiehvehownhlogicimggbiomrkercnidclicldeci-mkgidentifygmetteubtypggrdgtumpdictgclicloutcomeClicopthologicbiomrkerhowprognoticvluethroughtropectivetudieStillmnycerviclcncerptienthvetumcurncedepefvbleprognoebiomrkerdividullyThemjgolthtudydevelopcompheniverobutcomputtilmodelpdicticerviclcncerttmentpeoutcomeWetegrteourcentlydevelopeddvncedlerng-bedtechniquebuildprognoticmodelugbout600cerviclptientcecollectedtwotutiTheprognoticmodelmolidbdividulizedccerviclcncerptientMooverourwkexpecteddcovercltimgmultimodldtledgdynmicptienttrtifictiupptdptivettmenttrtegiefutuProjectSummrySkcncermotcommcncerUStenquibiopyhpthologycfirmtiHowever~70%biopieyieldnignfdgpentgnunneceryhelthcburdenBiopieloviveocedcomplictiuchbleedgfecticrhpthologicnlytime-cumgdelygttmentCfoclmicrocopy(CM)imgektcellulrolutiTwoCMtechniqueuedevlutekleiflectnceCM(RCM)whichpermednvivelytctkexvivoCM(EVCM)whichllowrpidimggfhexvivotueouttime-cumgtueprocegRCMhtterenivy(9094%)pecificy(8285%)kcncerdignoecompddermocopyducenignbiopie~75%LikeweEVCMcndetectidulcrcomurgiclmrghighenivy966%%pecificy892%TheeimgechllenggnovicedpogmjbrrierirclicldoptiThcompoundedlckexperttechgourcethfieldToovercomethbrrierwehvectedCME-ccdedAnnulWkhopCfoclMicrocopyCutneouDignotictMemilSlKettergCncerCenter(MSK)WhilewkhopfocueCMwelofmilirizettendeedvnceCMcludgmultimodltechniqueuchfull-fieldopticlcohencemogrphy(FF-OCT)le-fieldcfocl(LC-OCT)RCM-OCTThe2024two-dywkhoppentedpervirtullyWehvegdwld-nownedfcultyexpertethfieldnticiptegloblprticiptibedourpviou6wkhopThewkhopterctivecludglectuh-imgecquicedcuicompetivequizzeR13funduedprovidecholrhipttendeeunderpentedgroupwomenmiedividuldbiliettendwkhopundertkenoberverhiptMSKWefurrpromoteprticiptiegroupthroughourmrketgoutcheftenurgphyiclvirtulcceibilyThewkhoplerngobjective()fmilirizeunderlygopticlprcipleocedtermology(b)cognizefetuneoplticflmmryklei(c)developkillcquirgimge(d)underttegrteCMcliclurgiclwkflow(e)gfmilirypplictinovelmulti-modldeviceTheoverllgolwkhopencourgeclicinepecillythoeunderpentedbckgroundtegrteCMmultimodldeviceclicProjectSummrySpecificAimSolidtumccountnerly90%dultcncerchllenggelimteSurgerydjuvntrpy(egrdichempyimmunpy)powerfulmethodttgolidtumStillynotuniverllyeffectivecurtivewouldnefignificntlyomemenugmentgtum-killgpeLocldeliverycyxicimmunotimulrygenerpygentepecillycombtihprovenveryeffectivepromotgolidtumclernceGiventhpotentilwouldpowerfulhvepltmutblyimultneoulydelivermultipleimmunotim-ulrygene-rpypyloddictlyttumthupromotgclernceWhilecurnttrtegieuchlocldrugdeliverylentivirumRNAdeliverymethodcouldgenerteuchmodific-tiyufferlimtibroderueuchpermnentmodifictif-trgeteffect(lentiviru)trnientgeneexpi(mRNA)drugleelimedpylodSelf-mplifygRNA(RNA)hhowngtpromeprolgedn-tegrtiverpeuticgeneexpicoupledlipidn-noprticle(LNP)coulderveviblemethodloclgenedeliverytummodifictiUntilcentlypotenterlyimmunepetriggedupentryRNAcellhevelyctrgpotencyRNAtrdtrtegielowergRNAimmunogenicyuchcptgmodifiednucleoideN1-methyl-peudouride(foundllmRNACOVIDvcce)yieldgn-functilRNAHow-everwehvecentlydcovedcompleteubtutiRNA5methylcytide(5mC)drti-cllyduceimmunecogniRNAwhilepervgRNAplictigeneexpicpbili-tieledgelevtedprolgedtrngeneexpiThpowerfuldcoveryempowerppli-ctiRNArpeuticpplictiprovidenopptunyoptimizeer-pieefficientmultiplexgenedeliveryTochievethIpropoetudieoptimizgRNApltmtwopprocheThefirtpproch(im1)volvecengbothRNALNPmultiopti-mizeirgenedeliverycropneltumtypeugourt-permgRNAexpnnov-tivegenedrivecettewouldelectivelyenrichexpiuicidegenetumovercomedrugtnceTheecdpproch(Aim2)focumximizgtrngenecrgoRNAceng1)howmnygenecnencodedgleRNAimplementgRNAequenceelement2)mximumpoiblelengthRNAcnuccefullydelivedThwketblhnewnch-mrkRNArpeuticprovidgpltmefficientlydelivergnextgenertigene-rpieolidtumttmentProjectSummryPncticductldenocrcom(PDAC)olidtumlimedttmenptidmlfive-yerurvivlrtely12%necetgdevelopmentimprovedrpeuticthmlignncyWhilecncerimmunpyhhownpromehemlogiclmlignncieomeolidtumpplictichimericntigencepr(CAR)TcellrpyPDACfceobtcledueuniquechrcterticcludgdemopltictrompoTcellfiltrti(wkDrLekip)ToovercomeechllengewepropoegroundbkgpprochugCD4+TcellexpghighlevelenzymticllyctivemoleculeCD26engeergmmeol-dictedCARPviouwkPulolb(co-p)hdemtrtedCD26mrkTcellfvblepropertiemkgmnideltemplteCARengeergCD26enzymticctivydegrdgimmunouppivepeptideholdpromemodelgtummicroenvirmentlimgmyeloid-domntfetuPDACWehypoizeengeergCD26+CD4+CARTcellmeol-trgetedCAR(Meo-CAR)wecnenhncePDACimmunpyefficcyPlimrydtupptthhypoCD26+CD4+Meo-CARTcellhowgrobutctivygtPDACmeol-poivetummiceAim1thgrntfocuegimpctCD26+CD4+Meo-CARTcellupmodelgtummicroenvirment(TME)cludgchemokemyeloidcelllikelyltedCD26enzymeWeueytemichibigeneticknockoutCD26determeimptnceenzymticctivyTMEmodultiAim2elucidtehowCD26+CD4+Meo-CARTcellenggeendogenouimmunepeenhnceefficcyco-dmtedpurifiedCD8+CARTcellbothimmune-competentimmune-deficientmouemodelThertilebothimlieundertgterctitweenCD26+CD4+Meo-CARTcellendogenouimmunepecomplexPDACmicroenvirmentWepropoedeepenthundertgugcgenicthopicmouemodelytemticllyevluteefficcyCD26+CD4+Meo-CARTcell/CD8+Meo-CARTcellvribleCD26ctivy(Aim1)ltertiendogenouhotimmuneytempence(Aim2)Thenticiptedimpcurfdgignificntprovidgpro--prciplep-clicldtupptgdevelopmentCD26+CD4+bedcellrpypprochePDACptientBecueCD26enzymticctiimmunouppivepeptidemymigtemyeloid-domntfetuPDACtumthpprochferpromgvenueimproveoutcomechllenggolidtumWhileweutilizemeoltrgetntigenthpropolpprochdptblentigennetigenPDAColidtumCollectivelyweeekvlidtechrcterizennovtiveCD26+CARTcellrpypltmcnuedvolutiizeolidtumimmunpiefutuThpropoloutlethe-yertrgplncellulrimmunologymechnobiologyfergpplicntdivereexperteefieldTheplbryexcelmodelgimmunepeltibiophyiclfetutrgetcelltutiltngthimmunologymechnobiologycellbiologyctenexceptiltrgenvirmentcduciveucceMettoccurvrietygnvrygmechnicltteIncentyerbiophyiclpropertieemicroenvirmenthveemergednfluencermettticepfence(MSP)vimutulbiomechniclcrotlkwhecncercellmimictiffneirenvirmentweknownmechnociprocyOurplimrydthhowncyxiclymphocytecomprgcyxicTcellnturlkillercellelectivelydetroytiffercncercelldurgmettticdemtiprocewecllmechnourveillnceOurtudycombiophyiclmeumentvivomodeldemtrtgmicroenvirmentltiffnefluenceimmunevulnerbilyimpctggtriimettticoutgrowthIn-depthnlyemettticcelldiffenrgneutilizgmiccemicrocopygle-cellRNAequencgdictemicroenvirmentltiffnehpeimmunedcrimtiSpecificllymetteexhibcedtiffnegeneSpp1plygrolemtgthtiffneFurrtudieugCRISPR-bedknockoutytemhowloSpp1tencncercellThuggetmechnourveillncetrgettiffgnmettemgbiophyiclbmettticepfenceBuildgeplimryobervtiwepropoemicroenvirmentltiffnedictteefficcymechnourveillncethltihiphpebothmettticepfencepowernti-tumimmunpyWevetigtethhypotwopecificimAim1employvivomouemodelexmehowdtctmicroenvirmentffectcncercellmechnictrncripmicimmunevulnerbilySpecificgenecludgSpp1mnipultedexploirrolemechnourveillnceAim2utilizeynticcncercellnichevetigteifenvirmentltiffnedependentlyctrolmechnourveillnceefficiencyTheuccefulcompletieimcouldidentifybiomrkerguidgntumimmunpymnoveltrtegiettgmettticgrowthdvncgknowledgeenhncehumnhelthPROJECTSUMMARY/ABSTRACTGlioblm(GBM)motcommprimrymlignntbrtumdmlprognolckeffectiverpeutictrtegieWhiledventimmunpyhignificntlyimprovedptienutcomevrietyextrcrnilcncerenovelpprochehvechievedlimeducceGBMThegolthtudyvetigtemechnmunderlygbrmicroenvirment-pecificuppieffectiventi-tumimmunymededrrntepidermlgrowthfcrcepr(EGFR)ignlgfurrmowhertrgetgthcogenectenovelvulnerbilieenhnceimmunepethdedlydeeExteniveplimrydtwhichlevergehighlynovtiveEGFRctivtedimmunocompetentmugliommodel(MADR-mEGFRvIII)dictetum-tricEGFRignlgimpirtrtumlTcellfiltrtipromotedevelopmenttummicroenvirment(TME)enrichedmicroglimyeloidcelltypeuniquebrMooverplimrydtdemtrtenocitweenEGFRctivtinimmunouppivewoundhelgigntulkedpoprognomyeloidcomprtmentimmunecelloltednewlydignoedGBMptienttumSpecificAim1utilizetrngenicTcellytemengeedntigen-pecificcjunctimultiplemodlievivoEGFRbltidetermepceimpctrrntEGFRignlgtum-progrmmedmyeloidcellTcellcyxicfuncticllprolifertiexhutiThroughcptifunctilphenotypicydeignedoltectriiechfcrcomplexbrimmuneTMEthpprochexpectedprovidenovelightroleEGFRctivtidygultgeffecrTcellpeSpecificAim2endevelucidtexwhichrrntEGFRignlgpromotedtctimmunouppivemicrogliphenotypechrcterizedVEGFIL-1brTMEnemphEGFR-mededtum-microglicrotlkUgvroco-cultupprochevivoknockdowntrtegiepceimpctEGFRctivticodtimicrogliIL-1ignlgtum-ocedmicrogliphenotypeoverllnti-tumimmunepeeedSpecificAim3focueegrtilcombriltrtegietrgetgEGFRugERAS-801novelclicltgemllmoleculehibirdriveenhncedTcellfiltrtifollowedimmunecheckpotblockdeupptprolgedTcellfunctiTMEOverllthprojectprovidefirtcompheniveementmechnticunderpngfunctilcequencerrntEGFRctivtimyeloid-domnttumimmunemicroenvirmentultntimpcnnti-tumimmunepeGBMByidentifygdynmicterplytweencogenicEGFRignlgimmuneevhwknlyexpfundmentlknowledgeterectietwohllmrkcncerloenbledevelopmentner-termrpeutictrtegieptientthgrvemlignncyPROJECTSUMMARYInNovemr2023NewYkCy(NYC)NYcmefirtjurdictiUSdoptnddedugrwrngpolicywhichquiturntdplywrngllmenunextemhighddedugrThedopthpolicyhpotentilduceburdennutri-ltedchricdeecludgoytype2ditehertdeeHoweverlmotnol-wldtudiehveexmedwherddedugrwrngllffectpurcheturntfoodMoovernol-wldtudiehveexmedwhomewrngeffectlrgetAlounknownpychologiclmechnmcouldexplhowddedugrwrngllchngehviTheWrngImpctModelhetblhedcigttevergewrngchngehvichnggthoughtfeelgliefhneverenppliedddedugrwrngWedetermewherwhomhowddedugrwrngffectturntpurcheAllAimuerigouqui-experimentldeign(diffence--diffence)eechngepurcheNYCefterwrngimplementednetchngecompreoutwrngovermeperiodWecomtwocomplementrydtourceFirtweprtnerMFournnovtivemobilepheppwhomwehvecompletedrigoupilottetUgMFourbilyendlocti-bedurveypnelprticipntwepropectivelycollectceiptcumerexgchturntNYCmtchedcompreWecollect4petedcro-ectidt(2e2fterwrngimplementedtln=10000cumer)WelocollectmticumerdemogrphicchrcterticirthoughtfeelgliefboutddedugrSecdweobtdteteverypurchemdetTcoBellturntntiwide(cludg>3millrnctiperyerNYCle)2023-2028Weueedtexmewherddedugrwrngducetlugrpurchedchturnt(Aim1112)determewhertheffectdiffercumerlowereductilowercomeBlckHpnicidentie(Aim2)Weloueedtdetermewherddedugrwrngledmegtivethoughtfeelgliefboutddedugr(Aim3)OurcentrlhypoddedugrwrngllducetlugrpurchedturntNYCltivecomprelrgerductimgcumerloweductilowercomeBlckHpnicidentieCompletieAimcouldlygroundwkdoptiddedugrwrngllcroUSduceoytype2ditenutri-lteddeeMettticprottecncermcurbleevblyprogelethldeedepeexpgttmenptiStrdccluderpietrgetgrogencepr(AR)pthwykeygulrprottelegeurvivlDepedecdepprovlmopotentARSignlgInhibir(ARSI)nerlyllptientmettticprottecncerdevelopcurncedueemergencectrti-tntprottecncer(mCRPC)EvencentdvncemechnmdrivgmettticprogidiveremoleculrunderpngARSItncemfullyelucidtedcomplictgdevelopmentrpieovercometnceWiummicroenvirment(TME)cncerocedfibroblt(CAF)phenotypicllyfunctillyheterogenouhvevrygroletumprogirpeutictncehowevermnyemechnmmeluiveWehveveledAp(ASPN)+CAFocedwecologicloutcomecludgmettwehvefurrdemtrtedyenrichedrpytntmetteAectedproteASPNhenhowncommunictethroughoutTMEchetrtecncercellmigrtimettticdevelopmentOurnewdtdicteASPNloprotectprottecncercellenzlutmideecd-genertiARSIPlimrydtupptASPNTMEgultemettrpytncethroughctivtiHER2/3trgetblepthwyptedvolvementmigrtimettARSItnceCtentthplimrynlyehowASPN+CAFco-loclizeHER2HER3expimCRPCPlimrymechnticdtdicteASPNbdHER3ducectivtiHER2/3downtmpthwycludgMAPKPI3KclciumignlgOurplimryfdghighlightimptnceASPN-HER2/3mededleetrcellulrclciumbothHER2/3ignlmplificticlciummicrodomocilltiwhichcriclmigrtiCollectivelyourdttrglyuppurcentrlhypoASPN+CAFpotenteprottecncermigrtimettARSItncectivtgHER2/3ignlgdjcentprottecncercellOurgol1)DefemoleculrmechnmASPN-ducedHER2/3ctivti2)DetermemechnmASPN-HER2/3gultedclciumocillticellulrmigrti3)ElucidtefunctilroleASPN-HER2/3prottecncermettrpytnceWeexpectthutcomepropoedtudieprovide1)criclmtinovelmechnmHER2/3ctivtiASPNTME2)opptuniepurpogHER2/3dictedrpienovtiverpeuticpprocheprottecncerByugcuttgedgetechnologieweexpcurntprdigmpertgroleCAFcncermettrpytnceUltimtelyetudiehvepotentilimpctcncerrpeuticptienutcomeColoctlcncer(CRC)3rdmotcommcncerUnedSttebothmlefemleAdvncementttmenptiuccefullyhelpgCRCurviv(CRCSpotttment)livelgercurntly14milliCRCSUnedStteDepelivglgerCRCSexperiencgnegtivepychologicl(iecogniveimpirment)phyiologicl(ierteriltiffne)deeCRCSexperienceimpirmentpectcognicludgcogniveprocegpeed(CPS)lerngmemyexecutivefunctiCPSgmotimpidcognivedomCRCSfurrexperiencecedlevelrteriltiffneprticulrlymeucrotid-femlpulewvevelocy(cfPWV)Phyiclctivy(PA)commendedfollowgcncerdignoimprovequlylifelleveympmcncerttmentdecerkcurncedevelopmentcombidiecludghyperteniditehyperlipidemihoweverlevelPAducedCRCSIngenerlpopultideedpopultimoderte--vigouPA(MVPA)ocedimprovementvrioudomcognicludgCPStteroutcomerteriltiffneprticulrlycfPWVuggetgMVPAmyoccupyimilrneficilroleCRCSlleveideeffectimprovequlylifelgevyThepropoedcro-ectilcomprtiveerchtudyguidedcentrlhypoCRCSexhib()wevculrcognivefunctilowerPAlevelthnmtchedctrol(b)trgerocimgthoevribleuppt(c)nlyevculrfunctimedirocitweenPAcogniCRCSThefollowgimteted(1)compCPScfPWVMVPAtweenCRCSmtchedctrol(2)exmeocimgCPScfPWVMVPA(3)determeifcfPWVervemedirocitweenMVPACPSThefollowgtrggolguidecomplethtudycludg(i)didcticexperientiltrgCRCprogidevelopmentttmenptiurvivhip(ii)clicltrgdmtrticgterpttineuropychologicltetInterntilCncerCogniTkFcebttery(iii)eductilclicltrgfurrundertcliclpplicticrdiovculrfunctirk(iv)erchtrgilizticlibrtidtprocegterpttiActigrphccelerometerTheoutcomethtudyhighlightimptncecognivculrfunctiPAlevelociCRCSwelllyfoundtifutuerchPAhvilterventithpopultiThepropoederchtrggolmycollbtgtemhelpmechievemyht-termgolcompletgpropoedtudyupptmylg-termgolceivgfcultyerchpoifieldexercecologyProjectSummryAbtrctChimericntigencepr(CAR)TcellgeneticllyengeedTlymphocytedeignedenentigenmountnimmunepeThoughCARTcellhveceivedFDApprovlttmenteverlhemlogicmlignncieucceolidtumlimedimmunouppivetummicroenvirmentttment-limgdvereeffectuch-trgetf-tumxicycykeleeyndromeThoughvetigrpttrtegiemigtgelimtiuchbiomterilhpgtummicroenvirmentlogic-gtedCARTcellpventn-pecificxicynopropoedtrtegyhovercomeechebrrierTourmountelimtiIpropoeuenovelelf-embledhydrogelimplnttumThhydrogeluedcjunctiplCARTcellclledzipCARwhichuepldprprote(zipFv)enentigenThehydrogelcompoed4rmPEGlkerdectedleucezippercnlodedzipCrgoprote(pylodprotemodifiedleucezippercludgzipFv)ThehydrogeluppliezipFvdprprotecyke(IL-7)chemoke(CXCL9)IhypoizeuethuhydrogelovercomebrrierCARTcellrpyolidtum1)oppogTcellnergypromotgprolifertiecticvy2)pventgntigenecpeviencpultizipFvtrgetgmultiplentigen3)imprtgptiotemplctroloverCARTcellctivyAim1demtrtedvntgehydrogelmirgCARTcellmigrtiprolifertimumodelROR1+lungcncerAim2documentefficcyfetydvntgehydrogelxicymodellungcncerTodemtrtepventintigenecpeROR1-MSLN-deficientlungcncercelllectedugCRISPR-C9knockoutInmumodelntigenecpeecellueddemtrteuperiefficcymicettedzipCARTcellhydrogellodedzipFvgtbothntigenThpropolbuildroundfivekeycompentcriclerchcliclkillupptmydevelopmentndependentengeer/cientt(1)nterdciplryerchprojectfocugnovelurgiclbiomterilenhncementCARTcellctivy(2)multi-dciplrymenrgDrGrtff(biomteril)Wg(immunpy)Col(cliclmedicenimlmodelimmunology)(3)cdemicengeer-cientterchcductcommunictikill(4)cliclwneprogrmovereenDrYoldColntillycognizedurge(5)pildevelopmentctivieguidemytrggolPROJECTSUMMARY/ABSTRACTTheco-uebccocnnbpvlentppercgmgdultUnedStte(US)henhowndverelyffectttmenrclicloutcomeYetcurntlynocommendedttmenttrtegiebcco-cnnbco-uentilodttmenttrtegiebccocetimgthoewhouecnnbTtmentterventiddgco-uehveenplimrynehveendeignedevlutenterventicompdctrolcdhroughfully-powedromizedctrolledtrilOurplimrydtupptedlrgerlertuhhown1)cnnbco-uehproundnegtiveimpcncigttebtence2)vniclenFDApprovedphrmcpybccocetimyneficilducgcnnbueCollectivelyourulthowpromevnicleducgcnnbuegivenetblhedefficcybccocetitrgjutifictievlutibcco-cnnbco-uettmentpropoedheWepropoepirpromgphrmcpy(vnicle)pychoociluppttrgetgco-uederbolterttmenutcomeducehrmThtudycompletelymote12-weekttmenttrilmgdultSouthCrol(ge18+N=200)whoco-uecigttecnnbgulrlyPrticipntcludedwhomokecigttedilynerdily(20+dypt30gulrbccoproductueexcluiry)hveuedcnnbtlet3timeperweekptmth(excluivemediclcnnbueexcluiry)Prticipntromized11vnicleplcebobothgroupceivenevidence-bedpychoocilterventicludel-timeynchroulydelivedctent(lldelivedvirtully)Theimtudy1)evluterte7-dybiochemicllycfirmedpotpvlencebtence(PPA)cigttet12-weekendttment(EOT)vcomprgvnicle+pychoocilterventiplcebo+pychoocilterventiprticipnt(Aim1)2)compcnnbuefquencymounttweenvnicleplcebogrouptrgetqudteuntilEOT(Week1-12Aim2)3)explodiffentilttmenutcomemgmlevfemleprticipnt(ExplryAim)Thenurgentneedevlutettmentterventiddgco-uebccocnnbgenerlpopultidultThepropoedterventiupptedrigouprierchcludgourownwkdecentrlizeddeignmoteterventideliveryctrieclbilyerventiddco-occurrgbccocnnbuePROJECTSUMMARYNeodjuvntperiopertivechemoimmunpytrdcttmentptientectblen-mllcelllungcncer(NSCLC)UntuntelymjyptientectbleNSCLCdotnefneodjuvnt/periopertiveimmunecheckpothibir(ICI)-bedrpieunclerEftdevelopmoeffectivettmenttrtegieprpeutictncehveenhmpedourlimedundertgmechnmgovernpeICIthucouldervevlidtedbiomrkerguideneodjuvnt/periopertiveICIttmentOurlg-termobjectivedeveloprtilneodjuvnt/periopertivecombtirpiepventtncecenefICI-bedttmentRecentlywenlyzedNSCLCptientttedchempy(CT)pludulICIphe2NEOSTARtril(PICce)foundthoepderctedenhncedBcellfrctimrkertertirylymphoidtructu(TLS)compdnpderTheefdgwecpultedwhenugneodjuvntcombtiICIplunovelimmunomodulrygentourcentlyptedphe2trilNeoCOASTTobuildeobervtiourclicltrilwepermedplimryptil-omicnlypilotcohtNSCLCptientttedneodjuvntCT+ICIvrygperpyWefoundpthologicpewocedgggtiBcellgnizedtructu(egTLS)elevtedexpinti-tumBcelligntuenhncedcell-cellcommunictumimmunemicroenvirmentPclicllywefoundneodjuvntICI-bedrpywmoteffectivettmenttducgfquencymetteprolggurvivlourhumn-levntmodelptneoulymettticNSCLCrpeuticefficcywcegtightlycoupledenhncedBcellfiltrtiCequentlywehypoizeBcelltrncriptilimmunogenomicptillcpeneodjuvntCT+ICI-ttedNSCLCptientdifferMPRBcell-mededcyxicntumpecludgirterctiTcellugmentefficcyneodjuvntICI-bedrpyerly-tgeNSCLCWeteurhypodetermgtrncriptilimmunogenomicptillcpeBlegecellhumnNSCLCttedneodjuvntICI-bedrpy(Aim1)terrogtgimpctBcellTcell-mededpeneodjuvntICI-bedrpymumodelNSCLC(Aim2)vetigtgutilyBcell-centricphenotypepdictgnefneodjuvntICI-bedrpyectbleNSCLCuniqueclicltril(Aim3)ThpropollevergepltmuniquegloblclicltrilcohtNSCLCnovelhumn-levntmouemodelNSCLCwelltte---rtgle-cellptilmulti-omictechnologiedeferoleBcelllegentumpeneodjuvntICIprovidefrmewkdevelopmentBcell-ocedrpieimgcugternumrptientSummryIntrhepticcholngiocrcom(iCCA)ecdmotcommprimrylivercncerfterhepcellulrcrcom(HCC)nggivemlignncydmloverllprognoWhilefrtlecombtichempyimmunecheckpothibi(ICI)henmjcentdvncerpyptientunectbleiCCAmnunmetcriclneedimprovecurntmedinprogifeurvivlbout8mthWhdtupptgneedp-extgimmunepetumICIpehewepropoeddhigh-doecmlexternlmrdipy(EBRT)followedtr-tumjectiulogoudendriccell(DC)dulPD-L1(tezolizumb)/TIGIT(tirgolumb)blockdefurrenhnceimmunetimulryeffectRdicnduceflmmrytumcelldehtcnfvbletumnetigenpenttiInjectiulogouDCfterEBRTwouldnovelmethodbootgvivotumntigenuptkepenttiexptum-ctivecyxicTcellWehvettedubjectunectblelivertum(HCCiCCA)pilottudythEBRTDCpprochpromgpecceptblexicy(nogrde3xicy)The8ubjecthdprtilpecludgniCCAptientgogpet48mthBothemergencenewTcellcepr(TCR)cleexpniextgTCRclecludgcletumctivecyxicprilehveenoberveduggetgthcombticouldenhncetumctivecyxicTcellpeHowevermnyTCRclelohveerlyexhutiignlupgultimultiplecheckpotceprcludgPD-L1TIGITThucombgDCjectezolizumbtirgolumbmyhelpfurrenhncecyxicfunctieTCRcleWehypoizecombgEBRTfollowedtrtumDCjectitezolizumbtirgolumbcnimprovePFSptientunectbleiCCAeffectmededytemicexpnumctiveTcellperiWetethypothrough2im1)AecliclefficcythcombtirpypheIItudyfetyrun-phePFSprimryendpot2)identifyeffectthnovelcombtiimmunpytumctiveTcellperiWeuecRNAeqTCReqidentifyTCRcllexpnrncripmeprileTCRclebloodtumfocutumctiveTCRcleWelouecRNAeqflowprilechngeimmunecelltumbloodFllyweueimggcymetryexmetumimmuneptilltihiptumOurtudynlyidentifycliclctiviethnovelcombtirpylouette---rttechnologyimproveourundertgmechnmctipotentiltncethimmunpyPROJECTSUMMARY/ABSTRACTBcteri-hotterctiemerggcricllyimptntmechnmcncerprogipolydefedpcnceroucolicdypliHotprotepiblemtgbcteri-tntbrriercolcnlofunctigulrepililcelldiffentigrowthuchDeletedMlignntBrTum1(DMBT1)DMBT1ectedglycoprotehighlyexpedtepililbrrierehumngtrotetltrctPublheddthowDMBT1upgultedgtricmetpligtricdenocrcomexpimechnticroleDMBT1colicpcncerouleiunknownRecenterchuggetDMBT1lowepililprolifertimyhibdevelopmentcoloctlcncer(CRC)MyplimrydthowDMBT1genedowngulteddtlcolicdypliOurptiltrncripmicdtveldowngultedDMBT1expidyplticfocicompdnmlcolocyteInmouecoltueIueimmunluocencechrcterizeDMBT1proteexpiTheDMBT1tgpdomntlymid-cryptcolocytecyplmiclocliztienhncedtgnerpiclbderIfurrhowDMBT1expi3diffentmouemodelCRCzoxymethne/dextrnodiumulfteCdifficile-ocedtumigeneApcmLrig1CER/+Apcfl/+miceIn100%dyplticfoci(n=57foci11mice)immunluocenttgDMBT1proteducedpcecltiupgulted-ctenAnlyDMBT1expihumnCRCmplecludgtuemicrryctgerlydyplihowDMBT1protelocliztibundncecltedeeprogiSpecificllymodvncedpthologieclteDMBT1loectiBedmyplimrydtpublhedlertupperDMBT1myfunctitumupppecificllyctgerlyCRCdypliPvioutudiehowDMBT1trncriptillygultedvicniclnteimmuneignlgpthwy(egNF-BSTAT3)fectiflmmryboweldeeHowevercriclpthwymedgDMBT1downgulticolicdypliunknownMyhypoducedDMBT1expicolicdyplrncriptillygultedprovideelectivedvntgetumigenethroughhyperprolifertiltedcellpolryTotetthIdetermetimelemechnmDMBT1lougCRCmouemodelbiochemiclgeneticmnipulticellulrpthwycommlydygultedCRC(Aim1)IdetermehowloDMBT1mightdvntgeoutumdevelopmentCRCetblhgDMBT1knockout(DMBT1-/-)cellhumngnoidDMBT1-/-CRCmouemodelPotentillyloDMBT1tgmyidclicllydtguhgdyplictivechngeflmmryboweldeeprovidebiomrkererlydypltictrnmtihumnCRCProjectSummryMyoverrchggolcomebiomediclengeercpbledvncgmimllyviveproceduthroughmediclimggmchelerngTochievethIimdevelopbrodundertgdignoticterventilrdiologyrobuttechniclkillcquirgctructgpplygmchelerngtechniquebiomediclimggdtTherchfocueddgunolvedengeergproblemmgneticnceimgg(MRI)-bedevlutifocuedultroundbtcncerttmentprovidgtrgfoundtiuccefulcerterventilimggTrdillyMRIhprovidedqultiveightbiologicltueRecentdvnceimgecquictructideeplernghvectednewopptuniemkgqunttivemeumentphyiclchemiclpropertieugMRIDeeplerngtechniquefcetechniclchllengequnttiveMRIuchbencelrgetrgdtetircurntbilycopevricrocnnerprocolepecillyterventilctextThwkvetigtetegrtgphyicknowledgerchectutrgdeeplerngmodelmigteeproblemenblelibleclicllydeployblequnttiveMRItechniqueevlutgMR-guidedfocuedultroundbtcncerttmentAim1uephyic-medmchelerngdevelopnefficienttechniquemeurgMRlxtimebtugcfigurtitteimggAphyic-medneurlnetwkrchectutrgprdigmmethodicllyvetigtedugimulteddtThedevelopedmodelntdpreldtcquidugmulti-echocfigurtitteimggequencerigoulyevluteddtphnmhelthyvolunteerbtcncerptientcromultipleMRcnnertimepotAim2imdeveloptime-efficienttechniqueobtgdiffuimeumentbtimggfull3Dcovergeevlutgltivepermncecventilmodel-bedtechniquephyic-medneurlnetwketimtgdiffuiprmetercollecteddtAfterdevelopgequencetechniquediffuiprmetermpcompdgold-trdmeumenttrdizeddiffuiphnmhelthyvolunteerbtcncerptientmultiplecnnerTherchdvncecurntundertghowctegenerlizblemchelerngmodelMRIdeignmubilycliclctextAddillydevelopedMRItechniqueenblecliclterventiluequnttiveMRIupptgdevelopmentbiomrkerprovidel-timeevlutiMR-guidedfocuedultroundbtcncerttmentPROJECTSUMMARY/ABSTRACTMlignntgliommotcommprimrydultbrcncerffectgover20000AmericnechyerWhilemoleculrlytrgetedrpiehvedemtrtedtmendouucceemlignncielckeffectiveperlizedrpeuticpprocheededlybrcncerThegolthtudyvetigtecomplexphenomenphenotypicplticyglioblm(GBM)motlethlllbrtumdultdrivgtncetrgetedrpievin-geneticmechnmfcilteduniquebrmicroenvirmentExteniveplimrydtwhichcptelrgecohtgeneticllydiverepcliclgliommodeldrugclicldevelopmentGBMdictecogeneepidermlgrowthfcrcepr(EGFR)mtrdilgli(RG)-likecelltteGBMwhichdrivegliomiheterogeneyplticyMooverplimrydtdemtrtephrmcologicbltiEGFRducelegeprogrmmgRG-likeneurl/oligodendrocyteprogenir(NPC/OPC)-likeprogrmuniquelybrmicroenvirmentwhichhypoizeddriverpiddpttitnceEGFR-trgetedrpySpecificAim1utilizecuttg-edgegle-cellRNAequencg(cRNA-eq)comdnnovtivegeneticfluocentpterytemhigh-olutibrcodedlegetrcgelucidteevolutirymechnmdrivglegetrnmtifollowgtrgetedrpyGBMThroughuette---rtpcliclmodelcptuuniquebrmicroenvirmentthpprochexpectedprovideunpcedentedightfluencebrenvirmentdrivgcellulrdynmiclegetrnmtidurgperpeuticterventiSpecificAim2focuedefgignlgpthwyfciltebrmicroenvirment-dependentlegetrnidrivetncecogenebltiGBMUgnovelclicltgemoleculrlytrgetedrpeuticnovtivevromodelbrmicroenvirmentthimuncoverpivotlignlgpthwybr-derivedfcrdrivelegetrnictrietncegtEGFR-trgetedrpiemlignntgliomOverllthprojectpentignificnttepwrddeeperundertgmoleculrcellulrmechnmunderpngtumheterogeneyrpytnceGBMByelucidtgdynmiccellulrttetrnirolebrmicroenvirmenteproceethwkhpotentilignificntlyimpctdevelopmentmoeffectivetrgetedttmenttrtegieptientuffergthdevttgdeePROJECTSUMMARYTheoverllobjectivethpropoldeveloppplynovelproteogenomicpprocheidentifyrpeuticvulnerbiliechromoome3rrngedmyeloidleukemChromoome3veritrnveri(v3/t(33))leukemultrrnvexpicogenictrncriptifcrMECOM(MDS1EVI1complexlocupecificllytrunctedmEVI1)decedexpumuppGATA2Inv3/t(33)bnmlmyeloidleukemiptienthvenotrgetedpcirpieytnttrdcgimenlikeTyroeKeInhibir(TKI)oexperiencedml5-yerurvivlrte<5%Cequentlynunmetneednewpprocherpeuticllytrgetv3/t(33)-drivenleukemCnicllyMECOMcriclgultghempoiehoweverlterntivetrncriptMECOMdrivecogenewhenovexpedultchromoomlrrngementInddicogenicMECOMIhypoizev3/t(33)bnmlyledproductiddilleukemipecificprotemctrieggiventuthdeeHeItetthhypocomprgv3/t(33)poivenegtivemyeloidleukemicelllehelthycd-bloodderivedhempoieticprogenircellugnovelproteogenomicpprocheTotetthhypoIidentifyv3/t(33)pecificgenecombgRNA-Seqbulkproteomic(Aim1)utilizePcBiolgdequencgproteomicidentifynovelprotecodglterntivetrncript(Aim2)cptuv3/t(33)uniquepot-trnltilproceethroughutiliztimyN-termlproteomicmethodologytermedN-SPyCE(neo-N-termlSP3PyrideCrboxldehydeEnrichment)(Aim3)InexcgplimrydtIhveldyidentifiedeverlkeycidteMECOM-ffectedgenecludgHLA-DPB1IL16SPP1CD74ALDH1A1Pthwynlymybulkproteomicdtveledtrikgcltitweenv3/t(33)hrbgcellcedcp-mededproteectivyIhypoizepecificcpclevedubtrtepecificeffecrv3/t(33)biologyOverllthprojectpropoeutilizeproteogenomicdetectdeepecifictrncriprmvlidteirexpprotelevelvetigteleukemipecificprotemrpeuticllylevntPROJECTSUMMARYMettecentrlnervouytem(CNS)commcomplictibtcncerPrognotypicllyderfewmthImmunpiehvevolutiizedmngementmnytypecncerHoweveregenthvenotenytemticllytudiedmngementCNSmettebtcncerWecductgeverlPheIItrilexplolenewlydevelopedimmunpieCNSmetteTheourtrilhveldymetprimryendpotubetptientbtcncerhowgpeimmunpyWepropoetudycncergeneticimmunephenotypicchngemplecollectedptientedurgfterimmunpyOuroverrchgobjectivechrcterizemechnmtnceimmunpyCNSmetteTochievethwechrtco-evoluticncerimmuneytemovertimenmiclloctidurgimmunpyprilgDNARNAcncertueperipherlbloodcebroplfluid(CSF)Notblyugcuttgedgegle-celltechnologieweexmelterticncergenomeimmunecellhvitunpcedentedolutiFurrmoournovtivemouemodelbrmettewetudynovelcombtirpiecludgCDKhibiimmune-checkpotblockdeugmentefficcyimmunpyWelievethwkhpotentiluncoverbicmechnmttment-filueptientedcoveriehvetmendoutrnltilpotentilbwhichfeextgimmunpyprocoldevelopnovelttmenttrtegieProjectSummry/AbtrctThF31wrdllowKeleySclir(PI)erchtrgdvnceherwrdhergolcomgndependentcncermultimbidycienttnexperteterventidpttiimplementtioptimizecncercunderervedgroupCncer-oyco-mbidycommepecillydedlyBlckbtcncerurviv(BCS)AlthoughBlckwomenhvelowerbtcncercidenceyhvehighetbtcncermtlyrte(40%)nyUSrce/ethnicgroupneffectttriedprtcombidoyytemichelthdprieOypdicthighermtlymgBlckBCSpot-cncerdignoweightgpdictcemtlyTtmentequiedueterectgweight/rcetigmloctriecncerceng/ttmentdelyOnewyfightbckgtedpriedevelopdeliveroyttmentdpteddduniquechllengeBlckBCScommunyIdentifictiimptntrk/protectivefcrcnppliedevidence-bedweightloterventiprovidecluiveequblepotentillylife-extendgcThupropoedmulti-methodtudyueocioecomicfrmewkmulti-methoddcoverctulrk/protectivefcrBlckBCSoycompdBCSPISclirlevergeourcepnttrilfirtuequnttiveurveye100BCSnyrce-ethnicytetpotentilrkprotectivefcrdifferBlckBCS(Phe1)Secdugco-deignqultivemethodiltilgnevidence-bedweightloterventioydecollbtiourptientprtnerfiveBlckBCSoy(Phe2)Thtilodweightloprocolndelivedpilot15BlckBCSoyplimryevlutipotentilttmentheterogeneyfcr(Phe3)ViephefollowgF31imddedAim1ToproctivelyidentifyculturlmultimbidfcrnoyterventiBlckBCSExplryAim2ToexplooyttmentpeBlckBCSviubgroupnlyeWehypoizeBlckwomenoypthighetrkcolowetprotectivecoqultiveterviewidentifyimptntfcrmynothveencptudqunttivelyvribleemergedlevntdequtevribilycrompleimpctttmentpeThepropoedF31thuutilizePhe1urveydtPhe2qultiveterview(Aim1)wellPhe3pot-ttmentdt(ExplryAim2)Accdglynefextgpntpilotfrtructu(egcrumenttrtegieprticipnttrilcduct)FpnttriloutcomecceptbilyfeibilyplimryweightloprogrmPISclirprojecttrgplnllowcomphenivemulti-methodnlydpttifcrmfutulrger-cletrilfoundtifutuF32K23PISclirfutucholrexpertemultimbidyterventicnceroychricdeedproptelyimpctgunderervedgroupPROJECTSUMMARYIncentyerdenoehenidentifiednimptntrpeutictrgetdueobervedimmunouppiveeffecttummicroenvirmentBygmdenoeceprdenoebroduppimmunefunctidecedcyxicctivyTcellNKcellceddiffentiTcellTgulrycellIntummicroenvirmentdenoeelevteddueoverwhelmgleedenoetriphophtenicotmidedeneducleotidebothwhichdegrdeddenoeextrcellulrenvirmentdurgcncer-ocedtcdiStructurllyimilr5methylthiodenoedenoeextrcellulrdegrdtiproduceloobervedtimultedenoeceprIndependentimmunomodulrymechnmtum-expeddenoeceprhveenobervedctriegrowthmettproliferticncercellTheffectledefedcompdimmunouppivectiviehignificncebotholidtumpot-chempyrdimodelwhedenoeoetengtlyelevteddueurroundgdeddygcellIndividulcncercelllecommlydeletegeneencodgmethylthiodenoephophylepibledepletg5methylthiodenoeeprtelyobervedmodulteexpienzymepibleproducgdegrdgdenoeexpidenoeceprThevrieddundntpthwyultgdenoeceprtimultilimeffectivenegleceprgtenzymtichibirFthAim1Iengeertblehighffyhumnmethylthiodenoephophylewhichubtntillydegrdebothdenoe5methylthiodenoeEngeergnenzymefvbleketicprmeterelectivytbilyllowrpeuticchrcteriztiInAim2Ievlutevroefficcyenzymeimmune-dependentmechnmhumncncercellleFllyAim3IpermvivlyrpeuticpotentilFollowgxicologyphrmcologictudieIdeferpeuticeffecnCT26colcrcomyngeneicmucncermodelIueCD4CD8TcelldepletumimmunophenotypggightimmunomodulrymechnmpecificllyblnceeffecrverugulrylymphocyteProjectSummryPncticcncerthirdledgcuecncer-lteddethUnedStte5-yerurvivlrte12%Depeucceimmune-modultgrpieuchimmunecheckpotblockde(ICB)cnceruchmelnomglegentICBdecidedlyeffectivepncticductldenocrcom(PDAC)levgurgerypllivechempylyoptiover80%ptientCD8Tcellkeyeffecrnti-tumimmunepecognizeelimteerlymlignntcellcnencedurblepepventcurncemettticpdthroughdptiveimmunememyInPDACchricexpoucellulrctuenttummicroenvirment(TME)ledtermldyfunctiCD8TcelltermedexhutiExhutedCD8Tcell(TEX)hveducedprolifertivecpcynbilypertprolifertelimedprotectivecpcycompdfunctilCD8TcellwhichmjbrrierucceimmunpyPDACStelektietlhcentlyhownntgizgurfcecheckpotmolecule(uchPD-1)chricfecticnynergizeovexpiemicro-RNA(miR)miR-29CD8TcellbrogteTEXdiffentintigen-pecificcyxicyTcellmemyInprllelDttlbtUMMSMhcentlyuncovedTNFignlgdriveTcelldyfunctiPDACthroughmyeloidTNF-TNFR2dependentmnnerThegolthprojectdetermectriiTNFR2-miR-29CD8TcelldyfunctiPDACgenertedurbleT-cellmededntumctivyIhypoizemiR-29gulteTEXdiffentidowngultgimmunouppiveignlgprovidepromgterventiovercometnceimmunecheckpotblockdePDACUgcniclKPCmodelPDACengeedexpnetigenOvItrovirllyovexp(OE)miR-29ntigen-pecificOT-1CD8TcellobervedimprovedtumclerncelgltedphenotypictteCequentlythprojectIim(1)lterdiffentermllyexhutedcellprogenirmemy-likephenotypeexpLy108TCF-1CD127whichhhownubetpive-PD-1checkpotblockderpyInvlidtetrnltilimptnceefdgdevelopgneffectivecombtitrtegyugmiR-29mice(2)determepcectriimyeloid-derivedTNF-TNFR2ignlguptmtermlTEXdiffentiPDACtummicroenvirmentByvlidtgthnovelmechnticlktweenmyeloidimmunouppermlTcellexhuthwkmyuncoverlerogeniccircuriechrcterticimmunouppiveTMEuchPDACTkengerthwkenhnceourundertgTcelldyfunctiPDACTMEelucidtenovelTNFR2-miR-29xprovidenttrctivetrgetfurrexplodrpeuticllyPDACptientPROJECTSUMMARYEwgrcompedricttuecncerultchromoomltrnloctimotcommlyt(1122)(q24q12)whichfuelow-complexydom(LCD)RNA-bdgproteEWS(EWS)DNA-bdgdom(DBD)Friendleukemegrti1trncriptifcr(FLI1)TheultgcogenicfuiproteEWSFLI1dictlyterfentivefunctiEWSprticulrlythoetrncriptiDNApirultgexceivetrncriptienivyDNAdmgggentEWSFLI1pventBRCA1-locliztrncriptileDNAdmgeultgnppntBRCA1-deficientphenotypehomologoucombtideficiencyWhenDNAdmgeoccurEWSRNA-bdgdom(EWSRBD)mededociPARP-1eDNAdmgeepromotgiDNApirEWSFLI1evelyimpiretercticugPARP-1buildupDNAdmgeePARP-1hibirenivychrcterticEwgrcomHowevermoleculrmechnmunderlygEWSFLI1terctiEWShowthoeterctidruptntivefunctiEWSunknownPlimrydthdemtrtedhowEWSLCDmelf-ociveterctiprimrilymededtyroethroughoutdomTheeEWSLCDtyroeloplycentrlroleEwgrcommedgelf-ociveheterotypicterctikeyneopltictrnmtiEWSLCDlooceEWSRBDdrivgirco-locliztibiomoleculrcdenteHowevertructurlbEWSLCDEWSRBDunknownroleerctrncriptilDNApirfunctiEWSmunknownTheoverllgolthprojectelucidtetructurlmechnmfunctilimplictiEWSelf-ocihowylteEWSFLI1-drivencogeneWetethypoEWSLCDdictlyterctEWSRBDenhncenucleiccidbdgpropenyEWSterplytweenEWSLCDEWSRBDkeyDNApirtrncriptilfunctiEWSEnhncgourundertgmechnmunderlygEWSFLI1-drivencogeneenbledevelopmentmotrgetedrpeuticEwgrcomltedpedricmlignnciePROJECTSUMMARYTtmenptitriple-negtivebtcncer(TNBC)hveenverylimedHoweverpecificmoleculrfetuuchhighPD-L1expielevtedtummuttilburdencedtumfiltrtglymphocytetumimmunemicroenvirment(TIME)mkeTNBCnidelcidteimmunecheckpotblockde(ICB)-bedrpyPocliclpeTNBCICBmpyneceteidentifictinoveltrgetcpbleenhncgnti-tumeffectimmunpyEffectivecyxicTcell(CTL)-mededimmunepegtcncercelllydequtetumntigenpentti(AP)InufficienttumAPcompromeefficcyICBrpiepentgignificnbtcleolidtumimmunpyEnhncgurfceMHC-IexpiemergepluibletrtegypotenteICB-bedimmunpyGeneticltertintigenprocegpentti(APP)mcherydygultitricendolyoomlnetwkmcuedimhedtumAPWhilegeneticltertiAPPmcheryhveenextenivelytudiedfcrgultgendolyoomlnetwktumAPmundexplodOurlbryutilizedInfenceCellTypeDecvolutilghmidentifiedPIK3C2ApromgdruggbletrgetTNBCcellgultephophooidemetbolmDepletiPIK3C2ATNBCcelldemtrtedignificntupgultumAPenhncedcyxicypecificCD8+TcellWehypoizehibiPIK3C2AlterPI(34)P2metbolmultgdyfunctilendocyticveiclemtipventgternliztintigenMHC-IcomplexcgtumAPPIK3C2Adul-functiprotebothken-kectivieItkectivygulteendocypthwythroughPI(34)P2genertiroundneckendocyticveicleCverelyn-kefunctiPIK3C2ApventchromoomltbilyDuethdulfunctilyexctmoleculrmechnmctrigenhncedtumAPmunclerTheoverllgolthprojectchrcterizefunctiPIK3C2ATNBCcellimpcnTNBCTIMEAim1elucidtemechnmunderpngenhncedtumAPupPIK3C2AdepletiTNBCcellthroughtrncripmicprilgPI(34)P2quntifictiexmgOv/MHC-IturnoverrtevroInAim2weuePIK3C2Am-electivehibir(PITCOIN1)nti-PD-1combtrthopicTNBCtumyngeneicmouemodelpro--ccepttudydetermewherthcombtirpyflmeTIMEpromotepotenttumgivivoThprojectlignmytrgfutuphyicin-cienttwhoeerchgolcudcoverydevelopmentolidtumimmunpyProjectSummryClercellnlcellcrcom(ccRCC)whichccountpproximtely85%llnlcncertntvrietycncerrpiehighlylethlvHippel-Ldu(VHL)motimptnttumuppnlcncerloledhypoxiduciblefcr(HIFcludgHIF1HIF2)ccumultiAlthoughHIF2hibirhendevelopedpotentilrpeutictrgetnlcncerlymllpropotiptientpdHIF2hibtmentuggetgimptnceidentifygddilrpeuticvulnerbilieVHL-deficientkidneycncerMethyltidenoe(m6A)determeftemodifiedmeengerRNA(mRNA)hcentlyenhownplykeyrolegultggenexpicriclcncerdevelopmentAlthoughpviouerchhuggetedm6AmyimptntnlcncermoleculrmechnmhdroleccRCCtumigenegginotyetwellunderodOurplimrydtuggetVHLbdm6AenzymticcomplexproteMettl3/14gulteirterctiBypermgm6ARIP-SeqRNA-SeqnlcelloutVHLwehveidentifiedetgenewhoeexpimygultedm6AVHL-dependentmnnerAmgmPhophooide-3-KeRegulrySubun3(PIK3R3)nimptntcompentPI3KpthwymRNAtbilygultedVHLnm6A-dependentmnnerFunctillyPIK3R3depletipromotenlcellgrowumgrowthwhileovexpidimheccRCCcellgrowth2-Dcolymti3-DtgrgrowumgrowthWehypoizeVHLgultem6A-dependentgeneexpictrollgccRCCtumigeneThfirttudylkVHLmRNAtbilygultivigultgMettl3/14m6AenzymticcomplexwhichchrcterizencniclfunctiVHLdtctiverolenE3ubiquligeInSpecificAim1wedetermemoleculrmechnmwhichVHLgultem6AmodifictikidneycncerInSpecificAim2weexmefunctilroleVHL-m6AignlgccRCCtumigeneSpecificllyweexmerpeuticefficcyPI3KAKThibirkidneycncerxenogrftptientderivedxenogrftSuccefulcompletieimprovidemechnticightnovelignlgpthwyhowVHLgultegeneexpiimptntccRCCetfoundtirpeuticterventrgetgVHL-Mettl3/14-m6AignlgxccRCCProjectSummryRetncerpypible90%cncerptientmtlyOurundertghowcncercelltrpy-duceddethlimedMygoltterundertmoleculrmechnmcncercellrpytnceneyewrdimprovgrpyIdentifygchrcterizgnoveltncemechnmhouldfciltedeignmoeffectivecncerrpieImmunpyiizgrdwocommcncerrpieTheerpiekillcncercellprtviferropn-popticcelldethmechnmchrcterizedlipidperoxidtiSenizgcncercellterropmyimproveefficcyecncerrpieToeffectivelyenizecncercellferropwemutidentifyhowcncercellnmllytferropHowevermechnmwhichcncercelltferroppolyunderodIcentlyhowedtrncriptifcrnuclerfcrerythroid2like1(NFE2L1NRF1)quidprotectcncercellferropMyoverrchghypoNFE2L1centrlnimptntpthwypromotgferroptncecncercellThegoltherchprtmyoverlltrgplntetthhypodetermehowNFE2L1protectcncercellferropUltimtelytherchhpotentilmdvncecncerrpyIpropoetwoSpecificAimInAim1Itetwhercertpot-trnltilmodifictiNFE2L1quidferroptnceTheetudiecducteduggeneticphrmcologicpprocheperturbNFE2L1N-glycoylticlevgeeeffectferropenivyToupptuccefulexecuthimItdglycobiologymyco-pDrCrolynBerzziwhopieedthfieldInAim2IelucidterolenicotmideN-methyltrnfere(NNMT)ferroptncePlimrydtuggetNNMTwhichencodenenzymevolvednicotmidedeneducleotidemetbolmdicttrgetNFE2L1IhypoizeNNMTgultecncercellferropenivyltergdoxhomeotThroughmypropoedexperimentIdetermewherNNMTdicttrgetNFE2L1IloeferropenivycellwhichNNMTknockedourovexpedMpectrometryuedmeubundncedoxmoleculeecelllenlyzeroleNNMTferrop-lteddoxgultiItdmpectrometrymycollbrDrMrAbu-RemilehwhexpertmetbolomicWhguidncemyexperttemmenrtStndUniverymypropoedexperimentelucidtethnovelpthwypromotgcncercellferropeviidentifypoibletrtegiemimizecncerrpytncePROJECTSUMMARYAdoptivetrnferengeedTcelltrgetgtumntigeneffectivegtmotolidtumdue-prtpopertencerpidetdyfunctiRecenttudieendogenoutum-pecificTcell(Endog-T)hvedecridpopultitem-likePD-1+Tcf1+progenirexhutedTcell(Tpex)cnelf-newdiffenteeffecr-likeTcelltumTpexpfentillyidetum-drglymphnode(TdLN)wheymtedthroughctivtidendriccell(DC)ImptntlyTpexTdLNnecerypromotgpertentfunctilTcellpewellcferrgpePD-L1blockdeHowevernotclerwherengeedTcellmPD-1+Tcf1+popultiTdLNhowthimpctirlg-termpertencefunctumTotetthIdptedclicllylevntKrG12D-LSL/+p53fl/flmumodel(KP)lungdenocrcomovexpmodelnetigenOvlbum(Ov)compOv-pecificengeedTcell(TCR-T)Endog-TcellWhilemjyEndog-TcellTdLNwePD-1+Tcf1+TCR-TcellwepdomntlyPD-1-Tcf1+mrkerocedlckctivtimtenncep-exhutedcentrl-memyphenotypeCtentephenotypePD-L1blockdefiledcenumrTCR-TcellenhncetumctrolcomprEndog-TThuIhypoizefcruniqueTCR-Trpyuchirvrop-ctivti/fuhighcellnumrpromoteirmtiPD-1-Tcf1+ervoirTdLNtedPD-1+Tcf1+IlohypoizemtiPD-1-Tcf1+ervoirTdLNctullyndvntgeTCR-TrpycePD-1-Tcf1+popultimypoeuperifunctilpotentilcnmobilizedthroughvcctrgetgDCTdLNInthprojectIeekdeterme1)whyTCR-TcellmPD-1-Tcf1+ervoirTdLNtedPD-1+Tcf1+likewhtdecridEndog-Twell2)wherPD-1-Tcf1+TCR-TcellTdLNhvetem-likechrcterticfunctilpotentilcnunlehedvcctiInAim1Iuefluocently-lledtumKPmodelflowcymetryhigh-prmeterfluocencemicrocopydetermehowfuilrgenumrcell/vrop-ctivtiffectTCR-TcellmtiPD-1+Tcf1+popultiTdLNhowthclteirlocliztinerDCInAim2IueRNA-eqATAC-eqexvivoydecritem-nefunctilpotentilPD-1-Tcf1+TCR-TcellTdLNcompdPD-1+Tcf1+Endog-TIloevlutewhernovelTcellvcctipprochtrgetgDCTdLNcnctivtePD-1-Tcf1+TCR-TcellpromotetumctrolThroughthwkIdefemechnmwhichTCR-TcellmTcf1+tem-likeervoirTdLNpotentillyidentifyrpeutictrtegyenhnceTCR-TefficcytrgetgeervoircouldtrnltedclicimproveptienutcomeSUMMARYThechievementobteddiffenttypecncerimmunpyclerdurblelg-termurvivlomeceThemotfquentlyuedimmunpeuticpprochttmentimmunocheckpothibir(ICI)Howevermjlimtieimmunpieltivehighfquencylg-ltgimmuno-lteddvereevent(irAE)ocedttmentirAEtriggedICIcnffectmotnytueThugivencgburdenirAEdetermg)mechnmdriveirAEb)thoeptientwhothigherrkdevelopirAEc)noveltrtegiemimizeirAEwhileutgICInti-tumefficcyunmetneedTheirAEcuedICIttmentmlyduenoverpeCD4CD8cellTcell-producedcykemjmedirirAEUntilcentlymimlttentiwgivenIL-6medirirAEICIrpydepewell-etblhedroleIL-6pthogenenumrflmmrydeeThprtduefctIL-6cidedcykeproducednteimmuneytemWehvecentlyhownhumnCD4cell(notmoueCD4cell)helthyvolunteerproducehighlevelIL-6quicklyfterctivtiThelevelIL-6producedhumnCD4cellfterctivtiheterogenoumghelthyvolunteeruggetgpotentilgeneticfluenceAlthoughIL-6RexpitrictedleukocytehepcyteIL-6cnlotriggerignlcelldotexpIL-6R(egendolilcellneurcrdiomyocyte)cuepthologywhenolubleIL-6R(IL-6R)pentbdIL-6oceubiquiulyexpedgp130WehvehownhumnCD4cellproducehighlevelIL-6RupctivtiThehigh-fquencypolymphmpromoterhumnIL-6gene(-174G/Cr1800795)cnffectproductiIL-6Similrlypolymphm(r2228145)codggiIL-6RgenecnledenhncedlevelIL-6RWepropoeIL-6/IL-6RproducedctivtedCD4cellfterttmentcncerptientICImjmedirirAEcuedthrpygeneticpolymphmIL-6/IL-6RgenecoulddetermerkptientdevelopirAEWevetigte1)effectgeneticpolymphmproductiIL-6IL-6RhumnCD4cellhelthyvolunteer2)wherpolymphmIL-6/IL-6RgeneoceddevelopmentirAEICI-ttedcncerptientPROJECTSUMMARYHighgrdegliom(HGG)motcommmlignntbrtumdultuniverllylethlThetrdcHGGhmedunchngedover30yermedinurvivldevttglylownly15mthpotdignoEpigeneticrrtikeymoleculrfetuctriedeepthogeneTheegolthpropoldefeepigenomicdygultipromoteHGGgrowthdetermemechnmthroughwhicheltertidrivetumigeneHGGtumcedchromtcceibilytendhvemofvbleoutcomeWecentlyhowedSox9hibhnedecetyleHGGceH3K27cetyltiwhichignificntlyextendmedinurvivlmiceAnlySox9humnHGGveledterctnumerouepigeneticmodifygprotecludgHp1bp3heterochromtbdgproteFurrmowholegenomeequencgfmililgliomptientirfmilienomtedHp1bp3potentiltumupplo--functi(LOF)muttidrivgcogeneUgn-uteroelectropti(IUE)mouemodelHGGwefoundHp1bp3lo--functi(LOF)tumhyperprolifertivedecedmedinurvivlwhileHP1BP3g--functi(GOF)tunttumgrowthextendurvivlAddillyATAC-SequencgLOFtumveledglobldececceiblechromtTheeplimryultledmehypoizeHp1bp3chetrtechromtmodelglowtumgrowthHGGToundertroleHp1bp3gultgepigenomehowthimpctHGGprogiIpurpoetheimInAim1IdetermeeffectHp1bp3ourIUEPDXmodelInecdimIdetermeepigenomicltertiocedHp1bp3prilgH3Kme3H4K20me3mrkwhichpperltedHp1bp3HGGLtlyChIP-SeqHp1bp3HGGmouetumveledHp1bp3bdDNAtgenelocivolvedmethiee-crbmetbolmTheeimtheidentifymetbolicchngeHp1bp3mutnttumugmetbolomicdetermehoweltertidrivetumgrowthOverlltherchimexpourundertghowepigeneticdygultiHGGdrivedeeprogiImptntlythwknomtenewepigeneticcidtepotentildrugtrgetHGGProjectSummry/AbtrctColoctlcncer(CRC)ecdmotcommcuecncer-lteddethUnedStteDepedvncebothdignoticrpylrgeter-dividulvribilyrpypedignoticccurcycnobervedTheoptimiztimediclimgggentCRCcriclcompentimprovgourtechniclcpbilieltgerlydignoticcompletellgtum-poivetueurgiclectiurveillncepcirpyOnemjquimentimprovgcliclpermncerpeuticmediclimgggentchrcteriztitructurlfunctilchemtriecnceroutueeirdiffentbentnmltueThepecillyimptntgimynotufficientlylledextgimgggentclicllycceptbleimplementbleignl--bckgroundrtioInececurtiveurgiclterventichievemixeducceCRCptientpopultiduetechniclbilyllccurtelypcelytum-poivetueMooverediffencemypotentillyexplclicllyobervedvriptientrpypedeeggiveneTodevelopcomputtilwkflowtegrteCODEXimgghigh-dimenilhyperpectrlchemiclmppgtetmyhypomyexperimentltructudividedtwomcompent(1)Ipermplimryn-detructivell-feptiochemiclimggnmlCRCptientbiopieidentifydiffencefunctilheterogenouchemtrie(2)IpermptilomicidentifictiCRCltedtuerchectuugCODEXtegrtihigh-dimenilll-fe2DfrdpectrlmpThenovtherchdevelopmentcomputtilwkflowfrmewktegrtehighlymultiplexedCODEXhigh-dimenilll-fe2DhyperpectrlchemiclimggThpprochcnlednlterntivepenttiphyicochemicltuepropertiechrcteriztiidentifictiptiochemtrielevntCRCtum-vivefrtLg-termthcnuedfutuguidedevelopmenptimizticncerimgggentimproveptienverlloutcomeProjectSummryLrge-clecncergenomeequencgprojecthvehighlightedfquencymuttichromtmodifiercncerMuttigeneencodgmemrSWI/SNFchromtmodelgcomplexhveenidentifiedcloe25%llcncerThuundertgmechnmwhichSWI/SNFmodultegeneexpicriclimptnceInnmlcellctivySWI/SNFtrncriptilctivtiblncedpivePolycombcomplexutiwheSWI/SNFmuttedPolycombgfluenceWhRortlbwemkeuegenomicllyimplehighlylethlpedriccncerrhbdoidtumlckbothcopieSMARCB1cocompent2out3SWI/SNFmodelgcomplexeTheerhbdoidcelldependctivythirdSWI/SNFmodelgcomplexwhichlckSMARCB1TogmechnticightterplytweenSWI/SNFPolycombcjunctiPedricDependencyProjectwhichmymenredcollegueBonweerchedgeneticvulnerbiliepecificrhbdoidtumcellWepermedCRISPR-C9ceng16rhbdoidtum(RT)celllecompdover800cncercellleidentifiedgenewhoelopfentillycuelovibilyRTcellWehvedependentlyvlidtedimptncethgeneRTcellvibilyourplimrytudiehowencodedprotepePolycombfunctiWeehypoizelothprotefurrdruptSWI/SNF-PolycombblnceledgpigenewhoetrncriptiquidRTcellgrowthAddillythproteknowngulteimptntignlgpthwylomyfurrdygultetrncripthroughirdruptiElucidtifuncthproteprovidenovelightchromt-mededctroltrncripterplytweenSWI/SNFPolycombwhichdruptedcncerimptntlymylkeimptntignltrnductipthwySWI/SNFPolycomb-gultedtrncriptiAddillythroughtudythvulnerbilywegmechnticightctriedevelopmentnewrpieThroughrgwrdIextendmyexpertetudyignlgpthwydelvenucleuuemoleculrgenome-widepprocheegultichromtIguidedthjourneymyouttgmenrDrChrleRortwhohfntticcdccomplhmentmenrgtewhohfrexceededmyexpecttiThroughhlederhipcommmentAcdemicProgrmOfficepotdocdevelopmentmycceouttgourcetStJudeImcfidentmypotdocrltrgequipmellolIneedlunchuccefuldependenterchcerrunngmyownlbABSTRACTRetncetilllimtiimmunecheckpotntibodieMAPKpthwy-trgetedhibirDrug-lerntpertercellpopultithoughtctrieemergencetnttumLotrncriptifcrSOX10enhncedYAP/TAZ-TEADignlgfquentlyocedcquidtnceocedmimliduldeevivetrncriptiltteInournlyhumnptient-derivedxenogrftgle-cellRNA-eqdtwedetectelevtedlevelcniclTEADtrgetCTGFCYR61SOX10-lowvivecelltteWehowSOX10loufficientduceTEADtrncriptilprogrmcludgCYR61CTGFYAPTAZprlogh50%identySOX10-deficientcellhowedtrgdependenceTAZCYR61CTGFexpiFurrmoovexpictiveTAZwufficientmedelernceBRAFhibirMEKhibirWedevelopednovelcovlenthibirOPN-9643OPN-9652deignedtrgetcentrlplmtebdgpocketTEADTtmentSOX10-deficientcelleirOPN-9643OPN-9652ducedCTGFCYR61expiwellTEAD-dependentluciferepterctivyOurtudieimutilizenovelTEADhibirtrgetSOX10-deficientdrug-lerntmelnomcellThroughrgtThomJefferUniveryIlernmoleculrtechniquebio-mticdevelopcriclthkgkilllerncommunictemycienceThwrdwouldhelpmechievemylg-termgolcomgndependentcienttPROJECTSUMMARY/ABSTRACTPncticductldenocrcom(PDA)projectedecdledgcuecncerdethUS2030Whnocot-effectivecengpventimeumotnewlydignoedpnccncerptientpentlocllydvncedmettticdeewhichcrrieprognolethneyerPDAclifiedcliclblubtypeblptendgweurvivlInplimrydtwehowblPDAchrcterizedlohnedecetyleirtu6(SIRT6)ctivtiIntegrtedStRepe(ISR)whichndertumcellmoeniveCDK7trgetedrpieSIRT6hencentlyhownnoveltumuppPDAcoopertgcogenicKRASdrivenevenmoggivePDAHoweverelucidtgSIRT6rolemodultgISRmdcovedHewepropoethepecificim(1)IdentifyhowSIRT6mechnticllyffectATF4tbily(2)ChrcterizevivoefficcyCDK7iclicllylevntPDAmouemodel(3)DetermehowDNp63lterCDK7ienivyThfellowhipeekuppttrgDrAdrinneWllce-PovirkpotdocrlfellowtFdHutchCncerCenter(FdHutch)wrdhergolpurugncdemiccercncererchTolizecopepropoedwkDrWllce-PovirkpodDrSKugelwhoelbryfocueepigeneticdygultipnccncerloccelertehererchthroughcollbtiherco-menrDrAndwHieh(experttrnltilgulti)DrEricColl(cognizedlederpncubtypgerch)DrSunilHgni(cognizedlederpnctumbiologymicroenvirment)DrTrnGujrl(experthigh-throughputdrugcengdeign)DrWllce-PovirknefbdthexpertehighlycollbtivetmophetFdHutchwhichhoueledgerchgrouppncticcncercncerrpeuticProjectSummryDiffuemidlegliom(DMG)motcommmlignntbrtumchildnTheyurgicllycceiblefrctivechempyThepvlenncogenicdriver--nH3K27MmuttihneH3--undruggbleRdipytrdcDMGlyttmentprolgptienturvivlHoweverH3K27MDMGevblycurfollowgrdipyunimlyftlAgtthbckdropwepropoethR01pePAR-22-198NCIentledPciApprocheRdiSynticcombti(PAIRS)OurbrodgolimproveurvivlchildnDMGThepotdeprtuourtudyplncentlycompletedgenome-wideCRISPRcenimedtidentifygDMG-pecificvulnerbilieOurcenidentifiedcdilynticlethlytjunctiplictit(RS)cequentDNAdmgepe(DDR)ThvulnerbilydruggblehpotentilenhnceefficcyrdipyDMGynergticlly--trtegypecificllypropoedPAIRSOurtetblehypoutbleblncetweenRSDDRDMGcntippedrpeuticdvntgecombgrdiATRntgt(whichceRS)rdipluhibirDNApolymereQ(whichdeceDDR)Incollbticpteprtnerwehveidentifiedclicl-tgebr-penetrntntgtATRPOLQFclicltrilwentegrlmemrterntilPcificPedricNeuro-OncologyCtium(PNOC)DrwgupeourceourimtetthepecificpdictiourhypoAim1(trgetpecificy)tetpdictiynergtickillgDMGcellcombtirdipluATRPOLQntgtflecttrgetpeenhncedRSuppedDDR(ducedATRPOLQntgtpectively)Aim2(chromttructu)tetpdictiH3K27MdrivenltedchromtpropeldependencyATRPOLQAim3(rpeuticpotentil)tetpdicti()vribilyDMGptientperdipyflectptient-pecificdiffencep-rpeuticburdenDDRRS(b)mrkerRSDDRclteperpyvtrclicltrilptient-derivedxenogrftDMGThetudyplnenblednterctivecollbtimgthevetigrwhoekilletexceedumirprtDphneH-KognMDclicin-cienttmuchprcticlexperiencecliclcchildnDMGAChirRdiOncologytDn-FrrCncerIntuteDHKterctfquentlyDipnjnChowdhuryPhD-DNAenzymologtdeepexperteDNAplictipirInclicltudiepropoedAim3DHKDCwkcloelySMuellerMD-nexperndeigncductclicltrillederPNOCctiumTumbloodveeldyfunctilirgulrimpirgimmunecellfiltrtidrugdeliveryctgevehypoxielectggivecncercellRecentrpeutictrtegieimnmlizetumvcultutrgetgngiogenicfcrenultmllwdowefficcyduetnceover-prungOurlbdcovedmechnmdurgnmlvculrdevelopmentmydygultedtrgetbletumUgmiceexpfluocentubiquti-bedcellcycledicr(Fucci2)dtguhcellcyclette(erlyG1lteG1S/G2/M)wefounddtctendolilcellcyclette(erlyG1vlteG1)quidendolilcellpecifictivenouvrterilubtypepectivelyInddiwefoundendolilcellcyclectrolpecifictidygultedvculrmlmtiembletumvcultuTheemlmtiwepventedttmentcellcyclehibirPlbociclibnFDA-pprovedCDK4/6hibirdvncedbtcncerttmentYeteffectPlbociclibcellcyclehibirtumvcultuunknownWehypoizeendolilcellcyclettedygultedtummicroenvirmentledgimpidendolilcellpecifictiimmtuveelttmentcellcyclehibirenbleendolilcellpecifictinmlizetumvcultuToexmetumdolilcellcyclepecifictiIducedmmmrytumFucci2micefoundtumendolilcellprolifertiignificntlycedleendolilcelllteG1Addillytumendolilcellexhibdecedexpirteril-venou-cpillry-enrichedgenedictgimmtuveelThuAim1furrquntifyendolilcellcycletteubtypemrkerFucci2micemmmrymelnomtumcompdhelthymmmryftpd(MFP)kctrolThufrIttedFucci2micemmmrytumPlbociclibwhichignificntlydecedproptiprolifertiveendolilcellcedproptilteG1Aim2furrtethypoPlbociclibcellcyclehibircetumendolilcellG1tteemblehelthytueenblerteril-venoupecifictiWequntifychngeFucci2expinlyzegle-cellRNAequencgendolilcellMFPtumoltedvehicle-Plbociclib-ttedmiceidentifychngepecificticell-cellignlgFllywequntifychngeveelpermebilymturtuehypoxiftercellcyclehibirttmentItetdeliveryctrtgenttummodeldrugdeliveryuemicroCTquntifychngeveeldenytructuedurgfterttmentTheetudieelucidtehowtummicroenvirmentffectendolilcyclettepecifictimechnmwhichphrmcologiclcellcyclehibicnnmlizetumvcultudictgnewueuchdrugcncerpthologiclngiogenePROJECTSUMMARY/ABSTRACTThecentucceecheckpotblockderpiehvehighlightedpotentilimmunpycncerttmentStilllybout30%ttmentcipientexperiencelgtermtumgiThuundertgmechnmdriverpytnceeentilimprovgptienutcomeWenowundertefficcyimmunpydependpencepertencefunctilimmunecelltumTum-pecificCD8TcellctivtedtumntigendictlykilltumcellHowevertumfiltrtgCD8Tcellencounterchricntigentimultihotenvirmentlt(eghypoxinutrientdeprivtietc)uppirfunctiThuppivetummicroenvirmentultimtelyducenltedCD8TcelldiffentitteclledexhutichrcterizedducedeffecrfunctiimmunehibiryceprexpidtctepigenetictrncriptilprogrmOurlbhvedemtrteduppivemicroenvirmentdrivemichdriltltedmetbolmwhichpromoteCD8TcellexhutiWhileweundertmichdrilufficiencydriverCD8TcellexhutimechnmunderlythcnectimundertudiedIntetglyCD8TcellccumultelipidplipolyydiffentewrdnexhutedtteInthtudyweimundertimpctcedlipidccumultiCD8TcelldiffentifunctiCrtetrnptedmichdricvertedcetyl-CoAcyolwhectubtrtedenovolipogeneThucrtetrnptcnectmichdrilmetbolmcyoliclipidynccumultiPlimrydthowvrohibimichdrilcrtetrnpter(SLC25A1)perveeffecrfunctichricllytimultedTcellducelipidctentTheedtuggetexhutedCD8TcellmyprogrmirmetbolmhuttlecrtedyfunctilmichdriultgceddenovolipogenelipidccumulticyolThuwehypoizechricllytimultedCD8TcellpproprelymichdrilcrtelipidwhichhibeffecrfunctipromotediffentinexhutedtteWetetthhypo(1)evlutgimpctbolhgcrtetrnpncriliztieffecrfunctiCD8Tcelltummicroenvirment(2)determgroledlipidCD8TcellfunctiTheightgedetudiehelpuundertwherccumultedlipidpentdedweightexhutedCD8TcellwherccumultedlipidpentnuntppedourcefuelmykeyirvigtiPrciplInvetigrWuXiohuProjectSummryReplictittenoccurwhenDNAplictidruptedledgDNAdouble-trbk(DSB)mtiReplictitcnlotriggedcogeneexpiocedtumdevelopmentNotblyplictitctevulnerbiliecncercellcnexploedcncerttmentNeverleourundertgdetiledDNApirmechnmupkbkgedueplictitwellourcpcyeffectivelytrgetocedvulnerbiliecncerttmentmlimedDNApolymere(POLQ)pecilizedDNApolymerecriclDSBpircompromedPOLQfunctiledgenomictbilyrdienivySubtntilevidenceuggetPOLQplynimptntrolemicrohomology-mededendjog(MMEJ)GivenpvlencemicrohomologietcncerbkpotPOLQ-mededMMEJthoughtvolvedpromotggenometbilyocedcncerpceunderlygmechnmmunclerInthtudywedcoveduniquerolePOLQpirDSBlkedkbkgevelgnewmechnmquiPOLQcopeplictitBedrolePOLQpirdmgedkwefoundhibgPOLQledcelldethunderplictittheffectignificntlytenifiedwhenATRhidWepropoecomdrpeutictrtegyutilizgPOLQhibirATRhibirwouldynergticllyerdictecncercellexperiencghighplictitGivencurntpropoeduePOLQhibirprimrilyttgBRCA-deficienttumthtudyubtntillybrodenpplictiPOLQhibirWehypoizerolePOLQpirgbrokenkmbttgplicti-tedcncercellPOLQhibirATRhibirpropoevetigtemechnmhdPOLQ-mededMMEJpirbrokenkWeexmehowPOLQenggedpirplicti-ocedDSBtudycollbtivefunctiPOLQ-mededMMEJbk-ducedplicti(BIR)pirgbrokenkWeuecell-bedyxenogrftmouemodelexplocncerrpeutictrtegyugPOLQhibirATRhibirThtudynlyhedlighnrolePOLQ-mededMMEJcopgplictitlolygroundwkpotentilcncerttmenttrgetgcncervulnerbilieocedplictitSceplictithighlyocedcncerthtudyddillybrgightDNApirmechnmmodultegenometegrydurgtumdevelopmentPROJECTSUMMARY/ABSTRACTFoodecurytrgmedirltihiptweenpovertybtcncermtlyUnedStteNtildthidentifieddultwomenexperiencgfoodecuryhve54%loweroddptgbtcncercengpttwoyerwhencompdfoodecuwomenCountieveryhighlevelfoodecuryignificntlyocedlter-tgebtcncermgwomenge65olderErlydetectiducebtcncermtlyrtecelikelihoodtterttmenptiHoweverhigherfoodecuryhenoceddelyedutiliztiduceddhencecommendedmediclcmgdividulcommuniePrtnergextgcommunyprogrmferupplementlfoodtncemyprovidenopptunyencourgebtcncercengthhrder--chpopultiThepropoedtudypplycommuny-enggederchmethodimproveccebtcncercengmgmrglizedpopultiexperiencgfoodecuryThecentrlhypoddgbrrierbtcncercengpromotidiverecommuniewomenfoodecurycncecenguptkeultimtelyimprovgcncerhelthequyWeteurhypovifollowgSpecificAim(1)Identifybrrierfcilrimplementgcncerpventerventifooddtriiettg(2)Developtilodcommuny-bedcncerpventerventipromotebtcncercengmgwomenfoodecury(3)Evlutecceptbilypproprenefeibilycommuny-bedterventipromotgbtcncercengmgwomenfoodecuryTochieveAim1Icollectqultivedtboutfoodbnkdtriieventclientervedugprticipnbervtiemi-tructudfieldnoteterview(n=20)dictedctentnlyguidedColidtedFrmewkImplementtiReerchgn-depthundertgfcrelucidtemechnmimpctimplementtiFAim2IueInterventiMppgytemticproceplnngcommuny-bedterventipromotebtcncercengmgdiverewomenwhoervedfoodbnkFAim3Icductpilottudyterventifoodbnknurveywomenge40-74yer(n=50)evluteelectimplementtioutcomeTherchtignificntlyimproveundertgfoodecuryocildetermntcncerhelthprovidenimplementtimodelpromotecncerpventi-rkpopultiThetrgplnfciltedmenrhipmypexceptilfcilietUCDvThpropoldecrintegrtivecomphenivetrgplnupptcientificpildevelopmentpropelmewrdmylg-termgolcomgndependentpublichelthercherSUMMARY/ABSTRACTCncerocedfibrobltpnctictelltecell(PSC/CAF)bnmltumbloodveeltwomjfcrctriettmentfiluPSC/CAFctriecollgen-richextrcellulrmtrix(ECM)whichimpirdrugdeliverypromotecncercellurvivlctrienimmunouppiveenvirmentCAFhveenhownhveimilrroleupptgmettticedeePDACCurntlynogentvilblecnimultneoulyelectivelyducectivtedPSC/CAFnmlizengiogeneBothctivtedPSC/CAFngiogenicendolilcellelectivelyexphighleveltegrv3Thenoexpegrv3nmltueWedevelopedProAginovtiveprotedrugdtctmechnmcticurntlyvilbletegr-trgetggenttrgetgtegrv3tnoveln-ligbdgeProAgioducepoptegrv3expgPSC/CAFngiogenicendolilcellhighefficiencycrugctivtgcpe-8tcyplmicdomOurplimrydthowProAgiohnti-tumctivymultiplePDACmodelenhnceeffectgemcHlogicnlyehowedProAgiodecedcollgendepletedPSC/CAFtumInpheIclicltrilglegentProAgiohdemtrtedexcellentfetyprilepromgphrmcoketicprilenti-tumctivyptientPDACWehypoizeducgpoptegrv3expgcellProAgiopecificllydepletebothngiogenicendolilcellctivtedPSC/CAFledghibicollgendepoiPDACtumwhichenhncedrugdeliveryceenivyPDACetblhedrpieThProjecththeSpecificAim1)TochrcterizexicydetermecommendedpheIIdoeProAgiocombtigemcnb-pclxelWecductpheIclicltrilProAgiomettticPDACptientnoprirpygemcnb-pclxelThegoldetermecommendedpheIIdoeevlutephrmcoketicProAgiochrcterizexicyAecdryobjectiveobtplimryctivydt(overllperte)ProAgiogemcnb-pclxelPDAC2)TlyzeeffectProAgioptienttumvlidtemechnmdrugctiPDACptientenrolledexpnipheundergopidp-pot-ttmentbiopieWevlidtemechnmProAgioctiegchngetrtumlcollgenbloodveelPSC/CAFubtypeimmunecellv3expieptientmpleSmplenlyzedvimultipleximmunluocenceptilquntifictiglecellRNAequencg3)ToevlutephrmcodynmiceffectProAgiongiogenetumperfuiTheperfuichngetumfterttmentProAgiopluchempymeudugqunttiveDCE-MRIllptientPROJECTSUMMARY/ABSTRACTColoctlcncer(CRC)devttgdeenoeffectiverpeuticoptiptientuffergdvncedmettImmunecheckpothibir(ICI)ferpromgttmentpotentilmllubetptientmicrotelletble(MSI)/mmtchpirdeficient(dMMR)tumHowevermotCRCptienthvemicrotelletble(MSS)/mmtchpirpricient(pMMR)tumpdpolyICITheenurgentneedidentifynoveltrgetbiomrkerpeimmunpyMSStumwhichctuteover90%mettticCRCZFP36L2nRNA-bdgprotemutted5-10%CRCmemrTIS11genefmilywhichknownuppflmmtiblockgexpiproflmmrychemokecykemRNAimmunecellPlimrydtourlbuggetloZFP36L2functihumnCRCledcedTcellcrumentnmllyimmunologicllycoldtummicroenvirment(TME)MSS/dMMRTMETheedtuggetZFP36L2myloupptrnlticykechemokeCRCmechnmimmuneevifurrZFP36L2muttimygivecedimmunecellfiltrtiCRCtumwhichmyenhncepeimmunpyToddthwehvedevelopednovelyngeneicmoueZFP36L2knockoutCRCgnoidmodelZFP36L2knockoutgeneticllyengeedmoueCRCmodelTheeolllowudeletebilyZFP36L2gulteflmmryecmeCRC(Aim1)ehowZFP36L2muttiimpctcompoifunctilyTMECRC(Aim2)TherchelucidtefunctilcequencemuttiZFP36L2whoefunctihumncncerpolyunderodMobrodlyourwkceourundertghowtumhpeirloclimmuneenvirmentupptdeeprogiOurterrogtiroleZFP36L2CRCddcriclunmetneeddevelopnovelttmenttrtegieMSSCRCidentifyclicllyctiblebiomrkerpeimmunpyThwkhpotentilignificntlyimproveurvivlqulylifeCRCptientPROJECTSUMMARYApproximtelyhlfllcncerptientUnedSttettedexternlmrdipy(RT)pproximtely40%llcurtivettmentgttriedModernttmentplnngytem(TPS)deignedoptimizetrgetdoedtriiuchdoetumvolumemximizeddoeurroundggntrkmimizedWhilethpprochuccefulducgeverydetermticgnxiciemountgevidenceuggetchticrdi-ducedecdprimrycncer(SPC)rkeriouccernfollowgRTttmenthouldcidedTPSdoeengeThpentlyimprcticlduelimednmiclmtipentptientplnngcomputedmogrphy(CT)imgetudieFurrmoTPSdocomputedoener-out--fieldgneirgrolyundetimteirmgnudeneglectcomputementilyAwhole-bodycomputtilphnmnthropometricprmeterbedptientdemogrphiccouldupplementlimedgeometricmtipentplnngimgeImplementgthmodelytem-pecificMteCrldrnptimultiwouldnprovideprcticlmencomputedoegndtlttmentfieldhighdegeccurcyPviouwktUniveryFlidhproducedlrgetdultpedriccomputtilphnmlibrriedtepentgdividulbothbiologiclexeoverwiderngeheightweightgeGiventhmtiIhypoizecomputtilphnmproducedmerggCTplnngimgeptient-mtchedtetrhedrlmeh-typephnmcnuedcomputeccurtener-out--fieldgndoeccomntSPCrkfollowgRTpotentilcliclimplementtimediclcdupplementtipropectiveTPSdoeoptimiztifutuepidemiologicltudieThepropoedprojectchievehroughcompletifollowgSpecificAimAim1Developytemgenertiwhole-bodyptient-pecificmehphnmrdirpyttmentplnngCTimgeAim2CtructMteCrldrnptourcetermexternlmrdipyytemenmlgndoeccomntSPCrkfollowgrdipyttmentThedevelopmentthytemfulfillnurgentneedRTdoimetrymethodwhichcomputedoeSPCrkllgnbodypot-ttmentProjectSummryStgrnule(SG)cyplmicgggtemedtlledtrnltiicomplexeupcellthveemergedcriclgulrcogeneSGcncfercncercellbilythrhbiologiclcdicnimprttumigenictrnltilttethroughmRNAequetrtiHowevermechnticundertghowSGendogenoulygultetumigenevivomeluiveMyerchpropollevergehumnizedzebrfhmelnommodelwhetumdevelopmentcnvulizedmnipultedpcurtgeglecelligydUgthytemIhvefoundSGmedmelnompcurcellpertdurgtumiprogiFurrmomyplimrydthowCRISPR/C9-mededbltikeySGcompentg3bp1melnomgcelldelyetblhmentcncerpcurzeneentilgcellpheemergencemelnomTkengeroverrchghypomypropolSGmedmelnompcurcellenhncevibilyuptumigenictcemedubequentlyccelertemelnomgeneenblgncogenictrnltilprileTotetmyhypoIfirtdetermeimpcttgrnulemtimelnomgeneperturbtgkeycompentuggeneticllyengeedzebrfhchemiclbiologyIubequentlytetwhermodifictitgrnulemtiltermelnomcellcogenicyugflowcymetryubcutneoutrnplntyInddiIelucidtectriiRNAequetrtitgrnulewrdmelnomdevelopmentugproximyllgtrnlmeprilgInfunctillyolvectriiSG-equetedmRNAugzebrfhgeneticLtlyIpermimmunotghumnmelnommpleproteencodedmRNApfentiltrnltimelnomgcellegcervtiemoleculeirpotentilervemelnombiomrkerUltimtelyultobtedheprovidemechnticightwrdfunctilroletgrnuledurgcnceriAtgrnuledetectedcromnycncertypethwkelucidtenodetumbiologycnexploedhltbrodpectrumcncereyInthpropolIetblhtrggolexpmycceptultechniclexpertecncerbiologyRNAprocegInddiIpentimenblecquipilkilletnecerychievemylg-termerchgolwhichrunmyownlbtncdemicerchtutitudygbicbiologyRNAprocegdurgcnceriProjectSummryTheoverllgolthpropoldetermemechnmwhichInulReceprSubtrte2(IRS2)gultepdleemblycheckpot(SAC)uethmtitudynovelrpeuticpprochettmenttriplenegtivebtcncer(TNBC)TheIRSproteeentildprproteul(IR)ul-likegrowthfcr-1(IGF1R)ceprDygulthpthwythroughupgulticeprligdrivebtcncerigrowthmettUntuntelyterfergIISpthwyttmentbtcncercepr/lig-trgetedpprochehenunuccefuleftimprovebilytrgetIISpthwycncerrpyhdedfctmechnm()whichthignlgpthwyctriecncerproginotwelletblhedThpropolfocueIRS2cuethdprproteexpedpfentillyTNBCpplicnthcompellgdtIRS2plyculroleggiventuthbtcncerubtypeUndertgmechnmctiIRS2TNBCeentilexplogIRS2rpeutictrgetInthgrdtrigugcentevidencepplicntlblbhemergedimplicteIRS2micgultiSpecificllyIRS2expicedurgmiquidcellcyclerttpdleemblycheckpot(SAC)proceenupcechromoomleggtimtgenometegryImptntlynotudiedtehveetblhedmechnticroleIRS2SACgultiTowrdthgolpplicnthidentifiedcellcyclegulrykePLK1whichctrolSACnIRS2-pecificterctgproteTogerefdgvelpotentilIRS2-dependentvulnerbilycouldexploedrpeuticllypoibilyupptedpplicntplimrydtloIRS2expienizeTNBCmictdrugTovetigtehypoIRS2gultiSACutTNBCvibilytrgetgthfunctiIRS2hibtumgrowbothprimrymettticepplicnt1)InvetigteroleIRS2pdleemblycheckpot(SAC)gultiThehypoIRS2expilocliztieentilefficientmicSACctivtiexmed2)EtblhmoleculrmechnmwhichIRS2gultemicSACThehypoIRS2promotefidelypdlemthroughcrumentctivtiPLK1exmed3)AerpeuticefficcytrgetgIRS2-dependentcellcyclefunctiTNBCThehypocutetrgetgIRS2expi/cell-cyclegulryfunctienizeTNBCmictexmedABSTRACTNturlkiller(NK)cellkeymedirnti-tumimmunepectgdictlykillcncercell(CD56dimubtype)crupro-flmmryimmunepopulti(CD56brightubtype)RecentdcoveriehoweverhveveledNKcellubtypepropertietue-identdptivememy-likephenotypeTue-identNKcellhveenhownhveelevtedproductichemokeuchCCL3XCL1turncrucventiltype1dendriccell(cDC1)CD8+TcelltumAdptiveNKcellhveenhownpertmthlgerthncventilNKcelldplyenhncedtumcellkillgGivendiveryNKcellpericrucilidentifywhichNKcellubtypeexttumkeynti-tumpeToddthourgrouphgenertedpn-cncertlNKcelluggle-cellRNA-equencgdt326ptientcro17cncertypeIndogoweidentifiedpromentpopultiCD56brightNKcelldplygeneigntuuggetiveboue-identdptiveNKphenotype(bright-tNK)Wefoundbright-tNKdplyhighexpichemokecykeuchCCL3XCL1IFNGuggetgfunctilroleimmunecellcrumenttumUggeneigntuetimteltivebundncebright-tNKbulkRNA-eqdtwefoundbright-tNKocedignificntlylgerdee-feurvivlcncerptientThubright-tNKmycriclnti-tumimmunypentttrctivephenotypemimicnextgenertiengeedNKcellrpieAltlecurntlyknownboutbright-tNKthpropolimdvnceourundertgfunctibright-tNKtumidentifymechnmpromotgirdtctphenotypeInAim1weuethoglmethoddetermewherbright-tNKpopultiocedcedcrumentnti-tumimmunepopultiuchcDC1CD8+TcellWedevelopbiomticolcnpidwell-etblhedoletimtefrctidiffentNKcellubtypeimmunecelltypebulkRNA-eqdtAddillywepplyhighly-multiplexedptilimggolterrogteptildtriibright-tNKNKcellpopultitumirociimmunecelltypeInAim2weuegenedeliverypltmcentrncriptifcrpromotefetutue-identdptivephenotypeCD56brightNKcellWentrnimotpromggenetrgetourclicl-grdeducedpluripotenttemcellNKcell(iNK)pltmholticllyevluteeffectnti-tumfunctiAlgerthpropolimdvnceourundertgbright-tNKNKcellubtypetumUltimtelydriverfvbleNKcellpropertiecndilytegrtedourgroupnch--didepipeleNKcellrpieenhnceirefficcydurbilySUMMARYPncticcncer(PDAC)prticulrlylethldueprttncerpiehighcidencemettTheoverllgolourerchprogrmdefemoleculrmechnmgultgtumprogimettPDACidentifygnewrpeutictrtegieimproveptienturvivlThpropolfocuenctivrvivecykeletlmcherypro-cogeneVv1whichGTPexchngefcrctivrpotentRc/Cdc42mllGTPegultectdynmicVv1rrntlyexpedubetpnctictumcltepoprognoHewehveidentifiednovelroleVv1gultiglutmemetbolmwelievectriecellulrenergyleveltegrtgpotentpro-vivefcrneentilmetbolicxPDACVv1promotecveriglutmeglutmtevienzymeglutme(GLS1)Furrwehveidentifiednovelmechnmwhichglutme/glutmtexctrietumprogimettthroughbothloclizedenergyproducthroughprcignlgbothglutmteflmmrycykeOurubtntilplimrydtuppthypothpropolecpicexpiRc/Cdc42exchngefcrVv1gulteglutmemetbolmlknutrientttuctdynmicviprolifertiUgcombticellbiologylivecellfluocencemicrocopybiochemtryvivomodelwetetthhypovetigtghowVv1mplifieglutmectbolm(Aim1)howglutmteproductidrivetumprogimettpnctictumcell(Aim2)SuccefulcompletherchprovidefundmentlmechnticdvnceourundertgmetbolicdependenciePDACidentifyrpeuticvulnerbilieptientVv1-poivetumetblhnovellktweencykeletlignlgglutmemetbolmPROJECTSUMMARY/ABSTRACTCncer-ocedchromoomlbnmliefquentlythroughpunctutedepodegenomictbilyThexemplifiedchromothriphtterg-tchgdividulchromoomewhichgenertedtctrrngementigntu~30%pn-cncergenomeChromothripdrivenmicerrmtirrntnuclerbodietermedmicrucleientrpm-eggtedchromoomeoutidenucleuDuedefectnuclerenvelopeemblymicrucleiundergquentirveribleruptuctivtenmlnuclerproceecludgDNAplictiDNApirtrncriptiDurgmicentrychromoomemicrucleiundergoextenivebkgetenhunddfrgmentthroughcompletelydefedmechnm()Ourlbrycentlyidentifiedfrgmentedchromoomemboundthroughoutmiprote-mededterwhichfcilte-cptifrgmentnucleuubequentemblyThccdegivehighlycomplexyetloclizedrrngementtenobervedcncergenomeInddideletumuppgene/mticogenicfuigenechromothripcnloultcirculriztimplifictigeneextrchromoomlDNA(ecDNA)Whileeverlkeymechntictephveenwellchrcterizedource()micchromoomefrgmenttimunclerToidentifygeneticdriverchromothripIcentlycductedpooledCRISPR-C9cenugchromoome-pecificmicrucleuytemIunexpectedlyidentifiedgenomemtenncemechnmknownFncinemi(FA)pthwyfuncticricldriverchromothripcomplexgenomicrrngementMyplimrydtuggetFApthwypromotemicchromoomehttergthroughcrumenttructu-pecificDNAenducleeunder-plictedDNAtermedemicrucleiwhichnfollowedmicDNAynprocemynlogouproceglte-plictgfrgileegenomeHeIpropoefurrdeferoleFApthwymicDNAynchromothripFirtIcomphenivelyidentifygimicrucletedchromoomeundergogctiveprocegdurgmiFApthwyIlodetermewhermicDNAynquidprimgfrgmentemblynextcellcycleSecdIlevergep-cliclcellmodelvetigtewherhibiFApthwypentfeiblerpeutictrtegyuppchromothrip-ducedemergencedrug-tntcncercellhrbgecDNATheetudiehedlighnhowgenome-protectiveDNApirmechnmcnco-optedpthologicldrivercncergenometbilyInddherchplnupptmypco-pdertticommteeIhveloetblhedwell-defedtrgcerdevelopmentplnfurrboltermybiliendependentercherfocuedcncerbiologyProjectSummryMigenctivtedproteke(MAPK)ignlggultecellgrowthnmlcellfquentlyoverctivtedcncerWihpthwyRAFkecoignlgnodeprticulrtetcncerdrugtrgetDepeextenivetudyRAFkefunctigultimcompletelyunderodIntriguglyeverltudiehvehownexpiCRAFprotenotCRAFkectivyeentilgrowthKRASmutntlungcncerTodtelyhfulfunctimodifygmuttihveenuedtudyCRAFfuncthctextetenutilizedvroexogenouovexpiexperimentwheichiometryn-phyiologiclntivecffoldgfcrbentInterpttieexperimentlultcnlocomplictedmodulrntuRAFdimereldomclerwhichRAFhomo-/hetero-dimerpibleobervedcellulrphenotypeAclerundertgCRAFcogenicrolecludghomo-/hetero-dimerfunctiwouldmfutuefttrgetCRAFKRAS-drivencncervihibrgeteddegrdtimechnmThpropolutilizecombtiundbeedircnbump-holemethodologieelucidteroleCRAFKRAS-drivencncerundertltivectivyvriouRAFdimerSpecificllyItethypoCRAFroleKRASmutntlungcncermlectiveRAFdimerdimhdowntmignlgpvenrwexiclevelMAPKignlgCfirmgthhypohdictimplicticncerrpeuticdevelopmentwoulduggetCRAFdegrdernotcompetivective-ehibirwouldeffectiveumubtypeThprojectlodvncefundmentlknowledgeRAFkeexpmethoduedtudymIncfirmgcentrlhypothpropolIvlidtegoldilockpmeRAFignlgoltleomuchignlgimpedecncergrowthInimeundbeedircnngpidrigoufollow-upchrcteriztiexpknowledgeCRAFmultiplefunctiterctiprtnerInimtwoIvlidteco-muttilpprochvelltivectriiechRAFdimercncergrowthMAPKignlgThimlohbrodpplicticellignlgerchcouldctutegenerlizblepprochtudygprotehomo-/hetero-dimercerveddimerizterfceWhiledvncgknowledgeRAFbiologythfellowhiploproviderichtrgenvirmentcrotwocuttgedgeerchtutiHrvrddeprtmentChemtryChemiclBiologyDnFrrCncerIntuteTrgcludegulrmeetgmymenremrlevntcientificexpertopptuniepentmyerchternllyexternllyMenrhipprovidedBrinLiuAndwAguirgtlyfciltemydevelopmentndependentcncerercherProjectSummryAtypiclteridrhbdoidtum(ATRT)ggivepedricbrcncerlcktrdizedttmentgimenAfterrdipyttmenturvivufferlg-termneurocognivedefectThucriclneeddectgunderlygbiologyATRTidentifynovelrpeutictrtegieATRTdrivendiffentiblockcuedbillelicctivtiSMARCB1nocurntmuttiultgdygultedcellfiltermllydiffentecequentlycquicogenictteNturllyneurlprogenircell(NPC)upectedcelligATRTirtlleddiffentihenimplictedpedricbrtumigeneHoweverATRTpentuniquefetuimplycellignottrictedcentrlnervouytem(CNS)DepegdrivenlySMARCB1loATRTcompdthemoleculrubgroupdiffentclicloutcomewhichlyedplyneurlfetuATRT-Sichedgehog(SHH)FurrmoATRTmoleculrlyidenticlextrcrnilmlignntrhbdoidtum(MRT)Apotentilexplntienneurlfetuneurlctcell(NCC)puttivecelligbothATRTextrcrnilMRTemergeneuroecdermnmigrtethroughoutembryoTheehypoethpropolSMARCB1loterctcellidentynmiclloctidurgtumigenetrgetblevulnerbiliecnenbleSMARCB1-depletedcellovercomeirdiffentiblockPvioulyFurnrilngeedhumnducedpluripotenttemcell(hiPSC)DOX-ducibleSMARCB1knockdown(KDhiPSC)NPCderivedehiPSCwediffentedoutSMARCB1expi(KDNPC)exhidnATRT-SHHtrncripmepentedblockneurldiffentimedthopictumThhiPSC-derivedSMARCB1knockdownpltmlevergedvetigtehypoethpropolTounveilterctitweencellidentySMARCB1loRNAeqnlyepermedhiPSCwediffentedoutSMARCB1expiNPCNCCTochrcterizeterctitweennmiclloctiSMARCB1lodurgtumigeneKDNPCNCCengrftedtrcrnillyubcutneoulyReultgtumnlyzedviRNAeqSceKDNPCunblediffentefurrNCAM+neurhigh-throughputpooledCRISPRcenpermedKDNPCidentifytrgetblevulnerbiliecnovercomeirdiffentiblockCidtegenevlidtedvroviIPTGducibleknockdowndrugttmenttudiefollowedvivovlidttgthopicllyengrftedKDNPCbrtumcidtedrugIfuccefulthpropolprovidenovelightunderlygbiologydrivetertumlheterogeneyATRTidentifynoveldrugtrgetthvercometlleddiffentifundmentlfetuATRTPROJECTSUMMARY/ABSTRACTPncticductldenocrcom(PDAC)motcommmpncticcncer5-yerurvivlrtely12%Immunpyuchnti-PD1ntibody(-PD1)ttmenthenlrgelyeffectivePDACAlthoughTcellnturlkiller(NK)cellbothhvepotentnti-tumeffectmotimmunpyerchhfocuedmodultgT-cellctivyThufunctiNKcellhighlyundertudiedPDACUtilizgimggmcymetry(IMC)novelmultipleximggpltmourlbryhmdeurprgpotentillyimptnbervtictivtedNKcellnotTcellpfentillyco-loclizetumepililcellPDACtummicroenvirment(TME)Thdcoverywrrntvetigtgtrtegienti-tumeffectcgco-locliztictivtedNKtumcellHewedemtrtepn-hibidipeptidylpeptide(DPP)enzymeknownvolvedcncerprogiblockgimmunectivtiugpn-DPPhibirBXCL701(701)enhnceefficcy-PD1rpyyngeneicmuPDACmodelTheffectocedcedNKcellfiltrtiductifibrocedexpiCXCL9CXCL10IL-18NotblywefounddividulDPPhibidemtrtemimlnti-tumeffectcompdpn-DPPhibiFurrmlyzgpubliclyvilbledtetvroywefoundNKcell-ttrctntchemokeCCL3CXCL11ltivelyundexpedPDACThuggetctie-pecificchemokegrdientugCCL3/CXCL11cnerveceNKcellccumultiBedeobervtiIhypoizecgco-locliztictivtedNKcelltumcellPDACpromotenti-tumeffectTotetthhypoIimdetermeimpctDPPhibiptilfunctilttuNKcellmuPDACTMEutilizgIMC(Aim1A)erpeuticimpctdepletgCXCL9CXCL10IL-18nti-tumeffectmeded701+-PD1rpyvivo(Aim1B)mnipulteCCL3/CXCL11expiPDACTMEenhnceNKcellmigrtivro(Aim2A)nti-tumpevivo(Aim2B)SuccefulcompletieimidentifyfcrgulteNKcellfiltrtiPDACTMEimpctNKcell-tumepililcellco-locliztiimmunepeTheefdgfillgpknowledgeurroundgtr-tumlNKcellmigrtilocliztifunctilttuPDACprovidenewpprocheexplogNKcellenhncenti-tumimmunectivyAbtrctThee/theRfKefunctidowntmmodulrRASGTPe-drivenignlgkeydrivermnycogenicignlgnetwkDepeexteniveeftchrcterizemoleculrfunctiRfkedevelopphrmcologiclmodulrcncerrpiemnypectRfkegultrcellulrfunctinotwellunderodRecentwkuggetterplydiffentRfm(A/B/C-RRf)cnhveproundeffecndowntmignlgmymjdetermntbilyphrmcologicllytrgetcncerdrivenmutntRASRfHewepropoeytemticbiochemiclnlyRfgultrcellulrfunctiphrmcologyLevergguemoleculroldectgdruggbilyRAFmwedefepthwymkeRfkeenivetntpecificcleATP-competivehibirco-hibitrtegieInddipplygnewRNAbrcodgmethodologywevedevelopedwepermdeepmuttilcntructufunctiphrmcologyRfmFurrmoweytemticllynlyzehowuptmdowntmmodulrRfkeignlgffectctivytrcellulrterctiRfkeTogeretudieprovidemocompletepictuRfkegultrcellulrfunctimyfciltemoeffectiverpeutictrgetgRAS-Rf-drivencncerPROJECTSUMMARYAmjcompenttummicroenvirmenttum-ocedmcrophge(TAM)plycriclrolechetrtiimmunouppicncercellprolifertingiogenemettwelltncecncerrpieAbulkTAMetblhedtumcircultgmocytetrgetgthdiffentiprocepentnttrctiverpeutictrtegyNotblycykemcrophgecoly-timultgfcr(M-CSF)grnulocyte-mcrophgecoly-timultgfcr(GM-CSF)bothocedTAMdiffentiNeleM-CSFGM-CSFcnlohvedtctfunctileffectytimultediffentceprdowntmignlgpthwyIncentyertudieemerggfieldimmunometbolmhvedemtrtedchngetrcellulrmetbolmdowntmcykectivticnctivelygulteimmunecelldiffentifunctiDepellthdiffenceTAM-ocedfunctiducedM-CSFGM-CSFdiffentedcellwherlydiffentilmetbolicchngemocytectrieefunctildiffencempolyunderodMyplimrydthowGM-CSFderivedmcrophgehveignificntlyhigherexpiTAMmrkerCD206PD-L1thnM-CSFderivedmcrophgeediffenceldycpicuoumocytefterly7hourcyketimultiIntetglymyplimrydtlohowGM-CSFnotM-CSFulttrnient7-hourperiodpromentglycolyticocilltimocyteTogereultdicteM-CSFGM-CSFcnproduceuniqueeffectmocytemetbolmTAMmrkerexpidiffentedcellCidergpvioutudiemyplimryfdgcentrlhypothpropolM-CSFGM-CSFderivedmcrophgeexhibignificntdiffenceTAM-ocedfunctilchrcterticdueerlydiffentilmetbolicchngemocyteIpropoetetthhypothroughfollowgpecificimAim1ChrcterizediffenceTAM-ocedfunctilttrieirgultitweenM-CSFGM-CSFterlyendpotdiffentimocyteTAM-likecellAim2InvetigtewherdiffenceerlymetbolicchngeducedM-CSFGM-CSFmocytectriediffenceTAMmrkexpidiffentedcellTheeimchievedthroughcombtiimmunologycncerbiologygenome-wideprilgcellmetbolmtechniquehumnmocyteoltedhelthydperipherlblooddiffentedvrocultuTAM-likecellCollectivelyultthwkdvnceourundertgimptntfunctildiffencetweenM-CSFGM-CSFducedTAM-likecellpotentillyvelnovelmetbolicmechnmctrolTAM-ocedfunctiwhichmyultimtelyimproveTAM-trgetgcncerrpeuticABSTRACTTheuccePD-1-trgetedimmunecheckpothibir(ICI)rpyhvolutiizedcncerttmentcomgnewtrdcvrioutypecncerHoweverttmenutcometriplenegtivebtcncertilllimedToenhnceefficcycheckpothibirrpyimptntgdeeperundertgPD-1gultummicroenvirmentBcelltumimmunemicroenvirmenthveenundertudieddepeirgrowgcognikeyplyerhpgtummicroenvirmentThepencetum-filtrtedBcelldicteprognomnytypecncerIntetglyourpviouerchp-cliclmodelhhownenivydulICIrpycludgPD-1-trgetedttmentdependennBcellleerextentCD8+TcellTheefdgemphizeimptncetudygPD-1ignlgBcellimproveclicloutcomecheckpothibirrpyThegolthtudyunderthowPD-1ignlgpthwygulteBcelltummicroenvirmentOnemmechnmPD-1modulteTcellfuncthroughprogrmmgTcellmetbolmllowgmmeetenergyquimentneededdiffentivriouubpopultiWehypoizePD-1ctivtum-filtrtedBcellltermetbolicprogrmBcellftedeciimilrTcellPD-1-trgetedrpypotentillyimpctBcellprolifertiurvivldiffentifuncthroughmetbolicprogrmmgwhichervemmechnmPD-1gultentumfunctiBcellAim1ToevluteourhypowedecthowPD-1-trgetedrpymodulteBcelldiffenthroughmetbolicwchexvivoWecomprimrymuBcellcultutte---rtmetbolicprilgoldetermeifhowPD-1blockgedictlyltedBcelldiffentimetbolmThpprochllowevlutiglycolyfttycidmetbolicmcheryBcellctrolecelldiffentigermlcenterBcellntibody-ectgcellfunctilubetBcellAim2WeuePD-1ftemppgmice(PD-1C/tdTomRo26floxp-YFP)trngenicbtcncermodelexmehowPD-1-blockgeguideBcellftedecifunctivivoElucidtgterctitweenBcellPD-1ignlgpthwywhichhofrecpedttenticncerimmunologyfieldwouldtrglyenhncecliclctivyICIrpytumwheBcellcriclnti-tumpePROJECTSUMMARYOteorcom(OS)mettledgdrivermtlynpietilodmettticdeeDepedevelopmentnumerouttmentmodlietrgetgprimrytum40%p-tienttilldiemettticprogiDevelopgtrgetedrpiemettticOShencompli-ctedextenivegenomicrrngementdiffercroptientcommfetuOStendmettizelungThepgcliclneeddetermefcrpiblelungme-ttOSfciltedevelopmentnovelntimettticrpiePvioufdghvedemtrtedimptnceltertienhncerctivypecifictrncriptifcrctivtggenenecerymettHowevercenttudieepigeneticubtypeOSuggetmnymodeltudiedpvioulydivergeepigeneticubtypethdeemotcommmotdedlyclicHewepropoeim1tudytrncriptifcr(RUNX2SP7)pecificubtypeOSmotclicllylevntweplnchrcterizehowectedenovoenhncerctivtinovelloopcluterctrnnovelenhncer-genecnectipromotelungmettOurgoldefemettenblgcircuryAim2tethypoprocelungcoli-ztidrivennterplytweenRUNX2ignlglungmicroenvirmentthroughlgi-tudleriedynmicchromtttechngeechuniquegenedependencieWeeekundertbiologymettticprocechrtgchromtttetrnidependencieoteor-comcellgrowgvivoctextlungmicroenvirmentIfuccefulwehopeexpcurntrenlOSttmentydcovergeprimrylergettummettedurglungcoliztiABSTRACTMelnomdedliettypekcncerItcncudurgiclectiifdetectederlyodvncgmethodpventierlydetectimelnomcriclTomodelhumnmelnomZlbdevelopedzebrfhmodelmelnocyteexpghumnBRAFV600Ep53nullbckground(BRAFV600Ep53-/-)ThetummedthzebrfhmodelgeneticllyhlogicllyemblehumnmelnomtrnpncyzebrfhmkemoptimlmodeltudygmelnomiWecnimgemelnocytezebrfhugTg(mfmCherry)expmCherryfluocentproteunderctrolpromotermfzebrfhthologhumnMITFgeneWhenimggBRAFV600Ep53-/-zebrfhovertimeweillyobervehighmfexpiwhichwecllcncerpcurze(CPZ)SomeCPZprogmtumwhilemgrowthrtedCPZmtumctivtenembryicneurlctprogenirtteIncdiblyimggfluocentpterTg(ctEGFP)llowidentifictrckgglecellgmelnomce100%melnocyteexpgctgomtumBecueneurlctctivtidefgtrnmtivetepCPZcometumundertgmechnmrnicrucilmyveltrgetblepthwypventmelnomImtetedextrcellulrmicroenvirmentroleneurlctctivtiCPZBytrnplntgCPZIobervedCPZmelnocytehighmfmCherryexpipperhvelowermfexpifollowgtrnplntOnepoiblecuethbenceligknowngultemfctivywhenmelnocytemovedirCPZmicroenvirmentUptmpthwyknowngultemfgenetrncripticludec-KWntcAMPIhypoizemfexpichngedurgneurlctctivtiduebencec-KWntcAMPgulryligInAim1ItetthlookgtproteRNAchngemfftertrnplntchemicllyprovidgCPZmelnocyteligc-KWntcAMPpthwyugtempertuenivemfmutntAecdplimryobervtiwCPZmelnocyteexpgctevendytrnplntfterthnuullyobervedzebrfhScemelnocytetrnplntedgrowth-fcrrichMtrigelIhypoizepecificgrowthfcrMtrigeldictmelnocyteemelnomInAim2ItetthpermgproteomicglecellRNAequencgidentifyprotectriectductiircellulrourceTheeprotefurrvetigtedchemiclgeneticpprochetetirufficiencyneurlctctivtiCPZCollectivelyvetigtgctriimfgrowthfcrneurlctctivtidvnceundertgmechnmunderlygmelnomictriebrodeftundertdriverthcomplexprocevivoPROJECTSUMMARYThpropolimvetigtedygultilterntivepolydenylti(APA)cutemyeloidleukemi(AML)DygultiAPAhenidentifiedhempoietictemprogenircellAMLpvioutudiehvecompdbulkpopultiHSPCAMLptienthelthydTheeextentdygultimlignnthempoietictemcell(HSC)moleculrgulrdrivgthphenomenmpolyunderodToddequetithpropoloutletwopecificimlevergepvioulydevelopedcomputtilpltmidentifyghiftpolyAeugetgle-cellolutiThefirtimuegle-cellRNAequencgdtAMLptientchrcterizechngepolyAeugetweenmlignnthelthyHSPCtmtcheddiffentitgemedThidentifyifchngeAPAigteleukemictemcelltrictedmocommtedprogenirPolyAeugeheterogenoutweenptientevenhelthydocomprmedimproveccurcyidentifygtruechngepolyAeugeTheecdimextendequence-beddeeplerngfrmewkmodelpolyAeugehumnHSPCover/underexpidiffentCPAgulrThmodelelucidteextentwhichCPSF6ubunclevge-fcrIcomplexdowngultedttrncriptillevelAMLptientdriverrntpolyAeugeAMLIfCPSF6downgultinotufficientexpldygultedpolyAeugeddilfcrctrieidentifiedFllyCRISPRperturbtitudieuedeifmodultgexpiCPSF6expi(implictedgulr)ffectdiffentitteAMLcellleprovidgfunctilevidenceAPAvolvedmtgleukemictteThecompletieimprovidenewundertgAPAmyeloidmlignnciemyledidentifictinovelrpeutictrgetPROJECTSUMMARYGlioblm(GBM)CNStumderivedglilcellItmotcommftlprimrymlignntbrtumdultmedinurvivl15mthCurntttmenttrtegievolveurgiclectifollowedrdipyccurntchempyUntuntelyGBMhighlytntrpyevblycurultgpoptienutcomeGBMhendecridhvgnoxygen-deprivednicheperivculroxygen-richnicheDeeperchrcteriztietumenvirmenthveledpencecellulrheterogeneyngiogenevibothnicheThecriclcellulrplyervolvedetumhviglioblmtem-likecell(GSC)GSCeemidebothhypoxic(lowoxygenlevel)nmoxic(nmloxygenlevel)nicheyetmtirtemneelf-newlcpciecrobothcdiStrtegietrgeteGSChveprovenunuccefulrmpromgvenueerchTheneeddevelopgterundertgGSCbiologytrtggulrymechnmwhichydpthypoxicenvirmentGBMpromotetumgrowthHowevermottudieexplgGSCpermednmoxiccdiFurrcentrlpectpot-trncriptilgenegultrnltiwhegeneticmticvertedtunctilprotemltivelyunexplodTheobjectivepropoederchtudytrnlti(mRNA--prote)gulrytepproteynGSCoppoedmocommlyexplotrncripti(DNA--mRNA)gulrytepdeidoutcomeillumtgytemicprogrmhypoxicdpttiToccomplhthobjectiveourpprochAim1ueriboomeprilg(RIBO-eq)cjunctiRNAequencg(RNA-eq)ferqunttiveundertgtrncriptiltrnltilgulrypumRNAtrncriptIutilizeboechniqueclrifyfluencehypoxrnltilgenegultiGSCIexpectfdgenegene-etpentgbiologiclpthwymodultedhypoxipdomntlythroughtrnltilgultivelgnovelltcidtefuturpyTovlidtethdcoveryfrmewkIpermnrryfunctiltudieelectedgeneInprllelAim2focuprticulrettrnltilmcheryknownIntegrtedStRepe(ISR)whoememrenecellulrtmodultetrnltiurvivl-ocedtrncriptWhburgegevidencerrntISRhvimlignntcellterrogtgmechnmthroughwhichISRmymedetrnltilchngehypoxicGSCpentnvenuethroughwhichhltuchdptivehviAlgerthpropolpromotefurrundertgGSCbiologypecttrnltigultiunveilgnoveltrgetfutuGBMrpyultimtelyctriebrtumptientcPROJECTSUMMARYOver60%Tcellcutelymphoblticleukem(T-ALL)hrbmuttiNOTCH1ignlgpthwymkgNotchctivtimotcommcogenicpthwyT-ALLHoweverpn-Notchhibiroceddoe-limgxicieprimrilygtrotetlWepvioulyhowedtrncriptifcrETS1eentilNotch-ctivtedT-ALLurvivlETS1hibiimpirT-ALLurvivldowngultemjcogenicNotchtrgetgeneFurrETS1deletihlimedxiciemumodelTheefdguggettrgetgETS1mighthvetrgnti-leukemiceffectmofvblexicyprilethnNotchhibirWhileETS1NOTCH1ctivtemnyoverlppgpthwyc-gulryelementdowntmETS1lewelldefedmyplymoeentilrolethnNOTCH1ctivtiomeT-ALLenhncerIidentifiedeuchenhncerwhichETS1myplymoeentilrolethnNOTCH1HeETS1quidctivteexpiMYBcriclT-ALLcogene(tenttivelynmedE-MeETS1-dependentMYBEnhncer)MyplimrydthowETS1quidE-MectivtiMYBexpiE-MepihumnT-ALLcelllehibMYBexpicellurvivlBedeplimrytudieIhypoizeETS1driveT-ALLurvivlctivtgE-MeeentilgulryelementT-ALLcogeneIvetigtethhypothroughtwoimInmyfirtimIdetermecequenceE-MeblockdeNotch-ctivtedT-ALLurvivlvivougtwomumodelInmyecdimIfurrdefec-gulryelementcogenedowntmETS1T-ALLTheenhncertrncriptifcrdependenciegultecogeneexpiT-ALLcurntlypolyunderodrgbrriertrgetedrpeutictrtegieMypropolhelpcloethgpknowledgeFllyoverllimpctthprojectdeferoleETS1drivereentilT-ALLcogenicpthwyenbledcoveryoentiltrncriptifcrT-ALLOVERALLSUMMARY/ABSTRACTThemjyolidtumchildnhveuniqueigcompdthoedulttemmgirembryiccellDepethdtctitilllimedundertgdiffencemicroenvirmentepedrictumcompddultcncerhowediffencemightctrielegeplticyttmenttnceToddthknowledgegpwepropoecomphenivevetigtiptilbiologyetumOurgolhedlighnpecificcellmechnmtummicroenvirmentplyroleducgrpytncepedricolidtumTherchfocupromentpedriccnceruchrhbdomyorcomneuroblmWilmtumTheprimrygolthmulti-dciplryProgrmetblhcomphenivePedricSolidTumMicroenvirment(PSTME)Atlwouldleddcovergbicmechnmdenovocquidtncemodernrpieuncovergtummicroenvirment(TME)trgetblevulnerbiliedriventnceThemotivtictgPSTMEtlurgentneedimproveurvivlptienthigh-rkubtypepropoedcncerdecettment-ltedmbidieBydelvgtriccietummicroenvirmentimpcnttmentpeweimdvnceourundertgpedricolidtumpvewymoeffectiverpeutictrtegieTheProjectupptedcollbtimgtwotutidtctuniqueourcetechnologiecomplementryexperteA)ChildnHoplLoAngele(CHLA)groupprovidewellnnottedtumpecimencliclmtinethnicllydivereptientpopultiledgenertgptilproteomicdtugpedricTMEpecificntibodypnelB)CliniIntuteTechnology(Cltech)groupprovidenovtiveptilomictechnologiecludgptiltrncripmiccopynumrnoveldtciencepprochetegrtivenlygenerteddtThempleelectedpentolidtumdiverybedetblhedcliclrktrtificticriclpottrni(potchempypelpe)enucptudiveryPSTMEThePSTMEtlimpctcommunythroughgenertieilycceibleTMEtlprovidguerfriendlyerchbledtbemultiomicptilnlyecommextrcrnilolidtumclicloutcomedtItloprovidenovelcomputtilpipeletegrtinlyptildtTheeopenourceolmdevilblecommunyInummryignificncepropoedprojectetblhmentntlllowdcoveryfundmentlmechnmextriccncerrpytncegolledgubtntivelyimprovedprobbilycucoupledducedrpy-ltedmbidychildnfflictedolidtumABSTRACTOurPCAerchcenterbrggerUCLANeurourgerytemCltechptilglecelltemctructcomprtiveptiltllow-grdegliomThecollbtitweenthecompentPCAerchcenterhldygenertedplimrydteverlgliommpleWeexptheftgenertecomprtivetlgliomdtctprogioutcomeugtegrtedptiltrncripmicproteomicchromoomeprilgBycomprglow-grdegliomeventullytrnmetydolenrdotcurIDH-mutnthigh-grdegliomweimundertmoleculrcellulrmechnmtlow-grdetgepdictivemlignnttrnmti(MT)uggetterventitrtegiepventMTThecomprtivenlyexmethetypechngelow-grdegliomdiffenutcomecelltypecompoummicroenvirmentpthwypecificgeneexpiFromUCLABrTumTrnltiReource(BTTR)centerwehveldycollected99fh-frozenlow-grdegliommplecollectpproximtelynddil100mplelow-grdegliomdiffenutcome(MTdolentno-curnce)38%curntcohtptientunder-pentedmygroupwectuecrudivereptientpooldertterundertwhichptientmythigherrkmlignnttrnmtieneedmofquenturveillnceerlierterventiWengenertentegrtedmulti-modlptiltltrgetg2500mRNA10prote10DNACNVtrnloctiFromhighenivymultiplexedRNAeqFISHyweblecptunlycelltypemicroenvirmentmtilogenepthwycouldculprogimlignncyLtlyweuedt1)pdicttumprogibedcelltypecompoimicroenvirment2)deignterventitrtegiebedptildtugcounterfctulfencemodelffectimmunefiltrtgpdicrprogi3)buildmodeltumprogidynmicbedgeneexpimechnictueOurcomphenivelow-grdegliomtuecollectegrtedptildtettrncripmicproteomicchromoomlbnmliemodelbuiltugdvncedmche-lerngolextendextgcpbilieHTANctiumteroperbleThetlcomputtilolueduwidercientificcommunyfurrundertmechnmledgmlignnttrnmtiPROJECTSUMMARY/ABSTRACTPncticDuctlAdenocrcom(PDAC)trckcomeecdledgcuecncerlteddethUnedStteThdmlprognolrgeprtdue>80%newlydignoedcegdvncedtgeFrptientdignoederlytgeI5-yerurvivlrtecheover80%ThuPDACmtlyrtecngtlyimpcteddevelopmentnerlierdetectitrtegyEventhoughPDACmjhelthuetillnoeffectivecengtetpprovedgenerlpopultilyptientfmilyhry/pencepthogenicgermlevrint(PGV)levnthigh-rkgeneferdhigh-rkdividul(HRI)hvepublhedguidelecommendgcncerurveillncePDACpdomntlymicrocopicPncticIntpililNeoplm(PnIN)leictegizedbedirmphologiclfetulow-grde(LG)whichcommhveverylowprobbilymlignnttrnmtihigh-grde(HG)whichrcidedhighrkprogivivecrcomdivererouteprogiLGHGPnINpolyunderodWehypoizedevelopmentcomphenivemoleculrcellulr3DtldepictkeyeventprogiPnINPDACfirttepidentifygmuchneedederlydetecterceptitrtegieImptntlyourp-cncertlfocucommubetHRIptienturveillnceprogrmwhocrryPGVcniclDNApirgeneBRCA1BRCA2PALB2(ferdgBRCA)ThgeneticubtypectegenomictbilytteupptPDACdevelopmentyetexctmechnmunclerThroughdeepgeneticthe-dimenilptilmulti-omicmppgcomputtilmodelgwepropoecte4DmodelmoleculrcellulrtrjecrieunderlyevolutigBRCA-drivenLGHGPnINmlignntPDACthroughthetegrtedim1)deigngBRCAprogl2)determemechnmunderlygprogi3)ectprogiwrdtrnltilimpctupptedthefunctiluni)BiopecimenUncollectprocennottebiopecimenii)ChrcteriztiUnpermmoleculrcellulrptilchrcteriztiiii)DtScienceUnprocenlyzecomputtillymodelvulizedtWehveemblednexceptiltemexpert(BRCAFoctgPDACBFoPCtem)complimentrymulti-dciplryexpertePDACcliclpthologycomputtilbiologymodeldevelopmentBRCAdeficiencyDNApircncergenetictummicroenvirmentlgcuttgedgetechnologyexpertWeungtheuniverieOgHelth&ScienceUniveryJohnHopkUniveryIndinUniverylltrgtiePDACerchcommunyHTANmultipleNCIctiTogerwelevergetltrnltildetecterceptiuecepoedcliclevlutiHRImfututudieextendgllPDACAbtrctPncticdenocrcom(PDAC)thirdledgcuecncermtlyflectgfctthnly9%ptientpenttumloclizedprimryeovtmjyptientpncticcncerunectblettimedignoWehvectedprogrmpnidentifictinewmoleculrtrgetptiltrncripmicidentifictipeptide/mllmoleculeligpclicleventulcliclevlutierpiePeptidetrgetedrdiucliderpy(PTRT)moleculrlytrgetedttmenttrtegyuerdiolledpeptidebiologicltrgetgvecrdeigneddelivercyxiclevelrdidoepcelycncercellthvexppecificceprPeptidehighceprffycjugtedchelrdignoticimggugporemimogrphy(PET)ptienttggelectiublecidtePTRTubequentttmentmirgInturnpeptidentblyrdiolledtermede-energy-emterlutetium-177(177Lu)PeptideuperideliverydueeeyncomprblepotentilffypecificyimprovedphrmcoketicprilelowimmunogenicyWenowhve40ptillyequencedpncticcncermpleech4000loctiequencedtdepth18000geneAcrollemplewehveidentifiedClud-4(CLDN4)prticulrlypromgtrgetCLDN4ptrgetournly1)tightjunctiprotenotcceiblenmltue2)ovexped(~16x)llptient97%cncercluterptilgiwehveequencedPeptidehveenidentifiednnomolrffyCLDN4wehvedemtrtedpecificccumulti~20%IA/cctumperinelmettePDACmodelOurptilnlyempledicteifwecndeliverpeptidecrrygt-emterllCLDN4expgcellllcncercellcouldceiverpeuticdoerdiFurrwehvedevelopedfirtcomputtilmethodgenertecyclicpeptidepecificbdgdomhvenowgenertedpeptidegttightjunctigiCLDN4Clotridiumperfrgenenterox(Cpe)nturlligCLDN4weevlutemuttedpeptidefrgmentthligcyclicpeptidedeignednewmchelerngolOurpecificimAim1)Aeoptimizeclud-4peptidevroAim2)Evlute64Cu68G-lledclud-4peptidecellcultumouemodelpncticcncerAim3)Evluteclud-4peptidelledlutetium-1773A)cellcultu3B)xenogrfttrngenicPDXmouemodel3C)combtirpyimmunpyPncticcncer(PnCn)nioutncerpycludgimmunpywhichlrgelyctrieduppivetummicroenvirmentTrgetgmoleculrpthwytegrlPnCntncecurntrpymnunmetneedNotchignlggultePnCngrowthmetttummicroenvirmentWhiletudiehvehownNotchignlgmcrophgemyeloidderiveduppcellplynimmune-uppiverolebtcncerlungcncerexmpleourpropoltudypvioulyuncognizedroleJAG1gultimetbolicfnecventildendriccell(cDC)underlieponti-tumpeimmunpyTheoverrchgobjectivethpplictidefeiftrgetgJgged1(JAG1)NotchligwhoeexpiclteweprognoverelyclteBATF3eentiltypeIcDC(cDC1)developmentcouldvereimmunpytncetumpotum-filtrtgcDC1TcellcDC1cellpenttumntigentum-killgTcellthuplycriclroleupptgTcellnti-tumimmunyimmunpyHoweverdendriccellpentlownumrtendplyfunctiluppipncticcncerptientOurcentwkveledJAG1functinhibiryNotchligcDC1developmentwellcDCmetbolicfneWelofoundbltgJAG1ducedmrkedtumgiprolgedtum-rgmicelg-termurvivlcgvivgtum-filtrtgDCNotch-ctivtedtum-killgTcellWeteurcentrlhypoJAG1promotePnCnrpytnceuppgcDC1metbolicfneCD8Tcellnti-tumpethroughtheterltedimInim1wetetifnti-JAG1blockgntibodycouldenizetnttumimmunpyInim2wevetigtemechnmwhichJAG1impircDCmetbolicfneeentilnti-tumctivtiAim3focumechnmnti-tumTcellvigtimededJAG1blti/blockdeWeuecombtiuchthouKPCmouemodelimmunophenotypicllydefedKPCthopictumhumnPnCngnoid/myeloidcellcocultuhumnPnCnpecimenWeemploycuttg-edgemcymetryvetigteterplytweentumcellurroundgimmunecelltumtromWetegrteimmunophenotypgptiltrncripmicrimmunecellpopulticliclhpthologiclmticltemoleculrfdgptienutcomeThwknovtiveweillumtenovelfunctiJAG1mtenncePnCnrpytnceexplopotentilnovelimmunomodulryttmentthdedlydeePROJECTSUMMARYOvrincncerdedlietgynecologiclcncerprtcuenowidelyuedcengtet80%tumdignoedtltetgeThoughovrincncercenghpoten>ldignoetumterlytgewhenp>enutcomefr?er(90%urvivltgeIcncerv<20%tgeIII/IV)centcengtrilprotebiomrkerhvefiledhowmtlynetThhhighlightedthemchllengeovrincncerceng(1)Avoidgflepoi>veultledgunneceryprocedudeelowpopul>pvlence(2)Achievghighenougheni>vyclicllyuefultet(3)Enurgcceibilyp>entcomplincecengMuchmyerlyPhDwkwkmymenrlbhpieedhighpermncebloodtetuecell-feDNAfrgment>p?erndetectcncerTheefrgmenmicycndetectubtlechngeDNAhedtumcellevenuglow-covergeequencg<1mLbloodirn-viventumkemcceibleppelgp>entGivencri7clcliclneedoverrchggolmywkdvnceourundertgovrintumigenedevelopncceiblehigh-permnceliquidbiopyovrincncercengAlim>curntliquidbiopieydtcptem>~50%genomecomprgpetelementwhichhvelgenimplictedcrcogenehveendiculttudyduecompletegenomefencetechniclgenomelignmentchllengeInplimrywkIhownovelpprochIdevelopedllowtudypetlcpeht-dequencghiden>edover800newelementnotpvioulyimplictedcncerThebilyuethpprochht-dequencgopendotudygpetlcpecell-feDNAwhemotfrgment150-180bplengthIpropoethepecicimInAim1Iexpthpprochdevelopnovelbiom>cpprocheenblgtudypetelementcell-feDNAInAim2Idevelopteteni>vepeciccell-feDNAliquidbiopieovrincncerInAim3Ichrcterizegenomicchngepetelementdurgovrintumigenenml>uep-cncerouleumSuccefulexecu7eimhpoten7ldvnceourundertgroleo-clleddrkgenomeovrintumigenechngeprdigmliquidbiopieillum7ngcncer-ltedchngepetelementpplyedcoveriecengtechnologyovrincncerThwkmyloervebfutupn-cncercengmethodThepropoedwkprovidemeouttgmenrhipcien>ctrgbictrnl>lciencehelpmedvncemycerfutuphyicin-cien>tdependentve>grPROJECTSUMMARY/ABSTRACTDrivermutticfercedfnecncercellcnloencodenetigentimultennti-cncerimmunepeThnti-tumimmunymededprimrilyTcellcepr(TCR)cognimutti-derivedpeptidepentedHumnLeukocyteAntigen(HLA)complexeL858Rpromoteuncheckedgrowthmotcommepidermlgrowthfcrcepr(EGFR)muttilungcncerccountg40%llobervedmuttiprocogeneHowL858Rmytimultennti-tumimmunepenotyetunderodTheobjectivepropoedwkundertmechnmthroughwhichEGFRL858Rmuttiffecttumbiologyprovokgnti-tumimmunyMyplimrydthowL858R-derivedpeptidecpblebdgtbilizgHLA-A*0301HLA-A*1101complexeIntwothoglyL858Rpeptide-HLA(pHLA)complexetimulteCD8+Tcellmotrglythnwild-typeEGFRpHLAcomplexeFllyugpHLAmultimerflowcymetryIhveidentifiedCD8+TcellhelthydPBMCcognizeL858RpHLAcomplexthroughirTCRIhypoizeEGFRL858RmuttigenertenimmunogenicnetigenprovokeTcell-medednti-tumimmunyduehighcllymuttiInAim1IfullydefedetermntL858RimmunogenicychrcterizgEGFRL858R-derivedneopeptidebilyctivteTcellIemployHLAimmunopcipticoupledliquidchromgrphympectrometryidentifyL858RpeptidepentedHLAdetermeltivectriiCD4+CD8+TcellimmunepeexmeexhutiphenotypeL858R-pecificTcellptientugglecellRNATCRequencgInAim2IdetermebilyEGFRL858R-pecificTcellupptumgrowthIlodetermehowmutticllypHLAexpiffectnti-tumimmunepeThtudyemploycuttgedgegeneticolcomputtilpprochegenertedetiledundertgdptiveimmunygtomticmuttitumFurrmothpropoltilodphyicin-cientttrgvetigteclicllylevntdetermntTcell-mededimmunepegtEGFR-mutntcncermdevelopmentndoptiveTcellrpylrgeubetlungcncerptientTheoverrchggolourpropoldevelopp-cncertlkcncerSknidelmodeltudyerlyphetumigenecueeilycceiblemirgn-vivemplgAprimrybrriergtenvirmentkcellcquilrgenumromticmuttidurgechperlifefuelggrowthdivereettumvrioucelltypegnOurtlfocuevolutimelnomcutneouqumoucellcrcomwhichpectivelymelnocytekercytecueededlietmkcncerpiblenetimted20000dethperyerUnedStteSklimmunologicllyctivegnprovidgopptunietudyroleimmuneytemcncerdevelopmentTheroleimmuneurveillncetrgkcncerillutrteddrmticcekcncerimmunouppeddividulrpeuticucceeimmune-bedrpieThemjunmetneedunderthowimmuneytemtercttumerlyirdevelopmentToddthneedwedeignedntldeducehowimmuneytemhpetumevolutidurgtrnip-cnceroucnceroutgeThccomplhedthrougheriemoleculrypermedpcur-ocedcncer(iekcncerndjcentp-curlei)Specificllyweperm1Bulk-cellDNA-equencg2T-cellB-cellceprclotypg3Bulk-cellRNA-equencg4ptiltrncripmic(10XVium)5Sptiltrncripmic(10XXenium)6Sptilproteomic(IBEX)compdividulprogitgeechpcur-ocedtumCollectivelyeyvelkeygeneticimmunologicleventoccurrgttrnip-cncercncerCompletietudievelcidtedignoticprognoticbiomrkerpoiblynoveltrgetrpeuticterventiOurtemhcollbtivetrckcdtudygevolutikcncercliclimpctOurwkhctriedWldHelthOrgnizticlifictimelnomwehvedcovedmultiplebiomrkerhveentedrouteuecliclprcticedignoemelnocyticneoplmAnmjcompenurcenterweetblhcodedictedpernelchrgedgolengggHTANnetwkbrodercientificcommunylypublicNobtrctvilblePROJECTSUMMARYWepropoectructhe-dimenil(3D)multimodlmoleculrtlcoloctlcncer(CRC)crodiffentgeetdeeWeimddemerggcliclchllengergerly-etCRCceexplgmoleculrdiffencetweenerly-etlter-etCRCWehypoizerrntterctitweencrcogenicmicrotummetbolicnichetummicroenvirmentledccelertedtrnipcnceroucellttemlignnttteOurtlfocuptillymppgtrnipcnceroucnceroucompentmetumutilizgphylogeogrphicmppgpprochctedividulizedgloblprogrjecrietweentumubtype(erlyetCRClter-etmicrotelletbleCRClter-etmicrotelleuntbleCRC)Weemploycuttg-edgetechnologieuchcumizedptiltrncripmicco-detectidexghighlymultiplexedimmunluocencemicrocopyuntrgetedimggmpectrometryhlogiclutluocenceimggcomphenivelychrcterizeCRCtuetvrioumoleculrlevelptilcleWeemploy3DmultimodltrtegyctructgvolumeterlevgeriltueectievluteddiffenttechnologiePidwholeexomeequencggle-cellRNA-equencgdtnchourptilnlyeourpviouHumnTumAtlNetwk(HTAN)dtWelevergeourpviouuccebuildgcoloctltleHTANenudtleedopen-cceueerchcommunyWehvetrgtemexpertegenomicprilgmulti-omicptilnlybiottticrtificiltelligenceOurpropolemphizeourtemextenivetrckcdCRCerchctiveprogrmCRCgutepililbiologyCRCmicrobiomeepidemiologypthologyOurgolprovideunpcedentedightgenetictrncripmicmetbolomicmicrobilrchecturlfetuCRCptillyolvedmnnertterundertCRCcrovriougegroupProjectSummrySeverlggivetypebtcncer(BC)nutrillylinnglutmemetbolmglutmeuptkehenhownenhncedBC-homgcllcellpopultiThepecillyignificntmettoccurpproximtely70%womenmettticBCmclicllycurbleTheenzymeglutme(GLS)ctlyzecveriglutmeglutmteIhvehownlotropicBCcellleultducedoteolyDurgoutgrowthmettedetructidrivenchnge-mgoteoblt-degrdgoteocltknownvicioucycleAmetboliccverictlyzedGLSloeentiloteobltlegecommmentgeneticllymodifiedmouemodelwueddeleteGloteobltprogenirSurprglyloGLSfunctioteobltprogenirledduceddetructioteocltnumrThpropoleekidentifymechnmwhichglutmemetbolmnichefluencedetructihowycouldexploedrpeuticllyIhypoizelofunctilGLS-tropicBCcellduceenecence-likephenotypeducetumburdencferenivyenolyticrpywhileGLSlooteobltprogenirlimleeoteoclgenicignlducgdetructicuttgfvicioucycleInSpecificAim1IfollowupdtnRNA-eqnlywhichdictedupgultiYpel2(Yippee-likeprote2)GLSKOcellgenehenlkedcellcyclertenecenceendolilcellIueCRISPR/C9KOovexpYpel2vriouGLSWTKObtcncercellletetcellcyclectivydetectmrkerenecenceIlotetpenceleveloteolyticfcruchPTHrP(vro)RANKL(vivo)FllyIteteffectgeneticdeletiphrmcologichibiGLS(CB-839)enivyggivebtcncercellleE07714T1-2MDA-MB-231-BoMenolyticttmentvrovivoInSpecificAim2determeeffecx-drivenGLSKO(GLSOBKO)oteobltdiffentifunctiIco-cultuoteobltmiceGLSOBKO-tropicBCcellexvivoteteobltdiffentifuncticludgproductioteoblt-pecificprote(RUNX2OPNOCNetc)ThllowmedetermeeffecttumcellignlgcompromedoteobltprogenirTodetermeeffectGLSlooteobltprogeniroteoclgeneoteocltfunctum-rgIpermRNA-copenlyTrtrte-RetntAcidPhophte(TRAP)tgtueectiGLSOBKOmicewildtypectrolFdgtherchhvepotentilprovidenewmtibouthighlymbidyetcurblemnifettimettticbtcncercouldevenpoibilyugp-extgcncerrpietrgetgglutmemetbolmmelemettticburdenbtcncerPROJECTSUMMARYThpplictiimddurgentneedpcerceptghedrydiffuegtriccncer(HDGC)ocedpthogenicgermleCDH1muttielevtglifetimecncerrkup80%developgdvnceddiffuegtriccncer(AGC)prticulrlytyounggeHDGCptientpoeuniquechllengecncerterceptirkductidueggiventuAGCwhichocedpoprognoCequentlythoepthogenicCDH1muttidvedundergoprophylctictlgtcmie(PTG)HowevercidenceAGCCDH1crrievrieignificntlyly25-45%mutticrriedevelopAGCwhilemnyptientmnegtivedurgurveillnce(nml-ppergmucoN)tbletT1tge(trmucoltgewhichcidedpcncerouleiAGCctextHDGC)outprogiAGCyerevenlifetimeTheefctdictePTGmjopertiocedchricphyiclpychoocildbiliemynotneceryllCDH1mutticrriehoweverpviouttempttrtifyrkbedpecificvrintfmilycncerhryhvenotenuccefulolidentifyptientthighrkAGCdevelopmentpotentillyquirgPTGcurntlylckgThlrgelydueourlimedundertgerlieteventdriveT1leidevelopmentprogiTofillthvoidweembledCenterGtricP-CncerAtlMultidimenilEvoluti3D(GAME3D)compoedcienttwhowkcloelygerbridggmultipledciplehvelgtgexpertepthobiologyHDGCwhodevelopednovtivewkflowmultimodlchrcteriztimodelgN-T1-AGCpthologicctuumCDH1germlemutticrrierTheoverllobjectiveourGAME3DReerchCenterdevelopmultimodlgle-celldynmic3Dptiltlnml-ppergmucoT1leiAGCthroughlgudlmpleCDH1mutticrriermtrn-rkmucoT1leinAGCAim1buildmultimodldynmic2DptiltlmptrniT1le-rkmucoubequentevolutiAGCAim2employvolutirytechniclcomputtilpprochebuildptiotemplthe-dimenil(3D)tltgle-celloluticptuN-T1-AGCpthologicctuumAim3levergecompleteuece2D3Dtlebuildcomputtilmodeltuminml-pperggtricmucopthogeneprogiT1leiultimtelyN-T1-AGCpthologicctuumOurtlhigh-vluecurntHTANperiprovidenexceptilviewgle-cellptillcpeN-T1-AGCpthologicctuumgenertgnvlubleourceHTANfieldunderterlietphehumnAGCdevelopmenthigh-rkCDH1mutticrrierthuidentifytrgetidelterceptrjecryPROJECTSUMMARY/ABSTRACTBtcncermotcommcncerwomenTriple-negtivebtcncer(TNBC)lckexpietrogencepr(ER-)progeterecepr(PR-)humnepidermlgrowthfcrcepr2(HER2-)motcommtrgetblemrkerbtcncerTNBCdemtrtewverllprognomgbtcncerubtypeduelckwell-etblhedtrgetedrpieBecueTNBCttmentliehevilyn-pecificrpieignificntneedextidentifynovtivewyhrnetumimmunemicroenvirmentenbleeffectiveueimmunpyIpropoevetigtehowtrcellulrproteMALT1promoteimmunouppumimmunemicroenvirment(TIME)TNBCMALT1effecrproteCARMA-BCL10-MALT1(CBM)ignloomeprotecomplextimulteddowntmcerncogenicGprote-coupledcepr(GPCR)ducepro-urvivlNF-BtrncriptilctivtiMALT1ctvwombiologicfuncti(1)moleculrcffold(2)proteeOurlbryhdemtrtedTNBCcellMALT1proteectivypromotetumprogimettducgepilil--meenchymltrni(EMT)InmnycncercludgTNBCmlignntcellundergogEMTmodulteurroundgmicroenvirmentpolrizeimmunecellwrdcncer-promotgimmunouppivephenotypeBedmyplimrydtIhypoizeMALT1proteectivyTNBCcellpromotetumimmuneupphroughproductinimmunouppiveecmeInAim1thpropolInlyzeMALT1gultiTNBCTIMEchrcterizgMALT1protee-dependentectiimmunouppivecykeTNBCcellExperimentltechniqueutilizedthimcludeCRISPR/C9edgmouebtcncermodeltumcell/immunecellco-cultuflowcymetryglecellRNAequencgOlkproteomicInAim2thpropolIevlutenovelMALT1proteectivygeneigntuclicopthologicutilypdictgTIMEttuTNBCExperimentltechniqueutilizedthimcludeueptient-derivedgnoidnlyptienttumpecimenmultiplexmultpectrlimmunluocenceerieiliclyeInummrythprojectevluteMALT1proteepotentildrivertumprogivieffectTNBCTIMEComplethpropolprovidemerigouerchtrgmrkbletemcienttphyicin-cienttThtrgexperienceppmecerphyicin-cienttwhodevelopnewnovtivetrtegiettmentptientmlignntolidtumSUMMARYN-Hodgklymphom(NHL)pentbout90%lllymphomdignoedechyerclifiedbedcelltype-BcellTcellnturlkiller(NK)celltypelocti-nodlextrnodltumgrde-ggive(highgrde)dolent(lowgrde)Folliculrlymphom(FL)motcommdolentB-celllymphommlrgelycurblemlignncyThemotclicllychllenggpectFLtrnmtidiffuelrgeB-celllymphom(DLBCL)chrcterizedemergencemoggiveubclelofolliculrgrowthptilrchectutncettmentledgmuch-htenedurvivlperiodtypicllylethn2yerAmgT-celllymphomngioimmunoblticT-celllymphom(AITL)emotcommubtypechrcterizedtumfolliculrhelperphenotypeurroundednflmmrymicroenvirmentrbizgvcultuprogidrmticchngeptilrchectuAlthoughdcoveryFLtrnmtiAITLtumevolutiwillydocumentedover50yergobiologiclmechnmcliclimplictimpolyunderodNobiomrkerextpdicrrpiepventmetteprogihighlyggivelymphomBothetumhijcknmlfolliclebiologyecpeimmuneurveillncepotentillydeveloptncecleYleHTANCenterimlevergeltetdevelopmentgle-cellptilomictechnologiectructptiotempltlhumnFLtrnmtiDLBCLAITLevolutiSpecificllywepplyhigh-pleximmunluocenceproteimggmpllmjcelltypeptilwholetrncripmeequencglkcelltypemuttillcpecllevolutiptilterctummicroenvirmentWefurrtegrteptilomicdtglenucleuRNAequencgidentifycellubtypenichecrotuempleovervrioudeetgectructcompletecelltlocedtumtrnmtidiffentgenderrcil/ethnicgroupncomputtillymodelptiotemplevolutirydynmicFllywepplytegrteptil-epigenome-trncripmeco-prilgunveilepigeneticmechnmunderlyguchtrnmtipotentillydcovererlieteventpdictprogiThepropoedptiotempllymphomtlpentvlubleourcetetrngehypoeuchhowdiffenttumcleemergeterctcompetecooperteptiltuectextdrivelymphomgenehowTcellcognizeterctdiffentmutntclehowmicroenvirmentco-evolvetumcellhowpdictlikelihoodtrnmtirpeutictrtifictiptientSgle-cellptilomictechniquecomputtilmodelcnppliedtypehumntumHTANctiumPROJECTSUMMARYInfirt6mthfterCOVID-19vccepprovl34billidoewedmtedglobllypotentillyvg72milliliveLipidnnoprticle(LNP)-mRNAbedCOVID-19vccehveenbleducebothtrgTcell-ntibody-mededpegtSARS-CoV-2triggergmyeloidntigenpentgcell(APC)uchdendriccell(DC)demtrtgefficcyLNP-mRNAtechnologymodulteimmuneytemPrtlydueucceCOVID-19vccehennewedttentiengeergnovelLNPmultittermodultemyeloidAPCcomprtment1)eirfe-tungdjuvnticyLNPlipidmulti2)improvgvivotrgetgefficiencyLNPwrdmyeloidAPCAlthoughdvncementLNPlipidchemtryenrichourrenlLNPmultiuedmodulteimmuneytemhntencpdgdetiledundertgmoleculrcellulrchngeducedupuptkeLNPpecificcelltypetueInfctttemptelucidtentemechnmLNPimmunogenicyhvetenledcflictgccluihveturnuggetedmechnmLNPimmunogenicyrrLNPmulti-dependentThelckcenuntemechnmLNPimmunogenicyfurrhighlightimmunogenicyechLNPcomplexfuncti)lipidmultintupylodb)ptterncognicepr(PRR)prileuniqueechimmuneubetc)LNPtrgetgefficiencyechcelltyped)celltuedeectextLNPttmentWhoutprlleleftgmechnticundertgimmunogenicyechLNPmultimdifficultrtillyelectLNPmultitilodprticulrdeectextcludgcncerInugLNPcncerimmunpeuticmycentrlhypotteLNPlipidmultidriveupirimmunogenicycomdnengeergtrtegycepecifictrgetgDCvivocnynergizeimmunotimulrypylod(ieIL-12)progrmDCcelltteenhncenti-tumimmunyInAim1IchrcterizechngeDCphenotypefunctrncriptilprileupuptkeDC-trgetedLNPbothtedyttetumlctextugDC-Tcellco-cultubulkcRNA-eqtedLNPtrnfectedDCInAim2IengeerClec9trgetedbi-pecificntibodieimproveLNPtrnfectiDCvivoTheoutcomethprojectbothmechnticundertgterplytweenLNPDCthccurupLNPuptkenovelbi-pecificntibody-bedtrtegyceDCtrgetgvivoPROJECTSUMMARYBtcncermotcommmmlignncywomenccountglmonethenewfemlecncerdignoeechyerTheprimrycuebtcncer-lteddethmettticdeewhetumcelldemteecdryebodyHumnbttumexhibcedenynervefirdenycompdhelthytuecednervtiocedhigherrtedtnrgnmettNotblytriple-negtivebtcncer(TNBC)highlymettticmoleculrubtypeexhibcedperipherlnervenervticompdubtypePviouwkOudlbdemtrtedenynervepromotevromigrtivivomettTNBCcellThegolthprojectuncovermechnmdrivgcedenynervenervtiTNBCwhichcouldprovidenoveltrgetducemettimproveptienturvivlTRPV1n-electivectichnnelpennenynervedriveneureoutgrowthgenertiStimultiTRPV1ctivtec-Juntrncriptifcrwhichupgultedowntmgenevolvedneureoutgrowthuchterleuk6(IL6)OurplimrytrncripmicnlyveledIl6c-Juntrgetgenevolvedneureoutgrowthupgultedwhenprimryenyneurweco-cultudTNBCcellIlofoundTNBCcellpromotedenyneureoutgrowthcedc-JunexpiTRPV1-dependentmnnerIhypoizeTNBCcellectitimulteTRPV1enynervedjcenlthytueledgc-JunctivtinupgultigeneocedneureoutgrowthgenertiuchIL6ultimtelydrivgneureoutgrowummicroenvirment(TME)InthepecificimItetthhypofurrelucidtehowTNBCcellcruenynerveTMEInSA1Ivetigterolec-JundowntmtrgetuchIl6drivgTNBCcell-mededenyneureoutgrowth2DInSA2Iutilize3DhydrogelmodeldetermeeffectTNBCcellenyneureoutgrowthexploleTRPV1medgoutgrowthToourknowledgethnovtivepprochfirtdecriptinerve-cncertercti3DytemInSA3IexmeroleTRPV1crugenynervemmmrytumvivoThcompletedbothgeneticphrmcologichibiTRPV1yngeneicmouemodelTNBCSuccefulcompletieimprovidevlubleightmechnmthroughwhichTNBCcellpromoteenynervtiTMEAnervtidriveTNBCcellmetttrgetgthnewlydcovedmechnmcouldferpromgclicltrtegyimproveptienutcomeAlignedtherchpropoltilodtrgplnhendeignedtegrtecliclerchtrgppmecerndependentphyicincienttPROJECTSUMMARY/ABSTRACTTrnmtinmlcellcncercellvolvecomplexchngefluencedcogenectivtumuppdruptedignlgpthwyimpogmetbolicdemutedthroughlterticriclmetbolicpthwyvilbilynutrienttummicroenvirmentuppttumexpniPvioulywehvehownelectrtrnptch(ETC)neceryvivotumiprogiHoweverexcthdcrucilroleETCtumgrowthmomewhtunclerWehypoizeETCuppttumgrowthmtgoxidtivetricrboxyliccid(TCA)cyclectivyplenhgNAD+cvertgucctefumrteproductilipidnucleotidehemeglutthieHowevercompheniveundertgTCAcycleimptncetumgrowthhnotenchievedthufrHencewechoefocuourvetigtimltedehydrogene2(MDH2)keyenzymevolvedfltepTCAcycleexploignificncetumgrowthMDH2htwodtctfunctivolvgcverimlteoxlocettecyolicNAD+generthroughmlte-prttehuttlePlimrydtdemtrtebenceMDH2impidthopictumgrowthmulungdenocrcom(LUAD)cellimmunocompetentmiceThpropoloutleourplnfurrvetigteneceyMDH2tumiprogiugnovelMDH2floxedmoueleKr+/LSL-G12DTrp53fl/fl(KP)mouemodelLUADFurrmotumprogycomehypoxicccomntdecleETCfunctimichdriNAD+genertiMooverMDH2plyrolegenertgcyolicNAD+ThuweddwhercyolicmichdrilNAD+ctlimgfcrLUADKPmouemodelToddthwehvelogenertedcdilmiceexpgcyplmicmichdrilLcbcillubvH2O-mgNADHoxide(LbNOX)enzymewhichcvertNADHbckNAD+cyolmichdripectivelyTocomplementeexperimentwepermCRISPRknockoutMDH2oxpCyLbNOXMiLbNOXthopiclungcncermouemodelugmouecelllederivedKPmouemodelAkeyetexperimentewherMDH2quidnmllveolpililcelldevelopmentfunctidultmiceTheevetigtienhnceourundertgneceymichdrilmetbolmdependentTCAcycleNAD+genertiupptglungtumgrowthnmllungepililcellfunctiProjectSummryThepprovlnti-PD1/PD-L1nti-CTLAimmunecheckpotblockde(ICB)rpiethoen-mllcelllungcncer(NSCLC)hdemtrtedimmunpiecngenerterobutpeubetptientdvnceddeeHoweverwhilenerly45%ptientdemtrtemjpthologiclpeICBmedinprogi-feurvivlNSCLCptientmdmltround7mthItnowwelldocumentedpertentterfergmm(IFNy)cykepthwyignlgplyprdoxiclroletummicroenvirmenthenocedbothtncepeICBledgulievegternuncedectthpthwyAccdglythcykepthwyquecomplexIFNytimulteexpi~200hllmrkterfer-timultedgene(ISG)thutillunclerhowmjyISGfluencetumimmunyhendifficulttudythpthwylevntbiologicctextUgnovelfunctilgenomicpltmdevelopedourlb(Perturb-mp)myplbwbleknock-out(KO)35cykegeneprllelKPmouemodelNSCLCvetigteptiltemplphenotypetgle-cellolutiItwfoundKOSoc1negtivegulrIFNypthwycuednovertgrowthdvntgeprdoxiclcebothCD8+CD4+T-cellfiltrtumFurretumwefoundmoenivePD-L1blockdethnwildtypetumWehypoizeSoc1KOcuechricupgultumcellIFNyignlgledgcyke-mededfiltrtiTMEwhichfollowednceimmune-hibiryignlexpumcelluchPD-L1InAim1wevetigtefluenceSoc1KOtumimmune-compoiTMEtumphenotypeugPerturb-mptrncripmicWencrobteedtCITE-eqhumnlungcncerpecimenfurxploleSOCS1humnmlignncyInAim2weuePerturb-mpKOll162ISGdetermehowechimpcttumimmunyctextimmunecheckpotblockderpyTMEbiologytdepthTheeexperimentcludeementimmune&tromlcrumenttumgnizti&diffentiundnlyptiltrncripmicidentifymechnticprogrmctrolledechISGReerchSummryHigh-grdeerouovrincncer(HGSOC)motcommhlogicubtypeovrincncerDepegogeftdevelopeffectiveurgiclttmentgimendvncedHGSOCoverllurvivlrtely30%prtdueltedignoHGSOCmgmotchemo-enivellepililmlignncietdignoHoweverubetdvncedtgeptientfilpdilrpyhdmlprognoTheeundertgmechnmthroughwhichHGSOCmettizedeveloptricchemotncecrucilimproveefficcyttmenturvivlptientThepropoedOvrinCncerAtlReerchCenter(OCARC)uetegrtemultiplette---rtmoleculrcellulrprilgpltmctructthe-dimenil(3D)ovrincncertlchrcterizgHGSOCmettdevelopmenttricrpeutictnceugdivereptientcohtdignoeddvncedHGSOCTheCentercompoednAdmtrtiveCothecnectedunBiopecimenUnChrcteriztiUnDtProcegUnThemulti-PItemMDAnderCncerCenterUniveryArknbrggerterntillycognizedexpertovrincncerbiologyttmentmpectrometrybiomticimggThtemhvecomplementrymultidciplrycientificexpertequidtegrtimultidimenilmultiprmetricdtneededctruct3DovrincncertlddkeyerchproblempropoedTheAdmtrtiveCoprovideupptnecerypropoedOCARCfrtructuTheBiopecimenUncquipecimencollectclicopthologicmtipptueectiTheChrcteriztiUnpermptillyolvedubcellulrtrncripmeprilgFFPEtueectiugnovelSTOmicpltm3Dmetbolomicpeptidomicglycomicprilgughigh-olutimpectrometryimgg3DtromltumcellprilgugCOMETmultipleximmunluocencepltmTheDtProcegUnbuilddtwhouehotglldtgenertedChrcteriztiUnBiopecimenUnItpibletegrtgllvilbledtidentifykeyignlgcircuunderlie3DptilchngephenotypicprileThefltlidentifydiffencecellulrmoleculrctentcell-cellcrotlkignlgnetwkHGSOC(1)primrymetttice(2)tricchemoenivechemotntHGSOCItbrgdeeperightmultidimenilHGSOCtumecoytemocedtricchemotnceWeexpectthurultuedcdemicerchercliclercherdutryprtnerimproveourundertgmoleculrbovrincncerttertrtifydeemngementimproveptienutcomeOurulthvepotentilleddevelopmentnovelgentgtchemotntHGSOCPROJECTSUMMARYPedrichigh-grdegliom(pHGG)whichcludediffuemidlegliom(DMG)mgmotlethlllpedriccncerurvivlrlyexceedgtwoyerThemotcommmuttipHGGfoundhnevrintH33(H3F3A)nerly50%llpHGGexhibgg--functimuttiteirlye27(K27M)glyce34(G34R/V)BothhnemutntultwidepdepigeneticimpcttrncriptilctroldtctcliclhviAddillyroughly30%pHGGhrblo--functimuttichromtmodelgproteATRXwhichco-occurbout20%H3K27Mtum90%thoeH33G34R/VmuttiHowevercurntlynoknownmechnmexplgpco-muttitweendiffentH3F3A-mutnttumStudiehvedemtrtedbilyH3K27MhibctlyticfunctiEZH2nH3K27methyltrnfereATRXhenhownimpctlocliztiPRC2nouchocihenmdeH3G34R/VmuttiEZH2ectlyticubunpolycombpivecomplex2(PRC2)piblemtgpimnyerlydevelopmentlgenecludgthoevolvederlybrdevelopmentTheoverllobjectivethpropoldetermehowATRXloimpctdevelopmentlgeneexpiH3G34R/VmutnttumcellThecentrlhypotteco-muttiH3G34R/VATRXult(i)pproprePRC2locliztiH3K27me3plcementledg(ii)expiPRC2-pedneurodevelopmentlgeneubequentcetumcellgrowthTheplimrydutledthpropoluggetmeetPRC2trgetgeneupgultedbothH3K27MleATRXlo/H3G34RgerThefirtimeeroleccurntH3F3AATRXmuttiPRC2dyfunctiwhichlooktbothlocliztifunctiPRC2tknowntrgetthroughoutgenomeTheecdimlookhowH3F3AATRXco-muttiffectexpiNPCmrkergenehowthimpctcellprolifertirtetumgrowthSuccefulcomplethpropolexpectedultclerundertgwhyATRXlopfentillyelectedH3G34R/V-mutntgliomoverH3K27M-mutntgliomThknowledgeultbilydeignutilizemopecificrpieH3F3A-mutntgliomwhichcouldprolgurvivlupwrd50%pHGGptientPROJECTABSTRACTFtiguemotdtgympmffecttween60-90%lldividulbtcncerThepvlenceftiguece80-96%whenedividulceivgchempycommttmentmodlyThhighpvlenceftigueccernclicinptientirfmilieftiguedebiltgympmterfedividulphyiclwellgcludgirbilypermdilyctiviedeceocilfunctigHoweverlckundertgwhtcueftiguemketilgterventiduceftiguedifficultYetwhilevetigrhveerchedmnybiologiclpthwyltiftigueemechnmdeervefurrvetigtilmicrobiomeCompellgevidenceuggetmicrobiomefluenceympmuchftiguephyiclwell-gImptntlydividulbtcncerhveenfoundhvedimilrlmicrobiomehelthctrolwhichnfurrlteddurgchempyAddillytudiedividulchricftigueyndromehveuggetedthrlmicrobiomemightplyroledevelopmentftigueGivenhighpvlenceftigueexperienceddividulbtcncexplgthltihiptweenlmicrobilchngeftiguephyiclwell-gurgentlyneededInvetigtglmicrobiomedividulbtcncerhpotentilmourundertgbiologiclproceftiguecncerffectmillidividulnnullyTheobjectivethlgudltudymourundertgbiologiclmechnmocedftiguephyiclwell-gclrifyimpctchempylmicrobiomedividulbtcncerceivgchempyThtudyuedtbiopecimenhveencollectedthroughDukeUnivery1000PtientProject(1KP)The1KPprojectngogclicldtpoirywhichptientcludgdividulbtcncerundergogmtecmycentedcomphenivedt(demogrphicdeeftiguephyiclwell-g)biopecimencollectiuchlmicrobiomempletmultipletimepotppopertivelyovercoure6mthTheimAim1Chrcterizelmicrobilchnge(ltivebundncelphdivery)prichempyup6ubequentmth25dividulbtcncerAim2Explowherlmicrobilchnge(ltivebundncelphdivery)ocedftiguephyiclwell-gmeudPtient-ReptedOutcomeMeumentInmtiSytem25dividulbtcncerceivgchempyReultpropoedtudyenhnceundertgltihiptweenlmicrobiomeftiguedividulbtcncerceivgchempymfutuerchctilodterventimeleftigueenhncephyiclwell-gdividulbtcncerPROJECTSUMMARYProttecncer(PC)ledgcuemlecncer-lteddethOncedemtedPCcurblegrdullyprogellrpeuticoptiThemechnmunderlygggivefetulethlymettticPCmnunmetcliclneedWehveptedmettticPCdplyhighetlevelchromoomltbily(CIN)wehvehowntrncriptilprogrmmgllowPCCIN-dpttiurvivldvnceddeeYetmoleculrunderpngCINimpcnPCmpolyunderodUggeneticproteomicepigenomichigh-olutimicrocopywefoundCINlkedtrncriptilwirgbookmrkguggetgroleCINcellprogrmmglethlPCHighCINPCmhighlydependennmicfidelyprogrmlikeectrolledMASTLketrlethlcttrophicCINlevelWefdMASTLgultenewltemicproceevolvedcentroomebiologycykePCcellHoweverubtrteeffecrwhichMASTLgulteefunctimunknownFllyourvivodttrglyuggetlevntroleCINimpctgnti-tumimmunyPCInthpplictiweueuniquegeneticmodelidentifyubtrteccrwhichMASTLkegultenewfunctihighCINPC(Aim1)WevetigtemoleculemechnmunderlygCIN-ducedtrncriptilprogrmmggenebookmrkgPC(Aim2)explotumimmunecelltricextricmechnmtriggedCINPCmyenhnceimmunpyefficcy(Aim3)ThroughetudiewemechnticllyuncovernovelpectCINcequencePCmyidentifynewpotentilttmenttrtegiethlethldeeABSTRACTPtientjuvenile-etcurntpirryppillom(JoRRP)uffercurrgepililppillomlgpirrytrctcuedlow-rkHPVviruepdomntlyHPV6ThmotcommnignneoplmchildnvrieignificntlycliclcourePtientundergverge4-5urgeriefirtyerpot-dignoevececnulthunddurgerieprogicncerThelckeffectivemedictiignificntlylowerqulylifechildnRRPhighlightneednewbiomrkerrpieTodeveloprpeuticprognoticmrkerquiovercomgdeepgpknowledgevirlhotcellfcrproduceppillom(iecidtetrgetmrker)ThnowpoiblethnkdevelopmentmodelnmlJoRRP3Dtrtifiedqumouepilium(SE)Ugfhtummtchedndeed(ND)tuechildnJoRRPwegenertedprimrymolyerkercytewhichwenengeedgnotypicepililrftWihetblhedpipeleternllyctrolled2D/3DmodelwehvemdeignificnttrideOurglobltrncripmenlye2DJoRRP/NDkercytedefedJoRRP-pecificEMT-likedeeigntuwhichwevlidtedrftptientpecimenSgle-cellRNAequencg(cRNAeq)HPV6+RRPpecimen(vmtchedHPV-NDctrol)furruncoved16trncriptillydtctkercyteubpopulti(cluterC0-15)CSrtrikgimilryourcentlypublhedcncerocedHIODENubpopultiducedhigh-rkHPV16BothlocteduperficillyerwheHPVmplifictioccurbothhbiomrkercludgELF3trncriptifcrwhichquidHIDDENmtiOurnewdthowHPV16E6/E7cogeneufficientduceHIODENuggetgcervedHPV6E6/E7ctiviemightducenlogouubpopultitepililurfceInAim1wetetwherhowHPV6E6/E?duceCSwherCSquidvirlprogenyproductiOurcRNAeqdtloveledtrikgbundnceHPV6E5trncriptcrocluterdictgimptncevirlprocee/kercytephenotypeWhilefunctilow-rkHPVE5/proteuntudiedtrnltildeemodelHPV6E5wptedbdEGFRERBB2ceprtyroekeInAim2wetetwherHPV6E5/E5utJoRRPphenotypewherydootletprtviEGFR/ERBB2ignlgPROJECTSUMMARYProgimettticdeeN-SmllCellLungCncer(NSCLC)ignificntcuemtlyCentrlnervouytem(CNS)mettewhichcrrypoprognolimedttmenpticnmtrpnchymlly(IP)tuebrcebroplfluid(CSF)filledpcetweenlepmengeThelttertermedlepmengeldee(LMD)difficultdignoettpthophyiologiclmechnmunderlygprogiLMDpolyunderod60%ptientLMDhveprccurntIPmettemechnmpromotgwchLMDvimunknownIntetglyptientEGFR-mutntNSCLCmolikelyprogLMDprticulrlyttncetyroekehibir(TKI)trdceptientWhilethird-genertiTKIuchOimertibhowexcellentbrpenetrncetntCNSdeecludgLMDmpgcliclproblemTheprimryimthprojectidentifymechnmunderlygprogipertenceLMDdetermewhtfcrfvthprogiceTKI-tntEGFR-mutntdeeIhypoizeubetIPceprogiLMDoccurthroughvipnchymlcellthroughperivculrpcebrthprogipromotedmechnmynergticllyfoterTKItnceIhvevlidtedmultipleNSCLCmumodelcombidIPLMDfollowgtr-rteriljecticludgnEGFR-mutntmodelemergetlte-tgeTKItncewellyngeneicmodelInAim1IutilizeptiotemplbrcodgelechrtnmiclroutecelltrverechlepmengelpceInprticulrIdetermewherLMDmettedecendpnchymlmetteenterCSFytemiccirculticroblood-CSF-brrierInehowpthwydowntmmechnoeng1-tegrpvioulyhownourlbrypromoteCNSTKItncemymodultebilyEGFR-mutntcellcompletethjourneyttnceThenAim2IvetigtemechnticroleproteTueInhibirMetlloprotee1(TIMP-1)identifiedourbiopoirympleupgultedCSFptientLMDTIMP-1cnignlthrough1-IntegrCD63promotenchge-dependenturvivlmirrgphenotypeobervedourLMDmodellevroGivenrole1-tegrthpthwyIvetigtewhertromlTIMP-1levelplydulroleEGFR-mutntLMDpromotgcellurvivlwhilelopromotgignlgunderlygTKItnceAgrdutetudentDrDNguyenlbryPthologydeprtmenttYleUniveryIhveupptdivererrytrnltilcliclerchermymenrcollbrThroughcompletierchpropoeddurgNRSAF31fellowhipIhemyexperimentlkillIprogwrdmygolcomgndependentercherfieldCNSmetteTleDevelopmentnovelnnpeuticovercomerpytnceugcnebrtumptneoumodelProjectSummry/AbtrctHigh-grdegliom(HGG)cludgglioblm(GBM)unimlyftlprimrybrtumDepedecdeerchhveenlmotnogulrydrugpprovlttmentGBMUnedSttecevcizumb2009ThelckrpeuticdvncementhighlightrpeutictnceHGGdependencypcliclrodentmodeldotfhfullycpulteheterogeneycomplexyhumntumToddeunmetneedgolthpplictidevelopnovelnnpeuticovercomerpytnceugcompnidogHGGptneoumodelThecurnttrd--crpieprimrycurntHGGcueuphgyductiultcelltnceenhncementtemnefetuGliomtem-likecell(GSC)hveenlkedtumcurncedrugtnceEnrichmentGSCfterchempyocedmoggivetumboundGliomcellprticulrlyGSChighlylyelevteduphgyTheeuphgypromgtrgetHGGimprovettmenvercomerpytnceAmoquoledrugchloque(CQ)hydroxychloque(HCQ)hveentetedeverlclicltriluphgyhibirdemtrtedirpoiveeffectimprovementmedinurvivlptientfterrdi/temozolomidettmentHoweverCQ/HCQufferlimedpotencyhibguphgydvereeffecttrpeuticdoeleveln-pecificdeliveryprileFurrmoblood-brbrrier/blood-brtumbrrier(BBB/BBTB)poeuniquechllengeuccefulrpeuticdeliverybrtumRecentlywehvedevelopederienovelbmoquolederivtive(BAQD)phrmcophohybridiztipprochBAQDhveouttguphgyhibg-lyoomldruptg-cpbilie30-50timemopotentthnCQHCQTheledBAQDundergogINDubmi(#165331)firt--humnclicltril2024WelodevelopednovelBBB/BBTB-trvergtum-penetrtgnnoprticle(BTN)ignificntlyimprovedrugdeliverybrtumInthpropolwepln1)developerieBAQDlodedBTN(BTN@BAQD)vetigteireffectvergdrugtncecncertemneHGG2)evluteirdeliveryefficiencyntumefficcythopicgliomrodentmodel3)ultimtelydetermephrmcoketic(PK)xicytumuptkerpeuticpeelectedBTN@BAQDdogptneouHGGSN-38highlypotentmetboleirotecnco-lodedBTN@BAQDkillbulkgliomcellWenticiptethurBAQDlodednnoprticlecnefficcioulyimprovettmentbrtumthrougheffectiveuphgyhibipotentBAQDefficientdeliveryhighccentrtidruggliomouruniqueBTNtrtegypectivelyOurtemexpertecGMPnnoprticleproductiuccefulexperiencemovgnnmulticlicltril(NCT05519241)fcilteclicltrnltiBTN@BAQDProjectSummry/AbtrctMlignnttumecpeimmuneurveillnceevdguppgdrtgimmunefunctiThecentucceimmunecheckpotblockderpylietrgetguppivemechnmffectgeffecrfuncticyxicTcellHowevermjy(60%)ptientdvncedmelnomfilpdimmunecheckpothibir(ICI)rpymnythoedopdultimtelygodeveloptncedeeprogiWhilebilypromoteimmunepetumhlrgelyfocuedtumpecificfcr(egtummuttilburden)vribilyhotimmuneperimyloexplheterogeneypeeenICIttmentfiluICIrpywkthroughmultiplepthwyleeimmunouppivebrkentedptiveimmunecellAveryimptntmechnmctiICItrgetghibiryceprCD8+Tcellwhichpotenteeffecrnti-tumCD8+TcellfunctiAlthoughICIcnneweffecrfunctiCD8+TcellmotptientmettticmelnomdotpdcheckpotblockdeduemultiplemechnmpnngbothdptiventeimmunyAcentlydecridcellpopultintelymphoidcell(ILC)pentecdrylymphoidgnperipherlbloodtuehveendecridmodultedptiveimmunepeType3ILC(ILC3)cncteimmunouppivemicroenvirmentthroughectiInterleuk-17(IL-17)ledcrumentimmunouppivecellpopultictinimmunouppivemicroenvirmentILC3firtpderflmmti/tumdicttefurrntedptivepemyultimtelydetermeeffectiveneICIrpyHoweverroleILC3mechnmhdICIfiluCD8+TcellctivticurntlynotwellunderodThebilymopecificllydefefunctiILC3melnomtummicroenvirment(TME)hpotentilmnovelcombttmenttrtegiedicttedowntmntedptivecellulrpedriveICIrpyeffectiveneHoweverthcurntlynotwellunderodPROJECTSUMMARYTum-AocedimmuneMcrophge(TAM)metbolicllyfunctillyheterogeneoupopulticellplycriclrolebothnti-tumimmunytumgrowthImptntlytypeTAMfiltrteneoplmhenhownprognoticfcrtumgrowthenivycncerimmunpieHenceelucidtgmechnmdetermediffentipro-tumnti-tumTAMtummicroenvirment(TME)cnlednovelrpeuticpprocheFnerly40yerhenknownhibimichdrilelectrtrnptch(ETC)whichcompoedfivemultiprotecomplexecriclnti-tumctivyTAMHowevermechnmwhichctivyETCctrolledTAMhowthprocedetermefunctieimmunecellTMElrgelyunknownIntetglytermlenzymeETCComplexIV(CIV)lyETCcomplexwhichcoproteubunplcedcloelyltedmtunectivypeignltuemicroenvirmentUggle-celltrncripmic7novelmouetrwegenertedwedemtrtedtypeIIIterfer(IFN)potentlyducegletrncriptencodgpeptideNDUFA4L3microRNAmiR-147humnmoueTAMmelnomtumNotblywelohowedNDUFA4L3miR-147wkccertmodelCIVproteubuncompoiTAMthroughdegrdtiubequentplcementcocompentCIVNDUFA4ImptntlyNDUFA4degrdtiultNDUFA4L3miR-147ductiIFNgeneticdeletiblocktumgrowthleddrmticccumultinti-tumTAMTheewehypoizegultiCIVubuncompoictivyTAMthroughductiNDUFA4L3miR-147IFNkeyevolutirilycervedmetboliccheckpotwhichTAMdiffentictrolledwhichcouldtrgetedctextcncerimmunpieThuim1thprojectweuetwovelcdillyknock-outtrNDUFA4NDUFA4L3wegenertedgle-cellptiltrncripmichumnizedmoueMISTRG-6upptdevelopmenthumnTAMetblhhowCIVubuncompoiTAMgultenti-tumimmunypecheckpotblockdehibirInim2weuemoleculrmodelCIVnmicolutiwegenertedmetbolomicnoveltechnologiemeucellulrmetbolmmiphgyrtetglecellleveldetermehowCIVproteubuncompoictivyctriemetbolicfunctiltteTAMAcentptdemtrtemcrophgeptientlofunctimuttiNDUFA4howtrikgpro-flmmrygeneigntueverlETChibirengeedchimericntigencepr(CAR)-expgmcrophgecurntlyundergogclicltrilcncerourtudiemylednovelrpeutictrtegiecomplementextgcncerimmunpieAbtrctImmunouppivehomeotticmechnmpventimmunecelltueelimtgolidtumlimgefficcynti-tumimmunyPcedectiehomeotticmechnmcnledtterundertghowtumpertgrowtueOurpritudiedemtrteA20protepotentgulrimmunehomeotgultgbothpro-flmmrycelldethignlOurcentplimrydtvelA20highlyexpedtummicroenvirmentthnepecificbiochemiclmotifthprotetrbothcutenmneticntumimmunyThpropoldectcellulrmoleculrpthwywhichA20gultenti-tumimmunyPROJECTSUMMARYPncticductldenocrcom(PDAC)celldependglutmemeetiruniquemetbolicneedGlutmefuelwiderrybioynticpthwyhoweverdepeeetblheddependencietrgetgpecificenzymevolvedglutmeutiliztihveyetyieldneficilultThpropolbedourplimrydtdemtrtgbrodlytrgetgglutmeutiliztiviubtrtenlog6-dizo-5-oxo-L-nleuce(DON)hproundeffecnPDACtumgrowthmettWehvedcovedeffectDONPDACcellfnedictlylkedprge(An)upplyThobervtiexcgcuebilyDONexertdeleterioueffecttumthroughblockgAnbioynhneverenexmedMetbolictrgetgcntriggerdptivepellowtumcellecpeeffectnutrienttWehvefoundPDACcellrobutlyupgultemcropocymetbolicdpttiDONttmentInthwyprote-derivedmocidproducedthuptkepthwyhvebilydmpeneffectDONuggetgmcropocyhibimightneficiltrtegyenizePDACtumDONTogmechnticightDON-duceduptkewepermedhigh-throughputiRNAhumnkomecenidentifygWNKlyedeficientproteke4(Wnk4)potentgulrDON-timultedmcropocyWnk4plynimptntrolernptkidneyhnotenlkedmcropocyrolecncerhnotenelucidtedInthpropolwe(1)exmerolemcropocymetbolicdpttiDONPDAC(2)decipherfunctiWnk4mcropocyPDACtumgrowthThpropoedprojectignificntnovtivecueetblhmetbolicmoleculrmechnmunderlygfunctilyglutmemimeticPDACdecipherrpeuticfrmewknewcombtitrtegiePDACSUMMARYAcutelymphoblticleukemi(ALL)motcommhemlogiclmlignncyledgcuecncer-lteddethchildnUnedStteMulti-drugchempyhvtlyimproved5-yerevent-feurvivlover80%howeverprognochildnfrcrylpeddeelepoivecompletemirtedroppg30%Migen-ctivtedproteke(MAPK)ignlgpthwycervedcroeukryoteyethumnTheeenzymeplycentrlrolegultgcellulrctivieurvivlprolifertitpediffentimotilyngiogeneMAPKpthwycoupledivereextrcellulrignl(growthfcrhmecykeenvirmentlte)dtcttrcellulrgeneprogrmvieriectivtgphophyltieventProvidgdictputekeMAPK/ERKke(MEK)fmilyenzymeloclledmigen-ctivtedprotekeke(MAP2KMKK)CurntlyfourFDA-pprovedMEKhibirwhichblockputERK1/2rmpthwyllwhichhibMEK1/2LoMAP2K7(kMEK7)picequentmplifictidowntmmigen-ctivtedproteke(MAPK)ignlgthoughtctrieT-cellcutelymphoblticleukemi(T-ALL)pthologyCurntlylyknownfunctiMEK7phophyltiJNKdowntmignlgprtnerMAPkeignlgccdeHowevertructurllyfunctillyhomologoumMEK4lofunctiphophyltethdowntmkeTheltiveputMEK4MEK7eemvriblectextdependentThgpknowledgecurntlymjimpedimentfullyundertgMEKignlgpthwyctextcncerAlthoughbothMEK4MEK7ctivteJNKlyMEK7ppermedeJNK-dependentflmmrypeimmunecellLikewepoiblehibiMEK7ctextT-ALLmyledcompenryupgultiMEK4-promotedJNKphophyltiEquippedhighlyelectiveMEK7hibirweuniquelyenbleddectthcriclkeccdefirttimeHewepropoefurrdevelopmentnewmoleculrolttenuteMEK7-mededJNKphophyltiTheenewprocompoundnppliedcellulrdectiJNKrmMAPkeignlgccdectextT-ALLClicllylevntmouemodelnemployedidentifyoptimldrugtrget()T-ALLPROJECTSUMMARYTheignificntevidencecncer-typepecificptternexhmeceprexpiignlgmnycentrlnervouytem(CNS)tumtencltgirhighex-pecificyThuppthypoexhmeceprplytumigenicpthologicrolecromnyCNScncerHoweverirmechnticfunctiCNStummlrgelyunknownThpropoleekddeknowledgegp2ecncermengiomglioblm(GBM)InAim1Iexplomechnmunderlygprogeterecepr(PR)expiignlgmengiommotcommprimrytrcrniltumMengiom27timemocommfemlethnmlecnettgexogenoufemlehmerpy70%exphighlevelPRuggetgfemleexhmemydrivemengiomtumigeneUghumnmengiomxenogrftmicettedclicllylevntdoeynticprogetIdevelopedmodelfemleexhme-drivenmengiomThedtpentedthpplictiuggetprogetducePRexpicetumgrowthduceurvivlthroughpoivefeedbckmechnmquiprogeteremembrnecompent1(PGRMC1)n-cliclhmeceprpthologicrolebtendometrilcncerThecentrlhypomydocrlderttiprojectprogetligctivtePGRMC1driveexpiPRmengiomthroughgultiNFBtrncriptilctivyPRdrivemengiomgrowhroughcyplmicctivtiMAPKignlgtrncriptilctivtiTNFSF11TGFAIRS2ThroughmdermygrdutewkI(i)vlidtepthwythroughwhichPGRMC1drivePRexphroughChIP-QPCRluciferepterlo--functivlidtimodel(ii)identifyhmlccrvolvedPGRMC1ignlg(iii)vlidterolePRdowntmtrgetdrivggrowthprolifertimengiomthroughg-lo--functimodel(iv)cptehumnproteomicdtdefeexpilevelproteimplictedPRPGRMC1ignlgpthwyhumnptientInAim2IoutlepropoeddictimypotdocrltudiechrcteriztiexhmeignlgpthwyGBMThemotmlignntprimrybrtumdultGBMtenmrkedhighexpirogenetrogencepryetlimedtenctrdicryfunctildteceprGBMhimpededdevelopmentexhme-trgetedrpeuticFthprojectIpln(i)permtegrtedproteomicphopho-proteomicchrcteriztihmeignlgnetwkGBM(ii)chrcterizemechnticllyvlidtepthwythroughwhichexhmeignlgfluenceGBMpthology(iii)developcombtirpietrgetgeignlgxeTkengereprojecttegrtegeneticbiochemtryproteomicchrcterizerpeuticllyvulnerbleignlgpthwymengiomGBMAbtrct/SummryPncticductldenocrcom(PDAC)pentemotggivemlignnciemothn50%ptientpncticcncerpentgmettticdeemlyliverttimedignoWehvepvioulydecridpencemicropncticcncerwhichcoulddetermeoutcomeFurrmoweveledmicrobilmodulticnffecttummicrobilcompoiimmunecelllcpetumgrowthWehvenowplimrydthowgmicrobildtriicrotumcellulrcomprtmentMooverwehveenblepermptilmicrobilfunctilementtgilglecelllevelWehveidentifiedimilrmicroprimrytummtchedlivermettuggetgmicrobileedgprimrytumliverMoevidencethourfdgvelgNEToprocehotdefenegtmicroupgultedliverdurgmettticproceTheoverllgolthpropoldeeplychrcterizeloctidtriiptilfunctilymicrotummicroenvirmentprimrytumwellirfluencetumgrowthp-mettticnichelivermettmtiTothendweuemultiplemethodologiecludgtte---rtmicrobil-hotimgggilglecellmicrobil-hotequencgdetermeloctibctericellulrcomprtmentptterndtriifunctilypeciechrcteriztigercengculturomic(Aim1)WenuemultiplemouemodelfullychrcterizerolehumnPDACmicroprimrytumgrowthmettticnichelivermettmtiddghumn-pncticcncerderivedmicrollowgvivotrckgmicrobil-ctgcncercellwellloclgloblmicrobilbltivrognoidmicrobilco-cultuement/modultiNETodetermeirrolemedgmicrobileffect(Aim2)TheuccethpropolhhighpotentildevelopmentnovelmicrobilmodultitrtegietrgettummicroenvirmentwhichcouldultimtelyledimprovedoutcomeptientpncticcncerPROJECTSUMMARYDepedvncecncerrpymettticdeeoverwhelmglyftlccountmotcncer-lteddethSytemicrpiefilctroldemteddeeduemixntecquidtnceTheproceedrivedrugtncemettcombtumcell-tricmechnmuchgeneticepigeneticchngeextricfcrcludgtumimmunemicroenvirment(TIME)IpropoecompheniveerchtrgplnvetigtebothdimeniF99PheMydocrlwkfocuecncercell-tricmechnmroleClud-1(CLDN1)expipromotgchemotncemettcoloctlcncer(CRC)Mywkthufr(Aim1A)detilnovelmechnmwhichCLDN1terctdictlyceprtyroekeEphrtype-Acepr2(EPHA2)CRChibdegrdtiTheceprote-levelEPHA2enhnceAKTignlgCD44expipromotecncertemnechemotncePviouwkhhownCLDN1expipromoteCRCmettmouemodelMyfutuwk(Aim1B)vetigtemoleculrdetilCLDN1/EPHA2tercticompptternCLDN1EPHA2expiptient-mtchednmlprimrytummetttictumtuelookpecificllytroleCLDN1/EPHA2terctipromotgmettAim1providetrgbiomticgnoidcultuthopicmettmodelK00PheInmypotdocrlpheItudyextricfcrfluencgbtcncer(BC)dmncymettliverCncercellpddtnrgnerlytumdevelopmentTheedemtedtumcell(DTC)cnenterttedmncyurviveilrpylyctivteyerlterultglpeItwell-cceptedfcrgultgdmncyctivtidependmicroenvirmenthorgnEventhoughhepticBCmettecrrywtprognofcrgultgdmncyctivtiliverundertudiedprticulrlyfullytctTIMEInAim21IueimmunocompetentmouemodeltudyroleT-cellgultgBCdmncyliverEvidenceuggetheptictelltecell(HSC)ctivtimycriclfcrDTCctivtiActivtedHSChllmrkn-lcoholicfttyliverdee(NAFLD)NAFLDmotcommliverdeewldimpctBCmettnotwelltudiedAim22uemouemodelNAFLDtudyeffecnBCdmncymettAim23uenovtiveexvivowholetuelicecultutudyignlgnetwkgultgBCdmncyimmuneeviAim2providetrgcncerimmunologydvncedcncermodelccurtelymodelTIMEnlyticltechniquecpblegle-cellolutiThepropoedtudieferightcuerpeuticvulnerbiliemettticdeeprovidemultidimeniltrgprogrmppmecerndependentcncerercherPROJECTSUMMARYThecidenceEndometrilCncer(EC)henrgnotblecemtlyrteepecillymgBlckwomenwhofcehigherrkggiveECubtypeCurntdignoticmethodECvivecotlytypicllyutilizeddvncedtgedeehighlightgcriclneederlydetectechniqueThprojectimenhnceerlyECdetectiundertcomplexterplygeneticocilenvirmentlfcrctrigECrkfocuddgdprieECoutcomemgdiffentrcilethnicgroupInpropoederchweimdetermeburdenrgermlepthogenicvriocedendometrilcncerrkrcillyethnicllydiverecectrolcohtutilizgAllUSbiobnkdtetThpprochprovidenewightgeneticfcrfluencgECepecillyunderpentedpopultiWectedvncedrkmodeltegrtewiderryrkfcrcludggeneticpdpoilifetylefcrcomphenivepdictivemodelcombggeneticdtn-geneticfcr(egBMIditehryPCOS)vlidtedcrodiffentrcilethnicubgroupfergperlizedrkementolECTheuccefulcomplethprojectyieldcompheniveundertggeneticn-geneticfcrctrigECrkprticulrlyrcilethnicgrouphveenhricllyundertudiedThedevelopmenttegrtedrkmodelfcilteerlydetectiECledgtimelyterventipotentillytterurvivlrteThprojecthpotentilvolutiizeECcengpventitrtegiemkgmmoeffectivecceiblecrodiverepopultiddgignificntpublichelthccernProjectSummryAirpollutiknownenvirmentlrkfcrlungcncerdetiledmechnmdrivgirpolluti-ducedcrcogenekeymoleculreventvolvedmedundexplodUndertgunderlygmoleculrmechnmpthwyvldevelopmenttrgetedpventiverpeutictrtegielungcncerducedirpollutiOurpvioumetbolomictudyfdghveuggetedimptntrolemocidpeptide(buildgblockprote)modifygocitweenirpollutiexpoulungcncerrkCompheniveproteomicnlyprovidecriclighthowebiomoleculeperturdirpolluti-ducedlungcncerAlthoughhigh-throughputgleomicpprochehvehownignificntpotentilvelgbiologiclpeirpollutiexpoulungcncerdevelopmentytenoverlooktercnectimgomiclyerMulti-omictegrticnfermoholticviewunderlygmechnmMooveromic-bedrkpdictimodelhveemergedpromgolidentifydividulthighrklungcncerirdevelopmentpplictitilllckgDurgF99pheIfocuvetigtgkeymoleculrigntupthwyunderlygirpollutixicylungcrcogeneInAim11IdetermepotentilmediroleproteculpthwyirpollutiexpoulungcncerUgndvncedproteomicnlyMeet-In-The-Middlehigh-dimenilmedipprocheIcomphenivelyevluteproteprileundertirvolvementmedgetiologyirpolluti-ducedlungcncerInAim12Icductnovtivemulti-omictegrticroproteomicgenomicmetbolomicidentifyhighlycltedmoleculrnetwklkgirpollutixicyelevtedlungcncerrkUgpoteriegrtipriegrtiIexpectidentifyctentmoleculrnetwkctgnovelcloelyltedomicignlcludgglenucleotidepolymphmprotemetboleunveilirpollutirolelungcncerdevelopmentAlthoughlow-doecomputedmogrphytrdcenglungcncerprimrilycommendedhevymercurntmokerNotblypproximtely45%lungcncerceoccurlightmokernever-mokerfllgoutidecommendtiguideleTrnigmyK00phetwld-clcncererchtuteIfocudevelopgomic-bedrkpdictimodelenhncelungcncerrktrtifictimokgttuInAim21Idevelopgenomicproteomicmetbolomicrkcoever-never-mokereprtelyevluteocidividulcomdrkcolungcncerrkInAim22Ievlutepdictivepermncedividulcomdomic-bedrkcolungcncerrkmokgttuABSTRACT-Thefocuthpropollethlmettticprottecncer(PC)TheimthtudydevelopnnovtivemimllyviveliquidbiopyycnuedidentifymoleculrubtypelethlprottecncerPCptientbiologicllyggivedeePhenotypgLrgeOncoomeUltimteEvlutiPtientSttu(PLUS)identifybiomrkerht/lgpettmentprogivelyetumphenotypedurgPCevolutiunderttmentpuWepropoefocuextrcellulrveicle(EV)knownlrgecoome(LO)identifiedplmptientggivecncerUggoldtrdmethodweobtedpupopultiLOpermedextenivempectrometryNGSexperimentidentifiedetproteRNAmrkerhveenvlidtedmultipleexperimentvrofewpilotptientcohtexpledplimryultInthpplictiweemploynovtivetechnologietrnlteoureftdefeLO-bedigntuCLIAlbrydetermecliclutilyourliquidbiopypprochPCptientlethldeebothctrtitnthmeenivepceWelevergenexpnivecohtclicllynnottedPCpecimen(N=600)bopectivelypropectivelycollected2dependenteInAim1wepermnlyticlvlidtiLOoltechnologiecliclueInAim2wedevelopnLO-centedmultinlyteydetectlethlPCpdictARSIpeInAim3weeenivypecificyPLUSmetttichme-enivePCptientpdictlethloutcomeWectuefocuPCcueignificncePCopencliclquetichllengeltiveum-typeliquidbiopydevelopmenurexteniveexperiencefieldPCmoleculrlcpeYetgpptunyourLO-bedyexpedtumtypefutuOurtudytechnologicllynovtivelikelyultidentifictinewmrkerultimtelypplictimicrluidicdeviceCLIAlbTheM-PItembrgexpertenlyEV(DiVizioSttDemichel)loctDNA(Demichel)CTC(Stt)propoethoglpprochedetermewhichmethodmgd-bedmicrluidiccptuwhichnchmrkedgtdenygrdienthtpermncecomplexclicllbProjectSummryColoctlcncer(CRC)ptienthighbody-mdex(BMI)hvepoefficcychempyctgnurgentneeddeigntrgetedrpythgroupcncerptientDurgoyexcevcerldipoetue(AT)depoedroundmjgnbdomentriggerytemicmetbolicdygultictenenvirmentcducivecncerdevelopmentprticulrlycoloctlcncer(CRC)OeATectemoextrcellulrveicle(EV)compdn-oeATwhichcntkenupdtnttueEVlipid-membrnedveiclecrrycrgopntcellimptntter-gncommunictiUndproteomicnlyveledtheEV(OB-EV)n-oe(N-OB)EVdtctlydiffenttermircrgenrichmentglycolyticenzymetrioephophteomere1(TPI1)OB-EVCequentlyOB-EVttmentCRCcellultedhigherTPI1levelcompdN-OBEVttmentFunctillyOB-EVcedblglycolyhumnmoueCRCcellenhncedbilyCRCcellm3DtumoidpheroidCRCcellcnrrntlyceglycolyuppttumgrowthggivehowevernotknownwherepro-tumigeniceffectcngetenhnceddurgoyInF99pthgrntIdetermeifcrgoAT-derivedEVutilizedCRCcellchngeirmetbolmpromotepro-tumigenicphenotypewherenhnceddurgoyIuenovelmouemodeltetltumigenelckgEVectidipocytechllengedoyelucidteroleOB-EVcrgoCRCdevelopmentThegolthproject1)cfirmwherOB-EVtrnferTPI1CRCcellgultiglycoly2)determecogenicroleOB-EVTPI1CRCdevelopmentvivoTheultthtudyhelpdvncefieldEVbiologycncerdurgoyidentifypotentiltrgetcncerrpeuticoeCRCptientInK00pthgrntIexpelucidtgimpctAT-derivedEVimmunepopultiCRCTMEOeCRCTMEknownimmunouppivecedfiltrtiM2-likemcrophgeHoweverlcktudieenumertgunderlygmoleculrplyermedgobervedphenotypeTheeIpropoedetermewherOB-EVprogrmmcrophgeoeTMEnimmunouppiveM2-likephenotypepromotetumprogiIeekK00lbcompheniveexpertetumimmunologyocedignlgpthwyprovidemetrgIquicompletemyprojectchrcterizeimpcyCRCTMEPROJECTSUMMARY/ABSTRACTTherolegermlegeneticvrivirlfectidevelopmentprogihentudiedextenivelydulttumuimmunedeeLettentihenpidterctiefcrbirthdefectpedricmlignncieprticulrlycutemyeloidleukemi(AML)whichyoungetptientdrivenlmotexcluivelytructurlvrint(SV)polyunderodetiologyThepvlencegenefurncriptocedleukemlivebirth10x100xgterthncidencechildhoodleukemiwhichuggetrkfcrmutterctSVOnepoiblecidteterctipencegermlemuttiplimrynlyhhownptienthrbgSVenrichedgermlemuttigenepibleDNAdouble-tdbkpirAncidtetimgvirlfectigeneticlly-pdpoeddividulClicltrilgenerpyvirlvecrfiledprtduevirltegrtictivtgcogeneuchMECOMRecentwkhhowndictmechnmderivtivechromoomemtmotcommbkpotleukemihumnherpeviruecludgCMVeglegtetrkfcrchromoomlbirthdefectAddillygermleomticcopynumrhtequencevrinthveendocumentedffectge26trnmtipecific(ETS)fcrwhichprticiptehigh-rkgenefuieenbotholidliquidtumTheefcrirbdgedetermedevelopmentlftecrotueyetirmotifhttempet--glemotvribleclfetuhumngenomeSmllchngedogecteddruptibdgemotifvrirmpequencemyufficientpdpoedividuldeeTheprimryobtcletudygemechnmhlgenmllmpleizedcovergecohtembledrchildhooddeeThevtquntywhole-genomewhole-trncripmelg-dequencgdtprovidedGbriellMillerKidFirt!(GMKF)CtiumTherpeuticllyApplicbleReerchGenerteEffectiveTtment(TARGET)X01LgRedPilotProjecmic-coldpedricleukemiptientnegtethobtcleIpobothcomputtilfrtructumpleizequidddthurgentneednowplcellowgudetermeifpdpoirkcnmigtedcengprophylxTheoverllgolmyF99trgphechrcterizegermlevrintpermfunctilvlidtivrintzebrfhmodelhigh-rkpedricAMLDurgmyK00pheIpropoechrcterizegermlegulryplicgtructurlvrintvirlgenomictegrtictlytrkleukemiThetrgdtultgthfellowhipwrdetblhfoundticientificpilkillmycerndependentercherPROJECTSUMMARYReerchAttimecncerdigno40%-60%ptientoverweighroeDepethderthlertuimpctweightttucncer-ducedcchexi-untentillolenmwhichdictlyctriefunctildependencypottmenutcomedecedurvivlAnoyprdoxhenpotultedhoweverepidemiologymequivoclnef/detrimentoycchexittuWhileoycchexideeppoeendweightpectrumepthologiehomeunderlygperturbti(egmichdrildyfunctimicrobildybio)myexcerbtefunctildecmentwhenembidieco-occurEvidenceupptrolemichdrildyfunctiprogicchexiIndeedwehvehownimpidmichdrilfunctidygultedmichdrilqulyctrol(biogenedynmicmiphgy)ocedcchexiFurrevidencelkpecificmetbolemicroirmetbolicpthwycchexittuIncidentllyoyloocedmichdrildyfunctiltertigutbcterilpopultiHoweverimpcycchexiocedperturbti(michdrildyfunctigutdybio)hnotenetblhedTheegolmyF99/K001)undertmicrobilmetbolicperturbtiocedcncercchexioette(F99)2)ugmulti-omicexmeltihiptweenmicromichdricncercchexiidentifytrtegieterventiMycentrlhypocncer-ducedcchexiexcerbtednoettegutmicrobil-muclemichdrercticentrlcodthwenedphenotypeItetthhypotwopecificimfollow1)Exmeimpcymicrobilltertimetbolicperturbtikeletlmucledyfuncticncer-ducedcchexioette2)Etblhmicrobiome-michdrercticncercchexictexyidentifytrtegieterventiTheetudieuncoverimpcycncercchexiidentifymicrobiome-michdrilterctiprovokgnovelopptunieterventiCerGolMylg-termerchgolcomendependenterchertp-tiererchtutifocuedpventi/ttmentcncercncerrpyltedf-trgeteffectcludgcchexiCerDevelopmentPlnThepropoedcerdevelopmentplndeignedenhncemyknowledgetechniclexpertepilkillSpecificllyIceivetrg1)oyphenotypgccheximodelg2)michdrilhvi3)microbiomemicrobilmetbole4)pildevelopmentThepropoedF99/K00wrdnimptntteplizgmycergolThpropoederchtrgthF99/K00providemecumenlunchuccefuldependentcerfieldcncercchexiSUMMARYPieergerchcncerbiologyoverptfourdecdehuncovedpericogenetumuppemttumigenecrodiverecncertypeSuchgeneticltertictutenimptntpecttr-tumheterogeneywhichocedpoprognotncerpyThecentpplictigle-cellRNA-equencgtumbiologyhhedfurrlighncompoidynmictr-tumheterogeneyTheYni&WglbmnyhveprovidedevidenceuchheterogeneynotexcluivelyexpledgeneticcuerrlothroughprocecellulrplticyEmerggevidencelopotcrucilrolecellulrplticyprocedrugtnceInn-mllcelllungcncer(NSCLC)tumttedKRASG12Chibirhveenhowndptundergogndeno--qumoutrni(AST)WhilethleevidenceupptmjrolecellulrplticytumdptttmentwelcknundertgdetermntdynmictrtegiepventgcellttetrniInthpropolweeekdetermemoleculrprogrmmtchromtlcpeugcuttg-edgemulti-omicpprochecoupledcliclly-levntNSCLCmumodelirderivtivegnoidInAim1wepropoeytemtictudydeno--qumouplticyeekgidentifydeletechromt-mededmechnmOurpprocheekidentifytetmentrictgbilycncercellundergoASTWefirtdetermedynmicchromtlcpechngedurgASTmu-derivedLUADgnoidThenwempfunctilvulnerbilielgASTugPerturb-SeqpprochfllywetetpotencytrictgASTmllmoleculehibirgtchromtmodifierInAim2wepropoepdictdynmiccellulrdpttictext-pecifictrgetedrpieuedttNSCLCWefurreekpplyepdictiprimrytummpleclteclicloutcomegolpdictgdptiveproceOverllimpctthwkprovideightcellulrplticylungcncercliclly-levntettgidentifictitrtegieynergticttmentcombtihibcell-ttetrnielimteemergenceggiveubpopultiAbtrctMelnommoterioutypekcncerAlthoughimmunecheckpotblockde(ICB)rpyhnefedmnymelnomptientmotptientdotpdcurntICBVccecnpromoteICBrpeuticefficcygenertgmplifygtum-ctiveTcellCventilvcceocedlimtiuchlowtbilybiovilbilypextgnti-virl-vecrimmunywekntigenicyccernovergenomictegrtivirulentverimRNAvcceholdgtpotentilcncerimmunpyYetcurntlermRNAvccetilloced1)limedbiotbilydepetructurlnucleoidemodifictiultglimedhelf-lifemodertentigentrnltiefficiency2)complictedtime-cumgerr-preenzymticmRNAproducti3)limedlodgcpcynnocrrier4)htimmunememyToddelimtiwepropoedevelopgnovelhighlytblemodificti-femultivlentmllcirculrmRNA(circRNA)elicpotentdurblentumimmunyICBcombtiimmunpymelnomSmllcircRNAcompdmimlRNAelementtrnltepeptidentigenWehowed1)mllcircRNAhhighlodgcpcynnocrrierefficientlyccumultelymphnodentigen-pentgcell2)termu-femllcircRNAeirfelodednnoprticlehighlytbleltivecurnttte---rtmodifiedmRNAvcce3)circRNAvcceelf-djuvntedduetricctivtrcellulrptterncognicepr4)circRNAprolgntigentrnlticcompniednteimmunotimultiwhichpromoteTcellpe5)circRNAmyproducecctemericlgpeptidentigenltivemimlntigenundergoproteolyticprocegoptimlntumTcellpe6)low-doemllcircRNAvcceoutpermeverlcurnttte---rtmodifiedmRNAvccegenertepotentdurbleTcellimmunyFurrmultivlentcircRNAvcceelicedignificntlypotentedICBrpeuticefficcymelnommiceTheobjectivethprojectdeveloptetmultivlentmelnomcircRNAelicmultivlentntimelnomTcellpeducemelnomtumimmunouppielucidteirmoleculrcellulrmechnmelicntedptiventumimmunyeirmelnomrpeuticefficciexicymiceOurhighlycollbtivetemhcomplementryexpertecircRNAvccemelnomvccologycliclmelnomimmunpyccomplhgourcientificgolIfuccefulignificntdeliverblethtudyetblhcientificfrmewkugthnovelmRNAvccemelnomcombtiimmunpyProjectSummry/AbtrctChriclymphocyticleukemi(CLL)motcommmdultleukemiccount20%leukemi-lteddethnnullyInCLLhyperctivtiB-cellcepr(BCR)peledover-ctivtimnydowntmeffecrdriveprolifertiurvivlcludgBrunTyroeKe(BTK)LYNKeSignlTrnducerActivrTrncripti3(STAT3)ThlgterctimicroenvirmentledmetbolicprogrmmgcedmetbolicplticyllowgCLLcellthriveundervrioucdiOurlbhpvioulyhowndeliverycermidevicermidennolipoome(CNL)trgetthmetbolicplticydruptSTAT3ignlgpthwyledgdecedtrncriptilctivyimpidglycolycelldethmultipleCLLmodelcludgptientmpleHoweverrtiglycoly/STAT3trncriptilctivylyprtillyprotectCNL-ducedcelldethuggetgthrmechnmtplyHeugndvncedmichdrilmetbolomicwkflowIhowCNLdruptoxidtivephophylti(OXPHOS)electivelyhibgComplexIIIelectrtrnptchThdruptiOXPHOStimedependentclteCNLducedupgultiglycophgolipidbothwholecellmichdrilextrctuggetgnunexpectedlkImptntlywhileglycophgolipidtypicllyeenprotectivehuntwymopopticcermideIhvehownhibiglucoylcermide(gtewylipidglycophgolipidpthwy)mtiprotectCNLmededmichdrildyfuncticelldethCLLfurrupptgthcnectiLtlyglucoylcermideblockdelodimhebilyCNLlterLYNBTKphophyltiGiveneeffectIhypoizeiliccidctgglycophgolipiddowntmglucoylcermidectivteSIGLECS(iliccidbdgproteknownnegtivelygulteBCRignlg)ledgmichdrildyfuncticelldethInightthprovidenovelrpeuticfrmewkCLLptientdeepenourundertglipid/protebiologyThefirtimthpropol(F99Phe)identifiekeyglycophgolipidmetboledrivgeeffectdetermemechnmwhichylterBCRignlgeffecrmichdrilfunctievluteirrpeuticpotentilvivoTheknowledgekilllernedetudienuedtudyrolelipidmetbolmmetbolicplticygliomtemcellmechnmgoverngmichdriltrnfertweenecelltrocytectextglioblm(K99Phe)PROJECTSUMMARYCncerdriventerctitweendiverecelltypeirtuemicroenvirmentEmergggle-cellptiltrncripmicytemmppgcncertueprocecpturgdiverycelltypetteexpogimptnceptilcellterctidetermgrpeuticpedividulptientMulti-omictwdevelopedITCRcludgCoGAPSprojectRSpceMrkerDomodevelopedourgroupcnnlyzegle-cellptilmulti-omicdtfercelltypephenotypetummicroenvirmentidentifywhichcellterctdcoverhowcell-cellterctidrivemoleculrchngeHoweverenlyeyieldtticnphotcnnotcptudynmiccncerecoytemMmticlmodelgcnfillgptweenenphotllowgtemrmhypoehowwhycellterctencodeirhypoeimultirulepermvirtulexperimentHoweverimultiruleirprmeterdifficultmtchgenomicdtThpropolbridgegptweenbiomticmmticlbiologymerggourbiomtict-wgle-cellptilmulti-omicdtPhyiCellngent-bedmodelgfrmewkdevelopedourgroupimultemovementterctimnydividulcellgentvirtultueenvir-mentThegluetweenepckgenovelcellhvigrmmrencodecellrulelernedhigh-throughputdttuiveterptblehypottementcnumticllytrnmedimulticodeInthpropolwefecellhvigrmmrwhilenlyzgpvioulypublhedcncerdtctedigltempltekeycelltypecncerecoytemfePhyiCellimpttempltectePhyiCellCloudfezero-tllcloudourcebuildexecutevulizecn-cermodeloutwrgcomputercodeWefeCoGAPSSpceMrkerprojectRDomolerncellhviruleptiltrncripmicdtmtmgrmmrextendPhyiCelldcelltypepoiruledtrdgle-cellptilmulti-omiccleWedevelopophtictedpipelePhyiCellmodelcnquntifymodeluncerttyumticllyfmodeltrn-cripmicdtvlidtemodellwldtumdtetWeextendPhyiCellCloudfull-fledgedciencegtewycludeecuerchbleuerrgedttructucode(API)cnectPhyiCellCloudPythRBiocducrpipeleITCRcot-fehigh-permncecomputgbckendemlelyrunlrge-clemodelexpltiuncerttyquntifictipipeleEductilexpertecommunyfeedbckcludgndvybdnnultrgwkhopdilyclroomuedriveubilyfementAlgerthpprochbridgebiomticm-mticlmodelgprovidecomphenivepltmptient-pecificmechntictummodelgenblefutucomputtilly-drienexperimentldeignvirtulclicltrildigltwerchPROJECTSUMMARY/ABSTRACTWhileimmunpiehvevolutiizedcncerttmentubetptientprticulrlythoequmoucellcrcom(SCC)foundklcvylrynxeophgulungcervixexhibvrygpeimmunecheckpotblockde(ICB)ultg60%lperteTheedprieptienutcometrglyuggetextencegeneticvriunderlieirdtctpeICBAlthoughpecificcogenicmuttipibledrivglpeSCCptientmunclerimpertivegrpmechnmcncerimmuneevidividulpecificgeneticprileenhncepciimmunpyRecenterchhidentifiedpopultum-gcell(TIC)klcvySCCtnti-tumimmunydrivelpeTheerTICtenoverlookedtumimmunologytudiedepeircriclrolepromotgcncercurnceWehveidentifiedctivtgmuttiPIK3CAgenefound20%cutneouhedneckSCCcnenhncetemnetricimmunetnceSCCultgrpidlpefterICBThepropoederchcttwomimTheF99pheimdetermehowPIK3CAmuttiexpimmune-tntTICSCCtumIvetigtewherPIK3CActivtgmuttiduceTICelf-newldediffentifollowgICBttmentIexplolePIK3CAmutnthveSox2protecricltrncriptifcrmtgtemnetbilyTICThimprovideightbilydruptPIK3CAmutnt-ducedSox2tbilyduceSCClpefterimmunpyTheK00phebrodergolidentifyghowgeneticltertienhncetricimmunetnceTICInfirtprtK00pheIdeigngenome-wideCRISPRcenidentifycidtegenepibleendowgPIK3CAmutntTICtnceTcell-mededferropIexplohowPIK3CAmuttiprogrmmetbolmTICenhnceirtrictnceTcell-ducedferropInexpcopeidentifygeneticdetermntydPIK3CAmuttidriveimmuneeviTICByCRISPRgeneedgItroducecogenectivtumuppctivtichromoomlrrngementgenefuicopynumrvrikercyteevluteirpotentilpromoteimmuneevivivoThwkdcoverpotentildrugtrgetbiomrkerpdictgptientpeimmunpyMyultimtegolcomendependentvetigrtledgerchtuticductterdciplryNIH-fundederchctrigfieldcncerbiologytemcellbiologyimmunologychrcterizgnovelmechnmcncertemcell-pecificimmunetncePROJECTSUMMARYPychologicldtnimptntcompentcncerccndverelyffectttmentcomplincequlylifeurvivlDtboutpychologicldtBlckbtcncerurvivpreThnimptntgpgivenrcildpriebtcncerBlckwomendvereimpctpychologicldtbtcnceroutcomeThepurpoepropoederchAnIn-depthExmtiPychologiclDtBlckBtCncerSurvivgdetiledundertguniquerolemultilevelfcrpychologicldtexperienceBlckbtcncerurvivhowBlckwomencopebtcncerltedpychologicldtTheentilidentifypotentillymodifiblefcrdtmngementterventiBlckbtcncerurvivAhighlyqulifiedmulti-dciplrytemhenembledupptmyerchtrggolThepdocrl(F99)erchprojectmixedmethodtudyguidedmodelcncerltedwrietudyim1)leverggnextglgudlcohttudycomplgudllevelpychologicldtociociodemogrphiccliclfcrpychologicldtrceBlckWhebtcncerurviv1b)leverggnextglgudlcohttudyevlutectriihelthclted(ptientprovidercommunicti)pychoocilfcr(mediclmtrut)pychologicldtmgBlckWhebtcncerurviv1c)Determeifhelthcltedpychoocilfcridentifiedim1bmede/moderteocitweenrcepychologicldt1d)ugprimryqultivefocugroupdtdecrihelthcpychoocilfcrctriedtmgBlckWheurvivThepotdocrl(K00)erchprojectgolundertBlckbtcncerurvivtrtegiecopepychologicldtUtilizgStruCbgroundedymethodologycommunyenggedpprochtudyim2)decriBlckbtcncerurvivtrtegiecopgpychologicldtug-deperviewThepropoederchlignNCIkeyerchcncerurvivhipwhichmguepriizeddgpychologiclccerncncerurvivPROJECTSUMMARYRecentdvncementnext-genertiequencgtechnologiehveultedgenertivtquntiepubliclycceibledtpecificcncerThwelthmtihignificntlyenhncedourcomphenideemechnmItnowevidentltertiepigeneticgeneticfcrcndruptterctitweengulryelementirtrgetgeneledgbnmlgenegultiNumeroutudiecducteddtctcncertypehveyieldedpromgoutcomeunveilgpvioulyunknowncncerubtypechrcterizeddtctiveenhncerlcpeMooveretudiehveidentifiedclicllylevntgulryelementhveimplictiprognottmentNeverlemjycncernlyetendccentrtepecificcncerubtypefilcplizeentibdthvilbledtencompgboumigenicnmltuecelltypeAmemrENCODEprojectwehvectedRegtrycidtec-RegulryElementnextenivecompiltinerlyemillipotentilenhncerpromoterulrhumngenomeTheeelementhveenchrcterizedcroover800humncelltypefergvlubleightn-codggiHoweverimptntnoteRegtrylckclicldtllexperimentlfdgweobtedhelthydividulwhichlimpplicbilycncererchToddthlimtiwepropoedevelopmentgulry-elementtrget-genetlwhichenbleercherexplocnectitweengulryelementgeneocedcncer(Aim1)Drwgupourexpertegulrygenomicthe-dimenilchromtrchectuwepermextenivenlyidentifygermlevrintomticmuttigeneticrrtiffectcCREpdictireffectmoleculrphenotype(Aim2)Fllyenhncecceibilyeolweetblhnewcloud-bedcomputtilnotebook-bedenvirmentequippedmodulrcumizblecompenttegrtivedtvuliztiThenvirmentflexibleuer-friendlyllowgerchereilycceutilizecncer-pecificgenomicdt(Aim3)FllywecollbteITCRmemrpermcommunyoutch(Aim4)Togereolimplifyimprovecceibilycncer-pecificgenomicdtABSTRACTCerviclcncerhighlypventbleerlydetecttmentduelckcceibleerlycengopticidencemtlytillveryhighlow-ourceettg(LRS)High-rkhumnppillomviru(hrHPV)piblemotcerviclcncerceWHOcommendtetghrHPVpemptivelyttgllptientwhopoiveprimrypventitrtegyLRSNerlyllvilbletetlookhrHPVDNAwhichcnulverttmentcuecnnotdiffentefecticlernturllyDetectblehrHPVmRNAhowevertrglyocedhighergrdecerviclpcncermkgmopecificbiomrkercerviclcncerrkThpropolimddneedmopecificerlycerviclcncerdetectechnologydevelopgnovelvrovivomethoddetectghrHPVmRNAInF99phethpropolIdeveloppilotmple--nwermRNAtetHPV16HPV18IfirtdevelopmimllytrumentedmethodpprgmRNAdetectibothproviderelf-collectedcerviclmpleInmplifythmRNAugnmlyproducel-timefluocentignlwhichIduglow-cotfluimeterItegrtedividulycompentwkflowmimluertepmkgtetdeploybleLRSIwkmypDrReccRichrd-Ktumnetblhedexpertfieldpot--ccncerdetectechnologiedevelopetInwkmyco-pDrKthleenSchmelerVPGloblOncologytUTMDAnderCncerCenterexteniveexperiencetrnltgcncerdetectechnologieLRSpilotetcliclmplebothHounBrzilThtrgplnhelpmegexperiencetechnologydevelopmentcientificcommunicticliclcollbtibothlocllyglobllyenhncedloctimytrgtRiceUniveryTexMediclCenterwheIhveccewld-clequipmentourcecliclcollbrInK00phethpropolIdeveloptechniquedetectghrHPVmRNAvivoThperml-timeerlycerviclcncerdetectimirgwhichcnhelpedeeprogimttmentfterthnpetedvromplgtetgInpropoedprojectIuecombtiequence-pecificfluocentmRNAllgptmer-mededlldeliveryhigh-olutifluocenceimggdetecthrHPVmRNAenivelypecificllyvivoIeekmenrexperiencebiomrkerlldeigndeliverytntutirobutimggourcecliclcollbtiThepropoedwkppmencdemiccercncerercherdedictedimprovggloblcceerlycncerdetectiInddechniclexperienceIdevelopmycientificcommunictikillbuildnetwkcollbrmenrnextgenerticncerercherlygfoundticerdevelopgdeploygnovelcncerpventechnologiecliclimpctroundwldPROJECTSUMMARY/ABSTRACTOverpt40yertrdrpycutemyeloidleukemi(AML)highlyftlbloodcncermcombtichemodruguchcytrnnthrcycleDrugtnceAMLevi-tblyoccurovertimeWhileevidentdrugtnceAMLburdentenoceddowng-ultum-upptrncriptifcrmnifetticogenictrncriptifcrfuirpeuticpprochedictlyfocuedepivotlbiomoleculemtechniclchllengeOurlg-termgolidentifymoleculrgulrprtnercncer-ocedtrncriptifcrunderthowycro-gultecncerutilizgthundertgpventtiver-peuticpurpoeTheoverllobjectivethpropolundertrolemechnmunderlygncodgRNAdegultiprimrylpedAMLWecentlydcovedchrcterizedPU1enhncerRNAcpbleducgmyeloidcelldiffentiwhilehibgcellgrowthWelod-covedncodgRNAhidRUNX1-ETOtrncriptifcrfuiderivedemotfquentchromoomltrnloctiocedAMLWefurrveledhidlpedAMLptientTheewepropoePU1gulryRNActRNAmodulrRUNX1-ETO/PU1ximptntRNAgulrbothprimrylpedAMLTowrdendmylbhgenertedchemo-tntAMLcellmodelweplnpuruefollowgpecificim1)DetermeroleRNAprimrylpedAML2)Defemechnmunderlygdeg-ultiAMLTheeimchievedugvrietypprochecludgRNAterctigenegultivichromttructuuetrncripmicgenomicdtAMLptientdrug-tntAMLcellleAMLmouemodelCompletieimprovidenimptntightfunctienhncerRNAprimrylpedAMLprovidecientificbmodultgctivietum-upptrncriptifcrwellcogenicfuiproteThepromegulryRNAcouldutilizedAMLttmentUltimtelythcouldexpectedultdevelop-mentnovelRNA-beddrugcircumventcurntchllengetrgetgtrncriptifcrircogenicderivtivecncerrpyPROJECTSUMMARYDiffuemidlegliomH3K27Mlterti(DMG-H3K27M)ledgcuepedricbrtum-oceddethAllDMG-H3K27McometntrditrdcmotchildnuccumbirdeetwoyerdignoNewttmenptiurgentlyneededThepplicntlg-termgolcomengeergcncercellbiologylederchgroupdvnceextrcellulrveicle(EV)-beddrugdeliverycentrlnervouytemdeelikeDMG-H3K27MEVpotentignlgvehicletummicroenvirmentundertudiedDMG-H3K27MTheoverllobjectivedefehowDMG-H3K27MderivedEVctrierditnceheterogenoutumdevelopEVdeliveryvehiclebr-penetrntrdioenizerwhileequippgpplicntkillcometrgdependentcncerercherPlimrydthowomeubcleDMG-H3K27MhentlyrditntcnleeEVdilytkenuprdioenivecellcepr-mededmnnerTheeEVprotectcipienttumcellrdi-ducedcelldethTheecentrlhypocrgoDMG-H3K27MextrcellulrveicleprticulrlymicroRNAdriverditnceetumtrgetgefcrcnenizeDMG-H3K27McellrdipyAddillyelectiveuptkeEVDMG-H3K27McelluggetEVcnexploeddrugdeliveryolThertiletherchprovidenovelightmechnmrdiotnceDMG-H3K27MmyultnewpprochetrgetthcncerThehypotetedpurugtwopecificim1)DetermemechnmEV-mededrdiotnceDMG-H3K27M2)EngeextrcellulrveicleelectivelytrgetbrtumcelldeliverrdioenizerThefirtimcrriedoutprtderttierchueptient-derivedDMG-H3K27McellproteomicpprochechemiclhibirdefemechnmEVuptkemiRNAmimicntgomirlouedovexpilencemiRNAfoundEVcrgoleedrdiotntcellidentifymiRNAcferenhncedrdiotnceDMG-H3K27MTrgetvlidtedugzebrfhxenogrftmodelTheecdimencomppot-docrlerchfocuuggle-cellmicrluidicmethodengeern-tumextrcellulrveiclepecificywrdbrtumcellegircpbilycroblood-brbrrierdeliverrdioenizerTheerchpropoedthpplictiignificntcueprovidenewightroletumheterogeneydrivgrpytnceThprojectloidentifynewmechnmDMG-H3K27MrdiotncedevelopnnovtivetrtegydrugdeliveryoptimizerpeuticefficcyrdioenizerbrpotentillyimprovgttmenutcomechildnDMG-H3K27MProjectSummryLg-dequencgrpidlytrnmgourknowledgehumngenomewellpprochuncoverghumngeneticvriltertiInctrtrpidpcelghmicnovtilg-dequencghumngenomebothmticdevelopmentgenertilg-dcncergenomedthveeenlgggWhccurcycotlg-dequencgbothpprochghtdwenticiptelg-dcncergenomeequencgocomenewfrtiercncergenomicprimryengecncergenomicdcoverieTheoverrchggolthpplictictlyzelg-dcncergenomeequencgeftthroughdevelopmentmticmethoddcoverychrcteriztiomticgeneticlterticncergenomeWepropoetheleerchctiviechievethgolFirtweimproveextgmethodlg-dnlycludgbothlg-dlignmentemblydevelopdowntmbiomticolomticvrintdcoverylignedlgd(Aim1)denovolg-dembly(Aim2)Secdprllelmticdevelopmentwegenerteourcelg-dcncergenomedtuednchmrkgevlutilg-dmticmethod(Aim3)Wepecificllycomppermncevrintdetectilignment-bedembly-bedpprochegenertetprcticelg-dcncergenomepplictiFllyweimbuildexpnctivecommunyercherwhoterctgenertenlyzedevelopmticmethodlg-dcncergenomedt(Aim4)Thecommunybuildgeftillyfocuprovidgturiluerexmplebednewlydevelopedmticmethodnewlygenertedlg-ddteventullyimetblhctlogfencecncergenomeemblieuecncererchcommunyPROJECTSUMMARY/ABSTRACTImmunecheckpotblockde(ICB)imedtvigtgimmunecelluchT-cellhexhidcliclucceubetptientyetfilpplicblemnytumubtypeTheeunpiveubtypeupgultegeneigntuocedmocid(AA)metbolmdeprivtiHoweverhowAAdeprivtictriepoICBpemunclerUpchricntigentimultiT-cellcomeexhutednlterntivediffentitteentillocyxiceffecrfunctiprolifertivecpcyT-cellexhutivolveextenivetrncripmicepigeneticmodelghoweverlocykeproductioccurdepedequteexprncriptencodgcykeuggetgpot-trncriptilmechnmtrictgeffecrfunctumThelg-termgolelucidtemechnmunderlygT-celldyfunctummicroenvirmentlevergeeightenhnceICBefficcyThepdocrlerch(Aim1)imvetigtehowloclAAvilbilylimeffecrfunctum-filtrtgT-cellPlimrydthowedtrtumlT-cellcnnotenggeefficienttrnltiyexperienceglutmedeprivtummicroenvirmentElevtedtrnltildemdowntmchricT-cellceprignlgcnnotmetwhenextrcellulrAAlimgtrictgbothglobltrnltirtecyxiccykeproductiSpecificAim11eekdetermehowloclAAvilbilyimpctexhutedT-cellproteomeNcenttrncripmictrnlmicltertipriledevluteimpctAAlimtigene-pecifictrnltirtefollowedriboomlfootprtgyidentifycelltte-AA-dependenttllgvivoSpecificAim12vetigteimpctenhncgAAvilbilyICBAbrod-pectrumAAtrnpterovexpedT-cellexmewherenhncetumctrolpeICBovercomeimmunouppiveeffectcferdcncer-ocedfibrobltvitrictgtrtumlAAvilbilyMypotdocrlerch(Aim2)focurolen-codgRNAtrnltiluppidurgtermlT-cellexhutiIprilehowT-cellexhutiimpctexpin-codgRNAexmewhern-codgRNAubequentlymodultetrnlticykeproductiOverlletwoprojectunveildtctmechnmdrivgT-celldyfuncthroughtrnltiluppidurgerlytum-filtrtiltetermlexhutiTheerchtrgplnoutledthpropolcompletedjotmenrhipDrSnhVrdhnDrJyntChudhurMemilSlKettergCncerCenter(MSK)MSKp-notchcncererchenvirmentbundntourcecjunctiupptGertnerSlKettergGrduteSchoolgurnteeuccefulcompletipropoederchcerdevelopmentplnProjectSummryTheF99pthpropolvetigterolebrenrichedE3ubiquligeTRIM9melnomprogiTheK00pthpropolvetigteterfcetumneurhowerfcefluencecncerprogiTumcompoedmultiplecelltypeheterogenoucncercellCellulrheterogeneymyttrieddediffenticnceroucellwhechrcterticirdiffentedttelotnewecquidMelnomcncermelnocytecellderivedneurlcthenuggetedhveundergedediffentiIntetglybr-enrichedE3ubiquligeTRIM9highlyexpedggivemelnomptientmplemultiplemelnomcellleIntriguglyneurwhichloexpTRIM9loderivedneurlctTheGupnlbidentifiedTRIM9potentgulrexocyctdynmicdictedxnvigtidevelopgneurThelbfoundTRIM9negtivelygultectpolymereVASPvin-degrdtiveubiqutinegtivelygulteexocypventgSNAREcomplexmtiMyplimrydtuggetTRIM9modultefocldheimphologynumrcellizerommigrtidictedmigrtipeextrcellulrtiffneprolifertiproteeectimelnomInddiplimryTRIM9immunopciptimpectrometryexperimentidentifiedeverlpotentilprotetercrgultefocldheidynmiccellcycleprogrffickgmelnomThegolthpdocrltrgpropoldeferoleTRIM9focldheidynmicmigrtiexocyvrotumgrowthmettvivomelnomIuecombticellmoleculrbiologytechniquebiochemtrymicrocopymouemodelmelnomTheterctitweencnceroucellcelltummicroenvirmenthenuggetedfluencetumprogiInptientnervtedtumcltedmbidyInddineurlctivymllcelllungcncertumceprolifertimettmiceAlthoughproghenmdedeletgmechnmunderlycncer-nerveterctiultgcedtumigenepoprognomuchyetundertThepotdocrltrgpropolimidentifymechnmwhichciproclterctitweenneurcncercellcetumprogiToidentifymechnmIuecellulrmoleculrbiologytechniquebiochemtryMSygedF99phecombtineurociencetechniquewhichIgK00pheTogerpdocrlpotdocrlwkimnwerhowcellulrphenotypecncerprogiffectedeirggexpibr-enrichedE3ubiquligeterctitweenneurcnceroucelltummicroenvirmentProjectSummryThevtmjy(90%)cncerepililntulqumoucellcrcom(OSCC)ccountptiecefflictg744884peopleyerlywldwideLte-tgecncerdignoocedlowurvivlrtewhedividuldignoedtnerlytgehveignificntlytterchnceurvivlCurnttrdcengexmtitenfilidentifybnmlgihighrkmlignncythuneedimprovedceurvivlrteDrGrcieVrgmyphdevelopeddetectipprochcommultipleopticlimggmodlievulizelrge(widefieldWF)complementrymicrocopic(nleropticlmicrocopyNLOM)ll-feidentifictineopliThpprochhdemtrtedubtntilimge-bedltertihigh-rkleiugytempcliclnimlmodelAmnynovelopticlytemourerchhowroomoptimizthpromgtechniqueThehlgevlutgcomplexdtidentifygmotimptntfetuocederlycncerchngenddilchllengeprticulrlypplictihumnpecimenHeIpropoenpprochcomll-femultimodlopticlimggrtificiltelligence(AI)developdt-drivendignoticdetectierlyhigh-rkleipotentilmlignntultimtelyceurvivlrteInF99pheIoptimizeevluteWFytemtegrtgemlepectrlcpbilycptuwiderngepectrlfetuhumnOSCCmpleThoptimizticquiddilimge-bedmtippliedmchelerngmethodextrctmotimptntfetuocederlycncerchngewhilepotentillyimprovgytempermnceMyderttiwkdurgF99pheequipmetrgexpertetegrtibiomediclopticunderguidnceDrGrcieVrgtUniveryTexmediclBrnchtGlvenmchelerngupptmyco-pDrHeidiSprttdvncetrnltilerlycncerdetectiInpotdocrlK00pheIccentrtedevelopgmultimodlll-feopticlpprochedt-drivenerlycncerdignoticTherchvolvecomplexdeci-mkgcnextendydcpbilietrdilmchelerngThuItrnipot-docrlpheItrdvncedAImethoduchdeeplerngwellexplotegrtiptientcdenhnceerlycncerdignoticTheuccefulcomplethprojectdvnceemerggnviveerlycncermultimodlmicrocopytechnologiethroughcuttgedgedt-drivenpprocheultimtelyenhncgerlyepililcncerdetectidignoticNobtrctvilbleCompdn-HpnicWhe(NHW)AfricnAmericn(AA)20%molikelygetcoloctlcncer(CRC)40%molikelydieCRCThenegtiveimpcthelthequyCRCcidencemtlyundeniblethoughcomgclerncetry-pecifictumbiologyloplyignificntroleAgterundertgncetrypecificbiologyCRCetiologyquidifwefullyelucidtetruectriicncerdpryATG16L1criclLC3lipidtiuphgoomemtiATG16L1mhowncetrypecificexpiCRCtueAlnehomozygoytidue300ATG16L1(A300A)mopdomntNHWthehomozygoytmeidue(T300T)mopdomntAAInCRCA300AgenotypeocedducedmettcedoverllurvivlT300TgenotypeocedcedrkCRCUgogenicCRCcellwefoundchempieenhnceuphgyhowmpeuticefficcyT300TcellthnmoetblhedcyxicbedchempiewhichhvemocellkillgefficcyA300AmCollectivelyedtuggetthrmttuATG16L1promoteggiveCRCpentkeypivotlbiomrkertrtifyCRCttmentpeltiuphgicfunctiOurhypoATGL16LT300TmprognoticdicrpeAACRCptientpentpdictivettmentbiomrkerttmentdecihelpducedprteoutcomeSpecificAim1DetermewherATG16L1mdiffentillypromoteggiveCRCgrowthmettvivoUgogenicmlefemleATG16L1T300TATG16L1A300Amicewechemicllyducecol-ocedtumugzoxymethne(AOM)dextrnodiumulfte(DSS)10FollowgAOM/DSSexpouwedetermetumnumrizeloctiT300TA300AmiceMlefemleApcm/+miceATG16L1T300Tcro-bdATG16L1A300Amice11Weoltetumepililcelltromlfibroblttumrgtrngenicmiceovertimedefeltertiirmoleculrbiologyetblhnovelcellle1213ThimmbiologiclmechnmpromotgggivetumgrowthmettptientdiffentATG16L1mSpecificAim2DetermewherT300Tmpdicttumpeimproveoutcomecombti-ttmentgimentrgetuphgyp-cliclogenicmouetummodelThepemlefemlemucoloctltumugcelloltedAim1defedeirT300TA300AmicedrugcombtiutilizeuphgykillwheuphgyducedrugefficcyThdefeimptnceT300TA300AmexpipectboumepililcelluphgiccompetencytummicroenvirmentThimmwhyAACRCptienthvepopetrdcrpieultgweoutcomePROJECTSUMMARYAccdgttticprovidedAmericnCncerSociety2023bout19millinewcncercedignoedUnedSttemothn609KpeoplediethdeeSuchdtfirmlyhighlightimptncectuedeftfdneweffectivewydetectttcncerultimtegolducgnumrdignoeftlieEprncripmichltelyenlrgedightfieldcncerbiologyRNAmodifictioccurcodgn-codgRNA(ncRNA)cludgmicroRNA(miR)miRmllgle-tdncRNAwhichplycrucilrolenegtivegulrgeneexpypicllyviprtilbe-pirgcomplementryirtrgettrncriptPot-trncriptilmodifictiphenomenocedmiRuchimpceclevgemiRNAequenceAdenoe--InoeRNAEdgeventcnltermiRcniclequencefunctiRecentlymodifiedmiR(miRm)hveenpropoedpotentilnovtivebiomrkercncerdignourveillnceHoweverccurntprilgmodifiedmiRhyetvetigtedcncerproperlyAddillynoleourcefereycompheniveculttitudymiRmcncerSolutiegpwouldpoivelyimpctdcovergnovelpotentilcncerbiomrkeruncovergcncer-ltedmechnmocedbrodermiRNAomeRecentlyweccurntlypriledcniclmodified(eghiftedDNA/RNAeded)miR>13KdultpedriccncermpleTheCncerGenomeAtl(TCGA)TheTherpeuticllyApplicbleReerchGenerteEffectiveTtment(TARGET)poirie(38coht)(Dtefnoetl2022CncerReerch)Weccurtelyidentified>8KexpedmiRm(>5-foldcniclmiR)BymerggcniclmodifiedmiRwebootedqulyclutergultimprovgptientclicopthologictrtifictiAddillybrodermiRNAomeprilguncovedlrgernumrignificntprognoticigntuWeloimplementednd-hocmiRm-trgetpdictimethodvlidteduniquetrgetghiftedmiRmTheeourpropoltendoutle(1)functi(2)pot-trncriptilgultibrodermiRNAomecncer-ctextmnner-iliclyeexperimentlvlidtiMoovermkeextenivemountgenerteddtvilblecientificcommunywepropoe(3)buildgomiRGtefelycceiblelegtewyomiRGtepltmerveolI)elucidterolemiRmpotentilcncerbiomrkerII)deducefunctigultibrodermiRNAomecncerWeimctepltmomiRGtedptblenewnlymethodholdgpotentilleddcoverynovelrpeutictrgetttgthdedlydeenticiptedfutucliclpplictiAbtrctActivtgKRASmuttioccur20-40%n-mllcelllungcncer(NSCLC)About20%KRASmuttumhveco-occurrgmuttiKEAP1tntmotrpiedifficultttTheenewttmentneededCurntlywefoundeco-mutnttumexphighlevelhnedecetyleproteHDAC4imptntirurvivlKRAS/KEAP1co-mutntNSCLCcelleniveHDAC4/5hibirclledLMK235whileglemutntcellnotKnockdownHDAC4/5ttmentTSA(hibClI/IIHDACcludgHDAC45)himilreffectThuhighHDACexpipentnAchilleheelnderco-mutntcelleniveLMK235HDAC4/5hibiMechnticllywefoundLMK235ducexicyctivtgtumuppproteclledRBctivtgproteclledBIMtriggercelldethLtlywefoundLMK235cuetrikgynergticxicywhencomddrugAMG510(ib)KRASG12C/KEAP1co-mutntNSCLCAMG510pecificllyhibKRASG12CmutntFDApprovedInclicltudieKRASG12C/KEAP1mutntNSCLCtumpdedlewellAMG510thnKRASG12Ctumwild-typeKEAP1ThhighlightneedimprovettmentetumThefdgLMK235cueynergticxicyAMG510uggetthdrugcombticouldimprovepeeptientInAim1weetblhLMK235TSApecificllytrgetKRAS/KEAP1co-mutntnotglemutntNSCLCcellWedetermehowRBctivtedLMK235cfirmroleTheroleBIMBIMcetyltilodetermedctgmutntBIMeirblockhibcetyltetgireffectcellpeLMK235InAim2weexmecomdeffectAMG510LMK235FirtweetblhcombtiAMG510+LMK235pecificllytrgetKRASG12C/KEAP1co-mutntcellThdecomprgenivypnelNSCLCcelllevryKRASG12CKEAP1ttugenertgcelllewheKRASG12C/KEAP1muttedLtlywetetpeKRASG12C/KEAP1doubleglemutnttumAMG510+LMK235miceTheimpctignificncepropoedtudiehighKRAS/KEAP1co-mutntNSCLCdifficultttThecurntgrntidentifieHDAC4/5trgetblevulnerbilyecncerLMK235ducexicyuniquelyKRAS/KEAP1co-mutntNSCLCnotglemuntNSCLCecouldwytrgetedoublemutntcncerThegrntloclicllylevntKRASG12C/KEAP1mutntNSCLCpdedlewellG12ChibirAMG510clicltudiethnKRASG12Ctumwild-typeKEAP1ThegrnthowLMK235combtiAMG510cuetrikgynergtickillgpecificllyKRAS/KEAP1co-mutntNSCLCThucombtiAMG510LMK235(compoundlike)coulduedimprovepeeptientSUMMARYThpropolimtrnlteourengeedextrcellulrveicle(EV)neffectivecncerrpyMjbrriereffectivechimericntigencepr(CAR)-TcellrpyolidcncercludelimedCAR-Tcelltumfiltrtiloirfunctummicroenvirment(TME)evelife-engxicieDeignerEVcyxicimmunecellhvepotentilovercomeecruciluecomeeffectivecell-feimmunpyolidcncerInpePAR-22-071weoptimizeourdeignerEVderivedengeedNtuKiller(NK)cellleNK92ttmelnomdedlietkcncerDethRecepr5(DR5)highlyexpedcncercellmyeloid-deriveduppcell(MDSC)cncer-ocedfibroblt(CAF)MDSCCAFmjcompentimmunouppiveTMEWetuiulydcovedDR5-gticgle-chvriblefrgment(cFv)wehighlyeffectivekillgDR5+tumcellwhenexpedn-cyxiclymphoblticlymphomSup-T1cellWedevelopednewlentivirlvecrdelivermoDR5-cFvurfceEVfectedNK92cellvecrEVengeedcell(DR5-cFvEV)wemoeffectivekillgDR5+melnomthnDR5ntibodieDR5-CAR-TcellSytemicdeliveryDR5-cFvEVignificntlyhidDR5+tumgrowthvivomultiplecncermodelAuniquefetuDR5-cFvEVyignificntlyhidMDSCCAFvrovivocedCD8+Tcellfunctiptient-derivedgnotypiccultuLodgiRNAmutntNRASDR5-cFvEVfurnhncedirtum-killgeffecnmelnommutntNRASWefurrdevelopDR5-cFvEVclicltrnltiInAim1weoptimizecyxicyimmunetimulryfunctiDR5-cFvEVugdiffentpprochetetedeignerEVtte---rtmodeluchptient-derivedgnotypicmelnomcultugeneticllynnottedmelnomptient-derivedxenogrft(MPDX)Aim2wetetdeignerEVmoueclicltriluggeneticllynnottedMPDXhumnizedmiceInAim3weoptimizebioprocegtrdizewkflowengeedEVproducticeDR5-cFv-EVyielddevelopStrdOpertgProcedu(SOP)uptmproductidowntmprocequlyctrolThpropolppourdeignerEVGMPproductiexplodnlterntiverpyCAR-TcellWeexpectthurdeignerEVqulifiedNCItrnltilprogrmctuepthwrdclicupcompletgpropolProjectAbtrctThemotimptntunmetneedcologyovercomelckeffectiverpydvncedolidtumdultchildnDepemjdvnceimmunpyrdirpypcimedicenuclermedicevtmjydvncedolidtumpentgclicllydytillcurbleRdinoticrpiefertmendoudvntgepcimediceptientelectiovercncerttmentmodlieledobjectivepely30-60%ptientInnovtirdiophrmceuticlrpy(RPT)ddmjbrrierctenttumctrololyneededuboptimldrugdeliverylcktentirdiuclidettrgeteFcncerRPTdmtednuncjugtedcheltedrdiuclidecombtideliveryvehicleuchpeptidentibody(rdioimmunpy)ThprojectimdevelophighlyvertileRPTpltmhrneeengeedbctericcentrterpeuticrdiuclidetumWehypoizenengeedbcterilfuiprotecnervenvivtificilceprmllrdiuclidecrrier(nti-2222-(14710-tetrzcyclododecne-14710-tetryl)tetrceticcid(DOTA)-rdiohpten)ThctructDOTA-bdgSlmellcnpecificllycolizetumfollowgtrvenoudmtrticledviliverpleenNotblybcteridotcolizerdioenivedmrrowkidneywhichtypicllygn-t-rkdurgRPTBedknownphrmcoketicbiodtriiclerncepropertieengeedbcteriDOTA-rdiohptencnjectedpcelyttimepekbcteriltum--nmltueccumultirtio(egfter48hourtum--pleenrtio104typicl)ThetrtumlbctericptuDOTA-rdiohptenplmDOTA-rdiohptenrpidlyefficientlyexctedbodyvinlrouteThprojecthtwoAimInAim1wegeneticllyengeerSlmellexpurfce-nchodDPBchrcterizefunctilyvroInAim2wedemtrteefficcyourpropoedrdio-rnoticttmentprdigmbedSlmell-DPB+86/90Y-DOTAmouetummodelThtrtegyheverlpecificdvntgeoverrdioimmunepprocheThenumrrdiohpten(DOTA)bdgepergrmtumhpotentildermgnudegterthnnumrurfce-mrkerecncercellThetrtegyproduceunpcedentedrpeuticdicecriclgn(tumvkidneymrrow)cueSlmellcledbloodhourfterjecticcumultikidneymimlSlmellengeerghightumpecificydeeptuepenetrtiplticymkehighlypromgRPTEngeedSlmellcomdvivocptufen-immunogenicbiothoglDOTA-rdiohptenferhighlypromgengeedbcterirdinoticpltmcologyProjectSummryThecentrlhypomyF99-phepropollckT-cellfiltrtihumntummycuedpencetum-derivedT-cellexcluder(TCE)TMEwhichovexpedtumtueimpirfunctiTcellcludgirbilymigrtetumtueThprovidepotentilexplntiwhybothptneourpeuticTcell-medednti-tumimmunyfilfquentlyptientimmunologicllycoldtumByemploygecme-widevroT-celltrnwellmigrtihigh-throughputceng(HTS)pltmwetetedoverthouolublehumnprotemigrtictivtedTcellwrdchemokeignlSLIT2widentifiedcidtetrgetvlidteddictlyhibT-cellchemotxwrdCXCL11commchemokefoundhumntumtueTheN-termlfrgmentSLIT2wfirtcfirmedmedeT-cellchemotxhibiDetiledfunctildommppgdemtrtedfirttwoleuce-richpet(LRR)domwhecniclceprROBO1bddpenbleSLIT2functigultgT-cellchemotxMenwhileROBO1expicouldnotdetectedT-cellurfceFACStgolubleROBO1extrcellulrfrgmentfuiprotefiledneutrlizeSLIT2hibiryeffecnTcellcollectivelyuggetgnovelT-cellpecificSLIT2ignlgxdependentROBO1InyngeneicmouepncticcncermodeldrmticllyelevtedT-cellfiltrtedwobervedSLIT2knock-outPn02tumSLIT2-KOtumwejectedimmune-competentC57BL/6micewhileSLIT2wild-typetumgwSuchdiffencedimhedwhenSLIT2-WT/KOtumweocultedimmune-compromedNSGmiceAnti-SLIT2mocllntibody11C8neutrlizedhibiryeffectSLIT2T-cellchemotxvrogle-gentttmentledPn02tumgivivoThefunctilSLIT2ceprexpedTcellbroderimpcttumlSLIT2immunectextuTMEpotentilynergticeffectnti-SLIT2/nti-PD-1comboubjectfurrvetigtidurgF99phetrgInK00phethpropolIwouldlikeexpmytudyundertdyfunctiTcelldurgtumprogiTheetudiemightcludedcoveryddilTME-pecificextrcellulrfcrdrivedyfunctilnti-tumimmunyT-cellflmedtumIpropoeetblhvroHTSpltmidentifycidtetrget(1)promotecentrlmemyT-cellphenotypefvegiecdrylymphoidgn(2)duceT-cellprolifertivecpcyducepopticigntu(3)uppT-celleffecrfunctidriveexhutiphenotypeMulti-omictudieducibleexpinimlmodelutilizedprlleltrgetidentifictivlidtipurpoeCollectivelythpropoederchextendourundertgtumimmuneevimechnmleddcoverynovelimmunpytrtegiecncerptientPROJECTSUMMARYImmunecheckpothibir(ICI)enblenti-tumimmunyblockgimmunogulrycepr-ligtercti(egprogrmmedcelldethprote1[PD-1]lig[PD-L1])Depeirwidepduccennti-cncerrpyICIfunctipolyptientmetteloelevtedfrcturkptedptientceivgICIrpyMyplimrydtdictePD-1globlknockourphrmcologicblockdedecemboumnvemicemice-mettticdee(E0771tumcell)FurrmoPD-1blockdeducetngthcompdIgGctrolttmentmicemetteTheedtctentptlofrctuptientttedICIIhvelofoundthteocltctivyCD8+Tcellpopulticpbleectgpro-oteoclgeniccykeelevtedmrrowfterPD-1blockdeIehypoizedetrimentleffectPD-1blockdetemCD8+Tcellexpniwhichpromoteoteoclt-duceddetructumtnceICImicroenvirmenttemTcelldyfunctiIpropoe(1)determehowimmunecellfluencePD-1blockde-ducedlo(2)vetigtemechnmhdTcelldyfunctumtnceICImicroenvirmentInAim1(F99phe)IueTcelldepletidoptivetrnfertudievetigterolemrrowimmunecellPD-1blockde-ducedlotum-ocultedmiceIlotttum-ocultedmice-PD-1combtibphophteepventiloInbothetudieIephenotypevimicroCTbiomechnicltngetgtumimmunephenotypeviflowcymetryhlogyInAim2(K00phe)IutilizediglptilprilgcRNAeqtechnologychrcterizeTcellfiltrtimetteidentifykeyignlgpthwytweentumcellimmunogulrycell(myeloidderiveduppcelltumocedmcrophgeTgulrycell)cyxicTcellwhichimptntecpemetttictumcellTcellnti-tumpeIuede-identifiedhumnbtcncermplevlidtemyfdgelucidtemechnm()whichmetteecpeTcellurveillnce(egTcelluppiTcellexhutilckTcellfiltrtummicroenvirmentetc)WhcurntlckundertgmechnmhdloptientttedICItumcelltnceICIfterdemthpropolhelpmngehelthmilliptientceivgICIechyercfirmmechnticllywhernti-ptivevereICI-ducedloFurrmoIuncovernovelmechnmmettticimmuneeviwhentrgetedmyceefficcyICImettticptientProjectSummryGlioblm(GBM)motdevttgbrneoplmhighmbidymtlyDepemultimodlttmentcludgurgeryrdipychempydeecurftlGivenpublichelthimptncenunmetneednewttmenttrtegieprolgptienturvivlwhileimprovgqulylifeSPAK(SPS1-ltedprole/lne-richke)OSR1(oxidtivet-piveke)t-engkephophyltectivteNKCCKCCico-trnpterwhichkeyplyerrgtrcellulrCl-cellvolumepecelltThimptncecuecellvolumedeceductltrcellulriictngth(viCl-K+)erliettimuliledpopCncercellcncounterctpro-popticignluggulryvolumecethroughSPAK/OSR1/NKCC1ctivtiTheeekecnervetncemechnmcelldethOnhcellvolumegultineentilmechnmcellmigrticfedpcebrOurplimrydtuggeneticphrmcologiclhibiSPAK/OSR1howekedeceGBMcellmigrtiprolifertumgrowthvivocouldervemechnmrpytncechemdipyHoweverSPAK/OSR1functimechnmrpeuticroleGBMmunexplodWehypoizeSPAK/OSR1exertcogenicfuncticell-ttncemechnmllowgcncercellurvivehotileenvirmentenhnceGBMmlignncyThegolthpropolevluteifSPAK/OSR1ervemechnmtncetrdcWeevluterpeuticefficcySPAK/OSR1hibiugnovelmllmoleculehibircombtichemo-rdipydecriroleSPAK/OSR1tumtnceOurlg-termgoletfoundtierchprogrmtudylevnceSPAK/OSR1pthwyGBMprogiidentifygdruggbleignlgpthwygulteGBMcellviprolifertiThernotictypepcimedicewhichtrgetedrdiolledcompoundguedbothdignottmentTrgetedrpiecncerpeuticeffectivenewhilelimgideeffectScepublictiNETTER1trilult(12)ue177Lu-DOTATATEttneuroendoctum(NET)ptienthcedignificntlyTheprocoltrilwfour200mCidmtedttmentt8-weektervlThprocolceivedFDApprovlUnedSttehcometrdc(SOC)motethroughoutwldOnhlrgegroupphyicincienttlieve177Lu-DOTATATEttmenthouldperlizedechptient177LuemelectrrpyloemgmmcnuedimggTheepoiblequnttedoepergntrk(OAR)tumugimggtechniqueuchSPECT/CTAegOARdoimetryfterechttmentllowperlizti177Lu-DOTATATErpyRetropectivetudiehvedemtrtedignificntlengngprogifeurvivl(33v15mo)overllurvivl(54v25mo)whenptientweblectuettmentup23Gydeliveddoeirkidney(4)InddiOARdoimetrygrowgtetperlizgrpiebeduptumbiologyThugolthwkdevelopvlidtecoteffectiveptientfriendlytechnologyenbleperlizti177Lu-DOTATATEugdilymeumentrdioctivyptientOARtumoutquirgerilvnimggcenterThePerlizedRemoteRdiTrckgPtbleOrgnDoimetryDevicePRRTPODDPODDhtptient-friendlyrdimeurgdeviceptientcnueirhomeTheprimryOARptientkidneyhoweverPODDloprovidedtccurtedoeetimtiOARphyicinelectedtumthuenblgttmentperliztibedupmximumlerteddoeOARcumultivetumdoerpeuticrtio(iertiotumdoedoeOAR)doimetry-bedmetricOurprojectctfourpecificim1)DeigndevelopchrcterizecompctimggdetecrocedtwoluePODD2)UelticdiglNETptientphnmimultioloptimizePODDdeignbothOARtumdoimetry3)InclicptienttudievlidtequnttivegntummeumentcpbiliePODD4)CductptienttudycludgthomemeumentcomprgOARtumdoimetryetimteugPODDerilSPECT/CTimggAtccluhprojectwehvevlidtedourPRRTPODDtechnology36-ptientcohttechnologydyupptclicltriltudynefptientperlized177Lu-DOTATATErpiewheperlizticnbeddoeptientOARtumtumbiologyABSTRACTRdirpynecerycompentcurntttmentmnybrtumRdirpylevergerpeuticrtiowhichtumcellufferrdidmgediewhilenmlbrcellpirrdidmgelenegtivelyffectedImprovementrpeuticrtiobdlyneededbothimprovebrtumcuprobbilylimrkrdieffectnmlbruchrdinecroneurocognivedyfunctiEftwidenrpeuticwdowrdirpybrtumhvecludedchemiclpprochecomRTdrugtendedcetumcellrdioenivynmlcellrdiotncehoweverdtefeweffectiverpiehveemergedRecentlydvncephyichveproducedultr-highrterdidoedelivery(termedFLASH-RT)CompellgptpotnmltueprotectiFLASH-RTdoedeliveryhowevermoleculrmechnmFLASH-RTlrgelyunknownIntetglyferropcelldethmechnmhveenimplictedOurmultidciplrycollbtivetemhlevergedcomplementryexpertedevelopourceplimrydtimprovebrtumrdirpyrpeuticwdowthroughbothchemiclphyiclmenWehvecteduniqueexperimentlpltmtwovelcompent1)Ahighlytunbleveryhighdoe-rteelectrFLASH-RTmprovidedHighIntenyGmm-rySource(HIGS)tTringleUniverieNuclerLbry(TUNL)2)nOrgnotypicbrlicecultu(OBSC)ypltmllowterrogtiboumnmlbrtuecellnelevted-throughputdry-cultuytemhighlymenbleexperimentbothtrdRTouruniqueFLASH-RTmEncourgglyplimrydurOBSCytemhowATMkehibieemprotectneurferropticdethTochieveourlg-termgolwidenrpeuticwdowwepropoetwohypoe1)ATMhibicnwidenrdirpeuticwdowbrtumenizgtumcellprotectgneurepecillyunderFLASH-RTcdi2)CncercelldependdpttimtrpidgrowthbredptticnexploedenhncetumcellkillgWetetehypoefollowgim1)OptimizeHIGS-FLASHmprmeter(doedoe-rtetrgetg)enhncedmettticbrtumcellkillmximlprotectinmlbrundernmlATMhibicdi2)TetgenetictrgetrdieniztiglioblmcellundertrdFLASH-RTdoerteOSBCytemWeexpectthprojectelucidtecyxicmechnmbothtrdFLASH-RTgenertehighly-trnltbledrugdrugtrgetwidenrpeuticwdowbrtumIfuccefulthprojectexplrgercengetddilbrtumtypevivomodelvlidtiThedemoplticmllroundcelltum(DSRCT)memotlethldolecent/youngdult(AYA)rcomTheEWSR1-WT1genefuiprimrydefggeneticdriverlterthrcomtterundertgEWSR1-WT1cogenicmechnmneededidentifynovelrtilrpeutictrtegiemoeffectiveWepropoeddeknowledgegpetblhgfirtgeneticllyengeedmouemodelDSRCTdefepthobiologymofullyhrnegtwocentnovelobervtiDSRCTnmelyductineotrncriptcurntARID1AlofquentddilgeneticltertiecncerAim1DevelopgmouemodelDSCRTgermleomticgenomeedgWeuevivoomticchromoomlengeergmethodpieedourlbry(AV)duceEWSR1-WT1trnloctimicebedco-expiC9twogRNAtrgetgdeidtrnloctibkpotAp53muttedpproximtely10%DSRCTceweducetrnlocticcomntlyp53deleticohtmiceenhncetumdevelopmentPromptedcentfdgARID1AmutticommlyobervedDSRCTptient(eeAim3)welotetcequenceArid1loDSRCTiprogivivoAim2DefglcpeEWSR1-WT1-ocedneotrncriptDSRCTWe(JWOD)hvecentlyptedddidygultgexpimnytrgetgenecogenicfuiuchEWSR1-WT1lodriveexpicompletelynovelequencewhichwehvetermedneotrncript(JWOD)Theeunnnottedmulti-exicpolydenyltedRNAnotexpednyhelthytuedictlyducedltedlocliztiptternco-fcrocicogenicfuiproteAubetneotrncriptctivelytrnltedproteproductpentgpotentilnetigenWebuildupourildcoveryeequenceuemmodelytemdectgEWSR1-WT1mededgenegultiwelldetermgwhtroleeneotrncriptirencodedproteplytumbiologyAim3DetermgrolecurntARID1AloDSRCTWhileDSRCTdplyelowetomticmuttirtenyhumnolidcncertriguglyctivtiARID1AubuncniclBAFcomplexmotcommecdrymuttiDSRCT(bout6-12%ce)gmocommthnevenTP53lterti(ML)WepropoeueogenicmodelARID1AloDSRCTcellledefephenotypicepigeneticeffectthcurntecdryltertiDSCRTuechemiclfunctilgenomiccenidentifynovelvulnerbilieocedARID1AlowhichmyloyieldmogenerlightDSRCTpthobiologyAbtrctTheoverllgolthleerchexmepychoocilethiclcliclimplicticidentlmediclfdgcllhempoie(CH)helthyvolunteerhempoietictemcell(HSC)dThepropoedprojectfocuefeibilyCHferpencemutticquiddurgperlifetimehempoietictemcellCHhelthydividulnotcideddeettelthoughocedcedrkcrdiovculrdeecedrkhemlogicmlignncielowerurvivlrteCurntlymotpeoplecomewCHncidentlfdgdurgwkupndeeMnycliclquetiboutCHmcludgwher(1)diffentCHmuttioceddiffentlg-termhelthoutcome(2)muttifquencythholdocedcedrk(3)nymodifible/lifetylefcrlterrkocedCHThpropolpentuniqueopptunyepychoocilcliclethiclimplictiidentifygcidentlCHfdgmghelthyhempoietictemcell(HSC)dtNtilMrrowDProgrm(NMDP)whichmngelrgetwldwidegtrydividulwhohvevolunteeddteunltedptientneedHSCtrnplntAftertemcelltrnplntCHthrigteddmyidentifiedcipientTheNMDPcentlymlizedprocenotifygdpotentilCHThvetigtievlutefeibilytrckgpychoocilimpctcliclmrkermgthwehelthygroupdSpecificllywe(1)qultivelyexmepychoocilimpctceivgmtiboutcidentlmediclfdggroupcentHSCdcductgeriefocugroup(N=30-40Aim1)(2)demtrtefeibilycductglgudltructudhelth-ltedquly--life(HRQoL)telepheterviewHSCddignoedCH(N=30Aim2)(3)demtrtefeibilypropectivelytrckgcliclmrker(bloodolclciumco)HSCddignoedCH(N=30Aim3)ThvetigtiignificntcuelygroundwklrgervetigticidentlfdgCHhveimplictihowuchfdgcommunicteddividulceivgthmthroughtrdhelthcengThevetigtinovtivecue(1)firtvetigteCHhelthydpopulti(2)pentuniquelow-ourcelow-burdenopptunyidentifydividulCH(3)focuepotentilpychoociluedeliverycidentlfdghelthyd(4)demtrteourbilycollectlgudlcliclmrkermtiyounghelthycohtFdgthtudyleddictlylrgervetigticidentlfdgthhelthydgroupwhichhveimplictinlyHSCdbrodrngehelthyilldividulwhomcidentlmediclfdgdcoved7ProjectSummry/AbtrctTheoverrchggolthNGCCenterlevergeexpertemllmoleculedrugdcoverytrgetidentifictiproteIDRbiochemtryidentifydvncemllmoleculetrgettrncriptilfuicoprote1)trgetgtrncriptilmcheryco-optedfuiprotedrivecogenictrncriptilprogrm2)DictlyimpirIDRfunctimllmoleculeTrncriptilfuiproteducecogenicgeneexpiprogrmdrivecncerdevelopmentprogiTheeprotectneomphictrncriptifcrcrug-wirgtrncriptilgulrycomplexeRtildrugdeigndictlytrgettrncriptilfuiprotemmjchllengecueeprotelckenzymticctivydothveobvioupocketmenblemllmoleculebdgInddimechnmwhichfuicoproteco-opttrncriptilgulrycomplexecompletelyunderodAuchdevelopmentnewrpietrgettrncriptilfuiprotehlggedeftdeveloptrgetedrpiemutnncoprotevolvedcellulrignlgOurtemhdcovedMedirtrncriptilco-ctivrcomplexco-optedctrolcogenicgeneexpiprogrmducedtrncriptilfuiproteWehvefurridentifiedCDK8kemoduledruggbleentrypotwhichimpirMedirfuncthroughnoveltrppgmechnmOurtemprobiochemicltrncriptilmechnmthroughwhichCDK8/19hibirlterMedirfunctidevelopCDK8/19hibirmximizeMedirimpirmenttudyemllmoleculedvncedpcliclmodelEwgrcomrhbdomyorcomWefurridentifiedvcci-ltedke1(VRK1)kecomeynticllylethlfollowgCDK8/19impirmenurtemdevelopnovelpecificVRK1hibirevluteirefficcyglegentcombtitrtegieAcentrlmehcentlyemergedmnyfuiprotectDNAbdgdomlkedntricllyddedgi(IDR)TheIDRmedeelf-ocipheeprtihenhowneentilcogenicntuefuiproteOurtemhdevelopednnovtivebiochemiclmethodidentifygkeyprotegiIDRmedeelf-ociWempkeyelf-ociiduethefuiproteIDRidentifymllmoleculeimpirbilyegidrivepheeprtiProjectSummryAbtrctThwrdupptAzmeerShripolMSlg-termgoldevelopgexpertekillneededcomendependentvetigrexplgrolepolyphrmcymicroenvirmentldygulticutemyeloidleukemi(AML)ugnppliedmicrophyiologiclytem(MPS)pprochThetrddunubiccytr(DNR)chempyAMLult5-yerurvivlrtelethn30%70%ptient>60yerolduccumbdeefter1-yerdignoPolyphrmcywhichue5drugttcombidiecommvulnerbleptientHowevermunclerwherpolyphrmcyhnimpcnAMLchempyAMLtudiemotlyfocuedfdgtricmuttihempoietictemcelllegegivedyfunctilAMLcellHoweverrolemrrowmicroenvirment(BMME)tenoverlookedStudieugvivomodelhowedAMLcellcndygulteBMMEthroughcell-cellterctichemokeignlgAzmeerpDrBenjmFrchhowedAMLcellhibiteoblticcellfunctiviC-Cmotifchemokelig3(CCL3)clicllylevntmuAMLmodelHoweverchllenggproveAML-BMMEignlghumnceduelckliblevromodelhumnBMMEAzmeerShripolddegperchthroughnnovtiveerchplnlevergehbckgroundppliedMPSFF99pheAzmeerdevelopnvrohumnBMME-chipmodelugEmulteChip-S1micrluidicytemfibr-hydrogelencpultictgoteoblticendoliltromlcellcomprtmentimptntgulrtemcellmtenncediffentiUgBMME-chipheelucidteroleCCL3dygultihumnBMMEvetigtetrgetgCCL3ceprCCR1CCR5ugmllmoleculehibircueBMMEdygultiAML-BMME-chipFK00pheAzmeerexploeffectpolyphrmcycommcombidydrugcludgmetmcpprildditrdchempieBMMEfunctiugAML-BMME-chipvivomodelAMLAzmeerShripolhwkedcloelyhpdeveloptrgplnemphizedbuildgnewknowledgemethodologiclkillpphimmonindependenterchcerpthThetrgplncludeimprovgknowledgecncerbiologycncercellignlgcliclphrmcologybiomticnlyAzmeerhmenrlodevelopedplnidentifygpotdocrlmenrTogerpropoederchtrgplnprovideoptimlopptunietructuAzmeerdevelopnewkillprogwrdcncerercherPROJECTSUMMARY/ABSTRACTFui-poivelveolrrhbdomyorcom(FP-RMS)mpolyunderodhighlyftlcncerchildhoodThepthognomicfuicoproteARMSPAX3-FOXO1(iePAX3FOXO1P3F)trncriptifcrfuidrivgARMSproghroughdygultigeneexpichromttteMjobtcledevelopmentrpieFP-RMScogenicfuiprotecludehighdegecmtilplticyfuiprotedriverlckknowledgeboutproteprtnerublemechnmhibgclergfuiToolveegpweneedcomphenivecodtedpprochdcoverdevelopchemiclgentclrifylevncevrioumoleculrmechnmcpblehibgPAX3-FOXO1-mededtumigeneWeembledtemchemiclbiologtmediclchemtRMS-focuedphyicin-cienttwhoeuniquecomplementryexpertehigh-throughputcengchemoproteomicqunttivemoleculrterctinlyetrncriptilbiologymediclchemtryphrmcologyRMSbiologypplieddcoverydevelopmentmllmoleculeimpctPAX3-FOXO1functiFP-RMSAkeygolCenterexplomultiplemechnmctrgetgPAX3-FOXO1eftemphize1)identifygdictmll-moleculebderPAX3-FOXO1netneighbprotemypurueddictfunctilmodulrilentbderdegrderdevelopment2)developmentPAX3-FOXO1degrdercludgheterobifunctilproteolytrgetgchimer(PROTAC)moleculrgluedegrdetrgethijckgubiqu-proteomeytem3)dicttrgetgPAX3-FOXO1trgetgtrncriptilnetwkcollbrmodultefunctifuictroltrncriptifuiWepropoethecomplementryProjectupptedfourReerchGroupcludgHigh-ThroughputScengGroup(HTS)Moleculr&CellulrMechnmGroup(MCM)MediclChemtryGroup(MedChem)PhrmcologyGroup(Phrm)TheSpecificAimvolvellfourReerchGroupclude1)LigDcoveryPAX3-FOXO1(Project1)2DcoveryDevelopmentTrgetedProteDegrderPAX3-FOXO1(Project2)3TrgetgPAX3-FOXO1-ocedcogulrytrncriptilcomplex(Project3)WhileimexplomultiplephrmcologicmodeperturbgPAX3-FOXO1ctiviembiouourcomdexperteexperienceblncgggfocugdrugdcoverydevelopmentenbleourgolccelertgidentifictirpiePAX3-FOXO1-poiveFP-RMSOuruniquetngthlomTFCCNetwkultgknowledgegenerlizbletrgetgfuicoprotechildhoodcncerccelertgdvncecliclcPROJECTSUMMARY/ABSTRACTTheprimryobjectivethpropoldeveloploclizedcncerimmunpyugprticle-nchodcykeprolgedtrtumltentielicdurblenti-tumimmunepeItwellknownimmunotimulrycykecnelicrobutnti-tumimmunepepclicltudieloexhibeveimmune-lteddvereeventdueytemicexpouThecurntdrugdeliverymethodologycnnotutblyupplycykedyweekfilgfullydduexicylimedefficcyWehypoizenchgcykelrge-izedprticletrtumljectiwouldenhncelocltenticyke(egIL-12IL-15)drivetumhibiwhilevoidgytemicexpouuchcykecuedvereeffectTotetthhypowedevelopnovellocldeliveryytemphyicllynchFc-cykeprticlehvgurfce-dectedFc-bdgpeptideOurplimrytudiehowtrtumldmtrtiournewprticle-nchodcykeignificntlycetumtenticykemrkedlyduceytemicxicyMooverloclttmentourmicr-meter-izedprticle-nchodcykepromotecupolyimmunogenictummodelelicnti-tumimmuniectroloverdtntunttedleiOverlltwopecificimpuruedthpropolcludg(i)developlipoome-nchodcykeprolgedtumtentiovereweekmimlytemiclekgefecyke(ii)elucidtemechnmwhichprticle-nchodcykeelicdurblenti-tumimmunyimproveefficciepolyimmunogenictumOurimplemultechnologywouldfullydddoe-limgxicyproblemuecykecncerimmunpyprovideneweffectivettmenptidifficult--ttolidtumwhencomdimmunpeuticThwklodvnceerchdrugdeliverytechnologyelucidtgcrucilphyicochemiclchrcterticcircumventytemiclekgelocldrugdeliveryThwkloignificntlydvnceourundertghowloclizedimmunotimulrycykeimpcttummicroenvirmentledgenhncedytemicnti-tumimmunytterttmenutcomeProjectSummryPncticductldenocrcom(PDAC)cncerpoprognolimedttmenptiMultipleleevidencehvehowncncercellfquentlycomeddictedctivenuclercyplmictrnptutirctiviecludggrowthmettARANgrdienthighnuclerRAN-GTPccentrtiquidproperhuttlgtweennucleucyplmTheRANguneexchngefcrknowngulrchromoomecdenti1(RCC1)ctivteRANmtctlyzeRAN-GTPmtinucleuTherolethxPDACnotfullyunderodOurplimrydthowhighRCC1cltedpoptientprognoOurtudiedemtrteRcc1depletimuPDACcellltertedyttedtriiRnultgwidepdltertiubcellulrproteomeWefoundeverlcellulrpthwyimpctedRcc1depleticludgmocidfttycidmetbolmwellRNAprocegBedefdgwehypoizeRCC1crucilPDACmtennceovexpimyplyroletumprogiTheeF99pheIpropoevetigterolemechnmwhichRCC1lterPDACmetbolicctivydriveprogiugtte---rttrncripmicmetbolomicpprocheIlodeleteroleRAN-RCC1xgultimRNAproceglterntiveplicgugeverlimggmoleculrtudieFllyIuewell-tudiedKPCmouemodelPDACcroedcdilRCC1ovexpimodeldetermeroleRCC1ovexpiPDACdevelopmentprogiMotptientPDACdieduemettticdeeInK00pheIfocutudygmettticPDACproceIvetigtecomplexmechnmcrotlktweentumcellmetttrgergnmicroenvirmentIimdetermehowRAN-RCC1ximplicteddrivgmettticprogiugnimlmodelptienttueReultetudieimimproveourundertgmechnmdrivePDACprogiOurtudiepotentillyidentifypotentilnewvulnerbilierpeutictrgetultimtegolimprovgttmentoutcomeptientuffergthggivedeeABSTRACTTriple-negtivebtcncer(TNBC)nggiveubtypebtcncerccountpproximtely10-20%llbtcrcomtenocedpoprognoWhilecventilrpieuchchempyrdipyimmunpiehelpmngementTNBCmotptienttilldevelopdtntmetthvelowoverllurvivlrteTodtelyfewpecificttmenptipprovedumubgroupdevelopmentnoveltrgetedrpienunmetneedImptntlyTNBCtenpentdvnceddeeetumlotenftcognizedmoleculrtrgetcnfoundubtypelimgirrpeuticoptiHowevertum-ocedmcrophge(TAM)filtrtiTNBCfquentlyobervedcomplexterplytweenimmunecelltumcelltummicroenvirment(TME)cnleddeeprogiSpecificllyignlgenertedTMEcncueimmunouppipromotgngiogeneimmuneeviwhichledtumdevelopmentTheterplyM1M2mcrophgepopulticocideetummrkerprticulrlyimptntTMEMooverhighdenyTAMprticulrlyM2mcrophgeocedpooutcomevrioucncercludgTNBCThprovidetrgbexplogTAMpotentilrpeutictrgetSpecificllynoveleftceM2M1polriztipromgrpeuticpprocheTNBCHewepropoetwo-prgedpprochtrgetM2-richTAMpopultivergimmuneubvericomdtrgeteddetructumcellpopultiuggenedeliverypprochProkryoticvirueuchbcteriophgehvenotropmmmmlincellcnengeeddelivergenelowefficiencyOnhnimlviruehvepotentiltrgetedgenerpyquielimtintivetropmmmmlincellowecomdfvblebiologiclttrieeukryoticprokryoticviruefciltetrgetedytemicgenerpypplictiInAim1weexplouniquettrieAAVPtrgetedhybridvecrctgc-genomicelementdeno-ocedviru(AAV)phge(P)dplygligmotiftrgetmultiplecomprtmentTNBCtumcellocedvcultuRGD4CTAMCSSTRESACdeliverhumntumnecrofcr(TNF)modultetummicroenvirmentyngeneicmodelTNBCAim2dedictedchrcteriztiimmunomodulryeffectTNFexpummicroenvirmentpotentilpolriztinti-flmmryM2-likeTAMpro-flmmryM1-likeTAMpopultiPROJECTSUMMARY/ABSTRACTOykeyrkfcreverltypecncerDevelopmenthelthyweightetghvidurgchildhoodhpotentilducecncerrkdulthoodPdolecencekeyrkperiodchildncomemodependentirfoodchoiceetghviN-homeotticetgieetgthccurpeexternlcuerrthnphyiologiclneedcepdolecencerkfcroyIndividuldiffenceteroceptiprocewhichternlbodilyttelikehungerfullneenedtegrtedterptedgultedmyctriepropenyn-homeotticetgAnumrtudiehvefoundchildnoyhvepoteroceptivewnethnchildnouytudieexmgltihiptweenteroceptietghvilckgFurrmounknownifoy-ltedimpirmentteroceptiduedequtephyiologiclignlgternltte(botmupprocee)/impidcogniveterpttieignl(pdowngulti)LevelghlhungerhmeproducedmchtypicllypekjutemeldeclefollowgfoodtkehoweverthpefoodtkeblunteddividuloyAltedghlectipemelmyultcctteroceptiveignlgbrTheprimrygolthR21tterunderthowdividuldiffencemultiplefetuteroceptictrieobjectively-meudn-homeotticetgchildnTodothchildnge7-10yerouy(n=60)completeeriequetinilbry-bedhvilmeuteroceptiOneprteoccichildncumendlibummelfollowedn-homeotticetgtk(EtgAbenceHunger[EAH])providglivmplemeumentghlleptedurgfteretkFAim1wedetermeifteroceptiocedkcltkeEAHtkwehypoizeteroceptiverelyocedtkeFAim2weexmelivryghlleptteroceptiveignlhunger/tietywehypoizechildngterpotprilghluppihvetterteroceptivewneetleEAHtkelevtedleptttenuteltihiptweenghlupperoceptiFAim3(Explry)weuecluternlyidentifyprileteroceptibedgloblytem-pecific(egcrdicgtric)teroceptinexmediffenceetghviexecutivefunctiweighttweencluterThprojectextendourundertgdrivern-homeotticetgvelhowteroceptivewneimpctfoodtkeettgfoundterventitrtegietilodchildnbeddividuldiffenceteroceptivefuncti1ReerchTyroekehibir(TKI)uchlectibhvetrnmedurvivloutcomeptient2newlydignoednplticlymphomke(ALK)poiven-mllcelllungcncer(NSCLC)F3motptientilTKIrpyulttumpevribleleveldeehrkge4ctrolExtricfcrthvribilyuchimmuneytemhvenotenwelltudiede5tumcidedimmunologicllycoldHoweverourdtuggetimmunecelltum6microenvirment(TME)hpeextentTKIpePtientALK+NSCLCexperiencefter7deeprogiTKIcgnumrneutrophilp-ttmentbiopieFurrir8overllurvivlignificntlyhterTKIwhencncercellhvecedtrncriptilctivy9CXCL5CXCL8potentchemottrctntneutrophilWelieveneutrophilALK+NSCLC10TMEimpirtumctiveCD8+TcellMumodelALK+NSCLCquiCD8+TcellnotCD4+11TcellutedlectibpetumclernceAnlogouptientALK+NSCLC12mumodelupgultepotentchemottrctntneutrophilct1)cedLy6G+13neutrophil2)fewerctivtedCD8+TcellTME3)ducedpivenelectibOur14centrlhypocrumentneutrophiltummededcykedecelectib15piveneimpirgnti-tumTcellInthpropolugthopicmouemodelALK+16NSCLCwedetermehowneutrophilmodulteTMECD8+TcellpeALK+NSCLC17CidteDrErSchenkcergolcomeledglbry-bedphyicincientt18identifygcriclTMEimmunecelldrivettmentpeALK+NSCLCShepplynovtive19technologiemodelytemgenertecientificrtileclicltriltetgnovelimmunpie20ptientNSCLCTochthgolDrSchenkmterCRISPRmodifyimmuneTME21ctentmouemodelALK+NSCLCtetTKIpepplyundpprocheexplo22TMEcRNAeqfullpectrlflowcymetryptiltrncripmicInprllelhecqui23killetneceryclicltrildevelopmentimplementti24EnvirmentTheUniveryColdolyNCI-deigntedcncercenterColdohn25terntilputticlicltrnltilwkALK+NSCLCDrSchenkhdycce26multiplehdource(co)crocncercenterlepergrduteleveldidctic27couretutilupptThcicOncologyProgrmDiviMediclOncologyShe28hembledpnelccomplhedmenrcludgTMEexpertDrRphelNemenftum29immunologtDrEdurdoDvilJillSlnkyneutrophilexpertDrSenColgnterntil30ALK+NSCLCexpertclicltriltDrRoCmidge31PROJECTSUMMARY/ABSTRACTReerchN-mllcelllungcncer(NSCLC)wlddedlietcncerptientNSCLCcnhvedrmticllydiffenutcomeillumtgnurgentcliclunmetneedimprovedrktrtifictiOurtudymotivtedfollowgunolvedquetiNSCLCcology1)Whtlikelihoodcurnceptientdefivelytteddee?2)Whichptientdvnceddeemotlikelynefcolidtiverdipy?3)Whtlikelihoodptientdevelopcentrlnervouytemmett?Wectendpdictivemodelderivedl-wlddtcollectedprttrdccludgtumgenomicprilgimggclicinnotecomdnewercliclyuchcircultgtum(ct)DNAequencgrdiomicdvnceperlizednwerequetiledgimprovedoutcomeptientWehvecentlydevelopedmethodovercomebrrierugl-wlddttrnmer-bednturllngugeprocegelimtgneedtime-tenivemnulcurticlicinnoteyieldgtructuddtcricldevelopgpdictivemodelInproprcipletudywevlidtedprognoticvluectDNAequencgmergedrdiomictumgtrytuegenomicdtcterichlynnotteddtetndermgnudelrgerthncentmnullycurtedcohtOurplimrytudiehowmultimodlmodelcptgcomplementrydttmimproveoverllurvivlpdictiovernygledtmodlyuchtgetuegenomictrdcbiomrkerBedeultwehypoizepecificcombtimodelencompglwlddtctDNAclicogenomicourcemoccurtelymtumbiologyptienutcomethngle-modlyvribleWeimproverktrtificticliclmngementNSCLCtudygwherhowl-wlddtcnueddevelopmultimodlrkmodelfutucoulddeployedcliclettgmimlptientclicinoverhedCidteJutJeeMDPhDnIntrucrThcicOncologyServicetMSKHgoltegrteAI-extrctedclicogenomicdtdcovermultimodlbiomrkernteoplticpeptientcncerHeundergofive-yertrgperiodmultidciplrymenrhiptemcludgexpertcomputtilcologymchelernggenomicnturllngugeprocegrdiomicthciccologyobtkillnecerycomendependenttenu-trckphyicincienttEnvirmentMSKncdemiccncercenternownedptientcnovtiveerchtrgjunifcultyeekgcerdependentphyicin-cienttMSKhomeMSK-IMPACTnFDA-uthizedtum/nmlequencgyover100000mpleequenceddteMSK-ACCESS129-geneliquidbiopyyBothylevergedextenivelythpropolPROJECTSUMMARY/ABSTRACTCncerimmunpyhvolutiizedcologyChimericAntigenRecepr(CAR)TcellprticulrhvehowndrmticucceeomeliquidtummultipleFDApprovedproductoverlppghemedictiYetptientpeengeedcellrpiehighlyvribleunpdictbleGivenbothextrdrycotextrdrycurtivepotentilengeedTcellrpiemtchgrightcellrightptientmlrgeunmetcliclneedYethowptientTcellvriblypdwelthdiffentpotentilynticgeneticltertimunexplodOurlgtermgoldevelopperlizedcellulrimmunpiedignotictetnecerynomteoptimlengeedcellpecificcncerptientAfirttepwrdthgolwedevelopclblepooledcengmethodologierpidlyypprovedpropoedcellulrimmunpyctructtclecrolrgenumrptient(SpecificAim1)IncohtliquidolidtumptientwedecttricvribilyptientTcellynticllyengeedCARpetivetimultiymodel(SpecificAim2)FllywedetermepdictiveclteptientpecificengeedTcellfunctiughighdimenilimmunecellprilgptientcliclmetdt(SpecificAim3)WehypoizeengeedimmunecellpermncehighlyvribleptientpecificmeumentthvribilycrocncerptientTcellnomtefutupdictivedignotictrtegieperlizedcellulrimmunpychoiceInthK08MendCliclScienttReerchCerDevelopmentAwrdpplictipplicntDrTheodoRothMDPhDCliclPthologtStndUniveryDeprtmentPthologyInddiencloedReerchPlnthpropolencompefive-yerTrgPlncompletehmendcerdevelopmentprimrygolcomgdependentcdemicphyicincienttrunngerchgroupdevoteddevelopgperlizedcellulrimmunpieDrRothundergotrgdignoticydevelopment(TrgAim1)highdimenilimmuneprilgtechnologie(TrgAim2)uccefulumptierchdependence(TrgAim3)DrRothmgmendtrgovereenmultidciplrygroupdtguhedphyicincienttcludghprimrymenrDrAnumnStpthyco-menrDrCrytlMcklllgeniAdvyCommteecompoedDrEdEnglemnHowrdChngDvidMikloStndUniveryprovidenouttgenvirmentcompleteDrRothtrnierchdependencehighlyctivecliclcellrpyprogrmovereenhco-menrDrCrytlMckllvibrnterchcommunieimmunpygeneticdignoticydevelopmenthighdimenilmoleculrtechnologieCompletiReerchTrgPlnpropelDrRothdependenterchcerncdemicphyicincienttPROJECTSUMMARY/ABSTRACTQuoviSodjiMDPhDTenutrckAtntPDeprtmentHumnOncologytUniveryWcSchoolMedicePublicHelthMdHlg-termgoluehcquidcliclerchexperterdicologydrugdcoverycncerimmunpydevelopttmentcnimproveliveptientolidtumcludgpedriccncerneuroblmHeimdeveloptrnltilerchprogrmvetigtguelow-doetrgetedrdiucliderpy(TRT)enizetumkillgchimericntigencepr(CAR)TcellThepurpoethcerdevelopmentwrdprovideDrSodjiupptmenrhipneededdevelopuccefultrnltilerchprogrmHpropolpermedunderprimrymenrhipZchryMrMDPhDnexpertimmuno-rdiobiologyChrtinCpiMDnexpertCARTcellrpyOrmemrhmenrhipcommteecludePulSdelMDPhDnexpertimmunogeneticJmeyWeichertPhDnexpertrdiuclidechemtryBrynBednrzPhDnexpertnuclermediceThetrgplncludemlcourewkemrntilcfenceh-trgctivieexpexperte1)tumimmunologyCARTcellengeerg2)rdiochemtrydoimetry3)lbrymngementmenrggrntmnhipCARTcelllivgdrugtilodechptientcndictlycognizekillcncercellTheyhveenveryeffectivegtbloodcncernotgtolidtumcludgemotcommchildhoodcncerneuroblmwhichverydedlycncerwhenlpeThlimtiCARTcellolidtumhenttriedirbilypenetrtetumloirkillgpotentilovertimeTRTmrdiwherdioctivechemicllkeddrugcnelectivelydelivercncercellhenhowncefiltrtiimmunecelltumuceptibilytumcellimmune-mededdetructiThegolthpropolueTRTdeliverrdilltumthroughoutbodyovercomefcrpentlylimucceCARTcellgtolidtumlikeneuroblmThpropolim1)identifymountTRT-emtedrdiCARTcellcnfelyt2)determeifhowthmrdicepotentilCARTcellkilltumcell3)evlutewherTRTcombtiCARTcelleffectiveerdictgtummumodelneuroblmThpropollygroundwkjutifyevluthcombtirpyclicltrilptientneuroblmOurnticiptedfdghveenmoutrnltilpotentilrpeuticpprochcouldtetednycncerwhichtum-electiveTRTgenttumurfcentigen-pecificCARTcellcouldengeedPROJECTSUMMARY/ABSTRACTPtienttriple-negtivebtcncer(TNBC)ccountpproximtely15%llbtcncerdignoedproptelyburdenedmettticdeebtcncerdethduehighrtecurncelckrk-ducgttmenptiurveillncepheThetrniurveillncemrkeddtprognoticuncerttygrdgfercncercurncettimewhenctctcologytemdecePtientTNBCtgterrkpopychoociloutcomeTNBCfquentlyoccuryoungerptientBlckHpnicptientptienthrbghigh-rkgeneticmuttiDepedineedptientTNBCnocopgupptivecterventicurntlyextthpopultiToddthgppropoedtudydetilfive-yerplndevelopfepilot-tetnure-ledcopgupptivecterventi(TRANSITIONS)ddneedptientTNBCytrnicurtiverpyurveillncetMchuettGenerlHoplthecommunyffileTheimthproject(1)developfeTRANSITIONSbedplimrydtptientTNBCdiveretkeholderfeedbckwellptientfeedbcknopenpilottudy(N=5-8)(2)evlutefeibilycceptbilyTRANSITIONScductgpilotromizedctrolledtril(RCT)(N=75)(3)etimteplimryeffectTRANSITIONSimprovgpychoociloutcomepilotRCTThecidteDrKthrynPotembledmenrtemcompdterntillycognizedvetigrhvilterventiptient-ptedoutcomecncerc(JoephGerPhD)TNBC(LeifEllenMDPhD)upptivectrilptientbtcncer(JmieJcobPhD)Acientificdvycommteeprovideguidncequltivedtmethod(LrTgerPhD)equybtcncerc(BeverlyMoyMDMPH)nure-ledterventicncerurvivhip(TeHgnThomPhDBARN)biotttic(DutRbideuPhD)DrPotchieveherht-termgolthroughcodtederchtrgpln(1)hvilcognive-hvil-rpy-bedterventidevelopment(2)RCTdeigntetgcduct(3)lgudlementnlyInddigulrmenrhipmeetgexperientiltrgcludederchplnDrPotcompletedvncedcourewkdidctictrgttendpenttemrntilcfencepublhfdgpeer-viewedjournlThK08propoldetilDrPotplngmenrhipdidctictrgcerdevelopmentfciltehertrnierchdependenceDrPotlg-termgolcomendependentvetigrledgnurecienttupptivecologyWhddiltrgmenrhipthK08provideDrPotctrientilterntileftduceympmburdenimprovequlylifeptientcncerProjectummryThK08CerDevelopmentAwrdpropolDrFilipedeCrvlhodecrierchplncerdevelopmentprogrmledgupncdemiccerndependentUrologicOncologturge-cienttvetigrDrDeCrvlhourologttBrighmWomenHoplcommtedndependenterchcerfocuedccelertgdevelopmentrpeutictrtegietrgetimmune-uppivetummicroenvirmentblddercncerThCerDevelopmentwrdllowDrDeCrvlhocomepricienttum-ocedmcrophgebiologyblddercncerultimtegoldevelopgnovelmcrophge-dictedrpeutictrtegieblddercncerptientDrDeCrvlhomendDrEliezerVnAllenco-menrDrKentMouwElizthMtendflederblddercncergenomiccncerimmunologyDrVnAllenChiefDiviPopultiScienceDn-FrrCncerIntutehmendoverdozenyoungvetigrmoveduccefuldependentcdemicpoiDrDeCrvlhologdnouttgcientificdvycommteecollbrexcelmouemodelttticcncergenomicguidecerdevelopmentcientificprogTheerchpropolfocuetum-ocedmcrophgewhichimmunecellcriclroletumgrowthimmuneeviRecentevidenceveledrpy-ducedcverinmllynti-tumTAMtum-permivephenotypeThecentrlhypocpltducechricimmunouppiveIFNignlgcncercellledgTAM-filtrtedphenotypeimmuneevtment-tnttumThecentrlhypotetedpurugtwopecificim1)DetermemechnmeffectivenetrgetgTAMimproveenivyblddercncercomdcpltimmunecheckpothibi2)Decttum-TAMcrotlkmedecplttnceTheetudieexpecteddecthowTAMhibcyxicT-cellcplt-tntblddercncerterririeimmuneevicroblddertumwellpoiDrDeCrvlhoubmcompetiveR01nercomplethAwrdPROJECTSUMMARYMlignntgliomdevttgbrcncernoimprovementprognooverdecdeOnekeymechnmgliomprogidynmicmetboliccommunictitweentumcelltummicroenvirment(TME)AlthoughextrcellulrcidopthologiclhllmrkTMEpcepH-dependentmechnmunderlyggliommetbolicprogrmmgmpolydefedThpropoloverrchggoldcovergenepthwygultggliommetbolmgliom-vculrcrotlkThpropolfocueSlc44glil-enrichedodium-bicrbtecotrnpterwpvioulyidentifiedntrcellulrextrcellulrpHgulrSlc44-mededpHgultiimptntglil-vculrterctifterjuryrolegliomprogiundefedTogddgthgpknowledgeInlyzedTheCncerGenomeAtl(TCGA)dtbefoundhighSlc44expiclteprolgedurvivlgliomptientCrobtivelymyplimrydthowedSlc44gfuncti(GOF)drticllydecetumgrowthngiogeneptient-derivedxenogrftCRISPR-mededdenovomouegliommodelwhichfurrcomplementedlo--functi(LOF)tudieugglil-pecificSlc44knockoutmiceTheedtuggetnhibiryroleSlc44gliomocedrrntvculrmodelgMulti-omicprilgSlc44GOF/LOFmouegliomfoundSlc44negtivelygulteexpikeylipidbdgprotefttycidbdgprote5(FABP5)whichcoupleddygultedlipidmetbolmFurrnlyTCGAdtbehowednvereexpiurvivlcltitweenSlc44FABP5gliomptientInnimmunocompetentmouegliommodelFABP5ovexpivereSlc44hibiryeffectgliomgrowthuggetgnntgticSlc44-FABP5xgliomFllycomphenivetrncripmicprilgSlc44GOF/LOFgliomveleddygultedgeneigntuvolvedcidicpHpelipidmetbolmendolilfunctiBedeplimrydtmycentrlhypoSlc44uppegliomprogiprtgultglipidmetbolmgliom-vculrterctiTotetthhypoIfirtdefeSlc44rolegliomprogi(Aim1)NextIdetermehowSlc44hibgliomgeneviprogrmmgtricgliomlipidmetbolm(Aim2)UpcompletiAim12K99pheIetblhSlc44rolegliomprogiocedlipiddygultiInR00pheIdetermehowSlc44medegliom-vculrterctifocuendolilmetbolm(Aim3)ThepropoedtudiedefepH-dependentmechnmwhichgliomhijckbrvcultuprogultimtelyetblhgndependenterchprogrmbridggcncerglilvculrbiologydecipherhowgliomprogepotentilrpeuticimplictiPROJECTDESCRIPTION/ABSTRACTMDM2mplifictioccur35%llmlignnciepproximtely10%everlhighlyggivemlignnciecludgglioblmMDM2criclnegtivegulrtumuppp53high-levelMDM2mplifictiultfunctilctivtip53genomic-drivereventtumigeneetumEventumnmlMDM2expidruptiMDM2/p53pthwycntriggerpopInthctextmultiplephrmceuticlcompniehvedevelopedpotentMDM2hibirdvncedclicldevelopmentvrietymlignncieInourtudiehighlypotentMDM2hibirBoehrgerIngelheim(BrigimdlBI907828)wefoundMDM2-mplifiedglioblm(GBM)rcomexquelyenivethdrugSpecificMDM2-mplifiedtumdrugttmentoceddegrdtipro-urvivlMCL1proteupgultipro-popticproteMooverbrigimdlttmentultuppimultipleDNApirpthwycriclcoverybothendogenouexogenougenoxictBedeobervtiwehypoizecombtienhncedpopnbilypirDNAdmgecteuniquevulnerbilyMDM2-mplifiedGBMbrigimdlWetetheAimAim1EvlutemechnmexqueMDM2hibirenivyMDM2mplifiedGBMAim2DefeeffectbrigimdlcellulrpegenoxictAim3EvlutetrtegieenhncerpeuticwdowMDM2hibirGBMProjectSummry/AbtrctNUT-fuicoprotemotcommlyBRD4-NUTdriveNUTcrcom(NC)nggivepolydiffentedqumoucncer65-mthmedinurvivl<20%3-yerurvivlNCpdomntlyffectdolecentyoungdultnoutelyeffectiverpyhcriclunmetneedBRD4-NUTdrivegrowthlterghnemodifictichromt3Dtructuupgulteexpipro-growthgeneWedemtrtedBETbromodomhibirvereeepigeneticmodifictiblocktumgrowthTheefdgledttmentNCnumeroumlignncieBEThibirHowevercliclefficcyBEThibirmpylimeddictgBEThibirledotfullyddNCbiologyThegolthpropolovercomelimtiBEThibiNCeimproveptienutcomeidentifygtrgetblemechnmgenegultimtNCgrowthUgourcomdexpertetrnltilNCcncerbiology(CAFnch)chromtbiology(KPEgen)wetketwo-prgedpprochimproveNCttmentthroughmechnm-bedtrgetdcoveryBothprghpmeidentifygfcrcooperteBRD4-NUTpromoteNCgrowthlednewrpeutictrgetOurfirtAimbedupourcentdcoverypumuppgenehnemethyltrnfereEZH2complementcogenectivtiBRD4-NUTSimultneouhibiEZH2BRD4-NUTynergticllyblockNCgrowthvrovivoHoweverpcemechnmynergymunknownAddillyxicywobervedomexenogrftmodelthuxicyhumnlikelyTheewepropoeidentifymopcerpeutictrgetdetermgkeyfcrmedecogenicynergytweenEZH2BRD4-NUTOurecdAimmotivteddcoverynovelMLL1NUTM1fuiptientOurproteomicdtdicteMLL1keybdgprtnerMENINbothpentBRD4-NUTcogeniccomplexprovidgbiochemiclevidencethfuimyvelnewfcrcooperteBRD4-NUTAccdglyhibgterctitweenMLL1MENINducediffentiblockgrowthNCcellThecombtiMENIN-MLL1EZH2hibiynergticllyblockNCgrowthvroThdtuggetcombtirpyMENIN-MLL1EZH2hibircouldpotentillyplceBEThibiwhichwetetp-cliclmodelNCAim1DetermemechnmwhichEZH2cooperteBRD4-NUTdriveNCgrowthAim2ElucidteroleMENINBRD4-NUTcogenicfunctiProjectSummryAmgmenprottecncermotpvlentmcncerthirdmotcommcuecncer-lteddethWhileptientloclizeddeehvepoiveprognothoemettticdeehvefive-yerurvivlrte30%Themrpeutictrgetprottecncerrogencepr(AR)Motptientttednti-rogendeveloptncectuedeeprogimettticctrtitntprottecncer(CRPC)Secd-genertinti-rogencludgenzlutmidebirtereextendlifeexpectncyeventullyulttncettmentTheefdghighlightneednewttmentpprocheneceryovercomelimdevelopmenttnceAmny20%ggiveprottecncerhvemuttiultgupgultiWnt/-ctenignlg-ctentrncriptifcrctivtedpeWntpthwyignlgTocuechngegenetrncripti-ctenterctDNAbdgproteclledTCFImptntlycentnlyidentifiedWnt/-ctenpthwyemotdiffentillymodultedpthwymgenzlutmide-tntdividulTotrgetWnt/-ctenpthwyweuedtructu-beddeignoligomericmcrocycleidentifynewmoleculepotentlyhibWnt/-ctenignlggrowthprottecncercellOurgolevlutebilymcrocycle13ledhibiridentifiedourcenupp-ctenignlgctrtitntprottecncerugvivomodelprottecncerWelodetermeimpct-ctenhibiimmunecellABSTRACTThK22propolimenhncepplicntpriqunttivetrgcombtimlcourewkmlguidncetrnidependencemoleculrcncepidemiologtvetigtgbiologiclbhelthdpriefemlecncerRcilethnicdpriewelldocumentedovrincncerdedlietgynecologiclcncerBlckwomencompdWhewomenhvehigheroddltetgedignodproptelyweurvivlrtedepelowercidenceMooverBlckHpnicwomenhveexperiencedlowerdeclerteovrincncermtlycompdWhewomenSocildetermnthelthlyprtillyccountedprieuggetgbiologiclfcrlikevglmicrobiomemyplyn-trivilroleThevglmicrobiomecnhpetummicroenvirmentthroughproductipro-crcogenicmetboleductinteoplticmetboleHowevercompoivriehotfcrcludgrceethnicyclteocilddvntgeuchpovertyWhilercillyethnicllydtctvglmicrobiomemyhveuniquemetbolicprileoceddiffentilovrincnceroutcomenotudiehveevlutedthpoibilyTheepplygfrmewkKriegerecoocilywehypoizethroughembodimentocilddvntgercilethnicdiffencefunctileffectvglmicrobiomectrieovrincncerdprieWepropoetudyuenuntrgetedmetbolomicpprochcompmetboleprilecervicovglfluid120ptient(40Blck40Hpnic40Whe)rceethnicyocilddvntgeToteurcentrlhypowehveetthepecificimnmelyi)chrcterizercilethnicdiffencevglfluidmetboleprilemetbolicigntumgOCptientii)ediffenceocilddvntgevglfluidmetboleprilemetbolicigntumgOCptienttdividulneighbhoodleveliii)evluteltiveimptncevglfluidmetboleocilddvntgeOCggiveneOCcurnceCompletipropoedK22enhncecientificknowledgerolevglmicrobiome-ducedflmmtiovrincncerprogiThtudyidentifybiologiclpthwyctriercilethnicdiffenceovrincncerprogiThcientificknowledgeuefulidentifygmetbolecnerveprognoticbiomrkerovrincncerdeigngfutumechntictudieMoovertclicllevelourtudyprovideevidencehowrpeuticterventivolvemodultgvglmicrobiomemyneficilpecificrceethniciedictepotentilvluepplygvglmicrobiomemetboleprilgcliclettgThepropoedK22tudyprovidepplicntnecerytrgkillourcetrnidependencemoleculrcncerepidemiologtPROJECTABSTRACT/SUMMARYImmunpyhvolutiizedhowcologtttcncerptientOnetypeimmunpycludeimmunecheckpothibir(ICI)uchthoeenggePD-1cyxicCD8+TcellbolteriffecrfunctiHowevereverlcncertypegle-gentrpymodertelyeffectivewhencomdtrd--c(SOC)chempycombtigimenimproveoverllperteTherpeuticefficcymyhmpednumeroubrriercludgimmuneuppivetummicroenvirment(TME)OnemjcellulrcompentTMEcludemyeloid-deriveduppcell(MDSC)whichcltepourvivloutcomeuppntumctivyCD8+TcellpeeICIToovercomeeobtcleimmuneuppiwedevelopednovelpprochtrgetMDSCbiogenemrrowmigteirproductifunctibootICIctivymouemodeltriple-negtivebtcncer(TNBC)cncertypeelicrobutMDSCpeWeidentifiedmetbolicvulnerbilyMDSCtrgeteddependencyuggentknowndihydroottedehydrogene(DHODH)hibirDHODHhibirblockdenovopyrimidemetbolmgclicllytetedrpycutemyeloidleukemiWefoundcombgDHODHhibirbqur(BRQ)PD-1blockdeignificntlyducedtumgrowhtrpeuticefficcydependedupductiMDSCuppivectivyHowevertumtillgwtroducgtwoimptntgpFirtmunclerhowDHODHblockdeprogrmMDSCfunctiecdlymunclerhowrpeuticefficcycnfurrugmentedRegrdgfirtgpAim1F99phewefocuunfoldedprotepe(UPR)bedrtilewefoundUPRpthwyepdowngultedpthwymyeloidprogenirgiveMDSCpriwkfieldhowedUPRkeypthwywhichMDSCmedeirctivieprticulrlyvrncriptifcrXBP1RegrdgecdgpwepropoebuildSOCchemo-immunpypltmugmentntumpeTheeAim2K00phewedetermewhercptgBRQpclxel/nti-PD-1mocllAbgimenwhichclicllyuedTNBCbolterCD8+TcellpechievedurblentumimmunyOurcentrlhypoDHODHblockdeprogrmMDSCwrdleimmuneuppivettethroughnXBP1-dependentmechnmUPRpthwyWefurrhypoizeMDSCmigthroughthpthwyfurrenizeTNBCSOCchemo-immunpygimenNewdvncegedtherchhvepotentilmclicldeignnovelmoeffectivecombtiimmunpiePROJECTSUMMARY/ABSTRACTEophgelqumoucellcrcom(ESCC)lethlcncer10%-25%5-yerurvivlrteGivenimptnceerlydetectiiproceESCCmuttterdefedTotudythprocewefocuedpneoplticcellwhichhvepotentilprogneoplticcellWecomphenivelynlyzedgle-cellRNA-equencg(cRNA-eq)dtethumnESCChelthydwellnmldjcentcncerdtetvelptilchrcterticpneoplticcellWellyzedcRNA-eqdtmouemodelcrcogen-ducedESCCidentifyfetupneoplticcelltemplctextStrikglymoleculrnlyveledpneoplticcellthoughhlogicllynmlexhidelevtedcopynumrvriducedTP53CDKN2AignlgcompdhelthynmlmplebothptiltempldtetTheCELF2geneemergedrobutmrkerpneoplticcellcrobothdtetvlidtedncedpenceCELF2+cellTrp53Cdkn2doubleknockout(PC)gnoidTheeCELF2+cellhowedcedplticycquirgcncertemcellfetuundergogepilil-meenchymlplticy(EMP)Aim1determecellulrprogrmmgCELF2+cellwhenTP53CDKN2AbltedTheprogrmmedtemnevlidtedcomprgtumigenicyCELF2+CELF2-cellPCgnoidAddillytumigenicygeneticllyengeedmouemodelTrp53Cdkn2deletitetedpencebenceCELF2+cellCellulrprogrmmgloevlutedcomprgexctcelllegewild-typePCgnoidPC-derivedtumEmploygcuttg-edgegeneticbrcodgwetrceenticellulrtrjecryCelllegeetblhedAim1motliblefencepneoplticcellnmleophgelcellFurrmocelllegepopultinlyePC-derivedtumelucidtemechnmcllelectidurgtumigeneAim2ddroleEMP-undergeCELF2+cellimmuneeviAlthoughEMPcventillyknownfunctivimettroleimmuneeviletudiedOurplimryexperimentidentifiedmeenchyml-CELF2+celltumnicheleechemokecykeAim2dcloeefficiencytumigenicywhenmeenchyml-CELF2+cellco-cultudimmune-jectedcellInddicidtechemokecykegenemnipultedpneoplticcellteurwkgmodelCollectivelypropoedtudyelucidtecellulrgeneticmechnmESCCiUnderguidnceDrJe-IlPrkmenrDrKoerchkilletuchmouegeneticgnoidcncerignlgwellkillwrgtechgmenrgexpeddurgK99pheCompletgerchtrgignificntlyfcilteDrKotrnindependentvetigrPROJECTSUMMARY/ABSTRACTThelg-termobjectivethK08MendCliclScienttReerchCerDevelopmentAwrdppcidtendependenterchcerhelthervicecommunictierchimprovgcoutcomeptientdvncedcncerDepecologyprcticeguideleemphizglignmentptient-clicinundertgprognottmenttentptientvluettmentdecidvncedcncerdcdncecommCequentlyethirdptientdvncedcncerceiveend--lifecctentirpfenceExtgpprochelleveegpundertgpromotegol-ccdntchvehddppotgultIndequtettentiemotilupptmngguncerttylikelyctriehtcomgextgpprocheWehypoizenterctivevulid(VIS)uedptientircgiverclicindurgnoutptientvcnefficientlyeffectivelypromptnecerycommunictihvitrgetemotilupptuncerttymngementThecidtepropoennovtivepprochdeignevluteVISfcilteptient-clicinemotilupptmngementuncerttyctextdeci-mkgroundppgcncerttment(egchempyrdirpy)Thetrgmenrgplndeignedprovideknowledgekill(1)Deigngledgclicltril(2)Behvilterventidevelopment(3)Implementticience(4)PildevelopmentThepropoedercheptient-cgiver-clicinhdundertgfollowgeriouillnecvertioutptientettg(Aim1)developfehighlycceptbleubleterctiveVISpprochgdecipcncerttmenvertime(Aim2)evluteubilydevelopedVISptientdvncedcncerircgiverclicindurgoutptienncologyv(Aim3)Thecidteueproceuer-centeddeignBehviChngeWheelterventidevelopmentfrmewkguidemethodnlyAim1nticiptedgenertenovelightproceepromotghdundertgptientperpectiveperceivedccurcyclicin-generteddocumenttieriouillnecvertiFdgAim1uedidentifyextgcommunictigptructuderiouillnecverticologyVIScoulddd(ieNeedAement)Aim23generteevlutenovelcommunictiolVISpprochgdecipcncerttmentInculttihtemmenrcientificcollbr/dvcidteuetrgulterchBehviChngeWheelterventidevelopmentfrmewkytemticllyguidenexttepthlewkpromotggol-ccdntcubmhfirtR01propolPROJECTSUMMARY/ABSTRACTThK08mendcerdevelopmentwrdpropoldetilerchtrgplndeignedtciltecerdevelopmenttrniLNwerMDPhDndependentphyicin-cienttvetigrDrNwerpedriccologtnIntrucrPedrictChildnHoplPhildelphi(CHOP)UniveryPennylvni(Penn)Herlg-termgollednNIH-fundederchprogrmfocuedpclicldevelopmenterlynch--didetrnltrgetedrpieimmunpieimproveoutcomechildnleukemiDurg5-yerwrdperiodcricltechniclcientifictrgcquidTcellchimericntigencepr(CAR)Tcellimmunobiologyglecelltrncripmicerly-pheclicltrildeignlederhipcientificcommunictiUnderprimrymenrhipDrSrhTinlederdevelopmentmoleculrly-trgetedCARTcellrpiehigh-rkpedricleukemco-menrhipDrMrtCrrollnexpertcuteleukemiignlgtemcomplementrydvycommteeenicienttthcientificerchprogrmtrgplnboltedource-richenvirmenttCHOP/PennDepehighcurtemotchildnB-cellcutelymphoblticleukemi(B-ALL)fntB-ALLhvedmloutcomeMotcefntB-ALLchrcterizedKMT2Arrngement(KMT2A-R)ultgfuiprotecomplexcricldprprotemendriveleukemogene/fquentctivtgRASpthwymuttiPromgpcliclerlycliclefthvefocuedmllmoleculedruptiKMT2A-menbdg(men-i)MEKhibir(MEK-i)blockdeRASignlgCD19-dictedCARTcellimmunpy(CD19CART)hchievedhighpertechildnB-ALLcludgfntKMT2A-RALLHowevertlet50%eptientultimtelylpeThecentrlhypothpropolcombgCD19CARTphrmcologicdruptipecificKMT2A-RALLbiologicvulnerbiliecludgmen-bdgrrntRASignlgimprovettmentefficcylg-termmiKMT2A-RALLTotetthhypocombriltrtegymen-i(Aim1)MEK-i(Aim2)CD19CARTgtKMT2A-RALLvetigtedTheeffectedulpprocheelucidtedbothnti-leukemirpeuticctivyCD19CARTfunctilypertenceSuccefulcomplethcerdevelopmentwrdidentifypromgco-rpeutictrtegieCD19CARTpoedrpidclicltrnltichildnKMT2A-RALLTheeerchtrgeftlopropelDrNwertrnidependenceetblhgrobutcientificpipelefutuvetigtrgetedhibirimmunpiepedricleukemAbtrctHotdefenepemmmlinimmuneytemcnverypotentquiexqueptio-templcodtiThcodtieentilmtchimmunectivypecificmirgulteimmunepemimizedmgenmltuetermtepewhenhzrdelimtedStimulrterfergene(STING)nendoplmicticulum-ocedignlgproteeentiltrncriptilgultinumerouhotdefenegenegtmlignntcellSTINGctivted23-cyclicgunoemophophte-denoemophophte(cGAMP)nendogenouecdrymeengerwhichproducedcGAMPynthe(cGAS)pecyolicDNAdngerignlDepepotentntumctiviedemtrtedSTINGgtpclicltudieerlyclicltrilhveyethowignificntntumpecncerptientCurntSTINGgtdeignlwyONledg-trgetf-tumxicyhelthytueThepropoedR35progrmtegrtefourerchhrnethimptntnturldefenemechnmnovtefeefficciouSTING-trgetedrpyimmune-tntcncerInnnotechnologywedeignynize(pH-hypoxi)ANDlogicnnoprticleSTINGgttyprotectednmltuectivtedpecidicpHhypoxiignlhenttummicroenvirmentThenumimlxicyhelthytuewhilepromotgtrgetedSTINGctivtimlignncieInSTINGignlgweemploycryo-electrmicrocopyvetigteynergyPSC7AcGAMPSTINGbdgctivtiIndendriccellbiologywevetigteSTING-mededtrnmtihempoieticprogenircellcventiltype1dendriccell(cDC1)defermifictintumimmunyInimmune-cologyweemployptient-derivedtumfrgmentproSTINGgtroleimmunetnttumFurrmoweeprognoticvlueSTING-cDC1igntuectgrpeuticpettmentlikeSTING-trgetedterventicheckpotblockderpieThroughournch--clicbck--nchpprochourgolppotbrrierhvetymiedeffectivetrgetgthcrucilbiologiclpthwyultimtelypplyeightetblhuccefulSTING-trgetedrpycncerptientunpivecurntttmentPROJECTSUMMARY/ABSTRACTGlioblmpentemotlethltypecncerDepeextenivemoleculrchrcteriztipcimediceefthvelrgelyfiledglioblmrpyuggetgecomplextumilientecoytemthvercomegulrrpeuticpprocheAggtrglyocedcedcidencemtlymotcncercludgglioblmHowevercellulrmoleculrmechnmwhichggpromotetumiprogimpolyunderodTue-pecifictemcellctriedevelopmentnewlgenertimorgnNeurltemcell(NSC)undergoltlenocelldividurgnmlhomeotcomectivtedtuejurywoundpeNSCidepecilizednicheprovidemtenncecuegulteblncetweenquiecenceprolifertiInflmmtinutrientctrtNSCnicheggbrpromotequiecencedecedgenertivepotentilLikenmlbrglioblmctcellulrhierrchietem-liketumcelltpexWhilectroverilecncertemcellctrierpeutictncevinmlbrgenertinewvcultuevinti-tumimmunyCncertemcelldplymrkbleplticyndergrpeutictrgetgtrtegiechllenggInpropoedtudieRichlbrylevergeightggnervouytemmoleculrcircurycncertemcellunderthowggpromotetumgrowhroughcellunomoumechnmterctimicroenvirmentWelevergeplimryobervticncertemcellprogrmeentilmetbolicpthwythroughtegrtiextricignltum-filtrtgimmunecellvcultupromoteepigeneticprogrmmgempowergutedprolifertielf-newlimmuneeviBedthbckgroundwehypoizeggpromoteprogrmmgtumimmunemicroenvirmentcellunomounuclertructurlgultimdevelopmentnovelbrtumttmentUgptiltrncripmicmetbolomicptienttumgnoidwevetigtemetbolicltertiggtummicroenvirmentderivemulti-modlrpiedruptdynmicgrowthurvivlmechnmtumPROJECTSUMMARYCncerttmenthentrnmedcldrugcludeKeytrudOpdivoenbleimmuneytemcognizeelectivelykillcncercellUntuntelymnycncerfrcryuchimmuno-cology(IO)drugodevelopgnovelpprocheugmentirefficcyhighpriyewouldundoubtedlyledignificntductideemtlyOnepotentillypromgwychievethpromotetrncriptilctivtincientendogenoutrovirue(ERV)trotrnpocncercellydthholdlevellernceuchyelicnimmunepenpprochtermedvirlmimicryCncercellctivtedERV/trotrnpophenotypicllyembleviru-fectedcellubequentlycognizedkilledcyxicTnturlkiller(NK)cellWedcovedhnemethyltrnfereSUV39H1keycompentnenzymticcomplexeentiltrncriptililencgERV/trotrnpocncercellSUV39H1trgetgctivtedERV/trotrnpocncercellledgtimultrcellulrntivirlpthwyterfer(IFN)ignlgInpclicltudieSUV39H1hibitimultedtr-tumlfiltrticyxicT/NKcell(iecvertedcoldtumhot)enizedfrcrytumimmunecheckpotrpySUV39H1trgetgloexhidt-lentumctivyducgplictitdouble-tr-bk(DSB)cncercellpumblypromotgtrncripti-plictikcflicttctivtedERV/trotrnpoImptntlySUV39H1hibihdnoeffecnERV/trotrnpoilencgnmlcelldictgrpeuticwdowcncerttmentTheoverllobjectivethprojectdcoverpotentelectiveSUV39H1hibirpropertieubledefivelyteurhypouchcompoundwouldpowerfult-lentumdrugimmunomodulrInplimrytudiewepriledpropertieknownSUV39H1/H2hibir(chemiclpro)providedt1536-wellTR-FRETydemtrterobutnedehighthroughputcen(HTS)OurerchplndvnceeplimrytudiehfourimAim1identifyelectiveSUV39H1hcffold320000compoundHTScmpignAim2utilizetructu-beddeignpprochcvertcliclgrdeSUV39H2hibirpotentSUV39H1-electivecompoundAim3uebiochemiclADMEyertivecyclemediclchemtryidentifyledcompoundpotentcellulrctivyAim4furroptimizeeledcompounddrug-likepropertieexploirt-lentumimmunomodulryeffectugvivocncermodelTheultgdrugleddevelopedthtudynticiptedhvebrodutilyteurrpeutichypopentcricltepouroverllobjectivedevelopSUV39H1hibirrpeuticcncerptientpecificllythoetumfrcryIOgimePtientlife-enghemlogiccncerexperienceomniftiguedtpympmwenomnidurgfollowghopliztihigh-doechempyDepenurgentneedlimedympmmngementprocolcomphenivelytrgetchllenggttment(ieptienutptient)ympmdemfcedhemlogiccncerptientWedevelopedteted6-eirpt-ledtelehelerventihemlogiccncerptientfollowgdchrgeptientttment(Ne2Dy)Ne2DytechemdfulnemedtihviltrtegieimproveomniltedftiguedtpympmNe2Dydemtrtedtrgfeibilycceptbilyignificntimprovementprimry(omnid=120)ecdryoutcome(ftiguedtmdfulned=38-89)Ne2DydoenotddptientettgwheptientdecrileepqulyepecillypoThpilotromizedctrolledtrilextendNe2Dyptientettg(Ne2Dy+)efeibilycceptbilyenggemenutcomeptternHemlogiccncerptient(N=60)ptgomniympmdurghopliztiromized(11)Ne2Dy+UulCNe2Dy+delivedvielf-pcedmobilepphoplclude1)mdfulnemedtipromotgcceptncechllenggptientettg2)briefvideoleepeducti(egleepdrivecircdinrhythm)hviltrtegieimproveptientleepquly(egtimuluctroldytimectivy)3)olmngeptientleepdrupti(egleepmkerplug)Oncedchrgedhomeptienttrnipvioulyteted6-eiprocolWehypoize1)Ne2Dy+feible(ccrulN=60/24mth<25%ttri>75%dhenceementterventi)cceptble(M>3/5tfctiproceduM>3/4tfctiNe2Dy+)enggg(Ne2Dy+pplog-video/killprctice>2x/week)2)Ne2Dy+improveomniympmevery(primryoutcome)ecdryoutcome(ftiguedtpp-leeproulmdfulneympmmngementelf-efficcy)belehopldchrgefter6-eiprocolcompdUulCDrFherceivedvncedtrgexpertmenrhiphvilleepcncerympmmngementhvilterventidevelopmentptienutptientettgromizedtrildeignttticlmethodoptimizghvilttmentgimenimprovetrniptientoutptientettgThtrghelpDrFherpuruefutuequentilmultipleignmentromizedtrilegomniympmmngementtrtegiepivechllenggttment(ieptienutptient)heterogeneouympmdemfcedhemlogiccncerptientFdgcouldmdpttipychoocilterventiptientettgetblhnewmodelytemticympmmngementvrioucncerhoplizedpopultiPROJECTSUMMARYThegolthprojectdetermewherpoiblepromotedevelopment/mtennceCD8+Tcelleentilnti-tumpePD-1immunecheckpotblockde(ICB)rpytrgetgPSGL-1(P-electglycoprote-1)StudieexhutedCD8Tcell(TEX)chricLCMVfectiidentifiedtermllydyfunctilTEX(TTEX)progivediffentileexhutedcellcpcyeffecrfunctiecellderivetem-celllikePD-1+elf-newgcell(TSC)expgtrncriptifcrTCF-1AlthoughnotyetwelltudiedcncerprogenyTSCdeigntedpcurexhutedTcell(TPEX)foundmouemodelmelnommelnomcncerptienttumwheirfquenciepdictpePD-1ICBTheidentifictieubetcidedprdigmhiftgceTEXwepvioulythoughtmimllylterirnti-tumpecueepigenetictbilyHoweverductiTPEXpePD-1ICBcuerpidTEXdiffenticednumrTTEXctrigimmunpytnceThufundmentlquetiwherTSC/TPEXcngenerted/mtedceptientpeprogifeurvivlPD-1ICBWeidentifiednunexpectedfunctiPSGL-1TcelltriccheckpothibirpechricvirlfectumPSGL-1ctuptmPD-1promoteupgultimultiplehibirycepr(IR)TTEXdiffentidurgchricntigentimultiAlthoughVISTAPD-L1homologuewhownligPSGL-1vrofunctivivohnotenetblhedbdgPSGL-1mycricldriverTEXdiffentiWehowedPSGL-1enggementgerTCRignlgelicTTEXdevelopmentbothhumnmoueeffecrTcellvroundercgtegrlcnectiimmunehibirypthwylevncehumnnti-tumpeInctrtPSGL-1deficiencypventTTEXdevelopmentovercomghibiTCRignlgcferdchrictimultipromotgignificntctrolnnti-PD-1tntmelnomNotblythoutcomecpultedPSGL-1blockdefocuthpplictiWhPSGL-1-/-TcellwefdgterfquencieCD8TcellteffecrfunctiexpgenewhichidentifyTSC/TPEXcludgTCF-1UgPD-1ICBtntmelnommodelddimelnomptientmplewepropoetethypoPSGL-1blockdepromotegenerti/pertenceTSCTPEXpventgenggementVISTAnovellig()WedetermefteecellPSGL-1ICBlegernti-PD-1Wetetnovelmocllnti-humnPSGL-1ntibodieirbilyupptTPEXdiffentiblockTTEXdiffentienhncenti-tumTcellpecrobtepotentilclicltrgetgPSGL-1novelimmunpyAbtrctWehveidentifiedhighlytumpecificcellurfcentigenALPPL2ALPGnotexpednynmltueexceptplcentALPPL2expednumrcncercludgmeoliomovrinlunggtricpncticendometriomteticulrcncerALPPL2ethoercellurfcentigengenuelytumpecificoppoedtumocedTheexquetuepecificymkeALPPL2nttrctivetrgetdevelopgcncerrpiequihighdegepecificyWepropoedevelopnALPPL2-trgetedbpecificTcellenggerttmentALPPL2poivecncerTrgetpecificyhllmrkournewrpydevelopmenteftInddiweengeerCD3rm(1)lowffyCD3rmhpotentilducgtrgetdependentcykeleethuggwiderrpeuticwdow(2)tumkillgcykeleemededtwothholdcndiffentillyimpctedCD3rmengeergAmildmiml-trgetcykeleedeidAnimptntvribleffectdevelopbilyrpeuticwdowmoleculrrchectuwhichbpecificctructedInthpropolweddthecriclueietrgetpecificyCD3rmoptimiztimoleculrrchectuueytemengeergpprochidentifynoptimizedTcellenggermtchgcompentmimprtnexcellentdevelopbilywiderpeuticwdowenblgtrnlticlicltetgInAim1wegenerteALPPL2BiTEengeedCD3rmvrintmcomptibleclicltrnltiInAim2wetudytum-pecificcyxicycykeleeytem-engeedBiTEtrgetgtruetumpecificntigenALPPL2InAim3wedetermeefficcyvivoidentifyledALPPL2BiTEclicltrnltiImpctSuccefulcompletipropoedtudyleddictlyclicltrnltinovelbpecificTcellenggerunpcedentedtumtrgetgpecificymultiplecurblecncertypedicliclneedPROJECTSUMMARYProttecncer(PC)motcommcncermgmenRdirpyntegrlprttrdcttmentPCLoclcurncePCfterrdirpyuullyigteprimrytumeAdoeeclticlicllyignificnttum(cT)focermede-high-rkptientptedultignificntlyimprovedbiochemicldee-feurvivl(bDFS)outcgrdixicyCurgtrprottictumcurntlybedmultiprmetric(mp-)mgneticnceimgg(MRI)terpttiMRIultbedProtteImggReptg&DtSytem(PI-RADS)Howeverltivelylrgevribilypermncemp-MRIcludgPI-RADSctuepoebrrieridentifyclicllyignificntprottetumttmenttrgetimproveptienutcomeInthprojectwepropoedduebothMRItechniquecgytempectdevelopolcnumticllydeletetrprotticcTeilytrnferdcliclueTochievethgolAim1webuildqunttiveMRI(QMRI)oletcludgmgneticncefgerprtg(MRF)rterilpllg(ASL)diffui-weightedMRI(DW-MRI)Tholetprovide3-dimenilhigh-olutiqunttivempdictlyocedtumphyiologypthologyfetuInAim2bedQMRIoutputwedevelopnumtedPCtumprobbilymodelegmenttimethodcnumticllydiffenteclicllyignificntprottecncerprottictueAim3vlidtitudyWevlidtepermnceournewlydevelopedmethodgtbiopyultcomppermncephyicincurcTfocibedmp-MRIPI-RADScurnttrdc(SOC)WeexpectultthprojectprovidecompletelynewetQMRIoltumegmenttimethodimprovecurntSOCmp-MRIPI-RADSThllowuccurtelyidentifyclicllyignificntPCtctprottebootirrdichievemximlloclctrolprottecncerrdirpyoutcgrdixicyABSTRACTThemrkbleeffectiveneCOVID-19mRNAvcceherldtrnmtiveimmuniztipltmgtvirlfectiAkeynovticognized2023NolPrizeplcementuride(U)N1-methylpeudouride(m1)irmRNActructThubtutiduceideeffectcentigenproductiHoweverpplygm1-modifiedmRNAvccelmcncerimmunpytroducehotnewcomplexchllengeTheerngeundertgimplictiU--m1ubtutinti-tumCD8+Tcellpedevgeffectiveprimgbootgtrtegiectgmopdictivenimlmodelurmountgimmunouppiveelementtummicroenvirment(TME)ToddechllengethpropoloutleerchfrmewkbuiltroundmechntictudiegolgenertgnewmRNAvccepncticductldenocrcom(PDAC)cncerurgentunmetrpeuticneedSpecificAim1eekengeernewclmRNAvccetrgetgclicllylevnttumntigenmeol(MSLN)mutntKRAS(KRASG12D)SubAim11ctmechntictudiemtrtegieoptimizgmRNA-encodedntigendjuvntpropertiedevgeffectiveprimgbootgpprocheenhnceimmunogenicyducecgenicySubAim12uetrgentPDACmodelevlutewhernewvcceignificntlyimproveefficcyTcelltrnferrpieSpecificAim2evlutenewmRNAvccehumnizedimmuneytemmouemodelDueignificntterpeciediffencenteimmunepemRNAvccevlmoveydtrdilmouemodelSubAim21imunderteffectevccehumncventiltype1dendriccellubequentCD8+TcellctivtiSubAim22focuevlidtgvccefetyefficcyhumnizedmouemodelengrftedhumnPDACtumSpecificAim3eepotentilllele-pecificKRAShibirprogrmimmunouppivePDACTMEthuenhncgmRNAvcceefficcySubAim31vetigtewhernewmRNApltmpventtumcurncePDACmouemodelttedllele-pecificKRAShibirSubAim32eekelucidtehowcombgmRNA-bedimmunpieKRAS-trgetedrpieimpctimmunogenicyPDACcellcompoiimmuneTMEnti-tumefficcyDeliverblerngedevelopgoptimizgnewmRNAvcceytemticmechnticevlutievccebothcventilhumnizedmouemodelfllyvetigtgynergieclicl-tgemutntKRAS-trgetedrpieThenticiptedimpctctdvncgundertghownewmRNA-bedimmunpieenbleprimgutgcncer-immunycycledevelopgeffectivecombtirpiegtPDACfutuclicltrnltiMettticlungcncerkill>160000peopleUSnnully10%-50%ptienturgicllyectedlungcncerdevelopdtntmettThemnunmetneedunderttumgenomicdrivemetteSMARCA4motfquentlymuttedmemrSWI/SNFcomplexlungdenocrcom(LUAD)ltertioceddevelopmentmettticdeeWheSMARCA4cnicllyctchromtmodelermechnticvetigtiourlbvelncniclROR2/p-GSK3S9pthwyvolvedlo--SMARCA4mededtrncriptilgultimettLUADSpecificllyknockdownSMARCA4LUADcellcevimetteIncedSMARCA2upgulteROR2hibiROR2brogtevimettSMARCA4-deficientLUADMooverROR2cebundncetrncriptifcrC/EBPctivtinuclerGSK3bUgGSK3hibirwecuedviSMARCA4KD/ROR2KDcellOuroverrchggol1)elucidtemechnmthroughwhichSMARCA4-deficientLUADgultetrncriptipromotemette2)determeroleROR2/p-GSK3S9pthwymettSMARCA4-deficientLUADTwopecificimteurhypoeAim1InvetigtemechnmthroughwhichdeficiencySMARCA4promotemettLUADWepermRNA-eqChIP-eqATAC-eqelectedctimirgmpectrometryugLUADSMARCA4dTAGcellmeugenetrncriptichromtcceibilyquntifytrncriptifcrltimeAnvivoCRISPR/gRNAcenpermedidentifyfunctildowntmtrncriptifcrROR2/p-GSK3S9pthwyNextweuempectrometryimmunoFISHdecodemechnm()throughwhichSMARCA2upgulteROR2SMARCA4-deficientLUADexplolterntivetrget()uppmetteAim2EvluterpeuticefficcytrgetgROR2uppmettSMARCA4-deficientLUADWeeclicllevnceROR2/p-GSK3S9pthwySMARCA4-ltedLUADleverggourclicllynnottedbiopoiry>2000humnLUADpecimenWenueourLUADptient-derivedgnoidmodelexmequimentp-GSK3S9metteSMARCA4-ltedLUADtetwherphrmcologichibiROR2ugnntibody-drugcjugtecurntlyclicltrildecemetteSMARCA4-deficientLUADFllyugpublhedKrLSL-G12D/Trp53fl/fl/Smrc4fl/flgeneticllyengeedmouemodelwevetigtecell-pecificdependencyROR2/p-GSK3S9pthwyImpctOurwkprovidemechntictrnltilevidencehighlightdeficiencySMARCA4nimptntmettticdriverLUADthroughROR2/p-GSK3S9pthwyprovidenimptntpclicljutifictifutuclicltriltrgetgROR2SMARCA4-deficientLUADdecemettSummryTheobjectivethpropoldetermemoleculrmechnmunderlygluml--neuroendoctrndiffenti(NET)prottecncer(PC)NETunderlecriclprogiprottedenocrcom(AdPC)neuroendocPC(NEPC)lethldeenocuUndertgmoleculrmechnmdriveNETmypvewydcovergcricldruggbletepidentifygbiomrkerNEPCprogiInourplimrytudiewegenertedmodelytemwhewepuhprottelumlepililcellLNCPwrdNEcelltypeoverperiod28dyviovexpi(OE)glegeneFOXA2chromt-pieergfcrTime-coureRNA-eqnlyeFOXA2-OEcellveledgrdulloepililgeneexpigNEtrncriptilprogrmThtrncripmichiftccompniedubtntilltertiTFbdgchromtmodelgtlumlNEenhncerccompniedmrkblechngeDNAmethylti3DchromtrchectuIntetglyFOXA2ducedtrncriptineurlTFclledNKX2-1dy14(D14)OEexpiNKX2-1quidcompletiFOXA2-drivenNETFurrNKX2-1FOXA2bdpromoterenhncerpectivelyyterctechthroughchromtloopgco-occupyctiveenhncerFurrwefoundgilDNAdemethyltiroundFOXA2-bdgemrkbleup-gultiTET1keyenzymectlyzeDNAdemethyltiD14followgFOXA2OETheeplimrydtledourcentrlhypoenhncer-boundFOXA2terctpromoter-boundNKX2-1driveluml--NEtrndiffentivolvg3DchromrgniztienhncerprimgctivtiwhichquigilDNAdemethyltimededTET1TotetehypoeAim1firtdetermewherbilieNKX2-1bdDNAterctFOXA2bothquidrolefciltgFOXA2-ducedNETnvlidtethpthwyddilNEPCmodelAim2evlutewherTET1ductD14quidFOXA2-drivenNETthroughmodultggilDNAdemethyltiNEenhncerprimgLtlyAim3vlidtegenomicepigenomicprogrmmgcliclmplecomprtivenlyeptiltrncripmewhole-genomeDNAmethylti3DchromttructuAdPCvNEPCmpleWeloexmedowntmgenegultedTET1hibirtetefficcyuppgNEPCgrowthvrovivoBtctructicnhelpfeme-pentgdividulrgqulylifemigtgimpctbodyimgedruptiduepperncechngergmtecmyAulogouctructiwidelycognizedeffectivelgtermdvntgeovertechniqueHoweverulogouctructiproceducomplexlengthyopertiquirgubtntilkillexperienceMooverviprocedutypicllyquiddequtelyptientbodilymomecemultiplevineededPriwkvetigtedimplemoldmelycopiedpopertivehpeizeptientbtmirrodverictrlterlbtceunilterlbtctructiButmnyptientdeiquidiffentbtmftermtecmyoimplycopygpopertiventivebtmdequteThepropoedtudywouldhiftcurntcliclprcticeprdigmenblgptient-pecificmoldptientwhoectructivegolnotmelyproduceirpopertivebtMooverwhilefewpro--ccepttudiehvedemtrtedfeibilyugptient-pecificmoldhpetuebtmcriclbrrierprogfieldnoehrigoulyevlutedirimpctInctrtpropoedtudycluderomizedctrolledclicltrilevlutiThegolthtudydevelopclicldeci-upptlghmdeigngptient-pecificbtmoldtuehpgWehypoizeulogouctructimoefficientwhenpermedptient-pecificmolddeignedugourclicldeci-upptlghmThepropoedprojectignificntcuehpotentilimproveefficiencyulogoubtctructinimptntcompentbtcncerhbiltiThevetigrmulti-dciplrytembrggcomplementryexpertebiomediclmticbiottticengeergtechnologyctructiveproceduThnovtiveprojecteekovercomelimtipritudiedevelopgclicldeci-upptlghmenbledeignptient-pecificmoldubleptientwhoectructivegolmocomplexthnproducgirpopertiveppernceOurpprochentildevelopgclicldeci-upptlghmmedouxperienceimgeperceptimchelerngimgeproceghpemodelgcductgthoughevlutiromizedctrolledclicltrilOurtemnefexteniveourcevilbleMultidciplryBtRectructiReerchProgrmAfteruccefulcomplethtudywepuruepthclicltrnltinlogouextgproducterviceuchcurntytemdeigngptient-pecificmolduedmiblectructiABSTRACTWeddcriclproblemcliclcologynmelyhowhighlyheterogeneoudrugtnttumcellpopultidevelophowycntrgetedMottumdeveloptncelmoteverytyperpycludgtrgeted-rdi-chemo-immunpyultimtelyledgcncerdethIteentildevelopnovelmethodundertproceeledgdrugtnceundercomplexvivocdiwhetromlimmuneelementterctmlignntcellWetudyqumoucellcrcom(SCC)mjctriburhumncncerburdenemotcommolidtumtyperngetuecludghednecklungeophgubldderkWeuewell-etblhedmulttgecrcogen-ducedcutneouSCCmouemodelcdentilpenttihumncncerdrugtnceMouecSCCdplymnygeneticltertieenhumnSCCcludgmuttiRPI3KeNotchpthwyThemodellocptecriclroleplyedn-mutgenictumpromotgfcrcncerdriverThpropolbuildourpviouwkccegourextenive-houemouetumgenomictrncripmicdtbeInAim1weueglecellnlyeprimryppillomcrcommetteducedchemiclcrcogeneunlyzededurgchemo-immunpieWeueournovelbiocomputtilMetgenepprochidentifywirgtrncripmicnetwkgletumcellfterrpySglecellnlyenmelycRNAeqCyTOFMIBIFISHcomdour-houedevelopednlyticlolidentifyhighplticyttetumcellpopultienricheddepletedperpyirmoleculrptilltihipcelltructutumInAim2wetetfidelychemiclcrcogenemodelrobutpenttihumncSCCbiologyundertkglgudlvlidtitudiefhhumncSCCtuecollectededurgchemo-immuno-rpynlyzedugmetechnologyInAim3weempiricllytetfuncticidtegene(Metgenecompent)expedhighplticytteirctriidrugtnceCRISPRi/dC9CRISPR/MultiC12technologyuedtetgenectiviedurgdrugrpyglecombrilgeneknockdownyngeneictummodelvivoOurtrtegycdentiluekchemiclcrcogeneytemmodelfetuhumncncerdrugtnceTheprojectpivePAR-23-281undertkecro-peciedcoverymoleculrbdevelopmentdrugtnttumcellTheknowledgegedctriedcoverybiomrkerrpeutictrgetthdrugtntcellpopultiOurcomputtilmethodologyourextenivetrncripmicdthunddtuetummplehdOncologyModelFumNCIPHubSummryCncercellhrbigngenomictbilycludggenomerrngementwhichcnctrietumdevelopmentFhfulDNApircombtthtbilypowerfultumuppmechnmwheerreoupirledpthologicloutcomeThehentgenomictbilycncercellmkemmovulnerblehighdmgeburdenDNAdmggrpiemgtmotwidelyuedmotuccefulcncerrpieDNApirenblednuclercomprtmentpirdomSptilgniztipirfciltebiochemiclctitrictctipecilizedcomprtmentwhilebrggDNAleicloeproximythufvgrrrntgenomerrngementWehvemdeilprogvelgmechnmunderlyg3D-gniztigenomefollowgDNAdmgeBedouremldcoverymechniclcedrivg3DrrngementgenomefollowgdmgewepropoetterundertmechnmpibleemblyDNApirdomevlutephyio-pthologiclcequenceemblgedomfollowgttmentchempeuticdrugWeloexplocnectitweenDNAplictiDNApir3DOurtudiehouldvelcommrulegovernggniztiDNAtrncti3DwhichturnhvepotentilidentifynovelvulnerbiliemotcommmodliecncerttmentPROJECTSUMMARYOver500000urvivchildhoodcncerlivgUnedSttedyCrdiovculrdeeledgcuencncerltemtlythcohtSubgroupurvivcludgdividulpvioulyexpoedrdichetbdomentlbodylotttment-ltedrkctellticrdiometboliccombidiecludgtype2ditemelluchricflmmtihyperteniwhichfurrmplifieirrkcrdiovculrdeeTilodclbleutbleterventitrgetmodifiblerkfcruchoythuurgentlyneededducecrdiometbolicrkthcohtTime-trictedetgvoluntrybtencellclictke14-16hourperdyhendemtrtedp-cliclhumntudiecombterkThmodeftgpperfeiblefeutblediverepopultiReultefficcytime-trictedetghoweverdcpntcrotudieometudiedemtrtgmrkedimprovementweightglycemicctrolcircdinrhythmlignmenrhowgmimleffectYeterventihnotentetedchildhoodcncerurvivunknownwherwouldnefficciourk-ducgterventhpopultiThepropoedSTRENGTH(SurvivenggedTime-RetrictedEtiNGfterTHerpy)Studywouldfillthgpdetermgefficcytime-trictedetgduceweightimprovemrkercrdiometbolicrkrdi-expoedurvivoverweight/oyTothendwecductpheIIbromizedctrolledtril300rdi-expoedurvivchildhoodcnceroverweight/oyenrolledChildhoodCncerSurvivStudy(CCSS)Prticipntromizedeir6-mime-trictedetgterventifollowed6-mthmtenncepheuulcwhichctmiledeductilhouthelthylifetylehviWe(1)Determeimpcttime-trictedetgmeuweightttuweight-ltedoutcome(wtcircumfencepercentbodyft)(2)Aeimpcttime-trictedetgcrdiometbolicrkprile(bloodpuglycemicctrolultncedipokemrkerflmmti)(3)IdentifymodertgmedgfcrwellbrrierfcilroceddhenceterventiweightlogolmgfutuimplementtieftThepropoedtime-trictedetgterventiwhichgroundedocilcogniveycludetepweprogibuildelf-efficcyugnudgemotivtilterviewgThpropollevergenovelmHelechnologydeliverfullymoteoticllygroundedhvilterventiducecrdiometbolicrkddburdencncerttmentmgdult-gedurvivchildhoodcncerTime-trictedetgmypentutbleterventiimprovelg-termoutcomehighlymbidurvivcohtPROJECTSUMMARYLungcncerledgcuecncerdethmgAfricnAmericnpopultiAlthoughmnyctiblebiomrkertrgetedttmentvilbleignificntlyprolglungcncerurvivlptientn-Europenncetrylelikelyundergext-genertiequencgtetgceivedtrgetedrpiethnirwhecounterprtStructurlenvirmentlfcrlikelyctriethdpryhoweverevidenceuggetgomticgenomicdiffenceloctrieeverllungcncerdrivertrgetblebiomrkerhveenfoundhvediffentltertifquencietweenpopultiHoweverAfricnAmericnptientevelyunderpentederchtudieclicltrilegenomiclcpelungcncerAfricnncetrympolyunderodOurplimrynlybedl-wldobervtildtclicltumequencguggetpvlencetrgetbleltertiKRASROS1fuidiffentptientAfricnncetrydependentmokgttuIntetglyncetrymymodifyeffectmokgexpoulungcncergenomeTP53muttiweignificntlyenrichedmokernotnevermokerAfricnncetryMooverignificntenrichmenthightummuttiburdenlightmokercompdirwhecounterprtlepvioutudiehowghigherrklungcncermokerAfricnncetryuggetgdiffentgenomicmechnmultntfluencencetry-mokgterctiInthprojectwetketheprllelpprochecomphenivelychrcterizelungcncergenomeptientAfricnncetryInfirtimweidentifyvlidtemogenomicdiffencetweenptientAfricnEuropenncetryfocudrugtrgetbleclicllylevntbiomrkerWelolocu-pecificgermlencetryidentifygeneticn-geneticctriburomticdiffenceInecdimwefocuvetigtgterctitweenAfricnncetrymokgexpouomticltertidevelopcomputtilpipeleleverggf-trgetdpnelequencgtudygenome-widegermlefluenceInthirdimwedevelopdeeplerngmodelllowufurrundertgenerlizbilyncetry-pecificyimmunpyoutcomepdictiFllywemoveydpnelequencgidentifynewmrkerptientAfricnncetryugwhole-genomeequencgcoupledRNA-equencgThepropoedtudybrodenourknowledgeboutcomplexltihiptweengeneticncetryenvirmentlexpouncetry-envirmentterctictriggenomicdiffenceThefdgvelgermlefcrocedomticphenotypeimproveimmunpyoutcomepdictiledfututudydcoverynewttmenptiAfricnAmericnptientPROJECTSUMMARY/ABSTRACTThpplictidevelopedupptRozlynRodwMDMHScurntAtntPPedricHemlogy-OncologytYleSchoolMedicetrnigdependencephyicin-cienttwhovetigtelteeffectchildhoodcncerrpyHerlg-termcergolimprovehelthqulylifechildhoodcncerurvivdevelopgimplementgnewmethodcenttment-ltedcutelg-termxiciecncer-dictedrpyDrRodwprojectbuildherpriwkuedqunttivemethodidentifyympmchempy-ducedperipherlneuropthy(CIPN)childncncermeuocedimpctWhmenrhipupptmultidciplrytemexpertpedriccologyhelthoutcomechildhoodcncerurvivhipttmentxicyqultiveerchurveydevelopmentphyiclrpyimplementticienceDrRodw1)cquidvncedtrgqultiveerch2)lerntechniquenecerydevelopvlidteurvey3)trimplementticiencethroughcombtididcticexperientiltrgctiviemenderchCIPNdebiltgideeffectthccurup87%childndurgcncerttmentItprticulrlyimpctyoungchildnterfergkeymdevelopmentlmilenecnhvelifelgimpcnirhelthErlydetecterventicnimproveympmup80%cemedCIPNchllenggdignoecuenovlidtedcengmeuchildnyoungerthnfiveeventhough~40%childntrkCIPNunderfiveProxy-pturveycompletedpnrgurdinhveenuedcenhelthcdiyoungchildnhvenotendevelopedCIPNThprojectoverrchggolimproveCIPNcengyoungchildnge1-5yerdevelopgnovelproxy-pttrumentpnrgurdincncompleteWeim1)developemnovelproxy-ptympm-bedurveycenCIPNugqultivemethod2)propectivelyevluteurveypychometricpropertie3)collectplimrydtmurveyimplementtiThtrumentenbleidentifictiptientCIPNwhocnnefterventipromotechildhoodcncerurvivlg-termhelthAlgpropoedcourewktherchprovideDrRodwtrgexperiencedependentlycductfututudieimedtfurrvlidtiimplementthtrumentShepplyknowledgegedthroughthprojecttudieimedtcengerlyterventtment-ltedxiciechildhoodcncerurvivABSTRACTAlthoughimmunpyepecillyimmunecheckpothibir(ICI)hemergedpowerfulcncerttmentlethnhlfdvncedN-SmllCellLungCncer(NSCLC)ptienthvepdedThecrucilneedbiomrkerenbletterpdictieICIrpyovercomeICItnceAmgctrigfcrICIrpytnceimmunouppiventutummicroenvirment(TME)emotchllenggDepeimptntrolebtumlmicrobiottum-filtrtgimmunecellhugegplkgpecifictum-idgmicrobiotchngeimmunecellubpopultiNSCLCttedICIWehypoizentegrtivepdictimodelcptetrtumlmicrobiotimmunepdicrhpotentilubtntillydtguhICIpdern-pderimproveelectiptientmotlikelynefICIrpyWepropoecplizeextgpropectivelycollectedp-ICItumbiopieICI-ttedNSCLCthecoht(n=500)BylCollegeMedicecohtBonLungCncerSurvivlcohtMftCncerCentercohtPtientclifiedICIpder(defedcomplete/prtilpetbledee)n-pder(defedprogi)ugmodifiedRepeEvlutiCreriSolidTum(mRECIST)creriToidentifynewpdicrdtguhpdern-pdereICIrpywepropoefollowgtheSpecificAim1)ToidentifytrtumlmicrobiomeprilepdictiveICIpeugWhole-MetgenomeSequencg(WMS)2)TochrcterizeptilimmuneigntupdictiveICIpeuggle-cellImggMCymetry(IMC)3)TodeveloptegrtedpdictivemodelICIpecptgcliclmicrobilimmunologicldtugdeeplerngpprocheIntegrtummicrobiometerctiimmunefiltrteTMEltivelynewfieldvetigtichllenggendevwhichhnotenptedNSCLCThpropoedtudybuilduprchivedml-fixedprff-emddedpecimenpoirie(p-ttmenttumecticobiopie)mtucliclttmentpeurvivldtthedependentcohtexperiencepropoedexperimentlmicrobiomeptilimmuneprilg(WMSIMC)pprochetutilcofciliemultidciplryerchtemcludgcncerepidemiologtimmunologtmicrobiologtcologtbiomticexpertProjectSummryOnlybout20%pncticductldenocrcom(PDAC)ptientexpectedurviveeyerdignooverll5-yerurvivlrteptedtdevttglylow8%whichlowet5-yerurvivlrtellmjcncerAhllmrkPDACdeneextrcellulrtromclleddemopliwhichcnoccupyup90%tumvolumeThedemoplictphyiclbrrierpventgdrugchgtumcellAddillydemoplictbrrierpventimmunecellfiltrtgtumlimgefficcyimmunpieSytemicllydmtedtromltrgetgrpiehveprovidedpromgrouteducgdemoplillowbothcelldrugentertummodilyHoweveregenthvewiderngef-trgeteffectwhichlimdoeptientcnceiveTheoverllgolthpropoldvnceloclctrolledleepltmtrtumldeliveryhyluridellowglocllyelevtedccentrtienzymeoutytemicvolvementAim1focuuemulti-clemodelgpprochdefeprmeterpceimplntdeignneededchieveunimdtriihylurideexcedhumntumAim2focueduemediclimggchrcterizeeffecttromltrgetggenttumbloodflowdrugccumultiAim3chrcterizeeffecttromltrgetgrpiehveimmunomodulrygentimprovedimmuneurveillnceevlutettmentefficcyThepropoedtudieetblhnovelpprochtrgetgtumdemopliimprovgmtrnpttumenhncgimmunecellfiltrtumPROJECTSUMMARYThprojectfocuenewepigeneticvulnerbilyhumnglioblm(GBM)motcommdedlydultprimrybrmlignncyWedcovedbromodom(BD)-ctgchromtgulrBRD8eentilGBMlckgp53mutti(TP53WT)whichmkeup~71%ce(SunetlNtu2023)(1)BRD8mtmlignncycripplgp53-mededtumuppiwydtctpvioulydecridmechnmprogrmp53netwkthroughEP400hnecetyltrnferecomplexBD-dictedoccupncyhnevrintH2AZtp53-ducedtrgetencgpivechromtttepventp53-mededtrnctivtiCentrlthpplictiourfdgtrgetgBRD8TP53WTGBMmodelchromtevictgH2AZenhncgchromtcceibilyenblgp53bdtrnctivtetrgetThchromtmodelgccde(ferdBRD8/p53epigeneticwchthpropol)-etblhep53ctivyTP53WTGBMnmlizggeneexpievokgcellcyclerthibggliomgeneprolggurvivlxenogrftmodelTP53WTGBM(1)Wedvncethwk(i)velgBRD8oppoep53functin-mlignntbrcell(ii)ettgupgle-cellgeneexpipipele(iii)howgBRD8BDlyBDelectivelyprogrmp53netwk(iv)engeergGBM-premouemodeltctp53whichwecnblteBrd8(v)etblhgTP53WTGBMgnoidptientThebovefdguppthypotrgetgBRD8TP53WTGBMevokeBRD8/p53epigeneticwch-etblhep53-mededtumuppiDepeedvncehowBRD8/p53epigeneticwchwkwheruefulttgptientTP53WTGBMmobcuTheegolAim1defeepigeneticmechnmwhichtrgetgBRD8-etblhep53-mededtumuppiTP53WTGBMgnoidThccomplhed(Aim11)defgetgenetrnctivtedBRD8/p53epigeneticwchtgle-cellolutichrcterizggenomicepigenomicfetueloci(Aim12)identifygpthwyducedBRD8/p53epigeneticwchfciltep53-mededcellcyclert(Aim13)elucidtgdynmicBRD8/p53epigeneticwchhowmodultedEP400ThegolAim2demtrtepclicllevncetrgetgBRD8-etblhp53-mededtumuppivivoThccomplhed(Aim21)egeffectivenetrgetgBrd8engeedGBM-premice(Aim22)etblhgeffectivenetrgetgBRD8ptient-derivedxenogrft(PdX)modelTP53WTGBM(Aim23)evlutgheterogeneyp53-ducedtrgetglecellGBMptneouPdXmodeldefgcellpopultiimpctedBRD8/p53epigeneticwchTheoverrchggolthpropolddundertgcomplexterctitweentumhorgnmfciltenewrpeuticpprochecncermediceSpecificllyweimetblhmechnticexplntiobervtwoIL-6ocedmumodelcncercchexiKDdelytumgrowthccelertecncercchexihtenurvivlWedcovedthuncouplgmycequencebiochemiclterctwoimultneoulyoccurrgNADPH-dependentpthwyWiumcedproductiLPPcequentlyturtiglutthieytemledferropticdethcncercellSytemicllydoximblnceNADPHdepletiimpirbioyncticoteremgulrmetbolictdnlglThepropoleekbuildedcoveriethewyFirtwedetermepecificpolyunturtedftenricheddietferropducgdrugcludglicenedmedictiexcerbtenti-cncereffectSecdftervlidtgglucocticoiddeficiencycriclcompenturvivlductihorgnmugplmliverdnlfocuedyweueytemticphrmcologiclcueexperimentenblerpeuticwdowKDterventiThirdwetrckhowoxidtivetducedGDF-15elevtimycpiIL-6elevtidrivecchexocednoxivineurlcircucuenegtiveenergyblnceccelertecchexietKDfedmiceTheulttherchmytetcienttmediclpilAcombtidmtrtiynticGCmyimprovefoodtkenmlizeglucoehomeotutiliztinutrilubtncedelyetcncercchexiextendurvivltum-rgmicefedKDwhilenotcounterctgducedtumgrowthducedKD-ducedferropTheetudieemphizeimptncecidergimpctcncerttmenthottumSUMMARY/ABSTRACTBtcncerledgcuedethUSmjpublichelthburdenewomnouteightceivedignoherlifetimeAdvnceDNAgenotypgequencgtechnologiehveledidentificti>300germlevrintctriebtcncerrkHoweverdylrgeomictudiecludewomenmotlyEuropenncetryeventhoughplimryevidencedicteclerneftudyggeneticllydiverempleAgenomewideocitudy(GWAS)Hpnic/Lt(H/L)womenetenthnumrdividulcludedpvioutudieleddcoveryprotectivevrintlypentpopultihveIndigenouAmericnncetryTheevrintignificntlyddpdictiveccurcybtcncerpolygenicrkco(PRS)H/Lpent16%USpopultiometteup37%ToddlckH/LpenttigenomictudiewehvectedLtAmericgenomicbtcncer(LAGENO-BC)ctiumwhichclude~28500LtAmericnbtcncerptient~32600unffectedwomen11diffentcountrieUSdpOurgoltudyLtAmericn-pecificgeneticrchectubtcncerdeveloppdictivemodelccountvrincetrygeogrphyBycombgextgtudieLAGENO-BCqudruplepriH/LBCGWASmpleizecequentlyprovidepowerquiddcoveryddilvrintctrigbtcncerrkimprovgpdictivepowerPRSrktrtificthoepopultiInfirtimwepropoedcoveruceptibilylocigeneocedbtcncerH/LcductgGWASncetry-mtchedmulti-tuemodel-bedtrncripmewideocitudiedilyvilbleRNAequencedt(TWAS)Theenlyepetedoverllrkubtype-pecificrkInecdimweueknownnewgeneticrkvrintimprovebtcncerrkpdictiugncetry-wpprochetegrtgextgmodelbedn-geneticrkfcrThwkexpectedultdcoverynewrkvrintepecillylevntpopultindmixedIndigenouAmericnncetrlbckgroundInddiutilizgncetry-mtchedmulti-tuemodelTWASnewocilkedncetry-pecifictue-pecificeQTLexpecteduncovedItloexpectedPRScocpteH/Lvrintegilncetryheterogeneymopdictivethne-ize-f-llpprochBeydpropoedwkthpplictiLAGENO-BCbuildgupourceervefoundtifutucollbtivetudieddgbrodrngecientificquetiltedbtcncergeneticH/LpopultiPROJECTSUMMARYSexulproblemcommdtgpertentptientgynecologiccncer(GC)YetmotptientGCwhoexperienceexulccerndotmirclicintenduelckpprtihowdooeffectivelyNegtiveliefuchlowelf-efficcygdcuiexulhelthexpecttidcuifurrlimptientctiveenggementedcuiAptient-focuedy-guidedterventiStrtgCverti(STC)couldidellyuedddechllengeempowerptientdriveclicldcuimeetirneedSTCwdevelopeduebtcncer(BC)ptientfoundeffectivepopultiCompdBCptienthoweverGCptientundergodiffentttmentexperienceuniqueexulhelthccernhvedtctneedexulhelthcommunicterventiTheewemodifiedSTCuneedwomenGCcductedpilottrilnewterventiclledSTCGynecologicCncer(STC-GC)fdgtrgupptfeibilycceptbilyBeeerventicndemtedefficcytrgetpopultimutevlutedTheprimryobjectivepropoedtudythuevluteefficcySTC-GCterventimgptientttedGCptgexulccernFemleptientnytgeGC(N=200)romizedceiveeirSTC-GCterventi[videowkbookourceguide]ctrol[uulcpluourceguide]InAim1weevluteefficcySTC-GCfciltgptientcliclcommunictiboutexulhelth(primry)eedugrigoudiloguenlyptientcliclcommunictiboutexulhelthimprovgptientexulpychologiclhelthoutcometpot-terventi2-6-mthfollow-up(ecdry)InAim2weexmewherterventi-ltedceptientelf-efficcyoutcomeexpectncieexulhelthcommunictimedeeffectSTC-GCptientcommunicti(Aim2)wherenhncedexulhelthcommunictimedeeffectSTC-GCptientexulpychologiclhelthoutcome(Aim2b)InAim3wecduct-depthqultiveterviewpurpoivempleptientSTC-GCclicinGCptientprovidemtimultipleperpectivectextulizeterptqunttivefdgtrilAfirtefficcytrilexulhelthcommunicterventiwomenGCfdgthtudytrumentldvncgefttegrteexulhelthroutecncercFurrpropoedtudyhnumruniquefetucludgqultivevetigtimultipleperpectivenovelpplictidiloguenlynlymultipleterventimedirmedicllycluiveptientpopultiwhichheightentudyimpctnovtiDtthtudyervepltmfutudemtrilSTC-GCmultipleettgPROJECTSUMMARY/ABSTRACTDepeimpivecliclucceImmunecheckpotblockde(ICB)rpycncerrpytncecommlymllubetptientmountltgntumpehighlightgurgentneedidentifytrtegieovercometnceimprovepiveneimmunpySuchtnceltedfctmnytumimmunologicllycoldActivtgnteimmunytumcellpotentmenwhichcoldtumcnturnedhotOnepromgtrtegytriggernnteimmunepetumducgtrcellulrccumultiendogenouviru-mimeticnucleiccidcncercellOurplimrydtdemtrtetrgetgRNA/DNAheliceDHX9promgunexplodtrtegywhichvirlmimicrycntriggedtumDHX9nbundntRNA/DNAhelicecpbleunwdgbothRNADNAduplexewellmocomplexnucleiccidtructuItfuncticludegultiDNAplictrncriptiRNAprocegtrnptmtenncegenomictbilyHeweprovidedtbltgDHX9ducemtidouble-tdRNA(dRNA)derivedendogenoutrovirlelement(ERE)provokgnntumimmunepecoldtumIntriguglyelimtgDHX9loducedccumultiRNA-DNAhybrid(R-loop)ledgnlynntivirlimmunepeloDNAplictitDNAdmgeSmllCellLungCncer(SCLC)cellInvivoelimtgDHX9cueignificntdecetumgrowthwhileducgmoimmunogenicTumMicroenvirment(TME)SCLCmouemodeldrmticllyenhncgpiveneICBToourknowledgethfirtdecriptiroleDHX9tumimmunygenomictbilyidentifictinovelvirlmimicry-ducgtrtegyenhncentumimmunybootcncerimmunpyExcglywenowpentfirt--clllybiovilblemllmoleculehibirDHX9whichllowuevlutetrnltillevncetrgetgDHX9SCLCimmunpyettgOuroverrchghypotrgetgDHX9ducedRNAccumulticugntivirlignlgwhileccurntlytriggergmtiR-loopcompromggenometbilytriggergetum-triceventgtlyimproveICBInAim1wedetermewhichdRNAubtrteDHX9wheryimmunogenicwellhowDHX9eneuppeR-loopWelodeletemechnmwhichDHX9lotriggercelldethSCLCInAim2wedectimpctDHX9lohibiTMEtglecellolutiweevlutewherDHX9depletihibiducerobutntumimmunyblebootcncerimmunpyugmuimmunocompetentSCLCmodelSCLCGEMMTheuccefulcompletieAimoutlenentilynewvirlmimicry-ducgtrtegywidepdpplicticncerttmentt-lenti-cncerrpyimprovepiveneimmunpyProjectSummry/AbtrctThecgevidenceoverptdecdecompoigutmicrobiomeimptntcncerrpyeffectivenecludgchempyendocrpyimmunerpyInfctmodultimicrobiomeclicltrilenhnceimmunpycliclpemultipleolidtumDepeexploitudiemicrobiome-cncerrpyxltivelyltleknownboutmechnm()utilizedgutmicrobiothperpypetnceInmettticctrtitntprottecncer(mCRPC)dedlymdeetr-tumlrogenlikelymedeimmunpyendocrpytnceCollectivelythePIthpplictihve1)identifiedchrcterizedlyknownhumn-ocedbcterilgenecpblecvertgglucocticoidn-cventilrogen2)collectedequenced5-yermicrobiomebiopoirydividuldvncedprottecncertkglrogenx-trgetedrpy3)demtrtedpeimmunpydvncedprottecncerquirogenceprhibiTcellWkggerweprovideevidencepeciegutmicrobiomeproducerogenmetbolectligrogenceprThobervtiundercoourcliclobervtigutmicrobiomeendocrpyimmunpyeniveverutntptientdtctignificntlyuniqueWepropoerogenmetbolmgtrotetl(GI)microbioterveuniqueourcetum-ocedrogenpromoteendocimmunerpytnceWepropoefollowgimAim1Defefunctilignificncemicrobil-derivedrogenimmunpyeffectiveneWedetermeifmicrobil-derivedrogenufficientmederpytncehowemetbolegultemuhumnTcellfunctiAim2DetermeGImicrobilgenepthwyrogenmetboledetermntrpeuticpetncemCRPCTheetudieidentifynovelbcterilpeciegeneocedendocimmunpytnceAim3Evluteimpctmicrobil-derivedrogenproductumtricgrowthMHCIexpibirterecette/pdnetnceWeevlutecue--effectltihiptweenmicrobilmetbolmrogenendocrpytnceCumultivelyetudieprovidemechnticundertghowhumnmicrobiomepromoteendoctncehibnti-tumimmunyprovidenovelmicrobiot-ocedrpeutictrgetducerogen-mededimmuneuppiChimericAntigenRecepr(CAR)combtinextrcellulrgle-chvriblefrgmentgi(cFV)cognizetumprotentigennMHCdependentmnnerntrcellulrgrnduceextrcellulrtimuliimilrTCellRecepr(TCR)ignlgOptimiztiCARctructhighimptncecurntCARrpiehveignificntdrwbckcludgCARTcellxicyevecykeleeyndromeneuroxicylckCARTcellpertencevivoexpnivroThenewfocutungCARtrcellulrignlviimmunoceprtyroe-bedctivtimotif(ITAM)ceeffecrfunctipertenceEch3-zetchITAMequenceuniquedtctketicphophylticludghierrchypecificyZp-70upphophyltiOurpviouwkdetermedITAMdiverywneceryTcelldevelopmentttenutgTCRignlgImptntlyITAMdiveryhloenhownneceryTCR-drivenproliferticykeproductiHoweverroleCARzetchdiveryCARignlgpertencefunctihnotenfullyexplodInterctitweenTCRpMHCoccurtterfcetwocelltwo-dimenil(2D)membrnemicroenvirmentInilbdgeventcludgffyketicTCR/pMHCterctiCAR/proteepipeterctidicttebdgtbilydowntmignlgeventcludgphophyltiITAMWehvefoundCARexpgpecificITAMequence(zet-AAAzet-BBBzet-CCC)genertediffergmountFcebdlifetimefterterctgCD19TheeCARmyctmechnoenimilrTCRdcrimtgqulyterctintigencellulrderivedceppliedbdMechnticllywehypoizefetungcombtiITAMequencediffentillygultebdlifetimephophyltiignltrnductiledgdiffentilimmunectivtidependgITAMmotifUndertgbiologyITAMpecificyhimptntimplictitungctivtiCARTcelloutchnggpecificyProjectSummryChricmyeloidleukemi(CML)nggivehemlogiclmlignncycuedcoproteBCRABL1Althoughtyroekehibir(TKI)cnhelpCMLptientchievemoleculrmiycnnotfullycudcueleukemictemcell(LSC)tillpentbodyThpplictiimtudynovelctiblemechnmctrolelf-newlurvivlLSCtentuppterly-tgedevelopmentLSC-pecificfrtlerpycettment-femiupTKIdctutiOurtemdcovedtrncriptifcrKLF4pegeneencodgdul-pecificytyroe-phophyltigultedkeDYRK2llowgLSCelf-newprogdeeThudeletgKlf4geneCMLmouemodelwocedlowerfquencyLSCledgleukemigiDYRK2proteupgultiInddihibgSIAH2ubiquligeloledupgultgDYRK2protewhichocedcyxicyCMLcellBedefdgwehypoizeDYRK2criclcheckpothiburvivlelf-newlLSCcnctivtedthroughgeneticphrmcologicltbiliztiDYRK2proteInthpplictiwepropoevetigtegultiDYRK2CMLLSCthroughgenetictudievlidtethmoleculrtrgetidentifyDYRK2tbilizerdrugdevelopmentInSpecificAim1wepropoetudymechnmDYRK2ctivtiLSCelf-newlthroughphophyltidowntmtrgetInSpecificAim2weexplogenetictbiliztiDYRK2protedeletggeneencodgubiquligeSIAH2permggenome-wideCRISPR/C9cenidentifypthwygultgDYRK2expiInSpecificAim3wepropoevetigtgnti-leukemicpropertiephrmcologicltbiliztiDYRK2protemllmoleculeidentifieddpprochcell-bedcenp-cliclmouemodelglegentcomdimtibTheecomphenivetudieelucidtehowDYRK2gulteLSChowDYRK2expigultedwhtmllmoleculetbilizeDYRK2protedevelopgLSC-dictedrpyleukemiPROJECTSUMMARY/ABSTRACTThegolthpropolidentifymechnmcttrophicmuttilproceedriveveryrpidevoluticncergenomeOneeproceechromothripwhichvolvemivechromoomerrngemennlyefewchromoomeoccurglecelldiviMygroupidentifiedgenerlmechnmexplchromothripUgglecellgenomictechnologydevelopedmylbry(Look-Seq)wedcovedchromothripigtecncer-ocedrrtinucleuclledmicrucleichromoomebridge(Fig1ReerchStrtegy)TheetructuhvefrgilenuclerenvelopeundergoptneouruptuwhichexpoeencloedchromoometerphecyplmwheundergoefirtwveexteniveDNAbkgeWhencelldmgedchromoomeentermithchromoomeundergoeecdwveDNAfrgmentticocidentburtmicDNAplictidmgedchromoomeAftercellexmidividechromoomefrgmentcneggtededughtercellfrgmentcndtriedtweenbothdughterRecptiefrgmentdughtercellnucleiultmtinuclerbodieimilrifnotidenticlpvioulydecridpolyunderodnuclerbodieclled53BP1bodieChromoomefrgmentenuclerbodieligtedgenertechromothripInddigenertgchromothripwecentlydcovedchromoomeenuclerbodieubjectedchromttrncriptillterticnherbleovermnygenertiuggetgchromoomltbilyhentlylkedtbilytrncriptiltteDepethcentprogmnyfundmentlquetiboutmechnmchromothripmunclerddedthpropolThemechnmchromoomefrgmenttiboerphemimpolyunderodThe53BP1bodypeeletwellunderodpectDNAdmgepehumncell53BP1bodiepropoedprotectgenomethhneverendictlydemtrted53BP1bodieccumulteDNAendjogfcrundergodelyedDNAplictiundergotrncriptiluppillunclermechnmunclercequencegenomeBecuepprochewedevelopedcludgourglecellgenomicmethodweuniquepotckefundmentlproblemInddiourwkchromothripweloexplotechnologiewedevelopedddmechnmnpolyunderodcttrophicmuttilprocecommcncerclledchromoplexyAcompheniveundertgbothemuttilproceeeentilundertcnceripthogenehoweeventvrydiffentcelltumtypeEwgrcom(ES)ecdmotcommtumpedricpopultidefedpthognomictrnloctimotfquentlyEWSFLI1whichledexpinovelyetnotpentlytrgetblecogenictrncriptifcrThettmentgimenEScludecyxicchempyurgery/rdiwhichhveimprovedoverllurvivlrtepproximtely70%Howeverdepetenifictirpeuticgimenlg-termoutcomeptientmettticlpedEwgrcommextmelypooverllurvivlrtedroppg20-30%ThulterntivetrgetedrpiecombtirpieeentilimprovgptienutcomeThpropolddeignificntgpknowledgewrdttmenthigh-rkESOurlbryhcentlyidentifiedp21-ctivtedke(PAK)ctivtedpromotemettESPAKfmilye/thekegultekeycellproceevolvedmettticprogidrugtnceimmentlyemerggcidtenti-cncertrgetWecentlyptedPAK4whichhcogenicpropertieniducriclignlgccdecludgR/MAPKWntPI3KignlgignificntlyovexpedmettticESnegtivelycltedptienutcomeInvrovivomoleculrphrmcologiclperturbtiPAK4ESmodeldemtrtedignificntnti-tumnti-mettticctivyInddiwehveplimryevidencePAK4novelgulrlterntiveplicgubequentlymodulteEWSFLI1ctivyUgournovtivette---rtpprocheuniquevivoexvivomodeloverrchggolgddilmoleculrightPAK4-mededmechnmESvetigterpeuticpotentiltrgetgPAK4WeexmePAK4rolenovelgulrlterntiveplicgPAK4-mededdowntmproteo-trncripmicigntuctrieESprogiWelovetigteeefficcybiologicllyrtilclicllypplicbleynergticrpeuticgimenWehypoizePAK4tegrteignlgeventcriclESdevelopmentprogigultenoveldowntmeffecrcludgpliceoomecompentignificntlyctriecogenicpropertieOurimcludefollowgAim1DefgPAK4dictubtrtefunctilubcellulrignlgnetwkprimrymettticEwgrcomAim2EvlutiPAK4novelplicggultgprotekedicteffectEWSFLI1functidowntmgenegultiESAim3AerpeuticpotentilhibgPAK4combtimechnticllyrtiltrgetedgentugthopicmettticESmodelCompletietudieprovidenewightESbiologyimpctESrpyprovidgnovelrpeutictrtegiecnmovedwrdclicltrilttmenthigh-rkESProjectSummry/AbtrctTheprogiblddercncern-vivemuclevivedeepentcricltepoceddvereclicloutcomeyetpolyunderodtmoleculrlevelHowevercgevidenceuprogenocedlegeplticywhichtumphenotypeundergoewchlumlblubtypeTheewepuruecomphenivemoleculrnlyluml-bllegeplticyelucidtemechnticbthphenotypicwchInplimrytudiewehvehownptient-derivedblddertumgnoidpentmodelytemtudygtumplticythplticyveribleWehveidentifiedKMT2DhnemethyltrnfereKDM1Ahnedemethylehvgoppogctiviemodultgluml-blplticygnoidctentireffecthneH3lye4methyltiModultiluml-blplticyffectoutgrowumgnoidcultuctentroleprogivivedeecnultimprovedpeentumbvedotnntibody-drugcjugtepprovedttmentlocllydvncedmettticblddercncerFllyugcellulrbrcodgpprochlegetrcgwefdKMT2DmuttipromotecllexpnignoiduggetgcllcompeticndrivepdphenotypicltertidueplticydurgtumprogiBedourplimrydtwehypoizeluml-blplticycllcompetihumnblddercncerdrivenepigenomicprogrmmgTovetigtethhypowepuruethecomplementryimtegrtenovtivevrovivomoleculrbiomticpprochefollow(1)AnlyKMT2Dfunctimodultgluml-blplticydrugpeetblhpceroleKMT2Dplticyvivenepeentumbvedot(2)Anlychromtlcpeblddercncerplticyprogiidentifychromttteocedluml-blphenotypictrni(3)InvetigtiKMT2DfuncticllevolutiexmemechnmwhichKMT2DlopromotecllexpniblddercncerOverllourfdghvetrgtrnltilimpctthroughidentifictiepigeneticmechnmpromoteplticytumprogiblddercncermyledimprovedrpieggivedeeSummryThegolthvedpropoldevelopnovelrpeuticpprochovercomgtncerdirpytriplenegtivebtcncer(TNBC)vetigtemechnmvolvedThenurgentunmetneeddeveloptrtegieovercometnceopeTNBCptientrdirpycnimprovedThpropolbedhypovculndolilgrowthfcr(VEGF)ignlgthroughneuropil-2(NRP2)popultumcellpentTNBCctrieignificntlyrditncehibiVEGF/NRP2providenovelrpeuticpprochovercomgtnceThefeibilythpprochtngnedciderblyvilbilymAbblockbdgVEGFNRP2pecificllyvilblecliclueThepprochuednefvilbilylrgecollectiwell-chrcterizedgnoidderivedbtcncerptientptient-derivedxenogrft(PDX)modelTNBCThefirtimvetigtemechnmwhichVEGF/NRP2ignlgpromoterditncebedobervtiVEGF/NRP2ignlgpromotetrncriptinricoxideynthe2(NOS2)celevelnricoxide(NO)BedthfdghypovetigtedVEGF/NRP2ignlgutS-nroyltikeyprotectrierditncecludgnuclerfcrE2-ltedfcr2(Nrf2)nntioxidnttrncriptifcrTheecdimtethypotrgetedhirctiVEGFNRP2cerdioenivyTNBClevelclicllyignificntmechnmdependennNOS2hibiThgolccomplhedegpelrgepnelTNBCgnoiddiffentubtypeexhibter-tumheterogeneyrdinti-NRP2rpyugfunctiblockgmAbRNA-eqpermedidentifypotentilbiomrkertntpopultithmtiuedidentifymllmoleculerpeuticcnuedtrgetthoepopultiimprovecliclvibilyNRP2ttmentcombtirdiThimlovetigteimpctthpprochvivougyngeneicmettticPDXmodelTNBCOverllwkpropoedthpropolcouldignificntlyimproverpyTNBCelectgthoeptientwhocouldnefnti-NRP2-enhncedrdipycequentlyducembidymtlyocedTNBCPROJECTSUMMARYWhileimmunpiehveprovedcompellgefficcygrleukemirpplicticutemyeloidleukemi(AML)tillhmpedbencetum-trictedtrgetThemotubleAMLtrgethdhelthyhempoietictem/progenircell(HSPC)mtumyeloidcellledg-trget/f-tumxicyimpirmenthempoieticctutiToddthuewehypoizedepipe-engeergdHSPCuedcventilmrrowtrnplntticnendowhempoieticlegeelectivetnceCAR-Tmocllntibodie(mAb)outffectgprotefunctigultiThtrtegyllowtrgetggeneeentilleukemiurvivlgrdlehdexpiHSPCthuducgrktumimmuneecpentigendowngulti/loWehveldyidentifiedglemo-cid()chngebrogtebdgrpeuticmAbtrgetgFLT3CD123KIToptimizedbe-edgpprochtroducemCD34+HSPCwhichtlg-termengrftmentmultilegediffenticpcyWecfirmedvivotnceepipe-ededhempoieCAR-Tttmentccomnterdictiptient-derivedAMLxenogrft(CirtietlNtu2023)Hewecplizeechievementexplotte---rtgeneticengeergolvivomodelgobjectivei)genertefunctillyvlidtetelthFLT3KITIL3RAgenemultiplexbe-edgii)identifyt-permgCARcfigurtimulti-AgtrgetgAMLmpleiii)vlidtetnceededHSPCnewimmunpiedictedgtetrgetThprojectprovidefundmentldvncementnewmoeffectiveimmunpypprocheAMLhouldddillyhvebrodpplicbilyeverlhempoieticmlignnciePROJECTSUMMARYImmunpiebedblockdeimmunecheckpothvevolutiizedcncerttmentcentyerTodyimmunecheckpothibirdevelopmentimctivtetum-filtrtgTcellfciltetumcelldethInmnytumtypehowevermotbundntmfiltrtgimmunecellmyeloidcelluchmcrophgeneutrophileoophilwhichcntumicidlwelltumpromotgCequentlytrgetgimmunecheckpotgultebothTcellmyeloidcellmyhvebrodimplicticncerimmunpyCD200Rillyidentifiedmyeloid-trictedhibiryimmuneceprwlterlodcovedexpedlymphoidlegeepecillytum-filtrtgeffecrTcellClicltrilptientdvncedcncerunderwyugntibodyrpeuticblockthpthwyUntuntelylckundertghowthpthwywktummicroenvirment(TME)ubtntillycompromepplicticncerimmunpyInourcenttudiewefoundCD200R-deficientmiceweignificntlymoefficientjectgmultiplelegeCD200+tumCD200R-deficiencyulteddygultichemokemyeloidcellctentfewerneutrophilmoeoophilimmuneeffecrtumAddillywefoundCD200R-deficienttumntigen-pecificTcellhduniquephenotypehowedmopotentnti-tumctivyvivoIntriguglyCD200R-deficiencymyeloidcelllopromotedtumngiogeneTheoverllgolthpropoltethypoeCD200Rblockdeenhncechemoke-mededccumultiimmuneeffecrtumenhnceTcellfunctiTMEimultneouhibingiogeneignificntlyimproveefficcyCD200RblockderpyTochieveegolwefirtevluterolekeychemokegultedCD200Rignlgcrugimmuneeffecrtumvetigteirroletumngiogene(Aim1)SecdweuemiceCD200R-deficencyTcellevlutetricroleCD200RignlggultgTcellccumultifunctum(Aim2)TheetwoimpvewywrdthirdtenwherhighffyntgtntibodyCD200RhtterefficcyifCD200Rblockdengiogenehibirhveynergticeffecthibgtumgrowth(Aim3)InmtigenertedetudienlydvnceourundertgcncerpthogenelopvewyhumntrilCD200Rblockde-bedcombtirpieProjectSummryAndptiveimmunouppivemicroenvirmentmjbrrierimmune-bedrpieolidtumcludgglioblm(GBM)CurntmodelytempclicldevelopmenteirlckubtntilcompentimmuneytemlyupdiffentpecieimmuneytemwhichdplyignificntdiffencewhencompdhumnimmuneytemTheedeficiencieleddcnecttweenpcliclcliclerchHewepropoedevelophumnizedmoueytemtudyimmuneytemterctiGBMBytkghempoietictemcellGBMptientweengrfthumnimmuneytemmiceFrommeptientweobttumtueTcellThllowctinulogoumoueytemwhecompentimmuneytemtumcell-bedrpyllcomemeourceIndogoweimvoidnycomplictiwouldcellcomgmultipledividulWevlidteulogoumoueytemgenertgchimericntigencepr(CAR)TcellptientownTcellTheedictedTcellllowevlutimodelytemboermhowtumpdimmunpyhowextgimmuneytempdimmunpyReultnimlmodelcompdptientceivgmettmentclicltriltUniveryPennylvniInilwkfocudemtrtgfidelyytemigtgtumimmunemicroenvirmenttermboumchrcterticimmuneytempeThoughchrcteriztiimmunecellubpopultinti-tumctivyhelpidentifydcpnciecurntmodelwellwhichnewulogoumodelpferbleAtccluhprojectwehvedemtrtedfeibilyugulogoumterilglioblmmodelgelucidtedpecttum-immuneterctiemodelmotueduePROJECTSUMMARYNeuroblm(NB)motcommextrcrnilolidtumchildhoodleddproptenumrchildhoodcncerdethnevenmodproptedethrteBlckchildnDepeddiGD2ntibody(dutuximb)immunpydprieoutcomemuggetgrcil/ethnicdiffenceimmunymyctrieNBptienthelthequyWhileocildetermnthelth(SDOH)likehoueholdpovertyhveenfoundplyroleoutcomedpriehighrkNBbiologicfcrctrigrcildprieNBurvivllrgelyunexplodDutuximbquinteeffecrimmunecellenctntibodydependentcellulrcyxicy(ADCC)efficcyWehvefoundpencecircultgcyxicnturlkiller(NK)cellocedobjectivepedutuximbpheItrilptientlpedNBFurrmteimmunecellfiltrtehigh-rkNBtummydiffertweenBlckn-HpnicWheptientBlckptienthvgmoexhutedtum-identNKcellWeehypoizercildiffencehigh-rkNBptientnteimmunecelllcpeduegenomicncetrySDOHexpouctrieoutcomedpriefollowgGD2immunpyAChildnOncologyGroupromizedpheIIItrilevlutewherddidutuximbductichempy(ductichemoimmunpy)improveevent-feurvivl(EFS)overllurvivl(OS)newlydignoedhigh-rkNBptientThetrilcludenovelemddedhelthequyubtudycptupnt-ptedrceSDOHThegolthpropolutilizetril-derivedbiologicmplei)PermtumbedglecellgenomicproteomicfunctilvetigtiefterchemoimmunpydetermetumimmunemicroenvirmentmrkerfluencgEFS/OSii)PermimmunophenotypgfunctilydefeperipherlhotimmunemrkerfluencgEFS/OSiii)Exploocitweentumhotimmunelcpepnt-ptedrcedvereSDOHchildDNA-bedgeneticncetryclicloutcomeAtccluhprojectwehvedefedimmunebiomrkerEFS/OScrollptientevlutedimmunebiomrkerpoEFS/OSeeifyenrichedBlckchildn/childnexpoeddvereSDOHImptntlyefdgmyidentifynewimmunpeutictrgetpecificptientpopultiimproveurvivlchievehelthequyptienthigh-rkneuroblmABSTRACTCncer-ocedRASmutntwececidedcogenicequivlentHowevercglyclermutntmeRASm(H-K-NRAS)mocid(cod1213)cnexhibdtctGTPeeffecrbdgignltrnductumigenicpropertieTheedtctimyctriedprierpeuticpewellenrichmentpecificRASmmocidubtutiechcncertypeThudeeperundertghowechmocidubtutifluenceRAStructubiochemtryfuncticouldyieldmengfulbiologiclclicldvnceKRASmutntwell-tudiedwherbiochemiclcequencenmocidchngeeRASmcnextendednunclerInprticulrerchmutnt-pecificfunctiNRASdomntRAScoprotethyroidcncercutemyeloidleukemimelnomlimedHeweexmebilyeightdiffenncogenicNRAScoproteduceptneoumelnommouemodelWefdthncogenicubtutievenmemocidNRAShvedtctmelnomgenicpotentilOurplimrydtlkgtermelnomgenicpotentilemutnttructurlfetuenhnceBRAFffyctivtiMigen-ctivtedproteke(MAPK)ignlgTheeobervtictenttudielkgcgMAPKctivymelnomprogihumnneviFurrmoweprovideevidencecurntknowledgeKRASmutntcnnottrnltedNRASBededtwehypoizemelnommtidependubtuti-m-pecifictructurldiffenceNRASenhnceBRAFdimeriztiMAPK>ERKignlgInAim1wepropoetegrtedX-ryNMRcomputtilbiochemiclpprochedetermetructurlenemblebiochemiclpropertieNRAScoprotevrygmelnomgenicpotentilcompeprileimilrKRASmutntInAim2wedecricombtitructurlbiochemicllive-cellpterexperimentdetermehowNRASmutntdiffentillycognizepromoteBRAFctivtiInAim3wetetccepttrnientphrmcologiclpprochcouldpventmelnomelimtgNRAS-mutntcncerpcurwilevtedMAPK>ERKignlgkIfuccefuletudieuncoverdtguhgtructurlbiochemiclfetuNRAScoprotemyledidentifictinewterfcedrugtrgetgdetermemoleculrbNRAS-drivenmelnomgeneelucidteRASm-pecificmechnmRAFctivtetpotentilpventitrtegyNRAS-mutntmelnomPROJECTSUMMARY/ABSTRACTAcncerdignodictlyenexulproductivehelth(SRH)neentilcompenthelthydevelopmentdolecentyoungdult(AYA)Nerly60%AYAundergogcncerttmentptneedSRHcounelgyetthneedrlymetThgpcleveptientthighrkmkgunmeddecicnnegtivelyimpcthtlg-termSRHAlthoughntilguideledveclicinpibilydcugSRHclicinrlyenggeecvertiThepropoedtudyervefirttepwrdimprovgSRHoutcomeAYAcncerptienturvivdevelopgnterventi1)providedividulizedefficientptient-centedc2)enhnceptient-clicincommunictiDrFderickcompletemldidcticcourewkwkhopcerdevelopmentprogrmfocuedhvilterventiciencemixedmethodnlyclicltrilcductppherchievethgolSheguidedrobutmenrhiptemctgPrimryMenrDrFyer(AYAcologyqunttiveerchclicltril)Co-MenrDrQun(LGBTQ+AYAcncerccertilymixedmethoderchterventicience)Co-MenrDrBor(SRHcncerqultivemethodterventicience)Thtemupptedcientificdvycommteewixperteimplementticiencetechnology-bedcommunicterventimHelthInddiDrFderickhveccebundntdivereourceCnecticutChildnUniveryCnecticutSchoolMediceMopecificllypropoedprojectdevelopfeepro--ccept(POC)ReproductiveSexulhelthPtientEductiCommunictiTool(ReSPECT)novelptient-centedweb-bedterventillowAYAdcetlycommunicteSRHqueticcernircologyclicinfertime-vgtrtegyclicineptientneeddividulizecounelReSPECTct3prt(1)nAYA-centedp-vquetini(PVQ)lertclicinptientSRHqueti/ccern(2)trgetedptienteductibedPVQpicelecti(3)clicin-centedguidnceddgpecificSRHccernStkeholderterviewAYAurvivpedriccologyclicinguidedevelopmentfementReSPECTthroughqultiveterview(Aim1)NextReSPECTundergoPOCtetg30AYA/clicinpiroutptienncologyclictCnecticutChildnChildnHoplLoAngeleefeibilycceptbilyubilyperceivedimpcnAYA-clicinSRHcommunicti(Aim2)evluteplimryoutcomecomprgp-pot-terventiurveydt(Aim3)AttudyccluiReSPECTdytetgromizedctrolledtril(plnnedR01)ThepropoedterventifirttepdevelopgytemticprogrmerchimproveSRHctenthouAYAptientwhocurntlydothveccevlourceyneedProjectSummryThe-omicerhmdepoibleidentifyeverlmoleculrmrkervolvedpdictgurvivlperpieWecurntlylckneywyobthighctentmoleculrmtiwhileprovidghigholutiptilprilgcroptienttueThpropolimprovidephyicinnentilynewmultiplexedmoleculrimggtechnologyhpotentilferbothhighctentmoleculrexpiptilprilgglehlogyimgeRmnpectrocopycjunctiurfceenhncedRmnctterg(SERS)nnoprticle(NP)nopticlimggtechniquecnferunurpedenivymultiplexgcpbiliefieldhlogyimggpotentilproviderichmoleculrdetilmicrocopiclevelClicinbleutilizeimggtrtegymetueectippdhlogyIncptgpthologywkflowcouldenblephyicintterundertptientmoleculrpriletrtifyptientceivemoteffectiverpeuticgimenpoibleThuniquehlogyimggtrtegylohpotentilidentifynewmoleculrtndptienttuemplecoulduedpdicthowggiveirdeehowwellptientlikelypdgivenrpieThnovtiveex-vivodignotictrtegyhhighlikelihoodclicltrnltifergrpidwholetueectiimggmultiplemoleculrbiomrkerimultneoulyOurpprochgdevelopgneweteniveSERSNPbtcheechdeigneduniquepectrlbrcodeenbleimultneoumoleculrterrogtinentuemplegleimgeAfterfbrictichrcteriztiournewlydevelopedmultiplexedSERSNPwetetirmultiplexedimggcpbilietrgetgefficiencyvrioubiomrkercellcultude-identifiedhumntueectiWefirtteurnewmultiplexedimggtechnologytrgetimmunecellRecentlytudiehvehownimmuneytemplykeyrolecncerdevelopmentthudenyloctypeimmunecellfoundcroptienttumcnpdictrpeuticpeFilufullyundertimmunepriletumheterogeneycroptienttumcnleddmtrtieffectiverpieceptientmbidyOurNPctivelytrgetmultipleimmuneceprthroughchemicllycjugtedntibodieWeetrgetgefficiencyournewlydevelopedNPmicrocopicRmnimggolcompgoldtrdimmunohchemtry(IHC)tgTheeultnimptnttepclicltrnlthnewmultiplexedRmnimggpprochproviderpidptilmoleculrprilgwhileenblgimprovedperlizedrpyItimptntnotewenotlimedterrogtgcncertendvetigtelevntcliclpplicti(iewoundhelgneurologicldeefectioudeeuimmunedee)couldnefnewmultiplexedimggtrtegyferimprovedenivymoleculrpecificyPROJECTABSTRACTPncticdenocrcom(PDAC)nlmotunimlyftldeemottendignoedfterdevelopmentmetteThetumuppgeneTP53motcommlyltedgenehumncncerhencognizedgeneticdriverPDACup75%ptientWhilefunctiTP53mutticncercellctuetudiedknowledgen-cellunomouroleprimrytummicroenvirmentmlimedTheultimtegolourwkexplotrgetPDACtumcelltummicroenvirment(TME)cequencep53muttrnltiptientrpieRecentlyourlbrydcovedcoopertiveignlgnodetweenpgeneticPDACdrivercogenicKRASmutntp53enggedthroughterctivebdgtweenmutntp53CREB1Thmutntp53/CREB1complexubequentlyctivtemultiplepro-metttictrncriptilnetwktumcellOurplimrydtdictemutntp53/CREB1GOFlodriven-cellunomoufunctithroughctivtiWNT/-ctenignlgelementdictcncerocedfibroblt(CAF)curteprimryTMEpro-mettticlcpeWehypoizetrgeteddruptimutntp53/CREB1complexvibleopptunyverecell-n-cellunomoufunctimutntp53rpeutictrnltiPDACAccdglyobjectivethgrntpropolgddilmechnticighthowp53muttitumcelldrivepro-metttictercticncerocedfibroblttetifdruptimutntp53/CREB1complexubvertvltepmettticccdeUggeneticllyengeedmiceptientderivedmodelytemim1wecfirmeentilelementmutntp53/CREB1-WNT/-ctenignlgxctcncerocedfibrobltenhncemigrryvivephenotypeMooverwetetefficcycomdtrgetedpprochedruptmultiplelevelmutntp53/CREB1-WNT11ignlgxmigtemettInim2weclrifyrolemutntp53/CREB1-WNT/-ctenignlgxcurtifibroticTMEltechemotncemettwhiletetgveribilyuggeneticphrmcologictrtegieInAim3weuehumnPDACbiopecimenderivedgnoidclteourfdgAim12Thepropoederchignificntcuep53muttipent70percentPDACptientmuntrgetbleAuchourpprochdruptn-cellunomoumutntp53gfuncticouldexpoenewrpeuticvulnerbiliemrtilcombrilttmenttrtegieThepropoederchnovtivecuewetudymodultenovelmutntp53/CREB1-WNT/-ctenignlgxundermemultiplecheckpotmettticccdeGivenpvlencemutntp53humncncerknowledgegedthpropollohbrodpplictimlignntdeeeentilylignoverrchgmiNIHPROJECTSUMMARYInmmmlmjynrogenwteproducedgutmicrobiomemmmiAmmineuroxcledtwomjpthwy1)cveriviucycleenzyme(UCE)nxicuexcti2)imiltiglutmte(Glu)glutmtedehydrogene(GDH)nglutme(Gln)glutmtemmiumlige(GLUL)lotermedglutmeynte(GS)IncentyerUCEGlu/Glnynhveenfoundvolvedtumgrowth/developmentvrioutuePrtillyelevtedUCEctivieimplictedtumpromotivimechnmuchenhncedpyrimidepolymeproductiLikeweGlu/Glnbioyngenerllythoughttum-promotgvrioucncerCurioulywhilelivermgnhlemmiwteroletwommihlgpthwylivercncermytemticllyunexplodInhepcellulrcrcom(HCC)mjhlogiclubtypelivercncerUCEexpendown-gultedclteweprognoGSexpifquentlyelevtedyetcltetteroutcomeUgmouemodelHCCdrivencogenic-ctenwecentlypted-ctenleddecedexpiUCEcedexpiGSIncedmmilevelweobervedplmtumtertilfluidwhichweexcerbtedbltihepticGSTheedtdictethncogenic-ctenleddruptinrogenhomeotdefectivemmi-clerncepromoteHCCgrowthThemgolthpplictitudyroleUCEHCCtethypolowergmmiburdencnrpeutictrtegyHCCttment/pventiWepropoetheSpecificAimAim1TethypouppiUCEexpictriegrowthHCCdriven-ctenThde1)ovexpgknockgdownUCEvriouHCCmouemodel2)tudygmechnmhowdown-gultiUCEmypromoteHCCAim2Studyhowcogenic-ctengulteUCEtrncriptiWetethow-ctentercttrncriptifcruchC/EBPHNF4tethowyterctUCEpromoter/enhncergigulteexpiAim3tetglowergmmiburdencnrpeutic/pventivetrtegyHCCThdefeedgmicelowprotedietteteffecngrowthignlgHCCprogivivoSuccefulccomplhmentprojectdetermeroleUCEHCCidentifyhypermmemirkfcrhelpetblhdietryterventitrtegyttg/pventgHCCPROJECTSUMMARYThemjyptientlow-rkthyroidcncerundergotlthyroidecmyrkietttmenptiSferlevivelterntiveferptientequivlentcurnceurvivllowerrkdebiltgftigueerioudvereoutcomeToducelg-termmbidythyroidcncerimprovehelth-ltedqulylifeurvivimpertivepvenveruetlthyroidecmyWehvehownurge-prctice-levelfcrmotpotentctiblectriburtlthyroidecmyoveruePtientthyroidcncerwouldnefnterventrgetknowncuetlthyroidecmyoverueturgeprcticelevelInthpropolourexperiencederchtemdptextgevidence-bedterventimulti-compentmulti-levelterventipromoteleexteniveurgeryurge(LESS)Theterventicompentoticlly-bedgroundedBehviChngeBllprcticloldeigngevlutghvichngeterventipolicieAfterpckggterventicompletguertetgwetetterventieffecnrtetlthyroidecmynetblhedtte-widevluecollbtivehryuccefullyimplementgurge-prctice-levelterventiWeloekeymechnticoutcomeurgeprcticeptientlevelTheultpropoederchprovidecrucilevidencefutulrge-clemulti-ehybridtype2effectiveneimplementtrilteteffectiveneLESSducgtlthyroidecmyrtewhileimultneoulyexmgimplementtitrtegieTheterventibuilnnextgpltmdeignedphyicineilytiloduerneedwhilemgclbleInterventicompentcludedee-pecifictrtegiceducticommunictikilltrgud-feedbcktrtegiehvebrodpplicbilyptient-docrttmentdecicncerTherchignificntcuedecgrteunnecerytlthyroidecmyptientlow-rkthyroidcncerduceptienthrmimprovelg-termoutcomemiNCIOurexperiencedmultidciplrytemhryuccefulcollbtiexperiencehvilterventideigntetgcluter-romizedteppedwedgedeignmkeuwellpoiedchieveimthwrdThpropolcriclupptglg-termhelhyroidcncerurvivourlg-termgolducgoverttmenttervengurgicldeciPROJECTSUMMARY30leThecniclphophooide(PI)3-ke(PI3K)/AktignlgpthwyuefemembrnePIlipidgultecellgrowthfquentlyhyperctivtedcncerAktloctivtednucleupolyunderodmechnmWedcovednuclerPI3K/AktpthwycompoedPIke/phophtemodifyphophtidyloilphophte(PIPn)lkedp53(p53-PIPnignloome)PIPKIynizep53-PIP2tbilizegulteMDM2ThePI3Koilpolyphophtemultike(IPMK)cvertp53-PIP2p53-PIP3whichveredPTENp53-PIP3crufullAktpthwyledgnuclerAktctivtigulteFOXOMDM2genomictcellurvivlHypo/ObjectiveNuclerAktdoectivtedp53-PIP3Thep53-PIPncomplextbilizedMDM2MDM2loPIPn-lkedIPMKPTENctrolgenertip53-PIP3ctivtenuclerAktMutntp53-PIP3-Aktignlgunlikep53wtctutivelyctivtedfurrtimultedgenoxictultgenhncedcellurvivlpromotgtumipromotiWetetth4imAim1DetermemechnmnuclerAktctivtip53-PIPnignloomeDeferolemechnmIPMKkePTENctivywrdp53-PIPncomplexeelucidtgtructurlterctiIPMKPTENp53Ugthtructurlmtiwedetermehowgenoxict-ducedPTMp53IPMKPTENgultep53-PIPnignloomenuclerAktctivtiAim2TheiduelkPIPnp53MDM2defedmutntmdeblockPIPnlkgenuclerAktctivtiWedetermeifdiffentPIPlkgep53wtp53mtAim3Defemechnmp53tbiliztiMDM2HSPPIPnThetbilyp53keyp53-PIP3ctivtiAktgultedMDM2MDM2loPIPn-lkedmechnmwhichPIPnHSPgultep53-MDM2pthwytudiedMDM2PIPnlkgebdgmutntuedvetigterolePIPngultgMDM2ligectivyterctip53p53tbilyThePIPkePTENgenerteMDM2-PIPncomplexedefedtudiedAim4Deferolep53-PIPnignloomegultgtumgrowthUgcellulrmumodelbtcncerwedetermefunctilrolep53-PIPnignloometumuppip53wttrnmti/tumprogip53mtWelodetermewherexpip53-PIPnp53-PIP3-AktcomplexecliclbtcncerpecimenclteclicloutcomeSignificnceWehvedcovednovelnuclerPI3K/Aktpthwycffoldedp53dependentcniclmembrne-loclizedpthwyenivePI3KhibirclicundercgrpeuticlevnceAlop53-PIP3-Aktpthwydiffentillyctivtedwild-typemutntp53thmypentfundmentlmechnmmutntp53cogenicctivyABSTRACTTheNtilLungScengTrildemtrtedefficcylungcncerceng(LCS)low-doecomputedmogrphyducg5-yerlungcncermtly20%lhighrtefle-poiveultTheUSPventiveServiceTkFcecommendnnulLCSLDCTdividulge50-80yerwhocurntlymerly(qu15yer)moked20-pck-yerhryDepetkceGrdeBcommendtimjccernLCSpotentilhrmocedfle-poiveultwhichdefedhvgemodulequirgfollow-upnochngelungcncerdignoftereyerSpecificllyflepoivemyburdenptientclicinhelthcytemdueecomicpychologicleffectextrimggviveprocedufermgcncercomplictiprocedunignleiTheneedtteretimteburdenfcrffectflepoiveultl-wldprcticeovermultipleroundcengmptient-clicincvertiguidedevelopmentterventiduceflepoiverteoptimizerk-nefrtioLCSTheprimryobjectivethpropolidentifyburdenfle-poiveulttptientclicinfcilylevelundertimpctfle-poivecrocengctuumUgrichourcelgudlLCSdt>40KLCSexm17fcilielkedtte-bedcncergtrydtweccomplhobjectivethroughfollowgpecificim(1)Identifyttudeknowledgeexperiencefle-poiveultLCSmgptientclicin(2)Determeptient-exm-rdiologt-fcily-levelfcrffectfle-poivefdglungcncerceng(3)Aecumultiverkfle-poiveLCSexmover5-10-roundnnulcengcromultilevelfcrAnetimted145milliUSdulteligibleLCStrkexperiencgflepoiveultThtudygenerte-depthknowledgeboutpotentilhrmfle-poiveLCSultTheefdgmymptient-clicinhddeci-mkgcvertimyhelpduceflepoiverteidentifygmodifiblerdiologrfcily-levelfcrPROJECTSUMMARYFercurnce(FoR)pervivedtgccernmgbtcncerurviv(BCS)pertyerftercncerttmentLg-termurvividentifyhelpmnggFoRirmotpgunmetneedEffectiveclbleFoRterventineededddlientemotilcognivehvilcompentFoRCognivehvirpy(CBT)welluedddecompentptientfcemnyobtclepychoocilcduelckvilbleprovidercottimectrteHelerventicnovercomeeobtcleWedevelopedfedevlutedFoRtude104weektrgetedeHelerventideignedtechBCSCBTtrtegiemngeFoRthroughdidcticctentterctiveolWeromized196BCSmoderteeveFoRCBTnttentictrol(helthmngementctentHMC)obervedignificntductiFoRp-potterventimgllBCSWhilewehypoizedCBTwoulduperiHMCourqultivedtdicteCBTHMCmechnticllydtctducgFoRWelofoundBCSromizedtelephe-bedmotivtilterviewg(telecochg-MI)hdhigheHelthdhencetenticompdnotelecochgTheFoRtude20trilddelimtiourlttrilenhncgterventictentthroughdelivergCBTHMCddgculturllypivectentdoublgterventidurti(8week)lg-termfollow-upmigoulydeignedctrolcdiWeddedecdryendpotehelthcutiliztiphyiologiclmrkerchrictllotticlodThpheIIIromizedctrolledtril(RCT)deignedevluteefficcyFoRtude20ugmentedtelecochg-MIduceFoRmgBCScompdtwoctrolnttentictroluulcctrolWecruntildiveremple800BCSNCICommunyOncologyReerchProgrm(NCORP)CommunyMy/UnderervedSeWetrtifyccrulrceenroll300BlckBCS500n-BlckBCS(Hpnicn-Hpnic)AmgfemleBCSmoderteeveFoRenrolledNCORPSewepropoefollowgAimAimIEvluteefficcyFoRtude20duceFoRt3mth(1mthpot-terventi)compdttentictroluulcAimIIEvluteefficcyFoRtude20improvepychologiclhvilcequenceFoRcludgnxietydepiHRQLhelthcutiliztiExplryAimEvluteefficcyFoRtude20ducellotticlodbele3mthcompdttentictroluulcFdgctrieetblhgnevidence-bedclbleeHelerventrgetgFoRcnwidelydemtedtlowcotledgfutuerchdemtiimplementtiFoRtudemgurvivllcncertypeimprovgqulycncerurvivhipPROJECTABSTRACTSmllcelllungcncer(SCLC)neuroendocprottecncer(NEPC)ggivehigh-grdeneuroendocneoplm(HG-NEN)tenmettizedotpdwellttmentLungcncerledgcuecncermtlywldwideSCLCpent~15%lungcncerProttecncermotcommolidtumecd-ledgcuecncer-lteddethmgmenUSMothn20%mledvncedprottecncereventullydevelophighlyggiveNEPCmBothSCLCNEPCchrcterizedimilrgenetic(RB1TP53lo)phenotypicfetuwellubtntiltr-tumlheterogeneywhichimplictedrpeutictnceIdentifygdevelopgnovelttmenttrgettrtegieSCLCNEPCcriclunmetneedDelt-likelig3(DLL3)nntigenexpedcellurfceHG-NENwhenmltueexpitrictedtrcellulrcomprtmentpdomntlycfedGolgipprtuDLL3expiclteneuroendocmrkerexpiRB1loggivecliclfetuBedover-expiDLL3HG-NENwepropoeutilizeDLL3-trgetedrdiolledmocllntibody(mAb)n-vivedignougPETimgg(89Zr-DFO-SC1656Ab)wellimge-bedrpy(177Lu-DTPA-SC1656)OurcentrlhypothvexpiDLL3HG-NENleicnexploeddignoticrpeuticpurpoeToexmethhypoourpheItudyevluteptientffectedHG-NEN89Zr-DFO-SC1656mAbPET/CTThoewhoexhibufficienttrgetexplet80%growgleitted177Lu-DTPA-SC1656AkeyueuchggivemlignncieneedobjectivelydetermettmentefficcyquntifygrdidoedelivedtrgetegtumrdioenivywhichengenderuceptibilyttmentWeuemoleculrgenomicolidentifyDLL3trncriptcompeknownmoleculrigntubloodtuecndefeneuroendocprottecncertumcltepeThepropoedtudyvetigtefetymechnticbefficcyrdinoticpecificllytrgetgDLL3noveltrgetlethlmlignnciewhichcurntlylimedrpeuticolextOurexteniveexperiencedevelopmentDLL3-trgetgPETgentvlidtiSCLCNEPCmodellgourplimrycliclPETdtSCLCNEPCptientwellourexpertencillryuemoleculrgenomictummrkerpoiuuccefullycompleteimthtudyPROJECTSUMMARY/ABSTRACTNovelPETImggGuideTherpyHepcellulrCrcomLivercncerthirdledgcuecncerdethwldwidehepcellulrcrcom(HCC)ctutgmothn75%lllivercncerLocogilrpie(LRT)uchtrncterrterilrdioembolizti(TARE)Yttrium-90(Y90)plycriclrolecptientHCCFptientundergogLRTtimeeencetimequiddetermehownHCCpdLRTcricldetermnverllclghmoutcomeeptientCurntmethodpdictpeY90LRTlytrd--c(SOC)nmiclimgguchmgneticnceimgg(MRI)computedmogrphy(CT)whichmmbiguoumthfollowgttmentDurgthcriclwgphyicinptientfceuncerttypectdeettueligibilyfututerventifquentlycompromedmbiguieoceddetermgttmenutcomeInthprojectwepropoeevlutennovtivemoleculrimggpprochpdictpeY90LRTmucherlierthnSOCimggWehvepvioulyevluted18F-FSPGPETlivercncerfoundhighlyubleleidetectievlutiperpyCncercellccumulti18F-FSPGmededxCT(SLC7A11)trnpterctivywhichhighlycltedtncerdiThuwehypoize18F-FSPGPETpentnidelbiomrkerpdictpeHCCY90LRTtbeleofterrpyidentifyidulY90-tntdeeerlycurnceComplementryimggliquidbiopyvolvecollectibloodbodyfluiddetectum-derivedmoleculrpecimencludgcircultgtumcell(CTC)circultgtumDNA(ctDNA)InthpplictiwepropoedetermeifctDNAlevelctibleettgptientHCCundergogY90LRTtriggergfutu18F-FSPGPET/CTexmtieptientOuroverllobjectiveevlute18F-FSPGPETmenpdicterlypecurncefollowgY90rpydetermewherPETimggctDNAcltedOuroverrchghypo18F-FSPGPETpdictpeY90rpytumcurnceoerthntrd--c(SOC)imgghighlycltedctDNAliquidbiopyWeteurhypotwoSpecificAimAim1Toevluteltihiptween18F-FSPGuptkeHCCleictDNAbloodcliclpeY90rdioemboliztirpySOCimggAim2Toevlutevoxel-wecltitweenpot-ttment18F-FSPGtr-tumlccumultiSOCimggptientHCCwhohveundergeTARECliclImpctThtudyholdpotentilimproveHCCdeemngementprovidgnovelimggliquidbiopypprochepdictpeY90LRTmucherlierthncventilmenProjectSummryMultiplemyelom(MM)ncurblemlignncymtuplmcellccountg18%newcncercennully10%hemlogiclmlignncieImmune-bedrpeuticterventitrgetgB-cellmturtintigen(BCMA)ledhighperteptienthevilyptteddeetwoChimericAntigenRecepr(CAR)T-cellproducttrgetgBCMAFDA-pprovedDepemrkblecliclpemotptienthvedeemiducedBCMACAR-Tcellrpydotltmothn18mthGivennovelttmentpprocheurgentlyneededylyidentifictibiologicllyrpeuticllylevnttrgetToddthgpknowledgewedevelopednoveltegrtedpipelebedmpectrometrynlyevenMMcellleRNAequencg(RNA-eq)900+ptientStrtg4000+cidteweidentifiedmothighlyexpedcellurfceproteWennottedcidteproteexpimnyhelthytuevlidtedexpipromgtrget31ptientmplelpedfrcryMMwellnmlhempoietictemcellTcellSixcidte(SEMA4AILT3CCR1LRRC8DFCRL3IL12RB1)BCMApentedmotfvbleprilemlignnthelthycell(DiMeoFetlCellReptMedice2023)WehypoizethurtrgetdcoverytrtegyuncovednovelMM-ocedntigenmeettrictcrerilevntimmunpeutictrget)yhighlyfquentlyexpedptientb)irexpinmltuemimlc)trgetgentigenimpctcriclfetuMMbiologyInAim1wedefedtriintigenexpiMMptientepecillyhigh-rkptientlpeddeetteWepcelymeuntigendeny(numrmoleculepercell)primrymrrowmlignntplmcellflow-cymetryWeueuniquecoht50MMptientwholpedprogedfterBCMACART-cellrpycomprgexpiptternBCMAFurrweuenmltuerryupieurgiclpecimengle-cellRNAeqdtBMmplehelthydpdicn-trgetf-tumxicyTheetudiedefelevnceledtrgetuchSEMA4AMMptientidentifyroletrgetgnovelntigencueptientwholpeBCMA-tnr-negtivedeeTheulterveoptimizedeignCARctructbedqunttiveprilgntigendenymlignntnmlcellInAim2weceneverlCARcognizgSEMA4AwectructedupnntibodydcoverycmpigngenertgnovelpurifiedmocllntibodieWefurrytemticllycompmultipledul-trgetgpltmtrgetgSEMA4ABCMAILT3vrovivoTheetudieerveidentifyledtrtegymypventntigenecpemximizeelimtiMMcellTheoverllcidencertecoloctlcncer(CRC)hdecledoverpttwodecdelrgelyduepopulti-bedcolocopiccengmovlpcurdenomEventhoughcolocopyhenneficilcncerterceptihlimtihveubtntilfncilhelthcequenceNerlyllcolocopyptientUSundergocciouedti/neiwhichpible~$15BhelthccotnnullyReectipolypmnywhichdothveneoplticpotentilloexpenivergcolocopycot~50%Colocopymemnydenomledghighrtetervlcncerccountgbout7000newCRCceechyerKeyfcrledgthhighmrtecludewrd-viewgendocopemepolyphdcolicfoldubtleerrtedpcurleidprieendocoptpriciencyTheeueunderlieunmetneedimproveddenomcengtechnologie1)enbleenticolvulizedcludghdmucolfold2)moeniveobjectivepolypidentificti3)providel-timepolypdigno4)cndetectttdenomtpotcoutquirgedtiOpticlcohencemogrphy(OCT)cro-ectilvivomicrocopyimggtechnologyfurrdevelopmentcnddmnyedenomcengneedHewecteclicllyvlidtenewOCTytemtwodtctOCTprothptimizeddenomcengTheOCTytemutilizenovtivetechnologyobtthe-dimenilmicrocopicimgeenticol5mute(Aim13)OnepropoedOCTimggproopertethroughcceyptcolocopeccelertgclicltrnlthroughcomptibilytrdccolocopy(Aim11)Thproutilizenovelextendeddepthfocu(EDOF)opticllowgcentedcollumencptuhigh-oluticro-ectilOCTimget3DpologyWeuethcolocope-comptibleproclicltudy200ptientdeveloptetnumtedmchelernglghmpolypclifictivivo(Aim2)TheecdOCTprotermedtrogrdetedcpuleendomicrocope(R-TCE)deignedcendenomunedtedptienttpotc(Aim12)TheR-TCEdevicetedEDOFOCTimggcpuleertednudvncedcecumvirottgcw-likemotiOncecpulecentedlumenbllopulledbckthroughcolwhileimggAftercpuledevelopedwecductclicltudyetblhR-TCEcliclproceduntetfetyfeibilywhole-colR-TCEimgg45ptient(Aim3)FllyenblefututtmentmlldenomidentifiedR-TCEnR-TCEdevicebltedimutivedenomdeveloped/tetedwepolypomodel(Aim14)Thenurgentneedidentifyeffectivettmenttrhepticcholngiocrcom(CCA)highlydemopltictumbileductfive-yerurvivlrte5%OverhlfiCCAcedignoedftermettepentwhenttmentchoicelimedmimllyeffectiveThelg-termgolourwkidentifynovelrpeuticterventiimproveoutcomethdevttgmlignncyThpropollevergeourexcgplimrydtuggetgimmunecheckpotproteB7-H4over-expedmothn60%iCCAcewheddiknownTcellimmunouppiverolemededmembrne-boundmexertcriclrolectroltumgrowthtromldepohroughpvioulyunknowncoopertitrcellulrmTGFpthwyGeneticbltiB7-H4mumodelgenertedco-expiNotch1trcellulrdomctivtedAkt1(Nicd1/Akt1)ugleepgutytrnpo/trnpoehydrodynmictilvejecti(HTVI)ignificntlyprolgurvivlproundlylterurroundgdemopliMechnticllyB7-H4over-expiceleveldockgceprltent-TG1GARPthupromoteleectiveTGF1ctivtidowntmSMAD2/3-dependentpthwyWehepropoetheimvlidteourhypothroughctivtiTGFpthwyB7-H4hpeuniquedemoplticpepromotetumgrowthiCCAophrmcologichibhcro-tlkctrietumhibhrougheverlcomplementrywyInAim1wedectmoleculrmechnmthroughwhichB7-H4promotecncercellgrowthmotilypermgvrofunctiltudieiCCAcellle(muhumn)ptient-derivedgnoidupgeneticmnipultiB7-H4/TGFxFurrmoweunveilfulltercmetrcellulrB7-H4exctubcellulrlocliztiInAim2weclrifyhownewlyidentifiedxhpedemoplticctiimmunefiltrticompoitructcelltypeprticulrlycncer-ocedfibrobltdepoirgnizecollgengeneticllyvertileHTVI-bedNicd1/Akt1mouemodelwhich-upptedourplimrydt-highlyemblehumniCCAendogenouexpiB7-H4InAim3weeefficcyphrmcologicllymodultgB7-H4xugcliclly-levntdrugblockgTGF1identifiedvulnerbiliecombtimocllntibodydictedgtB7-H4geneticthopicmumodelHecombgourlrgecollecticellle/gnoidhumnmplemouemodelglecell-bedpprochegle-firrtificiltelligence-bedpltmwedectpvioulyunknownB7-H4/TGFcro-tlkyieldnewightiCCAbiologyThepropoederchhighlyignificntceuccefulcompletiwouldetblhB7-H4xnoveltrgetiCCArpycouldimproveclicloutcomethdedlycncerCerviclcncermecdmotcommcncerkillerwomenwldwidennnulcidencemothn600000nnnuldethrte300000FurrcerviclcncerdproptelyffectcommuniemedicllyunderervedmywomenUSbrodimprovedrpieurgentlyneededPrimryecdrypventipprochelovriblyeffectiveevenpriCOVID-19pemicjut18girlwvcctedgthumnppillomviru(HPV)cue90%cerviclcncerVcctirtelodroppedhrplydurgpemicevenUnedStteCurntWldHelthOrgnizti(WHO)etimteHPVvcceuptkerte21%Thevtmjycerviclcncerdignoedfterprimryecdrypventifillocllydvncedcerviclcncer(LACC)Approximtely40%womendignoedLACClpediedeeeventrd--ccurtivettmentcplt-bedchemdipy(CRT)CRThmedtrd--cmothntwodecdenovelpprochehvefiledimproveoutcomeWehveidentifiedcriclprognoticfcrbctericlledLcbcilluer(Ler)cervicltummicrobiomewhichwitummetbolmutilizelctteocedttmenttncepourvivlFurrcommenlLcbcilli(lcticcidbcteri)tumetendrivenlctteuchhednecklungcncerlopperledttmenttncepourvivlOurobjectiveundertpecificllyhowLerlcticcidbcterifluencecncercellimmunecellmetbolmugtte---rtproximyproteomicmcymetry(Aim1)Welotetnovelrpeuticpprochetrgeteirtumidentbcterielimtgplcgpecificbcterilpecie(Aim2)metboliceffecttumidentbcteriviloclbcterilengeergytemicmetbolmtrgetgnti-cncerrpie(Aim3)Trgetgcervicltumbcterirpeutic(BugDrug)prdigm-hiftgidecplizgltiveimplicycervicovglmicrobiometendencydomtedLcbcillupecienlythtudyledimprovedmicrobiome-bedrpeuticimproveoutcomecerviclcncerthpro--cceptmodelcoulduedmtummicrobiome-bedrpeuticcrocncertypePROJECTSUMMARYPAX3-FOXO1ltedfuictecogenictrncriptifcrmodelchromtdriveubetchildhoodrhbdomyorcom(RMS)dmlcurteTherpietrgetPAX3-FOXO1lckgRecentlyweetblhedmTORC1PAX3-FOXO1geneticdependencyexploblethirdgenertibi-tericmTORC1hibirnowphe1tetgUnlikerpmycRMC-6272pventmTORC1-drivenemblyeIF4Fenugcp-dependenttrnltiThcpdtrikgefficcyptient-derivedxenogrft(PDX)RMC-6272duceprolgedmiwhilerpmycnloglytbilizedeemirrgirmodeteffectptientHoweverPDXeventullygrowhowtnceRMC-6272-ttmentmkgclerknowledgegppventueffectivelytrgetgPAX3-FOXO1vimTORC1WhtmoleculrbPAX3-FOXO1ddicticp-dependenttrnltihowcnwertillycomthgentovercometnceenblecurtiverpy?Thpropolddeequetigolprovidgmoleculrlymedtrtegyidgogclicldevelopmentbi-tericmTORC1hibirchildhoodcncerAim1defemoleculrbRMC-6272efficcyfuipoiveRMSExcglymticproteomicdtledunchghypoPAX3-FOXO1quicp-dependenttrnltiownexpiWeuepcebiochemiclymRNAtrnltiproteyntetthBuildgobervtiptient-derivedxenogrft(PDX)drivenlefquentPAX7-FOXO1fuihowducedpeRMC-6272wedefemoleculrfetuuntrnltedgi(UTR)PAX3PAX7fuiquimTORC1eIF4FirtrnltetwherUTRequencedetermeRMC-6272efficcyAim2defetmenugmentRMC-6272efficcyPDXSglegentrlyuccefulcurgevengeneticllyimplecncerlikefuipoiveRMSdeedweoberveemergencetnceRMC-6272mpyWefdBEThibir(whichdecePAX3-FOXO1expi)RAShibir(whichbluntfeedbckctivtiMAPK)echynergticRMC-6272Wehypoizeuchmechnm-bedcombtifercurtivettmentcompmcombtichempymtylpedRMStudieUgphrmcodynmicmodelgPDXweidentifyfeoptimlbiologicdogcomgentnfdtrtegytprolgurvivlpventtncetrnlteclicltrilCompletieimdetilhoweIF4FchetrtecogeneoutputfquentlylethlpedriccncerdefetrtegiefurrenhnceeeffectfercurtivettmentBeydguidgbi-tericmTORC1hibirueRMSknowledgegedenbletudytrnltilctrolrpeutictrgertrncriptifcr-drivenmlignnciebeddetermntpewedefehePROJECTSUMMARYTrgetednnotechnologiehvehowngtpromeovercomgrodblockcncerrpeuticTummetthlimedpetncechempeuticmodertepenewntibodyrpieOurRNAnnotechnologyhhowngtprometrgetgmettticdeedeliverbothgeneilencgchemicldrugrpieOurlggolovercomecolcncerecdmotcommcuecncerdethprimrilyduemuttiKRASubequentlungmettexpectedurvivlmthKRASgenecodeK-RprotecidedundruggbleKRASmuttifoundup45%coloctlcncerWehvedeignednepigeneticpilencemutntK-RthroughepigenomeedgWectedfuiprotectgnuclee-ctivedC9hnedecetyleHDAC1trgeteddC9-HDAC1promotermutntKRASWecnlodcombntdC9-HDAC1-gRNAribucleoprote(RNP)complexexoomeilenceK-RwedeignedRNAnnoprticlecrrygmutntK-RiRNAhibKRASmutntlungcncerwelouccefullyctructedRNA4WJcrrygSN-38hibcolcncerlungmettThegolthpropolidentifymechnmgovernhighdeliverypltmilenceK-RcolcncerWetenddectivtemutntKRASviRNA-ligdplygexoomelodeddC9-HDAC1-gRNAribucleoproteiRNAchemicldrugdividullycombticoloctlcncerprimrymetttumugthopicPDXxenogrftmodelWevetigtemechnmctiK-RhibicludgcditegrtiemblydC9-HDAC1gRNAcrRNAuchequencelengthquimentilencgmutntKRASuppgcolcncercellWepplyRNAnnoprticleienttidplytrgetgligurfceexoomeInteddelivergdC9plmidwedeliverribucleoprotecomplexdC9-combntprotegRNAExoomedplyRNAnnoprticlenptmerbdcolcncercellpecificllyWeengeerRNAnnoprticleceurfcedplydenynegtivelychrgedRNAligenhncenegtivezetpotentilexoomepventgbdgvlgnhelthycellnmllyhvenegtivelychrgedlipidmembrneWetryenhncerpeuticefficcyducexicyovercomgendoometrppgn-pecificcellentrythroughRNAligmnipultiZldenygrdientultrcentrifugtiizeexcluicolumnelectexoomemllerthn100nmecpemcrophgeengulfmentimprovebiodtriiThprojectmultidciplrypprochbuildtrgfoundtiwhicherchercndeploylrgeprotecomplexettcncertum-pecificdeliveryeffectivelytrgetgthoepvioulydifficulttrgetlikeK-RSummryAntumimmunourveillncecyxiclymphocytegenerllycceivedbiochemiclprocewhichtumpecificmrkercognizedctivtgceprlymphocyteurfceWehvefoundhowevercyxicTcellnturlkillercelllopdmechniclpropertiecncercellpfentillydetroygtrgetphyicllytifferThmechniclmimmunourveillncewhichwecllmechnourveillncepperprticulrlylevntdurgmettwhencncercellmodelircykelenvdenewgnInthpropolwevetigteterplytweenmechnourveillncephyiclpropertiemettticmicroenvirmentCellulrmechnicmodultedctuoulycell-extricbiophyiclignlAprticulrlyimptntmnifetthcrotlkclledmechnociprocyducecelltifferenvirmentcometiffermelvethoeterloclecometerWherenvirmentlly-ducedtiffengmightenizecncercellmechnourveillncevivohoweverhnotenexplodThntetgqueticuemettticmicroenvirmentvrywidelyirphyiclpropertiernggveryrigid(eg)veryt(eglung)EnhncedmechnourveillncerigidmicroenvirmentwouldetblhgimewhichcyxiclymphocytectrolpectrummettticepfencedproptelyuppgoutgrowthgnlikeUgmouemodelmettwehvefoundcncercellcolizgignificntlytifferthncncercellcolizglungvivoexpnimettexquelyenivecyxiclymphocyteBuildgeplimryobervtiwepropoemicroenvirmentltiffnedictteefficcymechnourveillncethltihiphpebothmettticepfencepowernti-tumimmunpyWevetigtethhypotheSpecificAimAim1exmehowdtctmettticmicroenvirmentffectcncercellbiomechnicimmunevulnerbilymicehumnAim2determeifenvirmentltiffnecnndependentvriblectrolefficiencymechnourveillnceFllyAim3pplytte---rtrigidydependentcelltgtechnologyidentifynovelmechnogulrmettvivoOurpropoedtudiegnizedroundcceptullynovtiveidecrotlktweenenvirmentlmechniccellulrcyxicydetermewhemettegrowInddiweemployhighlynovtivetechnologiecludgupendedmicrochnnelr(SMR)devicerpidlymeucelldembilytcellbedtiffneTheuccefulcompletiourSpecificAimcouldidentifybiomrkerguidgntumimmunpyiddevelopmentnoveltrtegiettgmettticgrowthpecifictrgergnAuchthwkhighlylevntNIHmictriedvncementknowledgecouldimprovehumnhelthPROJECTSUMMARY/ABSTRACTPoly(ADP-riboe)polymerehibir(PARPi)mtychempeuticgimenBRCAmutnvrinbtcncerDepeilpoivepelg-termclicluccePARPirpylimedowgevbleemergencetnceideeffectocedcurntdogeWecentlyptedlonucleoomelidgenzymeAmplifiedLiverCncer1(ALC1)hyperenizeBRCAmutntcncercellPARPiNotblyALC1lopermkillgBRCAmutntcncercelltub-nnomolrPARPidogePARPienivycrovriouengeedmodelchemotnceBedeobervtiouroverrchggolemployALC1-deficientBRCAmutntcncercelldefecellulrbiochemiclmechnmcnexploedcircumventcliclhurdleocedPARPiOurplimrydthighlightroleALC1medednucleoomelidgpromotgpirbedmgeleiclledbiceHoweverunclerhowALC1logenertebicehowthctriePARPihyperenivyBRCAmutntcncercellThepropolddethknowledgegpvifollowgSpecificAimInSpecificAim1wetegrtevroctutigeneticcomplementtinlyDNApirplictiydefemechnm()ledcedbicechromtuploALC1TheeexperimentprovidenewmechnticighthowperturbgchromtmodelgvolvedbedmgepircnlevergedugmentgPARPenivyBRCAmutntcncerInAim2weuegle-moleculeplictrctllgyelectrmicrocopyCRISPR-bedgeneticedgptient-derivedprimrycelldetermehowbiceultmodelgplictikgenertileiccentutePARPenivyTheeexperimentuncoverhowcommunictitweenbedmgepirplictikcnexploedenhncerpeuticpotentilPARPiOurtudieprovidefoundtidevelopnewpprocheimproveefficcyxicyprileclicllyuedPARPiwhileimultneoulyhighlightgnewbiomrkercneffectivelypdictPARPipeBRCAmutntptientPROJECTSUMMARYKeeentildevelopmentdegultiirctivyctriecncerprogimultiplehumnmlignncieWecentlydemtrtedceprtyroekerrngeddurgtrnfecti(RET)enceundiffentedtteepidermlprogenircellrrntlyctivtedcutneouqumoucellcrcom(cSCC)Ourlg-termgolhelpdeveloppiclelectiveREThibireffectiverpeuticpventicSCCTheoverllobjectivethpropol(i)elucidtemoleculrmechnm()RETgultihumnepiderm(ii)defeRET-gultedimpcttumimmunemicroenvirmentwhiledemtrtgrpeuticefficcytrgetgRETcSCCpventiOurcentrlhypoutedexpiRETnerlyctibleeventcSCCdevelopmentultdruptiE3ligeterctienblgdegultidowntmkepromotgimmuneecpethroughdowngultiMHCexpiThertilethprojectdetermtiRETgultictivtiepidermctetrgcceptulfrmewkdevelopmentrpeutictrtegieimedtctrollgRETignlguchhibgRETeffectiveecdrypventicSCCt-rkperInfirtAimourpropolwetetcentrlhypochrcterizgRET-Sih1terctidefgkeydowntmbrnchegultedepidermlRETInecdAimwevetigtetimgcequenceRETctivtidurgprogihumncSCCnmlkcrcomuevluteefficcytrgetgRETthroughgeneticbltiphrmcologichibiphocrcogenevivoTheerchpropoedthpplictinovtiveouropicuefocuehibgnovelmoleculrtrgetrpeuticllytermlmturtimenkcncerpventiThepropoederchignificntcueexpectedjutifypcliclclicltudieREThibiecdrypventicSCCUltimtelyuchknowledgehpotentilducecidencekcncerthcountryPROJECTSUMMARYColcncerledgcuecncer-lteddethbothmenwomenUnedStteAbnmlDNAmethyltiptterngnepigenetichllmrkcolcncertypemjctrigfcrgenometbilytumuppgeneilencgthdeeDepedeepppciroleDNAmethyltidevelopmentcncerculmechnmctrieevolutiDNAmethyltibnmliecolcncertypecequencethhllmrkepigeneticmodelgcncerdevelopmentmpolyunderodThpropoleekddefundmentlknowledgegpOurplimrydtimplicteproteubiqutineentilpot-trnltilmodificti(PTM)gultgctivyDNMT1primryenzymepibleepigenetichernceDNAmethyltiptternthroughmiccelldivimjtrgetepigeneticcncerrpyBuildgedttudieAim1chrcterizeubiquignlgnetwkterfceDNAmethyltihernceTherpeuticpotentiltrgetgubiquignlggulrthpthwylocidedInAim2wetetmechntichypocnectgovexpiE3ubiquligeUHRF1DNAmethyltidygulticoltumigeneAim3vetigten-cniclfunctiUHRF1gultiheterochromtichnePTMignlgimplictiDNAhypomethyltirpyOverllourtudietterfceubiquignlgDNAmethyltiherncevelfundmentlcuecequencebnmlDNAmethyltiignlgcolcnceridentifynovelpprocheenhnceefficcyDNAhypomethyltirpyttmenttrtegymngethdedlydeePROJECTSUMMARY/ABSTRACTImmunecheckpothibir(ICI)hvedrticllyimprovedcncerurvivloverptdecdethurvivlcometcotnewclimmune-lteddvereevent(irAE)chrcterizedflmmryu-immunepthologiethccurpertlgfterICIdctutiTheeirAEcnhvemjimpctlg-termquly--lifebuurbilypproprelyddmlimednufficientundertgirAErteeveryprileAumtedmethodidentifymirirAEcouldimprovecliclcbiomediclerchphrmcovigilncehoweverirAEtenlydocumentedclicltextcnnotcurntlyumticllyextrctedEHRtcleTheoverrchgobjectivethpropolcteppliedmtictechnologiecncerurveillnceerchurvivhipcptientttedICIOurcentrlnovtidevelopmentcliclvlidtinturllngugeprocegmethodprticulrlyneurllngugemodelcnhlecomplexieEHRirAEextrctiuguntructudtructuddttmInSpecificAim1wecductclicltrilmtic-tedirAEdetectiEHRmeurgfeibilyeffectiveneimprovggtrtiAllinceA151804nNCIcoopertivegroupirAEbiopoiryThfirttrilmtic-beddvereeventdetecticncercmjtepwrdclicltrnltiInSpecificAim2wedevelopnewmethodextrctirAEccdgireverygrdedetiledtrdizedcomputtilphenotypgpermexternlvlidtiInSpecificAim3weoptimizegenerltlrgelngugemodelirAEmtiextrctiouttk-pecificfe-tungcludgnovtivemethodtilmodeldignoticgechptientThwkhighlyignificntdevelopgpplygvlidtgmticmethodtkefulldvntgeEHRupptlg-termgolimprovgquly--lifeurvivlptientttedICIThclicltrnltilwkcrriedoutnexperttemcncerclicinclicltriltmticincomputercienttCPMV-PolymerDeviceEnhnceOutcomeIntrtumlImmunpyStemetz(PI)hercolleguehvedevelopedplntvirunnoprticleimmunpyctivtenteimmunecelltummicroenvirment(TME)lunchdptiveytemicdurblentumimmunySpecificllywefoundnnoprticlebedcowpemoicviru(CPMV)timultepotentntumpeolidtummouemodelcnecncerptientIntrtumlimmunpyCPMVovercomeimmunouppiTMElunchgdptiventumimmunyimmunologiclmemypventcncercurnceCPMVterctimmuneytemmultivlentmnnerultgccdeeventbootedvidychieveunpcedentedpotencyThetrtumlimmunpydevelopmentpipeledvncgquicklyeffectivenefcechllengenecetgtterdeliverymethodKeyueclude(1)Lrgetumtenneedmodrugmultiplejecticomplictgprocedupoiblyffectgrpyultduevribily(2)Highfluidputumcuedfcrlikevculruecfedcellgrowthcnimpededrugdeliveryevenpuhdrugouttum(3)Fquentdogccomtptient(/ownerwhenptientdog)ffectgirgnectuettmentTheewepropoelow-leeCPMV-polymerblendmultideliveryjectbledeviceCPMVcptedpolymerblendpplygclblehotmeltextrui(HME)procegtechnologyPokki(MPI)nexpertHMEprocegbiologicourplimrydtcfirmtructurlbiologicltbilyCPMVleeddevicetechnologyFllyprote/polymermeltcvertedjectbleimplntmicroprticleugroutelyvilblemillgmoldgequipmentWefulfillfollowgimFirtwemulteCPMV-ldenlow-leedeviceetblhtuneleertecfirmtructurltegrybiologiclctivyleedCPMVdeliverytechnologySecdwepermclicltetgetblhefficcymechnmctifetyfunctidoedeliverydeviceWhilepprochCPMVtrtumlimmunpytum-gnoticwefocumettticbtcncerTomimicptientpopultidiffentubtypebtcncerweueimmune-competentmouemodelmettticdeecludgmodeltriplenegtivebtcncerHER2+ER+/HER2-tumThirdpludewrdtrnltiwepermphe0cnetrilenrollgcneptientn-mettticmettticmmmrytumcollbtiCo-IPeCompnidogptneoutumprovideuniquelypowerfulourcecnuedtrnltilerchwellttmentomeewell-lovedpetAbtrctPncticcncerthirdledgcuecncerdethUnedSttemotptientfrcrycurntlyvilblerpieHoweverwehveobervedenydenervtilowevenhltprogipcncertgemlignntdeetrngenicmouemodelpncticductldenocrcomThwkctriedurgencetetundertgrolenervouytemcncerthoughtgtrgetgnervecouldnovelwyimproverpeuticefficcyWehvefoundbothenyympticneurexpmembrneboundprotecognizedimmunologtcheckpotproteSpecificAim1thtudyexmeimpctenynerveimmunecellfunctiemerggtummicroenvirmentcludgpecificctriineurllyexpedimmunecheckpotprotetumgrowthimmunepeImptntlybothenyympticnervehveloenimplicteddevelopmentecdrylymphoidtructuInSpecificAim2thtudyweevlutechngenervtidrglymphnodeWeexmewherchngeenyympticnervtilymphnodeneurlexpicheckpotprotectriepro-tumigenicimmunepeWelodetermeiflymphnodenervtgnerverpeutictrget/prognoticbiomrkerFllySpecificAim3weevlutewhercombgchempycheckpotrpyterventidictlytrgetperipherlnerveimproverpeuticefficcyOverlletudieprovideeentilmtiboutnovelneuro-immunepthwycnuedimproveptientcABSTRACTLymphedemffectpproximtely200milliptientglobllychrcterizedccumultilymphfluidttuedueobtructilymphticytemInWeterncountriemotcommlyoccurdicutcomecncerttmentelfmotfquentlyurvivbtgynecologiclcncerLymphedemchricprogivedeehnocuCurntttmentpprochemlyddympmtuewellgdcomtphyipycompiWecentlydevelopednligned-bridednnibrillrcollgencduimplntedbridgegilymphticobtructinewurgiclttmenttrtegyOurplimrypcliclclicltudiedemtrteimplntticduduceympmocedlymphedemWepropoedvncetrnltilerchpplicthnovelbblecdudelivermuch-neededurgiclpventtivettmentlymphedemBedtechnologydevelopedFibrlignCppviouvericduhowedpromgpcliclcliclultlymphedemttmenbjectiveoptimizetructurlmechniclpropertiecdutrgetglymphedempventiwell-etblhedmouertlymphedemmodelAccdglySpecificAim1wehypoizelignednnibrillrcduoptimllyengeedtructurlmechniclpropertiepromotecpillryflowlymphticendolilcell(LEC)functiWedetermeoptimlpropertie(tiffnennibrildimeterdegrdtirtecpillry)cdumximizeLECphenotypelymphticproutgInSpecificAim2wetethypothptimllyengeedlignednnibrillrcduccelertelymphticgenertinmlizelymphticflowmutilmodelecdrylymphedemWefirttetrpeuticefficcymouemodellymphedemwhichcdumultiimplntedmouetilimmedelyfterductilymphedemOutputmeucttilvolumelymphdrgeptternbeddocynegen(ICG)imggICGimggenblen-vivetrckgperfuiovertimetrckbilycdupromotelymphngiogeneThecduwhoepropertiemximizelymphticgenertilymphdrgeundergofurrnlymoclicllylevntrtmodellymphedemducedlymphnodeectiirrdiAim3HecduimplntedimmedelyfterlymphedemductiurgerypventtiveterventiTtmentgroupcptimllyengeedcducompdnottmentctrolgroupfencecdumultiOver3mthwequntifyedemccumultimicrocomputedmogrphylymphdrgeptternICGimgglymphticgenerticfirmedhlogiclquntifictilymphticdenyThroughthdutry-cdemiprtnerhipwenticipteetudiedvnceurgiclpventilymphedemProjectSummry/AbtrctEpidermlgrowthfcrcepr(EGFR)ceprtyroeke(RTK)ncogenicdriverfquentlyovexpedmuttedn-mllcelllungcncer(NSCLC)MnyEGFRhibiruedttNSCLCdrugtncecommNecumumb(Neci)nEGFR-dictedmocllntibodypprovedubetNSCLChrbgwildtype(WT)EGFRefficcyverylimedPtientwhoetumhrbmuttedEGFRtenderiveignificntnefEGFRtyroekehibir(TKI)tncevriblydevelopMechnmtnceEGFRhibircomplexnotfullyknownOurobjectivethprojectevlutenewgenvercomgdrugtnceNSCLCugpcliclmodelTheprojectbuildourcentdcoverycombnthumnprotePEPDG278DducedegrdtiEGFRHER2bdgirextrcellulrdomHER2cloelyltedEGFRkeyctriburdrugtnceNSCLCPEPDG278DnenzymticllyctivemutnthumnpeptideDloknownprolideimptntcollgenmetbolmWelofdPEPDG278DducedegrdtimuttedEGFRHER2thccurNSCLCtrglyhibNSCLCcelltumtntcurntEGFRhibirWeenvrgeteddegrdtiEGFRHER2moeffectivethnlyhibgctivtictivyirtyroekeke-dependentfunctiloimptntircogenicignlgOuroverllhypoNSCLCcelltumtntcurntEGFRhibirvulnerbletrgeteddegrdtiEGFRHER2PEPDG278DPEPDG278DducedegrdtinlyWTEGFRHER2lobrodpectrumclicllylevntmutntWetethypothepecificim1)ePEPDG278DhibicogenicignlgntumctivyNSCLCcelltumexpgWTEGFRcompPEPDG278DNeci2)determeifPEPDG278DhibcogenicignlgbrodpectrumEGFRHER2mutntNSCLCcellducgirdegrdticompPEPDG278Doimertib(Oi)whichthirdgenertiEGFRTKIpferdEGFRTKINSCLCptient3)determeifOi-tntNSCLCcelltumenivePEPDG278DifcombgtwogentenhncerpeuticoutcomePEPDG278DOicomplementechmechnticllytrgetgEGFRmutntThepropoederchignificntcueddedrugtnceNSCLCwhichmmjcliclproblemWeexpect1)howPEPDG278DrpeuticllyuperiNeciOi2)etblhnovelcceptducgdegrdtiEGFRHER2neffectivetrtegyovercomgdrugtnceNSCLCTheefdgmygenertetrgenthumcliclevlutiPEPDG278DNSCLCtimulteerchEGFRHER2degrderAltertiglycoyltihveenoceddevelopmentprogimnytypecncerchriccutedeeStructurlglycnnlypurifiedprotetenprovidetbiomrkermtitimecumgcntkedytenweeknlylyhfulmpleToddthlimtiourgrouphdevelopedtmledntibodycptuliderrypprochdictlyprileN-glycncptuderumglycoproteThmethodcommethodntibodyrryimggmpectrometryctenewmethodmultiplexedN-glycnnlyImptntlythyquilyfewmicrolererumutilizeimplifiedprocegwkflowquinoprotepurifictiugrmodifictiprinlyThmethodferdGlycoTyperInthmethodN-lkedglycnPNGeFleedlidentibodycptudglycoprotedictlynlyzedMALDI-TOFmpectrometryWehveuedthmethodologyidentifybiomrkerp-mlignntmlignntliverdeeOurplntrnhmethodwhichutilizenovelglyco-technologycommercilettgTohelptrnltethfdgwepropoeetblhnter-dciplrymulti-tutilerchtemwkgtrtegicllincebothdutrycliclprtnervlidteouridentifiedbiomrkerThpplictipenttrueynergticefttweengrouptMediclUniverySouthCrol(MUSC)cliclgrouptUniveryTexSouthweternMediclCenter(UTSW)ndutrilprtnerGlycoPthIncwhohlicenedechnologyWelievethmultidciplrytemledrpidrigouexmtipropoedbiomrkerpnelProttecncerledgcuecncer-lteddethAmericnmenItetimtedechyermothn180000newprottecncerptientdignoedpproximtely26000ptientUnedSttedieprimrilyduemettThoccurdepedvnceerlydetecttmentThevilblettmenptilimednotveryeffectiveocedeveideeffectFurrmoprottecncerptientcndeveloptncecurntlyvilblerpeuticTheethpropolhelpdevelopeffectivettmentddmechnmrpeutictncemenmettticprottecncerEnhncerzethomolog2(EZH2)pecificllymodifiehneH3protetlye27tightlywdgDNAilencggeneexpiOurpviouwkhowedEZH2upgulteddvncedprottecrcommettticprottecncerprottecncerptientwhohvehighexpilevelEZH2hvehterurvivltimethnprottecncerptientlownoexpiEZH2WelofoundhighexpilevelEZH2ducechromoometbilypgmnyimptntprotepiblepirDNAdmgeDNAdmgeimproperDNApircnlediprogimnycncercludgprottecncerRecentlyphrmcologiclhibirPolyADP-riboepolymere(PARP)hveenclicllytetedttmentprottecncerhoweveredruglyeffectiveubetptientDNApirdefectFurrmoptientcndeveloprpeutictncePARPhibirTheettmentPARPhibirlemynoteffectiveeveryptientuggetgimptncebiologiclmechnmgultgdevelopmentprogiprottecncerMotdvncedprottecncercellhvehigherlevelEZH2PARP1protecompderly-tgeprottecncercelluggetgimptnceeproteprottecncerprogiWefoundEZH2dictlyterctmethyltelyePARP1InpropoedprojectweidentifypcelyhowEZH2-mededPARP1lyemethyltigultePARP1functiDNAdmgepirtrncriptictivyUndertgemechnmledfutudeignnewhibirEZH2PARP1FurrmoourplimrydttrglyuggetPARPi-tnttumhvehigherlevelEZH2compdPARPi-enivetumuggetgEZH2plycriclrolePARPi-tnceTheeourwkprovidenovelrtiletrgetEZH2PARPi-tntPCThecidencehepcellulrcrcom(HCC)rgrpidlywldwideInUSthcncergrowgtrtefterthnnycncerNewbiomrkerpecificHCCtuetrgetcricllyneededdevelopimproveddignoticrpeutictrtegiettermngecgtumburdenWhilelphfeprote(AFP)commerologiclmrkerHCCnotuetrgetcurntlyguedimggbiomrkerdetectumwhichgrowgrpidlycidenceIndividulHCCcellevlutedugcRNA-eqtrjecrynlyidentifypromgerly-tgetrgethighlypecificumThmethodologyexmemoleculrpthogenedrivehepcytetrnmtiidentifypromgimggbiomrkercnccurtelydtguhmlignntnignleictexttummicroenvirmentAntibodielrgedimenihveducedbilyextrvtevcultudiffuepenetrtetumclertertilpceultghigherbckgroundPeptidemuchmllerizelowermoleculrweightThedimutivedimenicnovercomeirgulrmicrovcultuheterogeneouuptketrnptbrrierfoundHCCtumTheeprotefrgmentcnextrvtethroughlekytummicrovcultudeeperpenetrtitterccetumtrgetPeptidehvelepotentilimmunogenicyllowgpetueCventilliggdevelopedpecificbdggletrgetlyThtrtegylimedeffectiveneheterogeneoutumcellpopultiuchHCCMomerpeptiderrngedmultimercfigurtiproducemultivlentlig-trgetterctiIncedenivyoccurimultneoudetectimultipletrgetGterpecificymultimerbdglrgercomdtrgetepipeCncertrgetmydetectedtlowerlevelexpnerliertimepotPeptidepecificGPC3CD44EpCAMuednildemtrtiPeptidepecificnewerly-tgeHCCtrgetidentifiedcRNAeqidentifiedertedThemultimerlledGd-DotvivouedetectHCCtumugMRimgglledIRDye800opticlimgglprocopyCell-derivedubcutneoutummodeldotccurtelyflectmoleculrgeneticprilevculrdeliveryhumndeeAp-cliclmodelHCCugptient-derivedtumpecimenimplntednthopicloctivlidtepecificmultimeruptkeTheetumprovideclicllylevntmoleculrgeneticprileTumimplntthopicloctiprovidevculrdeliverytcttromvcultupenttivecliclcenrioSuccecompletipropoedimultpeptidemultimervlidtedndvncedp-cliclmodelerlycncerdetectiflectheterogeneyvribilycellurfcetrgetexpedHCCAbouttwomilliperdignoedcncereveryyerUSTheEffectivecliclmngementcncerptientcludguelrpiecnimproveoutcomeducecotHoweverdhencertelrpiecncerttmenthveenpted20%dependgdrug2PoPtient-providercommunicti(PCC)ebrrierdhencelchempieddidveredrugeventlckknowledgeboutdhenceTimelyeffectivePPChighlevelempthyhownproviderddptientemotilccernwntneedcnenhnceptienttruthelthcproviderirclicloutcomeuchdhenceemergencyerviceutiliztiNewdiglhelthpltmuchecumegg(SM)throughptientptlcnprovideneffectivetimelychnnelElectricPtient-ProviderCommunicti(EPPC)PtientoutcncercglyugecumeggcommunicteirneedAMy2019out1MptientvedYleNew-HvenHelthSytem(YNHHS)bout436000ptientuedptientptlultgmothn27MmegeWhidentifictiquntifictiEPPCSMctentwecnmeuociimpcnptient-centedoutcomeHoweverextgtudieidentifyEPPCptternlrgecleSMdtlimedyfocuedlyptientmegemimllycludedprovidermegeSometudienotclbleymnullycodedEPPCptternmlletSMWefillthgpugnturllngugeprocegmchelerngpprocheutilizebigSMdtInourpviouwkwemppedexpiSMEPPCcodecommunictiugRoterInterctiAnlySytem(RIAS)methodcodemediclterctidevelopedElectricPtient-ProviderCommunictimer(EPPCmer)olItcndetecttheEPPCcodemtieekggivgocio-emotilhviInthtudywe(1)feEPPCmermoeffectivelyextrctmogrnulrEPPCcodemtieekg(egmedicti-lb-imgg-lted)mtigivgocildetermnthelth(egtrnpttiecomicccernfood)ocio-emotilhviprtnerhipbuildghddeci-mkgWefeEPPCmerugSMYNHHSClevelClicevlutegenerlizbilyugVeternAdmtrti(VA)dtprtnerhipbuildghddeci-mkgWeloecoqulybi-dictilcommunictiexmgproviderpeptientquetSM(2)WepplyEPPCmerSMcohtptientdiffenttypemettticWenextrctchrcterizeEPPCcode1yerwthpropectiveptientproviderSMexmeirocicoptient-ptedcommunictiement(3)WeeimpctEPPCcodeptientoutcomedhenceugphrmcydtptient-pteddhencedtemergencyroom(ER)vhopliztiHepticfibromjcuemtlyptientn-lcoholictehept(NASH)Hepticfibroloplymjroledevelopmenthepcellulrcrcom(HCCwhichecdledgcuecncermtlywld-wideHeptictelltecell(HSC)genertehepticfibroctivtedliverjurymechnmirctivtinotfullyunderodUpctivtiHSCtrtexpggeneuchlph-moothmuclect(SMA)collgentype11(Col11)whichmrkerhepticfibroUpctivtiHSCcomehighlyglycolyticcequentlyproducehighlevellctteLcttehenuggetedplyrolegultggeneexpiupHSCctivtimechnmmeluiveWefoundhighglycolylctteproductictivtedHSClrgelydueductihexoke2(HK2)expiOurulthowHK2quidctivtiHSCliverfibroIntetglywefoundlctteproducedcueHK2expiducehnelctyltiwhichquidgeneexpictivtedHSCInbenceHK2ductigeneexpiimpidHSClcttecouldoverrideeffectHK2deletigeneexpiWelofoundHK2deletihepcytettenuteNASH-ducedhepcrcogeneTheeourultuggettrgetgHK2couldrpeuticbothliverfibroNASH-ducedHCCInthgrntpplictiwefurrvlidteroleHK2liverfibrohowffectNASH-ducedHCCWeemploymouemodelNASH-ducedHCCwhichextenivefibroWeueemicetudyroleHK2terplytweenliverfibroHCCFllyprocceptweverifyifytemicHK2deletiwhichdoenotelicdverephyiologiclcequencecouldhibbothfibroHCCmouemodelNASH-ducedHCCPROJECTABSTRACTHepcellulrcrcom(HCC)ignificntgloblhelthproblemexpectedcomethirdledgcuecncermtlyUnedStte(US)Amgptienterly-tgeHCCpproximtely70-80%ptientexperiencedeecurncefterurgiclectinoytemicrpycurntlypprovedperiopertiveettgNeodjuvntimmunpy(immunpydmtedpripotentillycurtiveHCCecti)imutilizeprimrytumourcentigenenhnceytemicnti-tumimmunypventdeecurnceNeodjuvnttudielofernopptunyterrogtemechnmhdboumenivytncerpieprovidglrgerquntietumenble-depthprilgtumimmunemicroenvirment(TiME)notpoibleneedlebiopieWecductgneodjuvntpltmtudyevlutemultipleprogrmmedcelldethprote-1(PD1)-bedcombtiHCCThethetudyrmnivolumb(NIVOnti-PD1)NIVOplucbozntib(CABOmulti-kehibirVEGFR-2AXLc-MET)NIVOplultlimb(RELAnti-LymphocyteActivtg3LAG3)OuroverrchghypoddiCABORELAnti-PD1pbrriercrumentfunctiTcellerly-tgeHCCWelovetigtetertirylymphoidtructu(TLS)cervedmechnmpeneodjuvntnti-PD1-bedimmunpybedourplimrydthowgtrgocitweenmtiTLSmjpthologicpeHCCttednti-PD1immunpyInAim1weutilizehigh-prmetermultipleximggmcymetry(IMC)p-ttmentpot-ttmenturgiclectipecimendetermeddiveeffectCABORELAdenyptilltihipimmunecellTiMEWeloevlutewhertriplecombtiCABOnti-PD1nti-LAG3enhnceTeffecr(Teff)crumentfunctiurvivlpcliclmodelHCCInAim2wevetigteclldynmicTLSnti-PD1ttedHCCthroughT-cellcepr(TCR)B-cellcepr(BCR)equencgdividullymphoidgggteWedetermeimmunophenotypeTLSthroughptilfunctilnlyTLS-ocedTcellBcellInAim3wedetermecellulrcompoigniztiimmunpy-ocedTLSthe-dimeniemploygnewtechnology(CODA)nder3Dctructi2DimgetckThimprovidefirtmulticellulrtructu-functinlyTLSimmunpy-piveHCCundertifTLShighlycervedtumcrotumThefldeliverblethprojectundertgmechnmpepromgnti-PD1combtiidentifictieffectivefeiblerpeuticcombtineodjuvntettgHCCcnbroughtwrdlrgertudieultimtelyimproveoutcomeptienterly-tgeHCCThemothn600000dolecentyoungdult(AYAge15-39tdigno)cncerurvivUSThenumrAYAurvivctuegrowduebothncedcncercidencettmentdvnce(iefive-yerurvivlrte>80%)FAYAurvivimpctttmentignificntlg-ltgcludgdifficultphyiclympm(egpftigue)emotildt(egnxietydepi)ncedrklg-termhelthproblem(egecdcncererly-etcrdiovculrdee)PertentphyiclympmemotildtctrieignificntocilecomichelthburdendruptgAYAurvivbiliecompleteireductichieveunomybuildceretblhpeerromnticltihipbuildfmilyAYAurvivptympmmngementcriclunmethelthcneedyetpucyterventiddiruniqueneedFollowgcompleticncerrpymnyAYAurvivgrdullylotfollow-upircologytemwhileccurntlyfilgetblhchelthcproviderwhowirrkhelthcneedBrrierfollow-upcAYAmultifcetedmycludeurvivliefbouttrnigcnvigtghelthcmodelcentedroundolderdultdueprtge-pecificcompetgdem(egchildcwkchool)fncilcotocedc(eggunudunderud)AcequenceAYAexperiencedequteurveillncelteeffectmedopptunieympmmngementpychologiclupptwhichfurrperpetuteirunmetneedWehvedevelopedncceiblediglhelerventiAYASTEPS(SympmMngementTrnigEnggementPot-TtmentCAYASurviv)deignedenhnceAYAurvivbiliemngeirhighympmburdenenggefollow-uphelthcInmedORBITModelterventidevelopmentAYASTEPShenytemticllyrigoulydevelopedfedthroughPIpriwk(K08CA245107)AYASTEPSgnizedixmotelydelivedeiprovidgcognive-hvilptientctivtiy-bedkillexpectedledlowerympmburdencedhelthcenggementimprovgAYAelf-efficcyympmmngementctivtiWepropoeromizedctrolledtrilexmeefficcyAYASTEPScompdAYAeductilmtiimprovgympmburdenhelthcenggementAYAurviv(N=260)whoceivedcncercdiverehelthcettg(ierurlurbnmedicllyundererved)croNthCrolSelf-efficcyptientctivtiexmedmedirterventieffectTheplnnedtudyhpotentilproduceclicllyimpctfulhelthnefnunderervedundertudiedgroupcncerurvivwhohveignificntympmburdenexperiencebrriercenggementhvelimedcceAYA-pecifichvilterventiPROJECTSUMMARYRdipycnernettmentprottecncerrdi-ltedgeniurry(GU)gtrotetl(GI)xiciecnnegtivelyimpctqulylifemgurvivRdipycmgebldderctumledggrobleedgflmmtipfibrowhenevelife-engcomplictiUp20%menttedrdipyprottecncerdevelopmildmodertelteGU/GIxicietenpermnentnegtivelyimpctqulylifeup5%developevelife-engeffectquirgmediclurgiclterventiRdiexpoudriverkltexicygeneticpdpoiignificntctriburcnexplwhyomeptientdevelopxicywhilenotdepeidenticlttmentplnOurpriwkhowlteGUGIxiciepolygenicetiologyrkmodifiedcomdeffectmnylow-penetrnceglenucleotidepolymphm(SNP)rgttrctivepoibilyugpolygenicrkcoidentifyuceptibleptientpritrtgrdipyTowrdthgolwedevelopednovelmchelerngpprochcommtimnyrkSNPdoe-volumeprmeterrdiogenomic(ML-RGx)rkcoOurplimrydthowthmodellgpprochout-permextgmethodhowpromeueclicThepropoedprojectpplythmethodlrgetrgdtetNCI-upptedInterntilRdiogenomicCtiumbuildML-RGxmodelGUGIxicynexternllyvlidtedugdtbiopecimentwolrgepheIIIrdipytrilcompletedthroughNRGOncologycoopertivegroupBiomticpprocheppliedpriizeSNPcluimodellguncoverbiologicpthwyunderlyggeneticpdpoinmltuejuryThetudyhtheim(1)trML-RGxmodelechrdi-ducedGUGIxicydefethholdlowhighrk(2)vlidteML-RGxmodeltwodependentdtetNRGOncologycoopertivegrouptril(3)efeibilyimpctML-RGxmodelttmentplnngwkflowRdiOncologyclicThwkbrgperlizedmedicefieldrdicologyimproveprottecncercOurnovtivemodellgpprochelouncoverimptntmoleculrpthwycouldtrgetedterventipvent/migtexicieProjectSummryPARPhibir-bedynticlethlrpyuchBMN673(Tlzoprib)howgtefficcyBRCAmutted(homologoucombtipir(HRR)-deficient)cncerpcliclclicltudiedemtrtelimedefficcymjycncertypeHRRpricientToimprovePARPiefficcyextendirrpeuticpplictiddilcombtipprochenecery5-zcytide(AZA)DNAmethyltihibirwhichhowcgcliclueepigeneticrpyolidtumAZAhenptedenhncePARPipethroughtrppglrgeDNMT-PARP1complexeDNAbkeenhncgmticyxicdouble-trbk(DSB)BedourplimrydtdtAZAmyloffectDNApirducgHRRdefectenizgtumPARPiMooverwehypoizecombtiAZABMN673myenhncetumimmunepethroughgenertinovelnetigenupgultiMHCclImoleculeHowevereffectivenethcombtirpylimedpobiovilbilytwodrugchllengecodeliverytumduedtctphyiochemiclpropertieBMNAzInourplimrytudiewedevelopedmllizednnocrriercouldelectivelyccumultetumeffectivelypenetrtecoexperimentltumimptntlycouldefficientlylodbothhydrophilicAZAhydrophobicgentBMN673wmoeffectiveuppgtumgrowthPARPi-eniveNSCLCtummodeltltivelylowerdoeWepropoefurroptimizeBMN/PAZAmulti(Aim1)evluteirvivophrmcoketicbiodtriumpenetrtiefficiencyugtummodelcloelymimichumnNSCLC(Aim2)Welovetigterpeuticefficcyunderlygmechnm(Aim3)Theetudiedduef-trgetxicyAZAPARPiprovidepromgfetrtegyexpcliclueynticlethlrpybothHRR-deficientHRR-pricientcncerptientPROJECTABSTRACT/SUMMARYImmunecheckpothibir(ICI)hvevolutiizedcncerttmentmnyptientfilpdExpgpeICImjgolimmuno-cologyWecentlydcovedblockgexoomebiogenethroughgeneticdepletinSMe2cnovercometnceICImultiplemouemodelledgrobutntumimmunepehibumgrowthTheewehypoizemllmoleculehibinSMe2couldnovelrpeutictrtegypromotentumimmunyThenoclicllyvilblenSMe2hibirCurnthibirhvelowpotencyunknownelectivypophyicochemiclpropertieOurtemcentlycrriedouthumnnSMe2highthroughputcengcmpignfollowedtructurloptimiztihTheeeftledidentifictiPDDCfirtnnomolrpotent(IC50=300-600nM)electivellybiovilblenSMe2hibirPDDChoweverexhiblimtihmperclicltrnlticludgmodertepotencypoolubilyhighprotebdgunexpectedlylowexpouhigherpecie(rtdogprimte)DepeelimtiwepentplimrydthowgeffectivenePDDCnICI-tntmouemodelHewepropoetheimbuildefdggolidentifygnoptimizednSMe2hibireffectivecromultiplemouehumncncermodeldydvncementIND-enblgtudieInAIM1weynizePDDCnlogimprovepotencyolubilyphrmcoketic(PK)AnlogtetedvropotencychemicltbilyolubilyterpeciemetbolictbilypermebilyelectivyCompoundmeetgppecifiedvrocreridvncePKtumtrgetenggementtudiemiceInhibirpgmouecreripriizedPKrtdogApdefedPcliclTrgetProductPrileguideouroptimiztictivieInAIM2PDDCelectedoptimizednlogwhichhownproviderobuthibumnSMe2ctivyvivoAim1evlutedefficcy/lerbilymultiplemoueyngeneicmodelWecompireffectivenenSMe2knockoutmodelwelltetirbilyuppgrowthftertumwelletblhedWedelvemechnmctievlutgimpcthibirlegerICIimmunefiltrtumuggle-cellnlyticolInAIM3weevluteefficcy/lerbilyoptimizedPDDCnloghumnmodelcncerWeevlutebilyblocktumexoomeproductivivogcompmllmoleculehibigeneticknockoutgultgbilyimmunecelleffectivelytrgetkillircncercelltrgetSuccefulcompletieimexpectedproduce1-2prodruggoodlbiovilbily(F%>30)cceptblefetyprilerobutefficcyhibgtumgrowthbothmouehumncncermodelthroughnimmune-dependentmechnmSuchultwouldhighlyignificnthpotentilgtlyexpnumrptientwhopdimmunerpiePROJECTSUMMARYAmplificticogeneMYCNdrivehigh-rkprogivedeetncerpypooverllurvivlrtelow45%high-rkneuroblm(NB)ptientFurrmothnhlfllhigh-rkptientlpepot-lpeurvivlrtely10%MYCN-drivenNBtumhvepoimmunepedueltivelylowmuttillodlowMHC-IexpiducedimmunecellfiltrtiAultNBtenimmunologicllyquiecentthulimgimmunpypprocheMYCNmplifictihcentrlrolechetrtgmetbolicprogrmmgfvNBgrowthdpttimicroenvirmentTumcellimmunecellextcomplexenvirmentwheyhcompetepecificnutrientThroughundtrncripmicmetbolomicimmuneprilgTH-MYCNGEMyngeneicmouemodelNBwehveidentifiedcyteemetbolmelectivevulnerbilyMYCN-drivenNBWehvelofoundMYCNdrivenimmuneuppivetummicroenvirment(TME)durgcogeneprogrmNBtumctecytee-poTMEBylckgdenovobioynticenzymeTcellexquelyvulnerblecyteetrvtiwhilecyteeupplementtiT-cellctivtiexpnieffecrfunctiOurcentrlhypoMYCN-driventumtricmetbolmcrumenrcytee-cumgcell(uchPMN-MDSC)depleteextrcellulrcyteethublockgTcellnti-tumctivyThpropolim(1)elucidtehowcogenicMYCNwimetbolicenvirmentNBdriveimmuneuppi(2)modultemetbolicenvirmentNBenhnceimmune-bedpprochehigh-rkMYCN-mplifieddeeAbtrctProttecncer(PC)eledgcuecncerdethmgAmericnmenAdvncedPCptienttenceiverogendeprivtirpyclcrntdeecur2-3yerferdCtrtiRetntProtteCncer(CRPC)AndrogenRecepr(AR)ntgtuchenzlutmide(Enz)birtere(Abi)curntlyfvodrpeuticPCptienthowevervirtullyllptientdeveloptncePot-CRPCtterpeuticopticurntdeelimedWedcovedn-ceprtyroekeACK1novelepigeneticmodifierprottetumgultgAR/AR-V7expiEnthuededtwedevelopednewclACK1mllmoleculekehibir(R)-9b(R)-9bhibACK1downgulteARprottepecificntigen(PSA)expiuppprottexenogrfttumgrowthMooverimmunecompetentmouemodel(R)-9bduceignificntCD4+CD8+TcellctivtigtyngeneicprottetumEmploygexvivo3-Dywecfirmed(R)-9bfunctillyvigteperipherlbloodmuclercell(PBMC)CRPCptientmountrobutimmunepegthumnCRPCgnoidTogeredtdictedACK1hibir(R)-9btum-trictum-extricctiviehottummicroenvirmentnovelclhibirmuchneededimmunomodulryctivyProlged(R)-9bttmentexhidnmlhlogyuggetgnotocedxicyfurrundercgimptncetrgetgACK1overcometnceAR-trgetedrpieWehvecompletednextenivep-InvetigtilNewDrug(IND)tudiecludgphrmcoketicphrmcodynmicmetbolmtudiemoue/rt/cnemodelwhichveled(R)-9bpoeedexcellentdrug-likepropertieTheedtubmtedFDA(IND#167907)ThpropoldictedwrdpheIclicltrilACK1hibir(R)-9bCRPCptientexmebilyovercomeCRPCtncecyxicimmunomodulryctivySpecificllyweSpecificAim1Toefety/lerbilyphrmcoketicnti-tumctivy(R)-9bCPRCptientSpecificAim2Toevluteperipherlbloodtuemrkernti-tumimmunepefter(R)-9xpouOverlluccefulcomplethtudyopennewrpeuticmodlyCRPCptientwhohvedevelopedtnceEnzlutmideAbirterewhichcriclunmetneedAbtrctAccurtedoedeliveryttumecruciluccerdipy(RT)cncerttmentHoweveryetnotechniqueclicbilymirRTThprojectpropoeX-ry-ducedcoutic(XA)computedmogrphy(XACT)fciltedoemirgdurgRTPuledX-ryrdiwhenbdtueledrmoelticexpniwhichgenertecouticwveTheewvecnenedultrictrnducerroundirrdedtuefednXACTlghmctructX-ryenergydepoi(XED)mpAnexpertcomputtilbiomediclimggDrPeycurntchllengedevelopefficientXACTlghmenblel-time/nerl-timequnttivemirgXEDfocupropoedprojectExtgRTetupcliclyneedtegrtetrnducerrrydoptXACT-bedrdidoimetryoutignificntlyffectgextgRTprcticeDrPeykeypernelgogprojectfundedNIH/NCI(R37CA240806)AmericnCncerSociety(133697-RSG-19-110-01-CCE)DrLingzhgXingPrciplInvetigrTheeprojectimchievevivodoimetryugXACTAlthoughXACTheenubtntilutiliztidoimetryerchcertchllengehderclicltrnltiThefirneguboptimlignl--noertio(SNR)XAignlmfocuDrXingR37erchwrddevelopgdvncedtrumenttiolvethDrPeyerchwellthR50propolddelghmicchllengewhichcludelimedviewrtifctbencequnttivedoemtilckcpbilycctgcouticheterogeneyctructeddoempThekeyobjectivethpropolcohentimgogNCIACSprojectProwgiruniqueenergydepoichrcterticnttrctivechoiceRTMuchlikeX-rycliclpuledprmloknownproducecouticwveDrXinggroupcentplimrytudie(DrPeyctrii)hvehowncpbilydoemirgdurgprrpywhichledNIH/NCIU01Awrd(U01CA288351)SceXApr-ducedcouticwvehunderlygphyicDrPeylghmR50wrdlonefU01grntDrPeydocrlpotdocrltrgdevelopgdvncedmodel-bed(MB)lghmcouticmogrphicmodlieexperienceXACTqulifyhimchievepropoedimMBctructicomputtillytenivehencegrphicprocegun-bedccelertiimplementedchievgl-time/nerl-timedoemirgTheR50wrdprovideprotectedtimeDrPeyexpherchctivygroweederchcientthelpchievegolpropoedR37&U01projectwhichpuhclicltrnltiXACTprocouticrdidoimetryPROJECTSUMMARYImmunpyholdpromecucncerHoweverlyubet(<20%)ptientexhibdurblepeimmunpyThcueimmunecheckpothibirneedimmunecelltumHowevermnytumfoundimmunologicllybrncoldielcktumfiltrtglymphocyte(TIL)OvercomgthbrrierkeycucncerWecentlydcovedcncercellmphyiclnnocletentcle(tunnelgnnotu)cnecthrvetmichdriimmunecellwhichdepleteimmunecellRecentevidencehowmichdri-hrvetgtumhvepoclicloutcomeThenunmetneedtrgetthnovelmechnmimmuneeviThetwodtctcomplementrytrtegiechievethgol(1)EngeerCAR-TTILSextrmichdri(ugmentedTcell)uchnylomichdricncercelldoentnotfullydepleteimmunecellirmetboliccpcy(2)DblebilycncercellmnnotuhrvetimmunecellmichdriInthpropolweimdevelopnimmunpeuticgimencometwotrtegienimmunecheckpothibiSpecificllyWeevlutediffenrgnelletrnplnttechnologiedelivergmichdrinnocletructuTcellexvivoprifuicellrpy(Aim1)(2)Tetntumefficcyemichdri-ugmentedTcellcombtidrughibcpbilycncercellmnnotunimmunecheckpothibir(Aim2)Dectmechnmunderlygmichdrilhrvetg(Aim3)Theetudiecnledprdigmhiftimmunpygenertefundmentlightcncer-immunecellcommunictitnnocleABSTRACTMuttiBRAFprotekekeydrivermelnomthyroidcncercolcncerExtgdruglikevemurfenibtrgetmotcommBRAFmutnt(V600E)illyeffectiveptientclicltncevriblydevelopfterfewmthV600EBRAFnmllyignlmomerickewhichdilyhidefirt-genertidrugRetnceedrugmededBRAFdimeriztiwhichtriggercmtilchngekenC-outnC-tteblockdrugbdgNewhibirhveendevelopedcognizeC-ttetrgetBRAFdimeremoleculeexhibmyteriouphenomenclledprdoxiclctivtiwhichycnceBRAFctivyunderomecdirrthnhibPrdoxiclctivtilkedductiBRAFdimerhibirunderlygmoleculrmechnmnotwellunderodndergchllenggdeignnewhibirvoidUgntegrtedbiophyiclpprochwebuiltmodelprdoxiclctivtidecrillotericcouplgtweenhibirbdgBRAFdimeriztiqunttivermodynmictermInourpprochdtetFRETmeumentquntifyhibir-drivenBRAFdimeriztiglobllyfourdimeriztimodelyieldgrmodynmicprmeterdecrillotericcouplgmechnmunderlygdrug-drivenBRAFdimeriztiRemrkblyulthowhibir-drivendimeriztiymmetriclfirtdrugbdgeventtriggergdimeriztitrglyecdbdgeventctrigltleddildimeriztiffyThmodelccurtelypdicthpeBRAFkectivticurvemeudfunctihibirccentrtidemtrtgprovidelticphyiclfrmewkundertgprdoxiclctivtiWeplnuethpprochexpourundertgprdoxiclctivtiRAFkeInAim1weclifylrgeetRAFhibirbedirllotericcouplgtngthcmtiC-helixypromoteunrvelgmechnticcnectitweenhibirbdgcmtilchngeBRAFdimeriztiInAim2wepplythpprochcogenicmuttiBRAFunderthowemutticoupledhibir-drivendimeriztictivtiInAim3weextendourtudiehigher-dercomplexeBRAFcludgcffoldgprote14-3-3whichcneirwekenhnceBRAFdimeriztidependgmodeterctiBRAF/CRAFheterodimerwhichnimptntignlgpeciecellctlyticlly-ctivecogenicBRAFmuttiCollectivelythwkvelmoleculrmechnmunderlygprdoxiclctivtiRAFcomplexeiddeignnewhibirvoidtriggergprdoxiclctivtiPROJECTSUMMARYSteotcticBodyRdipy(SBRT)henetblhedneffectivefefeiblefirt-leoptilungcncerThequetdoeeclticetumctrolurvivlnefimultneoulymimizenmltuecomplictiquipcerdideliverygicludgcnceroutrgetmlletpoiblerggiroundtrget(clledmrg)enuufficientdoetrgetpencepoiguncerttymlycuedpirrymotiThepecillycriclSBRTvulnerblegeometryerrduehighdoeperfrctiteepdoegrdientlgdeliverytimecechncechngemotiP-ttmentimggtechnologiehveenuedidpoumgtttmentmYetmrgize6-10mmtillroutelyuedccommodteytemticromchngepirrymotimgnudebeleperiodCequentlyhighdoe(cloepcriptilevel)delivedlrgevolumenmltueyieldgxicyccernThetrgunmetneedmrgductilungSBRTTheultimtemmrgducti4Drdipy(RT)modifiemulti-lefcollimrpoiltimepetummotilwydictrdumKnowgtumpoiltimepque4DRTNeledtenopprochcnprovideccurtelible3DtumtrckgToddthproblemourgrouppropoed2016tumtrckgchememeurgcttedx-ryphltelydemtrtedpotentilfeibilyugtte---rtphcountgdetectechnologyTheoverllgolthpropoldeveloptrnlteprotypeytempproprecpbily3DtumtrckgevlutepermncephnmptienttudiedemtrtecliclimpctjotgtrgcomplementryexpertetemtJohnHopkUniveryMchuettGenerlHoplVxImggWepuruefourpecificim(SA)SA1DevelopprotypehrdwytemimgetumgicttedkVphSA2DeveloptwytemdtprocegpipeletumtrckgSA3IntegrtedevelopedytemmprotypepermphnmexperimentchrcterizepermnceSA4Implementytemclicpermptienttudiedemtrtefeibilydvntgel-time3DtumtrckgtrnlteenduerThenovthprojectnovelytemmeurgcttedkVx-ryphimgetumgiugtrcktummotiDeliverbilyenudplimrytudietemcomplementryexperteOurprojecvercomemjhurdle4DRTenblgmrgductilungcncerSBRThencegenerteubtntilcliclimpctAlthoughfocuglungcncerSBRTtechnologyexpectedtrnltblemnytumefcgmeneedl-timetumtrckgProjectSummryOurlg-termobjectivedefeepigeneticmechnmenuccurtegenomemtennceexploefdgimprovehumnhelthSge-tdDNAlei(SSL)mgmotbundntgenomicrrtiprimryourcePoly-(ADP-riboe)Polymere(PARP)ctivtiwhichchetrtedowntmpireventInomticcellrrntSSLpirpromotemutgeniceventlevnttumigeneIncncerSSL-ducggentcludgpoomere1hibir(TOP1i)lkyltgdrugmtyrpiewhichcnpotentedpencePARPhibirSSLpirthufundmentllyimptntnlynmlgenomemtenncelopotentilcncervulnerbilyInthpropolwevetigteepigeneticctrolSSLpirfetumpolyunderoddteIncentunpublhedwkwehveidentifiedmcroH2A1nbundnthneH2AvrintmmmlinchromtneffecrthproceMcroH2A1exttwolterntiveplicemmcroH2A11mcroH2A12rrntmcroH2A1plicghdlpolyunderodfetumnycncerMcroH2A11nmbdpoly-(ADP-riboe)derivtiveourplimrydtpotmcroH2A11-pecificroleSSLmovlWefurrfdmcroH2A11levelverelycltedenivySSL-ducggentcncercellleWehypoizechngeSSLpirpriciencydueltedmcroH2A1plicghvedictimpcnmuttiburdentumdevelopmentcncerttmentpeInAim1wevetigterolelterntivelyplicedmcroH2A1mSSLpiridentifypecificpireffecreroledmge-proximlchromtenvirmennpirketicugnovtivecell-bedpterWenvetigtehowmcroH2A1mmnipultiffectcncercellenivySSL-ducggentAim2determeimpctmcroH2A1genometegrypecificllyctextTOP1-ltedleiwhichultcedmuttiburdenlevnthumncncerWhtprotectgenomeexceiveTOP1ctivymunknownWehypoizemcroH2A1mctrolTOP1-ocedDNAdmgemutgeneWetetepdictiuggenomicpprochecell-bedmodelAim3etblhproprciplemcroH2A1functicncerctextimpidSSLpirFirtwedetermedependencyTOP1-ocedtumigenemcroH2A11mouemodelThenwetetwhermcroH2A1plicgimblncehumntumgnoidpdictenivySSL-ducgdrugPARPhibirCollectivelyetudieprometrnmcurntmodelSSLpirdvnceourundertgepigeneticpthwyctrolmuttiburdenSSLenivycncerProjectSummryWehveptentednovelpolymer-bedvivo-deliverypltmrpeuticntibodieuguper-hydrophilicpolymerpoly2-methcryloyloxyethylphophylchole(PMPC)(US20220175857)Thpltmprovidefollowgfetunyntibodietetedi)prolgedbodycircultiii)pecificdeliveryirpectivetrgetloctibodyiii)protectienvirmentimmuneurveillnceiv)electedleetpecificloctiuppeenvirmentInddhpltmgrntpenetrblefetucentrlnervouytem(CNS)lymphnode(LN)whentibodydeliverygtlychllenggAnti-cncerntibodydictgCD20ruximbllowedcompleteelimtiytemicllymettizedB-celllymphomwhichCNSLNviengeergthpltm(nRTX)MoovernimlttednRTXevokedpotentnti-cncerimmunepethroughefficientleetum-pecificntigenLNImptntlythpltmhchievedfedeliveryruximbmicertn-humnprimteThyernRTXhenelectedcollbrprojectNnotechnologyChrcteriztiLbryprogrmwrdclicltrnltiVerycentlyweuccefullyimplifiedthpltmfurrmoothclicltrnltiugtrtuzumbHER2-dictgmocllntibodyoutimpirgmotfetultedbove(provilptent#63/579586)Theprimrydiffencethnoveltechnologynnocpulepltmenue-dictedmodifictintibodiePMPCpolymeroutmkgepipecognicpbilyFc-dependentntibodyfunctiuchntibody-dependentcellulrcyxicyFc-ceprbdgWeheppliedthnewpltmntibody-drugcjugte(ADC)improveirnti-cncerefficcyovercomeknownueurroundgADCcliclueThee-pecificPMPCengeergADCllowedheightengdrug-ntibodyrtio(DAR)two-foldcompdpntlADCKdcyl(T-DM1)eHER2dictgADCpprovedFDA2013ttbtcncerMooverechnologyenbledexertguperinti-cncerctivygtvrioucnceroucellcomprKdcylwhileprovidgCNS-deliverblefetuImptntlyPMPC-engeergKdcylhighDARuccefullyducednti-cncerimmunepeoutchngedverexicyUnderthpropolwecfirmeffectivenee-dictedPMPC-engeergADCgrntigenelectivelyexpedhumncncercellderiveddiffentdeebckgroundWelotetifficcieptient-derivedxenogrftmouemodelAtendwedevelopnovelADCfurngeergPMPCpolymertructuovercomerpy-tntueADCTheetudietendeddevelophighlylibleclicllylevntufficientlyfeADCPROJECTSUMMARY/ABSTRACTDNAmethylti(DNAm)rrnciehllmrkcoloctlcncer(CRC)ubtntillyoutnumromticmuttiSofrmotDNAmtudiehvefocuedCRCtueInctrtDNAmchngepdignoticbloodpolychrcterizeddividulCRChvegtpromeerlydetectiMooverDNAmpotentillymodifiblethupentemotpromgtrgeterlyterceptiCRCTheewepropoelrgetpropectivetudydtechrcterizelcpegenome-wideDNAmmrkerocedCRCexmebiologiclrolebloodDNAmCRCOurcentrlhypoDNAmltertip-dignobloodpdictCRCrkunderliegeneticeffecnCRCuceptibilytumgeneexpicptulifetyle-ltedchngeggytemicimmunepthwyunderlygCRCdevelopmentToddthhypowelevergegenome-wideDNAmnlyupptedX01HG012677p-dignowhebloodcell1150ce2460mtchedctrolidentified4propectivecohtrcillydiveremenwomencludgNureHelthStudy(NHS)NHS2HelthPilFollow-upStudy(HPFS)BlckWomenHelthStudy(BWHS)Prticipnthveprovideddiet/lifetyledtevery2-4yeroverpt20-40yer~80%cectrolhveengenotypedprigenome-wideocitudieubetmhveloprovideduptwobloodmple10yerprt(250ce500mtchedctrol)CRCtumtuevilbleRNAequencg(n~250)moleculrdt(n~460)InAim1wechrcterizelcpegenome-wideDNAmmrkerp-dignobloodocedCRCcidencethroughnepigenome-wideocinlyewhtextentddgDNAmmrkercnimprovepermnceetblhedCRCrkementolbedknownepidemiologicrkfcrInAim2wetegrtebloodDNAmgermlegeneticDNAmqunttivetrlocumgeneexpidtidentifyDNAmpthwyunderlyggeneticeffecnCRCdevelopmentexmeocibloodDNAmtumgeneexpiInAim3wepropectivelyexmeepigeneticgeccelerti(diffenceepigeneticchrologiclge)DNAm-bedetimtecircultgimmunecellcompoiltiCRCWelolkepigeneticggimmunytumlmoleculrmrkermbiologyInddiwedevelopdiet/lifetylecochrcterizedividulpotentilepigeneticggytemicimmunemodulrycpcyocethcoCRCrkTkengerupptldypprovedX01vetigtieim4lrgeetblhedcohtprovidecot-efficienpptunypropectivelychrcterizeroleDNAmCRCetdeveloppotentilDNAm-bedtrtegieCRCrktrtifictipventiALPHA-EMITTERTHERAPYOFOSTEOSARCOMAPROJECTSUMMARYThe-yeroverllurvivlptientcurnteorcom(OS)20%Curntrpymettticoteorcom(OS)lrgelyeffectiveOverptfourdecdenewrpiehveenidentifiedOSOuroverllobjectiveevlutepotentilefficcyxicytrgetedlph-prticlerdiophrmceuticlrpy(RPT)gtOSTrgetedlph-emterrpypromgttmentmodlynotuceptibletncemechnmobervedchempytrdilrdipytrgeted(iepthwyhibi)rpyimmunpyThcuelph-prticlecuemiveirprbleDNAdouble-trbkdmgeirpectiveoxygentidoe-rtecellignlgmuttilburdenOteorcomexpegnglioideGD2ceprcntrgetednti-GD2ntibody(Ab)Hu3F8Wepropoeevlutefetyefficcy225Ac-Hu3F8(A3F8)nturllyoccurrglrgenimlmodeloteorcomActium-225em4lph-prticleperdecyh10-dyhlf-lifeTheeexperimentclient-owneddogwhichdevelopmettticOSdeethigherrtethnpeoplewouldfirtevlutirdiophrmceuticlrpy(RPT)nlph-emter-cjugtedAbtrgetbotht-tueclcifieddemtedOShighlyrdiotntdeeAtwo-cyclettmentchemeuedwhefixeddmtedctivy(AA)A3F8dictlyimgedSPECTugnovelproprietrytechniquedevelopedRpidLLC(Hopktrtuphlicened-prticleemterdoimetryimggtechnology)obtphrmcoketic(PK)doimetryttmentplnngidentifyAAblncepotentilxicymximumnti-tumefficcyThepecificim1Identifymximumlertedbddoe(MTAD)dmrrowclient-owneddogOSutilizgSPECTimggcollectPKltedoe-limggn(DLO)bddoe(AD)meudxicy2DetermettmentefficcytMTAD3Evlutehowdiffentmeudclcultedquntie(egtumburdentumADDLOAD)ltedxicyefficcy4UgdtcollectedAim1-3developphrmcoketic/doimetrymodelhelpguideoptimiztiRPTttmenthumnOSptientNewttmentfundmentllydiffentthoecurntlyvilbleurgentlyneededoteorcomRdiophrmceuticlrpyhighlypotentlph-emter225AcuchrpyThepropoedtudiewouldyieldquiddtlunchcliclRPTtrilgtOShumnPROJECTSUMMARYANDABSTRACTCncerdolecentyoungdult(AYA)defeddignodividulged15-39yerdignoedpproximtely90000AYAechyerCurntttmentgimenAYAdignoedcncertencludecrdioxicttmentgimenwhichhveenocedcedrkcrdiovculrdyfunctiurvivOurplimrydtdictehertAYAcncerptientexpoedcrdioxicttmentmodliehvefunctilphenotypeppermirrhertfunctin-ttmentexpoedptientwhodecdeolderThecidencethpoibleccelertedcrdicggphenotypeurvivAYAcncerpopultiunknownpotentildiffencerce/ethnicygeneticncetryunclerhowknownbiologiclmrkerggcltehertfunctipotentillyfurrfluencedevelopmentcrdioxicyhnotenvetigtedToddthgpourundertgcrdicggurvivAYAcncerweteverllhyponccelertedcrdicggphenotypectriedevelopmentpocrdiovculrhelthurvivAYAcncerthrmrkerggcnfurridentifythoetgtetrkcrdiovculrdfunctiTowrdthpropolhtwoobjective1)elucidtedefeccelertedcrdicggdivereurvivAYAcncerpopulti(N=1200)2)identifypdicrnccelertedcrdicggphenotypeimpctrce/ethnicygeneticncetryocildetermnthelthetblhedggbiomrkerthphenotypeTochieveeobjectivethpropollevergedivereurvivAYAcncercohtnchodechocrdiogrphicementcrdicfunctiProjectDANCESDtbiopecimenenblevetigticcelertedcrdicggmulti-levelement(dividulneighbhoodpopulti)driverthphenotypeEtblhedggbiomrkerlonlyzedidentifyltihipccelertedcrdicggWhoverll5-yerurvivlrteAYAcncerptientmgover84%growgegmenturvivAYAcncerwhohvepotentilenjoyeverlmodecdelifecncer-fehighlightgimptncepriizgirlg-termhelthpot-cncerttmentCrdicdyfunctimbidymjlteeffectthpopultipropoedercheftdeignedidentifyrkfcrdrivereeventcrodivereAYAptientpopultiSUMMARYN-mllcelllungcncer(NSCLC)mdedlietcncernovelrpeutictrtegieneededimprovettmenutcomeptientthdeeFTY720(Fgolimod/GilenyNovrt)phgoenlogdrugpprovedttmentfrcrymultipleclerodueimmuneuppfunctiImmuneuppiFTY720quiphophylti(P-FTY720)mlyphgoeke2(SphK2)Howeverpro-drugFTY720outphophyltiexhibnti-cncerfunctivrioumodelcludgNSCLCOurpublhedunpublhedplimrytudiedemtrtedFTY720notP-FTY720dictlybdtrgetcyplmicSETcoprotewhichovexpedmjyNSCLCcelltumCyplmicSETknownhibirprotephophte2A(PP2A)FTY720-SETbdgpventhibirySET-PP2AociledgctivtumuppPP2AMechnticllyctivtiPP2AFTY720ducenecropcelldethNSCLCcellcultunimlmodelthroughmtiRIPK1-C16-cermide-n-muclemyoIIA(NMIIA)enrichedpo(wecoednmecermidoome)tplmmembrneThuwedeignedthpplictetnovelhypoFTY720functilmimeticmedeNSCLCcelldeumuppletprtdictlybdgtrgetgSETcoproteultggenertiplmmembrneponecropThetheSpecificAimpropoedthpplictiAim1)DefemechnmwhichFTY720medenecropviducticermidoomeAim2)IdentifyhowFTY720-ducedcermidoomectivtedPP2AmedenecropAim3)DetermerpeuticcliclignificncetrgetgSETFTY720functilmimeticlikeA7-2medePP2A-dependentcermidoomectivtiNSCLCtumuppiTheetudiehelpdefehowtrgetgSETducenecropugmoleculrgeneticphrmcologictructurlolcludgX-rycrytllogrphycryo-EMMooverdbtedthpropolhelppdictwhichNSCLCptientlikelynefttmentFTY720nlogdrugWeloutilizefunctilmimeticFTY720uchA7-2whichcentlydevelopednloghibSETducenecroptnnomolrccentrtibence/pencemutnt(G12C)-K-RhibiruchibdgribuppNSCLCtumgrowth/progiThuetudieprovidefirt--clttmenptipcirpyttmentptientfrcryNSCLCPROJECTSUMMARY/ABSTRACTAdvncehumngenetichveidentified400+genewhenmplifiedmuttedpromotetumigeneWhilehenubtntiluccedevelopgdrugkemetbolicenzymedegultedcncerypennlytyfrcticncerdriverdcoveddteThevtmjy(~80%)ecncerdrivermundruggedprtcueirdruggbilymunknownAmgeundruggedcogenetrncriptifcrwhichpentlrgefrcticncerdrivernioulycidedundruggbleToddthchllengeourlbhdeployedtte--rtcytee-focuedchemiclproteomicprileligblecytee300+cncermodelpentg23tumtypeThpn-cncerDrugMpidentifiethouligbleecrocncerproteomevelgbothcommuniquelyligbleecrocncerubtypeBycptggeneeentilycyteeligbilyweuncovedmultiplelegetrictedtrncriptifcrmymkepromgcidtemllmoleculehibirdevelopmentAtpthltwSOX10trncriptifcr(TF)quidproliferti>85%melnommodelwhichctedhighlyligblecyteecerveddomWedemtrtemutthcyteedruptSOX10trncriptilctivymgbundertkecovlentmllmoleculecenwhichidentifiedchemiclprodruptSOX10ctivyAnexplrymediclchemtrycmpignyieldedmopotentnlogdruptSOX10trncriptilcomplexblockmelnomtrncriptilnetwkbrogteprolifertimelnommodelddictedSOX10Inthgrntpplictiwebuildourcochemiclproteomicpltmcptedvncebiochemicl/biophyiclmethodologieynticchemtryptientderivedmelnommodel1)defemechnmwhichSOX10liggdrupttrncriptilctivy2)developpotentpecificolcompoundtrgetgSOX103)chrcterizeimpctphrmcologicldruptrncriptilnetwkprolifertidvncedmelnommodelTheerchpropoedhetkefulldvntgedvncehumngeneticfunctilgenomicwhichnomteSOX10primrytrgetquidmelnomgrowthcommultr-highthroughputchemiclproteomictechnologiedefedruggbilythTFcncerdriverThpprochcriclfirttepdevelopmenttrgetedrpiegtclprotetrdillycidedydlmphrmcologiclterventiIfuccefuldevelopmentthchemiclprohpotentilrdicllyhpenext-genertrgetednti-cncerrpieSUMMARYSmllcelllungcncer(SCLC)ftlmlungcncerwhoedevelopmentcloelyocedbccomokgPtientSCLChvemedinoverllurvivlly8-10mthfterildignoSCLCdevelopmentfquentlyocedmuttiTP53(p53)RBltedtumuppgenegoverntrnthroughcellcycleDruptiegeneledmllrpidlydividgcellDepeidenticlmuttiSCLCcellcndopneeverldtcttrncriptil/epigeneticttecludgneuroendocn-neuroendoctteHowecellttedifferpolyunderodItlounclerhowtducecelldethdiffentSCLCcelltteIntherchwefocuuniquemetbolmSCLCcellidentifynewexploblevulnerbiliecnuedkillSCLCcellInplimryRNAequencgmpectrometry-bedmetbolomictudiewefdSCLCmetbolmcelltte-dependentOurultppotcell-tte-pecificrolecyte/cytee(Cy)metbolmSCLCbiologyWefdbothneuroendocn-neuroendocSCLCcellquiCyproliferteInbenceCyn-neuroendoccellpdividgwheneuroendoccelldieIntriguglycelldethpelocelltte-dependentASCL1highneuroendoccellprimrilydiepopwhileNEUROD1highneuroendoccelldieferropTheefdguggetcelltte-pecificdiffenceSCLCmetbolmmygultedtcteniviepopticverun-popticcelldethIntherchwedetermehowCydeprivtriggercelltte-pecificlethlmechnmSCLCcellWepropoetheSpecificAimWefirtdetermehowdtctneuroendoccellttedicttechoicediepopveruferropfocugroleGCN2/ATF4mocidengpthwypolyunturtedphopholipidmetbolmNextwedetermehowNotchNRF2ignlgpthwygovernpeneuroendocverun-neuroendoccelltteCydeprivtiFllywedevelopnovelCy-degrdgenzymerpyelectivelytrgetSCLCcellducecelldethcognizgpecificcellurfcentigenTheetudieteurcentrlhypowhichCymetbolmpentnoveltrgetblevulnerbilySCLCAlgertherchunveilnovellktweencellttemetbolmcelldethSCLCUltimtelyweimhowhowtrgetgthmetbolicnetwkcouldlednewttmentthdevttgdeePROJECTSUMMARYWhBlckmenwomenexperiencgdproptelyhighburdencoloctlcncer(CRC)criclneednewimprovedrkpdictiolidentifythoethighetrkundergocengterliergemofquentlyneededBlckdulthvehighetcidencemtlyrtenyrcilethnicgroupUSlyprtlyunderodirrkfcrhvenotenwell-tudieddteFurrBlckAmericnexperiencepertentlyhighrteerly-etCRCdignoedyoungerdultgedlethn50yerErly-etCRCnemerggpublichelthccernduergcidencerteledgcentlyducedroutecengge45yerUSEtblhedrkpdictioluchNCIColoctlCncerRkAementToolwedevelopedvlidtedwhepopultihveenhownpermpolyBlckwomenhvenotyetentetedBlckmenInthgrnuroverrchggoldevelopnewperlizedCRCrkolimprovedccurcyuniquelytilodBlckAmericnbuiltvlidteddtBlckmenwomenOurnewweb-bedrkmodeldevelopedugrichlgudldtlrgepropectiveetblhedUScohtBlckdultSournCommunyCohtStudyMultiethnicCohtStudyexternlvlidthefurrcohtBlckdultOurtheim()developexternllyvlidtenewrkpdictimodelcoloctlcncerBlckmenwomenbedupeilyobtblelifetyledemogrphicocilcengfcr(b)builddynmicrkmodelCRCBlckdultugmodernttticlmche-lerngmethodobptimlpdictipermnce(c)determeifccountgecoloctlcncertumimprovedividulizedpdicticcurcyournewrkmodelBlckdultDuehighCRCcidencedethrteBlckdultournewrkpdictimodelhveignificntfr-chgimplicticoloctlcncercengmtlyBlckcommunyOurnewcliclrkolprovideccurteperlizedrkementCRCwhichcnuedBlckdultirphyicinidentifythoethighrktrgeptimltimelyeffectiveCRCcenglifetylepventitrtegieledgerlierdetectiCRCmovlpcnceroupolypdurgcolocopyducedmtlyOurpropoedwkcloelyligncurntkeyiveNCIuppterchimprovghelthequycncerPROJECTSUMMARYCncer-ltedftigueemotcommdebiltgxicie/ideeffecttemmgcncerttmentPtientwhoenduhemlogicmlignnciedproptelyffectedThefeweffectivettmentcncer-ltedftigueprtcueunderlygetiologypthophyiologynotwellunderodHoweverdrupticircdinrhythmdygultiglucoemetbolmtwoltedmechnmpoiblyunderliecncer-ltedftigueTime-trictedetgdilyetgptternentilcumgfooddefedctentwdow(eg10h)everydyWhenetgwdowligndylighthourtrglyentrcircdinproceemodultephyiologiclgultiwhole-bodymetbolmIthypoizedtime-trictedetgcnlievecncer-ltedftiguebloodcncerurvivvigultgcircdinrhythmimprovgmetbolmThproject12-weektwo-rmpheIIromizedctrolledtrilcomprgeffecttime-trictedetg(10hdytimefeedg/14hftgtnight)vctroluntrictedfeedgrmcncer-ltedftiguefollow-upt24weekloplnnedAtl96bloodcncerurvivcruedeligibleurviv2mth2yerpot-curtivettmentuffermoderteeveftiguecumefoodwdow>10hnotemployedwyhometnightTheyromized11terventictrolAllprticipntmeetnutrdcunutriguidelecncerurvivthoeterventigroupelf-elect10-houretgwdowwhichmeetguideleAtbele6week12week(pot-terventi)weeptient-ptedftiguemeucircdinctivyrhythm(vinctivytrcker)glucoemetbolmvictuouglucoemirgPrticipntlogirfoodtkeugmyCircdinClockmrtphepptbelethroughout12-weektudyAim1provideiletimteefficcy12-weektime-trictedetgterventivnuntrictedetgptternptient-ptedftigueAim2emtenncedietryptternutbilynychngeftiguet24weekMechnticimeeffecttime-trictedetgcircdint-ctivyrhythm(mempludecrophe)glucoemetbolm(ftgbloodglucoevergebloodglucoeglucoeexcuri)pecificllyexplg1)ocitweenchngecircdinrhythmglucoemetbolmftiguebelepot-terventi2)ocitweendhenceterventichngecircdinrhythmglucoemetbolmftigueThetime-trictedetgterventiclbleexpenivelendgelfcceiblemotcncerurvivDtgenertedheuedmlrgerpheIIImulteclicltriltetgeffecttime-trictedetgcncer-ltedftiguemgurvivhemlogiclmlignnciefurroptimizeterventientrcircdinrhythmimproveglucoemetbolmllevecncer-ltedftigueNucleotidemetbolmeffectivelytrgetednti-cncergentiruelimedxicyn-trnmedcellepecillynti-cncerimmunecellOuroverrchghypomocompleteundertgnucleotidemetbolmengmechnmpenucleotidedepletienbleophtictednti-cncertrtegietrgetcncercellwhileprgnmlimmunecellIndtmpmeourpplicti(1)WeidentifymoleculrmechnmwhichrtelimgteppyrimideynctlyzedenzymeCADllotericllygultedUTPWeengeerctutivelyctiveCADmutnteimptncethgulryctivy(2)Wedetermedp53-dependentriboomebiogenecheckpot(RBC)triggedpyrimideribucleotideufficiencyfetuwepropoeunderliekeymetbolicdiffencetweencncernmlcell(3)Wedcovedtwomethodperturbgpyrimidemetbolmduce10-30foldceenivyclicllylevntcyenlogOurobjectiveunderthowperturbtipyrimideengpepyrimidedepletiimpctcncermetbolmnti-tumimmunecellfunctiperpyOurrtiledruptgCADpyrimideengultpyrimideoverflowperturbtiRBCcueveriblecellcyclertechwhichdiffentillyffectcncertumimmunecellmetbolmfunctiOurpecificimtetfollowghypoe(1)Pyrimideoverflowlimcncercellfunctiwhilepromotgnti-cncerTcellctivti(2)Uridenlogmodultepyrimidelvgepthwyctivypromotgenivypyrimide-bedchempeutic(3)ChricpyrimideynhibiduceGEM-enivecncercelltte(4)TheRBCtrtumimmunecellfunctilimp53-WTcncercellxicy(5)BypRBCpotenteeffectimmunpychempeutictrgetgpyrimidebioynThctriiignificntcuepyrimidemetbolmmjcncertrgetimpctbothcncernti-tumimmunecellfunctiwhoeefficienttrgetgneedimprovementTherchnovtivecue(1)weutilizenovelCADhyperctivemutntbedourwkidentifygCADllotericgultimechnm(2)weueeprtifunctiMDM2mutntterrogteimpctRBCcncerimmunecellfuncticultutum(3)welevergeourexteniveexperiencecellulrmetbolmundertmetbolicimpctperturdpyrimideengpepthwypyrimide-bedchempeuticCompletieimfundmentllydvnceourundertgpyrimideyngulticellcyclectrolmechnmpdnucleotidelimtiThemtigedelucidtetrtegietrgetcncercellwhileprgnmlimmunecellfunctimgfutupprochehibcncertrictrgetpromotenti-tumimmunyPROJECTSUMMARYExoometypemllextrcellulrveicle(EV)ectedllkdcellderivedendoomeTheyhvemnyphyiologiclpthologiclfunctiuchcellprolifertidiffentingiogenewoundhelggultiimmunycncerprogiTheyloplyrolemtgtummicroenvirmentdrivgcncermettthroughcrgodeliverycipientcellprcucmnnerThelbryDrAlWever(UnDicr)tVerbiltUniverySchoolMedicetudiegulticncercellmigrtiviexoomerolecncercellexoomecncerggivenemettThelblocrrieouterchbiogeneRNA-ctgexoomedevelopmentimggoltrckexoomeThepropoedtudiethR50pplictiDrBgHwnSung(ReerchSpecilt)ltedtwoNCI-fundedR01grnt1ExoomeectibtcncerprogiThprojecttetcentrlhypodheimoleculecrriedcncerfibrobltexoomedrivemultipletepmettticccdebtcncer2RegultiextrcellulrveiclebiogenethroughcelldheiThprojecttethypobiogenemotily-promotgEVcncerctrolledynten-dependentgultiEVmticrgolodgdowntmctivtedleukocytecelldheimolecule(ALCAM)-mededdheiDrSunghwkedDrWeverpt15yerAnexpertcellbiologyEVimggtechniqueDrSunghetuptte---rtimggtechniquedevelopedexperimentlimggolimgenlymethodherlbryThprojectupptthoegogeftPROJECTSUMMARYOncogenictimulierlycncerouleiuchdrivenRASmuttitriggercogene-ducedenecence(OIS)whichctbrrierpventmlignnttrnmtiEtblhmentmtennceOISdependennutedDNAdmgepe(DDR)temrrntDNAplicticcumultiDNAplictitHenceprogimlignncyquiDDRctivtiecpeenecencewhichwhenccompniedgenometbilyccelertecrcogeneFtncegRASpvlentmettticprottecnceruggetgthrrtimydriverprottecncerprogiggiveneHoweverpcentucogene-ducedplictithowffectplictiktegrymunclerWhilecenttudiehvehighlightedplictikverlmentbilizetedkpromotektrtwhercogenicignlgdruptkprotectimechnmculmtgkdetbiliztimunclerFurrmowherextdtctprogrmtrnmuptmcogenicignlgplictikcuektbilynimptnuttgquetiTheeknowledgeeentilundertghowpmlignntleitrdevelopgcncerwhichwouldhelpdeignrpeuticenizecellcogene-ducedplictitThegolthprojectexplictemechnmlkcogene-ducedplictitDNAplictiktegryWepropoeTIMELESS(TIM)kprotecticomplexntegrlctuentplomekeydetermntmodultgOIStrnmtiOurplimrytudievelOISducedHRASG12VccompniedTIMdowngultin-trnmedcellwhichmededPARP1-dependentpoly(ADP-riboyl)tiTIMnovelTIMpot-trnltilmodifictiprimeTIMproteomldegrdtiCverelyTIMupgultedOIS-pedcleKrG12DprottecncermodeldictgTIMctivyttlledkmydetermepecogene-ducedplictittnceOISWethuhypoizedeprotectitlledkviTIMdowngultinunppcedcogene-ducedmechnmctrieDNAplictiktbilycueOISTotetthideprottecncerwe1)determehowdeprotectitlledklkedenecenceducedHRASG12Vcogenecellulrmodel2)explictemechnmTIMdowngultimededRAS-PI3K-PARP1proteolyticignlg3)determeroleTIMpgenecencepromotgtumigeneugKrG12D-drivenprottecncergnoidmouemodelWeexpectvelhowmodultiTIMtlledktegrygenerlpotenteOISexertelectipupOIStrnmtiThknowledgehelpdevelopTIMg--functitrgetexploOISuppgtumigeneMimllyviveliquidbiopiehvevolutiizedourundertgcncerbiologyemergedbiomrkerdeemirgdrugdevelopmenthveenlimedfewcommercilentiecdemiclbriequetechnologiclcpcyTheCircultgBiomrkerCo(CBC)tUniveryWcCrCncerCenter(UWCCC)wetblhed2017levergenovtivetechnologiecliclerchfrtructuexpcceebiopecimenyUWfcultyNCICncerCentercrocountryCumUW-developedliquidbiopytechnologydecde-lgcollbtitweenbioengeergbiomrkererchertUWferunprlleledenivyrtrgetnlyteDrJenniferSchehrwhoplyedntegrlroledevelopgfgcumliquidbiopytechnologiecejoglbfoundgdicrDrJohuLng2015wuccefullycruedfcilymngerCBCdurgceptictueperhedtrjecryTheCBCupptNCI-fundederchprogrmbothdictlythrougherviceprovidedpecificNCIgrnttrilwelldictlyhdourcefcilypurugimNCIcncercenterupptgrnt(CCSG)dvncecientificprtnerhippcimediceercheductiDrSchehrdeliverhighlevelcientificnovtichievementbiologybiomrkerdcoveryprovidgexpertcientificoverightvetmentdevelopgcglymopowerfulcomputtilolrpiddthlgprticulrttenthoughctuoueductienggementundergrduteentry-leveltffTheCBChnowuppted64diffentprojectvolvg34diffentprotenucleiccidbiomrker9NCIgrnt29clicltrilNCIcoopertivegroupphrmceuticlcompnieUniverieDrSchehrleddevelopmentnewmethodnewcncertypenewliquidbiopybiomrkernewcliclpplictiwelletupdtmngementbiomrkerutilyevlutigogclicltrilDrSchehrloctivelyenggeddevelopgprocectroldemtrtgnlyticlvlidycumtechnologiepuruibtggulrypprovlimplementtiroutecliclueWhcentuccefulexecutiUH2nlyticlvlidtinmRNApnelprottecncercircultgtumcellCBChnowgedpprovlUH3gulry-pprovedclicltrilwhichultfirtclicllyctibleliquidbiopydevelopedCBCunderDrSchehrFutudicticludedevelopmentumtedwkflowcircultgtumDNA(ctDNA)extrctilibrrypprti>5000plmmpleovernext5yercumctDNAyevlute821trgetedmuttihigh-enivyfrgmenmicptterngdiffentetumigLeverggnovtiveproblem-olvgcomputtilolhighefficiencynextenivecollbtivenetwkDrSchehrdevelopimplementnovelliquidbiopybiomrkercliclueProjectSummryEngeedTcellemerggpromgrpeuticgentgtwidevrietycncerHoweverdepemrkbleuccegtbloodcncerecellmlrgelyeffectivegtolidcncerdueirbilyutntumctivypechrictumtimultiprocetermedexhutiWhilentigentimultieentildrivgcquieffecrfunctiTcelltrgctuedtimulticncuecellloeeffecrcpbilieenternexhuteddyfunctiltteLimgtenydurtiignlgcouldenbleTcelluteffecrfunctioutccomntexhutideedcenttudiehvehownhibgignlgtcellchrictimulticnenhnceTcellpertencetumctrolHoweverometimultineededeffecrfuncticriclhverpeutictrtegiecnduceignlgctivyppropreteniedurtioptimlfunctiInthpropolweeekdeignbuildtetynticfeedbckctrollerTcellignlgmptimlignlgprolggnti-tumeffecrfunctimigtgexhutiFeedbckloopwidelyuedengeergmtytemtdefedetpotcouldctuteneffectivetrtegytempergexceiveignlgTcellduechrictimultummicroenvirmentToenblefeedbckcircudeignwefirtdefeltihiptweenputignlpthwyoutputdowntmgenegulryfunctilpeTheeput/outputltihipcriclfeedbckcircudeignyvelhowmuchignlgctivyeliceddiffentputhowmuchoptimlutgdeidfunctidefgoptimlytemetpotfeedbcktngthWemeueput/outputltihipTcell(Aim1-2)utilizgdul-pthwypterytemwehvedevelopedenbleccurntlive-cellmeumentctivytwokeyignlgnodeErkNFATprimrymoueTcellNextmedequntifiedput/ouputltihipweidentifygeneticcompentctuthfeedbckctrollernproceedbuildprotypecircutetirbilybootntumTcellfunctimouetummodel(Aim3)IfuccefulourwkdefenewtrtegycounterexhutiengeedTcellrpieetblhnewprdigmengeergelf-gultgcellrpiecnmptimlfuncthroughenvirmentlengternldpttiProjectSummryImTechniclDicrProteomicMcromoleculrCrytllogrphyShdReource(PMCSR)tHerrtIrvgCompheniveCncerCenter(HICCC)ColumbiUniveryIrvgMediclCenter(CUIMC)IjoedPMCSR2018etblhedexpederviceptfolioUtilizgcuttg-edgempectrometernovtivemethodologiePMCSRhenupptgvriouerchprogrmcludgCncerGenomicEpigenomicPciOncologySytemBiologyCncerPopultiScienceTumBiologyMicroenvirmentItimpctevidentnovelimmunpytrgetidentifieddeeperundertgcncerpthogenechievedelucidtikeymechnmdrivgtumigeneThePMCSRervicehveenwidelyutilizednlyHICCCColumbiUniveryloexternlcncercenterhighlightgignificncebrodererchcommunyThwidepdugeundercoPMCSRexceptilputtievidentouttgrtgdurgcentP30CompheniveCncerCentergrntnewlInptfiveyerIhveenco-uth47peer-viewedrticleMyimenhncePMCSRcpbiliefurrdvncgextgtechnologietroducgnovtivemethodologiecludgAumtedDeepProteomicPrilgBiluidComphenivePipeleImmunopeptidomicCellSurfceomePrilgLbAumtiTheuccefulimplementtietechnologicldvncementignificntlyimpctcncertudiettrctgubtntilfundgfotergcollbtiledghigh-impctpublictiInummrythwrdprovidecertbilymellowmectueexcellenceervgcncererchcommunyThedvncementnlyelevtePMCSRcpbilieloenrichbroderlcpecncererchmrkgignificntimpctwrdimproveddignoticttmentultimtelycuProjectSummryThelbryDrJohuLngfocuedtrgetgttmenttntPCthroughdevelopgnewbiomrkerpcimedicltrtegieugliquidbiopiedcovergnovelvulnerbiliePCtrnltgedcoveriebiomrkerclicltrilDrJmieSpergerhenntegrlprtDrLnglbrypt11yerhctried3NCIfundedRO1projectco-uthod24publictiTogerDrLngSpergerhvedevelopednovelliquidbiopyywhichhelpedidentifypertentAndrogenRecepr(AR)ignlgmenttedARignlghibir(ARSI)duecomplexgenomiclterticludgARgenerrngementmplifictimutticndetectedliquidbiopieCurntlyDrSpergerledtwoNCIfundedprojectLnglbryThefirtprojectMoleculrgultiTrop-2dvncedprottecncerBiomrkerrpeuticniche(R01CA276269)imlevergeliquidbiopieoltterundertwhichptientmightnefTrop-2trgetedrpieTheecdprojecttledEnhncgepigeneticnlyrcellmulti-phemicrluidicimdevelopnovelmethoddetectepigeneticchngedevelopgnewmethodugtechnologyco-developedlbryDrDvidBeeDrSpergeruniquelyqulifiedledeprojectoverdecdeexperienceydevelopmentliquidbiopieugmicrluidicProjectSummryDruptiepigeneticmechnmgultegeneexpifquentlyfoundcncercollbtegeneticltertidrivecncerphenotypeuchrpytnceimmuneecpeSce2016DrBennetterchpeciltthR50wrdpplictihupervedtemercherpermedkeyexperimentNCI-fundederchprogrmundicrDrJthnLichttUniveryFlidHelthCncerCentertudyhowepigeneticmechnmdruptedcncerDrBennetthtrgtrckcdimptntctriicncererchhwkhentrumentlucceCA195732U54CA193419U01CA225566Hehdemtrtedglutmtelyemuttmocid76hneH2BfundmentllylterchromtdynmiccceibilycugchngegeneexpicellgrowthpropertiefvtumigeneDrBennetthowedttmentcutelymphoblticleukemicellhrbgmutnthnemethyltrnfereNSD2PRC2hibircnctivteglucocticoid(GC)ceprexpienivyecellGCrpyInddihehdetermedgeneticdependenciegrowthrpytnceuvelmelnomwellidentifiednHDAC8-drivenpermnentlegewchmtedfterdrugdrwlmelnomThR50wrdprovidecertbilyDrBennettctuemkgimptntctriicncererchdvncgundicrlrgerNCI-fundederchprogrmDrBennettlederchtempermkeyexperimentccomplhimDrLichttheNCI-fundedR01wrdR01CA266078(HnefoldMuttiCncerPthogene)multi-PIR01CA256193(Chrcteriztrgetgepigenetictteunderlyguvelmelnomlivermett)multi-PIR01CA262483(Defgtrgetgepigeneticplticy-drivendrugtnceimmuneecpemelnom)InddifundgthwrdllowDrBennettpieernewdictiechprojectepecillypplygcuttg-edgetechnologiebuildgcollbtiNCI-fundedvetigrDrBennettnexpertwidepectrumepigenomictechniqueuchbiochemiclygeneexpinlychromtprilgCRISPRceneentilucceewrddvncgundicrNCI-fundedcncererchprogrmTheetudievelnewepigeneticmechnmcogenectrietumprogiheterogeneyrpytnceimfdgnewtrgetpthwyterventicncerptientultimtelyledtterptienutcomePROJECTSUMMARYFmothn200000womenwhodevelophmeceprpoivebtcnceryerlyendocrpytletfiveyerducecncercurncenerly50%ceoverllurvivlYetlmothlfptientpcridendocrpyfiltkellirpillEductimder-bedtudiethcliclettghvehddppotglymlleffectdhencemocomplexterventihveprovendifficultutInthpropolwefocupmenopulympmwomendecrimjbrrierendocrpydhenceWehvedrwntwocomplementryeterchfdgfirttrilchempyettgcentlyptedrouteympmmirgmngementcnimprovenumroutcomecludgurvivlecderchn-cologicchriccettghhownnumroutcomecnimprovedoutchhigh-rkptientnphyicinprovidertweenphyicinvWepropoenterventrgetghigh-rkptientwholdyhvepodhenceendocrpyInromizedtudyweroutelycollectptient-ptedympmdtptientCliclphrmcytemupptptientmngeympmddbrrieroycnctuedilymedictiTheprimryobjectivetudyimprovedhencepecificimfollowAim1Aeimpctympmmirgmngementcliclphrmctledfollow-up(terventi)ptientdhencelendocrpyWeeimpct12-merventidhenceevlutedhencegt24mtheterventidurbilyAim2DecriimpctterventiympmWemodelvergetrjecrieptient-ptedoutcomeovertimetudygroupWelomodelympmdhencelevelceideeffectmyceifdhenceceAim3ExploimpctterventipotentilmechnmimprovementdhenceWeuemedinlyexmeltihiptweenterventipropoedmechnmcludg1)beleympmevery2)elf-efficcymngemedictiympm3)temcommunictiptient4)ocilupptIfuccefulthtudyhpotentilimprovecthouwomenMnynewlypprovedcologicmedictilgentoerventiwouldlonimptntmodelcdicouldmdeigncologiccdeliveryPROJECTSUMMARYTheNtilYouthTobccoSurveyhowedpvlencee-cigtteuemghighchooltudenthkyrocketed12%201728%2019mhight141%2022Whilediffentgulrypolicie(uchFDAe-cigtteflvencementTobcco21)curntlyplcetrygllevethvpgepidemicmgyouthyoungdultnurgentneedeffectivelycommunictepublicboutrke-cigtteuenicoteddictiHoweverhowenggepublice-cigttepventimegeprticulrlychllenggSocilmedipltmuchTwter/XIntgrmTikTokYouTuverypopulrUnedStteepecillymgyouthyoungdultPvioutudiehvefoundocilmedipltmwidelyuedpromotee-cigtteproductvpehopcompnieunder-uedpublichelthuthieeductgcommunybouthelthrke-cigtteueSocilmedimrketge-cigttehelthierlterntivecventilcigtteultedcommperceptimgyouhtvpghrmlectivySocilmediexpoue-cigtte-ltedctentcouldffecte-cigtteue(vpg)hvivpgpromotictentledgmovpgvpgpventictentledgducedvpgTheeocilmediproviderichnturldtourceboutvpg-ltedmegediffentmt(textimgevideo)Thepurpoepropoedtudyidentifykeyfetue-cigtte-ltedocilmedi(Twter/XIntgrmTikTokYouTu)pot(epecillyvpgpventipot)ocedhighocilmediuerenggement(uchnumrlike)pplygdvncedrtificiltelligencettticlmodelgtechniquefurrvlidtemugcombtinleurveytudyemi-tructudterviewtudyTochieveourgolwechrcterizekeyfetuTwter/Xpot(tweet)ltede-cigtteocedhighocilmediuerenggementuchnumrtweetfveugnturllngugeprocegmchelerngttticlmodelgtechnique(Aim1)Wechrcterizekeyfetue-cigtte-ltedIntgrmpotocedhighocilmediuenggementthroughdeep-lernglghmttticlmodel(Aim2)Wechrcterizekeyfetue-cigtte-ltedTikTokYouTuvideohighocilmediuerenggementugrtificiltelligencetechnique(Aim3)Wevlidtekeyfetuelectedocilmedipotthroughcro-ectilnymouleurveytudyemi-tructudterviewtudy(Aim4)Reultpropoedtudyprovidevlubleguidncedeigngeffectivevpgpventimegefutupublichelthcmpignhelpeffectivecommunictirkocede-cigtteuewhichhelppventicounter-uptkee-cigtteyouthyoungdultPROJECTSUMMARY/ABSTRACTThecurntpplictieeklryupptPrhntKSghPhDwhoerveDicrGenomicShdReource(GSR)tRowellPrkCompheniveCncerCenter(RowellPrk)AtntPDeprtmentCncerGeneticGenomicDrSghwkcloelyCncerCenterSupptGrnt(CCSG)lederhipmemrprovidecentrlizedefficientpprochupptgerchcliclpopultibedgenomicendevwhilefciltgpeer-viewedfundgpublicticrumenteftDrSghupptllgenomicivetRowellPrkprovidgexpertellpectydeignmplepprtiQCdtgenertinlyeDrSghctubjectmtterexpertCCSGmemrutilizggenomicpprochedcquinlyzegenomicdtetcrobictrnltilcliclpopultitudieDrSghplyvlroledcovery-drivenerchCCSGmemrwelldignoticpplicticomplementtrdilcliclevluticncermpleDrSghvolvederchdeignNGSyupptgoldevelopgperlizedrpiebeduniquegeneticmkeupptientcncerTheGSRntegrlprtRowellPrkCCSG(P30CA016056)whichcncercenterDicrDrCceJohnervePrciplInvetigrIncurntCCSGptgperiod(2018-pent)Ocr2023128NIH/NCIgrntpplictiutilizgGSRerviceDrSghexpertewewrdedRowellPrkfcultyInmeperiodGSRctried210peerviewedpublictiDrSghhover19yerexperiencefieldgenomicepigenomictrgfocucncererchDrSghctivelyprticiptemeetgfocuedcltivecienceltedclicltrilmulti-PImulti-tutilprogrmuchRowellPrkOvrinSPORE(P50CA159981-08)P01Progrmgrnt(P01CA234212)WeternNewYkCenterReerchFlvodTobccoProduct(CRoFTU54CA228110)DrSghlederhipexpertecriclctueducceCCSGprogrmRowellPrkerchmiAPIRowellPrkCCSG(P30CA016056)DrJohnerveUnDicrthR50Co-bedcientt(PAR-22-188)pplictiABSTRACTTheprojectimcpteemerggtechnologiegenomictrncripmicepigenomicproteomicnlyedvncedrpedriccncerTheprojecthnddilemphtrnltgultenewpprocheclicllyctiblemthroughdevelopmentptbletetultCLIAclicltetglbThepropollevergecpbilieourceMi-OncoSeqCLIApcicologylbfirtetblhed2013TheMi-OncoSeqlbhequencedovertenthouptientmpledtetegrtednlyetumRNAtumDNAmtchednmlDNAThprojectcptelg-dmethyltiequencgugNnopotechnologycomplementextgpnelyvilblebedIllumht-dtechnologyThelbryopertePromethi24OxdNnopopuruegolThelbrydevelopgimprovedccelertedbiomticpipeleueclicltetglbOverllenewtechnologienlyticlmethodppliedourcohtdvncedrpedriccncerimprovedcliclptgiddignoticprognoticrpeuticdeci-mkgSpecificerchcluderoleimprtgtructurlrrngementtergenicmuttipromoterwppgdevelopmentecncerirmechnmrpytncePROJECTSUMMARY/ABSTRACTTriplenegtivebtcncer(TNBC)motggiveubtypecedpropenymettfewttmenptiMountgevidenceuggetcncertem-likecell(CSC)TNBCctrieerlycurncepoclicloutcomeThuidentifictinovelrpeuticpprocheeffectivelytrgetgCSCcrucilimprovgoutcomeTNBCWepropoetrgetCSCTNBCexplogirovexpwodoxgultgenzymeNQO1SOD1rpeuticvulnerbilyUtilizgpotentNQO1-bioctivtbledoxcyclgcompoundIB-DNQwhichgenertelrgemountctiveoxygenpecieCSCvifutiledoxcyclgwepropoeexmefeibilyutilizgIB-DNQlecombtiSOD1hibieffectivelytrgetCSCcroEMT-METCSCttectuumWeddthepecificim1)TodemtrteefficcyIB-DNQlecombtiSOD1hibrgetgCSCvromouemodelhumnTNBC2)TodetermemechnmcelldethducedIB-DNQbedpro-oxidnttrtegie3)TodetermehowIB-DNQbedpro-oxidnttrtegiemodultentumimmunyimmunocompetentmouemodelThpropolevlutenovelpro-oxidnt-bedpprochelectivelytrgetgCSCTNBCelucidtemechnmctifutileoxidntgenerrctivtgmichdrilpopticpyropticcelldethultnttimultintumimmunyANQO1SOD1ovexpedmnyolidtumthrpeutictrtegymyhvewidepplicbilyProjectSummryThethe-dimenil(3D)chromtrchectummmlpentmrkbleyetnotfullyunderodbiologiclproceThehigh-throughputchromoomecmticptu(Hi-C)techniqueknownHi-CtrumentlidentifygdiverechromttructuDepethwywhich3DchromtrchectuTcellfluencedtumimmunemicroenvirmenthowthimpctcnceroutcomemlrgelyunexplodRenlmedullrycrcom(RMC)toutprticulrlyggivecncerpdomntlyffectyoungdividulAfricndecentepecillythoeicklecelldee(SCD)TtmenptiRMCcurntlylimedThemotpromgmgmimmunecheckpotblockde(ICI)HowevertrulyhrnepotentilICI-bedrpienurgentneeddeeperundertgRMCimmunemicroenvirmentunderlygmechnmRMCThe3DchromtrchectucellltedRMCmltivelyunchrtedterriryGuidedexpertecncerbiologtDrLiuqgYngepigenetictDrWenboLiDrPvloMouelclicinpecilizgrnlcrcomourtemhhrneedpowerHi-CWeimeddeletedtctchromttructuCD8+TcellSCDptientctrtthoehelthydividulundertrmifictiechngedevelopmentprognoRMCIntriguglyourplimryfdghighlightignificntmodificti3DgenomictructuCD8+TcellderivedSCDdAnotbleobervtidimhedchromtlooptemmgSLC7A11locuSCDcdiThlocuplypivotlroleferroppecilizedmprogrmmedcelldethvolvgirBuildgeightwepotulteferropSCD-ducedCD8+TcellctrieimmunetnceobervedRMCltedchromttructugcentrlthproceOurprojectnchodthepecificobjective1)EtblhcnectitweenltedchromtrchectumoleculrpthwylkgSCDRMCtumigene2)Delve3DgenomicmechnmdrivgferropCD8+TcellSCD3)AeignificncebothferropltedgenomicrchectuCD8+TcelloverlldeelcpeOurtemenvidecdeICICART-cellrpyemergefrtlettmentRMCenhncgcurteddgcurntlimtitrdcBydelvgrolelted3DchromttructuRMCmoleculrmechnmwehopeequipcientificcommunyightcrucildevgtrtegiefelyeffectivelyenizeRMCICICART-cellrpieThedtgenertedourvetigtilygroundwkerly-pheclicltudieledDrPvloMouelTheetudiepivotlddgquetiboutnextgenertiICIT-cellrpietilodRMCPROJECTSUMMARY/ABSTRACTRurl-ervgprimrycclicourColdoImplementtiScienceCenterCncerCtrol(COISC3)eekddequiehvilcncerrkunmetocilneedClicneedefficientlow-cotolcenddmultiplerktmetimetechnologycnprovideimptntefficiencieMyOwnHelthRept(MOHR)web-bedterventi3cofuncti1)RkFlggg2)Gol-ettgptient-priizedrk3)ServiceLkgeourceOurprrilfoundptientceivgMOHRimprovedphyiclctivy(p<0001)diet(p<0001)hvicerkmnytypecncerMOHRlohowedimprovementhelthhviignlducedbccoue(mlln)ThuMOHRhgtpotentilpventcncerHoweverweidentifiedtwokeygpFirurCOISC3clicvoicedneedmoflexiblemenudeliveryoptiteiblydoptutterventiSecdchieveequblecheffectiveneprticulrlythoeunmetocilneedclicneedprovidetructudfollow-upSuchfollow-upceptientcceourcehvilrk/unmetocilneedthulevelgplygfieldddcncerrkOurnewplimrydthowclicptientvlueMOHRtructudfollow-uptrtegiemdptientirgolprovidelevntourceWedevelopedfrtructupilot-tetedtwodtctimplementtitrtegybundleprovidethfollow-upThefirtbundletermedRemder-Reourcemege(R2mege)volveelectrictext/e-milentumticllyMOHRTheecdbundleR2NvigtrtffechclicperllydeliveremderourceEchtrtegybundleddectextuldetermntuccefulimplementtiutmentidentifiedourPrgmticRobutImplementtiSutbilyModel(PRISM)HoweverltiveimpctR2megeR2NvigtiircombtiunknownInAim1weenggetffptientprtnerourCOISC3flizeimplementtiplndeliverR2megeR2Nvigtimenuoptico-developedplimrywkhopInAim2wecductromizedcomprtiveeffectivene-implementtril1400dultptienttwomocncerrk(cludgbothufficientphyiclctivyfru/vegetbletke)cro7COISC3clicevlutecomprtiveoutcomeR2megeR2NvigtilecombtiWeemulti-leveloutcomecludg1)Effectivene2)Implementti3)PrcticeVlue(cludgptientexperiencecot)InAim3weueourertivePRISMproceco-developnimplementtidpttiutmentguidemotcot-effectiveimplementtitrtegyidentifiedAim2OverllweexpectducemultiplecncerrkequblyprtddgunmetocilneedimproveoutcomeimptntptientprimrycocietyProjectSummry/AbtrctDepeprogttmentdvncedmelnombroughtpprovlueimmunecheckpothibir(ICI)motptienttntrpyillypdnlpeAcriclpthwyctrolpeICIgultedterfer-gmm(IFN)WhileIFNignlgceexpiimmunotimulrygene(IStG)quidpeICIloduceexpiimmunouppivegene(ISpG)uppttumimmuneecpepromotetnceICIThduloppogroleIFNignlgupptneedidentifynpprochhixpiISpGoutlimgexpiIStGimproveperteICI-bedrpieWehveidentifiednewtrncriptilgulryfunctiUnc-51-likeke1(ULK1)downtmIFNceprdependentuphgy-ltedfunctiWehvehownmlignntmelnomcellhibiULK1peIFN-ducedtrncriptiISpGoutffectgexpiIStGbothvrovivoImptntlywehvefoundULK1terctIRF1nuclercomprtmentmelnomcellhowhibiULK1kectivyducebdgIRF1ISpGpromoterginotIStGRemrkblyhighlevelULK1cltepourvivlnimmunouppivetummicroenvirment(TME)melnomptientMooverplimrytudiewehowdrug-trgetedhibiULK1nti-PD-1(PD-1)rpyduceignificntcepercentgeIFNperproducgCD8+Tnturlkiller(NK)cellductifquencyTgcompdPD-1ttmentleco-cultuyugB16melnomcellpmel-1plenocyteThegolthprojectdetermeifblockgULK1limIFN-ducedimmunouppiveeffectpromotenimmunotimulryTMEovercomgtnceICImelnomAim1determemechnmwhichULK1medeimmunouppivefunctiIFNmelnomcellItcludegenertipecificCRISPRknockout(KO)celltudiedetermeroleIFN-ducedULK1-mededphophyltiIRF1melnomcellAim2determedictroleULK1immunecellfunctigtmelnompeICIvivougcdilUlk1KOmiceAddillyweueCRISPR/C9geneedgpecificllytrgetULK1primryhumnCD8+TcelltudyrolegultiignlgccdegenetrncriptiCD8+TcellctivygtmelnomAim3determeroleULK1ICI-tntmelnommodelWedetermeeffectgeneticphrmcologiclhibiULK1peICIvivoAddillyweclteexpiULK1IRF1protemelnomptienttumbiopieexpiISpGIStGimmunecellfiltrti/ctivtipeICITogerpropoedtudiehoulddefivelyetblhroleULK1rpeutictrgetovercometncemechnmICIrpymettticmelnomPROJECTSUMMARYTheexpilevelprotergemethyltrnfere(PRMT)ignificntlyelevtedcncercellocedpoclicloutcomeThtrglyuggetirpotentilnovelclrpeutictrgetcologyMjphrmceuticlcompniehvedevelopedovertenelectivepotentPRMThibir(PRMT)curntlyerly-tgecliclevlutiHoweverdueundertudiednturgemethyltipot-trnltilmodificticomphenivemechnticundertgPRMTfuncticncerurgentlyneededenblecliclpplictiehibirNotblycentclicltrilultdictectivyPRMTlemyufficienteffectivecncermngementptientTheeimpertivecductmechnm-drivenpcliclevluticombtitrtegietrgetPRMTlgiderpeuticdrugchievecliclucceBothhigh-grdeerouovrincncer(HGSOC)triple-negtivebtcncer(TNBC)hcliclgenomicchrcterticuchpoprognohomologoucombtideficiencypotentilimmunoctivyGivenurgentunmetmediclneeddevelopeffectiverpeutictrtegieedeeourplimrytudiehvemergedlrge-cledrugcombticengcncergenomicprilgetblhtrgrtilepplygPRMTttgHGSOCTNBCOurhypocueunctrolledproliferticedDNAdmgectivtedcogenecncercellmututbnmlleveltrncriptiplicgprotergemethylthroughenhncedPRMTctivie(PRMTddicti)TtmentPRMTcndrupthyperctivtedPRMT-gulomeenblecncercellurviveWeveembledtemvetigrdivereexperteourcetetthhypothroughthepecificimSpecificAim1ChrcterizemoleculrmechnmPRMTimo-combtirpieSpecificAim2EvluterpeuticpotentilPRMTHGSOCTNBCpcliclmodelSpecificAim3InvetigteeffectPRMTtmentnti-tumimmunepeTheoverrchgobjectivethpplictiytemticllyexplodynmicchngegulomeducedPRMTtmentcncercellThferfhightirmechnmctiprovidertileclicldevelopmentPRMTimo-combtirpiefieldcologyPROJECTSUMMARYSurvivlcerviclcncertgntgUnedStteDepemnytervengclicltriltrdc(SOC)defivechemdirpy(CRT)hmedunchngedceddiccurntpltum-bedchempyrdi1990Retheverl-foldcludeptientpopultidproptelyffectedbrrierchentrdiotncegrodeeevidencedloclcurnceftermenprimrytumdoe>200GydelivedbrchyrpypluEBRTufficientytemicctroldtntfiluctrigtwothirdcerviclcncerdethAuboptimlimmunepettimedefiveCRTocedloclgildtntcurncewelldethcerviclcncerWehvepvioulyhownenrichmentimmunouppivecellhighexpiqumoucellcrcomntigen(SCCA)knownSERPINB3ocedhigherrkcurncefterSOCCRTcerviclcncerCRTducefurrfiltrtumpermivemyeloidderivedcellPlimrydtuggettumocedmcrophgemyeloid-deriveduppcellgulryTcellcedmid-ttmenttumpecimenptientundergogtrdCRTUgpcliclmodelwefdbrchyrpytimultedexpiimmune-timulryignlgterdegethnnequivlentdoeEBRTFllySERPINB3dictlypromoteexpichemokecruimmune-uppivecellprticulrlymyeloid-derivedub-popultibluntgT-cellnti-tumpecerviclcncerWehypoizebrchyrpyledelivedprimrytumprigillymphnodeEBRTfelymimizeptienttripfurrtimulteimmuneytempotenteefficcyimmunpyTwoimpropoeddictlytetthhypoAim1determeifccelertedbrchyrpy-wrdchemdirpy(ABC-RT)feeffectivepprochhtenoverllttmenttimemximizenti-tumimmunepethroughpheI/IIclicltrilptientlocllydvncedcerviclcncerAim2determeifABC-RTpotententi-tumctivyimmunecheckpotrpie/myeloid-cellhibirCCR2iugpcliclmutummodelnoveltrcvrybrchyrpyytemdevelopedthpropolSecdryendpotvlidtecidtebiomrkerSERPINB3potrpyFDG-PETpdicrcurncefterthexperimentlpprochpropoedpcelytrtifyptientubequenttrilcptgdrug-ABC-RTcombtiSucceeimprovideplimrydtupptromizedtrilABC-RTbedgimencompdSOCultimtelyprdigmhiftdefivettmentcerviclcncerThepropoedtrnltiltudieprovidetempltetegrtirpieynergizeCRTimmunepeTheoverllgolthpropolimproveurvivlptientlocllydvncedcerviclcncerProjectSummry/AbtrctTheobjectiveprojectdevelopwld-firtX-rydul-energyce-mmicroCT(DECBCT)dedictedtropertiveimgglumpecmypecimenimprovgpoivemrgidentificti(PMI)thu-cllrte-urgerybtcervgurgery(BCS)BtcncermledgcncermgwomenUSBCSuedprtBCttmentmjyceInBCSpecimennegtivemrgctgtumexcedmimumrimnmlfibroglulr(FG)dipoetueoppoedmovlentibtmtecmyPoivemrg(PM)iebtcncer(BC)cloepecimenedgeifmedcnledhigh-urgeryrteWhileBC-dipoetuectrtcnhighBC-FGtuectrtmlowtrdX-ryimggTheecricllyimptntdeveloptropertiveimggtechniquediffenteBCFGtuedurgBCSOurDECBCTenblednovtivelghmimgectructinlycnyield3DvolumetricpecimenimgeenhncedBC-FGctrtcndictlyimprovetropertivePMImimizemedPMItthuddeneedduceBCScll-urgeryrteThepecificimproject(1)TodevelopDECBCTqunttivelumpecmypecimenimgg(2)Tocquihighly-mpledDECBCTviveductl/lobulrcrcompecimen(2b)TooptimizedptcndeignDECBCTBCScliclwkflow(3)ToevluteDECBCTugptientpecimencompiletumdtbeTheprojectbuiltupourpviouuccedevelopmentcliclpplictigle-energyce-m(SECB)CTkeyoutcomeprojectwehveetblhedfeibilyDECBCTyieldgenhncedBC-FGtuectrtimprovgtropertive-PMIAUC095higherthuledgducticurntBCS-urgeryrteThefirtdtbequnttiveimgeirhpthologiclnlydtbtmlignnttueloctedprovideunpcedentedmountdetiledmtiboutbtnmltumtuevlubledevelopmentmchelerng(ML)-/deeplerng(DL)-bedmethodumtedtropertive-PMIBCSfundmentlundertgBCchrcterticdvncgbtcncererchpplictiProjectSummry/AbtrctTocquercncerercherdiverebckgroundexpertemutwkgerdcovermoleculrtrgetdeveloprpeuticMnyvetigrunbleccomplhirerchgoloutccepecilizedexperteophtictedtechnologie/expenivetrumenttiimpoiblemteroperteirownlbThememrP30CA125123grnt-upptedDnLDuncnCompheniveCncerCenter(DLDCCC)tBCMfundedmothn$180Mcncererchgrntover$41MNCIgrnt(dictcot)DrReddyhighlyccomplhedcncerphyicincienttProgrmDicrP30grntdicrDLDCCCUnDicrthR50pplictiAGeneticllyEngeedRodentModel(GERM)co-bedn-tenutrckerchpecilt(RS)TechniclDicrGERMcoIdevote>70%myeftplynirplcebleroleprovidgcomphenivemouecncermodelerviceeNCI-fundedcncererchprogrmmypeciltyourGERMcotte---rtequipmentTheeervicecludegenertivriougeneticllyengeedmoue(GEM)modelCRISPR/C9ytemugzygotegene-trgetgytemugembryictem(ES)cellmicrojectrngenezygotevrofertiliztiembryotrnferderive/quicklyexpGEMmodelcryopervtipermembryolg-termrgeGEMlegenotypenlyGEMleInpt5yerImytemmemrhvegenerted1653knockoutknock-trngenicGEMmodelmnywhicheentiluccemnyNCI-fundedcncererchprogrmImhighlyexperiencedcncerercherwhohpublhedover80mnucriptIhvemtedmethodologieholdpecilizedexpertenecerymouertembryomnipultigenomeengeergImcolederwhohctriedignificntlyNCI-fundedcncererchprogrmledvetigrFundgthR50pplictiprovidemehigherdegeunomydevelopnewtechnologieerviceIncollbtivetigrIdevelopnewembryomnipultigenomeedgytemrtNilertwellnewgenome-edgmethod/trtegiemoueuchprimeedgmimizef-trgetgeventpprochececdillleleproductiefficiencycdillyexpdee-ocedvrintIimplementenewytemtechnologieourcoervicetterervecncererchernovelrodentcncermodelWhR50upptIupdtemyknowledgeenuugetgenome-edgytemmethodologygenerterodentmodelttendgmeetgterctglederfieldMygolmkeourGERMcofullycpbleprovidgcompheniveervicemouertNilertcncermodelupptcncererchdevelopmycernterntillycognizedRSfieldrodentgenomeedgrodentcncermodelPROJECTSUMMARYBrcncermdevttgdeeprticulrbrmette(BM)btcncerpentledgcueftlywomenThemjhdrnceignificntcliclnefBMpopermebilymocllntibodie(ietrtuzumb)crobloodbrbrrier(BBB)ultgurgiclectirdirpiefirtlerpeuticoptiWhourtemexperiencedhighlyccomplhedcientttrgtrckcdbictrnltilcliclerchwepropoedvnceciencemettebrfocug1)undertgfundmentlbiologyHER2+btcncermettebrviptienttue-bedgeneticdectirkfcr2)dvncementl-timevulizticncercellneurltemcell(NSC)trgetgHER2+BM3)pplictrgetedNSCdeliverytrtuzumbnloguppgrowthHER2+BMThenovelprdigmetblhedthpplictidvnceourundertghowcncercellvdepdthrubrpotentillyhelpherldnergeneticllyengeedtemcelltrgeteddeliverycdunti-HER2rpygtHER2+BMSummryAcutemyeloidleukemi(AML)biologicllygeneticllyheterogeneouhempoieticmlignncychrcterizedblockgemyeloidcelldiffentiunctrolledprolifertiimmtumyeloidcellAlthoughttmenptiAMLhveprogedoverptfewdecde5-yeroverllurvivlAMLptienttill<30%TheemhighunmetneeddevelopnovelmoeffectiveAMLrpiewhichquideeperundertgpthophyiologyAMLidentifictinoveleffectivemoleculrtrgetOurplimrydthowedprpeckleprotecompent1(PSPC1)highlyovexpedvirtullylltypehumnAMLPSPC1knockdown(KD)proundlyuppeprolifertipromotepopducerobutdiffentidivereAMLcellbrogteirleukemogeniccpcyFurrmoPpc1deletihltleeffecnhempoietictem/progenircell(HSPC)functitedy-ttehempoienmlmouedevelopmentDepegmemrDroophilBehvi/HumnSplicg(DBHS)protefmilyocednuclerprpecklectgSFPQNONOneirprpecklenNONOvolvedPSPC1-mededhyperprolifertimyeloiddiffentirtAMLcellMooverneirN-termlRNAcogni/bdgmotifnC-termlcoiled-coildom(eentildimerizti)PSPC1imptntpthogenicfunctiPSPC1AMLcellIntegrtedPSPC1ChIP-eqRNA-eqnlyeWTvPSPC1KDAMLcellidentifiedkeytrgetgeneimptnncogeneprolifertiurvivldiffentiAMLcellmotifnlyveledputtivetrncriptifcr(TF)myocePSPC1trgetgenetrncriptilctivtipiBedeexcgfdgwehypoizePSPC1ctnoveldetermntAMLleukemogenePSPC1hibipentfehighlyeffectiverpeutictrtegyvriouAMLwhePSPC1terctkeyTFdictteuniqueleukemictrncriptiprogrmunderlygmultipleAMLTotetthhypowe1)uelo--functigenetictrtegyfurrvlidtePSPC1novelrpeutictrgetAML2)determewherPSPC1commtrgetAMLduceddiffentAMLdriverwhercogenequidPSPC1duceAML3)dectmoleculrmechnmwhichPSPC1duceAMLdefgPSPC1-gultedcommtrncripmePSPC1tercmecromultipleAMLuntietudygctriiPSPC1prtner/trgetgeneAMLchrcterticleukemogeneTheuccepropoedtudiegfundmentlknowledgeAMLbiologyleukemogeneetblhgPSPC1criclnoveldetermntAMLleukemogenewhichcnledbkthroughAMLttmentdevelopgwytrgetPSPC1ugRNAi/mllmoleculehibirfeeffectiverpeutictrtegyvriouAMLEwgrcom(ES)pedricmlignncywhichcrriedvereprognomettticmBemettelthoughlecommocewtclicloutcomeYetthmdeemundertudiedduechllengemodelgRecentlywehvehownESmettetriggedevehypoxiprimrytumwhichledmtipolyploidcellprogenywhichhefternmedHYP-4ncellhvehighpropenymettHowevermechnmunderlygbilyHYP-4ncellcolizemunknownThtypecientificqueticnddedfunctilgenomicpprocheuchCRISPRcenYetguchychllenggettgmettvivoduelownumroeouleidevelopgnimlmodelircllntuOnhmotextgvromodelfilfhfullycpulteheterocellulrterctioccurrgenvirmentThuwepropoe3Dbicellulrmicrluidicpltm(3D-BMP)whichmimiccdiEScellencounterdurgoeoudemtiercholenblehigh-throughputgenomiccenmett3D-BMPctbioengeedmicroveelcovedendolilcellemdded-mimickgmtrixoteobltoteocltItllowctrolimptntprmeterenvirmentiemtrixtiffnehydrotticpuoxygenteniAuchenbletetgrpidtructurlfunctilchngeoccurrgdurgmettticproceimultneounlymultiplevdgcoliebothwhichnotchievblenimlmodelThegolourprojecttetutily3D-BMPtudiebiologyESmettcludglrgeclegenomicyTothendweueHYP-4ncellhighpropenymettirdiploidcounterprtderivedmeEScelllecultudnmoxi(NOR-2n)whichdotmettizeoptimizeexperimentlcdi3D-BMPtflectirdiffencemettticpropertietetirterctienvirment(Aim1)ThmodeluedpermfocuedCRISPRidrop-outytrgetggenemothighlyupgultedHYP-4ncellelectcidtemoleculecrucildemtitueurvivlthenvirment(Aim2)Theelectedtrgetfirtvlidtedvi3D-BMPntetedvivougnthopicxenogrftmodelprovideevidencebiologicllevnceourpltmThepropoedtudy1)vlidte3D-BMPmodelcpultgkeytepoeoupd2)tetexperimentlpipelevolvgCRISPRcen3D-BMPfollowedvivovlidtiercholidentifictidrivermett3)pieererchmechnmESoeoupdInfutuourexperimentlettgcnuedtudydiffentpectmettbiologyEStummodelgthprocevivomchllengemnycncerPROJECTSUMMARY/ABSTRACTChricpcommympmffect30-40%cncerurvivdimhgirqulylifeimpirgphyiclfuncticghelthccotBtcncerurvivctutelrgetgroupurvivmothn41milliUSNerlyetwobtcncerurvivwhotkeclmedictiknownromtehibirffectedchricpfulcdiromtehibir-ocedrthrlgi(AIA)AIAocedducedphyiclctivycedrkfllducedAIdhenceledgcedoverllmtlyWhufficientliefcventilttmentrpidlygrowgpopultibtcncerurvivnurgentneeddevelopnoveleffectiveclblepmngemenptiMdfulne-OrientedRecoveryEnhncement(MORE)nnovtivemdfulne-bedterventi(MBI)rootedffectiveneurociencetegrtetrgmdfulnepprlvgkillpecificllytrgetchricpltedympm(egpychologicldt)AlthoughefficcyMOREpn-cncerpopultihenetblhedpotentilthmdfulneterventiddpcombidympmbtcncerurvivhyetcfirmedTheerigoudequtely-powedromizedctrolledtrilneededccluivelydetermewherMBIuchMOREcnlleveAIAToddthcriclgperchcliclcwehvecvenedmultidciplrytemcductEnhncedPCopgCncer(EPIC)trilfollowgpecificim1)evlutepecificefficcyMOREmnggAIAmgbtcncerurviv2)evlutepecificeffectMOREcombidympmqulylifedhenceAI3)elucidtecognive-ffectivemechnmMOREpmngementmgbtcncerurvivTheMOREterventiwetetligndownwrdpirlchricpmodelneurociencebeddcoverieplimrytudieFthmulteromizedctrolledtrilweromize200btcncerurvivfecologicdeeAIAetwoeight-weekttment1)MORE2)upptivegrouppychpy(SG)Weeprimryoutcome(p-ltedfunctilterfence)ecdryoutcometbeleweek8(endttment)week12week24(primryendpot)ugvlidtedptient-ptedoutcomeEPICddmjmethodologicllimtiextgMBItrilcludgpnotgprimryoutcomenoeligibilyquimenthvgpMBIundervetigtihvgendevelopedtrgettmngementrrthnpmngementEPICprovidetimelycliclevidenceMOREneurocience-medmdfulne-bedterventipco-mbidympmdurgcncerurvivhipFurrvirtuldeliveryenuMOREhighlyclblebrodchimprovepmngementmillibtcncerurvivcroUSSummryThR35focuenovelmechnmunderlygctrolkeyUPRcompentimpctmelnommettgedrrthnyoungmice(i)tum-tricmechnm(NRF2ATF4)implictedtnceenivyrpy(ii)tum-extricmechnmdefetetlmicrobiotcompoiimpctnti-tumimmunyThOIApplictilevergedcoveriemdedurgourR35upptperiodwhichenbledudefegultifunctiATF4emUPRignlgcompentpro-nti-popticignlgSeverlfundmentldcoveriepurued(1)effectggltedmetbolicignlgexemplifiedeffectprgeynthe(ASNS)glutryl-CoAdehydrogene(GCDH)ATF4SpecificllywhileASNShibipromotemelnomtncerpyGCDHhibicuemelnomcelldethlthoughbothphenotypeATF4-dependent(2)effectgggutmicrobiotcompoiccomntimpcndegenti-tumimmunytumpropenymettizeAmgfundmentlquetiwedd(i)WhtcferATF4pro-popticvnti-popticctiviehoweffecteddurggg(ii)Howdogutmicrobiotchngebcterilcommenlthccurggimpctnti-tumimmunytummett?(iii)CouldATF4hibi(throughtrgetgomemodulr)uednoveltrtegyenhncetumeniztirpyyounggedniml?Twerequetiweemploynovtivetechnologiecludgcdilknock-outmiceCRISPR-C9technologygle-cellRNAeqptiltrncripmicmetbolomiccomputtilpprocheModelyoung(2mth)ged(12-15mth=5570-yer-oldhumn)miceueddefemechnmunderlyghowkeyUPRignlgcompentATF4impctmelnommettmechnmInlletudiehouldvelnovelprdigmmelnombiologyimpctgmettunderlevntphyiologiclcdiPROJECTSUMMARY/ABSTRACTCncerprogihevilyfluencedupptivecelltummicroenvirmentMcrophgenimptntcompenttuemicroenvirmentplyimptntrolebothphyiologiclpthologiclproceeMcrophgefiltrtetumtuegrdedtum-ocedmcrophge(TAM)leukemi-ocemcrophge(LAM)leukemiAlthoughcnectitweenLAMhemlogicmlignnciehlgenppcedmoleculrmechnmwhichLAMpromoteleukemogenefrleunderodWehveemployedFncinemi(FA)geneticdderocedmrrowfiluprogip-leukemicmyelodyplticyndrome(MDS)cutemyeloidleukemi(AML)tudyDNAdmge-immunepeUgDNAdmge-ducedp-leukemicmouemodeldeficientmjFAgeneFnc(Fnc-/-)cogenicMLL-AF9AMLmodelwecentlydemtrtedpertentDNAdmge-cogenict-ducedimmuneceprTREM1(CD354)promotedleukemiprogimiceCompellgevidenceuggetimptntpthologiclroleTREM1vrioutypecncermlylkgupgultichetrtgflmmrypeTAMHoweverhowTREM1functileukemicmicroenvirmentmunclerToexplothwegenertedcdilTm1mouemodelwhichwedeletedTm1genepecificllymcrophgeugLyM-CdeletertrWefoundmcrophge-pecificdeletiTm1mrkedlylimedexpniFnc-/-p-leukemicHSCMLL-AF9leukemictemcell(LSC)Fnc-/-p-leukemicMLL-AF9leukemimiceMocentlywegenertednduciblemcrophge-pecificTm1-KOmouemodel(Tm1fl/flCf1r-iC)foundtmoxifenducti-mededLAM-pecificdeletiTm1ltedgeneigntuM1M2mcrophgekewedmcrophgepolriztiwrdM1-likettubothFnc-/-MLL-AF9leukemimodelStge-pecificdeletiTm1ignificntlyducedPD-L1expiLAMeleukemimiceWelofoundTREM1+LAMquidtimultgmigrtiexpniLSCbothFnc-/-MLL-AF9leukemimodelFllyTREM1+LAMAMLptientwefoundpromoteengrftmentleukemiccellptient-derivedxenogrft(PDX)modelTheeplimrytudieetblhpotentillktweenTREM1-poiveLAMleukemidevelopmentWehypoizeTREM1-driventerctitweenleukemi-ocedmcrophgeleukemitemcellpromotedevelopmentleukemiThegolourtudy1)exmeroleTREM1LAMleukemidevelopment2)vetigtefunctilterplytweenTREM1+LAMLSCFirtlepltum-bedchempiekillcncercellthroughmtibulkyDNAdducthoweveredductlomhelthytueledgideeffectignificntlyimpctptientqulylifePot-rpylohenlkedchempy-ducedtemcellenecencewhileneuroxicyecdrytumlkedcedmutgenetemcellDNAultimtelycgclicinuelowerdoeleeffectiveCequentlyneedimproveDNApircpcyhelthycelloutcompromgdrugeffectivenecncercellWepropoeelectivelycenucleotideexcipir(NER)pltum-DNAdducthelthycellwhilemtgcncercellkillgefficcythroughpplictipivemechnicltvilowtenyvibrti(LIV)NotddgthproblemctuedeceeffectivenechempygimenqulylifecncerurvivOurobjectivethpropoldetermewherLIVpfentillyenhnceNERcpcypltum-bedDNAdducthelthycellthumigtgchempeuticide-effectThecentrlhypoLIVupgulteNERLINC-dependentmnnerducgpltum-bedchempyxicyenecencehelthytemcellFurrcncer-oceddowngultidepletiLINCcomplexelementduceeffectiveneLIVNERThhypowmultedbedourplimryfdgcncercellducedLINCcomplexexpifileLIV-ducedmechnoignlgLIVenhnceNERbulkyUV-ducedDNAdducthelthytemcellloLINCcomplexdruptNERTheimthtudydeterme1)LIV-ducedchngepltumxicyhelthyLINC-dbledcncercell2)LINC-mededltertichromtdynmiciDNAdmgepeIfuccefulultourR15AREApropolyieldnovelundertghowexternlmechniclcemLIVvolvedDNApirLINCcomplexdependentmnnerpotentillyopengupn-phrmcologictrgetedrpeuticterventideceideeffectlg-termequelefollowgchempeuticttmentmodlieTherchimproveundergrdutetentibiomediclwkcegivetudentnopptunyctueireductiourdeprtmenttBoeStteUniverywhichferlyBiomediclEngeergPhDprogrmIdhoAbtrctAndrogencepr(AR)ignlgctueplydomntrolelltgeprottecncer(PC)cludgctrti-tntprottecncer(CRPC)hvedevelopedtnceecdgenertiAR-ntgtegenzlutmideWeidentifiedlgn-codgRNA(lncRNA)NXTAR(LOC105373241)loctedcvergentlyARgenepedhumnprottetumcellledcovedttementpromotebdguptmARpromotercugignificntloexpiARplicevrintAR-V7PrdoxicllyARbdNXTARpromoterhibiARACK1/TNK2mllmoleculehibir(R)-9xcludedARbdgNXTARpromoterCequentlyhnecetyltrnfereGCN5bounddepoedH3K14cetyltimrkenhncgNXTARexpiTrnltillevncenegtivegultiARcmeppntwhennoligucleotidederivedNXTARex5(NXTAR-N5)uppedAR/AR-V7expiprottecncercellprolifertiInddiphrmcologiclrtiNXTARug(R)-9bbrogtedenzlutmide-tntprottexenogrfttumgrowthOverllourtudyuncovernegtivefeedwrdloopwheNXTARctnovelprottetum-uppglncRNAhibgAR/AR-V7expiwhichturnupgulteNXTARlevelcompromgenzlutmide-tntprottecncerThertiNXTARcouldnewrpeuticmodlyptientwhohvecquidtnceecd-genertiAR-ntgtBededtwehypoize(i)rpeuticoligucleotideNXTAR-N5(ii)combtiACK1hibir(R)-9b(iii)WEE1hibirAZD-1775NXTARlevelcouldnewrpeuticmodlieptientwhohvecquidtnceecd-genertiAR-ntgtToddthhypowepuruefollowgimAim1DetermemechnmNXTARuppiCRPCAim2SynPSMAtrgeted`BivlentTrivlentnnoprticleNXTAR-N5oligo(R)-9b/AZD-1775hibirpylodAim3InvivochrcteriztiBi/TrivlentnnoprticleovercomeEnz-tnceprottecncermodelptientderivedxenogrft(PDX)ABSTRACTMultiplemyelom(MM)plmcellmlignncyTtmentuullyvolveproteomehibirdexmethenimmunomodulrychempeuticttmentoutulogoutemcelltrnplnttiBecuetriccquidmedictitncellmyelomptienteventullylpeTheexpiprourvivlmemrBcl-2fmilyprticulrlyMcl-1keyproceurvivlmyelomcellBecueMcl-1criclmedirdeeproginimptntmechnmcquitncerpyblekifMMptientprticulrlythoetlpewouldnefnMcl-1-trgetedrpy?AfewelectiveMcl-1hibircurntlygdevelopedgtetedclicltriluntuntelymotpvioutudiewetermtedcueundeirbleideeffectepecillycrdicxicyToddthneedwedevelopednovelMcl-1hibirKS18vetigtemechnticunderpngMcl-1roleMMdetermefeibilyMcl-1hibirpeutictrtegyTheertiletherchdetermewherournovelMcl-1hibircnuedlgextgchempeuticgenteffectivelykilltntmyelomcellthuhibirpventMMlpeOurplimrytudiedemtrtedunlikechempyKS18killtntcelluggetgcouldcomdtrdilchempyttMMwhilemimizgpoibilytncedevelopmentmoeffectivelyToevluteefficcylikelymechnmctiKS18combtiextgMMttmentwepropoefollowgSpecificAimFirthibgMcl-1viKS18ufficientverecquidchempeutictnceMMvro?WetetKS18lecombtirpeuticgentuedttmentMMcludgbtezomibveneclxthirdgentcombtibtezomibdexmethewhichprtclicltrdcMMptientSecdcnMcl-1hibiverebtezomibtnceMMvivo?WedetermehowMcl-1hibimodultecquidtncechempeuticgentthirdwhtefficcyMcl-1hibirbtezomibcombtifrcrylpedptientmple?WevetigteefficcyKS18btezomibcombtiptientmpleTheeignificntdcoveriewoulddemtrteefficcytrgetgnti-popticproteMcl-1MMwellcncermodultglpeprovidgneededpcliclvlidtineceryclicltrnltiThctriiignificntcueexpectedhvebrodtrnltilimptncettmentMMFurrmothpropolenhncefrtructuercheductCooperMediclSchoolRownUnivery(CMSRU)fergbiochemiclbiomediclerchexperienceunderervedmytudentwhowouldwelckuchopptuniePROJECTSUMMARYWhilepproximtely85%BlckwomenptgcenedCerviclCncer(CC)compdbout83%WhewomenBlckwomenhvehighercidencecerviclcncermolikelypentprogedtgeCChvehigherrtemtlyCCfctBlckwomen80%molikelydieCCthnWhewomenYenlytwoevidence-bedterventiEvidence-BedCncerProgrmRegtryhveendeignedpecificllyBlckwomenTheeterventiwedeveloped1990ydotdddiveryethnicycultumgBlckwomencludgAfricnAmericnwomen(AAW)BlckAfricnImmigrntwomen(BAIW)TheepopultihvediffenceknowledgewnehviltedcerviclcncercengimptntciderctgeffectgterventiewomenTocteterventipdculturldiverymgBlckwomenmeetpecificneedAAWBAIWweneedundertuniquediffencemultileveldetermnt(ydknowledgehvi)cerviclcncercengmgBAIWAAWOurlg-termgoldeveloppubliclyvilbleevidence-bedCCterventiBWcompenttrgetedpecificllyBAIWAAWInourpviouwkBWCCcengwefocueddgggtgdiffencehvildetermntuchknowledgettudeBAIWveruAAWInthpropoedtudyweexpthfocuexmeentnchedtructurlbrrierocioecomicfcrfluencerouteCCcengfollow-upperpetuteCChelthdpriebothBAIWAAWOurpecificimclude(1)identifymultileveldetermntrouteCCcengfollow-updhence(Colpocopy)mgBAIWAAW(2)Aim2Co-deigncompentmulti-levelterventipromoteCCcengfollow-updhence(Colpocopy)mgBAIWAAW(3)evluteterventicompentpfencemgBAIWAAWfeterventiToccomplheimweuennovtivecommuny-enggedtudent-tenivepprochthroughfocugroupurveyThpropoedprojectuncovermultilevelfcrfluenceCCcengfollow-upmgBAIWAAWhelpfillignificntgpknowledgecliclprcticegrdgvrioudetermntCCcengfollow-upepopultiThprojectupptdevelopmentmultilevelterventiplnctcoeductilcompentlevntBW2ubcompentpecificllylevntAAWBAIWThprojectlomptummrizeourterventideigndecritprcticepublichelthpilwhichcoulduedNtilCncerIntuteSUMMARY/ABSTRACTTheNtilCncerIntuteetimte~40%perUnedSttedignoedcncertomepotirlive(http//wwwcncergov)While5-yerurvivlrtectuecedueimprovementcliclcCenterDeeCtrolPventiptcncertillecdledgcuedethUnedStte(wwwcdcgov)Innovtivemeulrgerdtetquidctueeimprovgtndcliclc(Rhitl2021)Thelt15yercncererchhnefedtmendoulydventnext-genertiequencetechnologieEverpentthgenomicvolutiTheCncerGenomeAtl(TCGA)FoverdecdeTCGAledwymoleculrlychrcterizeover10000tum33diffentcncertype(Ellrottetl2018Dgetl2018Bileyetl2018)FromeeftroecommmelltumuniquemnyhprognoticdignoticdriverdeeAmgebiomrkercncerpdpoigermlemuttictrigcncerdevelopment(K-LHungetl2018)DepethlrgeeftTCGAceethevilydwrdcncertypeelectipot-cncerdtcollecthumkgdifficultidentifypdictivepventivedeemodelToddthuemnyccernghumnhelthNtilIntuteHelthhunedproduceAllUReerchProgrm(Rmizetl2022)Thphenomenlprogrmcurntlyhover400000prticipntwhohvegedhirelectrichelthcd(EHR)geneticmti(Doerretl2021)ThnumrexpectedgrowemilliccluiPrticipntelectideegnoticcrumenthfocuedunderpentedmielmot50%prticipntptgn-WhePlimrynlyurncebillgcodeuggetAllUcollectifrufuldtettudycncerWefound35%(3484998553veri6lee)hve(hd)ptedneoplmFurrmoth35%mkeup~80%llbillgcodeoccurncehdelectrichelthcdghighlightgAllUdtetwrdgenvirmenttudycncerHewepropoetwombiouimruntwotemundergrdutetudentchieveouroverllobjectivechrcterizequntifyimpctknownpdpoicncermuttidevelopmodelcncermdignoAllUReerchProgrmSeprtedgenotypeenvirmenteimeeki)identifyegeneticterecticncerpdpoidtbeAllUgenomiccohtii)dcovercomputtillghmfetucnpdictcncermdignoCollectivelyeimencompdobletkwell-tdundergrdutebiomticWelookwrddvncgcncererchcommunyydtum-pecificphenotypeexplgwholedividulfdnovellkcombidiecncertriggerhelpelucidtemgherbilycncerPROJECTSUMMARYThR50pplictiupptctivieDrAlexHerrReerchSpecilt(ClicinScientt)promotgupptgNtilCncerIntute(NCI)-podclicltrilnetwk(CTN)erchbothntillyCyHopeCompheniveCncerCenter(COHCCC)DrHerrclicltrnltillymphomvetigrwholedclicltrilprogrmfocueddevelopgnovelrpiettmentHodgkn-HodgklymphomWhCOHCCCDrHerrAoceMediclDicrCliclTrilOfficeBrkCenterCliclReerchChiefLymphomDiviDeprtmentHemlogyCo-LederLymphomDeeTemHentillederNCIclicltrilnetwkmemrSWOGLymphomCommteeWkgGroupNCILymphomSteergCommteeervetudychir/prciplvetigrtrnltilmedicechireverlclicltrilNtilCliclTrilNetwk(NCTN)ExperimentlTherpeuticCliclTrilNetwk(ETCTN)NotblyhetudychirgroundbkgSWOGS1826trillrgetHodgklymphomtrilcductedNCTNfirtNCTNcollbtitweenHodgkdultpedriccoopertivegroupwhoeoutcomepoedchngetrdcHeltillederDiveryEquyIncluifocuducgbrrierclicltrilenrollmentThroughthR50wrdDrHerrperhedeftceCOHCCCNCI-podCTNerchctivie(1)buildgpecilizedcliclerchfrtructumngeNCI-CTNtrilgrowmultidciplrytutilNCTNlederhiptem(2)ledexpnegrtiCOHCCCcliclerchfrtructucrogil/ntilenterpceNCTN/ETCTNtrilenrollment(3)enhncediveryprticipntCOHCCCcliclerchprticulrlyNCTN/ETCTNtrilThpplictiloupptexpniDrHerreftwrdettgntilNCI-podclicltrilnetwkerchgendlymphomervgSWOGLymphomdolecentyoungdult(AYA)limenrgjunivetigrdeigngNCTNETCTNtrilcductgprctice-chngglymphomcliclerchNCTN/ETCTNThR50wrdllowDrHerrunifyherchgendmedrivgexpgdiverifygternlCOHCCCNCI-fundederchdovetilgexpnihntilNCI-fundederchlederhipABSTRACTTheefficcycell-bedimmunpiettgolidtumhmpedduechllengepertgfiltrtifunctipertenceCD8+effecrTcellThetummicroenvirment(TME)deignedfvtumurvivldepletekeynutrientextrcellulrpcectghotileenvirmentunmenbleCD8+effecrfunctiRegulryT(Tg)cellcnthriveglucoe-lowTMEdueirdptblemetbolic-wirgwhichpromoteurvivlTgfcilteiruppieffecrimmunecellHighfquencyTgTMEocedducedpeimmunpiecedmlignncypoclicloutcomeMetbolicdyfunctumnlyuppturvivlimmunouppivecelldrivenccumultimetbolicproductectedtertilfluidTMEwheycnctignlgmoleculecommunictgneighbgcelldrivguppivephenotypeSucctecriclmichdrilmetboleectedtumduentrcellulrbuilduphypoxiccdiTMEWehveidentifiedextrcellulrucctepromoteductiTgCD4+TcellfurrenhnceTh1-uppgphenotypeTgWepropoehibgeffectuccteTgductiphenotypetrgetguccteignlg-pecificllyucctecepr(SUCNR1)-CD4+TcellTgwecncenumrtum-pecificTCR-trnducedCD8+Tcellfiltrteolidtumenhncgnti-tumpeducgtumburdenWetetthugtumhvemodifieducctelevel(ugCRISPR/C9)mllmoleculentgtSUCNR1CD4+TcellWTSUCNR1-/-CD4+Tcellcomphenivelyeeffecttum-deriveduccteTgductiTMEUtilizgour-houehighvidyTCRcognizetumntigenMAGE-A1PRAMEubequentlydeveloprpeutictrtegytrgetguccteignlgttenuteuppiveeffectTgtum-pecificCD8+effecrTcellnti-tumpeugSUCNR1-/-TcellmllmoleculehibirtrgetguccteWeexmethvivougdvncedhumnizedmouemodel(MISTRG)upptmyeloidcellthuctgnimmunedivereTMEWeimultneoulyuemumelnomimmunecompetentmodel(B16OVAOT-1)terrogteeffectuccteimmunouppiTMETheetudieprovidenovelnovtiverpeutictrtegycombtgidentfiltrtguppiveTgTMEceefficcyTCRimmunpyoutcomeolidtumABSTRACTCncerhenchrcterizedchricpolyhelgwoundwheflmmryprolifertiveproceectueuncheckedoutnmlhelgolutiflmmtiIneenecncerpentnimblncepro-flmmryoverpro-olvgproceeIncoloctlcncer(CRC)wepropoethpro-flmmryimblncemydrivenrchidiccid(AA)-richWeterndietoceddowntmlipidmetbolmTheroleAAcncerdevelopmentprogihowevertillctroverilwhenvrovivohumndtcidedOurplimryLC-MS/MSdtuggetddedlipoxygenepthwyCRClipidmetbolmwheAAderivtive(egLTB45-HETE)prciplgene(egALOX5ALOX5AP)lrgelyover-expedtumvnmlmpleRecentvivomudtuggetdedcncercellmembrne(popticdebr)commlygenertedrpidlygrowgttedtummymourceAApromotetumgrowthSurprglyglecellRNASEQdtuggetmjyAAlipidmodultggeneexpedimmunecelltummicroenvirment(TME)rrthntumcellmelveuggetgroleAAgultgimmuneTMEMooverourplimrynly>2000CRCuggetimmunectivyTMEtrgpdicrlg-termCRCurvivlThecentproliferticheckpothibirhfullydemtrtedpotentilmodulteTMEenblecncercuUndertgpcelyhowddedAAlipidmetbolmimpctimmunyCRCTMEthucriclunmetneedcouldlednovelrpeuticpprocheCRCbedlipidmetbolmignlgHewepropoe1)ddnovelfetuquntifiedAApthwylipidmedirlrgefenceethumnhighlycliclly-moleculrlycurtedCRCWedetermeirbilydtguhpoiblyfeubcledefed)cenumoleculrubtypg(CMS)enrichedvdimhedimmuneTMEb)TMEimmunectivticoc)CRCgenotype2)eeffectAA-bedpro-flmmryvpro-olutimedirpidogeneicptientderivedgnoid(PDO)outtctimmuneTMEclrifymechnmcti3)deferoleAAALOX5tumgrowthmettticprogimuyngeneicCRCthopicmodelWenchexperimentlplnAAupplementtiemblgWeterndierderdemtrteflmmryeffectCRCTheeimdecipherpotentilgultgAAlipidderivtivenovelrpeuticpprochenhnceimmunectivyTMESummryDiet-ducedoyffectbout40percentUSwomencecidencembidymtlypotmenopulbtcncer(BC)Oylocerklrgehigh-grdetummettcurncegrdlemenopulttuOurlg-termgolctriedevelopmentnewrpeuticpprochettmeny-ocedhumnBCOurerchpropolddethterrogtgmechnmwhichdietrylipidccelerteBCtumgrowthwherBCptientoyhveuniquemetbolicvulnerbiliecnlevergedrpeuticllySupptedpublhedevidenceourownplimrydurcentrlhypoettgchricdietrylipidoverbundnceuchoyBCcellwidutilizefefttycid(FFA)overglucoeupptcncerlipidnbolmultgccelertedtumgrowthTheulenivyhelthdipoemicroenvirmentdicttewhertumourceelipidlocllyytemicmetbolmWeteurcentrlhypopurugthepecificim1)TetifdietrylipidrrthnglucoepfentillyutilizedBCcelllipid-richenvirment2)Determemetbolicftebdfttycidbttum3)AetrnltilimplictinltedmetbolicprogrmttmentBCptientoyInim1weuediffentdietrygeneticmouemodelcnccelerteBCgrowthquntifyltiveuptkedietryfuelirourcelenveruoeBCInim2weuetbleopefuitrceftedietry-derivedFFAetblhirbiochemiclctriitumgrowthInim3weuephrmcologiclhibirlipolycircultgFFA-lowerggenttetrpeuticpotentiltrictgFFAupplyhibgtumgrowthWellyzeexpilipidmetbolmgenehumnBCtrtifiedbodymdexmeuoyttuOurpprochwhichcollectivelyddephyiologydipoebiologytummetbolmenbledourcomdexpertenutrimetbolicttu(DrChix)dipoetuebiology(DrHilgendf)vivotbleopetrcgtudytummetbolm(DrDucker)TogerwehveetblhedytemwhichBCtumgrowthcnccelertedolelymnipulticircultglevellipiddependentdipoyocedmetbolicyndromeThlipid-centricviewtummetbolmgenertetrgtetblehypoefuturpeuticterventiSpecificllywepropoephrmcologicldietryterventitrgetgcncermetbolmneedoptimizedlipidmetbolicprogrmtumwhichdetermedmetbolichelthptientGlioblm(GBM)unimlyftlncidencerte299-323per100000peopleDepecentrpeuticdvnceourundertgtumbiologyGBMmcurblemedinurvivllethntwoyerCriclunnwedquetictrigthdmlprognoeludeclrificthroughtrdilnlyhumncliclmterilmllnimlmodelcludei)howdoeurgicltrumimpctGBMdevelopmentdjcentbrtummicroenvirmentii)whtuniquecellulrmoleculrpropertieidulfiltrtgtumcelldurgdeeprogiiii)howdourgicllyducedelectipugenertedenovomoleculrcellulrheterogeneynotpentunectedurgiclmpleDevelopmentcutletttmentwouldprovideignificntqulylifeimprovementGBMptientultimtelylimedlcknimlmodelproducehllmrkfetuGBMtumTypicllyrodentmodeluedtudyGBMhoweverrodentdiffervtlyhumn(egbrizecomplexy)mkgurgiclterventidifficultimulteByctrtmi-pigbrmrkblylikehumnbrlrgerizepermlevnturgiclimggtudieTheewepropoedevelopfirt--kdyngeneic(tctimmuneytem)gliommodelmi-pigcpultehllmrkfetuhumngliomDevelopmentthmodeluppttudieheimpoiblerodentmodelhumnptientThufrwehveetblhedcogenectivtedtrnmedpiggliomcelllepigbrcfirmedirtumigeniccpbiliemouemodelco-mipigInpropoederchwedetermeoptimumengrftmentcdiecogenectivtedtrnmedpigcellimplntgmhotpigbrunderchricvtrnientimmunouppivemicroenvirmentWelotudyimpctprovcilttmentnti-flmmryimmuneuppivedrugToelimtenypotentilimpctimmunectivtitweendiffentdhotwepetmepprochducevivovirlcogeneThelevncepropoedyngeneicpigmodeletblhedthroughnlycceptedhllmrkMRimggteotcticguidedtrcrnilurgerypthologyfetuhumndeefollowedimmunephenotypgDevelopmentlrgenimlgliommodelexpectedfciltenewighthumngliombiologyAfirttepwepropoetethypomi-pigyngeneicgliommodelcpultekeyfetuhumndeeFurremodelexpectedproviderobutnewpltmfututudienotpoiblerodentmodelprcticllychievblethroughnlyptient-derivedmterilThcludenotlimedevlutinewrpieimggtudieurgicltechniqueFllydevelopmentthlrgenimlmodelenblenlyulrgercientificcommunynwerclicllylevntquetipplicbleGBMbrmettticcncerPROJECTSUMMARYDepedvncecncerttmentfive-yerurvivlrtepncticductldenocrcom(PDA)12%OyhenlkedPDArkepidemiologicllyimplygdietmetbolmhverolePDAtumibiologiclbthcltinotclerDtourlbhowhighftdiet(HFD)cnccelertePDAdevelopmentPtf1-C/LSL-KrG12D(KC)mouemodelPDAFurrcentwkhhowncuteflmmticnepigeneticllyprimecrcellpnctumigeneWehypoizeHFDwhichhenclerlydemtrtedlterflmmtirngetuecnimilrlyprimepncpromotepventtumdevelopmentThetwoimourpropolvetigteeffecttwoHFDchoenpecificllycueyenrichedclefttycidknownhvedtctbiologicleffectAim1exmeeffectHFDcompdlrd(HFLD)whichctmotlyturtedlgchfttycidocedoyPDAtumigeneTotudyhowHFLDmyprimepnctumgrowthweuecRNA-eqcATAC-eqdefedietryeffecthelthypncWelolevergeournewlydevelopedCYTO-TgmouerpidlyoltecrcellmetbolomicthullowgudrwcnectitweenchngegeneexpichromttructumetbolmcrcellctextHFLDWenuetmoxifen-duciblePtf1-CERT/LSL-KrG12D(iKC)modeltudyeffectHFLDtumgrowthuenthopictummodelgenertedHFLD-cdiediKCcrcelldtguhtweencrcell-tric-extrictumgrowthmechnmInAim2weexmeeffectHFDcompdcocuil(HFCD)oclicllymtchedHFLDPDAtumgrowthCocuilcompdmediumchturtedfttycidItcommdietryftwpptientuewhenttemptgelthierprticulrlykegenicdieteffectHFCDPDAtumgrowthnotknownWeuecRNA-eqcATAC-eqourCYTO-TgmouechrcterizeeffectHFCDhelthypncfollowedtumgrowthexperimentiKCmiceWegppotmechnmunderlygnyobervedeffecttumgrowhroughtudiethopictummodelugHFCD-cdiedcrcellAim2defeeffectHFCDtumgrowthfirttimecueourHFLDHFCDoclicwebledictlycompeffectediettumgrowthUndertgmoleculrbunderlygdiffentileffectcompoillydtctHFDenblemomeddietrycommendtiptientpotentillyducecncerrkABSTRACTThpplictivlidtemimllyvivemulti-tgertificiltelligence(AI)-bedcylogichlogicepigeneticbiomrkeridentifylpmlignntlei(OPL)highrkprogilcvyqumoucellcrcom(OSCC)ugmiveextgdtetpropectivetudyrcillyocioecomicllydivereOPLptientOSCCptientuffer5-yermtlyrte40%ccountgedethperhourUp10%USpopultihlleiwhichmllproptihigh-rkOPLtrnmOSCCMjchllengeextmirgrktrtifygeOPLWhilegrdeuedcommendttmentprognoticvluelowThecurntlynoliblecliclhlogicmoleculrmrkerdetermedividulrkptientmedypligrdeThequlyOPLgrdghemxyleo(HE)tedlidebedvilbilyurgepthologttypicllybentource-ctdloctiCurntlynvivemplgcnuedettgtrictedccechvenotenvlidtedplcetuedignoHewedeigntgedpprochdignogmirgOPLugcylogyhlogyepigenomictep-wefhidermimizedignoticviveneOurpprochumteimproveprognotictiOPLrkugdeeplerngOurcentrlhypohlogicmoleculrptternOPLcnrk-trtifiedugdeeplerngdividulizeprognoptientmeppntOPLgrdeWeteurhypothrougheriecientificimwhichtkengercteprdigmhiftmngementOPLetblhglyedtrtegyecltecomplexydignotictet(bruhwburgiclbiopy)ecltgcncerrkOurtudyproceedfollowg3im1)TrdeeplerngbeddiglpthologymodellpmlignntleiprogirkpdictiWeuelgudlcohtknowncnceroutcometrdeeplerngmodelugcylogyhlogypectivelypdictrkprogiOSCC2)Vlidtemergecylogyhlogyepigenomicigntuctemulti-tgemulti-modlPROSPECTcougmultiplecohtWefediglcylogyhlogybiomrkereprteextgvlidticohtknowncnceroutcomeNextweuebruhwbpdictbiologicllylevntepigenomicltertitrniOPLOSCCWectePROSPECTco(PmlignntOrlLeiPthologyEpigeneticRkPdictiTool)whichrkcocomcylogichlogicepigeneticcoequentillycliclmtipdictrkcncerprogi3)TetPROSPECTcopropectivemulti-tutilclicltudyOPLptientenrolledgeogrphicllyrcillydiverepopultiWefeourPROSPECTcopermrobutlybruhbiopietueeprtepropectivecohtOPLptientwhichcrueddurgcourethtudyfourcliclewheptientpopultipoediveryrceocioecomichelthdpriediceTetgPROSPECTcothpropectivecohtettgelrge-cleclicltudyuen-vivebruhwbmirOPLhigherccurcythncurntclicltrdPROJECTSUMMARY/ABSTRACTCncerrdirpygenertectiveoxygenpecie(ROS)whichcuebothgledouble-trDNAbkrpidlycructivtePolyADP-riboepolymere12(PARP1&2)Dul-pecificyhibirPARP12(PARPi)promgttmentBRCA12-deficientcncerlecombtirdiProgiveftiguecommideeffectrdirpytenocednemiSevenemiltedrpy-ducedMDS/AMLlomotcommdoe-limgxicyPARPicugFDAdrwtwoPARPimtenncerpy2022ButwhyrdiPARPipfentillytrgeterythropoiethngenoxicrpie(egcplrnucleoidenlog)meluiveAmjcliclchllengecombtirpymimizgmrrowxicyActivePARP1&2ueNAD+ubtrtecovlentlkADP-riboe(ADPr)melveprotegenertePoly-ADPr(PAR)chWhilellnegtivelychrgedPARcncomemnydiffentflvPARP12cnriboylteubtrteprotediffentidue-SeGlutmeAprttePARchcnht(fewADP-riboe)lgtrighrbrnchedHnePARyltiFcr1(HPF1)newlydcovedPARP1&2gulrHPF1eentilgePARyltiPARP1&2uppePARchelgtiAltertiPARchtructugnizticouldffectomenPAR-bdgprote(der)ledgdiffentbiologiclimpctInplimrytudiewehowed1)PARPi-ducedcutehemlogiclxicyquipencePARP1prote2)HPF1criclbothPARP1PARP2u-PARyltidurgnmlplictiDNAdmgepe3)YetHPF1dpenblehempoiemudevelopment4)Hpf1/Prp1doubleknockout(DKO)micehvenomeurbledevelopmentdefect5)ButHpf1/Prp2DKOmicePrp1expidiedembryicllyevenemiBededtwehypoizeHPF1mightpromgtrgetcncerrpyblncgDNAdmgepevnmlhemlogiclfunctiWefurrhypoizeHPF1coopertePARP2gultePARP1ctivtidynmicdurgnmlhempoieimplictirdiPARPi-ducedmrrowxicyTotetthwepropoedeterme1)howHpf1Prp2collbtegultePrp1dynmictdmgee2)howHPF1gulteubtrtePARchtructurlpecificyupDNAdmge3)howHPF1deletictivti(E284A)cuehempoieticfilucgPARP1proteccumultiTheultuncoverpvioulyuncognizedtructurlfunctiHpf1rdiPARPi-ducedhemlogiclxicyddubtrtePARchpecificyPARP1ctivtidurgnmlplictirdicncerrpyeventullyprovidetrtegymigtehemlogiclxicySummryProttecncer(PC)motcommlydignoedn-kcncerAmericnmenAmjyloclizedPCcneffectivelymngedrdiurgery5-yerurvivlrteover99%Howevertncefrtlettmentevblydevelopledgctrti-tntPC(CRPC)medinurvivlly4-6yerEZH2PolycombgroupprotectutePolycombRepiveComplex2(PRC2)lgtwocoubunSUZ12EEDEZH2mgmotup-gultedgeneCRPCwell-etblhedrpeutictrgetEZH2depletiledcellulrenecencebolhePCgrowthEZH2whenPRC2complexmethyltehne3lye27everlcentlyptedn-hneubtrteledgPCprogiTheefunctiPRC2-EZH2couldblockedenzymticEZH2hibiruchEPZ-6438HoweverenzymticEZH2hibirhvelimedgrowth-hibiryeffectPCAccdglycenttudiehveveledn-enzymticroleEZH2ctivtgtrgetgeneuchARThfunctidependentPRC2rrmededcoctivruchP300c-MycAnumrPROTAChveencentlydevelopedhopgdegrdellEZH2proteUntuntelyePROTACmedlrgelyeffectiveywemotlyderivedenzymticEZH2hibirwhichwehownlyblebdEZH2trimericPRC2complexthuunbledegrden-PRC2EZH2AddgthignificntlyunddedgpwepropoedeveloperiePROTACugfirtmllmoleculewehveidentifiedbdoltedEZH2prote(oloEZH2)Wepropoeeolo-EZH2PROTACdegrdenewlyynizedEZH2proteultimtelydocgllEZH2complexefullyblockgEZH2functiWetetirtrgetefficcyPCmodelWelouePROTACdecutctlyticn-ctlyticroleEZH2vrioutgePCUltimtelyweoptimizeledcompoundtermfvblephrmcoketicxicyprilehvgignificntner-termimpcndevelopmentnewttmenttrtegieprottecncerProjectSummryGenome-wideocitudie(GWAS)hveidentifiedover200geneticlocibtcncerTotrnlteefdgnimprovedundertgcncerbiologythudeepventtmenteentilidentifytrgetgeneelociHoweverculgene(underlygbiologiclmechnm)munknownmotGWAS-identifiedbtcncerrklocidepecentpublictitrncripme-wideocitudiehvedcovedfewputtiveculgeneProteflgeneproductkeywkgmoleculecellulrfunctiThuprotehvemodictimpcndeerkthnmRNAInddiprotelevelmRNAlevellymodertelycltedmedincltigly046mnygeneclticloezeroTheecompdvetigtgRNAdictlyvetigtgprotemymolikelyvelculgeneunderlygbiologiclmechnmWepropoenovelproteogenomictudyidentifyputtivetrgetprotebtcncercplizgmultipleextguniqueource1)nmlfh-frozenbttuempleover5000cncer-fewomenSunGKomenTueBnk(KTB)2)proteomicgenomicdt125btcncertuempleCliclProteomicTumAnlyCtium(CPTAC)3)GWASdt~427000btcncercectrolthelrgectiWecductwell-powedproteome-wideocitudy(PWAS)tegrtggenomicproteomicdtbttuethercilgroup(Aim1)Wepropectivelyvlidtepromgbtcncerrkprotep-dignoticnmlbttuenetedce-ctroltudycludg120cidencebtcncerce480dividullymtchedctrol(Aim2)Weevlutebiologiclfunctipbtcncerrkprotecductgeriebiomticnlyevrofunctily(Aim3)Thepropoedtudycductednterdciplrycollbtivetemexpertbtcncerepidemiologygenomicproteomicbiomticbiottticlmot20yercollbtiThpropoedprojectextmelycot-efficientcuebttuemplegenomicdtAim1vilbletnocotthpropoedtudyThepropoedtudyhighlynovtivefirtpropectivebttue-bedproteomictudylofirtproteogenomictudytegrtggenomicproteomicdtOurtudyhighlyignificntimpctful1)unveilgtrgetprotefutumechnticerch2)improvgourundertggeneticbiologiclbbtcncer3)hvgimptntimplictideepventtmentthcommmlignncyHMGA1ChromtRegulrPncticCrcogeneABSTRACTBckgroundWepropoeelucidtemechnmmededHighMobilyGroupA1(HMGA1)chromtgulrpncticcrcogenePncticductldenocrcom(PDAC)highlylethlcncerchrcterizedvivetumcelldenedemopltictromHMGA1geneexpictivteddurgembryogeneilencedpotntllymotdultdiffentedtueIndiverecnceruchPDACHMGA1come-expedwhehighlevelptenddvereoutcomeHMGA1roleHMGA1pncticcrcogenelygngemergeHewefocuctiblepthwydowntmHMGA1novelrpeutictrgetPDACOurcientificpmeHMGA1drivetumprogiPDACbedfollowgplimryult1)HMGA1highlyovexpedPDACwhehighlevelpdictdecedurvivl2)Awecentlypublhed(JCI2023)ilencgHMGA1blockdiverecogenicpropertiePDACcelllewhiledepletgtum-ircellxenogrft3)InKPCmicePDACdrivenmutntKrTp53deficiencyHMGA1drupttumigenewhileprolggurvivl4)SurprglylojutgleHmg1llelepncticepiliumufficientimpirboumtrommtiKPCmice5)MechnticllyHMGA1functinepigeneticwchctivtgtrncriptilnetwkvolvedproliferticogenictrnmtiPDACcelllemodelcludgFGF19growthfcrgene6)TrgetgFGF19geneexpifunctiFGFR4ceprblockdexenogrftmodeldrupttumtrommti7)MotimptntlytumhighexpibothHMGA1FGF19defemoleculrubclhumnPDACexceptillypooutcome8)InKPCmiceHmg1deficiencypncticepiliumultcgimmunecellfiltrtipnctictumuggetgHMGA1lodriveimmuneeviTogeretrigugultupptfollowghypoe1)HMGA1quidPDACprogitrommthroughepigeneticltertigenenetwkfoterrrntprolifertidiffentiTMEignlg2)HMGA1tumcellmodulteTMEpromoteimmuneevi3)TrgetgpthwygovernedHMGA1providenovelrpeutictrtegieAim/ApprochTotetthwepropoefollowgSpecificAim1)TopcelydefeHMGA1-dependentmechnmtumprogiugKPCmiceprimryhumntum2)TotettrgetgHMGA1pthwyrpeuticefficcypcliclmodelImpctThwkhouldvelnewprdigmPDACpthogenelednovelpprochetrevenpventeproundlyclcrnttumGlioblm(GBM)ftlcncerbrhowgltlechngeurvivloverdecderpeutictrilDevelopmenncolyticvirue(OV)ertiveextendourfirtdecriptigeneticlly-engeedOVourG-eriecolyticherpeimplexvirue(oHSV)ieG47whichhenhownbothefficciouGBMfeuehumnbrOuroverrchghypocedefficcyproducedimultneoulytimultgtrtumlimmunepenIL-12-expgoHSVdimhgimmuneuppidenoe(ADO)tummicroenvirment(TME)GBMTheextrcellulrADO(eADO)pthwyimptntboumcellimmunecellIndeedeADOTMEhencidednimmunecheckpotcngultebothntedptiveimmunyMucheADOproducedplmmembrneecnucleotideCD39CD73metbolizedADOdegrdgenzyme(ADE)ElevtedADOleveltrglyimmunouppivetumhibgcyxicT-cell(CTL)tum-ocedmcrophge(TAM)NKcellbdgADOceprA2RlougmentgimmunouppivectivyTgTheTMEtumcnhveADOlevelmnyloghigherthnnmltuehigheADOcnduceggivetrGBMMooverhypoxicommGBMhypoxiduceleeATPNAD+bothpoibleourceADOADOlotimultengiogenecommfetuGBMInlightthhouldnotedthuroHSVG47-IL12hpotentnti-ngiogenicctivynothidhypoxiimmunpeuticThepoibilyimprovgtumrpyblockgADOhendemtrtedmicethufrhhdlylimeduccecliccncergenerlhlymimllyenexplodGBMNelemultiplepotentiltrgetextAmgtrgethownfluenceimmunouppivectivieADOCD39CD73nucleoidetrnpteruchENT-1ADOcepruchA2RADEdenoedeme(ADA)denoeke(ADK)TheeweplndetermeifgenthibgCD39CD73A2RcombtiecnctynergticllyvroimproveGBMimmunovirpyFthwehvepnel5n-immunogenicmoueglioblmtem-likecell(GSC)levribleexpiADOpthwyTheehumnGSCimmunecelluedterrogteADOignlgwelleffectCD39CD73A2RhibirvroNextweplnmketwoveloHSVexpgADAADKtetireffectbothvrovivoimmunocompetentmiceFllywehypoizecombtrtumlG47mIL12G47mIL12ADEpluytemichibirADOpthwycnynergticllyimproveefficcyvivoTheetudiehouldidentifynoHSV-ADOpthwyhibircombtiwrrnttrnlticlicGBMptientProjectSummry/AbtrctTrncriptigrowthfcrt(TGF)pleiotropiccykeignificntrolectgnimmunouppivetummicroenvirmentHighlevelTGFtrglyocedpocncerprognocurntlyn-vivemethodvilblequntifycykevivoThpropoldecrideignevlutinovelbiologicporemimogrphy(PET)rdiotrcerelectivelyqunttivelydetectTGFvivoThepropoedbiologicctructcombntprotecptgextrcellulrdomhumnTGFceprII(TRII)lkedFcfrgmenthumnIgG2vintibodyhgegiThcombntprotewfurrmodifiedppendg147-trizcyclne-147-triceticcid(NOTA)copperchelrvip-SCN-BnctivemoietyTheultgpcurmoleculelled64Cuproducectiverdiotrcer64Cu-FcTRIIThe64Cu-FcTRIIrdiotrcerevlutedpcliclefficcyimggmiceugmllnimlPET-MRIThpropolimeefficcy64Cu-FcTRIIcludgdoetrtiexperimentdetermeoptimldogecubtimerdiotrcerblockgtudycomprvivoPETtrdizeduptkevlue(SUV)exvivotumlyteTGFccentrtifourmutummodelnexperimentdetectchngeTGFexpiefterrdirpyProjectSummry/AbtrctCncermetbolicllyheterogeneoudeeAtcomotmetbolicpthwymichdriplycentrlrolecncercellprolifertimigrtivimettrpeutictnceDueignificntmountomticgermlemutticncer-levntmodifictimichdrifoundWhileomemichdrilmodifictiprovideggivedvntgecncercelldetrimentlMoundertghowcncercellmnipultemichdrilmodifictiplenhmichdrilperigultemichdriltedmetbolmwouldeholdgtprometcklecncerdownSupptedourplimrywkwehypoizemllpopulticncercellcncertemcell(loknowncncergcell)cnhiztllytrnferirmichdrimcrophgeDuepdpoedmodifictimichdricncertemcellwefurrhypoizeecncertemcellderivedmichdricouldwimetbolicpthwymcrophgethuledglterntivectivtimcrophge(M2)ThehypoetetedtwopecificimWeillytetproducibilyhiztltrnfermichdrieddiffenttypecncer(Aim1)Welodetermeifuchmichdriltrnferctivelycductedcncertemcellpivelychievedviphgocymcrophge(Aim1)Oncemichdricncertemcellpentmcrophgeweexmehowemichdrimkrgemetbolmoxidtivephophyltictiveoxygenpecieproductimcrophge(Aim2)Addillywedetermepolriztipectrummcrophgepecquiexogenoumichdricncertemcell(Aim2)WhuccefulcomplethpropolmticollectedthR03nlyprovidenewightnewimmuneevimededthroughhiztllymichdriltrnfercncertemcelllopentnenticgtrgetmoeffectiverpeuticterventipecificllytrgetgcncertemcelltumocedmcrophgeInddimyloervepro--prciplepplytypetromlcellmyccounrcncerlteddeePROJECTSUMMARY/ABSTRACTThecidencehemlogiclmlignnciehigherperlivgPLWH(PerlivgHIV(HumnImmunodeficiencyViru))TherkdevelopgclicHodgklymphom(CHL)PLWH5-26timegenerlpopultiTheUS(UnedStte)HIV/AIDSCncerMtchtudydocumented163-foldcecidenceCHLPLWHftertroductiARTcompdp-ARTerCHLnunuulB-cellmlignncy<5%tumcellmidt>95%nigncellcompoedimmunetromlcellMotmixedcellulryhlogiclubtypeCHL80-100%CHLPLWHEBV-ocedOurpvioutudyuglimedpnelntibodiehowedimmunemicroenvirmentCHLPLWHdifferthoeeenimmunocompetentptientFurrmoimmunemicroenvirmentplycrucilrolepthogeneCHLDNAleukocyteunttedHIV-fecteddividulhowDNAmethyltichngedictiveggCombtiARTcnprtlyvereepigeneticggdoenotentilycctWehypoizepertentepigeneticltertiimmunecellPLWHlg-termcombtiARTultltedrrntgeneexpiimmunecellInctextpenceufficientnumrCD4+TcellbnmlimmunecellctriepthogeneclicHodgklymphomypiblecedltiverkdevelopgCHLPLWHcombtiARTWepropoeidentifypertenttrncripmicchngeimmunecellnignlymphnodePLWHcombtiARTddwhereltedchngecndocumentedCHLmplePLWHWeelectnign/ctivelymphnode21PLWHART21ge-mtchedn-PLWHgroupCHLmple26PLWH26ge-mtchedEBV-ocimtchedn-PLWHdividulWecludepidnignlymphnodeCHLmplemeptienttudyRNAextrctedmpleevlutedBulkRNABrcodgSequencg(BRB-eq)NnotrgnCounternlyFnCounternlyweuepnel~100genepenttiveimmunepehemlymphoidtumidentifydiffentillyexpedRNAvlidteultBRB-SeqTuemicrryppdprffblockptiltrncripmicproteexpiundertkenugCoMXTMSptilMoleculrImgenlyytemevlutetuemicroenvirmentgle-cellptilctextThediffentilRNAexpinotddedCoMXTMddedmultiplex-immunohchemtry-uhybridizti(RNAcope)ThenovtiveBRB-eqwepropoevlidteignificntlyducecotRNAequencgexpinlyPROJECTSUMMARYWhilehveentmendoudvncettmentetrogencepr-poive(ER+)btcncerlte-tgeER+mettticbtcncer(MBC)hverypoprognoThechiefumendoctncewhetumdotpdER-trgetgrpieEndoctncemjbtcncermtlyprimrychllengettmentER+MBCThemotwellknownmechnmendoctncehotpotctivtgmuttiERledligdependenceTheehotpotmuttieffectivelyhidnewetclendocrpynovellelectiveERdegrder(SERD)ervebiomrkerSERDpivetumWefoundnoveln-hotpotERvrintunknownignificncedoublehotpotmutti(cmeERmolecule)cliclwhole-exomeequencgtumcquidtnceERhibiTheegledoublemuttifquentltterpent~5%tnttumWhoutpcliclchrcteriztievrintpentnunknownentytermbiologyrpypeInpilottudiewefoundycfertrgtnceelectERCDK4/6-trgetgrpietructumodelguggetypdictedlterERbdglighibir/trncriptilco-fcrRobutpclicltudiewell-etblhedmodelbtcncerquideefdgcntrnltedclicInthpplictiwepropoecomphenivepcliclchrcteriztiepvlentnovelERvrintthroughtwopecificim1)ecogenicpotentildowntmignlgnovelERvrintpecificllydetermehowydygultedowntmERtrnctivthroughtrncripmicepigenomicproteomicprilgpterytructumodelg2)prileirpetrgetedrpiecellleptient-derivedgnoidnimlxenogrftmodelAtendgrnttermweexpect)vlidtenovelERvrintpotentilbiomrkermypdicttnceERCDK4/6hibirprticulrlynovelSERDb)identifytructurlbwhichenovelvrintprticulrlydoublehotpotmuttidygulteERc)identifypotentiltrgetblenodetumcquienovelERmuttiOurultwouldhelpdeignclicltrilovercometncemyvoidunneceryddilburdenxicyhevilyp-ttedptientDevelopgbiomrkerpdictpelSERDloenbletrtifictiptientwhoetumexpenovelERvrintlternterpeuticgimenoutdely(pcimedice)Theetudiehvetrgpotentilducemtlyocedbtcncerthuwell-lignedmiNCIImge-guidedrmlblti(IGTA)mimllyvivelowcotcceiblecncerttmentptientcludgthoewhooillcidteurgeryrdipyHowevermunder-utilizeddueltivelyhighercurncerteThlikelydueccurteetimtettmentzeboundrieTherchprogrmpropoeddthchllengepplygdvncedtechniqueimgenly(pecificllydeeplerng)detectmigtepotentillyundetectedcompletettmentlivertumblthroughmultipletgeprocedufollow-upperiodTheecriclimprovementhelpbrodenpplicbilyceuccerteIGTAwhilemtgmnydvntgeSpecificllywedevelopnovelfullyumtedpipelekidneyegmenttigtrtibeddeeplerngcouldduceimpctundetectedcompletettmentimproveyercncer-feurvivlmkeIGTAmottrctiverpymoptientWehypoize1)deeplerngtechniquecnegmentkidneynlleimnnerdtguhbleexperiencedrdiologt2)deeplerngcnupplntbiomediclmodelggenertgdemtivecrfieldtpeedublecliclpplictiThedeliverbleourwkwouldimprovettmentnltumeverlwyFirt3-dimenilementdelivedbltizebedp-opertivedignoticqulyimgeetblhvirtulmrgwhenptienttilltblellowl-timedjutmentoperrdececurncerteSecdcluientiprocegledeeplerngrchectumkegleeilyimplementbleprogrmclicThepropoederchterdciplryengggclicinimggcienttcompheniveeftcurtelrgemounthighqulyttmentimgglevergethdtdevelopgdeeplernglghmegmenttigtrtipdictitrtegiewell-uedthproblemdomThetechnologywouldfcilteidentificticompletettmentl-timeuep-opertivedignoticqulyimgeimproveccurcyetimtgttmentzeultgdecertepot-ttmentcurnceVelcrcompoundkillcncercellexpgelevtedlevelPDE3ASLFN12ducgcomplexmtitweenetwoproteVelcr-ducedPDE3A-SLFN12complexeheterodimercompdtwoPDE3AprotetwoSLFN12proteWehypoizeolefuncticomplexmtivelcrpedimerizeSLFN12SLFN12dimerctivemSLFN12RNeultgcyxicymededdegrdtiSLFN12ubtrtetRNA-Leu-TAAWetetthhypoexperimentoutledthpropolFirtwedetermewherexpihighccentrtiSLFN12cnducetRNA-Leu-TAAdegrdticyxicybencePDE3ASecdwetkelo--functipprochdetermewherpotmuttSLFN12homodimerterfceI131QcnhibSLFN12-mededcyxicyoutvelcrttmentThirdwetkeg--functipprochewherFKBP-mededchemiclly-ducedhomodimeriztiSLFN12ulttRNA-Leu-TAAdegrdticyxicybencePDE3AvelcrttmentTheultimtegoltherchdetermewherSLFN12dimerizticnlevergedctenentilynewcncerrpeuticmodlyIfwefddimeriztiSLFN12neceryufficientRNectivtiweenvidevelopgnewtypemllmoleculeterSLFN12cncer-pecificdimeruchRAFdimerRAS-mutntcellmimickgrolePDE3Avelcr-mededcyxicpe7PROJECTSUMMARY/ABSTRACTCncerdignottmentmngementcnchllengeromnticltihipFdividulcommtedprtnerhipcncerdydicendevquiterperlcommunictidptcouplenewlyFdividulwhohveendignoedmettticbtcncer(MBC)effectivecommunictiirprtner()epecillyimptntprovidgupptutgcloeneMtgexultimcyprticulrhenlkedpoivecncermngemenutcomequlylifedividulbtcncerCommunicticnhelpfcilteexulwell-gepecillyimptntdvncedtgebtcncerwhenprtnermutetblhnewnmexpecttiexpgirexuldeimcyDepeimptnceexulymettticbtcncerptient(MBCP)irprtnerltleerchhexplodhowMBCPcommunicteboutimpctbtcncerexulytimcyIdentifygpecificmfetutlkmyhelphdercoupleynvigtetimcyctextMBCpivotlfirttepundertgifhowcommunicticnnefdividulltilwell-gThepropoedpilottudyhtheim1)identifymeMBCPcommunictiboutexulytimcy2)determewherpecificfetucommunictiocedexultfctiltiltfctidividulwell-gMBCP3)determefeibilycollectgdnexulytimcyprtnerMBCPPilotdtcollectedvinleurvey82MBCPTheurveyctvlidtedcleopen-endedquetiPrticipnthveoptipdopen-endedquetiugPhicnudio-cdgurveytwcgcceibilyMBCPrngebilieFeibilycollectgddildt25%MCBPprtnerlodetermedccdncetweenMBCPirprtnercommunictiexplodThemticnlycltinexplrymedimodelemployedddtudyimUgcommunicti-bedpprochthprojectprovideplimrydtgrdgltihiptweencommunictiexulltildividulwell-gdetermefeibilycollectgdtprtnerdividulMBCThefdgpilottudydddertherchcommunictiboutexulymgMBCPidentifymfetucommunictiMBCPfdneficilwhennvigtgexulytimcyirltihipPROJECTSUMMARY/ABSTRACTLow-doecomputedmogrphy(LDCT)hencceptednefficcioupopulti-bedpprochlungcncerceng(LCS)bedfdgNtilLungScengTril(NLST)whichdemtrted20%ductilungcncerdethTheefdgubequentcommendtiUSPventtiveServiceTkFceDecemr2013lgexpedguidele2021ultedLCSviLDCTgimplementedvrietycommunycdemicettgtrtg2014HowevernycengprogrmccernboutpotentilLCSledoverdignolungcncerOverdignodetecticncerthroughcncercengneverwouldhveendignoedbencecncercengwouldneverledignificntptientmbidymtlyptientlifepnifleftunttedAnydignolungcncergenerllycueptientenggeggivettmenverdignomyultnxietyeriouphyiclhrmunneceryloequlylifefncilhelth-ccotThevribilyuncerttyoverpotentilLCS-ltedhrmhledextenivedebtegrdgblncetweenhrmnefLCSAlthoughtrgetevidenceoverdignocomeromizedctroltril(RCT)lg-termfollow-upptientprticiptgRCTgenerllynotpenttivethoecommuny-bedettgCompdNLSTprticipntdividulprticiptgcommunybedLCSettgmolikelyoldercurntlymokehvehighcombidburdenSpecificllyprticipntceivgLCSccommuny-bedettgwemolikelyhveCOPDthmbrchiectchricbrchditehypertenicompdNLSTprticipntthucglikelihooddethndeeelungcncerprogeTheediffenceuggetmgnudeoverdignomyverydiffentetimtederivedRCTObervtiltudieneededprovideourcerobutevidencemextencemgnudeoverdignolungcncerdividulceivgLCScoutidenRCTALCSprticiptictueevolvethevidenceneededmfutucliclpolicydecimkgTheeprimryobjectivethtudyproducerngeetimteoverdignomgptientdignoedlungcncerwhoprticiptedLCSprocecommuny-bedhelthcettgPROJECTSUMMARY/ABSTRACTPtient-ptedoutcome(PRO)meuPROMpowerfulolcncercenhnceclicin-ptientcommunictiidentifyproblemticympmttmentpriiefciltehddeci-mkgprolgurvivlNpeignificntlyundermepenttivenePROdtroutelycollectedprtcliclccompromgutilypromotghigh-vlueequbleptient-centedccncerclicThelckdequtepenttivenelohmperueroutelycollectedPROdtqulyimprovementvlue-bedhelthcThenurgentneeddeletepenttivenePROdtcollectedroutecncercidentifyunderlygcuenpedevelopnovelmethodenudtpenttiveneDepecompellgevidenceexpgchPROMcollectiunderpentedptientimprovgirPROMcompleticriclenupenttiveneroutelycollectedPROdtmotcurnterchfocuemethodcecollectitedmethodenhncePROdtpenttiveneTheoverrchggolthpropolchrcterizedeletecuenpedevemigtitrtegieimprovepenttivenePROdtcollectedroutecncercByexmgdtPtient-ReptedOutcomeMeumentInmtiSytemGlobl-10meucollectedprtroutectevenRdiOncologyclicMGenerlBrighmhelthcytemwe(Aim1)chrcterizenpeGlobl-10croclicproviderptientlevel(Aim2)identifymultilevelcuenpepotentiltrtegieimprovepenttivenePROMcollecti(Aim3)developeffectivemodifictimg-dtmethodenhncepenttivenep-extgPROdtOurexpectedoutcomegenerlizbleknowledgetrtegieddnpePROMenhncgPROdtpenttiveneroutecncercTheuccefulcomplethprojectelucidtechrcterticPROMnpetricteocimultilevelfcruccefullrge-clePROMcollectidivereptientpopultiInightthendevloguideevolutidevelopmentPROMcollectiprogrmexpirchunderpentedcncerptientimprovedtpenttiveneThturnenbleutilyPROdtqulyimprovementhigh-vlueequbleptient-centedcncercPROJECTSUMMARY/ABSTRACTInUnedStteprottecncermotpvlentmlignncydproptelyhighercidencemtlyrtemgblckmenthnirwhecounterprtBlck-whemtlydpriehveenexmeddiffencettmentbedocioecomicfcrimplictedAprtectribureffectmoleculrgeneticfcrrcildpryevidentCompderliertudiefocugherblemuttigle-nucleotidepolymphmmocentlytue-bedgenomicnlyeenblednext-genertiequencgtechnologiehveemergedvetigterce-pecificomticltertiircliclimplictihveldygenertedpromgfdgHowevertue-bedgenomicnlyextmelychllenggmettticprottecncercue-pdomntmettticdeetuemplenotlwyobtbleAnlyebedcircultumcell(CTC)nemerggliquidbiopypprochcnprovidegloblnphotprimrymetttictumprovidemtiptiltemplheterogeneyclecnnoteilychievedthroughnlyetuebiopympleWhcentdvncegle-celltechnologienlyeCTCtgle-cellolutifernvivepprochchrcterizemirdynmicchngecncermultidimenilperpectiveNeletudiegle-cellCTCnlyhverlyenptedprtlydueciderbletechnologychllengeMoovernotudyofrexmemuttillcpeCTCctextrcilurvivldpryRecentlywehveetblhedcomphenivepipeleenrichmentenumertioltiwholegenomemplifictiequencgdtnlygleCTCBedthpipelewewecentlywrdednNCIR01projectdeveloplrgepropectiveprottecncerptientcohtdetermemuttillcpegleCTCttmentpedeeprogimettticprottecncerIntriguglyourpilotwhole-exomeequencgnlygleCTChoweddtctmuttiligntutweenblckwheptientmettticctrti-tntprottecncer(mCRPC)Buildgupeerchtngthvilbleourceplimrydtwecductwhole-exomeequencgCTCpidblckwheptientidentifyrce-pecificmuttiligntuevluteirocircilurvivldprymCRPCBypplygcuttg-edgegle-cellequencgtechnologylrgegogmulti-ethniccohtthpropoedtudyhpromeidentifynovelgenomicbiomrkerocedrcilurvivldprymCRPCwhichmytprognotrtifictipcimediceoptimlmngementprottecncerptientcludgrcilmiewhounderpentedpvioumoleculrprilgtudiePROJECTSUMMARYApproximtely42%newcncerceUSviewedpotentillyvoidblecludg15%cuedexcebodyweightphyiclctivyHowevermotUSdultphyicllyctivePhyiclctivyterventierchhfocuedprimrilymodifygcogniboutwhtrtilly-thkgperhoulddoimproveirhelthultgmodeteffectlg-termhvichngeAfcrhenlrgelyoverlookedterventierchwhileengggphyiclctivymyplentomecnnextmelyunplentexperienceHowomeefeeldurghvicntriggerociveproceecludgimplicttude(egfvble/unfvble)wrdtrgethvhpertequicklyvoluntrilyoutidecognivectrolAcentmet-nlyhowedignificntpoiveocitweenpoiveimplicttudewrdphyiclctivyphyiclctivyenggementOurdthowimplicttudewrdphyiclctivydifferdydycroutiAvrietyexperimentltrtegieuchguidedimgeryvuliztihvehownpromechnggimplicttudewrdphyiclctivyHoweverrlyhveeterventitrtegieendelivedl-wldettggulrbddvriimplicttudeWeexmewherimplicttudewrdphyiclctivycnexperimentllymnipultedffect-bedterventitrtegiedeliveddilythroughterctivemobiletechnologymedeterventieffectphyiclctivyhviThepropoedtudyddnovtivel-timemeuimplicttudedurgdilylifemgdult(18+yer)televtedcncerrkduectivyoverweight/oyprticiptgngogtril(N=120)AnffectcdiprovidedilygolltedenjoymentfeelggooddurgphyiclctivyInctrtntenycomprcdiprovidedilyhertrtegolTwodilyenhncementffect-bedcdievluted(1)tilodctivytypectextcommendtitfyperllyimptntpychologiclneed(TYPE/CONTEXT)(2)vgprcticeceliencypoiveemotidurgphyiclctivy(SAVOR)OnechdyyplnenggephyiclctivyimplicttudeeedmngmobileImplicAociTet(IAT)irmrtphecpturgctimectegizephyiclctivyedentrywdgoodbdPhyiclctivyoutcomemeudugccelerometrySpecificim(1)determewherimplicttudemedeeffectttmentphyiclctivy(2)explocro-utimodertgeffectuchutilctrt(egcidentltpftigue)ThtudyelucidtehowwhywhenterventitrtegiecnfluenceimplicttudeleduccefulphyiclctivychngeInightbouteffectmedircnbck-trnltedfementttmenttrtegiemelveledgmoeffectiveutbleterventiPROJECTSUMMARYRoleJMJD4PncticCncerIn2023nerly50000ptientdiepncticcncerUSThmlignncyhewturvivlrtedictgurgentneedtterrpieAmocompheniveundertgdrivgcepncticcncermyfurnhnovelidehowcurtilthdeeJMJD4nenzymehenimplictedprotelyehydroxyltidemethyltiHoweverpcephyiologiclfunctiJMJD4mechnmctihvemedunolvedOurplimrydtdemtrteJMJD4upgultedpnctictumJMJD4bltiducegrowthclogenicyhumnpncticcncercellwhileJMJD4ovexpimytimultecellviFurrweprovideevidenceJMJD4tercttwotrncriptifcrvolveddevelopmenttumchemotncetpemedirNRF2HIF-2mjcompenthypoxipepthwyThuggetvrioupotentilmechnmwhichJMJD4couldffectpncticcncercellBedeplimrydtwepoJMJD4promotepnctictumigeneMooverwehypoizeJMJD4functitletprtthroughmodultgNRF2HIF-2Totetehypoewepropoetwopecificim(i)TodetermeroleJMJD4pncticcncercell(ii)TovelhowJMJD4cttmoleculrlevelCompletietudiegtlydvnceourmechnticundertgJMJD4rolepnctictumFurrmoourerchmynomteJMJD4enzymenoveltrgetttmentpncticcncerBecueJMJD4noteentilnmlcellmllmoleculehibirJMJD4pdictedhvemimlideeffecthighlydeirblefetuLtlyightgedhelikelyhveimplictittmenrdeecludgcoloctllungcncerwheJMJD4loovexpedFLASHrdipyutilizgultr-highdoertehpotentilgubtntilevolutirydvncementcncerttmentUltr-highdoerterdiprovidenefdecednmltuexiciewhilemtgequivlenttumkillgeffectAmgdiffentmodlieprticlerpyhennctiveerchtegrteuniquechrcterticFLASHeffectcueprrpymlyclicllyeblemodlycnpotentillyttdeepetedtumunderFLASHcdiThudevelopgmethodenbleFLASHprrpyclicllyvilbleccelerrnimptnttepbothunrvelbiologiclmechnmugpclicltudieclicltrilwellexplophyiclhrdwquimentcliclimplementtiInFLASHprrpymmodultideviceimptntcceieenblgultr-ftdoedeliverybedclicllyvilblecyclotrynchrocyclotrytemTheewktrnmgnultr-highdoertemo-energeticprpencilmulti-energypotfterpgthroughvrygthickneemodultgmterilInthwymulti-energylyerpencilmcnngprplncndelivedcompletelylethnecdoutneedmpugenergywchgThemotcommmodulrridgefilterwhichctunimdenypikevrygheightThelimthdeigncludetrictedtructutbilymodultiflexibilyWepropoedevelopnewclheterogeneoudenyrngemodulrbednovelPixelPrttechnologyfcilteFLASHrpyByctuoulyvrygrtiofilmentirPixelPrttechnologycpble3Dprtgphnmvoxel-weheterogeneoudenyByutilizgmterildenynoptimiztiprmeternewdevicehverobuttructuhighflexibilymodultiThehypo3DprtedheterogeneoudenymodulrdegrdemenergycrotrnvereplneprticlembedbothloclmterildenyppgpowerdtriimterilWhgterflexibilycompdcurntbrymodultilydeigncomplexmodultichievblepplictiuniverlrngemodulrptient-pecificmodulrOurdeliverblecludedeignmethodoptimizedenytructurngemodultiexperimentllyvlidtedmodulrprFLASHrpypplictiThepecificimAim1DevelopmentdenyoptimiztilghmrngemodultiAim2Experimentlvlidtichrcterizti3DprtedheterogeneourngemodulrAim3Developmentptient-pecificmodulrPrFLASHrpyIfuccefulpprochenblenewclrngemodulrenbleFLASHprticlerpyflexibleemblyptient-pecificmodultiProjectSummryAbtrctElectriccigtte(e-cigtte)uemgdolecentnemerggpublichelthproblemIn2020195%highchooltudent47%middlechooltudentuede-cigtteeventhoughe-cigtteueknownhrmfuldolecenthelthultgnicote-ltedympmddictivriouhelthue(egdepiveympm)ocedueddictiveubtnceInpeurgentneedddthuelckeffectiveterventidolecente-cigttecetiThueffectiveutbleterventidddolecente-cigtteueurgentlyneededThtudyimedtctgclblee-cigtteueceterventiugmrtphepplicti(pp)whichcndelivedlrgepooldolecentThtudytetlunchclblemrtpheAI-enhncedpp-bedterventideliverycnfeiblyimplementedchoolprimryccliccommunyettgdolecente-cigttecetiAnrtificiltelligence(AI)-enhncedmrtphepp-bedterventicot-effectivetrtegyfcilteperlizedmegehvilproblemUgAI-teduerprilgtechniquebedprticipnte-cigtteuettuptternubtnceuettudeque-cigtteliefboute-cigtteerventiendperlizedctentmdfulne-bedtrgmoduleTimelymegeentpeuerurgeuee-cigttebedelf-ptltimethroughmrtpheppInddiAIblenwerppuerquetivinumtedchtbotWepilottetterventiummtiveevlutiugqui-romizedctrolledtudyugdelyedterventideignInPhe1wefemrtphepp-bedterventibedfeedbckobtedprticipntterviewubily(functiterfcectent)ubilyurveytkpermncetetInPhe2wepilottetterventiugqui-romizedctrolledtudydeignWeexmeubilyviubilyurveyprticipntenggemennppuevifquencyAI-ppue(echfetu)dtentedppmuteppueperdyInddiweexmee-cigttecetiltedoutcomechngepp-bedterventievlutge-cigtteuefquenciecompdctrolgroup(3mthdelyedterventi)termqurtetpot-terventi30-dy3-mthpot-terventinumrdye-cigtteuedpt30dynumrquttempttentiqudequnicoteddictiliefperceptiboute-cigtteWeexmefeibilyterventibeduerexperiencefunctiterfcectentOverlgtermfdgthtudyctrieuefulmthoetetgeffectivenemrtphepp-bedterventidolecente-cigtteuecetilrgecleABSTRACTProtekefuncticellignlgthroughgultedphophyltipecificubtrteCurntmethodllowecomphenivelyidentifyubtrtegivenkeyetwelckgenerlmethodologydetermgwhichubtrtecriclpecificfunctikeLikewepprocheprobgfunctilimpctphophyltihupuchkeyubtrtelckgHewepropoedeveloptechnologyllowgdictedphophyltigleprotekeubtrtetdefedeWihpprochweengeerkemutntcnlyphophyltedeignerlleleeubtrteToccomplhthgolwelevergeknowledgekephophyltiepecificygedthroughourcentcomphenivenlyhumne-thekomecequentundertgtructurldetermntkeelectivyWeetblhfeibilyechnologyugtumuppkeLKB1modelytemLKB1hwell-defedubtrteperiphophyltgctivtget14downtmprotee-thekeexcluivelyThridueWeengeerLKB1otedphophylteSeriduedoenotcnendogenouubtrteWenengeercompentgmuttiekeyubtrteAMP-ctivtedproteke(AMPK)phophyltictivtimutntLKB1Humncncercellleco-expgellelenlyzedLKB1-dependentctivtiAMPKexcluiLKB1ubtrteTodetermewherthytemfhfullycpulteendogenouignlgweexmephophyltietblhedubtrtedowntmAMPKweglobllympchngephophoproteomepeAMPKctivtiAutcomeetudiewehveetblhedytemwhichgleubtrtekephophyltedidenticldynmicntiveubtrteFututudieexpthpprochLKB1ubtrtefciltgtudiehowLKB1functitumuppWeultimtelypplyechnologygenerllyprotekeimplictedcncerwhoecriclubtrtecurntlyunknownMetbolicdyfuncti-ocedteticliverdee(MASLD)cidedwld-widepublichelthproblemcuedmetbolicyndromeItetimted30%wldpopultihveMASLDSuchproptiubjectceup56%next10yerTheburdenMASLDextendedignificntocirkHCCdevelopmentMooverpdictedcidenceMASLD-ltedHCCUSccurntlycgpvlenceoyUntuntelymjyHCCptientdignoeddvncedtgelimedttmentmodlielethn20%five-yerurvivlrteRecentlyueimmunecheckpothibirimmunpyemergedpromgrpeuticoptiHCCptientdvncedtgemkgfirt-lettmenteptientHoweverhendemtrtedimmunpyleeffectiveptientMASLD-ltedHCCWehypoizeltertigutmicrobiotcompoi(dybio)MASLDptientcnledcegutpermebilyledgmicrobiltrnlocticehepticexpoumicrobiotcequencedivereflmmryfcrcnledcellulrprolifertiprogiMASLDHCCmemyprovideerlypdictiprognoHCCTheewepropoepilottudyteurhypogenerteplimryultfutulrge-cletudieWepropoed3im1)TochrcterizebelegutmicrobiomediveryocedMASLDoutHCC5diffentgroup(N=20echgroup))MASLDoutcirrhob)MASLDcirrhoc)MASLD-ltedcirrhoticHCCd)MASLD-n-cirrhoticHCCe)HCCoutMASLD2)TocltebeleequentilchngegutmicrobiotimmunpypeimmunpydvereeventHCCptient(N=60)outMASLD3)ToevlutewhergeneprotelevntuceptibilyprognoMASLD-ltedHCCmyltercompoigutmicrobiotmyexplpot-immunpyoutcomeMASLD-ltedHCCTochievethpilottudy2yerwetkedvntgeextgerchfrtructutBylCollegeMedice(BCM)MDAnder(MDACC)cludg1)IRBpprovedprocolptientcrumentbloodolcollecti2)SupptgplimryultignificntocitweenMASLD-HCCrkprognobiologicllyltedgeneticcircultgmrkerWholeGenomeShotgunequencgpermedolmpletcofcilyBCMBloodmpleproceedtetignificntgeneticprotemrkertMDACCtRule-BedMedice(RBM)Tex-bedcompnyFdgthtudymyhedlighnrolemicrobiotMASLD-ltedHCCwouldfluenceprognotictitrtegieimmunpyperlizedpprochMASLD-ltedHCCPROJECTSUMMARY/ABSTRACTUndertgmechnmdrugctiimptntidentifygettgwhichdrugeffectiveterptgevenpdictgpotentilmechnmdrugtnceFnti-cncerdrugkeypectirmechnmctimechnmwhichedrugpromotecelldethThefirtidentifieddethpthwywpopmdehtnowblyunderodInddihlgenknowncellcnlodien-popticwyThecventilwdomhdenenecroticmdethnotgultedydotultctivtidefedignlgccdeuepecificeffecrmoleculeItnowclerrdilthkgcctSeverldtctmgultednecrohvenowenidentifiedAdefigultedcelldethhexpedohourundertgnti-cncerdruggenerllyhvecpcyctivtemultipletypecelldethTheexctcompoideypehow/whyevrycroctextmchllenggtudyduelckolimultneoulyevlutgllmechnmcelldethglempleToddeuewepropoedeveloptrgetedgRNAlibrrycnuedferwhichtypedethctivtedvivoThpropolfocuedevelopmenptimiztifilutetgthnewoletblhutilyolutilimthmethodOurolevlutedctextdrughibhnedecetyle(HDAC)whichwehvepvioulyfoundducevriedmcelldethcrodoeenvirmentThemethoddevelopedthpropolhvepotentiltrnmtiveprovidgfirtightmechnmgultimnyundertudiedtypenecroticdethenblgnewtudieexplohowemechnmvrycrodoetimedeectextPROJECTSUMMARYWhilebtcncerprognohubtntillyimprovedoverltthedecdecurncemignificntrkprticulrlyAfricnAmericnptientptientlow-middle-comecountrie(LMIC)NovelterventineededpventcncercurnceducemtlyIncgevidenceuggetgutmicrobiotmyfluenceefficcycncerrpythuimpctgcncerprognoOnhcncerttmentprticulrlychempymyleddybiogutmicrobiotchngebcterilmetbolicctivieTheeltertimightpertydtimettmentultgductineficilbcterifluencglg-termbtcnceroutcomeThugutmicrobiotpotentiltrgetimproveefficcycncerttmentlg-termhelthoutcomebtcncerptientHoweverimpctcncerrpyprticulrlychempygutmicrobiotftercompletirpywellfluencegutmicrobilg-termbtcncerurvivllrgelyunknownToddeknowledgegpwepropoecductgpilottudyevluteocip-pot-chempy-rdipygutmicrobiomeprilebtcncercurncemtly(Aim1)Weueextgp-ytemticttmentgutmicrobiomedt364cepermhotgunmetgenomeequencg110pot-chempy/-rdipyolmpleVietnmBtCncerStudy(VBCS)Welovetigteimpctchempygutmicrobiomeprile(Aim2)Weexmechngegutmicrobildiverytxbundncemicrobilmetbolicpthwymicrobiomedybiodexemg110btcncerptientpidp-pot-chempyolmpleThpropoedtudyfirtevluteocip-pot-ytemicttmentgutmicrobiomeprilewellirgutmicrobiomedybiodexerkbtcncercurncemtlyt5yerpot-dignoFdgthpropoedtudyupptlunchfull-cletudyfullyundertrolegutmicrobiotbtcnceroutcomeeventullyledgdevelopmentmicrobil-bedterventiimprovelg-termcnceroutcomequlylifeurvivProjectSummryYouthelectriccigtte(e-cigtte)uepublichelthccernMnyyouthegerquvpgourpritudyetimted673%dolecentvperptedpt-yerquttemptnverge53timept-yerquttemptHoweveroverlluccevpgcetimlowmjydolecentvperhduntedquttemptMenwhilecurnte-cigtteueignificntlymopvlentmghighchoolthnmiddlechooltudentover90%fquentdolecentvperthoeged15-18yeroldItimpertivedevelopge-pproprevpgceterventifocuolderdolecentddirpecificneedthucurbghighvpgpvlencemgthvulnerblepopultiThefmilyenvirmenteentilyouthgrowthpntluppthlgendocumentedcriclprotectivefcryouthubtnceueIn2022nerly16dolecentvpereekgtncequtghdldyoughtdviceirpntcgivermodolecentvperhdkeddviceirpntthnugmobilepptextmeggprogrmPeercochhenuccefultrtegybccoubtncecetiprogrmcnectgpntcurntdolecentvpercommunypntwhohveuccefullyhelpedirkidquvpgcnneffectiveterventiimproveterventifidelyeffectiveneGroundedSocilInfluencemodelSocilCogniveTheythfeibilytudyimdeveloptetPnt-helpg-PntyouthVpgCeti(PhP-VX)progrmprovidgpnt-fciltedyouthvpgceterventiInAim1ourmultidciplrytemprtnerPntAgtVpge-cigtte(PAVe)ntildvoccyeductigniztinerly14000rce/ethnicdiverepntuppterdvncetrnltiepidemiologiclerchyouthvpgputndvybd(iepntdolecent)multifcetedvpgterventiprovideletrgeiweeklypnt--pntupptInAim2Wecductfeibilypilottet100dydcruedthroughpedricEHRytemhlfceivgPhP-VXprogrmhlfctrolgroup3mthementcductedtbele3-mth6-mthfollow-upInAim3weexploeffectiveneterventilivcote-vlidtedpt7-dypotpvlencebtenceprimryoutcomeThtudynovelugEHRidentifyenrolldolecente-cigtteuercptgPhPpeerupptyouthvpgcetiprogrmThfeibilytudyhighlyignificntddgyouthvpgcetiprtnerhiprobutcommuny-bedgniztiTheuccethR34tudyppufutuR01prgmtictriltetefficcyPhP-VXthroughEHRpntupptmultiplepedricclic1SummryThegolpropoederchdevelopbcterilvecrdelivercolyticvirue(OV)AimmunpieOVgmnycncerhvehdclicluccettgexternllycceibletumDepepromethpprochpodeliverylimefficcyOVttgternlolidtumToddthuewedevelopedviru-delivergSlmell(VDS)crrycolyticviruecncercelltumBypecificllycolizgtumVDSprotectvirlgenomeclerncebloodcircumventdifficultyugOVimmunpyolidtumWepropoedeliverH-1prvoviru(H-1PV)VDSpventequetrtivirlprticlen-tumgncedeliverytumWehypoizeimmunogeniccelldeth(ICD)cuedH-1PVduceproducticyketriggerimmunecellfiltrtigenertememyCD8TcellThnewlymedntumimmunyelimtecncercellgrdleirloctibodyWehveetblhedfoundtherchhowg(1)deletihomologoucombtigene(RecBSbcBSbcCDRecF)Slmellperveeentilhirpvirlgenomequidmtiplicti(2)deliveryH-1PVcncercellVDSproducefunctilvirlprticle(3)producedviruprticlefectivekillcncercellThepropoederchplnhtwoAim(Aim1)meubcterilvirudeliverytummicequntifytumpecificyfetytuemplificti(Aim2)quntifyducticyxiccelldethVDS-H1PVgenertintumimmunepeWehypoizewhendmtedmiceVDS-H1PVproducefunctilviripdthroughouttum-fectgneighbgcncercellWetetthhypodelivergVDS-H1PVmicemuhepcellulrcrcomtummeurgvirltertumhelthygnWelomeufiltrtictivtiTcelldendriccellmcrophgeNKcellWenticipteVDS-H1PVducecncercelldethducetumvolumegenerteT-cell-mededntumimmunypventtum-implnttiVDSheverldtctdvntgeoverrpeutictrtegieCompdcellulrcrrierVDShignificntlyhigherrpeuticdextumccumultinotrtelimgVDS-H1PVloheverldvntgeovermicrobilrpieItdictimmuneductiOVrpypecificllytumnotdependennextentbcterilcoliztumOnlymllnumrbcteriquidetum-loclizedfectimplifierpeuticpeThecombtrgetedtrcellulrdeliverySlmellimmuneductiH-1PVcoupledvntgebothytemABSTRACTMirgttmentpeKpoircom(KS)ugpentclicljudgementdequteWhileobjectivemirgKSleicnpermedmeumentquidtedioutime-cumgmkgmimprcticlueroutecliclcbuylow-middle-comecountry(LMIC)clicThledclicinLMIClyubjectivemirgtrtegiewhichmyunnecerilyprolgttmentcurunnecerychempyxicieKSmmjpublichelhtmotcommcncerledgcuecncer-lteddethmgmenMlwiMozmbiqueUgKeny1-4CurnttrdcmirgKSttmentpeloimpceTheemethodbedcliclementleiheightubjecthumnvriTheypermprticulrlypolyperdrkkledgrcilequiedvereeffectcludglopecicrdicxicyneuropthymrrowuppifncilxicydecedqulylifepmtuttmentdctutiundermgeffectivene78ToddechllengewepropoetetnewtechnologySkScn3D(SS3D)elucidtectriicliclprcticeoptimizepermncetegrtewkflowAfricwheneedgtetSS3Dimplelow-cotuer-friendlytechnologycomliquidlentechnologyrtificiltelligence(AI)providghigh-oluti3Dimge/mpKSkleicpteleiheightvolumeWemllyfetechnologymkeuer-friendlyeytegrtewkflowUgKenydetermemeumentimprovementl-wldcliclprcticeectriiimprovedclicloutcomeOurpecificimAim1RefeSkScn3DTechnologyUgeProcolRouteKSImggEtAfricWeenggeend-uer(clicinnure)ptientfeSS3Dthrough)focugroupdcuib)dctechoiceexperimentidentifyquntifypfence-deignhrdwtwtrdopertgproceduc)ertiveHumn-CentedDeignwkhopAim2CompReproducibilyAccurcyKSLeiSizeMeumentBetweenSkScn3DCurntStrdCMeumentWecompccdnceclticoefficient(qunttivemeuproducibily)coefficientdetermti(qunttivemeuccurcy)tweenSkScn3Dmnulmethod(ruler-bed)Aim3VlidteOptimizeSkScn3DCliclWkflowRel-WldSettgWerolloutfedSS3DpckgevrietyprcticeloctiEtAfricdetermewherdevicepermrobutlyefficientlydiffentettgSpecificllywemeudeviceubilySytemUbilyScledevicecceptbilypproprenefeibilyvlidtedqunttivetrumentclicwkflowtimeburdentime--motitudieimplementticotctivy-bedmicro-cotgPROJECTABSTRACTE-cigttemotpopulrnicote-deliverydeviceuedUSdolecentMnydolecentdotlikegddictede-cigttewntquHowevernoempiricllyvlidtedterventihelpmquuge-cigtteWehvedevelopedndolecent-focuedmrtphe-ppclledKick-Nic!uenengggmulti-medirichterctivecognive-hvilrpypltmtechcopgkille-cigtte-pecifictriggerupptcetiAppctentdde-cigtteppelqumotivticopgkillwdevelopedugfocugroupevidence60dolecente-cigtteuerThetructumtdeignppwdevelopedugertivefeedbck14dolecentAfeibilypilot19dolecentwhouedppdictedwengggeyueuefuluppte-cigttequeftAnopenllpilottetgueppenggementmethodcommlyueddiglterventiweidentifiedyouthimptntenggement[textmegemder&weekly-percheck-]8highchooldolecenthveedtrilcompletgllppeiweeklycheck-ement100%tentiThecurntpropolAim1ExmeefficcyKick-Nic!AppWecductnRCT306dolecenthighchoolwhouee-cigttegulrly(>/=1dy/weekptmth)wntquAdolecentromizedACTIVE(Kick-Nic!Appeightweeklgtextmegemderweeklyvirtulcheck-&ement)CONTROLcdi(ementleferrlNCIQuVpgwebpge)E-cigtteueeedtbelebiweeklydurgttmentendttment(EOT8week)nt1236mthfollowup(FU)Slivrycotelevel</=30ng/ml)verifyelf-ptbtencetEOT6-mthFUWeexplochngebccocnnbuehviOurprimryoutcome7-dybiochemicllyverifiedpot-pvlencebtence(PPA)rtet6-mthecdryoutcomeclude7-dyPPAtEOT%dye-cigfe(durgttmenttEOT36mthFU)ctuoubtence(tEOT36mthFU)Weloexmeimpctppenggementcopgkillknowledgebelevrible(nicotedependencee-ciguefquencyex)bccoproductueoutcomeAim2IdentifytrtegiedemtiimplementtippchoolIndividulqultiveterviewup50%youthACTIVEcdiexmelikebilyppenggementmethoduedhowdemteppyouthchoolettgInterview20chooltff/dmtrrexmehowppcouldimplementeduedchoolettgThuthnovtivepropoluppttetgwelldemtiimplementtichoolnppelgdiglppddecriclneedndolecent-focuede-cigtteceterventiTITLEUnrvelgVculrMededImmuneExcluiMelnomPROJECTSUMMARYMelnommprimrycuekcncer-lteddethAignificntnumrptienthowtncecheckpothibirwhileexperiencedeeprogifterilttmentnefAdeeperundertgmechnmunderlygtumimmuneuppieentilEffectiveimmunpynlydependcncer-pecificTcellloirdictctcttumcellTheexcluiimmuneeffecrcelluchcyxicTcelltumpnchymhenlkedducedimmunpypeHoweverexctbiologyhdthptterntummicroenvirmenthyetfullyunderodRecenterchemphizepotentiltrgetgtumvcultuimprovetumimmuneuppiThecedvculrlekeocedvculrdetbiliztihenuggetedhderimmuneeffecrcellfiltrtumAngiopoiet-2(ANGPT2)rpeutictrgetmnycncergultevculrmodelgmodultgTIE2ceprtyroekeignlgendolilcellOurltettudydemtrtedANGPT2promoteT-cellexcluumcocugvculrdetbilizttumperipheryThhighlightneedcomphenivenlyvculrgultumimmuneexcluideeperundertgmoleculrmechnmthroughwhichANGPT2ffectT-cellexcluimelnomInthpropoedtudyweimvetigtevculrdetermntimmuneexcluumcomelnomWeplnelucidtedevelopmentimmuneexcluidiffentimmunecelldurgmelnomprogiexmeptilvculrchngecltiimmunecellpoi(Aim1)MooverwedetermemoleculrmechnmhdANGPT2-drivenT-cellexcluimelnom(Aim2)ThvolveelucidtgltihiptweenANGPT2expilevelvculrlekeT-cellexcluihumnmelnomtuevetigtgeffectANGPT2hibidevelopmentprogiT-cellexcluiugmouemelnommodelEmploygmulti-omicmethodweimdeciphermoleculrmechnmthroughwhichvculrbnmliectrieimmuneexcluummicroenvirmentmelnomOurpropoedtudycouldidentifynoveltrgetbiomrkerddimmuneexcluipotentillyenhncgeffectiveneextgimmunpieABSTRACTChemiclmodifictiRNAplycrucilrolegultggeneexpiphyiologiclpthologiclcdiOneundexplodpectthgulticomectiveoxidtivepecie(ROS)whichmodifynucleobeRNAElevtedlevelROSoxidtivetpvlentcncercellultgmetbolicprogrmmgdrivenfcruchctivtedRASexpiHoweverourundertghowROS-ducedRNAmodifictiffectgeneexpicncerctextmlimedThtudyimfillthknowledgegpexplgrolegulryimplictioxidtivemodifictiRNAfocuKRAS-drivendoxperturbtin-mllcelllungcncercellTheprojecthtwomobjectiveThefirbjectiveidentifyptternoxidtivemodifictiRNAducedcogenicKRASThchievedthroughcombtinext-genertiequencgtechniquechemiclmethodctehigh-olutiprile8-oxogunemodifictiRNATheecdobjectiveundertmoleculrplyerdemodifictiThdethroughbiochemiclCLIPnlytechniquefocugproteheterogeneounuclerribucleoprote(hnRNP)fmilyByelucidtgeterctitudyimuncoverpotentilfluenceoxidtiveRNAmodifictigeneexpichngecncercellTheoutcomethtudyignificntlyctrieourfundmentlundertggenegulticncerSceoxidtivethllmrkmnypthologiclttetechnologiclcceptuldvncementmdethtudylohvebroderlevnceundertgroleoxidtiveRNAmodifictipthogenedeePROJECTSUMMARY/ABSTRACTWhilebccomokghdecleddrmticllymgdolecentnowlmotrpvlenceelectricnicotedeliverydevice(ENDSnicotevpg)uehnrpidlyfueledocilmedipromotinovtiveproductengeergdvertgeffectivelyvergfivedecdeprogyouthbccoctrolThecehighchoolvpg2017-18wlrgene-yercenyubtnceuedover44yerMirgFutuhtrckeddolecentubtnceueIn201926%UShighchooleniptedptmthvpg5%ce2018hrpetflectivpgroundge16MotyouthwhoeENDSuehvenevermokedbccohowevernicotevpgocedubequentibccomokgThhighpublichelthimptncecuehighchoolgeddolecentdevelopmentlperiodhighetlifetimevulnerbilydrugueprogentnchedddictiveptternThuENDSueputdolecentthighrknicoteddictiecltientnchedcombutedbccomultiplebccoproducrdrugddictiddinegtiveheltheffectvpexpouRecenturveydictethverhlfdolecentwhovpenicotewntqunoknowneffectivettmentidmilliUSdolecentwhohvegunvpenicotequThegrowgcenueffectiveterventineededdolecentp-ddictiopertilizedmildmoderteubtnceuedderrtileerlyterventicouldpventecltenlifelgptterndrugueThuhewepropoeenrolldolecenttlenceweeklyvpgptmthwhoemildeveryuewouldexcludemmotceticlicltrilBecuevpghcomeopvlenthighchoolttimeunpcedentedhvilhelthwkcehtgeeffectiveterventiclblechoolcommunyettgneededWedeignedQuVpgfullymotediglhvilterventigroundedCogniveBehvilSocilCogniveDnceTheydevelopmentllyppropremidltedolecentbccovpgcetiQuVpgdelivedovertwelve20-muteeiyoungdultlycounelQuVpghhightfctirtgtentibtencerteplimrytetgdolecentetblhednicotedependenceHewepropoetetQuVpgpromotenicotevpgcetiyouthwhovpeltletlenceweeklythutrkprogilgpectrumddictiveddernomildmodertedependencevpednicotethumeetgcrerip-ddictiTomximizegenerlizbilytrilhvefewexcluicreriubyndromlpychricubtnceuedder(SUD)ympmexcludefercliclcthoenyeveSUDTodoowepropoeenroll300dolecentge14-18highchoolcommunyettgwhogtryquvpgdouble-bldprllelgrouptent--tttrileffectQuVpgvEnhncedUulC(pychoeductidvicequferrlfetextg-bedupptThQutg(TIQ))btenceENDSbccouedruguetend12weekttment6-mthfollowupAdhencetentiwell-documentedchllengedolecentmokgcetrilcentivizedupptednovtiveEmochmrtphepplictidelivereimdercollectdilyvpgdtThpropolnovtivepiveurgentgrowgquetbccovpgcettmentdolecentirfmiliechoolPoiveultdefeneffectivefdbleclbleterventicndeployedhomechoolcliclettgcombtrpidlyurgentepidemicyouthbccoueProjectSummry/AbtrctAfricnAmericn(AA)dividulprottecncer(PC)fceignificntlyweclicloutcomethnirEuropenAmericn(EA)counterprtThetrgcltitweentgedee(loclizedverumetttic)tdignolg-termurvivlWhileptientdignoedloclizeddeehve99%5-yerurvivlptientpentgmettticdeehveignificntlywepropectnbout32%5-yerurvivlAmimllyviveplmbeddignoticmethodcouldignificntlyimprovechncedetectgPCtnerlytgethuducePCltedmtlyThetwextgenertiequencg(NGS)-bedmethodlikelyhvequidenivypecificyerlydetectiPCliquidplmbiopieThefirtbedltedfrgmenttiprilecncerderivedcellfeDNA(cfDNA)Inthwholegenomeequencg(WGS)ppliedplmderivedcfDNArtiohtnmlfrgmentizedictepencecncerTheecdmethodbedpecificptternmethyltedDNAlocicrogenomecomcell-femethyltedDNAimmunopciptihighthroughputequencgWefoundltedcellfeDNAfrgmenttiprilehighlyeniverobutdicrpencemettticprottecncerInthpropolwevetigtewherthmethodcnidentifycewhenAAmenpenttdignotltertime-potfterpot-primryttmentmettticPCWelovetigtewherclicllyuefulenivypecificytedwenlyzempleterliertgedeeWenchmrkoptimizenexperimentlcomputtilprocoldetectprottecncertvrioutgebedfrgmenttiprileplmderivedcellfeDNAThppliedAAptientpentedmettticdeetdignolterdevelopedmettticdeeAAPCptientloclizedlocllydvnceddeeAAPCcewheequentilplmwcollectedtvrioutimernggrighteurgerytenyeredeeprogiWedetermeenivypecificyfrgmenmicprile-bedmethoderlydetectiPCvrioudeetgeSimilrlywenchmrkoptimizenexperimentlcomputtilprocoldetectprottecncertvrioutgebedcellfemethyltedDNAprileThenextgenertiequencgbedmethyltiprilgplmderivedcfDNAmpleppliedAAPCvrioudeetgewedetermeenivypecificyDNAmethyltiprile-bedmethoderlydetectiPCvrioudeetgeThetblhn-vivemethoderlydetectiPCAAmenProjectSummryHCVmjwldwidefectgover58millipeoplecug300000dethHCV-ltedcirrhohepcellulrcrcom(HCC)echyerNigerihpproximtely22millipeoplelivgHCVpvlencerterngg01-30%dependgpopultigiHCVctrieboutqurterHCCNigeriwhichfifthledgcuecncercncerltedmtlythcountryApproximtely15-45%perfectedHCVptneoulyclervirueftertetgpoiveerologicltet(nti-HCV)cfirmtiHCVvimilbry-bedmoleculrHCVvirllod(VL)tetgneceryidentifythoewheedttmentInNigerimnyLMICccelbry-bedVLtetmlimedultmnypeoplecengpoiventi-HCVctiveHCV(defedpoiventi-HCVdetectble(>LLD)HCVRNA)neverlkedcttmentSuccefulttmentHCVhignificntlyducedrkHCV-ltedHCCThelckgleteppot--c(POC)tetdignoctiveHCVfectibothhigh-low--middlecomecountrieignificntimpedimentwifttmentimpctgbilyendHCVepidemicpventlg-termcomplictiuchHCCHewepropoedevelopvlidtenHCVtetDASHpltmdignoctiveHCVtpotcenivelydetectgHCVvirlRNAobvgquimenttwo-teperologiclbrybedmoleculrtetgTheDASHHCVtetdeignedeilyopertedn-lbrypernelettglcklbryfrtructuAcpillrybloodmpleimplycollectedfgertickddedtetcrtridgeertedDASHnlyzerAfter15muteney--dqultivepoivenegtiveultpperunuchcenFollowgdevelopmentdignoticccurcyDASHHCVevlutedbothdplmpropectivelycollectedwholebloodmpleNigeriThecceptbilyubilyDASHHCVloevlutedl-wldettgmgtrkdultthediveregeogrphicgiNigeriThtudyexpectedledpprovlmllptblechepPOCmoleculrdevicerpidgletepdignoctiveHCVwiderngeLMICettgignificntlycevilbilycceHCVtetgthuducecidenceHCV-ltedHCCABSTRACTAdrwbckgenome-wideocitudie(GWAS)btcncerrkltedphenotypeirlimedightgenotype--phenotypemechnmidentifiedgenomicgiAlthoughtegrtgGWASfunctilgenomicdtetlikeGenotype-TueExpiProject(GTEx)TheCncerGenomicAtl(TCGA)hyieldedpromgultidentifygcidtetrgetgenemnytr13epprocheoverlookcomplexylterntiveplicgmdiverytrncripmeIndeedcenttudielgdRNA-equencg(RNA-eq)dtcrotuevelmuch40-60%humntrncripmeunnnotted68dueoverlookedmWepropoe-lignextgbt-pecificht-dRNA-eqdtetugnovelmnnottidevelopedlg-dRNA-eqdtWentegrteeextgbtcncermmmogrphicdenyGWASdtidentifym-plice-e-pecificmechnmunderlyggeneticocibtcncermmmogrphicdenyphenotypeWebuildourcentwkwhewedevelopedhowcedpromem-leveltrncripme-wideocitudie(oTWAS)nnovtivemchelerngfrmewktegrtegeneticllexpedmgenephenotypicociSpecificllywefirtquntifymexpilterntiveplicgeventGTExTCGAugnoveltrncriptemblielg-dRNA-eqdtet(Aim1)WenchmrkmultiplettticlpprochelignmenrmcductgexteniveevlutitudieWenlevergeenewlylignedmlterntiveplicgeventbttueppmlterntiveplicgeventlikelymedegermlegeneticocibtcncerrkmmmogrphicdenyphenotype(Aim2)ThnovtivepropollignNCItrtegicobjectiveUndertgMechnmCncerDetectgDignogCncerddecriclchllengetudyggeneticetiologybtcncerpriizgpotentilculbiologiclmechnmfurrfollow-upOurpropolunique-quntifytegrtemulti-tuemulti-leveltrncripmicfencepnel(bothht-lg-dRNA-eq)robutGWASummryttticugcuttg-edgecomputtiloltrncripmicnoveltegrtivefrmewkBycombgpubliclyvilblemulti-level`omicdtetytemicgenomicepidemiologyfrmewkourwkprovidebothmoleculrdtourceproduciblecomputtilfrmewkcneilyexpedtuetrSpecificllywedevelopopen-ourcecomputtilpipeledevelopgtue-pecificnovelmnnottiht-dRNA-eqlignmentexpiquntifictictemtpubliclyvilbleptlho-plice-QTLummryttticpdictivemodelllowgbrodererchcommunyexploimilrvetigticrotrtuePROJECTSUMMARY/ABSTRACTCerviclcncer4thmotcommfemlecncercuecncer-ltedmtlywldwidedepegpventblethroughHPV(humnppillomviru)vcctierlydetecttmentpcncerouleiInhigh-comecountriecerviclcncercidencemtlyrtehveenducedthroughHPVvccticengbedcylogyHPVtetgHoweverlow-middle-comecountrieepecillyub-ShrnAfricburdencerviclcncermhighduelckeffectiveprogrmvccticengWhileWldHelthOrgnizti(WHO)commendcerviclcncercengugnucleiccidtetdetecthigh-rkHPVDNAmotlow-middle-comecountriehvedifficultyimplementgHPVtetgduehighcottetneedlbfrtructutdpernellgmple--nwertimeThenurgentneednovellow-cotccurtecceiblepprocheimprovecengThegolthprojectdeveloppot--cHPVDNAtetmeetWHOgolcerviclcncercenglow-middle-comecountriedptgtegrtgtwovti1)nextrcti-femultiplexedmlnucleiccidmplifictiy2)fullytegrtednucleiccidmplifictilterlflowdetectipltmclledNATFlowTheultgNATFlowHPVtetfdblerpidimpleuetpot--cWeim1)dptextgextrcti-femultiplexedmple--nwerLoop-MededImlAmplificti(LAMP)ydetecteighthighrktypeHPVNATFlowpltmdemtrtetechniclfunctily140provider-collectedcliclpecimen(2)evlutecliclpermnceNATFlowHPVtetMozmbiquefirt558bnkedpervedmplenpropectively1890womenundergogcerviclcncercengtHoplCentrldeMpuurroundgcommunyclic(3)evlutebrrier/fcilrcerviclcncercengugNATFlowHPVtetMozmbiqueWehveemblednterdciplrytembedUSMozmbiqueAutrliextenivecollectiveexperiencedevelopgevlutgcommercilizgclgnewtechnologiepventcerviclcncerWehvetrgcdcrrygouttrnltilimplementtierchlow-middle-comecountriecludgMozmbiqueOurdutriltemhexpertedevelopgtrnltgwell-deignedtrumenttichemtriepot--ctetOurtemidellyueddptvlidteppcleNATFlowHPVtetccelerteglobleftpventcerviclcncerPROJECTSUMMARY/ABSTRACTScetroductie-cigtteUS2007hendrmticcepvlencee-cigtteuemgdolecentTheehighpvlencertehveendrivenprtliefe-cigttelehrmfulthncombutiblecigtteUntuntelymountgevidencedictee-cigttepoeignificnthelthrkE-cigtteloctnicotewhichcnterfenmlbrdevelopmentBecuetilldevelopgdolecentbrmovulnerblenegtiveeffectnicoteexpouputtgdolecente-cigtteuertgterrknicotedependencewellducedimpulectroldeficttenticogniThulthoughmnyhdhopede-cigttewouldervemokgcetiolymyfctuhergnewgenertidividuldependennnicoteTheewefcenurgentneedpromotee-cigttecetimgdolecentUntuntelyempiricllertue-cigttehnotenblekeeppceirrpidcepopulryTheeknowledgegpcomduniquechllengewkgdolecente-cigtteuerhvehdeddevelopmentempiricllyupptede-cigtteceterventithpopultiwecurntlylcktrgetede-cigtteceterventidevelopmentllyppropregroundedempiricllyupptediehvichngecceptbledolecentTocteuchterventimtiveerchneededtterundertdiffenttypedolecente-cigtteuerbedirmotivtiuerrthnptternueIdentifictiuchtypologycriclechtypehvedtctcueueptternliefpfenceultgneedtype-pecificterventiMoovergterdolecentenggementneededenuctenteterventiwellmeggurroundgmcceptbledolecenttkeccountirperceptiirownueAmixedmethodpprochutilizedgrmtivedntypedolecente-cigtteuerterventiltrgetpecificechtypemdevelopmenttilodcognivehvile-cigtteceterventiechtypeAmple1200highchooltudentwhohveuedne-cigtteptmthcruedSelf-ptdtuedidentifye-cigtteuertypebedmotivtiuewellcognivehvilclteechtypeFocugroupuerechtypewelltudentwhohveuccefullyquuge-cigtteprovidefurrmtiboutcognivehvilterventrgetcetineedpfenceThefdgthprojectfillcriclknowledgegpultdevelopmentcognivehvile-cigttecettmentprocolpecificllydeigneddolecente-cigtteuertilodirpecificuetypeevlutedfutuclicltrilPROJECTSUMMARY/ABSTRACTChrictetlflmmtimjrkfcrdevelopmentcoloctlcncer(CRC)Itwell-cknowledgedpro-flmmrycykederivedimmunecellplycriclrolelmoteverydevelopmentltgeflmmti-ducedcncercludgCRChowevermoleculrcellulrmechnmunderlygchrictetlflmmtiledgtumigenetillguncovedThuundertgmechnmctrolflmmrypemucolimmunecellcnneficilttmentflmmti-ocedCRCOurplimryulthveveledpotentilroleE3ligegeneltednergylymphocyte(Gril)mtgtetlhomeotctrollgcrcogeneStudiebothCRCmumodelptienthowcltitweenGrilexpicolductetlflmmtumgrowthuggetgroleGrilctrollgtetlflmmtiimptntlyprojectgGrilpotentilmrkerdignoCRCWedetectedmoeveCRCgrowthGrilknockout(KO)micecompdwild-type(WT)micewhichwocedcedexpiimmunecellderivedpro-flmmrycykecolMooverGrilexpihempoieticcellprticulrTcellimptntctrolCRCRemrkblywedetectedhighernumrterleuk(IL)-17producgTfolliculrhelper(Tfh)17cellcoltum-rgGrilKOmiceirpercentgepoivelycltedcncereverySimilrlywedetectedhighernumrGril-ufficientTfh17cellptientdvncedCRCcompdptienterlytgedeeuggetgnewroleTfh17cellpromotgtetlchricflmmtineoplticdeeIntetglyelevtednumrTfh17cellGrilKOmiceweocedccumultiTh17BcelldictgTfhcellcouldenggecrotlkpro-crcogenicimmunecellWepropoecentrlhypoGrilmttetlhomeotctrollgctivypro-flmmrymucolTfh17cellInAim1wedetermelktweenGrilexpiTfhcelltetltumigeneInAim2weexmemechnm()wheGrildeficientTfh17cellctriecolcncerdevelopmentInbothimweutilizegeneKOpprocheBcl6/IL17/IFN-ptermiceTheimplicthwkignificntceprovidenovelightgeneticlktweenflmmticncerdefenewmrkererlydetectiflmmti-ocedCRCguidedevelopmenteffectivecolcncerimmunpiePROJECTSUMMARYTheoverllgoltherchdetermehowlipidmetbolmupptoxidtivephophylti(OXPHOS)cutemyeloidleukemi(AML)temcellLeukemitemcell(LSC)piblelpeAMLmjgolfieldidentifygnovelwyerdicteAML-LSCRecentlylipidhveenidentifiedeentilmetbolicubtrteAML-LSChowevermechnmlkglipidOXPHOSnotknownToddthIhvedetermedlpe-pecificcidtegeneugRNA-SequencgdtcohtpedricAMLptientchrcterizedthroughTherpeuticllyApplicbleReerchGenerteEffectiveTtment(TARGET)tudyTheultuggetfttycidoxidti(FAO)purpoeddrivehemebioynfuelOXPHOSAMLlpeInthK38StAARTSpplictiItetthhypotudyglipidmetbolmOXPHOSvroAMLcelllevivougpedricptient-derivedxenogrftAim1uetbleopemetboletrcgexperimentdetermeifplmtekeycrbourcehemeAMLcellLSCpropertieThenAim2teteffecthigh-ftdiengrowthggivenepedricAML-LSCxenogrftobtedthroughStJudePublicReourceOfPtient-derivedExpedLeukem(PROPEL)progrmAML-LSCAim2lotetedeffecthigh-ftdienOXPHOSctivyheme-ctgprotectentugcompheniveproteomicprilgthroughDukeMoleculrPhyiologyIntuteMetbolomicProteomicCoTheultetudieprovidemechnticlktweenlipidmetbolmOXPHOSAML-LSChvepotentilidentifynewrpeutictrgetMyMenrtemIntutilEnvirmentCerDevelopmentPlngermycliclHemlogy-OncologyfellowhipprovideuperbtrgexperienceenuuccetherchppmefututrnidependencePedricHemlogy-OncologyphyicincienttABSTRACTGlioblmunimlylethlbrtumdepeggivexictrdcttmentcludgurgeryrdichempyOnembrrierundertgglioblmtumbiologydevelopgmoeffectiverpiedependenceviveurgiclprocedudignoTheneedobttumtueildignoptientglioblmlimed1)trtumlheterogeney(genomicepigenomic)2)templheterogeney3)mplgerr4)urgicleligibilyAddillyurveillnceglioblmmdignoticchllengececurntdeetendtguhblettment-ducedflmmtermedpeudoprogicventilimggwhichctriedignoticmbiguyttmentdelyTheidentifictin-viveprognoticbiomrkerlgudlmoleculrprilgglioblmcouldovercomeechllengeimprovgrktrtificticlicltrildeignurveillncetrdcOurpriwkveledchngeperipherlimmunecellpopultiwhole-bloodmpleptientprimrycurntglioblmcltettmentpeoverllurvivlthuupptgcceptloclytemictummicroenvirmentInn-CNStumcircultgtumDNA(ctDNA)hceivedciderblettentietumburdenpdictttmentpeelectrpieHowevercliclctDNApprocheugomticmuttinlylimedglioblmduelckcurntomticmuttiignificnttertumlheterogeneylowdetectbilyomticmuttibloodWehypoizemethyltiprilgcell-feDNA(cfDNA)cnovercomeelimtiepigeneticmodifictidetectblecfDNAcpdcelligcellttetbledetectblelowputgenomicDNA(<250ng)fergterbdthmtiboutttecelligdiffentilpeclllegettmentToourknowledgecfDNAmethyltihnotenevlutedpropectiveclicltrilbiomrkerbrtumbiologycltedclicloutcomeTotetthhypoweemploypropectivebloodmpleptientglioblmenrolledcompletedromizedPheIIVERTUtril(NCT02152982)determewhercfDNAmethyltiptterncluterpecifictumtueDNAmethyltipttern(Aim1)WenchrcterizeimpctchngecfDNAmethyltiptternclicloutcomecludgurvivl(Aim2)FllyweevlutewherctivtittecircultgimmunecellpopultiferdcfDNAmethyltiptterncnuedn-vivelydtguhpeudoprogicurntdee(Aim3)Theetrnltilimhvepotentilguidedevelopmentn-vivedignoticurveillncepltmptientglioblmwhichcouldimpctttmentelecticlicltrildeignPROJECTSUMMARYFhedneckcncerptientpoiveurgiclmrgultttmenttenificticedcotncedrkcurncedethPoiveurgiclmrgrtelcvycncerhighetmgolidmlignnciehvenotimprovedoverpttwodecdeIfpoivemrgidentifiedtropertivelyurgelieverbldecriptidurgphecllpthologtloctemrgectddiltueReloctgpoivemrgeugcurntprocolnovuliddifficulthedneckduecomplex3DnmyTheenoturprg-ectifilimprovecologicoutcomeToddthunmetneedIhvedevelopedprocolctevirtul3DmodelectedcncerpecimenhowemrgmplgInpricdverictudyIetblhedfeibilyplcg3Dpecimenmodelnugmentedly(AR)envirmentguide-ectiARuperimpoecomputer-genertedimgeuerviewlwldthuprovidgcompoeviewThegolthprojectdetermeccurcyplcg3DpecimenhologrmurgicldefectctulhedneckcncerptientdevelopcumARtwimprovetimeccurcylignmentInAim1Idetermeccurcylignmentprojected3DpecimenmodelurgicldefectThetumectedpertrdc3DcnneduplodedARenvirmentTheurgewerMicrotHoloLen2ptblehfeARhedetTheurgelign3DpecimenhologrmectidccurcymeudInAim2IdevelopcumARurgerypltmimprovetimeccurcylignmentTheextgARtwhignificntlimtiurgicluecludglimedvoicecommbilydjuttrnpncylcklock--plcefetuToddthImctgcumARtwcollbtiVerbiltIntuteSurgeryEngeergIncdverictudyurgelign3DpecimenhologrmectidugbothcumextgARtwTimeccurcylignmentmeudDurgthprojectInefguidncemyprimrymenrwhetblhedurge-cienttubtntilexperiencebrggnewtechnologieopertgroomwelltheco-menrexpertepecificAddillyIundertkedvncedtrgARytemurgiclpthologyprocegclicltrildeignwhichprovidetrgfoundtipurugmycergolcomgurge-cienttfocuedimplementtiARytemimproveeffectivenecologicurgeryThprojectlygroundwkfutuR01pplicticludeexpniARtechnologyolidmlignnciepropectiveclicltrildetermewherue3DcnngAR-guidedcologicurgeryimprovepoivemrgrteultimtelyptienutcomePROJECTSUMMARY/ABSTRACTRoleTh2cykeprogenir-mededmtumlymphticLymphnodemettcommeventbtcncertrgdicrpooutcomeduepdnodlmettticcelldtnrgnwhichledmtlyptientMettticburdenlymphnodedictlycltedenytumlymphticveelOutgrowtheveelpromotedmrrow(BM)derivedprogenirco-exppecificmrkerlymphticendolilcellM2-typemcrophgeThubetdubdMyeloid-derivedLymphticEndolilCellProgenir(M-LECP)pentmiceptientmettticbttumnotcncer-fedividulWepvioulyhowedcliclbtcncerdenylymphticprogenirignificntlycltetumlymphticmtimettelymphnodeTheedtundercocliclignificnceM-LECPneeddefeirpropertiemechnmducetumlymphticmtiWepvioulyhowedM-LECPM2-myeloidcelllymphtic-pecificmrkerwhenewlymedlymphticveelexpmcrophge-pecificmrkerThmlignmenttweenmrkerirpectivelymphtic/myeloidlegewell-documentedunexpledHowevercnexpledcidergtrBMprogenirknowndoptphenotypelegetrgetedpiremployfuimenepirertgtriggercellprolifertiFuiBMprogenirtrgetedcellulttrnfergenomicmterilencodgM2myeloidmrkerwhichexplirpperncenewtructuWeedM-LECPmyeloidprogenirprtillymphticidentymightimilrlyueBM-enbledfuogenicpropertieexplymphticveelOurplimrydthowmyeloidpcurttedTh2cykeIL-4IL-13IL-10vrodiffentecellcomdM2-myeloidlymphticendolilfuogenicphenotypeThledhypoctivtiTh2pthwyM2-dmyeloidpcurco-gultelymphticlege-pecificfuogenicpropertiecollectivelypromotebilymtuprogenirducenewlymphticveelThhypoupptedourdtdemtrteco-developmentM2lymphticfuogenicpropertiediffentedM-LECPwellmultipleevidencefuieprogenirlymphticendolilcellvivovroWetetthhypothroughfollowgSpecificAim(1)DetermevivoignificnceTh2pthwyM-LECPdriventumlymphngiogene(2)DetermewherfuogenicpropertieducedTh2fcrgulrTLR4enbleM-LECPtriggertumlymphticmtiSignificnceTh2fcrcouldplyprmountroleenblglymphngiogenicfunctiM-LECPthroughfuicceptprovidenovelfrmewkdeletggenertumlymphticveelExplthcceptcnlednewrpeutictrgetpvgwyuppumlymphtichibilymphnodemettPROJECTSUMMARY/ABSTRACTImmune-bedttmentcutemyeloidleukemi(AML)nggivehemlogicmlignncymftloverhlf20000ptientdignoedUnedSttennullymnunmetcliclneedTheimpetuueTcell-bedimmunpypprocheAMLttmentundercodcurtivepotentilllogeneichempoieticcelltrnplnttiAMLrgimmune-mededgrft-veru-leukemictivydTcellemerggcltivedttweenimmunelcpeAMLttmentefficcyUndertgmechnmeffectiventi-leukemicTcellctivyAMLmrrow(BM)ewheAMLemergefundmentldvncgimmunpeuticpprocheAMLOurplimrydthighlightimmunouppiventuTcellAMLBMdynmicevolutiTcellclegrdtteTcellctivtiexhutiimmunomodulrypotentilmlignntAMLcellTcellWehypoizebothmlignntn-mlignntcellAMLBMpromoteimpidTcellimmunyledgdtctTcellcompoitdiffentdeetteThcerdevelopmentprogrmddtwopecificim(1)determeTcelltricfetuffectltihiptweenTcellphenotypeperideettuAMLBM(2)undertmechnticllyhowmlignnt(AMLblt)n-mlignntcellAMLBMhpefetuTcellcomprtmentThecidtehdevelopedthpropolnextenihergogTcelltudiehemlogicmlignnciecliclexperienceAMLDurgwrdperiodhecompletehererchcloecounelherprimrymenrOmrAbdel-WhbMDnccomplhedcienttleukemibiologygenomicwhoChirMSKMoleculrPhrmcologyProgrmAddilputfedherco-menrMrcelvndenBrkMDPhDnterntilexpertTcellbiologyhemlogicmlignncieherAdvyCommteeDrAbdel-WhbvndenBrkbothmenrouttgcdnvigtgphyicincienttwrderchdependenceUnderirguidncecidtedevelopkillcriclherfutulbryprogrmcludglernggenertenlyzeyngeneicmouemodelAMLbuildupherknowledgefunctiltudieprimryAMLmpledvncehercomputtilbiomticbilieequencg-bedimmunologictechniqueComplethpropolprovidecidtetrgmenrhipquidcultivtefeherexperteTcellimmunologyleukemierchetblhhercdemiccerndependentlbry-bedcliclvetigrdedicteddvncgimmunologicttmentAMLProttecncer(PC)motcommn-cutneoucncerUSmencueexuldyfunctiup90%ptientSexuldyfunctiocedlg-termductipychologiclhelthqulylifeAddgexuldyfuncticriclcompentPCcquieffectiveptient-providercommunicticommunictifciltecceevidence-bedexuldyfunctirpieOurpriqultivetudieidentifiedgpptient-providercommunictiboutexulhelthkeybrrierptientexulcoveryAlthoughmotUSptientceiveexulhelthcounelgPCprovidermnyptientdotdcuirexulhelthccernproviderdepedeihelpPCptientfceignificntbrriercommunictgproviderboutexuldyfuncticludglocfidencedueimpidmculyultdyfunctiFurrmolckptientcommunictiboutexulhelthocedwequlylifeAlthoughcriclneednterventiimprovePCptientexulhelthcommunictiprovidernoefficciouterventiextStrtgCverti(STC)nevidence-bedexulhelthcommunictikilltrgterventihprovenefficciouimprovgbtcncerptientelf-efficcyexulhelthcommunictiproviderrteexulhelthcommunictiproviderexulhelthSTCptient-fcgelf-dictedmultimederventicoelementkilltrgbrodlypplicblecrocncertypetgeHowevercurntmtSTCfocuefemlecncerurvivexulhelthccerndoenotddPCptientbrriercommunictiTheeddcriclneednterventiimprovePCptientexulhelthcommunictiproviderwepropoerigoulydptSTCPCpilottetdptedterventiInAim1wecductfocugroupPCptientdividulterviewPCprovideridentifybrrierfcilrptient-providercommunictiboutexulhelthPCcelicfeedbckdptSTCPCInAim2wecductubilytetgPCptientfeterventiInAim3wecductpilotromizedctrolledtrilSTCdptedPCefeibilyoutcomeplimryeffectSTCptientelf-efficcyexulhelthcommunictiproviderrteexulhelthcommunictiproviderexulhelthCductgthtudyctrieDrGuptdevelopmentndependentvetigrexperteexulhelthurologiccncerurvivhipcommunyenggementerchdevelopmenthvilterventi(focuptient-providercommunicti)deigncducthvilterventrildemtiimplementticienceFdgthtudygenerteplimrydtfutuNCIR01ubmidefiveefficcytrilpropoedterventiABSTRACTBtcncerUgpentpgpublichelthchllengechrcterizedlte-tgedignoehighmtlyrteprticulrlymgwomenidgrurlemi-urbnThpropolddethcriclueoptimizgvlidtgdeploygpot--cdignoticktilodprimrycclicUgwhemotwomenccecThepropoeddignotickcom(1)nFDA-cledumtedAI-enbledwholebtultround(2)mrtphe-enbledAI-poweddevicepermbrightfieldimggbiccylogypprticpteelf-ctedimmunodignoticchipquntifybttumbiomrkerOurpprochvolvetwo-foldvlidtitrtegyFirtwevlidtedignoticpermncepropoeddignotickUScliclettgcomprgtrd--cmethoduchultroundmmmogrphytuemplgpthology(im1)Utilizgqulyimprovementcyclefeedbckend-uerwefekpermnceubilyNextwevlidtektUgCncerIntutetilgUghelthclcpecidergfcrlikefrtructuhelthwkerexpertecceibily(im2)FollowgvlidtiguidedUgnCommunyAdvyBdweimplementcluterromizedctrolledtrilvolvgeightcommunyhelthcenter(CHC)crotwohelthdtrictUg(im3)AmobilebtcncerdetecticlicdeliverdignotickCHCdurgbi-mthlyBtHelthDyN=1000ptientferddignoticevlut4CHCWecompeffectivenedignotickwomenceivgctctrolCHCwhoferdtrd--cultroundtRegilHopl(N=1000)OurcollbtidrwupexperteengeergbiomedicldevicedevelopmentbtcncererchgloblhelthpoiguignificntlyimpctbtcnceroutcomeUgThivelignRFA-CA-24-005midevelopcncer-levnttechnologieubleuelow-middle-comecountrieByvlidtgdeploygprcticlcot-effectiveuer-friendlydetectidignotictechnologyweimempowerhelthcproviderUgultimtelyimproveptienutcomeIfuccefulthnovtitenhnceccetimelybtcncerdetectidignoource-ctdettgPROJECTSUMMARYWhole-genomeduplicti(WGD)cglyppceddefgmomentenblgchromoometbilyolidtumThpropolvetigtechempy-ducedWGDpromotemtipolyploidcncercellpperenecentbencefunctilp53bleecpeenecentttegenerteheterogenoudughtercellThefocuhigh-grdeerouovrincrcom(HGSOC)deriveurgentcliclneedimproverpyoutcomefctp53muttimotpvlentgeneticbnmly(90%)ocedneuploidythmlignncyPolyploidcncercellexhibhighlevelplticythoughtdrivgcepopultgtumhighlyggiverpy-tntmett-preprogenyCurntlygpknowledgecnectclicldecriptipolyploidcelltumpecimenlbryobervtimtipolyploidcncercellWehypoizecloethgpthroughCRISPR-C9cenidentifygenefunctillynecerymtipolyploidcncercellirdughtercellWefurrhypoizepolyploidcncercellcliclpecimencnidentifiedirlrgepolynuclermphologyemoputtivemrker(cyplmicp21cidcermideVEGF-R2)ultgnundRNAeqnlyOurpecificim(1)Defeeentilgenepolyploidlifecyclecricltrnitge(2)determeexpiputtivemrkerpolyploidcncercellrchivedHGSOCmpleThepropoedtudieervefoundtifutulrgermechnticdrugdevelopmenrprognotictudiepotentilimproveoutcomeovrincncerptientAnimmedeimpctcludepriizgptientngiogenehibirBevcizumbcommHGSOCoptiwhichmywktterVEGF-R2expgPGCCtumOfprticulrtetlorpeutictrgetgpolyploidpopulthrough-purpogextgdrugwouldcomdneo-djuvntchempyuedmtenncetrtegyfollowgurgicldebulkgReultobtedHGSOClikelyhvebroderlevncecepolyploidcellobervedmnyolidmlignncieProjectSummry/AbtrctAdoptiveTcellrpy(ACT)heneffectivegtcertbloodcncerhhdlimeduccegtolidtumuchpncticcncerlrgelycueACTTcellcomedyfunctiltum-microenvirment(TME)ThebigknowledgegpcuedyfunctiACTTcellmlycueomnyT-cell-tricgulrT-cell-extricTMEuppivefcrcnllpotentillyctrieACTTcelldyfunctiWhultimtegolovercomgTcelldyfunctiimprovgrpeuticefficcyIeekmocompheniveundertghowACTTcellmoleculrlyprogrmmedtricepigeneticgulrcomedyfunctilhowextricTMEfcrfurruppfunctiACTTcellugACT-ttedmouemodeldtACT-ttedpncticcncerptientSpecificllyuggle-cellmulti-omic(cludgepigenomic)ptilomiclgcomputtilnlyfunctilexperimentIim1)IdentifytrgetbleTcell-tricepigeneticgulr()ACTTcelldyfunctiTME2)Identifytrgetbletr-TMEcellulr&moleculrterctiuppACTTcellfunctiMypviouwet-lb&dry-lbtrgmyexteniveexperiencegle-cellnlybothcncerimmunecellmkemewell-uedprojectTheprojectcnignificntlyclrifyfundmentlbiologyTcelldyfunctivelctibleclicltrtegieimprovgACTefficcyThepropoedcomputtilfrmewkhouldlobrodlypplicblewidepectrumctextThenchmrkdtethouldloerverichourcebrodfieldcncerimmunpyhypogenertetgMylg-termgolledndependenterchgrouptperchuniveryugytembiologytudyqunttivequetiimmuno-cologyepecillyACTgtolidtumOvercourethwrdIupptedprimrymenrDrPhilipGenrgpieerACTrpycncermrkbletrckcdciencemenrgMyco-menrDrHenikfNewellGottrdoSettyChpullnownedexpertepigenomicgle-cellptilomiccomputtilbiologycliclciencepectivelyprovidgcomplementrytrgmydependencetrniTheylltmenvigtgtrnindependentfcultypoiWkcductedtFdHutchCncerCenterwhichferlltte--rtfciliequiduccefulAimddicollegilcientific&trgenvirmenttrgtutilupptPROJECTSUMMARY/ABSTRACTDepedvncecrocerviclcncercctuumcengttmenturvivhipcwomenocilvulnerbily(iepovertyrurlidencercilethnicllyundererved)womenoytype2dite(T2D)ignificntlymolikelydiecerviclcncerOyT2Dtenco-occurwomenocilvulnerbilyielivgpovertyrurlrcil/ethnicmizedgroupmolikelydignoedcdiThucriclneeddptevidence-bedterventiddSDoHbrrierengggcerviclcncercctuummgwomenchriccdiocilvulnerbilyTrgImhiftgmyerchexmgetiologychriccdi(cnceroyT2D)ocedhelth-protectivehvicugdptgevidence-bedterventimigtecnceroutcomedividulchriccdiThepropoedK01cerdevelopmenttrgbuildupmypriexperiencefocugthequiddiltrg(1)Enhncekillbiomediclmticbiotttic(2)Buildkilldevelopgevidence-bedterventiddcncerdprie(3)Developexpertemulti-levelimplementticienceiemethodAccdglypropoedK01provideprotectedtimeceivenecerytrgdvncemyexpertepropelmecomendependentimplementticienttfocuedimprovgcnceroutcomepopultilivgT2DoyocilvulnerbilyReerchThevilbilylrgel-wldhelthdtetelectrichelthcdclimdtprovidenopptunytteridentifypopultitrgetedterventiWenlyzeOneFlid+CliclReerchNetwkdtugltentclnlyexmewhichdegecombtifcr(oyT2DSV)ocedrkprilecerviclcncerdignoWenueInterventiMppgguideprocedptgPINPOINTterventi(PventgCervIclcNcerthroughHPVelf-cOllectiptIentNvigTi)womenhigh-rkprilecerviclcncerTheHelthBeliefModelundertfcrfluencgimplementtioutcomeProcrFrmewkImplementtiOutcomeuedevlutePINPOINTterventiTheoverrchghypothpropolPINPOINTterventicceptblefeibleupptgcerviclcncerctuumcwomenmultiplevulnerbilieSummryFdgmnR01grntpplictiNCIteteffectivenedevelopedterventifullypowedmpleByendthwrdIdevelopexperteimplementticiencepoigmyelfcomendependentimplementticienttPROJECTSUMMARY/ABSTRACTMichelBkleyMDMSnAtntPRdiOncologytStndUniverySchoolMediceHlg-termcergolcomhexpertemnggptienthemlogicmlignncieherchexpertettticgenomiccncerbiologydevelopimprovedttmentpprocheptientHeimdeveloptrnltilerchprogrmnlyzghumntumbloodmpleidentifygenomicmicroenvirmentlfcrpdictiveclicloutcomeoptimizerpyThcerdevelopmentwrdprovideDrBkleynecerytrgupptmenrhipdevelopherchprogrmgdependenceThepropolcompletedunderprimrymenrhipMximilinDiehnMDPhDAhAlizdehMDPhDwhobothexpertidentifyggenomicbiomrkerclicllymengfulmicroenvirmentlfcrThecerdevelopmentplncludemlcourewkemrcfenceh-pprochellowDrBkleycquicriclknowledgeexperte(1)cncerbiologyimmunology(2)biottticdtmngementpdictivemodelg(3)deignpropectivecliclprocolgrntmnhipNodulrlymphocyte-pdomntHodgklymphom(NLPHL)rubtypeHodgklymphommotcommlyttedtenivechempyoutrdipyThemjyptienthveexcellenutcomeirurvivlcnenedecdryxiciecludgcrdioxicieToducerpyocedmbidymtlythroughde-ecltirpyidentifyglowrkptientthoethighrkcrdioxicythpropoleek(1)decricelltteecoytempdictiveoutcome(2)uecircultgtumDNAgenotypeNLPHLetblhutilyurveillnceolthoedvncedtgedee(3)etblhnvivetetgheredcryrterydeerkThpropollyfoundtifutupropectiveclicltrilemploygmicroenvirmentlfcrelectptientublerpyde-ecltiPROJECTSUMMARY/ABSTRACTChimericntigencepr(CAR)Tcellhveemergedbkthroughttmentptienthemlogicmlignncieerng12pprovlUSFoodDrugAdmtrti(FDA)ce2017ExperimentlCARTcellrpiehvelodemtrtedcompletemiolidtumFDAprojectggrnt10-15pprovlperyer2025highlightgpotentilelivgrpieDepethcurntCARTcelldeignhvenotyetmededutedefficcyolidtumly30-50%Bcellleukemilymphomptientexperiencelg-termdeectrolTodevelopfepotentnext-genertiCARTcellrpiecriclundertwhyextgCARTcellucceedfilptientAcientttdbothexperimentlcomputtilimmuno-cologyIhvechoenfocumycerugytembiologypprochuncovermoleculrmechnmgoverngefficcyengeedTcellimmunpieThpropoloutletructud2-yertrgplncomphenive5-yercerdevelopmentprogrmcompletemytrglunchndependenterchcerMypecificerchgol(1)defemotrpeuticllylevntCARTcellubetptientlrgeBcelllymphom(LBCL)(2)overcomenimmuneuppimechnmtnceCARTcellrpyLBCLFirtIfollowdividulCARTcellclethroughtimeptientttedLBCLugmtchedgle-cellequencgtrncripmepnelurfceproteendogenouTcellcepr(Aim1)ThpprochtermedvereftemppgppotTcellclep-mnufctuphefuiproductought-fterpropertiecludgbilieexpperthometumInAim2IpplyvereftemppgmethyltinlyeidentifyigcircultgCARTgulry(Tg)cellIcentlylkedlimedCARTcellefficcyLBCLInAim3ImechnticllydectterplytweenTgn-TgCARTcelldeignpotentTg-feCARTcellrpycliclevlutiMywkgenertecompheniveCARTcelltlightledgpromgvenueengeergnext-genertiCARTcellrpieTheultmypropoederchpoivelyimpctpublichelthygrufficientplimrydttetgTg-feCD19-CARTcellrpyLBCLclicltrildeliverfundmentlightCARTgbiologymygenerlizedeecludgolidtumwheengeedTcellrpiehvenotmnifetedimilrlypotenteffectLBCLTobuildupmykillIhveembledmenrhiptemcludgmyprimrymenrDrCrytlMckllpieerCARTcellimmunpieco-menrDrSylviPlevrledercncerytembiologyndvycommteeexteniveexpertelevntllpectthpropolThecomplethK99/R00progrmppmecompeteR01fundglunchndependenterchcerfocuedimprovgimmunpieptientcncerPROJECTSUMMARYTheimmedeobjectiveourpropolceimmunedenyolidmlignnciectifydefectnti-tumimmunymximizeperteimmunecheckpotblockde(ICB)rpyAnimptnthllmrkcncerbilyuppexcludentedptiventumimmuneubetultgtummicroenvirmentlecduciveICBttmentStudieugcombriltrtegiehveccludedcedCD8Tcelldenydurgimmunecheckpothibiignificntlyenhncenti-tumefficcyn-immunogeniccoldtumToceCD8Tcellfiltrtiwehvedevelopedtum-trgetgbcterilpltmengeedectechemokecykewhichweferbiologiclcbio-cmentcructivteelectubetimmunecellWehvecompletedpro--prcipleexperimenthowbio-ccompoedtum-colizgEcolivecrectgmuC-X-Cmotifchemokelig9(CXCL9)terleuk-15(IL-15)medemigrtiexpnimulymphocyteWhilecyxicCD8Tcellthoughtmedemjytumcellkillgdurgimmunecheckpothibicomgcglyclerthverllefficcynti-tumpedependbroderpectrumcelltypepenttummicroenvirmentprovideupptuchCD4Tcelldendriccell(DC)nturlkiller(NK)cellTheewepropoegenerteddilbio-cectgmuCCL3CCL4whichnticiptedcrubroderpectrumimmunecellcludgCD4NKDCmocyteWehypoizebio-cceenivyolidtumimmunpypecificllyICBttmentcgtrtumldenytum-ctiveimmuneubetWepropoeelucidtechngetrtumlimmunecompoifollowgbio-cttmentirpotentilynergyimmunecheckpotblockderpypludeclicldevelopmenttrnltiAerietudieundertwoSpecificAimcductedi)developevlutenovelbio-ctendedcruupptiveimmuneubetii)determechngetrtumlimmunecompoimededglecombtibio-cvriouolidtummodeliii)determebio-ccombtiignificntlyenhnceefficcyICBrpytum-rgmiceTheetudiedeletetrtumlfquencyfunctilphenotypeimmuneubetfollowgbio-cdmtrtiwhichcnueduncoverpotentilmechnmctrignyobervedimprovementICBrpyIfuccefulwepdictbio-ccnuedcefquencytum-ctiveimmuneubetvrietyolidtumtypethuceenivyICBttmentInfutuendevweimgeleverggbilybio-ccruexpTlymphocytetrtegytrictcylyticctivycell-bedrpieuchchimericntigencepr(CAR)TcellrpyolidtumPROJECTSUMMARYOf150000dividuldignoedcoloctlcncer(CRC)echyer15%crryhedrypthogenicgermlevrint(PGV)cludgomeocedyndrome(uchLynchSyndromeFmililAdenomuPolypo)oced35-100%lifetimerkcncerIdentifictiePGVthroughgermlegenetictetgmttmentcengfmililccdetetgducecncercidencembidymtlyIn2022ntilguideleexpeddicticidergenetictetgllptientCRCyenly56%CRCptientundergogenetictetgUSCventilpthwygenetictetgquin-genetichelthcprovider(NGHCP)ferrlgeneticcounelledgeverlgpwheptientmyfilcompletetetgMtmgenetictetg(MGT)hemergedneffectivepthwycertegenetictetgwhichNGHCPpermp-tetcounelgcodtegenetictetgHoweverntiluptkeMGThenlimedThegolthprojectceueMGTCRCchrcterizgbrrierimplementgMGTCRCpilotgmulti-levelimplementtitrtegytilodebrrierWeebrriermgNGHCP(ieurgemediclcologtrdicologt)tutiltkeholder(ieclicnureclicmngergeneticcounel)throughemi-tructudqultiveterviewPtientperceptiMGTeedugequentilexplnrymixedmethodpprochCRCptienturveyedgrdgperceptiMGTemi-tructudqultiveterviewexploepfenceIdentifiedbrrier/needuedtilmulti-levelimplementtitrtegyctgprovidereductechnicltncegeneticcounelproviptienteductimterilThemulti-levelimplementtitrtegyMGTpilottetedttwotutiAlbmdetermeptientlevelch(clicloutcome)providerpercepticceptbilypproprenefeibily(urveydt)ThmenderchtructudtrgplngexperteimplementticienceexpoumixedmethodfciltemycerdevelopmentplnMylg-termgolueimplementticienceimproveoutcomehedrycoloctlcncerptientThefdgthpropolmhybrideffectivene-implementtril(R01propol)implementgMGTCRCptientprovidemedictpthwycomgndependentvetigrPROJECTSUMMARYChempymmotuedytemicttmentcncerHoweverdepeignificntimprovementchempygentchemotncemmjproblemcncermngementRecentlywedcovedelectivehibirheptCviru(HCV)NS5Aplicticomplexelbvir(Elb)dcltvir(Dc)nnlogElbmyuedenize-enizeolidhemlogiccncercellchemo-drugWecened1855FDA-pproveddrugfoundElbwmgpdrugignificntlyenizedmultiplemyelom(MM)cellcrfilzomib(Cfzproteomehibir)dexmethe(Dexcticoteroid)melphln(Mellkyltggent)ElbDccouldlo-enizeCfz-Dex-tntMMcellCfzDexpectivelyInddiweobervedElbDcenhncedchemoenivy-enizeddiffenttypecnceruchpncticductldenocrcom5-fluourcilgemc(Gem)etrogenceprpoivebtcncer(BC)celltmoxifentriplenegtiveBCcellGemMooverpenceElbDclowerdoechemo-drugwequidduceimilrcncercelldethcompdchempydrugleWedcovedElbDcignificntlyenhnceddrugtenticncercellhibgdrugeffluxthroughATPephopholipidtrnptg9B(ATP9B)Imptntlylthoughtummicroenvirment(TME)compentuchtum-ocedtromlcell(TASC)tum-ocedmcrophge(TAM)cnprotectcncercellchempy-ducedcelldethElbDcbrogtedTASCTAMprotectiveeffectuppgpro-tumlipidectiprogrmmgmectetype-I-IFNenizgMMcellCfzhibgTAMleedeoxycytideovercomgGemtnceolidtumFllyElbDcignificntlyimprovedrpeuticefficcychempieMMvivooutcedxicynmltueTheewehypoizeHCVNS5AhibirElbDccndevelopedcncerrpeuticgentdueirbily()enizecncercellchempieenhncgchemo-drugtentumcellmovgTME-providedprotectiTomimizecopethpplictiwefocuhumnMM(hemlogiclmlignncy)uehumnMMcellleprimryMMcellptientMMPDXmouemodeltethypoAim1elucidterolemechnmElbDcenizgtumcellchempyhibgchempeuticdrugeffluxthroughATP9BAim2elucidterolemechnmElbDcovercomgTME-mededextrictncehibgATP9B-mededcholeteroluptkedeoxycytideeffluxAccomplhgeimprovidejutifictioldevelopgnoveleffectivetrtegietrgetgbothcncerdrugeffluxTMEimproverpeuticefficcychempyAbtrctTheclicllcpemettticmelnomhenvolutiizedimmunecheckpotblockde(ICB)howeverdepeedvncementeffectiveneICBmettticmelnomlimedpproximtelyhlfptient1ThedevelopmentcquidtnceprtthroughloMHC-Intigenpenttilevemotptientexperiencedeeprogi25Recentdvncementhvehighlighteduedoptivecellrpy(ACT)ttmentICBtntmelnom(egCARTcell)68Howeverolidtummicroenvirment(TME)pentcriclbrrierucceTcell-bedrpielrgelyduedictcompetitweentum-filtrtglymphocyte(TIL)cncercellmetbolicourcendergTcelldyfunctilexhuted910ThenurgentcliclneeddevelopmentnewtrtegieengeerdoptiveTcellbilyutfunctihrholidTMEprticulrlyifepprochecncomdrpie(egmllmoleculetrgetedrpy)improveclicloutcomeOurgrouphvecentlyptedTME-ducedenvirmentltledepigenomemodelgeventTILcludglohnemethyltrnfereEZH211EZH2keycompentPolycombRepiveComplex2(PRC2)ducepigenetrncriptivimethyltilye27HneH3(H3K27me3)12LoEZH2H3K27me3ctivtedTcellledtrncriptilprogrmmgultnexhutedTcellphenotypeOurPlimryDtuggetprotectgEZH2ctivyctivtedTcellcircumventthexhutiproduceTcelldurblectivyhrhTMEPlimryDtpentedheevidencepvioulypteddependentgroupupptpmeourpropolprotectiTcellEZH2expi/ctivyctemodurblepotentACTInthnovtivepropolwerigoulytethypopervgEZH2functiTcellenbledoptiveTcellpertfunctimelnomtumenvirmentToteurhypowepuruefollowgSpecificAim(1)DemtrteenhncedEZH2ctivycnprotectTcellfunctiolidtummicroenvirment(2)EngeerEZH2itntCARTcellcombrilttmentmettticmelnomDuctlcrcomu(DCIS)nignbtdeepotentildevelopvivebtcncer(IBC)DCISdetectedround25%btrkcenyetnotpoibledetermepthologiclevlutiwhichwomenprogIBCThultoverttmentwholebtrdiprtilmtecmyprtilmtecmymtecmyelimterkprogiCtemprylertuptqultivelytromcollgenplyhroletumenglimprogicollgenfirwidthlengthcurvtupdictiveprogiThemoleculrcompoitromcollgenpentknowledgegpcouldpotentillypdictprogilimiverttmentwelllednewmoleculrighttromignlgltedbtcncerrkOurplimrydthowpeptidepentgcellterctivecollgendomgultedDCISleipthologypentrkpdictiveprogiFromthduroverllhypotromlproteomicigntuderivedpot-trnltilmodificticollgenurroundgmicroenvirmentdiffenteDCISleirchectupentgrkpdictiveprogiThexplrytrnltilprojectdevelopccepttromproteomicigntupdictiveoutcomebtcncerrkAim1wkdiffentetrptientterptientheterogeneyDCISleipthologyIBC90lumpecmie(29%blckwomen/71%whewomen)ocedDCISptiltromlcellulrproteomiccoupledmultiplexedimmunohchemtryBioigntuDCISrk(lrgeleihighnuclergrdecomedecro)evlutedcompdlowerrkDCISpthologieIBCInAim2weevluteclicllychrcterizedcelldefedtuemicrryReourceArchivlBtTue(RAHBT)ctgtuecoprimryDCISdignomedinpropectivefollow-up114yerpentg35%blckwomen/68%whewomenBioigntuptiltromlproteomicocednuclergrderchecturlgptternolidcribrimcomedecroevlutedltiveoutcomeMchelernglghmuedeignificncecollgentromlgultitweenpthologieubtypecliclchrcterticcludgncetrynoverllgolugtromigntuDCISleipdictprogiAlg-termgolchngecliclprdigmptientmngementoverttmentugmoleculrmrkerptientrkttimeclicldignoguidettmenthigh-rkptientlimiverttmentthoelowrkprogiPROJECTSUMMARYN-mllcelllungcncer(NSCLC)mgnever-mokerMuttiepidermlgrowthfcrcepr(EGFR)genecommfound>50%lungtumnever-mokerWhileEGFR-mutnttumexhibrobutpetyroekehibirdeeprogiuntuntelyevbleMnyptientStgeIVNSCLCnowexperiencedurblepelg-termurvivlfollowgttmentcheckpothibirHoweveruchnefrlyeenptientEGFR-mutntdeewherpiddeeprogifquentlyobervedThepopecheckpothibirEGFR-mutntNSCLClikelydueirimmunouppedcoldtummicroenvirment(TME)chrcterizedlowlevelfiltrtgCD8+CD4+TcellhighlevelgulryTcell(Tg)M2mcrophgeAnunmetneedextelucidtefcrctrieimmunouppedTMEdevelopefficciouimmunpeuticgimenptientEGFR-mutntNSCLCEmerggdtuggetetrogenctrienimmunouppiveTMEDtcncertypedemtrtebily17-etrdiol(E2)gulteeverlimmunecelltypecludgCD8+TcellFoxp3+TgmcrophgeneutrophilAlthoughwelletblhedetrogenctivemetbole4-hydroxyetrogen(4-OHE)plynimptntrolelungtumigeneltlettentihengivenirctriiimmunouppilungTMEueetrogen-modultggentttenuteeeffectPlimrydtourgroupdemtrtefirttimedmtrtinromtehibir(AI)mutEGFRL858Rmiceignificntlycetr-tumlCD8+Tcellfiltrtipromotenti-tumeffectFurrmoournewdtfirtdemtrte1)deletiCYP1B1(enzymepible4-OHEproducti)mutEGFRL858Rmiceducelungtumburden~50%2)4-OHEproductiignificntlyenhncedptientEGFR-mutntNSCLCcompdhelthyctrol3)4-OHEpolrizemcrophgeimmunouppiveM2phenotypenimmunepecieknownenrichedEGFR-mutnttumTheenoveldtprovidetrgrtilevetigtguenAInti-PD1rpyEGFR-mutntNSCLCThepropoedmultidciplryerchvolvetudiemouemodelmutEGFRL858RdelEGFRL747S752lungdenocrcom(Aim1)complementedimmunebiomrkernlyeugrchivedpecimenptientEGFR-mutntNSCLC(Aim2)ReerchunderbothimpermedprllelfcilterpidtrnltiultgdtcliclettgelectiptientpopultinefmotnetrogenmodulrFdgenhnceourundertgctriietrogenmetboleimmunouppiTMEEGFR-mutntNSCLCmdeignnovelclicltrilemploynAIcheckpothibirimprovelg-termurvivlPROJECTSUMMARY/ABSTRACTRenlcellcncer(RCC)lethldeewhoecidenceClercellnlcellcncer(ccRCC)motggivededlietvrintthcncerccount~85%llRCCceWhileignificntdvncettmentpprochehveenchievedtwodtctgroupptienttrkdethkidneycncerthoewhopentmettticdeethoewhocurfollowgurgeryInptdecdelcpeimmunpeuticpprochefocuuecykedvncedccRCChexpedrpidlySpecificllycykecnplypivotlrolenumerourpeuticgimenctgeveryphecncerimmunycycleTheimmunpeuticpotentilcykehendemtrtedhowpromgultttvrioucncercludgccRCCThultedgrowgnumrclicltrilexplocyke-beddrugnlyglegentlocombtidrugThurpeuticpotentilIL-21novelttmenptiptientdvncedccRCChenevlutedphe12clicltrilDepepromgnti-tumeffectevedoe-limgxicieytemicdmtrtiIL-21wefquentlyptedclicltrilultedetrildctutimodertecliclefficcyTheefutucyke-bedpprochequioptimiztiirphrmcoketicprilecehlf-lifeccentrtitummicroenvirmentmimizgirf-trgetytemiceffectInthexplryR21propolweoutlenovelpprochttccRCCimg(i)tum-pecifictrgetgnovelengeedIL21bedimmunocykeuperiPK/PDpropertie(ii)limide-effectfquentlyeenytemicIL-21dmtrti(iii)ignificntlyduceFcR-mededf-trgetxicyWehvedeignedgenertedfirttimenovelimmunocykehumnizednti-CD70-IL-21fuintibody(Ab-IL21)ThntibodyimultneoulybdCD70ligpecificllyexpedccRCCenhnceNKcellcyxicygtccRCCImptntlydruptiheprbdgctivyournewIL-21proteultignificntimprovementPK/PDpropertiehowmrkedlydecedhepxicyAb-IL21fuintibodyWefocudeigndeploymentnovelAb-IL21highetffyIL-21RWelodetermemoteffectivetum-pecificproteeclevblelkerfuinti-CD70ntibodyIL-21fullyleeIL-21ducenti-CD70mededADCCpecificllyRCCtummicroenvirmentToteurhypovlidterpeuticvlueAb-IL21wepropoefollowgSpecificAim(1)DevelopmentledgAb-IL21fuiuperiIL21ctivytrgetpecificy(2)Toevlutenti-tumefficcyAb-IL21humnizedmouePDXmodelInctivtiVHLtumuppprote(pVHL)fquentlyobervedclercellRenlCellCrcom(RCC)ThemuttedpVHLdoenotbddegrdegulry-ubunhypoxi-duciblefcr(HIF-1/2/3)undernmoxicugovexpiHIF-dependentpro-ngiogenicfcruchVEGFEPOPDGFetcAultRCChighlyvculrntuExtenivetudiehveetblhedhibiHIFpthwyufficientupptumgrowthVHL/RCCcellfergnttrctivetrgetttthdeeWehvehownpuhokiolhibHIFpthwyhypoxi-mededexpipro-ngiogenicgenenumrcncercellleHokiollohibctutivelyctiveHIFpthwyexpipro-ngiogenicgeneVHL/RCC4cellundernmoxiFurrwehvedetermedmechnmctihokiolugchromtimmunopciptiexperimentTheefdghvelloweduynizenewclbbedHIFhibirimprovedefficcynti-ngiogenicpropertieundervrocdiInthprojectwepropoetwopecificim(i)determetructu-ctivy-ltihip(SAR)hokiolnloghibiHIFpthwy(ii)determeefficcyelectedhokiolnlogxenogrftRCCmouemodelAtcomplethprojecurexpecttiwehveevlutedpotentilrpeuticefficcyhokiolnlogttmenttrtegyRCCInddiprimrypoiveimpcurfdgpotentiloutcomemynefttmenrytemicproblemocedVHLmuttieghemngioblmtCNSFllyctivtiHIFpthwyplycriclroledevelopmentmnydiffentcncertypetmultipletgeEvlutihokiolnloghibirHIFpthwyexpectedprovidenimptntolfurrdefectrihpthwycncerdevelopmenttnceRelevncePublicHelthRCCnimptntdee60000newcepdictedechyer>13000dethTheclercellcrcommotcommmRCCmkgupnerly70%ceUntuntelycuRCClyvilblethoelimedtgedeewhichcnurgicllyecteddteytemicrpiecnnoterdictecncerifhpddtntlyIndvncedtgeytemicrpiegiventbilizedeeNocventilcyxicchempygenthvedemtrtedignificntctivythdeempycombtiAnti-VEGFrpiehveenlrgelyeffectivepoiblyduectriipro-ngiogenicfcruchEPOPDGFetcRCCThumnunmetmediclneeddevelopmoeffectivettmentRCCThepropoederchevlutehokiolnloghibirHIFpthwymoeffectiverpeuticgentttmentRCCTheRfmilyprotectfourmjmlgereprotectutivelyctivtedthirdcncerInptdecdehibirmutntR(RG12C)hveendevelopedmotptientdmtedRG12Chibir(RG12Ci)lpeIntetglyeRhibirtnttumhveRignlgctivtedignlgmechnmunderlygthdrugtnceunknownTouncoveredrugtncemechnmIdevelopedRctivyenRctivydependentproximyllerppliedmRG12C-ddictedcncercellttedRG12CiobervedRG12CiblockedmutntRignlgtplmmembrnewhilewildtype(WT)RctivtedtendomembrnefuelcogenicignlgcellgrowthWhileeultplimryetudiewede2DcellcultudotdeletewhichprticulrRmenbleRG12CitnceeexcgfdggquetiwhercncercellcnevdecentlydevelopedRhibirtrgetgRG12CG12DG12RG12SloctivtgRignlgTheeobjectivethK99/R00propolexpmoleculrolkRutilizeeolprileuncovermoleculrmechnmdrivgRhibirtnceThecentrlhypodrivgthwkWTRcompentimutntRhibigenerlfetucncercellemployevdeRhibirPrilgubcellulrRctiviedurgRhibirttmentuncovergmoleculrcompentdrivgthgniztiRignlgllowtterundertgRhibirtnceillumtinewrpeutictrgetTovetigtethhypofollowgpecificimdded(1)DevelopgpplygRencomplexcncercellmodel(K99)(2)DenovodeignRmelectiveol(K99/R00)(3)PrilgdectgmechnmunderpngRhibirtnce(R00)InpropoederchIproteengeercurntnewRol(enproximyllerperturbr)lgmicrocopyproteomictechniquedetermehowRhibirimpctcomprtmentlizedRignlgTheexpectedoutcome(1)nexpniolcnppliedvivomodelpropecificRm(2)tterundertghowRhibiropertehowdrugtncecnoccurOfnoteIlieveenewRolgttetcncercommuny(egNCIRive)cnuefulpplictiydcopethpropoluchdignoticrpeuticTowrdcompletipropoedwkItdprotedeignmethodcomplexcncermodelguidedndvycommteecompoedexpertcncerRignlgcellcultuThelg-termgolthprojectdevelopndependenterchprogrmbridgeprotedeigncncercellbiologyunderthowcogenicignlgpthwywimelvedurgcogenedrugtncePROJECTSUMMARY/ABSTRACTThpropolddelckptient-derivedmodelytemhmeceprpoive(HR+)btcncerlolckethnicllypenttivemodelbtcncerThemjynewlydignoedbtcncer(>70%)HR+two-thirdetimted42690btcncerdethHR+btcncerRecurntHR+btcncerhendifficulttudygivenprolgedcliclcourelckppropreptient-derivedmodelytemTheemodelhveendifficultderivegrowptlowtke-rte(~10-20%)modellogirHRexpiovertimeInddumoxtricfcruchcncer-ocedfibroblt(CAF)ignificntlyimpcttumbiologyrpyperlycptedtudiemodelHR+deeTheeddthgpweeutdevelopmopenttivemodelcurntlpedHR+btcncercpteelementtummicroenvirmentemodelTochievethwehvedevelopedmethodderivgHR+ptient-derivedmodelytemctgbothprimryptient-derivedtumgnoid(PDO)oltedlpedmettticHR+tummtchgprimrycncer-ocedfibroblt(CAF)hightkerte(~50%)Theemodellotterpentptientethnicrcildivery~35%ourmodelunderpentedethnicie(egAfricn-AmericnHpnic)UgenovtiveolwehveldyidentifiedSUCNR1driverttmenttnceHR+btcncerTheedtleduourhypotrgetgSUCNR1verettmenttnceobervedmettticHR+btcncerwecnueouruniquePDOmodelp-clicltetgpltmenovelttmenttrtegieWepropoetwopecificimAim1motechnologydrivenperRFAthR21expnumrvilblemettticlpedHR+ptient-derivedmodeloltedethnicllydivereptientpopultiInAim2weInvetigterpeutictrgetgSUCNR1curntHR+btcncerugourPDOmodelOurpropolignificntcueddemultiplefundmentlchllengebtcncerttmentmngementcludglckptient-derivedmodelHR+btcncerlcktummodeldiverercilbckgroundctriiCAFtnceMotimptntlywetendmkeemodelolvilblewholefieldeimpcttherchwellydourpropoederchProjectSummryMothn80000dolecentyoungdult(AYAge15-39yer)dignoednnullycncerUnedStteltivelyfewenrollcncerclicltril(CCT)LimedAYAprticiptiCCThderbilyfurrimproveAYAcncercoutcomeIniveceAYACCTenrollmenturgentlyneededThpropolidentifieeverlimprovementimmedelyddblehbleSidneyKimmelCompheniveCncerCenter(SKCCC)mediclcenterNCIctiumgroupThepprochignificntlyimproveAYAclicltrilprticiptSKCCCfurrdevelopgimplementgclicltrilolwebbveAYAAlertYoungAdultNvigtiAllinceillyhemlogicmlignncie(HM)/pedricBMTprogrmnydTheeterventicrofertilizecollbtthelevel1)Ptient2)Multi-dciplryProvider3)Center/SytemTheolutipropoedimproveAYAcceenrollmennCCTtngncliclerchenterpddcncerdpriellNCIpriieThpropolutilizenewmulti-fcetedlertytemcludenelectricmediclcd(EMR)lertidentifyAYAptientpotentilclicltrilwhichyeligibleWeeklyclicltrilerchmeetglertmulti-dciplrytemAYAclicltrilpriyltPtientlertviourEMRdictlylkedptientmobiledevicehighlightCCTenrollmentupcomgppotmentAumtgidentifictrileligibleAYAptientprovidgtimelymtitudytemphyicinkeepgAYAptientenggedthroughEMRdictedmobilephemeggoptimizeenrollmentcomplinceAdedictedcliclerchnureyoungdultnvigrtercterlyAYAptienthelpAYACCTenrollmentbridgeknowledgewkflowgptweenourdultpedricctiumtrilAcohtpriAYACCTprticipnturvivnvigrervepokepeopleourAYAwebeocilmediAnAYApychoocilnvigrroundoutprtnerhipimproveAYAupptLtlymulti-fcetededucticmpignlunchedimprovellinceNCI-ctiumenrollmentuehighlightedtjotHM/pedricBMTcliclerchmeetgWectecro-netwkenrollmentFAQdocumentUgdiglcommunictiweprovidemtiAYAboutCCTupplementdcuiproviderWeextendgogprojectedDiveryIncluiCliclReerchProgrmtSKCCCcludenAYAptientfocuoptimizeenrollmentunderervedmieBetprcticeidentifiedthprojectdilytrnferrbleentiSKCCCenterpcdemicmediclcenterAntillycognizedBMTexperttrgcommmentNCI-fundedclicltrilexteniveknowledgecliclerchopertiDrSympoedledeeftuccefullyenhnceAYAccrulProjectSummryMrglzelymphom(MZL)ecdmotcommubtypedolentlymphomB-cellmlignncywhetummicroenvirmentplynimptntrolepthogeneFurrmolckliblepcliclmodelcludgcelllewhichhhmpedrtildrugdevelopmentthcommdolentlymphoidtumThephophooide3-ke(PI3K)protekeB(Akt)mmmlintrgetrpmyc(mTOR)pthwyefquentlydegultedpthwyhumncncerneentilcompentB-cellceprignlgpthwyimptntpthogeneB-cellmlignncieIntetglyPI3K/AKT/mTOR(PAM)pthwyhibiruchcopnlibcpivertibhvehowntrgcliclctivyptientlpedfrcryMZLThetumuppgene(TSG)phophtetenhomolog(PTEN)negtivelygultePI3KignlgwhileTSGliverkeB1(LKB1)loknownSTK11negtivelygultemTORignlgPritudieugheterozygougloblknockoutPTENhypomphicmuttideceLKB1expigeneticllyengeedmouemodel(GEMM)ledrmtidolentlymphomwenotwellchrcterizedddypemlignncieuchpheochromocymprottebtpncticcrcomTheewehvegenertednovelGEMMwhewehvetrictedctivtiPAMpthwyBcellugC/loxPytemCD19-Cderctemocelltype-pecifictummodelmoccurtelymimicunderlyghumndeelg-termgolugemodelevlutgtrgetedimmunpiehumnMZLWetetfollowghypoeAim1TotudyimpctPI3K/AKT/mTORpthwyctivtidevelopmentmrglzelymphom(MZL)ugnovelgeneticllyengeedmiceAim2TodetermeoptimldrugcombtrgetgPI3K/AKT/mTORpthwyMZLTheetudiefirtdemtrtepoibilymodelghumnMZLmiceugmodelfunctilimmuneytemThnovelmodelhvetmendouimpcnourundertgunderlygbiologydeeourbilydeignfuturtilerpiethcurblemlignncyProjectSummryOurlg-termgolundertimmunobiologycnceridentifymoleculrdriverpromotemettticprogicncerWedcovedpotentchemokeCCL24expedexpliclyggiveetrogencepr-negtivebtcncercellOurplimrydtvlidtedexpiCCL24ignificntlyhigherbtcncerhighCCL24mRNAlevelggivebtcncerocedpoprognoPermuttitudievelediRNA-mededknockdownCCL24ovexpgbtcncercellpromotedmeenchyml--epililtrni(MET)CCL24mypromotecncercellEMTmettknownchemottrctntimmunouppcellfurruppntumimmunyTheewehypoizechemokeligCCL24drivevivefetubtcncercellledgmettOurpecificim1)determecliclignificnceCCL24btcncerductiEMTunfvbleclicloutcome2)determecogenicfunctiCCL24rpeutictrgetgCCL24btcncerInprllelwedetermeifCCL24ctriebtcncermettpromotgfiltrtiimmunouppivecelltbttumeThnovtivecceptexplopvioulyunknownroleCCL24drivermettticprogiggivebtcncerWeexpectprovidepcliclpro--ccepncogenicfunctirpeutictrgetgCCL24btcncerPROJECTSUMMARYTheoverllgolrgpropolemployqunttiveimggnvivelychrcterizetummicroenvirmentlheterogeneytriplenegtivebtcncer(TNBC)pdicttmentpeoutcomeTNBCnggivebtcncerubtypenotblediverydeebiologycliclpenttiRecently-pprovedimmunpietroduceexcgnewvenueneodjuvntttmentTNBChoweverpeimmunpyvriblettmentcnentilignificntdvereeffectfncilcotVribleperpycnttried-prtheterogeneytummicroenvirmentffectgrpeuticdeliveryefficcyThroughnnovtivepprochknownhbtimggmultiprmetricmgneticnceimgg(mpMRI)cnuedptillyolveloclmicroenvirmentleidtcttumubgihbtFerchcompentthpropolwepropoeuequnttivebtimggmtictechniqueidentifytumhbtwhole-leihbtigntuTNBCptienttrtifictiWehypoizeimgg-derivedhbtigntuidentifiedprtmentcnidtrtifygTNBCptientcedprobbilychievgpCR/decedrkcurnceWetetthhypothroughfollowgpecificimAim1(K99)TotropectivelyidentifytumhbtigntupttmentmpMRItrtifyTNBCptientpdictttmenutcomeAim2(R00)Topropectivelyemployhbtimggughybridporemimogrphy(PET)/MRIimprovedTNBCptienttrtifictiSuccefulcompletimyerchimprovidecliclly-trnltblemethodologyimprovedundertgndividulleiphyiologycouldguideperlizedttmenttrtegieoptimlptienutcomeToprovidemenecerytrguccefullycrryouteerchimthpropoloutlemend-trgplnthefocu1)tngnmyexpertecliclbtcncererch2)ceiveddiltrgcomputtilpthology3)obteductiltrgh-experiencePET/MRIpperchdependentR00pheydThtrgprogrmexecutedunderdictmenrhipNIH-fundedercherclicinpecilizgmediclcologynuclermedicepthologyrdiologytkeplcewell-equippedetblhedcncererchenvirmenttUniveryWhgnFdHutchCncerCenterAoutledmycerdevelopmentplnfundgthpropolueddedictetimeeductilwkhoptrgemrlggulrmeetgmymenrhiptemTogerrgerchpropolenuImwell-ppdchievemycergolcomendependentvetigrfocuedtrnltinovtiveimggtechniquecliclprcticefurrperlizebtcncercPROJECTSUMMARY/ABSTRACTTrgetghllmrkbiomrkerprottepecificmembrnentigen(PSMA)henuccefulmllmoleculedrug-deliverytrtegyvrioupylodprottetumcellwhichevidentFDAcentpprovl177Lu-PSMA-617clicldvncemenur18F-CTT1057(nirverible-bdgphophmidte-bed)PSMA-trgetedPET-imgggent(NCT04838626NCT04838613)HoweveftdevelopPSMA-trgetedchempeuticnnomedicehvehdlimedcliclrpeuticefficcyOurlg-termgoldevelopvertiletelligentlydeignedpltmelectivedeliveryynergticrpeuticpylodfernovelttmenptilengngimprovgqulylifemettticctrti-tntprottecncer(mCRPC)ptientTheoverllobjectivethprojectdevelopPSMA-trgetedmll-moleculeduldrugcjugte(SMDDC)ervecompnirpeuticourPSMA-trgetedPET-imgggent(NCT02916537NCT03427476)Ourcentrlhypotum-ectivtileetwodtctchempeuticpylodprottecncercnchievedmoeffectivethnmllmoleculedrugcjugte(SMDC)leglyglechempeuticpylodThertiledevelopgSMDDCetgroundwknewdul-drugrpeutictrtegyptientmCRPCdvncedmlignnciePSMA(+)neovcultuTwopecificimpuruedtetcentrlhypo1)Aeptio-templcrgo-leeprottetumcellPSMA-trgetedmll-moleculedulprocjugte(SMDPC)2)DetermepotencyenhncementSMDDCrgdulpylodprottecncercellleFAim1PSMA(+)PSMA(-)prottecncercellleuedeptio-templcrgo-leePSMA-trgetedSMDPCrgtwodtctturn-pro7-Amo-4-methylcoumrhydroxymethylrhodmegenEtblhedPSMActivyyueddetermeIC50modebdgPSMA-trgetedSMDPCInAim2vroeffectivenenSMDDCrgbothMMAEExtecnvnSMDCrgeirMMAEExtecnleevlutedPSMA(+)PSMA(-)prottecncercellleThepropoedwknovtivecueimutilizeuniquecombtidrug-deliverytrtegiePSMA-ligpromotedternliztinovelcid-lbilelkerpH-triggeddrugleetwodtctchempeuticdrugdiffergmechnmctiThignificntchievementcueprovidepro--cceptdevelopgclicllylevntchempymCRPCmlignnciePSMA(+)neovcultuFutuplncludeexpgelectidrugpylodPSMA-trgetedSMDDCepcliclIND-enblgtudieTheexpectedpoiveimpctetudieylllikelihoodetfoundtigenerldul-drugtrtegytrgetedchempybiomrker-chrcterizeddeeProjectSummry/AbtrctElevtedexpiKIF20Amickequidpromotecykefltepcelldiviner-univerlfetuhumncncerIncedKIF20Alevelocedpoprognomultipletumtypecltechromoomltbily(CIN)CncercelleniveloKIF20Afunctivibothmllmolecule(KIF20Ai)CRISPR-mededKIF20Aknockout(KIF20A-KO)wheRNAi-mededdepletiKIF20AgenerllylertedhnotmeduenzymeroleCINWefdcgKIF20Aiccentrtileddoe-dependentlovibilycltencemicdurticueddefectivechromoomecgiWhileperturbgmiclicllylevntrpeutictrtegycurntgenttrgetmicrotubuleduceneuroxicywhichlimutilyegentpcludeiruetumcentrlnervouytemGlioblm(GBMocrtedehydrogene[IDH]-wild-type)nggivehighlyprolifertivebrtumlimedttmenptiRdipycentrltrdcttmentGBMHoweverfrcrycellultimtelyledcurncehighlightneednewtrtegieWehvehownperturbgmivulnerbilyGBMcellhvedemtrtedovexpiKIF20AetumIndeedwefdptient-derivedmodelGBMeniveKIF20AiInctrtn-trnmedcellhvelowenivyKIF20AiInddimiccellhighlyeniverdipymicrtducedKIF20AiferpotentilrdioenizgetumenhncgcurnttrdcBedeobervtiourplimrydtwehypoizecncercellutilizepvioulyunderppcedctivyKIF20ApromoteefficientmicprogipventCINFurrmowepotulteblockgthfunctihrpeuticpotentilTheobjectivethpropolfurrchrcterizeimptnceKIF20ActivyerlymivetigteimpctKIF20AipotentilnewrpeutictrtegyGBMTwoAimpropoed1)DefequimentKIF20AerlymietblhgimpctKIF20A-KOerlymiidentifygeentilKIF20AfunctiexmgfcrdictteKIF20Aienivy2)DetermeimpctKIF20AumgrowthcomprgKIF20AirdetgKIF20AirdioenizerthopicGBMPDXmodelTheuccefulcomplethwkprovidertilefurrexplo1)cellbiologyKIF20AKIF20AifurrourundertgCINidentifycellulrchrcterticmechnmdictteenivyKIF20Ai2)pcliclimpcttrnltilpotentilKIF20Ain-microtubule-trgetgnti-mictrtegybothglegentcombtitrtegyGBMtumtypeABSTRACTChimericntigencepr(CAR)-engeedTcellrpybkthroughimmunpylymphomNeverle40-60%pdgptientlpeprtduepopertenceCAR-TcellInthgrdourplimrytudiehveidentifiedrolenhibiryceprfunctitrictexpnipertenceTcellThpropoltethypoimilrnturlTcellCAR-TcellweloctrolledthhibiryxAim1weexmeculrolethceprximpirgrpeuticefficcymuCAR-TcellInAim2weexmeexphhibiryceprhumnCAR-TcellteteffectblockgthceprugmentgCAR-TfunctiTogeretudieguidefututudiedeveloppotentrpeuticimprovgcliclefficcieCAR-TrpiePROJECTSUMMARY/ABSTRACTAdolecentyoungdultcncerurviv(AYACS)fcemultipledpriecludgimpidpychoocilheltholtilimedccepychologiclerviceunmetneedpychoocilupptDepeedprielckterventimigteedprieimprovequlylife(QOL)AYACSFurrmopvioutudiemgAYACShvetenoverlookedirdiveredevelopmentltgepfenceccerngpychoocilcWhileexpivewrgterventihvedemtrtedpoiveeffectvriouhelthoutcomemgolderdultcncerurvivhelthyyoungdultyhveprimrilyenimplementeddividul-bedpprocheOnenovtiveidedptuchterventiAYACScomdividul-bedwrgocilupptgrouppeerexperiencgimilrchllengeThuthpropoedtudyimdevelopevlutevirtulgroup-bedexpivewrgterventigroundedcceptulfrmewktiloduniquedevelopmentlneedAYACScptgircommunictipfenceTheoverrchggolenhnceQOLducetAYACSAim1(K99)developvirtulgroup-bedexpivewrgterventiefeibilycceptbilyTopromotegroupcoheigroupcompoipfence(iege-imilrgenerlgroup)eedeterventiAim2(K99)feoptimizeterventibedqunttivequltivedbtedAim1collbtitkeholderuchMDAnderYoungAdultAdvyCouncilAYAclicproviderAYAgniztiwellPImenrhiptemFllyAim3(R00)eeffectterventiQOLperceivedttbiomrkercompdctrolgroupIfuccefulerventidywidepdexpnicludgunderervedcommunielimedourceupptThePIlg-termcererchgolcomendependenncologynurecienttcncerpventictroldevelopgevlutgnovelpychoocilterventiimproveQOLelimtehelthdpriemgAYACSTochievethgolPIeekpecilizedtrgvriouuchpychoocilhvilterventiundertgdiveredevelopmentlneedAYACSpriciencyqunttivequltivemixed-methoderchtbiomrkerpildevelopmentThepropoedtrgobtedthroughh-trgmenrtkgmlcourectiveprticipticfencetutiltrgInummrypropoederchplntrgenblePItrnidependenceprovidgnecerykillplimrydtuccefullycompetefutuR01-levelgrntPROJECTSUMMARY/ABSTRACTCerviclcncerfourthmotcommcncerffectgpeoplecervixwldwidefterbtcoloctllungcncer569847newceeveryyerInUnedSttecerviclcncercidencemtly7723per100000womenpectivelyubtntildpriebothcerviclcncercidencemtlycrorcilethnicgroupLtprticulrdproptelyburdenedcerviclcncercompdn-HpnicWhe(NHW)cidencemtlyrte50%higherthnNHWAmgwomendignoedvivecerviclcncerLtmolikelythnNHWdignoedtndvncedtgewhenfewerttmenptiDepevergegedignollcerviclcnceroccurrgroundge50mjycengterventifocuyounger/productivegedpeoplecervixThugrowgurgencyimprovgcerviclcncerpventimgmiddleoldergewomenntillyterntillyInUSmiddleoldergeimmigrntLtdproptelylikelyervedtettglikeCommunyHelthCenter(CHC)In201756%poeign-bnLt/olivedtwomileCHCCHCprovidecriclfrtructuferhelthchricllyunderervedpopulti(egthoeouturnce)Evidencelouggetfewerrcil/ethnichelthcdpriemgptientervedCHCundercgimptncetudygundertgcdelivedeettgTheegolpropoederchprtcerdevelopmentwrd(1)decricerviclcncercengrte23-ttenetwkCHC20122023mgmiddleoldergeMexicnimmigrnt(2)exmedividulgniztiltructurllevelfcilrbrriercerviclcncercengmgmiddleoldergeMexicnimmigrnttheCHCloctedPcificnthwet(3)co-developmulti-levelterventiimprovecerviclcncercengmgmiddleoldergeMexicnimmigrntCHCThcerdevelopmentwrdetblhDrVquezGuzmnmulti-dciplryvetigrfocuedimplementgdemtgnovelprimrycmulti-levelterventitrgetcomplexunderervedptientpopultiducedpriegoggulrtimelyhigh-qulycerviclcncerpventicengervicefety-netettgTheK01wrdprovidemendtrgDrVquezGuzmndevelopexperte4(1)temciencetegrtiocilciencecliclerchpproche(2)killknowledgeboerventiimplementticience(3)cerviclcncercengcncercommunictikill(4)expcommunyenggedexperteTochieveegolDrVquezGuzmnhembledwell-fundedetblhedmenrgtemexperteheltherviceerchprimrycterventideignimplementticiencetemcienceCBPRllwhomhveuccemenrgfcultyerchdependenceProjectAbtrctBtcncerbrmett(BCBM)ocedpoprognoedmlurvivl4-6mthfollowgdignoMngementBCBMmmjcliclchllengeduedequteundertgmechnmunderlygBCBMlckdrugeffectiveblood-brbrrier(BBB)penetrtiThunurgentunmetneedidentifyctibledrugtrgetBCBMdevelopnovelrpiettgptientBCBMRerrngeddurgtrnfecti(RET)ceprtyroekehyperctivtedthyroidn-mllcelllungcrcom(NSCLC)twoREThibirelperctibprletibceivedFDApprovl2020ttgthyroidcncerNSCLCBothREThibirducedbrmetteNSCLCclicltrilhoweverirefficcyBCBMtillunknownScehenptedRETovexpedBCBMREThibir(elperctibprletib)croBBBwecductedplimrytudiefoundelperctibignificntlyducedBCBMcidencewhendmtededyfollowgtrcrdicocultumcellHoweverelperctibdidnotignificntlyuppprogidevelopedBCBMourttmentmouemodelwhichuggetneedidentifypthwy/genecfertnceetblhedBCBMREThibiToidentifypthwyco-ctivtedRETwenlyzedpubliclyvilblebtcncerdtetfoundcltitweenRETtrunctedgliom-ocedcogenehomolog1(tGLI1)knownmedirBCBMprogiThroughchemiclcenfollowedpcliclvlidtipvioutudyidentifiedFDA-pprovedntifunglkeczole(KCZ)electivelyhidtGLI1-drivenBCBMvivoexcellentBBBpermebilyledgwdow--opptunyclicltrilBCBMOurplimrytudiefurrveled(i)ctivtedRETtGLI1pfentillyco-ovexpedBCBMtuecompdmtchedprimrytum(ii)tGLI1ovexpienhncetncebr-tropicbtcncercellREThibirvro(iii)tGLI1knockdownenizebr-tropicbtcncercellREThibi(iv)REThibirynergizeKCZvroBedefdgwehypoizetGLI1medeBCBMtnceREThibidultrgetgRETtGLI1ynergticllyhibBCBMInthR21projectwedetermeroletGLI1BCBMtnceRETmpy(Aim1)determeifdultrgetgRETtGLI1ynergticllyhibBCBMugtrcrdicjectimouemodelelucidtepthwycrotlktweenRETtGLI1(Aim2)ProjectSummryThepropoedprojectddecriclneedttmentdvncedprottecncer(PC)ecdledgcuecncer-lteddethmgmenUnedStteProtte-SpecificMembrneAntigen(PSMA)highlyexpedPCcellTrgetgPSMAuedclicllyimggrdio-ligrpyDepedvncecncercttmenptidvncedPCptientmlimedduechllengeocedeffectiveelectivedrugdeliveryPCcellCombgPSMAtrgetgnnotechnology-bedpprochwepropoedevelopnovelytemicPSMA-trgetedglycodendrimernnopltm(TgDN)cpbleelectivetrcellulrdeliveryhighpylodpotentchempeutictumcellloenblgcombtirpiethroughmultifunctilurfcedendrimerOurprierchhydroxyldendrimerhowedpotentiltrgetedtrcellulrdeliveryerlycliclpromeThnewTgDNtechnologydeignedimultneoulychieveelectivetrgetghighpylodPCcellducedide-effectlowimmunogenicyvivotbilywterolubilyeeclbilyflexibilyglemultipledrugdeliveryWeueCbozntib(Cb)multyroekehibirprocceptCbpprovednlcellcrcomhepcellulrcrcomUSAEuropePCclicltrilwtermtedduenegtiveideeffecttlerteddoeTgDN-bedtrgeteddeliveryCbelectivelyPCcellcnhighlyneficilenhnceefficcyducef-trgetxicyWechieveourgolthroughfollowgim1)WeynizeTgDNvriblePSMAliglodgdetermeirvrocncertrgetgPCptient-derivedxenogrft(PDX)primrycultugnoidPSMA+PCcell2)WeynizePSMAtrgetedTgDN-CbcjugtevetigtemximumlerbledoehelthymicevivoefficcyPCPDXnimlmodelevlutepotentilf-trgetcyxicyOurlg-termobjectivedevelopclbleytemicdendrimer-drugchempieimprovedefficcyducedytemicide-effectcnuednlyPCburcncerwellOurtemhignificntexperienceynvivotudieclicltrnltidendrimernnomediceIfuccefulourtechnologyhllfilllg-tgtechnologygpttmentPCprovidenurgentlyneededefficientecomicfedrugdeliveryclicltrnltiProjectSummryAcutelymphoblticleukemi(ALL)nggivehemlogiclmlignncyThedeecidencepekchildnyoungerthnfivedeclguntilmid-20cgfterge50DepedvncettgpedricptienttleneoutfivechildnlpedieleukemiT-cellALL(T-ALL)penthigherrklpethnB-cellALLubtypelpedeeignificntcuecncer-lteddethchildnChildnleukemiexhibgncedrkttmentfilulpedepertelyneednlterntiverpyducedurblemiHoweverdevelopglterntivettmentquiidentifygctiblepro-leukemicpthwyleukemiccellprticulrlydrug-tntleukemiccellbleedeecuelpeWewell-poiedfulfillthmediclneedcuewecentlyidentifiedrrntctivtikeMAP2K7bulkT-ALLleukemiccellleukemi-gcell(LIC)popultivolvedfrcrylpeddeeInbencepotentpecifichibirMAP2K7wehowedprocceptleukemiccellvulnerblephrmcologiclJNKhibioledowntmtrgethoweverlowpotencyf-trgetxicypventtrnltgJNKhibirclicBedefdgwehypoizedicttrgetgnovelMAP2K7hibircncettmentpeerdictgchemotntleukemiccellInthpplictiwepropoedevelopgtrgetedhibirrntlyctivtedMAP2K7pthwythroughcenMAP2K7protebderugDNA-encodedchemicllibrrie(Aim1)tudygkehibiryctivyefficcyidentifiedhibirp-cliclmouemodelccelerteclicltrnltiT-ALLptient(Aim2)TochievethgolweembledcollbtivetemcompoederchcienttexpertegeneticxenogrftmouemodeltudyT-ALLphyicin-cienttvolvedclicltriltTexChildnHoplmediclchemttCenterDrugDcoverytBylCollegeMediceThepropoedtudycnultnewrpietrgetnoveltrgetttpedricptienthigh-rkleukemiProjectSummry/AbtrctThelg-termgoltherchducefunctilimpctcogniveimpirmentimprovequly--lifewomenttedbtcncercncer-ltedcogniveimpirment(CRCI)ThepvlenceCRCIfollowgbtcncerhighcnpertchricllyfterttmenthendedBtcncerurvivtenelf-ptcognivedeficprimrilyexecutivefunctig(plnngproblemolvgmultkg)memyprocegpeedTheecogniveimpirmentcnhveubtntilimpcteverydylifecludgwkcommunyvolvementdrivgfncilmngementNeuroimggtudieuggetthmydueltedctivyfrprietlcognivecircuMetcognivetrtegytrg(MCST)whichprticipnttughtgenerlcognivetrtegycnppliedknownnovelctextdevetkpecifictrtegieuccefullyenggenctivymyprovideolutiOuroverllerchhypoMCST(1)feible(2)improvehvildicecognivepermncewomenCRCIwhichocedimprovedneurlctivtifunctilcnectivyfrprietlneurlcircuryThprojectimexmefeibilyMCSTimpctwomenttedbtcncer(1)cognivepermnce(2)frprietltg-ttefunctilcnectivy(3)tk-bedBOLDctivtk-ttefunctilcnectivycognivectrolcircuryPrticipnt(n=50)romizedMCSTgroup(ten45-muteeiover10week)nctivectrolgroupOutcomeeedtp-pot-terventiFeibilyoutcomenlyzedugdecriptivettticpted95%cfidencetervlTtmenutcomenlyzednnlycovrince(ANCOVA)comppot-terventioutcometweengroupctrollgp-tetvlueCohendeffectize95%cfidencetervlptedNeurloutcomeexmedmedirttmentgroupeffecncogniveoutcomeeriepthnlyeComplethtudylikelyultclicllyfeibleterventiimprovecognictivypermncedividulCRCIppdefficcytetgThepropoedtudyctenterchpriieNCIDiviCncerPventiCncerMohotSMprogrmPAR-22-216whichuppterchlted(1)chricympmmngementimprovedqulylifeducedcncerburden(2)foterggtercollbtitweendcipleneceryimprovecomplexhvilympmABSTRACTCrnilrdipy(CRT)CNScncerleddebiltgcognivedecleprticulrlyccerngpedricgrdeII/IIIbrcncerurvivCRTtriggerflmmtitroglioledgcognivedyfunctiAtrocytectrolvilbilydenoe(ADO)neuroprotectntmodulrcognividenoeke(ADK)whichgetelevtedpot-CRTADOexertneuroprotectictivtidenoecepr(A1R)plyimptntroleynpticplticycogniADKctrollgynpticADOlevelA1Rctivtife-tuneleep-wkecyclewhichdygultedfollowgCRTSleep-wkedrupticogniveimpirmentmgmotcommympmbrcncerptientundergogCRTmechnmunderlygoccurncenotfullyunderodThecircdinclockcentrllymededuprchmticnucleu(SCN)functitcellulrlevelvintrictetrncripti-trnltifeedbckloopctgtrncriptifcrArylReceprNuclerTrnlocrLike(ARNTLloknownBMAL1)CircdinHydrocrbLocomOutputCycleKput(CLOCK)proteThoughroleeprotecncercomplexwehvehownBMAL1uppegrowthhepcellulrcrcomverctgtumuppgeneUgmouemodelCRTtrocymourplimryobervtidictei)BMAL1bdtrgeteAdkgenecircdinmnnerii)CRTduceBMAL1nmlcncer-rgmoueSCNWehypoizeCRTdruptBMAL1-mededleepgultibothnmlcnceroutuecelltype-pecific(trocyte)ADK-dependentmnnerUggeneticpprochtrocyteelectivedoubleknockoutClockBml1vrovivothpplictidetermeimpctBMAL1CLOCKAdkgenebrgi-pecificexpicircdinprotemicebrouttrocymceivgcrnilrdipyThtudyvelkeymechnticmtigrdgleep/wke(dy)gultifollowgCRTbrcncerProjectSummryPolyketidenturlproducthveplyedctueplycriclrolecncerchempyThoughypotenttentum-electivegentccegrmcleupplieegentcomplicteirclicltrnltiCurntoluticludgchemiclyntroptimiztihveprovidedmodetuccebuurlckundertgmchepibleirproductiultimtelylimbilytteffectivelevelproductiTypeIpolyketideynthe(PKS)lrgemultifunctilenzymethrgnizedmoduledcteenzymticprotemimllyctg-kecylynthencyltrnferencylcrrierprote(ACP)Whilenidelizecryo-electrmicrocopy(cryo-EM)lyfewTypeIPKStructucurntlyextemnylckolutiirACPdomLikemnylrgeproteyextnturllyhighlydynmicttewheirctivyopertethroughdctemechniclproceeInmotTypeIPKSbioynthroughemblyketideunwhichhuttledtweenenzymticdommenACPHecomplexmovementtweendomechmoduleultynchriccptumultiplettemeprotecomplictgtructurlevlutiInthprogrmourtemexplopthwyenbleelectiveevlutittetrppedTypeIPKSThroughtwopecificimweferuniqueolutiwrdoltgPKSmegynthehotcellproducgmthroughcombnttechnologiecryo-EMtudieOverlltwokeyfundmentldcoveriethprogrmnpprocholtgPKSenzymecryo-EMtudiedictlychllenggcurntmethodprimryundertgelectivymechnicvolvedPKSctlyWenticiptethprogrmfernlybtructurlolutilrgePKSenzymeloferightmodulrtermodulrdynmicecomplexmultimodulryntheColoctlcncer(CRC)3rdmotcommlydignoedcncer3rdledgcuecncer-lteddethUnedSttePodietryqulygutmicrobiomeltedmodifiblefcrimplictedburdenthdeeHowevermechnmthroughwhichyterctimpctCRCdevelopmentprogipolyunderodOurtempvioulydevelopednovelEmpiriclDietryInflmmryPttern(EDIP)cobedplmflmmrymrkerAhigherEDIPcolkedhigherlevelflmmtihigherrkdevelopgCRCdygdeeThoughdiethenhownmodultegutmicrobiomedietryeffecttriggerflmmtidybioCRClrgelyunknownWehvehownpro-flmmrydietrypttern(higherEDIP)ocedhigherrkdevelopgCRCwhichtumdepletedtum-filtrtglymphocyte(TIL)mgCRCurvivhigherpot-dignoEDIPlopdpoedptientdietumdepletedTILnottumhighlevelTILWefurrdemtrtedhigherEDIPwocedgterrkcoloctltumenrichedbcteriumclledFuobcteriumnucletumnottumnegtiveFnucletumTheefdghedlighnpotentilmechnmhowdiet-ltedflmmtimyfluenceCRCtumdevelopmentprogiHoweverourtudiewelimedglebcteriumcoltuewenowhvebilyexperteuemobutmethodidentifydiveremicro(bcterifungivirueetc)widerrngehotimmunecelltumBedourplimrydtweteverrchghypopro-flmmrydietryptternduceccentrtiimptntcncer-fightgimmunecellcollteroverllblncemicrocoltuecgrkdevelopgggiveCRCleddethWelevergedtmg291menwomenColoccohtdietolmpleidentifygutmicroocedEDIPeirimpcnurvivlmgCRCptientInddiweutilizeRNAeqdtOncologyInmtiExchngeNetwk(ORIEN)mg2500CRCptientidentifymicroimmunecellCRCtumtuelkedEDIPdetermeirimpcntumcliclchrctertic(egCRCtge)hotfcr(egexbodymdex)urvivloutcome(curncell-cuemtlyCRCmtly)Atcompletiourtudyweexpecthve)identifiedmicroocedflmmrydietryptterngutCRCtumtueb)determedhoweEDIP-ltedmicrolkedurvivloutcomemgCRCptientfirttimeTheeultmdeignlrgertudiedietrytrtegiemigtgdybioguttumtueocedproflmmry(high-EDIP)dietryptternCRCprogiTheenoveltrtegiemyloervedjunctrpieimproventi-cncerttmentpewhileducgideeffectPROJECTSUMMARY/ABSTRACTThecidenceerlyetcoloctlcncer(EOCRC)hcedptfourdecdepdictedce140%203045Itecdmotcommcncerthirdledgcuecncerdethdividulunder50yeroldUSA467Incentview47wepropoedcedrkEOCRCdrivenexpoomewhoeentrygloblenvirmentpcedemimicwldwideceEOCRCcidenceExpoueupectedexpoomehencgpt40yer(hEOCRC)yllimpctgurdincol(flmmtimicrobiomeepigenetic/geneticchnge)expouglobloccurdurgdevelopmentpotentillydurgchildhoodInthprojectwefocuroleexpountibioticdurgdevelopmentimpctEOCRCpproprep-cliclmodelAntibioticoveruehcomeerioupublichelthccernovermillidoepcridnnullyUS5023Ituefnthighover50%dictlyexpoed>5dy17Indictexpoupgnncyffectfntgutmicrobiottbirth1920tnerlygeexpoucnledmultiplehelthdder-cludgCRC212223Repetedexpouctrientibiotictnceltedgutmicrobiotpro-flmmrypro-crcogenicoutcome28-32uggetgmywdowdevelopmentlvulnerbilyHoweverepidemiologicnimltudiehvehowncflictgultnecductedimpctntibioticcommlypcridfntchildncolctgubtntilgpourknowledgemechnmwhichntibioticimpctEOCRCWeddthgptetghypoexpouerlylifentibioticcommlypcridchildncuexiccol(oceddybioflmmtiltedgeneticigntu)promotemuttiledgEOCRCUgmouemodelCRCwetetthhypotwopecificimAim1ToidentifydevelopmentlwdowuceptibilyntibioticAim2TodetermeifdybiocuedntibioticdriveEOCRCUpcompletiweknow(1)impctntibioticEOCRCrk(2)developmentlwdowcoluceptibilyntibiotic(3)whtmicrodriveEOCRC(4)wheremicrognmpromotecedmuttimechnmcugCRCThecquidknowledgecricldevelopgnoveltrtegieidentifydividultrkterventimimizerkEOCRCmeddecimigterkfteruentibioticdpenblegtfectimoimptntlyprovidefoundtifututudieidentifycompenthumnmicrobiomemedecedrkEOCRCProjectSummryPncticductldenocrcom(PDA)projectedcomeecdledgcuecncer-lteddethUnedStteyer2030unleignificntprogmdeimprovgrpythdeeThecurnt5-yerurvivlrte~12%howgmodetceoverlt30yerAlthoughchempyperteimprovgeytemicrpielyprovidemimlurvivldvntgeInddiPDAlrgelytntimmunpyMettcommeventPDAptientlimutilyurgiclectimoteffectiverpeutictrtegyPDAUndertgfcrctriePDAprogimetthpotentilvelnovelrpeutictrgetRecentlywehvehownnembryicneurotrophicfcrPleiotroph(PTN)mrkuccefullungmettemouep-cliclbtcncermodelCequentlyblockgPTNphrmcologicllygeneticllyducemettenizemettticbtcncercheckpotblockdechempyThecurntpropoleekdetermewherPTNhibirpeuticllyefficcioupcliclmodelPDAPTNexpedPDAoceddeeprogiHoweverhvelyenlimedeftperturbPTNfunctimodelPDAWehveolddrpeuticutilytrgetgPTNrobutmodelPDAThpropoldictlypivePAR-22-2216whichcllpplictifocuednoveltrtegieenhnceeffectivenechempyimmunerpySuccecompletgimprojectnomtePTNnewpotentiltrgetttmentPDAWomenUnedSttehve18PROJECTSUMMARYlifetimerkdevelopgbtcncerAmgvrioubtcncerubtypetriple-negtivebtcncer(TNBC)crriewtprognoly11%TNBCptientdtlmettexpectedurviveyd5yerFurrmocurntrpieTNBCloprovidemrglmotcelyht-termcliclnefTheenovelmoefficcioudrugTNBCttmenturgentneedMotepililcelldependentupctctextrcellulrmtrix(ECM)urvivlundergopopwhenyloectctECMprocetermednoikHowevertumcellupdetchmentECMcpbleevdgnoikThecquinoiktncecricltepctriepromentlyTNBCtumgrowthmettThunoikducerpentvlublerpeutictrgetTNBCttmentHowevermoleculrdrivernoiktncecnrpeuticllytrgetedTNBCmlrgelyunknownProtekeexcellentdrugtrgetover25drugtrgetgkepprovedUSFDAttgwide-vrietycncerclicTheeidentifykecfernoiktnceTNBCcellwepermedkome-widehRNAcenidentifiedPDZBdgKe(PBK)drivernoiktnceTNBCcellWefoundPBKwovexpedTNBCpdictedpoprognoFurrmogeneticphrmcologiclhibiPBKducednoikTNBCcellBedeultwehypoizePBKcfernoiktncedriveTNBCtumgrowthmettTheoverllobjectivedetermevivolePBKTNBCtumgrowthmettevlutephrmcologicltrgetgPBKTNBCrpyAim1tudiedetermevivolePBKdriverTNBCtumgrowthmettFirtugmmmryft-pdjecti-bedthopicmouemodelTNBCtumgrowthmettwedetermeifgenetichibiPBKuppeTNBCtumgrowthmettWelomeucircultgtumcell(CTC)lodvivothmouemodelmireffectPBKhibinoikductivivoNextbedourplimryultwetetrolePBK-dependentphophyltrncriptifcrTWIST1progrmmgTNBCcellcquimeenchymlcellttecquirgnoiktnceAim2tudiecertefficcyPBKhibirvivoTNBCttmentTodoowedetermeifhighly-potentefficciouPBKhibirOTS-964cneffectivelyuppTNBCtumgrowthmettutilizgetblhedTNBCcellleptient-derivedxenogrft(PDX)-bedmodelTkengerourfdghvetrgcientificimpctetblhgnovelrolePBKdrivgcellttegulrypthwyfcilteTNBCtumgrowthmettwelletblhgPBKtrgetgneffectivepprochttgTNBCAbtrctWhileover90%ptientmettticprottecncerpdytemicrpieblockrogenceprignlgnerlylleptienteventullylpedieduedevelopmentcquidrpytnceThutrtegiepventcquidrpytnceneededWehveidentifiedrmoleculrubtypeprottecncerocrtedehydrogene1(IDH1)muttifilcquitncerpyThexplrypropolvetigtemechnmwhichIDH1-mutntprottecncerfilcquitncerpygolidentifynovelrpeutictrgetpventtnceMoleculrcequenceIDH1mutticncerhveenpvioulytudiedAMLgliomwhehenhownIDH1muttiledccumultiR-2HGhibi2OGdioxygenecedDNAhnemethyltimrkedltertiepigeneticgultigenetrncriptiHoweverAMLgliomdiffentmotolidtumcludgprottecncercueydotmettizehveuniquettmentprdigmWetethypoIDH1-mutntprottecncertrictedepigeneticctrolgenetrncriptinderglebledpttuchrpyhibi2OG-dioxygene()enhnceperpyInAim1wetudylrgetcohtptientIDH1-mutntprottecncerdtedecricliclgenomictrncripmicfetuthdeeAim2developtrngenicmumodelIDH1-mtprottecncertudymechnmrpytnceenivyvivoInAim3wepermtrgetedCRISPR-KOcenidentify2OG-dioxygeneupdeleticeDNAmethyltirpyenivyprottecncerTogereimprovideightmoleculrcequenceIDH1muttiprottecncermyidentifynoveldrugtrgetdbleepigeneticplticyquidcquidtncerpySummry/AbtrctThCerDevelopmentAwrd(K08)etblhehelthtteutiliecroeverletblhedevolvgrpielow-rkub-centimeterthyroidcncer(ppillrythyroidmicrocrcomPTMC)WhileurvivlPTMCfvblettmentcncurubtntilmbidyocietlcotAcceptblettmentcludectiveurveillnceprtiltlthyroidecmyrdiquencybltiDuedeeexcellentprognounlikelyettmentwouldyieldmengfuldiffenceurvivlhoweverpot-ttmentexperiencediffentThuttmentvluelrgelydrivenptientperceptipfencegrdgttmentexperienceThvluemyetimtedthroughtted-pfencetrumentdefeutilyp-defedhelthtteThufrltlednhelthtteutiliePTMCunclerwherptientclicingenerlpopultimotubleprticipnttudieetimteutilyThecidteddeknowledgegpetimtgutilieeriePTMCcliclvignetteugtimetrde-fpfence-bedtrumentTheeutiliencptedMrkovcot-effectivenemodelcomprgurgicln-urgicloptiSpecificllycidtetetfollowghypoe1)vergeutilyctiveurveillncehelthtten-feriprtilthyroidecmy2)ttmentcomplictiignificntlyduceutily3)generlpopultipdentignificntlyundetimtethyroidcncerutilieltiveexperiencedptienthelthcwker4)ctiveurveillncemocot-effectivemngementPTMCthnurgeryrdiquencybltiThelg-termobjectivetherchetblhpfence-bedhelthtteutiliecnuedhelthecomicerchoptimizeourcellocthyroidcncerFollowgcliclfellowhipurgiclcologycidtewppotedAtntPurgerytUniveryMrylBltimoHehceprtnedcientificmenrCDnielMullPhDenggeptientphyicintkeholderheltherviceerchThK08deignedtrnierchdependencethroughgrduteleveltrgurveydeignptient-centedoutcomebiotttichelthpolicyAddilpilcouredderchcerdevelopmenthelechnologyementThepplictidrwupourcethroughchoolmedicedeprtmenturgerychoolphrmcyWhdvncedtrgfdedK08cidtepoiedubmcompetiveR01pplictiDepeubtntildecepvlencemokgoverpt50yerpertentignificntdpriebccouemgtrngendergenderdivere(TGD)dividulThepvlencecigtteueTGDdividul457-623%compd398%cgenderdividul1Thelodpriee-cigtteuemgTGDpeopleltivecgenderdult(265%v55%trngendercgendermenpectively)2Trngenderdividulmyprticulrlyvulnerblecequencebccouehmerpymgthoewhomokecehertdeerk3mokgmyhdercoverygender-ffirmgurgerie4StigmdcrimtigenderdyphigendermytctriebccouedprieEnctedtigmdcrimtiwrdTGDdividulcomm(ptedover75%prticipntomemple5)experiencgtigmdcrimticeoddcurntcigttemokge-cigtteue/vpgduluemgTGDpeople6Genderdyphigendermytmyloled/excerbtedprienxietydepi7whichmjimpedimentmokgceti8mopvlentmgTGDthncgenderdividul9Anxietyympmco-occurmokgthighrteignificntlyimpircetiucce1011Similrlydepedmoodmjdepivedderbothmocommmgdividulwhomokethnmgthoewhodot1214ocedducedoddceti15TheegendermythighpvlencertenxietydepinderTGDdividulprticulrlyvulnerblemokgcetidifficultieAtilodmokgceterventibuildcognivehvilkillcetiwellducegendermytocednxietydepiympmhtrgpotentilmigtebccouedpriemgTGDdividulWepropoedptnextgmokgceterventi(knownQUIT16)dduniqueneedTGDpeopleInfocugroupTGDdividulwhouebcco(N=up32)provider(N=8)weexplowywhichgendermytocednxiety/depicompromecetiwellidentifyctentcurntveriQUITterventidoedoenotmeetirneedProviderlocommennnticiptedimplementtibrrierFollowgADAPT-ITTmodelqultivedtmdptterventiWentetfeibilycceptbilydptedterventi(QUIT+)pilotRCT(N=60)weloeignlclicllymengfulchngebiologicllyverified7-dypotpvlencebtencevergenumrcigttemokedgendermytnxietydepiympmdtlernceIfdeemedfeiblecceptbleterventidyhybridefficcy/effectivenetrilPROJECTSUMMARY/ABSTRACTPtientdvncedtriple-negtivebtcncer(TNBC)hvepoprognomedinoverllurvivl~18mthtrd--c(SOC)chempyHoweveroverllurvivlcnextendeduchTNBCptientlmodetly~25mthcombtiSOCimmunpyflectgrtileimmuneytemntegrlplyeroverllnti-cncerpeInTNBCimmunpyknownnimmunecheckpothibir(ICI)mocllntibodyblockPD-1/PD-L1xCD8+cyxicTlymphocyte(CTL)utireffecrfunctiApqueeffectiveICIrpyvilbilytumntigen(Ag)whichturncognizedAg-pecificCTLWenowknowpoiveeffectcertchempeuticICIefficcydueprtvilbilyneo-AgcognizedCTLTheeneo-Agthoughtderiverpy-ducedmuttiperhpn-mutteddetermntgenertedpot-trnltilprotemodifictiducedimmunogeniccelldethHoweverchempycngenerteyetntypen-muttedneo-AgwhichcurntlyoverlookedChempymedentumeffectcuecncercellpddiffentlynmlcellDNAdmgeTheeterventidmgenlyDNAloRNAcompentpliceoomeCequentlychempycnccompniedtrnienthibiplicgexpoedwidepdtrtentiTheptternDNAdmge-ducedtrtenticurntproduciblecellttedmechempyTrnltimRNAtrncripthrbgtedtrultgenertghdn-muttedneo-AgencodedtricequenceDiffentilpechempy-ducedDNAdmgemnifetedprncriptietcellplicti-ltedgenenmlcellnotcncercellp53genemuttifquentlyceTNBCThmyultgenertgcncer-pecificn-muttedneo-AgencodedtedtrSomeenoveltr-encodedequencemyctimmunogenicneo-epipecncognizedCTLHewehypoizechempyttmentp53-mutnttumcellgenertenovelchemo-neoepipe(CNE)whichcnidentifieduedimmunogenmobilizenewpooltum-pecificCD8+TcellOurrtileflectcceptCNEpeptideequencewouldcompletelynewimmuneytemwouldcpblegenertgrobutimmunepeInthpropolweidentifycidteCNEpeptideAim1nAim2determeirimmunogenicybdthducedCD8+TcellperiImmuniztielicCD8+TcellperiimilridenticlducedchempyprdigmuggetnovelCNEOurlg-termobjectivecefquencientumCD8+CTLICIefficcyTNBCdeetillunmetcliclchllengeABSTRACTRecentlyourlbdevelopednovelimmunerpeuticpprochdelivergTTnetigenurrogteelectivelytumLterifectivivowhichttrctp-extgTT-pecificmemyTcell(genertederlierlifedurgchildhoodvccti)nowkillghighlyimmunogenictumcellThhenpublhedltyerScienceTrnlMedOurultimtegoltetthpromgrpyptientdvncedpncticcncerAlthoughLterihenteted15yercncerptientthwlwythroughtrvenou(iv)jectiInpvioutudiewefoundLterineedjectedtrperinelly(ip)derchtum(Lteriimmedelyelimtedbloodthroughimmuneclernce)HoweveripjectiLterihneverendeeptientTheewedevelopedolvulizeLterivivoporemimogrphy(PET)cnieweuplodedLteri-TT18F-fluodeoxyglucoe(FDG)FDGglucoenloguetrnptedcellthroughglucoetrnpter(GLUT)nphophyltedhexoke(HXK)FDG-6-phophtewhichcomedcellultgpoiveFDGignlmeurblePETcnThmethodologynmllyuedvulizetumvivoHoweverhewedtwntFDGignltumLterimirLterivivoItknownLterrnptglucoethroughviPEP(phophoenolpyruvte)PTS(phophotrnfereytem)StrvtiLteri-TTbcterilefollowedcubtiLteri-TTFDG(up5mCi)vrowhgtepelimtefeFDG(uperntnt)ultedhighlyrdioctiveLteri-TToutkillgLteribcteriMoimptntlyLteri-TT-FDGwvibletummettePET/CToutbckgroundnmltue1hrfteripjectiOurultuggetfurrimprovementpoible(higherdoeFDGdiffentcubtimemirg)ThllowumirdtriiLterivivowhichnwereverlquetiuchwherLtericcumultetummettely(likemice)twhttimepotdoweeehighetnumrLtericltumizewhtenivymethodologyInpclicltudiewefoundLterilyvibletum(immuneuppivellowgLteriurvive)mettenotnmltue(lckimmuneuppiLteriimmedelyelimted)rgqueticnweueLteri-TT-FDGdetermeuccerpydigno?ThumgolthpropolfetuneLteri-TT-FDGhumnpplictiTochourgolpecimfollowAim1ChrcterizgLteri-TT-FDGvroAim2TetgLteri-TT-FDGdiffentmouemodelpncticcncer(Pnc-02KPC)ProjectummryPottrnltilrgyltiprotetlledrgyltrnfereATE1criclmodificticncerprogimettATE1neficirygulrhibiwhichtenultelevtedmett(egprottecncer)pooutcomeUntuntelyphyiologiclroleATE1(rgyltictivy)cncermpolyunderodmotlyduelcknlyticlmethoddcoverproteubtrteATE1cncermpleArgyltigulteprotehlf-livecellulrytemthroughArg/N-degrpthwypentethe(rgeprolecetylti)N-termldegrdtiignl(N-degr)proteturnoverHeweimdcoverproteubtrteATE1cncerdevelopmenttrgetedprotedegrdti(TPD)hijckgATE1rgyltictivyWehvedevelopednundproteomicprilgmethoddcoverATE1ubtrteirpcergyltiemethodtermedctivy-bedrgyltiprilg(ABAP)UgABAPwehveuccefullypriledrgylti12mplecludg4cncercellleInthpropolwewouldlikeetblhlibrrycncerouubtrtecommlyuedcncercellleugNCI60pelletTotkedvntgergyltrgetedprotedegrdtigtcncerwehveenggedATE1protetet(POI)throughourmodelHlo-FKBPytemWedcovedfirttimeenggementATE1cncertrget(egSHOC2RAD52)uccefullyducedPOIdegrdticellulrmodelWetermedechnologyrgyltrgetgchimer(ArgTAC)OurplimrydndegrdtidtfirtfewPOIencourgedufurrdevelopechnologynovelpprochTPDfieldWepplyeriette---rtpprochecludgproteomicmoleculrbiologychrcterizemechnmctiducedPOIdegrdtifterenggementATE1AeriemoleculreventchrcterizedcludgcellulrproximytweenATE1POIrgyltipolyubiqutiPOIPOIdegrdtidependencyUBRE3ligeproteomeTochieveoptimldegrdtibrodcncertrgetweexpourolcompounddeignedHlo-FKBPytemWelofurrdevelopnewATE1bder/cruerthroughpeptideoptimiztibedLIAT1(ligATE1)bdgdomATE1ugcengtructu/computermodelg-beddrugdcoveryMoArgTACtrgetgPOIynizedteteddegrdtictiviecellmodelexppplictiArgTACThepropoedABAPArgTACpltmhelikelygenertectlogcoprotegultedrgyltifergenerlvolutiryTPDtechnologytrgetgcoprotedegrdtirpeutictrtegycncerDurgchempy34%btcncerurviv(BCS)experiencecncerttment-ltedcogniveimpirment(CRCI)CRCIdegrdememyexecutivefunctiwellqulylifeAnumrBCSexpectedceemilli2030loncepvlenceCRCIOneundertudiedrkfcrdietnunderlygmechnmggutmicrobiotPot-ttmentcedfruvegetbleftcumptiprotectgtCRCIBCSHoweverneirthltihipnunderlygmechnmuchgutmicrobiomehenvetigteddurgttmentwhenCRCIgAdhenceMederrnendiet(MedDiet)henhownimprovememycelevelFeclibcteriumprunziigutbcteriumocedttercognivecon-cncerpopultiInBCSundergogchempythbcteriumlkedneurologiclxicyAMedDietdurgttmentmyeduceCRCIcidenceeveryvigutmicrobiomeTheobjectivethtudydetermeifdietltedCRCIBCSifgutmicrobiomemechnticlkMycentrlhypohigherdhencecompentMedDietegfruvegetblemounturtedftfirltedhigherconeuropychologicltetdmteddurgchempygutmicrobiomemedethltihipTheimthtudyfollowAim1DetermeltihiptweencompentMedDietgutmicrobiomecognivefuncti30BCSedurgfterdjuvntchempyttmentbtcncerAim2DevelopMedDietterventiBCScductgemi-tructudterviewmgBCSwhohvecentlycompletedttmentundertirviewttudewrdMedDietAim3Cduct12-weekMedDietpilotfeedgtudymg30BCSundergogdjuvntchempyTocompleteeimIneednterdciplrymenrgtemtrme1)cductgerchcncerptient2)deigngctrolledfeedgtril3)qultivedtcollectinly4)dvncednlycomplexdietryneuropychologiclgutmicrobildtetThroughtrgthmenrgtemthroughcourewktellrfciliefedmytutiIcompleteK99phethpropolthu(1)undertltihiptweendietgutmicrobiomecognidurgbtcncerttment(2)undertBCSttepfenceMedDietdurgttment(3)provideplimrydtubmwoR01grntubmi(4)ppmeledfeedgtrildurgR00phewrdunderthowgutmicrobiomecnmnipultedthroughMedDietduceCRCIThK99/R00llowmecomendependentvetigrledggutmicrobiome-focuedptient-meddietrytrilduceCRCInegtiveimpctPROJECTSUMMARYNerly13000newcelryngelcncerdignoedUSnnullyTrnllermicrourgery(TLM)hcomeprimryurgiclpprocherly-tgeendolryngeltumTLMprovidetumctrolwhilellowgmximllvgenmltuepervepot-ttmentlryngelfuncti(ievoicewllow)HowevernolibletropertivepprochepprovedidurgeubjectivevulementtumbderdurgTLMledgpot-TLMcurncedeeubtntilproptiptientPnumumb-IRDye800henuedmultipleclicltrilner-frdfluocence(NIRF)imggdurgurgeryvrioumlignncieCurntfluocenceguidedurgery(FGS)clicltrilugpnumumb-IRDye800quropertivepthologiclcfirmticncerefurrurgiclcticnmdeydtrdcMrglbiopiedurgTLMlimedvolumenumrwhichcfoundpthologiclementtropertivettemptidentifyclicllyoccultvivemrgThelckFGSclicltudiedurgTLMptientlryngelcncerhenbrrierdetermgifcurntmetricguideFGSwouldpplicbledurgTLMproceduAddgthcliclbrriercricltepdetermgneftropertiveNIRFpoivelyimpctbothTLMurgeryoutcomeptientlryngelcncerWepropoeclicltudydemtrtefeibilynovelcombtropertiveopticlimggpprochedeteccculttummrgptientlryngelcncerObjective1etblhmetrictropertiveopticlimggdefepthology-cfirmedoccultlryngelcncermrgThobjectiveccomplhedcltgtropertiveimggdurgtllryngecmyprocedupot-ectuenlyecludghpthologygoldtrdtruepoivetruenegtiveoccultdeeObjective2tetccurcytropertiveopticlimggmetricidentifyoccultlryngelcncermrgdurgTLMThobjectiveccomplhedugimggmetricidentifypoiveopticlignlydgtmentplnnedptientwhoundergoTLMOutcomeetudieueddeignromizedphe2triltetcomdimggpprochguideTLMptientlryngelcncerThelg-termoutcomeetudienticiptedpoivelyimpcttropertiveidentifictioccultmlignncywhilemimizglocricllryngelfunctiOurcurntcliclpproch-irrdinotbeddtGuidelevrywidelynotrootedobervedxicieAfquentlycedbothcrcyextgoutcomedtwellheterogeneymultiplerdicoureperptientvribletimetweenttmentItcctlckdteveproblemthougheolvedgiventeepcenumr-irrdicepublheddtWhtcurntlckdbcumuchmofundmentlproblemevenifwehdenoughoutcomedtnocceptulfrmewkoutcomemodelfdtTheneeduchnpprochguidecliclttment-irrdiurgentWhile-irrdiuedrptientvolumegrowgrpidlytudieptldy16ptientcomerdipyhveceivedprirdivolvednereToovercomechllengedecridbovewepropoenovelpprochguide-irrdibedimggevolutinmltuedmgecoveryInthpcedtmoplentifulimggtdefedclicllylevntfollow-uptimepotFurrmowecnbuildouruccedecribgnlyzgnmltueperdiToovercomechllengedecridbovewepropoenovelfrmewkguide-irrdibedtwovtiveccept1)QuntifygevolutinmltuedmgecoveryfterRTThetimefcroimptnt-irrdicntudiedugevolutirdi-ducednmltuedmgeimgg2)NmltuerdioenivyndividulptientcervedtweenRTcoureWhiletheemtuivenotknownifnmltuepeptientcltewhen-irrdgmWehveuniqueplimrydictgtrgltihipprovgthhypowouldenbleutegrtepefirtttmentplnngecdBedetwocceptwemultedourtwodependentimInSA1wedecrinmltuecoverybedfollow-upimggugimggbiomrkerliverlungjuryfterrdipyWehypoizewecnprmeterizedoe-dependentcoveryrdi-ducedjuryuggleptient-pecificcoveryprmeternmlliver(SA1)lung(SA1b)fterrdipyInSA2weexplofeibilyperlizti-RTbedobervednmltuepetfirtRTOurwkghypothbervedrdi-ducedimgechngefterfirtRTpdictnmltuepetecdRTwhencctedillygivendoedtriiUpcompletieimwepoegenerlizblefrmewk-irrdillowucpteptientdividulpefirtrdtmenttimehpedceplnng-irrdiPROJECTSUMMARY/ABSTRACTMettpiblemothn90%prottecncer-ltedmtlymciderblechllengedevelopgeffectivedurblerpieIntetgly80%llptientmettticprottecncer(PC)developmettedroppgir5-yerurvivl26-30%whichunderconeedvelundertexplouniquecellulrpthwymechnmcogeniceventdriveimtimtenncePCmetteEentildevelopmentpcliclcengnovelrpeutictechnologienurgentneedliblecvenientvro/vivocellulrmodelcpulteuniquePCmettticenvirmentProtte-SpecificMembrneAntigen(PSMA)expedepiliumnerlyllPCceprogictrtitncemettticdeeTumvculryhmjimpcntumgrowthdrugpivenepecttumoxygentipermebilychempeuticPCcell-vculrendolilcell(EC)crotlkduceexpiPSMAurfcetumvcultuPCnlcellcrcombtlunggtriccoloctlpncticblddercncerCequentlyPSMA-trgetedrpie(rdipeuticwellmll-moleculentibodydrug-cjugte)ctivelygpuruednticiptedmodultePCtumvcultudeevolvgpthologiclngiogeneOurlg-termgoldevelopflexible3DbioprtedtummicroenvirmentmodelcnervepcliclcengpltmenhncedevelopmentnovelrpeuticgentvrioucncerThtudyimdevelopwell-defedvromodelmimicmoleculrcellulrmetbolicterply-tummicroenvirmentmettticPCcfirmimilrlypivecliclcdinoveltrgeteddignoticrpeuticgentThertileundertkgpropoederchdevelopgproduciblepdictivePCtum-modelccelerterpeuticdevelopmentPCmimizecliclfiluPROJECTSUMMARY/ABSTRACTFewchildncurntneuroblmurviveNewrpieprticulrlyimmunpiebdlyneededSomepromgulthvecentlyenpentedneuroblmtrilCARTrpydemtrtgdictedTcellrpeutichvepromgroleplyfutuWepropoedictTcellkillneuroblmcellugmultpecificTcellengger(MTE)bdROR1PD-L1CD3ROR1trgetedcueexpedmotneuroblmptienttumhenhownnecerytumimigrtiggivecncerfetumultipletypecncerPD-L1trgetedcuecellurroundgROR1-poivecellgkilledMTEupgultePD-L1peterfergmmleedenggedTcellWhilePD-L1upgultinmllydefenemechnmgtimmuneurveillnceourmoleculecvertcncervulnerbilycuemocncercellupgultePD-L1tterTcellbleenggekillmduePD-L1CD3bdgmotifMTECcernboun-trgetf-cncerxicyduePD-L1expinmlhumntuemigtedcenthumnclicltrilulthowgDvoceticeptnMTEtrgetPD-L1chievedgoodcncerctroltdoewewelllertedclicltrilWepropoefollowgAim1Determeextentwhichptient-derivedneuroblmvulnerbleR2P3pluctivtedTcellAim2DetermeR2P3efficcypedrictumheterogeneouROR1expiThenovtitemco-trgetgROR1PD-L1whichddetwocommmechnmtncedictedTcellrpienmelytrgetheterogeneyupgultiPD-L1FurrnovtilteMTEelfwhichctgledombderROR1PD-L1CD3whichtendovercomemnufcturgchllengeocedhevy-lightchpirgTheignificnceourpropolmoleculewehvedeignedcouldrpidlydvncehumnclicltrilchildnneuroblmpedricolidtum(egEwgrcomrhbdomyorcomoteorcom)ifultetudieupptfurrclicldevelopmentOverhlfcenturyfiledclicltrilcurntneuroblmptienthtughtuboldctivethoughtfulnewpprochemutdvncedTriple-negtivebtcncer(TNBC)dproptelyffectAfricnAmericn(AA)womenmtlyrte65%higherthnCucin(CA)womenThemechnmunderlygheightenedggivenemettAATNBCmeluiveThtudyvetigteimmuneuppivetummicroenvirment(TME)drivgfcrAATNBCprogiSpecificllydelvenovelroleS100A7terplytricIFNignlgelucidtgirimpcnTNBCggivenemettAAwomenOurcentfdgvelelevtedS100A7expiAATNBCptientmplecellleltiveCAcounterprtMooverhigherS100A7expicltecedtumburdenvrioup-cliclmodelcludgAATNBCptient-derivedxenogrft(PDX)WelotedS100A7knockout(KO)mouemodel(genertedourlb)exhibducedtumburdenwhilettmentnovelS100A7-neutrlizgntibody(nAb)howpromgefficcyhibgTNBCgrowthmettMechnticllyS100A7demtrtedenhncecPLA2/PGE2/IFNGR1ignlgAATNBCcellmodultgtricIFNignlgThprocegenertenimmuneuppiveTMEupgultgPD-L1downgultgFtumcellAddillyAATNBCtumtuemnifeightenedimmunouppichrcterizedcedPD-L1expifiltrtiFoxP3+TgcellOurpropoederchimmeticuloulyuncoverhowS100A7chetrteIFNpivegene(PD-L1F)genertenimmunouppiveTMEAATNBCThvetigtilevergedivereAATNBCcelllehumnizedPDXmodelgeneticllyengeedmouemodel(GEMM)ovexpgmS1007mS1007KOS100A7nAbThetudyoverrchghypopoS100A7ctrieAATNBCggivenefotergnimmunouppiveimmuneeviveTMEvigultgtricIFNignlgultgPD-L1upgultiFdowngultiTheerchtrtegyencompethekeyimAim1elucidtehowS100A7ignlggulteIFNpivegeneAATNBCugAATNBCcellmS1007GEMMAim2determenovelroleS100A7gultgmcrophgeplticyTcellfunctiF-mededimmuneeviAATNBCAim3evluterpeuticefficcyS100A7nAbcombtichemoimmunpyugAATNBCPDOPDXmouemodelThimlodetermeprognoticignificnceS100A7downtmignlgmoleculeAATNBCInddhimetblhociS100A7vriouimmunecellTNBCrcildpryTheightgedpoedidentifynovelS100A7-mededdowntmignlgpthwydetermeclicllevnceS100A7AATNBCThtudyholdimmenepotentilmdeignnovtiverpeutictrtegietilodAATNBCctrigimprovedoutcomethhigh-rkpopultiPROJECTSUMMARY/ABSTRACTBckgroundMlignnteffui(ME)fquentcomplictimettticbtcncer(MBC)ocedeveympmdiprognoTtgMEvolvepllhrougherilmovlexcefluidwhichntypicllydcrdedIntedefluidcoulduedubtrteliquidbiopy(LB)guidettmentMEdvncedMBCProblemDrugtrgetpdicrpeMBCtmendouunmetcliclneedProcurgolidmetttictuecnchllenggduecceibilydeeerkocedtuecollectiAmjimpetuthpropoederchopptunyLBcircumventelimtiMEcircultgtumcell(ME-CTC)cnerveurrogtemetttictuemoleculrchrcteriztiHoweverlowproptiMETCltiveimmunecellmnyMEcomplicteprilgeftSolutiWehvecollbtedDeepcell(DC)compnydevelopednrtificiltelligence(AI)-tedmphology-bedpprocholteME-CTCDCbiomrker-gnoticpltmprovidendvntgeovertrdilbiomrker-bedtumenrichmentmethodctgmphologicltleME-CTCmgnovelbiomrkerttmentpetnceOurpilottudiedemtrtefeibilymoleculrchrcteriztiME-CTColtedugDCpltmHypoWehypoizethltgME-CTCugDCpltmdowntmprilgcnfciltedevelopmentLBolevlutgknownctiblebtcncer(BC)biomrker(egER/PR/HER2PIK3CA&ESR1mutti)dcovergnewpdictivemoleculrmphology-bedbiomrkerdrugtrgetSpecificAimInAim1wefirtvlidteDCpltmugprimrycellMEME-derivedgnoidNextweuevlidtedpltmolteME-CTCgenertecopynumrmuttiprileecellmtchedrchivltumcompttugenefquentlymuttedBC(egPIK3CAESR1)detectME-CTC-pecificrrtiInAim2wepermgle-cellRNAequencgimmunocychemtryoltedME-CTCME-derivedgnoiddcoverexpi-bedbiomrkerettuknownBCbiomrker(egER/PR/HER2)InAim3wepermcltivenlyetweenttmentpevME-CTCmphologymoleculrigntu(Aim1&2)ueME-derivedgnoidvlidtitudieTrnltilimpctDevelopgpltmoltgtumcellMEliquidbiopyoldcovernovelpebiomrkerdrugtrgetcntrnmttmentMEplliveettgrpeuticopptunyimproveoutcomeptientwhodevelopedevttgcomplictiPROJECTSUMMARYChimericntigencepr(CAR)-TcellrpyhemergedpowerfulnewcllivgmedicecncerrpyepecillyptienttnrfrcrybloodcncerHoweverpplictiCAR-TcellrpyolidcncerhhdltleucceduechllengeheterogenountigenexpilimedtumfiltrtiCAR-TcelldyfunctiimmunouppivetummicroenvirmentCombrilttmentpprocheuchtegrtirdipyCAR-TcellmyprovideneffectivetrtegypropgtentumimmunyovercomeobtclepoedolidtumInplimrytudyugCAR-Tcellco-expgomttcepr2(SSTR2)trgeteddeliverynimmunomodulrydoe177Lu-DOTATATEwenotedrpidtumloclizti177Lu-DOTATATEubequentgilrgeetblhedtumFurrmoourplimrydthownceerumIFN-perfollowgttment177Lu-DOTATATEuggetgrdi-ducedeffecnT-cellimmunyOurobjectivethR21propolexplopotentiltrgetrdipy(TRT)delivedytemicllythroughSSTR2-expgCAR-TcellnFDA-pprovedrnoticenddipy(177Lu-DOTATATELutr)enhnceCAR-TcellrpyOurSpecificAim1)Invetigteimpctimge-guidedTRTntumimmunepeWehypoizenoptimizedTRTdoecnflmetumndergmmouceptibleT-cellcyxicyfciltgtumerdictiGuidedCAR-TcellimggdoimetryetimtiwecductdoepetudyidentifyoptimlrdidoethnovtivecombtirpyAddillyutilizgheterogenoutummodelweexplopotentilimmunomodulryTRTpromotetumkillgthroughTRAIL-F-mededmechnmprtillydependentCAR-TcellThpprochholdpromeddgomemechnmtumtnceuchntigenecpe2)ElucidteunderlygmechnmynergticcombtiTRTCAR-TcellrpyUgyngeneicmouemodelntctimmuneytemtummicroenvirmentweimvlidteelucidtekeyphenotypichvimoleculrpthwydrivgynergytweenimmunomodulrylow-doeTRTCAR-TcellrpyOurexperimentlpprochencomptechniqueuchflowcymetryimmunohchemtryglecellmulti-omicnlyThepropoedwkfernewtrtegycombgenddipyCAR-TcellrpypplicbleytemicdeewidepdmetteFurrmoddmechnticightundertgimmunomodulryeffectrdiABSTRACTPncticcncernggivepfulmlignncy5yerurvivlrtelethn5%medinurvivlbout424mthTheoverlllckuccechempyttmentundercotletprtcompleteundertghowpncticdenocrcom(PDAC)growvdelocldtnttueThectuenoveldcoveriepectgeneticmuttipdpoedividuldevelopgPDAChpthologiclfetuprognoticimplicticliclimgg(functilmetbolicnmicegPET/CT)defeclicltgeguidettmenptiHoweveroverllechdignoticmodlylrgeprtmdependennenCequentlyneedetegrtemeumentcelltuegnlevelmultipleimggmodlieevluteccdncecrodiffenttypemeumentptilclederchrcterizemoleculromic-typecliclphenotypeltihipLkgmeumentediffentdciplerdiologypthologyhigh-throughputmoleculrmeumenthelpetblhmodefivephenotypePDACctentcromultipleptilcleRecentlymnychngePDAChveevolvedroundchngemetbolicpecttummicroenvirmentterctitweentumcellurroundgtromlcellthuwefocuidentifygmetbolicllydriven/ltedphenotypeWehypoizechrcterizgPDACmicroenvirmenttum-tromterfcetcelltuelevelenbleementglycolyticflmmrychrctertictumltipecifichlogicltumchrctertic(egpeurlvilymphovculrvi)thled1)n-viveimggtetidentifyPDACphenotype2)newpotentilcellulrtrgetttmentAdt-drivenytembiologypprochugtrncripti-ignlg-metbolicnetwkctructictrt-bedmodelguedtiebdwiderrydprtedtcludgcellulrmicrocopy3DpervedrchectutueimggPET/CTimggderdefen-vivefunctilmetbolicphenotypgmeumentPDACcpdcellulrphenotypeThectrt-bedgenomecletegrtivemodelgfrmewkllowimultneounlymultipletypedtterctgpopulticellAddillythroughcquimulti-prmetriccro-ectilimggpoibleevlutewhernotmetbolicchngecellulrlevelhvenymnifettituelevelTheenvirmenttemourceembledtUCLApoeduniquepoicrryoutetudiechieveuccedevelopgn-viveimggpprochphenotypgPDACPROJECTSUMMARY/ABSTRACTThencdibleneedfdnewbiomrkerimproveourbilyperlizecncerrpyidentifythoehvexicyttmentThgrowgneedhledquetpropolfocugeproblemerchgolutientledPAR-19-325CliclChrcteriztiCncerTherpy-InducedAdvereSequeleMechnm-bedInterventilStrtegieUntuntelyfewbiomrkerhveenidentifiedcnpdictxicyrdirpy(RT)RTcnernecncerttmentuedtver2/3cncerptientThprticulrlynotblectextloclizedprottecncerwhichnexceedglycommcncerwhichRTtrdcttmentBecueurvivlohighltexicyfterRTimpcnqulylife(QOL)criclInfctprottecncerptienthvehighetcncerttmentltedyerliveddbilywldwidelikelyflectghighcidencehighcurtemodernrpyRT-lteddvereequeleltedcomplexloclhot-pecificperpydictggerm-lebiomrkerpentllptientcellmotlikelyplcefdbiomrkerpdictgxicySglenucleotidepolymphmmicroRNAtermedmiR-SNPhveenfunctilbiomrkercnidentifyptientltedtperpyHowevermotpviouefttudyggermleDNAhvelrgelyignodmiR-SNPenotcptudmotDNAevlutipltmOurpriwkhidentifiedpnelebiomrkerpdictgignificntltegeniurry(GU)xicyRTprottecncerptientThePROSTOXbiomrkerpecificllypdictlteGUxicyfterteotcticbodyrdipy(SBRT)ndvncedmRTuedvncedtechnologydeliverhighdoerdiperttmenteicdengRTcourejut5eiOurgrouphlohownromizedtrilcgphyiclpciSBRTdeliveryducepot-SBRTGUxicywellInthpropolgolfurrvlidtepdictivepowerPROSTOXddilcohtexpebiomrkerpdictthoetrkcutexicycnloledchricxicyprottecncerptientvetigtebiologicldiffenceperdhoehveeigntufllyevlutewhercuttg-edgedptiverdipycnhelpducexicyptientfurrcgpciSBRTdeliveryReultthpropolignificntlydvnceourbilypventignificntltedvereequelerdiprottecncerptientwholrgegroupptientwhocurntlyuffergtlychricxicyttmentDcoverymllmoleculetrgetgPolycombRepiveComplex1ABSTRACTThedcoverymuttidygultichromtmodifiermjcncerdriverhpidcedphrmceuticleftidentifypecifichibirPolycombRepiveComplex1(PRC1)PRC2chromtgulrmedetrncriptililencgmtcellulridentyThePRC2ubunEZH2ctlyzehneH3lye27methylti(H3K27me1/2/3)ActgimmedelydowntmcniclPRC1(cPRC1)pecificllycognizeH3K27me3vipecificChromobox(CBX)domubunencepiPRC2trgetgenechromtcompcti3DloopgNotblyn-cniclPRC1(ncPRC1)whichlckCBXproteomecPRC1complexecncruedmedepidependentlyH3K27me3mechnmpolyunderodEZH2ovexpedhyperctive1-2%llcncerctlytichibiruchTzemettimedtblockgcPRC1-dependentgenepiwecentlyFDA-pprovedttmentEZH2-mutntB-celllymphomSMARCB1/INI1-mutntrcomHowevermountgevidenceomeEZH2-dependentcncerlyprtillydependennctlyticctivycPRC1-dependentpiwhichexplwhyhibirlikeTzemettcnhvelimedefficcyMooverceEZH2hwell-knowntumuppiveroleometueccernhibicouldcueecdrycncerThunewpprocherpeutictrgeturgentlyneededttmentEZH2-dependentcncerWeeekdictlytrgetcPRC1complexerpeutictrtegyhenmotlyunexplodWehypoizemllmoleculetrgetgcPRC1ubunctdowntmdependentEZH2H3K27methyltrnferectivyfciltemechnticighttrctblecventilgeneticolvelnewterventipotrpypotentillyprovidgmenovercomecurntlimtictlytichibiTheoverrchgobjectivethprogrmidentifydiveremllmoleculectivygtcPRC1determeirmechnmctiTochievethwehvedevelopedeniveHTS-comptiblecPRC1/PRC2lumecentpterycomplementedpublhedecdrytertirythoglywhichldyyieldedcfirmedhcompoundctivygtcPRC1/PRC2downtmdependentH3K27me3SuccefulidentifictimllmoleculecnctlyzemechnticexpltienbleementpclicltrgetvlidyedvncgnovtivebicchromterchledgimpctfultrnltiltudiehighlylevntEZH2-dependentcncer1ProjectSummry/AbtrctVirtullyftl60yergopedriccncernowcurble85%childnwhohveccectempryttmentrobutupptivecHowever80%childnbnlowmiddle-comecountrie(LMIC)pictulepromgWhenviewedgloblperpectively30%childnLMICurviveirdignocncerhighlightgtrkctrttweenhigh-comecountrie(HIC)LMICpentgelrgetdpriegloblhelthWhilecurblecncerchildnnotpventbleWhnoopptuniepventicot-effectivemlignncy-pecificttmentcglyvilblenccurtedignotenpentdiffencetweenpotentilurvivlcertdethModernmethodcertcctdignouchflow-cymetrycygeneticmoleculrgenomictrdcHICunvilblemnyLMICttmentcenterTrnmtivedignoticpprocheutilizgcot-effectiveclbletechnologyurgentlyneededAgenomicequencgpltmcomemocceiblenlyticlcpbilieexptegrtgequencgchildhoodcncerdignoticpentnopptunyovercomegloblpthologygpClifictipedriccncerught-dRNAequencgetblhederchettgcplmtennceexpenethpprochprohibivemotLMICHowevernnopoequencgpltmquimimlcplvetmentlimedlbfrtructuprovidgnopptunycot-effectiveclblemoleculrdignotictechnologypedriccncerttmentcenterWepropoeetblhvlidterobutclifictimodelpedricleukemextrcrnilolidtumlymphomugnnopoequencgWelevergecloeprtnerhiptweenvetigrtUniveryNthCroltChpelHillStJudeChildnReerchHoplInduHoplHelthcNetwkPktnoptimizetechniclnlyticmethodologiennopoequencgchllenggmplepecificllyml-fixedprffemddedpecimenWehrdenextgprocoldeploymentLMICcpteournlyticpipeletegrtednnopoequencgbe-cllghrdwtepwrdfdblepot--ccncerdignoticenduerOurobjectivedevelopvlidtecot-effectiveutbledptbleoluticlicllylevntdignocogenomicclifictichildhoodcncerLMICugglobllycceiblepltmProjectSummryTum-pecificimmunpypromgmodlycpbleimprovgclicloutcomechildnffectedhigh-grdegliom(HGG)Wehvepieedfirt-genertidoptivecellulrrpy(ACT)pltmutilizgtltumRNA-puleddendriccell(DC)exppolyclltum-pecificTcellttmentvivefrcrybrcncerWehvedemtrtedfetyfeibilypromgp-cliclerlycliclefficcythpprochcludgprolgeddee-femiomettedubject(>25yer)rdiogrphiccliclpefirt--humnpheI/IIclicltrilttgptientmedulloblm(MB)HGGbrtemgliom(FDAIND1405817298)Inthpropolwedevelopnext-genertipciACTpprochugcombtiptient-pecificntigenprilgugnovelcncerimmunogenomic-bedlghmdevelopedourlbnovelgeneenrichmenttrtegyllowutrgethunddtum-pecificntigenglepoolRNA(tRNA)SELEX-CTL(SelectiveExpniCyxicTLymphocyte)pltmtimultielectiveenrichmentpolyclltum-ctiveTcellpcurfquency1-3%ftertimultRNA-puledDCThpowerfulpprochgenertgenrichedTcellpopulticognizgplurlytumntigenuniquelyddechllengedelgtumntigenicheterogeneycfrtglyptient--ptientvrintigenexpidevelopmentntigentrgetgtrtegieWehypoizegivenpcliclclicldtwehvegenerteddemtrtgcpcyengenderpolycllTcellpegtHGGMBntigenugDCpuleduntrictedtltumRNApprochtudiedthpropolelectivelyidentifygmplifygptient-pecifictRNAuniquelyidentifygtgexpgpdgtum-pecificTcellueACTctutehighlyignificnthighlyeffectivepciimmunpypprochttmentpedricptientviveHGGOurSPECIFICAIMS1EvlutefetyefficcyimmunologiceffectACTtrgetgnetigenuniquelyexpedtum-ocedntigen(TAA)pcliclmodelpedricHGG2Determecpcyelectivelyolteexpntigen-pecificmemyTcellvropedricptientHGGwhohveceivedACTurcenter3Cductphe1clicltrilpciACTtrgetgtum-pecificntigenchildndolecentyoungdult(AYA)viveHGGProjectSummryTcell-bedimmunerpiepromgpprochttcncerChimericntigencepr(CAR)euchrpydevelopedengeergprotecompdtumcognimotifTcellmjignlgmoleculecotimulrymoleculeEngeedTcellexpgCAR(CAR-Tcell)hvehownmrkbleclicluccettgBcellmlignncieirefficcyctrollgolidtumlimedThemjhurdleTcellttmentovercomgirchrictimultiCAR-TcellexhutiChricTcellctivtiduceoxidtivetccumultitgrnule(SG)SGubcellulrcyplmiccomprtmentctRNA-bdgprotetrnltillypedmRNASignificntproghenmdeundertgcompentSGcouncovergrpeuticpotentilSGgulrcncerneurodegenertivedeeHoweverfunctilroleTcellSGnetwkTcellexhutimechnticlktweenSGcoCAR-TcellexhuticompletelyunknownWepropoetethypougmenttiSGgulrynetwkledCAR-TcellexhutiUgourcentlydevedCARctructfluocenceptertrckSGemblymtenncelivgcellwenlyzeSGdynmicctivtedexhutedCAR-TcellwhenSGcogulrG3BP1downgultedWemeuhoweffectiveG3BP1-downgultedCAR-TcellctrollgtumcellgrowthvrovivodetermeifG3BP1downgultiimproveCAR-TfunctilgevyNextwetrgetuptmmetbolictgulrtetwherCAR-TcellfunctiimprovewhenmetbolictgulrdeficientOurnovtivepropolexploTcellSGnetwktrnltilgulrmetbolictgulrytrgetimproveCAR-TcelllgevymechntictietweenSGnetwkCAR-TcellddecriclgpfieldThprojectexpectedprovidenovelightnunexplodTcellbiologynlypurtterundertgthprocefciltedevelopmentnovelcncerrpeuticCncerptientelevteddepiveympmhvehigherrtecncermtlycurncedimhedqulylife(QoL)helthcexpenduchempyndhenceDepiloprtillydrivercil/ethniccncerdprieAucheverldvygroupcommenddepicengevidence-bedttmentcrocncerctuumHoweverlyefourdepedcncerptientceiveevidence-bedttmentdepidue(1)uboptimlcologtferrl/pcribg/trgcompoundedcomplexlghmttmentguidele(2)lowptientuptkedueknowledgegpcncer-ltedphyiclympmtigm(3)gniztilfcrlikecliccultuourcelederhipupptllultgpoptient-providercommunictie-ize-fllSWferrlhighnohowrteltlectuldeliveryevidence-bedttmentDepeeverlytemticview/met-nlyeupptgeffectiveneeverlttmentdepicncerptientfewifnyyequy-medmulti-levelimplementtrilextThenurgentneedhybridIIIeffectivene-implementtipycho-cologytrilWepropoetettrtegyefficientlyutblydelivergcomplexttmentlghm/guidelefciltgefficientcommunicti/trige/ferrlproceecologytemextgmentlhelthfrtructucgproptiptientwhoceiveevidence-bedttmentInmedColidtedFrmewkImplementtiReerch(CFIR)20implementtimppguer-centeddeignprciplewerrivedtiCnDepCcentedrounddiglpychoeducti-ctivtiol(completedclicfuiehome)ttmentelectiuppt(egurgency/every/pfencebedcommendtiSW/fncilcounelgdividul/grouprpymedictiexerceORwtchfulwglkgedjunctivep/mood/exercepp/ource)technicltnceeducti/feedbckolultcology/mentlhelemddctextulbrrierttmentuptkemovecliclghviltegrtictuumFeibilyupptedubilytetgpilotRCTprotypefocugrouprcil/ethnicmycncerptient/cologytemfeibilytudyvtexperiencedelivergTAlldemtrtgignlubilyeffectivenetegrticliclwkflow(egleverggextgceng/ttment)Wepropoeuecjotnlyefeourtrtegyecductgclic-levelcluterromizedtrilmedequyutbilyenhncedREAIMfrmewkteteffectiCnDepC(vuulc)ttmenptimiztiimplementtidicecot18prottelunggtrotetlbtcncercliccommunycdemicettgervgocioecomicllydivereptient(n=1900ptientmoderte-evedepiveympm)ProjectSummry/AbtrctThebrodobjectivethpropolundertmoleculrmechnmhomologoucombti(HR)humnunderthowcequencedefectcombtilDNApirultchromoomltbilyunderliepdpoicncerTheprotevolvedcentrltepHRDNApirgcludeRAD51BRCA2RAD51prlogRAD51BRAD51CRAD51DXRCC2XRCC3MuttieproteknownpdpoedividulcncerTheobjectiveundertfunctieprotegenomemtenncevicombtilDNApirhoweprotemedepotentehomologouDNApirgRAD51WepropoeundertirmechnmcthroughbiochemiclnlyectutedctiugpurifiedprotechrcteriztidefectivemutntproteidentifiedptientpopultivulizgdividulhvieprotectgglemoleculeDNATheSpecificAimundertmoleculrfunctiBRCA2protedetermefunctiRAD51prlogRAD51filmentmtiRAD51-dependentDNApirgABSTRACTTleWASpignlgT-celllymphomPeripherlT-celllymphom(PTCL)ggivedderlethn50%overllurvivlfter2-3yerdignoTheedmloutcomenomllprtecdrylimednumrvilblebiomrkerdeeprogilimedknowledgeT-celllymphombiologyEmergentevidencedictectcykelenplypivotlroledurgT-celllymphomdevelopmentgrowthhoweverct-ltedproterolectibletrgetT-celllymphomtillneeddefedOurplimryfdgdemtrtectgulryproteWkott-Aldrichyndromeprote(WASp)oceddecedevent-feurvivlpromoteT-celllymphomgrowthurvivlInthpropolwelevergegeneticllyengeedmu(GEM)modeldevelopptneouperipherlT-celllymphom(SNF5FL/CD4c)wecplizenterntilctiummothn100T-celllymphomcecollectedccompnygnnottedclicloutcometetroleWASpdurgemblyct-dependentignlgcomplexeuptmcogenictrncriptilignlgdeferoletummicroenvirmentdrivgWASp-dependenncogenicignlgLungdenocrcom(LUAD)commlydrivenKRASmuttipible7%llcncermtlyLUADpdomntlylveolrtype2(AT2)cellwhichfunctifculttivelveolrtemcellelf-newgplcglveolrtype1(AT1)cellThefirtllele-pecificKRAShibir(KRASi)wecentlypprovedLUADcliclneflimedtriccquidtnceHlogictrnmtiLUADqumoucellcncer(denoqumoutrniAST)henptedmcquidtnceKRASiSuchcncercellttetrniemerggcentrlmechnmtncecologicrpieImptntlyynotocedcquidgeneticeventdrivenepigeneticprogrmmgtrncriptil-wirgcellulrdiffentiprogrmTomeetchllengettmenttnceclicidentifygtrgetgcellttecfertnceKRAShibirmutoughturgencyWeuedgeneticllyengeedmouemodelptient-derivedxenogrftgnoidptientmpleidentifyLUADdiffentittedrivetnceKRASiWefoundKRASipromotequiecentAT1-likecncercelltteLUADtumTheAT1-likeLUADcellexhibhighgrowthpotentilupttmentcetiwhebltiAT1-likecellenizetumKRASirobutlyimprovettmentpeNotblytrgetgKRASLUADtumhrbgmuttiSTK11encodgLKB1tumuppvriblyledhlogictrnmtiASTtntKRASiTheefdgimplictegeneticllydetermticdiffentiprogrmkeydrivertnceKRASilungcncerwheLKB1-pricientcncercelldoptnAT1-liketteLKB1-deficientcellundergoqumoutrnmtiWehypoizetrgetgeirAT1-likequmoutrnittemedLKB1ttuovercometnceKRASiLUADToddthhypowe(i)vetigteigftelveolr/qumouttetumuglege-trcg(ii)modeloutcomecybltiverpietrgetgAT1-like/qumoutteutilizglege-blti(iii)uncovermoleculrcellttedriverevlutemtrgetctextLKB1priciencydeficiencyTodothwetkedvntgenovelgeneticllyengeedmouemodel(GEMM)KRAS(G12D)KRAS(G12C)mutntLUADwehvedevelopedWevlidteourfdghumnptient-derivedtuexenogrftOurpropoedtudyllowuetblhAT1-likequmoutrnitte(i)LKB1genotype-pecificbiomrkertrictncelpepotentilLUAD(ii)trgetcybltiverpieovercometnceKRASiwellidentifymoleculrdriverecelltteThuthwkelucidtenovelcellulrmoleculrmechnmpeKRAS-trgetedrpymtrtegieovercomettmenttnceLUADptientPROJECTSUMMARYPncticductldenocrcom(PDAC)lethlmlignncyprojected2ndledgcuecncer-lteddethUnedStte2030dml5-yerurvivl12%PDACfrcrytrdchempyimmunpyduetriccquidtnceTwokeyculprocedrpeutictncefquentfiltrtumimmunouppiventeimmunecellprticulrlyneutrophilic/grnulocyticmyeloid-deriveduppcell(gMDSC)wellpro-flmmryignlgcncer-ocedfibroblt(CAF)whichdomten-tumtromctcellulrntennetrnmflmmrycuefurrckgMDSCtummicroenvirment(TME)IndectgunifygmechnmunderpltihiptweenekeyctuentTMEchemoimmunpytnceourdtuncovernovelignlgterctitweengMDSC-derivedtrnmembrneTNF(tmTNF)TNFR2-expgflmmryCAFdrivgtum-permiveeffectMooverovexpiTNF-TNFR2ignlghumnPDACtumtrncripmeocedchemoimmunpytncecromultipledtetpnngdiverecliclettgBuildgeobervtioverllmhpropol(1)mechnticllydectpthogenicignlgptilterctitweengMDSC-tmTNFCAF-TNFR2governgchemoimmunpytncePDAC(2)ctlyzepclicldevelopmenthighlyelectiveTNFR2ntgticntibodyTY-101whichtrpTNFR2momerpventemblyignlgtrimerdruptgMDSC-CAFcrotlkovercomechemoimmunpytncepcliclmodelAim1defepcectriigMDSC-tmTNFCAF-TNFR2ignlgcommunictiptilterctichemoimmunpytnceugnovtivepcliclmoueknock-/knock-outmodelg(mu)gle-cellptilmethodologie(humn)Aim2elucidtemoleculrmechnmwhichgMDSC-CAFcrotlkgultegMDSC-TNFproductivicoopertiveMAPkeSTAT3ignlgMooverwelodetermefunctilignificncethcoopertivegMDSC-TNFmechnmCAFpolrizti)vivougtemgMDSCdepleti-doptivetrnfermodelb)humnptientperipherlbloodgMDSCubjectenrolledphe1clicltrilvetigtgMEKSTAT3hibidvncedPDACFllyAim3determeifelectivetrgetgTNFR2ugTY-101improveenivychemoimmunpymodelggMDSC-CAFptilhbtCAFplticyprolgurvivlvivoTogeruccefulcompletieimuncovernovelighttum-permivelerogenicrolemyeloid-CAFcrotlkTMEwellgenertecompellgpcliclrtilecompendiumnovelpdictivebiomrkernupcomgclicltrilcombgneodjuvntTNFR2hibichemoimmunpyptientoperblePDACurtutiSUMMARYTrnloctiRenlCellCrcom(tRCC)pentrubtypekidneycncerocedggivehvipoclicloutcomeThepvlencethdeehighpedrickidneycncerpentg20-40%tlceRCCNotewthytruecidencethdeedultlikelyundetimtedignificntnumrptientundergoehlogiclmclifictiTRCCchrcterizedgenefuiultgchromoomlrrngementvolvgTFE3(Xp112)locuTFEB(6p21locu)vriouprtnergeneDepeidentifictimultipleTFE3genefuitRCC(ieSFPQ-TFE3NONO-TFE3PRCC-TFE3)noeffectivetrgetedrpieptienttRCCInplimryultupptedDOD(W81XWH1810586)ourgrouphgenertedSFPQ-TFE3NONO-TFE3PRCC-TFE3TFE3-OetblhedircogenicpotentilKnockgdownTFE3-wildtypefulllength(TFE3-wt)hidprolifertRCCByugFluocenceRenceEnergyTrnfer(FRET)microcopyimggourdtuggetTFE3-OdimerizeTFE3-wtcenedcompoundhventi-prolifertiveeffecthibgthprote-proteterctiThuthpropolimidentifymllmoleculeelectivelybdleucezipperdomdruptTFE3-O/TFE3terctiOurcentrlhypoTFE3chimericprote(TFE3-O)plykeybiologiclroletrnloctinlcellcrcom(tRCC)pentrtiltrgetrpeuticterventiOurhypohibgprote-protehomo/heterodimeriztiTFE3-O/TFE3-wtmyfernovelrpeuticopptunyOurcentrlhypoimccomplhobjectivethpplictipurugfollowgpecificimAim1TooptimizeolcompoundidentifynewmllmoleculehibirtrgetgTFE3-OdimeriztiAim2TotetbiologiclntumeffectnewmllmoleculehibirtrgetgTFE3-OdimeriztiAim1propoeoptimizeledcompoundcentlyidentifiedourlbterferndemetbolefexendeItlocennovelcompoundtrgetgTFE3dimercumizedcell-bedntiprolifertiyimultneoulymirTFE3dimeriztittuthroughFRETVlidtedhmoleculecomprgynticllytrctblecffoldubjectmediclchemtryoptimiztitructu-ctivyltihiplipophilicylbiovilbilyeentilpropertieToccelertegenerticompoundbiologicltetgourimemploycomputer-ideddockgledcompoundlevnthumnTFE3homologymodelfocuedrtildrugdeignAim2utilizeouretblhedvromodeldetermentumeffecptimizedolcompoundidentifiedAim1whichdruptTFE3-Oprote-proteterctiThimndetermentumeffectledgcompoundglegentrtilcombtiProjectSummryFthpropolpePAR-22-085Microbil-bedCncerImggTherpy-BugDrugwefocumettticpncticductldenocrcom(PDAC)everlPDACprticulrlydifficulttrgetgenerllycidedclcrntpnctictummicroenvirment(TME)fetunbundncetum-ocedmcrophge(TAM)fewTcellTheemethodprogrmTAMenhnceT-cellctivtiprolifertilikelyynergizerdipycheckpotimmunpyctrolloclmettticdeeBifidobctericommenlpfentillytrgettumlBifidobcterihenfoundtrnloctegtrotetltrctubequenthomgplictipecificllytumBuildgefdgwecentlyptedytemicllydmtedBifidobcterium(iv)pecificllycolizeplictehypoxictumgiNotblywelofoundivdmtrtiBifidobcteriumlocvertedn-pdgmicepderctextloclimmunpy/iizgrdi(IR)Thdtervepro--prcipleytemicdmtrtiBifidobcteriumcnenhncetumctrolcombtiimmunpy/IRWehvenowuccefullydevelopedgeneticolgultegeneexpiBifidobcteriumlgumWepropoevetigteytemicdmtrtigeneticlly-engeedBifidobcteriumdelivergnovelhumnIL-2(SumIL2)TMEcombtirdipy/immunpyThtrtegycenterhrnegbothntedptivepro-immunepeimedtcplizgeverlknownmechnmtumeviInddiourplncludepcegenecircupceproteectibcterielf-detructiytemicrpeuticdeliverynovtiMotimptntlywenticiptethurpprochugBifidobcteriumelicignificntnti-tumeffecteverl1BifidobcteriumelectivelytkenuptumSumIL2ectipcelyctrolledfterbctericoliztiwhichobvettment-limgxicycommlyocedIL-2dmtrti2Ourplimrydtpentedhedicteytemic(IV)dmtrtiBifidobcteriumcvertn-pdermicepdernti-CD47immunpyrdipy3InctrtEcoliBifidobcteriumhumncommenlnerobicbcteriumgivgourpprochlexicprilemotrnltillevnceOurpprochtkedvntgenturlfetugeneticengeergBifidobcteriumvigteimmuneuppiveTMEviytemicjecthucouldhvebrodpplicbilyhrd--ttcncerPROJECTSUMMARYThemotcommprotteddernignprotteenlrgementprottecncer(PC)ocedggttriedhmlimblnceloglulrhomeotGivenmjimpctprottepthologiehvemenhelthirignificntburdenhelthcytemimptntelucidtecellulrmoleculrmechnmunderlygprottehyperprolifertiggcncerTodtemottudiefocuedelucidtgidentyvrioutemcellprottepopultivlidtgirtemcellpotentilcultuytuegenertiRecentglecelltrncripmichighlightedpvioulyunderppcedprotteepililheterogeneyimptncelegeplticygenertgtrtumcellulrheterogeneyTodteltleknownboutfunctilcelltypemtepililhomeotwhtpecificdygultienbleirunctrolledprolifertiggcncerInplimrytudiewefoundp63cedWntignlgmrkpvioulyunchrcterizedprottelumltermede(LumI)popultictrienmlhomeotticcllgrowthTheecellWntignlgpperignificntlycegedmouehumnprottemplectutelrgeproptiPCcellBededtwehypoizeLumIcellirWnt-p63ignlgquidmtenncecllexpnilumllyertctprottethhybridtrncriptiltteexpgectepoolcellmouceptibletrnmtiMooverdurggrowtherlytumclemlignntcellhijckthprogrmrpidprolifertiInthpplictiwevetigteroleLumIcellirpecificWnt-p63ignlglumlcllexpniggcncerultimtegolfdgnewtrgetblemechnmwouldhltcncerprogiWepuruethgolthroughtheSpecificAim1)FunctilnlyeWntignlgprottelumltermedecellggcncervivovroprottegnoid2)Invetigterolep63lumlplticyprottecncerthroughlo-g--functitudiecoupledgenecircupprochefetungp63protelevellegediverificti3)Elucidtegenegulrynetwkco-fcrctrolledp63LumIttetrncripmicepigenomicmechnticvlidtiptrgetgeneco-fcrTkengerourtudieprovidecompheniveundertglumllegeplticyeffectcllexpninmlggmlignntcdiThepropoedtudieferightnovelmrkerdetectiprogivecncerleinewvenuecell-trgetedcncerrpiefocuedWnt-p63ignlgABSTRACTAnetimted400metricnplticproducedechyerwldwidelethn10%cycledMicropltic(MP)defedprticle<5mmgenertedwergwerdcrdedpltictrhtitextilenowubiquiuenvirmentMPenterbodygetihltictctkMPhveenidentifiedllhumntuetypetudiedcludgbloodplcentlungTheimpctternlizedMPhelthunknownGivenMPmycotedxicchemiclbiilmctgpthogenphyiclpenceMPmyduceloclflmmryimmunepeurgentneedetblhcrcogenicpotentilMPexpoubodyeuchlungInthR21wepropoeterrogtebrcholveolrlvge(BAL)fluidMPthciccologyptientgightpotentilltihipMPlungcncer(LC)ledgcncerdignocuecncerdethUSmotweterncountriePritudiehvedocumentedBALmimllyvivepprocholtechrcterizeMPirwylivgperInpropoedR21tl~275ptientundergogBALtMftCncerCenterTmpFLupectednewprimryLCtggnprimryneoplmdignolungfectienrolled10-mLmplecovedBALfluidervedtudyMPPtienthryurgerieBALffectedlungeligiblePrticipntcompleteurveydemogrphicmokgoccuptilhrymediclcdviewedcptuhrypulmrydeeproceduMPBALfluidtudiedphyiclbrytUniverySouthFlidTmpFLchrcterizedbundncemphologyugtrdopticlAmicFceMicrocopychemiclcompoiugRmnpectrocopymethodwidelyuedemerggtudieMPbiologicenvirmentlmpleStrgentproceeplcelimctmtimbientMPcliclbInerie300tudyprticipntcludg~25ourcentlyedpilottudyptientcfirmedcidentLC(~50%prticipnt)compdptientpthologietlnumrMPBALmpledjutmentptientgegenderrcemokghryoccuptigimodelAociexmedLCoverllexplrynlyeLCubtype(iedenocrcomveruLC)OrfetuMPcludgmphologypolymerubtype(egpolyethyleletephthlte(iepolyeter)polypropyleneemynticpolymerfir(iery))urfcecotgctmntloexplodociLCrkThepropoedvetigtiferefirttudieexmeMPimpcthumnhelthfocuLCDtgenertedhelpfillnimptntknowledgegpprovidefoundtifutuerchthnowubiquiupollutntwldwideProjectSummryBileductcncerloknowncholngiocrcomecdmotcommprimrylivercncerItcidedncurblecncernoidentifiblerkfcrcnrpidlycomelethlunlecndetectederlyenoughfullyectedCro-ectilimgglckenivycellulrtructubiochemiclpropertiebileductwllWhilecombtiendocopictrogrdecholngiopncgrphy(ERCP)bedbruhcylogytrn-ppillryendobilirycepbiopywhichtencidedgoldtrdhhighpecificyferlylowenivyAnveryignificntchllengecurnttrdcpprochedifficultycquirgtuempledequtehpthologicexmtiBecuepoprognotechniquecpbleliblydetectgp-cncerbileducturgentlyneededWecentlytroducednewdignotictechnologycomlightcttergpectrocopydiffueflectncepectrocopyidentifybiliryductp-cncererlycncerdurgroutedignoticERCPproceduItemploygle-potwrdlookgultrmuptilgtgfiropticproToenucliclcceptncetechniqueimproveccurcycnngenternlurfcebileducthtertimeugnERCPcter-comptibleprooutquimentcholngiocopewouldmjdvnceTheewepropoedevelopidelookgptilgtgfiropticprocpbleprlleldtcollectmultipleloctibileductwllignificntlyimplifypeedupoperticliclytemWetetpermncenewendocopictrumentdetectgbileductp-cncerouerlycncerouleiptientundergogERCPpotentilmlignnciewellflmmrytrictugllneDepenotbleimprovementchildhoodcncerurvivlrteptientlpedfrcrydeefcegrimpropectchildhoodcncermcommetcuedethdeechildnThprogrmimtcklethuefocugprimrilychllenggpedriccncerhigh-rkneuroblm(NB)tumympticnervouytemwhichccountup15%childhoodcncerdethcommetolidtumyoungchildnRecenterchourterntilcollbtivetemhvelednovelmechnmcncerdrugtncelkedepigeneticctivtiLINE1(L1)trotrnpoWehveprovidedplimryevidenceetrotrnpocneffectivelytrgetedextgnucleoideveretrncriptehibir(NRTI)fergpromgvenuepurpogefeeffectiventivirlgentpotentilttmentfrcrytumWhileignificncetrotrnpoctivtihenetblhedvrioudultcncertypeubtntilknowledgegpextccerngrolepedricmlignncieClogthgpimpertivectrollgtrotrnpoctivtiNRTIpotentillyloimmunpeuticpprocheholdubtntilpotentilignificntlyimprovgttmenutcomepedriccncercludgfrcryNBOurprogrmeekexplofeibilytrobiome-trgetedphrmcologiclimmunpeutictrtegieNBThexpltiguidedcompheniveementtrotrnpoctivieirimpcntumchrcterticNBlollolidtumchildhoodemployguniqueexteniverngepcliclmodelcliclmpleocedcomphenivecliclmoleculrdtOurprogrmcplizelgtgfrufulcollbtitweenUSAutrlintemdrwgupourcomplementryexpertebictrnltilcienceWelobuildupourtemfoundtilerchepigeneticctroltrotrnpocncerircognihumlTcellimmunypotentildruggbilytrotrnpo-ducedmlignnttrprticulrlydrugtnceOurpecificimfollow(SA1)comphenivelychrcterizetrotrnpoctivyNBolidtumchildhoodepotentilrpeuticdignoticignificnce(SA2)vetigteimpcttrotrnpodepiNBttmenttncepotentilveretrncriptehibirenhncefrcryNBttmenutcomepcliclmodel(SA3)exploimmunepeL1trotrnpontigenevluteefficcynti-L1immunpypcliclNBmodelTheoutcomepropoedprogrmguidertildeignfutuphrmcologiclimmunpeuticterventifrcryNBubequentlypolycurblepedriccncerProjectSummryTumcellexpoedwiderrytrngghyperctiveproteynmetbolmnutrienxygentrvtummicroenvirmentetimuliquumcellctivteprotectivetrncriptilprogrmpromotetumcellurvivlgrowthX-boxbdgprote1(XBP1)hypoxi-duciblefcr1lph(HIF1)twomotimptntt-ducedtrncriptifcr(TF)ctivtecogenicmettticgeneexpiprogrmemblgcomplexetunfoldedprotepe(UPRE)hypoxi-ducedpe(HRE)elementpectivelyTheetrgetDNAequencemotifoverlpmnytrgetgeneTriplenegtivebtcncer(TNBC)motggivemettticubtypebtcncerhevilydependenntrgupgultiXBP1(plicedctivemXBP1)HIF1irdowntmt-pivegeneexpinetwkDepeproundneedtrgetedrpiegtecogenicTFymlrgelyuntppeddrugtrgetduechllengetrgetgprote-proteprote-DNAterctiTheeourtemcentlydevelopedmodulrtrtegyctefullyyntictrncriptilp(STR)dictlyhibincogenicctivyTFblockgirbilybdgultepecificDNAequenceUgthynticpltmwehvedeignedpotent(lownM)highlypecificcellpermeblevivoctivehibirHRE/UPRE-driventrncriptiOurledSTRdictlyntgizeXBP1/HIF1DNAbdgvrocellultgpotentgloblhibihypoxi-ducedgeneexpiprogrmblockdehypoxi-ducedggivephenotypeuchcellvinti-prolifertiveeffectlyundercdihypoxiInnimltudiedmtrtiledSTRignificntlyhibtumgrowthhypoxi-ducedgeneexpivlidtg-trgetctivynimlThepropoedprojecttethypoXBP1/HIF1trncriptilpecntightlyctrolledoptimizedSTRdictlytrgetirhdDNAbdgeThccomplhedthroughthecomplementryAim1)Developultr-potentphrmcologicllytbleSTRcellbednimltudie2)MpSTR-bedprogrmmghypoxi-ducedXBP1/HIF-dependentgeneexpicogenicphenotypeTNBC3)TetefficcyoptimizedSTRhibgTNBCgrowthmettchemotnceugvrovivomodelTheetudieprovidefhightmoleculrunderpngpthogenedptivetpeTNBCdetermeeffectblockgXBP1/HIF1-DNAbdgtlevelchromttrncriptildynmicetblhefficcytrgetghypoxi-dependentgeneexpiTNBCtumgrowthmettchempeuticenivyAbtrctBcellmlignnciecompmothn50%bloodcncerpproximtely85%lymphomllmyelomDepecentttmentdvncementignificntlyprolgptienturvivlmnyBcellmlignnciemcurblehighlightgneceydeeperundertgdeepthogeneDurgpt3decdeercheftpthogeneBcellmlignnciehveenprimrilyfocuedgeneticepigeneticltertiwellircogenicignlgpthwyRecentendevhvedvncedundertgfluencetromlcellimmunecellubetmlignntBcelltummicroenvirmentThnewR01projectimelucidtenovelprdigm-hiftgmechnmBcelltumigenettmenttncelpedrivencommenlbcteri-derivedmoleculeWecommenlbcterioutnumrhumncellbodyctutelrgetpoolntigenBcellntigencepr(BCR)ligToll-likecepr(TLR)expedBcellhumnAlthoughcommenlbcterihveenimplictedcrcogenehumncnceruchcolcoloctlpncticliverlungbtcncerBlymphocytelycelltypehumnbodyexpepecificntigencepr(BCR)cnproducepecificntibodiepecommenlbcterilntigenEvenbencecommenlbcterrnmigrtiytemicfecticommenlbcterilntigenligmtolublemoleculelrgefrgmentcnleedcommenlbcteriviectiheddgdigetibcterildeth-oceddecompoiSuchcommenlbcteri-derivedolublemoleculelrgefrgmentcludgntigenligmygccevriouBcellubetlymphoidgnthroughbloodcircultilymphticdrgeHowevervetigticommenlbcteri-derivedmoleculeBcelltumigenelckgWeddthcriclgpcncererchBedourpro--cceptplimrydtwetetcentrlhypocommenlbcterilmoleculecnenggeBCRTLRignlgdriveBcelltumigenettmenttncelpeWefurrexplouchnewknowledgedevelopnoveldignoticrpeuticimproveerlydetecttmentBcellmlignnciepventlpeSuchcommenlbcteri-beddignoticrpeutichvemechnmctidtctcomplementrycurntlyvilbledignoticrpeuticecneilytegrtedcurnttrd--cytemtrnmmngementlcpeBcellmlignncieimproveptienutcomeWomenhigh-rkbtleiuchtypiclhyperpli(AH)lobulrcrcomu(LCIS)hveup4-10-foldcedrkvivebtcncer(BC)compdwomenn-prolifertivebtdeeChemopventielectiveetrogenceprmodulr(SERM)romtehibir(AI)hveenhownromizedctrolledtril(RCT)duceBCcidenceup50-65%mghigh-rkwomen70-80%ltiverkductimgwomenAHLCISHoweverchemopventiuptkemlowt<15%Crdiovculrdee(CVD)locommwomenHMGCoAductehibirttuedprimrypventiltiverkducti~25%mjvculreventAbouthlfeligibleUSptientcurntlyttprimrypventiCVDThctrtlethn15%eligiblehigh-rkwomentkgchemopventiWhilenumeroutudiehveencductedelucidtecomplexieBCchemopventideci-mkgnotudiehveencductedctextpventiverpyCVDInthprojectwevetigtewhewhyptientjourneyundertgirrkdcugrk-ducgmedictiirproviderdivergenceultgloweruptkeBCchemopventiltiveuettCVDUgertiveequy-focuedhumn-centeddeignweuncoverdiffencedeci-mkgproce(SERM/AIvtt)compwhywomnmyoputSERMS/AIpventivemeubupt-ttexploifwomencnnefclibrtgchemopventideci-mkgprocectextmofmilirttpventiverpyCVDWedevelopedrigoulyevluteddeciupptolRelRkptientBNAVprimrycprovider(PCP)RCTcechemopventigenetictetgmghigh-rkwomenInthpropolwefeedeci-upptolbeddeeperundertgchemopventiuptkectextpventiverpyCVDOurhypoequy-focuedhumn-centeddeignprocewhichdeignedenhnceundertglowdoptichemopventictrtgdeci-mkgdividultrkCVDcnclrifybrrierimprovechemopventiuptkeSpecificim1)pplyhumn-centeddeignfeRelRkBNAVBCCVD2)cductcluterromizedtrilromizti60PCPtrdeductilmterillecomdptientproviderdeciupptimprovechemopventiuptkemg200rcilly/ethnicllyhigh-rkwomenge40-74yer3)cductnequy-focuedevluterventiimplementtiThpropolddeignificntpublichelthproblemgivenburdenBCCVDmtlyprticulrlymgrcil/ethnicmieIthpotentilillumtepvioulyunddedbrrierchemopventideci-mkgctextterventiuedtrpvenrchriccdiuchttCVDPROJECTSUMMARYWhilecurntttmentpprochecncumotchildndignoedcncerchempy-ducedcogniveimpirment(CICI)hemergedignificntmediclproblemnegtiveimpcnqulylifeGivenmochildncncernowurvivedulthoodidentifictibiomrkercnpdict/medeuceptibilycognivedeclecjunctinovelrpeuticterventittCICIurgentlyneededPoly(ADP-riboe)polymere1(PARP1)mnicotmidedeneducleotide(NAD+)cumgenzymectivtedDNAdmgecuecellulrNAD+degrdtictrigneurodegenertiSimilrlyourplimrytudiedemtrtevriouchempeuticcludgmethotxtecpltpclxelcueneurlDNAdmgeultgcedclevgePARP1expidultmouehippocmpuhumnexcryneurRemrkblywefurrhowPARP1hibhroughdmtrtipotentPARP1/2hibirvelipriffectivelypventcplt-ducednxiety-likehvineurogenicdefectTkengereobervtitrglyuggethyperctivtiPARP1chempycueNAD+loturrimpirneurlcognivefunctiBedegerfctmethotxtewhichroutelyuedchildhoodcncerloceclevedPARP1expipotentillymedgneuroxicywehypoizemethotxte-ducedPARP1hyperctivticuecellulrNAD+loneffectcnpventedhibiPARP1ctivythumelgCICIInddigivenNAD+lohprovenpromgbiomrkerge-ltedneurodegenertivecdiwelopropoetethypoNAD+ocedmetbolecnnovelbiomrkerpdict/medeCICIToddehypoeAim1tetifvelipribpventmethotxte-ducedcogniveimpirmenttum-feprimryT-cellcutelymphoblticleukemi(T-ALL)juvenilemouemodelInddigivenimptncePARP1ignlgcncerdevelopmentweloevluteimpctvelipribtumgrowthchempynti-neoplticctivyugclicllylevntT-ALLptient-derivedxenogrft(PDX)miceSubequentlyugcell-typepecificcdilPARP1KOmiceAim2tetwhichneurlcelltypepibleCICIMooverweloelucidteifNF-kB-mededcyclooxygene-2(COX-2)flmmryignlgkeydowntmPARP1effecrdrivgCICILtlyAim3tetifPARP1-dependentNAD+metbolicpthwycnpromgbiomrkercnpdict/medeuceptibilycogniveimpirmentcohtALLpedricptientprimryT-ALLjuvenilemiceOurpropoedtrnltilwkprovidecriclmechnmmedgCICIpvewytrnmtivecliclterventimelecognivedbilieocedchempyultimtelyimprovgqulylifepedricALLcncerurvivProjectSummryCovlenthibirBruntyroeke(BTK)effectivemultipleB-cellmlignncieptientdctueegentduetncelernceHighlyelectiveveriblen-covlentBTKhibirhveendevelopedovercomeeproblemcurntlygtetedclicltrilptientchriclymphocyticleukemi(CLL)B-cellmlignncieDepeeneficilfetun-covlentBTKhibirhighoverllperteeenerlyclicltrilomeptientdidnotpdttmenrlpedfterilpempyThprojectbrodlg-termgoltterundertetncemechnmledglpedeignttercombtitrtegieuenoveldrugovercomethtnceOurpecificimelucidtemoleculrmechnmtncethnovelclBTKhibirterrogtgignlgpthwymutntBTKcellkedeficientWeplncomphenivelyevlutedependencekededBTKmuttipotentilurrogtekectivtedmutntBTKWelotetgquimentBTKurvivlignlgcellPLCG2muttiLtlyweidentifygenomicbBTKdegrdertnceGivenwidepdueBTKhibircroCLLB-cellmlignnciecgcidenceptientcquidtncen-covlentBTKhibirultthtudyhvemjrpeuticimptnceptientvrietyB-cellmlignncieOurfdgmfutupplictideemirgn-covlentBTKhibirboutdevelopmenttncemechnmBTKdegrdernowguedclicltrilThegolthpropoltterundertnovelignlgxedprottecncer(PC)ptientnext-genertirogenceprignlghibir(ARSI)ThetrdueARSIPCptienthelplimtumprogievblyultdevelopmentrpeuticllytntdeeWehveidentifiedynticlethlltihipetblhedwhenARSIcomdCD105ntgtcrotuximbbedfdgARSIpromoteCD105upgultiPCepiliocedtromlfibrobltmphogenicprote(BMP)ignlgdowntmCD105ceprignlgupptmultiplemechnmARSItnceCD105wfoundmedirrogenceprplicevrintfibrobltgrowthfcrcepr3(FGFR3)ignlgttmentemergentmllcellneuroendoc(t-SCNC)lldemtrtedlimARSIenivyCD105expiPCocedfibroblticcellprottemrrowlopotentedprcignlgglutmeWeptedroleglutmenlymetboleupptivetumexpniwneceryufficientimpctt-SCNCFGFR3ignlgImptntlyeirARSIcrotuximbglegenthdnoeffecnltergtumprogipcliclmodeltetedWecentlyptedphe2tril(NCT03418324)demtrtgfeibilycombgARSIcrotuximb-enizgPCptientbirtereenzlutmideGivenefdgwetethypoPCdemtrtgtnceARSIhibiCD105combtiplutmideprovideextendedenivycompdplutmidelefollowgpecificimAim1propectivenlydvncedPCptientngogromizedclicltrilceivgplutmidepencebenceCD105hibi(NCT05534646)DurgthtudyweobtpropectivebloodcircultgtumcellunderthowchngebiologyltechngecliclhviTheeeftlevergenovelnnotechnologypltmigtgnovtivemoleculrnlytechnologieprogrmwhoecurntdevelopmentupptedthroughnnotechnologyllincecncerAim2velmechnmctiplutmide/crotuximbcombtiWeueveretrnltipprochhelpidentifylevncenovelglutme-BMP/CD105ignlgxPCtroml-epililrogenignlgdefecrerielectgptientwhonefcombttmentPhrmcodynmicpemicecompdmenctrtitntprottecncerp-pot-ttmentmpletrilProjectSummryPncticductldenocrcom(PDAC)highlyggivecncerPDAC4thledgcuecncerlteddeth5-yerurvivlrte<12%ultg200000dethperyerErlydetectumizeechleurgiclectip-mettticdeehturvivlnefCliclimggimptnterlydetectimlltumUntuntelynodividuldignoticimggtechniqueufficientlyccurtedetectimllpotentillycurblePDACPDAChprueextrcellulrmtrixwhichcnctute90%tumvolumeAdomntcellulrcompentthmtrixfiltrtgimmunemocytecludgmyeloid-deriveduppcell(MDSC)MDSCctrietumprogtmenttncethroughvrietymechnmultimtelyculmtgfiledntumimmunepeAcliclimggmodlyporemimogrphy(PET)cpblequnttgmoleculrfetuMDSCpentPDACdrivetumigeneprogtmenttnceMechnticllychemokecepr2CCR2expedmocytemytrumentlecurgidenceeCCR2poivemocytePDACtumThemocytechemottrctntprote-1(MCP-1)pecificligCCR2ducemigrtibdgcompentTMEwheMCP-1expielevtedThecentrlhypothpropol18F-CCR2PETimgggentcnenblefunctilimggMDSCmocyticcellprovidgvlubleightirroledurgtumigeneprogiperpyThhypotetedcompletgfollowgpecificim1SynCCR2PETimggtrcerSA1Syn18F-CCR2-1ynethebckupcidte2Invrochrcterizti18F-CCR2ligSA2InPANC-1MIAPC2cellleSA2bInmouemrrowderivedmocyte(BMDM)humnmocyte3TotetevlutePETimggcpbilydeveloped18F-CCR2cidteSA3Selectiveuptke18F-CCR2protumimmunecompromedrodenrthopicmodelpncticcncerdetermedmicroPETMRimggSA3bCCR2PETligpecificydetermedblockgn-rdiolledCCR2-1ligfollowedmicroPETMRimggSA3cTheenivybilydeletetummrgPETevlutedcomprh-pthologyurdiogrphydemtrte18F-CCR2propecificllybdgiocedCCR2+mcrophgebundnceOverllthprojectenbledevelopmentnnovtiven-viveimggolctCCR2ntgtProjectSummry/AbtrctTummettpiblevtmjydethepililcncercludgbtcncerUndertghowcncercellpddtntepertdmntdemtedtumcell(DTC)eventullycureentilimprovgttmentthdeeThelg-termgolmyerchgroupidentifypthwygulteeproceeenbledevelopmentrpiecnpvenrttmettticcurnceWecentlyidentifiedrolentioxidnttpetrncriptifcrNRF2promotgurvivlloclcurncemmmrytumfollowgtrgetedrpyWefoundNRF2ctivtedfollowgdiveretrgetedrpiecequencemetbolicoxidtivetNRF2mctutivelyctivtedcurnttumwhefunctipromotecurncethroughgultgdoxhomeotnucleotidemetbolmWhileeultidentifyfunctiNRF2loclcurnceroleNRF2promotgmettticdemtimltivelyunexplodEmerggevidenceuggetmettticdemtiocedmetbolicoxidtivetCtentthwecentlyfoundNRF2trncriptilprogrmelevtedmetttictumptientbtcncerHoweverthoughundertgNRF2gultidurgmettticdemtihowNRF2ctivtifunctillyffectmettmunknownThpropolbuildthwkdefegultifunctiNRF2durgmettbtcncerInnewplimrydtwefoundNRF2uppepro-flmmryignlgbtcncerCtentthNRF2knockdownledfiltrtiimmunecelltummicroenvirmentBedupefdgcentrlhypothpropolNRF2promotebtcncerprogihibgpro-flmmryignlgtweencncercelltumimmunemicroenvirmentWetetthhypothroughthepecificimInAim1wedefemechnmfunctiNRF2gultumimmunemicroenvirmentInAim2wedetermeroleNRF2uppiflmmryignlgpromotgoutgrowthdemtedtumcellInAim3wetetwhertrgetgmetbolicpthwycnpventgrowthNRF2-hightumOurwkvelnewmtihowNRF2functigultetumprogimyuncovernovelrpeuticopptuniepventmettticcurnceAbtrctNovelimmunerpieneededhelpmjyptientmelnomolidtumwhilnefirppdgimmunecheckpothibirdoptivetrnfertumpecificTcellemethodcovercometnceimmunerpieMoterchhfocuedengeergCD8TcelldictlytrgetkillcncercellthpropolfocuhelperCD4TcellwkchetrtgfunctiimmunecellThegolthpropoldeveloprpeutictrtegyugCD4TcellovercomettmenttnceolidtumCltivetudieptientcncerhowhvggternumrtumpecificCD4TcellocedctivtiimmunecelltumtteroutcomeWkmouecncermodelhowCD4TcellcnwkthroughupptCD8TcellthroughnteimmunecellkillgtumevenwhenTcellnotpentThemoteffectiveCD4rpiemouecncermodelhvecomdCD4TcellignlctivtenteimmunecelltumeignlxicwhengiventhroughoutwholebodyWehvefoundtwopotentnteimmuneignlIL-12IL-18cnengeedCD4TcellcntrgeteignlpecificllytumWefdCD4TcellengeedthwycndetroytumctivteCD8TcellctivteimmunecellmouecncermodelInourfirtimweidentifywhichmoleculemdeTcellimptntthprocewhichimmunecelltumtrgetwhichimmunecellpibletumcelldethUethpprochptientmelnomquiwyproducelrgepopultiCD4TcellpecificptientcncerweobtecellurgicllymovedtumptientExtgmethodgrowtumpecificTcelltumhvehdomenefCD4TcellmotlylotdurgtrdproceWehveidentifiedwyidentifytumpecificCD4TcelltumuethmtiolteecellwyTcellowecngrowmInourecdimwedeveloplibleproceolteexpecellmtirfunctiwellengeermhumnveriIL-12IL-18ignlweexplodmiceWenuehumnizedmouemodeltetwherCD4TcellgrownhumntumcneffectivelytrgethumntumimmunecellThegolthwkdevelopnewtypettmentcncerugCD4TcellengeednteimmuneignlcnuedclicltrilptientttmenttntmelnomolidtumPROJECTABSTRACTWedevelopedtrnltedCD28cotimultedchimericntigencepr(M28zCAR)Tcelltrgetmeol(MSLN)cncer-ocedntigenthvexpedmjyolidtum65ptienthveenttedpheI/IItrilno-trgetf-tumxicyHvgdemtrtedgillydmtedCARTcellvoidpulmryequetrtienhncederlyntigen-ctivtedCD4CART-cellhelperfunctiwedelivedM28zCARTcelltrpleurllyptientmlignntpleurlmeoliom(MPM)promotgtumfiltrtiToovercomentigentducedT-cellexhutiwetted27ptientMPMnnti-PD1gentftergledoetrpleurlM28zCARTcell(medinurvivl18mthv10mthfollowgecdlepembrolizumb)Tofciltetum-pecificcheckpotblockdechievefunctilpertenceoutpeteddmtrtinti-PD1gentwetrnltedCART-celltricPD1domntnegtivecepr(PD1DNR)8ptienthveenttednoCAR-PD1DNR-ltedxicieRecognizgneceyIFNpthwyolidtumkillgCARTcellweexploedc-KITmuttiD816V(KITv)cotimulrydom(NtCncer2023)AglefuiM28zKITvCARTcellwfetedTGF-mededuppiprolgedurvivldemtrtedfunctilpertencemultipleolidtummodelcludglow-ntigenexpgtumclicllyvilblekehibireffective/ftunblefetywchHewehypoizewheIFN-mededcyxicypdomntmechnmKITvCARTcellgthigh-ntigen-expgtrgetlow-n-ntigen-expgtrgetIFN-mededupgultiICAM1tumcellfciltgLFA1(CART-cell)-ICAM1ynpe(cedvidy)popIFNcepxpgtrgetcellpectivebiologicmechnm(Aim1)KITv-ducedIFNpotentecyxicyCD441BBzKITvCARTcellgtlow-ntigen-expgtrgetCD28cotimultipromotehelperfunctiCD428zKITvCARTcellhoweverPD1DNReentilfunctilpertence(Aim2)PD1DNR-mededcheckpotblockdeextendydPDL1-expgtumcellcounterctPDL1-ovexpgM2mcrophge(Aim3)TheignificnceourpprochlieeffectivecombtiolidtumpecificcFvthntrgetfe(MSLN)cotimulrydom(KITvCD28)checkpotblockde(PD1DNR)tumfiltrti(gildelivery)TheimpcurpropolextendydpleurlcncermjyggiveolidtumexpMSLNThepropolnovticludeexplogIFN-mededcyxicmechnmheterogenountigen-expgolidtumcedCART-cellvidythroughecdynpepotentgCD4CART-cellhelperfunctiugmentCD8CARTcellcounterctgPDL1-expgM2mcrophgeCART-celltricPD1DNRProjectSummryPGC-1fmilyprote(PGC-1PGC-1PPRC1)trncriptilcoctivrctcentrlhubcodtediverecellulrputpromotetrncriptigenegultemetbolmmthomeotTrncriptilcoctivrPeroxomeProliferr-ActivtedReceprGmmCoctivr1(PGC-1)over-expedcoloctlcncer(CRC)K-RmuttipromoteurvivltumcellPGC-1fmilyprotelcktricenzymticctivyfunctifciltgterctitweentrncriptifcrepigeneticmodifiertrncriptiimcheryToidentifyprote-proteterctiquidPGC-1promotegeneexpiweimmunopciptedPGC-1identifiedbdgprtnermpectrometryOurdtvelEtrogen-ReltedRecepr(ERR)HotCellFcr2(HCF2)PGC-1bdgprotewepropoequidPGC-1gultetrncriptigenepromoteCRCurvivlOurlg-termgolhibCRCgrowthblockgPGC-1ignlgwepropoecnchievedpventgPGC-1ignlgthrougheirERRHCF2InAim1wedetermemechnmwhichphophtePGAM5modifiePGC-1ceERRtrncriptiInAim2weidentifyPGC-1-HCF2gultedgenedetermequimentHCF2ignlgInAim3wetetloPGC-1loPGC-1-ERRterctiloPGC-1-HCF2terctiloboerctivivougthopicubmucoljectiimmunodeficientmiceceivgCrpr-C9-modifiedptient-derivedtumgnoidetblhlivermettePROJECTSUMMARYDiffuemidlegliom(DMG)devttgprimrybrtumchildnPtientprognomlmedinurvivl~9mthfterildignoDMGdrivencurntlyemethiemuttihneH3(H3K27M)ledwidepdepigeneticdygulticogenicgeneexpiPpotgvulnerbilieducedH3K27MmuttihpotentilledpcirpieDMGptientTumprogrmmetbolmgenertebioynticpcurunctrolledprolifertimtdefenemechnmGlucoe-6-phophtedehydrogene(G6PD)generteriboe-5-phophtewhichpcurnucleotidebioynItlogenerteNADPHwhichmtglutthie(GSH)ducedtteGSHturneentilglyoxle1(GLO1)dexifymethylglyoxl(MGO)wteproductglycolyOurtudieogenicptient-derivedmodeldicteH3K27MmuttrncriptillyupgulteG6PDGLO1expiDMGComdhibiG6PDGLO1ugdoxycycle-duciblehRNAnovelbrpenetrnthibirynergticllylethlvrocuetumgivivoMechnticllyG6PDGLO1hibidepletenucleotidecueccumultiMGOledgmcromoleculrglyctipopDMGDeuteriummetbolicimggnovelclicllytrnltblemethodvulizgglucoemetbolmvivoOurtudiedicteMGOdowngulteglycolyglyctgphophoglycerteke1(PGK1)Imptntlylctteproducti[66-2H]-glucoeltedterlytimepotfollowgG6PDGLO1hibiwhenchngecnnotobervednmiclimggDMG-rgmiceBedeultwedetermewhercomdhibiG6PDGLO1brogteDMGproliferti(Aim1)[66-2H]-glucoeprovidenerlydoutperpyt3T(Aim2)OurpplictinovtivecueweidentifyurknowledgefirttimeG6PDGLO1cogene-ducedmetbolicvulnerbilieDMGOurpropolignificntcuewehveidentifiedG6PDGLO1hibirynticllylethlhvepotentilclicltrnltiFurrmowevlidte[66-2H]-glucoengentcnprovidebiologicllymengfuldoutttmentpevivoWenticiptethurtudieprovidepcliclfoundtineededeimgg-drivenclicltrilourG6PDGLO1hibirDMGptientInummryourpropoldevelopmetbolicrpyimggcnimproveoutcomequlylifeDMGptientSUMMARYMcrophgeimptntctriburbiologytummicroenvirmentAtumpenetrteprotticcpuleyvdelipid-richdepotknownperi-protticft(PPF)AnbilyutilizethenergyourceimptnttumprogiPPFwhedipoetue(WAT)enceprottedepotdipocyteidentmcrophgetermeddipoetuemcrophge(ATM)PPFctivtedATMltivelyundertudiedcompenttummicroenvirment(TME)AdipoetuepentnutrientervoirwhichtumcellcngccedipokeBrowngWATultmovculrmultiloculrftphenotypenotclerwherthpentndptivemetbolicpePPFuppccelertetumgrowthTheheterogeneylipidvilbilyprotteTMEATMidelipid-richrgeenvirmentcompoedprimrilydipocytewhetumocedmcrophge(TAM)hbtromwhepucydipocyteMetbolicprogrmmgtumcellwelldocumentedhoweverlimedcenttudiehveptedATMvcerlfrbtTMEcncquimetbolicllyctivtedphenotype(MMe)dtctM1/M2phenotypeOurplimrytudieidentifiedpotentillycriclimmuno-metbolicignlgxmcrophgevolvgpro-flmmryceprterctgprote140(RIP140)lipid-gultgfttycidbdgprote4/5(FABP4/5)DicylglycerolO-cyltrnfere1(DGAT1)ynizeneutrllipidquidftbptirgeRIP140co-ctivrNF-kBimptntpromotgpro-flmmrycykechrcterticM1ctivtimcrophgeM1/M2polriztibrowngWATBothFABPDGAT1cngultedvivovrougmllmoleculehibiromewhichdevelopmentgtetedpotentilrpieThepropoedtudyvetigtecentrlhypoPPFhighlydynmicdepotcedlipidTMEcnpromotetumprogriggerglipid-richATMectepro-tumigeniccyke/chemokelipidmedirthuwchgATMhrmfulpro-flmmryMMephenotypeWeuevivovromodeltetwherltergDGAT1FABP4/5ctivytumuppiveOurimdefemechnmgultgimmuno-metbolicxATMTAMprottecncer(PC)determewherMMephenotypeubpopulticedlocllyvivePCToourknowledgethfirttudyvetigterolefunctilignificncenundertudiedphenotypeMMemergebothflmmrylipidignlgpthwyprotteTMETrgetedrpietetedmulticellulrgnoidcultulevntmuxenogrftmodelSuccefulcompletietudieettgemocomphenivep-cliclvetigtipotentiltrnlticlicmediumtermPROJECTSUMMARYAcutemyeloidleukemi(AML)devttghempoieticmlignncychrcterizedcllexpnileukemitemcell(LSC)DepedvncementchempygimentrgetedrpiemotAMLptientmcurbleThunovelrpietrgetgkeyleukemogenicpthwyneededRNAmodifictieentilmodulrpot-trncriptilgenegultiirdygultiemergectriburAMLThroughntegrtednlygenome-wideCRISPR/C9cendtwedcovedAMLcellpfentillydependMETTL1nRNAmethyltrnferemlyctlyze7-methylgunoe(m7G)modifictrnferRNA(tRNA)METTL1highlyexpedLSCAMLpecimenhighexpiocedpoclicloutcomeMETTL1depletiignificntlyuppeAMLgrowtherdicteLSCvrottenuteAMLproginAMLptient-derivedxenogrft(PDX)modelImptntlythoeeffectlrgelydependennMETTL1m7GmethyltrnferectivyferguniqueopptunyAMLrpythroughdevelopmentmll-moleculehibirtrgetgenzymticctivyVihigh-throughputcenwehvedcovedelectivepotentMETTL1hibirpromgnti-AMLctivyMooverMETTL1loignificntlyducem7GbundncetRNAPheGAAoverllexpiThturnledtrnltiupprncripthevilylytRNAPheGAA-ltedcoduchtyroe-protekeHCKThedecedexpiHCKdueMETTL1depleticouldfurrdruptC-X-Cchemokecepr4(CXCR4)ignlgwhicheentilLSChomeotDepeeightwedotyetundertexctmechnmwhichMETTL1loultAMLuppiLSCerdictiWehypoizeMETTL1functinm7GmethyltrnferedriveAMLdevelopmentutLSCfquencymkgpotentildruggbletrgetttghigh-rkAMLTheehypoeddedtheSpecificAimAim1furrcolidteimptnceMETTL1functiAMLugmouemodelInthAimweutilizenumrAMLmodeldiffentgeneticbckgroundrigoulydetermeroleMETTL1AMLiprogiAim2undertroleMETTL1/tRNAPheGAA/HCKignlgLSChomeotThAimdeletemoleculrmechnmthroughwhichMETTL1/m7GxfcilteLSChomgelf-newlbilyAim3evluterpeuticpotentilphrmcologicllytrgetgMETTL1ttAMLChimericntigencepr(CAR)Tcellhvedemtrtedirefficcyttgblood-bedcncerHoweverdurbilypetenhdedchllengeltedlg-termTcellpertenceengrftmentTheucceCARTcellimmunpyliediffentittuoverllfneCARTcellproductCurntprocolvolvectivtiexvivoexpniptientTcellhoweverctivtiledirveriblediffenticompromgirrpeuticpotencyOurcentwkhowedmnufcturgprocolutilizgn-ctivtedTcellultuperidiffentichrcterticducedexhuticcdntneflg-termtumctrolNeverlequiecentTcellhighlytntlentivirlfectiCARTmnufcturgyieldignificntlimtin-ctivtedTcellThegolthtudyhrnetrictemnequlien-ctivtedCARTcellimproveirtrnductiefficiencyeffecrfunctienhncgirdurbleefficcyfollowgfuiQuiecentTcelletypeIterfer(IFN1)-mededntepeuplentivirlvecrtrnductiwhichlimCARTcelltrnductiefficiencyOurplimrydtdictep-ttmentn-ctivtedTcellnIFN1-bdgproteenhnceCARTcelltrnductiefficiencypromotemvecentrlmemyphenotypeTherchdelveimpctIFN1blockdeCARlentivirutrnductifunctin-ctivtedTcellbothvroxenogrftmodelvivoGivenutedtypeIIFNignlgfciltetumimmuneecpetncerpiewehypoizectuouIFN1blockdenlyenhnceTcellfnehibgntepelentivirlvecrlomplifierpeuticefficcyTcelltumlinnIFN-mededimmuneeviToexplothfurrweevluteeffectutedIFN1blockdectructglentivirltrnferplmidencodgbothCARectednti-IFN1bdgprotevriouxenogrftmodelcncerAnkeypecurvetigterplytweenSAMHD1IFN1ignlgpthwyquiecentTcellSAMHD1trictnucleotidevilbilyveretrncriptiupgultedIFN1GivenVpxcompentnturlHIVdegrdeSAMHD1weeimpctVpxcptiefficiencyveretrncriptivecrtegrtiCARlentivirun-ctivtedTcellOurhyporgVpxwhichtrgetrte-limgtepvirltrnductipthwyynergizeIFN1hibiquiecentTcellultimtelyenhncglentivirltrnductiefficiencyboltergfunctin-ctivtedCARTcellTheetudiepentignificnttepwrdenhncgTcellfnecountergnti-virldefenetriggeddurgmnufcturgWededicteddvncgn-ctivtedCARTcellpltmultimtegolimprovgcliclpotentiln-ctivtedCARTcellvibleCARrpyGivenourwell-etblhedtrnltilfrtructuourfdgholdimmedeclicllevnceProjectSummryRAD51-dependenthomologoucombti(HR)eentilfhfulDNAdouble-trbk(DSB)pirthufegurdgtgenomerrngementneoplticcelltrnmticogeneDurgHRiDSBproceedyieldgDNAoverhngwiftlycotedReplictiProteA(RPA)perveeDNAoverhngctivteDNAdmgecheckpotSeverlHRmedirplykeyroleRPA-RAD51exchngehelpenutimelyemblyRAD51-DNAnucleoprotefilmentcpblecductgDNAhomologyerchubequenttrviRAD51prlog(RAD51BRAD51CRAD51DXRCC2XRCC3)HRmedirembledtctCX3(RAD51C-XRCC3)BCDX2(RAD51BCD-XRCC2)complexemedeRAD51filmentemblyGermlemuttimemreRAD51prlogcomplexegivebvrincncercutivecncer-preyndromeFncinemiThundercocrucilroleRAD51prloggenomemtenncetumuppiDepeirfundmentlimptncegenometegryirvolvementcnceruceptibilyltleknownboutmechnmwhichBCDX2CX3ervemedirRAD51-dependentHRThegolthpropoldetermetructurlmoleculrbwhichCX3(Aim1)BCDX2(Aim2)promoteRAD51-DNAnucleoprotefilmentemblyhowirdygultiledcncerOurtudielohedlighnhowhigherdercomplexeCX3BCDX2prtnerproteuchPALB2HELQmedeRPA-RAD51exchngeDNAcfercellulrtnceDNAdmgggentfunctiprotectitdmgedDNAplictikgtnucleolyticttriMechnticquetigrdgmoleculrroleeRAD51prlogcomplexenwedourMulti-PIerchtemthroughcombtigleprticlecryo-EMgle-moleculeDNAcurtygerbiochemiclbiophyiclcell-bednlyeWeexpecurmultidciplryynergticpprochyielddeeperundertghowCX3BCDX2complexefulfilircrucilfunctiHRfurnhctiblemtidevelopmentmllmoleculecncerrpeutictrgetgdtcttepRAD51-mededHRpthwyOteorcom(OS)motcommmlignncypedricpopultiOverllurvivlrtembout65-75%ignificntlyweptientmettticfrcry/lpeddeetenlg-termoutcomelethn30%TheWnt-ignlgpthwydowntmtrncriptilctivr-ctenvolvedmyridcellulrproceecludgprolifertidiffenticogeneInOSrrntWnt-pthwyignlgultunctrolledtrncriptiWnttrgetgenepromotegrowthmettticpdWhenWntpthwyctivted-ctenfetercttrnductit-likeprote1(TBL1)/highlyltedfmilymemrTBLXR1TBL1protectt-ctennuclerdegrdtimTBL1/-ctencomplexmedetrncriptiWnttrgetgeneOvexpiTBL1XR1nuclert-ctenpoivelylteddvereclicopthologiclfetupoprognoptientOSTegvivtfirt--clmllmoleculehibirelectivelybdTBL1hibgTBL1/-ctencomplexmtiImptntlythoccurouthibgnmlphyiologiclrole-ctencellmembrneWepvioulydemtrtedglegentTegvivthidtumgrowthuppedlungmettwhichdictlyleddevelopmentPhe1/2clicltrilttmentlpedpedricolidtum(NCT04851119)SubequentlyugourOSyngeneicmodelwehveevidenceTegvivtlterOSimmunouppivemicroenvirmentcgcyxicTcellNKcellfiltrtiFllywehvecentlycompletedcombtidrugcenTegvivtidentifiedclicllypplicblemoleculrlyrtileynergticprocompoundcludgmulti-tyroekehibirHDACWeexecutethedependentyetcomplementryimouroverllobjective(1)identifytrncriptillychrcterizecllevolutiTegvivt-tntOScell(2)ertilecombrilrpeuticgimencnquicklytrnltedchigh-rkrcomptient(3)identifyeffecttrgetgTBL1/-ctenevolutumimmunemicroenvirment(TiME)Aim1IdentifictiubpopultimoleculrprilgTegvivttntOScellUecellulrbrcodgcRNA-SeqprilglgudllyTegvivtttedvivomodeldefepecifictrncriptiltteemergencecelltteAim2Invroexvivovivoeefficcyxiciemo-combtirpyhigh-rkOSAim3EffectgeneticphrmcologictrgetgTBL1/-ctentummicroenvirmentWedectlgudleffecttrgetg-cten/TBL1ignlgTiMEimmunecellctuentgightmechnmimmuneexcluiTheultprovideightmechnmtnceTegvivtp-clicljutifictirtilcombrilrpeuticpprochefututrildevelopmenttthigh-rkpedriccncerptientThnewR01propolembletemexpertetumimmunologyimmunpymouecncermodelmelnomIFN-IignltumignlgglecellptilomicnovelttticlpprocheWedevelopednuchthoumelnommodelgenertetummelnomcellig(melnocyte)PDL1KOCTRLrNrQ61RmuttiOuroverrchghypoUVBelicloclytemicmelPDL1-dependentIFN-IproductipromotemelnomprogtmenttncethroughtumflmmrymemyGenerlpprocheWecompoutcomemelnocytePDL1(melPDL1)expumimmuneurveillnceTMEcompoumprogiuchthoumelnomducedUVBTrnplntbletumleuchthoutumgeneticllyengeedueddtcthottettumignleffectmedglevnutcomecfirmmechnmTheeoutcomecompddthumnmterilvlidtehumnlevnceAim1TethypoUVB-ducedIFN-IelicmelPDL1-dependentflmmrymemyCTRLverumelPDL1KOmT/mGTNQ61Rmice(melnocyteEGFPpter)ducedUVBTMEeffecteedpectrlflowcymetryRPPAbulkRNA-eqcRNA-eqptilimggpprocheCell-cellterctitetedCOMMOTcfoclimggIFN-IeffecttetedIFNARIFN-IquntifictiEffecttum-pecificimmunyuepmelcellgenepterIFNARKOcelleffecrfunctrffickgyOutcomecludetumflmmrymemyltencygrowthctrolDetiledmechnmterrogtedtrnplntbleleuchthoutumengeedtetpecificmoleculepthwyHumnlevncecfirmedhumntueAim2TethypocuteUVBffectltermelnomttmentpeEffectUVBIFN-Ittmenttnce(egthroughtumflmmrymemyverulterntive)eedimmunecheckpotblockdeelectedmllmoleculehibirMechnmdefedugbovepprocheCutneouUVBIFN-Ieffectmetttice(tumdrglymphnodelung)elucidtedplimrytudiedelogticpventfulldetiledmechntictudieMettetrckedimggidentifiedRNA-eqdtetugmT/mGmiceNovelttticlnlyticpprocheuedlloutcomeepecillycRNAeqptilimggABSTRACTAntigenpenttifundmentlcompentcncerimmunyTheprimrycyxiceffecrcncerimmunyCD8+TcellwhichcognizepeptidentigenpentedctextMjHcomptibilyComplexClI(MHC-I)TheefoundtilterctitweencncercellimmunecellunderlieucceimmunpyAntigenderivedomticmutticllednetigenhvegrnedignificnttetdeignnextgenertiimmunpieHowevernetigenufferignificntcllheterogeneytumpecificdividulptientlimgirwidepdueengeedimmunpielikecncervcceToddthlimtidvncempectrometryhveenbleddictmeumentfullperipeptideknownbdMHC-IwhichcollectivelyknownimmunopeptidomeEvercgdeptholutimeurgimmunopeptidomehvelednumerouourcecncerpecificntigenydnetigencludgpeptidederivedcryptictrnltieventnovelunnnottedopendgfrme(nuORF)NotblyimmunpytrilcncerhveveledntigenpecificCD8+TcellpeextendfrydjutmuttednetigenepecillylowtummuttiburdenptienthighlightgcriclneedundertddilcletumpecificntigenlikenuORFAdeeperundertgmechnmwhichnuORFpentedmyvelnovelpthwycouldphrmcologicllytrgetedcecncerimmunogenicyWehypoizenuORFntigenynizedproceedpentedthroughn-cniclmechnmutilizecp-dependenttrnltico-trnltilqulyctrolfcilteirpenttiMHC-IimmunourveillnceOurplimrynlydemtrtepecifictrnltihibirpromotecp-dependenttrnltilterntigeniclcpelungcncerInthpropolwebuildupeobervtiutilizecombtiophtictedgeneticllyengeedmouemodel(GEMM)humncncercellledefemechnmfluencenuORFbioynprocegntigenpenttiCD8+TcellcogniInAim1weevlutehowphrmcologiclphyiologiclmnipultrnltilterpentticogninuORFderivedntigenInAim2weectriico-trnltilqulyctrolmechnmhpgn-cniclntigenpenttiUltimtelygolthpropolundertmechnmwhichnuORFpentedmoeffectivelyenggethcltrgetimmunpyProjectSummry/AbtrctThecguegenetictetgdevelopmentyndrome-pecificrkmodelhtrnmedhedrycncerrkementWewefundedunderR01CA132829wrd(4/1/2008pent)de-velopPREMM126PREMM5rkementmodelwhichuefmilyhryidentifydividulclicllyignificntrkcrryggermlepthogenicvrint(PV)ocedLynchyndrome(LS)TheemodelcommendedntilguidelewidelyuedWeubequentlydevelopedPREMMplumodelkeeppcechnggprcticemultigenepneltetgeverlhedi-trycnceryndromePREMMplupdictrkcrrygPVe19geneimplicted18hedi-trycncerwdevelopedvlidtedptientdtpproximtely30000ptientPublhedJournlCliclOncologythyermodeldemtrtedgterthn90%enivynegtivep-dictivevlueDepeprogdevelopmentttermethodologierkementfctntilguidelecommendfmililcncerrkementprimryceementrlypermedlevgmnyptienthedrycnceryndromeunidentifiedPtientmrgl-izedbckgroundevenlelikelyceiveguidele-dictedrkementgenetictetgult-gcncerhelthequieProviderptmultiplebrriercductgrkementcludgtimecliclppotmentknowledgerkcrerilimednumrgeneticcounelRke-mentcnprovidecompheniveytemicidentifictiheredcncerrklgclercli-cldeciupptprovidercriclunmetneedFurrthrkementmuttegrblecliclwkflowwellclbleutblediverecliclettgToceccecom-phenivecncerrkementwehvedevelopedptient-fcgPREMMpluelectrichelthpplic-ti(pp)Wepropoeuenimplementticiencepprochdeignevluteclbleutbleimplementtitrtegiewecducurimplementticiencetudy5500ptient3diverecommunyhelthettgechwhicherveuniquemedicllymrglizedpopul-tiWefeppimplementtitrtegietilgmuniqueneedecheyer-lgp-implementtipheWeuemixed-methodpprocheevluteoutcomethtudygtmultipletrgoticlfrmewkToccomplhegolwepropoefollowgSpecificAim1)Evluteptient-fcgPREMMpluppdiverecommunyhelthettglrgemulti-centerimplementtitudy2)Evlutebrrierfcilrytemtichedrycncerrk-ementfelg-termtrtegieclbilyutbily3)BuildEHR-comptibleppli-ctievluteirbilyfurrceutbilyclbilyThprojectproducenpprochhedrycncermultigenetetgclbleutblemnyhelthcytemProjectAbtrctASPSCR1TFE3(AT3)fuicoprotetrncriptifcrexpedjunctiet(X17)chromoomltrnloctidefelveolrtprtrcomwelllrgetubetXp11-rrngedpedricnlcellcrcomBothlteddedlycncerpoprognoegenerllydevelopyoungptientExpiAT3mouemodelhprovenbilydrivebothrcomgenenlcellcrcomgeneechdependenrgeneticperturbtiWeidentifiedVCPterctAT3celllehumnmouetumtueTheterctiwloidentifiedtdetiledlevelchromtdtriihevilyoverlppgChIP-eqechproteAT3VCPwhichco-loclizepromoterenhncercrogenomedrivgenhncerloopmtiVCPnmllyfunctieggeunfoldemovgubtrteprotemembrnecomplexeevenchromtTypicllyhibiprote-leveldepletiledmetbolictlocyplmicrolegoverngqulyctrolprotefoldgHoweverAT3expgcellVCPdepletimimicAT3depletielfVCPdepletinlyimpcttrncriptrgetgenelo3DrchectuchromtwheenhncerloopAT3VCPlotupVCPdepletiInhibiVCPenzymticctivypecificmllmoleculrhibirloimpctAT3trncriptiltrgetcltitweenVCPhibidepletilimedwhichuggetimpctVCPtructurlcompentdtctenzymticctivyPlimrybiochemtrytructurlnlyehvedemtrtedAT3terctpecificllyVCPhexmertenzymticctivyThlllednoverllmodelAT3-mededtrncriptilprogrmmgdependgVCPco-fcrYetpcemechnmVCPgultgtrncriptAT3trgetlocimcriclgpknowledgeThpropoldetermebwherVCPenbleAT3trncriptilimpctthrougheggeenzymticfunctitructurlcffoldhigherderchromrgniztiUpcomplethpropoletblhroleVCPnobligteco-fcrAT3potentilnovelrpeutictrgetttmentlveolrtprtrcomPROJECTABSTRACTLymphedemdebiltglife-lgrogenicequlecncerttmentwhichcomgnimptnturvivhipuedueimprovedcncerurvivlPtientflmmrybtcncer(IBC)highlyggivembtcncerquiytemicrpyurgeryrdirpycologiclctrolTheettmentplcemthighetrkdevelopglymphedempproximtely50%developg12mthfollowgurgeryTheedevelopgtrtegiepdictpventttlymphedemwouldignificntlyimpctwell-gptientIBCGenerltrtegiettglymphedemcludephyiclrpyctuouuecompigrmenturgiclttmenthvecentlyentroducedcnprovideomeimprovementwellgympmburdenGivencompleteoutcomeeterventiepecillyhigh-rkgrouplikeIBCptientfocuhcentlyhiftedrk-ducgurgerieImmedelymphticctructi(ILR)lymphticveelttimexillrylymphdenecmy(ALND)hultedignificntlylowerrtelymphedemmgbtcncerptientptientwhoceivedILRUntuntelynetudieILRhvefocuedIBCptienthvevetigtedlgudloutcomemeuwhichwouldenblecompheniveoutcomeementcludgidentifictipotentilbiomrkerWepropoegle-rmclicltrilvetigtgimpctILRdevelopmentlymphedemIBCptienttglehigh-volumecenterpecilizgttmentIBCptientWehypoizeILRptientIBCpventtivegtlymphedemdevelopmentdefedobjectivecliclthholdmeumentpventchngelymphticrchectupumpgchrcterticlymphedemvulizedugner-frdfluocencelymphticimgg(NIRFLI)wellfunctilltertiperipherlbloodimmunecellocedlymphedemdevelopmentThhypoddedfollowgSpecificAim(1)determecidenceclicllymphedemIBCptientfollowgILR(2)etblhlgudldynmicimgg-bedprileIBCptientfollowgILRugNIRF-LIprovidel-timevuliztiobjectivechrcteriztichngelymphticveelrchectufuncti(3)identifyblood-bedflmmti-ltedigntulymphedemptientIBCthroughlgudlnlyerummpleourclicltrilcohtugnflmmrycyke/chemokerryThepropoedtrilllowobjectiveementlymphticveelnmyfunctilchngelymphedemwelldefeimmunechrcterticcltelymphedemdevelopmentIfuccefulthwkwouldprovideimpetuchngeurgicltrd--cptientIBChelpdicthighetrkptientpecilizedttmentcenterurgiclterventiSUMMARYTheomttubtype2cepr(SSTR2)exped80-100%NETSSTR2trgetedlph-emterrdioligrpy(-RLT)emerggnexcglterntivet-emterrdiophrmceuticlduehigherlerenergytrnferdeneiiztrckultenhncedmtidoubletdDNA(dDNA)dmgeup80%tumperteerlyclicltudieHoweverpclicltudiehow-RLTcncuedoedependentltenephroxicychrcterizedltetubulrjuryfibroflmmtiBuildgcentbkthroughourgroupweteverllhypo[212Pb]Pb-VMT--NET(212Pb-VMT)tumpecnmximizedthroughttmentchemecptebiomrkertubulrjurydoimetrydoefrctinephroprotectiveuperoxidedmutemimeticmigtenephroxicyInAim1wedevelopdetiledundertgroleuperoxidedmuttubulrdDNApirfollowg[212Pb]Pb-VMT--NETttmentInAim2weidentify[212Pb]Pb-VMT--NETdoggimenchievemximltumpeducenephroxicyuguperoxidedmutemimeticWecptefollowgnovtivemethod(1)novel-RLT[203Pb/212Pb]Pb-VMT--NETrnoticpirtrgetgSSTR2(2)novtiveSSTR2expgtummodel(3)ubiomrkern-vivedetectubulrjury(4)dDNAjury/piroltudymechnmerlyubclicltubulrdDNAdmgefollowg-RLT(5)novelnephroxicymigtitrtegybeduperoxidecvengghowpromgtumpeimprovementexternlmrdiIfuccefulweexpectefdgdvncetrnferblebrodrnge-RLTnlypncticNETneuroblmloprottebtmelnomdifficultttcncermenble-RLTPROJECTABSTRACTCncer-ltedftigue(CRF)emotcommfunctillylimgympmptedcncerurvivWhilenotrdcextCRFmngementclicllyupervedexerceet-knownterventiCRFExercepcripti(ExRx)urvivhowevercurntlyguidele-drivenlckgperliztilimgoverllefficcyRurlcncerurvivexperiencepohelthoutcomecludgcedrkCRFhvelimedccecliclexerceprogrmtnefimprovedExRxperliztiThelg-termgolthvetigtidevelopneffectivetelehelthexerceprogrmrurlcncerurvivCRFWhilemnyvetigtiterventirurlurvivfocuimplementtietblhedervicethpropolutilizenovtivecceiblemethodologytegrteementexerce-ocedmechnmCRFmedicliclefficcytrilThepurpoeeementprovidefoundtifutunovtiimprovedExRxperliztioptimizgdividulurvivoutcomedoofirtnunderervedpopultitnefoutcomeThvetigticcomplhedpurugthepecificimAim1vetigteefficcynoveltelehelthexerceprogrmrurlcncerurvivCRF(BfBwellTelehelthProgrm[BfBwell-TP])romizedctroltrilRurlbtprottecncerurvivfiveyercompletgcurtivettmentexperiencgCRF(N=134)cruedterventiw-ltctrolgroupApilotvetigtiBfBwell-TPdemtrtedfeibilycceptbilyimilrductiCRFcompdclicllyupervedprogrmupwhichbedBfBwell-TPutilizeextgtelehelthmethodologiedelivercombtiynchrouynchrouexerceeipidCRFmirgympm-triggedExRxperliztiupptCRFimprovementAim2exmeeffectimpidobjectivephyiclfunctifttycidoxidtiducedCRFpeexercedurgterventegrted-progrm(everytwoweek)moteementBothhveenocedftiguebothcnpecificllytrgetedExRxperliztiRecentdvncehvellowedmoteemenbjectivephyiclfunctiuemotelycollectedtbledriedbloodpot(DBS)mplemetbolomicnlyeimpidfttycidoxidtiFllyAim3exploddilbiomrkerexerce-ocedCRFmedhroughvetigtidynmicexercemetbolicprileetblheddurgctrolledlbry-bedexerceeiThAimpermnecerywkprovidefoundtidevelopmentmotelyeeddynmicexercemetbolicprileThpropolignificntcueutilizencceibleterventiduceCRFunderervedrurlcncerurvivtegrtenovtivemethodologydrivectuedimprovementerventiultimtelyducgburdencncerrurlurvivPROJECTSUMMARY/ABSTRACTGlioblm(GBM)motpvlentmlignntprimrybrtumnextmelyggivemdiffuegliomigtgtrocyticlegeDepecentdvncementmultimodlGBMrpywhichcpteurgeryrdipychempyupptivecoverllprognomdmllg-termurvivlrImmunpyholdpromeleverggimmuneytemtrgetelimtebrtumcellHoweverhighlyimmunouppiveenvirmentGBMpentcriclimpedimentuccefulimmunpySLIT2/ROBOignlgnovelimmuneevimechnmtummicroenvirmentGBMHighSLIT2expiGBMptientultccumultiimmunouppivetum-ocedmcrophge(TAM)wellvculrdymphiThfurrupptedpventiTAMtum-upptivepolriztingiogenicgeneexpiupytemicSLIT2hibiultgimprovedtumveelfunctienhncedefficcychempyimmunpyGBMmouemodelTherpeutictrgetgSLIT2/ROBOtercticurntlytrictedbiologicnoctiveclicltrilGBMevlutgSLIT2/ROBOhibirpeutictrtegyIncomprbiologicmllmoleculemimizeimmunogenicyrkenblettermngementdvereevent(AE)bedirmenbilyphrmcoketicoptimiztiholdpromecentrlnervouytem(CNS)penetrtiInpePAR-23-264ourthe-yerpropolimetblhnovelmcrophge-bedimmunpypprochGBMbedtrgetgSLIT2/ROBOterctimllmoleculewhichmyynergizecurntFDA-pprovedrpieGBMOurexperteydevelopmenthigh-throughputceng(HTS)dcoverymllmoleculeimmunomodulrh--ledoptimiztiimmunophrmcologyuniquelypoiuchievethgolAim1completecengCNS-focuedchemicllibrrymllmoleculeSLIT2bdgfollowednevlutibilyhhibSLIT2/ROBOterctiugfluocence-bedyAim2AvlidtephcompoundSLIT2/ROBOhibirugpnelcell-fecell-bedycludgnvropheroidviyugptient-derivedcellGBMtueAim2BpermexplrymediclchemtryplimrytructurloptimiztipvlidtedhderguidefutuexteniveoptimiztiTheproximlexpectedoutcomethwktroducgfirt--clmllmoleculeSLIT2/ROBOhibircidtepcliclevlutiprticulrlynovtivecombtirpieGBMPROJECTSUMMARYDrPrikhcultntDiviHemlogyDeprtmentMedicetMyoClicRocheterMNholdrnkAocePMediceMyoClicAlixSchoolMediceDrPrikhlomemrCLLDeeTemLymphoidMlignncieDeeGroupMyoClicCompheniveCncerCenterScejogtfftMyoClichcliclerchefthvefocuedchriclymphocyticleukemi(CLL)DrPrikhoverllgolimprovecptientCLLthroughdevelopmentnovelclicltrilcollbtiNtilCliclTrilNetwk(NCTN)TofurrhobjectiveDrPrikhpropoethR50pplicti1)completeECOG-ACRINtrilEA9161ARomizedPheIIIStudyAddiVeneclxIbrutibOuzumbVeruIbrutibOuzumbUnttedYoungerPtientChricLymphocyticLeukemi(CLL)AllinceCliclTrilOncologyclicltrilA041702ARomizedPheIIIStudyIbrutibPluOuzumbVeruIbrutibPluVeneclxOuzumbUnttedOlderPtient(65YerAge)ChricLymphocyticLeukemi(CLL)prticiptefloutcomenlycltivebiomrkernlydrftgbtrctmnucript2)developtudyprocolerveNtilPInextECOG-ACRIN-ledfrtleCLLprocoltledEA9231MeurbleReidulDeeGuidedFrtleTherpyChricLymphocyticLeukemi/SmllLymphocyticLymphomPtient<70YerInddiwrgtudyprocolctivtgtudyDrPrikhlopiblecompletgflnlypublhlevntbtrctmnucriptultthwk3)erveMyoClicPInextAllinceCliclTrilOncologyclicltriltetutilymeurbleiduldeeolderptient(>65yer)pvioulyunttedCLLAddillyhroleChirCLLDeeTemViceChirLymphoidMlignncieDeeGroupMyoClicCompheniveCncerCenterDrPrikhovereetrtegicplnllclicltrilCLLcroMyoEnterpcludgNCTN-podtrilDrPrikhloprticiptectivelycollbteeverlcltivetudiegcductedmplecollectedCLLptientenrolledECOG-ACRINtrilcrocountryDrPrikhviewopptunyubmthpplictiNCIReerchSpecilt(ClicinScientt)R50wrdignificntcriclopptunyctuehcergoldevelopgimplementgcompletgmotcuttg-edgette---rtclicltrilCLLcductedNCTNProjectSummrySenecenceenecenceocedecryphenotype(SASP)hvelgenimplicteddrivgtumigeneHoweverpro-tumigenicmechnm()enecencetillnotfullyunderodpotgneedttermodelytemtudyroleenecencetumigeneWecognizedbtcncermodeluedirrdicledmmmryftpdfollowedimplnttiyngeneicComm-DcellcouldnidelytemtudyenecenceeffecttumigeneImplnttiComm-Dledoenotulutgrowumquip-irrdigltumigeneSimilrlyttmentmmmryftpdchemiclpriimplntticnlodrivetumigeneBothetypettmentloknownduceenecencedeedwefoundirrdiducemiveenecencetueThuwehypoizetumigenethmodelytemlieductienecencedrivetummtrgetgenecentcellpecificSASPfcrimpirtumigeneWepropoetudythmodelytemfurrhowtumigenequiductienecencetwopecificimInfirtimwettirrdednimlenolyticdrugmoveenecentcellpriimplnttiSCp2mmmrycellcomptumcidencethgroupctrolrmttedvehicleleOurplimrydtdictetrgetedmovlenecentcellnviclxblocktummtiExteniourtudieetblhenecencecndriveerlytumigenemultiplemodelInecdimweexmehowenecencedrivep-neoplticcellgrowthurvivldiffentivivougmultipleximmunluocenceWepermRNAeqidentifySASPfcrupgultedpeirrdiWetetefcrirbilyenhncegrowthSCp2humnmmmryepililcell(HMEC)vroSASPfcrenhncegrowthurvivlecellelectedtrgetgdetermeirroletummtiWeuemllmoleculehibirceprterfergntibodieSASPfcrdetermehowblockgeputtivegrowthpromotgfcrimpcttummtiSuccefulcompletietudieetblhwhertumigenelumlmmmrycellimplnttiytemdrivenenecenceidentifymechnmwhichenecencedrivetumigenedemtrtebilyenolyticmllmoleculehibirtrgetgSASPfcrimpirtumigeneTheepentfirttepggmechnticundertgroleenecenceerlymmmrytumigenelgtermgoldevelopgnti-enecencepprochepventtmenthumnbtcncerOrlnticncermedicti(OAM)comgtrdcgrowgnumrptientMultiplemyelom(MM)chricmyeloidleukemi(CML)chriclymphocyticleukemi(CLL)hemlogicmlignnciewhichcotlylg-termOAMlife-extendgrpyHoweverOAMndhence(iedelygnottrtgtkgmo/lethnpcridppgue)criclundertudieduecndrmticllyffectcnceroutcomeThepodhencechrcterticthoetrkpodhenceeffectpodhencehelthoutcomepolyunderodprticulrlythoehemlogicmlignncieMulti-levelfcrffectdhencemyuniquebeddhencephecludgi(timepcriptifirtdoetken)pertence(ctentlytkgpcrid)OurplimrydtmgptientMMidentified3dtctOAMdhencetrjecrygroupWhilelmot63%ptientmtedner-perfectdhenceover6mthover27%gnt85%droppedlow70%10%hdctentlyverylowdhence(40%)Self-ptedrceethnicy(n-HpnicBlck/AfricnAmericnHpnicvn-Hpnicwhe)pdictedverylowdhencewhichwocedducedqulylife(QOL)Sytembrrier(iecdelypeciltyphrmcybrrierurncepprovlhighcot)ympmccernfluenceddhencenegtivelyffectedQOLemploymentdeciOurlg-termgoldeveloptrgetedculturllyeniveterventiimproveOAMdhencehelthoutcomeprticulrlymggroupmottrkdprtecnceroutcomeTheoverllobjectivethoticllyguidedtudycomphenivelychrcterizeOAMdhenceipertenceidentifytemplclte1)multi-levelfcrcerkpodhence2)helthoutcomeocioecomicllydivereptientMMCMLCLLApropective(p-rpy[T0]petedmthlymeu[T1-T12]e-yerpot-rpyi)mixedmethoddeignued306ocioecomicllydivereptientpcridlg-termOAMrpyMMCMLCLLAim1chrcterizeipertencepheOAMdhenceAim2identifymulti-levelfcrfluencgOAMdhenceipertenceAim3exploltihiptweenOAMdhenceipertencehelthoutcome(helthcutiliztiQOLmoleculrpeprogi-feurvivloverllurvivl)Aim4explofcrffectgptientexperiencetkgOAMtidurgpertencebedemi-tructudterviewmpleubetdiffergleveldhenceThtudyfillcriclgpneededidentifythoetrkndhencetrgetedupptmfutuclicllylevntterventiimproveOAMdhencectrieequblehelthoutcomemdhenceerchcncertypeProjectSummryCARTcellrpiehveenvolutiryptientlped/frcryhemlogicmlignnciehoweverlperteuncceptblyhigh~60%ptientlpgleukemilymphommultiplemyelom(MM)whemofollowupneededlpelikelyevenhigherNotblydultptientrlydeveloplg-termimmunologicmemyfunctillg-termpertenceCARTcelllpepdictblytenoccurrgfterlofunctildoptiventi-tumimmunyOneolutiht-liveddoptiveimmunygeneticllymodifyhempoietictemcell(HSC)trngeneCARThwouldultCARgexpedcrohempoielg-termHowevercykeleeyndrome(CRS)mededTmyeloidcellthlg-termpn-hempoieticexpiwouldputptienttgtrkcyke-mededxicyWepropoenlterntivecceptwheHSCtblytegrtedDNAencodgCARhowevertrncriptilyedcecellhvediffentedNKcellgenertefeefficciouHSCCAR-NKfcrieWeelectedNKcellrkCRSmimlneedthymicdiffentiyhveproventrckcdCAR-mededkillghoweverdefglimtiCAR-NKcellrpiehenpertencewhichthpprochdeignedddvilg-termctuounewlWehypoizecludgNK-pecificgulryelementctrollgCARtrngeneexpigenerteNK-pecifichighlyefficcioulg-termnti-cncerimmunyInplimrydtwedemtrtedptientHSC-bedCARtrnductrnplnttiettgmumodelgenertemimlTcellcnhighlyctivepventgtumgrowthNKcellgenertedthwyoltedexvivomtcylyticnti-tumfuncthroughCARWefurridentifiedvinlycomprtiveATAC-eqdtlibrryNK-pecificgulryelementfoundledemblyegulryelementproduciblyledCARexpihighlyenrichedNKcellfdgwevlidteddiffentvivoHSCtrnplnt/NKdiffentimodelugptientHSCHewevetigteifnturllyoccurrgNK-pecificgulryelementembly(Aim1)cnlevergeddevelopmodelHSC-bedpertentdoptivecellulrrpypltmnti-tumimmuny(Aim2)eekundertbiologymximizeefficcyHSCCAR-NKcellfcrypprochSpecificllyweuetheeprtevivomodelllowNKdevelopmentpot-huHSCtrnplnttiPROJECTSUMMARYLeukemipentmotpvlentmcncermgchildnSequencgtudieidenticltwdicteilgeneticlterticnmnifeterlydurgfetldevelopmentAcutemyeloidleukemi(AML)heterogeneoudeewhichchrcterizedvriougeneticlterticludgfuicoproteNUP98-NSD1fui-poiveAMLpoprognoticubtypecommlydignoedpedricptientcygeneticllynmlAMLThenuclerpocomplexmemrNUP98fuehnemethyltrnfereNSD1RecentlyNUP98-NSD1genefuicombtrncriptifcrWT1(Wilmtum1)muttiweidentifiedchempytntpedricAMLcohtdevttg4-yerevent-feurvivllethn10%TheunderlygwhyNUP98-NSD1WT1muttiocedrpytncelpenotknownInplimryexperimentwectedhumnizedytemNUP98-NSD1rrngedleukemiwdogenouexpifuigeneoutWT1lofunctimuttiStrikglyNUP98-NSD1fui-drivenleukemogenedplyeddevelopmentldependencywheexprnmp-ntlfetlliver-derivedhempoietictemcell(HSC)leerextentpot-ntlcdblood-derivedHSCunbletrnmdultmrrow-derivedHSCInvroendogenouNUP98-NSD1coprotecferdcllelectiprolifertidvntgefetlHSCwhilevivothroughxenotrnplnttimiceNUP98-NSD1fhfullycpultedAMLTheewehypoizeepigeneticttefetl-derivedHSCpermiveNUP98-NSD1-mededleukemictrnmtipeddevelopmentlttefterbirthTheoverllobjectiveourprojectdefemechnmctiNUP98-NSD1HSCcrodevelopmentunderthowWT1muttidriverpytnceidentifynovelrpeutictrgetNUP98-rrngedleukemiInAim1wepropogvetigtecellulrdevelopmentldependencyNUP98-NSD1-mededleukemicixenotrnplnttiWeegle-cellepigenetictrncriptillcpeNUP98-NSD1fui-poiveHSCcrogenyInAim2weplnchrcterizedowntmeffectWT1muttiNUP98-rrngedleukemiWeobervedccurntWT1loledmoprimivetemcellhierrchynenrichmentquiecentleukemictemcellFllyAim3wepropogidentifyrpeuticpprochegtNUP98-rrngedleukemiWefunctillyerolecidtegeneugouretblhedmodelprimryPDXptientmpleOurgolchrcterizenovelrpeutictrgetNUP98-rrngedleukemiThepropoederchhpotentilchngeourundertgwhychildnuceptibleNUP98-NSD1rrngedAMLprovidetrgrtilrpeuticterventifutuFunctilmoleculrchrcteriztiOncetlStemCellCRCProjectSummryBckgroundColoctlcncer(CRC)ecdmotdedlycncerwldwidenerlyemillidethnnully1CRCdevelopultccumultggeneticepigeneticrrticolicepiliumledgmtinigndenomevolvevivedenocrcom23Depedvncettmenptitncerpycurncemevbleptientdvnceddeeccountghighmtlyrte45TheunderlygmlignntfetuhveententtriedLGR5+CSCHoweverunexpectedfdgcertLGR5-celluttumgrowthupelectiveblthpopulti67ctentcentdecriptipotentilecdtemcellpopultifetl-likechrctertic8-10Whilerigugrpeuticperpectiveextenceecdpltictemcellpopultimoprimivette(hefterferdOnFSCOncoFetlStemCell)olelybedtrncriptiligntuGpDepecenttudiedecribgextencemoleculrunderpngfunctillevncerpeuticimplictiOnFcellulrtteCRCmlrgelyunexplodHypoWehypoizeOnFSCwktemLGR5+temcell(SC)fueltumovolutiCRCOnFcellemergeerlydurgtetltumigene(ieupctivtiAPCgtekeeper)TheirtncerpyhighgenertivepotentilmkemcricldrivertumplticycncercurnceSpecificAimWehepropoefunctillychrcterizeOnFSCCRCInAim1wefirtgenertephenotypictrncriptilptertrckdynmicLGR5+CSCOnFSCThencouplgepteruicidegene(ieDTR)weimdectfunctilterplytweenediffenttemcellpoolCRCInAim2weuemulti-omicpprochdetermemoleculrdriverOnFttephenotypicplticyCRCInAim3wepermtrgetedphenotypiccengidentifycompoundbleelectivelydepleteOnFSCThephtetedcombticurnttrdcLGR5+SC-trgetgrpie1112WevlidteourpdrugcombtivivougbothmouetumoidhumnPDO/PDXTheimdetermeelectivecombtirpyupericurnttrdcImpctThefdgetudieuncovernewlyercomplexyCRCbiologyetblhmechnticfoundtideigngeffectivecombtirpieendurgimpcnCRCttmentColoctlcncer(CRC)growggloblepecillymgyoungerdultImpiddiffenticriclmechnmwhichCRCcellunlockcelltteplticyenbleneoplticcellpertrrthnturnoverrpidlynewgtetlepiliumeventullycquimlignntfetuThemoleculrunderpngimpiddiffenticomplexchllenggunrvelRecenttudieourgrouppotlighttrncriptifcr(TF)SOX9pivotlfunctilmedirimpiddiffentiCRCDruptgSOX9duceddiffentiducedtumburdeneverlCRCmodelprkgdeeperquiryOurplimrydtupptcompellglktweenrrntSOX9ctivyctivtifetltetlgenemouehumnmodelCRCBedefdgouroverllhypoSOX9impirdiffentifciltgdevelopmentlprogrmmgCRCTovetigtethhypowehvedevelopedpowerfulvrovivoytemddtwoSpecificAimInAim1wepplyundpicmodelgnlyepidgecellRNAATACequencgdtgeneticllyengeedmicenomtegulrfetlprogrmmgneoplticcell(1A)BytegrtgmRNAopenchromtTFbdgprileourmouemodelptient-derivedgnoidwevetigteifSOX9dictlygultefetlgenevipieerctivy(1B)WedetermeifSOX9quidfetlgenectivtivivothroughhpthologyglecellchrcteriztigeneticmouemodel(1C)Fllywelevergenewlyengeedcellulrpltmenbledrug-ducedrpiddegrdtiendogenouSOX9(dTAGytem)tudyrolechromtccehnemrkdepoifetlgeneexpi(1D)WeobervednewchromtcceibilytTACSTD2rrntexpiproteproductTROP2fetlglycoprotehumnCRCOurplimrydtlodicteSOX9dictlygultetrncriptiTACSTD2InAim2wetethypoTROP2functilcompentSOX9-mededdiffentiblockCRCevlutgnecey(2A)ufficiency(2B)BeydTROP2weytemticllyevluteht-lteddevelopmentlfcrugcumengeedendogenoudiffentipterytemkgwherechcidtequidimpiddiffentipoiveelectigeneticcen(2C)ThroughfunctilvetigtiTROP2wetngnkeylktweenSOX9developmentlprogrmmgOverllrmedrobutmodelytemrigoucientificmethodhypo-drivenpprochourpropoldefebicmechnmwhichrrntSOX9ctivypromoteCRCByfergdeeperightimpiddiffentirrntcelltteplticyweimpinewtrtegienext-genertiCRCrpeuticPROJECTSUMMARY/ABSTRACTMyelodyplticyndrome(MDS)groupge-ltedmrrowfiludderchrcterizedcypeninemiItetimted10000newceMDSdignoedUnedStteechyerThcuedfunctildeclehempoietictemcellmrrowcuecquidgeneticmutticruptirbilymkebloodcelleffectivelyCliclmngementMDSmchllengglimedttmentvilbletemcelltrnplnttimlycurtiverpyHowevermotptientunbleceivetrnplnttiduedvncedgeco-mbidieThupgneedtterundertcomplexydeewhichcnleddevelopmentnovelrpieSomticmuttiplicgfcrgenecludgSRSF2U2AF1SF3B1ZRSR2foundmotptientMDSPtientcrrygplicgmuttigenerllyolderhveferiprognoethigherrktrnmgecdryleukemiRecenttudiefoundmuttiplicgfcrgenetriggernelevtedlevelcellulrR-loopwhichctRNADNAhybridtructudplcedgle-tdDNAWhileR-loopnturl-productctivetrncriptiifleftunolvedycouldpoegenometegrydueirpropenyducedoubletrbkHewepropoetethypotrgetgR-loop-ducedgenomictbilynttrctiverpeutictrtegyMDScellcrryendogenoumuttiRNAplicgfcrOurplimrydtuggetcellmuttedplicgfcrexquelyeniveclicllypprovedPARPhibiruchOlpribnovelPARP1-pecifichibirAZD5305MooverweprovideevidencePARPcnphyicllyoceR-loopdmpenR-loop-ducedgenomictbilyPARP1ctivytR-loopcoulduedpdictivebiomrkerPARPhibirpeThpropolhtwopecificimInAim1weplndectunderlygmoleculrmechnmPARPhibirenivyctextplicgmutntMDStetrpeuticpotentilPARPhibirp-cliclMDSmodelInAim2weplnexpidentifycombtirpytrtegiePARPPARP1-pecifichibirWefirtplndetermewhercombgPARPATRhibircnduceynergticeffectMDScellRNAplicgmuttiNextweplnidentifytetnovelenizerPARP1-pecifichibirevluteoptimlcombttmenttrtegyugp-cliclmodelSuccefulcomplethpropolledvlidtinewttmenpticnhopefullyimproveoutcomeMDSptientAbtrctAdenoidCyticCrcom(ACC)commlivryglcncerwhichnotrdytemicrpyACChheterogeneouhviwhilemotptienthvendolentdeecourepproximtely30%hveveryggivedeeThecurntlynotrdmrkerprognoticteelectgttmentEpigeneticchngetightlylkedtumigenecncerproginumeroutudieimplyDNAmethyltimyervevlublebiomrkeridentifymoleculrdeeubtypeHowevertudieevlutgwholeACCmethylomeevolutirytrjecriemethyltidurgiprogiACClckgWeidentifiedmethyltertumheterogeneyACCdiffentillymethyltedgenegiccdgACCtrncripmicubtypeAddillyweloidentifiedcircultgtumDNAbloodACCptientirlevelclteddeecurnceperpydeeprogiuggetgcliclutilyctDNAdynmicOurcentrlhypoDNAmethyltiigntuACCcnidentifyprognoticllydtctrpeuticlevntmoleculrubtypecircultgmethyltimrkermyuedn-viveoll-timeubtypgtrtificttmentmirgInAim1weexmeDNAmethyltrncripmicprile200clicllynnottedACCtumlgtermfollow-upevlueDNAmethyltifgtrncripmicbedACCubtypgInAim2weprilemethylti/trncripmepidprimrymetttictumidentifymettticpecificchngedevelopmettticpropenycopdictmettticeInAim3weprileDNAmethylticircultgfeDNAmtchedtumbloodmplecollectedprtpropectivetudyldyeddevelopblood-bedmethylticoACCubtypgAddillywevlidteignificnceourblood-bedmethylticodetectgACCubtypeevolutipdictttmentpeugbloodmplecollectedprurclicltrilOurerchfirtvetigteACCDNAmethyltimrkeridentifyggiveACCtildignothroughouttumprogiAccurtedignothroughimplebloodtetllowclicindetectevolutideel-timeguidettmentelectiPROJECTSUMMARYOurpropoederchemploynovtiveundpprochenovelpcliclmodelelucidtehowdemtedHER2+btcncercellcellurvivebrmicroenvirmentemetchroumettThroughfunctilchrcteriztiphenotypicllytblepcliclmodelHER2+btcncerbrmettwedcovedltent/dmnt(Lt)HER2+celldplytemcell-likechrcterticdowngulteimmunectivtgenurviveequilibriumnteimmuneurveillncewhilebrmettticcellecpemettizeMoovermetbolicllydtctHER2+br-tropicLtcellmetchroubrmetttic(M-BM)celltntrdiytemicHER2trgetedrpieAXLmemrTAM(TYRO3AXLMERTK)ceprtyroekefmilyenrichedLtM-BMAXLexpienrichedmetchroubrmettticleicompdmtchedprimrytumHER2+btcncerptientOfnoteAXLpdomntlynuclerebrmettticleiourpcliclbrmettticmodelytemCRISPRffypurifictiugulryelementveledenrichmentTEADtrncriptifcrtAXLpromotergiLtM-BMAXLimmunopcipti-mpectrometrynlyidentifiedWRNHeliceInterctgProte1(WRNIP1)mgnuclerproteterctAXLWRNIP1idmtenncegenomictbilyunderplictivetpromoteurvivlLtM-BMcellDepletiAXLLtM-BMcelldmtrtimllmoleculeAXLhibir(BGB324)ultttenutedmettgcpcyNoticeblycedAXLexpiducedcyxicywloobervedtumtd/expoedNKcellwhiledmtrtiBGB324ugmentedcyxicyThuourcentrlhyporpytntbr-tropicHER2+btcncercelldependennnuclerAXLignlgpeurvivlmembrnouAXLexpiNKcellultdyfunctiThepropoedimdeletehowTEADignlgpepromotebrmetteimpctAXLhibirlimgtumcellurvivlctivtgNKmedednteimmuneurveillncePROJECTSUMMARY/ABSTRACTThethe-dimenil(3D)genomefoldggniztinucleucellplykeyroleepigenomicgultibothnmlphyiologydeeSequencg-bed3Dgenomictechnologieuchhigh-throughputchromoomecmticptu(Hi-C)hveptedytemticllyltedgenomegnizticncercellYetetudieliedpopultiverggcelldictfencegenomegniztibedchromtctctAulthowgenomefoldedtrue3DdividulcncercellvivohowthfoldggniztievolvegulteddurgcncerproginmlpvivevivetumcellntivetueenvirmenthowltertigenomegniztidrivetumigenemeluiveToddegpknowledgeweppliednimge-bed3DgenomicmethodwepieedtermedchromttrcgfhfulKr-drivenmouemodel(K-MADM-Trp53)lungdenocrcom(LUAD)developedfirtugle-cell3DgenometlnycncerWeobervedteotypicl3DgenomeltertidurgcncerdevelopmentcludgtrikgtructurlbottleneckpvivedenompriprogiLUADdictgtrgentelecti3DgenomeerlytumigeneWefurrfound3DgenomegnizticltedtcthlogiccncertteglecellhiftthgniztivelpotentildriverLUADprogiInthpropolweimtethypochnge3DgnizticncergenomedrivetumigeneThetudieAim1utilizeophtictedmultiplexedvivoCRISPRknockoutcenetblhfunctilimptnce3Dgenome-gultedcidtedrivergeneLUADprogicfirmimilrltertioccurhumnLUADbiopecimenThepropoedwkAim2uegeneticphrmcologicmnipultiepigeneticprilgmethod(ChIPCUT&RUNchromttrcg)LUADcellmouemodeldefehowchromt-modifygenzymeRnf2gultecncer3Dgenomethroughn-cniclfunctipromotgnctivechromttteFllyexperimentAim3levergenlogouuchthoumouemodelEGFR-drivenLUADKr-drivenpncticductldenocrcomdetermehowcogenicdriver(KrvEGFR)tueig(lungvpnc)impct3DgenomeultnteffecttumbiologyTogereexperimentetblhhowlterti3Dgenomeeeduchromttrcgdrivectext-dependentcncerdevelopmentunderlygmechnmpromoteirpro-tumigeniceffectircpcyervenovelpdictivebiomrkercncerrpyABSTRACTAcutelymphoblticleukemi(ALL)motcommchildhoodmlignncypdomntlydevelopgB-cellpcurB-cellALL(B-ALL)mledgcuecncer-ltedmtlychildnB-ALLurvivfcelg-termrpy-ltedmbidieMooverB-ALLdproptelyimpctchildnHpnic/Lethnicywhohvehighetrkdeeferiptienutcomecompdn-HpnicwhechildnPventiB-ALLmneentilgolmigtechildhoodmtlyuffergducedpriethnecetenundertgdeerootcuePrmountthelucidtgmechnmgeneticpdpoiB-ALLPviougenome-wideocitudie(GWAS)hveidentifiedtlet15rklociocedchildhoodB-ALLmotceculvrinthvenotenidentifiedOurpropolimtegrteultlrgemulti-ncetryGWASchildhoodALLgle-cellepigenomicdtfollowedtrgetedbeedghempoietictemprogenircell(HSPC)ppotculvrintdcernirimpcnnmlhumnBcelldevelopmentThroughthnovtivecollbtivepprochwehypoizeweuncovermechnticightrootcueB-ALLdevelopmentcouldmfutupventivetrtegieInourfirtimwecductmulti-ncetryGWASfollowedttticlfe-mppgnlyknownB-ALLrklociugextggenotypedtTheeulttegrtedgle-cellcceiblechromtdtpnnghumnhempoieBcelldevelopmentugSCAVENGEmethodwehvedevelopedpvioulyidentifypecificBcelldevelopmentltgeunderlieB-ALLpdpoiidentifyculvrinttechB-ALLrklocuInourecdimwegenertenewgle-cellmulti-omicdtcludgjotcRNA-cATAC-eqglecellhumnHSPCundergogBcelldiffentivroTheedtenblegulrymppgcellcroBcelldevelopmentcludgrtermedecelluedmplevntcellttetrgetgenefe-mppedB-ALLrkvrintFllyourthirdimwevetigtefunctilimpctB-ALLrkvrintuggenomeedgWepriizeixculvrintourmppgpprochecludgvrintARID5BGATA3hvepvioulyenidentifiedculctriecedB-ALLrkHpnic/LchildnWecteeixvrintdividullypecificcombtivibeedghumnHSPCmultiplednubjectBcelldiffentivetigteireffectBcelldevelopmennillegimteV(D)JcombtiknowndriverB-cellleukemogeneOurnovtivevrint--functimppgpprochvelpcemechnmthroughwhichB-ALLocilocimycechildrkdevelopgleukemimyhighlightnovelrpeutictrgetmfutupprochechildhoodleukemipventiABSTRACTThecidencepncticductldenocrcom(PDAC)cgdepeuecventilrpiecludgimmunecheckpothibir5yerurvivlmdmlt~12%1LtedetectirpeutictncectutetwocrdlchllengePDACmngementHowevernowclerfollowgilKRASmuttitkeoverdecdeovertcncerdeveloppmlignntleiclledpnctictpililneopli(PnIN)RecenttudiehveloidentifieddividulthighrkPDACwhohvetrgfmilyhryhrbpthogenicvrintcnceruceptibilygeneImggfurridentifiepmlignntpthologieuchtrppillrymucouneopli(IPMN)Bothdvncegenetictetgimgggerexceptillyprotrcted>10yerlgwdowilentPDACprogiundercoopptunieterceptprogiHewehvetrgetedmuttedKRAS(mKRAS)driveup90%PDACWefoundpvioulyKrG12DvccehltPnINprogi40%KPCmicehrbheterozygouKrG12DmuttiThtudyprovidedpmetetgourmKRASvccecomprgixpeptidecpdgmotcommKRASmuttiptientectedPDAC(NCT04117087)WeprovideevidencefetyductimKRASpecificpdomntlyCD4TcellimproveddeefeurvivlTheedtprompteduetudyevlutefetyimmunogenicyvccegeneticllypdpoeddividul(NCT05013216Aim1)PromgplimrydtetblhcceptultechnologiclfeibilyWehypoizemKRASvcce()triggermKRASpecificntumimmunydividulpmlignntleiPnINIPMN(b)lowprogiPnINPDACurvivlnefKPCmicewhengivenpriductiKrG12DmuttiAim1(ldyed)Aim2tudyfetyimmunogenicymKRASvccedividulgeneticpdpoihighrkIPMNpectivelyWetudymKRASpecificTcelltermmemyexhutipolyfunctilywellcllyrichneTcellperiInAim1weloidentifyTCRclecyxicgeneigntuvlidteirfunctiknockgelectedTCRhumnTcellAim2llowuexmeeffectvccepmlignntIPMNtueugimgemcymetryInpirbidictiltrnltiwemovebckAim3ducibleveriKPCmouedetermeoptimltimepotvcceterceptichrcterizelgudlchngeimmunecomprtmentPnINleivetigteroleCD4TcellpventgPnINPDACprogiEtblhgvcceeffecthighrkcohtgermutudiechngecellulrrchectuevolvgimmunouppiveprocogenicignlhouldllownovelcombriltrtegiewhichvccewouldcodmtedimmunemodulrenulgtermefficcyhighrkgroupPROJECTSUMMARYDepeignificntcliclucceAR-trgetedrpiemngementprottecncer(PC)tnceettmentmignificntchllengeThtncetenmnifetpertenvenelevtedlevelARARignlgEmerggevidencedictedygultiubiquti-bedprotedegrdtiprocepivotlccumulticogenicprotelikeARctrigrpeutictnceWhilerolevriouE3ligedegrdtiARtumigenePChenextenivelytudiedcrucilyetunddedgpourundertggrdgpecificE2enzymepibleARdegrdtiOurerchidentifieUBE2J1unticE2ubiqucjugtgenzymeccountbleARubiqutiPCPlimryultvelfquentloUBE2J110-15%PCptientleddygultedARubiqutidegrdtictrigccumultitnceAR-trgetedrpyByutilizgubiquti-bedARdegrderwehveuccefullyttedARdegrdtiimpededgrowthrpy-tntPCtumInlightecompellgfdgwepropoetheimvlidtecentrlhypoUBE2J1erveE2ubiqucjugtgenzymegultgARdegrdtitnceAR-trgetedrpieTheoverrchggolthtudyunrvelmoleculrfunctiUBE2J1governgARubiqutidegrdtivrioufcetPCtumigenerpytnceInAim1weundertkecomphenivenlyroleUBE2J1gultgARfuncticromultipletgePCemploygbothvrovivomodelWeutilizegle-cellRNAequencgptiltrncripmiceeffectUBE2J1-lotumheterogeneytncetgle-cellolutiInAim2wecomphenivelydectmoleculrmechnmthroughwhichUBE2J1gulteARdegrdtiWeidentifycricldomUBE2J1ppotpecificterctiubiqutieARvelE3ligepibleUBE2J1-mededARdegrdtiWeloexploltertiARctrometrncripmelcpectextUBE2J1-loInAim3weillyevlutevrovivoeffectivenergARdegrdtiugPROTAC-bedARdegrderAC67AC176vriouUBE2J1-KOPCmodelWeubequentlyepdictivevlueUBE2J1expibiomrkerpebothARntgtARdegrderComplethprojectnlyubtntillyfeourcomphenimoleculrmechnmgoverngARdegrdtirpytncedvncedPCpvewydevelopmentnimpctfulpdictivebiomrkerwellnewrpeuticpprochcombtthlethlcomplictimoderntrgetedrpieimprovgclicloutcomeptientSUMMARYThegolthprojectdeveloptrtegieerdictileukemi-gcell(LIC)AMLptientwhohveceivedilrpyveneclxzcide(ven/z)AdemtrtedpvioulylmotllAMLptientttedven/zeventullylpeThuprovidgimprovedrpeuticgimennurgentunmetneedOurpvioutudiehvedemtrtedmothneubtypeLICcnextimultneoulymeptientImptntlydiffentLICubtypecndemtrtehighlyvribleperpycludgtnceven/zThuLICheterogeneymypvlentfetuAMLbiologyuchpoeignificntchllengedeigngoptimlrpieeffectivelyerdictemCequentlymjgolthprojectchrcterizetrgetven/ztntLICOurplimrydtdictelinceuptkeclciummichdridtctfetuvulnerbilyven/ztntAMLcellThuwehvevetigtedroleclciumunipterMCUpotentilrpeutictrgetOurfdghowbothgeneticphrmcologiclhibiMCUhighlycyxicven/ztntLICImptntlynmlhempoietictem/progenircelldoththextenivelinceupMCUmichdrilmetbolmurvivlThuthxpperpentuniquefetuven/z-tntLICturnnttrctiveopptunyrpeuticterventiTotrnltethtrtegycliclprcticewehvelevergedcentfdghowwellchrcterizedchempygentmixntre(mix)trghibirMCUIntriguglywedemtrtemixeffectiveuppgmichdrilclciumuptkedowntmmetbolmtdoe10-100foldlowerthnuedcventilchempypurpoeIndeedtdoelow10nMweobervepotenterdictiven/ztntLICnoevidenceDNAdmgenodcernbleeffecngrowthnmlhempoietictem/progenircellBedefdgourgol1)permpcliclmodelgtudiepludecliclvetigtitterundertmixmechnmcti2)cductclicltriluglower-doemixcombtiven/ztrtegytrgetdrug-tntLICcemidurti3)permdetiledvivlyLICubtypeptientundergogven/z/mixrpytterdeferolemichdrilclciumuptkenymoleculreventctrierpytnceheterogenouLICcomprtmentTkengerpropoedtudieprovidecompheniveevlutimixclicltrtegyugmentven/zrpydetermepvlenceroleclciumuptkebiologydrugtntLICPROJECTSUMMARY/ABSTRACTMlebtcncercricllyundertudiedduebothrrydeeexcluimenbtcncertrilledgignificntknowledgegpbouthowmlebttumpdrpyTheefficcyextgendocrpiemenER+/HER2-btcncerhveneverencompdpropectivelythgolgogETHANtrilInril60ptientromized3endocgimen3-weekwdowphefollowedbiopyn4-mthneodjuvntphe+/-CDK4/6hibirmciclibfollowedurgiclectiThetrilwellpowedcompdiffencepertemeudwdowphe50%ductiKi-67neodjuvntpheidulcncerburdendexThdeignctenunpcedentedopptunytrnltiltudieugmpleppotttmenttimepotnnottedclicllylevntpeendpotThegolthpropollevergeptientmpleETHANtrilundertpdicthowmlebttumpdrpyWehypoizemultigenepeigntupdictpeETmenER+bttumTotetthhypoAim1wedetermeendocrpypeigntuugwholetrncripmeequencgppotttmentpecimenWedetermehowechdrugttmentultchngegeneexpicompefemlepdicrpeigntuWepermtrtifiednlypdern-pderdcoverbiomrkerwhichvlidteduglrgecohtptientER+/HER2-btcncerttedwdocrpyInAim2weutilizeourglecellprocegpipelewhichweuedhowdtctpemlignntcellubpopultifemleER+/HER2-bttumdecterogeneyendocrpypemlebttumThnlydefefetulowbundncecellpopultimydrivgtncephenotypeFllyAim3weddcricllckexperimentlmodelmlebtcncerugourgnoidfrtructugenertemleptientderivedgnoidWeuegnoidtetetrogenceprgenegulryfunctiepcliclefficcytrgetedrpeutictrtegieCumultivelyetudieddignificntknowledgegpwhyrpieeffectiveineffectivemenbtcncerTheefdggenertepdicrpeidentifypthwydrivgtncegenerteutilizeexperimentlmodeluncovertricbiologymlebttumIfuccefuleightledmopcettmentgimenimproveoutcomemenbtcncerProjectSummry/AbtrctColoctlcncer(CRC)ecdmotcommcuecncer-ltedmtlyUnedStte(US)AlthougheverleffectivepventierlydetecticengmethodvilblecengmunderutilizedThemotfeibleCRCcengmodlyverge-rkdividullowourceettguchFederllyQulifiedHelthCenter(FQHC)ol-bedfeclimmunochemicltet(FIT)OnechllengeugFIThoweverfollow-upcolocopyquidfternbnml(iepoive)ultcheckcolctumpolypcncerThenefFITcengCRCrkmtlylizedlyiftimelycolocopychievedFQHCntegrlcompentfety-nethelthytempenttrgfrtructuhelthervicedeliveryerchPrierchuggetthnly18-57%FQHCptientbnmlol-bedcengultceivecolocopyThelimederchfocueidentifygeffectivetrtegieimprovefollow-upfternbnmlFITultInddimuchprierchhencductedtegrtedhelthcettglthoughmotcunderervedpopultidelivedthroughptchwkpublicprivteprimrycproviderpeciltyproviderhoplettgTheeprmountunderthowcefollow-upbnmlFITultecomplexl-wldettgwhichcnyieldfdgmolevncemotvulnerbleptientubgroupInpropoedpplictiweutilizeprgmticcluterromizedtrildeignelrgetFQHCnteteffectivenemultilevelmulticompentterventi(ptientproviderhelthytem)trgeteverlbrrierfollow-upbothFQHC(primryc)GIpeciltycettgTheterventimedprierchnovtiveddebrrierfollow-upcolocopyn-tegrtedprimrycettgGIpeciltycettgtngnccodtitweenFQHCGIproviderThetudycducted6clicmeFQHCytemTheeromizeduulctheterventicdiThepecificim1)compeffectivenemultilevelterventiuulccdiceiptcolocopy6mthnbnmlFITult(primryoutcome)2)ytemticllyequlychllengeterventiimplementtiundertfeibilyltiveimptnceterventielement3)meucotterventiimplementtimpotentildemtipdThepropoedtudyddeimptntgpCRCpventictrolerchfocugcompletiCRCcengprocemedicllyunderervedpopultiFdghvepotentilchngecliclprcticecndptedFQHCcliclettgfceimilrchllengemnggptientbnmlFITultThedcoveryBRCA1BRCA2genehomologoucombtipirchrcteriztiroleegeneheredpdpoibvrincncerhvehdtmendouimpcncncerpventtmentYetfmilyhrymemotimptntrkfcrecncergtdelrkmunexpledWepropoetwohypoe(1)Inomefmiliebtcncerduepvioulycrypticn-codgvriltergtrncripti/oxpiknownbtcncergene(BRCA1BRCA2PALB2ATMCHEK2BARD1BRIP1RAD51CRAD51DTP53)(2)Inomefmiliebtcncerduerprivten-codgvrintgultgexpicriclgenenocncer-pdpogllelecodgequenceTotetehypoewedeploynewtechnologielg-dequencggenomiccDNAFir-eqidentifictigiopenchromtcelltypechoicemivelyprllelptery(MPRA)compeffectvrintverufencellelemnyeimultneoulyCRISPRhibi(CRISPRi)cidtegulrygiWepropoetegrteepprochedcoverchrcterizeclen-codgpthogenicvri1253extendedfmilieevelyffectedbt/ovrincncerwhomnoculvrinthveenfoundnycurntgenomictechnologyInAim1weuedptive-mplglg-dgenomicequencgdetermepectrumllclern-codgvrintextendedTADknownbtcncergeneInAim2weuelg-dcDNAequencgchrcterizetrncriptilcequencecomplexSVrdeeptricSNVco-eggtgbtcncer(Aim1)InAim3weueFir-eqnlye(ldyh)fllopintuepililcellMCF10AmmmrycellidentifycidtegulrygibtcncergeneThenrvrintepekco-heredbtcncerunolvedfmilieweueMPRAtetllele-pecificdiffencepterctivyprllelilencegiCRISPRievluteireffectgeneexpiInAim4weextendAim3genome-wideidentifyvrintnerbtcncer-levntgenelieopenchromtgico-eggtebtcncerunolvedfmilievelllele-pecificdiffencegulryctivyWeexpectdcoverclicllymengfulgeneticvrin-codggulrygicludgpetivegenomicneighbhoodprticulrlyubjectcomplexrrngementWeexpectthpprochdictlypplicblenycomplexdeenheredgeneticfluenceAcutemyeloidleukemi(AML)devttgmlignncydmloutcomeptientprticulrlyelderlywhemotceoccurThecentpprovlBCL2hibirveneclx(Ven)combtihypomethyltggent(HMAuchzcytide/Az)ttmentAMLelderly/unfdulthubtntillyimprovedoutcomeeptientStillboutthirdptientttedVen/HMAexhibpoperpymotptientwhodopdeventullylpeVen/HMAtntdeeMooverptientwhoeAMLctmuttiTP53genefrcryVen/HMAllmchempyThecentrlpmethprojecttr-ptientheterogeneyleukemigcell(LIC)popultikeydriverrpytnce/filuAtlettwodtctmLSCcnfoundAMLptientemoprimivephenotype(p-LIC)emocyticphenotype(m-LIC)WhileVen-bedrpieneffectivemenerdictep-LSCnewlydignoedAMLptientm-LICtntVen/AzcnmedelpeThegolthwkidentifychrcterizedtctLICubtypeirvulnerbiliedeignmoeffectivemodurblerpieWehvefurrhownm-LICexhibupgultiInhibirApopProte(IAP)IAPhibiugdrugclledSMACmimetic(SMACm)potentlyenizeAMLcellVen/Az-ducedpopvrovivoprticulrlymocyticubpopultihighlytntVen/AzleIntriguglySMACmrpylohighlyeffectiveterdictgTP53mutnt/deletedAMLcellwhichgenerllyfrcrycurntlyvilblerpieThuvrygubtypeAMLLICvulnerbletrgetgdtcttrtegieMechnticllywehowSMACmcombtiVen/AzducencniclNF-BignlghighlevelTNFwhichcuecelldethpopHewepropoechrcterizemoleculrphenotyperpeuticvulnerbiliediffentLICubpopultiderdeignmoeffectiverpieInfirtimwechrcterizepthwymoleculrmechnmmedediffentilvulnerbilietntLICubtypefocumocyticTP53mutntubtypeTheecdimlevergevrovivomodelgthoughundertgcllheterogeneydiffentprimryAMLpecimenphenotypevriouubclehowdtctLICubclediffentillypdVen/AzSMACmrpyFllyAim3clicltrilefetyefficcycombgSMACmdruglpntVen/Azlped/frcryAMLettgSmplerilueddetermewherhowlpntenizeLICVen/AzrpyducgdeepermiInlletudiehouldleddevelopmentrpeutictrtegielimirctroldevelopmentdrugtnceAbtrctThemotcommmlignncymenweternwldProttecncer(PC)pdicted288300newce34700pecificdeth2023Whcentdevelopmentcomphenivecengbiopytrtegieten-yerurvivlrtePClrgelyimproved98%deepecificmtlyducedly4-8%Howeverwidepddoptietrtegiehloledignificnverttmentdeeledgignificntloptientqulylifenddedfncilburden22billidollrnnullyUSleTotterdetectguidebiopien-vivemgneticnceimgg(MRI)hemergednmtiveccompnygollgProtteImggReptgDtSytem(PI-RADS)nterntillyetblhedcgytemchrcterizgrkclicllyignificntPC(cPC)foclleidetectedMRIWhileimgdeferbiopielow-rkptientwheneverpoible~30%ptientnegtiveMRItillendupproceedgbiopydueuboptimlnegtivepdictivevluecurntMRItechnique(~90%)Thledunnecerybiopiepot-proceducomplictipopultiwhichpvlencecPClyround8%ThemjydetectedPC(70%)loclizedperipherlzeprotteThunurgentneednoveln-viveimggtechniqueimproveourcpbilymodefivelyruleoutcPCperipherlzeprottevoidunnecerybiopiecomplicticotOurtemhpieedprotteMgneticRenceFgerprtg(MRF)techniquewhichimultneoulyquntifieT1T2~40ecperliceWepropoedeveloprpidproducibleMRFmethodqunttivelymoccurtelychrcterizeprotticperipherlzetuederlimiverdignooverttmentptientnocPCWedevelopnovelprotteMRFtechniqueprovideimultneoumoti-robutT1T2diffuiquntificti(Aim1)Rpidwhole-glimggchievedleverggnoveldeeplerngtechniquemulti-liceimggDeep-lerng-bedprotteegmenttiderivedMRFignlevolutifurrdevelopedumticllyextrctqunttivemetricperipherlzepot-proceg(Aim2)Theedevelopedmethodpplieddignotictudypopulticlicldictibiopyecpbilymoccurtelymbiopydeci(Aim3)UpuccefuldevelopmentthMRF-bedmethodprovidemoqunttivetueementprotteoptimizgbiopyvoidnceptientnegtiveMRIPROJECTSUMMARY/ABSTRACTOverviewThegolthtudyexmeefficcynoveldiglpplicti(SHIFT)improvgexulhelthoutcomequlylife(QOL)pychologicloutcomehempoietictemcelltrnplnt(HCT)urvivBckgroundSexuldyfunctimotcommpertentcomplictipot-HCTover50%mle60-80%femleHCTurvivptglg-termimpirmentexulfunctipot-HCTImpir-mentexulfunctiocedweQOLltihipdtfctipychologicldtwhichfurrctriembidythpopultiHCTurvivexperienceuniquewiderngebiologicterperlpychologiclocilfcrimpctirexulfunctiGivenmultifc-rilntuexuldyfunctimultimodlpprochneceryddptientpecificueccernDepecgueHCTpvlenceexuldyfunctiHCTurvivter-ventiimproveexulhelthoutcomelckgLimedvilbilyclicinexperted-dgexulhelthccerntmottrnplntcenterhderclbilydemti-perupptivecterventiddexulhelthccernWedevelopedelf-dmtednoveldiglpp(SHIFT)HCTurvivexperiencgexulhelthccernSHIFTcludefivemodulefocuedempowergptientddirexulhelthccernttentibiologicterperlpy-chologiclocilfcrctrigexuldyfunctiWecentlycompletedpilotromizedtrildemtrtgfeibilySHIFTpromgefficcyimprovgexulhelthoutcome(ieexultfctetfuncti)wellQOLpychologicldtcompdenhnceduulcReerchPlnWepropoecductmulti-eromizedtrilSHIFTveruenhnceduulc300HCTurviveefficcySHIFTimprovgptient-ptedexulhelthoutcomeWeloeimpctSHIFTptientQOLpychologicloutcomewellexplomedirmoderrterventieffecnptient-ptedQOLEnvirmentThprojectcductedtMchuettGenerlHoplFoxCheUniveryMimiTheeehveupptivecerchtrnplntexperiencefrtructupro-ceecductrilTheMGHerchtemhexpertedevelopgtetgupptivecdiglhelerventiptienteriouillneHCTurvivenuuccefulim-plementtirilcrolltudyeRelevnceReerchDtthprojectuedobtFDApprovlSHIFTdiglrpeuticcnpcridddexulhelthneedHCTurvivABSTRACTThetrnicurtive-tentttmenturvivhipcnnoverwhelmgcfugtimeptientcoloctlcncer(CRC)SurveillncecncercurncecricllyimptntprtCRCurvivhipcCRCcurncecommmycurbleifdetectederlyHoweverup60%15milliCRCurvivUSfilceiveurveillncecommendedAmericnSocietyCliclOncologyNtilCompheniveCncerNetwkAmgCRCurvivgpknowledgeboutpurpoeurveillncerkcncercurncePrticulrlycueCRCurveillncepckgetheeprtecompent(CEAbloodtetimggendocopy)knowledgebouturveillncekeyurvivelf-efficcymnggurveillnceToimproveknowledgeboutelf-efficcymnggurveillncepromoteeffectiveupptenggementurveillncewedevelopednterventiprotypeCurntTogerAfterCncer(CTAC)CRCurviviruppterTheobjectiveR01evluteeffectiveneCTAC1)improvgknowledgeboutelf-efficcymnggurveillnce2)improvgceipturveillncewhileegfcrfluenceimplementtidiverecommunycologyprcticeOurpropoedtudylevergeourceNCICommunyOncologyReerchProgrm(NCORP)SWOGCncerReerchNetwkcductprgmticromizedctrolledtrilCTACvtticlecncerurvivhipmti654urvivStgeIIIIICRCSurvivromized21CTACrmgivenoptiveiruppterprticiptemCTACterventiThnovtivetudyhfollowgim(1)TodetermeeffectCTACkeyclicloutcomeknowledgeboutelf-efficcymnggurveillnceceipturveillnce(2)ToexploociupptercluiCTACurvivknowledgeboutelf-efficcymnggurveillnceceipturveillncetfctiuppterenggementurveillnce(3)ToefcrltedueCTACcrodivereurvivcommunycologyprcticeettgThroughtherieAimweexpectdemtrteeffectiveneCTACimprovgknowledgeboutelf-efficcymnggceipturveillncecohturvivtgeIIIIICRCInddiweexpectobtnewknowledgeupptfutupopulti-bedimplementtiCTACImprovgknowledgeboutelf-efficcymnggurveillnceimprovgceipturveillnceledimprovedclicloutcomelrgegrowgpopultiCRCurvivABSTRACT/SUMMARYRdipy(RT)neffectivettmentmodlypelvicmlignncieHoweverrdicyt(RC)widelycognizedirveriblechriccdipted8-11%cncerptientttedpelvicRTTheympmRCcncludehemturicedurryfquencyurgencyctencedyuriFeweffectivettmentextlleveedvereympmnoFDApprovedpventtivegentHyperbricoxygenrpydoelleveomeympmuetrictedcceibilycotctrdictiledgpoptientcomplinceTheill-defedpthophyiologymechnmRCthwrtdevelopmentnewrpieOurGWASixlrgeprottecncer(PC)RTcohtidentifiedSNPtgggAGTcltedptient-ptedhemturidefgympmRCAGTencodengiotenogenprtn-ngiotenytem(RAS)Ourubequentmulti-eclicltudyuppthypongioten-cvertgenzymehibir(ACEi)rdioprotectivebldderRCween165%ptientnottkgnACEivly48%thoetkgnACEidurgRT(p=001)Inmecliclcohtleeextrcellulrveicleu(uEV)cedcircultglevelpro-flmmrychemokeCCL2weignificntlyocedympmRCInourmumodelACEiprotectedgtmicturichngeimmunecellcrumenturoliljuryfterRTBededtwehypoizeRASmodultipventgCCL2-dependentimmunecellcrumentpventbldderjuryfterRTOurobjectivechrcterizevetigtemechnticroleRASphrmcologicmodultueflmmtijurybldderfterRTdevelopu-bedbiomrkercliclRCOurfourpecificimuecomdpclicltrnltilpprochAim1TochrcterizemechnmbldderflmmtiimmunecellcrumentdevelopmentbldderjuryftergledoefrctedRTfunctidoeirrdedvolumeAim2TodetermeoptimldurtiACEingiotenceprblocker(ARB)elicmximlrdioprotectimechnmpventiprogivebldderjurydetermerpeuticrtiougnthopicPCmodelAim3ToebldderuEVleeketicnnoprticletrckgnlyepdictivebiomrkerRTjurychrcterizeEVcrgoprotefunctilbilyducecellulrt/dmgepeourmouemodelAim4TovlidteuEVketicbiomrkerlteRCpdicrRASmodulrpeugbiompletwoclicltudiemenceivgRTPCAnEVbiomrkercoulduedidentifyptientneedgerlymigtgterventiuchnACEivoidprogieveRCABSTRACTNuclerceprteroid-dependenttrncriptifcrcfercellidentyfunctiTheyguidedevelopmentmthomeotdulttueuchteterepiveAndrogenReceprwhichgovernmle-pecificgnphenotypeArrntAR-drivengeneexpiprogrmgiveprottecncerWhentncefterrogen-deprivtirpy(ADT)deedvncemuchmolethlmettticctrti-tntprottecncer(mCRPC)tencomgtntADTovexpgARNewevidenceuggetmnytrncriptifcrepigeneticco-ctivrprotemyctedee-pecificenhncerARdrivetumepecillyttment-lpedmCRPCByhrnegophtictedmoleculrbiologycomputtilbiologytechniquewempepigeneticmechnmtwkmCRPCclicllylevntPDXmodelcellleepigenomecloelymtchgmCRPCtumWehowhowpAR-xugmllmolecule(ARveregtARIA)wedeignedynizeddevelopednovelmechnmctiwheARundergoechemicllyducedfunctilwchcugARupptum-drivggenenmllyctivteWetudywyARcteupercluterdeedgenomehowournewrpywkltergco-gulrcruedAR-upercluterAtccluhwkwehouldhvemechnticundertgARunderfluencenveregtprovidefunctil3DepigeneticmpgulryddictidvncedPChveexplodrpeuticpotentilpromgnewARrpeuticPROJECTSUMMARYTtmentimmunecheckpothibir(ICI)henvolutirymelnomcncerHoweverlyubetptienthvedurblepefirt-lerpyimmune-ltedxiciemignificntchllengeGivencriclunmetneedfeeffectivebrodlypplicbletrtegiethettgwecductpbioticfood-enricheddiet(PFED)terventicomdtrd--cICImettticmelnomptientThtudyeekterveneightourownwkdemtrtg(1)gutmicrobiomepriledietryhbpdictpeICImelnom(2)well-chrcterizedgutcommenlctentlyimplictedICIpehighlypivepbioticdietryterventi(3)gutmicrobiomerpeutictrgetICI-ducedxicieWhoverrchggoltetrtilly-deignedmicrobiome-trgeteddietryterventicncerptientundergogctiverpycnprcticllyimplementutthroughoutttmentPFEDclblepprochfocuedprovidgmultiplekeymicrobiot-cceiblenutrientthroughprovipbioticfoodnutrilcounelgelectivelytimulteneficilgutmicroenhnceuverllgutecoytemNutrientmicrobiot-derivedmetboleeterctiupptcentrlmechnmunderlygfvbleimmunepeICI(egblncgflmmtieffecrT-cellfuncti)ThufurrterrogtemechnmtetwherPFED-mnipultimicrobilcommunycouldeffectivendjunctiverpyICIwetrnplntpidptientfeclmplegerm-femiceexmeimpctpotvp-dietmicrobiomemelnomgrowthICIpewellmucolnti-tumimmunyThroughetudieweevluteeffectPFEDgutmicrobiomehotmetbolomemucolytemicntumimmunepeICIIntegrtivenlyebothhumnmouetudieprovideignificntightdiet-ducedchngemicrobiomemicrobiot-mededchngemetbolomefluenceimmunepeICIhighlightvenuewheptientdietmyfluenceuccemicrobiome-trgetedtrtegiegdevelopedthettgNotblyprogfutumulticentertrilrobuttrnltilcliclendpotwedefefetyefficcyprilePFEDndjunctcurntICIgimen(nti-PD1mpynti-PD1+LAG3nti-PD1+CTLA4)Thoughourtudiefocumettticmelnomdietrypprocheenhncegutmicrobiomenti-tumimmunyICIpelevntpplicbletgecncertypeAcceiblepproprelyfeduccefuldietryterventifercot-effectivefedjunctcouldimplementedcroprcticeettggeogrphieddgignificnthelthcdprieultimtelyfergpotentilimprovecmnyptientPdictiReidulCncerBurden(RCB)erlyttmentcnenhncelg-termurvivloutcomebtcncerptientundergogneodjuvntchempy(NAC)irlg-termurvivl1-3Ner-fr-dpectrl(NIRS)mogrphy(NIRST)provideopertildvntgeoverimggtechnologie(egmmmogrphyultroundMgneticRenceImgg(MRI)CTPorEmiTomogrphy)NACettgcuenviveptblelowcotdoenotueiizgrdiexogenouctrtgentCrucillyNIRScptubiophyiclchngetueoccurrgvculrtr-extr-cellulrmtrixcomprtmentTheeubtlechngeignltumerlypeNACevenevibletumizemodifictioccur4-7Compdopticlimggmodlieueflectncelightwhichlimtueimggdepth89quihigh-powerlerpogfetyrk10NIRSTcptudiffuedmogrphicignlllowgdeeperbttumengInourpvioutudiewehvepieedNIRSTytemquntifievculrchngebtdurgNAChighlightgtumpebouttwomuteptientemi-cledpoi1112ThytemcltetumNIRSTchngeclicloutcomebedidulcncerburden(RCB)clificti13OurcliclNIRSTdt35womenNACperudeuNIRSTpotentilvolutiizecliclpprocheptientThlieftemcentlypublhedultwhichhowcenmlizedpercentgechngetlhemoglobtum(HbT%)endfirtcyclecompellgbiomrkerdcerneirRCB-0RCB-IIllcecle(p0001)13Athoughmulti-clReceiverOpertgCurvenlyfernAUnderCurve080emphizgpciHbT%dtguhgtweenRCBcleWeenvgeelevtgourytemefficiencytegrtgflexiblecircutripthroughleekwerble64-chnnelbtterfcepplyg3Dimgectructiflectfulltumpe(tedprtiltumvolume)foclpourpropoedAim3OurpvioudtfurrdicteNIRSTdignoticpermncemundimhedwhenlygolelyctuou-wveignlptient-pecificcttergetimtederivedmmmogrmMRIdefedbtdeny14TheeighthvehpedhrdwpltmpropoedAim1HowevercurntertiourNIRSTytemfcechllengedependencylrge-cofirbundleceivglightptientbtByph-goutecumromefirbundleweopenvenuenovel3Dimgectructimethoden-hnceddeeplerngeutAim2IneencethprojectfocuetechnologiclnovtiimedtctgcompheniveNIRSTbtimggpltmdeignedectRCBerlytgeNACAccdglywetrnigthpltmcdemicexplticlicllyprcticlolutiwhileccurntlyeekgddilfundgfcilteexpniveclicltudieeeeblefutuPROJECTSUMMARY/ABSTRACTAcutemyeloidleukemi(AML)bloodmrrowmlignncymnifetnggivedeequiimmedettmentAkeyplyerAMLmixed-legeleukemigene(MLLKMT2A)foundchromoome11q23MuttiMLLfquentlycltepoprognopromptgneedrpeuticcneffectivelytrgetegeneticltertiMLLknowncomover80genectgchimericproteimplictedAMLAmgeENLcompentYEATSprotefmilyhenidentifiedeentilmtgdygultedgeneexpidriveleukemogeneTrgetgENLYEATSdomuniquetructumnopen-endepigeneticderpocketferpromgrpeuticvenueDepeignificnttridemdedevelopgmllmoleculehibirtrgetgENLYEATSecompoundufferlimedefficcylckelectivymetbolictbilyThePItemhpvioulydevelopednumrpotentmllmoleculeENLhibirBycouplgnewlydeignedNnoBRETytemircellulrpotencynlyeyidentifiedpromgcompound(Cmpd13)demtrtedfvblechrcterticfurrvivophrmcoketicnimlefficcytudieNotblyCmpd13ignificntlyimprovedurvivltimeMOLM-13xenogrftedmiceetblhgpotentilllydmtedrpyInprllelPItemhloueduniquelydevelopedphgedplytechniquecombtimediclchemtryidentifypotentpeptidicENLYEATShibirtENL-S1fhhighcellulrpermebilyignificntvrti-leukemieffectAddillyPItemcplized(ProteolyTrgetgChimer)PROTACtechnologybkthroughtrgetedprotedegrdtiUgthtrtegyydeignedpotentPROTACGxj-47uccefullyelimtedAMLcellwhiledemtrtglowcellulrxicyBuilntrgplimryultPItempropoeignificntlyexpirmultipltmtrtegydevelopmentENLhibirPROTACpurugtheprimryobjective1)TodevelopmopotenttbleelectivemllmoleculeENLhibirPROTAC2)TodevelopmopotenttbleelectivepeptidicENLhibirPROTAC3)Topermrigouphrmcoketic/phrmcodynmicnlyeemoleculeimgidentifypotentilInvetigtilNewDrug(IND)MLL-rrngedAMLIfuccefultherchholdpotentilvolutiizeAMLttmentprovidgignificnthiftttmentmodliecgurvivlrteimprovgptientqulylifeTherchcouldloervepieergblueprtdrugdevelopmentdeeimilrgeneticltertithuhvgbroderimplictifieldtrgetedrpydevelopmentProjectSummryBrmettpvlentmgptientmettticbtcncerBrmettcnemergemulti-focloperblerdi-tntleimledgcuedethbtcncerptientNoeffectiverpiencucurntlyvilblebtcncerbrmett(BCBM)Emerggevidencedictethnerte-limgtepbrmettticevolutioverutgrowthdemtedcncercellthroughccurntenggementprolifertiveurvivlpthwyOnekeyprotevolvedepthwyYeAocedProte(YAP)trncriptilco-ctivrYAPtrgetHippoignlgccdenuclerlocliztiociTEADfmilytrncriptifcrctivtedowntmgenequidprolifertitncepopWkDrEr(co-PI)hvehownYAP-TEADocineceryufficientbtcncercellmettticoutgrowthbrdowntmcelldheiignlgmechnotrnductiuggetgtrgetgYAP-TEADtercticnpotentillyprovidecliclnefhibgmettticoutgrowthdemtedcncercellbrSeverlTEADu-plmiyltihibiruchVT104hveenidentifiednewclpotentYAPhibircneffectivelyhibcncercellprolifertumgrowthHoweverechllengeugedrugbrmettttmentirlimedccumultimulti-foclmettticleicuepencemultiplebiologiclbrrieruchblood-brblood-tumbrrierCurntlyextgdrugdeliverypprochenotufficientlyeffectiveovercomgebrrierDriventhpgneedwepropoedevelopmcrophge-bedtechnology(McrophgeEnbledbrMettTrgetgMEMT)trgeteddeliveryYAP/TEAD-trgetgdrugmulti-foclbrmetteMEMTcompoedmcrophgecrrygYAPhibirlodednnoprticle(NP)irurfceLeverggctivemigrtimcrophgewrdtumMEMThuttleurfce-nchodNPbrmettticleiWehypoizetrgeteddruptiYAP-TEADterctimettticcellenbledMEMTcouldhibmettgrowthfergnewpprochttgBCBMTwodependentimhveenplnnedInAim1wedevelopoptimizeMEMTcpbledelivergNPmulti-foclbrmettticleiWetudytue-cell-leveldtriiMEMTecpbilydelivergNPbrmettticleimuhumnizedBCBMmodelInAim2cptgpcliclly-tetedYAPhibirMEMTweevluteMEMTefficcydruptgYAP-TEADterctihibgbrmettprogivivoIfuccefulMEMTvolutiizehowBCBMcneffectivelytrgeted/ttedopennewvenuecliclerchunlockgunlizedpplictiYAP/TEAD-trgetgdrugttgbrmettePROJECTSUMMARYIndequtelymngedympmcuedirdeettmentultunneceryuffergchildncncerterfeirqulylifemyimpcturvivlCommunictiemphizechildelf-ptctiblechildpntclicltemkeyeffectiveympmmngementTheerlycncerttmentperiod(ECTP)keytimeimplementterventitrgetgympm-ltedcommunictiDiglheltholcludgmobilehelth(mHelth)ppemerggpropoedolutiuppthelth-ltedcommunictitweenptientclicinTheOfficeNtilCodrHelthInmtiTechnologypriizerouteueptient-genertedhelthdt(PGHD)dtcdedptientcomplementclicldtcliclcAchievglrgergoltegrtgPGHDmHelthppcliclcquittentidtecuryteroperbilytrddtexchngepenttidtelectrichelthcd(EHR)IntegrtgPGHDcliclcloquittentifcilrbrrieruchptient/fmilydhenceptgcceibilyPGHDEHRclicinenggementOurterpiltemenggedchool-gechildn(6-12yer)cncerpntclicinco-deignColMeHelthychild-centricppprovidenevidence-bedtructuchildnptelevencommympmdemtrtedfeibilycceptbilyOurnextcricltepdvnceColMeHelthyclbleimplementtidevelopevluteclicin-fcgppteroperbleelectrichelthcd(EHR)ytemtegrteviewdcuichildndtprtcliclwkflowTheprojectcductednerlypheBehvilInterventiDevelopmentTrildefefekeycompentimplementgColMeHelthydurgECTPttentiunderlygmechnmterventiidentifyddfcilrbrrierperpectivechildnpntclicinDurgAim1weemployuer-centeddeignmethoddevelopWeb-bedclicin-fcgveriColMeHelthyppEHRtegrtiSMARTFHIRppAim2llowuoptimizeimplementtiColMeHelthynimplementblecommunicti-upptterventicliclettgdurgECTPengggchildnpntclicindefefekeycompentterventiDurgAim3wecductgle-epetedmeutrilevluteefficcyimplementgColMeHelthyECTPimproveympmcommunictiTheimmedeexpectedoutcomeuccefulimplementtinteroperbleclbleSMARTFHIRppimproveympmcommunictidurgECTPThepropoedwkbuildchevidencemeeurlg-termgoldelivertimelyevidence-bedclleveympmpromotequlylifechildncncerAbtrctPeopledvncedcncerexperiencegterfquencyeveryphyiclpychologiclympmrnkgleepdifficultiewry-nxietydepiftiguefourmotcommdtgympmTheeympmmympmcluterctriefunctilimpirmentpoqulylifeunderttedepecillyrurlcommunieThetrgevidencebiohvilterventiimproveeympmHowevercognive-hvil(CBT)cceptncecommmentrpie(ACT)tenotimeenergytenive(eg12-20ei)nottilodpeopledvncedcncerPlimryReultInpepecificneedpeopledvncedcncerwecompletedpilotromizedctrolledtrilbrieftegrtedCBT-ACTterventiutilizgmoteffectivecompentettmentFdgOurCenterUnderSt(FOCUS)four-modulemHelerventecheptienthowctrolympmwhenpoiblewhilectuglivemengfullydepeeympmFOCUSprticipntdemtrtedttticllyclicllyignificntimprovementomnievery(d=-098)wry(d=-086)depi(d=-077)ftigueterfence(d=-059)elf-ptphyiologicleepefficiency(effectized=092)leepltency(d=-066)pychologicldt(d=-078)ThepropoedprojectguidedbiohviloticlmodelbuilducceourpilottrilcompletelrgereffectivenetrilFOCUScompdtelemedice-mHelthmtictrolthympmcluterevlutedoe-peprticulrlymgrurlptientexplobiohvilmedirympmchngeOurprimrygolthtudyimprovethympmcluterfunctilttudepeympmqulylifepeopledvncedcncerunderervedrurlcommunieInnovtivefetucludeourpopulti(50%rurlApplchin)ympmcluterfocutelemedice-mHelthdeliverytilgpeopledvncedcnceruebiohvilpprochAim1EvluteeffectiveneFOCUSympmcluter(leep-nxiety-depi-ftigue)Aim2DetermeimpctFOCUSdoeympmeveryterfenceexmeugeptientgeogrphicloctigenderExplryAim3ExmebiohvilmedirttmenteffectDeignMethodThpropectivetripleblded(ptienterchtntttticin)gle-eromizedtrilFOCUSvmtictrolWecru120prticipntdvncedlungprottebtcncermyelommelnomThetriltkeplcetTheOhioStteUniveryJmeCompheniveCncerCenterAllprticipntcompleteementtbele612week612mthWehypoizeFOCUSprticipntwhoueppmofquentlydemtrteimprovementympmcluterlgudllycompdctrolgroupvipychologiclflmmryendocmedirPROJECTSUMMARY/ABSTRACTMothnethirdpproximtely2milliAmericndignoedcncerechyerexperiencemoderteevepltedirdee/ttmentTodte38tteDtrictColumbihvedoptedmediclcnnblw24hveubequentlydopteddult-ue(iectil)cnnbuelwenbleptientcnceruecnnbpmngementCliclprcticeguideledotcommenduecnnbmngecncerpcglimedmixedevidenceIntedguidelectueemphizeopioidrpycnernecncerpmngementThetngthuchcenuvrieomewhtcrocncerctextCenuppropreneopioidrpytrgetptientdvnced(iecurble)cncerepecillythoelimedlifeexpectncyItlotrgptientundergogctivecncerttmentcurtivetentInctrtguidelechricpmngementmgcncerurviv(iethoewhohvecompletedcurtivettmentmi)flectnemerggemphopioid-prgpprocheRegrdleguidelecommendtimnyptientcncerpferlimirvoidugopioidInthctextbedpritudiedocumentgrtecnnbueexceedg25%mgptientcncercnnblwcouldledptientuecnnbplceopioidrpydowntmeffectunknownmydiffercrocncerctextTheobjectivepropoedtudyddevidencegpbouteffectttecnnblwpmngementprctice(egceippioidrpy)outcome(egceiptttmenpioidcnnbuedderptient-ptedp)cncerWecductqui-experimentlevlutittecnnblwuguniquecombtwoextgpopulti-beddtource(SEER-MedicSEER-MHOS)WelocollectnlyzeurveyterviewdtexplohowttecnnblwhvefluencedcncerpmngementperpectivecncercenterlederphyicinptientTringultgultourpolicyevlutimtiboutcncercenter-levelimplementtittecnnblwphyicinprcticecommendgptientprcticeugcnnbcncerptngnvlidyobervedpolicyeffectEchyertteciderenct/mendcnnblwTomthrpidlyevolvgpolicyctexteentilunderthowelwffectpmngementptientcncerelrgetgroupcumerrpeuticcnnbOurpropoedtudyhignificntpotentilimpctpolicyprcticeABSTRACTThegolthtudyundertpychoocilequeleirbiologiclocildetermntmgptientdvncedhedneckcncer(HNC)ceivgimmunpyImmunpyhcentlyenpprovedFDAdvncedHNCPtientdvncedcncertenexperienceubtntilcliclprognoticuncerttyledgcedpychoocilburdenwhichturnctrieweurvivlcludgHNCHoweverevidenceimmunpy-ltedpychoocilburdennotwell-documentedprticulrlyHNCPtientHNCufferhighpychoocilburdeneimmunpylikelyduecommlg-ltgdee-ttment-ducedideeffect(egdrymouthdifficultyopengmouthmuco)uniquelyignificntlyimpctHNCptientcricldilyfuncti(egetgpekg)TheepychoocilburdenpecultedevenhighermgthoeceivgimmunpyduedvncedcncertgeuncerttyimmunpylengthideeffectGivencrceevidencepgneedvetigtepychoocilequele(egftiguedepi)mgptientceivgimmunpyopecilizedccntrgetedimproveQOLlg-termurvivlAddillyidentifygbiologiclocildetermntpychoocilequelehighlightrkfcrprovidetrumentlguidnceterventiltrtegieWehvefoundgterflmmtiocedweympmticideeffectcludgpychoocilympmpoQOLurvivlcncerptientNeverlewherimmunpy-ocedflmmtiprtbiologicldetermntpychoocilequeleunknownFurrmemerggppcigut-brcnectihuggetedvolvementgutmicrobiomepychoocilequeleOurplimrydthowflmmti-ltedtxlkedhighpychoocilequeleuggetgrtidepletedbcteriirmetbolehpotentilveredybio-ocedphenotypeStilllrgertudiewrrntedvlidtefdgedevelopmentdividultrgetedterventiSocildetermntloimpctwiderngehelth-ltedcdictrieubtntillyhelthdprieHoweverwherhowenvirmentl/communyocildetermntfluenceptientpychoocilequelemgthoeceivgimmunpyunclerTheewepropoevetigtgbiologiclocildetermntpychoociloutcomeHNCptientceivgimmunpyThefdgtudytrumentldevelopgnlydividulperlizedtrgetedterventi(medbiologicldetermnt)lopublichelthcommuny-levelterventi(medocildetermnt)ultimtegolmultilevelterventi(combgdividulcommunylevel)improvepychoociloutcomeubequentlyQOLlg-termurvivlthoedvnceddeePROJECTSUMMARYGlioblm(GBM)motcommlethlprimrycentrlnervouytemcncerdultwhettmenteffectivetendebiltgUnlikemnyperipherlolidtumGBMhighlytntcncerimmunpyThebenceimmunefiltrteGBMultnimmunologicllycoldtumtricimmunetncemededGBMcellnddilfcrctrigfiluimmunpyGBMthufrChimericntigencepr(CAR)T-cellrpyhcentlyhownmrkbleuccettmenthemlogiccncerhveenttemptmdeexploCARTcelltrtegiegtGBMHoweverCARTcellGBMfcechllengecludgtrtumheterogeneydynmicexprgetceprtenbilyTcelltrffictummededeidntumeffectInctrtlckTcellfiltrtemnyolidtumepecillyGBMbundntimmuneuppivemyeloidcellcludgmcrophgeTheecvertgeimmuneuppivecelltumicidlphenotypepentpromgtrtegycell-bedrpyThenowtrgtetgenertgCARmcrophgewhichulogoumcrophgetrnducedCARdelivedvirlvecrexvivoenhnceireffecrfunctiHoweverexvivopprtiCARmcrophgecomplextimecumgduen-dividgntumcrophgetenefficientWepropoennovtivetrtegypentvolutirywyproduceCARmcrophgevivoferpromgnewpprochcellrpygtGBMThfirttudyevlutefeibilyproducgCARmcrophgevivougnmRNAdeliverypltmentumefficcyCARmcrophgeGBMimmunpyWehypoizegenertgCARmcrophgetrgetgEpidermlGrowthFcrReceprVrintIII(EGFRvIII)vivougmRNA-lodedexoomehveignificntctivygtGBMEGFRvIIImutntproteexpedurfce50%GBMcellOurpvioutudyhowedwecnefficientlyproducemRNA-lodedexoomeproteexpiolidtumvivoFurrmoourplimryexperimenthowedexoomelodedEGFRvIIICARmRNAcnproduceCARmcrophgevivoenhncedeffecrfunctiOurcurnttudyteverllhypothroughfollowgpecificimInAim1weevlutedynmicxicyCARmcrophgeproductivivougCARmRNAexoomeInAim2weevlutetrncripmicfunctilprilevivogenertedCARmcrophgeFllyAim3weentumeffectvivogenertedCARmcrophgempycombtimyeloid-dictedrpygtbothmuhumnEGFRvIIIexpgGBMIfuccefulourpropoederchcnovercomemjtechniclhurdlehlimedcellrpyGBMgtlyexputilycncerttmentProjectAbtrctPedricHGGcompglioblm[glioblmmultime(GBM)]npltictrocymdiffuetricptegliom(DIPG)collectivelymotcommmlignntbrtumchildnPtientHGGhveverydmlprogno<5%5-yerurvivlGBMptientmedinurvivl<1yerptientDIPGpotgnurgentneedlterntiverpeuticpprocheChimericntigencepr(CAR)engeedcellurfcemoleculecompecificyntibodiedowntmignlgeffecrcelluchTcellTheexpiCARTcellhhownenmoupromeeffectivelyttgmlignnciedictlykillgmHoweverCAR-TcellrpytenhmpedbilyTcellpenetrteolidtumhibirytummicroenvirment(TME)RecentlyhengttetdevelopgCAR-mcrophgegtolidtumimprovephgocyticctivyntigenpenttimcrophgegttumHewehypoizethdtctivepriciencymcrophgemicroglifiltrtemlignntbrtumprovideuniqueopptunyexploirphgocyticpropertieengeergctivtiepilphgocyteugexogenouexpiChimericAntigenRecepr(CAR)trgetedwrdbrtum-pecificntigenInAim1weengeermoteffectiveCAR-expgphgocyteefficienttrgetgpHGGdemtrteuperiofficcyB7H3CARphgocyterpycombtiblockgephgocycheckpot(nti-CD47)immunpyhumnizedxenogrftmodelpHGGInAim2weIdentifymotefficientcelltypecnfunctiCAR-expgphgocytecnmotefficientlytrfficbrtrgetpHGGtumcombtiblockgephgocycheckpot(nti-CD47)immunpyfllyAim3wetudyvivobiologyCAR-mcrophgeeffecnTMEyngeneicmouemodelhigh-grdepedricgliomProjectSummryMotmendignoedprottecncer(PC)65yergeolderRdipy(RT)neffectivecurtivettmenterly-tgePCHowever20%PCptientcndevelopltetenirveriblechricdvereide-effectfterirRTRdicyt(RC)clicllyignificntchricxicySympmRCcludehemturiurrydyfuncticludgcedurryfquencyurgencyctencedyuriecnignificntcliclccern~31milliPCurvivUSTheeympmcnmoprouncedolderPCptientcuepextgurryympm/ducedfunctilerveputtgmtcedrkdyfunctifterRTducedjuryRTdoe-volumectrtuedlowerrkdevelopgttment-ltedxicyblddercnnotvoidedcompletelyPCRTttmentplnignificntvricidenceeveryRCextmgtPCptientwhichuggetnimptntrolehotfcrperlechPCptientTheurrymicrobiomeltedurologicdeecommolderdultdybiohenlkedurrydyfunctiunltedfectiButnotudiehvevetigtedeffectRTurrymicrobiomeeffectdybioRCmgPCptientTheewehypoizeRT-mededurolildmgebldderleddruptirouteurryfuncticeurryfquencyproduceurrymicrobiomedybioemicrobiomedybiocouldn-viveu-bederlybiomrkerRCOurcliclgenetictudieidentifiedignlgpthwylkedmicrobiomeimmunecellcrumentupptthhypoUgbnkeduourpropectiveclicltudyRCup5yerfollow-upwellourpcliclmouemodelRCwehvedemtrtedwecndetecturrymicrobiomedepelowbundncewehowevidencedybiofterRTThprojectuebnkeduourclicltudytethypo(i)microbilcompoi/metbolicpotentilurrytrctchngedRT(ii)dybio/metbolicdygulticlteptientptedoutcome(PRO)cpturgbldderdyfunctifollowgRTThenugourmouemodelRT-ducedbldderjurywetethypo(iii)chngemicrobiomemyervepotentilbiomrkerRTjuryuroliumifchngemicrobiomepetuejurycruedimmunecellThchievedcomprgdybiofunctilmicturiloclytemicbiomrkerbldderjuryfterfoclRTentiblddervolumejutblddertrigeFllyugbnkedubothourhumnmouetudieweevlutewhermigrifrdi-ducedbldderjury(ngiotencvertgenzymehibir)exertprotectiveeffectltergflmmryimmuneproceevoidgdybioOurobjectiveuenovelmobilehelth(mHelth)hvilterventipprocheenbleptientwhohveundergehempoietictemcelltrnplnt(HCT)effectivelycopeirympmimproveirbilyenggephyiclctivycnimprovephyicldbilyInNCIR21tudywedevelopedhybrid-permHelthCopgSkillTrgSympmMngementDilyStep(StepUp)terventiprocolcludgmobileppStepUpprovideHCTptientcognivehvilcopgkilltrgoccuptilrpy(OT)-ledctivycochgeienhnceirbilycopeympmftiguepdtterfephyiclctivyStepUphendevelopedexpertympmmngementmemrHCTmedicltemexteniveputHCTptientOurR21ulthowStepUpfeiblecceptbleptientdemtrtetrgignlterventinefcludgimprovementphyicldbilyympmctivy(dilytep)Thenextteptherchprogrmueromizedctrolledtril(RCT)tetefficcyStepUpcompdUulCPlu(UC+)StepUpcludee-perympmcopgkillewoctivycochgeidurgteniveoutptientcThenfollowgdchrgehomenddilfourtegrtedympmcopgctivycochgeidelivedvivideocfencgStepUpcludemobileppctivytrcker(Fb)cptudilyympmctivybiometricdtllowgtudytemprovidel-timeperlizedfeedbckOurcentrlhypoStepUpledimprovementphyicldbily(primryoutcome)wellecdryoutcomeympmeveryphyiclctivydiglbiomrkerflectiveympmburdenfollowgHCTARCT(N=177)uedpuruethepecificim1)TetefficcyStepUpimprovgphyicldbilywellympmeveryphyiclctivyelf-efficcyympmmngementcompdUC+2)Exmeltihiptweenympmctivy3)TetefficcyStepUpimprovgdiglbiomrkerflectiveympmburden(hertrtectivyleeptime)meudviFbThepropoedwknovtiveimpctfulHCTptientddeterfergympmtegrteevidence-bedcopgkilltrgOTeicectivywhiledecgympmterfectivyuemHelechnologyperlizedl-timefeedbckptientPoiveultwouldprovidefirtdemtrtiefficcyhybrid-delivedcognivehvilcopgkilltrgctivycochgterventiducephyicldbilyccurntlyynergticllydecgympmburdencgctivyThepropoederchhpotentilproduceignificntpublichelthnefdeigngextgmodehvilterventideliveryimprovgctuycodticultimtelyenhncgptienutcomePROJECTSUMMARY/ABSTRACTInptientgtriccncerwhoclicllyclifiedHER2-poiventibody-drugcjugte(ADC)prolgprogi-feoverllurvivlHowevernotllgtrictumneferpieeventhoewhoillypdevblydeveloptnceovertimeComplementrybiomrkermethodeneededidentifyptientpddeveloptnceHER2-trgetgADCrpiePclicldtweobtedHER2heterogeneougtricptient-derivedxenogrft(PDX)demtrtetumlphgoe-1-phophtecepr(S1PR1)ocetumpeADCHewevlidteS1PR1-trgetedimggpproch(ldyuedclicn-cncerpplicti)llowqunttivemeumentS1PR1evluteerlypeADCttmentmouemodelgtriccncerWeclteHER2membrnevilbilytumlS1PR1pencegeneticltertigtrictumpeADCWepermromizedimggrpeutictudiegtricPDXidentifybiologiclfetucfertumenivytnceADCAim1uemoleculrimggpprochevolvgporemimogrphy(PET)furrvetigteroleS1PR1ADCefficcyOurnovtivepprochcnqunttivelymeuADC-tumbdgthroughimmunoPETS1PR1throughrdiolledmllmoleculemeubjectl-timegtricPDXOurtudiehowthurimggpprochecomdnlyettuelevelcnqunttivelydetectdiffentlevelerlypeADCrpygtrictumprovidgtrgimpctAim2furretblhPETdetermepotentilmodultgtumlS1PR1vereADCtncegtrictumWemeuchngeHER2S1PR1pettmentenhnceADCefficcyFechtudywecltemgnudechngeourimggbiomrkerlger-termrpeuticoutcomewelldetermewhichcombtimultiplebiomrkerimproveevlutierlyttmentpeThprojectcouldprovidenexcellentfoundtimnyfutuvetigticludgclicltrnltiPETimggpprochepdictmirtumpeADCpotentilbroderpplictimembrneceprheterogeneoutumThelg-termtrnltilobjectivetudiepropoedetblhfoundticlicltudyugimggpprochentibody-tumccumultiS1PR1pdictivebiomrkertumpeHER2-trgetgntibodydrugPROJECTSUMMARY/ABSTRACTPeopledbilieepecillydefhrd--hergdividulctueunderpentedSTEMgrduteprogrmhelthciencepierchettgTheneedpromotedbilycluicientificwkcecognizedpriybothNtilIntuteHelth(NIH)NtilCncerIntute(NCI)ThehighttrirtedefundergrduteSTEMmjnverge83%droppgoutirprogrmecompletilrgelydueunwelcomgerchenvirmentdequtecceerviceill-equippedmenrToddthueUniveryRocheterJmePWilmotCncerIntute(Wilmot)propoeFutuDefScientt(FDS)progrmThmenderchtrgivebedveryuccefulummerternhipprogrmgedthroughprtnerhiptweenWilmotRocheterSchoolDef(RSD)bilguldefeductitutietblhed1876whetructidelivedAmericnSignLngugeEnglhTheprogrmimcedeftudentprticipticncererchfieldimproveSTEMmenrgenvirmentyoungdefcienttTheFDSprogrmcludeculturlcompetencytrgmenrAmericnSignLngugeterptertrgdvncedSTEMctentTheFDSprogrmeekmlizelguticllyculturllyppropreSTEMcncererchcurriculumtiloddefhighchooltudentcnlouedchoolntiwideTheFDSprogrmppliennovtivetilodpprochprovideneceryfirttepgrowgDefScienttTrgpipeleRocheterNYpromotgcncerSTEMeftntiwideUltimtelyprticiptgDeftudentlernkillcfidenceempowermucceedpotecdryeductiSTEM/cncererchcerInhibgt-dnergicCOX-2ignlgdurgperiopertiveperiodduceovrincncerprogiAbtrctThehtperiopertiveperioddyefterurgerycommlynotexploednti-mettticterventiDurgthhtcriclperiodtflmmrypepvlentmgcncerptientInvrotudiedicte-dnergicprotnoidignlgcnccelerteovrintumcellgrowthpro-mettticchrcterticIneverlnimlmodelcludgovrincncer(OC)vivoperiopertivephrmcologiclblockde-dnergictpe/ctivyprotgl-ynCOX-2enzymewhownducecncermettimprovelg-termurvivlrteEpidemiologicltudieuggeturvivlnefcidentlperiopertiveueuchphrmcologiclblockdemnyolidcncercludgOCRecentperiopertivemllromizedclicltril(RCT)btcoloctlcncerptient(n=38&34)dictedneficileffect-blockerproprnololoutCOX-2ynhibiredolcmoleculrbiomrkercncerprogiexcedtumThedrugwewelllertedexhidhighfetyprilecoloctlcncerptientplimryfdglouggetedimproved5-yerdeefeurvivlHewepropoecductmllexplrytwo-rmplcebo-ctrolledRCT60womenundergogOCdebulkgurgeryPtientttedbothproprnololedolc(plcebo)trtg5dyeurgeryup3weekfollowgProprnolol(extendedlee)edtlowdoe(20mgBID)cedurgerydy(80mgBID)grdullydeceddurgfollowg3weekbcklowdoewhileedolcgivenprllelttedymodertedoe(400mgBID)Thefterddunmetneedllevgcednxietycrottmentpectrumttenutet-lted-dnergictimultiproprnolol(whichlxiolytic)plceboctuedddil2mthtlowdoePrimryoutcometudyclude(i)crumentrte(ii)periopertivedrugfetylerbilydhence(iii)moleculrchrcterticexcedtumpecttumfiltrtgleukocytetrncriptilctivyltedpro-metttic(egEMT)pro-growth(STATGATAfmilie)tflmmryignlg(NF-B/cRelAP-1CREBGR)Secdryoutcomeclude3-yercurncertebedignedgementmediclcenteroutddilcotIfpromgoutcomeevidentthRCTlrgermulticenterRCTcnjutifiedidentifyddilmedgmechnmterventidevenovelbiomrkerttmentefficcyOCprogetwhererventicnimprovelg-termcnceroutcomeoverllurvivlOCptientAterventibedpurpogexpenivef-ptentfeeilydmtedmedicticneilyimplementedclicllymotmediclcenterwldwideProjectSummry/AbtrctWhilercilethnicdiveryUShcedovertimediverythoevolvedcncerbiomediclerchhnotflectedoverllUSpopultilybout11%ercheroverllrcil/ethnicmygroupTheeunder-pentedgroupcludewomenBlck/AfricnAmericnHpnicLthoedbilieidentrurlmedicllyunderervedtudentlowerocio-ecomicttu(SES)firtirfmiliettendcollegeRurltudentprticulrpennly3outevery10tudentpurugSTEMcerirfmilietendcomelowerSESleeductiRurltudentghighchoolmetetSTEMtudenthigherSESuburbnchooltendecetetjuniyerTheimptncecommunynotctentlycludedpipeleprogrmyetmnycommuniewheunder-pentedtudentideexperienceignificntcncerdprieThugolpurugcncererchducedprieircommunymyhighlylevntInthGegiScienceEductiIniveNCIYES(GA-YES)progrmmecncerdprietegrtedlltudenterchprojectcurriculumdevelopmentprocecommunyoutchenggementcompentBedupecceptourhypofocugcncerdprieimpcttudentowncommuniethpprochenhncetudentmotivtictuepuruefutuSTEM/biomedicltudiehighereductiultimtelyfutucercncererchByexplgunderlygmechnmepidemiologyrkpotentilterventimightffectedpriethpprochwoulderveenggetudentmodeeplydemtrtepplicbilycienceerchtudentowncommunyettgTovetigtethhypoourSpecificAimAim1Tocruhighchooltudentunder-pentedSTEMcerixhighchoolloctedrurlpertentpovertycountyGegiprticipteummermendcncererchtrgprogrmfocuedcncerdprietWhipCncerIntuteEmyUniveryAim2Todeveloptetnccompnygcurriculumfocuedcncercienceerchkillhelthequycerdevelopmentenggetudentllyer-lgAim3TofciltetudenutchenggementcommunieceivefeedbckltederchprojecteductecommunytkeholderboutcncererchcludgclicltrilAim4Toevluteht-lg-termprogrmoutcometudentchrctertictrcktudentprticipnt15yerpot-enrollmenteprimryoutcome(purugcercncererchbiomediclcience)Theimpctthpropolctriglg-termprogrmevlutimeurbleoutcometprcticebuildgdiverefutuwkcecncerbiomediclerchcertegrtgcncerdprieerchtrgnovelfocuunder-pentedrurllowerSEStudentCncerptientundergoghempoietictemcelltrnplnt(SCT)fcenumerouchllengecuetmentxicylengthyhoplizticoverypertentmediclpychoociltPtientdecrineedgmomtiuppthelpmmngedtmediclympmpoqulylifefeelppdSCTdhecriclpot-SCTpventivehviPtienteductihelthcprovidercriclmtiourceptientlodecriwntgmtiptientneedgtypemtiemotiluppttprovidedpeoplewhohveundergeSCT(iepeeruppt)cludglticmtiboutexperiencettmentcoveryideeffectwycopgPeerupptcnducedtocilolticehopeoptimmhelpptientfeelmomedempowedppdnmlizeirctiexperiencelertmvilbleourceupptmdecimkgmodelnewwyproblemolvgcopgReerchhowcncerptienthvelimedccepeerupptwhichchllenggprovideclblecot-effectivewyInpriprojectperiodthwrd(R01CA223963)wedevelopedwebe(clledMoic)bothEnglhSpnhdeliverpeerupptSCTcipientthroughcollectifirt-hurviv-wrtennrrtivepidcodtedeductilctentt/copgourceDevelopedexteniveguidncecommunydvybdfocugroupubilytetgtrgoticlfoundtiMoicwdeignedclbleeilycceibleblehelpptientundertrngeSCTexperiencewytilodiremotilproblem-focuedcopgneedMoicnowdyefficcytetgWepropoe2-rmromizedctrolledtrilevlutewherprovidgptientMoicpriSCTcnduceirpychologicldt(primryoutcome)improveptient-ptedclicloutcomeWeromize356Englh-Spnh-pekgptientcruedp-SCTMoicrigouweb-bedenhnceduulccdicludelyMoiceductilctentPrticipntcompleteementtp-SCTbele2-4-6-8-mthpot-SCTThetrilllowuchieve3im(1)etblhMoicefficcyimprovgptient-ptedoutcomeEnglhSpnh-pekgSCTptient(2)determemechnmdrivgMoiceffecnptient-ptedoutcome(3)exmemoderrMoiceffectptient-ptedoutcomeWelouerichqultivemethodexploptientexperiencewherhowMoicffectedpventblecliclSCToutcomegolmgmofocuedrigoufutuerchemechnmIfefficciouMoiccouldquicklyimplementedclicllyducedtimproveoutcomeSCTHigh-throughputementchempy-ducedcrdioxicyhumncrdiopheProjectSummryChempeuticgentcludgbdildrug(egnthrcycle)newere(egproteomehibir)ocedcrdicdvereeventcludgcedrkrrhythmTtmentrrhythmdifficultcurntlyvilblentirrhythmicdrugDevelopmenteffectiverpieehighlydeirblecnfciltedhumncellmodelhigh-throughputyCrdiomyocytederivedhumnducedpluripotenttemcell(hiPSC-CM)hveprovidednewpltmtudiedrug-ducedideeffectdeemodelghiPSC-CMhvetrnltilpotentilimprovecurntmodelprovidgclicllylevntchrcterticgrdgdeephenotypepedrugttmentTheycnloovercomediffencetweenhumnnimlcrdicphyiologychllengelg-termmtennceprimryhumncrdiomyocyteC2+hlgbnmlieplycentrlrolepthophyiologyhertfilurrhythmcouldpromgtrgetnovelrpeuticttchempy-ducedcrdioxicycechempycncueC2+leedptneoulytwrgtimedurgherttthuducgrrhythmOurobjectivechievenccurtehigh-throughputC2+trnientcodgnlyefunctilement3DhiPSC-CM(crdiophe)Weexpectechnologyllowudetectchempy-ducedcrdioxicyevlutepotentilrpiehighlyefficientmnnerOurpropoedtudynimptntcompentpplictihiPSC-CMtudychempy-ducedcrdioxicyUgourtte---rtequipmentcomputtilolweim(1)etblhhigh-throughputfunctilementhumncrdiophedetectichempy-ducedcrdioxicy(2)evlutenovelntirrhythmicrpiemigtechempy-ducedcrdioxicyThehumncrdiopheprovidettermodelchempy-ducedrrhythmcecliclrrhythmultcollectivehvicrdiomyocytecrdictueWeexpectthurhighthroughputfunctilyfciltedcoverynovelrpeutictrgetPftiguedthighlypvlentco-occurrgympmptientdvncedcncerWheneympmterfeptientdilylivecndimhirbilylivecgruentlyirvluegtlyducgqulylife(QoL)AnexcluivelymediclpprochmnggpftiguedtcnhvelerbleideeffectlimedpiveneTheneedpychoocilympmmngementterventideignedpecificllyptientlivgdvncedcncerEmerggevidenceuggetptientmynefAcceptnceCommmentTherpy(ACT)third-wveCognive-BehvilTherpy(CBT)pprochemphizecceptncemdfulneenggementvlue-guidedctivyThoughpilotultptientdvncedcncerhveenpromgACT-bedterventihverlyentetedwell-powedefficcytrilBuildgourtemextenivepriwkwedevelopedpychoocilterventiclledENGAGEENGAGEcludetrgtrdilCBTkill(egctivypcg)deceympmeverywhenpoibleACTkill(egmdfulne)promotecceptnceexperiencecnnotfullyctrolled(egprogno)goldecgympmterfenceimprovgQoLOurtwopilottrilENGAGEprovidetrgupptfeibilycceptbilypromeimprovgptient-ptedoutcomeThpropolprogeourwknNIHPheIIromizedctrolledtril(RCT)evluteENGAGEefficcyducgympmterfenceptientceivgcncercmedicllyunderervedDelivedthroughvideocfencgthbrief(4weekly45-muteei)terventihendeignedcceptbleptientidgmedicllyunderervedcludggrphicldplycceptvideomodelgkilludioctentummrieInthRCTweromize190ptientStgeIVcncer(btprottelungcoloctl)moderte--eveympmterfenceENGAGESupptiveCctrolPtient-ptedoutcomeeedtbele2mth4mthAim1determeENGAGEefficcyducgympmterfence(primryoutcome)t2mth(primryendpot)Aim2determeENGAGEefficcyimprovgecdryoutcome(ieelf-efficcyympmmngementcceptncemdfulnevlue-bedctivyympmeveryQoL)t2mthAim3tetmtennceENGAGEeffectprimryecdryoutcomet4mthAnexplryimeekightfutuimplementtieftugmixed-methoddtcollectiptientcologyprovidercliclederThtrilefirttetefficcynACT-bedterventiptientdvncedcncerwhoceivgcmedicllyunderervedENGAGEdilyimplementbleifhownefficciouourtemwellpoiedmoverpidlyimplementtiwklg-termimducguffergptientlife-engillneePROJECTSUMMARYTobccouemledgpventblecuedethillneourocietycue30%cncerdethDepeth283milliUSdultmokeMotm(70%)wntqumokgomedynotyetdyquirctivelyeekgttment--ymbivlentboutqutgAvilbleevidence-bedp-mokgttment(medicticounelg)nottypicllyfedpeoplewhombivlentboutqutgmokg(PAQS)duecotlimedourcemengfullyducemokgpvlencelow-cotclbleterventineededcneffectivelyenggePAQSencourgempmokgupptmthroughthprocecludgcnectgmvilbleevidence-bedttmentwhenydyquThecurntpropolpivethpublichelthgolNCIcllnovtiveclblemobilehelth(mHelth)mokgceterventiBuildgourprogrmmticwkdevelopgdiglrpeuticmokgcetipopulti-levelmotivtilterventiuer-centeddeigndevelopmentwkPAQSwedeignedmHelthpp(clledGEMS)whichblendoundcientificyevidence-bedttmenttprcticecommendtinovely-bedctentpiveneedpfencePAQSThebckterventierieequentilelf-guidedexerce(clledperlexperiment)deignedepecillyhelpPAQSclrifyirhelthgolbuildtngnirmotivticfidencequtgmokgtechmkillnecerychngeirmokghviThctentpidcti-ientedguidncehowqunbilyernfenicoteplcementrpy(NRT)-ppdictccefeevidence-bedbccoqulecounelgwelloldeignedenhnceenggementppmotivtielf-efficcyFdgcentromizedpilotGEMS(n=57)wepoiveCompdnidenticlverippoutperlexperimentGEMSwuedmotenmouerernedfeNRTquetedtmentmocceedfequlecounelgppMoovertwicemnyGEMSuerptedmokgbtencetfollow-upWenowpropoetetefficcyGEMSfully-powedromizedctrolledtril(n=800)ugntiwidecrumentviocilmedilrgehelthcytemcrudiverepenttivemplePAQSCo-primryoutcomeobjectivelymeudqueteirNRTqulecounelgcceedthroughppmokgbtencet6-mthpot-enrollmentApputiliztimokgductibccottmentueloexmedGEMSfirtknownppdeignedexcluivelyPAQSIfeffectivecouldprovidenovelhighlyclbleolcgttmentuemokgbtencemgPAQSddgignificntunder-erchedpublichelthgpPROJECTSUMMARYCncerimmunpyugTcellengeedchimericntigenceprT-cellceprdictedgtcncerntigenpromgnewrpeuticmodlyttgmnytypecncerHoweverlckefficcydueT-celldyfunctiprticulrlyolidtumettghtymiedprogMultipletexttumdriveTcelldyfunctiltteducgirbilyclertumGenehveenidentifiedimproveT-celliliencediffenttumtHoweveregeneticmodifictiimproveT-cellexhutitncetenctvidiffentmechnmctguncerttygrdgltivenefdiffentpprochehowcommmximumefficcyAltergtrncriptifcrctivyprticulrlyrobutwyfvfunctilrpeuticcelltteThefieldhidentifiedtrncriptifcrcnovexpedpromotetentiT-celleffecrctivymopertenttem-liketteAddiltrncriptifcrhveenidentifiedpromotedyfunctidowntmchricntigenignlgpemetboliccditummicroenvirmentcnknockedoutfvtentiT-cellctivyBothpprochehveyieldedimprovementtumctrolpcliclmodeluediffentmodelcflictgultleveuncerttyboutwhichmodifictimotneficilirmechnmWetendueproteengeergcteprote-bedhibirbdpventfunctrncriptifcrwhenovexpedTcellThllowctiovexpilibrriememrcnbothdececetrncriptifcrctivyfciltecomprgeneticmodifictiTcellThegolthStevenIKtzpropol1)UndertmoleculrmechnmtrncriptifcrcomplexegultgT-cellexhuti2)IncetnceT-celldyfuncthroughytemticmultiplexgtrncriptifcrperturbti3)DetermeltiveneftrncriptifcrperturbticounterdiffentourceT-celldyfunctivivotummicroenvirmentApecifiedfundgmechnmthpropoletthnimptntnewerchdictiourlbT-celldyfunctiengeergendogenoutrncriptifcrwell-bedpublhedlertuupptedubjectmtterexpertcollbtiThroughcengpooledlibrrieprllelchrcteriztimtrixmultiplexedengeedtrncriptifcrugvrovivomodeltum-ducedT-celldyfuncthpropolddimptntquetiwhichtrncriptifcrperturbtimoteffectivepromotgtnceT-celldyfunctiUgcuttg-edgegle-cellRNA-eqmppedtrncriptifcrperturbtiwedetermeeffectemodifictiTcellmutumThgrntyieldnewtrncriptifcrengeergolutiimproverpeuticcellgenertgbiologiclightnewerchpthcellrpyengeergPROJECTSUMMARYLivercncermjcuecncer-lteddethUnedSttegfiftheventhledgcuecncerdethmgmenwomenpectivelyThehighdemnewmoeffectiverpeuticttmentlivercncerepecillymotcommhepcellulrcrcom(HCC)nimprovedundertgvlgulryfcrunderlygHCCcellmetbolmeentiltumprogiGenome-derivedncodgmicroRNA(miRNAmiR)hveenveledcriclelementctrolpottrncriptilgenegultirtiliver-enrichedcolyticmiRNA(eglet-7-5pmmiR-122-5pmiR-148-3p)lordowngultedHCCcellpentnewrpeutictrtegyHowevercurntmiRNAfunctilexperimentlrpeutictudielimeduemiRNAmimicchemo-engeedvrocompdextenivevrioutypertificilmodifictiwhichtllydiffentnturlmiRNAmoleculeproducedvivoThlohrpctrtproteerchrpywhichbioengeedcombntprotegentproducedfoldedvivrthnynticpolypeptideprotemdevrohveenuedfoundenmouucceToovercomethbrrierPIhcentlydevelopednovelRNAmoleculrbioengeergpltmtechnologybeduppecifichybridtRNA/p-miRNAmoleculeidentifiedPIlbcrrierchievehigh-yieldlrge-clevivofermenttiproductruebiologicbioengeedRNA(BioRNA)moleculebictrnltilerchOurfollowgtudiehvedemtrtedmiRNA(eglet-7c-5p)electivelyleedBioRNAprodrughumnHCCcellgultetrgetgeneexpi(LIN28B)ctrolcellulrprocee(tumphemti)lipoome-polyethylenime(LPP)nnocomplexuperivivo-jetPEIdeliverBioRNAthopicHCCtuehibtumgrowthmouemodelOurfurrefthveledidentifictiproperhumntRNAcouplehumnh-p-miRNAnewcrrierferhumnizedBioRNAtrgetHCCInddihumnizedBioRNA/miR-148-3ppcelyproceedmiR-148-3phumnHCCcellmodultepecificmocidglucoetrnpterexpiwrdctrolmolyeglycolyGiveneexcgplimryfdgwehypoizenovelHCC-trgetedhumnizedBioRNAcnbioengeedueddectHCCnutrienthomeottummetbolmTotethypowepropoed(i)deigncleexppurifyfocuedgroupnovelhumnizedBioRNAhibiHCCcellvibily(Aim1)(ii)deletemechnticctiBioRNActrolHCCcellmetbolm(Aim2)(iii)etblheffectivenefetycidteBioRNAmodultiHCCtummetbolmprogivivo(Aim3)Succefulcomplethprojectferene---kdbiologicHCC-trgetedRNAmoleculeercholetblhnewrolemiRNActrolHCCcellmetbolmbuildolidfoundtidevelopmentnewmedieimprovettmentlethlHCCABSTRACTThecidencekcncerhcedoverpteverldecdeLimgexpouultrvioletrdiengggerlydetecticnducekcncerrteburdenHoweverfewerthn50%USdultenggepventitrtegieducetnngunburngevenfewerexmeirkceivecliclkexmtiProvidgmtidiverepopultidultboutirgeneticrkkcncerpcipventihdemtrtedefficcyimprovgkcncerpventihviOurpripcipventerventrilcptgfeedbckmtiheredvrmelnoct-1cepr(MC1R)genehowed(i)ignificnttetchtetfollow-through(ii)terventiefficcymgprticipnttMC1Rhigherrk(iii)compheniblecceptblemterilfedbothEnglhSpnhStillourecdrynlyedictedtrgetedfementterventimterilhvepotentilfurrenhnceefficcyBuildgouncourggfdgwepropoemultehybridtype1effectivene-implementtitudyevluteimpctpcipventerventiimprovekcncerpventidivereptientlowourcedcommunyprimrycettgidentifybrrierfcilrimplementtciltefutucle-upWecru1430prticipntnyrceethnicyfederllyqulifiedhelthcenterTmpFlidwhoptkcncerrkctivie(tnngunburng)1144romizedMC1Rrk(vergehigher)ctegyceivefedpcipventerventimterilnchodMC1Rulttrd(n-genetic)pventerventimteril238notceivenyterventimterilPrimryoutcometnngunburngphyicin-ptientcommunictiboutkcncerpventikelf-exmtiecdryoutcome(hourunelf-ptedunprotectihviferrlceiptpilkexmti)eedtbele612mthInAim1weevluteeffectiveneceiptpcipventerventiimprovekcncerpventictivieover612mthEffectiveneexmedeprtelymgprticipnttMC1RvergehigherrkInAim2weoticlly-medmedirimprovementprimryecdryoutcomeInAim3weeimplementtioutcomecludgchdoptiimplementtimtennceweeimplementtiequyWecductexterview30ptient20helthcwkerebrrierfcilrterventiprticiptiIfMC1Rgeneticmtiimpctpventictivieoticl30-50%llkcncercouldpventedStudyfdgcoulddictequbledemterventintillylowourcedprimrycettgfety-nergniztiABSTRACTIndividullivglikelycurblecncer(ILLIC)heterogeneougrowgubpopulticncerurvivwhohveuniqueurvivhipcneedPrciplmgeneedpychoocilttmentTtmentdepiprticulrlycricluphlfILLICptdepiveympmnegtiveequlecludglowerqulylifedeihteneddethuicidlyNumeroutrilmet-nlyehvedocumentedevidence-bedpychoocilttmentimprovedepioutcomeILLICHowevermultilevelbrrierlimcceThuILLICneedfeiblecceibledeptmenptiBriefdepicenernowroutelydmtedcologyettgTheedtcnuedproctivelyidentifyurvivneedpychoocilttmentEfficientidentificti(ID)ILLICthoughmochllenggDtnecerydetermelikelihoodcurbilycdeduntructudEHRfieldnecetglb-tenivemnulchrtviewidentifyILLICTolizegolproctiveIDdeliveryclbledepicILLICccurteefficientumtedIDpprocheneededSelf-guideddiglmentlhelerventi(DMHI)cnpidproctiveIDdeliverclbledeptmentOurtempvioulydptedeevidence-beddeptmentBehvilActivtideliveryviDMHIclledMoodivtedemtrtedMoodivtefeiblecceptbleefficciouDMHIThuproctivettmentdeliverymodelugelf-guidedDMHIuchMoodivtemypromgpprochdeliverevidence-beddeptmentILLIC[[WehvecfirmedfeibilycceptbilythpprochvicentpilottrilwhichwepecificllytilodMoodivteuniqueneedILLICtetedllmethodpropoedhe]]Imptntlyutblemodelmutddchricevidence--prcticegplimpychoocilcdeliveryThuimplementtioutcomedetermntmutccurntlyevlutedDictlylignedRFA-CA-22-027wepropoeHybridTypeIeffectivene-implementtril1)comphenivelyeeffectiveneproctiveID+DMHIpprochmgILLIC2)grmterventideliveryguideimplementtitprctice3)developnEHR-derivedphenotypelikelycurblecncerOurdiveretkeholderdvybdwhichcludeILLICcologyprovidergniztillederhguidedfedthpropolenuclicllevncectueprtnerourtemllpecttudydeignimplementtidemtitudyfdgThprogrmerchhpotentilexpevidence-bedpychoocilttmentccemnnerclblecrocologyettgultimtelydeceundueburdendepihouldedILLICSUMMARY/ABSTRACTMcrophge(M)nteimmunecellphgocytepilntigenpentgcellwhichcruciltuehomeotdptiveimmunepegultiThehighphenotypicfunctilplticyhighpenetrtirteeverlolidtumtypecludgpncticductldenocrcom(PDAC)mkeMcellrpyidelolidtumttmentTooverwreirimmuneuppiveprogrmcefiltrtedolidtumMcnengeedchimericntigencepr(CAR)dictirpecificyfunctiPhophtidyle(PS)negtivelychrgedmo-phopholipidmotlycfednerlefletplmmembrnebilyerflippedoutermembrneunderlethltPSuniverlet-mentigenpopticcelltenbnmllyexternlizedcncercellWehypoizePStrgetedCARM(-PSCAR-M)myuniverlthird-prtyf--helfdjuvntcellrpytrdilrpieolidtumttmentcuecncerttmentmodlieuchtrgetedrpiecnducetrnientmivetumcellpopToverifyweemployedKRAS-ddictedPDACmodelpilottudiehvectedn-PSCARcnprovokentigenpecificphgocyticcyxicctivieMgtKRAShibir(KRASi)-ttedPDACcellDuetructucervenePShumnmoue-PSCAR-MctedbothmouehumnPDACcellpotKRAStmentInprojectwepropoedemtrtenti-tumeffect-PSCAR-MndjuvntrpyKRASihumnPDACxenogrftmodelmoueptneouPDACmodeldectwkgmechnm-PSCAR-MAim1Demtrte-PSCARctiviehumnPDACmodelAim1generte-PSCAR-MughumnprimryMpermfunctilyvrodetermentigen-pecificphgocycellkillgInddiweexplowhercombtihibirtrgetgnturlPSceprMblockgedt-et-meignlfurrenhncetumicidlctivie-PSCAR-MAim1bdetermepolriztittu-PSCAR-Mflowcymetrynlydectmoleculrprogrmmg-omicnlyAim1cdemtrtetumicidlctivy-PSCAR-MndjuvntrpyKRASihumnPDACxenogrftmodelAim2Determetumicidlctivy-PSCAR-MimmunocompetentmouemodelWehypoizemu-PSCAR-McnnlykillPDACcelldictlymylowumimmunemicroenvirmentfurrprovokenti-tumimmunepeAim2producemu-PSCAR-MdetermeirphgocytickillgctiviegtKRASi-ttedPDACcellAftervlidtiweexmewher-PSCAR-MeffectiveimpirtumgrowthpventtumcurncendjuvntrpyKRASiptneouPDACmouemodelAim2bchrcterizeTMEmodelg-PSCAR-MviimmunophenotypgdeletepotentiltercellulrcrotlkimmunecelltypeABSTRACTCncerdproptelyffectBlckAmericnecomicllyddvntgedgroupyetedividulunderpentedcncererchTheCncerUndergrduteReerchEductiProgrm(CUREP)propoeddthdpryexpgdiverifygpoolfutucncerercherbiomediclwkceOurobjectivecteummerundergrduteerchprogrmcollbtiUniveryNthCrolChpelHill(UNC-CH)NthCrolCentrlUnivery(NCCU)NthCrolA&TUnivery(NCAT)twohricllyBlckuniverieCUREPimdm12undergrduteunderpentedgroup(URG)echyerfocugfirt-generticollegetudentthoeecomicllyocillyddvntgedbckgroundthoelimedprierchexperienceTheprogrmhthepecificim1)ProvideURGtudenth-experiencecncererchdurgten-weekummerternhip2)Incetudenttetpurugcercncererchfergpildevelopmentctivieeentilggdmigrdutepilchool3)Provideyer-lggroupcochg(covergummerfllprg)helptudenttegrtecdemiclifekillceirchnceuccefullycompletgirdegeCUREPferprticipntopptunieexpirknowledgeexplovrioupectcncererchdevelopkillneededuccefulcercncererchTheprogrmkeycompentcludedicterchexperienceunderguidnceprciplvetigrcductgcncererchTheefcultymenrcomediverebckgroundcludgURGpoeexpertebiccncerbiologypopulticiencetrnltilcncererchcncerdprieOurprogrmtructubuilduppvioulyfundedNIHU54prtnerhipeductilprogrmPrtnerfocuedcncerhelthdprietweenUNCNCCU(NCIU54CA156735)Thoughbouttwo-thirdPrtnerlumpurugdvnceddegetudentfcechllengevrioupectirliveOurnovtivepprochtegrtecdemictudylifekillcochgctgcompheniveprogrmppyoungcienttfutuchllengeStudentcductdependenterchunderuperviPImenrgrdutetudentpotdoclbrieerchtempecilizgpopulticienceTheirerchexperiencecomplementedtrgethicvrioupilcerdevelopmentctivieculmtgerchpenttitendummerAdtguhgfetuCUREPyer-lgcochgcompentencompgtudykillcdemicwrgtimemngementelf-efficcycerplnngwellneThholticpprochenbleprticipnttegrtecdemicocil/lifekilleffectivelyUltimtelyCUREPimceprticiptipenttiURGcncererchctrigignificntlydiverifictibiomediclwkcePROJECTSUMMARY/ABSTRACTOverllRcilethnicdpriecoloctlcncer(CRC)prticulrlyprouncedAfricnAmericnAlkNtivepeopleTheediffencecnnotexpledccecenghelthcleuggetgunderlygyetundertudiedctriburdeeetiologyprogipettmentOngognovtibiotechnologyenbledetiledevlutiunderpngtumhotmoleculrgeneticgenomicbiologyhveendequtelylevergedddedprieCollectivelyourouttgtrndciplrytemhexperteuecuttg-edgetechnologiedrivenovtivetrnltilcncerdprieerchdictlyfocueddevelopgnovelpventierlydetectidignottmentpprocheTochieveouroverrchggolducgpertentCRCdprieprticulrlythoepentmgAlkNtiveAfricnAmericnpeoplewepropoefollowgpecificimAim1ImproverktrtifiedcengerlydetectiCRCcrorcilethnicpopultidevelopgrkpdictimodelpermequllywellcrorcilethnicgroupAim2ReducercilethnicdprieCRC-pecificmtlydcovergvlidtgnovelmoleculrbiologiclchngeltedrklethlCRCpettmentrcillyethnicllydivereptientcnguideurveillncettmentelectiCRCurvivAim3DcovernovelrpeutictrgetCRCcrorcillyethnicllydiverepopultitetpotentilcliclterventiimedtducgCRCdpriedvncgourundertgdiffenceimilriegeneticmoleculrmicrobilchrcterticCRCdiverepopultitetgeffectivenenovelterventiclicltrilenrolldivereCRCptientOurwld-clvetigrtemhexpertebiccienceclicltrnltilerchmyhelthcncerdprieDurgP20SPOREplnngphewehvebroughtgerlrgebiopoiryvrioubiopecimentypedetiledclicldtlrgercillyethnicllydivereCRCptientpopultiequlnumrAfricnAmericnAlkNtiveHpnicn-HpnicWheptientthroughourlg-termlederhipgeneticepidemiologywehveccewldlrgetmotrcillyethnicllydivereCRCgermlegeneticdtetUtilizgeuniqueourceourprogrmcductfourtrnltilprojectupptedtheeentilcoprovidecentrlizedexperte)lederhipdmtrtib)biopecimenpthologymoleculrtechnologiec)biottticbiomticOurCerEnhncementDevelopmentlReerchProgrmenuwecrutlenteddiverevetigrdeveloppipelenoveltrnltilcncerdprieerchprojectThroughegrtedeftweenvilizgourgolutedtrnltilerchprogrmfocuedelimtgCRCdpriemobrodlyducgCRC-ltedmbidymtlyABSTRACTFerropmgultedcelldethdefedir-dependentccumultimembrnelipidperoxideultoxidtivedmgeplmmembrnedruptiFerropmcelldehtmechnticllymphologicllydtctmcelldethuchnecroppoppyropTrgetgferrophgrnedimmenetetcncererchcommunyowgpotentilelectivelyctivethmechnmcelldethcncercellTolizefullpotentilducgferropcncern-viveimggmrkerneededSytemxc-cyte-glutmtentipterplmmembrnetrnptermedgcellulruptkecyteexchngetrcellulrglutmteSytemxc-plycriclroleferropgultgvilbilycytecrucilpcurglutthiebioynthuimpctgcellulrntioxidntdefeneytemultimtelyfluencguceptibilyferropModultiytemxc-ctivyphrmcologiclhibirpotentilrpeutictrtegygultethmcelldethnti-cncerrpyMoleculrimggytemxc-ehpotentilidentifycncerppropretrnpterctivywouldubleferropductiedrugenggementhibiytemxc-livgubjectmirefficcytrgetgthemerggmechnmcelldethcncerTourknowledgevetigtiytemxc-rdiophrmceuticlthctextferrophyetptedWehvepieeddevelopment[18F]hGTS13homo-glutmterdiotrcerpecificytemxc-Imptntly[18F]hGTS13demtrteeverldvntgeoverextgytemxc-rdiotrcercludg1)cptiUV-ctivegroupthugtlyfciltgrdioynqulyctrol2)improvedtrnpterpecificy3)duceduptkemultipleimmunecelltypeimprovedcncerpecificyThegolthpropoletblh[18F]hGTS13PETn-viveimggmrkerdrugducedcncerferropcellcultup-cliclmodelclicllytrnlte[18F]hGTS13determgphrmcoketichelthyhumnvolunteerthroughnexplryvetigtilnewdrugmechnmWefirtetblhltihiptween[18F]hGTS13uptkeenivycncerferropvrovivoettg(SA1)Wentetbily[18F]hGTS13mirenggementpro-ferropticdrugvivopdictttmentpe(SA2)Ltlywetrnlte[18F]hGTS13firt--humntetgdetermebiodtriirdidoimetryhelthyvolunteer(SA3)Succefulcomplethprojectetblhfoundtiemployg[18F]hGTS13electptientlikelyeniveferropducgrpiemirttmenteffectThefdgthwkhvehighimpctducerferropdvncecliclvetigtiPROJECTSUMMARY/ABSTRACTMultiplemyelomecdmotcommhemlogiccncerUSmcurblevirtullyllptientdevelopglpedfrcrydeefterilrpyChimericntigenceprT-cellrpy(CART)volutirynewttmentptientlped/frcrymultiplemyelom(RRMM)whohveprogedeverlprtmenthvelimedttmenptimgInclicltrilRRMMptientttedCARThowedunpcedentedttmentperteimprovedptient-ptedoutcome(PRO)uchhelth-ltedqulylife(HRQOL)ympmburdenCARTnowvilbleRRMMptienttrdcfergptientnewhopedurblemitterHRQOLHoweverclicltrilhdtrgenteligibilycrerilckedrcilethnicdiverywhichlimgenerlizbilyfdgRRMMptientttedtrdcToddthlimtiweetblhfirt--kdpropectivecohtl-wldRRMMCARTcipienttMftCncerCentereledghigh-volumeUStutifergtrdcCARTdivereRRMMptientWhnevidence-bedpycheuroimmunologyfrmewkweevlutepychoocilfcr(iedepinxietyociluppt)immune-ltedfcr(ieytemicflmmtimrrowimmunemicroenvirment)yltekeycliclptient-ptedurvivhipoutcome(iecidenceeveryCARTxiciettmentpeprogi-feurvivlHRQOLympmburden)Immune-ltedfcrmyepecillylevntthpopultiurvivhipCARThrneeptientownimmuneytemkillcncercellcipientcnexperiencepotentillylife-engimmune-mededxiciePrticipntcompletePROementprovidebloodpecimenmplequntifictiimmunebiomrkertclicllydefedtimepotp-CARTfui(iebele)througheyerWelouemultipleximmunluocencetgnovelttticlmethoddevelopedourtemchrcterizebundnceptilltihipimmunecellmrrowmicroenvirmentThourcehighlyphenotypedRRMMptientytemticllycollectedPROdtbiopecimenllowuidentifypychoocilfcr(Aim1)immune-ltedfcr(Aim2)ocedkeycliclptient-ptedurvivhipoutcomemgl-wldptientttedCARTprttrdcStudyfdghvedictcliclimplictiIdentifygpychoocilimmune-ltedfcrocedCARTurvivhipoutcomemdevelopmentptienteducticlicldeci-mkgolFdgloelucidtemodifibletrgetdevelopgimplementgupptivecterventiueflmmti-ducgmedictiLg-termtherchimproveurvivhipRRMMptientttedCARTgrowgyetundertudiedpopultilivgcurblecncerAbtrctThpropolnewT32pdocrlprogrmtrnextgenertimulti-dciplrycncerercherexperteunrvelcomplexyfcrunderlygcncerrkdprieThertilethT32bridgegptweencncererchfieldtegrtiveeductiholticpildevelopmentTheT32levergetngthStndUniverySilicVlleyprovidepecilizedcncer-focuedtrgcrotrdillydtctfieldTheprogrmblendhighlyterctivefhrgopptuniecourewkemrternhiptStndUniveryloclbiotechcompniemenderchprojectCourewkemrcludecofergnewlydevelopedthprogrmTelernmethodtechnologieuedfoundtildciplecncererchepidemiologybiottticgeneticomicenvirmentlhelthhelthdpriecommuny-enggederchTheprogrmlotrtudentcceptcellocietycomplexterplytweenbiologiclocilenvirmentlfcrhpehelthoutcometbothmicromcrolevelThpprochcognizehelthnotolelydetermedgeneticdividulhvilofluencedocilenvirmentlctextwhichdividullivewkterctTheT32deignedtrtudentdiverekilletuchnovelerchmethoddtnlyticwelltkilllikecommunictemwklederhipThfrmewkproviderigoutrgwhichunderpnedprciplepibleerchcductDrJohnWteMelBdyledprogrmhvgovereenmultiplepvioutrgprogrmdecdeuccefulexperiencetrgfutugenerticncerercherTheT32menrgtemcompd26outtgfcultymemrcncer-focuederchprojectcromulti-dciplryfieldTheprogrmhextenivefncildmtrtiveupptteStndUniveryStndCncerIntuterigoutudentdvg360-degeevlutimgtemenrnternlexecutivecommteenexternldvycommteeBytegrtgmulti-dciplrypprocheT32htrgfoundtiwhichtedevelopkillvlfurrgircererchdeciphercuecncerunderlygdprieultimtelyprovidgvlubleknowledgegrdgpventiequblettmentthcommcomplexdeeAbtrctTheproblemcncer21tcenturymntilpriyuchferubtntivelg-termceropptunyp-docrlpot-docrltrgTheTrnltilCncerBiology(TCB)T32trgprogrmeekuppt2p-docrl4pot-docrlte2yerechemphizenchdideerchencompgtte---rtcncererchAlgtrgfundmentlcncererchteprovideddividulizedccemnybiccliclcncererchlgtrgpiblecducterch(RCR)cludgrigexperimentldeigndtterpttiUndertghowwkmultidciplrytemgfmilirytembiologylrgedtetnlyelomjgolourtrgprogrmTheTCBT32progrmoverrchggol1Totrp-qulycienttcpblecductgdependentcncererch2Tofotertellectultechniclcommunictikillquiducceedcdemicdutrilndyfutu3Toprovidenundertgbicpublichelthcliclproblemcncer4Toprovidetrgprogrmcludecncerlteddidcticjournl-ientedcourewellprogrmcludebiomediclethicRCRenhncedproducibilybiottticbiomticdtmgnlyehrg5Toprovidetrggrntwrgeffectivelcommunicticerplnng6Tomtprogrm-pecificcrumentprogrmttrctggeogrphiclbrodrngepplicntcludgunderpentedmyte7TohvegulrttprovidepecificT32opptunietepentirerchdevelopkillquideffectivecienttOurtrggrnteligiblep-docrlpot-docrlpplicntpoolhlmotdoubleddurglt5yerThebilyrggrntbridgenextgouttgfoundtibiccncererchprogrmourexperimentlrpeuticprogrmHroldSimmNCIDeigntedCompheniveCncerCenterdtguhetrdizedgenerlgrdutepot-grduteeductilprogrmWehve35commtedwellfundedfcultymenrdedictedgroupteergcommteememrlgCncerCenterdmtrtivetellectulfncilupptTheblood-tumbrrier(BTB)hderdeliverypenetrtiytemicllydmtedrpeuticgentbrtummicroenvirmentTheBTBcteddiltedlekymicroveelcuegilperfuivribilypocvectivedeliverygrdienttenwhiletilltgenhncedeffluxtrnpterexpight-junctegryToenhncerpeuticdeliverycroBTBwehvedeployedn-viveMRimge-guidedtrncrnilpuledfocuedultround(FUS)combtimicrobubble(MB)MBocillteupexpouFUSexertmechnicltemicrovcultuopenBTBugmentedpyloddeliveryYetdepepromethpprochtillroomignificntimprovementIndeedptilperfuivribilytilllimMBccediltedtumveelhvedimhedctctocilltgtrvculrMBhightertiltumputilllimtrnptwhenBTBopenedHeweimovercomeeobtclemoeffectiveFUS+MB-mededdrugdeliveryp-nmlizgbrtummicrovcultuviVEGF-R2blockdephrmcologiclpprochnotlimedBTBcueVEGFR2+endoliumdictctctbloodtmWepovculrnmliztiimproveFUS+MBdrugdeliverycueducetertiltumpuimprovetumperfuioxygentiveretumendolilcellnergylimimmunecellfiltrtifunctiInthpropolmodelbothprimrymettticbrtumwedevelopFUS+MBbedpprochelevergevculrnmliztiimprovedrugdeliverycroBTBAim1identifyvculrnmliztimgwdow()provideoptimlcdifocuedultround-mededdrugdeliverybrtumWeidentifyuchoptimlwdowdelivery2diffentizedMRIctrtgent[MultiHnce(~1kDimultgmllmoleculedrug)Gd-IgG(~150kDimultgmAbimmunpy)]T1MRImppguedpcelyquntifyptiotempldtriictrtgentfterFUS+MB-mededdeliveryAim2uethmtilevergevculrnmliztiugmentrpeuticefficcyfocuedultround-mededimmunpydeliverybrtumHewedeliverpromgimmunpie(CD47PD-1)wehypoizemytnefFUS+MBdeliveryettgvculrnmliztimylorpidlytrnltedclicltrilurtutiStudiecludelgudlementtumgrowthMRIgenertiKpln-MeiercurvenimlurvivlhlogiclnlytumpeBecuevculrnmliztiferopptunieenhncedimmunecellfiltrtiviugmentedendolilcelldheimoleculeexpiwelotetwhertumctroloccurthroughCD4/CD8Tcell-dependentmechnmProjectSummryTheFUtuSurgeScienttInvetigtgONcology(FUSSION)YESprogrmtUniveryAlbmtBirmghm(UAB)deignedcetetcncer-ltederchmgcollegetudentgroupwhounderpentedbiomediclciencegolctgpipelediverefutuphyicin-cienttcncer-ltederchprogrmTochievethgolFUSSIONprovide2-yermenderchexperienceugmentedmthlywkhopcncer-ltedpiccientificcommunicticercdemicdevelopmentTheNCIYouthEnjoyScienceprogrmprovidenidelvenuechievefollowgpecificimSPECIFICAIM1Providecncer-ltederchexperienceundergrdutetudentmenrguccefulphyicin-cienttTochievethimtudentprticipte2-yerexperiencecncer-lteduemendcienttphyicin-cienttcludgtwocecutiveummerfull-timeerchdedictedcienttSPECIFICAIM2Etblhcurriculumprovidefoundtilundertgvrietycncererch-ltedknowledgepiblecducterchpilcerdevelopmentkillcdemicdevelopmentdemtierchultStudentceivetructifoundtilcliclcncerpiclgtrgcientificcommunicticerdevelopmentcdemicpprtientergrdutemediclchoolSPECIFICAIM3ExpwnecurntcncererchimptnceFUSSIONprogrmtegrtgoutchopptunietudenterchdemtitrtegieStudentdemteirerchUABcmpuwidercommunietdeprtmentlercheventcmpuympoiumfmilyfriendcnttendcommunythroughnoutchpneldcuiPrticipnthknowledgeexperiencegedimpcthhdirundertgcncernemphimptnceerchddgcncerpventtmentdprieTheFUSSIONprojectuniquefocuphyicin-cienttToourknowledgenoYESprogrmhpecificfocuphyicinprtcncererchGivenUABexceptilucceerchtrgDeprtmentSurgeryexperiencedevelopgimilrerchtrgprogrmUABwellpoiedimplementuchprogrmMoovercuee-qurterAlbmpopultiAfricn-AmericnUABferuniquepopultivetigtecncer-lteddpriemyhelthThegtneedmophyicinwholoercherdertrnltecientificdcoveriedideIncgnumrdiveryphyicin-cienttcndictlyimpctptientdignottmenutcomemigtehelthdprieABSTRACTOVERALLOrophryngelcncer(OPC)rgepidemicproptilrgelyowghighlycurblecogenichumnppillomviru(HPV)ttribledeeHPV-ocedOPCtendignoedyoungdividulpentgnernmlfunctilttuhighqulylife(QOL)tdignoStrdrpyferexcellenttwo-five-yerurvivlprobbily95%79%pectivelyyetthighcotQOLlotLg-termurvivrkhotdebiltgdelyeddvereequelerpyRomizedtrileekgmigtexicyducgtenyytemicrpydecerdipydoeHPV-ocedOPCurprglyultedferiurvivl(egRTOG-1016HN005)Ornotewthyeftoptimizerpeuticrtio(egtrnlroboticurgery[TORS]highlycmlrdipy)tillyieldignificnterlyxiciepublhedextenivelyvetigrwellnumeroulteympmperrdevelopmnyyerurvivhipdependentdriverunemploymentyoungurviv(underge60)decilgtboutcncerrpylgftercu(medin7yerurvivl)Thevetigrhvefurrpublhedextenivelythedtctter-ltedhighlymbiddelyeddvereequeleenQOLhelth1)mibulrotediecro(ORN)2)lterdi-oceddyphgi(lte-RAD)3)ltelowercrnilneuropthy(LCNP)TodvncepcihelthOPCurvivwemuttegrteedividullequirytterdecriterectictiblephenotypicpenttitrjecriecluterdvereeventnovelrpiemigtechricdbilydvereeventevolveerlylteurvivhipThebencewellcurtedlg-termurvivcohtwtimuludevelopmentMDAnderOrophrynx(MDA-OPC)cohtnctivegletutipropectivelgudlcncercohtSce20151750OPCptienthveenrolledterdciplrychrcteriztiexpoudignotic/tggttmentdeectrolvlidtedclicin-ptient-ptedurvivhipoutcomeSurvivlgudlfollow-upPtient-ReptedOutcome/Functi(PROF)Cowhichhdtecquid31370PROquetini3687xicyimggtudieTheMDA-OPCcohtnunprlleledourcetegrtedOPCpecificProjectfocugdelyedttmentequelethrpidlygrowgcncerurvivpopultiTheOPC-SURVIVORP01ProgrmProjectimmtenrichMDA-OPCfrtructuextendgoutcomedtcollectiyd5-yerlg-termurvivhipupptthetegrtedProjectfocued1)otediecro(OPC-ORN)2)crnilneuropthy(OPC-NERVE)3)lterdi-oceddyphgi(lte-RAD)OurcentrlhypoclicllyfeiblePROobjectivemeuuncoverphenotypetrjecriedelyedcncerrpyduceddvereeventerlierdetectimechnticllytrgetedmigtitrtegieABSTRACTAnetimted79000Americnwedignoednlcrcom2022pproximtely13920diedprimrilyultmettFirtlettmentvolveloclizedurgiclmovlprimrytumytemicrpiegenerllyervedmettticdemtiWhileccRCCurveillnceprocolhveimprovedovercentyerggivemngementimmunomodulrchempeuticgentgenerllyhelduntilfterignificntcurncemettidentifiedlthoughthgenerllyolteeffectivelymngedeterdvncedcnceroupdwhichflectedpot-mett5-yerurvivlrtejut14%ThegolthPheIISBIRfurrddbencequntifibletrgetedmetbolebiomrkerccRCCtueccurtelypecificllypdicterlydeeprogimettUltimtelyweeekidentifythoeptientexpggiveubtype()nlcncerwouldneferlieriytemicrpyLikeweevluthnewlyidentified12-mrkerpnelcndetermethoeptientwhohvemettticdee100%pecificymycfidentlychooemocervtivemngementpprochTheclerunmetcliclneedtrtifyggivecncerubpopulticertmlignncielikeccRCCyetcurntlynoprognoticdignotictetmrketpdictmettInpilottudieLAGRANGESCIENTIFICwbleovercomemjproblemencumdpvioumetbolictudieuchprimrytumtueheterogeneydy--dywelllb--lbMSvribilyAddillyfurrfemenurp-nlyticlpot-cquinmliztechniqueddimetbolequntifictimethodhvedemtrtedtrgerccurcyhigherrobutneIndeedwehveidentifiedourfeibilytudiepnelmetbolemrker100%pecific83%enive100%PPV94%NPVidentifygccRCCptientprogmettttimeprimryccRCCtumecti(17-46yeroerthntrdc)InderhelpvlidteourprotypeweutilizeccRCCbiopoirieEternVirgiMediclSchoolPROBEcohtOntrioIntuteCncerReerchTumBnkUniveryFlidUniveryVirgiUTHelthSnAnniowhichccounver894nltumocedptientdtfollow-upWegpropectivetuecollectUniveryFlidJckvillectuecollectUTHelthSnAnniowhichccompniedupdteddtbefurrllowuidentifyptientwhounderwentprimryccRCCtummettized(Ce)vptientwhodidnotprogmett(Ctrol)PidNmldjcenttueobtedwhenfeibleFthPheIIR&Dweexpupourextmelyuccefulultourpilotpro--ccepttudiefurrdevelopourprotypecommerciliztitrtegieOverllProjectSummryTheVirgiAdvncgCncerCtrolEquyReerchThroughTrnmtiveSoluti(VA-ACCERT)Centerncdemic-publicprtnerhiptweennterdciplrytemvetigrVirgiCommwelthUniveryEternVirgiMediclSchoolVirgUSDeprtmentHougUrbnDevelopment-dmtedpublichougcommunieThegolcro-cuttgmeVA-ACCERTCenterimprovedemtiimplementtihelthpromoticncerpventiervicecome-bedcommuniecrotte-widepublichougytemneftcloeunjutgpcncerhelthoutcomemgmrglizedpopultiTheVA-ACCERTCenterutilizetwoeentiloticlmodelCollectiveEfficcyMechnmActiModelbuildocilcplcommunyempowermentcollectiveefficcyelementSocilCogniveTheySocilEcologiclModelmmulti-levelhvilchngeCommunymemrenggeVA-ACCERTCenterthroughefrmewkidculturldpttideliveryevidence-bedterventiprcticeirprticiptimycludeervgHougCollbtiveCommunyAdvyBdCo-LedprticipntCenter-upptederchproject/ervgpeer--peerhelthdvLedMultiplePrciplInvetigrtriddemtrbleexperiencecductgbothhelquycommuny-enggedcncerctrolerchVA-ACCERTCentercludefourterdependentcompentlrgefive-yermulti-levelterventilSocilDriverHelthReerch(SDOH)Projectdeignedimprovehelthydietryptternduceedentrylifetylethroughglowmoderte--vigouphyiclctivyCommunyRepiveReerchProjectiveupptdeignimplementtievlutidemtifourerchprojectReerchMethodMeuDtMngementCoprovidetegrlqultivequnttiveerchervicepnngdtmngementtudycodtimeudevelopmenttudymethoddpttiethiclcidertidthrgllCenter-upptederchivenAdmtrtiveCoupptgeentilternlexternlcommunicticodtiguidedeverldvyentieInddiVA-ACCERTlederhipenggedntilCtium-wideeftvolvgfourNtilCncerIntute-fundedACCERTCenterCentrlCodtiCenterTheVA-ACCERTCenterlohubgrowgmodiverewkceerly-cervetigrTheevetigrequippedkilluppthpenewdictipromotghelthequycome-bedhougcommuniefocuedcncerpventictroleftUltimtelyVA-ACCERTCenterdemtepromotefdgtprcticewide-cledoptiutbilycrocome-bedhougcommunielocllythroughoutcountryABSTRACTTheMchuettPrtnerhipCommuny-EnggedCncerCtrolEquy(MPCECCE)buildrobutprtnerhiptweenHrvrdTHChnSchoolPublicHelthMchuettLegueCommunyHelthCenterMGenerlBrighmThepropoedCenterwell-poedfurrccelertecommuny-cdemiccollbtidvncetrnmtiveoluticncerequyOurCentermedvncgcncerctrolequytngngcommunyhelthcenter(CHC)cpcydeliverevidence-bedcncercengbccottmentpromotgocildiglcnectimgptientircommunieAdvncgcncerctrolequyultCHCytemdeliverevidence-bedcgercommunygniztiupptcommunyneedThePrtnerhiphelectedfourloclpriieSDOHtrget(1)ocilcplwhichflectourceemddedocilcnecti(2)civicenggemenrcticommunytkeimprovecircumtnce(3)ccediglkilltechnology(hewrdferddiglcce)whichimpctequyccehelthcocilourceuppthelth(4)cceevidence-bedcncerctrolcbtcerviclcoloctlcncercengbccottmentflectgHelthyPeople2030objectiveWecductmulti-leveltervent2levelcommunylevelbuildcommunyocilcplcivicprticiptienblgenggementimproveidentccehelthecomicourceytemlevelimprovecncerctrolc(egcncercengbccottment)diglccediglneedcengnvigtineededourceToupptCentergolplnnederchwe(1)ctecommuny-prtnedpprochcductgerchbuildgbothcommunyCHCcpcyddkeySDOHthroughtrgAdmCo(2)cteprocedevelopgutgerchpivecommunytetthroughourCommunyRepiveProject(CRP)Progrm(3)ctennovtivecentrlizedpprochefficientcollectimngementhrgerchdtcroCenterthroughdtecoytemupptgmethodologicneedCenterthroughReerchMethodMeumentDtMngementCoThhighlytegrtedCentertrgemphcpcybuildgllprtnerWeimlkCHCcommuniewymximizecivicenggementprticipticncerctrolerchcddhelthequieugpprocheclbleutblecroMAntillyProjectSummry(Abtrct)GolTheoverllgolWhUACCERTdvncecncerctrolequythroughcommuny-enggedmultilevelerchterventiddimpctocildetermnthelthdverecncerctroloutcomeAimThepecificimCenter(1)Brgnovticncerctrolequyerchthroughcommuny-cdemicprtnerhipugmultilevelerchmethodmeudeveloptrnmtiveoluti(2)Aembleenggenexceptildiveretemcncerhelthequyvetigrbuildcpcymgcdemiccommunyprtner(3)OrgnizetegrteCentercompentmnnerfciltenewthkgbouthelthequythroughtrndciplrytemcience(4)Developerchmethodmeudtmngementhdource(RMMDMco)upptimplementtidemticientificllyrigouternlcrocenterproject(5)IdentifyopptuniedevelopplneffectivelyddocildetermtehelthducecncerdprieStrtegyWhU-ACCERTbuildlgcdcommunyenggederchducecncerdprieutmechnmcommunyputpiveerchThccomplhedengggvetigrdiffentdciplevetgdevelopmentcommunyprtnererly-tgevetigrWebuildexpertecommuny-enggederchemticienceocildetermnthelth(SDOH)deliverpiveproductuegogmeucommunyenggementmirdjuurproceeByctuoulyengggcommunyprtnerwebrgmengfulliefthroughimprovementcbuildtruterchenterpccelerteelimticncerdprieInnovtiimpctOurpropoedCenterprticulrlynovtivehvewidepdimpctdvncgnetwkcncerctrolequyercherbuildgtellectulcplenhncgcpcyhelthequycncerpventictrolWhU-ACCERThdtctivefetubuildutedfocucncerdpriepplytrtegiebuildmultilevelterventipivecommunyneedTheefetucludeuniquelydiveretemprurCommunyRepiveReerchProgrm(CRRP)enggementdevelopmentcommunyprtnererly-tgevetigrtrtegicdemtiproductnefcommuniefocuedtrtegycollectivetegrtiprojectcocroACCERTcenterThCenterultimtelydvncecncerctrolequypromotecpcybuildgmgcommunyprtnerOVERALLABSTRACTChicgoemotdivereyeteggtedcieUSchrcterizedeggioucncerhelthequieWepropoeetblhAdvncgCtrolEquyReerchThroughTrnmtiveSolutiPtientNvigti(ACCERTPN)Centerdevelopcommuny-enggedterventimeumethodproceoutcomeementerchercommunyprtnercpcyenggementcentedroundmenovtivemultilevelptientnvigti(PN)pprocheimplementticiencelernghelthytemddtructurlrcmSocilDetermntHelth(SDOH)golmigtgcncerhelthequieChicgoBlckLtxlow-comeCheecommunieTheACCERTPNCentererchprogrmcommencefirtyerlunchfive-yerigntuSDOHReerchProjecttwpidpivemticllylkedCommunyRepiveProjectTheSDOHReerchProjectlevergenovtiytemengeergrtificiltelligence(AI)developtettwomultilevelPNpprocheviHybridType2romizedeffectivene-implementtrilCommunyRepiveProject1developcommunictitrtegietrgourcenvigrhelthcprovidercommuny-drivencncerurvivhippicBlckwomenuchexulyftercncerviTruthTlkgTourCommunyRepiveProject2exploueAIocilrobotChicgoChwncommunyettgenhncedigllercycncerhelthlercymSDOHReerchProjectAddilCommunyRepiveProjectidentifiedubequentyerProjectupptednAdmtrtiveCothvereeopertilcientificctiviewellcommunyternlexternldvybdbuildcpcyenggementmgcholrcludgthoeunderpentedgroupbiomediclhvilciencecommunyprtnerimplementACCERTPNterventicptelivedexperiencethoewhofcecncerequieAReerchMethodMeu&DtMngementCoupptdevelopmentimplementtievlutiprojectdevelopgmeumethodegcommuny-levelSDOHcommunyenggementcncerctrolequyproceeoutcomeThCenterbrgtrgcientificrigignificntpotentilencttrnmtiveolutidvncecncerctrolequydemtrtedourfocuclgtrnmgPNwrdytemlevelcimprovementdequtelycloecncercdeliverygpdiveretrndciplrycommuny-cdemicerchtemexceptiltrckcdcncerctrolPNSDOHcommunyenggementimplementticiencertificiltelligencehumn-computerterctiytemengeergcommunymobiliztiptientdvoccymengfulenggementChicgocommuniemultecrlcommunyprtnerguidgNthStrnothgboutuoutu2SUMMARYTheBeckmnReerchIntuteCyHope(COH)wld-clcncererchtuticncerhoplmurngcienceprcticlnefthroughexquecnovtiveerchvleductifocuedelimtgcncerditeIncecncercidencergttmentcothighlightneeddvncecncererchthroughgrowthdiverewell-tdwkceWepropoentuti-wide10-weekerchexperienceundergrdutefocuedcncerggmetbolmclledCncerAggMetbolmerchexperienceProgrm(CAMP)TheCAMPR25commtedtrgfutucientificlederwhohvekilldevelopnoveltechnologietrnltemclicCAMPprovidefocuedmenderchexperiencemtchgundergrdutete(CAMPer)menr-ercherthemticCncerAggCncerMetbolmCliclReerchEchummerCAMPenble20CAMPerelectedviloclntiwideercheprticipteerchpnrccncererchbicdideCAMPerelectmg30experiencedCOHMenrwhohvetrckcdmenrgtudentdiveretetbckgroundPrciplepiblecducterchrigproducibilytughtfcultyH-lbryerchuxiliryctivieenhncedjournlclubdtguhedpekeremrweeklyCAMPererchpenttiwellnend--ummerpotereiInddiddloclcommunyneedbolterpipeleundergrdutethrivefutucncerercherwelopilotchool-yerprogrmwhichfivepotervedyerlymotivtedSTEMtudentnergilcomphenivepublicuniveryCliniStteUniveryDomguezHill(CSUDH)my-ervgtutiFcultyCOHCSUDHhvecollbteddeignthprogrmextendummerCAMPexperiencecdemicyerTheCAMPdmtrtivetructucludehighlyqulifiedDicrnAoceDicrInternlExternlAdvyCommteeRecrument/AdmiCurriculumDevelopmentAement/TrckgCommteeThquetfundgjutifiedourlgcdhotguccefulctiveummerprogrmcludelocltudentddvntgedgrouplevnceourtrgexperiencecncererchexperienceourMenrouttgcommmentCOHtrgnunticprtnerhiptweengiltutipencepecificgpfederlfundgundergrdutetrgctuumpnelementrychoolpotgrduteeductiPROJECTSUMMARYBtcncer(BC)midblegloblhelthchllengeffectgmilliwomenwldwidennullyThmlignncyledgcuedethmgwomenundercgproundignificnceDetectgBCtnerlytgenlyimprovettmenutcomeloignificntlyenhnceurvivlrteCurntlymmmogrphytrdcdignoBCcommendedcengproceducommencetge40prticulrlyduergcidenceBCwomenwhounderge50AlthoughmmmogrphydeceBC-ocedmtlyextdtctchllengemmmogrphylegenerlpopulticengFexmpletendequtehelthccceibilycertpopultiextdueocioecomicdprieBCmtlyheightenedBlckwomenltiveWhewomenwhichttriedlckccegulrcengerliergedeecidencehigherrtetriple-negtivebtcncerIncceibilymmmogrphyrurlpopultiferpfulmmmogrmexperienceloctrielcktimelyBCdignounderpentedpopultiScengmmmogrphyloexhibhentenivylimtitenmeBCterliertgeepecillywomendenebtwhocomppproximtely47%womenUSItthucommendedwomendenebtupmmmogrphicexmundergoupplementlcengproceduuchultroundMRIUntuntelyeimggproceduexpenive/dependentupvilbilypecillytdbtogrphernotwidelyvilbleunderervedpopultiThethunurgentneeddevelopmentnovtivecengmethodfcilteBCdetectincenttgelodeploybleprimrycettgcnoperteddependentuerexperiencelevelToddeproblemiSoHelthhdevelopedATUSAimggpltmwhichpentmjdvncementupplementlBCcengThnovelytemctndjutblewerbleimggdevicecnrpidlypermwholebtcn~2mutecoupledrtificiltelligence(AI)-tedlghmccurtelyidentifydignoeBCtnerlytgeThegolthDict--PheIIpropoldevelopvlidteLeiClifictiLeiSegmenttiDenyClculrAImodel3DATUSAimgeSuccefuloutcomethprojectetblhbelemeuATUSAdignoticpermnceVlidtiultllowiSoHelthubmecdFDAclernceAIdicticommercillylunchATUSATheATUSApltmtrnmhowwomencceupplementlbtimggcenumrwomenceivgdequtebtimggtimelydignothuvgliveTtmentn-mllcelllungcncer(NSCLC)quicombtimnyhighlyxicdrugrdirpyyet5-yerurvivlrtembout18%Immunecheckpothibir(ICI)trgetgPD-L1/PD-1hcuedprdigmhiftNSCLCttmentpertetillly15-20%PDXPhrmceuticlprtnerhipOgHelthScienceUniverydevelopgnextgenertiimmunpyclledARAC-02myledcurtiveoutcomelrgenumrNSCLCptientARAC-02(AntigenReleeAgentCheckpotInhibir)builtupourcoptentednnoprticlepltm(Pdx-NPTM)cpbleco-delivergmultiplerpeuticgentwhilekeepgmllizeleubleytemicdmtrtumccumultiARAC-02co-deliverpolo-likeke1(PLK1)iRNAkillcncerleentigenwellmodulteimmunouppummicroenvirmentPD-L1ntibodyhomecncercellerveimmunecheckpotblockdeimmune-timulntCpGenhncentigenpenttiledgtrgnti-tumimmunepeThepntft-trckSBIRpplictiwdeemedhighlyimpctfulnovelceivedrperfectcoNIHcientificviewpnelThedtwpublhedNtuCommunictiUSptentARAC-02compoiuewued2022WehvemetPheImilene(multioptimizti)progedPheIIproject(efficcyfetyevlutimultiplenimlmodel)TocecommerciliztideARAC-02wequetCRPfunduppttwoctivieAim1Toprotecttellectulpropertie(IP)ARACpipelePDXPhrmhendevelopgnext-genertinnoprticledeliverypltm(Pdx-NP)firt--clcombtiimmunpieutilizgourexpertennotechnologylgcncerytembiologyelectynergticdrugcombtimximizeefficcymimizexicyOurefttrgdthveledfiveUSptentuedpt2yerSpecificARAC-02wequetCRPfund(1)purueIPprotectiPdx-NPTMARAC-02brod(10countrieEU)(2)expIPcovergerpeuticcleydPLK1hibirthroughctutiptentpplictiAim2ToeGMP-complintmnufcturgARAC-02AkeyARAC-02compentPD-L1ntibodycjugtednnoprticle(A-NP)whichmixedPLK1iRNACpGclicThecnoprticle(NP)hldyenmnufctudtlrge-cleCROInthAimwepermtech-trnferynchrcteriztiA-NPmeCROprocefmiliriztiThimfollowedfullGMP-complintyncmpignwhichfundedthroughprivtevetmentStrgIPptfolioGMPdeenhnceouruccerteupcomgprivtefundrgfollow-PheIIBSBIRpplictiwrdcompleteIND-enblgtudieclicltrilARAC-02PROJECTSUMMARY/ABSTRACTBlckwomen42%molikelydiebtcncerthnWhewomenWhileocilecomictructurlculturlfcrctriethdprydiffenceBlckWhetumbiologymjdriverNewrpeuticddebiologicldiffencecouldolvercildpriebtcncerurvivlUntuntelydevelopgnewrpeuticlowrkyexpenivedepenvergep-cliclvetment$238milli95%newrpeuticfilFDAclicltrilKeliomicptentedgroundbkgtechnologyfirtcnkeephumnbttuelivelbUgthbttuewecnproducebkthroughmodelbtcnceruerpeuticdevelopmentUnlikeextgtechnologieourmodelcnpecificBlckbtcncerWhebtcncererlybtcncerdvncedbtcncerOurlg-termgolueemodeldevelopnewrpieediffentubtypebtcncerInourPheItudieweidentifypecificcdigenertemodelBlckbtcncerWhebtcncererlybtcncerdvncedbtcncerWihtccomplhedPheIIwepermlrgedefivetudieourbtcncermodelhowypdchempymewyhumnptientdoThvolutiizerpeuticdevelopmentbtcncerducgfilurteducgcotOurtrgetcumerbtcncerrpeuticdeveloperhve1000newttmentdevelopmentWeetimteth$1-2billimrkepptunyABSTRACTThpplictipentMT-601novelmulti-tumocedntigen(mTAA)-pecificTcellproductttmentN-HodgkLymphom(NHL)NHLmotcommhemlogicmlignncy~80550newce>20000dethUSexpected2023AdoptiveTcelltrnferegCARTcellhveimpivepotencyNHLyetloocedcykeleeyndrome(CRS)neuroxicyAddillylperteup60%pot-CARTrpyduelowntigenlevelloCD19expiTodtenopprovedrpieNHLptientwholpedfterCARTcellrpyultghugeunmetmediclneedlterntettmenptiNHLMT-601pentnovelTcell-bedimmunpyimultneoulytrget6tum-ocedntigen(TAA)(PRAMENY-ESO1urvivMAGE-A4SSX2WT1)thvexpedNHLbenrlimedexpihelthytuemimizgtumecpeenhncgnti-tumpeMnufctudulogouphemterilMT-601cognizetrgetcellvintiveTcellceprterctgtumntigen-expgtrgetcellpentgntigenctextbothclIIIHLAledgkillgtumcellexpgnyentigencrugptientimmuneytemnti-tumpeAlthoughcellulrimmunpiettemptddCD19CARTcellfilutrgetg2-3ntigenylimed1)nrrowepipecogni2)levgtumuceptiblelpeInddibrod-pectrumntigentrgetgMT-601lycellulrrpygexplodNHLptientwholpedfollowgCARTrpyAddildvntgeMT-601cludeout-ptientdmtrtinogeneticengeergFurrmoMrkermultiTAA-pecifictechnologywprovenclicllyfe>180ptientvrioukdcncerInphe1trillymphomptientugmultiTAA-pecificTcelltrgetg5TAAptienthddurblepemuchlgerthnthoetypicllyocedCARTcell(6yerveru28mth)NotblyMrkercentlyttedourfirtCARTcelllpedNHLptientwhohowcompletepet12weekpot-fuiBedthpromgclicldtMrkerpropoegle-rmPhe1clicltudydvnceMT-601ptientNHLlpedfterthirdleCARTttmentdothvepprovedrpyoptiTheobjectiveSpecificAim1mnufctuMT-601executecliclprocolttgNHLptientwhohvelpedfterCD19CARTcellrpyMT-601SpecificAim2cltebiologiclchrcterticproductprilecliclfetyefficcyoutcomeSuccefulcomplethgrntprovidecliclprocceptMT-601ttmentCARlpedNHLptientupptfutuclicltrilledgfutuBLAfilgcommercilpprovlMT-601ABSTRACTSomeurgeryproceducnmdemopecificthroughuedmtedtrcerenhncectrtthroughdiglimggfieldttimedex-ryfluocenceTodtenoctrtgenthevenenhownllowdynmicimggtuefunctiwytercturgeectiThprojectwetroducefundmentllynewtypectrtPu-EnhncedSengSurgery(PRESS)whichbedroundmjdcoverycommlyvilblehumn-uectrtgentcnuedtimultgimmedefluocencewhenhypoxipentThPRESSimggllowvuliztivculrptencydynmicwhileurgeplptetuecoulddilydeployedguidecologicurgeryThctrtcome-AmolevulicAcid(ALA)whichnFDAcledprodrugmetbolizedhemeyncyclemothumncellproducepropphyrIX(PpIX)ntermedepeciePpIXhdelyedfluocenceemihnotwidelycknowledgedprinowignificntlymplifiedlckoxygenrounduchmicrogilhypoxipentthroughoutmotolidcncerThecodcoveryledgthprojectwdelyedfluocenceignlPpIXcneffectivelyimgedoverfewmillecdfterhtpuledexctilightthignlprovidedictimgedictivelckoxygenidetueThnidelurgiclignlhighlighthypoxictueopprochmethodprotectedueourytemWedvncefundmentllynewimggytemtemprilyequencedpuledlightfolloweddelyedcptuemiignloverpnfewmillecdImggquirpidgtglownoecmertegrtednoptimizedethrdwemddedytemctrolcumterfceInPheIwefenlphprotypeytembedupcurntlbrygrdeytemtettechnologiclfeibilypropoeddeignphnmnimltumThewkbckedupnetwkledgexpertneurourgeryphodynmicoxygentumbiologyuppurerlyphetetggivefeedbckignlvlidtiutilyneventulpheIIThegolprojectdevelopfundmentllynewurgiclimggytemcpbledelyedfluocenceimggdplyl-timeoxygentimptueurgiclguidncewhiletkgdvntgeclicllypprovedALAgentThetechnicltemvolvedtcompnyhnexpertknowledgefieldhetblheduccefulcommercilimggytemptWhenfullydevelopedueurgePRESSimgeguidncehouldpoedtrnmwytueevluteddurgurgiclproceduColcncercueover50000dethechyerUS(12%tlcncerdeth)Colocopy(over16milliprocedu/yer)moteffectiveprocedudignottmentcolcncerScenggeductihtgegtroenterologt(GI)hvectedignificntcolocopybcklogProductivyimprovementneededdelyedcengledcedcncermtlyLoopgdurgcopeerticueignificntchllengecolocopyMucolttchgledptientpneededtiwhichddptientrkcoverytimeproceducotScopeertiexertpetivebiomechnicllodtffcugveryhighpvlenceendocopy-ltedjurie(ERI)endocopt(75%)nure(85%)Loopgledprolgedvribleertime(4-18m)bedendocoptkillWedevelopglow-cotroboticflexibleovertu(leeve)cpblebldumtedertifixticolTheovertufciltetrightwrdcopeertiduceptientpneededtipventERIendocoptnureenblefterertiSubtntilproductivyimprovementcnchievedfterertime(3m)improvedcoveryroomefficiencydueedtiductiTechniclnovtienblebldumtederticlude()EfficientOrigmi-pckgg36lgovertu2envelope(b)Progivectutidevicepropulivip-growth(c)Novelpneumticteergcturteergctroltrtegyumtedertirtuounmy(d)Proprietry-houemnufcturgmethodOrigmi-pckgglglendertuWehvedemtrtedbldumtedovertuertinch-prtuourigidcolmodelunder1mInPheIwehowfeibilymoclicllylevntflexibleilicecolmodelex-vivopcetuemodelwhichpentmochllenggterrInAim1wedevelopctrolledcoluffltiytemctemofvbleterrumtederticompdnmllycollpedcolScedevicedvncecoloutvulfeedbckAim2wetegrtenelectromgnetic(EM)trckgytemprovidetrjecryfeedbckendocoptInAim3wedemtrteumtedovertuerticlicllylevntcolmodelInPheIIwecompleteproductdevelopmenttetgpprti510(k)ubmiThetrgmrketpullendocoptnureduehighpvlenceERIEndocoptdmtrrexpedgnebuyuchdevicebedpecificuece()ERIductillevetffg/ttrichllenge(b)Productivyimprovementdriveproceduvolumevenuepr(c)Sedtielimtiduceptientrkpot-opcoverytimeproceducotSuccefuldeviceoperticndeliverignificntneflltkeholderhpotentilmengfuldoptihigh-volumeproceduDictPhe2SBIRCloud/SubcriptibedCumer-RepiveDoimetryTool-PrticleEmterPROJECTSUMMARYRdiophrmceuticlrpy(RPT)defedmcncerrpyuetrgetedrdiuclidedeliverrdicncercellirmicroenvirmentgrowgmnyphrmceuticlcompniedevelopgproductthThedoimetricevlutirpeuticrdiophrmceuticlkeyquimentgulrypprovlttmentplnngCurntlyvilbledoimetrytwpckgewedevelopeddignoticimggrpievolvgtemterpplictiTheedotcludefetueentil-emterrdiophrmceuticlrpy(RPT)InthPheIIpplictiwebuildupourpviouwktrnirdiologiclprotecti-beddoimetryprdigmwhebiologicendpotlg-termchticeffectewhoeendpotnmltuexicyrpeuticefficcyWeimplementmethodologyuemcrocopicctivymeumentderivectivydtriitmicrocopiclevel(wecllmcro--microM2)Becuehtrngehighpotency-prticlebilyemicroclectivydtriidictlyhumnptientcurntimggtechnologyM2mlmeentilegnmlgnxicyRPTTheM2methodologywdevelopedtJohnHopklicenedRpidLLCNodoimetryproducthimplementedM2technologyThewkpropoedthPheIIpplicticpted3D-RD-Sourcloud-bedMediclInternlRdiDoe(MIRD)CommteeS-vlue-comptibledoeclcultiolBedclientquetthhenidentifiedgtetneedThepecificimthpplicti1EtblhlibrrymicrocleS-vluethedoe-limgtuelevntRPT(kidneymrrowlivrygl)2Etblhcpdgpptimentfcrmpwhole-gnctivyccentrtiub-tructuctivyccentrti3ImplementcumizbleM2doimetryllowgueruplodmicroclegeometrygivenmcrocopicllydefedtue4IntegrtecomputtillytetM2functily3D-RD-Spltmugldybuilt-uncerttyclcultipltmclculteuncerttyocedmicroclebddoe5Sce-emterdoimetryM2methodlikelyunfmiliruernewRPTwedevelop-leeductilmterilcceible3D-RD-SpltmAim5flectimptnceeductgbothRPTprctiergulryuthiegrdgpecilcidertilted-emterdoimetryThe-lemterilbuild3D-RD-Scloud-bedpltmSupptthgrntcompletecompentmulti-compentubcripti-bedbrower-cceibledoimetrypltmRPTeventullycludelleentilelementneededupptttmentplnngcncerptientundergog-emterrdiophrmceuticlrpyABSTRACTDuevtnumrpotentildrugcombtitetgmllclicltrilimpoibleputtgpupcliclerchfdmotpromgcompounddvncehumntudieWhilecertdrugcombtieffectcnnowmodeledilicothpprochgenerllylimedt-tudiedbiologiclpthwymynotwknlyzgcomplexdeemechnmvolvemultipletercnectedpthwyProteimmunoydetectctivtedbiologiclpthwynlyzge-pecificphophyltike/irubtrtenmlizedgtbundnceunmodifiedproteRecentlyntetdetectgquntifygprotemuttihemergedduedevelopmentnovelrpeuticoptibedcovlentbdgdrugmutntprotetrgetedprotedegrdtiCurntlynoimmunoymeurgmultipleprotetrget(tlphopho-)cromultiplemjcncerpthwywhichcnolvediffentillyphophyltedkekeubtrteWhileeverlpltmbuildgmultiplexedprote-bedyextyeir)hvelimedbilydetectphophylti(immunoy-bedtechnologie)b)low-throughputexpenivetendifficulttrdize(LC-MS)mkgmubledcoveryproteomicnotroutecengtenhunddthoumpleImptntlyneenlyticltechnologieidelquntifygprotetrgetctgmultiplephophyltedepecificprotegiTheeextgycnnotccurtelymeukectivtedequentilphophyltieventWepropoeedevelopmentPth10-multiplexedprote-bedmulti-pthwyprilgyBed-AtedMSpectrometry(BAMS)pltm-whichimultneoulymeuprotetrgetcro10mjcellignlgpthwyRAF-MEK-ERKcellcycleHippoMycNotchNrf2PI3K/AktTGFp53-cten/WntItchievebrodmulti-pthwycovergecludgtrgetuniqueechpthwylocommtrgethddiffentpthwyegproteubtrtemultiplekeByelectglevntprotemodifictiefutuycncfigudextendcovergeelectedpthwypriledeepthwythncnceruchditeInpropoedPheIwetrtproductdevelopmentfocugillyRAF-MEK-ERKpthwywhichhhighetfquencygenomicltertiInfollow-upPheIIwerpidlyexpycovergemg9pthwyugmethoddevelopedthPheIPot-PheIIwefocuyumtipplygPth10humntuenimlmodelegptient-derivedxenogrft(PDX)SignificnceAbiologicllylevntmurizedmodelytemhumntue3Dgnoidferpowerfulnewpltmhigh-throughputbiomediclerchcludgdcoverynovelcncerttmentgimentWhilemicrocopyplyvlrolegnoidexperimentticurntimggytemefficienttcpturgir3Dmphologylrgenumrwhichquidwidevrietyhigh-throughputexperimentInddicurntmicrocopeunblecd3DvideodynmicuchcellvibilycellmigrtiproceecnvelmechnticpropertielikediffuipermebilygnoidcompcticromothnjutfewmpleneffectivemnnerultgexperimentlchllengecrowidevrietyctextPropolRmOpticimdevelopnewcomputtilmicrocopepltm(MCAM-96)prllelizedhigh-ctent3Dimggvolumetricpecimenuch3Dtumgnoidmodelt50XfterpeedthncurntdevicecroentiwellplteTheMCAM-96locdprllelizedlive-cellvideoypronovelmechnticdynmicproceeJotlydevelopedopen-ourceimgenlytwrpidlycomputetempllylignedttticgnoidmphologyfunctimeWenchmrkytempermnceerienovellivegnoidimggexperimentttwoub-wrdlbpprtiourfirtmrket-dyproductSA1MCAM-96hrdwtwdevelopmentverifictiRmOpticproducenewprllelizedmicrocopehrdwimultneoulyimge96fullwell(8x12rry)2fluocencechnnelt03m4mhlf-pchlterlxiloluticro100mxilrnge10-45ecPrllelizedtwgterclibrtell963Dcndtbeuplod15ecWenchmrkytempermncegtmtchgtep--cnmicrocope10unique96wellpltectgvrietyfluocentlylled3DtumgnoidSA2MeurgcyxiceffectchempylivergnoidWefirtdeveloptwcropdividulgnoidproject3Dimgery2D-focucompoeubequentlyextrct100keymphologiclfetupergnoidpercnWhRjgoplnLbtVirgiTechwenteurnewytemwkflowcellvibilyylgudllymircyxiceffectchempy(3xdrug)3DlivergnoidtumcellSA3TrckgtumgnoidxicycellmigrtidurgimmunpyWhSokerLbtWkeFotweenhnceMCAM-96prllelizedtiltedlightheetrryopticlectied3Dcptuecompletgerieexperimentcd96Xprllelizedtime-lpevideoTcellco-cultudtumgnoiddurgvrible-doeimmunpyttmentProjectSummryBemettmjcuembidymtlycncerurvivItcloelylkeddvncedkeletlggwhichdrivenccumultiged(enecent)cellecteproflmmrymoleculePhrmcologicllydelygggmmoteffectivepventivetrtegygtmettOteopodrugeffectivelyimpedeggmettirneftrnientSenolyticdrugnewcldrughvehowncompellgpcliclevidencedelygkeletlggHoweverirclicldoptihenlowdueheterogeneoucellulrenecencetue-pecificefficcyThpropolimdevelopvlidtedemerlizedpper(DBP)-bedhumnmetbolicenolyticyuppt-trgetgdrugdcoveryttmentgimenDBPnoteoid-pidthlicedemerlizedcompctmtrixpervetriccollgentructuwhilemgcceiblemicrocopicimggDBPcnproducedlrgequntiettchtblytuecultuplticThfetueffectivelyenbleDBPceivemechniclttrnmtedvivibrtiAttchgDBPtrd96-wellplteprovideuniqueopptunydeveloptrdizedfunctilnlyticlhumnmodelphenotypicyInAim1wedevelophumnizedmetbolicyWehumnizeDBP-bedmodelhumnmrrow-derivedmeenchymltemcellhumnCD14+mocytemimickgmodelgcycleNextwectenbolicctbolicyugmodelvlidteknowngentFllywetetwhermodelcncpulteoteopottmenutcomeugDenoumbZoledrteInAim2wedevelophumnizedenolyticyWefirttroducep-enecenteobltco-cultuhumnCD14+mocytectengedmodelNextwevlidteenecentmodelceoteocltdiffentimerlptiWentetmodelenolyticdrugrpy(DtibQuercet)migtenegtiveimpctFllywevetigtewhervibrtilmechnocultuffectenolyticdrugpeThepropoedDBP-bedmodelprovidepdictiveydrugcengwhichcouldignificntlyimpctfieldccelertgidentifictinewnti--ggdrugimprovedttmenttrtegieOverllthpropolignificntctriifielderchhpotentilmkemjimpcnlivecncerurvivCncereledgcuedethglobllydetectictuoumirgeffectivettmentcriclimprovgptienutcomeCurntlycncerdignogenomicnlyperlizedttmenttenquiviveproceduuchbiopiewhichcncotlytime-cumgcrryrkptientAnlterntivelevivemethoddetectgcncerdetectum-derivedcircultgfeDNA(cfDNA)biologiclfluiduchbloodThmethodhhownpromedetectcncerflectgeneticchngeuchmuttipenttumtueInddiprimrycncerdignohighlyenivedeemirgcrucilmimliduldee(MRD)ettgwhichferlow-levelpencecncercellbodyfterurgeryttmentcnpdictcncercurnceoverllurvivlegttetclicinbiomrkerSlivbiologiclfluidhenexplodourcecfDNAbloodcellhnotyetenutilizedbydevelopmentduelckchrcterizticfDNAlevelvlidtictenttumDNApenceAefficiencymirgiduldeecncerdetectiliefquentpetivemplgcfDNAptientlivpentnttrctivemodlyney--obtmpletypecludgnt-homeettgInthpropolweimdevelopevlutenydetectmirlevelcfDNAtumlivcompenivydetecticfDNAobtedplm/bloodptienthedneckqumoucellcrcom(HNSCC)whewecentlydecridevolutirytrjecrieerlyvltegenomicdrivereventemergencebothHPV+HPV-HNSCCDepehighpvlenceixthmotfquentcncerwldwidemotHNSCCptientctuedignoedlte-tgecncerundercgneedeniveerlydetectiwelldeemirgttmentpeTochievenecerydegeenivywhttenlowtumDNAfrctilivweueduplexequencgmimizeequencgerrdeveloplghmmchelerngmodelgenomicnlycfDNAceenivytegrtgignlDNAmethyltidtAultthPheIpropolwevetigteuecfDNAlivmplecompplmcfDNAtetgdevelopexperimentlcomputtilmethodologylivcncergenomictetquntifycot-effectivenethpprochimdevelopliblen-vivemethoddetectgmirgcncerHumnppillomviru(HPV)piblelrgeproptigloblcncercecludghedneckcerviclnlcncermgHPV-ltedcncercuedcerthigh-rktrviruwhichcncuelg-ltgfectieventullyleddevelopmentcncerouchngeThemtyddgHPV-ltedcncerpventiprticulrlythroughprophylcticvccticengdefivettmenterlyp-cncerouleiDepeuccepventieftpvlenceerlylte-tgeHPV-ltedcncertilltggergover18000dethnnullyUSOnepromgnewttmentpprochimmunpyprticulrimmunecheckpothibi(ICI)Howeverly15-30%ptientpdICIttmenthighlightgneednewtechniquebootefficcyAlthoughexvivodoptiveTcellimmunpiewhichhumnTcellgeneticllymodifiedoutidebodytrgetcncercellpromgyhveignificntlimtiduecomplexycotneedmyelobltivelymphodepletiEffectiverpeuticcncervccehvelgenholygrilpotentillyfecot-effectivevivo-elicedTcellrpiecoulduedlltgedeebootcncerimmunpyoutchllengerkexvivodoptiveTcellrpieWhilecventilvccelrgelyhvenoteneffectivenewerhighlyimmunogenicmRNAcncervccehvedemtrtedclerevidenceefficcyducticurncedethlte-tgemelnomtrgnti-tumpepncticcncerMi-circulrRNA(mcRNA)highlybiotblerpeuticcncervccepltmcnelicrobutctivtiexpnilg-ltgntigen-pecificTcellchievgbkthroughlevelup8-foldhigherthntte---rtmRNAvcceurprglyimprovedfetylerbilyOurgoldevelophighlyimmunogenicHPVE6E7mcRNAvccecoulduednf--helfHLA-gnoticproducrprtperlizedHLA-pecificcncervcceInthpropolweplnbuildignificntbodyhighlyencourggvrovivodttcilterpiddevelopmentmcRNArpeuticvccepltmhighlyimmunogenicvcceHPV-ltedcncerKeyultpropoedvetigtiltudiedemtrteuperiefficcyLNP-encpultedmultivlentmcRNAHPV16E6/E7vccecompdN1-methylmRNAvcceInAim1wehowmultivlentHPVmcRNAvccecnutexpilgcctemerencodedHPVE6/E7epipeproceedpentedelichighlypotentdurbleTcellpecnyieldrobutimmunpycombtiICIHPV-ltedcncermiceInAim2wechrcterizeimmunogenicy5epipecluterencodgllphumnMHC-bdgepipeHPV16E6E7PBMCcollectedhumnubjecteimmunogenicymultivlentHPV16epipeclutervccecompdnchmrkHPV16mRNAvccePROJECTABSTRACTXylyxdevelopgpdictivemulti-gnmettticbtcncercell-bedypltmddlck-vromodelgnotropicmettticbtcncermrketccelertedrugdevelopmentBtcncermotcommlydignoedcncerwomenmotcommlymettizeliverlungMettcue~90%cncerdethmettticbtcncermecdledgcuedethcncerSurvivl5yerfterdigno27%nocuTheextrcellulrmtrix(ECM)liverlungknownplycriclrolemettticvicoliztiAnimlmodelpopdicrmetthumnpdictive-vromodelmettticbtcncernotcommercillyvilblelevgignificntunmetneedmrketgp/opptunyphyiologiclly-levnt-vropltmenblehigh-fidelycell-bedphenotypicygnotropicbtcncermetteThSBIRFtTrckupptdevelopmentvlidtitudiecommerciliztimulti-gnmettticbtcncercell-bedypltmctgengeedgnotropicmettehownctentptientdtThetechnologiclnovtiproductgnotropic(liverlung)mettetemmgproprietrymethodoltgtegrtgcellulrhumntueECMtue-pecificpropertiehumntueOurpprochtegrtebtcncerptient-derivedgnoidtrdizedmulti-gntue-pecificprimryhumnECMenblgpdictiveygnotropicmettemjcompetivedvntgeoverllextgywhichlckmulti-gnhumntue-pecificyOurgolvlidtecommercilizetrdmulti-gnmettticbtcncercell-bedypltmpdictive-vromodelgmettticbtcncerducedependencenimlmodelde-rkpclicldeci-mkgSpecificim(1)Permmulti-omichmphologicprilgengeedhumnbtcncer/liver/lunggnotropicmette(2)Evlutehlogicmoleculrphenotypiceffectcncer-ocedfibroblt(CAF)engeedgnotropicmette(3)Evlutequlyctencyengeedhumn/liver/lunggnotropicmetteypltm(4)TettgeIVbtcncertrd--cdrugcombtirpietrgetgmtrixcompentAfteruccefulcompletiFtTrckprojectXylyxcommercilizemettticbtcncerypltmcienttphrmcompnieneedpdictivemettticdeemodeldrugcengthuducgmivecotocedlte-tgettriduepoefficcyfciltgdevelopmenttterttmenpti270000+ptientdignoedmettticbtcncereveryyerAdutrylederECM-bedgentyXylyxmrketproductwldwiderpidlygrowgcell-bedymrket($246B2022CAGR127%projected$603B2030)dvncgdrugdevelopment$42BbtcncerdrugmrketProjectAbtrctWidelyovexpedprottecncertueProtteSpecificMembrneAntigen(PSMA)hcomenttrctivetrgetbothimggrdiuclide-bedrpyprottecncerDepeexcgprogPSMA-trgetedrpeuticgentcouldpoehighrdiexpouwrdnmlgnexpceprInfctlivrygl(SG)tendoe-limggndetermehowmuchrdioctivycndmtedptienteligibilyttmenutcomefterThpplictiddecriclneedducerdiexpounmlgnwhilemtgtumuptkeWeefocuctructgPSMAderivtiveimgprotectSGerdiolledgentIncentyertmendouexcementhemergedoverprocndignoticrpeutic(Thernotic)TheegentnlycnveldeeeloemrdicnhverpeuticeffectenblgloclizedtrgetedttmentRecentlyUNCtemhetblhedtrifunctilizedTVSytemtmlewkflowdeveloprnoticgent(ptentpendgTripillBiotechnegotgUNClicenetechnology)InourplimryerchwehvedcovedNOTA-UNC-PSMA2cndemtrte2-3timehighertumuptkerodentmodel(compdPSMA-617)whileSGuptkely1/10thPSMA-617t24hpot-jectin-humnprimte(NHP)potentillyduectibdgbilyTVSytemTheeencourggultclerlydemtrtedfeibilyelectivelyducgSGuptkemimlimpcntumuptkePSMA-poivetumWhpromgimggcompentcompletedplimryerchthprojectTripillBiotechprtnerPrWuvlidterpeuticpotentilNOTA-UNC-PSMA2Theultggentlled64Cu67CuevlutedtbilyPSMAbdgffylivrygluptkevivpeuticefficcyThpplictiflectjoteftmultidciplrytemcompoedexpertchemtrydrugdeliveryrdiochemtrybiologycliclprcticemoleculrimggTheuccepropoedpprochwouldolvekeyuePSMA-trgetedrdipeutic(thceexpouSG)whichcouldgtlynefprottecncermngementAcuteMyeloidLeukemi(AML)NeedAdvncedTtmentAMLpvlenthemlogiclmlignncydult5-yerurvivlrtely32%Whilepproximtely32000AMLptientdignoednnullyUSdyprojectiuggetth360002027Curntttmentuchllogeneicmrrowtrnplnttihvelimedpplicbilyduehighmbidyttment-ocedmtlyTheProblemImmuneEviAMLcellemployimmuneevcticnotblyup-gultico-hibiryliglikeVoctiveIntetlPeptide(VIP)whichultexhutedn-functilTcellthwrtgneffectiventi-cncerpeCurntimmunecheck-potrpieugnti-PD1nti-PD-L1ntibodieeffectiveAMLptientSoluti-DevelopmentANT308-Fc3FuiCmbiumOncologybiotechtrt-updevelopgnovelimmunpeuticdrugttcncerCmbiumOncologyerchdicteroughly30%AMLcellover-expVIPwhichdmpenT-cellctivtiCmbiumOncologyhwldwideexcluiveliceneptentcovergVIP-ceprntgtEmyUniveryApeptide-bedVIP-ceprntgtVIPhybhowedpromep-clicltudiehdlimedpotencyhthlf-lifeCmbiumOncologyuedilicocenvivotetgidentifynovelVIP-ceprntgtANT308whichwhenfuedFcgiIgGprotecmeANT308-Fc3fuiCmbiumOncologyledcidtedrugANT308-Fc3fuiexhibenhncedpotencygtp-cliclmouemodelAMLbothhighlowlevelVIPexpiThewkfutuimpctcedpplygthpprochcncerSBIRPhe1&2ObjectivePhe1determeANT308-Fc3fuipotencyhumnTcellctivti(Aim1)nti-leukemictivymice(Aim2)tbilyphrmcoketic(Aim3)Phe2focuvivoxicology(Aim4&5)phrmcodynmictudieidentifypivebiomrkerclicltril(Aim6)TheSBIRft-trckpropolimdevelopnINDpckgeubmFDAupptgphe1clicltrilANT308-Fc3fuiAMLTheSBIRtemexperiencednti-cncerimmunologydrugdevelopmentledDrGryAltmnPhDbueexecutiveexperiencebiotechtrt-upobtgFDApprovlINDphrmceuticlThepropoedprojectimdvnceANT308-Fc3fuifirt--climmunpyenhncettmenutcomeAMLptientABSTRACTWhileTcellrpiehvehownefficcyhemlogicmlignncieextenhucceolidtumhprovenchllenggmlydueimmunouppivehotiletummicroenvirment(TME)MrkerpropoeovercomeimmunouppiveTMEdevelopgectedcombntfuiproteDECOYThepurpoeDECOYprotetrnmimmunouppiveTMEeupptrpeuticTcellgrowthfunctiWeepropoebrytrtegyTcellrpycombtwoTcellproductProduct#1ctDECOY-producgTcelldelivedtumhbilylterTMEmkgcdimofvbleubequentTcellrpyProduct#2MT-601ourulogoumulti-tumocedntigen(mTAA)-pecificTcellproductcognize6ntigenpentpncticcncercellIthhownnexcellentfetyprileilefficcyclicltrildvncedmettticpncticcncerThepurpoecombtiDECOYMT-601furrimproveourilcliclefficcyprotectgMT-601TcellimmunouppiveTMEThertilebrydeliveryytemmtfetyprileMT-601TcelleprtgdeliveryDECOYTcellIneencethtrtegyeprtefuel(DECOY)enge(MT601)drivgnti-tumctivyprovidgoperrbilyctrolengeddgmolefuelThbrypprochovercometrtegieimplementedtumevdeimmuneurveillnceInthprojectweevluteketicprmeterguidecliclpplictiProduct#1(DECOY)determeoptimlclicldmtrtiProduct#2(MT-601)whencomdProduct#1(DECOY)permGMP-complintvlidtiengeergruncliclimplementtibryproducttrtegySuccefulcomplethprojectultmendmenurFDA-pprovedMT-601INDuebryproducttrtegyueDECOY(Product#1)enhncecncerkillgcpbiliemTAA-pecificTcell-MT-601(Product#2)pncticcncerThpplictiepvewywrdcliclimplementtibryproducttrtegyddnunmetcliclneedpncticcncerptientIfuccefulthbrytrtegyllowfterextenidoptiveTcellrpie/cncerdictipurpoecgcellproductpotencywhilemtgfetyprileProjectSummryNturlproduct-derivedRNAplicemodulrgdevelopedttmentcutemyeloidleukemiwellcncerAnturlproductcomplexmoleculrrchectunlogueynevlutiproducticleuphveprovenchllenggHeweutilizeolynticbiologypltmynizecomplexpolyketideplicemodulrThemotetblhedetplicemodulrhcommmodectrgetgSF3Bmulti-protecompentU2-nRNPpliceoomeTheylohcommmotifcompdtwofunctilmoietieunedthroughcentrldieneCombgmoleculrdiveryprovidedmediclchemtryflexibilybilyclemetboleproductiugynticbiologyweproduce17S-FD-895highlypotentvivoctiveledAMLThovercomechemiclproductibottleneckpventgthlifevgcompoundchgclicltrilFromthmediclynticbiologypprochweidentifypromgproducticidtehp-cliclcdentilfurrdevelopednovelnticncerrpeuticPROJECTSUMMARYCervicltpililneopli(CIN)cuedexullytrnmtedHumnPpillomViru(HPV)whichfect14milliwomenUSeveryyermotcommvirlfectiproductivetrctOver3milliUSwomenfectedcogenictypeHPVmotcommlyledCINup1milliwomendignoedCINechyerUSCINpcncerouleiifleftunttedcndevelopcerviclcncerThebout604000newcerviclcncerceover342000ttribledeth2020Thctute9%globlburdencncermgwomenDepeimprovementcengvcctirtecerviclcncerhvecedgloblly45%lt30yerCurntttmenttrtegiegtCINdefedWldHelthOrgnizticludebothbltive(crypy)excil(loopelectrourgiclexcicoldknifecizti)proceduWhilebothhveprovenneficilttgCINyoceddiffentlimticrypylckeffectivenelimedcuelogticctrtocedgcotprocumentrgeexcilproceducrryrkdvereobtetricoutcomeTheneedcplequipmenthtgeproviderkillueultup80%womendignoedCINneverceivgcommendedttmentThueunderttmentlopecificllyffectblckwomenUSThethununmetneedimpleeffectivefdbletechnologycpbledeploygttmenttpot--cowomndignoedCINGyniddthunmetneedClrblexgelwhichmultedTrichloceticAcid(TCA)ctivegdientdicteddetructicogenicHPVCINClrblexdoenotquicplequipmentItprovidedpfilledyrgecrtridgevilbleimmedeuetnycerviclcncercengfcilyTCAhenuccefullyuedlow-vcoywter-likeoluticlicltrilchemiclbltivegentgtCINleiClrblexhnimprovedproprietrymultihgel-likevcoyenblgpcepplictrgettuepdictblebltidepthThimproveefficcyenhncefetypventccidentlpillgedmgehelthytueimplifieproceduThemultidelivedgle-uepplicrfelypplieClrblexpicllyurfcecervixchemicllydetroyneoplticleidurgquick10-muteproceduThettmenthcotgoodlethn$10perttmentPlimryerchdemtrtebilyClrblexbltecervicltueup7-8mmpenetrtiwhichexpectedufficientttevenhigh-grdeCINleiThepropoedSBIRPheItudyfocudevelopgcerviclpplicrfementgelmultioptimizedflowchrcterticcductgexvivoexpoutudiehumnuteridemtrtepotentileffectivenePheIIprojectexicologiccliclfetyClrblexAbtrctElectrprmgneticnceimgg(EPRI)wheelectrpubjectvetigtipromgolhbilyprovidempmultipletuemicroenvirmentprmeteruchprtiloxygenpu(pO2)pHHowevercurntlynotrumentvilblecnprovidemulti-prmetricmpdueverydiffentquimenttrumenthrdwCurnttrumenttiuch25mTpuleEPRItrumentJIVA-25developedulyprovidepO2mpdoenotprovideimgeprmeterhrdwdoenotupptctuouwve(CW)cquimethodneededimggpHIncurntprojecurgoldevelopmultifunctilimger(MFI)cnpermbothpuleCWcquiimultneoupO2pHimggTowrdthgolwedevelop25mTHlbch-typepermnentmgnet(Aim1)newmuli-modltrnm-ceiveelectricbedfieldprogrmmblegterry(FPGA)(Aim2)fllywebuildMFItrument(Aim3)Ourlg-termgolmkefunctilimggfdblecienttbiomediclfieldenhncerpieundertbiologyAbtrctTheprimryobjectivethprojectdeveloprpeuticIgAuniquelyhrnetumcylyticpotentilneutrophiltrgetEGFR-mutntn-mllcelllungcncer(NSCLC)enblgeptientlivetterlgerliveTowrdthgolTigTxdevelopgTIGA-001firt--clIgA-bedmocllntibodyttmentdvnced/mettticEGFR-poiveNSCLCplnefirt--humnclicltrilTigTxhgenertedrobutdtpckgeroundTIGA-001moleculeledgelectiourfirtdevelopmentcidteTIGA-001hdemtrtedexcellentvropotencyvivoefficcywelllertedn-humnprimtefvblefetyphrmcoketicprileTIGA-001utilizeourptentedtructu-drivenproteengeergovercomeknownmnufcturglibilienturlIgAenblgufirttrnmIgAcliclly-levntpltmtechnologyInthprojectweprogourTIGA-001cidteCMCctivievrophrmcologybiomrkeridentifictiydevelopmentupptfilgnInvetigtilNewDrugpplictiFDASupptedCMCctiviectvecrgenerthroughmtercellbnketblhmentSupptedphrmcologytudiefocuvrofetyementtudieupptGLPxicologypecieelectiBiomrkerydevelopedetudiecptedourfirt--humnclicltrilevlutedoe-PDpeltihipenbleptientelecti/enrichmenrwemclicltrtegyBecuerpeuticIgApltmtechnologypotentiltrgetwidevrietytum-ocedntigendemtrtgcliclprocceptourTIGA-001progrmwouldnlynefptientEGFR-expgtumwouldloopendougthpprochgrtrgetwiderngeddilcliclettgThprojectpropoetudyeffectnewpltumnticncerdrugpncticcncerWeuggetuniquecombtwoerch-implictiglycoclyxmodifictumoxtrcellulrmtrixcltienivycertpltumgentglycomoglycn(GAG)ttutumcteuniqueprilemgtnotjutpltumgentllcurntlyuedcliclnticncerdrugThecriclunmetneedttmentpncticcncertwo-fold1)rpeuticeffectivelyttdrugtntdee2)pdictivebiomrkeridentifywhichptientnefmotvilblerpieAmgchempeuticdrugpltumderivtivehvemjimptncerpeuticrenloxlipltcriclcompentFOLFIRINOXgimenttmentpncticcncerOurtudiehowtumexpghighlevelchdro-4-ulfte(C4S)cnexploedenhncedcellulrccumultumdeliveryPheIIpolynuclerpltumcomplex(PPCpecificllyTriplt)bvrincncerPDXmodelcuehighffyhighlyctiicdrughighlynegtiveGAGpropertynothdmucleroxlipltBiomrkerpdictdurblepethdrugwenotvilblenfurrdevelopmentTripltwupendedRecentlywehvedemtrtedTripltcoulduperimlepltumgttumexpghighlevelchdro-4-ulfte(C4S)C4Stum-pecificglycomoglycn(GAG)ttchedproteoglycnuchCD44glypicnyndecnexpedcellurfcetumtromThepoivechrgeTripltceffynegtivelychrgedGAGwhichfciltedrugccumultumcellcelevelPt-DNAdductIntetglywenotedcrbopltfollownoppoetndTogerourtudieupptpmeGAGlevelcnpdictcrboplttnceTripltenivyOurcentrlhypohighGAGlevelpncticcncercnexploedceTripltuptkeimproveefficcycurntttmentgimenAlrgeerchefngogundertfcrfluencetumperpyevlutetrtegieovercomettmentfilucuedtriccquidtnceStudieimedtidentificttmenttrgetpncticcncerhvemlyfocuedmRNAmiRNAprotewhilecrbohydrteuchGAGmltivelyunexplodThen-templtedrivenntuGAGbioynvolveccertedctimultipleenzymecomplictgnlyexpgenomic/proteomiclevelirrolecliclcologyNewtechnologieuchglycnductiveopellgmpectrometry(GRIL-MS)llowqunttivecompoilnlyGAGtummpleProthcceptpvewypurpogTripltcompnibiomrker-medclicltrilAbtrctColoctlcncer(CRC)rnkthirdmgnewlydignoedcncerUnedStteecdmotcommcuecncermtlyIndividulflmmryboweldee(IBD)teverlfoldhigh-rkdevelopgCRCGunylylcycle-C(GC-C)ctivtedupbdggunyl(GN)urogunyl(UG)ultgtimulticyclicGMP(cGMP)productiledgfluidectiproximltetenmlizebowelmovementTwollydmtedGC-CgtTRULANCELINZESSpprovedttmentchricidiopthicctipti(CIC)irrblebowelyndrome-ctipti(IBS-c)BeydfluidectiproximltetectivtiGC-CignlgUGGNlogultecolicepililhomeottumuceptibilyPieergultPIlbhowedtrncriptlevelbothUGGNduceddrmticllyhumncolpolypdenocrcomdietryupplementtihumnUGnlyhidpolypmtilodelyedirprogidenocrcomApc+/MmiceSubequentlyeverlercherhvehowndruptiGC-CignlgdueneruniverlloGNUGdrupttetlepililcellhomeoterlytgeCRCThulttmentGC-Cgtovercomethdeficiencymypentpromgnovelpprochttment/pventilltypeCRCInthctexrllydmtedplecntidedolcntide(Dol)nlogueUGeffectivelymeledGIflmmticutechricmodelexperimentlcolmiceInddidietryupplementtiplecntideuppedgenerticolictummiceHoweverwobervedthrllydmtedGC-CgthowedvertedU(llhped)rpeuticpeenimltudieTheeultdpoibilyhigherdoemightledexceivefluidectiproximltetewhichmightwhoutdrugprichgcolultgducedrpeuticeffectInddiGC-CignlglodruptedovexpicGMP-phophodietere5(PDE5)GIflmmrydeeCRCThucombtiGC-CgtPDE5hibir(ildenfilSil)mightproduceddiveynergticeffectPIdevelopednlmultidrug-lodedmicroprticleweequentillycotedtime-pH-dependentpolymerpmchproximltetegileedrugdtltetecolThSBIRphe1grntpropolevlutemicrophe-lodedmultiDoleirlecombtiSilpventcolocedCRCmiceSpecificimAIM1developoptimizedrug-lodedmicrophemultiplcebo(ctivepeptideSP-300)DolSilInpecificAim2optimizedmultiDolSileirlecombtievlutedpventAOM-DSSducedCRCB6miceColtue(proximlmiddledtlegment)collectedevlutitimultiGC-CPDE5ignlgSuccefulcompletipropoedtudieexpectedidentifyublemicrophe-lodedmultiDoleirlecombtiSilfurrn-cliclclicldevelopmentpventCRChumnSummryThecidenceeophgeldenocrcom(EAC)hced600-700%NthAmericce1980EAClyh18-22%noverll5-yerurvivlrtecuemotptientdcovedtndvncedtgeTheglemjrkfcrdevelopmentEACBrtteophgu(BE)whetetl-likeglulrepiliumplcenmlqumoumucoeophguBEffectpproximtely2-54%dultpopultiUnedStte012%16%BEptientproggEACnnullyMotBEptientnotprogEACyexperiencenxietyferboutiruncertfutuIturgentfdbiomrkeridentifyBEptientthigh-rkproggEACDNAhypermethyltpecificgenetdicroccurerlytumigenetypicllycetumprogiRecentlyroleepigeneticchngepthogeneBEEACweextenivelytudiedMultiplemethyltimrkerhveenuggeteddcrimtetweenhigh-rklowrkBEHoweverenivyltivelylowclicllypdictgptientthigh-rkproggEACRegrdleemethyltitudieclicllyuefulmethyltibiomrkerpdictgBEptientprogEACtillmgP-CncerDignowkgddthcriclunmetneeddevelopgenivedignotictetuetrgetDNAhypermethyltipnelidentifythoeBEptienthigh-rkproggEACRecentlywefoundeverlgeneDNAhypermethylticouldidentifyhigh-rkBEptientproggEACwhichdemtrtednextmelyhighenivy(100%)pecificy(100%)WhDNAmethyltetwecouldtrigeBEptienthigh-rklow-rkgrouphigh-rkptientceiveerlyttmentcludgmucolectirdiquencybltilow-rkptienthvelgerfollow-uptervlwhichdececotTheobjectivethtudyvlidteourplimrydtfurrdevelopnewmethyltidignotickpdicthigh-rkBEprogiEACInAim1wevlidtehypermethyltigenedevelopmethyltidignotickdiffenteBEptientouthighrkproggEACbothDNAMethyltiEpicrryPCRmethyltetInAim2Weuewholegenomeequencevlidtemethyltigenecnpdicthigh-rkBEptientproggEACnwedevelopTrgetMethyltipnel(dignotick)clicltrilThtetidentifyhigh-rkBEptienteproggEACwhichcrucilducgcidenceEACimprovgptienutcomeABSTRACTSurgiclmovllrynxproundlyffectptientqulylifeprticulrlylonmlvocliztiphyiclchngeppernceemotilchllengedptlivgnmllifePopertivelylryngecmyquiptientmprotectedutilizgvriouhetmoterexchnge(HME)filterwhichttchdeviceeir(i)extrlumlugdheivetrproundm(ii)trlumlugtrcheomln(TEButn)ertedmUtiliztieirdevicechllenggptientextrlumldheive-beddevicequichngeeverltimeperweekcugtueirrtijuryocilemotiltfrutrtidevicefiluTheextgproductlryngecmyptienthveenvoidmengfulnovtiover20yerutilizgntiqutedmterilwhileigngvtnumrnovtibiocomptiblemteriltechnologycouldddmotptientueTEButnfilueilyidentifibleproductTEButncirculrrigiddeignwhichunevenlydplcepuduelckunimyuniqueechlryngecmygrdgtrcheomlnmyThultpolerbilytentiduedermlirrtueeroiromdlodggmcueddevicemovementtrchellumendurgnmldilyctiviepeechpirtiMotlryngecmyptienthveundergemthyertrumticurgeriechempyrdinttemptenterocietyignificntchngephyiclppernceocilnxietieemotiltfrutrtiydptirnewnmlqulylifeTEButnfilulimptientbilyuccefullyutilizevrioutrlumlttchmentuchTrcheoeophgel(TE)voicertideviceh-feTEpeechproductiTheeTEButnfiluducequlylifeimpedgbilyturnnmldilyroutectivieftertlmovlirlrynxThPheIpropolimdevelopTEButncpbleimprovedtbilydurbilyducedpngltivemoticuedptvrioumlgeometriecfigurtiThprojectprovidenlterntiveh-fepeechproductiptientwhounbleuecurntlyvilbletrlumldeviceWeimutilizedvncemterilciencehveoccurdceigltrcheomnweventedTheecludehighelgtihightertngthlowdurometeriliceelmerlowercotNilwicompoewiuchbridtentProjectSummryThegolthPheISTTRctuedevelopmentOncurienovelovrincncertrgetgcompoundwhichbdfolteceprdeliverrdiuclideubletrgetedimggrpyproprietrymoietyThedeedifficultdetecterlytgenetimted75%womenpentgdvnceddeettimedignoThemtlyrteovrincncereletimprovedcentyer5-yerurvivlrtetgeIIItgeIVdeeetimtedt42%26%pectivelyTheefcrhighlighturgentlyunmetneednewdignoticolrpeutictrtegiethdevttgdeewhichimpctover20000womenperyerUSultgpproximtely14000dethOncuriehdevelopedtrgetedrdiophrmceuticlpltmenblgpciimggovrincncerfutudevelopmentwrdrpyThecompoundcludetwokeyfetu1)foltecepr(FR)bdgmoietyexploceprwell-documentedovexpiovrincncer2)Oncurieproprietryrdiuclide-bdgdomwhichbdrdioopehighffypventgvivodocicocompoundultgimprovedfetytrgetgefficcyIncollbtiSuznneLpiPhDUniveryAlbmtBirmghmcompnyhhowncompound(O5)bdovrincncercellub-nnomolrffyternlizednucleuInvivoO5henhownpecificllytrgetfolteceprpennovrincncertumxenogrftmodelDurgPheIwefemoleculrtructumulticompoundimproveynticclbilyeehlgenurdiollgchemtriemlibleefficientInvrotetgundertkencfirmcompoundFR-trgetgpropertierngeovrincncercellleFllycompoundevlutedptient-derivedxenogrft(PDX)modelovrincncerwhichmocloelyemblehumndeepthogenecompdxenogrftmodeluedilpro--ccepttudiepentedPlimryDtectiPendguccefulcompletiePheIAimubequentPheIIprogrmdvncecompoundthroughcriclfetyxicologyefficcytetgquidubminInvetigtilNewDrug(IND)pplictiFDAenbleclicltudieIthouldlonotedwhileOncuriecurnttrtegyevlutethcompoundrdiogrphicimggdeedignomecompoundtendeduedrpeuticwhenpidcyxicrdiuclideprtrnotictrtegyCurntlymrketedrdipeuticuchLutrPluvicemployedimilrtrtegydevelopgdignoticimgggentfirtfolloweddevelopmentrpeuticeffectivelymecomoleculeOncurieproductetimtedhveimilrvenuepotentilcompdeproductptedlyrngg$500milli$1billiABSTRACTMelnomfifthmotcommcncerUSlmot100000ceetimted2023Lte-tgedeehfive-yerurvivljut30%ultglmot8000dethUSleWhendetectederlymelnomhurvivlrte99%howeverwidelydoptedcengolmelnomcurntlydoenotextThecurnttrdckcncerdetectiliecliclvulementmolefollowednvivebiopyupiciouleiThelowccurcythpproch(84%enivy3-16%pecificy)ledmedmelnomhighrteunnecerybiopiebiopienignmoleAnverge25biopiequidechmelnomfoundultg3millibiopienignmoleechyerFthUSPventtiveServiceTkFcedoenotcommendroutevulcengkcncerdultcgpotentilhrmhighrteunnecerybiopieN-vivegeneticpectrocopictetcurntlyvilblehveeirenivieolow(low98%)pecificieolow(lowvulement)WehypoizelimedpplicbilyepprochetemlimedvilbilymelnombiomrkerStudiehvehowncombtigeneticmrkerhlogiclnlyfernexcellentcombtipecificenivedignohowevernomimlly-vivetechnologyextprovidemplethpurpoeWepropoelermicrobiopytechniquehrvetmicroler-izedtueugrg-hpedfrdleruchcenternnulucnmovedmimldmgepulelightBecuelertuemovleentillytntneou(microecd)biopyizeclehunddmicrometerprocedupotentillymuchlehrmfulthntrdilpunchbiopieImptntlyourplimrywkhowlermicrobiopypenetrtethroughepidermmelnocytewhemelnomigteTofurrdevelopthpprochwefechrcterizepermncelermicrobiopyhrdw(Aim1)vlidtevibilyextrctedmicro-biopiemoleculrnly(Aim2)Weenviourpprochprovidgp-fetueflepthologymoleculrnlymelnomwellpoibleurgiclguidnceoll-timeementtummrgInddihrvetedtuecoulduedprimrytuecultuflowcymetryOncethpro--prciple(R61)projectcompletewenticiptetrniglermicrobiopydevelopmentlphetetfeibilymelnomdignonR33pplictiAbtrctTheDNADmgeRepe(DDR)ntegrtednetwkDNApircellignlgpthwycriclwrdmtggenomictbilyTrgetgDDRcncerrpyexplotwoimptntvulnerbiliemnycncerThfirtthncogenicplictitduceDNAdmgegenomictbilyultglinceDDRcncercellurvivlTheecdmnycncerhrbgeneticdefectDDRDNApirpthwycompentcecncercellwiDDRcomelinncompenrypthwyThultopptunyynticlethltercticnexploedpecificllytrgetcncercellThemotuccefulDDRtrgetedrpiehibDNAdmgeenPARPprotecognizeDNAbkWhilclicluccePARPhibirdevelopmentDDRtrgetedrpeutichcomecglypopulrHowevermjycurntpprochehvetrgetedprotekedowntmDNAdmgeenclicloutcomeerpeutichvenotmetexpecttiNERxBiociencehdevelopednoveltrtegylizefullrpeuticpromeDDRtervenguptmDDRketrgetgpecificDDRenThehumngletdDNA(DNA)bdgproteplictiproteA(RPA)criclenDDRnoveltrgetcncerrpyWehvedcoveddevelopedchrcterizednovelmllmoleculeRPAhibir(RPAi)NERx-329blockRPA-DNAterctielicttechemiclRPAexhutiultvivticncerctivyPviouwkemployedchemiclynvrlyevivoxenogrfttudieemechnmcticellulrenggementrpeuticctivyRPA-trgetedgentNERx-329pentfirtclicllyviblegenttrgetDDRpthwydruptgRPA-DNAterctiholdpotentilignificntimpctcncerttmentThegolthdictPhe2pplicticcelertecommercildethnovelrpeuticwrdINDpprovlThgolmetthroughtheimcludgmultildeliveryNERx329egphrmcoketicpotencyfetyNERx329gcriclCMCwkquidflINDThekeydeliverbleechimprovidecomphenivedtpckgeultimtelypoiNERxBiociencecompleteflINDenblgtudiefirt--clfirt--humntrilnovelgenttrgetgRPAPROJECTSUMMARYN6-methyldenoe(m6A)emotbundntchemiclmodifictihumnmeengerRNA(mRNA)m6AmRNAdynmicllygultedeffecrprotetllmovepecificllycognizem6A-modifiedtrncriptwhichknownwrerererderpectivelyGrowgevidencehuggetedignificntrolem6AcncercludgcutemyeloidleukemiendometrilcncerbtcncerglioblmDygultim6AeffecrproteltedmetbolehveenhownignificntlyfluencedevelopmenttumdrugtnceprognopdcncervrioumHoweverundertgexplicrolem6AcncerbiologymcompleteCurnteftundertgeprncripmicgultihevilylyltergexpineffecrprotewhichtypicllygenertegloblltertimodifictilevelhunddmRNAubtrteperturbllmoleculrterctivolvgeffecrproteydirrolegultgRNAmodifictiWhuchcvolutedultchllenggdeduceexplicfunctim6ApecificgeneToidentifykeygulrym6A-modifiedtrncriptcncerolenbleefficientpcetlltim6A()tnyemultiplemRNAtethighlydeirbleOnemjchllengeextgm6AwrermethyltrnfereufferlowturnoverrtedependenceupuxiliryproteequenceRNAubtrteHewepropoedevelopdictedevolutipltmevolveRNAMTeimprovedctlyticefficiencyducedubtrteequencecogniThdictedevolutipltmlevergevrocomprtmentliztim6A-pecificendibucleechieverpidenrichmentfunctilMTevrintdivere(1010)librryTheevolvedMTefurrfuedRNA-trgetgCRISPR-Cytemchievee-pecifictlltim6Ahighefficiencyducedf-trgetedgPROJECTSUMMARYAlthoughdetectigeneexpiqunttivePCRbulkglecellRNAequencgpentcnernebiologiclquiryepprochelimedirbilymeutrncriptildynmicovertimethroughoutptilheterogeneytuedetectlow-bundncetrncriptcludgthoecykeCykeexpihpefiltrtictivyimmunecelltumtuepentnimptntcltepeimmunpyHowevercykeexpictext-dependentpleiotropicdynmicynchrouAuchprticulrlypolyuedglenphotmeumenttimedetectigleevenfewflmmrymediroltiToddechllengewecomdvnceCRISPR-mededtrncriptilctivtechnologygeneticlly-encodedetptgfluocentlypttrncriptilctivy9mocykeimultneoulydynmicllyutueWehvepvioulyvlidtedcocpbilyourytemptglegeneexpiplimrytudienowoptimizedetecticpbilieimplementC-Lox-bedromizedfluocentpteret-encodgtrtegymultiplexdetectiIfuccefulourtudyetblhnovelpprochmultiplexedhigh-enivyCRISPR-beddetectigeneexpiItloproduceolgentcndictlyppliedterrogtebtummicroenvirmentflmmticndptedfunctilgenomicvivotudieProjectSummryTumidecomplexmulticellulrecoytemcompdmlignntn-mlignntcellwheterctgcellmoleculegnizedpcetimeThediveryecellirterctiffectcncerprogidrugpetncepenpptuniemopcedignoticrpeuticInthpropolwebuildupourcentventiSlide-tggle-cellptilgenomictechnologyenblefcileptilprilghumntumWepplySlide-tgcrobrodrngetumpecimenenblefutudoptimimltrgequipmentWeextendSlide-tgmeunlytrncriptiloepigeneticttegenomevridividulcelltummicroenvirmentOurnovelcomputtilpipelellowemletegrtimoleculrcellulrhlogiclundertgtumyenbleptilloclizticelltypecomplextumenvirmentidentifictiptillyvryggeneexpiptterndrivenpthologywellgnizticellulrnicheThenovtithprojectyieldrobutmultiomicptilpltmrouteprilghumntumtcleApplygthpltmvolutiizeourbilydcoverchngetumptilmoleculrgniztidurgdeeprogtmentprovidenewbiomrkerdignoticprognotichighlightnewrpeuticvenuePtientn-mllcelllungcncer(NSCLC)epidermlgrowthfcrcepr(EGFR)genemuttihveenuccefullyttedEGFRtyroekehibir(EGFR-TKI)Oimertibhemergedepferdfrt-legentgivenignificntimprovementprogi-feurvivloverllurvivlHowevermjyptientdevelopcquidtncergetedrpyOimertiffectivecombtiMEK/ERKignlghibiovercomgevendelygcquidtnceoimertibp-clicltudieSgle-cellmoleculrprilghidentifiedYAPhibirmyovercomecquidtnceoimertivenfterexpouMEK/ERKhibiBulkmoleculrygle-cellRNA-eqmethodhveenmtmpprocheevlutgignlglterticultutueHoweverltleknownboutptillyolvedgle-cellubcellulrdetilignlgnetwkterctiNSCLCRecentlyrpidmultiplexedimmunluocence(RpMIF)y(developedPl)veledeffecimertibubcellulrgniztiignlgprotefcrTofurrevluteprote-proteterctiNSCLCcelltuethpropoletblhrpidmultiplexedprotetercti(RpMPI)methodtudydrug-enivetnthumncelllecultutuecellle-derivedxenogrftmiceptient-derivedxenogrft(PDX)EGFRmutti(EGFRm)RpMPIoptimizedugumtedllgmultiplexgchemtryignlgtercmectructiThprojecttethypoeglecellptilignlgnetwkterctimpqunttivelymodelMEK/ERKuptmcrotlkYAPuptmdefe20p-electedprotepirterctirtillydeignedcombtirpieovercomecquidtnceoimertibAim1mpoutptilignlgtercrirubcellulrlocliztimjgnelleugRpMPIdrug-enivetntEGFRmcellunderctroloimertibttmennlyMEKIERKYAPhibilyoimertibcomdMEKIERKYAPhibicdiAim2nmeuptilignlgtercmeugRpMPIvivougMEK/ERKYAPhibircombtioimertibmouexenogrftPDXmodel(pttment1-week1-mthuntiltnceoccurn=5ech)EGFRmhumntueoimertib-pivetnceclicloutcome(n=10ech)Thelg-termgolthR33uncoverptillytempllycodtedcquidtnceugubcellulrcellulrignlgnetwkmpThR33novtivecueiietblhenemerggubcellulrimge-bedignlgnlytechnologyguidertillydeignedcombrilterventiovercomgtnceoimertibThepropoedwkignificntcuegenertenewknowledgecompenryignlgnetwkNSCLCthighetmoleculrolutiglecellbwenotttblebulkignlgproteyProjectSummryWepropoefurrdevelopfevlidteouremerggfe-olutiy(FSA)technologyourltivelynewcompentedInterferometricder(CIR)12ThedevelopmentFSA-CIRddeignificntvoidbldpotcncererchcuepentlyll-feoluti-pheultr-eniveenzyme-fetechnologycomptibleeentillynymtrixUnlikeextgolFSA-CIRhenhownueful)mechnmActi(MOA)tudieundulterted/unmodifiedtrgetpronoltivemenivyb)full-lengthmembrneproteterctitudientivemtrixc)defgllotericmodultiwekprote-proteterctid)ccelertgqunttiveydevelopmente)potentillyddgbiomrkerdcovery/vlidtibottleneckf)permgqunttivetercticromtrixpectrumglepltmg)enblgex-vivomeumentguidefirt--humndoedetermti(FIHD)(eePfizerletter)FSA-CIRprdigmhiftgtechnologybednovelmoleculrterctrnductimethodfluocence-levelenivycpbilietrgetgprobgegmoleculrcellulrfetucncerbiologywellimprovgerlydetecticengclicldignoFSAmix--dgnoticmoleculrterctipircomptiblecomplexmtricemkguniquelypplicblebothbiccliclcncererchnCIRpentmjdvncementterferometricengduenunpcedentedlevelmple-fencecompentiCIRopertedoutexternlrmlctroluniquefetufrctivedex(RI)en<10-7RIUenivyTheopticlengeCIRuniqueptentedqueimplectgdiodelercpillrytumirrdetecrWhencombgterferometerdropletgenerrmpletroductiCIRfciltequntifictimoleculrterctioutltivemdependencetpicomolrenivyllowgoodmplethroughput(50erummple-fencepirrunqutuplet[5plictedropletpir]pluclibrtidyFeibilyourymethodologydemtrtedmechnm--cti(MOA)tudiequntifictidrugtrgetenggementneededrnoticultrenivevolumectdbiomrkerydevelopmenttrgetquntifictiDtdicteFSA-CIRhpotentilwidepdpplicbilydopthroughoutcientificcommunymtuenoughnR-33projectAtprojectcompletiweimprovidecientificmediclcommunyuer-friendlypltmtechnologybiochemiclmechnmctitudieidimprovgcncerprognoticbilymeupropertieuchmoleculr/cellulrmechnmimptntcncerProjectSummryThegolthpropolextenivelybrodencliclpplictiuniquenti-cncerbiologicdrugL-prge(ASNe)developglger-ctgnextgenertiveriournovelvrintEBD-300curntlyIND-enblgtudieASNeenzymedrugexplometbolicvulnerbilypecifictumcellviytemicdepletiL-prge(An)bloodycriclttmentpedriccutelymphoblticleukemi(ALL)CurtegtlyimprovedupcptiASNepedricttmentprocolhoweverdultALLptientlrgelypcludedASNettmentduexicycurntFDA-pprovedveriTheultignificntlyloweroverllcurtedultALLTheideeffectcurntASNetemtwocueeirimmunogenicydueirbcteriligecdirf-trgetL-glutme(GLNe)co-ctivyToexpuethdrugdultALLptientdictineeduperiASNe(1)ducedimmunogenicy(2)devoidGLNectivy(3)lgvivopertenceTogddgthneedEbDdevelopedEBD-3001tmmmlinASNe(derivedguepigfurrhumnizedduceimmunologiclrk)1tuperpecificASNe(zeroGLNe)InvivotudiedemtrtedhighefficcyEBD-300ALLvtlyuperifetycompdcurnt1t-le(Oncpr)2nd-le(Rylze)FDA-pprovedASNeThevivopertence(t1/2)EBD-300muchlgerthnRylzemkgpromgcidtecomepferd2nd-leASNeHoweverEBD-300notcompetive1t-leOncpr/AprlcueneedhighermofquentdogcheduleNotblyover130cumerdcoveryterviewKOLALLveledtrgneedlg-ctgEBD-300vrintblebk1tleThewkpropoedheengeertetnextgenertiEBD-300vrintlgvivopertenceuchlg-ctgvrintbothimpctALLptientprovideultimteASNeddildicti(wheuntilnowcurntASNeimplyoxicedultpopulti)ThcludebloodcnceruchcutemyeloidleukemiolidtumlikelivercoloctlcncerllwhichhveenhownpclicllyeniveASNeTochievethgolweengeerEBD-300novelhlf-lifeexteni(HLE)technology3-tepproceStep1generteHLEEBD-300vrintcfirmmodifictimtquidenzymticpropertiecliclefficcyInStep2p3vrintpgtrgentQChveirvivopertenceevlutedThepcidteproceedStep3cfirmnti-ALLpowermouemodelThefeibilyourpprochgenertelg-ctgEBD-300vrinthenprovenourplimrywkSucceheprovidenovelASNedrmticllyimpctttmentALLexpcncerlybloodAnprolifertiurvivlProjectSummry/AbtrctSomticmuttilterfoldgfuncticogenetumuppproteTheltertiprotetructudrivemlignnttrnmticellWhiletructurlchngeomticmuttedprotehveenextenivelychrcterizedhighptiloluticmtilltertinmuttedeffecrprotecncerproteomemeluiveTheheterogeneyprotecmtiprote-proteterctitumtglecelllevelmunknownunclerwhertumcellmegeneticbckgrounddifferprotecmtiprote-proteterctin-muttedproteHewepropoeimplementnewmpectrometry-bedprotefootprtgtechniquemeuprotecmtiglecellWecentlydevelopedCovlentProtePtgwhichferprotetructurlmtichemiclprotefootprtgtechniqueurveychemiclctivylyeidueprotedetermeltertiprotecmtiprote-proteterctiproteomeWepropoenewveriCPPthvercomecurntlimtimplepprtinlyglecellproteome(CPP-SCP)WequntifylyeecceibilyglecellCPP-SCPweetblhbioTMT-CPP-SCPvriCPP-SCPmethodcndictlycompchnge3Dproteometweeneverl(>10)glecellhighenivyWepropoenlyzetctglecellthltedtwocncercelllemutumtueOurgolfdoutwhermeumenttglecelllevelcpultetructurlltertiweobervedbulktummpleSpecificllymunclerwherrrntprotecmtiperproteobervedtequlbundncecrollcellifycfedubetcellcncercellletumWehopeCPP-SCPllowudiffentetweentr-tercellulrvriprotecmtifoldgProjectSummryUndertghowcncercellprogrmirmetbolmterctbiologiclproceegggivene/tncettmentprmountignificncedvncgcurntdignottmenttrtegieCncermetbolmhighlycomplexheterogeneouproceubjectmicro-envirmentlcueInvetigtgvtlycomplexmetboliclcpecncermextmelychllenggduetr-tumlheterogeneycncercellterctidiffentcelltypedynmicttemicroenvirmentMetbolomichengoldentrddetecticellulrmetboleTheddvntgemetbolomicmdetructiventuprohibglivecelltrvlnlylckgptilmtiFluocencemicrocopyferhighelectivyprovideubcellulrolutiHoweverfluophollmuchlrgerthntrgetedmetbole(egfttycidchole)thucnhderltertricmetbolmHewepropoefillthgpthroughnewpprochtermedbio-thoglmid-frdphml(MIP)imggByugviblemeneIRbptiducedfrctivedexchngeMIPmicrocopyllowhighlyenivyimggchemiclbdtviblediffrctilimWepropoedevelopnrile-bedIR-ctiveproproduceextmelytrgMIPignlpectrllyilentgiducemimlperturbtimoleculetetInfeibilytudiewehvedevelopederienrile-bedubtrteenectiviepecificenzymecludgcpephophteImptntlyduemuchlrgerfrdbpticroecthnRmncttergMIPlimdetectienrileenchefewmicromolrlevelwhich~1000timelowdetectilimlkyne-bedRmntgOntrumenttiidewehvedevelopedler-cnMIPmicrocopewhichcedimggpeedmillecdperpixelmicroecdperpixelBedeplimrytudiewepropoeytemticllydevelopbio-thoglmid-frdphmlimggthetep(1)Buildglibrrynrilechmeleeneimptntmoleculreventidecncercell(2)Buildglibrrynrile-tggedmllmoleculeenenutrientmetbolmcncercell(3)Developgmicroecd-clemid-frdhetgpectrocopyenblemultiplexbio-thoglimggOvrincncercelluedtetdOurtechnologyynergticllycoupletwovtiprodevelopmenttrumenttiBrodueechnologyvidemticommerciliztillowercherqunttivelymeuvrioumoleculreventtubcellulrlevelopenexcgopptuniemolecule-bedpcidignodcoverynoveltrgetpctmentcncerdeeDetectiliblebiomrkerpentttmentpedrugtncemmjcliclchllengeovrincncerExtrcellulrveicle(EV)pentnewopptunieemerggcircultgcncerbiomrkerTheecell-derivedmembrne-boundveiclectprotenucleiccidcrgowhichcouldpentmoleculr`nphottumNmelymoleculrnlyetum-derivedEVhvehownpromeenblen-vivel-timecncermirgAmjtechniclchllengefurrexplogEVpotentilccelertgirclicltrnltidevelopgeniverobuttrdizedycndetermeEVcompoicellulrigmoleculrprilecliclmpleMotEVmllveiclelimednumrepipeurfceimmunollg(iewekdetectbleignl)whichtenquiophtictedmulti-tepignlmplifictitrtegieAkeypectnewEVythurobutignlmplifictitrtegyweignificntfrctiEVmundetectedTheoverllgolthpplictiddetechniclchllengedevelopgntegrtednnoplmicengpltmTermednno-CRISPRnewytemcptegleEVcptunlyugplmicnnodkrryCRISPR/C13enly-femplificti-feRNAdetecticptudgleEVplmenhncementimplerobutignlmplifictiUgtegrtedytemwepermrigouvlidtiexperimentugcellleptient-derived3DgnoidmodeldiffentdrugpeetblhtrdopertgprocolevluteyproducibilyerchcliclettgFllywepplynno-CRISPRtechnologycomphenivelyprileEVerillycollectedhumnplmmpleovrincncerptientundergogttmentSucceheproducendvncedEVdetectipltmhighenivymultiplexedbiomrkerengcpbilyThhelpfieldunderthowwellEVmoleculrprileferddilightcncerprogttmentpecouldignificntlyccelerteclicltrnltiEVnlyerouteproceducncerptientccliclettgABSTRACTThetummicroenvirment(TME)plycriclrolehemlogicmlignncieepecillymultiplemyelom(MM)Echcellulrn-cellulrcompentTMEexertdiffenteffecnMMcellurvivlprolifertiimmuneevitncettmentSeverltudiehvehownCAR-Trpyproducenoverllperte78%lped/frcryMMettghowevermnyptienttilllpemedintimedeeprogibout1yerTheenurgentneeddefemechnmdeeprogitnceCAR-TbpecificntibodieugnvrocellcultuytemmimiccomplexTMECtuouprogtueengeergcludgdevelopmentvriou3DcffoldmicrluidicytemhimproveddiveryfidelycpcycultumodelcnuedcncerdeeerchMot3DvrocultuytemlcktegrlTMEdynmicperfui/fluenceimmune-tumcrotlk/prolgedcultucpbilieInddimotmodelcnnotmimichypoxicgrdientobervedtumwhichdrmticllyduceefficcymoleculrcellulrrpeuticThehypoxicTMElikelyprotecttumgtimmunpieltergcellulrmetbolmducgimmuneuppiTheenidelexperimentlvrocellcultuytemhouldmimicheterogeneountuhypoxicTMEllowmocompleteundertgcncercellimmunecellbiologyimmunpyvlidtidevelopmentefficciouttmenttrtegiecliclpplictiToddementiedlimtithpropolwefocudevelopgnovelmicrluidicdroplet-bedpltm(MDP)technologygenertenlyze3Dbiomimeticmulticellulrimmunogenictummodeltetcpbilie(1)etblhmultiplelevelhypoximetum-chipprllelproceg(2)vetigteptiotemplterctitweenTMEcncer-immunecelldurgrpy(3)quntifyimpcttte---rttrgetedimmunpyefficcydefemultiprmetric(dynmicecmictrncripmic)pecomphenivenlycellfteWecpteptienttumcellirmicroenvirmentMDPpdictttuptientpotentilpdern-pderPotentilpderimmunologicrpyuchCAR-Tnefnothvgweverlmthclicdetermewherrpyhchievedpenotwhilepotentiln-pderpdide-effectn-effectivettmenthelpclicinchooemrpyOurpprocheultdevelopmentvertilemultifunctilytemcnervenewnovtivetechnologydeepnlycell-cellterctipdictgoptimlrpydividulptientignificntlydvncegolperlizedmediceABSTRACTCncererchtendrivenhypoepotultepecificproteimptntdeehypoetentetedddgnntibodyytemThetechnologydevelopedhectenewgent(AEGISbodieAEGISClever)nlybdtrgetprote(likenntibody)loclevetcot10100foldlowerthnervice-providedntibodyweekrrthnmthcrorngeffieupptqunttiveerchTheeobtedpplyglbryvroevoluti(LIVE)librriebuiltnrtificillyexpedgeneticmtiytem(AEGIS)dectedpcelyelectedchemiclgroupAEGISbiopolymerlikeDNAup12buildgblockenhncedfoldggtertbilyfunctilgrouptclevgectiwhichgiveproductwhenAEGISClevercovlentlyttchedfrgmenttrgetpeptideAEGIS-LIVEhhighleveltechnicldecueplimrytudiected()pltmmnufctuAEGISDNA(b)moleculrbiologyupptAEGIS-LIVE(c)equencgfoldpdictiolnlyzeproductAEGIS-LIVEThetemhprovencncer-levnceAEGIS-LIVEctgAEGISBodiebdpecificllyelectivelybtlivercncercellcncer-levntproteheterologoulyexpedmmmlincellurfceoltedprotenthrxThefirtctlyticAEGISzymehTofurrechnologydevelopmentweAim1ApplyAEGIS-LIVEcteAEGISbodiebdProgrmmedDeth-Lig1(PD-L1)cognizedtrgetcncerrpyWelotrgetextrcellulrpeptideloopPD-L1foldmdeL-D-mocidTheecdmirrimgenturlmocidllowproductimirrimgeL-AEGISbodietblegtnucleedigetiWemetricebdgffietbilyvlidteirefficciecompdcurnttechnologieAim2ApplyAEGIS-LIVEcteL-D-AEGISCleverclevepeptidePD-L1nlogouegmentwhenemddedcompleteproteWemetricnchmrkeffyclevgertetbilygtnucleeThenewgenttrnmtiveceydothgntibodiecnnotcovlentlytgdetroytrgetproteFurrgentexpectedtblebiologiclfluidcludgcellcultubloodlivgnimlLgertermultr-tbleAEGISClevermyevencomedignoticrpeuticolProjectSummry/AbtrctInub-ShrnAfric(SSA)Kporcom-ocedherpeviru(KSHV)etiologiclgentKporcom(KS)endemicHIVcidencehighmkgKSemotcommcncerdultocedhighmtlyevenntrovirlrpy(ART)erAlthoughlleicommmgAIDS-KSptienteffectHIVfectilenvirmentKSHVctivtilcvyeKSdevelopmentcompletelyunknownUgnovtivevlidtedtechniquethtudyfirttethypoltertilenvirmentdurgHIVfecticricldetermntKSHVctivticedKSHVheddglcvyIpropoelrgedequtelypowedlgudltudy600UgndultmlefemlefollowedovertwoyerthegrouppeoplelivgHIV(PLWH)lgtermARTnewlydignoedART-nvePLWHHIVunfectedPrticipntenrolledtGenerlPopultiCoht(GPC)rurlUgwheKSHVeropvlencemghighetwldtTheAIDSSupptOrgnizti(TASO)AIDSHelthcFoundti(AHF)UgCbothlgtgHIVcclicwhicherveGPCOrlhelthexmticompletedidentifywherPLWHexhibmrkerldeecludgggivperiodtultgcedKSHVctivtihigherKSHVvirllodliv(hedder)OrlfluidcollectedidentifywherhigherlflmmrymrkerlowerKSHV-pecificIgAocedlKSHVheddgTocpturoleHIVchngecuglmicrobiomedybiolcvyctuedeffectlctivtiheddgKSHVweequenceV1V3gi16rRNAwhichgivehigholutipowerdiffentepecielmicrobiomeThefdgproducedthtudytrulyuniquefundmentlidentifygwhermrkerldeelmucolflmmtiducedimmunectrollcvylmicrobiomedybiofcrledgKSHVctivtilcvypriKSdevelopmentThenimmenegperchgrdeffectlhelthlenvirmennKSHVctivtiKSdevelopmentWecptenexceptilmulti-dciplrytemexpertnovtivevlidtedtechniquecollecttrulyuniquednlhelthlimmunepedicrrurlpopultiSSATheventivedicthpropolcomdcriclneedidentifyeffectlenvirmennlKSHVctivtiheddgmtineededturrfielderchterventirpeuticKSPLWHmkemypropolperfectfthCtlytwrdThemticquidubtntillyexpourknowledgefcrdrivgKSHVctivtilcvyeKSpthogenewhichtegrlidentifygtrgetterventigtKSdevelopmentSSAddihigh-rkpopultioutideSSAABSTRACTInSSAdethoccur5-10%PLWHdurgfirtyerftergntrovirlrpy(ART)cueeerlydethnotwellelucidtedmotptientMnyptientpentlymphdenopthyempiricllyttedturculo(TB)evenwhenTBtetgnegtivemyhveundignoedlymphoprolifertivedder(LPD)Accelymphnodebiopyhigh-qulypthologicevlutilimedtenledmeddelyeddignowhichmyctrieerlypventbledethfterARTiThebrrierpthologicdignolymphdenopthyMlwihvenotenextenivelytudiedLPDcludglymphommulticentricCtlemndee(MCD)commcuelymphdenopthyPLWHlikelydelyed/underdignoedInKCHLymphomStudywehveenrolledllptientnewlydignoedLPDce2013123/245(50%)PLWHlymphom19/35(54%)MCDLilgwedtrictwhichmkeuply10%ctchmentGiventhmrkedoverpenttiprticipntLilgwewehypoizemnyundignoedLPDthoughgpextundertgburdenLPDthpopultiCricllywhendignoedpproprelyLPDttblecurbleSSAToovercomebrrierdignonovtiverpiddignotictechnologieurgentlyneededimprovepeedccurcyLPDdignoetpotcThenumrmethodEBVKSHVmeumentcludgtrdilPCRpotcdeviceknownTINYTINYloop-mededmlmplificti(LAMP)-beddevicellowmplifictiquntifictiDNAtpot--coperbilyevenettgwheelectricynotvilbleOurcollbrhvehownTINYenivepecificdignogKpoircomkbiopiecnpotentillydignoeBurktlymphomugEBVmeumentthoughutilytpotcLPDhnotentudiedThpropolddecurntgpknowledge1)egmultifcrilcuedignoticdelyLPDMlwi2)comphenivelydecribgcliclchrcterticdignoePLWHpentglymphdenopthyHIVclic3)egutilyEBVKSHVmeumentFNAbloodexpededdignougtrdPCRwellTINYInummrythpropolopenerchfocudtctmypviouwkmyfirttimetudygdignoticimplementticiencefirttimewkgperipherlhelthcenterThmultidimenilpropolbuildwrdmylg-termgolimprovgoutcomePLWHLPDprovidgcriclmtiboutpvlenceundignoedLPDkeyimplementtichllengewrdccurtetimelyLPDdignonovtivedignoticmethodovercomeechllengeCncermledgcuedethwldwideTrgetedgenthvedrmticllyimprovedprognoover30cncertypefundmentllylimedevolutitnceCurntlynextgenertrgetedrpietropectivelydeignedcoverlibilieclicllyvilbletrgetedrpieUntuntelyeveryvetigtilcompoundhvetncemuttipventcompletedurblepeDeepmuttilcnng(DMS)hemergedpowerfulolevlutgmuttillcpetrgetproteDMScenhvecentlyenuedcdemiclbchrcterizetncelcpetrgetednticncercompoundemploytrdnextgenertiequencg(NGS)techniquemeuhighlycomplexmutntpoolNGShhigherrrteprohibccurtemeumentcomplexmuttilpoolDuplexSequencg(DS)nerrcctimethodenblepcemeumentmuttidownfquency1300000pooledcell-bedlibrryThePrchrdlbhdevelopedDeepMuttilScnngDuplexSequencg(DMS-DS)propoefeechnologycommercillyvibleervicenticncerphrmceuticldevelopmentInPheIthSmllBueTrniGrntwehrdencleourDMS-DStechnologyndutry-viblecengpltmInPheIIwecenllpprovedBCR-ABLhibirdeignbuildDMS-DScentwolungcncerdrugtrgethrdenourBCR-ABLDMS-DSpltmcommercilizedend--enderviceTheflproductthSBTGprojectrobutpowerfulmrketblenewercholdyuenticncerphrmceuticldeveloperOurcompnylevergethol(DMS-DS)expedeledcidtepriiztioptimizenextgenertidrugdeignTrgetedrpiehvevolutiizedclicloutcomenumeroucncercquidtncecricllylimirlg-termutilyHvgcommercillyvilblecengpltmcnccurtelypdictmuttillcpenextgenertirpieledmouccefulclicltrilttertrgetedrpiemoeffectivettmentplncncerptientWefirmlylieveourtechnologyccelerteeffectiventicncerdrugdevelopmentthurtemnunprlleledpoiucceedtcommercilizthproductPROJECTABSTRACTNerlytwothird18millinewcncerptientechyerfilttmentduetncenotfullyunderodEventte---rtclicltrilcologttruggleelectptientlikelypdnext-genertirpieTheoutdtedimpcepthologyolcurntlycliclue(egIHC)filliblydelivercriclmtiuchextentdrugtrgetexpiccurteementcelltteNewerercholcludgimmunluocencenlymcymetrylofilbridgethgpduecomplexwkflowlimdoptiexpertuercurhighmpleizequiment/pentprohibiveexpeneTheignificntunmetcliclneeddevelopmentnimproveddignoticolcpblegenertgpceccurtegle-cellmtienbleimproveddignoticttmenutcomecrotumtypeThegolthprojectcommercilizepltmrpidmoleculrnlymutefrgilecellpopultidergenertednproteexpicelltteco-loclizti(cludgimmunecell)glecellpciflowcymetrywhilepervgmpleTheuccefulcomplethprojectultvlidtedpnelprilgimmunecellccompnygcomputtilervicewhichcnuedtrdimmunluocentmicrocopeAuccefulprojecttherviceexpectedtrnltebilyprilemnymobiomrkerrngebiopymplethnpoibletpentUltimtelytechnologywelluedtrnltecliclettgwhecnuedoptimllyelectpderpcicncerrpieAbtrctProttecncerecdmotcommlydignoedcncermenUSAbout25000ce34000dethprottecnceroccurechyermkgledgcuecncer-lteddethUSmenIncidenceohighpproximtelyeeveryeightmendignoeddeeoverirlifetimecurntlynetimted32millimenlivgprottecncerUSDuethhighcidenceprottecncercteignificntecomicburdenetimtedtlover$13billiUSnnullyItwelletblhedrogenignlgdriveprottecncergrowthmettThurogendeprivtirpywhichhibrogencepr(AR)ignlgwidelyuedfirt-lerpydvncedmettticprottecncerHowevermjyptientproglethlmettticctrti-tntprottecncer(mCRPC)IntetglydeperogendeprivtimCRPCctuedrivenARignlgduepenceARplicevrintctutivelyctivenucleuARMABiodevelopgdulhibirAR-fulllength(AR-fl)AR-V7motpvlentplicevrintrogenceprmenmCRPCAR-V7expiptientmCRPCoceddrugtncepourvivloutcomeCurntlynodulAR-fl/AR-V7hibirmrketlevgptientmCRPCnpeuticoptiAfirt--cldulhibirhpotentilovercomedrugtnceynergizecventilrogenceprrpyfermuch-neededrpeuticoptimenmCRPCultimtelyimprovgclicloutcomeInthFtTrckprojectARMApropoe1)Permmediclchemtrycompoundoptimiztieelectivypotencymechnmcti2)Invetigtevivoxicyphrmcoketic3)EvluteefficcyledcidtemCRPCxenogrft4)Aeefficcyynergmenzlutmideddilmodelcludgptient-derivedxenogrft5)Permmechntictudiefoundticliclbiomrkerdevelopment6)PermGLPmnufcturgIND-enblgxicologytudieUltimtelythwkidentifyledcompoundprovidepro--prcipledtdvncegoldevelopgfirt--clphrmcologichibirAR-fl/AR-V7Thhibircoulddilycomdextgnti-rogenceprttmentnlyverelopvennetAR-V7-mededdrugtncenefgptienterliertgedeePROJECTSUMMARYThelg-termproductgolthprojectmllmoleculecncerrpeutictrgetgMYCcoprotewhichtrncriptilfcrgultekeytrncriptilprogrmquidcellulrgrowthprolifertiDuerrntexpimothn70%humncncerfunctilvlidtiMYChibirtcncergrowthMYChenmotought-fterrpeutictrgetcncerDepedecdeeftrpeutictrgetgMYChenunttbleduecombtifcrcludglckenzymticctivyobviouligbdgecnidhibiridentifictiRecenterchPIDrFerColelbrytDrtmouthhuncovednAchilleheelMYChenbledrpeutictrgetgthpvioulyundruggbletrgetWhileunrvelgmoleculrmechnmunderlygMYCterctiTRnctivti/tRnmti-domAocedProte(TRRAP)whicheentilmnyMYC-drivenrrnttrncriptilprogrmpromotecncerDrFererchveledvulnerbilyMYCThightleddevelopmentvolutirycengpltmwhichwlterdeployedcenmothn05millicompoundPrtilementhigh-throughputceng(HTS)eftidentifiedeverlhnlyblockedtrcellulrMYCTRRAPprote-protetercti(PPI)tlowMpotencylopotently(2M)ttenuted2D3DgrowthmultiplecncercelllehighlyMYC-dependentmnnerhighlightgpecificyelectivyhThegolcurntFt-Trckpplictih--leddevelopmentenyddilnewhfutuclicldevelopmentnovelMYC-trgetedrpeuticcncerThefocue-yerPheISTTRptiFt-TrckprojectccludehdcoveryeftcompletgHTShementwhileimultneoulytetghypougourcently-identifiedheterocyclicmidecompound(A1)MYCTRRAPPPIhibtenutetumgrowthhumnlymphomxenogrftmodelThefocutwo-yerPheIISBIRptiFt-Trckprojecth--ledgenertidvncedledugnertiveprocecombgmediclchemtryvroMYC-pecificbioyvroADME/xPKefficcymouehumnlymphommodelIdentifictlenefeefficcioudvncedledcompoundducetumburden>50%wouldctutetudyucceGivenubiquyMYC-drivencncerMYC-trgetedrpywhichcurntlylckgwouldimmenerpeuticvluecncerptientThFt-TrckpplictienblecompletifoundtiltudiewhichcurntlyundertkencoMYCIncbiotechcompnyco-foundedDrFerdriveproductwrdcommerciliztiMooverthSmllBueTrniGrntErlyCerScienttenbleuccefultrnigDrFerncdemiccienttndutryexecutiveovereebuedevelopmentctiviecriclenurnmtiverpycheptientABSTRACTProttecncer(PC)motcommlydignoedcncerecdledgcuecncerdethAmericnmen1Fmettticctrtitntprottecncer(mCRPC)rpeuticopticludetxnedrugdocetxelcbzxelRdium-223chlide(Xigo)deeSipuleucel-Timmunpy(Provenge)177Lurpy(Pluvic)24Untuntelyecherpielyferht-termurvivldvntgemCRPCultimtelyevdettmentLiketxnemomethylurttE(MMAE)potenttubuldruprknownhibprottecncertumgrowth5HoweverMMAEcnnotdmteddrugledueignificntxicynmlcell56ToovercomedoelimgxicyMMAEmutcjugtedtrgetgmoietySmllmoleculedrugcjugte(SMDC)ntibody-drugcjugte(ADC)deliverxicrpeuticpylodcncercellthroughcncer-pecificbiomrkerproteprgn-trgetcelltuedotexpbiomrkerSMDCADCcneffectivelycerpeuticdex(iecgefficcygttumcellwhiledecgxiceffectnmltue)drugpylod7TodtefourMMAEADCFDApprovedhowevernoADCSMDCpproveduemCRPCProtte-pecificmembrnentigen(PSMA)wellchrcterizedbiomrkerprottecncergtuccetrgetgdrugpylod(cludg18Fimgg177Lurdipy)dignoticrpeuticpprochePSMAexpedtlowlevelnmltuebuvexped>90%prottecncerexpicecncerprogemCRPCtge814CncerTrgetedTechnology(CTT)hdevelopeduniquehighffyPSMA-trgetedcffoldirveriblybdrpidlyternlizedPSMAexpgcell1516InddiCTThdevelopeduniquePhoAmlkerttchedcffoldctprodrug(CTT2274)leectiveMMAElytrgetPSMA+tumendo/lyoomeRpiddrugleePhoAmlkeridelquicklyccentrtedrugpylodidetumcell1719UgthuniquedeliverymechnmCTTnovelbckPSMA-trgetgCTT2274hpotentilbothdecexicyMMAEultubtntilnti-tumefficcyfergnovelrpeuticttmentdvncedprottecncerThFt-TrckSBIRdevelopvlidteCTT2274InPheICTT()permprocedevelopmenptimiztiCTT2274ynticprocedu(b)ephrmcoketicCTT2274(c)determemimumeffectivedoeCTT2274levntmodelprottecncerInPheIICTT()ynizen-GMPengeergbtchpermtbilytet(b)cductGLPcutertfety/xicy(c)cductGLPchricrtfety/xicytudySuccefulcompletietudieetblhrpeuticdexCTT2274etblhfutuclicldoeervefrmewkdowntmGMPynlrgenimlfety/xementcliclprocoldevelopmentINDubmiAbtrctThe23rdMidwetDNARepirSympoium(MDRS)tkeplceLouvilleKYJune1-22024tHelthScienceCmpuUniveryLouvilleTheMDRStrted1999tUniveryMichignAnnArbhmettvriouuniverieMidweteveryyercenexcept3-yerhuimpoedCOVID19pemicTheMidwetDNARepirSympoiumwigllycceivedumbrggerDNApirercherMidweternginnnulbdcugogerchtimultecollbtiterctledgDNApirerchernmltmopheIn2024wehve3ementDNApirercherkeynotepekerctughryledgerchergldlycceptgvtiAddilgolMDRScludemkgcotttendgympoiumexpenivepoibleprovideerlytgevetigrpotdocrlfellowgrdutetudentpriypentgirwklpotereiDNApirfundmentlcellulrprocecriclmtenncegenometegryhumnhelthDNApirdyfunctihenlkedmnyhereddeewellchricdeeuchcncerneurodegenerticrdiovculrdeeggThegnizerpleedthympoieriehenveryuccefulheenignificntcettendncepteverlyerOnekeyuccehenkeepcotttendncelowThlowcothenpoiblecuegnizerechyerheldympoiumtirhometutihveecudbmurlextrmurlfundgcoveromemjexpeneEpecillytimetrictederchfundgMDRSequlycfencewhichPIhveenblebrgirtudentpot-docrlfellowterctledgcienttfieldpentirwkmgpeerTocelebrte25thnniverryMDRSturngLouvillethirdtime2024ThetheprciplgolMDRS1)providevenuecienttmlynotexcluivelyMidweternSttepentdcucurnterchfieldDNAdmgepirmutgeneprovideopptuniefotercientificcollbti(2)Toprovidetudentpotdocrlfellowerlytgevetigropptunypentirwkpeerterctlederfield(3)ToprovidenexceptilvlueeympoikeepgmfdblePROJECTSUMMARYABSTRACTDecdeerchhveledcomplexycellulrignlgnetwkvolvedctrolcellulrproceeirexceptilvulnerbilytrgetdygultimnydeettelikecncerDurgmulttepprocetumiprogicncercellcquiuniquecpbilietermedhllmrkcncerclude)utedprolifertibencegrowth-promotgignlb)evigrowth-hibiryignlc)ctivtivimettd)enbledplictiveimmtlye)ductingiogenef)tncecelldethUnurprglyrrntctivtictivtiignlgpthwycompentwhichtypicllytegrteextrictriccueguidecelldivigrowthmigrtidefgfetumlignntcellDecdeerchimedtunrvelgcomplexycellulrignlgnetwkctextcncerhveledmnyprcipletrcellulrcommunictieentilnmlphyiologyuhedertrgetedrpeuticcncerttmentWhilemllmoleculrhibirtrgetignltrnducerhveenclicllyefficcioueverlchllengeuchemergencetncetumcellheterogeneyundruggbletrgethlimedwidepdueegentcncerThethepecificobjectiveFASEB2024CellSignlgCncerMechnmTherpyThefirbjectivedemteynizemotup--dteknowledgenewettechnologieurroundgmechnmrpeutictrgetgcncercellignlgpthwyToccomplhthgolwehveplnnederiekeynoteplenrypekermnyledgexpertfieldmultiplehttlkelectedpoterbtrctpotereieverlfocuedwkhopmldcuiScechllengethfieldduntgquicollbtiveeftolvemecdobjectiveenhnceterctitweencdemidutrycliclcienceTothendwehvepecificllyvedpekerpentgechepicplnngwkhopdcucertrjecriediffentdciplenvigtgproductivecollbtiThethirdobjectivevettellectullyfncillyfutuupptgpromgyoungteThegolencourgeteuccefultyfieldprovidgtellectulupptthroughdcuienicienttpotereiopptuniepekwrdcognizeirchievementprovidgfncilupptcompetivetrvelwrdTopecificllyceopptunietewehveplnneddeigntedJuniScienttSympoiumttrtmeetgcludgKeynotePenttiJuniInvetigrChrtTowerSlkIntutewhichgivetemoopptuniepentdcuirwkTheexpectedoutcomecedcollbtipromotrgyoungcienttfieldidentifictinewpprocheidentifygdevelopgrpeutictrgettrtegiecombtcncerPROJECTSUMMARYWequetprtilfundgMidwetTumMicroenvirmentMeetgheldtUniveryWc-MdPyleCenterMdWIMy20-222024Themeetgwugurted2015lymeetgtummicroenvirmentMidwetgiThmeetghighlyvluedctrierdciplrycientificfieldtummicroenvirmentfocuroleimmuneytemtromcncergrowthprogiThecfenceco-gnizerLMAndtDVMPhDSuznnePikPhDpecificllycommtedctgdiverecluivecfenceThemeetgcvene24pekerup150prticipntApecileftmdecruprticipntunderpentedcienceThemeetgloprovideumtecienttwhoerlytgeircerpentirdtnetwkfieldProgrmpicmultidciplrycludgcuttg-edgetechnologietudytum-tromtercticellulrextrcellulrmtrixfcrffectgtumigeneTheprogrmmtnpproximtelyequlmixvedpekerpekerelectedbtrctubmtedprg2024nemphbrodpenttipekermultipledciplecertgedemogrphicgeogrphicbckgroundOurKeynoteSpekerDrBndnHrleylederdeigngbiomimeticmodeltummicroenvirmentfocuglioblmmultimeAnterctivepneldcuifocuemerggtechnologietummicroenvirmentfieldAllteerly-tgevetigrhveopptunypentirwkpoterblzlpenttieiIndditwopotereiwhichllowllprticipntctriemeetgnetwkNtrnZhirPhDBrnchDicrCenterCncerTrgtNCIpenttefocuedpenttierly-tgegrnpptuniehoneroundtbledcuifocuedtecerdevelopmentFundgthroughthR13mechnmqueteddefrycotprticiptgmeetgerly-tgevetigrteWeexpecterchertudygvrioupectcncerbiologymicroenvirmentcultivtenewcollbtiteidentifynewmenrultnetwkgopptuniethmeetgABSTRACTSupptquetedKeyneSympoicfenceentledMicrobiotCncerImmunygnizedDrGigioTrchieriJennyPYTgHg-JienKungThecfenceheldTipeiTiwnMrch17-202024Thecceptflmmtiglkedtumpromotummicroenvirmentihevolvedcludecomplexnetwkterctintecquidimmunepetummetbolmtumimmunecellloclytemiceffectmicrobumpdpoipromotiperpiefllycncerco-mbidierpeuticideeffectThemetbolictumvirmentffectctivymetbolmimmunecellwhichmodultetumprogiperpiecludgimmunpychempyrdipyInnteignlgloffecttummicroenvirmentcomplexcrotlkvolvgnteceprtdimmunyclIMjHcomptibilyComplex(MHC)gultebothflmmtinti-tumimmunyFurrdvnceexperimentlnimlmocentlycncerptientunrvelgcomplexterctitweenmicrobiottepililurfceprimrytummettticeperpyeightpoibilypdictgptientpevriourpietrgetmicrobiotimprovgrpypedecgxicypventgco-mbidyTheenewcientificfetudthcfenceprogrmbrggerpectcncerbiologyimmunytenlydcuedteprtepecilizedmeetgexpoeudiencebiccliclvetigrenewcceptThecfenceloexploclicltrnltierpidlyemerggightcncerimmunobiologywhichcludewkhopentledEffectRceEthnicyMicrobiomeImpctCncerHelthDpriefocuttentihelthequypicltedcncerrpeuticpemgethnicllydtct/ddvntgedpopultiABSTRACTSupptquetedKeyneSympoicfenceentledCncerImmunpyBeydImmuneCheckpotBlockdeOvercomgRetncegnizedDrJmeAllAndSchietgerAnniRibPdmneeShrmThecfenceheldBrhColumbiCndMrch17202024Immunecheckpotblockderpy(ICT)hprovidedltgcuubetptientpecificcncerAttemptexpICTwrdptientcncerhveledomelimtiICTprticulrlympieThmeetgdcuomethoelimtiuchguplelernedfiledclicltrilmechnmtnceICTnewtechnologiewhichferpromemocompheniveundertgtum-immunepeAtrgemphloplcedexplgtum-immunyydTcellbiologyAtterundertgwhyimmuno-cologyclicltrilhvefiledptexpectedttermbiccienttdeignp-clicltudiemyguideimprovedclicltrilvoidmtkeptFurrelucidtimechnmthroughwhichcncereirfrcryilttmentICTgtnceovertimehouldprovidevenuepdictrtillydeignedcombrilttmentmghunddthoumillipotentilcombtiFllynewtechnologiecludghighdimenilptiotemplimggTcellengeergprovidenewopptunieexpourknowledgeimmunologyrpeuticperiometimeunexpectedwyThmeetgbrggercienttclicinmnypecttumimmunologythknexttepevoluticncerimmunpyItexpectedprovideprgbdwrdbicciencedcoverienewmoeffectiverpieProjectSummry/AbtrctThpplictieekupptFASEB(FedertiAmericnSocietieExperimentlBiology)ScienceReerchCfenceentledNuclerBodieHubGeneExpiThemeetgheldJuly24-282024tNigrFllNYThcfencebuilddictlymomentumpdeceFASEBmeetgheld2022NuclerbodieubcellulrtructucompoedproteRNAtypicllyoccupypcetweenterphechromoomeTheyhveenimplictedmnypectgeneexppot-trncriptiltgeFollowg2022meetghencedttentiltihiptweennuclerbodiehumeeprticulrlycncer-thpicmjfocumeetgInddibiophyiclphenomenliquid-liquidpheeprtiwfoundmjdynmicfetunuclerbodiethecdmjmemeetgTheprogrmh41cfirmedpekerwhomhlfdidnotttendfirtmeetgAepproximtelyethirdcfirmedpekererlycercientt(defedgrdutetudentpot-docrlfellowAtntP)TheprogrmcludeKeynoteLectuDiveryEquyIncluicellbiologylgCerDevelopmentMenrgeiAddilpekervtimdethutumnubequentlyubmtedbtrctThenticiptednumrprticipnt75-80ThegnizerpprochgnumeroucompniefoundtiddilupptgerfundgprovidedFASEBdecridbudgetectipplictiSimilr2022meetgcientificpt(FASEBJ36(11)e2258doi101096/fj202201455R)cfencepublhedAbtrctAinAmericnftetgrowgmotdivereUSrcil/ethnicgroupTheyhveuniquedprteptterncncercludggfirtUSrcil/ethnicgroupwhomcncerledgcuedethTheircidencecertcncerfrexceedthoegroupcludglungcncermgnevermokgfemlenophryngelcrcomCheeAmericnlivercncerSoutAinAmericngtriccncerKJpneeAmericnthyroidcncerFilipoAmericnCounterpvilgviewAinAmericnhvehighocioecomicttufvblehelthcertgrouphvehighrtepovertylowhelthcccelowrtecncercengAwecknowledgeimptncelivedexperienceAinAmericnpopulticludgchrictwergduehricltrumnti-AinrcmcclimtgetblhglifenewcountrynvigtgunfmilircomplextutihelthcytemwepropoeprdigmhifttudiecncerrkcludeexmtitructurlocildetermnthelthpecificAinAmericnpopultiWepropoeetblhntilASPIREASinAmericnPropectIveREerchcohtgng20000menwomenge40-75(cluivellAinAmericnethnicgroupthoewhomultircil/ethnic)vifocuedcommuny-enggedcrumentixgicompmothnthirdAinAmericnpopulti(Clini(ByALoAngeleOrngeCountyScrmen)NewYkMetro/NthJereyGterPhildelphiMetro/SouthJerey)ddintiloutchUSgiThpopulti-bedcohtclude1)multipleAinAmericncommunie2)collectidnhelthhviexpoucrolifecoure3)detiledmtitructurlocilenvirmentlfcr4)novelementepigeneticge5)pcidptivedeigndeveloptprcticecommuny-enggederchtrdillyundertudiedethnicgroup6)methodologicerchnlyticpprocheemllpopultiterectilyThcohtupptedntilnetwkerchercommunyprtnercommtedAinAmericnhelthwell-gWeuetrnpntequbleproceemgcientificcommunycollbrmerchpriiedtcollectihrgdemtimelyctiblepolicy-levnttudyultTheASPIRECohtthuubleddmulti-levelctriburuniquecncerburdenexperiencedAinAmericnpopultiThfirtpheddtructurlocildetermnthelthirimpctmultiplepthwycncericider1)helthcccecncerceng2)cncer-levnthelthhvi3)ocilepigenomictembodimentTheultimteviASPIREerverichctempryepidemiologicourcedvnceourundertgcnceretiologychievehelthequyAinAmericnpopultiTheGdReerchCfence(GRC)SignlgAdheiReceprwetblhed2000hcomepmiermeetgcellulrdheibiologymechnobiologyirlevncedevelopmenthomeotdeeThe2024meetgubtledAdheiGrowthFcrReceprHelthDeeheldJuly14July192024tSournNewHmphiUniveryMncheterNHThemeetgChirDrAlexerDunnDrPtrickDerkenDrMddyPrTheechirledgvetigrfieldcellulrdheicncerbiologyprovidecomplimentryexperteefieldApromentnewgolthmeetgcouplefundmentldcoveryciencecliclcncerdignottmentApvioumeetgweimdemteltetdcoverieccerngmechniclbiochemiclcrotlktweendheigrowthfcrceprwellhowetwoceprcleterctctextmultipledeeAddillywehighlighngogdevelopmentnoveloltechniquepromeccelerteprogourfieldWelikewelookwrdhowcgner-phyiologiclmodelgtterundertdevelopmentdeecliclpplictidheigrowthfcrceprmodultiLtlyweemphizeemerggpicfieldThterdciplrymeetgplyneentilroletigtgfotergcollbtimgcienttdiverebckgroundbioimggbioengeergcncerdevelopmentlbiologyTheeterdciplryterctiprovidepowerfulmenuncovergcommliehowdruptiignlgtcellulrdheicomplexectriedeetypicllytudiedeprtetellectulcommunieSpekercludeetblhedlederfieldwellyoungpromgvetigrInddiplenrytlkmeetgfetumlterctivepotereiWehveloplnnedfternofciltemlenggementmgtevetigrWehveedcceptclledwlkPI(troduced2022meetgChirweDrAnnMillerPtrickDerken)whichjunicienttgivenopptunyenggeeniledere--eeiImptntlytl10junicientt(tenewlyppotedyoungvetigr)vedgivelpenttipolicyctriemenrgcultumeetgAnimptntfetuthmeetgmcfencepcededtwo-dyGdReerchSemr(GRS)plnnedpdocrlpotdocrlteTheGRS(ChirDrTimoKohlerFernoVlenci)provideumfutulederfieldpentirwkthroughlpoterpentticollegilterctiveenvirmentIndderctiledercdemidutrygovernmentprovideGRSprticipntmenrgimedtdvncgcereexceptillypromgyoungcienttProjectSummry/AbtrctTheGdReerchCfence(GRC)Sympoium(GRS)RdiuclideThernoticMngementCncerrpidlyemerggfielddignoticrpeuticcologyheldJuly6-122024ThecientificgolthmeetgddchllengedvncementrdiuclidernoticfieldcncerTheugurlGRScompenttrgetpcliclciencewheGRCcompenttrgetclicllytrnltedciencempletimedcuiOurimctehybridpcerdioimmunobiologycncerttrctignificntnumrttendee(250)cludgcientttudentphyicincdemicompniedevelopgRdiuclideThernoticviblecfencectgfutucommunyTheuniquemtGRCGRSllowgprticiptipplictiencourgementhunpublheddtfotergdcuitweeneicteopptunymlmltercticollbtilikelyhveignificntutedimpcnfieldWewnegfundmentltrnmtiunpcedentedgrowthferpcentumlrpiedignoticwhilecgwnequlylifemimizedxicyideeffectprileTodymothn100phrmceuticlcompnieover250ctiveclicltrilugtlphgmmemtgrdiuclideupptednlyprivtentillbrieDOE(deprtmentenergy)AclerlyeenfieldRdiuclideThernoticdependcollbtitweencdemifederlprivtegniztimutulimchievgimprovedptienutcomeFundNIHR13cfencegrntpecificllytrgetedpromoteprticipticfencewomenunder-pentedmiepeopledbilieprticulrlygrdutetudentpotdocrlfellowerlycervetigr2024AUAOFFICEOFRESEARCHUROLOGICONCOLOGYRESEARCHSYMPOSIUMImplementtiScienceTrnltgCliclStudiePrcticePROJECTSUMMARY/ABSTRACTThpplictiquetuppurnnulUrologicOncologyReerchSympoiumdurgAnnulMeetgAmericnUrologiclAoci(AUA)heldFridyMy32024100pm500pmSnAnnioTXThe2024picImplementtiScienceTrnltgCliclStudiePrcticebrggerpieerimplementticienceclicltrilurologyeductefoterterctitweenurologtphyicinercherwhomnge/tudymlignnturologicldderTheympoiumbrglteterchdvncementimplementticienceclicltrilurologywldlrgetgrgntilterntilprivtecdemicprcticephyicincientterchertllcertgewellhveimmedepplicbilymlignnturologyerchErly-cervetigrcompignificntproptiympoiumpenterudiencepotereiprovideddilcientificdcourePropoedeipicclude1Improvgcductefficiencyclicltrilimplementticience2Implementgrk-lignedblddercncerurveillnce3Improvgproductivecimplementticience4Optimizgmokgcettmentptientblddercncer5Fciltgevidence-bedurgiclprcticeThePrciplInvetigrthprojectChrteRidnPhDLCSW-CAUADicrReerchProgrmPlnngChirShellieDEllMAPhDAocePUniveryKnMediclCenterTedSkolruMDMPHFACSPSurgeryUniveryChicgoAllfcultypoeexemplrycdNIHerchfundgmenrgteplnngurologyercheductiTheProgrmChirpriizedcidertircilethnicgender/genderidentyexulienttintilyculturlligiouge(d)bilycertgeocioecomicbckgroundccdnceDiveryEquyIncluiSttementReerchEductiCfenceCommunictiCommtee(RECCC)Supptthympoiumprovidetrvelwrdpproximtely20teerly-cervetigrLivercncermmjchllengeUSover41000newce30000dethnnullyHepcellulrcrcom(HCC)primrymlivercncerdevelopctextprogivechricliverdee(CLD)cludgn-lcoholicfttyliverdee(NAFLD)TheetiologyHCCnotfullyunderodupe-thirdUSptienthvenoknownrkfcruggetgyetuncognizedcueCynobcteriubiquiutertrilquticecoytemcludewiderngepecieproducgliverxtum-promotgpotentillycrcogenicpropertiecludgmicrocyt(MC)nodulr(NOD)cyldropermop(CYN)welllrgelyunchrcterizednnopept(AB)TodteveryltledictknowledgepotentilrolecynobctericynoxetiologyHCCOurnovelwkcommunieUSPcificNtUSCentrlAmerichveyieldedcompellgevidenceupptgrolecynobctericynoxexpoudevelopmentNAFLDHCCOurhighlynoveloverllhypopocynobctericynoxexpoucerkHCCdependently/terctimetbolicrkfcrWepropoenetedce-ctrolvetigticidentHCCce(n=1194)mtchedctrol(n=1194)cidentCLDce(n=824)mtchedctrol(n=824)pdignoticexpoudtbiopecimen(bloodulmpletumtue)fourwell-chrcterizedUScohtcollectivelycompdident30UStte5rcil/ethnicgroupThelbcterilmicrobiomefocucynobcterichrcterizedug16SrRNAIllumMiSeqpdignoticlDNAmpleHCC(n=334)CLD(n=164)cectrolevlutedirociHCCCLDrk(Aim1)MC/NODCYNABmeuddictcompetiveELISApdignoticmpleHCCce(erumn=458un=216lmplen=201)CLDce(erumn=440un=220lmplen=164)ctrolevlutedirociHCCCLDrkubetevlutedliquidchromgrphympectrometrydtctiMCNODmcgener(Aim2)SigntucynoxexpouHCCtumevlutedNnotrggeneexpi(n=98)(Aim3)OurpropoedtudyhighlyignificnthcriclimmedeimplictipublichelthUSglobllymymfutupoliciegrdgenvirmentlurveillncetetgcynoxwelltrtegiemigtehumnexpouProgrmDicr/PrciplInvetigr(LtFirtMiddle)TglibrcciVS/YffeMProtephophyltiplyvlrolecellulrcommunictigultgcellulrttectivyItdynmicprocectrolledkephophtewhichpcelygultedhelthycelldygulteddeelikediteflmmticncerThetudyprotephophyltiignlgfunctirpidlydvncgfielddrivgmethodologiclcceptuldvncementctrigrpeuticdevelopmentIncncererchprotekefquentlydegultedhvegedignificntttentiphrmceuticldutryMnyFDA-pprovedcncerdrugtrgetkenumeroukehibircurntlydevelopmentThclicllevnceetblhenexcgcnectrnltilcienceToupptdvncementknowledgethfieldweeekfundgenblettendncetejunifcultyunderpentedgroupt2024FASEBSummerReerchcfenceProtephophyltihelhdeeThbiennilcfencewhichgn1983ervekeyterdciplrygrgbrgggercienttdivereexperteItfocuepecificllybiochemiclmechnmfundmentlprciplephophyltiettgprtcfencefocuignlgnetwkytempprocheTheFASEBmeetghrichhrynnouncgbkthroughimenhncedemteknowledgecnledimprovedrpietrgetgbnmlkectivyprotephophyltihumndeeThe2024FASEBScienceReerchCfenceProtephophyltihelthdeehighlightcuttg-edgedcoveriefieldByungdcipleuchtructurlbiologybiochemtryytembiologychemiclbiologyproteengeergmedicecfencefoterterchngeidetimultenewerchdictiOurobjectivecludepromotgcommunicticollbticerdvncementdiverecienttfieldUltimtelyweimdvnceourundertgmoleculrmechnmgoverngvlbiologiclproceeidentifycricltrgetdignopventtmentcuhumeeOMBNo0925-0001/0002(Rev01/18ApprovedThrough03/31/2020)PgeCtutiFmtPgeABSTRACTAmjchllengecncergenomiccommunydetermgwhichomticmuttictrigtumigenewhichpenger(neutrl)muttiwhichmuttimperlizedttmentdeciUntuntelymotfunctiltudiecncermuttihvelrgelyignodimpctltedRNAprocegeventhoughthltertiwidepdcncermechnmbothcogenerpeutictnceWehypoizewemgcriclmtiboutcncergeneltertiwhennotcidergm-pecificfunctithlikelyffectcncerttmentGivenbdthlckundertgm-pecificcncergenefunctihigh-throughputpprochevllyneededidentifycncergenemvrintfunctillychrcterizeireffecncncerdevelopmentttmentAim1thtudygenertecompendiumhumnpn-cncergenemvrintpermglg-dtrncripmeequencgpnelcncercellleprimrylungtumbuildcompheniveetllele-pecificfull-lengrncriprmAim2identifygenemvrintocedtncevriblepetrgetedrpieptient-derivedpecimenxenogrftmodelAim3permhigh-throughputvrovivunctilchrcteriztiemdrivgcogenedrugtnceoutomticmuttiidentifym-pecificvrintfunctiAlleimfocugeneRAS-RTKpthwycethmotfquentlymuttedcogenicpthwyctmnytrgetblegeneComplethtudyvolutiizeourundertgm-pecificfuncticncergeneirctriicogenecncerttmentOurpprochprovidecncererchcommunymuch-neededfrmewkmethodologycncertudieprovidecriclightmechnmtumpetncecncerrpieABSTRACTPncticductldenocrcom(PDAC)lethlttment-frcrymlignncychrcterizedfibroblt-richtromWhileexternlmrdirpy(EBRT)tplecurntttmentPDACrpeuticefficcylimednmltuexiciebilytrgetmettticdeeTrgetedrdiucliderpeutic(TRT)prticulrlylow-moleculr-weightcrrierfernvenueimprovedeliverblerdidoerpeuticefficcycompdEBRTelectivelytrgetgtum(bothprimrymetttic)ubtntillyducen-trgetxicieThefibrobltctivtiprote-(FAP)electivelyexpedtum-ocedfibroblttummicroenvirment(TME)PDAC(~75%)mlignncieSeverlcliclimggtudiehvevlidtedpotentilmllmoleculeFAP-trgetedctruct(eg68G-FAPI-46)HoweverrpeutictrnltiFAP-TRThfiledmlydueirlowtum-iduliztiwhichdimhedeliverblerpeuticdoerpeuticefficcycliclpotentilRecentlywehvedevelopednendolyoomltrppgpprochlinndductmticyteeproteecetumiduliztiTRTubtntillyUgthdductmtipprochgolthpropoloptimize177Lu-225Ac-FAP-trgetedTRTctructobtgterundertghowPDACbiologyimpctdductmtidemtrteourctructrpeuticefficcyfetyPDACmodelundertimpctFAP-TRTPDACtummicroenvirmentcompctrtbiologicleffect177Lu(-)v225Ac()bedFAP-TRTAnchllengeFAP-trgetedrpieemergeheterogeneouexpidequcypcliclmodelcpultevribilieFAPexpiWehvegenertedpnelhumnimmtlizedptient-derivedpncticfibroblt(iPDPF)cpulteCAFheterogeneyvribleFAPexpiWehvelodevelopeduniqueCAF-tumcellco-implnttimodelultFAPhighFAPlowtumWehypoizecptgcyteeproteetrppggent(CPTA)tructuFAP-trgetedgent(FAPTA)llowmtrcellulrdductcpbledeliverghigherrpeuticefficcythroughenhncedPDAC-pecifictentiTotetthhypotwopecificimpropoedAim1focueoptimizg177Lu/225Ac-CPTA-FAPTAexmgdductmtidtriiPDACmodelStudieAim2deignedevluterpeuticefficcy177Lu/225Ac-CPTA-FAPTAvetigteimpctFAP-TRTrpyCAFheterogeneyWepropoeemploycuttg-edgepprochemodeltudybiodtriicellulruptketrffickgdductmtidoimetryrpeuticefficcy177Lu/225Ac-CPTA-FAPTASuccefulcompletipropoedtudieprovidecricldtquidprognovelFAP-TRTwrdgulrypprovliclicltrilfutuThe2024AnnulMeetgAmericnSocietyInvetigtivePthology(ASIP)heldApril20-23tRennceBltimoHrbplceHotelBltimoMDTheAnnulMeetgASIPprovideuniqueumpenttihrgcuttg-edgeerchexperimentlpthologyThetrgetudienceubjectmttermeetgdivereunedcommfocumechnmdeeReflectgtetASIPmemrhipfour-dycientificprogrm2024AnnulMeetgcompdmjympoiwrdlectuwkhopguetocietyympoipecileicovergdeepthogenebiomrkerdevelopmentpventidignorpeuticdvncedtechnologiegnytemytembiologyThprogrmcttrgcompentcncerpthobiologyMjcncer-ltedeifocu(i)CncerOy(ii)SptilTrncripmicHumnSpecimen(iii)CuttgEdgeTechnologieFutuBtCncerPventiDetectiSceng(iv)MetbolmCell-cellCrotlkChricLiverDeeLiverCncer(v)ArtificilIntelligenceBiomediclReerchInddiASIPOuttgInvetigrAwrdLectuhvepecificcncer-focuOxygenSengSignlgCncerThePtPentFutuAddilopptuniepentticncer-focuederchcludebtrct-drivenmympoipoterdcuieiwhichtentillyfetuyoungvetigrtecienttTheprogrmfurrprovidenumreifocuededucticerdevelopmentTheeeideignedteyoungvetigrbupenllttendeeEducticerdevelopmentpic2024clude()RecognizgRcmGrdute/MediclCurriculum(b)BuildgPoiveProductiveReerchLbryCultu(c)PrcticlApplictiArtificilIntelligenceInddiWomenPthologyholdpecileiPowerfulQuetiCnectgCollbtgBuildgCfidenceTheASIPgrdpromoticerdevelopmentteyoungvetigrnextmelyimptntpectAnnulMeetgAccdglymeetgprovidenlypecileventdeignedirneedloeihighlight/howceirwkSimilrlyProgrmCommteewkhrdenudiverymgprticipntpectgenderethnic/rcilgrouptgecertutilffiliF2024mgvedpeker42%women55%Atnt/AoceP(equivlent)90%mjeicludepekerwomenunderpentedTheolepecificimthpplictipromoteprticipteyoungvetigr2024AnnulMeetgthroughproviScholrAwrdprogrmtrgetedgrdutetudentpotdocrlfellowcliclident/fellowjunifcultymemrProjectSummryThe2024GdReerchCfenceMutgeneexplocuttgedgeerchmechnmcequencechngegenomicequencegnmcropecieDepegwell-etblhedcfenceMutgenemefrtpicbridggtrdilboundriemnyfielddotuullyterctechAltertigeneticblueprtngnmdrivemnypectbiologyuchvirltrictieffectivedptiveimmunycnhveerioupthologiclcequenceuchntimicrobiltncedevelopmentgglteddeedrivgcncerdmpengeffectivynti-cncerrpeuticImptntlycommmoleculrmechnmlkeppntlydivereproceeToexplocriclmutgenemechnmmeetghighlightwiderngeexperimentlpprochebicgeneticmoleculrpprochedeepequencgglemoleculebiophyicbrgggercienttllcertgebckgroundTheGRCcomp27vedpeker(junieni)28lottlkelectedbtrctwellnterctivepotereiwhichummrizedllypentertwoflhtlkpenttiInddiGRSwhichpcedemcfencehvefurrlpoterpenttiopptuniepecificllygrdutetudentpot-docwellcerpneldcuiApowerhourmmeetgfocuchllengefcgwomencienceugeppropreproun(LGBT+communy)nvigtgcommunicti-ltedchllengetweentemenrWeimfoternterctivefriendlyenvirmentwhichidecnfelyexchngeddependentlybckgroundeniyToendeiwkgmelupplementedvigouocilprogrmfotereterctiTheGRCprogrmgnizednemngevengeitled(1)Criclmutgenemechnm(Keynoteei)(2)Replictik-ocedmutti(3)DNAdmgemutgene(4)Trncriptiocedmutgene(5)ThefluenceDNAequencemutgene(6)Mutgenemechnmcncer(7)HowexogenouendogenouDNAdmgeledmutgene(8)Brrierducedmutgene(9)TheultimtecequencemuttievolutiTheGRCGRSthupromoteexchngeltetidetechniquebrodfieldmutgenedrivenewidecro-fieldcollbtiwhileenhncgpromotgcernextgenerticienttthexcgimptntfieldABSTRACTThemiAmericnSocietyPventiveOncology(ASPO)exchngetrnlticientificmtiducecncerburdenctueddevelopmentvetigrvolvedcncerpventictrolThe48thASPOAnnulMeetgheldtSwtelChicgoMrch17-192024Thepecificimnnulmeetgthcfencegrnt1)providemultidciplryumexchngecientificmti2)foterimplementtibrodendemticientificdcoverie3)provideexceptilpildevelopmentvetigrtnycertgeepecillyerlycervetigrmximizeirpotentilucceThpplictiquetprtiluppt2024AnnulMeetgwhichkeynethmultidciplrygniztipventivecologycommunyASPOnnulmeetgprovidehigh-qulyprogrmfoternewopptunieerlycermid-cerenivetigrwhoecerfocuedprimryecdrytertirypventicncerThe2024Meetgct4ympoi2lunchroundtbleei2wrdlectu4SpecilIntetGroupbkfteinetwkgmixertwopotereiCommunyScienceprogrmfotercommunyenggementAwenerASPO50thnniverrythyerweddedneweype-newmtwecllgLookgbckthkgwrdeeikickedfenivetigrfollowed4junivetigrteflhtlkelectedbtrctubmiP-meetgwkhopcludemultiplepildevelopmenteimeetgcncercenterAoceDicrProgrmLederCncerPventiCtrolmeetgNCItrggrntdicrMeetgplnngtketfctiurveypviounnulmeetgccountAbtrctolicedgngAugut2023The16btrctceivghighetpeerviewedrnkgpublhedCncerEpidemiologyBiomrker&PventipenteddurgppereipotereiMultipleivecludgthcfencegrntwhichquettrvelupptmyvetigrerlycercienttcommunycientt/dvocteenhncediverymeetgttendeeprogrmcommteevedpekerAllmeetgheldn-mokgADAcceiblecfencefcilieJournlledvertementemildictmilpublicizemeetgOver400prticipntexpectedttendSpekerprticipntmultipledciplecncerpventictrolerchpentfieldccernedtrnltgevidenceeffectivepventictrolprogrmByfotergcommunictimgmultidciplrypilASPOmeetghveenextrdrilyuccefultchgSocietygolupptgmenrgencourggdiloguepromotgnovtiveprogcncerpventictrolEchyerpproximtely90000dolecentyoungdult(AYANtilCncerIntutedefedge15-39yertcncerdigno)dignoedcncerDepecgcognhver10%AYAhrbpthogeniclikelypthogenicgermlemutticncerpdpoigeneweknowmnyAYAdotgetgenetictetgprticulrlytcenterwhelimedccegeneticerviceFocuedeftdeliverygeneticervicecommunyettgwhemnyAYAceiveircneededimproveoutcomethpopultiToddthimptntgpgenetictetgmgAYAddneednovtiveeffectivemodeldeliverygeneticervicecommunycologyprcticewepropoenenhncedmultimodlyeHelthmotegeneticervicedeliverymodelcouldceuptkegeneticcounelggenetictetgmgAYAOurenhncedeHelthdeliverymodelbuildupltederchdemtrtghighuptkeweb-bedp-tetcounelgnlterntivep-tetcounelggeneticcounelnodiffenceptientptedoutcome(R01CA190871Brdbury)Furrwepropoecptechtbottechnologyourweb-bedlterntiveddptient-pecificqueticeenggementprovideervicemdereductilupptthroughoutdeliverymodelTheoverllgoltudyevluteifourenhncedeHelthchtbotenbleddeliverymodelcnceuptkegeneticerviceproviden-feriptientptedoutcomecompdtrdmodelmoteerviceWecruAYAptientthroughNCORP(NtilCncerIntuteCommunyOncologyReerchProgrm)Wepropoeromizedtudy396AYAcncerptient(18-39YOtenrollment)communyprcticeevluteefficcynenhncedeHelthchtbotenbleddeliverymodelcompdmotegeneticcounelgtetgceuptkecncergenetictetgAYA(Aim1)InAim2weevluteefficcyenhncedeHelthchtbotenbleddeliverymodelproviden-feriht-termlgudlcognive(egknowledge)ffective(egdt)hviloutcome(egcncercengcommunictiltive)cot(Aim2)moderreht-termlgudlptienutcomeundertwhonefmoledeliveryterventi(Aim2b)CcurntlywecductCFIR(ColidtedFrmewkImplementtiReerch)-medproceevlutiundertmoderrterventiugeptienutcomefcilrbrrierfutuimplementtiutbilyedeliverymodelAYAcncerptient(Aim3)PROJECTSUMMARYCommunyoutchenggement(COE)hcomegoldtrdddghelthdpriecloghelthgpmizedmrglizedcommunieTheNtilCncerIntute(NCI)encourgellNCI-deigntedCncerCenterfoterhCOEknowledge-betprcticeoldoptidpttiimplementtiNCI-deigntedcncercentercientificcommunypublictlrgedvnceproggtburdencncercncerrkfcrUntuntelyhveenlimednti-wideopptuniefciltemutullerngCOEknowledgetprcticeolCOEdmtrrCOEercherCOEpilcncerurvivcncerdvoctecommunytkeholderTheScienceCommunyOutchEnggement(SoCOE)cfencepropoedAllinceBlckCOEScientificDicrwholedCOEOfficeProgrmeverlNCIdeigntedCncerCenterervgmyrurlmrglizedcommuniecroUnedStteTheprimryobjectivecfenceprovidepltmCOEcdemic-communytkeholderhtprcticecommendtiddequiecncerpventierlydetecticurvivhipBlckcommunieAfive-yercfencefundgquetedupptSoCOEcfence1tcfencepropoedhotedMyoClicCompheniveCncerCenterVirgiCommwelthUniveryMeyCncerCenterMy8102024FlidUnedStteSubequentcfencefocuAddgRcmDcrimtiCncerCReerch(2025)InnovtiveApprocheSocilDetermntHelth(2026)PciOncology/GeneticCncerC(2027)CommunyOutchEnggementStrtegieGloblOncology(2028)LedouttghelthequyercherCOEcientificdicrSoCOEcfencefoterdevelopmentutbleculturlly-piveourcefcilteCOEBlckcommuniecludg(1)humncpl(2)fnce/fundgmechnm(3)effectivecrumentenrollmenttentipproche(4)mtiytem(5)gulrypthwy(6)tutilcollbtiAddiltngibleoutcomepublhedmeetgproceedgcollbtimgcfenceprticipntcedexpertemgprticipntWeexpectmimum250delegteprticiptecfenceProjectSummry/AbtrctCAR-TcellrpyhdemtrteduccecurgBcell(CD19+)mlignnciehhownpromettglupuHowevercyxicht-livedntuCAR-TcellulteveideeffectimmunopthologyducerpeuticvluethcotlyrpyThenurgentneednoveltrtegieelicpotentpertenttum-pecificeffecrmemyTcellpemimizef-trgetxicyCAR-TrpyThmkeourwkhighlyignificntTcelldevelopmentfunctihomeotgultedTcellcepr(TCR)ignlwellcykeuggetedproptilTCRignltngthYetexceiveTCRctivticyketimulticntriggexceivecyxicTcellctivticugimmunopthologyrpidexhutinti-tumimmunyOurplimrydthowIL-2-ducibleTcellke(ITK)keygulrTCRignlgnegtivelygulteCD8+TcellhomeotticexpnieffecrmemyfunctiThebenceITKultedenhncedeffecrcellfteprogrmmgntigenenivynti-tumimmunyCD8+TcellmiceOurpilotexperimenthowdeletiITKhumnCAR-TcellloultedimprovedproductiCAR-TcellignificntlymoutblevrohvedequtetumkillgctivymimltuecyxicyWehypoizeITKignlgcnmodultedpromoteCAR-Tcellexpniurvivllg-termnti-tumctivywhilelimgeffecrcyxicyWepropoetwopecificim(1)determeITKroleCAR-Tcellexpnifunctifety(2)developnovelclCARmoleculectgmodulrydomITKignlghibiOurwknovtiveupptedexcgplimrydtchllengecventilthkgVlidtgthhypounveilITKrolelevntignlgpthwybiomrkerCAR-TcellproductifetyefficcyWelopropoedevelopgnovelclCARmoleculectTCRignlgmodulrwhichfurrourundertgCAR-TcellignlgenblehyproductifeeffectiveutbleCAR-TcellCompletipropoedwkddourknowledgenewmoleculrprcipledeignimprovedCAR-TcellproductifetyrpeuticefficcyOurp-cliclultdictlytrnferbleundertghumnCAR-TcellbiologyhvepotentilimprovgCAR-TrpyAbtrctThepurpoethR13ubmiquetfundupptlimednumrtedividulidentifygunderpentedmie(URM)junivetigr-vedpekerthoefmilycrgpibilieprticipte2024FASEBScienceReerchCfenceTheBiologiclMethyltiFundmentlMechnmHelthDeeTh15thFASEBSRCBiologiclMethyltiheldtShernPHotel28thJuly-1tAugut2024TheltFASEBmeetgwheldCtniItly2022wheDrDvieDrGeweelectedco-chirwkjotlyPrVnRechemPrStrhlwhotwoco-gnizer2024The2024cfencebuildupcientificexcellencepvioumeetgbrgggerdiveregroupcncerdevelopmentlbiologtchemtcomputtilbiologtbothclicinbiccienttcdemibiotechThevenuecientificprogrmfoterterctitweenprticipntdiffentexpertecertgePviouevlutihvernkedthcfencehighlyouttgpenttimpletimecientificterctidcuicollegiltmophefotergmenrhipcollbtihighimpctpekerwhomentidurticfenceWecommtedcgnumrbtrctelectederlycerercher/potdoc/te/URMprovidepltmhtpenttipotereiufficientfetimefotercollbtiThe2024progrmcoverllmjhightetfieldbiologiclmethyltiuchlyergemethyltiDNAmethyltinovelRNAmethyltiTheeprticulrlevntfielderchgivencentpromgclicltudieeverlmllmoleculehibircncerrpyOreidcutructufunctiRNADNAprotemethyltrnfere/demethyleirrpeutictrgetgDurggnizedeitlunchttendeehveopptunyMeetExpertdcuCerDevelopmentAfterveryucceful2022Womenciencewkhopweueimilrmtexpedcludedcuiboutwk/lifeblnceToummrizepecificgolthcfence1)Provideumpenttiunpublhedcuttg-edgeerchvetigrdiverefieldpplicblebiologiclmethyltibothcdemiphrm2)Providenopptunycientttudygdiverepectbiochemtrytructu/functideelevncemethyltidcucenterchdevelopmentecollbti3)Enudevelopmenttegrtiyoungvetigrdiverebckgroundthoetrdillyunder-pentedefieldbrodererchcommunyAbtrctChromoomlendhrbpetiveDNAequencetermedtelomecognizedheltercomplexmlrtructuclledT-loopwhichprotectvlgeneticmtipventerro-neouDNAdoubletrbkpirEchcelldivietelomehteneduntilychcr-icllyhtlengthcugcellulrpopenecenceThhtengcncounterctedribo-nucleoprotetelomerewhichfunctimttelometegryelgtg3endtelomeBecuethfundmentlroleplyedtelomerebout85-90%llcncerupgultetelomerelengntelomechieveimmtlyTheeundertgtelomebiologyhowtelomeremttelomeendvlundertgcrcogeneOneuchtelomericchngeertiribucleotide(ribo)telometelomereRibopentmotpvlentmgenomicDNAdmgeUnpidgenomicribolkedmultipletypecncerourcePARP-trp-pgleiwhichcncompromegenometbilySimilrgenomicriboriboertedtelomerettelomehighlyuceptibleptneouhydrolymypromotepmtutelomehtengthroughtrbkgeHoweverbiologiclimpctribotelomehenunexplodThprtcuetroducgribottelomeoutltergtgenomehnotenpoi-bleWehveovercomethlimtidevelopgtelomeremutnthighlyenhncedriboer-tiidentifiedcncerocedtelomeremuttimodertelyenhncedriboerttelomeWehypoizeribopentttelomeimpcttelometegrydetbilizetelo-merchectuctivteribucleotideexcipirToddthourcollbtivetempro-poecellulrbiochemiclgle-moleculetructurlgenomeribomppgproteomicpprocheInAim1wevetigtelevelribotelomeimpctribotelometegrycellulrvibilyhowribotelomelterDNAdmgepettelomeendInAim2wedeter-mehowtelomericribolterbdgheltercomplextelomericDNAhowriboltermtitbilytelomeredependentolutiG-qudruplexeInAim3wevetigtehowribotelomeidentifiedmovedpidribucleotideexcipirpthwyThpplictilevntcncercue(1)chngetelometegryocedncedrkcncer(2)penceunpidribolkedcncer(3)ignificntgpourun-dertgimpctribotelometegry(4)ribolikelypromotetelometbilywhichwouldduceextenivechromoomltbilydrivemlignnttrnmtiurvivgcell(5)wechrcterizgcncer-ocedvrintenhncedriboerti(6)undertghowriboltertelometegrymtennceiddevelopgtrtegieprotecttelometegryPncticductldenocrcom(PDAC)motdedlycommcncerlimedttmenptiChempymrgllyeffectivewhiletrgetedimmunologicgenthveltlenefWecentlyhowedwild-typeIDH1(wtIDH1)quidPDACcellurviveirhrhnutrient-limedmicroenvirment(TME)ThecyolicenzymeIDH1cvertocrte-keglutrte(KG)ugNADP+ccrInettgnutrientcrcyctiproduct(NADPHKG)helpneutrlizeferdiclbootmichdrilfunctipectivelyUnderTME-ocedcdiwedcovedllotericIDH1hibirdeignedpprovedelectivelyttmutnt-IDH1tumctullytrgetwtIDH1enzymeTumhveverylowMg2+levelwhichpermdruglikeFDA-pprovedivoideniboutcompetectillotericpocketledgcedefficcygtwtIDH1PDACcrotummodel(eeNtuCncer2022)Whilenti-wtIDH1rpypromgepecillycombtichempythpropolweidentifyprcticlfechemo-prgttmentthptimizenti-wtIDH1rpybedourcentlycquidightSpecificllytrtegie(phrmcologicdietry)furrenhncePDAClincentioxidntdefenemichdrilmetbolmurvivlprticulrlyeffectiveRelevntthwkolpriblyFDA-pprovedtrgetedttmentPDACThedrughibPARP1-mededDNApirdictedBRCA-mutntPDAC(<10%ce)whichllexhibhomologoucombti(HR)deficiencyPARPblockdehiftmetbolmwrdoxidtivephophyltiAkegenicdietloprogrmmetbolmthdictiducgglucoevilbilyInAim1wepirwild-typeIDH1(ivoidenib)PARP1hibir(olprib)bothHRdeficientpricientPDACugGEMMPDXmodelWehowfirttimewtIDH1blockdedictlyhibPARP(throughcedNADP+)duceBRCA-likephenotype(throughdecedKGhnehypermethylti)ultgtrgynergytweendrugevenHRpricientPDACThetentthcombtiexpdictiolpribmjyPDACInAim2wedemtrtenti-wtIDH1rpypotentedwhencomdkegenicdietThetwottmentynergizemechnticllykegenicdietdriveproductiferdiclhiftmetbolmwrdoxidtivephophyltiwhichmgnifiePDACneedwtIDH1WelohowbothrpieducehnecetyltilowglucoekegenicdietdepletecrbourcewhileducedTCAcyclectivyfterwtIDH1hibiloffectcetylCoApoolInAim3wenlyzePDACptientmplengogclicltril(NCT05209074)ivoidenibctivygtwtIDH1compdctrolmpleMetbolicDNApirchngeeedWelocomptumlMg2+levelerumTheeimmfututudietrileekgoptimizenti-IDH1-bedrpieptientAbtrctTrgetedprotedegrdtichimericmoleculehemergednovelrpeuticmodlyThebifunctilchimericmoleculeuullyhveeendbdgprotetet(POI)enddictgternrycomplexwrddegrdtiproteomelyoomeThePROteolyTArgetgChimer(PROTAC)ceivedmotttentidtePROTACctnE3ubiquligeligdictPOIubiqutirouteproteomedegrdtiBecuethPROTAClycpbledepletgtrcellulrproteAbout40%proteomeextrcellulrectedmembrneprotemnymltedcncerTobrodencopetrgetcludeextrcellulrproteLYoomeTArgetgChimer(LYTAC)wecentlypteduLYTACctedcjugtgliglyoometrgetgcepr(LTR)cellurfceligcnbdextrcellulrPOIThefirttwoLTRemployedLYTAClectcrbohydrtebdgprotecti-dependentmnnoe6-phophtecepr(CIM6PR)iloglycoprotecepr(ASGPR)Thecepr-ligterctriggerternliztiextrcellulrprotethroughcepr-mededendocyfurrducgdegrdtrgetlyoomeHoweverCIM6PRubiquiulyexpedmottypecellwhileASGPRmlyexpedliverItwouldidelcruLTRthvexpedcncercelldegrdeextrcellulrPOIocedcncerchievehighefficiencyelectivyAfterexmgeriecellurfceceprthvexpedcncerwefoundchimericmoleculecrufoltecepr(FR)coulddegrdeextrcellulrPOIcncercellhighlyeffectivelyInthpplictiwedemtrtefirttimecjugtiFRligfolte(FA)bderPOImembrnecncercellcnctedegrdercpbleelectivelydegrdgendogenoumembrnePOIcncerWepropoeexplopotentilthtrtegydevelopnovelFA-ntibodycjugtecndegrdecheckpothibiruchprogrmmeddethlig1(PD-L1)ttmentvrioucncerfocuhedneckcncer(HNC)InAim1weynizevriouFA-ntibodycjugtetetirdegrdtictivycellInAim2weevlute-vivodegrdtictivynti-tumefficcyPD-L1degrderyngeneichumnizedmouemodelfocuHNCInAim3wepropoetudymechnmFR-mededdegrdtiPD-L1underlygprcipleimprovednti-tumefficcyTheetudiefcilteetblhmentgenerlpltmdevelopmentefficienttue-electivedegrdercncerocedextrcellulrPOIwhichledeffectiverpeuticttmentmnytypecncerPROJECTSUMMARYOverptdecdeduluecombutiblecigtteelectriccigtte(e-cigtte)hnubtntillyTheevidencemixedwherthueptternhelpduluerquugcombutiblecigtteHoweverclerneedhelpduluerqumokggivenuecombutiblecigtteledgpventblecuedethdeeUScuge-thirdllcncerdethexctgnenmoufncilperlllTodtenopublhedtudiehveidentifiedeffectivephrmcpycounelgterventihelpduluerqumokgThegolpropoederchidentifymoteffectivephrmcpycounelgpprochehelpduluerqumokgSpecificllyugMultipheOptimiztiStrtegy(MOST)duluercombutiblecigttee-cigtte(N=500)whomotivtedqumokggquire-cigtteueifkedenrolledromizedefficient2x2x2fcrilclicltrilPrticipntromizedetwolevelechfcrPhrmcpy(VniclevNicotePtch)CounelgApproch(DulFocuedCetipprochwhichprticipntencourgedquire-cigtteueprtirquttemptvSmokgFocuedCetipprochwhichprticipntencourgedqumokgueire-cigttetrtegicllyplceircigtteervicehrmducti)CounelgInteny(4v1ei)Allprticipntcompletebelemeudemogrphicbccouehrycombutiblee-cigttedependencepotentilmechnmPrticipntuemrtphecompleteecologiclmomentryement(EMA)2weekp-trgetqudte(TQD)2weekpot-TQDprticipntcdmokgvpgmedictiuel-timecompleteEMApotentilmechnm(egcrvgductielf-efficcy)everyevengFollow-upementcombutiblee-cigtteuewellpotentilmechnmoccur481218263952weekpot-TQDPrticipntlocompletebiochemiclycombutiblebccoue(crbmoxide[CO])nicoteexpou(ucote)tbelee-weekp-TQD3mthpot-TQDPrticipntwhopt7-dypot-pvlencebtencemokgtWeek2652vedlbryprovidebiochemiclverifictibtence(CO<6ppm)provideumpleynicoteexpou(cote)TheedtllowuidentifytmedictipprochwelltcounelgpprochtenyhelpduluerqumokgPROJECTSUMMARY/ABSTRACTTheProblemCellulrimmunpietrgetgurfceproteemotexcgnewmodliecncerHowevermottumlckurfcetrgetcceptbleefficcyxicyprileOurSolutiProblemInwkcurntlycceptedtNtuCncerddthunmetneedwedevelopednewtechnologyclledtructurlurfceomicThpprochdeignedytemticllypronentilynewcltum-electiveimmunpytrgetthoebedcncer-pecific3-dimenilcmtiplmmembrneproteTodevelopthmethodologyweuedourjotexpertecellurfceproteomic(Wi)crolkgmpectrometry(Hung)Weillyppliedthtrtegycutemyeloidleukemi(AML)dedlybloodcncernoknownoptimlcellulrrpytrgetUgtructurlurfceomicAMLmodelfollowedptientmplevlidtiweidentifiedctivecmtegr-2(ITGB2)promgpvioulyunknownAMLtrgetVicombntntibodyelectiwedevelopednengeedT-cellrpy(CAR-T)trgetgITGB2WefoundthCAR-ThdhighlyfvbleefficcyvxicyprilecompdAMLtrgetundercliclvetigtiWenowpurugfurrpclicldevelopmentthCAR-TrpyAMLptientOverllHypoAimWehypoizetum-pecificurfceprotecmtictullywidepdtructurlurfceomictechnologyhpotentiluncoverentigenTheobjectiveourpropoltwo-fold1)furrdvncetechniclnlyticlpecttructurlurfceomictechnologyimproveourbilyidentifycncer-pecificurfceprotecmticrobroderrngedicti2)identifyhowwecnevenfurrimproverpeutictrgetgthcmti-pecificurfcentigenITGB2AMLevenydourcurntpprochTochieveegolAim1defelcpeurfceprotecmtivienhncedtructurlurfceomiccroeverldiffenttummodelvlidtiprimryptientmpleThwkultimtelydeveloppipelemovetrgetdcoverypotentilrpeuticAim2focuidentifygmechnticbcmti-pecifictrgetgtegr-2AMLourcurntcellulrrpyImpctFdgAim1brodlyimpctfulwrddoptidemtitructurlurfceomictechnologyTheeultidellynlyidentifynewimmunpytrgetcncerbupendoprobgurfceprotecmtinybiologiclytemAnAim2mdeignfurroptimizedcellulrrpypotentilclicltrnltidictlyneftgAMLptientTheTemThePIhvenuncommcombtiexperteimplementedproteomicmethodwellbloodcncercellulrrpydevelopmentCo-InvetigrtUCSFIITBomledgexperttegrbiologytructurlbiologycomputtiltructurlbiologycomputtilproteomicAbtrctTheFASEBSRCTGF-SuperfmilySignlgDevelopmentDeeCfence2024(hefterTGF-2024)brggervetigrwholedervrietytercnectedterlteddcipleterectthroughkeyroleTGF-ignlgproceBrgggeruchdiveregroupcientteentilcompheniveundertgementTGF-ignlgxdevelopmenthomeotgenertiggjurydeeThecientificpenttimlmldcuipoterpenttithroughoutcfencedeignedexpundertggeneticmoleculrcellulrmechnmproceewhichTGF-ignlgxfluencedevelopmentmtenncegnytemuncoverhowdegulthctrolultdeeThknowledgefundmentlunderthowTGF-ignlgpthwygultedhowyexecuteirfunctiundernmlcdirghomeotbodyfciltguccefultuepirgenertiTGF-2021levergenewimptntfdgprovidettendeebroderppciperpectivecomplexyTGF-ignlgxexmplerpeutictrtegiegtetedopptuniecidergdcugfutueTh13thFASEBTGF-cfenceThefieldTGF-ignlghenrpidlydvncgexpgprticulrlmot10000rticleperyerltedTGF-/BMP/GDF/Activ/NodlhveenpublhedptfiveyerThftpcewrrntcvengthcfenceenuucceTGF-2024tkepridetrgtrdicollegilycfencettendeemotimptntlycollbtigenertedthroughthcfenceThecollectiveexperiencebuilverpvioutwelvecfencehprovideducfidenceTGF-2024provideumextendeddcuicvertiterctinetwkgdebtgnovelhypoepriiztiunmeterchrpeuticneedcertrg/dviceprticulrlyyoungvetigrtediverebckgroundwhopentfutuercherthfieldSmllcelllungcncer(SCLC)highlyggiveneuroendoclungtumpible>30000dethnnullyUSSCLChtwo-yerurvivlrte~6%nopprovedtrgetedrpieydcently-pprovedimmunpySCLCillyhighlypivechempyrpidlydeveloptnceledgmtly~12mthAmjunmetneedSCLCttmentidentifictinewrpeutictrgetttmenttrtegieSCLChhricllyenttedgledeeoutptienttrtifictibedmoleculrmtiWecentlyidentifieddtctSCLCmoleculrubtypebedexpilege-ltedcogenictrncriptifcrASCL1NEUROD1POU2F3moctroverillyYAP1MYCLcogeneocedmotcommASCL1group(~70%SCLC)whileMYCovexpedNEUROD1/POU2F3/YAP1ubtype(~30%SCLC)ImptntlywefoundMYC-drivenSCLChuniquerpeuticvulnerbiliecompdMYCL-drivenSCLCMYChcpcydriveSCLCubtypeplticypromotgASCL1+tumNEUROD1+nYAP1+tteMYC-ducedNotchpthwyctivticriclSCLCubtypeplticyWhileASCL1henfquentlytudiedmuchleknownbout2nd-motcommNEUROD1+-ubtypeWehypoizeNEUROD1expidenoteneurltrncriptiltteSCLCNEUROD1-mededpiNotchignlgcriclumcelltteNEUROD1+ttehuniquerpeuticvulnerbilieWefurrpdictNEUROD1hibihifttumdevelopmentllypdictblen-neuroendoccellfteOurobjectivedetermefunctiNEUROD1NEUROD1+ubtypeSCLCidentifymechnmgulteubtypeplticyuncoverltihiptweenNEUROD1NotchignlgTowrdthendwectedfirtmouemodelNEUROD1+SCLCgenertedmicecdilNeurod1lotudyfunctivivoPlimrydthveidentifiedhighlycervedNEUROD1trgetgeneLrge-cleCRISPR-bedgeneticcenhveidentifiedpdicteddependenciehvepotentilrpeutictrgetgOurhypoetetedtwopecificim1)DetermefunctiNEUROD1MYC-drivenSCLCcellfte2)DetermemechnticltihiptweenNEUROD1NotchignlgSCLCubtypeplticyOurpprochnovtivecueweemploynovelimmune-competentGEMMMYC-drivenSCLC~17newhumnPDXglecelldtprimryhumnSCLCWeuette---rttechnologieglecellRNA-eqlegetrcgnewgnoidmodelcoupledourChIP-eqdtcomphenivelydetermeroleNEUROD1SCLCTherchignificntcueefdgledtterundertgSCLCmoleculrubtypeultimtelyfciltetilodSCLCttmentProjectSummry-AbtrctTummicroenvirment(TME)ctmnycelltypeco-extpromotetumprogiMotcncerrpeuticdeignedtrgenemoleculeedefedcelltypeFexmplevemurfenib(BRAFhibir)killmelnomcellthroughtrgetgmuttedBRAFwhepembrolizumb(nti-PD-1ntibody)blockPD-1Tcell-ctivtgnti-tumimmunyOuroverrchggolidentifytrgetblemolecule/pthwycriclmultiplecelltypeTMEUgpublhedglecellRNAeq(cRNAeq)dtetweerchedemolecule/pthwymeetgfollowgcreri1)yhouldhveimptntfuncticncercellimmuneuppivecelltypeuchgulryTcell(Tg)exhutedTcell(Texh)myeloid-deriveduppcell(MDSC)etc2)ynotimptnteffecrfunctimjimmunecellucheffectTcell(CD4+CD8+Teff)ntukillercell(NK)3)yhouldtrgetbleknownhibirNR4A1fll3creripentvlidtrgetcncerimmunpyIncurntpropolwetendueproteoly-trgetgchimer(PROTAC)technologydevelopfirt---kdNR4A1degrdermelnomrpyAim1Rtildeignnovelceltrol-bedNR4A1-PmodifygceltrollkerAim2DetermecellulrmoleculrmechnmwhichNR4A1-PwkhibmelnomAim3ExplpeuticpotentilNR4A1-PglegenrcombtiTheoutcomedefertilefutuclicltrnltiNR4A1-PenhnceICIrpypemelnomPROJECTSUMMARYGrft-veru-hotdee(GVHD)equeleimmunouppihveenmjbrrieruccellogeneichempoietictemcelltrnplntti(llo-HSCT)whichcnpotentillycuhemlogiclcnceruchleukemilymphommyelomGVHDcueddTcellttckcipientn-hempoietic-lymphoidtue(n-HLT)cludggtrotetl(GI)trctliverkAdvncedtrtegiemoggiveimmunouppigentcntterctrolGVHDCequentlycncerlpecomemjcuedeth(>50%)llo-HSCTptientPertglloctivedTcelln-HLTknowndetermntGVHDIndeedwecentlydcovedhibiRIPK1/RIPK3ctivyGItrctducebothloclytemicGVHDTheeobervtigerhighlightnurgentneedtterdefghowGVHDlocllymtedAhllmrktue-filtrtglloctiveTcellircpcypertfunctipepertentlltigenTheyhowtue-identmemyTcellfetuctubetTcf1+progenir-likeTcell(Tcf1+TPRO)gtbilyelf-newhvecquiduniquetrncriptilprogrmlocltueidenceHowevertrncriptilgulrctroleproceempolydefedWecentlydemtrteId3trncriptigulrimptntCD8+TcellmemypehdulfunctimtglloctiveTcellpedurgGVHDId3trexceivePD-1expieffecrdiffentilloctiveTcellpromotepertencebothTh1effecrTcellTcf1+TPROcellfiltrten-HLTDTcelllckgId3filmedeeveGVHDPD-1blockdecpcyId3-blteddTcellduceGVHDId3peexprncriptifcrwhichpromotePD-1trncriptiexurnteffecrdiffentictivtedTcellutexpiTcf1protewhichquidelf-newlmemyTcellBuildgefdgwehypoizeId3gultemtimtenncetue-filtrtgTcf1+TPROcellcriclGVHDmtennceleukemictrolthroughcodtgexpigeneenggedeffecrdiffentimemyTcelldevelopmentTwopecificimpropoedtetthhypoAim1defeeffectlloctiveTcf1+TPROcellGVHDmtennceleukemictrolchrcterizecentrlroleId3eTcellAim2etblhneficileffectID3-engeedchimericntigen-cepr(CAR)TcellelimtgleukemiOurfdgprovidenovelmoleculrightbiologytue-filtrtglloctiveTcelllednovelId3trgetg-bedn-HLT-pecificpprocheduceGVHDoutgloblimmuneuppiTheyloidentifymoleculrquimentCARTcellutTcelltemnetexhutidiffentienhncgefficcycncerimmunpyugCARTcellSUMMARYTheSytemApprocheCncerBiology(SACB)meetgimbrggercientificledererly-tgevetigrCncerSytemBiologybuildfoterthrivgcollbtivefieldthroughhrgcientificdvnceStrtedgrrootefterly-tgeCncerSytemBiologyvetigrfirtSACBmeetgwheld2016heldeveryyerSACBhpvioulyenco-podNtilCncerIntuteAociCncerSytemBiologt(ACSB)ThemeetgolelyfocuederchpicddcncerhentlycomplexptiltemplterptientheterogeneymultifcrilcuecequencecnnotunderodouttegrtgdiverepprochecombtrdilcientificdcipleTheSACBmeetgctevenplenryeipotereimnyopptunieerly-tgevetigrnetwkgmenrhipmoenivetigrcludgmeetPIlunchehppyhourSACBplenryeifocumnypectcncerbiologycoverdiverycomputtil/mmticlmodelgpprocheThproblem-dom-focuedprogrmmgprticulrlycduciveynnewidecollbtimgttendeeGivenhrythmeetgtrgemphdevelopmentfotergerly-tgevetigrwhichcludetlethlflpenttiggiventeddgpicteterly-tgevetigrthroughpecilpiceiAnfocumeetggrowCncerSytemBiologycommunywhichweccomplhtrgetgunderervederchcommuniechgouterchercomplementrypicuchcomputercienceengeergwellfundgupptvetigrddilfmilyneedTheSACBScholrprogrmed2022uppttlet8undergrdute/grduteteunder-pentedgroupbiomediclerchttendSACB2024meetgThprogrm2022whighlyuccefulimedtprovidgtrgnetwkgopptuniedividulmightnotblegeexperienceweSACBhuccefullyhelpeddvncecermnyerly-tgevetigrbrggerlike-mdedvetigrherchfdgSACB2024mthybridmeetgmtboth-pervirtulmeetgoptiThprovidevenueSACBchcolleguecrowldtillbleprovidetimteenvirmentneededfoterCncerSytemBiologyerchfutuAbtrctPncticDuctlAdenocrcom(PDA)3rdmotcommcuecncerdethUnedStteOneprimrypthologiclfetuPDAdenenetwkfibrillrcollgen(COL)cludgCOL1COL11bothwhichhveenhownocedPDAprogiCollgenignlvipecificceprurfcePDAcellwhichDcoidDomRecepr1(DDR1)uniquecollgenceprtyroeke(RTK)WehvefoundbltiDDR1hibdeeprogimettwheovexpienhnceeproceemouemodelPDAuggetgDDR1mjpromotermlignncyTheignlgnetwkctivtedDDRpeCOLmeluiveUgnnovtivepprochimultneoulympphopho-ctlyticprilemultiplekecelltuewedcovedtumxenogrftPDAcellexpgDDR1emddedCOL1cffolddplyuniqueprilectivtedkewhichpentnewDDR1-edignlgpthwyvelgpotentillydruggblevulnerbilietrgetehighlyfibrotictumWehvelofoundCOL5COL11fibrillrcollgenocedpooutcomePDActiveDDR1nlmot20-foldgterlevelCOL1motcommlyexmeligInthpropolwefocuhow1)COL11/DDR1ignlgxpromotePDAmettvrovivo2)howdtctCOLdiffentillyctivteDDR13)identifydruggblevulnerbilieocedCOL5/11-DDR1ignlgdevelopfututtmentehighlyfibrotictumPROJECTSUMMARY/ABSTRACTOutcomeptientgtriccncerwhichfourth-motlethlcncerwldwidepoimprovedrpieneededWhileimmunecheckpothibir(ICI)extendurvivlptientuffergvrietycncermotgtriccncerptientdotpdICITheoverlllowpegtriccncerICIrpynlydppotgtermbilyimproveoverllurvivllomenlrgeptiptientttedICIufferxiciettmentoutnycliclnefThuimproveoutcomegtriccncerptientcriclneedidentifynovelbiomrkerguideICIuefdnewtrtegieugmentICIefficcyThevetigrlg-termgolgdeeperundertggtriccncertummicroenvirmentfeueICITheobjectivethpropolidentifybiomrkerpdictICIpedcovertrgetctibleimproveICIefficcyBedvetigtivetempublhedunpublhedultcentrlhypopropolrtificiltelligencecnnlyzetrncripmicdiglpthologyptildtguideICIueptientgtriccncerTotetthhypocloecollbtitweencomputtilcientturge-cientthenetblhedpurue3imInAim1weidentifynoveltrncripmicdiglpthologyptilbiomrkerpdictICIpecomprgtummpleobtedgtriccncerptientwhodiddidnotpdICIInAim2weueexplblemchelerngpprochenlyzemultimodldtetpdictICIpeInAim3wepermpclicltetgrpietrgetpthwycell-cellterctienrichedICInpderneftceICIefficcyThecidtetrgethveldyenidentifiedThecceptulnovtithpropol1)rtificiltelligencecnnlyzemultipletmdtdcoverpdictivebiomrkeridentifyICIpemechnmpdictICIpe2)ctiblemedirICInpeidentifiblevidetilednlytummicroenvirmentThepropolloupptedmultipletechniclnovticludeue1)cuttg-edgeptilprilgtechniqueimultneoulycquibothptiltrncripmicmtummicroenvirment2)novelrtificiltelligencelghmidentifyimge-bedpdictivebiomrker3)novelrtificiltelligencelghmtegrteprocehigh-dimenildtetprovideprcticlguidnceprobbilyICIpe4)novelgtriccncergnoidpltmtetcidterpieimproveICIpeTheexpectedulttegrtednlyecliclcomputtilexperimentldtimpctfulyprovidenovelightgtriccncerbiologyhvepotentilimprovebothqulylifeurvivloutcomeptientgtriccncerProjectSummryHepcellulrcrcom(HCC)highlylethlcnceroyocedn89%cedrkHCCBecueneedfermoeffectiveHCCdrugcgpvlenceoycomplexltihiptweenoyHCCoy-ocedHCCnemerggchllenggueThelevelcompoibilecid(BA)plykeyrolemetbolicdeeHCCCychromeP450fmily8ubfmilyBpolypeptide1(CYP8B1)proteexpedlylivervlmgcholiccid(CA)12-hydroxylted(12-OH)primryBAHenceCYP8B1ctivycertio12-OHn-12-OHBAwhichlkedmetbolicdee(egoyditenlcoholicfttyliverdeenlcoholictehept(NASH))HCCrodenthumnHighleveldeoxycholiccid(DCA)ecdryBAderivedCAgutmicrobiotpromoteoy-ocedHCCmicepenthepcyteoy-ducedHCCmiceliverptientNASHwhichdrticllycerkHCCCurntlynoptedelectivehibirCYP8B1ThpropolbedourubtntilplimrydtUgncogene-ducedHCCmouemodelwedetermedCyp8b1knockout(KO)micedevelopleggiveHCCltivewild-type(WT)miceWeloidentifiedmultiplepromgCYP8B1hibirvihigh-throughputceng(HTS)ugnovelbiochemiclyelectivyyBedtructupromgCYP8B1hibirHTSCYP8B1/hibirbdgmodeourmoleculrdockgtudieIdeignedynizedeverlnovelcompounddplygelectivepotenthibiCYP8B1ctivyourbiochemiclycell-bedyelectivyyplimrymouetudieAddillyweuccefullyobteddiffrctiqulycrytlCYP8B1CYP8B1/hibirdetermebdgmodegterccurcywhichllowmedevelopmoeffectiveCYP8B1hibirIhypoizeCYP8B1plycrucilroledevelopmeny-ocedHCCnovelCYP8B1hibirignificntlydecertio12-OHn-12-OHBAdrmticllyducelevelDCAuppgdevelopmeny-ocedHCCIpropoetwoimtetmyhypoInAim1IdetermeroleCYP8B1exmgHCCgrowthoy-ocedHCCWTCyp8b1KOmiceevlutgHCCuppioy-ocedHCCWTCyp8b1KOmicettednovelCYP8B1hibirInAim2Ipermfurrchemiclmodifictitructu-ctivyltihiptudiederdevelopledcidtegterpotencyelectivyefficcyBydetermgroleCYP8B1oy-ocedHCCdevelopgnovelCYP8B1hibirIdevelopnewrpeutictrtegypotentildrugcidtettmeny-ocedHCCPROJECTABSTRACTOteorcom(OS)motcommprimrymlignncywldwideprimrilyffectdolecentWhile5-yerurvivlrteround70%loclizeddeemettticdeeurvivlmdml20%ltleimprovemenverptyerItcognizedterctimicroenvirmentcneirfciltehibcncercellmettthudeepernlyeterctimyidentifytrgetblevulnerbiliemettticOSPvioutudieourlbhvehownplteletpromotemetteverltypecncerInctrtrolemegkryocyte(MK)plteletproducgcellcncermetthnotenetblhedWhileMKprimrilycognizedplteletproduceryloervedynmicgulrproductibothfluencefluencedcellApvioutudyfoundco-cultuOScellMKcedOSprolifertiuggetgMKcouldfluenceOScellmicroenvirmentAddillytudyfoundbtcncertumrgmicedplyedltedMKpolyploidycedplteletRNAprotectentdemtrtgtumcnfluenceMKfunctilterproducedplteletMyplimrydtuggetplteletdepletimicedeceillungeedgOScelldmtedvilveMyplimrydtlohowcedMKdecedMKploidymicethopicOStumBedepvioutudiemyplimrydtIhypoizeOSMKbidictilignlgctrieOSprogimettexchnggignlgmedirledltertiMKdiffentimturtiplteletproductifunctiwhilelocgOScellprolifertimigrtiprimrytumTotudythmechnmIuenoveltibilimplnttechniqueetblhthopicprimrytumbothwild-typeMK-depletimice(PF4CiDTRmice)IuethpprochtetfollowgpecificimAim1tethypoOSprimrytumdygulteMKdiffentimturtiledgltedplteletproteomectentfunctiIpermtibilimplntproceduhmproceduWTmicecompmrrowMKmturtidiffentiviflowcymetrycrothetimepotevlutechngeMKthroughoutOStumprogiIeplteletfunctictivtibothgroupvigggometryflowcymetryFllychngeMKtrncripmeplteletproteomecompdtweengroupAim2tethypoMK-OSterctidurgprimryOStumdevelopmentpromoteOScellprolifertimettIdepleteMKOStumrgmiceexmehowtumgrowthprolifertilungmetttumtrncripmecompwild-type(WT)miceTheulteexperimentvelhowOS-MKterctiffectOSmettidentifycidtemedirfututudymechnmvolvedirpotentilrpeutictrgetPROJECTSUMMARYCell-cycleexcneirtrnient(quiecence)permnent(enecence)ediffentttethoughthvedtctmoleculrchrcterticFurrquiecenceelfnotglehomogeneouttecellmquiecentlgerdurtitimemoveprogivelydeeperquiecencetkglgerturncellcycleuptimultiWhileenecentcncercelltumuppiveylimprolifertidmgedcellcruimmuneytemquiecentcncercellourcedrugtnceyevdechempeuticttmenttrgetedtcyclgcelltirbilyprolifertefutuThemechnmctrollgquiecencedepthltihiptweendeepquiecenceenecencetillpolyunderodduelckrobutbiomrkerneceygle-cellytudyquetiveribilyHowevercriclneeduchtudiechempeuticttmentultmixecellfteByugfunctildoutgettcowhtmenenecentlg-termtllckcell-cycleentryprogiwefoundubetcellpuheddeepquiecencefilturncellcyclefterleettmentcellduceddeepquiecencefourdiffentttment2-12dyhowedcglevelSA-glgoldtrdmrkerenecenceThuwehypoize1)enecencedeepquiecencewhichcellneverwken2)trnitweendeepquiecenceenecencemrkeddecertiotweenpro-prolifertiveignlg(CyclD)nti-prolifertiveignlg(p21/p27)medgprogivedeceprobbilycell-cycle-entryExperimentpropoedAim1uetime-lpemicrocopypidpot-hocimmunluocenceimggmeucniclmrkerenecencecellmpermnentlyrtedfterleedeepquiecenceInAim2wepermRNA-equencgubetpermnentlyrtedcellAim1comptrncripmeextggeneigntuenecentcellFllyweuetime-lpemicrocopybioenCyclDp21/p27determeifrtioeignlpdictfutucell-cycle-entryCollectivelyeimhelpdefeltihiptweenquiecenceenecencectriemuchneededqunttivemechnticundertghowcelltrnitweentrnientprolgedpermnentcell-cycledrwlIfuccefulpropoedwkiddevelopmentmotrgetedeffectivechempyttmentprovidemoccurtebiomrkerdetermewhichcellnotprolifertefutuSUMMARYAfricnAmericn(AA)menhvetwicerkggivelethlprottecncer(PC)dignoedyoungerthnwhemenEpidemiologictudiedemtrtencedrkggivePCvmDdeficiencyAAmentenddeficientvmDcuemelnbbUVrdiducgunlight-ducedcutneouvmDynMountgevidencemylbdemtrtevmDdeficiencylterhmelevelprottewhichmyctriedpryPCobervedAAmenOurcentpublictiplimrydthowvmDttugulteprottedihydroteterelevelwhichcnectetwodprieprovidemechnmwhichvmDffectPCggiveneWefurrimplictemeglmedgeffectvmDprotterogenOurlg-termgolthoughlyexmeltihiptweenvmDrogenhmeytemicllyhowmyvryncetryHewepropoeexmemeglcriclprotevolvedprottehmegultiTheprojectcludethecomplementryyetdependentimpprochcomnlyptient-derivedmodelmouetudiecliclmpleAAwhemenmeglThpropolimtethypovmDdeficiencyledcedprotticrogenAfricnAmericnmenvimeglultgncedrkggivePCInctrterumlevelpucymtigrdggultr-tuelevelhmeGivenmeglgulteprotteTlevelANDmeglgultedvmDfurrundertgthmechnmprovidecrucilnewightcequencevmDdeficiencywhichmyunderpPCdprieAfricnAmericnmenNewightdictlylkvmDttuprotterogenhpotentilmoveneedlegenerlprctierwhowouldntkevmDdeficiencyerioulyAfricnAmericnptientOurfdgmyledcedcengttmentvmDdeficiencyultimtelydecgburdenggivelethlPCAfricnAmericnmenProjectSummryChimericAntigenRecepr(CAR)TcellrpyhvolutiizedttmentBcellmlignncietrgetgTcyxicyetumDepeucceCAR-TcellBcellmlignnciemothnhlfptientceivgCAR-TcellttmentfilchievelgtermdeectrolTherpeuticfilucnttriedmnycuecludgvereltihiptweenCAR-Tcellmnufcturgdurtiultgnti-tumpotencyAddillyCAR-TcellmnufcturgpoebrriercceuchcotdifficultymeetgupplydemequilibriumToengeernextgenertiCAR-Tcellenhncednti-tumefficcygterptientcceIgenerteCD1928zCAR-TcellvivougmodifiedlentivirlprticleengeedexpTcelltrgetgntibodyfrgmentferdthpropolProgrmmbleAntibody-mededCellulrKnock-InTcell(PACK-IT)ytemThePACK-ITytemuedexplomycentrlhypoengeergTcellvivofeibledelivermoefficciouCAR-Tcell(PACK-ITCAR-Tcell)dtctbiologicfetuducgcotcgcceIhvedemtrtedfeibilyPACK-ITytemgenertefunctilCD1928zCARTcellvroextendeduePACK-ITytemuccefullytrnduceTcelltumrgmiceBedpro--cceptexperimentIpropoe(i)optimizePACK-ITytemtermtrnductiefficiencyphenotypenti-tumpotencyultgCAR-Tcell(ii)vivocomprPACK-ITCAR-Tcellthoemdevicventilmnufcturg(iii)eimpctrmgPACK-ITCAR-Tcelldruggultblecykeceprnti-tumpotencyimmunocompetenthotCollectivelypropoedwkultmethodproduceCAR-TcellvivollowrigouchrcteriztiimpctelimtgexvivomnufcturgprocedevelopPACK-ITCAR-TcellrmedgultblecykeceprbootTcellfunctivivoThepropoedwktkeplcetStndUniverySchoolMediceledgtutiimmunologyimmunpyettgemphizenovtiDrCrytlMckllidelpthprojectdueherextenivetrckcdmenrguccefulphyicincienttherexperteTcellbiologytrnltilrpeuticInddiIupptedmultidciplrytemcludgmenrhipDrHowrdChng(genomewideequencgengeedlentivirlvecr)ChrpherBrne(tructurlvirology)AnuhKlbi(engeedcykecepr)PROJECTSUMMARYCncer-ocedcchexi(CAC)chrcterizedvoluntrylokeletlmucledipoetuemThmultifcrilyndromedrivencombtiducedfoodtkeltedytemicmetbolmApproximtelyhlfllcncerptientpentcomplictiocedcchexiledgcedmtlyfunctilimpirmentducedqulylifeEffectiverpiettcncer-ocedcchexicurntlylckgttmentfocuednutrilupptympmmigtiReoluticchexioptimllychievedthroughttmentunderlygdeeTrgetgmetbolicltertidrivecchexiidentifynoveldrugtrgetmnctivequiryTtmentcchexihmedeluiveduedeeheterogeneyEmerggevidencehuggetedmultipleubtypethcomplexdeewhichmyexpllckcenucreriueddecricncer-ocedcchexiAddillyedefifurrmuddiedctexywhichcncfounddignoecchexibedupbody-mdexhidelokeletlmuclemWhilecentwkhdecridctbolicchngemetbolicgnuchkeletlmucledipoetueliverthccurcchexiwellidentifiedflmmrymedircndriveeproceefurrtudieneededmocomphenivelyidentifyytemicphyiologiclchngethccurCACThnovtivepropolddmjgpourundertgCAC1)DocommcncermuttimodultedevelopmentCAC?2)HowdodietryterventiimpctcoureCAC?PritudiehveenlimedlcktrctblevivomodelCACdevelopnuchthouettgUggeneticllyengeedmouemodelweidentifynovelmodelCACdriventumgeneticdietryterventiBedupchrcterticthmodelweidentifynovelpotentildrugtrgetpecificubetcncer-ocedcchexiPROJECTSUMMARYEtrogencepr(ER)ignlgmdrivertumigeneER+btcncerducgprolifertiurvivlthroughgenomicn-genomicmenTheehibiERignlghenmtyttmentdecdeWhileprimryER+btcncerhltivelygoodilprogno~30%ptientdevelopttment-frcrycurncemettirlifetimemettgtwicelikelyptienthmeceprpoivedeeDepefquencydignobt--mettER+btcncermncurblecdiTtmentcludedmtrtiERntgtlikeFulvetrnrromtehibirtencombtiCDK4/6hibirwhichnegtivelygultecellcycledowntmERctivyTheettmentdeignedlowprogideecpbleelimtgmettticcellAnewendoc-trgetedrpyElcetrnthenpprovedFDAttmentER+ESR1-mutntdvncedmettticbtcncerIntetglythcompoundhowelectivegtctivymicroenvirmentntgtctivycncercellAlthoughElcetrnthenpprovedFDAcompoundundertudiedlypprovedfrctiptientThpropolutilizevrovivoexvivomodelbt--mettER+btcncerevluteefficcyElcetrntverutrdcwelldecttrncriptillcpewhichpromotedERmodulttmentettgIntr-IlicrteryjectiPDXcellp-cliclrodentmodeluedmodelmettevluteprogifeurvivlfollowgttmentElcetrntmo-gentcombtiCDK4/6hibirwellnovelrpeuticcombtiBecueElcetrnt-ducedER-ctrolledtrncriptilgultictextdependentNnoStrgGeoMxptiltrncripmicequencgERChIP-eqrpidimmunopciptimpectrometryendogenouprote(RIME)uedgdetermehowedrugcnctnntgtgtdiffentctextTheoverrchghypothpropolElcetrntextendprogifeurvivlp-cliclmodelmettcuedplyctextdependentgtntgtctivyThtudynlyledmocompleteundertgERbiologymettticmicroenvirmentloprovideightwhichcouldledimprovedptienutcomeThprojectlofdmeouttgtrgexperiencewkmultidciplryledercromultiplefieldbiologywhileIwkcompletemyPhDtrgtVirgiCommwelthUniveryAbtrctHepcellulrcrcom(HCC)dedlycncerpoprognolimedrpeuticoptiBiopiectrdictedHCCtrictgourbilyidentifyuniquetumdriverubequentrpeutictrgetInnovtivetrgetidentifictiHCCttmentthucriclerchgpOurlbhpvioulyetblhedfocldheike(FAK)driverHCC16%HCCptientpentgnmplifictiPTK2geneencodeFAKHowevermechnmFAKHCCtumpromotimunknownAfterttmentproteoly-trgetgchimerFAKHCCcellleundRNA-equencghowedcnectivetuegrowthfcr(CTGF)wignificntlydowngultedfollowgphrmcologicldegrdtiFAKCTGFhcentlyenetblhedtumpromotercroeverlcncertyperoleHCCmeluiveCTGFectedcellcndetectedcdiedmedivroerumvivoPlimrywkHCCcelllehcfirmedltihiptweenFAKexpiCTGFexpiundereverldiffentcdiCTGFexpiectidecedfollowgdegrdtiFAKCTGFexpiecticedfollowgFAKovexpiblexpilevelFAKCTGFhowhighclticropnelHCCcellleFurrmoknockdownCTGFwfoundignificntlyhibcellgrowthbothvrovivoGiventhplimrydtwehypoizeFAKpromoteCTGFexpiCTGFturnpromoteHCCFurrmowehypoizeerumCTGFlevelcnuedurrogtemrkerFAKexpi/ctivyHCCdictgutilyFAK-trgetgttmentclicWeddehypoe(1)determgmechnmthroughwhichFAKpromoteCTGFexpiHCC(2)evlutgctriiCTGFHCCgrowth(3)determgifCTGFerumlevelcltedtumFAKproteFAKY397phophyltilevelHCCmouemodelptientmpleThtudyutilizecombtivrovivomodelwellptientmpleobtedcliclcollbrOverllthtudychrcterizenoveltum-promotipthwyelucidteuniquepdictivebiomrkerHCCPROJECTSUMMARY/ABSTRACTIntricllyddedprote(IDP)clprotedothvefixedthe-dimeniltructuIDPcnfullyuntructudctmodulrgifoldedtructuuntructuknowntricllyddedgi(IDR)IDP/IDRdynmicfluctutgthroughdiverecmtilenemblellowmplywidepdrolebiologiclfunctibothdurgnmlpthologiclcdiIDP/IDRplypivotlrolemultudecellulrproceecludgnotlimedprolifertimigrtidiffentipopHeIfocuAblkeIntercr1(ABI1)modulrcffoldgprotewhoebiophyiclvetigtihdmeluivedecdeABI1multi-mmodulrdprcffoldgproteplycriclrolegnizticykelenvidowntmcodtictcykeletlgniztigrowthprolifertiignlmemrWAVEcomplexABI1loctrolprogiprottetumctprottetumuppwheloABI1ctrietummettItnowknownABI1lofunctinucleubdgDNAnuclerhmecepr(NHR)likerogencepr(AR)MyoverllgolvetigtemoleculrbABI1nuclerfunctiInAim1IelucidtemechnmterctitweenABI1ARThroughbiophyiclmethodItudyterctifull-lengthABI1full-lengthARThroughtrunctinlyIlodetermectriifoldeddom()IDR()echprotewrdbdgLLPSInAim2IdetermehowABI1bdDNAIdetermehowABIterctiARciprocllyffectechproteDNAbdgpropertieInthpropolIuenrryhighlyenivecomplementrybiophyicltechniquedetermeDNAbdgpropertieABI1pencebencefull-lengthvriouctructpoARARboundDNADueirdifficultyexpipurifictiltlevrodnbiophyicltructurlmechnmunderlygterctitweenABI1ARTheultobtedelucidtehowDNA-ABI1-ARxgultetrncriptiettgedevelopgnovelhibirprottecncerWhoutthknowledgeourundertgABI1functigultgARnmlprottecncermlimedThwkhvepoiveimpctprovidgmodeldetermgmechnmterctiABI1nuclerhmecepruchetrogenceprmjdriverbtcncerPROJECTABSTRACTCellidentycrucillyctrolledtrncriptifcr(TF)perturdcncerctrighighlyggivemetttictumuchpncticductldenocrcom(PDAC)PDACpentmidblechllengenlrmglylow5-yerurvivlrtelethn10%PdomntlydrivenmuttiKRASubequentlotumuppgenePDACpoedcomeecdledgcuecncer-lteddeth2030IntegrtedgenomictrncripmicproteomicnlyehveidentifiedtwodtctPDACubtypecliclblThecricldiffencetweeneubtypelieexpiendodermllegepecifiercliclubtypeexpgFOXA1FOXA2(FOXA1/2)HNF4criclpncticcell-ftedetermtiwhileblubtypedowngulteegeneledgloendodermlidentyThecliclignificnceeubtypeevidentblubtypecferhtermedinurvivlexhibdiffentilpefirt-lechempieWeendodermllege-pecificTFnlyervebiomrkercliclubtypeeentilgulrPDACubtypediffentiUndertgmoleculrgulrcliclubtypecrucilymyholdkeydevelopgeffectivetrgetedrpieimprovgptienutcomeFurrmoemergencetrgetedrpiehhighlightedrolechngecncercellidentytncemechnmHewefocupivotltrncriptifcrFOXA1/2HNF4plycriclrolepncticdevelopmentDepeirlevncecncerirpecificfunctiPDACmlrgelyunexplodInthtudyweimdefefunctilroleFOXA1/2HNF4cliclPDACubtypeexplgirgultigrowthcellulridentyAddillywevetigtehowMEK/ERKignlgfluenceFOXA1/2HNF4trncriptilctivyPDACheddglighnmechnmunderlyglegewchgupMEK/ERKhibiOverllwetetcentrlhypoFOXA1/2HNF4criclgulrtrncriptilnetwkgoverngcellulridentycliclPDACMEK/ERKignlgmodultectivyeTFTotetthhypowectutgmodultgexpiefcrhumnmuPDACcellgnoidleeggeneexpichngegenomiclocliztieTFthroughChIP-eqThpropolhowhowcogenicignlglege-defgTFgultecncercellidentyProjectSummryPncticductldenocrcom(PDA)ededliethumnmlignncie5-yerurvivlrtecurntlyt12%LtleprogwrdttmenthenchievedoverpteverldecdeWhilettmentmlignncieuchlungcncermelnomhveenvolutiizedimmunpyhenltleefficcypncticcncerptientAnimmunouppivetummicroenvirment(TME)chrcterizednbundncecncerocedfibroblt(CAF)immune-uppivemyeloidcell(IMC)cludgtumocedmcrophge(TAM)myeloid-deriveduppcellknownmjbrriereffectivelyttgPDAWehvecentlyhownKRASmjcogenicdriverPDAduceexpiC-CMotifChemokeRecepr1(CCR1)pncticmyeloidcellCCR1bltimicehibpnctictumgrowthenhncgCD8+TcellntumimmunyLoCCR1TAMdecedectictenimmunemodulrymetboleuppprolifertieffecrfunctiCD8+TcellexpiImmunepivegene1(IRG1)myeloid-pecificenzymeproducecteOurplimrydtloveledIRG1blthopicmouemodelPDAdecedtumgrowthenhncedCD8TcellfiltrtiupptgcriclroleIRG1/ctegultgnti-tumimmunyPDABedefdgwehypoizeCCR1-IRG1x-dependentmetbolicprogrmmgmyeloidcellctrieignificntlyuppinti-tumimmunypncticcncerInim1wedectmechnmunderlygfibrobltmededmetbolicgultiIMCthroughCCR1-IRG1xPDAOurplimrydthowedpncticCAFpromotedexpiIRG1mrrowderivedmcrophgeWeelucidtefibroblt-derivedCCLCCR1-dependentignlgpthwydrivgIRG1expiimmuneuppivephenotypeIMCugCAF-IMCco-cultuInim2wechrcterizectriiIRG1erlycrcogenedevelopmentpncticcncerugbothmouemodelhumnpncticmpleInim3weexplotrgetgIRG1combtiimmunecheckpotblockde/KRASG12DhibirpeutictrtegyugbothphrmcologiclgeneticpprocheTochieveeimwehveembledtemvetigrcomplementryexpertehumnpthologymouemodelPDAimmunometbolmpncticurgery/immunologycomputtilbiologyOurtudynlyprovidecriclightimmuneuppivefunctiCCR1-IRG1xPDAloidentifynovelrpeuticpprocheeffectivelyttgPDAPROJECTSUMMARY/ABSTRACTAcuteMyeloidLeukemi(AML)lethlhemlogicmlignncychrcterizedimpidmyeloiddiffentibltprolifertihibgnmlhempoieIocrteDehydrogene(IDH)muttihighlypvlentAMLctrieleukemogenethroughproducticometbole2HGMutntIDHhibir(EnidenibIDH2IvoidenibIDH1)upp2HGproductidiffenteleukemiccellfunctilneutrophilDepeilexcementdiffentigentoverllurvivlmmldiffentirpyfilducedurblepemotptientCcomnncogenicNrmuttimotctentpdicrprimrytncemutntIDHhibirWhileIDHmutticuetemcellburprglycogenicNrmuttiocedrrntmyeloiddiffentiTherolecogenicNrmodultgIDHmutntAMLleukemogenemechnmwhichctrierpeutictncecompletelyundefedThegoltherchpropoldefemechnticctriiNrIDHmutntAMLleukemogenechrcterizerolerpeutictnceThenovilblemouemodelcpulteptientphenotypeprovidedynmicrngetudycogenicNrWedevelopedtwothoglmouemodel(geneticllyengeedmouemodelptientderivedxenogrftmodel)IDHmutntAMLoutccomntNrWeutilizeerilIDHmAMLptientmpleenutrnltillevncePlimrydtdictecogenicNrcuerrntmyeloiddiffentiIDHmutntAMLledrpidlylethldeenotuceptibleIvoidenibmededdiffentiWehowvrohibiMekignlgpromoteIDH/Nrco-mutntAMLuceptibilyIvoidenibAim1propoechrcterizecogenicNrmededchngeIDHmAMLhempoie(Aim1A)leukemiccellpropgti(Aim1B)Aim2evlutemechnmwhichcogenicNrmodultepeIvoidenibchrcterizghowcogenicNrmigteIvoidenibmededdiffentichnge(Aim2A)evlutgroleMekttenutgIvoidenibpe(Aim2B)ThwkcfullyciderroleDNAhnemethyltimetbolmeproceeutilizgmetbolomicbulfeequencgRNA-SeqCompletieimelucidtenovelrpeutictrgetthhigh-rkAMLub-groupvelhowignlgenvirmentfluencecelldiffentitteperpyThprojectidelnpirgphyicin-cienttgivenblendcliclbicbiologiclquetiThewktrgplnoutledcompletedlbryDrRoLevetMemilSlKettergcommteephyicincienttbiomticmetbolmcollbrupptTri-IMDPhDprogrmItpppplicntchieveirgolgndependentphyicincienttPROJECTSUMMARY/ABSTRACTTheobjectivethprojectelucidtemechnmunderlygHMGA1proteleukemogenerpytnceKMT2A-rrnged(KMT2A-r)cutemyeloidleukemi(AML)KMT2A-rAMLnggivemleukemitntcurntrpieehighlylethlKMT2A-rleukemicuedrrngementKMT2Agene(merlyMLL1)whichencodebnmlfuiprotedrivepro-leukemogenicgeneexpicludgHOXgene(HOXA9HOXA10MEIS1)DepedvnceourknowledgefuiprtnerprotemcomplexeKMT2A-rprotehibirdevelopedtrgetefuiproteircomplexehowlymodetefficcyclicltrilthufrMoovermechnmunderlygKMT2A-rleukemogenemcompletelyunderodThudineedfurrerchnewrpeutictrtegieHeIpropoenovelpprochfocugHighMobilyGroupA1(HMGA1)chromtgulrfundmentlmoleculrwchquidleukemogenerpytnceKMT2A-rAMLOurcientificpmeHMGA1driveleukemogenerpytnceKMT2A-rAMLbedfollowgplimryult1)HMGA1upgultedKMT2A-rAMLhighetlevelfterbltcometntrpy2)HMGA1quidproliferticlogenicyKMT2A-rAMLcellle3)HMGA1bdpromotergiduceexpileukemogenicHOXgeneKMT2A-rAMLcellle4)HMGA1driveprolifertipeCDKN1AtumupplocuKMT2A-rAML5)AcentpublictiidentifiedCDKN1ApidriverchemotnceKMT2A-rAMLlthoughmechnmunderlygpiweunknown6)PritudiehowttgfrcryAMLptientcycl-CDKhibir(flvopiridol/lvocidib)peHMGA1downtmgeneptientbltuggetgcouldtrgetHMGA1pthwyKMT2A-rAMLBedeexcgplimrydtwehypoize1)HMGA1driveleukemogenechemotnceKMT2A-rAMLdictlyducgHOXgenepgCDKN1A2)TrgetgHMGA1enhncepecyxicrpyTotetthwepropoefollowgSpecificAim1)TodeferoleHMGA1KMT2A-rleukemogenechemotnce2)TodetermehowHMGA1duceHOXgenepeCDKN1AKMT2A-rAMLImpctThtudyhedlighnmechnmunderlygleukemogeneKMT2A-rAMLcouldlednovelrpeutictrtegieTheJHUSchoolMediceprovidenexcellentenvirmentPIBileyWetcompletepropoedtudieMWetlerncuttg-edgetechniqueproducefirt-uthmnucriptpentherwkrgrigoulyppherncdemiccerProjectSummryEwgrcom(ES)ecdmotpvlentcncermgchildnAggiventuESdrivenfurncriptifcrwhichEWS/FLI1ccount~85%ceDrugggEWS/FLI1difficulthighlyddedNewESrpiemodultenovelrpeutictrgeturgentlyneededRecentlyStegmierLbcollbtivelyuedCRISPR-C9developPedricCncerDependencyMpwhichtegrtedBrodIntutelrgerCncerDependencyMp(DepMp)Mothn18000geneweknockedout>100pedriccelllebundnceechguideRNAwmidfter21dyDthentrdizedcrollcellleogenedependencie(iegenecncerlegedependgrowth)cnfoundMgthdtIidentifiedIGF2BP1potentilESdependencyIGF2BP1ncetlRNAbdgprote(RBP)protectmRNAtrncriptdegrdtiMyplimrydtcfirmEScellhvedecedprolifertictextIGF2BP1knockout(KO)InAim1IueCRISPR-C9KOIGF2BP1pnelEScelllePDXmodelvlidteIGF2BP1novelESdependencyScetrgeteddegrdtiferuperemplctrolgeneticKOIlouedTAGytemdetermehowduceddegrdtiIGF2BP1impctESbiologyNextAim2IdetermemoleculrmechnmunderlygIGF2BP1dependencyEWS/FLI1L28BncetlRBPptwogenedependenciepoivelycltedIGF2BP1DepMpTheeIdetermehowIGF2BP1KOffecteproteirmRNAIlouenundtegrtedomicpprochidentifymRNAterctIGF2BP1ESFllyAim3IbiochemicllychrcterizeIGF2BP1dependencydetermgwhichdomneceryupptEScellgrowthhowIGF2BP1cognizeESlevntubtrteTogerthprojectvlidteIGF2BP1novelrpeutictrgetESuncovernewmechnmESmtennceIGF2BP1-ubtrteterctichrcterizedcouldlevergedidentifynovelIGF2BP1hibirIgkillCRISPR-C9genomeedgfunctilgenomicwellvivoexperimenttiIcomepedricolidtumexpertupcompletimyfellowhiptrgplnDn-Frr(DFCI)globllynownedcncertuteperfectplcemytrgcueDFCIffilehvemnyexperimentlcdemicourcelikeBrodIntutecomputtilbootcmpMypotdocrltrglgmychemiclbiologyexpertegrdutechoolputmeperfectpoitrtmydependenterchcerfocueddevelopgnewchemicloltudypedriccncerPROJECTSUMMARY/ABSTRACTColoctlcncer(CRC)ledgcuecncermtlyignificntlyffectedmultifcrilfluencecludghotgeneticepigeneticfcrdietmicrobilcompoiOnemottrigugterventimigtgcncerrkprogimodifygdietryhvipowerfulpprochhencglyvetigtedWhilemnytudiefocudividuldietrycompentunclerhowdtctmetbolicputdietrymilieutegrtefluencecncerprogiTwomjnutrienthveenextenivelylkedCRCfrucefirFrucehighlyenrichedWeterndietpromotetetltumigeneccelertgdenovolipogene(DNL)glycolyFirmetbolizedgutmicrobiotproduceht-chfttycid(SCFA)whichexertnticrcogenicctivyFrucecettemotbundntSCFAcvergetcommdowntmmetbolecetyl-CoAwhichcnuedDNLhnemodifictimkgcentrlmetbolecriclmetbolmepigeneticgultiThmkefrucecetteprimecidteevlutgcrotlktweenmultipledietryputCRCACSS2enzymepiblecvertgcettecetyl-CoAgenetrgeteverltrncriptifcrwhichctivtedpefrucecumptiThuACSS2imptntdueponexuctbolicnbolicmetbolmAkeyfocuthpropolmetbolicepigeneticeffectdietryfirfruceroleACSS2medgeeffectMyplimrydtuggetloACSS2expiocedgterCRCtumgrdeprogiThpotentillyduedowngulticelldiffentigeneupgultigenelevntCRCtummettuchepilil-meenchymltrniUgmouemodelwefoundmnipultgdietryfirfruceledchngehotmetbolmoppogdictihighlightgneedundertgtegrtedeffecteprticulrnutrientcncerctextIhypoizefrucemnipultecetyl-CoApoolutiliztipriizebioynticpthwydvntgeoutumgrowhtcetteexertepigeneticeffectcolicdiffentigenetrgetwhichmededACSS2-dictedhnecetyltiAim1determehowcettefruceterctffectCRCgrowthcetyl-CoAmetbolmthroughvrognoidcellcultumodelvivogeneticmouemodelAim2identifymechnmwhichcettefruceACSS2gulteCRCepigeneticmodifictidiffentittuthroughhneproteomicRNAequencgchromtimmunopciptiequencgThprojectprovidenovelightcombrileffectfirfrucefluencehotgene-dietterctiuceptibilydietryimpctCRCOurwkhignificntimplictidietryterventicnproundlyimpctcncerptientcProjectSummry/AbtrctErrchromoomeeggtiledneuploidyhllmrkcncerWhileweknownerlyllmoleculevolvedmmmlincelldiviwedotunderthowywkgergivenphepdlemechniclfunctihowmoleculrchngedeeimpctpdlemechnicThbigpictuquetidrivemywkThpropolimdefeimpctprotegulrcyke1(PRC1)ovexpimmmlinpdlemechnicPRC1crolkmicrotubulemntiprllelbundle(bridggfir)whichvolvedpdlemtichromoomeeggticykeRecentwkveledPRC1ovexpicncercltecedprolifertichromoomltbilydrugtnceYetmechnticundertghowovexpiimpctproperPRC1pdlefunctimgWhilevivotudiehvegununcoverPRC1bridggfirfunctiirunderlygmechnicmpolyunderodIndeedmechniclperturbtichllenggvivommmlinpdlecnnotyetctutedvroTobridgethgpourlbhcentlydptedbiophyiclolprommmlinmetphepdlemechnicvivowhichIhvetunedpronphemechnicThenphepdlebilyeffectivelygenertecewhilelodemgovermutetemtightctroloverdynmicmechnicbridggfiroverllpdleHeIpropoedetermehowPRC1ovexpidruptedynmicmechnicimpcttructurltegrypdlecncerIhypoizePRC1ovexpiproducenoverllledynmicdemblepdletructuSuchhviwouldprovideightwhyPRC1ovexpicltedcedchromoomltbilycncerInAim1ItethowbridggfirmicrotubulelifetimeproteketicchngepePRC1ovexpiIedynmicugliveimggfluocentlytggedproteInAim2ItethownphebridggfirlterirexpnirylidghvipeppliedcediffergvelociehowthpechngePRC1ovexpiIpplycevimicreedlemnipultimeulidgugphoctivtbletubulmrkInAim3IdetermehowPRC1ovexpiimpctoverllpdletegryhelthycellcncercellnturlPRC1ovexpiIuePDMS-bedcellcfementpplyextrcellulrcemeurtepdlefrcturgeventIovexpPRC1n-cncerletetufficiencyueiRNAdepletecncercellletetneceyTogerthwkvelbicphyiclprcipledrivgrobutnphepdlemechnicmyhelpuncoverhowccurtechromoomeeggtibkdowncncercellovexpgPRC1PROJECTSUMMARY/ABSTRACTProttecncerecdledgcuemlecncerdethAdvncedprottecncerwherpentttimedignorgfterttmentloclizeddeepdrogendeprivtivriblyfilcurctrti-tntprottecncer(CRPC)whichmcueprottecncer-ocedmtlyHevilyttedtumprticulrlythoettedecdryhmerpiefquentlycquineuroendocphenotype(NEPC)whichcurntlyccount15-20%CRPCNEPCcommlychrcterizedexpineuroendocmrkernggivecliclcouredowngultilorogencepr(AR)dimhepivenerogendeprivtirpiemkgmotlethlcurntlycurbleubetprottecncerThunurgentunmetneeddefenewrpeutictrtegiedeno-CRPCNEPCOurcenttudieidentifiedATAD2nup-gulteddruggbleprotettment-ducedNEPCMooverwedemtrtedATAD2hibirdrmticllyuppNEPCcelltumgrowthThegoltudytetrpeuticpotentilATAD2hibirlecombtirpyettgp-cliclmodeldeno-CRPCNEPCdefenewmechnmthroughwhichATAD2gulteprottetumigeneThegolthpropolbedtrgplimryultWepropoeuecelllemodeldeno-CRPCNEPCwellptient-derivedxenogrft(PDX)deno-CRPCNEPCtetpropoedcombtirpiep-cliclettgTheimpropoedprojectSpecificAim1TetlevelATAD2lrgecohtcliclpecimenSpecificAim2InvetigtefunctilroleATAD2dvncedprottecncerdefemoleculrmechnmthroughwhichATAD2ctrieprottetumigeneNEPCSpecificAim3TetrpeuticpotentilATAD2hibirlecombtirpieuedtrdcprottecncerdeno-CRPCNEPCgrowthmettProjectSummryAbtrctAltertieentilmetbolicpthwymjmechnmwhichcogenicKRASpromotetumdevelopmentgrowthpncticductldenocrcom(PDAC)KRAS-drivenPDACdependennmcropocy(MP)uphgyfuelhighmetbolicdemrpidprolifertiThuemetbolicproceettrctivetrgetdevelopmentttmentPDACGeneticdepletiKRASultdowngultiMPPDACAddillyourlbdemtrtedKRASdepletihibiERK-MAPKignlgdecedglucoeuptkeglycolyceduphgyenhncgdependencyuphgyeentilnutrientupplyAccdglydulRAS-pthwyuphgyhibivichloque(CQ)ynergticllyenhncedefficcyPDACClicldtdemtrtedtncetmentovertimethroughunknownmechnmPlimrydtdictefollowgRASERKhibibothuphgyductiMPdowngultrnientuphgicMPctivyturng/urpgbllevelfterprolgedttmentRecentwkhuggetedenutrientcvenggproceeblecompenteloechWedemtrtenveretemplltihiptweenuphgyMPfollowgdepletihibiKRAS-ERKMAPKpthwyFurrmowehowCQcommlythoughthiblyoomlcidifictidoenotpventdegrdtiMP-derivedproteWehypoizecompenrygultitweenuphgyMPctextRAS-pthwyhibiThudurgprolgedRAS-pthwyuphgyhibirttmentPDACcellupgulteMPcequentlybrogtgdependencyuphgyducgenivyuphgyhibiAim1tethypoupgultiMPcfertnceduluphgyRAS-pthwyhibivrovivoAddillywepentunexpectedobervtiprolgedhibiERK-MAPKpthwyultupgultiMPPviouPDACtudiehveemployedgeneticdepletiKRASdemtrterolecogenicKRASdrivgMPnoevlutihibirKRASERK-MAPKpthwyGivendependencePDACmcropocyticuptketumigenicgrowthimpertiveunderthowehibirgulteMPInilAim2tudiededictedcomphenivechrcteriztiMPgultictextgeneticphrmcologiclhibiKRASERKovertimeSubequentwkAim2determewherchngeMPviRAS-pthwyhibicpdchngeuptkeefficcynb-pclxelFurrundertgRAS-drivengultieeentilmetbolicpthwyPDACmfutudevelopmentRAS-pthwyhibircombtiTheetudiequimypplictidiverepectrumexperimentlpprochedvncemyundertgkeytepnti-cncerrpeuticdevelopmentfotermycerdevelopmentndependentcncerercherLo--functiBRCA1/2muttileddefectivehomologoucombti(HR)ctivyfrtleDNAdmgepirpthwyccurtelyddedouble-trbkInbenceufficientHRctivyBRCA1/2-deficientcnceruggetedctivten-cniclDNAmtenncemechnmdependenncoprotecncerouhibirprotephophte2A(CIP2A)CIP2AcoloclizegenometbilyfcrTOPBP1teDNAdmgedurgmiThcomplexuggetedphyicllyterfrgmentedchromoomecentrome-rgcounterprtenuproperdivicncercellurvivlAftermichromoomefrgmentcnundergochromothriplrge-cleerr-pregenomicrrngementChromothripticfrgmentlolyCIP2AproperdivinextcellcycleultimtelypotentecogeneCIP2AknockdownlethlBRCA1/2-deficientcncerdoenothrmHR-pricientcelldictgCIP2AuniquerpeuticvulnerbilyHoweverbfideCIP2AhibirhnotyetenproducedvitrddrugdcoveryeftmyquinovtivetrtegieRecentchemoproteomicnlyeidentifiednucleophiliccyteeidueCIP2Acncovlentlylled(liged)electrophileWhileledfrgmentprovidetrtgpotfurrdevelopmentecffoldl-electivelyenggeproteFurrmofunctilcequencellgCIP2AunknownThepropolechievechemiclhibiCIP2Augcovlentdegrder(egPROTAC)focuefollowgim(1)IdentifypotentelectivecovlentligCIP2A(2)Developheterobifunctilproevluteproximy-dependentdegrdtiCIP2A(3)AnlyzechemiclhibiCIP2ABRCA1/2-deficientcellEncourgglyplimrydtdictepropoedligllCIP2AbothcellulrvroettgBuildgeultfirtimynizefocuedprocollectibedcomputtilguidncenetrgetenggementugtte---rtchemoproteomicwkflowInecdimelectiveligcvertedheterobifunctildegrderchrcterizedCIP2AdegrdtiBRCA1/2-deficientcellThethirdimnevlutecellulrctivycovlentdegrdertrckgphenotypedictiveCIP2AhibidefectivemiThpropolprovidevlublechemiclolproCIP2AfunctilyfoundtirpeuticttBRCA1/2-deficientcncerDurgthfellowhipImgrtefulmendmultiplepRockefellerUniveryTrunKpomydvmterchemiclprodeigncelldivibiologyJinkunLyunexpertcomputtilchemtryEkterVogrdovlederchemoproteomicTheirmenrhipupplementedddiltrgbothRockefellerbrodercdemiccommunyThfellowhippentneentiltepwrdmygolpermgdependenterchtterfcechemiclcncerbiologyIntrhepticcholngiocrcom(iCCA)ecdmotcommprimrylivermlignncyUnedSttewldwideiCCAhdmlprognojut20%5-yerurvivlrtecidencethcdihencgoverltfewdecdeMnyfcrctriepoprognoiCCAcludguecurntdignoticcpbilielimedttmenptiThehenignificntprogltdecdeundertgmoleculrmechnmunderlygiCCAcludgidentifygocrtedehydrogene(IDH)gfunctiemotcommmuttipecificiCCAR132gmotcommThmuttiultlph-keglutrte(-KG)gmetbolized2-Hydroxyglutrte(2HG)ncometboleurrogtemrkermuttiThmuttiprovidepotentildevelopmentpcimedicetrtegieIDHmutntiCCAMnynewrpeuticIDHmutntiCCAugmllmoleculehibirmutntIDHhveendevelopedClrIDHytrilhowgpromgpheIIIultHoweverdepeedvnceccurtedignoiCCAprticulrlydignogubtypemchllengglowgimplementtipproprettmenttrtegieCurntnvivedignoticpprocheiCCAuchCtrt-EnhncedUltround(CEUS)MgneticRenceImgg(CE-MRI)ComputedTomogrphy(CT)hvevriedptenivy1820Imptntlyetechniquelckhighpecificy30%ptientwhopentcirrhorkgmdignohepcellulrcrcom(HCC)FurrmoeimggtechniquecnnotdetermepecificubtypeiCCAoutviveproceduBiopiegoldtrdcfirmgiCCAdignohvelgturnroundtimemyunublemoleculrnlyup20%ceDueelimticliclneedmimllyviveftimggolcpbledetectgiCCAIDHmuttidiffentgiCCAHCCToddthneedwepropoeuehyperpolrizedMRInoveldignoticpprochidentifygmIDH-producgiCCAByleverggenhncedenivypectrlchrctertichyperpolrizedcrb-13(13C)lled-KGmetboleweimtudydynmicmIDHenzymtichvivrovivoWeoptimizeimggprmeterechniquebuildwrdccurtenviveidentifictiIDH-mutntiCCAAim1Optimizenextgpuleequencemximizeenivy2HGthroughpectrledgAim2Chrcterizedynmicenivyhyperpolrized1-13CdiethylAlph-keglutrtemetbolmmIDHtrhepticCholngiocrcom(iCCA)cellAim3NvivelyidentifyIDH-muttedCholngiocrcomugHyperpolrizeddiethyl1-13CAlph-keglutrteptient-derived-xenogrftmouemodelPROJECTSUMMARYThecgnumryoungwomendignoedmettticbtcncerhwkenedurgencydefewhyymolikelyufferggivebtcncerhvencedrkdevelopglife-engbrmett(BM)Whilethhenexpledcedfquencyggivetriple-negtivebtcncer(TNBC)youngerwomenyounggepdicrBMrkdependenttumubtypeEvidencehemergedourlbmp-menopulhmeetrdiol(E2)keydriverBMvifluencgE2-enivecellbrnicheendocrpietrgetgER+tummicroenvirmentdeceprogioutgrowgBMlywhenuedcombtirdipy(RT)immunocompetentmodelThecientificpmethpropolE2endocrpieynergizeRTpromoteeffectiventi-tumlimmunepeOurlg-termgoldefehowendocrpieRTynergizedeceBMguidetrnltiFDA-pprovedendocrpiemngementTNBCBMOurpilotdthowendocrpyupgulteIRF-cecrumentcellbrThupgulteIRF-brRTcecncer-cellntigenpenttiynergizgendocrpydeceBM(Aim1)OurplimrydtlohowE2ctgER+trocytepromoteupgultiS100A4cncercellthwblockedendocrpyWhileS100A4nextrcellulrlyleedfcrmodultemyeloidcellcquipro-tumigenicpropertiecedexpiS100A4henocedtrcrnelprogirdiotncehighexpiS100A4pdictrdiotnceBCcellvroThuwepropoeendocrpiecerdioenivyBMthroughblockgeE2-ducedS100A4(Aim2)Imptntlydefghowdiffentendocrpie(elective-etrogenceprmodulr(SERM)electiveERdegrder(SERD)clicllylevntRTcheduleimpctnti-tumlperdiotnceneededguidefutuclicltril(Aim3)OurcentrlhypoendocrpieRTynergize1)upgultgIRF-trocytemicrogliblockmicroglictivtipromotecrumentTcellbr2)blockgS100A4upgulticncercellthupromotgrdioenivyTheecombtiendocrpieRTeentilelimteBMTheetudieignificntyprovidemechnticexplnticedrkBMyoungwomenpotentilchngecliclprcticeOurtudienovtiveychllengecurntdogmhowE2ctrietummetteutilizenoveltrngenicmodeleroleE2ERimmunemodultibrPROJECTSUMMARYBtcnceretimtedmotdignoedcncerAmericnwomenccount15%femlecncer-lteddeth2023Triple-negtivebtcncer(TNBC)nggiveubtypelckgeffectivedurblettmenttrtegieduebencetrgetblecellurfceceprcludgERPRHER2CequentlyTNBCptientfcewtprognomgbtcncerubtypeAdptiveimmunectivytummicroenvirmentwell-knownprognoticdicrTNBCptientcltedttmentnefHowevertumfquentlyevolvevoidimmunecogniwhichnegtivelyimpctptientprognoClicldtpidprimrymettticbttumdemtrteTNBCmettecommlydowngulteexpigenevolvedmjhcomptibilycomplexClI(MHC-I)ntigenpenttimechnmwhichCD8+cyxicTcellcncognizekilltumcelldplygrrntnetigenTheeundertgddgtumimmuneevimededloMHC-IhpotentilimproveTNBCptienutcomeOurcentrlhypobttumMHC-Iloultuniqueimmune-evivephenotypecnovercomethroughnovelttmentmodlieThpropoederchfunctillymoleculrlychrcterizeMHC-I-lowbttumevlutecumizedcombtiimmunpypprocheenhncenti-tumdptiveimmunyExperimentAim1determehowMHC-IloffecttumprogiimmunecellfiltrthroughbothvivoimmunocompetentmouemodelcomputtilnlyhumncliclbtcncerdtetInAim2IewherCD40grdemethyltggentceefficcyimmunpygtMHC-I-lowtumAlgerthwkcomphenivelymhowMHC-I-mededimmuneeviffectmultiplefcetbttumbiologywhichrpeutictrtegiehouldexplodclicimproveptienutcomeABSTRACT/SUMMARYBrtum(mlignntnign/n-mlignnt)ffectpproximtely25perper100000peopleUnedSttennullyItetimtedwe1323121peoplelivgcentrlnervouytemtumend2019TheburdenetumprticulrlylrgechildndolecentyoungdultwhebrtummgpcuecncerourcecncerdethWhimprovementttmenteverltypebrtumpropthpopultilgtermurvivcgAultexperienceneedurvivcglylevntTheBrTumEpidemiologyCtium(BTEC)wed2003fcilteterctimgbrtumopidemiologtclicinScedteBTEChfedyerlymeetgprticipntctedwkggroupledgfundgeverlctiumprojectTohelpenhnceprticipticecceibilycfencetellprticipntweferpropolNIHprtilfundg2024BTECcfenceMzGermnyentledEvolvgEpidemiologyBrTumSurvivhipOur2024meetgfocubrtumurvivhipcrogepectrumddiouruulpiccludgimprovementpdictgbrtumrkurvivlTheMzcfencefollowtrdilterntgtweenNthAmericnn-NthAmericneechyerABSTRACT/PROJECTSUMMARYTriple-negtivebtcncer(TNBC)heterogenouetdeecidedemotggivebtcncerubtypeTNBClckwell-defedendocmrkerlimrpeuticoptieptientThhpurdignificnteftwrddevelopgrpiedictedwrdtummicroenvirmentehvedemtrtedlymodetucceThttriedhighfunctilheterogeneymcrophgewhichprtdetermedirigdtctmoleculrlcpediffentTNBCubtypeOuroverrchgobjectiveelucidtelktweenmoleculrprileTNBCmcrophgeigfunctideretblhgroundwkfetungnextgenertimcrophge-trgetedrpiecidertummoleculrigntuproxymcrophgefunctiTheoverllobjectivethpropolexmepotentilenrichmentmcrophgediffenrigfunctilprileTNBCubtypedivergentmoleculrlcpeThecentrlhypolumlTNBCubtypeenrichedtumntgticTRMirbltigivewypro-tumMDMcoliztiThertiletrtumlmcrophgecntemdiffenrig(ieembryicllyderivedtue-ident(TRM)mocyte-derived(MDM))whichtrglyfluenceirfunctilprileMDMocedtumpromotgpropertiewhileTRMhveenptedplytumntgticroleOurplimrydtupptTNBCdivergentmoleculrprileenrichedmcrophgedivergenrigThpropolctpro--prcipletudiedemtrtemcrophgeTNBCmoleculrubtypeperveepililpropertieenrichedtumntgticTRMwhileTNBCmoleculrubtypehvecquidmeenchymlfetuenrichedtum-promotgMDMAlgrjecrycentrlhypotetedpurugtwopecificimAim1determeigfunctrtumlmcrophgeclud-lowluml-likeTNBCtumubtypeneedepililfetumTRMpoolAim2determekewgmcrophgecomprtmentwrdpro-tumMDMluml-likeTNBCftercetimcrophge-bltirpyThepropoedtudienovtivecueyetblhcltitweenTNBCmoleculrprilemcrophgeigfunctiTheprojectignificntcueetblhgmoleculrlcpeTNBCproxymcrophgefunctiervetilmcrophge-trgetedrpieccountmcrophgeheterogeneyPROJECTSUMMARYDouble-tdDNAbk(DSB)evemDNAdmgecngivedevttgchromoomlrrtiWhileDSBuullypidhighfidelythroughhomologoucombti(HR)cellrgmuttiHR-ocedgeneuchbtcncerltedgene(BRCA)1/2pivotn-cliclDSBpirproceclledmicrohomology-mededendjog(MMEJ)UnlikeHRMMEJhighlyerr-precnledgenomictbilycrcogeneAkeyplyerMMEJDNApolymeret(Pol)whichcruedDSBcrryoutDNAmicrohomologynnelgtreprtigp-fillgproceeviuniqueDNADSBpirmechnmmpolyunderodMnycnceruchBRCA1/2deficientbvrinprottepncticcncerexhibHRpthwydeficiencielyhevilyMMEJmkgPolpromgrpeutictrgetduefundmentlvolvementthDNApirpthwySuccefultrgetghibiPolttHR-deficientcncerquimechnticundertghowPolcodteMMEJTognewbiomedicllyimpctfulighteunknownmechnmIcometblhedbiochemiclcell-bedynovtivegeneedgtructurlbiologypprocheelucidtemoleculrmechnmMMEJidentifytrmoleculrtermoleculrterctidpenbleefficientMMEJPolDurgmyfirtyerLerlbIdetermedfirtDNA-boundtructuPolhelicedomugDNAubtrteIidentifiedntivePAGEcenThtructuveloltedPolhelicedompermgmicrohomologynnelgwhichprimryitepMMEJThtructulovelhowDNAthdedthroughhelicedurgMMEJhifthelicequternrytructutetrmerdimerhgedrottibothheliceC-termldomccommodteDNAmicrohomologynnelgtweenpromerTheeobervtiprovidenovelightrolePolhelicedomMMEJTheeplimrydtetblholidfoundtimytudieimedt(Aim1)defgmticltihiptweenPolMMEJDNAubtrteillumtgnoveltrtegiedevelopmentPol-trgetedrpeuticttHR-deficientcncer(Aim2)elucidtgcellulrmechnmMMEJvetigtgcellulrcequencemytructurlbiochemiclightTheecomdbiologicltechnicltudieddcriclunmetneedBRCA1/2-mutntbvrincncervelgnewtrtegiedevelopmentPolhibirvetigtedpotentilrpeuticttgHR-deficientmyopthieAntumpeCD8+TcelltightlygulteddtctmetbolicfneIthenptedtermllydiffentedexhutedTcelldplyimpidmichdrilpirti/glycolyuchlimedmetbolicerveceTcelldyfunctilyepecillytummicroenvirmentdvncedcncerThemoleculrmechnmwhichutgmetbolicfnehighlydiffentedeffecrTcell(TEFF)enhncementnti-tumimmunyhenill-defedIntetglycedlevelglutthie(GSH)obervedmjytumuchbtcncermelnomctrigcncerprogtmenttnceprtpventgglutthieperoxide4(Gpx4)dependentferropnir-dependentprogrmmedcelldethHoweverroleGSH-Gpx4metbolicxmodultgntumpeCD8+TcellmeluiveBedplimryultweobtedcentrlhypoutgGSH-Gpx4xwhilectivtidenoeA2Acepr(A2AR)criclgenertilg-livedTEFFdurblemetbolicpegttumcellbioengeergTEFFcdillyexpGclc/Gpx4A2ARhibiimprovevivopertencefunctiprolgefficcydoptivecellrpy(ACT)TotetthhypowedefedowntmmetboliccellulreffectutgGSH-Gpx4xwhilectivtiA2ARignlgTEFFcellfurrdetermefetyefficcydoptiverpymuhumnTcellbioengeedexpGclc/Gpx4A2ARhibiPROJECTSUMMARYGtriccncercurntlyfourthledgcuecncerdethwldwidedignoedpproximtelyemillipeopleperyerThemotcommtypegtriccncertetl-typewhichdevelopthrougheriemetplticdyplticleimchlggngpylicmetpliThehllmrkpylicmetplrndiffentigtricchiefcellpmolyticpolypeptide-expgmetpltic(SPEM)cellWhilegtriccrcogenehlogicllywelldefedmoleculrdrivercellulrmphologiclchngethccurechetgehvenotyetendcovedTrncriptifcrprotectrolcellftevigeneexpidurgdevelopmentdultprogenircelldiffentiTodetermeiftrncriptifcrloctrolcellftemetplticproceemchmylbprodexpielectfcrcrcogenicgtrictuefoundtrgupgultimtertrncriptifcrSOX9SPEMcellTofollowupthfdgIchrcterizedtwoveltrngenicmouemodelpylicmetpliSox9knock-outchiefcellfoundSPEMcellmtiubequentcrcogenewevelydruptedIhypoizeSOX9necerychiefcelltrndiffenteSPEMcellwhicheentilcrcogeneToundertignificnceSOX9SPEMcellcrcogeneIpropoethepecificimFirtIvetigtefunctilroleSOX9permgnvroexperimentuggnoidSox9knock-outtuedetermeifSOX9quidchiefcelltrndiffenteIloexmewherSox9knock-outchiefcellbletimultetrndiffenteSPEMcellSecdIpermtrncripmicprilgidentifydictdowntmgeneSOX9elucidtetrncriptilmechnmSPEMcellidentifyfunctiFllyIvetigteuccemicroenvirmentcrumentwhicheentilprogicrcogeneoutSOX9upgultichiefcellThelucidtebiologiclmechnmwhichSPEMcelldrivecrcogeneTogeredtprovidefunctiltrncriptilmechnmSOX9SPEMcelldurggtriccncerdevelopmentTherchmovefieldwrduncovergmoleculrmechnmgtriccrcogeneprovidepotentilrpeutictrgetpventggtriccncerdevelopmentProjectSummry/AbtrctPncticcncerlivermett(PCLM)pent50%ptientdignoedpncticductldenocrcom(PDAC)hmedinurvivl<6mthRecenttudiemicefoundmodultggutmicrobiomecnducePCLMtumburdenugmentgnti-tumimmunyThegutmicrobiomectntlyproducgntigentrvelliverThuggetgutmicrobiomemodultiducePCLMnti-tumimmunyltergntigenpentedliverhowevermechnmunclerMucolAoceInvrintT(MAIT)cellnnteubetTcellwhichcnclifiedtwophenotypennti-tumMAIT1pro-tumMAIT17phenotypeMAITcellcloelyterctgutmicrobiomederivedntigenthroughirctivtimechnmthcnhiftirphenotypeDictctivtiledMAIT17phenotypevolvgterctimicrobilriblvynpthwy-derivedmetboleligpentedntigenpentgcell(APC)viMHCIltedprote(MR1)IndictctivtiduceMAIT1phenotypetimultgMAITcellIL-12IL-18cepr15TheecykeleedAPCuptimultimicrobil-producedligCequentlygolthprojecthrnegutmicrobiomemodulteMAITcellphenotypewrdttmentPCLMPlimrydtuggetMR1expiupgultedPCLMtummicroenvirment(TME)whichpromotepro-tumMAIT17phenotypevidictMAITcellctivtiThuggetnbundncegutmicrobiomederivedMR1ligPCLMTMEInAim1wehypoizegutmicrobiomedygultiprovideMR1ligPCLMTMEwhichpromotePCLMviducgMAIT17phenotypeWetetth1)CltgbundnceMR1ligPCLMTMEMAIT17phenotype2)DetermggutmicrobiomecompoimicePCLMhotgunmetgenomicequencg3)chrcterizghowMAIT17phenotypepromotePCLMtumburdenglecellRNAequencgFurrplimrydthowpromotgMAIT1phenotypeducePCLMtumburdenAlogutmicrobiomedepletintibioticttment(ABX)promoteMAIT1phenotypewhichlikelypromotenti-tumTH1cellliverInAim2wehypoizeABXduceMR1ligPCLMTMEwhichpromoteMAIT1phenotypenti-tumimmunyWetetth1)InvetigtgMAITcellphenotypePCLM+ABXmicevlidtgfeclmicrobiometrnfer2)DetermggutmicrobiomecompoifollowgABX3)Probgnti-tumimmunyPCLM+ABXTMEimggmcymetryTheetudieidentifyMAITcellmglktweengutmicrobiomenti-tumimmunyffecthowPCLMlivercdittedTherchplnmyoutledtrgplnupptedexceptiltutilupptnexceptilmenrhiptemThprovidenunmtchedmultidciplryerchclicltrgexperienceperfectlylignmycergolABSTRACTGlioblm(GBM)rnkmgmotlethlhumncncerStrd--crpieferlypllimoleculrlytrgetedttmenthvehownltlenefptientThefiluchievetumctrolprtlyduepenceGBMtemcell(GSC)Theetem-likecellelf-newdiffentediverecelltypetumgenertgtrtumlheterogeneyctriengiogeneimmuneecpeAlthoughimpctGSCmctroverildefgirmoleculrgultimyfernovelrpeuticprdigmimprovecliclcptientfflictedGBMbrtumWehvefoundGSCdtguhedirdiffentedprogenynmlneurltemcelltmultiplelevelgulticludgtrncriptiepigeneticeprncripmictrnltilpot-trnltilmechnmInplimrytudieGSCdplyenhncedproteynltivediffentedprogenyneurltemcelluggetgefficientmRNAtrnltimyctrietumigeneDurgtrnltRNAdeciphergeneticcodebepirgmRNAcodtrnfercpdgmocidgrowgpeptidechPot-trncriptiltRNAmodifictigulteirtrnltilfunctiwhichcell-typepecificfluencedenvirmentlcueArrntmodifictiltertRNAtbilytructufoldgtricrexpdecodgThpropolfocuecurntlyundertudiedtRNAmodifictiGBMComprgexpipriledee-ltedtRNA-modifygenzymeIidentifieddiffentillyexpedtRNA-modifygenzymemrkptient-derivedGBMurgiclmplecultuAelectedmociderveco-fcrtRNAmodifictiIhypoizedietrytrictimocidcnprogrmtRNAlcpeIndeedplimrytudiegenetictrgetgtRNAmodifictienzymemocidtrictiducedGSCprolifertielf-newlvivotumgrowRNAmodificticnpecificllytrgetubettRNAoIlohypoizeltedtRNAmodifictichngehomeottRNApoolledcod-dprogrmmgtrnltidrivecogenicproceeGBMTotetthhypoIuempectrometrydetectchngetRNAmodifictiriboomeprilgundertdowntmproteomicchngeuptRNAenzymeknockdowndiettrictiCollectivelythpropolprovidemoleculrightroletRNAmodificticncertemcellmtenncemdevelopmentnovelrpieGBMWepropoedevelopevluterobutdeeplerng(DL)-bedpprochecpbleccurtelydeletgtrgetvolumepdictgcurncehedneckcncer(HNC)ptientRdirpy(RT)emotcommttmentHNCptientAdvncedRTtechniqueenblehighlycmldoedeliverytrgetvolumeHowevermjchllengeRTplnngHNCdeletgtrgettumvolumeDepevilbilycenuguideledeletggrotrgetvolume(GTV)clicltrgetvolume(CTV)HNCtime-cumgquiextenivecliclexperteItdemcompheniveundertggitrictenmytumhlogypdptternPcedeletrgetvolumeepecillyCTVeentilvoidmrglmeexcedoegntrk(OAR)AloextgDLtrgetvolumedeletilghmhvepdomntlyfocuedGTVdeletiophryngelcncerneglectgcommlyencountedtumubeuchlryngelnophryngelcncerwhichpent~30%HNCAnchllengeHNCmngementhighcurncerteTheduntg30%five-yercurncertetlet50%occurrg-fielddepecomphenivettmenttrtegieencompgurgerychempyRT18F-FDG-PET/CThcomeprttrdcHNCthnkbilyimproveccurcyGTVdeletivelpvioulyundignoedgilnodldeectriedeceter-tr-obervervribily(IOV)GTVdeletiHowevermotDLlghmhveuedcurderivedglephyicingoldtrd(ll)filgcptuIOVtumdeletineentilcompentrobutDLtrtegieWedeveloprobutdeletilghmcpbleccurtelydeletgbothGTVCTVvriouHNCloctibothprimrycurntettgWepropoediffui-bedDLlghmdeleteGTVCTV18F-FDG-PETctrt-enhncedCTwhilecpturgobervervribilyWelodevelopDLmethodcpteimggcliclmtipdictcurncewhercurnceoccur-fieldPROJECTSUMMARYPncticcncerhdmlvergelifeexpectncyroundixmthlrgeprtduemrkedimmunouppiurroundgtumpventgnnti-tumimmunepe(12)AmedirpncticcncerimmunouppigulryTcell(Tg)(3)Tgknownpro-tumigenicpopultipncticcncertumcompletedepletiTgultccelertedtumprogidictgdelicteblnceTgneeded(45)ThegolthpropoluevroychrcterizepopultiCCR6+TghowcedimmunouppivecpbilieFurreffectCCL20lychemokeligCCR6eedbilyhpeTgfunctiNextimpctCCR6-CCL20ignlgtetedugvivomodelpncticcncerimtrikgblnceneededtrgetgomenotllTgchievennti-tumimmunepeMyplimrydthowCCR6+TgenrichedpncticcncertumypoeuperiuppivebiliecompdCCR6-TgCCL20upgultedpncticcncerocedweprognothupoenttrctivetrgetovercomeloclimmunouppi(6)ThecentrlhypothpropolCCL20duceuperuppphenotypeCCR6+TgeuperuppCCR6+TgpibleCCL20-mededpro-tumigeniceffecteenPDACOurlbhenlederdefgrolechemokecncerthuperfectlyuedpuruethquetiUtilizgducibleTgbulkequencgfunctilyIextenivelychrcterizemechnmimmunouppiverenlCCR6+uperuppTgAddillyIuevivomodelpncticcncerexploimpctCCL20-CCR6pncticcncerprogummicroenvirmentthroughextenivenlyflowcymetryglenucleuRNAequencg(nRNA-eq)ThwouldfirttudypermnRNA-eqvivomodelpncticcncernurgentneedduenRNA-eqbilyttercptulrgefibrobltpopultipentpncticcncercompdglecellRNAequencg(78)LtlyItetbilynovelcompoundgenertedourgrouphibCCR6chemotxfunctipncticcncertum(9)CollectivelyedtgivegterightTgfuncticeundertghowimmunouppivepncticcncermicroenvirmentmevlutebilypromentpcliclmodelpnccncerccurtelycpultehumndeevetigteefficcynovelphrmcologiclcompoundPROJECTSUMMARY/ABSTRACTThemmmlinSWI/SNF(mSWI/SNF)complexepentdiverefmilyATP-dependentchromtmodelgcomplexe(CRC)plycriclrolemodultichromtcceibilygeneexpimSWI/SNFcomplexecombricllyembled29diffentgeneproductgenertethedtct11-15-ubuncletermedBAFpBAFncBAFcomplexeImptntlymSWI/SNFgenemuttedover20%humncncereverlneurodevelopmentldder(NDD)everlcepentgcutivegenomicbnmlieWhilebiochemicltructurlgenomic-bedtudiehvegundefeubun-pecificctriioverllmSWI/SNFcomplexfunctipecificroleDNA-bdghnederdompennubunmlrgelyunignedInprticulrfunctilctriiequence-n-pecificDNA-bdgdomcludgwged-helix(WH)domSMARCB1high-mobilygroup(HMG)domSMARCE1ARIDdomARID1A/Bubunhvenotenidentifiedpentkeyhubfquentgle-iduemuttihumncncerNDDIimdeferoleedommSWI/SNFcomplexfunctivrohumncellctextviementdee-ocedperturbtiDurgthF31fellowhipIdetermeroleequence-n-pecificDNA-bdgdom)propermSWI/SNFcomplexemblybiochemicltegryb)mSWISNFcomplexctlytic(ATPe)ctivynucleoomemodelgc)genome-widemSWI/SNFtrgetgDNAcceibilygenertihumncelllemodelytemIccomplhthgenertgwild-type(WT)DNA-bdg-deficientdee-ocedmutntvrintmSWI/SNFcomplexeevlutgirbiochemiclemblyichiometryctlyticnucleoomemodelgfunctiFurrIimdetermeimpctDNA-bdgdomperturbtimSWI/SNFcomplexgenomictrgetgDNAcceibilygenertiubequentgeneexpihumncellctextTherchelucidtekeyfetuDNA-bdgdom-mededSWI/SNFcomplexemblytegryctiviechromtlocliztilkgefunctiultgDNAcceibilygeneexpiprogrmhumncellnmldeetteThemechnmgoverngchromtmodelgcomplexctiviedurgbiccellulrproceehumndeemcompletelyunderodhighlyfquentmuttieproceeobervedhumncncerneurodevelopmentlcdiuchtudieuniquelypertentpenthigh-impctpriyfieldt-lrgeSummryThe2024FASEBSRCentledRegultiFunctiSmllGTPepentltetertilg-tgcfenceGTPebiologyfirtokplce1991SmllGTPebrywchetercvertGDP-boundfGTP-boundtteceprgulrymoleculewhenttedriveignlgthroughvrioueffecrmoleculeThcfenceprovidebrodcovergeRASuperfmilyGTPenumrmothn160memrdividedfivefmilieRASRHORABARFRANRASwfirtmllGTPeidentifiedmttudiedGivencogenicctivtinerly20%humntumRAShgrnedtenetetphrmcologicltrgetOncedeemedundruggblecentdeploymenttwoFDA-pprovedRAShibirclichnowdpelledthideWhvolvemenrmllGTPetumigenetetgrowgphrmcologiclhibiddilmemrthimptntuperfmilyignltrnducerTheFASEBSRCSmllGTPectuetrdiptmeetgbrgggerlederfieldlgtethoenewhexcgnewfdgdrivefieldwrdpromotecollbtiexpededevelopmentnewrpieInddimeetgprovidenumeroutrgcerdevelopmenpptunieteerlycercienttclicinThpplictieekprtilfundg2024FASEBSRCentledRegultiFunctiSmllGTPeThemeetgfetuKeynoteLectuDrAnneRidleyMrkPhiliptwolederGTPebiologyInddi27plenrytlkTwenty-ehttlkelectedubmtedbtrctdelivedyoungcienttAllttendeepentpoterOpptuniemldcuinetwkgboundover4-dymeetgcludeuncheduledtimefternowellMeet--ExpertluncheCerDevelopmentwkhopThirty-fivepercentvedpekernewcfencefuenewperpectivetechnologieThirty-eightpercentvedpekerwomenhlfeichiregnizerWhilethevedpekerunderpentedgroupccertedeftplnnedcruddilpekertewhomemrunderpentedgroupTentrvel/gtrtiwrdmdetepfencegivenunderpentedmiePROJECTSUMMARYWhgeexpougenoxicttuethroughoutbodycquiomticmuttiInbloodmrrowomticmuttifquentlyfoundleukemi-ocedgeneubethempoieticcellevenbencehemlogiccncerThphenomenhentermedCllHempoieIndetermtePotentil(CHIP)cuewhilemnypeopleuchmuttihvenoknowncliclimpctpenceecllpopultiocedcedrkpooutcomedeerngghemlogicmlignncycrdiovculrdeeoteopoCOVID-19WhileCHIPffecttlet10%peopleoverge70impctmny25%ptientolidtumlikelydrivengenoxictchempyrdiRecenttudiehvehownCHIPmyultrrntflmmryprogrmmgprticulrlymyeloidlegeimmunecellCHIPmutticnfiltrtetummicroenvirmentMoovererchuggetCHIPmyocedweoverllurvivlmgolidtumptientGivenimptncetumimmunemicroenvirmentcedburdenCHIPepopultifundmentlneedexmeterplytweenCHIPolidmlignncieexplohowclicllymngeolidtumptientCHIPThpropoleekuecliclequencgdtptientmplemouemodelexvivoexperimentdetermeimpctCHIPolidtumoutcomeimmunemicroenvirmentugtriplenegtivebtcncer(TNBC)modelytemTNBCnggiveubtypebtcncerlckexpietrogenceprprogetereceprHER2ImptntlyTNBCtenhpromentimmunecellfiltrteprognoticpencelymphocyteocedfvbleoutcomewhilepencetum-ocedmcrophgenegtiveprognoticdicrAim1levergemultiplelrgebiobnkpropectivelycollectedptientpecimennovelmouemodeldefeCHIPprognoticbiomrkerTNBCoutcomecludgoverllurvivlperpyAim2hrnebothptient-derivedimmunecellmouemodeldetermehowmyeloidcellCHIPmuttiterctTNBCcellTechniqueutilizedcludehpthologyflowcymetryimmunophenotypggeneexpinlyfunctilimmunecellyComplethwkprovidecomphenivetrgvehiclethfellowhipimultneoulyyieldnewightcliclmngementolidtumptientCHIPuggetgnovelrpeuticpprocheeptientTheetudieloprovidegterundertghowdygultedmyeloidcellignlgCHIPcleleddiffentilterctummicroenvirmentPROJECTSUMMARYPncticductldenocrcom(PDA)dedlydeefive-yerurvivlrte12%OncogenicKRAS(Kr*)ner-univerldriverPDActivyquidmtiPDApcurleipnctictpililneopli(PnIN)PnINmticcompniedfibroimmunecellfiltrtimtedevolvethroughoutdeeprogiCncer-ocedfibroblt(CAF)hveknownrolemodultgfunctiimmunecncercellvercellulrterctiDplyghighdegeheterogeneyCAFhvetum-promotgtum-trgfunctithoughtmededdtctfibrobltpopultiDtlbuggetdiffentiligCAFplyroleprogrmmgthheterogeneyNotblymeolilcellprotectivemolyercellleternlgnpotentilundertudiedourceCAFPDAPlimryexperimentdecridthpropoldemtrtethrthopicmouemodelPDAmeolilcellgiveCAFMooverourgroupfoundpotentilpopultiWT1+meolil-derivedCAFcomptrncriptillydtctpopultifibrobltexpghighlevelcykeknownimmunomodulryrolePDACtentthobervtidepletiWT1+cellducedexpiecykethopictumcocidedductumweightIntetglynceimmunouppivemcrophgefiltrtiwobervedupWT1+celldepletiuggetgthductumweightcnugmentedmcrophge-trgetgrpeuticComptiblehypothrigdictteCAFfunctioverllobjectivethtudychrcterizeourceCAFheterogeneyidentifygnovelpprocheelectivelytrgettum-promotgpropertieCAFPDAThecentrlhypomeolilcellgivefunctillydtctimmunomodulryCAFPDAThhypovetigtedthroughfollowgtwoAim(Aim1)DetermectriiWT1+meolilcellfibrobltcomprtmentctextPDA(Aim2)EvlutefunctilroleWT1+celltdiffenttgePDApthogeneTocompletethvetigticombtivivomodelvroycludgmcrophgepolriztimigrtiyueddetermepropertiemeolil-derivedCAFirfunctilrolePDAtummicroenvirmentThedtccumultedthtudyfurrfieldundertghowcelligdicttefibrobltfunctiPDApvewydevelopmentnovelfibroblt-trgetgrpeuticProjectSummry/AbtrctCollgenlyfoundtibodilytueervgtngncnectignlmicromcrocleTheimptncecollgencncerbiologyhenwell-etblhedfunctigultummicroenvirmentcedtiffneextrcellulrmtrixdygulticncercellignlgfluencetumprolifertiimpenetrbilyKeyeeffectterctitweenfibrillrcollgendcoiddomceprtype2(DDR2)ceprtyroekeimplictedmultiplehumncncerExtrcellulrbdgfibrillrcollgenDDR2trnducecellignlctivteepililmeenchymltrniprolifertimettThwkeekdevelopynticcollgenmimeticpeptide(CMP)terrogticollgen-DDR2terctiApermuttedtripleheliclpolymervolvedbiochemiclignlgcollgenhpotentilmnipultiolmodultgprote-proteterctiTheepplictihveenlimedtriprtentuwhichtrictrmlentropictbilySynticlkgecyclizthecollgentrmyovercomeelimtiTothendthwkfocuedeignynbiophyicl/tructurlchrcteriztibiologiclpplictilkedcyclicCMPtrgetedgtDDR2throughchemiclbiologypprochdecridtwoAimAim1evluteimpcttrtegicdeigntrtegiermlproteolytictbilypropoedCMPgolmximizgtbilyAim2vetigtebilyCMPterctDDR2vromodulteDDR2ignlgcelluloPriwkhetblhedmethodynmcrocyclicCMPolidphepeptideyn-cycliztidemtrtedphoctiCMPugdizi-bedphocrolkggentcnuedppunimoleculrcollgenheterotrimerSeverllked/cyclicwelllerDDR2-trgetedCMPhveldyenynizedhvedemtrtedpproprermltbilywellcpcyterctDDR2MethodcludegnicynphocticirculrdichromcollgeneymlclimetryX-rycrytllogrphymmmlincellwkcoupledWeternblotThwkendevdevelopbiochemiclolmodulticollgentercmeccentrtgcncer-implictedterctitweencollgenDDR2vinnovtivechemiclbiologypprochlygfoundtinewdcoverieurroundgrolecollgencncerbiologypotentilpplictidrugdcoveryTherobutcollbtivetrgenvirmenttUniveryPennylvnDeprtmentChemtryPelmnSchoolMediceMediclScienttTrgProgrmwellkilledphiptemexpertegnicyncollgentructufuncticeprtyroekecrytllogrphycellbiologyupptcompletipropoedfellowhipwkfcilterigoutrgndependentphyicin-cienttvetigrProjectSummry/AbtrctEtrogenceprpoive(ER+)btcncer(BC)ccountmjylldignoedBCwomenUnedStteWhiletrdilntihmerpieER+BCillyeffectivepproximtely40%ER+BCdeveloprpytntcurncemettwhichctriemotBClteddethThepenceG-protecoupledetrogencepr(GPER)uggetediddeeprogimettBCGPERizeddriverrpytnceduegticctivytmoxifentrdilntihmerpyER+BCGPERexpedcncer-ocedfibrobltmmodelerextrcellulrmtrix(ECM)whichplynimptntroledeeprogiPviouwkDrSuznnePikcollbrhdemtrteddynmicterctitweenhmeignlgECMtiffnedrivetumcellvimettHowevermechnmpibleedynmicterctipolyunderodTheehypopropoederchGPERctivtedCAFprimgTMEdrivetmoxifentntdeeprogiER+BCTheerchtrtegypropoeetblhpecificroleGPERctivtedCAFplyECMprotedepoigniztivroprroducgGPERknockdownCAFnthotropicER+tmoxifentnttummodelThevrovivowkcomplementednoveltummicrry(TMA)BCptientwheocitweenGPERexpiECMigntudmtedrpyptienutcomecnvlidtedThepecificimthpropol1)identifyhowGPERignlgCAFgultebiophyicl/biochemiclcuehowGPER-mededmtrixdepoifluencetumcellhvivro2)tethypoECMtiffnentihmerpyynergizethroughGPERignlgCAFdrivetumprogivivo3)defehowGPERexpiECMigntultehumndee/ptienutcomeTheerchtrgthpropolcductedunderco-phipDrSuznnePik(Sp)DrMrkBurkrd(Co-Sp)tUniveryWc-MdBothDrPikDrBurkrdprovidemenrhiperchcductedShelFertlwellprovideguidncehercerdevelopmenttentiShelmcdemiTheuccethpropolfernovelightmechnmntihmerpydrivendeeprogiER+BCprovideolidfoundtiShelcerndependenterchpABSTRACTPrognoptientmllcelllungcncer(SCLC)mpoduehighrtemettticdeevttr-tumlheterogeneylimedrpeuticoptirpiddevelopmentrpeutictnceOurlbhcentlyhownAl(ABL)fmilykehibireffectivettmentSCLCmettevivoTrgetedcombtirpiecnmimizecyxicdvereeventimpirdevelopmenttnceThuwepermedwhole-genomeCRISPR/C9lo--functienizticenidentifyynergizgcombtirpytrgetABLlloterichibirABL001CtentpriobervtiABLkehibidygultemichdrilmetbolicfunctilungdenocrcomnumeroupenizerABLkehibiveledcenvolvedprocegclerncemetbolicproductPlimryvlidticenhhownhibignicniMCTtrnpterynergizeABL001cuecelldethcequencemichdrildygultiphenotypeobervedlungcncercellfollowgttmentllotericABLkehibirFurrmotrgetedmetbolomicequencgveledfollowgcombttmentABLMCThibirlevelnumeroumetbolepeciecomeignificntlydygultedTheechngectenttllgglutmolymottrikglychrcterizedignificntdeceglutthienimptntmedirmetbolictpeMyhypometbolictducedhibiABLkewhenpidMCThibiulttllgglutmolyubequentloglutthiepromotgferropctrigynergticcelldethphenotypeobervedTheimthpropol1)determehowABLkemedehomeotticmetbolicfunctidefemechnmmetbolicdygultifollowgABLkehibi2)determemechnmdygultiglutmolyfollowgcomdABLkeMCThibi3)eextentwhichthcomdrpyctriecelldethviferropApprocheddeobjectivecludemetbolicprilgvitbleopetrcgglucoeglutmeSeheymeuoxidtiveglycolyticenergymetbolmWeloeextentwhichthcombttmentduceferropticcelldethvrodrug-ttmengenicknockoutexperimentSubequentlywepermvivodrugttmentexperimenteefficcycomdABLMCThibtmentSCLCmouemodelThvetigtiroleABLkemetbolicdynmicexplovelmechnmgultimichdrilhomeotABLkewellevlutepotentilttmentmodlyptientSCLCABSTRACTLungcncer(LC)ledgcuecncerdethmkgupnerly25%llcncerdethAlthoughomedvnceperlizedttmenthveimprovedurvivlrtengogcliclneeddevelopnoveltrgetedrpiegtLCubtypeprticulrlypoprognoHoweverourbilydevelopettmentcurntlylimedlckcompellgctibletrgetPubliclyvilblecengdtlgmultudepritudiehvevlidtednuclerfcrerythroid2-ltedfcr2(NRF2)trgelectivedependencylungcncerAccdgptientdtetimted15%30%LCtumhvelofunctimuttieirNRF2KEAP1emuttiocedtncecventilttmentpoprognoFurrmodepeimptnceutgtumgrowthgermleNRF2knockoutmouemodelproducegenerllynmlmicenoignificntdevelopmentlhelth-ltedueComdeultuggetNRF2hwiderpeuticdexmerfurrvetigtipotentildrugtrgetLCTheepropoederchexplopotentilNRF2novelrpeutictrgetlungcncerbiochemicllychrcterizgfunctilbdgprtnerToovercomehentchllengetrgetgNRF2weuedhigh-throughputptercenbiochemiclyidentifyPRMT5puttivemodulrNRF2ctivyWehypoizectivyNRF2KEAP1-mutntLCnegtivelygultedPRMT5-NRF2terctiloerctiledlerblelevelNRF2ctivypromotetumgrowthThhypoddedmppgbiochemiclterctitweenPRMTNRF2(Aim1)chrcterizgPRMT5-mededpiNRF2trncriptilctivy(Aim2)evlutgimpctmethyloomeperturbtiKEAP1-mutntLCgrowth(Aim3)ToccomplhfirtimweuectutedNRF2PRMT5crryoutdvncedbiochemiclydeignedidentifycriclidueneceryerctiFecdimweemploybothncentRNA-eqcombtiChIP-eqnlyuncovermechnmPRMT5-mededpiNRF2ctivyFllyugvilblemllmoleculehibirweehowdruptiPRMT5-NRF2terctifluencetumgrowthKEAP1-mutntLCThemtigedthprojectprovideolidfoundtidvncementfutudrugdevelopmenteftfocuedtrgetgNRF2PROJECTSUMMARY/ABSTRACTWeeekfundgupptprticipti15thbiennilFASEBSummerReerchCfenceProteLipidtiEnzymologySignlgTherpeutictkgplceJuly21tJuly24th2024tLoewVentnCnyTucArizProtelipidtipivotlprocecellulrfunctilipidtedproteplygcriclrolevriouhumndeecludgcncerfectioudeege-lteddderThcfencehricllybrggercienttdiverefielddcupicuchcyltipnyltilipidyntrcellulrlipidtrnptprote-lipidterctifotergterdciplrycollbtinovtiveerchideTheeventimefetunownedkeynotepekerEdwrdTteImperilCollegepentgtlkProprotelipidtidrugdcoveryThecfencefocufourterltedmedvncetructurlbiologyenzymologyenzymevolvedprotelipidmodifictirolelipidmodifictiphyiologiclproceedeenewmethodologietudygprotelipidtilipidtedprotecentrpeuticefttrgetgprotelipidtiThe8eifeturg42dtguhedpekercludg26vedfcultypeker16pekerpentghttlkGrdutetudentpotdocrlfellowgivetwo-thirdhttlkthirdgivennewvetigrWelocludeReerchSnphoteiwhich10-15tudentpotdocrlfellowwhobroughtpoterwenotelectedhttlkmprogrmvedgive2muteelevrpchTofurrceourimpcntudentpotdocrlfellowtheddileventheldcludgcerdevelopmenteimeet--experteieiDiveryEquyIncluicienceThequetedfunduedupptgrdutetudentpotdoctrvelgrntchildcupplementoftenhncecluivyprticulrlyunderpentedgrouperchcommunyPROJECTSUMMARYTheoverllgolthpropolimprovehtripyttmentlivertumdevelopgnccurteclicllytrnltblewkflowtrgetglivertumtrncotllyGloblly~780000dethlivercncerechyerUSthexpectedmothn150%next30yerHtripynemerggnvivenrmlniizgfocltumttmenthcentlyundergeuccefulPheIhumnclicltrilttmentlivertumItuefocuedhtdurtiultroundpuleproducetuecvtfoclpotCvtioccurnnometerclegpocketpenttuewhichrpidlyexpcollpecughighttrmechnicllydruptdjcenttuecellHtripydmgebryprocewhetueeirdetroyedntprovidgmnynefovercurntrmlbltechniqueAcricllimtihtripyoleueultroundvulizetrgettumTrgetgdignoticUSlimttmentubcotlpprochduecouticblockgeribcgelevgnetimted~50%livertumn-vulizbleeunttbleWhcentdevelopmentce-mCT-guidedhtripytumcnvulizedthroughoutlivercludgnethribcnnotccurtelytrgetedduecouticrrtitervengribpotentillyltergttmentizeloctiInthpropolwedevelopnccurteclicllytrnltblewkflowtrgetglivertumtrncotlhtripyThccomplhedfirtquntifygeffecttervengribhvetrgetgccurcythroughex-vivo-vivoexperiment(pcemodel)(Aim1)Secdlyrobutmchelerngmodeldevelopedpdicttrgetgfetwhichtdvlidtedex-vivo-vivo-ilicodtet(Aim2)Fllymodelcptedteteddeliverptient-pecificttmentplnrbbVX2livertum(Aim3)Thpropolcluderdiogrphicimgenlyex-vivo-vivodthpthologicement-vivottment(Aim13)developmentvlidtirobutmchelernglghmctemulti-dimenilnlynoveltrgetgmethodhtripyttmentAnccurterobuttrgetgmethodpermgtrncotlhtripylivertumcrucilexpgcohtptienteligiblerpyIthpotentillmotdoublenumrptientlivertumeligiblettmenttechniquetrnltbletumgn(egkidneypnc)wellProjectSummry/AbtrctThe2022GdReerchCfenceIntricllyDdedProteTheBiophyicBiologyIntricllyDdedProteheldJune23-June282024LeDibletSwzerlIntricllyddedprote(IDP)oppoedtricllyfoldbleprotedotdoptuniquefoldedtructutedextenembledynmicuntructudtercvertgcmtiIDPIDgifuncthroughecmtilenembledriverbiologicloutputThecmtiIDPdictcequenceirequencephyicochemiclpropertieenvirmentwhichyideIDPcomemnydiffentflvexemplifiedequencefetuuchmocidcompoiptterngycnextctextmulti-domprotediffentenvirmentlctextComdthdetermeirfunctimechnmctidiffentcellgnmSequencecnloencodemterilpropertieemergewhenmnymoleculecomegerlrgeemblieegbiomoleculrcdentethimptntbiologiclfunctiwellbiomterilcienceUndertghowequencegrmmrpcectextgivecmtifunctiglemoleculeemblietimeclepicoecdyerimptntelucidtghowIDPhpebiologyhowirdygultigivedeeOurvhmeetgtckleterdciplryquetiIDPbiologiclfunctidee-lteddyfunctibrgggerbiophyictpolymerphyictbiochemtcellbiologtcientteekgrpeuticllytrgetIDPTheGRCccompnygGRSprticulrlyvlubleentryyoungcienttfieldfciltedthroughnewlytroducedturileiSeipriizeemerggerchfocugqunttiveelucidtifundmentlprciplemechnmugbiophyiclbiochemiclcellbiologiclcomputtiloticlpprochehowcgbiologiclfunctiIDPcrocellulrlcpeKeycientificobjectivefollowObjective1ToddhowbicphyicochemiclpropertieIDPlteiruniquefunctilmechnmObjective2TodcudygultiIDPhumndeehowymytrgetedrpeuticterventiObjective3ToddroleddedprotepheeprtiunderliemticellulrbiomoleculrcdentedeeproceeWehveloidentifiedfollowgkeylogticlobjectivecfenceObjective4TopromotediverycluivenetricllyddedproteerchcommunythroughvtidiverepekerfundgunderpentedgroupPROJECTSUMMARYThenumrptientpotentillycurbletgeI-IIIn-mllcelllungcncer(NSCLC)cgpproprettmentelectidependupextentcncerpdlymphnodeTwolymphnodebiopyproceduendobrchilultroundguidedtrnbrchilnodepirti(EBUS)medcopyhveequivlentbilydetectpencelymphnodemetteyhvenotencompdirbilydetectextentcncerpddiffentillyfluencequly-djutedlifeyerTheextentcncerpdfluencettmentdeciwhichturnimpctptienutcomeSceEBUSmedcopycnbothccememedtllymphnodeEBUScnlobiopyhilrlymphnodeEBUShypoizedhvegterpotentilchngettmentdeci(AimI)EBUSlohypoizedocedhigherquly-djutedlifeyercuehgterpotentilchngettmentdeciocedfewerrkcompdmedcopy(AimII)AimIlevergengogcohttudygrnulrdn~2200ptienttgeI-IIINSCLCwhounderwentEBUSmedcopytwoCncerReerchNetwkhelthcytem(R01CA258352)TdclicinbtrctgrnulrdtrdiologybiopypthologyptAimIIlevergeptient-leveldtAimIlertuprimrydtcollectihelthutilieocedttmentchngepetggprocedu-ltedcomplictiimultetrilugpublhedrk-neffrmewkbeddecinlyticmodellgFdgthtudyhrmizedprtentilprcticeguidelefirt-lebiopyprocedudictqulyimprovementivemotivtetrilcomprgptient-centedoutcomeThlevetigtiexpectedducedignoticerroptimizettmentelectiimproveptienutcomeDrRudillpuruetwo-yererchfellowhiptUniveryWhgn(UW)fecliclpibilieundermenrhipDrFrhoodFrjhNtilCncerIntutefundedthcicurge-cienttprciplvetigrpnttudyHertrggol1)fulfillcourewkledgMterScienceHelthServiceReerchenrollelectivedocrllevelcouretUWSchoolPublicHelth2)cducthypo-tetgvetigtiddgcriclgpknowledgefieldthciccology3)prticiptemendcientificcerdevelopment4)developbrodnetwkmenrcollbrSheemddedfrtructuerchenvirmentnextgT32trgprogrmtUWSurgiclOutcomeReerchCenterhtdurgiclident13yerThtructudhighlymenddiverelynetwkederchtrgexperiencefcilteDrRudillcergolcomgndependentlyfundedthcicurge-cienttABSTRACTLungcncerledgcuecncer-lteddethUnedSttewldwideAround~80%lungcncern-mllcelllungcncer(NSCLC)motptientdignoedtndvncedtgeImmunpypecificllyimmunecheckpothibir(ICI)hdrmticllyimprovedurvivloutcomenowtrdcttmentdvncedNSCLCouttrgetblecogenemuttiHoweverly~20%ptientpdICIrdiologiclly~35%experiencedurblecliclnefGivenpotentilxicyfncilburdenettmentcriclidentifywhichptientnefICIerlypoibleUntuntelyextgtue-bedbiomrkerdotccurtelypdictICIpendividulptientMooveryufferfundmentlprcticllimticludgtr-tumheterogeneyufficientmplequlyquntyThecriclneedliblebiomrkerimmunpypecliclnefNSCLCToddthunmetneedwedevelopnviveimggblood-bedbiomrkertegrteecomplementrypprocheimprovepdictiimmunpypeoutcomeNSCLCSpecificllywe(1)developknowledge-guidedrdiomicbiology-meddeeplerngmodelenhncegenerlizbilyterptbily(2)propoenovelmethodextrctrpy-ducedmtilgudlimge(3)tegrteimggblood-bedbiomrkerfurrimprovepdictipeoutcomeWelevergelrgetutildtetmodeltrgetblhcliclvlidythroughrigoupropectivevlidtiSuccefulcompletiprojectfdnvivepprochccurtepdictiimmunpypecliclnefdvncedlungcncerThmyledpe-drivenperlizedttmenttrtegiedtguhgptientwhopdimmunpywhomcurnttrdttmentufficientveruptientwhotpdmynefnovelcombttmenttrtegieAddillyerlypeevlutiug-ttmentimggbloodmticoulduedguidedeciubequentttmentGivenrouteueCTcnbloodmplelungcncercpropoedbiomrkercndilytegrtedcurntcliclwkflowmyhvepoiveimpcnbrodptientpopultiPROJECTSUMMARYDepevtimprovementcengtechniquerpiebtcncermecdledgcuecncerdethfemlewldwideApproximtely30%tumprogmettticdeecurbleMettticbtcncerhighlyprolifertivethulyrpiddeoxynucleotideproductiThupptedcedctivyribucleotideducte(RNR)multimericenzymertelimgdNTPynRNRnttrctiverpeutictrgetmettticbtcncerRNRhibirgemcgFDA-pprovedttdvnceddeeInhibiRNRcueexceiveDNAdmgechromoomltbily(CIN)hibbtcncercellgrowthHowevergemcnucleoidenloguchhciderblef-trgeteffectnumerouenzymedplyevedoe-limgxicie(iemyelouppihepxicy)Thedevelopmentnoveln-nucleoideRNRhibirwouldpotentillyvolutiizeptientchibgtumgrowthoutxicieocedgemcThpplictidecrievlutiTMU27firt--clRNRhibirduceDNAdmgeCINbtcncercellhibtumgrowthxenogrftbtcncermodeloutducgovertxiciePropoedtudieexpenlyenumerouhumnmouecelllevetigteimpctTMU27genometbilywellefficcyfetycompdgemcpcliclbtcncermodelTheetudiedetermeifTMU27providefoundtilgentneffectivefehibirbtcncergrowthInddhprojectelucidtehowTMU27bdhibRNRugcryo-electrmicrocopyPlimrydthowTMU27tightlybdRRM1ubunlikelybdctlyticeFurrmoTMU27pdictedunblebdnucleotidebdgpocketDNApolymerelmbdcommf-trgetbdgidegemcctriexicyUndertghowTMU27hibRNRblocktumgrowthprovidenvenuedeigngnovelcln-nucleoideRNRhibircthighpecificypotencyefficcywhilevoidgideeffectevidentnucleoidenloguchgemcProjectSummry/AbtrctAlterntivepolydenylti(APA)mjmechnmpottrncriptilgultigenertedtct3untrnltedgi(3UTR)RNAtrncriptmothumngeneMechnticllyAPAmlygultedtrnthroughAPAgulrcgle-nucleotidevrint(SNV)enriched3UTRdowntmgenegiSeverlptedexmpledicteAPAcngultectivycogenetumuppgeneHoweveruptmgulrymechnmdowntmfunctiAPAcncerprogicliclcohtprticulrlyprottecncermlrgelyunchrcterizedProttecncerpenttifquentlytrtifiedgrouphighlyttblerogen-dependentprottecncer(ADPC)followedlethlctrti-tntprottedenocrcom(CRPC)ultimtelyproggmotggivemneuroendocprottecncer(NEPC)WhileignificntefthveenmdechrcterizegeneexpichngedurgprottecncerprogilktweenAPAprottecncerprogihnotpvioulyenetblhedOurplimrytudiefound3UTRlengthignificntlyhtenedCRPCptientcompdADPCptientignificntlylengnedNEPCptientcompdCRPCptientWefurrfoundAPAfcr-gultedgenelted3UTRcnfunctinovelcogeneCRPCNEPCImptntlymnipultg3UTRlengthelectednovelcogeneourdeveloped3UTRCRISPR-dC13EngeergSytem(3UTRCES)genertedtctmoleculroutcomeledgdecedprottecncergrowthvrovivoWethuhypoizeAPAdriveprottecncerprogicnpotentillyveredclicllymengfulmnnerInAim1weidentifyAPAtrgetgenedurgprottecncerprogictrtitncethroughmulti-omicnlyeprottecliclmplecellmodelInAim2wedevelopcomputtilmodelnmelyMARS3QTLferuptmAPAgulrInAim3wechrcterizemoleculrgultibiologiclfuncticlicllevnceferdAPAgulrue3UTRCESpcelyterfeAPAnovelcogeneOurpropoedtudieuccefulcompletietblhAPAnimptnttrgetblepottrncriptilgulrymechnmctrigmocompleteundertgprottecncerprogiABSTRACTOnegtchievementmediclcienceimprovedurvivlrtemgchildndignoedcncerAlthoughetimtedicte5-yerurvivlrtechildndignoedmlignncyner80%motedividulprige40demtrtedicephyicllimtinmllyocedelderlypopultiAmgttmentceivedpedriccncerptientmultimodlfrctedx-ryirrdichempyBothducegenoxictelimteprolifertivecncercellhowevermultifrioudictdicteffectrdichempycnnegtivelyimpctnmltuegrowthmtennceepecillyctivelygrowgpopultiPhenotypeobervederlierpedriccncerurvivccelertedetfriltydiceuchneuromuculrdecleInmumodelwefdweekfterimgeguidedpedricfrctedx-ryirrdihdlimbducedkeletlmuclefirizeimpidneuromuculrfunctifibroctivtitltedp53geneexpiAmgp53gultedgeneelevtedweekfterpedricfrctedrdiGrowthDiffentiFcr15(GDF15)gulrfoodtkebodyweightpetuchcncerrpieSglecellRNAequencg(cRNASeq)nlyveledrdiducedGDF15expiwtrictedmucleidentendolilcellAloweidentifiedubpopultineuromuculrjunctiocedmucleidentmeenchymlprogenircellexpgceprtyroekeRetimplictedmedgGDF15ctivyWefdourmumodelmultimodlpedriccncerttmenturvivhipdeficbodyweightgexcerbtineuromuculrltedphenotypeobervedfrctedrdileTheeourlg-termgolrigoulychrcterizemechnmwhettmentltedGDF15expiimpctneuromuculrltedphenotypeourmumodelmultimodlpedriccncerrpyurvivhipIdellyuchightwouldueduncoverterventittenutepedriccncerttmentltedneuromuculrdeclecembidyburdenurvivToccomplhourobjectiveweutilizeementkeletlmucletegryneuromuculrfunctiimggnlymouegeneticcRNAeqnlyflowcymetrygeneexpinlyphrmcologiclttmentmeubodyweightfoodtkeThepecificimthpropol1)determeifendolilcellpecificlop53GDF15knockoutimpctpedriccncerttmentltedfibroneuromuculrdefic2)exmewherRetctivygultepedriccncerttmentltedfibroneuromuculrdeficProjectSummryThpropolquetuppt2024GRCGRSmeetgChromtStructu&Functi(focuChromtImpcnGenomeFunctiAcroSizeTime-Scle)tBryntUniveryRhodeIlJuly6-122024The2024GdCfenceChromtStructuFunctibrggerouttgterntilexpertdcuirltetmotexcgerchchromtpowerfulgulrypltmhpegenomefunctiThecfenceddehowchromt-bedgenomegultiimpctlleentilDNA-dependentproceebomotfundmentlmechnticlevellotleveldeepthologieehighlyignificntThefieldevolvgtrpidpceduedoptinovelterdciplrypprochefielduchgenomicchemiclbiologytructurlbiologyTheepprochehveenblednewwyvulizecmtidynmiccleglenucleoomeirgulrclewholechromoomeSuchdvncellowg-depetgextgmodeluchheterochromtpdgugnovelynticbiologypprochewelldcoverynewmechnmmjunnwedquetiuchdogecompentiAtmetimelocomgclermnymechnmdcovedmodelcellvryugebedcelltypeetngnmllevelcriclunderttue-pecificchromtgultiSuchtuepecifictudieprticulrlycriclundertgigvrioucncerThcfencehlghryttrctgperchernewentrntchromterchIthennimptntumfotergnewidecollbtirdictued2024WectuetegrtenewmemrthgrowgfieldAlrgenumrtlkervederly-cercienttcienttunder-pentedgroupllpplicnthveopptunypentpoterirwkAddillypoterpviewhighlightelectedpoterhrlpenttiSufficientdcuimecheduledpromotelivelyfeexchngeideterpttimpletimeetidefternofterevengeimlterctihvelwyplyedkeyroletthcfenceTheGRCpcededGRSwhichweexpectfurnhnceterctinetwkgmgyoungercfenceprticipntCOLDSPRINGHARBORLABORATORYCONFERENCEMECHANISMSANDMODELSOFCANCERAugut13-172024RecentyerhveproducedtrnmtivedcoveriehveveledmechnmhddevelopmentprogicncerbothperpectivecncercellhotpeTheedvncehveultedtrgetedcncerrpiehveextendedptienturvivlwellnewimmunpiehveomeceultedcupvioulytrctblemlignncieStunngtechnologicldevelopmenthveenbleduterrogtecncergenomeepigenomeunpcedenteddepthophtictiuncovergchllengetumheterogeneyimpoecncerrpywhileloenblgmoccurterpeuticmirgAdvncefunctilgenomictechnologiellowuturncogenetumuppgenenftvrovivodetermeirfunctiTummodeluchgnoidhveendevelopedvelgnewightcncercellbiologywhileloenblgrpididentifictetgnewrpeuticWhdvncetructurlbiologywecnexmethe-dimeniltructucogenicproteprotecomplexefciltgdevelopmentmllmoleculehibirntgticntibodiePowerfultrtegielollowuterrogtehowmetbolicprogrmmgcncercellopenguppoibilynovelrpeuticpprocheexplometbolicvulnerbilieImprovementcomputtilbiologyyieldgnewightbiologiclnetwktumevolutiDemtiueetechnologiemodelmechnm-bedpprochethft-movgfieldgtlyfciltedmeetgbrgvetigrgerpenpenlydcuirltetunpublhederchfdgWeleedtrnextgenertilederfieldneentilprtthprocethfntticopptunyyoungvetigruchgrdutetudentpotdocpentirwktercne--eenivetigrTheMechnmModelCncermeetgtColdSprgHrbLbry(CSHL)epmiervehiclepromotgnexttellectullepcncererchpropellgfieldfutunefcncerptientThepcecopedividuleidecidedbopenlyubmtedbtrctEcheichidtwoetblhedcienttfieldwhoetblhmtecheibedubmtedbtrctThechirtroducegivenoverviewpicireibriefupdteirownerchPrticulremphgivenpromotgctiveprticiptigrdutetudentpotdocrlfellownewvetigrwellledgcienttfieldTheledgexpertdiverecncerbiologydeliverkeynoteddedurgcfenceItnticiptedmeetgprovideuniqueopptunieexchngedtidebothjunienivetigrdiffenterchypplymnypectcrcogeneGivenucceptmeetgheldtCSHLthpictween19962022wenticiptettendncebout400cienttlbrieroundwldPROJECTSUMMARYPncticductldenocrcom(PDAC)ededlietmcncerUnedStteThelowmuttilburdenPDACledlowfiltrtiTcellcouldcomecyxiccncercelldmtrtiimmunecheckpothibir(ICI)NetigenvccepromoteTcellvidotprotectTcellexhutiAnlyimmunpypprochecliclttmentPDACcombgcncervcceICIuggetefficciouimmunepevolvelterticell-cellcommunictimgtum-vdgimmunecellMumodelnetigenpedicteimultneouprimgtum-pecificCD8+CD4+TcellceurvivlthroughCD4+Tcell-dependentenhncementnti-tumCD8+TcellmyeloidcellfunctiIhypoizeeffectiveimmunpypePDACdependennltergcellulrignlgnetwktummicroenvirmentmtdurblecyxiceffecrttehderimmunouppiveignlTotetthhypoIutilizegle-cellRNAequencg(cRNA-eq)dtcompiledtlimmunpy-nvePDACprimrytumneodjuvnttrilcombtiimmunpyPDACmumodelperlizednetigenvccettmentPDACExperimentpoedAim1developttticlmethodutilizticellulrcommunictifenceolDomoidentifygcellulrterctidiffentillyoccurtweenttmentgroupcRNA-eqdtclicltrilcombtiimmunpyhumnExperimentpoedAim2identifymechnmwhichtum-pecificTcellexpednetigenvccePncVAX2ttcklivermettenthopicmumodelPDACthroughflowcymetryfencecell-cellcommunicticRNA-eqdtCollectivelyeexperimentmmechnticundertghowcombtiimmunpieenhnceimmunepePDACthroughenhncementTcellcyxicylterticommunictitweenimmunecellThpropoedwkhvebrodpplictiimprovgimmunpypprochettmentPDACdevelopcomputtilolcRNA-eqnlyehowcellulrcommunictiltedoutideperturbtimplefetuSUMMARYOuroverrchggoldevelopnovelrnoticprotte-cncer-pecificCAR-Tcellprdigmllowuccefultrgetgntigen-heterogeneouneuroendocprottecncer(NEPC)underimgeguidnceOurpropolexperimentbedobervtiNEPCdevelopmotcethroughcgde-diffenticliclttectrte-tntdeelgrjecryDLL3expicePSMAexpidecetumcellHencetrgetgDLL3wellPSMAbi-pecificimmunpeuticlogiclchoicewhendevelopgnoveltrgetedrpeuticpprochthdeetteOurpprochtkedvntgeextgtutilexpertedevelopgCAR-T-cell-bedrpeutictrtegiefollowgveryencourggclicloutcomehemlogicmlignnciemeoliomHeweimextendthpprochmettticNEPCWelizetrnlticliclCAR-TcelluccehemlogicmlignnciemettticolidtummuvercomeeverlobtcleItneceteytemicdeliveryCAR-TcellnyrpeuticuccequideliveryCAR-TcellmettticeufficientquntyirurvivlpotenteffecrfuncteepventumimmuneecpedueplticyheterogeneytrgetedurfcentigenTheewehvedeignederieexperimentddechllengelogiclequenceOurerchtemcomexperteCAR-TcelldeigndevelopmentT-celltrckgtechniquetrnltinovelimggproprottecncerclicltrildeignWecducteriep-clicltudiederfetechnologypptrnltiptientNEPCWegevlutgrpeuticefficcyDLL3-pecificCAR-TcellNEPCmodeldetermglowerDLL3-exphholdcncercellCAR-TtumicidleffectNextwedevelopDLL3/PSMA-bi-pecificCAR-TcellevluteirbilyerdictetumheterogeneouDLL3PSMAexpiugl-timemulti-pterbiolumecentimggTofcilteclicltrnlthpprochweverifyebi-pecificCAR-TcellcntrckedPETimggclicllypproved18F-MFBGrdiotrcerirefficcypdictedmeudugclicllyetblhedDLL3-PSMA-pecificrdiotrcer89Zr-DFO-SC1668G-PSMApectivelyInummrythpropolbrggertrnltbleCAR-bedrpeuticimggcompentgeneticllyengeedT-cellllowgn-vivemirgCAR-TcelltrffickgtumtrgetgtumpeOfnoternoticprdigmdevelopedvlidtedthpropolcnlotrnlteduedddcomprblecliclquetiDLL3-poivemlignncieProjectSummryAlg-tgproblemttmentglioblm(GBM)motcommdedlyprimrybrtumefficientdeliveryrpeutichighlyvivetumcellpervivelyfiltrtebrheltedmnyrpeutichdntctfunctilblood-brbrrier(BBB)Thproblemcompoundedfctp-cliclmodelGBMtendotcpultehighlyviventuclicldeedotcptemulti-modltrd--c(SOC)ttmentmjyptientceiveSOCterventiimptntcludeourp-cliclmodelgcueyignificntlylterclicllylevntdeettenewvetigtilrpielikelyfirttetedettgSOCFocuedultroundcombtrvenoulydmtedmicrobubble(MB-FUS)nemerggtechnologyhenhownducetrnientBBBopengoutpermnentdmgeInfieldneuro-cologyMB-FUShenptedcedeliveryvrietygentimproveurvivlpcliclbrtumtudiecurntlyundergogerly-tgetetghumnAcriclnexttepdevelopmentthnovelttmentprdigmchrcterizgphrmcoketic(PK)rpeuticclehvehricllyenexcludedttmentcidertiGBMdueBBBuchrpeuticmocllntibodie(mAb)ThpropoedF30projecttudydeliveryeffectnewimmunpeuticmAbnti-CD47(mCD47)ToddementiedgpneedDrGmeWoodwth(primryp)DrMirolwJnowki(co-p)DrGvDunn(co-p)MrMll(PD/PI)propoelevergePET-CTevlutgMB-FUS-mededdeliverymAbclicllypenttivenimlmodelvivepot-urgiclGBMThecentrlhypothpropolMB-FUSugmentdeliveryimmunomodulryeffectmCD47co-loclizedtrgetedgipot-urgicln-ctrtenhncgecticvymrgInAim1werdiolldefeMB-FUS-mededbiodtriiphrmcoketicmCD47peri-ectiln-CEgipot-urgiclGBMInAim2weeimpctMB-FUS-mededmCD47ttmentettgcurnttrdectiveurgerychempy(TMZ)SuccefulcompletipropoedtudiegenertecricldtrtillydeigngclicltrilugerventilMB-FUS-immuno-PETwkflowwhichweexceptillywellpoiedtrnltegivenouri)gogclicltrilevlutgdjuvntMB-FUSpriechtrdmthlydoeTMZGBMptientii)ouretblhedfrtructupplygMB-FUSimmunoPETbothnimlptientProgrmSummryWeeekfundgcfenceReveribleBiologiclAcetyltiHelthDeeunderupiceFedertiAmericnSocietieExperimentlBiology(FASEB)The2024cfence9thmeetgthhighlyvluedbiennilcfenceThuniqueumttrctcienttdivereexpertebiochemtrytructurlbiologycellmoleculrbiologydevelopmentlbiologytrnltilcliclerchWeimhowceltetcceptulighttechnicldvncefieldThmeetgprticulrlytimelycueexcgnewfundmentldcoverielkgecetyltimetbolm3DchromtcncerFurrmovelmllmoleculrhibirgdevelopedeffectivelyblockcogeniclyecetyltrnferelyedecetyleAprovilcuttg-edgeprogrmprovideblncedurveygroundbkgbictrnltilerchMjpicclude1)Wrerprotecetylti2)Rederprotecetylti3)Ererprotecetylti4)3Dchromrgnizti5)Metbolicgultiveriblecetylti6)Biologiclcetylticncer7)Biologiclcetyltidevelopmentgg8)Omiccetylti9)ChemiclbiologydrugdevelopmentTheFASEBmeetgtrdillybrgllprticipntglecfencevenueunoppoedeiThemtcludeplenrypotereimercovergtte---rtpiclederfieldcuttg-edgetimelylpenttielectedubmtedpoterbtrctjunicollegueprticulrlyp-pot-docrlteThenuctiveenggementjuniprticipntcfencetimultettendncetpotereiMoovermeetpekerperiodfollowgechplenryeiTwoterctivewkhopplnnedediverynetwkgncerdevelopmenterlyvetigrBothwkhopferprticipntopptunymllyhchllengeolutiyencountertwkplcepromotewnediverypeopleutillyhipnetwkgmenrhipTheprimryobjectivecfencebrggerpbiccienttclicinvetigrterterdciplrycollbtiAecdobjectivehelpdevelopmentnewgenerticienttvetigtgmoleculrmechnmvolvgKATKDACThegnizermkeccertedeftdeignmeetgenggeerveourp-potdocrlteerly-tgedependentvetigrcienttunder-pentedgroupWeprovidetrvelwrdt-poterwrdwellplenrytlkopptunieccomplhederlyvetigrvetigrunder-pentedcommunieenhnceirterntilvibilyllowmenjoyextendedccewld-clfcultyypderirceroptiAfricnAmericn(AA)menhve>80%highercidencemothntwicelikelydieprottecncer(PC)thnwhemenThehighburdenltgpooutcomePCmgAAmenlrgelyunknownRESPONDnti-widecompheniveeftundertPChelthdprieerchfocuedroletctextulenvirmentccecttmenthereduceptibilytumomticgeneticflmmrytummicroenvirmentwelltegrtiefcrdignoggivedeeAAmendignoedPCtween20152020hveenmpledcruedcncergtrie7tte(CliniGegiLouinMichign(DetroMetropoln)NewJereyTexNewYk)ByDecemr2023cohtclude>12700AAmenPCwhocompletedbeleurvey>7600whoprovidedliv/germleDNAtummpleobted>3400Overnext5yerwelevergeRESPONDcrumentfrtructuerchexperteupdtecombidielifetylehviexperiencetccecneighbhoodenvirmentldtwellobtmtiPCcologicoutcomecludgdeeprogi/curnce(P/R)mtlyLg-termfollow-upthcohteentilcedevelopmentprogivedeemytkeeverlyerfterdignoTheedtuedddnumrcientificquetihypoeimedtundertgkeyocilbiologiclfcrirter-ltihipctriedeeP/Rurvivlthhigh-rkpopultiInAim1weexmemulti-levelprovidergeoptilperlfcrdefeccecirltihipPCP/Rurvivlwellptient-ptedoutcomeInAim2wevetigteidencepertentlydvetedneighbhoodmodifictichricexpoulife-couretructurlociltPCggiveneP/RurvivlInAim3weevluteimpctlifetylefcrcombidcdigeneticrkfcrPCP/RmtlyLtlyAim4welevergedeeplerngpprocheppliedhpthologicimgeimprovepdictiPCP/RurvivlAAmenEchimddedtcterchdom(ccecocilenvirment/tlifetylegeneticfcrtumfetu)yetwhentudiedgerglecohtcientificynergygedfrmocomphenivepictumjfcrctriePCP/RPCurvivlAAmenWeexpectefdghvebrodchgignificnceddnumerouchllengecliclmngementpventiP/RAAmenultimtelyimprovehelthoutcomeFurrmoweexpectRESPONDcomenvlubleourcedvncgourundertgterectgmultilevelfcrctriglgtghighburdenPCmgAAmenPROJECTSUMMARYMultiplemyelom(MM)2ndmotcommhemlogicmlignncymcurblehighrtelpedrugtncedepecentdvncettmenptiuchulogoutemcelltrnplnttinovelimmunomodulrygentproteomehibirShterdurtiilpepdictpoprognoevenmodernernovelgentSeverlcliclfetuhigh-rkcygeneticcurntlyuetrtifygptienteverydeeHoweverubtntilnumrptientctuehvepooutcomeoutknownnegtiveprognoticfcrArrntepigeneticmodifictihveenlkedmoggivetypeprogiMMInddiDNAmethyltihnemodificticcumultgevidenceuggetpot-trncriptilgultivolvgRNAmodifictiprticulrlyN6-methyldenoe(m6A)ocediprogihemlogiclmlignncieEmerggevidenceuggetm6AlovolveddevelopmentprognoMMHoweverrolem6AoutcomeMMmlrgelyunknowndueprtlylckqunttivemethodmpwhole-trncripmem6AthigholutiSomenotblechllengeextgm6Aprilgpprocheclude1)lowoluti2)notqunttive3)quimentlrgemountputmteriltypicllynotfeiblecliclettgToddeclicltechniclneedwedeignedm6A-electivellylchemiclllgequencg(m6A-SAC-eq)whichfetutrncripme-wideprilgm6Atgle-nucleotideolutimodifictifrctimtiTheobjectivethpplictiuem6A-SAC-eqmptrncripme-widem6ACD138+tumcellMMptientidentifym6AmodifictiocedttmenutcomeWepplythnoveltechnologybnkedCD138+cellcollectedttimedigno~100newlydignoedptientMMenrolledourNCI-fundedclic-bedurvivhiptudywell~30mplePheIIclicltrilOurcentrlhypopecificm6AigntuCD138+tumcellttimedignoclteoutcomeptientMMWeidentifyltedm6Atrncriptocederlylpepefirt-lerpy(Aim1)wellmimliduldee(Aim2)Whpectoutcomeweexpect1)identifypecificm6AigntuvolvedpthwyocedttmenutcomemgptientMM2)etblhm6A-SAC-eqbrodercliclpplictiThepropoederchhighlyignificntcueexpectedverticllydvnceundertgbiologiclbttmenutcomeMMpromotedevelopmentnewprdigmprognoticrktrtifictibedm6Amodifictihbrodtrnltilimptnceperlizedmngementhigh-rkptientProjectSummry/AbtrctHigh-rkhumnppillomvirue(HPV)groupvirlpthogenfectplictekercytetrtifiedqumouepilium(SE)kmucoknowncuenerly5%llhumncncerHPVfectihighlypvlent>40millicurntlyfecteddividulUnedSttelePventiHPV-ocedmlignncielimedlckntivirldevelopmenterpeuticturnlimedlckknowledgeviru-hotterctipcedgledgcrcogeneSEThediffentiprogrmSEplynimptntroleupptgHPVlifecycleHoweveridentifictidtctcellpopultipibleupptgthprogihdenlimedlckgle-cellolutioldefeuchpopultiIncenttudygle-cellRNAequencgwutilizedidentifycompkercytepopultipentHPV-nveHPV-fectedSEAnovelkercytecellpopultienrichedHPV-fectedepiliumwidentifiedtermedHPV-duceddiffentidntepililn-cventil(HIDDEN)cellTheecellmnovelcellulrcomprtmennurfceHPV-fectednotunfectedepiliumimplictedcrcogeneTheErb-B2ceprtyroeke2(ERBB2)prtcoHIDDENigntudependentlyclteddvereptienutcomecerviclqumoucellcrcom(SCC)ERBB2cnclicllytrgetedcncer(egbtcncer)p-clicltudiehveuggetedcoopertivegultitweenERBB2HPVHoweverltihiptweenHPVERBB2ctextlevnceHPVlifecycleultgSCC-ltedpthologiemunexploduchtudiequi3DmodelSEBedplimrydtlertuthpropolhypoizedHPVfectienhnceexpictivtiERBB2urfceHIDDENcellcomprtmentERBB2ignlgpromoteHPVpthologieSETotetthhypoHPV+HPV3DgnotypicepililrftutilizedptillyolveERBB2expictivtidowntmignlgdefevirlgenepibleERBB2upgulti(Aim1)RftloutilizeddefewherERBB2quidHIDDENmtivirlgenomecopynumrexpiHPV-drivenpthologieuggenetichibiERBB2FDA-pproveddrug(Aim2)TheultdetermewherERBB2ignlgpromoteHPVvirllifecycledependentpthologiewherclicllylevntHPVphenotypecnuppedviextgFDA-pproveddrugpoiblepventiHPV-ltedcncertypeAltedmetbolmcognizedcommhllmrkcncerDygultiglucoemetbolmhenextenivelytudiedhoweverrolefttycid(FA)metbolmtumigenedeeprogiwellttmenttncempolyunderodFollowgourildcoveryFASNkeyenzymedenovolipidbioynnimptntgulrtumprogicoloctlcncer(CRC)tudieourgrouphvefirmlyetblhedncogenicroleFASNmultipletumtypeIncedfttycidbioynneedednlyccommodtehighrteprolifertiprovidgbuildgblockmembrneynloenhncecncercellbilydefendgxidtivet-chempy-ducedcelldethchnggmembrnelipidcompoiGiventrgrtiletrgetgFASNcncerrpynewclpotentelectivemllmoleculehibirFASN(TVB)hveendevelopedchrcterizedp-cliclcliclvetigtiOurgrouphcducteddouble-bldromizedplcebo-ctrolledwdowtrilTVB-2640ptientectblecolcncerReultterimnlythgogcliclvetigtiveledht-termlTVB-2640rpydemtrteexcellenn-trgethibidenovolipogenemngeblefetyprileHoweverourpclicltudieugCRCptient-derivedxenogrft(PDX)howedFASNhibirlymodetducetumgrowthdepeignificntdecelipogenevivoThutrgetgFASNleunlikelyufficienterdictecncercellInexcgnewfdgwehowedFASNhibipotentechempydrug-ducedDNAdmgecolcncercellultltedhnecetyltiInddiwedcovedFASNhibipromotectivticGAS/STINGpthwydowntmtypeIterfer(IFN)peTheoverllobjectivethtudyidentifynovelmechnmcnenhncentumefficcyFASNhibirCRCThecentrlhypodrivgthpropolcombttmenttrtegywhichcludeFASNhibipventchemotnceblockgDNAdmgepepotentgctivtinteimmuneignlgviepigeneticmechnmThefollowgSpecificAimpropoed1)defemoleculrmechnmwhichFASNhibiblockDNApirpthwy2)deletefunctilignificnceFASNhibimodultgtumimmunemicroenvirment3)determeimpctFASNhibienhncgefficcyCRCrpievivoOurhighlycollbtivegrouphqueexpertenovtivemodelytemtte---rttechnologynovelhibirmkerpidprogpotentillyprovidenovelttmenptiimproveptienutcomePROJECTSUMMARY/ABSTRACTAlkNtive(AN)peoplehvehighetcdedrtecoloctlcncer(CRC)wldtwoldhighercidencemtlythnUSwheThcncerdpryhpertedover30yerdepenceANCRCcengrtelevelimilrn-ANAholticpprochducgCRCcludebothprimryecdrypventivlYetnoepidemiologiclcohttudieextexplcedrkANCRCThfirtcohttudyvetigteetiologyCRCmgANpeoplegolidentifygnewrkfcrtrnltilpotentilprimrypventirkpdictiAddillyCRCrkcgmgtypicllylow-rkgroupcroUSuchyoungundertgcuethdeepopultiheendrmticcecncerrkoverptcenturymymobrodlymtiveLedAlkNtiveTriblHelthCtium(ANTHC)prtnerhipFdHutchCncerCenter(FHCC)thpropoederchetblhfirtcommuny-enggedcohttudyCRCrkmgANpeopleBuildgouruccefulpilotcrumenttudyAim1weenroll1000dividulpricolocopycengAnchgethe-fourgilTriblhoploutideAnchgeTheultimteoutcometetthtudycludebothcidentCRCdvnceddenom(denomupolyp1cmctg>25%villoucompenrhigh-grdedyplieileerrteddenom/polyp1cm)WecollectexpoomedtugculturllypproprepvioulyvlidtedquetinidemogrphicdiettrdilfooduefoodrgeprocegmedictioccuptilifetimeenvirmentlexpoubccoueWelocollectmediclhrycludglifetimentibioticprpumphibirnthropometricmtiwellobjectivemeuphyiclctivyleepcludgcircdinrhythmInAim2wecollectbiopecimen(tumtuecolbiopielivhirublood)biobnkmpleourcefutuwkImptntlyweldyhveIRBTriblpprovlfutubiopecimentetgcludgmicrobiomeepigeneticnlyeFSpecificAim3wecductttticlnlyeequetininthropometricbiomrkermediclcddteocirkfcrCRCThtudyutilizecommuny-bedprticipryerchpprochddkeyhelthdprycommunyccernByetblhgnANcohtuniquerkexpouwegtterundertgCRCmgthhighrkpopultiTherchprovidecriclmticnuedmfutuerchdeveloprkpdictimodeldeigneffectiveprimrypventitrtegiemgANpeoplepopultithighcgrkthdeeABSTRACTThenefpcicologydvncecoloctlcncer(CRC)hvenotenhdlldividulPrognomgmygroupmtubbnlylowcomprn-HpnicWhe(NHW)dividulImmunpyhrgublyenmotimptntdvncettmentCRCthptdecdeThprticulrlylevntmicrotelletbletumhrbhighmuttilnetigenburdenwheimmunecheckpothibir(ICI)highlyeffectiveFDA-pprovedHoweverdepedrmticctivyomeCRCptient(cludgevidenceAfricnAmericn(AA)ptientmyexhibtterpeICI)muchlrgerfrctiptientdotpdAultexteniveeftundertmnipultetumimmunemicroenvirmentfetufluencepeICItrgetedrpiegogthcomgAleededtudieidentifyuniquemoleculrtrgetdevelopgnewpcimediceterventiAnundexplodmoleculrmechnmpotentildvncefieldimmune-cologytrgetedrpyRNAplicgkeytepgeneexpigenertemultiplelterntivemRNAtrncriptencodgfunctillydtctprotemexpfunctilperigenomeWhendygultedcncerRNAplicgcnultpthogenicvrintimmunogenicnetigenWhennetigenpenthighbundnceICImoteffectiveTheignificnceRNAplicgCRCupptedtudydemtrtgplicenetigenenhncedICIblockdemouemodeltudiehowgpthogenicRNAplicevrintcndriveeveryhllmrkcncerpotentilrpeuticllytrgetedMountgevidencedemtrteRNAplicgeventfluencedgeneticncetryimptntCRCcludgourcentwkidentifygrce-ncetry-ltedRNAplicgocedcncerbiologyrpeuticpeurvivlOurgolundertctriiRNAplicgeventdpriettmentpeoutcomeCRCQuntifyghowrceethnicyncetryfluencetrncripmeoutcomegenertemuch-neededknowledgeCRCdprieOurpropollevergeextgdiverecohtbiopecimennnotteddtcludgLColoctlCncerCtium(LC3)DetroReerchCncerSurviv(ROCS)TheCncerGenomeAtl(TCGA)Weddtheim(1)chrcterizeexpiptternlterntivemRNAgeneencodgplicgfcrgeneticncetrycroelf-ptedrcilethnicgroup(250AA250Hpnic/L250NHWptient)(2)exmeroleRNAplicgtum-ocedimmunepe(3)determefunctilcequenceexpipriizedRNAplicevrintpectCRCbiologyvrovivo(ugCRISPR/C9genomeededCRCcellle)ThprojectfirtkdltelterntivemRNApecienetigenCRCoutcomecidergfluencegeneticncetryProjectSummry/AbtrctCncerurvivquilg-termcodtedcddphyiclemotilpychoocileffectcncerttmentRurlcncerurvivdproptelyffectedchricillnefcehigherrknegtivehelthoutcomePrimrycprovider(PCP)cognizeimptncedelivergevidence-bedprctice(EBP)cncerurvivhipcwell-poiedprovidecomphenivecodtedchoweverneedcncerurvivfquentlyunmetproviderdecrilimtiknowledgerk-bedurveillncelg-termeffectcncerttmentirmngementdequteourcegrowgdmtrtivedembrrierimprovgurvivhipcTheoverllgolthprojectteteffectiveneprgmtictrtegiepromotehighqulyevidence-bedguideleccdntcrurldultcncerurvivprimrycprcticeutilizgolimplementticiencegtterundertgdecimkgctitkenfciltehderimplementticromultiplehelthcytemTochievethobjectivewepropoethe-rmcluter-romizedmulti-levelterventiprovideeductele-menrgwher1)virtulcrifillgroletdmedicltnt2)tem-bedpproch3)uulcproducemoguideleccdntcncerurvivhipcTheprimryoutcomeprcticelevelcompletidocumentticncerurvivhipcmeudugpvioulydevelopedcompoecgytemcompelectrichelthcd(EHR)documentedctivyNtilCompheniveCncerNetwkurvivhipguideleTheecdryoutcomeeterventiutbilyrm12ctiviet1224-mthpotimplementtimeudfunctivirtulcritem-bedcctipromotepricncerdignoecodg(ICD-10)ueEHRolhelthmtenncederetnnuldergpproprecengcncerurvivPriimplementtimtiveevlutiecurntytemcprctice-levelbrrierfcilrdeliveryEBPcncerurvivhipcmmodifictiimplementtiGuidedNmliztiProceTheyweexmegenticfcr(egctitken/decimdeprctice)modifymodecmngementdeliveryTheRE-AIMevlutifrmewkuedexplopotentilpopulti-levelimpctgenerlizbilyterventil-wldcliclettgtrtegieThetudycducted16rurlprimrycprcticeKnwtentillydeignedbrgcdeliverychngeource-limedprcticehelthytemReultddnewevidencemgprgmtictrtegiefciltedoptideliveryEBPcncerurvivhiprurlprimrycPROJECTSUMMARYTheUShover18millicncerurviv(perdignoedcncernomtterwheycoureirdee)etimtedce22milli2030ThemjymlizedcncerurvivhipcgnizeddelivedcologytenthroughcdemicprivtecncercenterBecue70%cncerurvivlohvechriccdiceivecmultipleclicltemuboptimlcodticpoeignificntbrrieroptimlhelthoutcomeThegrowgnumrurvivnticiptedhtgecologyubpeciltpoeignificntddilchllengedeliverghighqulyurvivhipcPrimrycuniquelyueddeliverwholepercodtedccncerurvivcuetcopriizeperlizetegrtehelthcllcdiThviewendedNtilAcdemyMediceNtilCompheniveCncerNetwk(NCCN)guidelecommendcncerurvivtycnectedirprimrycclicin(PCC)Depethgrowgcogniimptnceprimrycprimryctemexperiencekeychllengedeliverghigh-qulyurvivhipcepecillyunder-unudcncerurvivwhoexperiencedproptelywehelthoutcomelycommunyhelthcenter(CHC)ctenthelthcLeverggourtemh10-yerprogrmerchTexCHCwepropoeprgmtictriltetgimplementtieffectiveneprimryc-bedurvivhipcdeliveryterventimgeightTexCHCeSpecificllywepropoe(1)Implementytem-levelcncerurvivhipcdeliveryterventiprtnerhipCHCclicinptientcommunypenttive(2)Teteffectiveneterventiimproveptientclicinoutcomeugtepped-wedgecluter-romizedtrildeign(3)Evluteimplementterventiugnertiveccurntmixed-methodpprochguidedPrcticeChngeModelOuroverlltudyguidedPrcticlRobutImplementti&SutbilyModel(PRISM)mximizeimplementtiutmentechCHCloclctextOurtudycognizelycunderervedcncerurvivcglyoccurrgprimrycCHCTogerourCHCprtnerwegenerteevidence-beneededgenerltprimryc-bedcdeliverymodelgoldemtgclgoptimizecncerurvivhipcequblyProjectSummry/AbtrctOrophryngelqumoucellcrcom(OPSCC)hemergedignificntgloblhelthccerncgcidencettriedhumnppillomviru(HPV)fectiAddillydividullivgHIV/AIDS(PLWH)fcehigherrkdevelopgOPSCCUndertgynergticltihiptweenHIVlHPVfectiOPSCCdevelopmentcricldvncgpventidignottmenttrtegieCD8+TcellplypivotlrolentivirlimmunytumurveillnceHoweverimpctHIVfectiCD8+TcellmlrgelyunexplodRecentlywehveidentifiednHPVtegrtihotpotPD-L1genectrigCD8+TcellexhutiInddiourgle-cellnlyveleduniqueubetexhutedCD8+TcellocedHIV-HPVco-fectiOPSCCmicroenvirmentWehypoizeHIVco-fectiduceelevteddyfuncti/exhutum-filtrtglymphocyte(TIL)prticulrlyCD8+TcellOPSCCmicroenvirmentAmulti-PIpplicticombgourexpertegle-cellnlyfunctilnlyHIVmouemodelCD8+TcellwevetigteimpctHIVfectiimmunecelllcpeHPV-poiveOPSCC(Aim1)Addillywechrcterizephenotypepecificytum-filtrtgCD8+Tcellcepr(TCR)cltemcellulrexhutittuctextHIV-HPVco-fecti(Aim2)FurrmoweetblhnovelmouemodelfhfullycpulteHIV-HPVco-fectiOPSCCexplodynmicterctitweenvirlfectumprogiCD8+Tcell(Aim3)Addillywevetigteimpctcomdntrovirlrpy(ART)immunecheckpotblockdergtum-ctiveCD8+TcellfunctipventgHPV-ducedneoplticgrowthTherchimenhnceourundertgHIV-HPVco-fectifluenceimmunepeimmuneeviophryngelcncerFdgmymnovelrpeutictrtegieenhnceimmunepeimproveclicloutcomeOPSCCptientlivgHIVhvebroderimplictiHPV-ocedmlignnciePROJECTSUMMARY/ABSTRACTCncerurvivcrdiovculrdeerkfcr(complexcncerurviv)growgpopultiirmbidymtlyrkignificntDepetrgcliclevidencebeetblhedguidelemngeCVDrkcncerurvivtenegecerychriccdicepecillydurgcncerttmentAhdcmodel(whentwomoclicindiffentpeciltiecmeptient)optimlcdeliverymodelcomplexcncerurvivhenhownproduceoptimlcombidymngementwhenprimrycvolvedNeverleUScncerurvivhipfocuetticpprocheuchprovidgurvivhipcplnguideleprimrycoutddgimplementtictextcdeliveryproceeTheepprochehveprovenufficienthiftcprdigmproducehdccomplexcncerurvivMnycurntlypropoedtetedcncerurvivhipctrtegiecidedcology-centricdotlignprimrycgenerlrienttimnggptientmultiplechriccdifl-wldctextprimrycprcticeReultourgogcenterchtudiedicteurvivmnggchriccdihouldnotdcnectedirprimryctemTheefeibilyuemutddedugtkeholder-medtrtegieenhncetrnltilpotentilhdclignmultipletkeholder(iecncerctemptientprimryctem)undertgthprdigmcbuildtem-bedccpcieThtudyemploydeigngdemtiyguidedperpectiveblendgimplementticiencecdeliverycceptulfrmewkExpltiPlnngImplementtiSutment(EPIS)CncerMulti-temSytem(cMTS)undertddmulti-levelfcrimplementghdchelthytemTheeperpectivehpetilgimplementtiPrimryCCnect(PC2)helthytemterventideignedligncomplexcncerurvivhelthctemmemrhelthytemimplementticrundertgcpcieprcticepromotedoptihdcdeliverymodelcomplexcncerurvivUghybridtypeIIIeffectivene-implementtitudydeignim(1)enggedivereprimrychelthytemtkeholdertilPC2mximizeimplementtitrtegiefhelthytemprimrycprcticectext(2)cductromizedctrolledtril(n=266ptient)teteffectivenePC2primryccnectichricdeemngementptient-ptedoutcome(3)evlutePC2implementtiugmixedmethodpprochmutbleugeterventiStudyultpoedhveproundimpcndoptihdcdeliverymodelthroughoutUSoptimllymigtecomplexcncerurvivCVDrkPROBLEMPedrictumpentveryhevyocilecomicburdenproundemotilvolvementnlydictlyffectedchildnloirfmilyfriendWhpedrictumneuroblm(NB)prticulrlevncecemotcommolidcncerchildnoutidekulltillkillbout40%ptientdignoedmotggivemTheeclerneedimprovettmentthdedlydeeDevelopmentmopotentimmunpiecouldimproveoutcomeeptientPREMISENturlkiller(NK)cellepecillywhenctivted(NKcell)mededictcyxicyntibody-dependentcellulrcyxicy(ADCC)Allcelltypeleeextrcellulrveicleclledexoomectbiologicllyctivecompent(proteDNAmRNAn-codgRNAcludgmiR)cndelivedcipientcellfluenceirfunctiExoomeleedNKcellcouldceefficcychemoimmunpyNBLtleknownbouthumnNKcell-derivedexoomeirrpeuticpotentilrolebiomrkerpechemoimmunpyNBOurgroupwfirthowmicroRNA(miR)NK-derivedexoomeblekillNBcellOURDATAWecnpropgtectivtebloodNKcellnmldptientNBugK562-mbIL21rtificilntigenpentgcell(APC)pluIL-2WedcovedeNKcellleelrgequntieexoomepurifiedNKexoomecyxicNBcellleWelohveplimryevidenceNK-derivedexoomectmiRctriecyxiceffectNK-exoomeWeloobervedchildnffectedNBpivechemoimmunpypentmrkerNKctivtiirbloodWehypoizeNK-derivedexoomekillNBcellthroughexoomltrnferMYCN-AURKA-TGFBR1-TGFBR2-trgetgmiRemiRcnexploeddevelopnnti-tumeffectimplementefficcychemoimmunpyNBptientWelohypoizepecificcircultgexoomlmiRcnexploedbiomrkerpechemoimmunpychildnffectedNBTheehypoetetedfollowgSpecificAim1)TotudycyxicymechnmrpeuticefficcyNK-derivedexoomelecomdchemoimmunpyNB2)ToeociNK-exoomlmiRcircultgRNAgeneexpiprilepeptientttedchemoimmunpygimenSUMMARYWefocuupcompletelynewimmunpeutictrtegyughumnmiR-enrichedNKexoomeTheultthtudyprovideimptntmtiproducghighlycyxicNKexoomewhichcouldpotenteefficcyextgchemoimmunpyThtudyloidentifynewexoomlRNAcrgobletrtifyneuroblmptientpechemoimmunpyABSTRACTAdoptiveTcellrpy(ACT)promgpprochttgptientdvncedmlignncieAdvncemoleculrbiologygeneticengeerghveleddeignuemodifiedTcellcncognizetumchieveignificnttumctrolupACTptientTheeTcelleirtrnducedtumntigenctiveTcellcepr(TCR)chimericntigencepr(CAR)YetelimtietblhedtumhnoteneffectivelychievedtypicllydueloT-celleffecrfunctifilulg-termurvivlMotACTtriluerpidlyexpedTcelltermllydiffentedexhibneffecrmemy(Tem)phenotypeTheeTemphenotypergcellmouceptibledvereeffecttummicroenvirment(TME)Theedevelopmentnovelmechnmbedrpeutictrtegiecnprogrmnti-tumTcellmtirmetbolicfneeffecrfunctummicroenvirmenturgentlyneededenhncerpeuticvlueACTOurPheIclicltrilthpropolbuildtrgvivop-clicltumctroldbtedugnovelexvivoprogrmmgcdimergerobutphenotypebothTh1Th17cellgenertehybridTh1/17cellWehvecentlyetblhedprogrmmgcdibrggernti-tumeffecrfunctiTh1celltemneTh17cellleduperihybridTh1/17(Tc/17)cellexhibglg-termtumctrolCD19CART-cellrpy(CD19-CTCT)pentnenmoucientificcliclbkthroughptientCD19-poiven-Hodgklymphom(NHL)howevermjuetillmgrdgxicymjyptientuccumbgdeelpeThuwehypoizeexvivoexpniprogrmmgCD19-CAR-TmetbolicllyenhncedhybridT1/17(Th1/17Tc1/17)phenotypeledrobutnti-tumctrolevenfewerdoptivelytrnferdcellAddillywehveuedcyplmicllytrunctedCD34tg(CD34t)CARTcellctructenblemopurifiedCART-cellproductviCD34electiwhichimimproveCART-cellntigenctivypertenceducef-trgetxicieFollowgpecificimpropoedetblhdevelopourpprochcommerciliztiSpecificAim1DefefedoemeCD19-CD34t-CAR-TcellwhileevlutgefficcyR/RB-cellNHLCLL/SLLSpecificAim2Etblhp-pot-fuimoleculrigntucltinti-tumpeWelievethpropolhelpdoptnovelexvivoprogrmmgcdigenertgrobutnti-tumCAR-TcoulduedfutuclicltriltrgermlignnciePROJECTSUMMARY/ABSTRACTTtgKRASmutntlungdenocrcom(LUAD)mmjchllengecliclcologyApproximtely20%KRASmutntLUADtumcrrylo--functimuttiKEAP1LoKEAP1hyper-ctivteNRF2drmticllyccelerteKRAS-drivenLUADFurrmoLUADptientKEAP1muttidotpdtrd--ccludgcentlypprovedKrG12ChibirmkgthemotggivehrdttolidtumBuildgourpritudiewehveobervedKEAP1mutntcellhvenltedmetbolmcnrpeuticllytrgetedInthpplictiwefocuchrcterizgmoleculrmechnmrpeuticpotentiltrgetgpolyolfruclypthwybothgeneticphrmcologiclpprochemultipleKRAS-drivenKEAP1mutntLUADp-cliclmodelInddiugnewlyetblhedmodelKrG12C-mutntLUADKEAP1muttiwedetermerpeuticpotentiltrdcKrG12ChibirSibcombtiKHKhibirblockfruclyUltimtelyourtudieprovidertilehibgfruclyKEAP1mutntLUADupptub-trtifictiptienthyperctivtiNRF2pthwyttmentpderrpietrgetgpolyolfruclypthwywhichpertentgolpcimedicePROJECTABSTRACTMerkelcellcrcom(MCC)rhighlyggiveneuroendoccrcomkNotblypproximtelyhlfllMCCptientdvncedmettticdeepdnti-PD1/PD-L1firt-leimmunpyttmentmkginemotpiveolidtumimmunecheckpotblockde(ICB)TheilpertetrglyuggetimmuneytemfuncticriclcognizgttckgMCCcellperhpcndctivtedAntetgfetuMCCtwodtctdeeetiologieInmjyMCCtumclltegrtiMerkelcellpolyomviru(MCPyV)expivirlntigenmllTntigen(ST)trunctedlrgeTntigen(tLT)drivecogeneThenvirlubetMCC(MCCN)drivenUVdmgehhighmuttilburdenInpolyomviru-poiveMCC(MCCP)virlntigenllowvetigtidptiveimmunepecncerettgIndeedtudiehveextenivelychrcterizedCD8+CD4+TcellcognizelrgeTntigenpeptideMCCPSomeMCCtudiedictepencecircultgtumfiltrtgMCPyVpecificTcellcnimproveoverllurvivlHowevercflictgdtupptthverllurvivlpeimmunpytrglycltedCD8+TcellfiltrtiTheeimmunecelltummicroenvirmentMCCmyctrignntumpeeirdictlythrougheffecrfunctidictlythroughmodultgTcellctivyRecentlytertirylymphoidtructuwhoemtidrivencrumentBcellweidentifiedbothMCCPMCCNubtypeweocedfvbleprognoticoutcomeAideirdocumentedpenceMCCtumroleBcellMCCnotwellunderodTum-filtrtgBcell(TIL-B)nemerggtetcncerimmunologyTIL-BcnhvepleiotropicroletumimmunyffecverllurvivlimmunpypemnycncertypeHoweverwhtdefeprontumroleBcelltummicroenvirmentmydependwhichBcellubetpentirfquencywheyloclizedtummicroenvirmentGivenbothubtypeMCChighlypiveICBimmunectivtipotentMCCIhypoizeTIL-Btummicroenvirmenthvechrcterticntumimmunyhvedictntigen-pecificpedriventumimmunyIvetigtethhypofollowgim1)DetermelcpeBcelltummicroenvirmentMCC2)ChrcterizentigenpecificpeBcellMCC3URMHFW6XPPDU\\\\Incliclprdigmcerviclcncerkercytefectedhigh-rkHPV(HR-HPV)genomewhichcometegrted(iHPV)humnchromoomefcilteprogivivecncerHowevercceptHPVtegrtinotroutelyuedcliclprcticeIntriguglywehvehowntlet25%HPV-poive(HPV+)cncerhrblyextrchromoomlHPV(eHPV)pthybridtumbotheHPViHPVWehvelohownnodiffencedtriiclicltgetweenptienteHPVveruiHPVtumeventhoughptienteHPVtumhvetterclicloutcomeBedthwepoeHPViHPVtumhvedtctmoleculrdrivermyquidiffentttmenttrtegieInvetigtinoveldignoticrpeutictrtegiecerviclcncermhighlyignificntdepedvncecengvcctiTheucceeepventiprogrmWethvenotenplictedource-pocountriegtetdeeburdenevenUnedSttedprievcceuptketillextmillitilltrkdevelopgcerviclcncerWewefirtdcovercurntomticERK2-E322Kmuttiprimrycncer(8%cerviclcncer)WehvenowhownERK2-E322Kmutti9timemolikelyoccureHPVtumcompdiHPVtumWehveloidentifiedpecificvirlplicedtrncript(VST)dtguheHPViHPVprimryHPV16-poivecervicltumwehvehownugVSTexpiHPVE5whichknownpromotengiogenehllmrkeHPVttuOuroverllhypoeeHPV-tumiHPV-tumhvedtcthotvirlgenomicclifictimrkerptienteHPVtumpdtterrpyngiogenehibirvcizumbthnthoeiHPVtumERK2-E322KmuttienhncegrowtheHPVtummothniHPVtumOurpecificim(i)chrcterizehotmoleculrmrkerdtguheHPV-tumiHPV-tum(ii)vetigtedignoticrpeuticutilyHPVvirlplicedtrncriptcerviclcncer(iii)vetigteeffectERK2E322KmuttigrowtheHPVveruiHPVtumWeexpecurerchctriiignificntimpctfulptientdignottmentWeprovidetrnltilutilyHPVtegrti(lck)identifyghotvirlmrkerclifictieHPViHPVtumttment-ltedptienttrtifictiAnovelgene-bedimmunpyducgmelnomdetructiInUSnerly100000newmelnomdignoe8000dethexpected2023Depedventimmunpyepecillycheckpothibirntibodie(Ab)dvncedmelnommprogivecurbledeemotptientThenurgentneednewmelnomrpieAulogoumelnomvcceueendogenounti--Glntibodie(Ab)(pentllhumnerum)djuvntenhnceimmunogenicypolyimmunogenictum-pecificntigen(TSA)melnomhveenexplodwelyprtillyuccefulIndiffentctextnti--GlAbplycriclrolerpidjectixenogrftegpigkidneytrnplntedhumncipientTheoclledhypercutejectixenogrfccurmutehourduefctpigcellexplrgemount-Glwhicheignhumncognizedhumnnti--GlAbOpiztipigcellAbledirdetructiprimrilycomplement-dependentcyxicy(CDC)loAb-dependentcell-mededcyxicy(ADCC)Ab-dependentcell-mededphgocy(ADCP)Similrlynti--GlAbpentChgdeeptientkillpreTrypnoomcruzicuethdeeTcruziexpelrgemount-GlepipeepromentgGl13Glb14GlcNAc(Gl3LN)cellurfceptientnti--GlAblyepremutecomplement-dependentdependentmechnmIfcncercellcouldmdeexp-Glircellurfceptientownldyextgnti--GlAbcouldtrgetdetroymCDCADCCADCPThedetructiglycoengeed-GlexpgmelnomcellCDCpencenti--GlAbcomplementhldyendemtrtedvrohneverenexplodvivoHewepropoenovelmelnomgenerpy13-glcyltrnfereknockoutmouemodelwhichmelnomcellelectivelytrnfectedvivogenecodg13-glcyltrnfere(13GlT)ThenzymevolvedyntermlGl3LNidueglycoproteBedcentdvncennotechnologywepropoeuefunctilizedlipidnnoprticle(LNP)deliveryvehicletrnfectiTheLNPhveDT7peptidefolteirurfcetrgetceprTfR1FRovexpedmelnom(cncer)TheeceprcnternlizeLNPnctivetrnptthudeliverggeneThetrncriptiunderctrolmelnocyte-pecificpromoterwhichddnlevelelectivytrgetgmelnomNotllmelnomcellneedtrnfecteddptiveimmuneytemwouldloctivtedultgpecificnti-tumimmunyThnovel-Glbedgenerpycouldultrpiddetructimelnomcellnti-tumimmunyvivoSUMMARYDepevilbilytrgetedrpieetrogenceprpoive(ER+)btcncerwhichcompover70%btcncermotbtcncer-lteddethttriedcurntER+btcncerThununmetneedidentifynoveltrgetttgER+ptientmettWehvefoundlevelSemph7(SEMA7A)mRNAwhichencodemembrnelkedprotecnlohedcelloceddecedoverllurvivl(OS)ER+btcncerptientFurrmoER+ptientttedTmoxifenexhibhtenedOSifirtumSEMA7AhighuggetgSEMA7AmydrivetnceendocrpyultgtumprogimettWehveplimrydtuggetSEMA7AovexpipromotetnceendocrpievictivticellurvivlpthwybttumcellAddillywehvehownERmededtrncriptidriveSEMA7AexpiSEMA7AexpgcelltntER-CDK4/6-trgetedrpieyetenivehibiurvivlpthwyWehvelodcoveddecgexpiSglemded-2(SIM2)trncriptilpknowntumuppivectivieloultctivtipro-urvivlignlgwellepililmeenchymltrni(EMT)tnceER-trgetedrpyTogerourplimrydtuggetSIM2bdSEMA7ApromoterpeSEMA7AtrncriptiWehveloidentifiedER+btcncerwomendignoed10yerpgnncyenrichedhighly-prolifertiveER+lumlBubtypefquentlyprogmettticdeewhileendocrpySEMA7AcnpdictlpethptientpopultiThuwepropoeSIM2mededpiSEMA7Amylotepotprtumbtcncer(PPBC)PPBCloexhibcedexpiSEMA7Aprogrmmedcelldethlig-1(PD-L1)enivePD-L1trgetgp-clicltudieAddillyTCGASEMA7AexpgtumenrichedmkerimmunouppicludgPD-L1PD-1FOXP3BedenewultwepropoehypoSIM2/SEMA7AwchmedeER+btcncerprogimettcferrgmechnmtrictncerpyEMTimmunouppiTMEToddthhypowepropoetheSpecificAimInAim1wedetermeSIM2/SEMA7AwchrpeutictnceprogiER+btcncerInAim2wedeferoleSIM2/SEMA7AwchltergimmuneuppiviPD-L1promotebtcncerprogiInAim3wenlyzeltihiptweenSIM2SEMA7AwomenER+btcncerpdictivefcrmettticcurncetncetrdrpyWeexpectdectgroleSIM2SEMA7AbtcnceridedevelopgnovelrpeutictrtegiePROJECTSUMMARYDepenovtidignottmentcoloctlcncer(CRC)memotcommcuecncer-lteddethUnedStteDurgtumigeneextrcellulrmtrix(ECM)drticllytiffenultgelf-mplifygfeedbckloopfurrgcncerprogiCRCcedmtrixelticycltedmodvncedtgewettmenutcomeCellenetuetiffnevegrwhichlybiochemiclignldownmnypthwycludgRho/ROCKpthwyTheRho/ROCKpthwyhenhownhighlydygultedmnycncerroleCRCtillhighlydebtedometudiehvehownelevtedlevelmettticleiwhehvecltedctivthpthwymettHewepropoetudymechniclctriiRhoActivtihowthmyledcedprolifertiignlgprticulremphcomprgmechniclenvirmentcollivermotcommmettticewhichhenhownignificntlytifferthnprimrytumtueWedevelopnovelhydrogelbiomterilcntiffenroundcell1kP(primrytum)6kP(livermetttictum)upexpou365nmlighvercoureweekemploygphomededoximeligtichemtrywehvepieedourpviouwkmkgphotiffenghydrogelwellimmobilizgfull-lengthprotenturlynticmterilToencodeubequentcellleedowntmywedevelopueenzymticllyenivepeptidecrolkerenblebiothogluer-defedhydrogeldegrdtiInAim2weexmeRhoActivtiprimryptient-derivedCRCtumgnoidfunctiprogivetiffengmtrixcomplevelRhoActivtimettticcncergnoidletiffgelvipull-downyWeternblottglentivirllytrnducedbioenctructInAim3wevetigtemechniclmemyRhoActivtimetttictumgnoidlewherverbleupytemtictengmtrixbckbeleprimrycoltiffneeWeexpectultetudieultnovelightrolemtrixmechnicCRCprogipotentillyopendobiophyiclroutetumoluttmentProjectSummryAcutemyeloidleukemi(AML)nggivecncermrrowThewell-documentedurvivldpryn-Hpnicwhe(NHW)ptienthvgtteroutcomecompdn-Hpnicblck(NHB)ptientTodteclicltrilmimlNHBptientprticiptibllpprovedttmentrktrtifictiytemHowncetrlrcilbckgroundflectedAMLNHBptientlrgelyunknownThmyhveledttmentprcticenoptimlNHBptientIndeedctrtNHWwhohvegoodprognoNHBptientNPM1muttihvendvereprognowhenttedtrdrpieThelckpcliclmodelNHBigfurrexcerbtethlckknowledgeAultltlenopcliclcliclevidencewhtextentcurntpprovedrpieAMLefficciouNHBptientThclerlyuncceptbleThpropoleeklevergenovelpprochegenertepcliclAMLmodelNHBigcomprpypebicbiochemiclpropertiemodelgenertedNHWptientThccomplhed3imthpropolThey1)UtilizeSleepgBeuty(SB)trnpoytemgenerteAMLmodelCD34+cellderivedhelthydNHBNHWig2)ChrcterizercildiffencerpyenivyDNAdmgepeAMLmodel3)DevelopptientderivedgnoidmodelNHWNHBAMLptientTheultthtudygtlymfluencercilncetryAMLrgNHBptientThmtiguidenewtrtegiegedpecificllywrdAMLNHBptientmdrugdevelopmenteftenufuturpieefficciouAMLptientllrcilbckgroundABSTRACTClimtechngegloblpublichelthemergencycecrdiovculr(CV)pirry/pulmry(R/P)mbidymtlypopultiexpoedmofquentextmetempertueventhighlevelirpollutiwildfiTheynergticeffecthetpenceelevtedirpolluticemtlyCVR/PmbidymtlylohelthcequencecertbtcncerrpiecuehertlungfunctlowerthnoptimllevelThrpy-ltedtuedmgemyceurvivuceptibilyCVR/PdeeextmetempertuirpollutiInthgrntweidentifybtcncerurvivuniquehelthrkclimtechngeelucidtgExpoumechnm/timefrmetetcludgwherp-dignoexpouclimte-ltedcdi(tempertuwildfimokeirpolluti)durgcncerrpypot-dignocuteexpouecdipdpoebtcncerurvivgterCVR/PxicyHowurvivrkcompdividuloutcncerWhichbtcncerurvivfcegtethelthrkclimtechngeuchHpnicwomenthoelowocioecomicttuTwerequetiweutilizettewideUthcoht21835femlebtcncerurvivdevelopedugUthPopultiDtbenepidemiologicdtourcectlifetimemedicldtlgudlidentilhrieThourceenbleumeuexpoutempertuirpollutibothpridignoyerfollowgWeloutilizecncer-fege-mtchedfemlepopultimple(N=65503)Weim1)Determeifp-dignolg-termexpouextmetempertuirpollutiocedCVR/PhelthoutcomeoccurrgwhileBCurvivrpylimed<5yerdigno2)EtimteociCVR/Phelthoutcomepot-dignoht-termexpouextmetempertuirpollutidignowrd3)Identifydiffenceeffectp-dignolg-termexpouextmetempertuirpollutiCVR/Phelthoutcometweenbtcncerurvivcncer-fecohtByidentifygextmetempertucdiirpollutilevelpecificllyhrmfulbtcncerurvivwherhigh-rkurvivubgroupfcegterrkthllowdevelopmentupptiveceftmngecncer-ltedheltheffectexcerbteddueclimtechngePedricndhencemedictiignificntpublichelthproblemrigouerchpetedlydocumentndhencecerkhopliztihelthccotdeeprogidethPrticipntourpvioutudiehvedecridmedictidhenceemottfulprtpedriccncercgivgwefound93%pntexperiencebrrier()medictidmtrtiWehvedeignedMedSuppry-bedmultilevelterventideignedddrootbrriermedictidhenceInAim1wedetermeifMedSupptterventiceproptiptientchempydhence95%higherOurtudydeignlevergeuniqueopptunycompnitudynupcomgrpeutictrilenrollt8pedriccncerprogrmThenhncemethodologiclrigthroughleverggrobutclicltrilfrtructuchievemulti-ecrumentdiveregeogrphicclicleWecrufmiliepedricptientALL(N=150)home-bedchempyFmilieromized11(1)MedSupptterventi(2)uulctrdizedeductictrolWeuebothMEMSelectricmedictimirgnovtivebiomrkerdrugmetbolemeudhenceInAim2wetery-bedmechnmterventieffectiveneTheeultcecceptulignificncethroughrigouexmtimechnmctiMedSupptterventimfututerventioptimiztrnltiInAim3weueImplementtiOutcomeFrmewkexmeimplementtieffectiveneenhncefutudemtiMedSupptterventiWeexmeltihiptweenimplementtiqulyterventieffectivene(Aim3)trtegiemyhderupptuptkeroutecmfutuimplementtitrtegie(Aim3b)Ourdeigncptenumerouelementubtntillycerigproducibilycludglevergglrgerpeutictrilmulti-eprticipntcrumentrigoumeumentdhencethroughobjectivehvilmeu(electricmedictimirg)phrmcologiclmeu(vlidtedbiomrkerdrugmetbole)FdgmkeignificntcceptulctriithroughexmghowMedSupptterventiwkpvewyfututerventioptimiztiFdghveignificnttrnltilimpctthroughexmgimplementtieffectiveneenhncefutudemtiMedSupptterventiUpcompletherchwehvennovtivelow-cotclbleterventienhncehome-bedmedictidhencepedriccncerdytrnltedcliclprcticeWhilethtudyfocuepedricALLMedSupptterventihpotentilhighimpctnumeroupedricdeeAbtrctDepedvncedignoticrpeuticmodlie5-yerurvivlptientpncticdenocrcom(PDAC)mwoefullylowUntuntelyAfricnAmericn(AA)rdproptebruntthdeebothcidencemtlyPDAChighermgtmBetterundertgcueedpriehelpdevelopnoveltrtegieddmPncticcncermutti-drivencncerAltertitumdrivergenelikeKRASTP53SMAD4CDKN2AltermultipletrncriptilpthwyntivepncticcellirmicroenvirmentultgtumgrowthprogimettePencebencemnyemutticnmodulteggivenecncercliclcoureptientPDACStudiecncercludgcolbtprottecncerhvedemtrteddifferggenomictrncriptillcpemgtCucin(CA)AAcnexplomercilhelthdpriepectcidenceoutcomeecncerHoweveruchdtctextPDAClckgGiven)genomic-trncripmicigntuhpePDACprogioutcomeb)AACAhvediffencepncticcncercidenceoutcomeirpectivetumtgec)rceoceddiffentilmuttiltrncriptiligntumultiplecncerwehveputthfollowghypoexplrcilhelthdpriectextPDACHypoDiffencegenomictrncripmicigntuctriedpriepncticcncercidenceoutcometweenAfricnAmericnCucinOurhypotetedthroughtwopecificimAim1focuedterrogtgmuttillcpePDACugdeepwholeexomeequencg(WES)ectedtumpecimenhlogicllyprovenPDACceAAPDACptientInddetgpecifichypoeboutKRASwecenpotentilpthogenicvrint(PPV)whichcouldctrigignificntlyoutcomedprietweenCAAAPDACptientInAim2BulkRNAequencg(RNA-eq)permedcoht100PDACpecimenAAptient(im1)identifyclicllylevnttrncriptilpthwyAAPDACtumtwowyFirtAACAcecompdccdgourpublhedPurISTlghmundertcidenceclicl/bltumubtypewhichpdictpefrtlerpyAddillywepermDe-novotrncripmicubtypgpthwynlyundertwherAAPDACtumhrbdtcttrncriptiligntucompdthoeidentifiedpvioulyCAceSuccefulexecuticurnttudieprovidefirttimedetilednlygenetictrncriptillcpePDACAAwhencompdCATheedthelputterundertpotentilrcilhelthdpriehelpudevelopnoveltrtegieddethuchievercilhelthequlyPROJECTSUMMARY/ABSTRACTThepecificobjectivethpropoldemtrtepro--cceptnovelcengpprochcerviclcncer(CC)ugpicllypplieddee-pecificplmidctgectedpterCCfourthmotcommcncerwomenwldwideDepevilbilycliclcengmethodeffectivettmenterlytgeCCUSdproptelyhighcidencemtlydueCCpvlentrurlBlckcommunieThdprydueprtlypofollow-upultgocioecomicbrrierpoccecliclcecommunieThelg-termgolthprojectmigteebrrierdevelopgenivehome-bedcengpprochCCmendignoticplmidAfirttepchievglg-termgolthpropoltethypopicllypplieddee-pecificplmidctgectedpterprotedrivenInhibiDiffenti1(Id1)promcnueddetectCCId1hmimlexpinmldulttuebuvexpedCCwheexpicltetgedeeTopiclpplictiplmidcervixwouldpromotetrnfectivinpecificendocyFollowgtrnfectiCCcellhveupgultiId1notnmlcerviclcellectepterprotecerviclcvyn-vivecollectiTheexperimentlpprochueCCcellCCtuefhlyectedhumnptientnimlmodeletblhfeibilypecificyCCcengplmidctgId1promectedpterAim1determecltitweenId1expipterproductiCCcelllevrygdegeId1expifhhumnCCtuefollowgtrnfectivroSpecificypterproductifunctiId1duepenceCCltivehelthycervicltueevlutedAim2etblhfeibilypiclpplictiplmidvivougmicerghumnCCtumxenogrftPlmid-ducedpterproductimeudfunctimefunctinumrtrnfectedcellfollowgpicltrnfectiThemimumtumburdenquidpter-beddetecticerviclfluiddetermedSuccefulcompletiimdemtrtefeibilypecificydignoticplmidpprochCCmodelLg-termimpctThwketblhfoundtidvncgplmid-bedpprochfututgedevelopmentugtrnltillylevntvecrcerviclpplicrmterilplmiddeliverypterprotecollectiUltimtelyweenvidignoticpprochlg-termenblehighlypecificcot-effectiveelf-ppliedCCcengfciltetrgetedcliclfollowupttmentdividulhigh-rkettgocedducedcceroutegynecologiclcProjectSummry/AbtrctPncticcncer(PC)emotlethlmcncerUnedStte(5-yerurvivlrtelow10%)PCptientuullydignoedn-ectbledee(80-85%)hvedmlprognourvivlperiodly3-6mthfterdignoNucleoidenlog(eggemcfluourcil)pltum-bednteopltic(egoxliplt)commlyuedchempyPCWhendmtedfedruggemc(Gem)fluourcil(5-FU)oxliplt(Ox)dplyignificntf-trgetxicycuglife-engdvereeffectmnyptientThenurgentneeddevelopnewrpeutictrtegiectgdeliveryvehiclebletrgetPCcelllimGem5-FUOxf-trgetxicyimproveoverllnticncerpeWehvecentlyptentedpltmuenundqunttivecenglghmdcoveryvlidticncer-pecificurfcentigenOurcentlypublhedulthowIntercellulrAdheiMolecule1(ICAM1)trnmembrneglycoproteimmunoglobuluperfmilyrrntlyovexpedPCcnervePC-pecifictrgetOurultuggetdevelopgnovelICAM1-bedpcinnomedicecnuccefullyutilizedttPCptientWehvecentlydevelopedmgneticextruechniqueynizeendoome-derivedveicleclledexoomemimetic(EM)highlyefficientproduciblemnnerOurEMhmebiologicligmphologynnoizecompoiexoomeclnturlcell-ectedextrcellulrveicleOurEMynoutpermcventillyuedexoomeoltilodgprocoltermprticleyieldbtch--btchctencyproducibilylodgefficiencyInthpropolwelevergeourexpertecncer-pecificntigendcoveryvlidtibio-nnomterilengeergexoomebiologytetnovelhypoEMexpgICAM1nnobodylodedGem5-FUOxcnuednoveldeliveryvehiclePCrpyWeynizeEMengeedICAM1nnobodiecognizekillICAM1-expgPCcelllodmGem5-FUOxICAM1-EMexhibcedtumpecificyduceGem5FUOxf-trgetdeliveryxicyTheenovtivetudiehvepotentilleddevelopmentnovelEM-bedrpiecnimproveefficcycurntcncerdrugdeliveryWhkeyexperimentlolvivomodelexteniveexperienceplceweddfollowgSpecificAim1ToengeerICAM1-trgetedexoomemimetic(ICAM1-EM)ugmgneticextruimethod2TodetermeefficcylodedICAM1-Chemo-EMhibgPCgrowthprogi3Todetermephrmcoketic(PK)biodtriilodedICAM1-Chemo-EMSUMMARYThehighercidencemtlycoloctlcncer(CRC)dividulelf-identifygBlckrcecompdllrceethnicieUSPvioutudiecomprgelf-identifiedBlckvelf-identifiedWheCRCfrozenmplehvedetectedignificntdiffencegeneexpidicteelf-identifiedrceignificntlyoceddiffenceCRCbiologyHoweverltDEGgenerteddependentlyechdividultudyhowlimedoverlpThlikelycuemllmpleizeechdtetlrgetetgTCGAdtet~60elf-identifiedBlckmpleComplexenvirmentlgermlegenomicfcrctrieDEGbiologiclultHowevermjbrrierdentnglgefcrcceglrgenumrCRCtuennottedpotentillycfoundgco-vriblelkedelf-identifiedrcilctegieTocductuchtudywepropoedemtrtefeibilyemblgmulti-dciplryerchtemnlyzelrge(>1000)elf-identifiedBlck/AfricnAncetry(AA)vWhe/EuropenAncetry(EA)mlfixedprffemdded(FFPE)tuemplerchivedtSnyBrookUniveryHopl(SBUH)KgCountyHoplCenter(KCHC/NYCH+H)HenryFdHopl(HFH)CXCL10ilDEGtrgetcethefewDEGidentifiedmothneRNA-equencedtetCXCL10nterfergmmducibleproteT-cellttrctnthenpoivelyocedT-cellfiltrtiCRCpot-opertiveprogfeurvivlTheducedexpiCXCL10elf-identifiedBlckCRCvWheCRCcouldepotentillylkelf-identifiedrcildiffenceCRCimmunologictrncriptilprileCRCoutcomeDtBrodglecell(c)RNAequence(eq)dtptlveledmyeloidcellprticulrlymcrophgecellubtypemjourceCXCL10expiCRCtumHowevernomtircilctegiewmdevilblethcRNAdtetAcentnlyTCGAdtveledmcrophgeigntutrncriptloducedelf-identifiedBlckvWheCRC(10)mdemtrtedwhermcrophgeigntutrncriptcoloclizedCXCL10trncriptmecellInAim1ptilprilgCXCL10expiCRCFFPEectiugRNAScopeTMuhybridiztipilotedevlutehypoCXCL10expgmcrophgeducedelf-identifiedBlckvWheCRCInAim2nnottiCRCFFPEtuepectpotentillycfoundgco-vrible(cludgetimtencetrydmixtummtchpir-immunohchemtryult)hrmizedoverrchggolcductgmultivriblenlyercileffectCRCcncerbiologyABSTRACTClercellnlcellcrcom(ccRCC)ccount~75%kidneycncer8thledgcuecncerdethUnedStteInddinerubiquiuloVHLlcpeccRCCdomtedmuttiepigeneticgulrSETD2PBRM1BAP1TheepigenomeproundlydruptedccRCCdefectepigeneticmrkDNARNAhneculmtgrrntgeneexpiMuttiSETD2hneH3lye36trimethyleoccur~25%primryccRCCce>60%ccRCCmetteCompletiTCGAenbledidentifictictiblemuttivirtullyeveryolidtumthoeprilenowdrivettmentdeciOnemjexceptihoweverRCCwhecurnttrdccheckpothibirnti-VEGFrpydoenotccount~50%RCChvgmuttichromtgulrlikeSETD2MnyccRCCdplyheterogeneouubclltrtumSETD2muttiwedotunderthowSETD2lodegultecellgrowthwhtpthwywkthroughAfterfirt-lerpyperte20%highlightgneedunderttrgetdrivermettlikeSETD2AcentnovelfdglkedSETD2ctivytrgetgN6-methyldenoemRNAkeymechnmctrollgmnyRNAmetbolicproceewhichhloenhowndegultedcncerctriemettticproceeOurplimrydtdemtrteSETD2loledlrge-cle-locliztim6Anenhncedenivynm6AhibirentergclicltrilThSETD2-m6AlkhnotenexplodccRCCctextcouldpentnovelSETD2effecrmechnmdrugtrgetccRCCWeexplothltihipfirttimethpilotR21tudymkgdictlylevntNOT-CA-23-060RNAModifictiCncerBiologyOurpropolignificntcue~30%ptientdignoedclicllyloclizedRCCexperiencemettticprogicemettticdeedeveloply~7%urvive>5yerOurcentrlhypoloSETD2driveggiveccRCCprtthroughdegultedm6Atrgetgpromotepro-mettticexpiprogrmOurpropolexpecteddeveloplevntccRCCcelllemodeldefelktweenSETD2/H3K36me3METTL3/m6AccRCCthroughfollowgpecificimInim1wempH3K36me3m6AMETTL3expiptternugRIP-/ChIP-/RNA-eqnovelSETD2ogenicnlcelllemodelInim2wepermtegrtivenlyomicdtuncovergene/pthwyimpctedSETD2lonm6A-dependentmnnerFllyim3wegeneticllyphrmcologicllymodultem6ASETD2ogeniccellledefecncer-levntcellulrgrowthphenotypeThwkexpectedpoivelyffecthumnhelthyieldgnewundertgmechnticunderpngSETD2drivencellgrowthdegultiuncovergnewwyrpeuticllytrgetthmuttiSUMMARYDepeignificntdvnceImmuno-Oncology(IO)ttmentlungcncerlo--functimuttiSTK11comprg20-30%cedemtrtepoprognoduetnceetrtegieOurpropoltrgetterctitweenpecifictumdiffentiphenotypeimmunetncepthwyocedSTK11-DeficientlungcncerFirtlywevefoundediffentiphenotypedrticllyfluenceimmunecompoummicroenvirment(TME)ptientpeimmunecheckpotblockde(ICB)FurrmowevedevelopedSTK11-MLDDnovelbiomrkermeuediffentiphenotypemypdictICBnefSecdlyweveidentifiedimmunegulrTRAF2prtnercIAP1promoterimmunetncepecificllyctextSTK11deficiencypperlkedneuroendocdiffentiphenotypeTheefdgprovidefoundtiourtwocomplementryimAim1focuechrcterizgterctitweentumdiffentiphenotypecpdgimmuneTMEphenotypecliclpeICBWellvlidteSTK11-MLDDbiomrkermultipleptientcohtdevelopcliclolfututrilAddillyugflowcymetryglecellRNAeqdtweidentifypecificuppiveimmunecellpopultitncephenotypeTMEoceddiffentSTK11-MLDDdiffentiubetAim2centerundertgTRAF2/cIAP1-mededimmuneevivlidtgTRAF2potentilclicltrgetlungcncerWellcductexperimentevlutgchngeTNFignlgultgSTK11loTRAF2/cIAP1egirimpcnnti-tumimmunyAddillywecductvivoexperimentexmeSTK11-/TRAF2-mededeffectTMEpotentilTRAF2hibienhnceICBpeWenticiptethurultetblhTRAF2/cIAP1hibipromgclicltrgetSTK11-deficientlungcncerwhilelodefgnovelmechnmimmunetnceddilpctmentcidteecncerFurrmoSTK11-MLDDbiomrkerexpectedhveuenlycliclpdicrICBpelopotentillyttment-electivebiomrkercoulduedidentifyptientlikelypdpcipprocheuchcIAP1hibiAphyicin-cienttthciccologymycergolcomeuccefuldependentcdemicvetigrfocugSTK11-muttedNSCLCimprovettmentoutcomeptientecncerWehveoutleddetiledmenrhipcerdevelopmentplncomplementmycientificpprochepromotemterykillnecerymylg-termuccepecificfocu1)biomticbiotttic2)tumimmunologyimmunecology3)cdemiclederhipAchievgegolccelertemyuccemximizemylg-termimpctfieldTleIdentifictiplicevrintderivedneo-ntigenhedneckqumoucellcrcomtrgettumvccerpyAbtrctImmunecheckpothibir(ICI)wecentlyFDApprovedfirtlettmentcurntmetttichedneckqumoucellcrcom(HNSCC)HoweverperteICIHNSCClethn20%TumpecificnetigenpdictpeICIrpyeimmunogenicnetigenpentideltrgetvcceenhnceICIpeAlterntiveplicgeventwhichpentfunctillyctiveHNSCCpentnundertudiedourcetum-pecificprotediverynovelnetigenThegolthwkidentifypotentilplicevrintderivednetigenelicnimmunepeervetrgettumvccedevelopmentUgnetblhedcomputtilpipeleplicevrintderivedpeptidepdictedpriizedThennimmunocompetentmumodellcncerutilizedevlutefunctilimmunogenicyrrntplicgvrintSplicgvrintproductbleelicnimmunepencptedvcceevlutedbilyenhncepelcncerimmunecheckpothibirFllyimmunepeplicevrintderivedhumnnetigenevlutedlcncerptientetblhroletrnltiuchrpieclicThepropoedwkhpotentiltrnmlcpetumnetigenHNSCCcludepvioulyuncognizedplicgvrintderivednetigenTheeplicevrintoccurthigherpvlencethnomticmuttigenertehighlyimmunogenicproteproductmoexteniveequencelterthnmuttiirderivtivenetigenpentideltrgettumvccedevelopmentWhilethwkfocuedlcncerroleplicevrintnti-tumimmunycnexpedimpcrheterogeneouolidtumPROJECTSUMMARY/ABSTRACTPncticcncerededlietcncerUSt5-yerurvivlrte~11%OnehllmrkthcncerdrivermuttiwhichcludeKRASp53muttiMuttip53tumuppcuetumcomemovivechemotntMoovermjctriburmbidypncticcncerptientcchexiwhichdefednvoluntrylomucleftdepoCchexidevttgyndromewhichffectbout80%pncticcncerptientcemtlydecequlylifeMotcchecticptientdtqulifychempyifydoyfrcrymCurntlycchextedclicnutrilupplementppetetimulntHowevernoFDA-pprovedrpiecchexiyetOurplimrydtimplictedPerppotentiltrgettummuclePDACWeutilizedge-ppropremumodelcncercchexiobervedPerpknownp53trgetgenecedPDACtumFurrweobervedhibiPerpdecedtumproliferti/burdenExpiPerpdemtrtednegtivelycltedptienturvivlMooverptientmutntp53lohdncedexpiPerpcompdptientwildtypep53InhibiPerpp53mutnttumceddowntmp53ignlgtrgetimplygpoiblectivtip53-ocedpthwyFurrmoweloobervedcedexpiPerpcchecticmuclewhichdeceduppventgmucleloSubequentlywelodemtrtedcedexpiPerpnerlyeventcncercdied-medimededmyotutrophyInthtudywevetigtediffentilrolePerptumprogichemotncemutntp53compdwildtypep53tumNextweutilizegeneticolmumodeltrgetPerpmuclevivoTheoverrchggolfirttwoimetblhPerpnefficienttrgettummucleInilicomodelgPerpprovidedltcompoundbdgffietwopdictedbdgePerpWehtltedcompoundwhichweuccefuldecgtumburdencugmucletrophyvroInthirdimwefurrchrcterize/modifyemoleculepecificyxicytbilytetmpcliclmodelPDACcchexiDevelopmentnovelrpiewhichhvepotentildecetumburdencuemuclewtgneficilimprovgptienturvivlchempylerncequlylifeProjectSummryWilliLTrvernAtntPDiviCncerPventiCtrolCollegeMedicetTheOhioStteUniveryDrTrverpdgPAR-21-295obtkillknowledgemenderchexperienceeentilcererchcienttfocugcncerhelthmtichelthdprieerchHlg-termgolbuildndependentprogrmerchutilizehelthmtechnologieimprovecncerccncerhelthequyTheht-termgolwrdperiodclude1)ggmltrgpychometricprcticlexperiencePtient-ReptedOutcome(PRO)irementcncerctext2)expgknowledgekillQultiveMixedMethodReerchApproche3)ggmltrghelthdprieerchfocupprochecncerhelthdprietudie4)developglederhipkilltrgerchcienttcludgtrgmnucriptwrggrntmnhipwrdbuildgpencehpectivefieldBlckAfricn-Americnexperiencegtercncerburdenpohelthoutcomefcemegtiveocildetermnthelth(SDH)(eglowerocioecomicttumobrriercetc)thnirn-HpnicWhecounterprtPROprovideddilprognoticmtimyledmoptient-centedcimprovedptient-providercommunictitterclicloutcomeuchurvivlHowevertudiehvehownBlckcncerptientlelikelycompletePROmolikelyptdifficultyundertgwdgPROquetiFurrmodequtelyegPROthpopultimyquicollectidtydtrdcliclmeuuchSDHThpropolimedtimprovgementptient-ptedoutcomemgBlckcncerptientIcductqultiveterviewBlckcncerptientundertccernbrrier(egcomputerlercyecuryccernetc)fcilr(egeductitnce)completgPROSDHemIlocductqultiveterviewcncercproviderundertirbrrierfcilrcollectiPROmtiboutSDHirmtineedirpfenceegugPROSDHprovidgcircncerptientTheknowledgederivedterviewptientprovidermdevelopmentfementimplementtiPRO/SDHoltilodneedpfenceBlckptientircncercproviderTheultgPRO/SDHoldeliverypprochundergofeibilytetgdptedmnnerupptiveproviderwkflowTheerchccomplheddurgthwrdperiodlyfoundtiromizedtrilteteffectprovidgcncercproviderPRO/SDHdnprovicclicldeci-mkgexmgwherchngemediclttmentcdictedProjectSummry/AbtrctReerchDepecentgroundbkgdcoveriefieldnnomedicetum-pecificdeliveryrpeutictillpoebighurdletrnltinnoprticle-bedpprocheEngeedbcterihvecentlyemergednoveldeliveryvehiclegtcncerproducgrpeuticuchbcterilxcheckpotblockdetkedvntgeircpbilyproducerpeuticuHoweverirrpeuticefficcyhenlimedgttumunbleccommodten-biologiclrpieThprojectimundertterctitweenbcterinnoprticletummicroenvirmentenblecodtietwopltmcncerrpythroughynergytweenynticbiologynnomediceAim1engeerbcteriprogrmtummicroenvirmentenhncepenetrtinnoprticleBcteriprogrmmedgnizerrntextrcellulrmtrixtumproducgproteehibiruptmpthwyAim2progrmuterctitweennnoprticlebcterienhnceddeliverynnoprticletumBcteriengeeddplypeptidetgnnoprticlecntrgetthprogrmmbleterctillowptilcodtitweenbcterinnoprticledrugdeliveryThedtgenertedheflectpotentilopptuniechllengecombgtwopltmctebiohybridytemcncerrpyThecompletieimgenertetrtegieprogrmbcterinnoprticlecnptillytempllycodteechdevelopbiohybridcncerrpyCidteJeeungHhnPhDpotdocrlerchcientttColumbiUniveryDrHhnobtedhPhDMediclEngeergMediclPhyicthroughHrvrd-MITjotprogrmThepropoedcerdevelopmentplnugmenthpvioutrgpphdependentcer(1)experientillerngynrpeuticnnoprticle(2)techniclexperiencedeignctructibcterilgenecircu(3)cientificknowledgetechniclkillcncerimmunology(4)lederhippilkilltrnidependenceMenr/EnvirmentDrHhnhembledtrgtemmenr(KmLeg)co-menr(TlDno)collbr(NicholArpiSimeSchrleKennethOliveMhKim)guidehimthroughpropoederchtrgctivieThepropoedcerdevelopmentplnutilizeexpertemenrhiptemtellectultechniclourcevilblethroughColumbiUniveryInddiDrHhnttendntilemrwkhopwhenourcenotvilblelocllyobtnecerytrgColumbiUniverycommtedupptgpotdocrlerchcienttthroughvrioucourewkhoppildevelopmentemrgnizedOfficePotdocrlAffirAllmenrhvegedmeetbinnullyenuDrHhnprogwrdtrggolProjectSummry/AbtrctSevermwherhurricnermignificntwd/pciptiffectmilliAmericnechyerdruptdeliveryhelthccerkhelthcomplictiWhileevermmyimpctcoutcomenycncerddgimpcnptientbtcncerhighlypvlentcncergoodoverllurvivlwhenttedhigh-qulychighpublichelthignificnceTheprimryerchobjectivethpropolcognizettmentdruptidverehelthoutcomeexperiencedptientbtcnceridentifypriizetrtegiepdhelthneedInthtudyweemploymixedmethodfrmewkccomplhfollowgim(Aim1)Toeimpctevermbtccutecervicemtlymgptientbtcnceridentifymotvulnerblepopultievlutepotentilmedirtheoutcome(Aim2)Todecridruptibtcncerccommunyccernperceivedcbrriertrtegiemigtecdruptipdhelthneedfollowgrmugdeperviewkeytkeholder(Aim3)Toidentifypriizetrgetedterventimigtedruptibtcncercpdpot-rmhelthneedthroughDelphimethodcommunyenggementImupptedmenrhiptemexpertecologyclimlogyheltherviceerchgeoptilnlymixedmethoddterppdneIlkrmdtcludgwdpeedfloodgpoweroutgebtdtbequntifyimpctevermcoutcomeidentifymedirculpthwyctegeoptilmpidentifyimpctedcommuniehelthytemThenIcductdeperviewdiveretkeholdercncercdterppdneInterventimppgfrmewkuedidentifytrtegiewhichneedpriizedtkeholderdurgDelphicommunyenggementwkggroupThroughmendtrgeducticrryg-outtherchpropolIccomplhmytrggolltedpplygnewqunttivemethodcquirgkillqultivenlymixedmethoddevelopgknowledgeimplementticiencecommunyenggementpptrtegieterventitudiedevelopgkillnetwkcerdependencephyicincienttThpropolprovidefoundtimydependentphyicin-cienttcerheltherviceerchfocugenvirmentlhelhtcncercoutcomeByidentifygvulnerbleubgrouppotentilmedirAim1decribgpriizgtrtegieAim23thpropolupptimplementtievlutimotpromgtrtegiefutuR01ABSTRACTProttecncerecdledgcuecncerdethffectbout13out100AmericnmenThetrddignopprochprottecncercpteprottepecific-ntigen(PSA)bloodtetdiglctlexmtibiopycentlyProtteImggReptgDtSytem(PI-RADS)loclizetrtifierkleibiprmetricMRI(bpMRI)imgeDetecticlicllyignificntcncer(cPC)mchllengeultgover-underdignoThuccurtedignotggprottecncerhveignificntimpcnuccefulttmentplnngcliclmngementAlrge-cleimggdtetcomewidelyvilblecliclettgmoprottecncertudiedoptgmchelerng(ML)deeplerng(DL)techniqueHowevercommpprochextgtudiehdrwbckugimggfdgegleiizerdiomicfetuThprojectimimplementvlidtecuttg-edgeDL-bedfrmewkdignoprognoprottecncerwhilefullyutilizgimggdtcliclco(egilPSAlevelprottegenomicco)Thepropoedprojectuette---rtDLrchectuuchU-NetimgetrnmerneurlddivemodeldevelopfrmewkrobutDL-bedprottezlnmyegmentti(Aim1)pdicticPCprobbilymp(Aim2)ectbiochemiclcurnceugterptblemultimodlDLfrmewk(Aim3)WeexpectefrmewkfernoveltechniquedptedprottecnceruniqueterptblefetumultimodlmrkertterundertdignoprognoeventullyhelpguidettmentelecticliclmngementThprojectbuildDrKimqunttivebckgroundmodelgnlyneuroimggdtDurgprojectDrKimgcliclexperteprottecncervimltrgdrivencourewk(egcologybiology)erchmenrhipThroughK25wrdDrKimlygroundwketblhgndependenterchprogrmcomputtilmethodprottecncerAlthoughimmunecheckpotblockdehtrnmedrpeuticoptilungcncerefficcydifferwidelyeventweenptientmrkblyimilrdeewhilefewhvelifelgmimjylpeftereverlmthNumerouclicltudiep-cliclmouemodelhvedemtrtedcertcompoimmmlingutmicrobiot(hrbgprticulrbcteri)wellcertlrgeclemnipulti(uchfecltrnplnt)cnprovidedrmticnti-tumimmunytuefrmovedteteAercherheedthphenomenctuedptvriouefficcioubcteriHowevermechnmwhichnyeegut-trictedcommenlbleelicnimmunepedtnttummunknownWedotppcewhichnmyhotimmuneytemfirtprovokedmicrobiotlocllymucotummicroenvirmentelfdrglymphnodeelewhe?Welodotknowwhermicrobiotdictly-progrmcyxicTcellwherydictlyimproventigenpenttiwhernynumrcellprticipteuptmnti-tumpefirttriggedWehveetupductmodelourplimrywkclrifythwhegutcolizticommenlBcteroideledtrikgnti-tumpeimmunogeniclungtumimplntThephenotypeTcell-dependenttrgenoughpertevenbenceexogenouimmunpyWelofdcloelylteddtctBcteroidepeciewhichcpbleimilrlycolizgguthoweverdoenotndernynti-tumeffectoervectrolcomprrFurrmobioengeergcollbrhveetblhednext-genertiprbioytemuchmicehouedeprtecgecnechhveirvcultucnnultedmicrluidiccnctuoulyexchngebloodflowRemrkblywefdtum-rgmouelckggutcoliztiexhibnti-tumefficcyceexchngebloodcolizedmoueTheewewhkthroughwhichblood-bnecompentefficcytrnferdwhichhotcellfirttrigged?ThepplicntDrRbiUpdhyynAtntPDeprtmentMedicePerlmutterCncerCentertNYUGromnSchoolMedicehoutled5-yercerplnbuildhcientificbckgroundimmunologymicrobiologywellhclicltrgmediclcologyimmunpyDrUpdhyycductpropoederchundermenrhipDrDnLtmnnterntillycognizedexpertTcellimmunologytrgtrckcdtrguccefulphyicincienttDrLtmnlbryNYUPerlmutterCncerCenterprovideideltutilenvirmentDrUpdhyyembrkpropoederchprogrmtrnipoindependentcdemicvetigrhownlbryeventulR01fundgPROJECTSUMMARY/ABSTRACTReerchCncercengdprieCheeimmigrntwomen(CIW)nundertudiedhelquyCIWunderervedfceeverlytem-provider-ptient-levelbrrierhelthcColoctl(CRC)btcncer(BC)mcuepventblecncerdethCIWWhilecengeffectiveducgmtlyecncerCRCBCcenguptkeCIWubtntillylowerthngroupwelllowHelthyPeople2030nchmrkThepurpoethtudydevelopevlutemulti-compentcommuny-bedterventi(Chigung)CIWdptgFilipoHelthStudynNCIEvidence-BedCncerCtrolProgrmimprovgCRCcengFilipoAmericnOurpecificim1)DevelopChigungdptgenhncgFilipoHelthStudyupptCRCBCcengCIW2)CductpilotRCTefeibilyplimryimpctChigungCRCBCcengCIWToccomplheimweemploycommuny-enggeddeignQultivefdgfocugroupcommunytkeholderdividulterviewCIWguidedevelopmentChigungwhichertivelyfedthroughddilemi-tructudterviewevlutedfeibilyplimryimpctpilotRCTCidteDrChrtWngimcomendependentptient-ientedvetigrwhodvncecncercengdprieerchimprovehelthequymedicllyunderervedcommunieDrWngpropoedtrgctiviefour1)qultivemethodology2)developmentcommuny-enggedterventi3)RCTdeignevluti4)cerdevelopment(egmnucriptgrntwrglederhipkill)Tochieveegolhehembledmulti-dciplrymenrgtemDrLherprimrymenrnccomplhedclicin-vetigrqultiveexpertewhohfocueddeemngementillneliefethnicllydiverebtcncerurvivDrWnivekyherco-primrymenrheltherviceercherfocucncerpventicomprtiveeffectiveneerchRCTdeignimplementtiHerco-menrcludeDrItzkowzntillederCRCpventiDrMzumdrexpertbiottticMJfwhohexpertecommuny-bedCRCBCcengterventiHerdvDrDiefenbchprovideexpertecncer-ltedhelthcommunictiEnvirmentTheIchnSchoolMedicetMountSihtrgtrdiouttgerchDeprtmentMedicernked12thntiwideNIHfundgTheDiviGtroenterologyctentlyrnkedmgp15diviUSNewWldReptntillynownedpieergerchcliclcgtrotetlcncerTheDiviGenerlInternlMedicehwell-etblhederchfrtructunexceptillytrgcduccefulwell-fundedmenddependentvetigrProjectSummryChromoomltrnloctiproducgcogenicfuiprotecommdrivermnytypecncercludgleukemiTrnloctivolvgNucleop98(NUP98)geneproduceNUP98-fuiproteocedpoprognocutemyeloidleukemi(AML)NUP98-fuiproteterctmixed-legeleukemi(MLL1)chromtmodifygenzymeMLL1moleculrdependencyNUP98-rrnged(NUP98-r)AMLIcentlyhowedtrgetgterctitweenMLL1bdgprtnerMenrpeuticllyeffectiveNUP98-rAMLMen-MLL1hibiugmllmoleculeVTP50469imultneoulypepro-leukemogenicgeneupgultemrkermyeloiddiffentiTheoverrchggolthpropoldefemechnmwhichNUP98-fui-Men-MLL1chromtcomplexmttrncriptillyctivechromtttetpro-leukemogeniclociIvetigtehypoNUP98-fuiprotedictlyexerttrncriptilctroltemcell-ocedgeneexpiprogrmviirocidynmicchromtgulrycomplexeIhveetblhednovelNUP98-rmuleukemimodelwhichNUP98-fuiprotecnpecificllyrpidlydegrdedmllmoleculeuchdTAG-13IuethmodeldefeimmedechngegeneexpichromtttethccurupNUP98-fuidegrdtiNextIdefeimpctNUP98-fuiprotedegrdtiAMLcellulrhierrchietglecellolutivivo(Aim1)Idetermemechnmwhichpro-leukemogenicgeneepigeneticllyilencedupdegrdtidplcementNUP98-fuiproteBedplimryCRISPRcenultIhypoizeilencgpro-leukemogenicgenen-cniclpolycombpivecomplex11(PRC11)neceryhltgelf-newlNUP98-rleukemiIdeferolePRC11NUP98-rleukemigeneticllyctivtgechcompentcomplexugCRISPRNextIdetermehowchromtlocliztienzymticctivyPRC11chngeupdegrdtiNUP98-fuiproteupMen-MLL1hibiFllyIdetermewherloPRC11functimedetnceMen-MLL1hibivivo(Aim2)Aphyicin-cienttdedictedimprovgoutcomeptienthigh-rkgeneticubtypeAMLmyoverllgolcomendependentvetigrledermyownlbrytudygcogenicfuiproteleukemiScemypviouerchexperiencewmotlyoutidethfieldIquifurrtrggdeeperexpertecogenicfuiprotebiologyepigeneticwellnewkillncenttrncripmiccomputtilbiologyglecellmethodWhexcellentmenrhipDrScottArmtrgmynewco-menrDrBrdBerntedynmiccientificenvirmentDn-FrrCncerIntutefncilupptprotectedtimeprovidedK08wrdIpoeddevelopledermyownlbrytudygcogenicfuiproteAMLProjectSummryPncticcncerfourth-motlethlcncercrobothexefive-yeroverllurvivllltget12%Inptientdignoedpncticcncerfirt-lechempygemcnb-pclxeloutFOLFIRINOXtenquiecd-lechempycombtimedinurvivlrngg626mthNewrpeuticcombtineededOnepromgpprochovercomgthimpecenterenecenceCellcnundergoenecencepeplicticogeneductrgeteddrugrpycludgmotchempeuticgimenuedpncticcncerHoweverwhileenecentcellhveenimplictedtumigenevipro-flmmryfcreencircultiprtenecence-ocedecryphenotype(SASP)irdicttumlctivyovertimedtriielewheunknownMoovercurntenecenceimgggentmllmoleculemeurglyoomectivyAnntibody-bedpprochctrtfergtertrgetgpecificybiologicllkurfcentigenNvivePETolenecencentigenimproveourbilyidentifyenecenceoptichngeopetrgetedlphrpytumThememrScottLoweLbhvepieedenecenceductipncticcncercombtrmetib(T)plbociclib(P)ledgleecykeSASPmodeltummicroenvirmentydUgimmunoPETtudycombtiTPrpyirmodelwehvefoundhedntigenuchVEGFIL-6decedtumenvirmentwhilemembrne-boundntigenlikeuPARelevtedWehypoizeenecenceducedchempytemplimmunoPETcnuednvivelyquntifyedynmicdurgrpyIncollbtiScottLoweChrteIcobuzio-DhueLbtMemilSlKettergCncerCenterweuenviveimmunoPETimgg(1)quntifypvioulyidentifiedenecencemrkerdurgenecence-ducgrpyhumnmupncticcncermodel(2)dependentlydcovermoenecence-pecificmrker(3)uetrgetedimmunoPETgentenddipyimprovedenolyticdeliveryIncollbtiPtriciRiiroPeirtWhgnUniverytStLouweloidentifyphrmcologicmethodpventntigenhedwhiledvncedPETctructiJoquLopez-HerriztCompluteneUniveryMdridenbledulrdiotrcerimmunoPETimggimmunepopultidurgrpyOureftquntifyenecencevivopropoedmrkerenhncetrgetedlphrpyenecenceguidedDrLBodeiclicllevnceAndSchietgerimmunologiclightThwkunlockmultipledictipcirnoticenecencegtpotentilcerdevelopmentR01erchencompgnumeroucncerPROJECTSUMMARY/ABSTRACTThegolthpropoedtudyexmeimpcttilpoliciedpriebccooutcomellowmeetblherchdependencenerly-tgevetigrThebccotilenvirmentgtlyfluencebccouedpriethroughpencedvertementpromotivilbilybccoproductCommuniepdomntlylowerocioecomicmypopultigrouphvemobccotilhigherbccopvlencehenceperpetutgbccouedprieTocurffecttilenvirmennbccouelocliectivelydoptgpolicielimbccoproductvilbilySomepoliciecludetrictileflvodbccoproduct(FTP)bccotilerliceng(TRL)policieducepencebccotilHoweverimpctepolicieelectedbccooutcomelteddpriemundertudiedunclerThpolicyevlutitudyuedvncedttticlmethodchievethemgol1)decriexmeimpctloclTRLlwfeeociodemogrphicdiffencetilerdeny-levelrce/ethnicycomeeducti2)explmeuimpctloclFTPtrictiociodemogrphicdiffenceproductlecommunie-levelrce/ethnicycomeeducti3)vulizevetigteterctiveeffectbothpolicieociodemogrphicdiffencedividul-levelexcluivedulyouthdultcigttee-cigtteueThK01MendCerDevelopmentAwrdprovideneceryfoundtimycerprciplvetigrkillednlyzgbccopoliciedvncednlytickillundertireffecnbccooutcomehelthdpriecommunieTheetudyfdghelppolicymkerercherundertneedveextgdoptnewtilpolicieddbccoueepidemicircommunieProjectSummryAdoptivecellulrimmunpyutilizgTcellengeedchimericntigencepr(CAR)hhowndurblecliclpehemlogicmlignncieHoweverlpemchllengeurggtterCARdeignCARnlogouTcellcepr(TCR)pecificllyengeeddictTcellpecificywrdtumntigenOptimlgultiTCRdynmiccrucilproperTCRfunctiAlteddynmicTCRleddfunctievenimmunedderWhileimptncectrolTCRdynmichenwelletblhednotblelckcomphenivetudiefocugpecificllyCARdynmiccludgendocycyclg/degrdtiimpcnCAR-TfunctiMypviouwkdemtrtedmodultgmoleculrdynmicCARgtlyimproveCAR-TfunctiByutilizgendocyticfetucyxicT-lymphocyte-ocedntigen-4(CTLA-4)cyplmictil(CCT)IprogrmmedCARdynmicubtntillyenhncedCAR-TefficcyvivoToctrolCARdynmicmopcelyelucidteimpcnCAR-TfunctifurrmodultiCCTfuivetigticell-tricgulrctrolCARdynmicneededInAim1thK99/R00pplictiIpropoeidentifyoptimlpoifunctilmotifCCTfuiComplethimnlydevelopnovelCARengeergpprochloprovidedeeperundertghowltergCARdynmicctrieimprovedCAR-TfunctiInAim2Iplnuncovercell-tricgulrCARdynmicugCRISPR-bedgeneperturbtiThimervefillgpourundertgimprovednti-tumefficcyCAR-CCTlouncovernovelgulrCTLA-4dynmicInAim3Ipropoedevelopelf-gultedCARCCTfuipentigentimultiThnovelengeerpprochenblepcectrolovertimgdurtiCARignlgwhichcrucilmtgCAR-TefficcylimedxicyAllimcenterengeergCARdynmicCCTfuidevelopnovelimmunpieThenovtiveightvertileengeergpprochpropoedthtudyloctrieignificntlyddgextgknowledgegpCARengeergThgrntfciltemycerdevelopmentdurgbothpotdocrltrgphetrniphendependentfcultygrouplederProjectSummry/AbtrctGliommotcommprimrybrtumdultubetwhichhvemuttimetbolicgeneocrtedehydrogene1(IDH1)Cncer-ocedIDH1mutnt(motcommwhichIDH1R132H)neomphproducecometbole2-hydroxyglutrte[(R)-2HG]whichthoughtctriegliommtiMutntIDH(mIDH)hibirblock(R)-2HGproductihveencentlyhownimproveoutcomelower-grdeIDH-mutntgliomptientpoedcometrd--cHoweverpemIDHhibirheterogeneouourundertghowedrugmywkgliomhenevelylimedlckfhfulnimlmodellower-grdeIDH-mutntgliomInnefttterunderteunnwedquetigrdgmIDH1biologyImdegeneticllyengeedmoue(GEM)modelmIDH1-drivengrde3trocymcircumventkeylimtiextgmodelprovideopptunyddfundmentlunnwedquetigrdgmIDHbiologylower-grdegliomIlevergedthGEMmodelhowIDH-mutntgliomenivedenovopyrimideynhibir(egdihydroottedehydrogene(DHODH)hibir)duenceduceptibilyIDH-mutntcellDNAdmgecuededrugHoweverwherthenivyDNAdmgeextendtrd--crpiemechnmunderlygeeffectnotfullyunderodMyoverllobjectivelevergekeydvntgemygrde3IDH-mutntGEMddfundmentlquetigrdgmutntIDHgliomIdetermepemyGEMmodelmIDHhibirevlutemoleculrigntumIDHhibirttmentdetermewhermIDHhibir/DHODHhibirlterperdiidentifymechnmunderlyghowIDH-mutntgliompdDNAdmggttmentImrdicologterchbckgroundgliombiologylg-termgoldictgmyowndependentlbryncdemicphyicincienttIimfocumyerchundertgmechnmdrivggliomgrowthgolhrnegthknowledgedevelopnovelrpeutictrtegieImcductgerchlbryDrWillimGKelJrMDtDn-FrrCncerIntute(DFCI)whichIctuedurgmypropoedK08erchAnIntrucr80%mytimepennerchKellb20%ptientcttgptientgliomtumIhveemblednexpertScientificAdvyCommteehelpguidemyerchcerdevelopment(1)DrStephenElledgePhD(HrvrdMediclSchool)(2)DrAlnDAndMD(DFCI)(3)DrBrdleyBernteMD/PhD(DFCI)(4)DrSmuelMcBryerPhD(UTSouthwetern)MycliclmenrDrPtrickWenDrDphneH-Kognbothwldlederneuro-cologyMytrgthenvirmentouttgpprtichievemylg-termcergolndependentvetigrPROJECTSUMMARYMyeloidmlignncychrcterizedcquimuttiteotypedderdtctptterncoopertgmuttiMuttigenelterpolycombpivecomplex(PRC)functiuchBCORtrglyocedcutemyeloidleukemi(AML)rgmyelodyplticyndrome(MDS)BCORctivtgmuttidruptn-cniclPRC11complexemblycuede-prgetgenevolvedleukemogeneWefoundmgptientU2AF1muttiBCORmuttiweenrichedexcluivelythoeS34FmuttiThpropoleeklevergethuniqueU2AF1cod-pecificco-muttidefemechnmwhichBCOR/PRC11ctivtipromoteplicgfcrmutntMDSprogiIhveembledcoht4193ptientmyeloidmlignnciegenertedogenicK562celllegeneticllyengeedmicemodelU2AF1S34FBCORco-muttiMyplimrydtdicteU2AF1muttictextffecttrncriptiloutputBCOR/PRC11ctivticombtiU2f1S34FBcdeletimicecuemotevehemlogicbnmlieMycentrlhypoU2AF1S34FencecdilelectiubcllBCOR/PRC11ctivtimodultgPRC11trgetgeneexpipromotecllexpniwengeffectivehempoiehllmrkMDSprogiAim1defecliclgeneticpthwyBCOR/PRC11-mededMDSprogiAim2determediffentileffectU2AF1S34FveruU2AF1Q157PmuttiBCOR/PRC11locliztifunctrgetgeneexpiAim3determeimpctBc/PRC11ctivtiU2f1S34FmutnthempoievivoThelg-termgolpropoederchgfundmentlighthowPRC11plicgfcrdyfuncterctpromoteMDSprogimrpeutictrtegieptientThepplicntDrRhulVedulncologttDn-FrrCncerIntute(DFCI)Hepend80%htimeenggedtrnltilerch20%htimecliclprcticecrgptienthemlogicmlignncieDrVedulhoutledfive-yercerdevelopmentplnenblehimmeethgolcomgndependenttrnltilvetigrfocuedmyeloiddeeprogiDrVedulpermpropoederchundermenrhipDrColemnLdleynexpertmyeloidbiologycllhempoieDrVedulhembledcientificdvycommteeterntillycognizedexpertprovidecientificcermenrhipHeobtddiltrguemouemodelhemlogicmlignncyerchcomputtilbiologybiottticthroughcollbticourewkDrVedulcductpropoederchtDFCIricherchenvirmentlgtrck-cdtrguccefulphyicin-cienttPROJECTSUMMARYAprolgedhopltyftercncerurgerycommpotentillyvoidbleproblemnegtivelyimpctqulycGol-dictedpthwydchrgewidelyuedurgiclcologyvoidunneceryextendedlengthtydchrgemilenemtedclicltemoutptientputTheultntdchrgepthwyrigidltlenoperliztinecerytepprocetenunclerptientTheegpcommunictimmtchexpecttitweencliclctemmemrptientcgiverctrieexceivelengthtyIntegrtiptient-ptedoutcome(PRO)cliclcetrtegyhownimprovecommunictilignexpecttiThemygpptunyuetrni--cfocuedPROemhoplettglignptientclicltemmemrdurgdchrgeplnngpventprolgedhopltyHypoAdchrge-focuedelectricPROolurgiclcologyptientdecelengthtyfterelectiveurgeryPROcludgdedchrgectivtilomeudJenniferCrcchioloMDhdevelopednelectricPROolGolDchrge(G2D)cologyptientfocueddchrgeplnngugmentcurntlyetblheddchrgepthwyWhileG2DolhenuccefullyemployeddurghopliztiptienthvepdedhveenchllengeimplementgechnologycludghelpgptientnvigtedigloldevgtrtegieceperteenucluivyoptimizgctentdevelopgPRO-promptedclicldeciupptclicinInpropoedprojectDrCrcchiolofelibrryctiblePROemmeudomlevntptientirdehopldchrgeShecludeptienturgiclcology(coloctlthcicgynecologicurgery)tMemilSlKettergCncerCentergolctivelyengggptientdurgdchrgeproceAim1RefectentG2DolPRO-bedclicldeciupptAim2SytemticllyplnbrodclicldoptiG2DugnimplementtimppgpprochAim3PilotteteffectiveneG2DolcompduulcReultledtterqulycttermedptienttteroutcomeTherchlgcerdevelopmentplntrgdvncedqultivemethodimplementticienceclicltriltudydeignhermultidciplrymenrDebhSchrgMDMPHJmieOtrfPhDAndwVickerPhDThomAtkPhDprovideDrCrcchiolofrtructuneededgrowhercerfcilteherprogwrddependenceercherclicltegrtiPROytemurgiclcologycProjectSummryCgiveremerggyoungdulthoodccountnerlyhlfllcgiverUnedSttehoweveryignificntlyunderpentedcncercgivgcholrhipLtleknownboutiruniquepychoocilneedderthcncercgivgourceupptmEmerggyoungdultcgiver(EYACge18-35)prticulrlyvulnerblecgivgpopultiTheyexperiencehigherrtepychologicldtthniroldercounterprtwellltgimpctirdevelopmentltrjecryultircgivgexperienceCgivgtthgeprticulrlychllenggwhennEYACmutprovidecpntcncerymutundergodtgltilhift=ctepychologiclcommunictichllengeuniquethptient-cgiverdydDignoedpntknownholdmtiboutircncerirdultchildnwhichctefurrdifficultieEYACcommunictgcopgirpntOpenfmilycommunictidurgcncerhenlkedtterocilpychologiclphyiclhelthoutcomebothcgiverptientThuignificntneedcommunictikillterventidictedtEYACirpntcncerhelpmnvigteterperlchllengeocedircgivgrolecnleddtThegolthprojectidentifycomplexcommunictineeduniquethgegroupdptnextgcgivercommunictikilltrgterventi(HelthyCommunictiPrcticeHCP)meetirge-pecificcommunictineedTheK99phethprojectcludetwoim1)identifyEYACunmetcommunictikillneedvileurvey2)ueurveyfdgdptterventimterilp-tetmEYACfocugroupTheR00pheprojectpilottetnewEYAC-tilodterventifeibilycceptbilyTheobjectivethpplictinlyctefirtcommunictiupptterventipecificllydeignedEYACloequipDrKtronecerykilltrgcompletepropoederchtrnierchdependenceShedvncehertrgfourkey1)pychoocilterventidevelopmentdpticncercgivg2)dvncedmixed-methodqunttivedeignnly3)deigngcductgRCT4)pilkilldevelopmentShecompletebothhertrgpropoederchfulluppthermenr(DrAllApplebumSmBnerjeeYuelLi)hercollbr(DrCrmLBylundCrlLFher)whocrHCPherdvybd(DrKthrynGeneYoungmeeKim)AtendherR00pheDrKtroubmnR01pplictetefficcynewterventifullypowedromizedctrolledtrilThK99/R00plnenbleDrKtrochievehergolfillgcriclerchourcegpEYACluncherchprogrmddgirneedProjectSummryImmunpiehvevolutiizedcliclttmentmelnomhoweverettmenttrtegiehveeneffectivettgltetgemettticmelnomleioverllptientpertelow50%illutrtgnunmetmediclneedmelnomrpyWehvepvioulydemtrtedmichdrilmetbolmplyednimptntrolemelnommetthenceIoughtvetigterolemichdrifciltgthggivemdeeIntetglyourplimryultdictepecificdeletimichdrilcomplexIubunNduf4tumcellleddrmticnti-tumimmunepeProteomicmetbolomicnlyetummplevelmichdrilcomplexIhibiducenupgultiprotevolvedntigenpenttihiftcholemetbolmchole-rcoepthwychole-phophtidylcholepthwyTum-InfiltrtgLymphocyte(TIL)nlyevelignificntceNKTcellHowevermechnmwhichmichdrilcomplexIhibiducentigenpenttimetbolicfluxhiftNKTcellctivtitillwgexplodBedourencourggplimryultIeekfurrexplomechnmwhemichdrilcomplexIctivytumcellmodulteimmunepetummicroenvirmentfocugtheAimInAim-1IdetermemechnmhowmichdrilcomplexIhibienhnceMHC-IdependentntigenpenttiInAim-2IplndetermemechnmwhemichdrilcomplexIhibicuemetbolichiftchole-techole-phophtidylcholepotentilroleNKTcellcrumentctivtiFllyAim-3IevluteefficcycombttmentimmunecheckpothibirmichdrilcomplexIhibipcliclmouemelnommodelWhileAim1prt2completeddurgtrgtgeprtAim2entiAim3cducteddurgdependentphewrdTheextenivetrgdiffentfieldpropoedthpplicticludgproteomicmetbolomicimmunologyprovideolmecomendependenterchertudymechnmwhichmichdrilcomplexIgulteimmunepetummicroenvirmentThtrgceivedvibrntcientificcommunieDn-FrrCncerIntuteHrvrdMediclSchoolThenvirmentexpoemecollbtidcuinecerycerdevelopmentfutuopptunieDrPuigervermenrhipupptiveetblhthoecnectictivelyguidemetlkmnucriptpprtitudentmenrhipexperimentldeigncerdevelopmentTogererchcerdevelopmentplnpropoedthpplictitngnmykillcompetivenecomendependenterchertmjtutiHepblm(HB)motcommlivertumchildnlievedhveftetrgcidencellpedricolidtumUntuntelyHBhpooverllurvivlrteptientpenthigh-rkdeecludgmettticlpettmentfrcrytumTheehigh-rkptientcnexpectdmlurvivlrtelethn50%duelimeduccecurntrpiecludgggivechempyurgeryTtmentfilueptientttriblepdfrcrycircultgtumcell(CTC)trvtebloodveelprimrytumurviveytemiccircultieeddtnteliverlydmntmimliduldee(MRD)multiplyfterrpyppedTheekeyunmetcliclneedelucidtehowCTCdrivethprocerpytncemettwhichcricllyhderrpeuticucceOuroverrchggolthoughlychrcterizemoleculrunderpngmettticprocemdeigntrget-guidedpcirpieOurrigouplimrydtdemtrteournovtivepipeleidentifygequencgCTCprimryptientliquidbiopieupptroleNRF2HBvculrvimettWehypoizeHBdemtidrivenupgultiNRF2ctivyillycuedchempyexpouwhichcntrgetedmimizeelimtemettMRDcurnceInAim1weeNRF2ctivydiffencemgprimrylivertumCTClungmettmpletweenchempynvettedmple()co-IPIFproximyligtiptermpectrometryimgg(MSI)ymplecollectedournovelclicllylevnrthopiccellleptient-derivedxenogrft(PDX)mumodelHB(b)IFglecellRNA-eqMSIprimryptientmpleInAim2wemnipulteNRF2ctivyvrovivohRNAovexpiCRISPRmllmoleculehibirtrtegieevlutepecificeffectphenotypelteddemtiymetbolm(MSI)migrti(Incucyte)vi(trnwell)CTCmettticburdenournimlmodelInAim3wetetefficcyclicllylevntmllmoleculehibirtrgencogenicpthwyctivtedNRF2()vroyvibily(MTT)migrti(Incucyte)vi(trnwell)(b)vivoytumweightvolume(MRI)CTCburdencidencemettOurterdciplrytemuniquelypoiedpermetudieournovtivevlidtedmumodelourunprlleledcceprimryptienttuewholebloodmpleOverllerigoutudieledthoughundertgroleNRF2HBtumcelldemtimuemultipletrgetedrpiehigh-rkHBptientPROJECTSUMMARY/ABSTRACTCANDIDATEApotdocrlfellowDrScottLowelbtMSKCCmyerchfocuectriioy-ducedn-lcoholicfttyliverdee(NAFLD)prticulrlyhepticlipidccumultilivermettpncticductldenocrcom(PDAC)Mylg-termgoletblhndependenterchprogrmimdectterctitweenoy/NAFLDmettultimtegolexplogthknowledgerpeuticnefThepropoederchmolidfoundtiwhichIcnetblhmyownerchgroupendK99pheRESEARCHLiverfquentmettticemnycncercludgPDAClivermetttypicllyocedpoprognoOy-ocedNAFLDmotpvlentchricliverdeeffect~25%popultiwldwidecomepdomntfcrhpgnichemettticcncerHoweverhowcncermechnticllytkedvntgelipid-richflmmryenvirmentNAFLDmlrgelyunknownMyerlypotdocrlwkhowlivermettfquentlyco-occurhepticlipidccumultiptientfttycidculdriverPDAClivermettmouemodelNAFLDMooveroemicekeylipolyenzymeuncventillyelevtedhepcytedjcentmettewhichccumultefttycidctbole-hydroxyyrte(OHB)upgulteInterfer-(IFN)peThpropoltethypomettducelipolyneighbghepcyteprovidefttycidwhichctemultifcetedpro-mettticprogrmIlevergefunctilgeneticmouemodelterrogtelipolynichehepcyte(Aim1)determectriifttycid-OHBepigenome(Aim2)IFNignlgimmuneniche(Aim3)NAFLD-drivenmettptilnlyticvlidteeulthumnmpleTheetudieillumtemechnmdrivelivermettoyNAFLDwhichcouldmnewtrtegierpeuticterventigrowgpopultiptientENVIRONMENTMSKCCprovidenidelenvirmentmeccomplhmytrgerchgoluccefullytrnindependentfcultyponcdemictutiMymenrDrLowewldledercncerbiologyexpertecncergeneticmouemodelInddiIhveembledndvycommteeetblhedcienttlevntexpertetrgcommmentmenrg(DrFeLiShermn)TogerllmenrupptmytrnidependenceprovidgvlubleerchexperiencecerguidnceWhcollbtiveenvirmentbrodpectrumourcetMSKCCthupptnetwkcteoptimlcdiuccefulcompletipropoederchcerdevelopmentplnImplementtiCompheniveSurvivhipCInterventiAcroFQHC-BedPrimryCPrcticePROJECTSUMMARYCncerurvivhipchllengedverelyctriecncerburdenmbidymtlyexcerbtedmultiplehelthcctextulbrrieruchcologyproviderhtgelimedcompheniveurvivhipcerviceprimryc(PC)Thecriclneedtegrtecompheniveurvivhipc(ieccodtipventiurveillnceterventi)PCettggivengrowgdemcutecncerccologtwhichhhiftedneeddeliveentilurvivhipcPCclicTherghiftwrdfollow-upcPCquiurvivhipcthoeettgeffectivelyimplementpromotecompheniveurvivhipc(CSC)cludgdhencetprcticeguideleccodtimngementphyiclpychoocilprcticlneedttentilifetylehvielf-mngemenptimlurveillncenewprimrycncer/curnceHoweverevidence-bedterventiimplementecproceeproviderktrtifiedoptimlcurvivddunmetneedthgrowgpopultiPCcricllylckgprticulrlycommunyfetynetPCclicurvivprimrilyrcil/ethnicmycommunielimedfncilourceGuidedEPISimplementtiRE-AIMevlutifrmewkwepropoeTypeIIeffectivene-implementtihybridtudycluterromizedclicltrilimplementPCclicintrgevluteurvivhiptrdc(SOCegurvivhipcpln)ltivecompheniveurvivhipc(CSC+SOC)terventi()unmetneedhelth-ltedqulylifelifetylehvi(primryoutcome)(b)cenghelthcutilizticquly(ecdryoutcome)cro14communyclicprtHelthChoiceNetwk(HCN)FederllyQulifiedHelthCenter(FQHC)SouthFlidprovidePCprimrilyrcilly/ethnicllydiverelowSESurvivWecru100PCclicin20clicHCNleder930dulturvivOurim(Aim1)TrclicinSOCCSCcdietblhcompentexperimentlcdiflizeneceryfrtructuHCNclic(Aim2)Cductcluterromizedtril(3FQHCytem14clic)evluteeffectiveneSOCvCSCcdiurvivunmetneedHRQoLlifetylehelthhelthcutiliztitfcti(Aim3)EvluteimplementtiutbilyCSCfutudemtiegdetermntuccefulimplementtiTheerchtemhexpertecrocricltrgetedthU01(egpychoocilmediclcologyprimrycheltherviceerche/mHelthEMR-tegrtedementterventimyhelth)The14FQHCclicervedover4300older(80%>50yrold)urvivdiverecommunie(eg58%Hpnic23%Blck46%Spnhpeker)limedfncilource(54%<$15Knnulhoueholdcome)ptfiveyerPROJECTSUMMARY/ABSTRACTOvrincncermotlethlgynecologicmlignncywomentrdcurgerychempyttmentcnprovidehtperiodmicnnoterdictedeepventcurnceCncerimmunpyhhowngtpotentilttgcncernoclicluccehenptedovrincncerOnemjhurdlecncerimmunpyneededovercomecvertimmunouppivetummicroenvirment(TME)ThegolthpropoldevelopeffectivennomedicecpbleprogrmmgcvertguppiveTMEovrincncerttmentTochievethgolIutilizevirlnnoprticle(VNP)cptevrioufunctilietrgetgdiffentpectTMEthroughbioengeergpprocheThetwoVNPuedthpropolcowpemoicviru(CPMV)heptBvirucpid(HBVc)whichbothhvewell-chrcterizedtbletructuvrobioengeergToll-likecepr(TLR)gthveendemtrtedpotentctivtenteimmuneytemmodulteTMECPMVtripleTLR247gteffectiveprogrmTMEovrincncerInmendK99pheIfocuugCPMVtripleTLRgtdevelopndjuvntntigencombti-uvcceovrincncerttment(Aim1)developgmulti-TLRgtvetigtemechnmcti(MOA)CPMVmulti-TLRctivticncerttmentdeignpotentTLRgtcombtidowntmpplicti(Aim2)DurgmydependentR00pheIueHBVcnnotechnologypltmdevelopmultiplefunctilrpeuticnnomterilimgprogrmuppiveTMEtvrincncervetigteMOAFirtIdevelopHBVc-bedTLRgtpro-flmmrycykecombtirpiewhichcnexertfunctiprogrmgTMEkillgcncercellccurntly(Aim3)SecdlyIdevelopHBVcmrtnnoprticlefunctiTLRgttrgetcvertpro-tumM2mcrophgenti-tumM1mcrophge(Aim4)DurgmygrdutetudyIhveentdmnipultgHBVcvroemblygeneticengeergHBVcdeignnoveltructuInpttwohlfyerpotdocDrStemetzlbtUCSDIhveentdytemticllybioengeergVNPpplictiengeedVNPcncerttmentAfurrtwoyertrgDrStemetzlbllowmeenrichmybckgroundcncerimmunologyimmune-cologytummodelgWhhelpguidncemydvycommteeendmymendpheIbleecutenu-trckfcultypoip-tiererchtuteetblhmydependenterchprogrmfocugugHBVcnnotechnologypltmdevelopnoveleffectivemulti-functilnnomedicecncerptientPROJECTSUMMARY/ABSTRACTThelg-termgolthpropoltrpplicntcomendependentcdemicphyicin-cientttudygimmunepegtlungcncerTheprciplvetigr(PI)hpvioulyobtedPhDtrgbiochemtrymoleculrbiologywellclicltrgternlmedicehemlogy/cologyHeABIMbd-certifiedmediclcologyThpplictidecri5-yercerdevelopmentprogrmprovidePImendeductilexperienceimdevelopgnewcientificexpertetumimmunologymoleculrprilghigh-dimenilnlycomputtilbiologymouemodelhumnlungcncerAtccluiwrdperiodPIhvecquidkillnecerychievehgolcomgndependentvetigrncdemicmediclcentertudyglungcncerimmunobiologyimmunpycrgptientthcicmlignncieTherchprojectcplizeexperteenvirmentWhgnUniveryStLouwhichhlg-trckcddevelopgupptgphyicin-cienttDrDvidDeNrdomenrPIcientificcerdevelopmentDrDeNrdowkpibleourcriclundertghowtummicroenvirmentpncticcncerledimpidimmuneurveillncehwkhledeverlclicltrilimprovgimmune-bedrpiepncticcncerAndvycommteecienttprovideddilcientificcerguidnceLungcncermotcommcuecncer-ltedmtlywldwideImmunecheckpothibhoughvolutiryneficilubetptientmettticn-mllcelllungcncer(NSCLC)Untuntelypetennotdurblenerly80%thoedignoeddvncedtgeNSCLCuccumbgirdee5yerdignoThetuemicroenvirmenthumnNSCLCchrcterizeddenetromlnetwkOurlbryhdemtrtedCAFcnimpirpenti-tumimmunypncticcncerwellmodelNSCLCWehvefoundtrgetgfibroviTGFbRhibicnimprovepeimmunecheckpothibibunlyettgchempyInthpropolwetethypofibroimpirbothT-cellprimgntigentrffickg/penttiedwhenTGFbRhibicomdchempyimmunpyFetudieweutilizegeneticllyengeedmouemodelhumnlungdenocrcommotcommtypeNSCLCwhichexpeovlbumwhichenbleueimmunepeTheidentificticellulrmoleculrmechnmwhichTGFbRhibinti-tumimmunywhencomdchempyimmunpyhclicllylevntimplictipectdevelopmentnovelimmunpytrtegieptientNSCLCPROJECTSUMMARY/ABSTRACTMylg-termcergolcomendependentcienttncdemicerchtutiMyerchtetfocuevetigtgnovelmoleculrmechnmunderlygimmunouppummicroenvirmentprovidenewrpeutictrgetpprocheimprovecncerimmunpyttmentThepropoedtudieK22wrdmfoundtimyfutuerchItrnercherjunifcultymemrHighrkhumnppillomvirue(HPV)cue5%llhumncncercludgmjycerviclcncernlcncerkcncergrowgfrctiophryngelcncerWehveuedmoueppillomviru(MmuPV1)viruthoughtmodelHPVfectilbrymicetudyhotfcrctriepertentvirlfectirkfcrtumprogicncerppillomviru-ducedneoplticdeeWehveidentifiedtkert17(K17)criclhotfcrexploedMmuPV1etblhpertentfectiThememechnmuedHPVnegtivehedneckcncermicehumnmodultetumimmunemicroenvirmentmedetnceimmunecheckpotblockde(ICB)rpyThegolthpropolvelmoleculrmechnmunderlygK17-mededimmuneuppiugMmuPV1nfecti-ducedneoplticdeemodelBedupwhtwehvelernedofrmypotdocrltudiewehypoizeK17functithroughdowngultgtumcellMHCclIIexpipolrizgmcrophgetummicroenvirmentpventTcellfiltrtiIpropoefollowgim1)deferoleimmunecellubetepecillyCXCL9-producgmcrophgeK17-mededimmuneevictextppillomviru-duceddee2)determetumcell-tricmechnmocedK17expictrieimmuneeviInAim1IpropoetetimptncemcrophgeK17-mededimmuneuppichrcterizgmcrophgeubetcomphenivelythroughphenotypgvivofunctiltrnfertudieInthimIctuecollbteDrHuyDhcomputtilbiologterchtettumimmunologyytemicllytudyimmunecellubettum-immunecell-cellterctimyplyroleK17-mededimmuneuppiInAim2IpropoetudytumcelltricmechnmgultedK17expifocuMHCclIIexpiOurplimrydthowednverecltitweentumcellK17expumcell-tricMHCclIIexpiInthimIcollbteDrHuyDhptiltrncripmictudiefurrvetigtehowMHCclIIexpigultedK17ffectimmunelcpetumWhtIlernedpropoedtudiemyhvebrodimpcnmnyepilil-igtedcncerwheK17ovexpedPROJECTSUMMARYThebrodobjectivethK08propol(1)fciltedevelopmentnecerykillllowPIDrAdmLchievehlg-termgolcomguccefulphyicin-cienttfocugbridggimmune-bednnotechnologyttmentlymphomhemlogicmlignncie(2)vetigtenti-lymphomimmunemechnmpthwycuedphmlrpypltmThpropolccernevlutgnewrpypltmdeignedlped/frcryBcelllymphomwhichclicllychllenggttepecillylpgfterulogoutemcelltrnplnrchimericntigenceprTcellrpyImmunpieuchimmunecheckpothibirbpecificntibodiehvelimedefficcydueuppivetummicroenvirmentytemicimmuneuppivecdiTheemethodlterloclytemicimmunemicroenvirmentneededimprovepeimmunpieRdirpy(RT)hendecridltergimmunemicroenvirmentlymphomgenerteytemicimmunepeHoweverthphenomenhnotenobervedclicllyCverelyphmlrpy(PTT)genertetrgT-cellpeolidmlignncymodelpromotgpro-flmmryT-celllcpePTTctedirrdgpecillydeignedgoldnnoprticlener-frdlightThennoprticlebblighttrnferenergyhetledgveryloclizedbltiWedeignedPTTpltmugbrnchedgoldnnoprticlecrryll-likecepr9gtCpGnimmunetimulntfoundPTTCpGcednnti-lymphomytemicpecludgcememyTcellTheewehypoizethurPTT/CpGpltmcnctetrgnti-lymphomTcellpecnynergizeimmune-bedttmentTotetthhypowepropoefollowgSpecificAim(1)chrcterizenti-lymphomimmunemechnmPTT/CpGBcelllymphommodel(2)determeynergticnti-lymphomeffectPTT/CpGcomdTcellenhncgimmune-bedttmentlymphommodel(3)determenti-lymphomefficcyubcutneoulymphomlyte/nnoprticlemixtuPTTpltmlymphommodelThecidtehmenrDrKimDrGdhvedeigneddetiledtrgplntilodcidtepecificneedgolTheplncluderigouerchcompentfdPInewknowledgeerchkillexmePTT/CpGpltmttermovethcceptclicltrilTheuccethpropolpropelddilwkevlutgcombtiPTTcellulrrpieledtrnlticlicltrillymphomPTTdeviceMotimptntlyprovideneffectiveoptiourptientlped/frcrylymphomABSTRACTAbout18womenUSdevelopvivebtcncerdurgirlifetimeHumnEpidermlgrowthfcrRecepr-2(HER2)clicllyvlidtedtrgetupgulted25%ecncerocedpodeeprognoCurntmedictitrgetgHERhveeverllimticueirdequteeffectiveneenivytncecncercellmutticugttmentfiluHERceprfmilyquinimptntdimeriztitepctivtieentilcncercellmtgrowthdiviInhibidimerizticurntlyclicllychievedntibodiecnnottrgetmuttedtrunctedceprmcnnotcroblood-brbrrierturngbrncturycncercellledgmettlpeOurlbdcovedmllmoleculethroughvirtulcengmoleculrmodelglghmpdictbdHER2dimerterfceurfcewhichwouldllotericllyhibceprctivtipventgdimeriztiThmoleculewhowncellulryhibSKBr3cncercellleovexpgHER2electiven-xicmnnerThfirt--clmoleculetrgetmemrthceprfmilyugnlloterichibimechnmIfdvncedclicltetgcnwkt-lerpyptientpopultitcurntmedicticombtirpiedecetncemettlpeTheoverllobjectivethpropolchrcterizevlidtenlogthhibirpdictedmodelghimilrbdgpoemehigherffyHER2dimerterfceWevlidteirterctiHER2ugcellulrbiophyiclbiochemiclyWelotudyireffecncncercelldowntmtrgetexpiphophyltileveltetp-permgledcompoundplmdtriipropertieefficcyHER2+btcncervivomodelThepropoedtudynovtiveduenewmechnmhibipropoedmodelgdictedelectivexicyhowncellulrtudieOurlg-termgolextendtherchltedceprmefmily(EGFRHER3HER4)implictedmnyolidtumomewhichlcktrgetedrpieTheoutcomethtudyferprocceptuhernewclnticncergenttrgetgHER2ceprTheprojectuppterchexperiencecncerdrugdcoveryrpeuticixPhrmDegrduteixundergrdutetudenttwoREAP-eligibletutiProjectAbtrctPtientcncerfceuncceptblembidymtlyeplife-engdygultedpefectiOncologicepctrie>15%cncerhoplizti10%cncerdethUSfrgtermbidymtlythnncncerepTimelyevidence-bedepcbundleimproveoutcomefquentlyedoltenottllcnceruggetgerlierccurtecognimyimprovecoutcomeCurntpprochedetectgttgcologicepufferterltedlimticludgpoccurcyeppdictiolptientcncerwellgenerlcology-pecificbrrierireffectiveimplementtiThCerDevelopmentAwrdupptPtrickGLyMDMSddgthchllengewhilecompletghdevelopmentndependentphyicin-vetigrtrgexperienceneceryimprovecncercdeliveryhoplTheoverllgolSepPdictiOncologyThroughImplementtiScienceTechnology(SPOT-IT)ueEHRdtdevelopncology-pecificeppdictimodelugmchelernguehumncenteddeignmethoddeignevluteubilytkeholder-medimplementtitrtegythmodelTheemefNCIgolrpiddevelopmenttetgfementnovtivepprocheimplementevidence-bedcncerctrolterventiDCCPSpriyhelthcdeliveryerchimplementticienceflectedAim1)developncology-pecificeppdictimodelugmchelerngEHRdt2)deignfeimplementtitrtegieimprovecologicepmngement3)cductpilottrildetermeerlyimplementtiproceoutcomeSPOT-ITTheeAimlkDrLycerdevelopmenbjective1)developcocncercdeliveryknowledge(2)enrichhknowledgeepepidemiologyoutcome(3)dvncehkillmchelerngmtic(4)gdvncedkillimplementticiencehumncenteddeign(5)enhncehcientificlederhipkillDrLychieveegolvi5-yercerdevelopmentplncptgdidcticfieldwkexperientilerchtenivemenrgTerriHoughMD(nterntillederepepidemiologyprgmticimplementtierch)BrHye-LttMD(ncologtpecilizgtem-celltrnplntticlicltril)MtwChurpekMDPhD(criclcphyicinmtictexpertemchelerngugEHRdt)DrLyexperiencedmultidciplrytemmenrdvcomdexceptilerchenvirmenttOgHelth&ScienceUniveryprovideuppttrgnecerychievehlg-termgolcomgledgcncercdeliverycienttAbtrctWetendepictignlgpthwydozenolmrkphophyltieventculmtetrncriptigeneductiphenotypeInlyccdehunddthouphophyltiectedynmicbiochemiclnetwkthrchetrteeentillyeverycellulrproceexprncriptilprogrmcellprolifertimigrticyxiceffecrfunctiTcellignlgnimptntexmpleSignltrnducthroughTcellceprco-timulrymoleculecdiblycomplexledimptntdtctdowntmeffectneceryproperimmunepepthogencncervcceAhumngeTcellignlgcomedetrimentllyltedledgimmunoenecenceleefficientprotectimlignncieMpectrometryhenbledprilgtenthouphophyltiedivererngecelltueUntuntelyfunctillychrcterizgtenthoupot-trnltilmodificticelluecodteeentillyllcellulrgnmlproceemfundmentlchllengebiologyHewepropoennovtivetechnologyenblefunctilementthouphophyltiehighthroughputWeemployCRISPR-mededbeedirwhichmuttecodgenomicDNAcoupledphenotypiccenproignlgeventledpecificTcelltimulti-pecificgeneexpiprogrmprolifertipePlimrydtourlbrytrglyuggetwecnfunctillycententhouphophyltieirctriiNFATNFKBignlgtimultedTcellInthpropolwefurroptimizeechnologycterobutliblecengpltmTovlidteourcengtechnologywechrcterizeubetphophyltiemutntugcventilgenomicengeergmethodunderthowourcengpltmcompclicpprochetudyphophyltiefunctiieemutttimeWeloextendthpprochprimryhumnCD8+Tcellhowwecnuncoupleignlgeventledcellprolifertiexpictivti/exhutimrkerPD1HighthroughputfunctilcengphophyltieprimryimmunecellvolutiizewywetudyignlgpthwycellulrdecimkgwywepprochdrugdevelopmenrdoptivecellrpiettcncervrietyhumnilmentocedggPROJECTSUMMARYSeveimmune-lteddvereevent(irAE)occurup~60%melnomptientttedcombti(nti-PD1/nti-CTLA4)immunecheckpothibir(ICI)cuettment-ltedmbidymtlyHoweverpthophyiologyunderlygeveirAEdevelopmentmunclernowycliclprcticepdictwhodevelopevexiciewhotBedourplimrydtwehypoizeclllydiverectivtedCD4memyTcellmopecificllyCXCR5PD1hiperipherlhelperT(Tph)cellpecificllyunderpICI-mededxicymelnomptientToddthhypowepermflowcymetryCyTOFcRNA-eqcV(D)J-eqimmunoSEQbrodlyeTBcelltteperipherlblood1)determewherTphlevelpttmentbloodpdictiveeveirAEdevelopmentmelnomptientttedcombtiimmunpy(Aim1)2)determewherTphclotypepfentillyexp-ttmentbloodenrichedirAEkleidurgcombtiimmunpyptientwhodevelopevexicy(Aim2)WhilepdictieveirAEperipherlbloodimptntclicllyptientwhoexperienceomedegexicyhveloenhownhvetterdurbleimmunpyperteTheechllenggmkeclicldecigrdgimmunpyoutlocidergprobbilydurblepeWethuutilizecell-feDNAmethyltiequencgpdict1)immunpyxicy2)durbleimmunpypeccurntlyp-ttmentplmugbothcell-tteigntungnoticmchelerngpprochwhichwevlidteheld-outcoht(Aim3)Bydogowelyfoundtifutuclicltrilwheimmunpydeci-mkgguidedrkverunefcombtiimmunpyugliquidbiopybiomrkerdefedheInummrythtudyveldetermntirAEdevelopmentwhichmbliquidbiopytechnologypdictbothimmunpypexicymkettmentfermoperlizedfutuProjectSummrySolryfibroutum(SFT)hricllyloclledhemngiopericym(HPC)t-tuercomoccurrgdultfntThnhedrycncerultnenvirmentltrchromoomlgenefuitweenNAB2STAT6chromoome12whichfuectivtidomSTAT6pidomNAB2CequentlytedNAB2pgerlygrowthpe(EGR-1)trgetgenefuiprotectivtemledgtumigeneThetlet6dtctfuivrintccountpthologicvrumggiveneSFTAnmicllyebloodveel-derivedtumcnoccurnywhehowevermoccurmengehedIntrcrnilSFThvehighrteloclcurnce(65%)mette(33%)overllurvivllethn10yerEirurgeryrdifirtlettmentgtthcncerhowevermnythcomechllenggcncercntrveloperbleoccurloctildyirrdedCurntlynopprovedchempygimenSFTAnti-ngiogenicdrugdevelopedtrcncerhveenuedSFTlimeducceNechempieenblecompletemitpegprtilpetbledeeeverlmthThevergeurvivlptientcurntchempie2yerUgCRISPR-bedgenomeedgweetblhedSFTcellmodelwhichcloelymtchendogenouNAB2-STAT6geneticchrcterticInddiweppdeverlprimrySFTcelllePDXnimlmodelectedptienttuemplefhfullycpultephenotypemlignntSFTUgeSFTmodelwepermedhigh-throughputywhichidentifiedBEThibirMivebibpromgcidtegtSFTHewepropoefollowgtheim()permcomphenivephenotypicyevlutevroefficcypecificyMivebibddilBEThibircurntlyclicltrilgtSFT(b)uncovermoleculrmechnmBEThibirSFTilfocuDNAdmgepirmechnm(c)evlutevivofetyefficcyBEThibircombtyroekehibir(TKI)PARPhibirOurcientificpprochwhichpncncerbiology(vrovivo)hypo-drivenmechnmtudiectrieignificntdvnceundertgttmentSFTOurobjectiveegle-ptientInvetigtilNewDrug(IND)clicltrilAbtrctTechnologicldvncementhveyieldednoveldrugtrgetimprovedcncerdetectitrnmtivenovtittmentmodlielckgLeverggourtemexpertegenerpybtcncercncerimmunologybtcncernimlptient-derivedxenogrftmodelwepropoeuecombntdenoviruhighertum-pecificexpiherpeimplexviru-thymideke(HSV-TK)whichuicidegenecuetumcelldethWecomHSV-TKourimmunecheckpotntibody(ieHMR-101)pecificllytrgettumcellleetumntigenchngetummicroenvirmentmofvbleimmunerpyTheimmunpywedevelopgmodifycncer-promotgimmunecellcomenti-cncerimmunecellTheenrmynti-cncerimmunecelltdcognizecnceroucellmobilizecirculteroundbodydetroymetteGivenpdomncetum-ocedimmunouppivemyeloidcelltriple-negtivebtcncerlocldeliveryHMR-101couldeffectivelyprogrmtummicroenvirmentnnti-tumimmunephenotypeThevirltrnductiefficiencyourvirlvecrveryhighttumechimericvirlvecr(lowneutrliztintibody)lowpdggnThvirlvecrfepprovedFDAtlowcothumnueAuchourtrtumltrtegywouldllowmximizgfullpotencyimmunpeuticntibodythuenhncgrpeuticdexWeenviechnologymovewrdclicltriltrglyuppteducceourcentlycompletedSTOMPtrilmetttictriple-negtivebtcncerTNBC(NCT03004183HSV-TKrdiimmunecheckpotrpymettticTNBC)ClicllyweenvhurtrtumgenedeliveryHMR-101progrmimmuneytempventptientlpeprolgnti-tumimmunythunefgptientceivgimmunpyFtriple-negtivebtcncerptientwhotypicllyhvedmlcliclpeduehighmettticrtecurncepotentilcliclimpcurtrtumlvirldeliveryctgnovelimmunecheckpotntibodyproundOverllrpeuticchournovelrpeuticgimenexpnivefergtrulytrnmtivepprochcncerttmentPeoblm(PB)nundertudiedclicllyggiveembryltumpelgldignoederlylifeDuerryknowledgepertgmoleculrcellulrbPBhmedmodetLikewepcliclmodelPBextmelycrcetllgeftdcovercdentilcurtiverpieducecollterldmgedevelopgcentrlnervouytemToovercomeprimiveundertgPBtumbiologyidentifyclicllylevntmoleculrheterogeneywecentlypermedbulkgeneticepigenetictrncriptilprilgizblecohtprimryptienttummpledefgfourdtctubgroupPB-RB1PB-MYC/FOXR2PB-miRNA1PB-miRNA2NmekePB-RB1PB-MYC/FOXR2ubgrouppentprimrydignoePBdurgfncyccountnuncceptblyhighmtlyrteLo--functimuttitrgetgmiRNAproceggenedefeclicllyheterogeneouPB-miRNA1PB-miRNA2ubgroupdignoedchildndolecentAnterntilcenudefienovelPBubgroupwcludedmotcentupdteWldHelthOrgnizti(WHO)ClifictiTumourCentrlNervouSytemhgunchngehowPBdignoedclicllyIntherchprogrmweimdvnceundertgbiologicllyclicllydtctPBubgroupthroughdeepvetigtiircellulrdevelopmentlpthologiclbWehypoizemoleculrubgroupPBexhibdivergentcellulrprogrmigtedcteprogenirttedurgpelgldevelopmentDclogcellulrhierrchiedevelopmentlignovelPBubgroup(i)olvecogenicmechnm(ii)mpcliclmodelgtrtegie(iii)implictecidtedependencie(iv)enbleevlutinovelrpeutictrtegieThhypotetedtwocceptullytechnicllynovtiveSpecificAimtegrtemultidciplrymultpeciepprochInAim#1welevergelrgegle-nucleutrncripmedtetgenertedmoleculrlynnottedPBptienttumdcovercellulrprogrmdrivgmlignncyInddiweutilizefirt--cltledevelopgmouehumnpelgldefeubgroup-pecificcellulrigveltum-enrichedmoleculrigntucollectivelymgpthogenicmechnmcidterpeuticvulnerbilieInAim#2wedelivererienovelgeneticllyengeedmoue(GEM)modelpenttivedtctPBubgroupcludgcomphenivephenotypicmoleculrchrcteriztiNovelGEMmodelvlidteupectedPBdrivergeneerveeentilpcliclmodeltetgnovtivettmenttrtegietrgetgpromentcellidentyprogrmSuccefulexecutherchprogrmovercomeeentilknowledgegppertentbiologiclcliclheterogeneyPBprovidepltmpurumopecificlexicttmenptiffectedptientProjectSummryOrlqumoucellcrcom(OSCC)ixthmotcommepililcncerwldwide50000newce/yerUSDepeglefquenturvivlrteltivelowerClicllyOSCCpentnecroticleitiffenedbderurgiclectiquiignificnttueloup2cmurroundleiowgfctetumpolymrgedquiignificntectienullmettticdeemovedEvenggiveurgiclpprocheignificntmbidymtlyocedOSCCthdrmticllyduceptientqulylifeWhiletiffenedbderhllmrkdeeunclerwhtextentmicroenvirmentlpropertieegmechniclchngeextrcellulrmtrix(ECM)tiffnectrietumprogiviTheroletiffnehenwelletblhedepililtumegbtbuurundertgOSCCltivelyncentlethn10tudiehveevenperipherllyddeduePlimrydtourgroupfirtdemtrtetifferenvirmentduceepilil--meenchymltrni(EMT)lepililcellydoptmoggivehviviveOSCC(Mtteetl2019Moetl2023)EMTeltuemightctriefquenttumcurnceobervedptientexceivelytifftummrgSceOSCCexceedglyvivelernedhvitiffenedtummutmemdclledceterdjcenrltuefcilteetblhmentecdrydeeThuwehypoizetumtiffneducecquicolidtimechniclmemyieEMTmigrtiwhichcnclledlterwhenultgOSCCcelldemtectrietummettvicurnceTotetthhypowepropoefollowgpecificimSpecificAim1ElucidtemechnmvolvedmechniclengledgmemycquicllSpecificAim2DetermewhtextentepigeneticchngeOSCCducememycolidtiProjectSummry/btrctTriplenegtivebtcncer(TNBC)motggivebtcncerubtypepoecliclchllengeduelckolpdictptientwhotrkdethduedeeTNBCubtypewepumedtepwrdhowevercentromizedclicltrilhvefileddocumentdiffentilimpctrpyTNBCubtypeImmunpienefmllubgroup(~7out100women)TNBCptientoced15-30%cegrde3immunexicieCurntlyllptientTNBCfedchempy-bedgimeneirfterurgery(70%)leten(~30%)eurgery(neo-djuvnt)F30%TNBCptientpcridneo-djuvntchempyTNBCptientpencebenceiduldeehenuedoptimizgecltide-ecltitrtegieStudieuchSWOG2212(SCARLET)gpropoedde-eclteneo-djuvntchempyTNBCbedTILiduldeeendpotHowever70%TNBCptienttteddjuvntchempynoetblhedprognoticolprtTILde-ecltgrpieBetterolneceryidentifypotentillylethlTNBCcehighccurcyTheoverllobjectivethgrntdevelopnovelolpdictirklethlyTNBCugmulti-modlpprochThecentrlhypoccurcylethlypdicticnimprovedmulti-clepprochcomprgnovelrtificiltelligence(AI)-bedolmmmogrphicimgepthologycludgptilimmunenlyThefollowgpecificimpropoedAim1)TogenertenovelmodelmmmogrphicrdiomicfetudetermeprobbilyTNBClethlyAim2)Toetblhrolegenertivedverrilnetwk(GAN)ugmenteddeeplerng(DL)modeldiglH&EimgepdictgprobbilylethlyAim3)ToprileimmunecellpologyptilltihipirctriirklethlyAim4)TotegrtemultimodldtmodelidentifictirklethlyTNBCAltefuimodeltegrteclicopthologiclfetuprobbilieobtedpthomicrdiomicimmunedtdevelopCPRIpdicticoeglethlyTNBCtrtifyptientbedirrkThecoprovideevidence-bedrtileecltgdeecltgrpyTNBCThedevelopedolCPRIcobedmulti-modlnlytegrtemclicopthologiclfetuuchgercetumizeThectuouCPRIcocoulduedeirctuoumeurkctegiclmnner(highlowrk)High-rkptientlikeptientidulcncerfterneodjuvntchempywouldcidteecltirpySimilrlyptientlowrkcouldcidtede-ecltiAbtrctTheCD8T-cellpecncercricldeectrolpecheckpothibirApvilgfetullhumncncerextmevribilymgnudethpetweenptientfcrcuethvribilyunknownWepvioulyptedcriclcompenttummicroenvirmentmnycncertypenimmunenicheprovideupptCD8T-celltem-likequlieThnichemllntigenpentgcellloclizedtumbderwheTCF1+tem-likeCD8T-cellideTheeTCF1+CD8T-cellpecifictumntigenctprogenirctuoulygiventi-tumeffecrCD8T-cellMotimptntlyifnichenotpenttumeTCF1+cellhvenowheurvivetummicroenvirmentcequentlyCD8pegtcncerhltedLothimmunenichekidneytumocedrpidprogideefterurgeryignificntlywepeimmunpyInthpropolweimvetigtewhtgeneticfetucncercellcquihelpmlimmtiimmunenichetumTodothwehvedevelopednovelmethodllowtgpucncercellhumnRCCtumWepermedRNAeqcncercellolted99T3clercellRCCptientfoundtwoverytrgclteimmunepecncervetigtedfurrheFirtlycncercellctivecelldethNFkBpthwyhdhighlyctiventigenpentgcellbiggerimmunenichemnymoeffecrcellSecdlycncercellhighleveloxidtivephophyltiglycolywefrleblegenerteeffecrtem-likecellirtumimmunenichewefrmllerptientprogedmpidlyfterurgerydidnotpdlterPD1blockdeThpropolexpupefdgcompletgfollowgimAim1firttudywhtgeneticchngeoccurcncercellcltetrncriptilignlghowheterogeneytummicroenvirmentmightdiffercrogiprimrytummettInAim2wepentdtcoldtumhvemutticelldethpthwywevetigtehowloprticulrflmmrycelldethpthwymightlimntigenpentgcellctivtiCD8effecrgenertiTMEugbothPDXyngeneicmouemodelAim3lernhowdiffentenergymetbolmytemcncercellfluencemtiimmunenichegulteCD8effecrdiffentiTMETogeredtprovidenewighthowcncercelllimimmunepegttumWhilemuchthwkfocukidneycncermechnmwedecridwelofoundprottebldderbrhednecktumFthbicmechnmwedecrithwklmotcertlyhveimplictiundertgCD8T-cellpemnycncerThebilydignoeclifyleukemlymphom(LL)childnyoungdultlimedKenymotSub-ShrnAfricLLpentnerlyhlfcncerthpopultiFlowcymetry(FC)fermjdvntgeleukemidignoThelycenterhimplementedflowcymetryweternKenydignoeLLbedAMPATHfencelbry(ARL)AmjgpcncercKenylckcot-effectivecengtetleukemilymphomThelyoptiptientupectedLLtrvelARLEldotpyoutpocketexpenivedignoticervicecludgFCThecurntFCwkflowARLuefour-tuten-colfluocentntibodytetgwhichfoureprteyneededperptientWehypoizewecncverurcurntfour-tuprocemrrowtterproceutilizgperipherlbloodmplegle-tuFCcengyddiltetglymllmyptientevidencemlignncycnnotolvedourgletuyThlow-cottetcecceibilybloodmplecntrnptedlbtedptienttrvelgmrrowproceduOurimthpropol1Vlidtemeuccdncetheflowcymetrytetcomprgmrrowpirtiperipherlblood(PB)ptientourhoplupectedleukemiWemeuccdnceourcurntgoldtrdfour-tumethodleukemidignomrrowmplenewten-colgletudryunizedgenty(DURA)ClerLLbLSgletudeignedlymphoidmyeloidmlignncycengdignoSimultneoulywemeuccdnceLSgle-tuymrrowmeyugperipherlblooddemtrteequivlencethoetwomethod2EtblhvlidtendptedflowcymetryyleukemidignodtntperipherlfcilieKenyWeidentifyptientupectedleukemiourprtnerperipherlfcilietrnptPBmpleARLnlyflowcymetryexpourchimplifygdignooutneedmrrowmplgtrnptgptienthoplfirtddgefficiencyproce3Developcompheniveeductilmodelenuht-lg-termimplementtiflowcymetrygiWhupptmediclexpertUnedStteBeckmn-CoulterARLtffnimplementcomphenivetrgprogrmfeturg-etrgctuoutelehelducti(ProjectECHO)nynchroulerngmngementytem(KluzCybnk)enuctuedeffectiveutiliztiutbilyFlowCymetryRecurntmettledgcuebtcncermtlyDmncycriclpolyunderodteptumigenicprocewhebtcncercellcnmn-prolifertivettetecdryelgperiodtimefteruccefulttmentprimrytumRectivtidmntbtcncercell(dDCC)enblecurntmettticdeetentnttrdcrpieuchdDCCpentmjcliclobtclebtcncerptientcChromtmodelgprovidefoundticellulrprogrmmgnecerydrivecellftetrniHoweverltleknownboutntuthmodelgctextdmncyOurpublhedwkdemtrtedbtcncercquibilydemtecniclhneH3cptichromtuppedplcedrhneH3vrintH33cptedcogntehnechpereHIRAThwchhnecompoiufficientneceryenbledemticequentlypromotebtcncermettOurubequenttudieveledHIRAnlyimptntcquirgmettticbilyprimrytumloctrollgtrnitweendmntprolifertivetteervgmjgulrfteDCCThuhewepropoeH33depoidrivenHIRAcomplexgultebtDCCftethroughmettticccdedetermgwhercellentermdmnrprolifertemovertmetteThhypotetedthroughthepecificimAim1focuetblhgH33depoichromteffecrHIRAgultgprolifertidmncywchbtDCCpecificmechnmwhichHIRA-mededH33depoiexerteffectwhileim2focupcelydefgflectipotmettticccdegultedHIRA-mededH33depoiirmetbolic/doxquimentAim3hfocudefgroleHIRA-H33chromtmodelgxmedgterctitweenlungenvirmentftedmntcncercellSuccefulcompletietudieunveilfirttimemjgulrepigeneticmodelgdriveetblhmentexdmncyCequentlypropoedtudieputwrdHIRAnimptntrpeutictrgetpventwkengcequentlyctivecurncemettticbtcncerMooverourtudieenbleunddcoverydoxmetbolicpthwyupptvlydiffentcellttedurgmettticccdeenblgfututudieimedtevlutgidpthwymuchneededlibilierpeuticlevnceerdictedmntcelleffectivelypventcurntmettticbtcncerABSTRACTUvelmelnom(UM)motggivemtroculrcncerdultPrimrydeecneffectivelyttedhowever~50%ptientdevelopmettUntuntelymettticleitenftleyerdignomkgUMemotlethlcncerMettticUMhtrglivertropmfrcrytrdttmentAclerunmetcliclneedviblettmenptioverrchggolthpplictihighlightnovelrpeuticvenuettmettticUMScemotUMmettefoundliverpiblepoprognoweeektterunderthowlivermicroenvirmentupptmettticUMInthpropolweuevroexvivognotypicliverliceco-culturgvivoexperimentlmodlievetigte1)HowUMlivermetteuceptibleferropprogrmedcelldethpthwyocedccumultixiclipidperoxidePubliclyvilbledtetourplimrydtdemtrteloBAP1trgdetermntlivermetteocedferroptictnceFurrmowefoundmutntBAP1UMcnttercopeteimpoedlipid-richmicroenvirmentLtlyourplimrydtuggetmutntBAP1UMmoenivephrmcologiclhibinti-ferropticmcherythnwildtypeBAP1counterprt2)InvetigtehowliverocedelenoproteomeexpihelpUMtvefoxidtivetTheliverbodyeleniumpoirymnygeneocedmelgferropticoxidtivetelenoproteprotehvetlenceeleniumctgmocidelenocyteePlimryvroexvivoliverliceexperimenttidemtrteenhncedelenoproteomeexpiwhenUMcelldoedexogenoueleniumcompoundlivercdiedmediTheedtupptedtrncripmicexpiptterndicteBAP1lo(likelymetttic)ocedcedgenefcilteelenoproteyn3)DetermehowtrgetgferropelenoproteomeUMlivermettemodultetumimmunemicroenvirmentSceferropnimmunogeniccelldethpthwyweueyngeneicytemhighlighthowferropducedelenoproteomeexpictivtebothnteperipherlnti-UMimmunepeSpecificllywevetigtehowetetimultephgocyticctivyhepticmcrophge-likecellcludgKupffercellMooverweueyngeneicvivomodelgtethowphrmcologiclductiferropgeneticbedductielenoproteomeexpihpeheptictumimmunemicroenvirmentByvetigtgpothighlightedbovewegmechnticighthighlightrpeuticvulnerbilieoceduniqueterplytweenlivermicroenvirmentUMmetteProttecncer(PC)howtrikgdegecliclvribilymotggmenhrbgdolentlowrkPCnotenirhelthdurgirnturllifetimeDefivettmentedolentlowrkcncerurgeryrdirpy(RT)rkunnecerycotttment-ltedxicyBecuethctiveurveillnce(AS)mngementtrtegyvoiddeferttmenthemergedtrdclowrkPCASctmirglowrkclicllyignificntPCptientttmentcurtivetentONLYprogiclicllyignificntPC(cPC)DetermgwhenptientprogeASctvriblemixerilprottepecificntigen(PSA)meumentimggprottebiopieHowevernocenuextidelettetmirgfquenciedurgASProttebiopyelfhmeurblembidyocedfectiurrytentipwengurryympmTheeneedoptimiztiASprocolimprovedetecticPCmenASProtteimggmgneticnceimgg(MRI)hcomentegrloldignoPCmirgmenASimprovedetecticlicllyignificntPCcompdprottebiopyoutMRItrgetghoweverccurcylimedAnegtiveMRItillmepproximtely20%cPCpoiveMRIultnegtivebiopy50%timeBetterimggquidimprovedetecticPCProtteSpecificMembrneAntigenPorEmiTomogrphy-ComputedTomogrphy(PSMA-PETCT)motenivetechniquevilbledetectimettticprottecncerTheccurcyPSMA-PETCTloclizeddeelimedhoweverhenhownPSMA-PETCTdddignoticvlueprotteMRIdetecticPCpecificllyimprovgnegtivepdictivevlueWehypoizePSMA-PETCTASptientimprovedignoticccurcyprotteMRIuchnegtivetudyobveneedurveillnceprottebiopyTheEvlutiProtteSpecificMembrneAntigenPorEmiTomogrphy-ComputedTomogrphyActiveSurveillnceProtteCncEr(ESCAPE)trilglermpropectivemulti-tutilclicltrilegnegtivepdictivevluePSMAPETCTdetectgclicllyignificntprottecncerWehypoizePSMA-PETCTcnruleoutclicllyignificntprotteASptientduehighnegtivepdictivevlueRoutemmmogrphiccengbtcncerducebtcncermtlyOnmmmogrmrdiologtemmmogrphicdeny(MD)mountfibroglulrtue(FGT)btwhichtrgrkfcrbtcncerWomendenebtmolikelydignoedtervltweencengexmctrigcedbtcncermtlyHowevercurntcengguideleverge-rkwomendottkeimggrkmrkerccountWomenveryhighrkbtcncergrdleMDceiventenifiedcengcheduleupplementlctrt-enhncedmgneticnceimgg(MRI)OnMRIrdiologteFGTwellbckgroundpnchymlenhncement(BPE)BPEdegewhichhelthyFGTbrightenduepencectrtflectgmetbolicctivyFGTWecentlydemtrtedBPEMRIwocedbtcncerrkdependentlymountFGTOrtudiecrobteourfdgupptgourpmeBPEnewmrkerbtcncerrkHoweverdueelectpopulticeivgMRIlterntivemeumentpprocheneededceimpctBPEwomenwhotbleceivecengMRICtrt-enhncedmmmogrphy(CEM)ncgly-uedbtcengmodlyubtntillyimprovebtcncerdetecticomprbleenivyMRIAfterjectictrtgenttwommmogrmthighlowenergietkenquickucceiMDeedlow-energyimgeBPEeedubjectivelyrdiologtmimlmildmodertemrkedproceed(comd)imgeperBtImggReptgDtSytem(BI-RADS)BI-RADSBPEmeudCEMhgoodgementBI-RADSBPEmeudMRIHoweverubjectivemeumentBPEvrietweenderpventgproduciblerkementerchAnobjectivequnttivemeuBPECEMneededrigoulyevluteltihiptweencedBPEbtcncerrkToddtherchgpwepropoeeocitweencncerfullyumtedmeuBPECEMAim1EvluteBPEproduciblemrkerbtcncerrkweimplementfullyumtedmeuqunttiveBPE462CEMevlutegementgoldtrdBI-RADSmeucompBPEMRIAim2DetermewherqunttiveBPEimprovebtcncerrkementmtchedce-ctroltudy154newlydignoedbtcemtched308cncer-fectrolwedetermeocibtcncerBPEccountgFGTrce/ethnicyproductivefcrrkfcrbtcncerOurlg-termgoluequnttiveBPECEMimprovebtcncerrkementenblgperliztibtcncercengimprovecengoutcomeducemtlyduebtcncerProjectSummry/AbtrctPncticductldenocrcom(PDA)devttgdeelckgeffectivettmenptiPDAchrcterizeddenefibrotictummicroenvirmentdepoedextenivediverefibrobltimmunecellpopultithnicheThediverycelltypePDAtumloextendcncercellmelveheterogenouubpopulticncercellcpbleymbiotichviuppttncerpyAccdglytrgetgcrotlktercticnmovebrrierllowmoeffectivecliclttmentInvetigtgcllPDAhviwehveidentifiedtwometbolicubpopultidiffentedirenivymichdrilhibiMetbolicexchngetweenepopulticfertncemededprgethverproducedleedthroughctutivelyctivetegrtedtpeenivecleFurrweoberveddegrdtiprgefunctienizePDAmichdrilhibirTrgetgmichdrilmetbolmPDAcellfunctilowertercellulrnucleotidepoolcompetetrdcchempypyrimidenti-metboleFurrtrgetgmichdrilmetbolmlofunctiducenti-flmmrypolriztum-ocedmcrophgeproviden-cellunomouchemotnceTherchpropoltrgetfcrunderpngprogrmmgPDAcellproduceleeprge(Aim1)WehveidentifiedcogenictpthwycntrgetedimpirurvivlprgeproducgcelldruptmetboliccrotlkFurrwehveidentifiedprgeproducgPDAcellhvehypermethyltedhnecltemeenchymltteAccdglywelevergemetbolicpprochenmlizehnemethyltiprogrmecelldeenizemmichdrilhibiInprllelwecomttmentmichdrilhibirpotentedthroughprgedegrdtitrdcchempy(Aim2)BothytemicloclprgeleveltrgetedcompdefficcyenhncgmichdrilhibirTheeexperimentpermedmultiplehumnmutummodelnlyzedthroughcombtechniquellowvivoementPDAmetbolicubtypeperpyFllywechrcterizemodelgimmunetromlcomprtmentPDAtumpemichdrilhibirpotentedprgedegrdtiidentifynewimmunetrgetgpprocheTogeredtprovideimptntightmechnmmtcncercellheterogeneygenerteimptntp-clicldtexmgimpcttrgetgmetboliccrotlkpthwyenhncePDAperpyPROJECTSUMMARYDepewidepdueucce[18F]FDG-PETimggcologymnyutiwhe[18F]FDGcnnotueddignottmentmirgepecillycncerwhehighbckgrounduptkelowtuedenylow-growgtumInfectiflmmtifquentlyledtlepoiveMnytrcergdevelopedprovideimprovedctrtenivyccurcycompd[18F]FDGOfprticulrtetnucleoidenlog[18F]FMAUwhichcptedDNAwhentumcelldividethudictlymeurgcedcellprolifertiuniverlhllmrkcncerPromgclicldt[11C]FMAUpclicldt[18F]FMAUhveledilclicltudie[18F]FMAUcncerptienthightetclicltudie[18F]FMAUPETmenettmentpediverecncertypeHoweverrdioyn[18F]FMAUverychllengghdergtrnltileftuchmulticenterclicltrilneededenuufficientcrumentptientpopultiOvermnyyerDrChenlbtUSChimproved[18F]FMAUynug1-potprocetillvolvelengthyctitep(~3hyn)uecroiveuntblegentnotcomptibleumtedynmodulehltivelylowctivyyield(~5%)mkgdopthpprochextmelydifficultTowidelyenbleclicltudiethpropollevergennovtivedroplet-rdiochemtrypprochdevelopedDrvnDmlbtUCLAnowgcommercilizedDropletPhrmwhichctipermed10Lvolumeted1mLvolumeenblghigheropeccentrtihigherctiyieldmuchhteryntimeAplimrytudyhowed[18F]FMAUcouldproduced<1hOurcentrlhypoethprojectcellprolifertiimggcnprovideuperiementttmentpe(egerlierpedetectihigherpecificytumgrowth)thntrcerdroplettechnologycnfciltewidepdcce[18F]FMAUclicltrnltiLeverggynergticcdemicdutryexpertecpbilieourmulti-PItemdvnceclicltrnlti[18F]FMAUvifourcomplementryim(1)Developnoptimizeddropletrdioyn[18F]FMAUtmulti-doecle(2)Cumizedropletrdioynizer[18F]FMAUproductinumtevlidteyn(3)Puruepclicltudieevlute[18F]FMAUegttmentpe(compd[18F]FDG[18F]FLT)upptfutuclicltril(4)Enblewidevilbily[18F]FMAUprovidglow-cotelf-hieldedynizerdevelopggent/cumbleketblhguertrgprogrmcompilgnINDmendmentcnfencedfututrilWelievequnttive[18F]FMAU-PETimggprovideerlyccurteementcncerttmentledgdividullytilodrpeuticplnimprovedptienutcomePROJECTSUMMARYIthenhownvricncerrkfluencedmuttimyheredcuedenvirmentlfcruchmokgultrvioletexpouultgromDNAplictierrHewepropoenovelfcrcncerrkwhichltedgeneticdiveryimmuneytemcrohumnbilydetectelimteerlycncerImmunourveillncecceptimmuneytemcturveillnceytemdetectdetroyneoplticcelleyprogdetectblemlignntcncerThprocelieTcellwhichcognizetummutti-derivednetigenpentedhumnleukocytentigen(HLA)moleculecellurfceultgtum-killgWhileHLAgenemgmotpolymphicgenevertebrtecludghumnocedeverlfectioudeecnlocerkuimmunyourplimrynlyuggetHLAdiveryfluencecncerrkThegolthpropoederchtudyctriiimmunogeneticefficiencytumimmuneurveillnceultimteeffecncncerrkOurplimrynlydemtrtenocitweenHLAhomozygoycedrkcncerlungcncerUglrgepropectivecohtdividuldeepgeneticphenotypicdtwevetigteltihipHLAdiverylungmelnomcncerrkterctiHLAimmunogeneticenvirmentlrkfcrAmucrcogenducedlungcncermodelfervlidticulywellmechnticightrpeutictrgetTheightgedetudiepotentillyimprovepdictivecncerrkmodelgermlecrrieruggettrtegieimmune-mededcncerpventiPROJECTSUMMARYThpropoldevelopgenerlizblemethodmkegeneticlly-encodedbioenmirdynmicbundncepoipecificpot-trnltilmodificti(PTM)proteThetrtegybedourpviouuccegenertgvidy-drivenbioendtcttypeubiqu(Ub)-modifiednucleoomeechencompdnucleoome-cognizgAnchUb-bdgUBDdomLkerdevelopedmximizeffypecificyFUb-modifiedproteprticulrdevelopmentntibodiee-pecificdetectigenthennioulydifficultOurgolextendvidy-bedtrtegyengeerenbledetecthetrctblemoleculrtrgetuchmultiplefunctillydtctUbignlfoundnucleoomeToccomplhthourtemdeveloprtilprotedeigntechnologyembrcemulti-vlentbdgtunblemoleculrflexibilyInAim1wedeigntetLkerdelivertunbledomgeometrymotiWedptnewmche-lernglghmdeignfuiprotefixctuentAnchUBDdomcmtilpcemximizevidypecificyFurrmoweexplotwewpprocheexpAnchperibrodenpplicbilyvidytrtegyInAim2wedoptplFASTfluogenytemtlltrnferrbleAnch-bdgtgubtrteInAim3wedevelopcumizedAnchyet-dplyDARPlibrryTheefficcyutilynewenevlutedvrocellwheyuedproignlgocedDNAdmgepirpthwyInAim4weteptimizecdiueengenomicpplictiuchCUT&RUNyThegentwedevelopthprojectllowercherproweviblelive-cellproceedifficulrimpoibleimgeextgtechnologieOurnovtivepprochdictlyddechllengebdghighlyflexiblemulti-domprotetrgetAuchultgtechnologydeignwkflowfdpplictidivereubiqutedtrgetmogenerllybdgtrgetwouldwecceibleduehighflexibilyProjectummryBRCA1BRCA2fcilteDNAdouble-trbk(DSB)pirvihomologoucombti(HR)YetBRCA1/2tenmuttedcnceruchbt/ovrin/protte/pncticcrcomBRCA-deficientcncercelleHR-defectiveuceptiblegentduceDNAdmge/pventDSBpirFtncePoly-ADPriboepolymere1(PARP1)hibir(PARPi)pfentillykillBRCA-deficientcncercellpprovedttHR-deficientcncerHoweverly~60%ptientpdPARPidrugtncemjproblemThudevelopgecd-genertipcimedicetrgetHR-deficientcncer/overcomePARPitnceurgentlyneededDNApolymeret(Polq)DNApirfcrimptntmicrohomology-mededend-jog(MMEJ)DSBhencentlyvlidteddruggbletrgetBRCA-deficientcncerPolqeentilBRCA-deficientcncercelldpenbleBRCA-pricientcellPolqnullmiceexhibnomjphenotypeRecentlyptedPolqhibir(Polqi)howedpfentilkillgBRCA-deficientcellYeteerlytgehibirhveignificntdeficiencie(iepoADMEPKprmeterlowpotency)whichmylimirefficcyclicltudieWehvedevelopednovellbiovilblePolqiexhib51nMIC50gtPolqpolymere(Polq-pol)electivelykillBRCA-deficientcellexhibtterphrmcoketicthncentlypublhedPolqiOurcollbtivetem(PomerntzJohnChilderlb)plnfurrimprovedemtrtepro--prcipleournovelPolqipotentillyt--clPolqidevelopgfollowgAim1OptimiztiPolqiviprodrugtrtegy2BiochemiclcellulrchrcteriztiPolqi3InvivoefficcyoptimizedPolqiBRCA-deficientolidtumWeexpectuccefulcompletieAimenbledevelopmentpotentillyt--clPolqiprodrugcidteProjectSummry/AbtrctMetbolicprogrmmghllmrkcncerpromptgmoleculrmechnmpromotetumurvivlgrowthtncettmentTherpeutictrgetgtummetbolmelievedpromgvenuecncerttmentTofurrdevelopmentmetbolm-trgetedcncerrpymomtineededccerngheterogeneytummetbolmhowtumtypetgetum/ptientchrcterticdetermemetbotypetumAlthoughpubliclyvilbleourceextgenomicproteomicdtuchTheCncerGenomeAtl(TCGA)HumnProteomeAtl(HPA)nouchdtbeextcncermetbolomeReourcelikeTCGAHPAhvecomecnernecncererchmkglckcncermetbolomeourceglrgomiprticulrlycemetbolomiccidedomiccloetphenotypeWepropoecteHumnCncerMetbolomeAtl(HCMA)collectgmetbolomicdnnumerouptient-derivedtummkgnopen-cceourcecncercommunytterundertrolemetbolmcncerInAim1wenlyzelrge-clecollecti(>2000)ptient-derivedxenogrft(PDX)ugmpectrometry-bedmetbolomicWeobtePDXNCIptientderivedmodelpoiry(PDMR)ChrleRiverLbryCrownBiocienceEchPDXmodelhldyenchrcterizedRNA-equencgwholeexomeequencgcomewelthptientmti/metdtInAim2weevlutehowmetbotypePDXvrybedgeneexpiptternpencemettticdeeurvivloutcomeUgcombtiunivremultivrepthwynlyeweuncoverkeyrolecncermetbolmeproceewhichpectcncermetbolmctrieheterogeneycroptientFllyAim3wectepublicourceHCMAugNtilMetbolomicDtRepoiry(NMDRloknownMetbolomicWknch)RwproceedmetbolomicdtuplodedthourcelgocedptientmetdtextggeneticdtfciltedtmgdcoveryeftpermedoutidevetigrExtgdtnlymoduleNMDRcludgunivrenlymultivrenlypthwynlymetboleclnlytegrtedHCMAmkemetbolomicdtcceibleeilynlyzblevetigrThourcectullybuiltupfutupropolexpHCMAprovidepowerfulourcenewdcoveriecncerbiologyrpeuticPROJECTSUMMARY/ABSTRACTChricmyeloidleukemi(CML)myeloprolifertiveneoplmdignoedbout5000Americnechyerchrcterizedpencet(922)PhildelphichromoomeproteproductBCR-ABL1tyroekeleukemiccellCurntrpyCMLcentedtyroekehibir(TKI)uchimtibmeyltewhichcnducecygeneticmoleculrmimotptientwhenjoynmlge-djutedlifeexpectncyThclicluccelednetimtedpvlence~200000CMLptientUSyer2050ttendntdrugcot>$10billicncludeburdenomeout--pocketpymentptientInddiTKIcnhveubtntilideeffectomewhichpotentillylife-engAccdglycentefthveenmdepTKIrpyCMLptientwhohvechievedmoleculrmiAbouthlfuchptientexperienceprogivemoleculrlpefollowgTKIppgburhlfeirmmoleculrlyundetectbleexperiencelow-levelcurncedoenotprog(collectivelytermedttment-femiTFR)uggetgbiologiclmechnmlimbilymllnumrleukemictemcellexpcuedeeTheemechnmnotunderodpentmjunmetneedcurntCMLerchwedothvevlidtedpprocheceproptiCMLptientwhoeligiblepirTKInceproptiptientwhocnmtTFRThpplictieekddeunmetneedexplognewlydevelopedCMLmouemodelTFRInthmodelhempoietictemcell(HSC)nextgcdildoubletrngenic(dTg)mouemodelCMLtrnplntedcipientcgenicB6miceoutuecdigrdiTheultgmrrow(BM)chimerctcledTgHSCbckgroundnmlBMpentgphyiologiclmodelerlyCMLMicerglrge(>10%)cledTgHSCunimlydevelopCML-likeleukemiwhenBCR-ABL1expiducedmicemller(<2%)dTgcledotdevelopCMLtedexhibfluctutglowleveldTggrnulocyteperipherlbloodmimicTFRThepropoedprojecttetwhertwodtctproceecogene-ducedplictivetBMmicroenvirment/nichevolvedbilyhotctrolmlignncyAim1tetwhercogene-ducedplictivetvolvedcptglo--functimuttip19ArfgenedTgdcellAim2tetwherelementBMnichecludgimmunecellcykequiddeectrolAim3trnlteefdghumnCMLBMmpleugptilmcymetrydefepogrphyCMLnichecltethTFRoutcomeTheeultyieldimptntnewknowledgeboutpthophyiologyTFRhouldmotivtenovelrpeuticpprochecefquencydurbilyTFRCMLptientProjectSummryAdolecentyoungdultcncerurviv(AYAge15-39yer)nimptntunderervedgrouptrkignificntfncilhrdhipThenerly90000newdignoecncernnullyAYAnerly680000AYAcncerurvivlivgUnedStteFive-yerurvivlrtemgAYAhigh(>80%)AYAhvepproximtely3559yerlifeexpectncymgcludg2540yerproductiveemploymentpidwkceUntuntelyAYAcncermyhvedequteurncecovergelimedfnciletexperienceignificntwkterruptiledggterfncilhrdhipdurgfterttmentThuAYAcncerurvivtgterrkfncilhrdhipthnAYAouthrycncerInterventiddfncilhrdhipextfewddAYAuniqueneedourknowledgenedddetermntfncilhrdhipwhichlietmultiplelevelAtdividullevelAYAlckfncilhelthurncelercyArgniztillevelementAYAeligibilyfncilupptourcehphzrdccefnciltnceprogrmuncodtedCHAT(LetCHATbouthelthurnce)progrmdeignededucteAYAboulthurnceLeengImpctFncilToxicy(LIFT)wdeignedytemticllyecncerptienteligibilycodteccefncilupptourceToddmultileveldetermntfncilhrdhipmgAYALIFTmutcomdCHATCombgCHATLIFTmylofcilteimplementticommuny-bedettgwhemotAYAceivecncercyetourcequidimplementnewterventilimedThpropolpdNtilCncerIntuteclldevelop/tetterventilpprochepvent/migtefncilhrdhipdividuldignoedcnceregfluencemultilevelfncilhrdhipterventiAYAhelthurncelercyfncilhrdhipWepropoefollowgpecificim(1)ToynizeCHATLIFTcteFFnterventidduniquemultileveldetermntfncilhrdhipmgAYAttedcommunycologyprctice(2)cductromizedctrolledtril(RCT)FFmultilevelterventiddfncilhrdhipmgAYA(n=408)(3)developguidnceimplementgFFtetedfutuhybrideffectivene-implementtrilThtudyfirtlwldefficcytrilmultilevelterventiducefncilhrdhipmgpenttivegeogrphicllydiverempleAYAttedcommunycologyprcticeStudyultguidefutueftcleupFFdivereettgwheAYAcncerurvivervedProjectSummry/AbtrctWehowedferdoxducte(FDXR)michdrilflvoproteducedDNAdmgep53-dependentmnnergultepopducedctiveoxygenpecieAlyhumnferdoxducteFDXRceivetwoelectrNADPHtrnfermettimecognteubtrteferdox1(FDX1)FDX2ubequentlyplyrolebiogeneteroidirulfurcluterproteDepeewell-defedbiochemiclfunctiroleFDXRtumuppitillpolyunderodIntetglycenttudiehowedFDXRmotctentcuteenfollowgDNAdmgeuggetgFDXRplyroleDNAdmgepepirIndeedourpilottudiehowedFDXRloexpednucleugultecellgrowthurvivlpotentillyvinuclerubtrte(p53Mdm2Mdm4)petTheeobervtipromptuhypoizenuclerFDXRhcriclbiologiclfunctumuppiTofurrtetwopecificimpropoed(1)TodetermehowFDXRubcellulrlocliztigulted(2)TodetermehownuclerFDXRexertbiologiclfunctiPROJECTSUMMARY/ABSTRACTRecentdvncetrgetedrpiehveprolgedurvivln-mllcelllungcncerptientHoweverlungcncertillmledgcuecncerdethUSwldwide5-yerurvivlrten-mllcelllungcncerdml24%Fmnytumdrug-trgetblemuttinotidentifiedlimgrpeuticoptichempyimmunecheckpothibirFthoedohveidentifieddruggblebiomrkeruchEGFRmutticquidtncener-univerlproblemTomkeprogextendglungcncerptienturvivlneceryidentifynewtrgetydthoecurntlyknownGenome-wideCRISPRknockoutcencglyuedidentifynewcncerdrugtrgetHowevereytilluffermjlimtigle-geneknockoutgenerllydotvelfunctigenefmiliehvedundntfunctiuchprlogRemrkblynowclerprlogougenectutetwo-thirdhumngenomeothbldpotppercovermuchgenomiclcpeTofullyterrogtefunctillhumngenewedevelopgdeploygnewmethodmultiplexedgeneknockoutInddimeduplictimkeprlogdifficulttudycouldloprovidenewpotentillycumizblepprochecncerrpycederngedgenometypiclcncercellcommlyhrbdeletictivtgmuttiemoprlogWehypoizetrgetgctivelyexpedprlogcncerhveloruppedprlogoupircouldcteynticlethln-cogenedependencyrpeuticwdowkillgcncercellHewepropoeovercomemjbrrierimpedgdevelopmentpplictinewynticlethlrpieFirtwebuilducceourprlogwkcefirtubmipermgrpidefficientytemticknockoutynticlethlprlogcromultiplecelltypeSecdwepplyournovtiveprlogPerturb-eqpprochdetermewhtprlogundergotrncriptildpttiLtwedevelopproducibletwpermnlydulgRNACRISPRcenenblgbroddptiourmethodgeneticterctimppgwhichmygoydprlogUltimtelyourfdgdelivernewcncertrgetcnueddevelopdeploynewrpieTheimpctthprojectidentifictidozenhunddnewprloggeneticterctidemtrtiomeecnhrneedupptumgrowthdrugtnceDuelownticiptedf-trgeteffectynticlethlrpieecouldppliedcombtiwixtgtrgeted-immuno-chemo-rpieuppdrugtnceimproveptienturvivlPROJECTSUMMARYIncedglucoeftmetbolmeentiltumprogiRecentwkhowedcold-ducedctivtibrowndipoetue(BAT)uniquedipoetuewhichproducehetviglycolyftmetbolmuppedtumprogieverlcncermouemodelduecompetiglucoeftourceWhedipoetue(WAT)nendoctuefunctimenergyrgegnourbodyrglipidectghmegultevrioubiologiclfuncticludgppeteglucoeftmetbolmulhemotItcommlyuedcliclproceduuchlipouctifttrnplnttiplticurgeryThuWATcoulddilyuedcellulrrpyHewepropoehowceutilythpprochwhichwetermAdipoeMnipultiTrnplntti(AMT)cncerrpyWeplnbioengeerWATdipoegnoidcomemoBAT-likewhichceirglucoeftutiliztilghvgcedglucoeuptkeftrgeThdeugCRISPRctivti(CRISPR)upgultedgenevolvedBATfunctiglucoeftmetbolmOurplimryultldyhowco-culturgCRISPRengeedBAT-likedipocytefivediffentcncercellleuppeirgrowthFurrmoimplntgengeeddipoegnoidxenogrfttwocncergeneticmouemodel(btpnc)ignificntlyducecncergrowthFllyengeergdipocyteeightdiffenthumnbtcncerptienturgicllyectedtueco-culturgmcncergnoidignificntlyducedgnoidgrowthHeweplnbuildeultWeengeerdipocytegnoidhvecedglucoeftutiliztiupgultgcombtigenenlyvolvedbrowngloglucoeftmetbolmglucoetrnpttetirbilyducecncergrowthvrioucncercellmodel(Aim1)WelotetbilyeCRISPRgenecombtidipoegnoiduppcncerxenogrftcncermodelvrioucellle(btcolpncprotte)everlgeneticmouemodel(btpnc)(Aim2)Fllyfurrdecttrnltilpotentilthpprochweueurgicllyectedtumtuebtcncerptientolteengeerirdipocytenco-cultumirpectivetumeirrpeuticpotentil(Aim3)Thdecrofullpectrumhumnbtcncertgecludgdiffenttgebtcncer(djuvntltecurncemettchllengg--ttbtcncerubtypeBRCAmutti)ComdthprojectdevelopnovelCARTlikerpeuticpprochttcncerutilizgbioengeeddipocytehvgtmendourpeuticimplicticncerttmentPROJECTSUMMARYBtcncermotcommcnceryoungerwomen(50yerttimedigno)whocomppproximtely19%cidentbtcncerceImprovedurvivlfterbtcncerdignohfocuedttentiimpctdeettmentlg-termoutcomeyoungerwomenStudiehvectentlyhownyoungerwomenhvegterpychologiclphyiclmbidyfterbtcncerthnolderwomenge-mtchedwomennocncerhrycludgelevtedleveldepiDepihenlkedttmentn-dhencepdicthtercurnce-feoverllurvivlwomenbtcncerhighlightgclicllevnceYoungerbtcncerurvivlopthighlevelftigueomnivomympmcncer-ltedtmypertyerfterdignocugignificntimpirmentqulylifeThecriclneedeffectiveclbleterventicnducedepienhncelg-termurvivhipthvulnerblegroupTomeetthneedwecductpheIIIromizedclicltriltetgtwewdiglveribriefmdfulneterventideignedyoungerbtcncerurvivThtudyccepthenpeer-viewedendedNtilCncerIntute(NCI)NRGOncologyNtilCommunyOncologyReerchProgrm(NCORP)whichimplementtudyprocolthroughnetwkcommunyclicleenurgbroddiveregroupprticipntTheMdfulAwnePrctice(MAP)terventihdemtrtedefficcyducgdepiimprovgphyiclpychologiclwell-gyoungerbtcncerurvivwhendelivedpergroupWehvedevelopedpilottetedtwodiglveriterventiedelivedlivelegroupoverZoomnexperiencedtrucr(MAPlivele)delivedvipilly-producedpp(MAPApp)Wehypoizebothdiglterventieffectiveducgdepiveympm(primryoutcome)improvgphyiclpychologiclympmwkproductivy(ecdryoutcome)tpot-terventiover6-mthfollow-upltivemedtilyctrolgroupInddetgefficcyweevlutecot-effectiveneeprogrmwhichcriclpymkecovergedecihelthcprovideremployermkedoptideciptientmkeprticiptideciWelocollectimplementtidttudyemfutudemtieftFllyweexplopotentilmedirmoderrterventieffectdetermehowepprochewkwhomwhichfciltetrgetedterventideliveryctentthoemotlikelynefPROJECTSUMMARYTheptdecdehwneedbkthroughcncerimmunpycheckpothibirdoptiveTcellrpienewpillrourrmmentnti-cncerdrugnowextHoweverourcurntrpiebedpmedptiveimmunylemededctivtedTcellcnelimtetumWhilegenertinti-tumTcellprmountmnyddilfcrmutcidednimmunepecludgccerpieolidtumrolenteimmunyuppivetummicroenvirment(TME)Microbil-bedcncerrpiehvepotentilddgllechllengecnimpedeucceimmunpyThpropolbedextenivepcliclcliclexperienceugnttenuted(DctA)trLterimocygenerpeuticcncervcceInthpropolwefocudictimpctLmocygene(Lm)hpgimmunephenotypeTMEWefdjectiLmtrtumlly(IT)ultproundchngeTMEcludgductiTgwhichwetrcectivtiTLR2SurprglybcterijectedIVloloclizetumwhilebcteriliverpleenelimtedbcterijectedbothITIVpertdefelytumlthoughneirttmentultductumvolumeHowevermicepvioulyimmunizedLmfollowedITjectidrmticllyducetumburdenwhichwehowquiCD8+TcellBedourplimrydtwehypoizeLmjectedeirITIVloclizeperttumceflmmrymilieuUppriimmuniztifluxLm-pecificCD8+TcellmedeclerncebothmgbcteriubtntilhrkgetumlthoughmechnmmdetermedCollectivelyedtvelimptncebothntedptiveimmunymedgproductivepetumAProjectSummry/AbtrctOvrincncerecdmotcommcuegynecologiccncerdethwomenroundwldHigh-grdeerouovrincncer(HGSOC)ccountmothn70%llovrincncerdethApproximtely50%HGSOChrbltertigenevolvedhomologoucombti(HR)DNApirpthwyTheetumtendpdwellPARPhibirchempyCCNE1(CyclE1)genemplifictiovexpifquentlyfoundHR-pricienvrincncerocedprimrychemotncepoclicloutcomeCCNE1genemplifictipent15-20%ovrintumovexpiCyclE1detectedover40%ovrincncerpecimenCurntlynoeffectivettmentpprocheypeHGSOCByugCyclE1-ovexpgyngeneichumnizedovrinptient-derivedxenogrft(PDX)modelHGSOCweidentifynovelrpiettmentHGSOCcncermplifictihighexpiCyclE1OurplimrydtuggetCyclE1downgulteIRF1typeIterfer(IFN)expiCDK2ke-dependentmnnerovrincncercellOurplimrydtlovelthvexpiCyclE1ovrincncercellpromotepro-tumpolriztum-ocedmcrophge(TAM)tummicroenvirment(TME)ExpiIRF1typeIIFNhenimplictedpro-tumpolriztiTAMcncerWeplnvetigtemoleculrmechnmunderlyggultiCyclE1typeIIFNignlgpthwyTAMCyclE1-mplified/ovexpgHGSOCtumdeveloprpeuticpprocheypeovrincncerWehypoizedowngultiIRF1typeIIFNCyclE1tumcellfoternimmunouppiveTMEHGSOCCyclE1-mplificti/ovexpipromotgpro-tummcrophgepolriztiWelohypoizetrgetgcventiltumcell-triccogenicfunctiCyclE1CDK2i(CDK2hibir)ATRi(AtxelngiectiRd3-ltedhibir)combtimodelgpro-tumTAMducedexpiCyclE1TMEimmunomodulruchSTINGgtprovidepromgrpeuticovrincncerptientCyclE1-mplificti/ovexpiInAim1wedetermehowcyclE1gulteIRF1typeIIFNbothhumnmoueovrincncercellleInAim2wedetermehowCyclE1-gultedtypeIIFNignlgpthwypromotepro-tumpolriztiTAMimmunouppiTMEHGSOCtumCyclE1-mplificti/ovexpibothvrovivoInAim3bedourcentfdgSTINGgmctivtetypeIIFNignlgpthwypolrizepro-tummcrophgennti-tumttuweerpeuticefficcyxicySTINGgtcombtiCDK2iATRibothyngeneicmouemodelhumnizedPDXmodelPROJECTSUMMARY/ABSTRACTDeerulgrulg-ourrulg-mobjectivecncerdignoidmedicldecimkgTkgprottecncerourprimryexmplettmenttermedehighrkerlytgeprottecncerhhownurvivlnetnotolowrkcncerMenwhileprottecncercen-gviprotte-pecicntigen(PSA)tetghledexceunneceryprottebiopieover-detectilowrkcncerNewtrtegieurgentlyneededdignogggivecncerwhilevoidgun-neceryprottebiopieover-ttmentdolentcncerRulgourrulgggiveprottecncertvriouclicldecipotptientcthueentilHoweverlckrobutn-lyticfrmewkmethodologydeerulgemjrodblockToddthpgnlyticneedthprojectdevelopnovelpermncemetricdictlytiedcliclutilyoetblhnnlyticprdigmdeerulgFurrmobutefcientttticlcomputtilmethoddevelopedmultiimultneoupermnceetimtimultiplexdignoticruleFivepecicimpuruedAim1focucceptuldevelopmentpropoednlyticprdigmwelldeerulgmethodglepdicrAim2ciderdeerulgmultiplepdicrwheepdicrcomdvitrdprocedueglogticgiAim34vetigtemultiplexdeerulgviempiricloptimiztilerBoolenclepectivelyAAim14trgeteirrulg-ourrulg-Aim5vetigteimultneourulg-outrulg-TheepropoednlyticmethodthoughlyvetigtedthroughrigouymptictudieexteniveimultiTheyppliednumrourprottecncerbiomrkertudiewhichmotivtedthprojectNtilCncerIntuteErlyDeeReerchNetwk(EDRN)Uer-friendlycomputertwmdevilbleerchcommunyTheepropoedmethodfciltemoeffectiveclicllylevntdignoticerchcncerwelldeePROJECTSUMMARYAlthoughimmunecheckpotblockde(ICB)hcometrdcncerrpymotptientcludg~70%thoen-mllcelllungcncer(NSCLC)filpdICBAccumultrnmggrowthfcr-(TGF)tummicroenvirment(TME)cndriveimmunedyfunctiducggulryTcell(Tg)hibgeffecrCD8+TcellultgICBtnceHowevergivenpleotropicmultifunctilntuTGFytemichibihenclicllychllenggmultipleideeffectThudevelopgtrnltblepprochehibTGFTMEprmountimptnceGlycoprote-Apetipdomnt(GARP)encodedLRRC32cellurfcen-ignlgdockgctivtgceprltentTGFhighlyexpedcncercell(cludglungcncer)ctivtedTgplteletWedcovedgeneticdeletiLrrc32Tgplteletenhncedprotectigtmouemodelflmmti-ocedcoloctlcncercolcncerWevlidtedGARPrpeutictrgetgenertgmocllntibodygt(clledPIIO-1)PIIO-1dimheTGFignlgTMEpecificllydueelectivebilycognizeGARPTgnotplteletTotettrnltilcpcyPIIO-1wegenertedhumnLRRC32knock-moueglobllyplcemuextrcellulrcompentGARPhumnequencethllowutudyfetyefficcyPIIO-1mumodelWefoundPIIO-1hglegentctivygtmultiplecncermodelcnpromoteCD8+TcellfunctivivoevidencedducedCD8+TcellexhuticedCXCR3+CD8+TeffecrfunctiTMEProlgedexpouPIIO-1didnotducepltelet-ltedxicyFllywefoundPIIO-1improverpeuticefficcyPD-1blockdegtmumodellungcncerGiveneexcgdcoveriewehypoizedruptgGARP-TGFxTMEugournti-GARPntibodyPIIO-1ugmentnti-tumimmunyCD8+TcellovercomeICBtnceptientNSCLCWetetthhypofollowgpecificimAim1DefehowGARPhibCD8+TcelldiffentiprogrmmgeffecrfunctiTMEAim2EvlutechrcterizePIIO-1nimmunpeuticgentgtpcliclmodelNSCLClecombtiICBupptdevelopmentipotentillyt--clnti-GARPntibodypheIclicltrilThtudyddroleournovelnti-GARPntibodyrpeuticefficcygtNSCLCelucidtemechnmwhichgulteCD8+TcellprogrmmgeffecrfunctiIthpotentilovercomerkocedytemichibiTGFpthwyproducenovelgentcncerimmunpyProjectSummryFbtcncerkeletlmettemjourcepdbilymtlyoceddeeprogiAolidtummettizgbtcncerdplytrikgtropmvertebrlpproximtely2-5vertebrlmetteeveryelgmettimplygvertebrl-pecificfcrkeydrivermettPivebloodflowcnnotexplcedmetttictropmvertebrlverulgdictguncognizedbiologicfcrlikelydrivehighrtevertebrlmettobervedclicllyWehveheidentifiednewkeletltemcellpiblegenertgoteobltmerlizemodelverteb(vertebrlkeletltemcellvSSC)provideevidencethcellmjdetermntvertebrl-pecificpthologycludghighrtevertebrlmetteobervedclicllyEvenfternmlizgllnmicfcrthroughuevivognoidvSSC-derivedtuecruedtumcellmoefficientlythncomprbletemcelllgTrgetglo--functivSSCugmouecledevelopedthprojectelectivelyducevertebrlmettrteInbothgnoidytemntivevertebvSSCdrivehighrteilvertebrleedgtumcelldictgvSSC-driventropmmjctrigfcrhdhighvertebrlmettticrteobervedbtcncerBuildgupthobervtiwehveidentifiedcidtetrophicfcrexpedvSSChvegenertedevidenceimplictgpecificvSSC-derivedfcrvertebrlmetttictropmoutgrowthHewepermkeytudieneededdvncerigunderlygmechnmclicllevncetrnltilrpeuticimpctthdcoveryFirt(Aim1)weetblhmettticfunctithvSSCntivevertebrlenvirmentcludgvetigtghowvSSCmygnizeentivertebrlmettticnichewhichvSSC-derivedcelltypectriemettNext(Aim2)wehveidentifiedcidtevSSC-derivedmedirdrivgmetttictropmhedetermehowecthfcrgultedhowignltumcellimpctmettLtly(Aim3)wedeveloprpeuticimpctthdcoverydetermgifhumncounterprtvSSCdplycervedmettticfunctixenogrftytemcductgpro--cceptrpeutictudieblockgcidtevSSC-derivedmettticmedirAlgerthtudyetblhnewtemcellpiblemgvertebdrivevertebrlmettefergnewmodelepecificykeletlmettenexplntihighrtevertebrlmetteobervedclicllynewrpeuticopptunieABSTRACTProgrmmeddeth-lig1(PD-L1)ceprprogrmmedcelldethprote1(PD-1)modultenti-tumimmunymjtrgetcurntcheckpotblockdeimmunpieHoweverclicltrilPD-L1/PD-1ntibodiebtcncerdtehvedemtrtedlylimedefficcyTheimptncebt-pecifictummicroenvirment(TME)gultgnti-tumimmunyvtlyunder-explodGivenbundncedipocytebttuewell-documentedocitweendipoybtcncer-ltedmtlyemerggoyprdoxnticncerimmunpyimpertivevetigtemoleculrunderpngcomplexdipoe-immune-tumnetwkdipocyte-richbtTMEWecentlyidentifiedpvioulyunppcedfunctillyignificntourcePD-L1whedipocyteAdipocytePD-L1mrkedlyduceddurgdipogeneoy-ltedchricflmmtiUgndipocyte-pecificknockoutmouemodelwedemtrtenimptntroledipocytePD-L1promotumgrowtenutinti-tumimmunyFurrmoourplimrydtdictephyiclfunctilterctitweenPD-L1lipidmetbolm-ltedprotepthwydipocytewhichuggetndipocyte-tricfunctiPD-L1BedourplimrydtwehypoizedipocytePD-L1impedenti-tumlymphocyte/ttumcellthroughlipidmetbolm-ltedmechnmWefurrpropoethctidipocytePD-L1prticulrlyimptntttummrgimmune-excludedtumwhedipocyteproximyboumimmunecellWecomouretblhedolexpertecncerbiologytumimmunologytrncriptilgultivlidtethnovelhypothroughfollowgAim(1)DeletehowdipocytePD-L1mededipoe-immune-tumcrotlk(2)DetermehowdipocytePD-L1expigulted(3)DetermehowdipocytePD-L1impctimmunpyoevn-oehotOurtudiedipocytePD-L1ignlglipidmetbolmprovidenewmoleculrexplntiPD-L1ctumimmunologyclerdeprtupvilgprdigmgrdgtum/immunePD-L1ctiThpropoedwkpentcceptuldvncewrdundertgptillcpebtTMEimmunegultumigeneclicllylevntyetmechnticllyunder-explodproblemOurultcouldlyolidfoundtidevelopgnewolpdictenhncerpeuticpePD-1/PD-L1immunpybtcncerptientepecillythoeoyPROJECTSUMMARYTheneurocogniveideeffectcncerchempypedricptienthert-bkgnlymutechildndelhrdhipdeehrhttmentytenlofceneurocogniveimpirmentffectirpermncechoolirdilylifecncerurvivTheebrxicienmedchemobrChempy-ltedCogniveImpirment(CRCI)cludeimmedeympm(cfuimemyimpirmenttxi)wellprolgedneurocognivemlfunctiTHEGAPINTHEFIELDNotenoughknownboutmoleculrmechnmchempy-ducedxicySpecificllymetbolicrrtibrenuefollowgrpymetbolicdruguchnti-folteMTXtrdcchildhoodleukeminunexplodfieldTobleferolutichempy-ducedneuroxicycriclfirtundertmoleculrmechnmxicycuedcommchempieTheeTHEGOALOFTHISPROJECTelucidtetrgetblemechnmmedemodifychempy-ducedneuroxicyfocuoxidtivedtHYPOTHESISAgoodundertgmoleculrmechnmCRCIquidbleferpventivecttmentPRELIMINARYDATAWeppliedmetboleprilgMTX-ttedmouehumncebroplfluid(CSF)tudymetbolicimpctdrugveledoxidtivedtCSFchoidplexu(ChP)gnproduceCSFWefoundddidmggChPCSFMTXlocuedxicyneurhippocmpuHoweverefdgferomehopeCSFcnervecdurpycueltivelycceiblecliclterventichellprtbrIndeedourdcoveryMTXttmentcueductiCSFlevelectedntioxidntenzymeSOD3bothmiceMTX-ttedptientledutetCSF-bedrpyChP-trgetedgenerpyexogenouSOD3expiplenheCSFprotectivecpcypventgmetbolicdmgehippocmpuevencueMTX-ducedhvildeficmiceAPPROACHWeteurhypoChP-CSFytemcnhrneedlterbrdoxenvirmentducedvereeffectchempyn-cnceroubrcellegmechnmwhichCSF-SOD3protecthippocmpuMTX-ducedxicy(Aim1)tudygrolenricoxide(NO)peroxynreMTX-ducedoxidtivedmgeChPcellneur(Aim2)tetgifumgoxidtiveblnceCSFcnchievedperipherlbr-pecificjectintioxidntwhereufficientmigteoxidtivedmgeChPhippocmpu(Aim3)IMPACTOurtudyvelctibleolmigteneurologicldmgeducedMTXchempieimmedepotentilntioxidntco-dmtrtichempymeliCRCIimprovedurvivhipProjectSummryOnlymicrotelletbilyhigh(MSI-H)humncoloctlcncerwhichccount10-15%llhumncoloctlcncercepdPD-(L)1blockdeimmunpyThevtmjy(85-90%)humncoloctlcncermicrotelletble(MSS)ubtypedoenotpdPD-(L)1blockdeimmunpyPD-(L)1blockdeimmunpywkthroughblockgPD-1functictivtecyxicTlymphocyte(CTL)ThectivtedCTLntrgettumcellctivtedethpthwyducetumcelldethTheetwofcreentilefficcyPD-(L)1blockdeimmunpyCTLmutctivtedtrgettumcellmutenivecelldethductiHumncoloctltumcellepecillymettticcoloctltumcellhighlytntcelldethductiLertuourpublheddtdictelthoughMSI-Hhumncoloctlcncerhhighleveltum-filtrtgCTLCTLlopentMSShumncoloctlcrcomOurpublheddtfurrdetermedtum-filtrtgCTLfunctillyimpidhumncoloctlcrcomSUV39H1hne3lye9(H3K9)e-pecifichnemethyltrnferectlyzeH3K9me3LertuourplimrytudiedetermedSUV39H1-H3K9me3epigeneticxpebothdethceprFASexpihumnmettticcoltumcellGzmxpicoltum-filtrtgCTLTotrgetSUV39H1-H3K9me3xwehvedevelopedmllmoleculeSUV39H1-electivehibir(termedF5446)WedetermedF5446effective1)decgH3K9me3depoFASpromotermetttichumncoltumcellcetumcellenivyFL-ducedcelldeth2)decgH3K9me3depoGzmbpromoterceGzmxpum-filtrtgCTLuppcoltumgrowthimmunecompetentmiceTochievetum-electivedeliveryimprovedfetyefficcywehvenowdevelopedexpnilennoprticleencpultedF5446(termedeNP-F5446)OurhypoeNP-F5446neffectivefegenvercomgcoloctlcncertncePD-1blockdeimmunpyThepecificimpuruechieveourobjective1)determetum/cell/ubcellulrlocliztrffickgbiodtriieNP-F5446yngeneicmouecoltumlivermetthumncolcncerxenogrftlivermettmodel2)cductphrmcoketicxicologytudieeNP-F5446tum-fecoltum-rgmice3)determeefficcyeNP-F5446overcomghumnmettticcoloctlcncertncePD-1blockdeimmunpyvivoTcellpelyTcellcepr(TCR)ntigenpecificyCD28ecdignlcdddilignlcludgcykecertTNFuperfmilycotimulryceprThelttercludeCD134(OX40)CD137(4-1BB)whichprovidepowerfulbootcllexpnieffecrCD8Tcellrobutcykeproductimetbolicfnemnyttriecludgpotentnti-tumcyxicyThemoleculrmechnmcotimulti-bedprogrmmgeffecrTcelllrgelyunknownInprticulruniquegeneigntuthproceydgenerlizedfcruchNFKBNFATuncleruggetgthrcriclproceehvegeundetectedOurcentpublheddthowedlymllnumrtrncriptilchngeftercotimultiwhichcouldnotexplpowerhdcotimultiAmjcehoweverpliceoomepthwywevidentwherthprocecouldhvepecificimpcneffecrTcellwunknownAnlyhowedpliceoomepthwyctedgroupRNAbdgprotevolvedlterntiveRNAplicgwhichhouldnotcfuedtedyttecotrplicgfcrAlterntiveRNAplicgcnmedeexkippgtrtentiproceegenertemultiplemRNAmglegenegtlyexpproteomecellWedemtrtedRNAbdgproteTrdbpplyedkeyroleeffecrTcellfunctiTheechngeTcellfuncticltedTrdbp-dependentexkippgIL-2pIKAROS(Ikzf1)mRNAerieRNAplicgeventmtudiedAim1exmehowTrdbpprogrmeffecrCD8TcellfunctiddgeffecrctiviecludetrgetcellcyxicypefectirolepecificcotimulrOurulttegrtedidentifictidictmRNAmgenertedTrdbpirpotentilfunctiAim2exmeecdRNAbdgproteTr2bnovelrolectrollgTcellpethroughctinultr-cervedpoexctedTr2btrncriptUgcombtinovtivepprochewetetifTr2bpoeximpctTCRenivyCD8CD4TcelldurgtumimmunyFAim3RNAbdgprotenetwkexhutedTcellededoptimizefunctrnltbilyOurpropoluecombtiilicocuttg-edgemethodbknewgroundundertghowlterntiveplicgthroughctiRNAbdgprotecnctroleffecrTcellprogrmmgInumnewundertgeffecrTcellirpotentilclicltrnltigedtherchPROJECTSUMMARYRecentdvncecncerimmunpiehvevolutiizedlungcncerttmentprdigmHowevermnyptientderiveltlenonefFDApprovedimmunecheckpothibir(ICI)Ahotclicltudiehvehownp-extgtum-ctiveTcellcricllyimptntchievenefICITheeugmentgnumrfunctilytum-ctiveTcellcouldpvewymoeffectivecncerttmentOncolyticvirue(OV)hveendevelopedirbilypecificllyplictecncercellledgcncercelllynotcyxicywrdnmlcellRecenttudiedictetimultihotnti-tumimmunylokeymechnmctiOVUgnovelcdillyplictivedenovirutype5expetwopowerfulnteimmunytimulrtudiepropoedhecnleddevelopmenthighlyeffectiveOV-bedrpeutictrtegiekilltumcellimultneoulyenhncennti-tumTcellpeEnggementCD40expeddendriccell(DC)CD40lig(CD40L)ledcquicrucilcro-primgfunctictivteCD8TcellMEM40chimericCD40LengeedtblecellurfceexpiInddipro-flmmrynti-virlfunctitype1IFNlofuncticrucilctivrDCOurpclicltudiemouemelnomlungtummodeldictetrleildmtrtiMEM40+IFNexpgcolyticdenoviru(MEM-288)wedevelopedducerobutytemicTcellpeynergyICIcpbleignificntlycurtilgbcopltumgrowthAkeyeffectCD40LIFNexpummicroenvirment(TME)wenhncementDCctivtimigrtidrglymphnodeduceTcellprimgTheefdgpromptedudevelopnovelcdillyplictivecolyticdenoviru(MEM-288)expemembrne-tbleCD40L(MEM40)IFNAphe1firt--humndoeeclticlicltrilglegentMEM-288nergcompletiwhilecombtrilMEM-288ICINSCLCptientexpectedgFll2023AprimrygoltudiepropoedhedefeMEM-288cliclctivyNSCLCptientbileimmunetimulryeffectMEM-288tummicroenvirment(TME)bilygenerteytemicnti-tumTcellpeTwoSpecificAimpropoedAim1DefgimpctuctivtiCD40type1IFNignlgDCTcellpetummodelAim2Impcncolyticviru(MEM-288)ducedCD40type1IFNignlgTMEmodelgytemicTcellpeNSCLCptientPROJECTSUMMARYHighSERPINB3biomrkerrdiotncepotentilrpeutictrgetcerviclcncerOurcentwkdemtrtedCRISPR-C9knockoutSERPINB3nhibirlyoomlproteeenizedcervicltumcellrdirpy(RT)-ducedcelldethInvivotrgetgSERPINB3iRNAnlyltedtummicroenvirmentignificntlyenizedSERPINB3-hightummodelRTImptntlyweetblhedtumcelldiedvilyopnewlydecridevolutirilycervedmodecelldehtdependentuplyoomlmembrnepermebilizti(LMP)lekgepotentproteecyplmSERPINB3-KOtumcellunderwentwidepdlyopwhenttedvrietycyxicgentchempieThuggetloSERPINB3expoedlyopdefultcelldethmechnmecellThemoleculrfetutumcelluceptibleRT-ducedLMPlyopunknownVlidtilyopleddictlytumctrolquidAddillymechnmthroughwhichRTduceLMPunknownNewunpublheddtuggetSERPINB3-hightumhvedtctmoleculrigntuchrcterizedenrichmentlyoome-ltedpthwyInecellLMPoccurofterttmentclicllylevntdoeRTwhilelyoomlruptuoccurdylterjutpricelldethFllywehveidentifiedcidtemllmoleculebdpecificllySERPINB3Thelg-termgolthwkdefenewttmentpprocherdiotntSERPINB3-hightumThpropoltethypotrgetgSERPINB3SERPINB3-hightumcellndermuceptibleRT-ducedlyopLMPgeventultunpidlyoomldmgeTheimpropoeddictlyddthhypoAim1DetermepdomntcelldethmechnmducedRTSERPINB3-hightumAim2Determemechnmrpy-ducedLMPledglyopAim3IdentifySERPINB3-trgetgtrtegiepecificllyenizetumcellnotnmlcellRTToccomplheimwepropoeueexvivognelle-bedpprochetep-wevrovivlycelldethmechnmledgtumctrolnnovtivep-cliclbrchyrpyytemwehvedevelopedmimicttmentdelivedclicSuccethpropolcfirmSERPINB3pdictivebiomrkerlyop-ducgCRTtrtegiegenertenewknowledgecricleventledgRT-ducedLMPcelldethprovidenovtiverpeutictrtegietrgetSERPINB3improveurvivlptientcerviclcncerugperlizedttmentpprochPROJECTSUMMARYWhileprimryerly-tgebtcncercurblemettticbtcncermclicllyignificntproblemRecentnlyecliclmplehvehowncedfiltrtiympticenynervefirmmmrytumphenomenknowntumnervtihighlycltedmettticpotentilbtcncerDepecenttetundertgbttumnervtitillextcriclgpfundmentlknowledgemoleculrcellulrmechnmbttumnervtiThegolthprojectddthgpknowledgetudygmetbolicgultibttumnervtiubequenteffectmettAwelthlertuuggetmetbolicdygulticouldfctlkedtumnervtiheightenedmettticpotentilFtncemetbolicwirgucherobicglycolyglutmeddicticncercellledchngetummicroenvirmentceectineurotrophuchnervegrowthfcrbr-derivedneurotrophicfcrwellpro-xogenicextrcellulrmtrixcompentDepeobviouimplictiblockgtumnervtiducemettticfquencyrpeuticpotentiltrgetgmetbolicwirgpventbttumnervticurbmetthnotyetencfullyevlutedTheewehypoizeerobicglycolyglutmeddictibtcncerpromotebttumnervtiledgheightenedmettToteurhypoweutilizeourtue-engeed3Dcultupltmhveenoptimized-houetudytumnervtiOurpltmcomptum-mimeticcollgenfirgniztibttummicroenvirment-mimeticdecellulrizeddipoetuemtriceNotblyourpltmcnmidlgudllyliveugopticldoximggdetermecelltype-pecificmetbolicchngecltinervtiWeevlutelktweenmetbolicwirgtumcellheightenednervti(Aim1)mettticpotentilbtcncercellfunctimounttumnervti(Aim2)Aim3focunlydeidentifiedptientmpleprimrymettticbttumunrvelocimgmetbolicprilenervticliclmettticoutcomeMechnticightgedviphrmcologiclhibigeneticdeletitrgetmetbolicenzymeneurotrophceprOutcomeourerchmylednlyknowledgegcltimgmetbolicwirgnervtimettloveltrtegiecurbmettticbtcncerprogiverfencedygultedcellulrmetbolmnervtiImptntlyourpltmcnbrodenedtudymetbolicgulticncer-nervecrotlktypen-neurlcncerprovenmlignntctriinervevumnervti(eglungpnccoloctlhedneckketc)PROJECTSUMMARY/ABSTRACTChromoomltrnloctioccurnerlyllhumnlymphoidneoplmmnyultrrntpirDNAdouble-tbk(DSB)genertedp-BcelldurgV(D)JcombtiInthpthologiclproceunpidV(D)JDSBducedtIgHlocujoecdn-IgHDSBgenertetrnloctiThen-IgHDSBoccurnunknownmechnmpentgeriouknowledgegpThertilethprojectroectiequencgdtbecompoedDNAtrnloctibkpotjunctimppedover2000humnptientcovergmotBcellmlignncieThnlyuncoved6n-IgHhumnfrgileze(HFZ)rnggize20-600bpwheDSBenrichedup1000-foldcompdurroundgDNAHFZDSBccounthlfllhumnBcellcncerbkp-BcelltgedevelopmentccurntV(D)JcombtiBuildgfoundtipviouwkcentrlhypothefcrcriclHFZDSBlymphoidcell1)Fmtigle-tdDNA(DNA)tructutHFZultgrilt2)Expictivti-ducedcytidedeme(AID)trgetDNActemmtchedDNAlei3)Pencenctivtedmtructu-pecificArtemenducleecleveeleigenerteHFZDSBTheoverllobjectivethpropol(1)UtilizediglPCR(dPCR)DNAequencgyquntifyDNADSBmtHFZundercdielucidteHFZDSBmechnm(2)howhowlopoomerefuncthroughphrmcologicgeneticbltienhnceHFZDSBmtiThecentrlhypotetedpurugthepecificim1)TodetermehowrilttbilizeDNAtructutHFZ2)TodetermeroleAIDHFZDSB3)TodeletehowArtemduceHFZDSBThenovtivepecttherchhumnptientdtwuedourcedemtrtemnyBcellmlignnceultn-romDSBtdcet20-600bpHFZhumnp-BcellleprimryhumncelluednlygeneticyuedcnquntifydelultgDSBmtipirhumnp-BcellleptientmterilThwkignificntdefeunifiedmechnmmnyBcellmlignncevolvgmultipletepechwhichcnffectedndividulgeneticlifetyleReultthpropolwouldpentignificntdvncementwrdpdictgdeehigh-rkpopultitilgttmentdividulFurrmoourycnppliedclicquicklydignoedeegenometbilycompentmirptientpettmentpotentillpeOverllultlederlydetectiprimrycncerpventiecdrycncernoverllductimtlyProjectSummryCncerterrifygdignoepecillychildyetthnkgtdvncettmenturvivlrtehvecedteeplyFCNS/brtumleukemwhichgerccountmjypedi-triccncerepoiveclicloutcomegenerllyquiueCNSrdipy(RT)HoweverRTcueignificntlg-termneurocogniveequeleimpctgnlycncerurvivloircgi-vernetwkocietySceRTcheduledjurypttmentfeibleunclerntuRT-ducedcognivejurymjobtcledogoReerchddgRT-mededcognivedefichfocueddividgneuroprogenircell(NPC)poolwhichmllnumrpotntldult-bnneurdenttegyruhippocmpu(whichdenttegyruprt)prticulrlyRT-eniveWhileNPCdmgelikelyctriecognivedeclewehvehowntermllydiffentedneurlgthoughtrdiotntundergomrkedynpticltertipeRTInthpropolwepentdthowgrdicompromeneurlplmmembrnelterneurlmichdrildynmicchngeexpigenevolvedlipidmetbolmcholeterolbioynMooverwedemtrteAPOEgenotypeocepot-RTcogniveoutcomehumnTheeobervtiherkenlg-neglectedtudien-geneticlocirdidmgecouldgiveucriclightmechnmRT-mededcognivedmgeMnyquetimunnwedhoweverHowwhtextentdoemechnmirrdivedmgecludgmembrnepermebiliztictriecognivedecle?DoeplmmembrnecompromeffectcellulrC2+ignlgknowncuegg-ltedcognivedecle?HoweproceeffecteddeliverylipidtrocyteneurApoE?Whtcequenceepigeneticchngeffectplmmembrnelipidcompoi?TheecriclquetiwhoenwerquidrtillydeignrpiecombtRT-ducedneurocogniveequeleWepropoeuequnttivemultidciplrypprochddeuecludg(i)determgcequenceRT-ducedplmmembrnecompromegrdileventeffectmichdrilERC2+(ii)defgroleectilipidcrrierApoEneurlpeRTwhiletetgcequencellelicvrintApoEchngeurfceglutmteceproced(iii)chrtgntucequenceltedneurlipidomeultRTcludgugbiomticpprochidentifykeypthwypotentilrpeutictrgetOurnovelmultidci-plrypprochdectntuRT-mededcognivedyfunctmoleculrynpticcellu-lrhvillevelTheultrnltilpropolhvepotentilgtlypoivelyimpcthelthcncerurvivthoeweexpoedrdiPROJECTSUMMARYTheobjectivethpropoldefemechnmfunctilrolenteimmuneignlgeventdurgbedmggcncerchempyTheegentducebedmgeRNAwellDNAWehvecentlydcovedcellelicnRNA-dependentnteimmunepeupencounterglkyltggentwhichpennemotcommlyuedytemicchempiecncerttmentOurplimrydtdemtrtelkyltggentduceDAMP(dmgeocedmoleculrpttern)pekignlgoberveddurgvirlfectiwhichknownimpctdowntmcellulreventuchpopInctrttypeDNAdmgggentthpthwydependRNA-ocedDAMPceprRIG-IquipliceoomlctivyFurrmowehvefoundASCC1whichencodeprotemetl-dependentRNAphophoeteredomocetricRNAupdmgequidductiDAMPpedurglkyltiTheedttrglyuggetmodelwhepliceoome-ocedprocegdmgedRNActivteDAMPignlgmyhvefunctilcequencetumcellfteupbedmgeInthpropolwedetermemechnmwhichASCC1functiocedprtnerprotegccedmgedncentRNAprocemprtthpedetermefuncticequencethignlgpthwy(Aim1)InturnwechrcterizeRNAtructuctivteRIG-IdurglkyltitctuteRIG-Iignlgpurifiedcompent(Aim2)TogeretudiehedlighnhirundecridmechnmwhichnuclerRNAqulyctrolpthwycnectednteimmuneignlgPROJECTSUMMARYAmgetimtedemilliAmericnwhohvecenedpoivepecificgeneticvrintltedHedryBtOvrinCncerSyndrome(HBOC)LynchSyndrome(LS)lethnhlfupdteevidence-bedcncerpventimeumyceerlydetectiyndrome-ltedcncerpventecncerlgerMotptientnewlydignoedhedrycnceryndromeceiveexteniveilcgeneticcounelcologytemmnyptientoutcncerdignottimeyndromeidentificticcegulrfollow-upccologtgeneticcounellimedPilotdthowmotfquentourcecptientHBOCLSprimrycettgmnyprimrycclicinunfmilirrpidlyevolvgcncerpventiguideleptientHBOCLSAlthoughprimrycclicinidellypoiedmketimelyferrlubpeciltdictedcncerpventicproceducceevidence-bedclicldeciupptoptimizecptientehedrycnceryndromedoenotextWepougprimryccliclencounterpromoteppropreubpeciltferrltetgehigh-rkptientimprovequlycclicloutcomeptientehedrycnceryndromeTochievethgolweexpneffectiveptient-centedprimrycclicldeciuppt(PC-CDS)ytemguideevidence-bedcehigh-rkptienteterventiimpcnup--dtecncerpventichddecimkgptientelf-efficcymngghedrycncerrkTheweb-bedntupropoedPC-CDSytempriucceimprovgprimrycwiderngechriccdihighuerteprimrycettguggetthpprochcimprovementmyneffectivetrtegyceppropreferrlevidence-bedpventivecdultehedrycnceryndromeToeterventiimpcncdultpecificpthogeniclikelypthogenicgenevrintltedHBOCLSweromlyign30primrycclicnetimted2488tudy-eligibleptientlbryolectrichelthcd(EHR)-documentedHBOCLSuulc(N=15clic)PC-CDSterventi(N=15clic)eterventiimpcn(i)updteevidence-bedcncerpventic(ii)ptientclicinementhddecimkgltedcncerpventic(iii)ptientelf-efficcymnggirhedrycncerrkTheprojectdeliverclbledptiveweb-bedCDSytemmptientpecificgeneticvrintirPCCevolvgtrdcfciltetimelycceppropreubpeciltyccnextendedguidedeliveryevidence-bedcthoegeneticvrintlikelychCenterDeeCtrolPventi(CDC)OfficePublicHelthGenomic(OPHG)Tier1ttucomgyerSUMMARYLynchSyndrome(LS)penthedrypdpoiyndromeocedDNAmmtchpir(MMR)pthwyimpirmentLS-ocedtumdemtrtehighlevelmicrotelletbily(MSI-H)cequentlyhighmuttilnetigenburdenwhichultimprovedpettmentimmunecheckpothibir(CPI)Wepvioulyhowedfrmehift(f)muttiencodgnetigenMSI-HtummyctrolCPIefficcyhvequntifiblydtctchrcterticpotmuttiuch(i)mjdivergenceelfledgdiffentilimmunogenicy(ii)hdexpiMSI-HCRCtumcroptient(iii)expihighlyimmunogenicepipecnelicnetigen-ctiveCD8+TcelldetectblebloodproxytrtumlctivyP-mlignntLSleifiltrtedTcellexpgproflmmrycyke(TNFIL-12)CTLA-4LAG3PD-L1checkpotuggetgerlyimmunectivticognumntigenLSenidelettgdeigncncerpventitrtegiecludgvcctiidentifictintigen-pecificTcellpevolvedimmuneurveillnceecpeWehypoizehighqulyhdnetigenexpifunctilTcellpericpbletrffickgclergMMRdleideterprogipmlignntpolypovertcncerLynchSyndromeThegolthpplictidectlcpequlyevolutinetigenexpedp-mlignntcoloctlpolypLSptienttrckidentifyimmunogenicntigencntrgetpventumdevelopmentTheUG3im1IdentifictinetigenexpedpmlignntcolpolypLynchSyndromeptientWemppectrumnovelhdnetigen-expgfrmehiftmuttip-cnceroucoloctlpolyp2Identifictif-pecificTCRcpblecognizgqulyf-netigenWecfirmimmunogenicyhdnetigenexpedpcnceroupolypidentifyf-pecificTcellcepr(TCR)cludghdTCRbrcodedpeptide-MHCtetrmerglecell(c)RNA/TCRequencgLSptientperipherlbloodTheUH3im1Vlidtef-netigenexpuetrffickgf-pecificTCReprtevlidticoht2AefluencepriMSI-Hcncerhdf-netigenperiTcellcogniubequentcolleiWedetermewherpriexpouhdMSI-Hf-netigenthroughirexpin-colicehpenewcolicleiTcellurveillncemodelp-vccti3Aef-pecificTcellexhutico-locliztiimmunouppivehubdvncedpcncerouleiUgbulk/cRNAeqptiltrncripmicmultiplexedimmunohchemtrywedetermemechnmimmuneecpePMEidentifycheckpotfutuimmunopventitrtegieHighlyggivecncerfquentlychrcterizedtumcellembolilymphticbloodvcultuTermedlymphovculrpcevi(LVSI)thphenomenhenhightetcncererchermypenneneceryeventdurgprogiloclizedmettticcncerDepeebiologiclimplictiltivelyltleknownboutmechnmdictlyenblepromoteLVSImtiExtgvroytemlckmulti-tuevculrcomplexymodeleeventInvivomodelwhilevilblenotmenblemechntictudiephrmcologiclcengcueheernumrnimlquiduchexperimentTheecriclneedfielddevelopmodelcnfhfullyctepecificphenomenltedmettticpduchLVSIUgournovelmulti-cellulrvculrized3DvropltmweweblemodeltrvtiepililemboliLVSImtiflmmrybtcncer(IBC)exvivofirttimeIBCnggivebtcncervrintchrcterizedexteniveLVSIGeneexpidtIBCptientidentifiedtromlfiltrtictivticriclcompentLVSIUgournewvropltmnimlmodelweweblecfirmthfdgwhenwedcovedmcrophgemicroenvirmentdictlypromoteLVSImtiLeverggournewvropltmwepropoenwerthemjquetiltgLVSIWhtmechnmpromote1)mti2)migrti3)tr-veelurvivltumemboli?WehypoizeLVSImtwo-tepprocewhemtrixpropertieepililmrkerE-cdherwhichtrglyexpedIBCgultetumembolimtiurvivlwhilecykexCCR7/CCL21homeepililembolilymphticTotetthhypowepropoeueournewvropltmtheim1)DetermerolemtrixmechniclymphticpumpgtemplketicLVSI2)DetermeroleE-cdherembolimtiurvivl3)IdentifymechnmpromoteembolihomgvcultuDepetrgcliclevidenceLVSIcriclp-mettticphenomenourbilyfullycteLVSIvrohevelylimedourmechnticundertgpiblepthwyFfirttimeourtemwblecteLVSIexvivougnovelmicrluidicpltmHewepropoeueourvropltmdefeignlgteppromoteLVSImtiurvivlvcultutterdefecricltrgetltedcncerprogiToexecutepropolwehveembledtemcompoedexperttuebioengeergcliclerchpcliclmodelbtcncerIfuccefulourwkfernovelcumizblepltmtudygLVSInewbiologicldcoverieholdrpeuticpotentilptientdvncedbtcncerPROJECTSUMMARY/ABSTRACTTriple-negtivebtcncer(TNBC)generllyttedchempywhichlychievecompletepeRelpeddeehnewttmenptilg-termoutcomepoThecentrlpmeourpropolTNBCurvivldependencyhighglucoe-6-phophtedehydrogene(G6PD)thiodoxducte1(TrxR1)functielevtedNADPHGSHlevelrrntly-ctiveignltrnducerctivrtrncripti(STAT)3whichdpttimechnmmkemrpeuticllyvulnerbletwochemotypeR001R002H182H333R001/R002(nturlproduct)modertedhighG6PDTrxR1STAT3functidecedGSHlevelducedgeneexpichngewhileH182/H333(zetide-bed)potentlyelectivelyhidSTAT3ctivygeneexpiTNBCcellThecollectivehibihighG6PDTrxR1STAT3GSHfunctigeneexpichngeledctiveoxygenpecie(ROS)build-upTNBCcellDNAdmgecellcyclertcelldeumgrowthhibivivoTNBCmodelThoughdeedG6PDTrxR1STAT3knockdownleledROSbuildupTNBCcellRNAeqprilghowedSTAT3hibileledenrichmentgeneDNAdmgeERtpeUPRenecencepthwyH182-ttedTNBCcellwenticiptediffencetweenchemotypectiviewhichweeekdefederttertilecompoundTNBCttmentNmlcellwhichhvelowbckgroundG6PDTrxR1NADPHGSHSTAT3functiunffectedWehypoizemodertidox/metboliceventgenegulthroughtrgetgG6PDTrxR1STAT3R001R002H182H333hibTNBCgrowthWefurrhypoizecompoundeffectmetbolicdoxSTAT3pthwyn-tumcellTMEctrientumpeWedefediffencetweenchemotype1InvetigteterctiSTAT3G6PDTrxR1compoundvrodefeirhibimode2StudyhowpecifictrgetgSTAT3zetidemodultiG6PDTrxR1STAT3functinturlproductdifferdowntmchngeglycolypenephophtepthwy(PPP)feedNADPHGSHlevelgeneexpivrovivo3InvetigteROSductiocedtpeDNAdmgecellcyclechngecelldethirmoleculrgulrcludgoxidoducteTNBCcelltumtuefollowgttment4InvetigtentumpehibirvivoCDXPDX4T1/Blb-cE0771/BL6modelWegnewdeptightTNBCdependencedygultedG6PDTrxR1NADPHGSHSTAT3functipfentileffecthibirX-rycrytllogrphictudiegivemicleveldetildictterctiTheuccefuldevelopmentR001R002H182H333ircombtirpyICIprovidenoveleffectivettmentTNBCPROJECTSUMMARYGivenimptntroletumuppcogenemetbolicprogrmmgignificnttrnltilpotentilidentifygundertghowprticulrcogenotypefluencetummetbolmwherechngeimpoelibiliecnexploedrpeuticllyFrommocenttudiehowevernuncedpictuhemergedhowgtuectextimpctexecutimetbolicprogrmmgevenmecogenicdriverFexmpledepehvgmedrivermuttipncticcncerlungcncerexhibdiffencebrnchedchmocid(BCAA)metbolmwhelungtumceBCAAuptkeuemnrogenourcewhilepnctictumdeceBCAAuptkeduedecedexpigeneBCAAmetbolmcompdnmlpncThuundertghowcell--igterctgeneticeventffectmetbolicdependencetumcriclelectgrightttmentpprocheptientBynlyzgmetbolomehumnn-mllcelllungcncer(NSCLC)mpleurgicllyectedptientcomprgthoeKRASmutti(K)thoeKRAS/LKB1co-mutti(KL)wenotede-glyceecrb(SGOC)metbolmignificntlyltedKLNSCLCimilrKLpncticcncermodelByfurrmetbolicnlyehoweverweclrifieddiffenceSGOCmetbolmtweenetwotumtypeWhileKLpncticcncerquiSGOCDNAmethyltiKLNSCLCdependSGOCviehydroxymethyltrnfere(SHMT)enzymemtdoxhomeotByetblhgbothmoleculrmetbolicpltmmeumetbolevolveddoxblnceutilizgclicllylevntmouemodelvivotudiewenowpoeddefecogenicroleSHMTdurglungtumigeneInAim1weterrogtemechnticbSHMTdependenceeNSCLCcellInAim2wevetigtemoleculrmechnmwhichLKB1gulteSHMTInAim3weexme1)wherSHMTuppiducetumgrowth2)whercombtiSHMThibichempeuticdrugduceoxidtivetcnfurrhibtumgrowthugvrioumouemodelWhilecriclroleSGOCmethylgroupdDNAmethyltiKLpncticcncerhenptedimptnceSGOCmetbolmKLNSCLCheterogeneytweenetwodeehyetelucidtedOurtudieprovidevlublemtiubtrtifictiNSCLCptienthyperctiveSGOCmetbolmttmentpderrpietrgetgdoxblncewhichpertentgolpcimedicePROJECTSUMMARYAlthoughdygultedgenetrncriptimjctrigfcrcncerdevelopmentdrugterferggenerltrncriptimchllenggtkThebromodom-ctgproteTAF1lrgetcompentmultiproteemblyTFIIDhighlydynmiccomplexervegenerltrncriptifcrtrncriptiieukryoteRecentlywptedTAF1hcriclroleAML1-ETOdrivencutemyeloidleukemi(AML)wheTAF1perturbtihdltleeffecnnmlhempoietictemcellimplygTAF1hpotentilerverpeutictrgetAMLCurntpprochetrgetTAF1limedmovlentmllmoleculehibirbromodomcludghighlyelectivepotentGenentechhibirGNE-371AtrZenecATRhibirAZD6738(cerlertib)whichwecentlypteddulTAF1-ATRhibirHoweverourowndtlgpvioulyptedobervtiupptnotiuchbromodomhibirlckcncercellkillpotentiljudgedcellprolifertiductipopp53DNAdmgeignlgtudieAuchTAF1nundexplodpotentildrugtrgetnoTAF1hibirhchedclicTotrgetTAF1moefficientlyweppliedtructu-guidedpprochgenerteddiffenteriecebl(CRBN)dictedPROTAC(proteolytrgetgchimer)degrderTAF1ErlyledPROTAChighlyeffectivegtAMLbloodcncercelllecompletedegrdtiTAF1tccentrtilow1nMductipopTAF1depleticellurvivlcncuedmovlenthibirn-degrdbleTAF1mutntexpidictg-trgetctivyLowdoenvivoctivePROTACdemtrtedignificnthibiAMLtumxenogrftgrowthcomptibilylg-termurvivlSupptedplimrydtcentrlhypothpropoltrgeteddegrdtiTAF1vibletrtegycombtAMLcncervulnerbleTAF1depletiOurobjectivedevelopfirt--clTAF1-electivePROTACexploirrpeuticpotentilThertileunderlygtherchprovidegenerlightfeibilyTAF1cncertrgetbuildnewcientificfrmewkwhenewtrtegiecncerrpiecndevelopedOurpprochutilizemethodtructurlbiologymediclchemtrycncerbiologypermednterdciplrytemercherclicincienttProjectAbtrctExpouultrviolet(UV)lighttweenge15-20yermotimptntetiologiclfcrkcnceryetdolecentyoungdult(AYA)thgemolikelyenggehelth-compromghvilikedooutdotnngoutkprotectiAnterventimodlyocilmedi(SM)pentnopptunychAYAwhomgmotctiveFcebookIntgrmTwteruerRecenterchuggetSMmylorichhubprolifertikcncermmtiyetchrcterticdiffuiptternthmmtirk/pventicommunicticropltmunknownChrcterizgkcncercommunictilcpectgeffectiverk/pventipotnundertgwhichmegetepecificgroup(TheSurgeGenerlCllActiPventSkCncer)couldenbletrgetedpventimethodAYAOurlg-termgolducehelth-compromghvi(egdotnnguncennue)mgt-rkAYAwhovulnerbledevelopgkcncerThpropolmobjective1)chrcterizeSMlcpegrdgkcncer-ltedpot2)develop/tetmegekcncerpventimgAYAclerpecificctentcientificllyupdteWhrobutmultidciplrytemweccomplhthobjectivevhepecificimAIM1Chrcterizekcncer-ltedcommunicticrothepopulrSMpltmAIM2Buildpdictiveexplblehelthcommunictimodeldetermediffuipotentilkcncer-ltedmegeAIM3Develop/pilottetun-protectidotnng-ltedmegeAYAfutuimplementtievlutiInAIM1weuectentnlyeekcncercommunicti/mmtilcpeFcebookIntgrmTwterdecribgmegefetuourcechrcterticpoter/uerocilnetwkidentifygnetwkchrcterticdiffuiptternkcncermmti(explry)InAIM2wepplymchelerngmethodchrcterizemegefetudevelop/evlutepdictivemodelmegediffuipotentiluglrge-cletrgdtpplymodelpdictenlediffuimetricgivenmegeebilychkcncerpventi-levntpopultiInAIM3weenggetwotkeholderegmentertiveroundmegedevelopment/tetg1)cncergniztitff(whoponirSMccount)2)tendedcipientemegefiveub-groupAYAged15-20yerWheboy/menWhegirl/womenWheBlckHpnicgyxulboy/menTheerchnovtivecuefocupotcrotheSMpltmMultilevelModelMemeDiffui(M3D)ThwkprovidetrgbfutudevelopmentimprovedtrgetedpventieftvidiglpltmfquentlyuedeilycceedAYAeffectivelyupptgNCImidvncecientificknowledgehelpllpeoplelivelgerhelthierliveProjectSummryDruptimoleculrcircdinclockdictivepoprognon-mllcelllungcncer(NSCLC)dictevidencecullktweencircdinclockdegultimlignncyhumncncermgWefoundBMAL1downgultedhumnNSCLCdictivecircdiruptilowBMAL1ndicrggivedeepoprognoInddideletiBMAL1mouemodelNSCLCccelertecncerprogiTheedtuggetBMAL1extenicircdinrhythmexerttum-uppiverolelungcncerHoweverhowBMAL1trtumigenemechnmvolveduppiBMAL1munclerApotentilcueBMAL1uppiupgultiMYC-fmilycoprotewhichmplified50%NSCLCWewefirthowmoleculrclockdruptedmplifiedMYCInddiourplimrydtuggetevenpenceglucocticoidMYCuppeBMAL1expibothNSCLCnmllungepiliumthudruptcircdinclockocilltiTodteMYCmplifictilyidentifiblecuethcircdindruptiNSCLCWhileCLOCK-BMAL1thuocilltimoleculrcircdinclocknecerymtnmllungrchectuidentywefoundMYCctivtiledlonmllunglveolrepililidentyductippropreprolifertiNotblyglucocticoidhveenhownlowhltgrowthomeNSCLCpcliclclicltudieourplimrydtuggetglucocticoidfiluppprolifertilungcellwhenMYCovexpedTkengerwehypoizeBMAL1uppicircdindruptiMYCNSCLCcricllolveolrcellidentyemergencemlignncytnceglucocticoidTotetthhypowepropoetwoAimInourfirtAimweterrogtedegewhichMYCuppiBMAL1drupticlockdrivelolunglveolrcellidentymlignntcelltrnmtiTotetthweBMAL1expiMYC-mplifiedlunggnoidmouemodelAprtthAimwetethypoMYCpventBMAL1bdgtypiclDNAtrgetWelotetocitweenMYCBMAL1mlignncyhumntummpleThfirttimedemtrteMYCdrupticlockcricldrivgerliettgeNSCLCdevelopmentInecdAimwetetdegewhichMYCcircdiruptiuppNSCLCpeglucocticoidWedetermeugvrovivomodelNSCLCmicehumnptientwherMYCoverrideglucocticoid-mededgrowthuppiviuppiBMAL1WelodetermemechnmwhichMYCctrolglucocticoidceprmoleculrclockpeglucocticoidOverlleexperimentdemtrteBMAL1tumuppiveproteNSCLCdbledMYCdrivemlignncyExtrmedullryfiltrtileukemiccellmenge(CNSdee/lpe)poprognoticfcrptientT-cellcutelymphoblticleukemi(T-ALL)TodtefewtudiehvevetigtedrolechemokeceprmedirignltrnductidrivgT-ALLfluxmengeTheCXCR3-CXCL10ignlgxplycriclrolegultgentrypecificleukocyteubetflmedmengeHoweverrolegultgleukemiccellmigrtrffickgmengempolyunderodThefocuthpropoluniquemechnmwhichleukemiccellhijcknflmmrypthwypvewymenge/CNSWedcovedupgultiCXCR3chemokeceprlevelubethigh-rkT-ALLCNSdeeOurplimryfdgprovidetrgevidenceCXCR3potenteT-ALLcellmigrtimengelfiltrtiWehvecompellgevidencemengelmicroenvirmentT-ALLcellmigrtemengelpericytewhichduceCXCL10peleukemi-derivedcykeThegolthtudyddhowCXCR3-CXCL10xmedeT-ALLtrffickgmengeWehypoizeT-ALLexploflmmryCXCR3-CXCL10pthwyfciltemengelfiltrtiOurrtileleukemiccellmydoptpro-flmmryignlggoverngnmlT-cellfluxdurgmengneuroflmmtriggermengelcoliztiUgENotch1-ducedT-ALLmouemodelpnelwell-chrcterizedT-ALLptientderivedxenogrftwepropoetudyhowCXCR3-CXCL10ignlgxgulteT-ALLcellmigrtifluxmengeInddiweeeketblhproprciplerpeuticpotentiltrgetgthignlgpthwyttmentCNS-volvedT-ALLFurrmowepropoeuemicrluidic3DcellcultuytemmodelT-ALLcellmigrtimengelnicheInAim1wedetermeroleCXCR3T-ALLtrffickgmengecductmechntictudieunrvelgroleUSP7/TAL1gultgCXCR3expimigrtgT-ALLcellInAim2wevetigtehowleukemiccellducepro-flmmryphenotypemengelpericytehowpericyte-derivedCXCL10cferT-ALLtropmmengeOurgoldemtrtedemtedleukemiccellducepro-flmmrychemokeCXCL10mengelmicroenvirmentmgupptivenicheleukemiccellfluxcoliztiTheidentifictimechnmwhichleukemiccellfiltrtemengeleddevelopmentnovelrpiePROJECTSUMMARYProttecncerecd-ledgcuecncer-lteddethAmericnmenWhilemotprottecncerhmeenivepdwellhmerpyubetptientlpelethlctrti-tntprottecncerIttillunclerwhyomeprottetummdolentyerrpidlyproglperpyAuchnurgentneednewbiomrkerdeeproginovelrpeutictrgettrtegiettment-frcryprottecncerWehveidentifiedmrkercellulrenecencet-ducedprogrmdrivencogenicultprottecncergeneticllyengeedmouemodel(GEMM)humnptientAenecenceleddurblecellcyclertductienecence-ocedecryphenotype(SASP)cnctivteimmuneclernceenecentcellhhricllyenthoughtenecencemyctnturlbrriertumigeneHowevermocentevidencehdemtrtedchricenecenceSASPproducticnlterntivelyledytemicflmmtiettgetumdevelopmentubequentprogimettWherenecencepecificenecentcelltypefunctillyctrieprottecnceretprogiimmuneuppimunknownToddthquetiwehvecroedGEMMwehvedevelopedcpulteerlyltetgeprottetumigenep16-3MRmicellowtrckgdepletip16+enecentcellUgemodelprottecncerptientmpleweobervedmrkercellulrenecencemelevteddurgdeeprogicnfoundmultipleheterogenoucelltypedepletienecentcellcnblocktummtivereimmuneuppiAuchwehypoizeenecentcellpromoteprotteimmuneuppumigeneirtrgetgcnctivteimmune-mededtumctrolInAim1weuemultiplexedtgglecellptiltrncripmicexvivofunctilnlyzeidentifyphenotypicllychrcterizedtctpopultienecentcelldurgdeeprogiprottecncerGEMMptientmpleInAim2geneticphrmcologicloluedeimpctenecentcelldepleti(ieenoly)SASPuppumprogiInAim3weevlutewherenolyticrpycnvereprotteimmuneuppipotentecurntlyeffectiventi-PD-1immunecheckpotblockde(ICB)rpydriveimmune-mededprottecncerctrolpcliclettgCollectivelyepprochehvepotentilnlydvnceourbicmechnticundertghowenecence-mededflmmticnfotertumigeneloguidetrnltildevelopment()prognoticbiomrkerggivedee(b)newrpeutictrgettrtegiettgprottecncerPROJECTSUMMARY/ABSTRACTCncerevolutidrivenDNA-muttgAPOBECenzyme(polipoproteBmRNAedgenzymectlyticpolypeptide-like)emergencetncerpypentpgcliclchllengeInprticulrAPOBEC3A(A3A)enzymeimplictedrngecncerhypoizeddrivetncetrgetednticncerrpieThprojectpropoeexplomechnmA3ActivydurgtrgetedrpyubtrtepfencepotentilmethodhibgctivylowcncerevolutiimpedeemergencedrugtnceAim1focuevetigtgroleA3AemergencedrugtncehypoizgA3AexpiupgulteddurgtrgetedrpyledgAPOBEC-igntumuttiWetetthuglungcncercell-lemodeltrgetedrpieueCRISPRtechnologygeneticllyelimteA3Amirimpcnemergencedrug-tntcellAim2eekdetermegenomictrncripmicproteomictrgetA3AAPOBECOurpviouwkuggetAPOBECmutgeneRNAedgdictedloclmeocletructurlctrtWecductcomputtilnlyeidentifyhotpotA3ActivyDNARNAirubequentproteeffectfgourundertgAPOBECmutgeneidentifyguper-optimlA3AubtrteAim3propoeevluteefficcyhirphirp-likemoleculeA3AhibirWenticipteA3Affyhirpubtrtemynderuceptiblehibihirphirp-likemoleculeTetgpermedvrocellewherhirpmoleculecnhindogenoucellulrA3ActivylowdrugtnceevolutiThroughcombticomputtilexperimentlpprochetherchdvnceourundertgAPOBECmutgenepotentillyfergnoveldignoticercholttmentAPOBEC-drivencncerSttementWkSullengerWheMPITheoverllobjectivethprojectdevelopnucleiccidbdgpolymercncvengeextrcellulrnucleiccid-ctgDmgeAocedMoleculrPttern(DAMP)ettgpncticcncerrpymigtectivticncercellmigrtimettfelyeffectivelyOurtrnltilhypottmentpncticcncerptientchempyurgeryduceleeuchnucleiccid-ctgDAMPdmtrtiecd-genertinucleiccid-ctgDAMPcvengerdurguchrpyprticulrlyimpctfulfelylimbilycncercellpdmobilizeultuchproflmmryttmentTheWheSullengerlbtrtedcollbtivelyexplobilyNASneutrlizedowntmTLRmededpro-viveeffectextrcellulrnucleiccidnucleiccid-ctg(NA)DAMPimprovePCrpyAwejotlypteddmtrtiNASPAMAM-G3drmticllyducedmetteyngeneicKPCpncticcncercelllivermicewhileloducgcircultgcfDNAlevelOurpublheddtugget1]flmmtipencectivtedflmmrycellpltelettumperipherypromotecncervimett2]modultgflmmtiNASctrolcncervimettThoughourilnlyequeencourgghmjlimtineedddedfciltetrnlthNAStrtegyclicSpecificllyNASPAMAM-G3wehveuedhwellknowndoelimgxicieFthSullengerlbhdevelopednewgenertiNASclledPAMAM-G35050tbilycvengenucleiccidDAMPvrovivowhilegtlyducgNAS-ocedxicyMooverSullengerlbryhcentlytrtedevlutectiiccyclodextrpolymer(CDP)hldyentrnltedcliciRNAdeliverymelnomcncerptientbilycvengeDAMPlimmettettgpncticcncerWelievebothegenthouldhvewiderrpeuticwdowthnfirtgenertiNASPAMAM-G3TheSullengerWhelbpropoeevlutepotentiletwoecdgenertiNASDAMPcvenggrpeuticpprochettgeIND-enblgtudietrnlthnovtivetrtegyclicttemptimproveoutcomepncticcncerptientTheSullengerlbpiblellvroNASbiochemtrynucleiccidDAMPnlyewellllnimlmodelnotvolvgptientderivedxenogrftTheWhelbpiblelltudievolvghumnmplecludgnimlmodelutilizeptientderivedtumxenogrftDrSullengerDrWhehllfdgmeetviZoomtlettwicepermthSummrySmllcelllungcncer(SCLC)highlyggivelethldeeccountgbout15%lllungcncerSCLCptienttenillypdchempyhoweverirtumvriblycur612mthTtmentgimenSCLChvemedlrgelyunchngedptdecdeNeleddiimmunpy(uchnti-PD-L1rpy)chempywcentlypprovedfirt-lettmentdultptientextenive-tgeSCLC(ES-SCLC)Althoughcliclnefddgnti-PD-L1henmodetncemedinoverllurvivl(OS)pproximtely2mtheulthveuggetednti-tumimmunycnplyroleSCLCttmentNotblylimedoptittgSCLCtrgetedgentemphizgcriclneedidentifygnewtrgetttmentprdigmOurpropoedtudieddeunmetneedSCLChencglycognizedhighlyheterogeneoudeewhichlrgelygultedfourtrncriptifcr(TF)Neuroendoc(NE)SCLCubtypehveenchrcterizeddiffentilexpiASCL1NEUROD1TFn-NESCLCPOU2F3YAP1AcenttudydemtrtedneentilrolemtergulrMYCdrivgevolutidynmiceubtypeSCLCpotultgirdependencemutultrncriptilepigeneticprogrmtumiurvivlWeimlevergeourcentdcoverietrgetedrpytte---rtpcliclpltmidentifynoveltrtegiemigtecommdependencieheterogenouSCLCWepvioulydemtrtedSCLCcellddictedCDK7-gultedgeneexpiprogrmmededprtcogenicmemrMYCfmilyTFpro-cogenicNElegeTFFurrmoourcentdthuncovedpvioulyuncognizedroleMUC1-CgultgcommcogenictrncripmebothNEn-NESCLCInddiwehveuccefullyetblhedmultiplethopicmuSCLCmodelwhichpentfourSCLCubtypecludeSCLC-ASCL1-NEUROD1-YAP1-POU2F3Imptntlyemumodelhventctlungimmuneytemmkgmpowerfulourceimmune-cologytudieUtilizgthpcliclpltmwe1)evluteefficcyMUC1-ChibirlecombtiCDK7hibirNEn-NESCLCvrovivo2)defeTMEltertiducedMUC1-ChibilecombtiCDK7hibi3)defecncertricextricmechnmwhichMUC1-CCDK7hibilecombtictrientumimmunyUltimtelychrcterizgunderlygmechnmocedpeourtrgetedrpiehelpdeveloptilodttmentSCLCptientABSTRACTThecentdevelopmentTcell-bedcncerimmunpiecludgcheckpotblockde(nti-PD-1nti-CTLA-4)doptiveTcellrpy(ACT)ugmodifiedptientTcellhledimprovedptienutcomevrietycncerHoweverdurblepeobervedlyfrctiptientFurrprogcnmdetudygtrgetgdiffentTcellignlgpthwyuchTcellcepr(TCR)-CD3ignlgpthwyTcellcognintigenTCRultgproximlignlgthroughurroundgCD3ubunkeytepum-killgPvioutudietrgetedntigenbdgeTCRenhncgTcellpetumntigentenledf-trgeteffectxicyIntedidentifictipecificextrcellulrterctitweenTCRCD3ubuncouldferpceguidncedevelopmentimmunpeutictrtegiemodulteTcellimmunytrgetgignlgthroughTCR-CD3complexoutltergntigen-pecificyOurplimrydthowedmuttgiduectntdomTCRultedltedTcellcykepeBedourplimrydurhypomodultgTCR-CD3ignlgimmune-mededcyxicytumntigencnenhncedoutlogpecificycncerntigenToteurhypoAim1weuenvrotrovirlTCRdplymethodnovelCD3-tetrmeryn-ilicotructu-bedTCRdeignpprochidentifyignl-enhncgTCRmutntenbleTcellmedemoeffectivevrotumkillgInAim2weidentifymechnmdriveltedignlgevidencedelectTCRignl-enhncgignl-hmpergmutntInAim3identifiedmuttitroducedgp100-pecificTCRdiffentntigenffieirvrovivotumkillgefficcynlyzedchrcterizetumkillgpotentilTcelldiffentiTcellexhutiptternnewignl-enhncgTcellclegoldevelopgnewtrtegyeffectiveTcellrpiegtcncerABSTRACTImmunpyhledmrkbleimprovementptienturvivlmnytumtypeInprticulrimmunecheckpothibirhvehownefficcymnycncertypeTheedrugctturngfpthwyctivteT-cellllowptientdptiveimmunepettcktumHoweververyltleknownbouthowimmunpyffectdiffentrcilethnicpopultiBtcncerdeeubtntildprieoutcomeBlckwomenhveprticulrlyhighrkmtlybtcncerlohvehigherrktriplenegtive(etrogenceprprogetereceprHer2negtive)btcncer(TNBC)whichmopiveimmunpyThetumimmunemicroenvirmenttrgprognoticfcrmgwomenbtcncertrgpdicrnefimmunpyInplimrydtwehvefoundbttumwomenAfricnncetryhvehigherrtelymphocyticfiltrtiwhichgenerllyocedtterpeimmunpyHowevernoclerdnhowwellBlckwomenHpnic/LrAinwomendocheckpothibirInthpplictiwefocubtcncerdprieimmuno-cologyReerchProjectFirtwepopultibed(cncergtry)dtdetermehowfquentlywomendiffentrcilethnicncetrygroupTNBCttedimmunpyWelolevergenextgtrillocllydvncedbtcncerISPY2whichcludenimmunecheckpothibirThetrilllowuexmegeneticncetryddirceethnicySecdweexmetumimmunemicroenvirmentmgwomenbtcncerltigeneticncetryltigeneticvrintwehveidentifiedocedtumimmunemicroenvirmentWepermdeepchrcteriztiugglenuclerRNA-equencgubettrilwomencomprgpdern-pderelectedtrtifictirceethnicyWetegrtelledtlevergegniztiltructuccompnygAdmtrtiveCoterptedtctextwhtldyknownboutcncerimmunologyimmunpyhelthdprieWebuildeultprojectdtetplnlrgerprojectddmombiouquetihowdiffentpopultipdimmunpyhowirrtedvereeventcompProjectSummry/AbtrctHER2-poivebtcncerhighlyggiveocedpoprognoHER2-trgetedrpypferdttmentecncerdrugtncemjproblemOurpvioutudiedemtrteddygultiGprotecoupledceprprticulrubgroupGPCRcoupleGprotei/oubun(Gi/o-GPCR)ctrieHER2-ducedbtcnceriprogiTrgetgGi/o-GPCRignlgblocktumprogienhnceefficcyHER2-trgetedrpyThpropolimdeletehowdygultedGi/o-GPCRignlgmyctrolHER2+btcncerproghroughpolytudiedCTLHE3ubiquligecomplexTheCTLH(crboxy-termlLHdom)complexmmmlinthologyetGID(glucoe-duced-degrdti-deficient)complexctmultipleubuncludgndpr/cffoldproteWDR26whichmyquidCTLHcomplexemblycrumentpecificubtrteubiqutidegrdtiTheCTLHcomplexwimplictedtumigeneexctfunctitumdevelopmentmlrgelyunknownWepvioulyfoundWDR26cffoldgprotegulteGPCRignlghighlyupgultedllmoleculrubtypevivebtcrcomocedweprognoInplimrytudiewetetedWDR26genedeletiNeutrngenicmouemodelHER2+btcncerhowedmmmry-pecificWDR26genedeleticpultedGi/o-GPCR-ignlgblockdebothhidtumigrowthlungmettWDR26likelypromotebothGproteignlgctrolCTLH-ubiqu-lige-drivendegrdtiSNF5(nepigenetictumupp)tumcellBedeexcgplimrydtwehypoizeHER2-drivenbttumWDR26upgultipromoteG-proteignlgfciltenuclerCTLH-complexemblyE3ubiquligectivyledgubiqutiproteomldegrdtiSNF5thSNF5depletictivtecogenictrncriptilprogrmprtupgultgEZH2(enhncerzetehomology2)ultimtelypromotgtumgrowthmetttnceHER2-trgetedrpyInthtudyugcombticellleeverlnewlydevelopedgeneticptient-derivedxenogrftmouemodelwedeterme1)howWDR26mnifetdygultedGi/o-GPCRignlgdrivebtcncerprogiviCTLHcomplex2)howCTLHcomplexgultebtcncerdevelopmenttrgetgSNF5proteomldegrdti3)whertrgetgCTLHSNF5functiimproveefficcyHER2-trgetedrpyTheultourtudiehouldfundmentllydvnceundertghowpolytudiedCTLHE3ubiquligecomplextrgetepigenetictumuppSNF5drivetumprogidrugtnceThknowledgehouldhelpuidentifynewtrtegieugmentgHER2-trgetedrpybtcncerABSTRACTMothn15000childnnewlydignoedcncerechyerUSAlthoughbkthroughttmenthveimprovedurvivlrteover85%cncermledgdee-ltedcuedethmgchildnwhileurvivfceignificntlifelghelth-ltedmbidymtlyStudiecncerpdpoigenegenome-wideocitudie(GWAS)hvecedourknowledgegeneticetiologypedriccncerHoweverthknowledgebehenbuiltlmotexcluivelyvetigtidividulcncertypeGivenemerggevidenceheterogeneoucncertypelohveignificnthdgeneticcompentwepropoecductfirtlrge-clevetigtipedriccncerpleiotropyToccomplhthgolwecomextggeneticdtetpermpn-cncernlyeup43000pedriccncercepentg>25cncerubtypetudiecludgStJudeCloud-hotederchiveuchPedricCncerGenomeProjectRel-TimeCliclGenomicGenome4KidChildhoodCncerSurvivStudyStJudeLifetimeCohtStudyNIHCommFundKidFirtPedricReerchCtiumtudieZEROChildhoodCncerProgrmAnotbledthrmiztieftwegnizeextgdtetctructlrgetunimlyproceedwhole-genome/-exomeequencg(WGS/WES)dtourcedte>20000pedriccncerceWheourcewecductytemticcompheniveerchcommvrintgenehrbgrcncerpdpoivrint(CPV)ctrierkcromultiplepedriccncertype(Aim1)Therchpecificpleiotropicrklocicomplementedcro-pedriccncevlutipolygenicrkgeneticcltihdherbilyelucidtegloblptterngeneticpleiotropytweencncerubtype(Aim2)LtlywechrcterizecliclimpctpleiotropicgeneticuceptibilyCPVrvrintburdenpolygenicrkco(PRS)rkpedriccncerdverecncer-ltedoutcomecludglpeerlymtlyubequentmlignntneoplm(SMN)SMN-ltedmtly(Aim3)Toegenome-wideignificntfdgwepermplictitudiedependentdtNCITARGET(TherpeuticllyApplicbleReerchGenerteEffectiveTtment)StJudecliclgenomicprogrm(Rel-TimeCliclGenomicGenome4Kid)evlutebiologiclfunctillevncepleiotropicvrintcludgpecificcncertypeAlgerthpropoedprojectpentuniquepprochlevergeextggenetic/genomicourcedetectnovelrklocictrigdevelopmentdtctpedriccncerfciltegenertinewhypoeboutcommcrcogenicmechnmCompletieimlopotentillyupptdevelopmentnewlghmpcimediceenhncedgeneticrkpriletterpdictwhomydeveloppedriccncerexperiencecncer-lteddvereoutcomedurgurvivhipSUMMARY/ABSTRACTRelpedpedricT-cellcutelymphoblticleukemi(T-ALL)tenfrcrycventilrpyoceddmlurvivlrtelethn25%ThudevelopmentnovelrpielpedT-ALLpentnurgentunmetmediclneedchildnRelped/frcryT-ALLtenenrichedleukemigcell(LIC)whichexhinhncedurvivlelf-newlcpcyOurlg-termgolidentifynewtrgetdevelopmentlexicmoeffectiverpieelimtgthcellpopultiWedcoveddenoedemectgRNA1(ADAR1)ctivtiquidLICmtenncedictgcell-type-pecificgeneprogrmpventterferctivtirrntdouble-tdRNA(dRNA)engApproximtely70%T-ALLptientexhibhighexpiADAR1thocedignificntlyweclicloutcomeStrikglywefoundhibgADAR1impirmlignntT-ALLprogenirprogtiTheedtuggetADAR1hfundmentlroleLICelf-newlrpeutictnceT-ALLTheoverllobjectivethtudydectmechnmthroughwhichADAR1RNAedgpromoteLICelf-newlT-ALLptientOurcentrlhypoctivtiADAR1upptT-ALLLICmtennceuppgrrntdRNAengnm-pecificmnnerWetetthhypothedependentim1)ExmeifADAR1promoteLICelf-newllpedT-ALLcgRNAedg2)elucidtemoleculrmechnmwhichADAR1promoteLICctivy3)vetigteifNOTCH1ignlgduceADAR1ctivtiT-ALLLICWedictlyevlutem-pecificfunctiADAR1p150p110mLIChumnthymicgnoidptient-derivedxenogrftmouemodelT-ALLWeueglecellRNA-equencgvetigtemechnmwhichp150p110mgultecellulrfunctigeneexpiT-ALLLICInAim2wepermccurntknockdowndRNAencombtiADAR1mknockoutLICdetermeifrrntdRNAengdruptLICctivieptient-derivedxenogrftmouemodelMechnticllywempdRNA-ctggeneuppedeirRNAedgdRNActivyADAR1InAim3weueg-ectehibir(GSI)DDL1-expgthymicco-cultuytemexmeifNOTCHignlgctrieADAR1ctivtiifecpicexpiADAR1cnpneedNOTCHignlgducetnceGSIhibiLtlywevetigteifADAR1dicttrncriptiltrgetNOTCH1TheetudieimproveourundertghowdygultiADAR1ctrieLICelf-newlT-ALLprogiFurrmoetudieexpourfundmentlundertgmechnmunderlygLIC-drivenmlignnciemybrodlypplicblecncertemcell-drivenmlignncieAbtrctMettdictcuemjydethptientolidtumthupentgmjunmetmediclneedInomecncertypemicrocopicmettemyhveldyoccurdttimedignoBecuenetblhedtummicroenvirmentmederpeutictncethroughvrietymechnmcncercelllikelymotvulnerbledurgirtimebloodtmerlydevelopmentmicromettThueffectivelytrgetgthoecellquictnturveillncederctchmeircircultiirerlymettticnicheeyhve-etblhedprotectivemicroenvirmentCurntlyFDA-pprovedytemicrpieolidtumunbledequtedooytermtentchempygivencyclellowcoveryxicymrrowgnevenlg-hlf-lifentibodieultpektroughCollectivelyourvilblerpielikelyfilprovideytemictumctrolmetteprtcuetermtentexpounlykilllypercentgecelldurgechttmentcycleenblgurvivgcelldevelopcell-tricdrugtnceloduedrug-fewdowenblecncercellpdOuroverrchghypowecnpventttmicromettlevergggenerpyprovidectntlg-termytemicimmunologicpucncercellWeteurhypomodelneuroblmmotcommolidtumchildnoutidebrHer2+btcncerbothwhichhvepoprognowhenmettticWehvedevelopednf--helftrtegyutilizggletrvenoudoecombntdeno-ocedviru(rAAV)tructnmlcellectebpecificTcellenggerbloodtmlgperiodtime(rAAVrh74-GD2-CD3rAAVrh74-Her2-CD3)pltmwetermTrnJoOurpecificim(1)Tetnti-mettefficcyGD2Her2TrnJopcliclmodel(2)TetfetyGD2Her2TrnJopcliclmodel(3)DevelopctrollbleexpiGD2Her2killwchIfuccefulourdtupptclicltrnltirAAVrh74-GD2-CD3neuroblmrAAVrh74-Her2-CD3Her2+btcncerFollowghumnpheIfetytudyweenviclicltrildurgpot-ductirpyettgmimliduldeeeirpvent/ttmicrometteimprovelg-termptienturvivlPROJECTSUMMARY/ABSTRACTFcncerimmunpieuchimmunecheckpotrpy(ICT)uccedependutedctivtrtumleffecrTcellcognizgtumntigenWhilemnymoleculrchngequideffecrTcellctrolcncerknownmnykeyepigenetictrncriptilfetuquidICT-ducednti-tumimmunyunknownWecentlyfoundpcliclrcommelnommodelnti-PD-1nti-CTLA-4ICTducetrgupgultrncriptifcrBhlhe40tumntigen-pecificCD8CD4TcellwhichcrucilICT-ducedtumjectielimtiWefurrdcovedcdildeletiBhlhe40CD4+Tgulrycell(Tg)CD4TcellCD8TcellndedmicettedICTcpblejectgICT-enivetumBhlhe40-deficientCD4CD8TcellexhidnotbleductiICT-driventerfergmm(IFN-)productioceddefectICT-ducedmodelgtrtumlmcrophgeGeneetenrichmentnlydicteddygultedmetbolmcertubpopultiCD4+CD8+TcellbenceBhlhe40HoweverenlyewedemicelckgBhlhe40TgcventilCD4CD8TcellTheeimptntdeletehowBhlhe40ctrienlyCD8loCD4Tcell(whichnowcknowledgedcricleffectiventi-tumimmuny)effecrfunctiWetetcentrlhypoBhlhe40pivotltrncriptilgulrbothCD4CD8Tcellnti-tumeffecrfunctidurgnti-PD-1/nti-CTLA-4ICTtum-pecificcncervccerpieInAim1weuecventilCD4CD8Tcell-pecificBhlhe40knockout(KO)micenewlygenertedmouemelnommodelexpdefednetigenmouercomledetermehowcell-pecificdeletiBhlhe40impctpenti-PD-1/nti-CTLA-4ICTtum-pecificnetigencncervccettmentWennlyzetumCD4CD8TcellpecificBhlhe40KOmiceBhlhe40ptermiceglecellRNAequencg(cRNAeq)mcymetry(CyTOF)CODEXmultipleximggehowloBhlhe40CD4CD8TcelllterimmunetummicroenvirmentInAim2wedectmechnmwhichBhlhe40gulteCD4CD8Tcellfunctictextdiffentimmunpieeverlpprocheuchfunctilygle-cellequencgytrnpoe-cceiblechromt(cATACeq)chromtimmunopciptiequencg(ChIPeq)luciferepteryInAim3welteourfdgmicehumnfirtmnipultgexpiBhlhe40humnCD4CD8TcelldetermehowBhlhe40gulteireffecrfunctinnlyzgp-pot-ICTttmentptientmpleTheetudiectrieourundertghowTcellcognizgtumntigenmteffecrfunctidurgICTrpeuticnetigencncervccecouldidentifyBhlhe40novelrpeutictrgetABSTRACTAnimlmodelbckmnybiomediclpcliclerchmouemotuedmodelgnmhumndeeerchUndertgchrcterizgmouemodelcidedkeyimprovgproducibilypcliclulthumnubjectTothendimptntuepclicltechniquenlogoumodernclicltechniqueceucceulttrnltewellcliclimplementtiUntuntelytrdiztipcliclrdirpy(RT)tudieugclicllynlogoumethodologiehnotyetenchievedInltfewdecdecliclRTtechnologyhdevelopeddrmticllytenymodultedRT(IMRT)pentgemotignificntdevelopmentHoweveredvncementhvenottrnltedpcliclmllnimlRTwhichlrgelyemblettecliclRT1970termueimplecirculr/ctngulrmgeometrieunimmtenielckhigh-quly3DtrgetdoecmlyCequentlymllnimlRTtudiedotimulterdiobiologiclrdioimmunologiclhypoxicxicyenvirmenthumnrpieTofullytrdizepcliclirrdirclicllynlogoumethodologieneceryfullyimplementIMRTHoweververetrnltiIMRTcliclpcliclcle(1-2dermgnudemller)henchllenggduetechnicllimtiengeergpproprelymllmulti-lefcollimr(MLC)Ourgrouphcentlydeveloped3Dprtedcompenr(3DPC)pprochprovideimpleliblecot-effectiveolutiimplementgmouebedIMRTIntermimplicycot-effectivene3DPC-IMRTquinoddilpecilizedequipmentidenexpenivecommercillyvilble3DprterprtgmterilUnlikeMLCytem3DPC-IMRThnoegment/tepdurgdeliveryledghterttmenttimenomechnicl/electriclprtledghighlibilylowermtennceducedQAeftOurcentrlhypowecndevelop3DPC-IMRThigh-throughputpclicllyuefulmllnimlIMRTytemugAItedcurgnovelhighpeeddoeclcultioptimiztilghmmechnmllowrpidwchgcompenrdiffentfieldWepropoefollowgpecificim(1)Deigndevelopment3DprtedcompenrIMRT(3DPC-IMRT)(2)DevelopmentVMATlike3DPC-IMRTAImoueegmenttimethod(3)Doimetricccurcyevlutipncticductldenocrcom(PDAC)mouemodeltudyTheuccepropoedprojecthelprdibiologyerchtterimultecliclRTenvirmentenblefututudiewheccurtecomplexdoedtriicriclPROJECTSUMMARYDpriecnceroutcomecertptientpopultiuchHpnic/L(H/L)ptientrootedprtlckundertgbiologicfcrmechnmpetncenovelrpeuticAlthoughmotptientexpgneprticiptecliclerchlypproximtely8%dultcncerptientenrollcncerclicltrilpercentgemieprticiptgclicltriloverllmuchlowerwhencompdgenerlpopultiUSH/Lmygroupexmplectueunder-pentedclicltrilTheunder-penttimygroupcncererchctriedpriecncercoutcomefilgprovideevidenceclicincienttneedfelyttdcovernewttmentmyptientcncerThprojectenblentegrtivenlydemogrphicclicldtcomdmulti-omicpprocheugbloodmpletuebtcncerptientelucidtediffenceimmunepebtcncerptientH/LrceImmunecheckpothibi(ICI)typeimmunpyhvolutiizedttmentmnyptientbtcncerHowevercompleximmunouppivetummicroenvirment(TME)btcncerndermlepiveICIpentrpeuticobtcleSpecificllycrumentmyeloid-deriveduppcell(MDSC)prohibT-cellctivtifiltrtiwhichleduccefulttmentthclrpeuticWeimchrcterizediffenceuppiveTMErcetumubtypeUndertgediffenceffectdevelopmentnovelttmentcombti&trtegieTheidentifictiptientpopultihigherrkdeemotlikelynefICIequlimptnceundertgcientificmechnmH/Lptienthvehigherpercentgeyoungwomen(<50yerold)dignoedbtcncertenmoggiveubtypecompdN-HpnicWhe(NHW)ptientTheediffencepertevenwhencctgocioecomicfcrOverllthwkhelpprovideightboutdiffenceimmuneTMEH/LptientbtcncerwelotrydetermeifuegnoidcouldhelpcendiffenceefficcygrddevelopmenneoureclicltrildevelopmentWevetigtgpromgrpeuticcombtihnedecetylehibinttcomdICIrgetMDSCIfwecndetermediffentilpetmentH/LptientderivedgnoidthwouldprovidepotentilprdigmchnggtrtifictiH/LptientbtcncerwhotnefeffectthnovelrpyProjectSummryFmocllntibody(mAb)-bedrdiophrmceuticlwidelyimpctpcinuclermedicetrtegiebothimprovecvenienceducerdiburdenn-trgergnurgentlyneededCompddict-llgtrtegieptrgetgmkemAb-bednuclerimggtrgetedrdiucliderpy(TRT)ferhyetlizepotentilimpcncliclpcinuclermediceHowevermodetucceehentlimtiextgptrgetgpltmhvedefeduccefulpltmneed1)nimmunogenic2)deignedmodulrtunblenymAbrdiuclide3)voidclerggentTodtenopltmhmetecrerimcriclneedptrgetgtrtegieimprovepcinuclermediceThelg-termgolthpropoldevelophotguetptrgetgpltmutilizecurcub[7]uril(CB7)hotdmntne(Adm)rdioligguetnuclerimggTRTelementlly-mtched203Pb(imgg)212Pb(rpy)CB7-AdmhotguetptrgetgbednimmunogenicmoleculeuemodulrpprochcnchievehighuptketrgettueugmAbtrgetgvecrlgtimenullifyneedclerggentThuhypoizedthpltmddhtcomgpltmyieldgtrnltblerdinoticpprochcncerttmentSpecificAim1thpropolDevelopmentevluti203/212Pb-lledrdioligptrgetgTochievethgollibrryrdioligynizedevlutedvrowellvivooptimizgprmeterhotguetptrgetgpprochcomprgdoimetrydict-llgtrtegyderdemtrtepltmubilyclicltrnltiSpecificAim2Evluti212Pbptrgetedlph-TRTmuxenogrftmodelUgtrtegieptrgetgdevelopedSpecificAim1wellfrcteddogpprochweetblhefficcyourhotguetptrgetglph-TRTWelocompdoimetryrpeuticdexrpeuticefficcyrdiologiclxicynlogoupprochedictly-lledmAbmouemodelcncervlidtedvntgeSuccefullychievgimpropoedtudieleddevelopmentvlidtinextgenertiptrgetgpltmublefututrnltiltudiedemtrtepotentilnnovtivernoticpplictiTRTThepltmrobutfecvenientlterntivedict-llgtrtegiemAbwidelypplicblepcinuclermedicehumndeeProjectSummryThpplictiddcncerhelthdprieBlckidentmetropolnDetropecificllyevlutgrcildiffencegeneticgultinti-tumimmunyHER2+btcncernexmpletypetrndciplrywkctlyzedthroughrobutgrnt-plnngfrtructudevelopedthP20BlckwomenHER2+btcncerhveubtntillypooutcomeoverllmgthoettedtrtuzumbcompdWheptientevenfterctrollgcliclociodemogrphicfcruggetgbiologicfcrmyloctrieEndogenoudptiveimmunymyquimentutedtumprotectiftermocllntibodyttmentrolegeneticgultiimmunelernceuimmunytumimmunywelldocumentedFurrtrgevidencercildiffencebothimmunepthwygeneticvrumimmunemicroenvirmentAtterundertgmechnmgultgpenti-HER2ntibodiecricldevelopmentimprovedclicltrtegiecluidivereptientpopulticidertigroup-dividul-levelgeneticdiffenceeentilenurgetrtegieequbleWehveembledtrgmultidciplrytemvetigrcommtedundertgbiologiclunderpngrcildpriecncerTheoverrchggolthP20(1)identifyncetry-pecificgeneticgulrmcrophgefunctipenti-HER2ntibodyrpypotentillyunderliercildiffencepergetedimmunpy(2)etblhrobutfrtructuupptdevelopnovtiveproductiveimmuno-cologyhelthdprieerchcollbtiThepplicticompeReerchProjectnAdmtrtiveCotnNCI-deigntedcompheniveCncerCenterDetroMichignwhemjycenutrctmedicllyunderervedbedHRSAdefiTheimthP20(1)ccelertetrnltilerchducercildprieHER2+btcnceroutcomechrcterizgrce-pecificimmuneprilepecttumenvirmenthotgeneticbckgrounddetermeirctriipettmentnti-HER2ntibodyrpie(2)tngnextgprogrmmtictructutcilteterectiltrnltilerchimmuno-cologybiologycncerhelthdpriechieveR01/P01-levelfundgultimtelyducecncerhelthdprieimmuno-cologyoutcomeThwkprovidebmovgwrdmce-cluiveequy-focuedpcimedicepprochueimmunpieimproveoverllttmentpeidentifynovelbiomrkerducercildprieoutcomeProjectSummry/AbtrctNturlkiller(NK)cellhvelgenknownprovidecriclerlydefenegtvirlfectimlignncieNeverlemotcliclucceocedugNKcellhentrictedhemlogiclmlignnciewhichcnprtlyttrieddefectiveNKcellctivtiperipherltueExtrcellulrmtrix(ECM)protepentllperipherltuewheymthomeotprovidgcffoldwellimptntdevelopmentlcueurroundgcellWehvecentlydcovedcriclroleECMprotewchgfuncticventilNKcellyexcircultienterperipherltueWeimvetigtehowECMprotegulteNKcellfunctikolidcncerSkbtcncerledgcuecncermbidymtlyUnedStteTheecncerfquentlydevelopprimryecdrytncecurntimmunpeuticInddichempiemcuewide-rnggideeffectthuignificntlyburdenhelthcytemDefectiveECMturnoverhllmrkkbrolidcncerTofullyelucidtebi-dictilterctitweenNKcellECMctextolidcncerdevelopmentweim(1)Determemechnmcollgen-ducedloNKcellkillgfunctiolidcncer(2)Determerolecollgen-IIIgultiNKcellhelperfunctiolidcncer(3)ExmeimpcrmjECMproteNKcellfunctilyTheoutcomepropoedtudievelnovelmechnmECM-NKcelltercticncerOurerchgtlyfciltedevelopmentnovelrpeutictrtegiehrneNKcellttmentolidcncerProjectSummry/AbtrctCerviclcncerburdenflldproptelywomenlow-middle-comecountrieAchievgcerviclcncerelimtiehigh-burdenettgquihighcovergeHPVvcctiTothendmnyAfricncountriehvetroducedHPVvccentilprogrmfervccefepdolecentgirlHoweveruptkegilowclteuptkeunder-tudiedThprojectim(A)collectprimry(qultivequnttive)ecdry(qunttive)dtKenyMlwiboutfcrhypoizedffectHPVvcceuptketenvirmentl/policyytemcommunydividullevelueedt(B)multi-levelmodelgidentifywhtmottrglyocedHPVvcceuptkemotivtivccte(C)gent-bedmodelexplowhtterventimymoteffectivetcgpopulti-levelcovergeHPVvcceecountrieKenyMlwiweelectedthtudydueirhighcerviclcncerburdenexperiencediffentvccedeliveryettgirntilHPVvcctiprogrmKenyfervccethelthfciliewhileMlwihuedchool-bedcmpignpluhelthfcily-beddeliveryThenlyeefercetudiecountrieugcidergediffentpprocheToourknowledgethwouldfirttudyurveylrgempleromly-electedAfricnpnt(n=3000echcountry)boutfcrocedirdughterHPVvcctittufirtytemticllycollectnlyzednmulti-levelfcrocedHPVvcctimotivtiegpolicypcehelthytemvccedeliveryctextocilcommunieTheprojectlevergeerchprtnerhiptweenNYUAPHRC(nAfricnerchpolicytute)IPA(whichhexteniveexperiencecollectgdtlow-ourceettg)UCLA(HPVvcctimulti-levelerchexperte)USC(pecificllyroundimultimodelghelthoutcome)TheloloclexpertebothKenyMlwemexpertllfcettudyMulti-levelnlyecludenewprimryecdrydtboutclteHPVvcceuptkeneceryderdeveloptrgetedcomphenivectext-pecifictrtegieceHPVvcctiimprovehelthoutcomeultimtelychievecerviclcncerelimtiAcerviclcncermjcuembidymtlymnycountrievcctiuptkencgchllengewldwideepecillydiverepopultithtudymymprcticepolicyettgPROJECTSUMMARYChildnhigh-rkneuroblm(NB)hveignificntrkttmentfiludethemphizgneeddevelopnoveltrgetedrpiewhichctutelg-termgolthpropolThepropoederchfocuecoproteglypicn-2(GPC2)whichglycophophtidyloil(GPI)-lkedcellurfceNBcncernotfoundvlnmltueTocplizeGPC2diffentilexpiwedevelopedGPC2chimericntigencepr(CAR)TcellpermedInvetigtilNewDrug(IND)pplicti-enblgtudieNBhowgGPC2CARduceferobuttumgiTheedtleddictlydevelopmentfirt--humnGPC2CARTcellPhe1clicltrilthpenedMy2023HoweverNBcellcnecpeGPC2CARpuledgtumlpelimglg-termefficcyThunurgentneedidentifymechnmGPC2CARTcelltnceNBdevelopnext-genertiCARpprochecombteproceeTowrdthgolourcentprilgtumecpedGPC2CARpuhowedNBlpeocedGPC2downgulticverelyupgultiGPI-clevgngioten-cvertgenzyme(ACE)WehvelofoundGPC2mjcompentNB-ocedextrcellulrveicle(EV)modultiwhichcnignificntlychngeGPC2cellurfcedenyTogerourpublhedunpublhedplimrydtuggetfollowgcentrlhypoAmjmechnmGPC2CARTcelltnceNBdowngulticellurfceGPC2drivenbothACE-ducedGPC2clevgecedheddgGPC2+EVcncircumventednewbictricCARdulntigentrgetgpprochWepropoetetthiglccepttwotegrteddependentSpecificAimInAim1wefocuvlidtgGPC2cellurfcedowngultimjmechnmGPC2CARtnceNBcludgdefgroleACE-ducedGPC2clevgedynmicmodultiGPC2+EVunderGPC2CARpuInAim2wedefeefficcyfetynewCARTcelldulntigentrgetgpprochwedeignedovercomeGPC2CARecpeNBGPC2CARTcellimultneoulytrgetgdilognglioideGD2viectedbpecificnteimmunecellengger(BiCE)lobdCD16NKcellmcrophgectivtentumnteimmunyGPC2-dependentmnnerThnovtiveCARBiCErpeuticpprochynergizedulntigentrgetgctivtgdptiventeimmunyOurultyieldcriclightCARTcelltnceenewimmunpeuticprcipletechnologycnppliedpotentCARwhentigenecpelimlg-termefficcyTheetudieloproduceINDpplicti-enblgdtclicltrnltilCARBiCErpeuticpprochdevelopdepertelyneedednewtrgetedrpiechildnNBPROJECTSUMMARY/ABSTRACTHepcellulrcrcom(HCC)motcommtypeprimrylivercncerdifficultdeettledgcuecncerdethwldwidecedcidentrteUSHCChwellchrcterizedrkfcrchricHeptBViru(HBV)HeptCViru(HCV)fectilivercirrhon-lcoholictehept(NASH)whichccounver85%llHCCceSuchwell-defedpopultimkeHCCnideltypemlignncychemopventiHowevercurntlynopventi-terceptidrugvilbleHCCHencenimmentneeddevelopeffectivegentpventterceptlivercncerHippopthwytrncriptilgulrTEAdomtrncriptifcr(TEAD)YAP/TAZcomplexehveenhownplyimptntroletumigeneStudieourlbhvedemtrtedkeyroleHippopthwyHCCpthogeneTheetrgetgTEAD-YAP/TAZcomplexcouldneffectivetrtegyHCCpventiOurlg-termgolidentifynovelHCC-pventiventurlproduct(NP)under-explodHwiinmicrognmnturlourceTheobjectivethpropoederchdcoverNPhibTEADplmiyltipventerceptiHCCThecentrlhypounder-explodHwiinmicrognmNCI-NPexcellentourcenewcncerpventiveNPdcoverycludgTEAD-phibirThertilepropoederchthncenovelpotentTEADplmiyltihibiridentifiedledcompoundtudiedirmechnmctetedvivofollow-uptudieTheobjectivethprojectccomplhedtwopecificim(1)IdentifyHCClevntTEADm()implementbioydevelopmentpermpilotNPceng(ii)PermHTSBGStructudetermtictivecompoundInvrovivoThepropoedprojectignificnthighlytrnltilcuethmulti-PIgrntimtidentifygnovelNPwhichhibTEADplmiyltiHCCpventerceptiTheultlikelylednewchemopventrilvetigteenewNPhigh-rkHCCpopultiThwouldhveproundeffectduceburdenHCClloverwldPROJECTSUMMARYCurntimmunpieuchnti-PD-1immunpyhvelowobjectivepeptientnecetgdevelopmentnovelrpiebootimmunepecncerpeettmentFurrmotimmunpieclicnti-PD-1immunpycludedpdomntlycnTcellWhilecombtiTcell-dictedrpiecnledexcellenutcomeomemotptienttillhvenoobjectivepecombtieimmunpieThuimpertiveidentifynovelrpeutictrgetwkynergticllynti-PD-1immunpyTcell-dictedrpieNturlkiller(NK)cellntelymphocytecnctroltumthroughdictcyxicyirimmunomodulryproducticykechemokeNKcellbundncetumcltecedptienturvivlptientpeimmunpieWepvioulyfoundkeyimmunomodulryfunctiNKcellirproducticykeFLT3LGwhichgultetype1cventildendriccell(cDC1)bundncetummicroenvirment(TME)cDC1nimptntntigenpentgcellhpenti-tumTcellpeWefoundNKcellproductiFLT3LGgultecDC1bundnceTMEwhichledcedptienturvivlpenti-PD-1immunpyWehypoizetrgetgimmunomodulryeffectNKcelltummicroenvirmentledmoprotectivecDC1ttertum-dictedTcellpecedefficcyimmunpieThucricllyimptntwedefehowNKcellgultedtummicroenvirmentInprticulrcellulrmoleculrmechnmgultgNKcellphenotypefunctumunknownmoleculrmechnmctrollgNKcellproducticykeFLT3LGunknownInAim1thprojectwedetermetum-tricfetugulteNKcellphenotypefunctumInAim2wedefemechnmgulteNKcellproductiFlt3LInAim3weelucidtemechnmgultgNKcellphenotypefunctihumnmettticmelnomToddeimwehvedevelopedecpictummodelvroNKcelltimultiyllowudefemoleculrmechnmgultgNKcellproductiFlt3LWehvelodevelopedcomplimentryhumnimmunologytudiemettticmelnommplellowtudyNKcellirimmunomodulryeffecttrnltilettgThetudieoutledthpropolprovidenwerlgtgquetibouthowNKcellphenotypefunctigultedTMEfoundtildevelopmentnovelimmunpietrgetimmunomodulryeffectNKcellceptientimmunepecncerGlioblm(GBM)motcommprimrymlignntbrcncermmgmotlethlcncerThemechntictrgetrpmyc(mTOR)dygultedpromentlyGBMhoweverextghibirlimedeirpotrgethibipophrmcologyCoPIKevnShoktelkedcliclTORKipnertib(MLN0128)llotericmTORC1hibirrpmycThfirtbtericmTORC1hibirRpLk-1howedmTORC1-pecificbdgbloodbrbrrierpermebilyLikerpmycthgentboundtightlycellulrchpereFK506BdgProte12(FKBP12)protewehowedexpedthighlevelGBMThuRpLk-1potentlyblockedctlyticATP-ubtrte-bdgemTORmTORC1ccumultedbrtumcellWehowedRpLk-1wmopotentthnrpmycTORKipnertibwhichwetrceduperiphrmcoketicprilecompdpnertibWenextgenertedtrtegypotentehibiRplk-1GBMwhileprgmTORhibioutideCNSdogmicebothRpLk-1br-impermebleFKBP12ligweynizedclledRpBlockThdrugcombtimigtedytemiceffectmTORC1hibirtedefficcyRpLk-1thopicGBMxenogrftWefurdthtrtegydeigngcell-permebleFKBP12-dependentkehibirknowndrugcffoldcludgFK-dtibOutideCNSehibirweenivedectivtiRpBlockenblgbr-trictedhibipectiveketrgetAcliclbtericmTORhibirRMC-5552curntlyclicltrilAGBMtrilopen2023LikeRpLk-1RMC-5552FKBP12-dependentWehypoize1)RpBlockpotenteefficcywhiledecgperipherlxicyRMC-5552GBM2)WecnfurrdevelopourtrtegydevelopFKBP-dependenthibirtrgetGBMcludgtrgetlibilieoutideCNSA1TethypoRpBlockenhnceefficcyducexicyoceduerpmyccliclbtericmTORC1hibirRMC5552GBMA2TethypolkgFK506high-ffyFKBP12ligJAK1/2hibirgenertenFKBP12-dependentJAKhibirSTAT3driveprogirpytnceGBMJAKhibirblockctivtiSTAT3howeverhemlogicxicylimirutilyWegenertenFKBP12-dependentvericliclJAK1/2hibirruxolibWecomFK-ruxolibRpBlocktrtegymximizehibiSTAT3thopicGBMxenogrftwhileprghemlogiclxicieSuccefulcompletideveloppclicltrtegyimprovebrpenetrtiwhileprgperipherlxiciekehibirprovidepcliclrtile1)TetRMC-5552RpblockcombtiGBM2)MovewrddevelopgbothFK-ruxolibRpBlockdrug1PROJECTABSTRACTHepcellulrcrcom(HCC)nggivemlignncypentg7thmotcommcncergloblly4thmotcommcuecncerdethwldwideAlthoughmgneticnceimgg(MRI)pentcommHCCdignoticprognoticolMRIfilprovideightHCCrktrtifictidoenotllowrtilrpeuticlloctiChemiclexchngeturtrnfer(CEST)moleculrMRIhpermnvivemeumenttummetbolmpdictivemlignncyIntegrtiCESTMRIcliclHCCmngementhpotentilrdicllyltercliclprcticeprdigmthrough(1)identifictimllmlignntnodulethoeuncventilenhncementfetucedignoticpermnce(2)improvedpdictumggivenemptientprognottmenttrtificti(3)mirgtummetbolmptientpotrpydiffentetweenpeudoprogichrcterizedtumgifollowgnilcetumburdentruetumprogiThpropolemploynovtiveOncopigCncerModeltrngenicpcemodelcpultehumncncerthroughducedKRASG12DTP53R167Hexpethyponvivemppgvivocte(Cr)metbolmempowerpdictidiffentilHCCtumggiveneCombgournovtiveOncopigCncerModelMRICRISPRprocoloptimizedunderourpvioulyfundedR03R21grntweimgeOncopigHCCtumengeeddplydiffentilCrmetbolmmlignntpotentildemtrteCrCESTMRIcnccurtelydiffente1)HCCmlignncyduetertumgeneticheterogeney2)trtumheterogeney3)peudoprogruetumprogiGenetrgetedcludeubiquiumichdrilCrke(CKMT1)whichcvertATPCrADPphophoctemeetcellulrenergydemCKMT1knockdownducehumnHCCprolifertimigrtivrowhilecedCKMT1erumlevelocedpoprognofollowgrdiquencybltiWeplnteurhypopurugfollowgpecificim(1)DemtrtepplicbilyCrCESTMRItrtifygHCCmlignncyflectivetertumgeneticheterogeney(2)DemtrtepplicbilyCrCESTMRIementtrtumheterogeney(3)DemtrtepplicbilyCrCESTMRIdiffentetweenpeudoprogruetumprogiOncopigHCCtumgrowthCrlevelquntifiedugpirrygtedliverCESTMRIprocolducemotirtifctMRI-guidedbiopycollectienbleco-gtrtibedcomprvromeumentCrCESTementCrCESTenivypecificyThpropolrdicllylterHCCcliclprcticeprdigmenblgnvivehigh-olutivivomoleculrprilgimproveHCCdignoticpermncettmenttrtificttmentpemirgProjectSummryProttecncer(PC)ecdmotcommcncerAmericnmenpible3%tldeth10%dethcncerMotptientexperiencelow-proggdeeignedctiveurveillnceTheeptientpdimmederdiclprottecmy(RP)rdiuedptienthvemodvnceddeeBecueignmentctiveurveillnceimperfectomeptientunnecerilyoverttedburdenunneceryideeffectcotlowerqulylifewhefewptientneedpromptrdiclttmentmyexperiencedelyThelimedttmenptivilbleggivedeeuulfilfewyerThununmetcliclneedlowxicypventive/terceptivegentnturlproductpventPCprogieirdurgctiveurveillncefterRPrdtmentSpheke-ocedprote2(Skp2)puttivecogenetrgeteverltumuppdegrdtiTheSkp2genemplifiedeverlhumncncerInPCSkp2ovexpedp-mlignnthigh-grdeprottictpililneopli(HG-PIN)primrytumuggetgroleerlytgePCSkp2deletiblocktumigeneRb1p53PtendeficientmouemodeluggetgSkp2myervenAchilleheeldrugtrgetgtpRbp53/Pten-deficientcncerHoweverhibirdruptSkp2prote-protetercticuedegrdthroughproteolytrgetgchimer(PROTAC)hvehdlimeducceThuwepropoetedcendictlynturlproducttrgetSkp2degrdtiIncollbtiNtilCenterAdvncgTrnltilScience(NCATS)weue500000nturlproductmpleknowncludehighlydiverifiedchemotypecncer-pventivepropertieToimplementcenwehvedevelopedcell-bedlucifereydegrdtiSkp2everlourcecludgourlrgePCptientcohurprotte-pecifichumnSkp2knock-mouemodelerlyprottecrcogeneourPCptient-derivedgnoidcultuptient-derivedxenogrft(PDX)modelInSpecificAim1(UG3)weoptimizeourcell-belucifereydevelopprotypeHTSycengkp2degrderpermmechntictudieproducthvepotentilutilyInSpecificAim2(UG3)wequntteSkp2protePCprogiThtepwrdidentifygptientwouldnefterceptiviSkp2degrderwhichimptntdevelopgnovelclicltrilInSpecificAim3(UH3)wecompletefull-cleHTSup500000nturlproductNCATSWepermctivy-bedchrcteriztibioy-dictedoltitructurlelucidtipermmechntictudieledgenerteddurgcengInSpecificAim4(UH3)wedetermevivochemopventiveefficcyxicymechnmtwocfirmedcompoundthroughdietrydmtrtinovelprotte-pecifichumnSkp2knock-mouecrcogenemodelPDXmodelImpctPoiveultthtudyidentifynovelnturlproductterceptiprogierlytgePCMeurgSkp2lrgePCptientpopultillowidentifictiptientmotlikelypdllowgdevelopmentnovelclicltrilPROJECTSUMMARYThecentpprovlimmunpiehvolutiizedpprochmnggblddercncer(BC)NeverlecompletepeobervedlymyptientnounmbiguoubiomrkerguidettmentelectiAkeyfcrctroltumgrowthpecncerimmunerpycrumentimmunecelltummicroenvirmentchemokeThechemokeCCL2(C-Cmotiflig2)tknownbilyducetrffickgimmunecellbdgprimryceprCCR2ThecrumentimmunouppivemyeloidcellCCL2promotecncereverltumtypeInbldderhoweverwehownunexpectedfdgCCL2ceprCCR2protectivegtcncerdevelopmentgrowthmechnmTcell-dependentWelohowpot-trnltilnrtiCCL2blddertumhibCCL2bilycruTcelleffecttumctrolThmyecriclhdfiluchemokeclicltrilmyexplcertprdoxeeentweenCCL2levelptienutcomecncerWepropoedeletgeffectCCL2nrtibiologyBCugnrti-tntcombntCCL2(rCCL2NR)whichmyblddertumTcellcrumentfciltenti-tumTcellimmunyBedcvcgplimrydtwehypoizenrtiCCL2BCbltetumprotectivefunctiCCL2/CCR2druptgTcellcrumentblddertumToddthhypotwopecificimpropoedInAim1wetethypoblockgnrtiCCL2rCCL2NRduceBCprogienhncgcrumentCCR2+TcellbldderrCCL2NRttmenteffecttetedtrveicllytillgrCCL2NRvrCCL2vctrolPBSweeklybldderWelodeletepecificmechnmwhichrCCL2NRexerttum-protectiveeffecttetwherrCCL2NRceCCR2+TcellcrumenrcectivticyxicyldycruedCCR2+TcellbldderrCCL2NRevlutedeirglegenrcombtitrdBCttmenttrtegieAim2tetwhernrtedCCL2levelhumnblddertumprognoticfcrpdictttmentpeimmunerpyBCptientMultipleximmunluocenceueddetectunmodifiednrtedCCL2levelBCtuemicrryWelotetwhertrveiclhumnrCCL2NRttmentultcedcrumentTcellhumnizedmumodelBCThefocuthpropoldevelopn-depthundertgnovelcellulrtrffickgmechnmimmunecellbiologyBCdevelopmentbkthroughimmunpytrtegypotentillyimprovelcpeBCttmentOverllR01wrdprovidedpenbleupptnewvetigretblhherdependentleBCimmunologyerch(ESI)ABSTRACTAlthoughmotmelnomdethcueddtntmettmechnmgultemettpolyunderodDurgmettcncercellencounteroxidtivetblooduccefulmettquicncercelldptthhotileenvirmentundergogmetbolicchngeOnewywhichoxidtivetcnkillcellthroughferropmrkedccumultilipidctiveoxygenpecieRecentwkDrUllckertudiedcovedmelnomcelllymphprotectedgtferropTheetudieveledlymphprotectferrophvghighlevelmounturtedfttycid(MUFA)oleiccidwhichhieldcelllipidoxidtiducgbundncepolyunturtedfttycid(PUFA)undergolipidoxidtimembrneTheeobervtiuggetmypoibletrgetlipidmetbolmcncercellpventcncerpdlymphnodeHoweverwedotknowwhtextentlymphnodemicroenvirmentprotectmelnomcelllipidoxidtiNdoweknowwhtlipidomicdpttimelnomcellundergolymphnodemicroenvirmentenblemmettizemoefficientlyTheobjectivethprojectidentifyexplolipidomicvulnerbiliemelnomcelllymphticmicroenvirmentpventerly-tgemelnommettToccomplhthobjectivethprojectueclicllylevntmodelmelnommettptient-derivedxenogrftwellmumelnommodelimmunocompetentmicehumncliclmpleThecentrlhypomelnomcelllymphnodemicroenvirmentundergopecificlipiddpttixidtivettrgetgedpttipventmelnommettlymphnodeThecentrlhypotetedthepecificim1)TovetigteextentwhichmelnomcelldependN-cylglyceynurvivllymphnodewherthynpthwycntrgeteddecemelnomcellurvivl2)Toectriidietrytrcellulrfttycidcglipidoxidticgdethmelnomcellmettelymphnode3)TodetermeextentwhichferroptncecntrgetedduceurvivlmelnomcelllymphnodeByidentifygfluencelymphnodemicroenvirmennlipidomicchngemelnomcellweexpectdetermelipidmelnomcellerveprognoticbiomrkeridentifyfeiblelipidomictrgetdietryterventipventpderly-tgemelnomimprovedeeoutcomeptientThemjycurnvrincncerpdperinelcvymcewhetumcellgrowpheroidmettizegncugmbidydethTheoverllgolthpropoldefemechnmwhichprotekectrolpheroidgrowthmettovrincncercelluethmtidevelopkehibirrpiettmentcurnvrincncerTheCdc42downtmeffecrprotekeMRCKMRCK(MRCK)highlyexpedovrincncerhveenimplictedcellmigrtivimettStrikglywecentlydcovedhibiMRCKimpidctcykelenmodelgfocldheiemblyblockgcellmigrtipheroidgrowthviovrincncercellvelgMRCKnewuntppedtrgetttmentcurnvrincncerMooverourmotcentfdghowedhibiMRCKblockedtumgrowthducedtumpopovrincncerxenogrftcemodelNeverlemechnticbMRCKuppvrincncerpthogenempolyunderodOuroverllhypoMRCKctrolpheroidgrowthviovrincncercellthroughgultictcykelenmodelgvolvephophylti/terctiproteocedctmyoignlgTotetthhypowehvedeignedtwoSpecificAimAim1IdentifyMRCKprotetercr/ubtrtectrieovrincncerugproteomictrtegieAim2DetermeeffectMRCKhibipheroidvibilyviugvrovivoovrincncermodelInAim1wepermfocuednlyourcurntMRCKubtrtecidteugphophtibodiempectrometry2D3DcultudecipherfunctiMRCKphophyltieventuge-dictedmutgeneNextwepplyundproteomicmethoddefeddilterctgprtnerubtrteignlgpthwyctrolledMRCKTogerweetblhbfideMRCKubtrtedefemechnmwhichMRCKpromotepheroidprolifertiurvivlviovrincncerInAim2wehibMRCKmirvibilyvictmodelgovrincncerpheroidgnoidceoltedptientmettticdeeNextugpnelthopicovrincncerptient-derivedxenogrftwehibMRCKmeuvivotumgrowthmettceTogerwkpropoedhedefemechnmwhichMRCKpromoteovrincncergrowthmettetblhMRCKnewtrgetcurnvrincncerPROJECTSUMMARY/ABSTRACTDepebkgdvncemelnomttmentuchdoptivecelltrnferimmunecheckpotblockdeclicloutcomemuntfcryduevrioufcrlimefficcyrpieTomeetechllengeimmunpyolidtumthprojectimdefeeukryoticelgtifcr-2ke(eEF-2K)noveleffectiveimmune-modulrytrgetcnexploedignificntlyimproveeffectivenecurntcncerimmunpyeEF-2Klgfmilytypicl-kenevolutirilycervedgulrproteynmoleculrproceffectenergymetbolmThkephophylteeEF-2100-kDprotepromoteriboomltrnloctiAP-ectiducemovementmRNAlgriboomedurgtrnltiPhophyltedeEF2unblectlyzeriboomltrnloctihibgpeptideelgtiOurplimrytudietrglyuggeteEF-2Kn-yet-unppcedcriclgulrntumimmunytegrtivetrgetgthkemyneficillymximizepotencyimmunpeuticterventigtmelnomemotggiveftlneoplmpibleover80%kcncer-lteddethBuildgourplimryobervtieEF-2KnlyhighlyexpedmelnomcellptientpecimenctrieporpeuticoutcomelobundntlyexpedimmunecelluchTcellgulteirfunctilctivywepropoetetcentrlhypoeEF-2Kmodultentumimmunyvigulryroleboumcelltum-ctiveimmunecelltegrtivetrgetgeEF-2KcouldexploednnovtiverpeutictrtegyttmentmelnomThroughcomphenivecellulrmoleculrp-clicltudiethmultiplePIprojectpuruefollowghighlyltedterctiveim(1)Determerole-depthmechnmeEF-2Kimmuneevi(2)DeferoleeEF-2Kgulrtum-ctiveimmunecell(3)EvlutentumefficcyeEF-2K-bedtegrtivetrgetedrpyWehveetblhedhumnizedmoue(NOD-cidIL2Rgnull)melnommodelwellmuyngeneicmelnomytemtherchwellpoedccomplhboveobjectiveTherchnovtiveignificntcueuccefulcomplethprojectwouldnlyveleEF-2Knoveleffectiveimmuno-modulrytrgevercomgtumimmune-tncewellgultgimmunecellfunctiloprovidenewrpeuticopptunieubtntillyimproveimmunpydvncedttment-frcrymelnomthrougheEF-2K-bedtegrtive-trgetedpprochProjectAbtrctOver297790newcevivebtcncerdignoe43170dethmettticbtcncer(mBC)expectedUSAthyer(SEERdtbe)Depedvncettmentloclizeddee5-yeroverllurvivlptientmBCmtdml29%CurntrpeutictrtegieprimrilyfocutumcellneglectimptntroletumtromplycncerprogiUndercgimptncetromlcomprtmenttromlgeneigntucnpdictclicloutcomebtcncerptient7Themotcommebtcncermettuntuntelycedeemettizecidedcurblettmentmlypllive8IntumtromctwiderrycelltypecludgfibrobltdipocytenervecellendolilcellimmunecellchdrocyteoteocyteoteobltoteocltNerlylletromlcelltypehenimplictedtumprogidictlyupptgtumcellgrowthurvivlmodultgimmunepetum/drivgloignevicioucycleupptfurrtumgrowth8Oneimptnttromlcellupptprimrytumprogienecentcellwhichwcentlydecridnemerggcncerhllmrk9Indeedwedemtrtedenecentfibrobltdrivetumgrowth10cteimmunouppiveenvirment11primrytumettgthroughexpip38MAPK-dependentenecenceocedecryphenotype(SASP)fcrWhermemechnmctivemettticettgmnopenquetiWehvefoundp38MAPKhibi(p38i)ducemBCprogrgetgmetttictromlcomprtmentnottumcellnumeroupcliclmodelInthpropolweexmehowp38MAPKctivtimetttictromctrietumprogimodifieimmunepellowmBCprogWeutilizegeneticphrmcologicolidentifycelltrgetp38idetermeifnewtromlcellwehveidentifiedenecentmetttic-ocedcncerocedfibroblt(meCAF)ctriecncer-ducedlodetermeifmeCAFmodifyhotimmunepeOurgolunderthowp38iltertromlcomprtmentdecemBCprogiothknowledgecnlevergeddevelopcombriltrtegiedeployp38ienolytic(drugkillenecentcell)immunpylimmBCprogiAbtrctTherpiddiffuigenetictetgcrodultcncerdignoeuniqueopptunyperlizecncerttmentpventpopultilevelGermlegenetictetgguidelehvebrodenedencompnerlyllptientbvrinpncticcncerllptientdvncedprottecncermnyptientcoloctlendometrilcncertypeThegrowguegenetictetgdrivgdevelopmentpcicologynewprdigmperlizgpventtmentbedgenetictetgultdditedtrdilly-meudtumfetuIncglynheredpthogenicvrintpecificgeneerveneentilcommthdcnectdiverecncerdignoeenblegeneticlly-trgetedcncerrpyHoweverweknowvirtullynothgbouthowgenetictetultmngedcrocncertypeWepieedGegi-Clini(GACA)GeneticTetgLkgeInivelkgdutry-providedgenetictetgdtSEERgtrycdlldultdignoedcncerGegiClini2013-19WefoundgenetictetgcrocncercdihcedrteolowltivecliclcommendtiOurfoundtilwkundercourgentneederchbouthowwellgenetictetgultbrodlytegrtedmngementcncerWenowcompletgnextpheGACAGeneticTetgLkgeInivemerggSEERdtlldultdignoedcncerGegiClini2013-21(N=1826000)nupdteplnnedcncerdignoed2022-23(N=456000)geneticultthrough2025Weuethuniquepopulti-beddtfrtructudetermewhergenetictetgultmngementeffectivelyperlizedcrocommcncerhightetgrteWeloexmecncermtlygenetictetgultmcommunictiboutprognoperlizedttmentOurhypoefollowExteniveneurgery(eggnpervtivmovl)well-perlizedtrglyocedclicldictiderivedtumfetuhotfcrctiblegeneticultnotn-ctiblegeneticultocioecomichelthcytemfcrReceiptchempygeneticllytrgetedytemicrpie(immunecheckpothibirpoly(ADP-riboe)polymerehibir)well-perlizedettmenttrglyocedclicldictictiblegeneticultnotn-ctiblegeneticultocioecomichelthcytemfcrAmgcncerptientttedytemicrpieptientPVhvelowercncer-pecificmtlyctrollgtumfetuttmentcombidieocioecomichelthcytemfcrProjectSummry/AbtrctNeuroendocprottecncer(NEPC)motvirulentmdeeLotumuppTP53/RB1ubiquiuNEPCmoleculrmechnmexplhowloTP53/RB1promoteNEPCdevelopmentlrgelyunknownFurrnoeffectiverpieNEPCThuclerneedclrifytrgetblemechnmNEPCowemydevelopnewttmentLoepilildiffentiecriclhllmrkNEPCWeidentifiedpecifictrncriptilpturnedTP53/RB1loblockrogenceprignlgepilildiffentiActivtineuroendocdiffenti/epilil-meenchymltrni(EMT)progrmnhllmrkNEPCWeidentifiedimptntctivrthprogrmloturnedTP53/RB1loImptntlyblockgpprotedrugpproveduecncerblockgctivrprotedrugcurntlyclicltrilprottecncerducegrowthNEPCtumvrovivoHoweverwefdcombtirpyprticulrlyeffectiveThpplictideignedclrifymechnmwhichtmentcombtiblockNEPCcellurvivlWehypoizeTP53/RB1loctivtekeyfcruppepilildiffentiwhileloctivtgthoepromoteNEPCdiffentico-trgetgthcomdxmoeffectivecueepilildiffentiblockneurl/EMTpthwydogoblockdptiveglegenttncemechnmAim1DetermemechnmwhichloTP53/RB1lopeepilildiffentigeneexpiComplethimprovidedetiledundertghowTP53/RB1loturnkeydowntmpblockepilildiffentiowecnpventoccurrgAim2DetermemechnmwhichblockgkeytrncriptilpctivteepilildiffentiComplethimdetermehowkeytrncriptilpblockepilildiffentiowecnidentifymotublephrmcologicgentuppirfunctiAim3BlockNEPClegeplticytumgrowthmetttrgetgkeytrncriptilctivr+pducedTP53/RB1loNEPCtummodelmiceComplethimidentifyvivopebiomrkermeufetyprovidertiletetthcombtifutuclicltrilfocuedptientNEPCWeexpecttudiepropoedmechnticllyclrifyfunctinetwkducedTP53/RB1locriclurvivlNEPCtumTheeultmyhelptrnltenewcombttmenttrtegyclicblockthnetwkmenNEPCner-termProjectSummry/AbtrctHedneckqumoucellcrcom(HNSCC)tenocedhumnppillomviru(HPV)fectiThecidenceHPV+HNSCChenrpidlyrgdurgpt2-3decdeThucriclgtterundertgpthogenicmechnmHPV+HNSCCctextimmunecognielucidtemechnticdetermntunderlygrpypivenevtnceHPV+HNSCCTheeffectimmunecheckpothibir(ICI)highlyheterogeneouHNSCCptienthowevermcompletelyunderodwhernti-HPVpectrieICIefficcyRecenttudiehowedHPV+HNSCCpdedtterthnHPVHNSCCneodjuvntnti-PD1triluggetgeffectiveHPV-ltedpemynefICIttmentThegolthpropoldetermewherhoweffectiventi-HPVimmunepemyctrieICIefficcytetgifbdthdepthTcellcepr(TCR)pegtHPVntigenffecutcomerpypeHPV+HNSCCughumnmpleclicltrilmuHNSCCmodelPritudiefocueddefedE7-derivedpeptideHPV-ltedcellulrrpyHoweverHNSCCtum-filtrtglymphocyte(TIL)ctmuchmoHPVE2-ctiveCD8TcellthnE7-ctiveeHencewetetTCRgtdiffentHPVntigen(egE6/E7vE2)elucidtemechnticcnectitweenHPV-pecificTCRrpeuticpeOurpropoedtudiemyovercomebrrierHNSCCfielddevelopnewolboxtrgetgHPV+HNSCCmximlbdthdepthTCRWeemploynovelwdowopptunytrilopenurtuti(HCC18-139)teteffectnti-PD1(nivolumb)vnti-PD1+nti-CTLA4nti-LAG-3neodjuvntettgeurgeryectilocllydvncedectbleHPV+HNSCCAddillyweemployHNSCCmouemodel(mEER)expgHPV16E6/E7ntigenwhichmllfrctum-rgcipientpdednti-PD-L1ttmentllowgunmbiguouidentifictipdervn-pderUgeneodjuvnttrilmplewetetwhernti-HPVimmunepeunderlieICIpeexmewherHPV-ctiveTCRclldynmicTcelltrncripmicTILclteICIpeOurmouemodelllowfunctilvlidtiexpedHPV-ctiveTCRclotypecltgICIpepermntigenmnipultienhncecliclpivenewelllygroundwkfutuclicltrgetbletrilSUMMARYThebilycncercellcquitncenticncerdrugultgeventulttmentfiluemotchllenggproblemcncerrpyOimertib(AZD89291)nEGFRmutti-electiveEGFRtyroekehibir(EGFR-TKI)FDA-pprovedptientEGFRmutnt(EGFRm)NSCLChcometnt1tgenertiEGFR-TKIviT790MmuttiEGFRmutti-poivedvncedNSCLCfrt-lettmentDepepromgcliclefficcycquidtnceevblyoccuroimertiblimglg-termcliclnefThuthoughundertgmoleculrmechnmccountgemergencecquidtnceoimertib3rdgenertiEGFR-TKIdevelopmenteffectivetrtegiemngecquidtncenurgentcriclunmetneedclicTelomemtenncevelomerectivtidictlylkedunctrolledcellgrowhuhllmrkcncercellWhiletelomerectivyilencedmothumndultomticwell-diffentedcellctivtedup90%tumThutelomerepentnttrctivetrgethighlyelectivecncerrpeuticIntriguglywefoundthimertib-ttedhumnEGFRmNSCLCcelllepoeubtntillyducedmRNAprotelevelhumnTERT(hTERT)ctlyticproteubuntelomerecomplexdetermectivyInEGFRmNSCLCcellleoimertibcquidtnceblhTERTlevelweelevtedcompdirpntlcelllecmeeniveoimertibmodultihTERTelevtiwlodetectedmjyEGFRmNSCLCtuelpedEGFR-TKIttmentKnockdownhTERTchemiclhilomereenizedoimertib-tntcelloimertibTheeplimrydtuggetcriclrolehTERT/telomeremodultgpeEGFRmNSCLCcelltumoimertib3rdgenertiEGFR-TKIThuwehypoizeeffectiveuppihTERT/telomerecricleventmtglg-termrpeuticefficcyoimertib3rdgenertiEGFR-TKIttmentEGFRmNSCLCThhypotetedccomplhgfollowgtheim1)ToundertmoleculrmechnmwhichoimertibuppehTERTexpiEGFRmNSCLCcell2)TodemtrtebiologiclignificncehTERT/telomeremodultigultgpeEGFRmNSCLCcelloimertibcludgdevelopmentcquidtnce3)Todevelopefficcioutrtegiemngg(delygovercomg)cquidtnceoimertibtrgetghTERT/telomereTheobjectivethpropolfullyundertmechnmwhichoimertibhibhTERTexpelomerectivydemtrtecriclrolemedgcellpeoimertib3rdgenertiEGFR-TKIcludgcquidtncedevelopeffectiverpeutictrtegiemngeoimertibcquidtncetrgetghTERT/telomereSummryPtientextrbrchiltumducemlignntcentrlirwyobtructi(MCAO)fceignificntmbidyly1-7mthmedinoverllurvivlAnetimted20-30%ptientlungcncerhveMCAOdurgcoureirdeeburmlignnciemettizeirwycnducecentrlirwyobtructiWehvecentlyptedPheItudyPhotrmededimge-guidedtertilphodynmicrpy(I-PDT)ournovelttmentplnnglightdoimetrypltmfepromgoutcomeTheout10ttedptientlivet2651283mthOurimge-bedttmentplnngwuedguidedmtrtilightdoerte(irrdince)lightdoe(fluence)trgettumwhileprgdjcentnmltueOurgolimprovertecompleteprtiltumpeextrbrchilMCAOI-PDTToendwepropoecetumbloodoxygenticelerlighttrnmioxygenupplyknownimproveefficcyPDTMutudieptedpllivex-ryrdipy(p-XRT)cncetumoxygentiltervcultuWeeexplouep-XRTimprovetumpeI-PDTOurplimrydtdemtrtep-XRTfollowedI-PDT(p-XRT/I-PDT)ignificntlyce(p<005)completepelocllydvncedmouetumcompreirI-PDTp-XRTUndercompecexemptiwehowedI-PDTdelived484hfter8Gyx1p-XRTcnprovidectrolextrbrchilMCAOtwoptientThenoeffectivettmentextrbrchilMCAOThuoverridgignificnceourpropolpivenenunmetcliclneedWehypoizetrdcp-XRT(8Gyx1)followedI-PDTfeimprovettmenutcomeptientextrbrchilMCAOthimprovementduechngetummicroenvirmentToteurhypowepropoeccomplhfollowgimAim1TocductPheI/IItudytetfetyefficcyp-XRTfollowedI-PDTptientextrbrchilMCAOWedefeuccedemtrtgtmentfeult50%prticipnthvgprtilcompletetumpe/ignificntimprovementqulylifephyiclpermncet3mthpotttmentWetrnmiimmunemrkertumpeevluteltihipchngelightAim2Todefemechnmwhichp-XRTimprovetumpeI-PDTmouemodelWedefehowchngetummicroenvirmentimpctlighttrnmumpewellctriinti-tumimmunytumctroltum-feurvivlTheedtmdeignfuturomizedPheIItrilp-XRT/I-PDTverutrdcPROJECTSUMMARY/ABSTRACTOverviewThegolthtudydemtrteefficcycognive-hvillybedpychoocilterventi(BMT-CARE)compduulccgiverptientundergoghempoietictemcelltrnplntti(HCT)identifycriclfcilrbrrierterventiimplementtidoptiBckgroundFmilyfriendcgiverptientundergogHCTexperienceubtntildteHCTycopeuncerttyptientprognoptientenduignificntxicieAddillyprimrycgiverptientdurgimmedepot-HCTcourecgivertenmn-gedemgcheduleppotmentexperienceubtntilcgivgburdenterfergirperllivepibilieSceedividulexperiencetenepecilizedcgivgburdenwhichpertedurgeverlmthfterHCTcriclneeddeveloppopulti-pecificterventiddirneedcrotrnplntctuumHoweverclbleterventiupptcgiverthroughoutptientHCTcourelckgWecompletedglecenterpilottrilBMT-CAREddneedcgiverpridurgfterHCTwhichentiledixe-hourvtdtudyrptdurgHCTcoureWedemtrtedterventiwfeibleplimrilyledclicllyignificntimprovementcgiverqulylifemoodcgivgburdenelf-efficcycopgkillThuthwfirttriletblhbothfeibilyplimryefficcyBMT-CAREimprovgoutcomecgiverHCTcipientReerchPlnWepropoecducthybridtypeImulti-eromizedeffectivene-implementtril400cgiver-ptientdydundergogHCTtetefficcyBMT-CAREvuulcimprovgcgiverQOLcgivgburdenmoodcopgelf-efficcyWeloexmeimpctBMT-CAREptient-ptedoutcomehelthcutiliztiFllyweidentifycriclfcilrbrrierBMT-CAREimplementtidoptiugRE-AIMQuESTmixed-methodfrmewkEnvirmentThprojectcductedtMchuettGenerlHopl(MGH)UniveryAl-bmtBirmghmMftCncerCenterwhichcollectivelycduct350-400trnplntperyerTheeehveupptivecologyerchexpertefrtructutrnplntexperienceproceecductrilTheMGHerchtemhexpertedevelopgtetgmulti-eplliveupptivecterventiptienthemlogicmlignncieircgiverenuuc-cefulimplementtievlutiBMT-CAREcrotudyeRelevnceReerchThprojectetblheentilfoundtifutuimplementtidemtrilBMT-CAREcliclprcticeAbtrctHtripynultroundurgicltechniquen-vivebltueueveryteneburtfocuedcouticenergymechnicllyfrctutuethroughcvtiApilotclicltrilliverbltihhownfetyefficcygoodlernceptientwhilelrgermulti-etrilcurntlyunderwyThpropoleekolvetwokeylimticurnttechnologyhderwidepdclicluehtripybltidivererngeptientThefirttrgetgCvtibubbleproducghtripyrpeuticeffectdictlyviblehighenivyctrnultroundimggHoweverpriirpypcetrgetloctihnuncerttydereverlmillimeterduefrcticouticfieldvrioundpeedAim1chievethgoldevelopgnultroundimggequencedictlyvulizehtripyfocuoutproducgcvtiTheecdlimtirrtiInddifoclhiftfrctueoundpeedheterogeneyducepekmpludehtripyoundfieldMeumentcouticimultihowignificntmpludeductiwouldcovedugrrticcti(AC)techniqueSimultifurruggetevenhighetpermncetrnducertechnologyhvelimedttmentenvelopewhentrgetgdivererngeptientFim2weoptimizenACtechniquehtripycoverthlotfoclpudetermetprcticeuewhenbltgtuevolumeFim3wevlidteboechniquehumncdverueultclibrtefurrcouticimultiClibrtedimultillowcomphenivetudiedivererngeubjectfciltedeigngnextgenertioptimizedtrnducerrryhtripybltiSummryTummticncercellprolifertidependenhncedriboomebiogeneproteynRiboomemoleculrmchepibleproteproducticellEmerggdtdictehibiriboomemtifuncticnpventcncermgcertctextFexmpleliverdeepdpoeptientlivercncercludghepcellulrcrcomrnimrkedenhncedriboomebiogeneInhibiriboomefunctipventlivertummtimouemodelThuddilcompoundttenuteriboomeproductictivymyblepventmtumUntuntelypvioulyvilblemethoduedtudyriboomebiogenelbiounoteilyclbleThhignificntlyhmpeddevelopmentnewriboomebiogenehibirToovercomethcriclbrrierwehvedevelopednnovtivepltmwecllribo-SNAPwhichllowuydynmicriboomebiogenetglecellolutilivgcellUgthpltmwehveuccefullycompletedpilotcompoundcenidentifiednewgenemllmoleculehibproteyncpcycncercellInprllelwehvelodevelopedecdnovelyclledSidBwhichllowurobutlyrpidlyidentifycompoundtrgetcellUgepprocheweuniquepoiidentifydevelopriboomebiogenehibireffectiventi-cncergentWenoweekexpoureftlrgerNCInturlproductlibrryThepropoldividedUG3UH3ectiUnderAim1wefurroptimizeribo-SNAPpltmcductmllpilotcenubetfrctiSOOKnturlproductlibrryInAim2weueSidBidentifytrgetcompoundidentifiedpilotcenourgogcenndependent3SOKcompoundlibrryExperimentdecridunderAim3dictlytetextentwhichriboomebiogenehibircnpventlivertummtimouemodelTheetheimhveclermilenewenticipteuccefulcompletiUG3phellowprojectdvnceDurgUH3phelrgecengexpentiSOOKlibrryunderAim4SidBuedAim5gdetermemechnmctipecificcompoundFllyunderAim6mouemodeluedtetwherledmoleculepventcncerprogiTheuccefulcompletientiprojectdecridthpropolprovidenunprlleledcollectiriboomebiogenehibircnfurrdevelopednovelrpeuticpventilivercncerABSTRACTNturllyoccurrgbioctivecompoundextenivelytudiednticncergentprticulrlyrpeuticterventiItetimtedbout25%llnewlypprovednticncerdrugderivednturlproductAlthougheverlbioctiventurlproductwetudiedprovenefficcioupcliclmodelirprogclicmeluiveduelckpecificywrdedeidclicllylevntterceptivetrget()ThuUG3/UH3RFADcoveryDevelopmentNturlProductCncerInterceptiPventkedvntgewldlrgetmotdiverelibrriep-frctednturlproductNIH-NCATSourcecenidentifybioctivefrctiwhichtrgetclicllylevntterceptipthwycoloctlcncer(CRC)TheetrgetmicroomlprotglEyne-1(mPGES-1)5-Lipoxygee(5-LOX)nhedecrboxyle(ODC)mPGES-15-LOXODChighlyover-expedcolicpneoplticleiirmetbolePGE25-HETE/LeukotrienepolymeplycriclroletumprogiThertileelecteclicllylevnttrgetbedfcti)lckhighlyelectiventurlgentwhichtrgetmPGES-15-LOXODCtn-xicdoeii)trgetgmPGES-1/5-LOXmypPGI2(nthrombotic)voidcrdiovculrrkiii)combghibirPGE2polymewouldprovideynergtichibiCRCBedbovertilewepropoefollowgAim/golUG3UH3pheGolUG31EtblhoptimlHTSymPGES-15-LOXODCugpurifiedprote~1500nturlproductfrctiNCATS2Etblhtetecdryyelectivyctivyugcell-bedyfurrvlidtetrgetgrowthhibignoidy3Evlutef-trgetcellulrxiceocednturlproductelectivehibirmPGES-15-LOXODCGolUH31CductfullcleevlutiNturlProductLibrriecollbtiNCATSthroughNCItnce(350000-500000nturlproductmple/frcti)HTSpotentilcncerterceptigent2IoltitructurlelucidtiMicroEDctiventurlcompound()bedelectivehibimPGES-15-LOXODCFollowedclgupledmolecule3DetermeEx-VivoIn-VivohibiryeffectbioctiventurlproductcompoundmPGES-15-LOXODCmetbolmefficcyCRCterceptiPROJECTSUMMARYTheprimryobjectivethpropolenovelgt4-1BBcotimulrypthwySA-4-1BBLglegentcncerimmunopventipcliclmodelcloelypenthigh-rkpopultiuceptiblelungcncerultgenvirmentlexpouAdvnceimmunologyleddevelopmentimmunpiemrkblecliclefficcygtvrioutumputimmuneytemtefrtbttlepventterceptttcncerTheperceivedmodliecncerimmunopventivccewhichwell-uedvirlly-derivedtumcueknownntutrgetntigenInmrkedctrtdeignpventivevccegtn-virltumhigh-rkpopultifceignificntchllengedueunknownntutrgetntigenThucncerimmunopventipprochdoenotquintigenervepltmpventwiderngetumtypetrnmtiveThe4-1BBcotimulrypthwyhentrgetedcncerimmunpycuecriclroleignlgthroughthceprplyexpniCD8+Tcellcquieffecrfunctilg-termurvivlThenturllig4-1BBLcellurfceprotelckcotimulryctivyolublemoleculeAnlterntivegticntibodie(Ab)4-1BBhveenpuruedcncerimmunpyhownignificntxicylimedcliclefficcyWehypoizednturlligwouldlckettrieAbgenertednoligomericmmoueligmSA-4-1BBLThmoleculehrobutcotimulryctivyolublemhowedrpeuticefficcyimmunedjuvntcompenttum-ocedntigen-bedvccevrioupcliclcncermodeloutdetectblexicymSA-4-1BBLglegentloprotectmicegtvrioutumtypehighlyignificntunexpectedfdgCncerimmunopventiefficcybfidefetumSA-4-1BBLgticAb4-1BBcepreffectivemSA-4-1BBLexhibunexpectedefficcypventgcncermicelckg4-1BBcepruggetgvolvementddilimmunepthwy()Aerietudieunder4SpecificAimcductedi)identifyddilpthwytrgetedSA-4-1BBLcncerimmunopventiii)eefficcySA-4-1BBLbccocrcogen-ducedpclicllungcncermodeliii)genertehumnveriSA-4-1BBLeefficcygtlungcncermouemodelexpghumn4-1BBcepriv)ecncerimmunopventiefficcyhumnSA-4-1BBLmouemodelhumnizedhempoietictemcelltrnplntedptient-derivedlungcncerVrioutudiecductedelucidtemechnticunderlyguccefiluSA-4-1BBL-bedcncerimmunopventiVlidtiSA-4-1BBLneffectivecncerimmunopventigenttrnmtiveubtntillychngecliclprcticecncerttmentignificnthelthfncilnefwldwideAbtrctMultiplemyelom(MM)ncurbleplmcelltumpcededdefedpneoplticttetermedmocllgmmopthyundetermedignificnce(MGUS)Strtegieeffectivelytercept/pventcliclmlignncymnunmetneedfocuthpplictiChngemicrobilcommuniehveenextenivelytudiedctextcnceroutcomerpyHoweververyfewculltihiptweenpecificmicrohumnmlignnciehveendefedublemodeltudyeterctilckgItcglyppcedMM/MGUSigteettgprichricflmmtiBcellctivtiunderlygtriggermunknownThpplictivolvethePI(DhodpkrFlvellPlm)complementryexpertetrckcdproductivecollbtiThepplictibedexcgplimrydtdecribgdcoverycommenlmicrobilpeciedictlyenggeeverlhumnMM-ocedB-cellceprThuppteddtnewhumnizedmodeltudyterctitweenhumnimmuneytemmicrobilcommunievivoThepropolloutilizebiopecimenMGUSptientttedhtcourentibioticducepthogenicbcteriStudiepropoedthpplictichrcterizefullpectrumhumngutmicrocnpotentillyerventigenictriggerhumnBcellMGUSItloevluteculltihiptweenpecificmicroctivtihumnBcellwellMGUScellutilizgnewlydevelopedmodelFllyevlutehowmicrobilmnipultiMGUSptientcnimpctflmmrymicroenvirmentknownpentimplictedpthogeneMGUStrnicliclmlignncyTogeretudiemylednovelpprocheimmune-pventicliclMMtrgetgunderlygpcurtteuchMGUSInightetudiemylohveimplictiterctitweenpecificmicrohumnBcellbrodlyimpctghumnuimmunycncerimmunpyProjectSummry/AbtrctTheoverrchggolpropoederchelucidtegmechnmdevelopmentcncer-prechricflmmticncerpventirpyChricflmmrydeeuchchricdermtpnctcolheptmjrkfcrcncerInddum-promotgimmuneenvirmentwhichemblechricflmmtikeydrivercncerdevelopmentcromjycncertypeBytudygmedirtrnicutechricflmmtiwehvedemtrtedterleuk(IL)-33cykekeyirchricflmmtieventullyledcncerdevelopmentkcolpncImptntlywehvecentlydcovednuclerfunctiIL-33epililcellplyneentilrolecncerdevelopmentchrickpncflmmtiTodevelopneffectivetrtegyuppcncer-prechricflmmtiwefocumechnmblockgtepdevelopmentcncer-prechricflmmtiFoundedournovtivedcoveryIL-33neentilircncer-prechricflmmtiweimdetermemechnmIL-33ductueexpoedflmmryultdevelopnovelrpeuticpprochhibIL-33expicncerpventirpyToccomplhthweuenovelmouemodelcliclmple(1)determemechnmIL-33ductichricflmmtriggedchemiclgent(2)vetigteroleIL-33cncer-prechricflmmtiocedvirlfecti(3)tudyhibirIL-33cnblockchricflmmtiubequentcncerdevelopmentTheoutcomeourerchetblhfundmentlpthwyuppchricflmmti-ocedcncerprovidemenpventcncerprogicurnceProjectSummry/AbtrctTheoverrchggolpropoederchlizeimmuneytempotentilbtcncerpventiBRCAmutticrrierImmunpeuticgenthveproveneffectivettgmettticcncervigtgntumimmunepedevelopdurgcncerprogimettInctrurerchfocuecncerimmunopventiimidentifyimmunepthwycnpventbtcncermtinmlbtglblockp-cncerouleidvncgvivedeeBRCAmutticrrierThpprochuniqueopptunydcovernovelimmunemechnmcnlevergedbtcncerpventirpythhigh-rkpopultiWhultimtegolerlyterceptielimterkmettticdeewevetigteunderlygmechnmimmunecellctivtiwehvedcovedBRCAmutntbtglWe(1)determebtgl-derivedimmunefcrduceimmunepeBRCAmutntbtgl(2)exmechrcterticimmunecellfiltrtgBRCAmuttibtgl(3)vetigteimpctimmunecellBRCAmutntbtglcncerdevelopment(4)identifynovelterventicnpotententumfunctilyimmunecellBRCAmutntbtglImptntlywelevergeouroptimizednimlmodelelucidtecriclimmunepthwygultgBRCAmutntbtgldifficultdcernhumntuedueter-ptientheterogeneyUltimtelypropoederchimetblhfoundtibtcncerimmunopventinefgptientthighrkbtcncerdevelopmentcurnceProjectSummrySugrydrklrgetgleourceclieUSdietctriepproximtely8%7%tlenergytkeUSyouthdultpectivelyUntuntelypvlencedilyugrydrktkeignificntlyhighernmetropolnUScountieltivemetropolncountie(djutedpvlencertio=132)Aletimted47%childnge2-5cumeugrydrkdilyHighugrydrktkectriedevelopmentnumerouchriccdicludgcncerDepecvcgdnrkyugrydrkhvirurlcountiemgpchool-gedchildnubtntilgpterventilertuFexmplefewugrydrkterventihvetrgetedneedUSrurlgifewhveeffectivelyuedclbletechnologyducechildugrydrkmotfilpnexternlvlidyfcrOurpplictiddeeneedbuildourtemextenivediglHelthexperteuccefulugrydrkerchrurlcommunieWetrgetHedStrtcrodefedrurl(ieRUCC4-9)ApplchiournBlckBeltOurpropoedterventrgetpntgentchngeimimprovepnt-childdydoutcomePhe1guidedAdpmefrmewkInprtnerhiprurlHedStrttffpntwepplyuer-centeddeignprocedpurextgevidence-bedugrydrkterventidiglterventiThnewprogrmclledweSIPmrterhighlyterctivetructudprogrmctgmultipleevidence-bedhvilchngecompentcludgueecologiclmomentryement(EMA)encourgeelf-mirgvergehvipntgfeedgprcticectiplnngourcehelpledrkgwtervoucherfmilieccernlted-hometpwterqulyPhe2guidedRE-AIMclude2groupcluterRCTdeign[weSIPmrtervctrol]3ement(p9-weekpot12-mthfollow-up)periodWepropoeromize12HedStrtcentercluternverge31pnt-childdydpercluter(tl372pnt-childdyd)WehypoizeweSIPmrtermoefficcioutducgugrydrkcumpthnctrolChngeecdryoutcomeloevlutedcludgpnt-childdydoutcome(egdietqulywterBMIQOLhvilyctruct)mtenncet12-mthpotterventiAddilecdryimcludeexmechdecripntenggementpplymixed-methodproceevlutievlutedoptiimplementtimgHedStrtWeloimexplomedirmoderr(egocildetermnthelthdicr)enggementefficcyoutcomeexplogniztil-levelmtennceThelg-termgolthprimrypventierchdevelopnefficciouugrydrkducterventihhighchmgrurllowocioecomicchildnge2-5irpntPROJECTABSTRACTTheuccechimericntigencepr(CAR)T-cellrpyolidtumquintigentrgetno-trgetf-tumxicyeffectivetumfiltrticyxicyprolifertinimmunouppiveenvirmentvivlntigent-ducedexhutedCARTcellWetrnltedCD28-cotimultedCAR(M28z)trgetmeol(MSLN)cncer-ocedntigenwehvedocumentedexpimjyolidtum64ptienthveentteddteno-trgetf-tumxicyHvgdemtrtedgillydmtedCARTcellvoidpulmryequetrtineferlyntigen-ctivtedCD4helperCART-cellfunctiwedelivedCARTcelltrpleurllyptientmlignntpleurlmeoliom(MPM)promotgtumfiltrtiToddT-cellexhutiweeirttedptientnti-PD1gentfterCARTcellemployedtum-pecificcheckpotblockdeCART-celltricPD1domntnegtivecepr(PD1DNR)34ptienthveentteddtenoCAR-PD1DNR-ltedxiciepeimggcedurvivlTopromoteIFN-mededcyxicyhowneentilolidtumkillgweexploedc-KITmuttiD816V(KITv)cotimulrydomKITvCARTcellhowntigen-ctivtiducedIFNignlgenhncedcyxicywhenddedignl3CD28(ignl2)provideynergticfunctitTGF-mededuppiprolgfunctilpertenceClicllyvilblekehibirproviden/ftunblefetywchKITvCARTcellToeffectivelydeliverenext-genertiCARTcellolidtumwedevelopedtrnltiltrtegyn-bltivetum-trgetedrdirpy(RT)genertechemokegrdientfcilteytemicllydmtedCART-cellchemotxtumfiltrtiprolifertipertenceHeweeektrnlteM28zKITv-PD1DNRCARTcellddkeylimtiolidtumcellrpyInUG3pheweexplohypoPD1DNRcheckpotblockdeextendydtumcellcounterctPDL1-expgM2mcrophgeimmuneuppfuncti(Aim1)Wedefeoptimlgimenn-bltivetum-trgetedRTpromotetumfiltrtiytemicllydmtedCARTcellchievgefficcyimilrgildeliveryInAim3weubmnINDpplictiprocewhichwefmilirhvetrckcducceInUH3phewecductpheItudyvetigtefetyfunctilctivyefficcymrkerpeptientMPMTheignificnceourpprochlieeffectivecombtiolidtum-pecificcFvthn-trgetfe(MSLN)cotimulrydom(CD28KITv)checkpotblockde(PD1DNR)trtegypromotgolidtum-filtrti(RT)CARTcellTheimpcurpropolextendydMPM(>150000/yerpleurlcncerUS)mjyggiveolidtumexpMSLNPROJECTSUMMARYNerly70%~30millidultcigttemokerUSwntqu55%pttrygqutlenceptyer-yever90%fildepeugmokgcetimedictiThevergemokerttemptqumokgtlet30timeebtg12mthlgerTheettempttypicllyoccuroverdecdemokgcrcogenxicntexpouultg480000dethnnullyNovellterntivemutcidedignificntlyducecombutiblecigtte-ttriblembidymtlymgmokerunblequtrdilpprocheTheSurgeGenerlReprhveundercodhelpgmokerwhocnnotqumokgwchlehrmfulnicote-ctgproducthrmductipproch-cndrmticllyducethhelthburdenE-cigtte(ECIGS)lnicotepouche(ONP)expoeuerfewchemiclfoundcigttemokethupromgncombutiblehrmductiolmokerwhowouldnwequmokgFirhrmductipotentillizedfundmentlquetimutnwedOnecnpertentmokerwchcombutiblecigtteeirECIGSONPS?Inilerchuggetthne-thirdmokerfullywchECIGSlthoughcomprbledtunvilbleONPSTwowhtfcrfluencewchg?ThefcrffectgtrniECIGSONPShveyetvetigtedThedoeeencombutiblelterntiveexpoeuerlowerlevelhrmfulchemiclthn?Onlylimeddictdutry-poddtextDocumentgltiveuccewchgECIGSONPSidentifygdriverwchgquntifygocedhrmductimerchoptimizemokeruccetrnigcombutiblecigtteWepropoefirtlgudlvetigtiubtutbilyECIGSveruONPScombutiblecigttemokgfcrimpctwchgirpotentilervehrmductiolPertentcigttemoker(n=200)motivtedwchcombutiblecigtteromizedix-weekgimenECIGSONPSBelemokgrteetblheddurgdy1-5Lbryvdy67eECIGONP-ocedubjectivewrdcgvlueeirECIGSONPSltivecombutiblecigttePrticipntnwchcigttemokgECIGSONPSixweekTheprimryoutcomemeulgudldilycountcigttebeleendix-weekwchperiodt26weekfollow-up(ecdryendpot)Chngebiomrkerpotentilhrmeedtbeleendix-weekwchpheecdryoutcomemeuThepropoedtudylignNoticeSpecilIntet(NOSINOT-OD-22-023)tudiehowENDSuefluencemokghrmductitudievolvewchgcombutiblecigtteelectricnicotedeliveryytemlterntivenicotedeliveryytemPROJECTSUMMARYMelnomdedlietmkcncerdproptelyffectgrurlUSdrivgupdproptecncerburdenChildnlivgerurlunderourcedcommuniecommlyexperiencemultiplehelthdpriecludgcedrkkcncerovertimeThduemofquentteneoutdoexpouhrmfulultrvioletrdi(UVR)unwhechnceunburnubtntillycedUntuntelynoevidence-bedunfetyterventidurbleeffectprotectgchildneettgepecillywhileplygoutdoHowfelypromoteyoungchildnoutdoplytimewhiletilldequtelyprotectgmhrmfulUVRexpouvexgerchchllengerurlcncerctrolequimultilevelpublichelthpprochcncerpventiIndictpethneedwedeignedmulticompentmultilevelunfetyterventiyoungchildn(ge3-6)enrolledctilptprogrmcro2rurltte(UTWV)Rectilptprogrmnturlly-occurrgopptunieerlycncereductiprotectindult-upervedettgGroundednecologiclly-vlidyhpgchildnhelthhviourterventipromotecommendedunfetytrtegiedpttitdividulocilenvirmentllevelInplimrytrilwedelivederventi2rurlcommuniedevelopmentlbebllprogrm(mgN=17temfemlemleplyer)InterventileguetemcocheplyerevidencedignificntimprovementkeyoutcomegterthnmgctrolNowwepropoemotrgentteterventwo-rmcluter-romizedtril16countie2rurltte(UTWV)mtchedkcncerburdencommuny-levelfcrThetrildd16legue64tem128coche640plyerprimryoutcomecludedictly-obervedunprotectihvidurgctilptprcticegmeA-wideUVRenvirmentlcndtobtedgeocodedlocticidedexplnrymodelSecdryendpotcludepnt-ptedchildunprotectiunburnMultilevelmechnmproceemoderrterventiimpcnchildunprotecticludedwellterventidelivery-ltedeffecthelpguidefututilgThprojecthpotentilpromoteltgchngechildnunfetyhvidurgenivebiologicltgeItdourlmedicllyunderpentedcommuniemgmotneedeffectivecncerctroltrtegieugpprochecncled-upttewidegicountryhelpducecncerdprieAbtrctMlignntcutneoumelnommotlethlmllkcncercug10000dethnnullyUnedStte200000globllymmjcologiclproblemOncolyticvirue(OV)cnelectivelyfectplicteerdictecncercelldefectivetypeIterfer(IFN)mechnmmjntivirlpthwyThePI3K/AKT/mTORignlgpthwycrucilurvivlgulrcellulrthelpblnceproteyncellcyclepopenuurvivlilienttumcellVeiculrmtviru(VSV)n-pthogenicenvelopednegtive-trRNARhbdovirupotentvccecolyticpotentilcromultiplehumncncerVSVhighlyenivetype-Iterfer(IFN)ecnnoteproductivefectihelthycelldueIFNmededntivirlpeDygultedIFNPI3K/Akt/mTORignlgcoopertetumigeneltedmnycncertypecludgmelnomMooverPI3KAKThibidimhecellIFN-IigntuTheewehypoizeloclhibiPI3K/AKT/mTORignlgpthwytumcteneedfulcdrtumlpdVSVviru-ducedcncercelldethultgtumgrowthdelyexteniurvivlmouemodelmelnomBecuedvereeffectocedVSVwehveengeednovelhybridVSVviru(VSV-MORV-G[VMG])wheVSVenvelopproteGplcedMnviruimproveirfetypotencyWecentlyidentifiedfetnturlcompoundtwopotentderivtiveF019F040F142hibircompetivelybdmTORS6K1kehibmTOR/AKT/IFNpthwyFurrmoourplimrydthowcedenivycyxicymelnomcellcolyticviruupp-rpyfetwhileprgnmlcellThuweexpectlocllyturngftypeIIFNpemTORcnervenovelphrmco-virpydvncedloclizedmelnomNoveloutcometemmgpropoedvetigtimroleloclturngftrgetpthwydevelopment/progimelnomervectlytdevelopprcticlolutimelnomctrolpoiblycncerignificntpublichelthburdenOurimdeignedtetthnovtivehypocelllepcliclnimlmodelmelnomFundgthcurntpplictienhncebiomediclercheductifrtructutULMCollegePhrmcyThepropoedwkdictlyvolveunderpentedmiefemletudenthrpenircommunictipenttikillencourgempuruecerbiomediclcienttprimryundergrdutetuti(PUI)Chempyducedperipherlneuropthy(CIPN)poemjcliclproblemduetentimedoe-limgideeffectocedmnycommlyemployednti-cncerchempydrugTheetCIPNevelyimpctqulylifeptientledgdogeductittmentdelyevendctuttmentlgerAbnmlpentimotlyfeethemideeffectCIPNCIPNympmcnoccurprichgpotcugdoelimgide-effectcugmjdcomtpPclxel(PTX)mgmotcommlyuedcncerdrugcueperipherlneuropthywhichdebiltgerioudoe-limgideeffectperipherlneurCurntlynophrmcologiclterventirpeuticpprochettmentPTXducedperipherlneuropthy(PIPN)ToidentifyrpeuticcidtepventPIPNwecrriedoutdrugcengFDApproveddrugidentifiedFluocolecenide(FA)neuroprotectivedrugcpblemigtgxldegenertiducedPTXvrovivoBedourcentpublictineuroprotectieffectFAmyhveenttriedenhncednterogrdemichdriltrffickgWedemtrtednnovtiveimggmethodub-cellulrmichdrrffickgneurllowchrcteriztinterogrdetrogrdetrffickgHoweverundertghown-michdrilgnelleircrgotrffickedctextPIPNyetdetermedLikeweeffectttmentFAn-michdrignelletrffickgmunclertimeTheidentifictipecifictrffickgxlcrgoPIPNFAco-ttmentcdiubequentcomplementfdgocedignlgmechnmnecerydeigneffectivefeneuroprotectirpieInthpropolwepropoe1ToIdentifyneuroprotectivemechnmMichdriTrffickgFuiBiogeneenhncedFAAxPIPN2ToIdentifyneuroprotectivemechnmFAtrffickgn-michdrilgnelleuchlyoomegolgiendoplmicticulumPIPNThepropoedpprochimpctfulidentifyFAduceddictiltrffickgneurlgnelleprotectxldegenertiTheerchlopropoeidentifictipoibleignlgmechnmocedFA-enhncedneuroprotectiCollectivelyourpropoederchbrodlyimpctfieldchrcterizgneurlubcellulrgnellecrgotplypromotgdevelopmentneuroprotectitrtegieThR15projectloexpoeeverlundergrdutetudenterchprojectpromoteerchdevelopmentexcellencetUNCChrlotteTheperineumthirdmotcommemettcolcncerDepecommoccurnceperinelmettdiprognoveryltleknownboutigchrcterticThelckbicerchperinelmetthtymiedttmentdvnceWehvepentlt4yertudyggeneticcoloctlcncerperinelmettlrgeterntilcollbtiBuildgfdgtheftwehepropoetheimdvncebicciencecliclcthcrucilAllimtkedvntgelrgetropectivecohtperinelmettptient(N=103)undergomulti-gigenomicnlyThegolprojectrigoulydefeevolutiryhrygeneticchrcterticperinelmettetieefetuclicloutcomeInSpecificAim1wedetermehowcncercellchperinelcvyhowireedgrouteimpctgeneticdiveryperinelmetteOurplimrydthowprounddiffencegeneticdiverytweenynchroumetchrouperinelmetteThemergeneticllyhomogeneoucloelylteddeepvdgedgeprimrytumwhileltterheterogeneoudotpperigtetvivefrtdictgireedgroutemydtct(dictgrowhrougherovcncercellleedurgprimrytumurgery)Inthimwemproutewhichperinelmetteeededtudyhowirighpegeneticdiveryugcombtihigh-efficiencyphylogeneticctructideepexomeequencgInSpecificAim2wedetermegeneticchrcterticcncercellucceedcolizgperineumWehvepvioulyfoundcncercelldemtgdiffenthorgnexpoedenvirment-pecificelectivepuOurplimrydtdictegenomicllyltivelytctcncercellmytndvntgeoverhighlymuttedneuploidcelldurgperinelcoliztiWeueourextenivelympledcohtperinelmettcecompdrivermuttiomticcopynumrlterti(SCNA)wellgloblmeugenetictbily(tummuttiburdenSCNAburden)tweenprimrytumlocogildtntperinelmetteInSpecificAim3wetudyhowchrcterticperinelmettelteurvivloutcomePrognoticfcrhelpclicinetimtelikelihooddiffenturvivloutcomeurgentlyneededWecollectdetiledfollow-updnourperinelmettptientcohtInAim3Awetudyocitweenurvivlgeneticchrcterticvetigtedim12InAim3Bwebrodenourquirymicroenvirmentexmevigle-nucleuRNAequencg(nRNAeq)multi-colimmunluocencewhercomporncripmetromlimmunecellpentperinelmetteclteurvivlProjectSummryTmoxifen(TMX)electiveetrogenceprmodulr(SERM)pprovedFDAttmentetrogenceprpoive(ER+)erlytgedvncedbtcncerAlthoughTMXmtybtcncerttment20-30%btcncerptientexhibnextgdevelopgtnceTMXrpycncermettpolyunderodmechnmTheenundertgmoleculrmechnmpdictiveclteepthologicleffectocedTMXttmenthelpdeignimproveddjuvntrpieovercomeTMXtnceltedpthologieeffectivemngementbtcncerInthgrdwecentlyptedTMXducerobutmtineutrophilextrcellulrtrp(NET)whichDNAfibrilexudedctivtedneutrophilcntrpkillextrcellulrpthogenbootntimicrobilhotdefenechricgrnulomudeeHoweverunctdNETleehenlkedeverlimmunopthologiecludgcncerBecuebtcncerptienttypicllypcridTMXfirrecdlerpywehypoizelg-termTMXttmentduceNETmtieptientwhichcltecnccountTMXtncecncermettThhypoupptedourplimrydthowgextentNETmtibtcncerptientdictlyproptildurtiTMXttmentNETpurifiedTMXttedbtcncerptientcecncercellurvivlLeverggchrcterizedlrgecohtbtcncerptientttedTMXtMDAnderCncerCenterthcliclexplrytudywequntifychrcterizeNETbloodmplep-pot-menopulwomendignoedER+btcncerceivgTMXrpyvrygdurtitimeclteclicldnco-mbidiecncermettcurnce(Aim1)WeexmephenotypetrncriptillcpeneutrophileptientfocuTMX-ctivtedNETpthwydentifiedu(Aim1b)LtlywedetermedictimpctTMX-ducedNETurvivltrncriptilprogrmmgbtcncercellpetmoxifenexpou(Aim2)BecueNET-ducgctiTMXbtcncerptientimpcnbtcncercellltetmoxifentncecompletelyunknownourpropoedtudieprovidenovelightmechnmtmoxifentncefuturpeuticopptuniepventcncermettdvereeffectTMXPROJECTSUMMARYThettmentpncticductldenocrcom(PDAC)mmjhurdle5-yerurvivl12%PDACtncechempyimmunpythoughtimmunouppivetummicroenvirment(TME)chrcterizedfibrotictromhighfiltrteimmunouppivecellcludgtumocedmcrophge(TAM)TAMblocknti-tumeffecrTcellfunctriggerexhutiIthenpotultedprogrmmgTAMnimmunotimulryphenotypecouldimproverpypeRecenttudieuggetmetboleigtggutmicrobiomefluencephenotypeimmunecellcludgTAMHoweverltleunderodboutuchmetbolecludgiridentyignlgpthwywhichylterTAMphenotypewheremetbolefluencecncerdevelopmentWeidentifygmicrobilmetbolemodulteTAMPDACTMEUgundgloblLC-MS/MSmetbolomiccenwefoundgutmicro-derivedmetboletrimethylmeN-oxide(TMAO)ducedignificntnti-tumeffectPDACTMESpecificllydeliveryTMAOtrperinellyupplementgdietTMAOpcurcholePDAC-rgmiceducedtumgrowthwocednimmunotimulryTAMphenotypectivtedeffecrTcellpeTMETheimmunotimulrymcrophgephenotypewduedicteffectTMAOTMAO-cdiedmcrophgecouldctivteCD8+TcellCombgTMAOimmunecheckpotblockdeducedtumburdenimprovednti-tumimmunepeTheedtuppurhypodietmicrobiome-derivedmetbolehpenti-tumimmunyttmentpePDACAim1chrcterizedietrymicrobilourceTMAOnti-tumpePDACWechrcterize(i)dietry(l-crnete)(ii)microbiome(egEnterococcuiengeedEcoliCutC/D)ourceTMAOirnti-tumeffectAim2tethypoTMAOducenti-tumeffectpotentgtypeIIFN/STINGignlgTAMWedeterme(i)quimenttype-IIFN/STINGpecificllymcrophgenti-tumeffect(ii)impctTMAOtrncriptilctivytype-IIFNpiveSTAT1/STAT3Aim3tetefficcyTMAOimprovettmentpep-cliclmodelPDACWeevlutetrnltillevnceTMAOug(i)geneticllyengeedmouemodelPDACptientderivedPDACgnoidcultu(ii)ttmenttrtegycombgTMAOSTINGgtOurtudiechrcterizeourcemechnmctrnltillevncenovelmimllyunderodhighimpctmicrobilmetboleTMAObootgnti-tumimmunepePDACTMEndergPDACpivechemo-immunpyInlgertermthwkmylygroundwknewdiet/microbiome-bedttmentPDACProjectSummryColoctlcncer(CRC)hhighmtlyrteduemettdrugtnceCRCcelldevelopmettticchrctertichijckgdiffentignlgpthwyfueltumheterogeneyfciltecncermigrtiviAddillymetbolicdpttiupptedcogenicmichdriurvivltrtegydevelopedCRCcellUntuntelybovemettticccdemedevolveddurgerlytummtiprogitgeActivtimultipletumigenicpthwyCRCcellledpofive-yerltiveurvivlrteptientcol(14%)ctl(17%)mettticcncerCurntnturlnti-cncercompounduchcmpcvbltehveuccefulcliclprileHoweverbothcmpcvblteterfecelldiviultgunwntedeffectnmlcellWehvedcovednturlplnt-bednti-cncermolecule(vertride[VTD])duceexpiUBXN2AproteCRCcellUBXN2Aubiqu-likectivyuppemTORC2-RicrpthwymichdrilmtltwocricltumigenicplyerCRCThprojectimdevelopmrtnnoprticle(NP)electivelyleeVTDttumethighloclccentrtiwhilelevgnmlcellmimllyexpoeddruglowxicccentrtiOurvrimlexperimenthvedemtrtednti-growthnti-mettticeffectVTDtcellulrlevelhveidedelucidtgmechnmThepropoedtudyvetigtenti-growthnti-mettticmechnmVTDdelivedce-cotedNPptientCRC-derivedgnoid(PDO)(Aim1)ACRCmettticmouemodellivertumcfirmnti-mettticmechnmNP-VTD(Aim2)Ourcentrlhypoce-cotednnoprticlelodedVTD(NP-VTD)uppoverdrivenmTORC2pthwyterfecogenicmichdriCRCcellHumntuehumn-likemouemodelmettticCRCuedthtudyopenpltmdevelopgnewrpeutictrtegieCRCprticulrlymettticmABSTRACTRenlcellcrcom(RCC)emotlethlurologicmlignnciepproximtely81800newce15000dethetimted2023ClercellRCC(ccRCC)lgmelnomhtrdillyenviewednimmunpypivedeeriedhryimmunpyttmentcludghighdoeterleuk2(IL2)terferllogeneictemcelltrnplntIndeedRCCwefirttumtypegrnerFDApprovlPD1immunecheckpothibi(ICI)HoweverunlikemelnommotRCCtumdothvehightummuttilburden(TMB)potentillyexplirimmunpypiveneWehveoughtexplthunnwedquetihvedemtrtedn-cnicltumocedntigenlikeendogenoutrovirue(ERV)myprtexplICIpeRCCNeleERVexpiunlikelyfullyexplccRCCICIpely25%RCCptientpdgle-gentICITheefurrenhncgICIpeclicllymengfulAcollbtitweenKimDomguezlbhuncovednpotentillyrobutourcetumocedntigen-tedtrWehvenotedccRCCtumhvehighetleveltedtr(RI)crollTCGAtumRIlevelecdryuppedn-enemededdecy(NMD)ctivythnecnubetccRCCRI-highnml-liketumMooverwehvefoundmTORignlgplykeyrolegultgNMDtrtentimTORhibicnpromotetrtentiFllyourplimrydtdemtrteclicldtetICIpivetumenrichedRI-highphenotypeInthpropolweehowNMDgultedccRCC(Aim1)determeimpctuppedNMDccRCCtumigenicy(Aim2)determeimpctNMDuppiultntenhncedtrtentumimmunemicroenvirmentICIpe(Aim3)SuccefulcompletiourpropoletblhoundcientificpmecombgtwoFDApprovedRCCrpie(mTORhibiICI)promoteexpihighlyeignnetigentedtr(neo-RI-ntigen)whichhouldprovokerobutntigen-drivenimmunepecnlevergedenhnceimmunecheckpotblockdeProjectSummryBRCA1BRCA2tumuppgenefquentlyctivtedcncerprticulrlyovrinbtcncerDepecentdvncerpymnyptientBRCA1/2-deficientcncereventullydiedeeenewttmenptineededThegolthpropoldevelopnoveltrgetedrpygtBRCA1/2-deficientcncercomhighdoetetrhydrolte(THF)vmC(VC)genertemetbolicgenoxcncercellThertilepropoedtrtegytemcentdcoveryhighdoeTHFctivemfolteoxidizegenertgpotentcrolkermldehyde(FA)whichkillcelldeficientDNAcrolkpiruchBRCA1/2-mutntcellInddiplimrydthowvmC(VC)promoteelectivekillgBRCA1/2-deficientcellTHFVCTHFynergizetgenertgctiveoxygenpecie(ROS)uggetgmldehydeROSgenertimightdrivecyxiceffectBRCA-mutntcellInctrtVCduceTHFxicynmltuemicewhichllowdmtrtihigherdoeTHFFurrmottmentTHFVCcombtiprolgurvivlmiceBRCA1-mutnttumBedefdgthpropolim(1)UndertmechnmelectivyvmcombtigtBRCA1/2-deficientcellugogeniccelllemetbolicolDNAdmgeymoleculrcellbiologytechnique(2)ChrcterizeterctitweenTHFVCmiceemploygmetbolomicultrenivem-pectrometrynlyDNAdductimmunohchemtryfrdmicrocopy(3)AeefficcyTHF/VCrpygtBRCA-mutnttummiceugthopicyngeneicmodelovrinbtcncermeurgimpctTHF/VCtumgrowthoverllurvivlByugtte---rtolcncermodelthprojectcouldprovidefoundtinovelrpeutictrtegyttmentBRCA1/2-mutntcncerInddicouldupptnuncventilpprochhrnegmetbolmcncerrpymnipultemetbolmgenertemetbolicgenoxcncercellOnlyetenpncticcncerptientlive5yerfterirdignoUntuntelythoutlookhnotimprovedignificntlydecdeThtrkctrtmorcncerwhichhvenefedtmendoulycentdvncetrgetedrpieimmunpieTheechempiemlyoptipncticcncerptienterpienotprticulrlyeffectiveyproduceignificntideeffectGivenpncticcncerptienthveceivedltlenefcventilcncerrpieneeddeeperundertgbiologypncticcncerHewepropoevetigtehowlowleveloxygen(hypoxi)promoteemergenceggivehvipncticcncercellCncercellmepnctumcnhowubtntildiverytmoleculrlevelhowypdrpieThebilyeffectivelytrgetllcncercellubettumctriettmentfiluPnctumhvegihypoxiwhichcuedvribleccecncercellbloodveeldeliveroxygentueOurilultdictemetbolicdptticncercellideehypoxicgiprogrmcncercelloycometntchempyInwdwhtdoenotkillcncercellmkemtrgerWepropoevetigtepoibleoutcomethprogrmmgprocecludgbilycncercellexperiencedhypoxictrietumgrowthwellirbilypddtntprtbody(mett)trpyTheecdprtpropoedtudyfocuidentifygmoleculrchngeducedcncercellhypoxiInthirdprtwedetermewhichemoleculrchngeenblecncercellurvivehypoxicquimoggivehviTheprojectidentifyfundmentldrivercellttediverypncticcncerwhichmypotnewgenertrgetedrpiectrolcellulrcompoumimprovettmentpeWehvedevedtwo-prgerchtrtegyfocugbothrolehypoxicpncticcncercelltummoleculrprogrmunlockedhypoxipromotetumprogiIfuccefulthtudy(i)fundmentllydvnceourundertgmoleculrbiologiclmechnmunderpngtr-tumlheterogeneytumprogidrugtnce(ii)providenovtiveexperimentlpprochevetigtgphenotypicdivery(iii)elucidtenoveltrtegietrgetgtumheterogeneymlignntprogidrugtncepnccncerBtcnceremergethroughyer-lgproceomticevolutiphyiclctrtmilkductchrcterizedccumultiherblegeneticepigeneticchngeWhileegeneticltertihveenextenivelytudiedlettentihenpidmicroenvirmentlcdielectegenotypeWehvedemtrtedevolvgp-cncerouhyperplticcellubjectedptio-templvrioxygentiduepovcultucidoduetermenttivemetbolmnutrientcrcyduecompetimgcncercelltweencncertromlcomprtmentAdpttiemicroenvirmentltpqueurvivleventullyultelecticellmoggivephenotypeTomodeleco-evolutirydynmictummicroenvirment(TME)vroweubjectednignbtcncercell(egMCF7MCF10AT)hrhcdiencountedTME(ienutrientdeprivtihypoxicidoultgmetbolm)weobervedcellurviveeelectipuexhidlipogenicphenotypechrcterizedrobutccumultilipiddroplet(LD)Weelectedthenutrienttdptedcle(NSA)furrchrcterizedtctmetbolicphenotypedetermeifthphenotypewchctrieggivetumhviTheelectedclemtedlipidphenotypeundernutrientpletenmoxicnmlpHcultucdiimplygthhrd-widmetbolicphenotypeIndeednutrienttdptedcell(NSA)wemomigrryvrohighlymettticthopicxenogrftmodelhowevergwmllerprimrytumcompdctrolcellWefurrchrcterizelipidphenotypeNSAcellegdiffentilgeneexpiptterndefedtctmetbolicpthwyFurrwedetermeifecleenggelterntenutrientcquipthwyuchmcropocyceprmededendocyencvengenutrientuemgenertelipidWeemploytbleopetrcgwellimge-bedy(livecfoclhighctentmicrocopyugOperPhenix)defemechnmlipidccumultidptedcellFllywepermmetbolicprilgmeuoxygencumptirteprproductirtedetermeirbilymetbolizelterntefuelcludglipidCombgepprochewepropoedeciphermechnmwhemicroenvirmentlt-ducedevolutiulthrd-widphenotypicdpttipentedlipogenicphenotypeAtendthtudyweexpecthvemocompletecompheniveundertgmicroenvirmentlly-ducedgeneexpichngethccurdurgcrcogenehoweltehrd-widphenotypicprileuchlipogenicphenotypectriecncerprogiAdeeperundertgthmetbolicwchhpotentilidentifynovelrpeutictrgetPROJECTSUMMARY(ABSTRACT)Anevolvgcceptctrieourundertgtncerogendeprivtirpy(ADT)rogencepr(AR)ntgtdvncedprottecncer(PC)bilycellevdeARblockdeturncompenryhmeceprignlgurvivlPcliclclicltudieuhvedemtrtedductiglucocticoidcepr(GR)expicfertnceAR-trgetedrpyElegnttudiehmeceprfieldhvehownpottrnltilmodificti(PTM)nuclerhmeceprcnmplifylterircniclctivyfvcncercellurvivldrugtnceOneuchPTMphophyltiWepublhedpn-AKThibiblockGRducti/ctivyovercomeGR-mededtnceAR-trgetedrpy(ARi)Weobervedthettgbothlig-dependentlig-dependentGRignlgFurrmoplimryproteomictudiehowGRphophyltiexpedprogictrte-tntPC(CRPC)ceignificntlyenzlutmide-tntCRPCThcelocltednceAKT1expiWefoundAKT1dictlyboundGRwhichvlidtefdgPhrmcologichibipecificAKT1knockdownAKT1ignificntlydecedpGR(134)nottlGRInddihibiAKT1hidpGR(134)expinucleuoutligWhencellweexpoedGR-pecificmodulr(GRM)CORT134combtiwzlutmidepence/benceligwelyoberveduppicellprolifertiCRPCnotveryeffectiveenzlutmide-tntCRPCCverelyAKT1hibidecedpGR(134)nucleu/outligwloocedhibicellprolifertiPhopho-emuttipGR(134)wlooceduppedcellprolifertiOurcentrlhypoducticogenicGRenzlutmide-tntCRPCmodultedPTMGRhibipGRwould-enizettment-tntCRPCenzlutmideWeteurcentrlhypoccomplhobjectivethpplictipurugfollowgpecificim(i)Chrcterizelig-dependentdrivenGRvPTM-drivenGRexpictivyptient-derivedxenogrftmodelugmulti-omicy(ii)PermfunctiltudiedetermemechnmPTMdrivenGRvlig-dependentGRctivylethlPC(iii)DetermerpeuticefficcyneftrgetgAKT-GR-ARnovelrpeuticpprochlethlprottecncerImpctTheultthtudyignificntlyexpourknowledgemechnmPTMdvncedPCroleiruniqueigntuplydeeprogitnceAR/GRtrgetedrpyCurntlyclicltriltetgrpeuticeffectARiGRMARiAKT1-pecifichibirPCOurfdgimmedeclicllevnceywouldguidewhttgeptientdvnceddeewouldnefGRMtwhttgelterntivepproche(trgetgGRPTM)uedGR-drivenlethldeeColoctlcncer(CRC)eledgcuecncerdethnoeffectivettmentlte-tgecncerErlydetecticolocopyppedlowerCRCrknotoceddethToducecncermtlyimptntdevelopeffectivegenthibghigh-rkCRCpeoplecncerdrivermuttidenomAlthoughhibicyclooxygene(COX-1/-2)NSAIDcludgpirhveencognizedpventgCRClg-termueNSAIDlimeddueideeffectmodertenticncerefficcyIteneceryerchlterntiveimprovedpventivetrtegiegentReerchhhownpro-flmmry5-lipoxygene(5-LOX)promotecolcncerdevelopmentmytrgethibgCRCFurrnuclerfcr(NF)-BJAK-STAT3knownctrieflmmtipromotiCRCImptntlywehvehown--cotrienol(TETE)whichmemrvmEfmilyhib5-LOXctivyNF-BSTAT3ctivtigrowthcncercellTE-13-COOHmetboleTEhenhownuniquehibirCOX5-LOXIngementefdgTE/TE(8/1)mixtuTE-13-COOHhveenptedhibchemiclly-ducedcolcncermiceBedeobervtiwehypoizeTE/TETE-13-COOHnoveleffectivepventivegentgtCRCDepeextgevidenceupptgourhypokeyknowledgegphdergtrnltiueepromggentclicInprticulrnticncereffectecompoundhvenotenexmedhumn-likeCRCmodelTheobjectivethpplictideletenticncereffectmechnmTE/TETE-13-COOHnnovtiveCRCmodel(AKC)whichlikeCRCptienthmutntApcKrptneoulydevelopdenomtumlrgeteteSignificnceTheuccethtudydevelopnewcncer-pventivegentgenerteplimrydtR01pplictifurrvlidteecompoundCRCpventiferkeypclicldttrnltibicerchclicAbtrctWhilebtcnceremotcommcncerwomenUSextmelyrmenccountglethn1%llbtcncerceAlthougheverlfcrmycerkdevelopgmlebtcncerfundmentldee-defgmoleculrpthwythrcncermunknownAultmlebtcncerhencidedimilrfemlebtcncereventhoughccumultgevidencedictebtcncermenmygeneticllyepigeneticllydtctUntuntelyunlikefemlebtcncerlckmodelytemhdervetigtimlebtcncerTheubiqu/proteomeytem(UPS)plycriclrolegultiprotequlyctrolthroughprotedegrdtiDygultiUPShenimplictedeverldeecludgneurodegenertiveddercncerTheUPScompoed3criclenzymeubiqu-ctivtgenzyme(E1)ubiqu-cjugtgenzyme(E2)ubiqulige(E3)WhileE3ligetenfounddygultedcncerpthophyiologiclignificnceE2ubiqu-cjugtgenzymemeluiveUbcH7(loknownU2l3)eE2enzymeubiquiulyexpedvrioutuegnOurlbhcentlydcovedUbcH7heterozygoy(UbcH7+/)ignificntlypromotecidencemlebtcncerMMTV-NeumicemouemodelHER2+humnbtcncerImptntlyloecopyUbcH7doenothvenyeffectfemlebtcncerTourknowledgethfirttrngenicmouemodelpromotebtcncerlymleBedeultwehypoizeUbcH7plyuniquerolepventimlebtcncerpromotgdegrdtincoprotewhichlyfluencemmmrytumigenemleTheultimtegolthprojectidentifymle-pecificcoprotebtcncerTowrdthgolwefirtvetigtepthophyiologiclcdiUbcH7+/-mlemiceepecillyfocugmmmrygldevelopment(Aim1)Wenpermvivo2H2O-llgmpectrometry-bedproteomicidentifyubtrteUbcH7mlemmmrygl(Aim2)FurrmoweloplncductRNA-eqidentifynltedignlgpthwy()UbcH7+/-mmmryglDepenumeroutudiebtcncermechnmgultemlebtcncermpolyunderodWeexpectthurtudieplceUbcH7novelpdpoigenedevelopmentmlebtcncerervgbkthroughthpenupnewdictierchthfieldSUMMARYWeveledcncercellcndemteerlytgecncerprogiftervribleperioddmncyygommettKnowledgebouthowerlyDCC(eDCC)hpemettticprogihowymdmntimmuneeviveyerhowygetctivtedlimedcricllyneededdevelopmoeffectivettmentWedcovedprimrytumovolvegeneticllygrowtrgergneededmogeneticllyevolvedlteDCC(L-DCC)cndmntlomycrrymogrowthpreprogrmHowfirtrrivgeDCCfollowgL-DCCcrotlkffectimmunenichelungmettdevelopmenthneverenexplodUggeneticlegetrcgprotebrcodgglecellRNAeq(cRNAeq)wefound79%mettwederivedeDCCeDCCL-DCCcoopertelungemettWelodcoveddmncyeDCCdrivenZFP281NR2F1terctieDCCL-DCCdowngulteNR2F1expicoopertivelyfoundmettMouemodelhumndtuggetimmune-urveillncedoenotfullyelimteeDCChoweDCCevdeimmunetrgetgunclerTothendwedcovedeDCChvelowmuttilburdendowngulteMHC-IcompdL-DCCupgulteimmuneuppGl-1TGF2InLungeDCCCD4CD8TcelleemdyfunctildepletiCD8TcelldoenotledeDCCoutgrowtmentnti-PD-L1rpydoecueeDCCerdictiWelofdtueidentlveolrmcrophge(AM)mtdmncyeDCCmyctrieimmuneeviwhilelouppgmettticoutgrowthWehypoizeeDCCL-DCCcoopertefoundmett()bilyL-DCCwkendmnteDCCviproductihibirpro-dmncypthwy(b)eDCCctgimmune-uppivelungnichellowmoimmunogenicL-DCCecpedetectiWetet1)rolecllcoopertimettfoundgcpcytweeneDCCL-DCC2)moleculrmechnmuedDCCprotectmelveimmuneclernce3)howL-DCClunglveolrmcrophge(AM)crotlkffecteDCCwkengmettticgrowthExplgequetiprovideightnovelimmuneevivemechnmerlyltecoopertgDCCmytrgeteddurgdmncyctivtiimmunetrgetgpprocheerdictemWelomydcoverwypventcoopertgerlylteDCCfoundgmettugctivrpro-dmncyprogrmOurwkmightexplwhydepecncercelldemtgerlymovlerlytgetum(egDCIS)ducemettticlpewhyPTizepoprognodicrnmelyerlyDCCmdmntunlectivtedlteDCCmofquentltertummovedRmotmuttedcoproteFDA-pprovedhibirtrgetmllubetRmutnttwothecogenicRignlgeffecrRf>MEK>ERKPI3K>PDK>AKTYettncehibirmmjchllengeThecequencecogenicRignlgvithirdeffecrRlGEFctivtimllGTPeRlmuchlewellunderodThehibiryRlGAPelectiveRltumuppRlpro-coproteElevtedctivtiRlmotpromentlyobervedpncticductldenocrcom(PDAC)tumtypehighetRmuttirtepourvivlMoleculrdetilRlignlghvecfoundedterpttiputtiverolecncerRlneentilgulrexocytcomplexhenceexocylothoughtueexocytignlgtermedirypromotecogeneThdulfunctiRlpentfundmentlknowledgegphimpededundertgroleR>RlGEF>RlignlcncerllgeneticperturbtiRllterbothignlgexocyWehvefilledthgpugCelegnmodeltudyRlignlgexocytfunctiWeuccefullyidentifiedeprti--functimenemuttidruptRlignlgnotexocyWehypoizetroducgthmuttihumnRALARALBprotelockmctivembrogteKRASignlgKRAS-poivePDACcelllewhilecricllytgexocytfunctilyAim1determemoleculrmechnmunderlygmeneeprtiRlfunctiStructuhumnRlproteuggeurmenemuttiwekenltbridgequidpropergunenucleotidebdgWenlyzeGDP/GTPcyclewildtypevmutnthumnRALA/Bvrol-timeNMRPDACcellWelomutteprtneridueltbridgephenocopyiglmuttiCelegnAim2trnlteourfdgCelegnpclicltudieugpnelKRAS-mutntPDACcelllewilevtedRALA/BctivyWecomplementdruptiendogenouRALARALBwild-typeveprti--functimutntRALARALBWetetKRAS-driventrPDACcellknowndependennRlGEF>Rlprolifertiurvivlnchge-dependentgrowthvikeyendpotexmedWehveunlockedvetigthirdcogeniceffecrRRlGEF>RlSubtntiourhypoexpectedtrnltebkthroughgeneticmuttihumncncercellPROJECTSUMMARYRdirpy(RT)trd--ccologiclttmentcentrlnervouytem(CNS)HoweverdurgcrnilRTnmlbrtuedjcenttumevblyirrdedcugtrnientveriblebnmliewellprogiveirveribleltexicieApproximtely100000ptientprimrymettticbrtumperyerUnedStteurvivelgenough(>6mth)developrdi-ducedbrjurycludgcogniveimpirment/neurologiclequeleignificntlyimpedgqulylifeTheeympmoccur50-90%dultptientfterttmentcneenoutcliclrdiogrphicevidencehlogiclchngeInthpropolweimetblhnovelrobutcell-bed3DbrgnoidmodelcloelymimiccomplexyhumnbrmicroenvirmentervgpltmtudypthophyiologiclproceeneuroflmmtiducedRTnmlbrtueFurrleverggetblhedUCLAptfolidimigrbrgnoidmodelcouldpromgcengtetgpltmcpultehumnbrperpeuticgentOverllthpropolnlychrcterizel-timedoe-dependentphyiologiclpenmlbrtueiizgrdiloprovidepro--prcipleevidenceupptuehumnbrgnoidmodelpltmcengtetgrdimigrenblgthudevelopmentdequtecountermeugtrdiCidergptient-derivediPSCmylevergeddevelopperlizedtetgmodelournovelbiomimeticmodelholdignificntpromecengptient-pecificrdimigrerpcimedicenerfutuPROJECTSUMMARY/ABSTRACTRdirpyhdefiverolecurghighrkveryhighrkevenoligomettticlow-volumemettticdeepheIIItrileettghvedemtrtedoverllurvivlnefHoweverrdirpylovolvecidentlrdidoectummllboweluthrwhichcuerdidoe-limgxicyLocogilctrolprticulrlypelviclymphnodegiwhecurntlypoiblerdidoen-curtivecnlimgfcroverllprottecurbilyeettgInthpropolweeekctette---rtPSMA-trgetgrpeutictkgdvntgethltivelyprotte-pecificurfcentigenWectetwomoleculectgPSMAliglkedlyoomlclevblelkerwhichturnlkedrdienizgmllmoleculehibirDNAdmggpeOnemoleculevolvepotenthibirATMecdvolvenhibirDNA-PKtwotrgettegrlrdiefficcyInSA1wetetenovelmoleculevroementhibiATMDNA-PKkePSMAexpgprottecncercelllecompdPSMAn-expgcellInSA2wetetemoleculevivoefficcyprottecncerxenogrftdetermetrgetenggementplimrynmltuexicyTheoverrchggolddedpropoederchprojectdevelopttmentcouldimproveurvivlmenlethlprottecncerimprovglocogilctrolwhichdoeimpcverllurvivlemenInddiifemoleculeuccefullyrdioenizelopoibleyllowexternlmrdidoede-ecltienblelenmltuexicyderimprovequlylifeoutcomeFllydowntmwkmoleculecouldcomdRdium-223ytemicllyrdioenizerpyprovenextendurvivlInthpilotgrntwedetermeilfeibilythpprochlyggroundwkfurrrpeuticdevelopmentPROJECTSUMMARYGpmcceptiptientknowledgecnctriepocdhencedecedqulylifeevennegtiveoutcomeepecillyunderervedpopultiThenurgentneedytemticllycptuchrcterizedevelopmechnmbtcncerptientknowledgehrgTheobjectivepropoedfeibilycceptbilypilottudycptulivedexperiencebtcncerptientchrcterizeirknowledgetypelevelgplgudllyTopiccludecompheniillne(typetgeprogno)ttmentdecimkgnvigtgemergenteventultgdevittmenttrjecry(eghopliztineutropenicfever)Incollbtitweenhumnfcrerchermediclcologtptientprtnerwecductemi-tructudCogniveTkAnlyterviewelicbtcncerptientexperiencelgudlly(prifirtttment6mth1yerfterdigno)Wecru~35dultbtcncerptientWenlyzeterviewdtugmticnlydeveloptxomyptientknowledgecrocctuumTheexpectedimpct1)undertgptientknowledgegpfunctime/experience2)ggightdeignghumn-centedculturllyeniveptienteductiPROJECTSUMMARYTheBRCA1PALB2BRCA2protemheterocomplexvolvedmtenncegenomictbilyvrinteproteimplictedmultiplecncerUntuntelyfull-lengthtructurldetilBRCA1PALB2BRCA2unolvedwhichobcucompleteundertgirmoleculrmechnmctiOurlg-termgolundertmoleculrfetuBRCA1-PALB2-BRCA2xhowdeeltedmutntimpctirtructuuchttertrgetedttmentpprochecnlizedTheprimrygolthpropolproducefull-lengthwildtypeBRCA1PALB2BRCA2(lgddilproteprtnerBARD1DSS1RAD51)determetructutbilizedheterocomplexeOurhypoptdifficultyolvgtructuecoproteduepencetricllyddeddomfildopttblecmtiunleprtlrgerheterocomplexThertilenovtiunderlygpropoedwkcell-feexpillowmllclevertilerpidoptimizticdicechnceynizgfull-lengthproteimilrolubilybiochemiclchrcterticntiveproteAddillycryogenicelectrmicrocopy(cryo-EM)cnterrogteprotedoptmultiplecmtictflexibletricllyddedgiBRCA1PALB2BRCA2knownpoeTwopecificimpuruedcompletethwk1)ExppurifychrcterizeBRCA1PALB2BRCA2complexe2)DetermetructuBRCA1PALB2BRCA2complexeuggleprticlecryo-EMTheucceprojecthgecentdvncementcryo-EMourcell-feexpipipeleThepropoederchignificntceprovideflexiblefrmewkproductitructurlchrcteriztiBRCA1PALB2BRCA2complexeTheeimdictlylignfundgopptunyNIHPAR-23-058NCISmllGrntProgrmCncerReerchYer202320242025ourgolgenertenimprovedundertgmultipletumuppproteThbicerchpropolbothfeibilytudywellmllelf-ctederchprojectcncompletedtwoyerMo-depthmoleculrphenotypgfunctilmechnticightBRCA-ltedDNApirproceeydcopecurntpropoldueboimefrmebudgetThtwkcombtimodetiledtructurlcomprmodeeltedvrintwouldfocueprtefollow-propolTheexpectedoutcomethwkynwildtypeBRCA1PALB2BRCA2lgtructurlchrcteriztiBRCA1-PALB2-BRCA2xItlolyfoundtiwkflowextendgourcell-feexpipipelebioenergyerchbiomediclfieldpermpplictiwrdcncerltedprotewhoetructumeluiveABSTRACTLungcncer(LC)thirdmotcommcncerUSAfricnAmericn(AA)hvghighetcidencemtlyWhilepvioulkgedmixtuexomeequencggenome-wideocitudieEuropen-AmericnAinncetryhowttticllycompellgeffectmuchLCherbilyAAyetexpledGeneticEpidemiologyLungCncerCtium(GELCC)lyctiumUStudieFmililLungCncer(FLC)fmiliedtemjydtcollectinlyeEuropen-Americn(EA)ncetryOurcentcro-ncetrygenome-widemet-nlyhhowngeneticrchectumypopultidtctLCrkgenerlpopultiPvioutudiehvehowndiffencellelefquencieduediffencercilncetrymoprouncedrvrintOurGELCCfmily-bedtudiehveidentifiedeverlveryrhigh-rkpthogenicvrintEAfmilieHowevernofmily-bedLCtudyhenexplodAAcueextmelylownumrAAfmilielimedcceibilyvilbilybiopecimenThpplicticplizeextgWholeGenomeSequencg(WGS)dtvlublecollectiGELCCAAfmilie(120FLCce146unffectedfmilymemr)282high-rkpdicLCfmilyhryLCerly-et154unltedctrolTocepowerepecillyrvrintdcoverywheAAFLCfmilielimedweloutilizepubliclyvilbleWGSdtAllUemotrcil/ethnicllydiverebiobnkUS(n~50080)externlpopultictrolWepropoedAim1identifyrlow-fquencypthogenicvrintocedLCrkAAAim2evlutecommpthogenicvrintocedLCrkAAGivenhighgeneticdiveryAAgeneticnlythundertudiedpopultiwouldfciltenewrklocupthogenicvrintdcoveryhnotenpvioulyfoundEAtudiecludgthoepecificAfricn-ncetrypopultihdcrodivergentpopultiReultthfmily-bedtudyprovidedtbecnmedfututudiegeneticdiffenceAAIdentifygnovelpthogenicvrintAAervetrtgpothelpfututrgetedLCcengperlizedrkementAAmoveucloerelimtihelthdprieABSTRACTDepedvncementtrgetedmoleculrrpiehepcellulrcrcom(HCC)mededlietmlignnciewldwidenverge5-yerurvivlrtelethn18%In2007FDApprovedfenibfirt-lettmentHCChlylimedpertenceoverllurvivlly28mthSce2018FDAhpprovedeverltrgetedrpiedvncedHCCcludglenvtibtezolizumbcombtivcizumbfirt-lettmentcbozntibgfenibnivolumb(combtiipilimumb)ecd-lettmentDepeencourggultettmentmnyptienttilldotpdcquitnceedrugThtudyfocumechnmtncecbozntibrpyHCCwhichcurntlymunknownCbozntibmulti-kehibirTheFDApprovedneffectiveecd-lettmentdvncedHCCptientwhopvioulyttedfenibytemicrpie2019Depecliclefficcy(improvedoverllurvivl22mthmedinprogi-feurvivl52mthcompd19mthplcebo)bout36%ptientdidnotpdcbozntibmnyptienteventullydevelopedtncecbozntibfterilpeTheeweplnidentifymoleculrmechnmtncecbozntibrpyHCCwhichprovidenewightmechnmdrugtncetumgrowthdevelopmentnewrpeuticovercometncecbozntibttmentWehvegenertedcbozntib-tnt(CR)HCCcellidentifiedpotentilmechnmHCCcellcquiCREGFRhyper-ctivtiWefoundEGFRhyper-ctivtedCRcelltumWelodemtrtedbothEGFRhyper-ctivtictriecbozntibtnceHCCHoweveromeimptntquetimnwedFexmplewhtmechnmwhichEGFRctivtedCRcell(Aim12)?ThegoltherchnwerthquetiwhichwouldprovidenewightmechnmcbozntibtncefernovelrpeutictrtegiettHCCptientTheneedidentifycuemotevemmlefertilyn-obtructivezoopermi(NOA)whepermgenicfiluultgnejcultenopermYetpoundertgmechnmgultgpermproductigeneticgenomicepigeneticdefectunderlieNOAydtructurlnumericlchromoomldefectfewendocropthiegenedefectNOAmenhvencedrkerioudeeuchcncerwhencompdfertilemenmenpermirejculteHoweverlktweenirfertilyirceddeerkhmedeluiveThprojectbuildtrigugdbteddtehowgpencedeficienciemmtchpir(MMR)/MSH5expigenemuttiepigeneticvrintpentNOAmenultgnbnmlcellulrpelkyltggentDNAdmgegenomictbilydeficiencydouble-trbkpiruggetgpenceDNApirdefectMMRMSH5deficiencycncueecellulrpeocedmlignncie(tethemlogiccolprottebtthyroid)fertilydueovrinpermgenicfiluWetethypodecedmmtchpir/MSH5expiubetfertilemenlednlydecedgenetictbilyimpidDNAbkdefectivehomologoucombtiloledmlignncieNOAWehypoizemmtchpir/MSH5deficiencycommlktweenfertilycedrkmlignncieTheetudieprovideightnuncognizedetiologyNOAn-productiveltedhelthrkpecificllycncerocedNOAProjectSummryThehenncenumrthyroidcncerurvivduethyroidcncercidenceyounggetdignoAlthoughubtntilproptieurvivwelikelycudilttmentduelimeddtubequentbilyphyicincfidentlyrk-trtifyurveillncecurncectuemnyyertenlifelgUnneceryurveillnceultcncer-ltedwryddiltetgledgflepoivetetultometncecomplictiddilttmentThroughourcollbtiSEEReGegi(cludeAtlntGterGegiRurlGegi)LoAngeleCountywehveccediverepopulti-bedcohtptientwhomwecndetermecurncerkwellcurnptimllg-termurveillnceOurmultiprgeddtcollectitrtegyllowuobtcurncedetilpthologyptugmentedmtlydtptientptphyicinchrtviewptgExternlvlidtioccuruecompheniveUniveryMichignPciHelthdtWedetermechrcterticcohttlowerhigherrkcncercurnceueedtmmotilodurveillncecpthwynfeurveillncecpthwyfteregtrde-fnetnefThebilyctegizethyroidcncerurvivmengfulcurncerk-trtifiedgrouptilurveillncecpthwycurncerknfeurveillncecpthwyfteregtrde-fmpproprelg-termfollow-upduceptienthrmimprovehelthccotThtudydrmticllychngecthyroidcncerptientervemodelrk-trtifiedurveillncecncertypeThprojecttudyglenucleotidepolymphm(SNP)rylhydrocrbceprp(AHRR)genemyfluencelungcncerrkBlck/AfricnAmericn(B/AA)ubjectAHRRnegtivegulrdexifictipevolvedmetbolmelimtibccomokecrcogenB/AAmenhvehighetrtelungcncerdethcompdllgroupyhow12%higherlungcncercidencerte15%higherlungcncerdethrtethnWhe/Europen(W/E)menElevtedAHRRexpihenimplictedlungcncerrkthuSNPimproveAHRRfunctiwouldlikelycelungcncerrkWehveidentifiedmeneSNPr35008248AHRRex4whilerW/EubjectpennethirdB/AAubjectTheSNPwnotcludedmotpvioulyuedrryhlycentlyguntudiedPlimrydtGWASexplhownoignificntociW/EubjectuggetnocimokgB/AAmle(p=387E-3)mokg-ltedcncerB/AAubject(p=004927)AB/AAdividulcomplymllfrctiubject(<4%)powerdetermeroleSNPthgrouphenlimedAHRRnegtivegulrrylhydrocrbcepr(AHR)UpbccomokeexpouAHRbdpolycyclicromtichydrocrnternucleudimerizeARNTTheAHR/ARNTdimerbdxenobioticpeelement(XRE)wchggenevolvedctivti/ectixenobioticcompoundInnegtivegulryloopAHR/ARNTturnAHRRwhichlobdARNTThetrncriptillyctiveAHRR/ARNTcomplexcompeteAHR/ARNTXREedmpengdexifictipeThefencelleler35008248(T)encodeleucetpoi114whilelterntellele(C)encodeturn-ducgproleComdnnotti-dependentdepleti(CADD)uggetSNPmightffectAHRRfunctiInco-crytltructuAHRR/ARNTheterodimerleuce114bderloopentwgARNTWehypoizeproletpoi114ctrAHRRloopcmtitbilizgAHRR/ARNTtercticgpiveeffectAHRR/ARNTheterodimerterfergdexifictipecglungcncerrkB/AAmoker34%whomcrrymlleleHewepropoetetocitweengeneticvrAHRRlungcnceroutcomeugextglrge-clegeneticdtB/AAdividul(Aim1)ueCRISPR-bedgenomeedgengeermllelegenomeouruniqueimmtlizedhumnlveolrepililcellleeeffectpebccomokevro(Aim2)tetwhermocidtpoi114ffectketicterctitweenAHRRARNT(Aim3)TogerpecificimthpilotprojectprovideightrolepotentilfunctilSNPAHRRcommB/AAubjectcouldhelpexplircedlungcncerrkABSTRACTTherolegermlegeneticvrivirlfectidevelopmentprogihentudiedextenivelydulttumuimmunedeeLettentihenpidterctiefcrbirthdefectpedricmlignncieprticulrlycutemyeloidleukemi(AML)whichyoungetptientdrivenlmotexcluivelytructurlvrint(SV)polyunderodetiologyThepvlencegenefurncriptocedleukemlivebirth10x100xgterthncidencechildhoodleukemiwhichuggetrkfcrmutterctSVOnepoiblecidteterctimgvirlfectieirpntchildnClicltrilgenerpyvirlvecrfiledprtduevirltegrtictivtgcogeneuchMECOMRecentwkhhowndictmechnmderivtivechromoomemtmotcommbkpotleukemihumnherpeviruecludgCMVeglegtetrkfcrchromoomlbirthdefectElewhewehvedocumentedgermleomticcopynumrhtequencevrintffectge26trnmtipecific(ETS)fcrwhichprticiptehigh-rkgenefuieenbotholidliquidtumTheefcrirbdgedetermedevelopmentlftecrotueyetirmotifhttempet--glemotvribleclfetuhumngenomeSmllchngedogectedhploufficiencyvrirmpequencemyufficientpdpoedividuldeeTheprimryobtcletudygeiremechnmhlgenmllmpleizedcovergecohtembledrchildhooddeeThevtquntywhole-genomewhole-trncripmelg-dequencgdtprovidedGbriellMillerKidFirt!(GMKF)CtiumINCLUDEcohtnegtethobtcleWhencomdthoupedricclicltrilprticipntProjectEveryChildthcomgX01LgRedPilotProjecmic-coldpedricleukemiptientwepobothcomputtilfrtructumpleizequidprognowplceWepropoechrcterizegermlegulryplicgtructurlvrintctlytrkleukemiltedpleukemiccdinotgtriplictiETSfcrERGnhentfetuDownyndrome-drivendee(500xmultiplierrkovergenerlpopulti)Whcolleguewehveidentifiedn-codgvrinttrgeffectDownyndromeThuggetcombtimpleizecohtdiverypenttimotcommtructurlvrinthumndeeGMKF!CtiumpentnidelopptunyddthurgentneeddetermeifpdpoirkcnmigtedcengprophylxTleFunctiltteCD8+TcellimmunydultT-cellleukemi/lymphomAbtrctAdultT-cellleukemi/lymphom(ATLL)ftldeemlignntCD4+TcelldevelophumnT-lymphotropicviru-1(HTLV-1)crrierRecenttudieourgroupfurruggetATLLdignoedCribngiNthAmeric(NA-ATLL)differthoedignoedJpn(J-ATLL)bothcliclpenttiimmuno-geneticlcpeMothnhlfNA-ATLLptientUSimmigrntCribndecentReltiveJ-ATLLNA-ATLLcedignoedtyoungergepentmoggivedeefcehteroverllurvivlThuimprovedundertgpthogenenovelrpeutictrtegieurgentlyneededItwell-knownnti-HTLV-1immuneurveillnceplykeyrolepventgATLLdevelopmentMultipleleevidenceupptnotiATLLcellchieveimmuneecpenlypventgntigenpenttilouppgytemicimmunepehotHencecceptullyrpieimugmentnti-ATLLcyxicTcellpe(CTL)houldhverpeuticnefCurntlyATLLtenmngedfirt-lechempywhichrlychievedurblepeNA-ATLLpoiblyfurrdmgeldywekenedCTLctivyhotAtmetimemultipletrgetedrpielyproducedlimedcliclefficcyMotmrkblytwoimmune-modultgttmentienti-CCR4mAbmoglizumbnti-PD-1mAbNivolumbhvefiledNA-ATLLwhilehowgomecliclnefmgJpneeptienthighlightgneedobtn-depthundertghotimmunefunctiNA-ATLLWecentlydevelopedhighdimenilpectrlflowcymetrypnelchieve-depthchrcteriztibnmedn-trnmedTBNKcellPBMCmpleourMtefio-EteATLLBiobnkWeveledATLLcellexhidphenotypeocedrobutimmunouppiWelodcovedeptientuniquepopultiphenotypicllyexhutedCD8+TcellproptiwhichdecedmiptientInthpropolwetethypoATLLcellducegenerltteimmunouppiptientpventneffectivedurblenti-ATLLeffecrCD8+TcellpeUgptientmpleouruniqueATLLBiobnkthoecollectedBelott/Zidovude/IFNtrilcductedDrRmo(UniveryMimi)wedefenewimmunecltefvbleoutcomethdevttgbloodcncerthoughhighdimenilflowcymetryfunctilTcellywellglecelltrncripmicTcellceprclotypicnlyePROJECTSUMMARYDietryfruceNASH/HCCprogiNlcoholicfttyliverdee(NAFLD)/nlcoholictehept(NASH)emerggledgrkfcrdrivgdevelopmenthepcellulrcrcom(HCC)DietryfrucemjrkfcrNAFLDubequentHCCprogiFruceprimrilymetbolizedkehexoke(KHK)KHK-deficientmicephrmcologichibiprotectivegtNAFLDunderlygmechnmpiblelrgelyunexplodWecentlydeignedtudievetigtewherlohibiKHKimpctHIF-protetbilizticrogHIFtbiliztipter(ODD-luc)miceKHK-/-micedcovedtetlHIF-tbilizti(meudluciferectivy)ignificntlyctentlyducedKHK-deficiencyIntetglyducedHIF-tbilyKHK-/-micefullycuedmllmoleculehibirpyruvtekeM2(PKM2)uggetgfruce/KHK-dependentHIF-tbiliztimymededPKM2hibirymetboleF1PCtentducedHIF-tbiliztiobervedKHK-deficientmicetetlexpiHIF-2-ducedirtrnpterDMT1ducedKHK-/-micectentourobervtiKHK-deficientmiceexhibptneouytemicirdeficiencyBecueplmireentilmximlneutropoiecoupledfctKHK-deficiencyloultmrkedlyducedneutrophilnumrpercentgeouroverrchghypofrucefciltecedtetlirbptiviKHK/F1P/HIF-2xledgpro-flmmryneutropoieturnctriedevelopmentHCCWetetthhypougfollowgtwopecificimAim1DetermewherdietryfrucepromotetetlirbptiKHKF1PHIF-2-dependentmnnerAim2Determewherdietryfrucepromoteytemicflmmtiledgpro-tumigeniclivermicroenvirmentduecedir-dependentneutropoiePROJECTSUMMARYThepropoederchimundertdcoverdprylungcncerdevelopmenttweenAfricnAmericnEuropenAmericncidergrceexFexmpleAmgAmericnMlehighetnumrdethoccurlungcncerwhichmodeththnkidneypncprottecncercomdAfricnAmericnMlehveignificntlyhigherdethrtelungcncercompdEuropenAmericnMleCigttemokgcidedtrgetrkfcrlungcncerHowevermokglecnnotexpldprylungcncerdevelopmenttweenAfricnAmericnMleEuropenAmericnMleThetrdilcoht-bedgenome-wideocitudiefiledidentifyAfricnAmericnMle-pecificgeneticloctiuceptiblecuglungcncerTheetudieimilrcurnttrdmediclprcticewhichlrgelyliepopulti-bedepidemiologicltudiewhichdividulgeneticepigeneticvribilielrgelyignodultgpopulti-bedccluiAultimilrcncertypepddiffentlymettmentceechtumhuniqueetmuttiAperlizedpprochcnidentifyptient-pecificgeneticepigeneticltertiledgdprielungcncercidencemtlymyovercomeuepopulti-bedtudieRecentdvncementexplblertificiltelligencehowpplygloclterpttibedgmeyecndcoverptient-pecificignificntgenelteddeecdinlyzggeneexpiprileptientWepropoedevelopnexplblertificiltelligence-bedcomputtilolexplomulti-omicdtdecipherglungcncerhelthdprydcovergfirtptient-pecificdprymtiecdcoht-pecificdprymticombgdividuldprymthirddprytweentwocohtcomprgcoht-pecificdprymtiwhichleddcoverycoht-pecificrkfcrThepropoedolcnppliedtdcoht-pecificrkfcrctgcomprgcohtbedrceexuchAfricnAmericnMlevEuropenAmericnMleAfricnAmericnFemlevEuropenAmericnFemleetcThudevelopedolhelpolvedprypuzzleextlungcncercidencemtlydiffentrceethnicieThepropoedwkimptntceidentifyheterogeneylungcncertperlizedlevelwhichmyhelppcimedicertildeignThimprovedpcimedicedeignhelpducelungcncerhelthdprietweendiffentethnicrcilcommuniemximizerpeuticnefllcommuniePROJECTSUMMARYPTP1Bn-ceprtypecogenicPTPloknownPTPN1volvedgrowthfcrignlgThePTP1BgenefquentlymplifiedcncercltepoprognoHoweverdepettrctivenePTP1Brpeutictrgetdevelopmentdrug-likehibirthenzymehprovendifficultprimrilyduelowcellpermebilylckelectivywrdPTPWhilenumerouvetigrdevelopgtrdiltypehibirtrgetducedctivemPTP1BtrgetgPTP1B-oxhimptntdvntgeltghibirbiovilbilyelectivyThegolthpropoldevelopchrgeneutrlhibirpecificllytrgexidizedmPTP1B(PTP1B-ox)whichextprcipllydeetteThpprochwvlidtedcenttudyhowggle-chvriblefrgmentntibodiecntbilizeoxPTP1BodogmodulteignlgpthwyltedenergymetbolmcncerInAim1weppevlutedivereulfeniccid-ctivecombrillibrrieInAim2wecenlibrrieppdAim1identifycompoundtrgexidizedPTP1BBedourexpertetrgetgdtctdoxmrpeuticllyimptntprotenovtivechemtry(NtChemBiol201220182023NtChem2021)welmotcertlyidentifymoleculetrgettbilizeoxidizedmPTP1BTheenucleophiliccompoundlyfoundtifututudiethpicnR21propolexmepotencySARcellulryABSTRACTUrolilblddercncerpentignificntgloblpublichelthburdenccountgome200000dethechyerAmgmnyenvirmentlrkfcrblddercncerdrkgwterctmtedgnicrenic(iAS)pentcommcueepecillymgrurlpopultiThmechnmpperepecillylevntherurltteNewHmphiwhichufferglehighetcidenceblddercncermgfiftytteDepelgtgknowledgeiAexpoupenthighlypventblecueblddercncerpcemechnmwhichiAceblddercncerrkmuncertledgnbencepot-expourkmigtitrtegieToddthuewenowpropoedevelopnentilynovelzebrfhmodelurryblddercncerllowgulevergemnydvntgezebrfhmodelgnmcludgfcilegenetrgetglghryproductiveueenvirmentlxicologyerchOurgrouphcentlydemtrteddultzebrfhhrbmmmlin-likectrctileurrybldderglecell(c)RNA-SeqidentifygbothbllumlurolilcelltypeimilrthoeobervedmouehumnBedefdgwenowpropoetetfollowgcentrlhypoeFirturolil-pecificcogenectivticomdtp53kdm6tg2ctivtiducezebrfhurolilneopliecdrenicexpoultertrncriptillcpecellcompoizebrfhbldderthirdcombticogenictimulirenicexpouccelerteechngebothp-mlignntneoplticzebrfhuroliumTotetehypoefollowgSpecificAimpurued1)Toexmebilyurolil-pecificcogenectivtumuppgenectivtiduceneopltictrnmtizebrfhurrybldder2)TodetermeeffectiAtrncriptillcpecellcompoinmlp-neopltic/neoplticzebrfhurrybldderTheetudieenbledourbrodlyter-dciplrymulti-tutilerchtemcompdexpertzebrfhcncermodelg(Lech)blddercncermoleculrgenetic(Rel)renicxicologyglecelltrncriptilprilg(Goodle)llowgupuruevrietyhighlynovtivetrtegieTogertudiepropoedthR21pplictidetermeeffectcomdcogenectivtumuppgenectivtizebrfhuroliumpotentillyledgvlublenewzebrfhmodelurryblddercncerInddietudieprovideveryfirtglimpehowgnicrenicltertrncriptillcpeuroliln-urolilcellvivotglecellolutimgfututrtegieeffectivepventirenic-ducedblddercncerAbtrctImmunecheckpothibi(ICI)cnctroltrcrnildeepproximtely50%ptientmelnombrmette(MBM)whichledgcuedethecncerptient-implictgimmunemicroenvirment(IM)modulticnrpeuticbrThehenprdigmhiftcliclmngementwheimmunpycncidedrrthntrdilurgery/rdiHoweverlckpcliclmodelvilblemodelIMptientMBMwhichneededtetimproveimmunerpie(IT)OurgolthR03propoldeveloptetptientderivedgnoidmodelmimicIMfoundptientMBMwhichhvefutupplictidevelopmenptimiztiITtrtegieThedevelopmentthmodelprovidefoundtildttudycellulrcro-tlkIMMBMwhichfoculrgerNCIR01OurlbryhexperienceugexvivoptientderivedbrgnoidurgiclmplepcimediceydrugcengOurplimrydtderivedglecellRNAequencg(cRNA-eq)ptientMBMmpledemtrteCD8+Tcellpnttumexpexhutimrker(iePDCD1CTLA4LAG3TIGIT)upptgrpeutictrtegietrgetgTcellctivtiFurrcell-cellcommunictinlyeourcRNA-eqdtuggetcncerocedfibroblt(CAF)domntcellceivgTcellcrotlkMBM-dictgTcellmodulteextrcellulrmtrixWehypoizeptientderivedgnoidmodelneedECMtTcellchrcterticptientMBMngnoidECMprovidenoptimlmodeltetgITtrtegieTheimthtudy1)ToidentifyTcellphenotypeimmunocompetentMBMgnoidoutECM2)ToidentifyTcellphenotypefollowgICIttmentMBMgnoidThedevelopmentpcliclimmunocompetentexvivomodelMBMhyetccomplhedfciltefollowgnovtii)etblhmentbiopecimenwkflowllowpervtumtromimmunecellbrmettgnoidii)identifictiTcell-tumcelltercticntrgetedfutuiii)identifictibiomrkerICIefficcybrThenovtigedthR03tudyctrieliveptientwdtgemelnombrmetteledgcuedetheptientOurdtprovidebfutuNCIR01pplictiPROJECTSUMMARYDiffuemidlegliom(DMG)lethlbrtumchildnPtientprognoveryblekmedinoverllurvivl~9mthTheetumtypicllydelictenmiclloctiuchbrtemprohiburgiclectiRdilytrdcprovideympmticliefHoweverdeectroltrnientchildnevblyfcetumcurncepmtudethTheneednovelrpieDMGptientepecillythoecncomdrdiGlutthie(GSH)eentilcvenggctiveoxygenpeciegenertedrdiGSHloeentildexifictimethylglyoxl(MGO)highlyctivemetboleptneoulyproduceddurgglycolyMGOducepopirveriblydmggproteDNAcncercelldptMGOproductiupgultgexpiglyoxle1(GLO1)whichdexifieMGOcjugtiGSHAnlyTCGAdtwellourplimrytudieptient-derivedDMGmodeldicteGLO1expiupgultedDMGInhibgGLO1ugpotentbr-penetrntGLO1hibirS-p-bromonzylglutthiecyclopentyldieter(BBG)brogteMGOdexifictihibprolifertiptient-derivedDMGcellImptntlywhileBBGlerttumgrowthmicergthopicptient-derivedDMGcomdttmentBBGrdiducetumgivivoBedeultAim1wedetermewhercombtiBBGrdinctiblerpeutictrtegyptient-derivedDMGmodelSuccefultrnltinovelrpieidedidentifictiimggbiomrkerpnerlyperpyDeuteriummgneticncepectrocopynovelclicllytrnltblemethodvulizgmetbolm2H-lledubtrtevivoOurplimrytudiedicteBBGdowngultelctteproducti[66-2H]-glucoeDMGTheeAim2wedetermewher[66-2H]-glucoeprovidedoutpecomdBBGrdipriMRI-detectblenmiclltertimicergthopicDMGvivoOurpropolnovtivecuewevlidteGLO1druggblevulnerbilyDMGThprojectignificntcueourtudieettgetrnlticombtiBBGrdiDMGptientCcomntly[66-2H]-glucoeenbleerlyementefficcyclicltrilptientmngementIneenceleverggmetbolmrpyimggttmentpewedeliverpcimediceenhnceoutcomequlylifeDMGptientProjectSummry/AbtrctThegolmotcncerttmentducepopticdeumcellmnyceettmentloduceubtntilf-trgetpophelthytueEvenbencerpymjypropectivemettticcelldiepopultgerlymettticnichegrichpopticcellmterilWhilenumeroutudiehvefocuedfetutumcellllowmurvivemettizefceuchttmentlettentihenpidfluencedygcellmelvecncerprogiThewkpropoedhevetigtehypopopticcelldriveefficientmettticpdhelthycncercellcueyeccdeplteletcrumentcogultimyeloidcellprogrmmgtmettticeWeddthhypofocugtheAimFirtweddrolephophtidyleexpoupopticcellcrugplteletpromotgtumcellurvivltrvculrnicheuprrivlmettizgcelllungSecdweexmeterfcetweenpopticcellcncercellmyeloidimmunenetwklungdurgextrvtietblhmentmettticnicheThirdwetudyeffectpopticcellptneoumettprimrytumtetwherblockgpro-mettticfetupopticcellcnducemettthettgWhileourwkfocuedfundmentlproceewhichpopticcellfluencemettweuggetmypotwrdrpeuticcombtipventmettPROJECTSUMMARY/ABSTRACTAllogeneichempoietictemcelltrnplntti(llo-HSCT)potentillycurtiverpyptienthemlogicmlignncieItlievedlloctivyupHSCTedlymphoidcellexprrnggceprupcognizglltigengrftUnlikelymphoidcellcellnteimmuneytemdotexprrnggceprnpecificllyduceddngermoleculeHowevercenttudiedemtrtednteimmuneytemcouldpecificllydtguhn-elfgrftubequentlyenhncelloimmunepeSignlgulryprote(SIRP)polymphicimmunoglobulceprexcluivelyexpedurfcentecellTheterctitweenSIRPubiquiulyexpedligCD47uppemcrophgephgocyticfunctiAhownmutrnplntmodelmmtcheSIRPtweendcipientcnupgultellocognipeOurgroupcentlyvetigtedroleSIRPvrintmmtchcipientllo-HSCThumnleukocytentigen(HLA)-mtchedltedd(MRD)ttmentdiffenthemlogiclmlignncieWefoundfirttimed/cipientSIRPmmtchcommlydetectedocedignificntlycedrkchricgrft-veru-hotdee(cGVHD)lowerrteerlylpe(BloodAdvnce2021FrtierImmunology2022)Wepropoedlrgegtry-bedtudyvlidteourultllo-HSCTcipientMRDwhichemotcommdourcello-HSCTThetudypprovedCenterInterntilBloodMrrowTrnplntReerch(CIBMTR)immunobiologywkgcommteeCIBMTRNtilMrrowDProgrm(NMDP)fciltetudyprovidgcientificttticlexpertewellocedclicloutcomemtibiopecimenWehypoizemmtchedSIRPelicn-elfcogniwhichfurrpromotedptiveimmunyledghigherrkcGVHDlowerrklpeInAim1wepermtropectivenlySIRPmmtchllo-HSCTMRDugCIBMTRdtpecimenAim2determeltivecliclignificnceSIRPmmtchenticohtubgroupllo-HSCTThetudynlydefecliclroleSIRPvrintmmtchllo-HSCTettgloignificntlydvnceourknowledgeGVHD/GrftveruLeukemi(GVL)llocogninteimmuneytemctexttemcelltrnplntPROJECTSUMMARYThgolthpropolvetigtenovelphmlnnoprticle-bedpprochgenertgtum-pecificTcellndoptiveTcellrpy(ATCT)glioblm(GBM)DepegmotcommlydignoedbrtumprognoGBMptientdmlltivefive-yerurvivlrte75%HencenurgentneednovelrpiethptientpopultiInpeweynizgnovelPruinbluennoprticle-bedmultiueddmterphmlrpy(PBNP-PTT)generteperlizedATCTGBMOurpprochvolvettgGBMtumcellecteddurgurgeryPBNP-PTTexvivoco-culturgmdendriccell(DC)TcellexpedPBMCourcedptienrmtcheddexpGBM-pecificTcellubequentATCTWeenviourrpydmtedptientftertrd--cgimenurgerychempyrdirpywhenGBMptientmimllyiduldeettegolmximizgimpctTcellrpythuimprovgurvivloutcomeIncentlypublhedtudyGBMtumcelllewedemtrtedPBNP-PTTgenertedmopotenttum-pecificTcelltermpecificycylyticfunctiwhencompdTcellgenertedfeze-thwlyGBMtumcellhetgtumcellhetblocktequivlentrmldoeInvivoourimmuneengeedTcellelimtedthopicllyimplntedU87xenogrfttumignificntlyimprovedurvivlcompdtum-rgnimlttedlyte-derivedntigen(PRAME)-pecificPHA-expedTcellctrolttmentOpertillyourpprochpentmoemlewkflowthnperlizedpprocheItvolvetrightwrdgledmtrtiPBNP-PTTGBMcelloltedfterurgery10muteugPBNPp-ynizedGLPtechniqueptblelerfollowedwell-etblhedDCTcellexpniprocolBuildgepromgfdgwenowpropoeynizemultiplePBNP-PTTnnmultigenerteexptum-pecificTcellcducttudietetgirefficcyvrovivoexvivowellmechntictudieWehypoizePBNP-PTTGBMtumcellugourPBNPnnmultiignificntlyenhncentigenleecptuPBNPirprocegpenttiDCllowgmobutctivtidivereTcellpopultiwhichubequentlydiffentecyxiceffecrlg-ltgmemyphenotypeidelATCTproductfeeffectivettmentGBMSuccethprojectdemtrteuePBNP-PTTnnmultigenertetrnmtivenewclATCTGBMProjectSummryN-mllcelllungcncer(NSCLC)cidencemtlyrtehighermgAfricnAmericn(AA)thnrcilethnicgroupAlowerpvlencelung-cncer-ltedgeneticmuttiAAdictetudygtrncriptifcrnewpromgdictiWehveidentifieddiffentillyexpedpfeRNAprilg120cliclpecimen72ptientcludg12pecimen12AA108pecimen60CucinAinugmlln-codgRNAdeepequencgfollowedbiomticbiottticnlyelleptientwiirnignmlignntpulmrynoduleWeidentifiedpfeRNAwlyexpedAAundetectbleeirCucinAinuggetgthpfeRNAnAA-pecificpfeRNA(AA-pfeRNA)TheueAACucinAingiveudictevidenceAA-pfeRNApotentilfcrhelthdprieNSCLCTheueptientnignmlignntpulmrynoduleprovideperfectmodelundertglungpneoplimlignntprogiAA-pfeRNAweidentifiedpecificllyducedendogenoulycelungpneopliprogeNSCLCAAgivgdictevidenceAA-pfeRNArpeutictrgethivolutilungpneopliNSCLCImptntlyweidentifiedAA-pfeRNAfollowgquimentclicllbryimprovementmendment(CLIA)complintlbrydevelopedtet(LDT)yprovidgevidencetrnltildevelopmentFurrhighexpipdictedweoverllurvivlAANSCLCTopventAA-pfeRNAfunctidruptNSCLCdevelopmentwehvedeignedoligocomplementryAA-pfeRNA(cAA-pfeRNA)optimizedmodificticjugtedeliverpfeRNANSCLClimccumultinmltueTheethprojectweprovidemechnticrtilerpeuticightdruggbleAA-pfeRNA(1)IdentifytrgetprotecnceroutueAAtge-I/IINSCLCcfirmirterctiptterncellulrdtriibothcnceroutuecelloberveeffectbicbiologiclctiviecellouttrgetprote(2)evluteefficcyfetyphrmcoketic/phrmcodynmicltihipligted-cAA-pfeRNA-2-MOE-PTOytemicdeliverypcliclnimlmodelOuroptimizedpecific&nturlpfeRNA-bedtrgetgytemprovidenewttmenpptunyAANSCLCducercilethnichelthdprieAloytemignificnttetercherfieldncRNA-bedrpeuticcncerttmentPROJECTSUMMARYROLEOFJMJD4INBREASTCANCERIn2023nerly43000womendiebtcncerUSdictgurgentneedtterrpieAmocompheniveundertgdrivgcebtcncermyfurnhnovelidehowcurtilthdeeJMJD4nenzymehenimplictedprotelyehydroxyltidemethyltiHoweverpcephyiologiclfunctiJMJD4mechnmctihvemedunolvedOurplimrydtdemtrteJMJD4upgultedbttumJMJD4blticnducegrowthvihumnbtcncercellFurrweprovideevidenceJMJD4tercttwotrncriptifcrvolveddevelopmentbtcncerchemotncetpemedirNRF2HIF-2mjcompenthypoxipepthwyThuggetvrioupotentilmechnmwhichJMJD4myffectbtcncercellBedeplimrydtwepoJMJD4promotebttumigeneMooverwehypoizeJMJD4functitletprtthroughmodultgNRF2HIF-2Totetehypoewepropoetwopecificim(i)TodetermeroleJMJD4btcncercell(ii)TovelhowJMJD4ctthroughNRF2HIF-2CompletietudiegtlydvnceourmechnticundertgJMJD4rolebttumFurrmoourerchmynomteJMJD4noveltrgetttmentbtcncerBecueJMJD4noteentilnmlcellmllmoleculehibirJMJD4enzymticctivypdictedhvemimlideeffecthighlydeirblefetuLtlyightgedhelikelyhveimplictittmenrdeecludgcollungcncerwheJMJD4loovexpedPROJECTSUMMARY/ABSTRACTSexulgendermy(SGM)dividulcompgrowgpopultiover20millipeopleUnedStteSGMdividulexperiencecncerc-lteddpriecomprtivelymofquentlte-tgecncerdignoemopmtucncerdethAlthoughedprietrkcncer-pecificneedSGMptientunder-ptedunder-tudiedOurplimrydtvelfewerthnhlfcologyprcticentiwidecollectSOGIdtcuecologyclicinlcktrghowdcuSOGImtinffirmgculturllyppropremnnerInvibilySGMpeoplefurrexcerbtecncer-lteddprieclicinerchercnnotevengdcuwyimproveeptientcncercoutfirtidentifygmircncer-pecificneedWepropoemedythfgtrgmodulecologyclicinwhichtechclicinwhyhowkptientboutirSOGIttucncerclicInfirtimwepropoepilotrgmodulemgcologyclicintthecliclentiwideWelerncologyclicinviewttudethmodulefeelgcompetencecrgSGMpeoplefterprticiptgthmoduleugqultiveterviewInterviewquetiderivedmodelhighlightgfivefundmentlctructprovideculturllypivehelthcdiveregroupptientdevelopedCmph-BcotecollegueWeuenertiveproceimprovemodulectentbedupthqultivedtInecdimwepropoelernviewttudeSGMptientbouttrgmodulectentugqultiveterviewbedthdtfurrfemoduleoptient-centricSGM-ffirmgpoibleUpcompletieimfltrgmodule1)cceeilyimplementblecliclprcticetke45mutelecomplete2)pecificllytrgetedbothptientclicinccernneed3)pplicblewidedivereudienceWhcompletietwoimflizedmoduledyfurrdevelopmentctextntilclicltrildybroddemtimgcologyprcticeAbtcncer(BC)dignoignificntlifeeventcndverelyimpcthelth-ltedqulylife(HRQOL)BCurvivducgmjtoceddignottmenverht-termOverlg-termBCurvivcnloexperiencemjtocedpertentympmttment-ltedlteeffectwellltedpychologiclocilfnciltpertlgurvivhipdverelyffectgHRQOLlg-termBCurvivThegrowgevidenceddiedividul-leveltneighbhood-leveltocilbuiltenvirmentlodverelyimpctcncerurvivhipoutcomecludgHRQOLMotpritudieHRQOLhowevexmeddividul-leveltlywefocuedht-termBCurvivprimrilyn-HpnicWhe(NHW)popultiTheignificntgpknowledgeboutmulti-leveltdverelyimpctHRQOLmglg-termBCurvivnotknownwherkeytdiffermgurvivdiffentrcilethnicmized(REM)immigrntpopultiwholikelyhvegterburdenbothdividul-levelneighbhood-leveltWecductR21pilottudyNrnCliniBtCncerFmilyRegtry(NC-BCFR)propectivepopulti-bedcohtenrichedAfricnAmericnAinAmericnHpnicwomencidentBCdignoed1995-2009whohveenctivelyfollowed14-28yercedignoFrom1116ctivelg-termBCurvivwhocompletedltetfollow-up(2019-2022)weelectpenttivempleBCurvivwhoelf-identifiedAfricnAmericnAinAmericnHpnicWecollectquetinidnlepheterviewHRQOLdividul-levelt(cncer-pecificocilt)updtedociodemogrphicchrctertic270prticipnt(90AfricnAmericn90AinAmericn90Hpnicurviv)UggeoptildtAmericnCommunySurveyweppendcenu-trctlevelneighbhoodchrcterticderiveocilneighbhood-leveltgeocodedddeWecollectbloodmple176prticipntmeuC-ctiveprote(CRP)pnelcykeexploocimulti-leveltHRQOLInAim1weexploocitweenmulti-leveltHRQOLidentifykeytechrcilethnicntivygroupInAim2weevriflmmrybiomrkermulti-leveltHRQOLThefdgthR21pilottudymdeignlrgertudytflmmtiHRQOLmglg-termBCurvivTheidentifictipecificlg-termBCurvivgrouplowHRQOLpecifictprilemurvivhipclyfoundtifututrgetedmulti-leveltrtegieterventiducemulti-leveltimproveHRQOLllrcilethnicntivygroupBCurvivultimtegolchievghighHRQOLimprovedurvivlhelthequyllurvivPROJECTSUMMARY/ABSTRACTLiporcom(LPS)motcommtypettuercomThemotcommubtypewell-diffented(WDLPS)dediffented(DDLPS)liporcomwhichchrcterizedgenomicmplifictimudoublemute2(MDM2)negtivegulrp53over90%cewhile7%humnWD/DDLPShvep53muttiPtienthvehighrkcurncefterurgiclectiptientmettticdeehvepooverllurvivlduepoperteytemicchempyWhileimmunpyhhowntmendouefficcyolidtumerchfocugimmunebiologyrcomhenlowerthntumtypeThenurgentunmetneedundertliporcomtummicroenvirment(TME)enbledcoverynewefficciouimmunpeuticpprochercomptientMemyTcellplycrucilrolenti-tumimmunyReidentmemyTcell(TRM)whichidetummytuedimmunygtcncergrowgtueOurgrouphvedemtrtedfvbleroleTRMTMEocedimprovedptienturvivlcromultipletumtypeChrcteriztimemyTcellLPSwherTRMpentfunctilhnotenexplodDDLPSptientwhohdimprovedprogi-feurvivlpheIItrilttmentPD1hibirwefoundhvepencetertirylymphoidtructu(TLS)necpiclymphoidtructuctT-cellB-cellrichgiimmunepopultiirtumScePD-1hibirwkblockgthproteTcellimpertiveweunderthowTRMterctTLSTMEIndermechnticllytetthnvivoptneouimmunocompetenttummodelnecerycecell-lederivedtumlckcomplextumevoluthccurlgideimmunepeGeneticllyengeedmouemodel(GEMM)modependblymimichumnmtummicroenvirmentCurntlynoetblhedptneoutummumodelliporcomOurfirtAimvlidtenAAV8-Ap22-eGFP/CPTENf/fp53f/fC57BL/6LPSGEMMmodelchrcterizetrtumlytemicimmunepeThetumimmunechrcterizthmodelcompdhumndrderetblhvlidyugpcliclmodelOurecdAimgenerteC-ducibleMDM2-ovexpgGEMMneededmodelmotcommcogenicdriverptedhumnliporcomTheuccefulcomplethprojectwouldhighlyimpctrcomcommunyprovidgnecerymodeluepclicltudiepurunoveleffectiveimmunpeuticptientAdevelopgbodypcliclevidenceuggettegrycompoumimmunemicroenvirment(TIME)highlyplticmodultedhotlifetyleexpouUnhelthfulexpoucludgoyctivyhighftdietcnledloCD8+TcelleffecrfunctumprogipcliclbttummodelwhilehelthfulexpouuchvoluntrywheelrunngcnfettumgrowthdygultedcdiTIMEledgcedtrffickgenhncedfunc-tiCD8+TcellAlthoughemerggp-cliclevidencecompellgeverlgpepidemiologiclknowledgegrdglkmglifetylefcrtumimmunyBCoutcomemFirtdepeuggetidheTheAmericnIntuteCncerReerch(AICR)TheAmeri-cnCncerSociety(ACS)cncerpventilifetyleguideleftercncerdignowhichlifetylefcrwherywkgerimpctBCoutcomehnotenwelletblhedSecderchrolelifetyleimmunyBCptienthprimrilyfocuedimmunecellubetcircultgperipherlbloodToourknowledgewherlifetyleoceddtctimmunecellphenotypebtTIMEemotlevntttmentpeBCprognohmedunvetigtedBuildgfextntpcliclevidencemultiplelepublhedplimryevidenceourgroupwedeignedcurnttudyddecriclgpknowledgeLeverggdt1160primryviveBCptientenrolledDtBnkBioRepoiry(DBBR)tRowellPrkwedevel-opedcompoelifetyledexco(LIS)flectgdhenceevencncerpventicommendtiTheAICRTheACScludg1)mtghelthyweight2)gphyicllyctive3)etgvrietyfruvegetble4)limgdproceedmet5)limgvoidgugr-weetenedverge6)limgvoidglcoholcumpti7)voidgmokgOurplimrynlye-velptienthighetverulowetLIS(egtertile)experiencetrikgurvivldvntgeBedeplimrydtwemultedourcentrlhypoCD8+TcellcompoibtTIMEmedeobervedocitweenLISBCoutcomeTotetthhypowelkdetiledlifetyledtmultpectrlimmunohchemiclimmuneprilg1160BCptientenrolledDBBRvilbleFFPEtumtueexecutemlmedipthwynlyevheSpecificAimInim1wedefeociLISCD8+TcellcompoibtTIME(celldeniertioclutertlCD8+TcellexhutedCD8+TcellctivtedCD8+Tcell)Nextim2weidentifyociCD8+TcellcompoibtTIMEBCoutcomeInim3wedeletectriiCD8+TcellTIMEbiologicltermedirieunderlygobervedocitweenLISBCoutcomePROJECTSUMMARYTriplenegtivebtcncer(TNBC)nggivebtcncerubtypeccount~20%btcncerdignoeImptntlyn-Hpnic-Blck(NHB)HpnicwomendproptillyffectedTNBCweclicloutcomethnn-Hpnic-Whewomen(NHW)evenwhenrkdjuteddignocliclfcrwellocio-ecomicfcrThdictebiologiclfcrlofluencecliclcoureTNBCptientdiffentrcil/ethnicbckgroundWecentlyidentifiedrobutTNBCprognoticubgroupbedBRCA1/2ttulevelnimmune-ltedgenetrncriptiligntuSpecificllywedemtrtedBRCA1/2mutnttum(BRCAmut)BRCA1/2wildtypetumhighlevelimmune-ltedgeneigntu(nBRCA-ImmuneHigh)ocetrpyperte(meudpthologiclcompletepepltum-bedchempy)InctrtBRCA1promoterhypermethylti(BRCA1meth)BRCA1/2wildtypettulowexpiimmune-ltedgeneigntu(nBRCA-ImmuneLow)lkedpoperteImptntlyBRCA1/2mutti(lkedtterprogno)lecommbothNHBHpnicTNBCptientcompdNHWptientwhileevidenceTCGATNBCdtethowhigherpvlenceBRCA1methcncer(lkedpoprogno)NHBthnNHWptientctentdprieclicloutcomeInddircil/ethnicdiffenceTNBCtumimmunecellfiltrtihvecentlyenptedBedeobervtiwehypoizetletprtdprieclicloutcometweenTNBCptientNHBHpnicncetryvthoeNHWncetryduediffentpvlenceTNBCmoleculrfetuocetterwerpeuticoutcomeHetetthhypoweeBRCA1/2genettu(BRCA1/2muttiBRCA1promotermethyltiSpecificAim1)levelimmune-ltedgeneigntu(pnel30immunegeneSpecificAim2)tropectivecoht~300primryTNBCmplewomenNHWNHBHpnicncetryWendetermepvlencefourTNBCprognoticubtype(BRCAmutBRCA1methnBRCA-ImmuneHighnBRCA-ImmuneLow)echrce/ethnicywrdcertgwherirpvlenceccountdiffencepeoutcometweenNHWNHB/HpnicTNBCptientSuccefulcomplethtudygenertenovelightbicmoleculrmechnmunderlygcncerhelthdprieprovidegroundwkfutupropectivetudyexpvlidteprognoticvlueypeptienttrtificticromofedrceethnicyubgroupPROJECTSUMMARY/ABSTRACTThpplictieeketblhPulClbiCerDevelopmentAwrdCliclOncology(K12)tColumbiUniveryIrvgMediclCenter(CUMC)HerrtIrvgCompheniveCncerCenter(HICCC)ThepropoedprogrmwhichclledCUIMCClbiCliclOncologyCerDevelopmentProgrm(CUIMC-K12)tkedvntgetrgfcultiecliclmedicebicpopulticiencewelldeeptechnologicourceCUMCdiverecommunyptienterveAMyUndererved-NCICommunyOncologyReerchProgrm(MU-NCORP)ewepoiedtrnextgenerticlicincienttmultiplepeciltie(MediclOncologyRdiOncologySurgiclOncologyPedricOncologyGynecologicOncology)permtrnltilclicloutcomeerchhelthequylenemphizghowdiverediffenceuchgenderrcezipcodehouldcidedpcliclclicltudydeigncrumentcductnlyWehvechoen46pmenrtCUIMCvergedictcotgrntupptpermenrexceedg$1McludgphyicincienttwhoterntillycognizedlederirerchexcellenceouttgmenrgcdAcofetuourprogrmfotergmulti-dciplrycncererchencourggmenrhiptemcompdbictrnltilmenrclicltrildvWelocludeecdrymenrjunintudeigntedJuniMenrwhofunctinerpeerourScholrervenextgenertiprimrymenrThecompheniveerchtrgenvirmenttCUIMC/HICCCprovideClbiScholrdvncedkillnecerypermtte---rtcliclerchbily1Permp-cliclrpeutictrnltilpopulticience/cncercdeliverytte---rtcliclerchdeveloptetcientifichypoegolducgmtlymbidycncer2Deigndmterllphe(iepilot/PheIIIIII)cncerclicltrilpropectivelyevlutecliclbiologiclptient-ptedecomicendpot3Cductcliclcncererchdiveretemettgexpedeccelertetrnltibicobervtilerchptient-ientedclicltril4Ciderhowdiveryhouldcludedemphizedclicltudydeigncrumentcductnlygolducghelthdpriecggenerlizbily5ObtpeerviewedfundgupptcerdependentclicincienttABSTRACTStJudeChildnReerchHopl(SJCRH)homelyNCI-deigntedCompheniveCncerCenterdedictedolelypedricgivgourtutiuniqueroledvncgntieftcombtcncerDevelopgnextgenerticlicincienttfocuedcncerchildndolecentcricllyimptntSJCRHprovidenexceptilenvirmentdvncedtrgptient-ientedcologyerchCliclvetigtcenterourmiOurfoundgdicrDrDPkelceivedLkerAwrddemtrtgpowercombtichempyTodywld-clbictrnltilerchtegrtedrobutcliclcliclerchenterpFourptientnewlydignoedcncer47%enrolledrpeutictril15dydigno83%llenrollmentStJudevetigr-edtril38%terventiltrilchildncncervetigr-edtutillypodTeourhemlogy/cologyfellowhipprogrmhvedependenterchprojecthigh-impctpublictigrntHowevertrnifcultypoiloprotectedtimeptient-ientederchchllenggThePedricOncologyCerDevelopmentProgrmtStJude(POCDP)propoebridgethgpleverggexceptilourcetrgenvirmentfedtSJCRHprovideprotectedtimemenderchtwocholr(trucr-levelfculty)ScholrmendScholrlyOverightCommtee(SOC)tilodirerchtetEchSOCcludecliclerchernepidemiologtbictrnltilcienttbiottticinnexternlmenrDidcticexperientiltrgfocuthe(1)TrnltilScienceMedice(2)CliclTrilReerchMngement(3)PilDevelopmentAdvncedcdemictrgcludeopptunyobtmterdegecliclvetigtiScholrenggeclicltrilviewprocetrildeignlectueriecliclerchturillederhipdevelopmenteiEchcholrexpecteddeignclicltrilpentirerchubmcerdevelopmentgrntTheVgScholrExchngeProgrmprovideopptunycholrgexpougnvedpekertprtnerCncerCenterScholrprogmidirSOCnInternlSteergCommteeprogrmeffectiveneevlutedcholrerchproductivy(publictigrntclicltril)feedbckcholrSOCevlutinExternlAdvyBdAtSJCRHdvncedgenomictrnltilciencenovtivevetigr-edclicltrilemldcoverielteeffectttmentourCncerCtrolSurvivhipProgrmprovidenenvirmentexceptilcliclcopptunietrgdevelopmentledernovrptient-ientederchchildncncerSUMMARYCncercchexicomplexmetbolicyndromechrcterizedmuclewtgweightlodecedqulylifePtientcncercchexiexperienceimpidmuclefunctiducedttmentlerncelowerurvivlrteDepeprogundertgcdiunderlygmechnmhighmtlyrtemunclerThepropoederchimvetigteroleplteletcncercchexidevelopmentyvolvedflmmtuewtgPlimrydtuggetnocitweenelevtedplteletcountp-cchexitgeplteletctivtieve/frcrycchexiThepropoedtudyhypoizeplteletplycrucilrolecrumentimmunecellleepro-cchecticfcrultimtelyledgmucleloTheerchtethypothroughtwoimdepletgpltelettp-cchectictgeeimpcnflmmtimuclewtgexmgeffectctivtedplteletmuclewtgcncerchempy-ducedcchexiTheprojectimprovidenovelightpotentilpprochetrgetgplteletcncercchexiPROJECTSUMMARYHigh-rkhumnppillomviru(HR-HPV)knowncue>95%cerviclcncercervicltpililneopli(CIN)ProphylcticvccevilblegtmotcrcogenictypehighlyeffectivenumrpeopleceivgvccelowvcceeffectivewomenwhohveldydevelopedCINInilfectiHPVultlow-grdeCIN(CIN1)motlycledimmuneytemHoweverfiluimmuneytemclerHPVcnledchricfectirkhigh-grdeCIN(CIN2CIN3)vivecerviclcncerTheemerggevidencevglmicrobiomeplynimptntrolethprocehowevermechnmlkgvglbcterihotpeHPVfecticerviclneopliprogiundexplodAntibodybdgmicrocnltertructufunctimicrobiomehoweverthhnotencomphenivelychrcterizedfemleproductivetrctOuroverllhypoproptibundnce/functilprilentibodyboundunboundvglbcteridiffertweenwomenoutHPVfectiwellthoenmlcerviclpthologylow-grdecerviclleihigh-grdecerviclleiOuroverllgoldefeocitweenproptibundncentibodyboundunboundbcteriirfunctiecomprgroupInthpropolweutilizevglmpleldycollectedcompheniveobervtilcoht(THRIVEHPV)pecificllycrugwomennbnmlppmertetfollowgmlgudlly2-3yerdetermeHPVttugiprogicervicldypliWetbcterilcellvglwbmpletbeleenrollmentntibodyboundunboundfrctinpermmetgenomicdetermebundncepecie/generfunctibcteriocedntibodyboundunboundbcteriechcomprgroupAuniquefetuthpropolhvgccelgudlmpledivere(>50%AfricnAmericn)cohtthfututudiedetermentibodyboundunboundbcteriltbilyovertimecomphenivemediclpthologiclmtiTourknowledgeourwkfirtdefentibodyboundunboundvglbcterilpopultitpecie/trlevelwomenoutHPVfectidiffentcerviclpthologieWenticiptethtudyvelntibodyboundbcterilpopultiocedhelthydeedmicroenvirmentcnidentifiedhigh-rkprileneedgmidttmenrtrgetednovelimmunologiclrpeuticProjectSummryEophgelcnceremotggivemhumnmlignncyEophgelqumoucellcrcom(ESCC)eophgeldenocrcom(EAC)primryhlogiclubtypeeophgelcncerClerrce-beddprieextgrdcidenceeophgelcncerUSEACmottenffectgCucinncetrymen(CA)ESCCprimrilyoccurrgAfricnAmericn/Blck(AA/B)menMoovereophgelcncercollectivelymodedlyAA/BptientcompdirCAcounterprtCurntlyourundertgbiologiclunderpngdecridrcildprieeophgelcncermlimedIncurntpropolwedictlypermcRNA-SeqeophgelbiopypecimeneophgelmucoAA/BCAubjecttetnovtivehyporce-ocedltertimoleculrcellulrheterogeneyeophgelmucoctriedprieeophgelcncercidenceInAim1weterrogtetueAA/BCAhelthyctrolnmleophgelpthologyInAim2weterrogtedjcentnmltuehumnubjectwophgeltumThtudypentfirtevlutirce-beddiffenceeophgelmucotlevelglecellolutiItlofirttudyexmethcellulrheterogeneybothhelthyeophgelcncerptientTouccefullychthgolpropoedtudieleverge(1)divereptientpopultTUH(2)PIetblhedpipeleeophgelbiopyprocumentexperteeophgelpthophyiology(3)collbrpectiveexperteeophgelcncer(DrWheln)clicltrnltileophgelerch(DrReichenbch)biomticnlylrge-clegenomicdt(Krmi)helthdprie(DrM)IdentificticelltypepthwydplygdiffentilpenttiexpiAA/BCAubjecthgtpotentilmourundertgbiologiclunderpngetblhedrcildprieeophgelcncercidencePROJECTSUMMARYComputtilnlyehvecometrumentlcncererchbunlymycncererchercomputtilcienttCncerercherepecillythoelimedcomputtildtciencekillfceubtntiltechniclchllengepermgdtnlyeTheechllengefllthebrodctegiedtolcomputtilfrtructuclude(1)cnectgdtettwolnlywkflowpermnnly(2)ugcomputeourceuchtutilcomputgclutercloudcomputgprocetenenmoudtet(3)permghigh-qulynlyeelectgwildergrryolvuliztivilbleTheimpctetechniclchllengecncererchevetrictgcncererchcommunydvncewrdundertgpventgttgdeeWhoutolvgeuecncerdtettwnlyolubtntillyunderutilizedturnmultimilli-dollrvetmentcncerdtciencenottrnlteimprovedptienutcomeWeddechllengethprojectctgGlxyCncer(Glxy-C)pltmGlxy-CmeetemerggdtcienceneedcropectrumcncerercherdividulexperimentltcomputtilcientterchlbclicltrilntilctiOurprojecthfourimAim1ExtendGlxy-Cdtetwkflowenbleemerggcncererchgle-cellptilmultimodldtnlyeWheexteniGlxy-Cenblemnynewcncernlyemkghigh-vluecncerdtetnovelnlywkflowwidelyvilbleAim2ExpGlxy-Cnewmchelerng(ML)olntelligentuerterfceTheenewcpbilieenuGlxy-CupptcgnumrcncernlyequiMLhelpuermoproductivetnceuerterfceAim3IntegrteueexternlcomputgerviceGlxy-CpowerlrgercncerdtnlyeUgexternlcomputgerviceenuGlxy-Cpermefficientcot-effectivecncerdtnlyeuecommunyAPImximizenumrerviceGlxy-CcncnectueAim4GrowGlxy-CcncerdtnlycommunythroughcollbtiITCRNCIHumnTumAtlNetwk(HTAN)dividulcncerercherTheGlxy-CcommunyenuGlxy-CpltmmeetneedcncererchermximizeimpctpltmcncererchTheGlxycommunynumrtenthouITCRcommunyhhunddnlyolHTANctiumhhunddcncerercherSuccefulcomplethprojectctiGlxy-Cwknchhvetmendouimpctcroelrgecommuniedogtte---rtcncererchmkgpoiblellcncercienttdoccurterobutefficientcomputtildtcienceerchABSTRACTPncticcyticlei(PCL)lyrdiogrphicllyidentifiblepcurdedlypncticcrcomydetectedmillipeoplennullyUSMotptientPCLhvedetermtecytwhichboypehlogicgrdeclicllyrdiogrphicllyuncertCurntlyuedcytfluiddignoticufferpoccurcyytypicllyquilrgevolumefluidunvilble~50%celedgbothmedcncerunnecerymjurgeryInthpropolwelevergeournovelmultiplexubtrteprilgmpectrometrymethodcomdproteomicfetrgetprotenvlidteourtwo-tierclifieridentifictimucouPCLhighgrdedyplivivecrcomgercideddvncedneopli(AN)Theflcliclyquily5LfluidAmicro-volumetricyexpectedimprovedignoticyieldcytfluidtetg~50%>90%ptientwhoundergoutevivetetgTheTier-1clifieridentifiemucouPCLwhichcrryvriblerkmlignnttrnmtipotentillymovg~25%ptientn-mucouPCLneedfurrurveillnceurgeryWevlidteTier-1clifierPCLmpleErlyDetectiReerchNetwk(EDRN)hlogicllydiverewell-nnottedbiopoiry+untetedmpleUCSFUCLAWefurrtetfeourTier-2clifieridentifictiANuguntetedbnkedmucouPCLUCSFnvlidteugexternlmpleEDRNpropectivelycollectedmpleUCSFUCLApriizedetectiANwhilemimizgburdenoverttmentWeloueourrdiologyerchengemPowerimprovecptumedptientcidentlclicllylevntPCLweexprcilethnicdiveryourPncCytRegtryOurgtrypropectivelgudlerchourceueptient-dictedputcludedemogrphiclifetylemtiTogerenovelolexpectedmkeignificntimpcnmngementdetermtePCLimprovedetectierly-tgepncticcncerwhileducgburdenoverdignooverttmentProjectSummryRelped/frcrycncerprciplcuecncer-lteddethTrgetedrpiewhichpentnewgenerticncerrpiehvedvncedttmentlped/frcryptientHoweverttmenteffecttillheterogeneouOnlyfrctiptientwhottedenewrpieexperienceclicllyneficiloutcomeTheecriclidentifynewpdictivebiomrkercnfurrtrtifyptientubgroupmotlikelyyieldfvbleunfvblettmenteffectAnlyn-romizedpheIIclicltrildtidentifypdictivebiomrkerprticulrlyimptntcueuchmticrucilguideefficientubequentromizedpheIIenrichedpheIIItrilimproveuccerteclicldrugdevelopmentInn-romizedpheIItrilprogi-feurvivl(PFS)hencglycidednimptntcliclendpotAetrildothvendependentctrolrmPFSmotcentprtmennwhichptienthdexperiencedprogihenuggetederveptient-pecificctrolThertiopidPFSnewveruprtmentuedevlutettmentefficcyThePFSrtiohcomenimptntendpoterpcicologyHoweverugpidPFSdtidentifyevlutepdictivebiomrkern-romizedpheIItrilhenhmpedduemjchllengettticlmethodFirtidentifictipdictivebiomrkertypicllychievedtetgterctieffectmultivriblemodelwhichuullyquilrgempleizeApheIItriluullyhvemllmpleizedetectgterctieffectchllenggSecdchllenggdelhigh-dimenilcidtebiomrkerThirdPFSrtioendpotdependentlycenodwhichctechllengeccurtettticlfencecuetrdilmethodcenoddtquidependentcengumptiFourthlckclicllymengfulttticlmeuevlutecompccurcypdictivebiomrkerToddechllengewepropoe)developnovelemiprmetricttticlmodelidentifycompdictivebiomrkerb)developnewclicllymengfulttticlmeuevlutecompccurcypdictivebiomrkerbedpidPFSdtn-romizedpheIItrilWeimplementttticlmethodnRpckgewellweb-bedpplictiWelopplyenewmethodthepcimedicecliclcohtOurnewmethodetblhytemticeffectivefrmewkdvncepdictivebiomrkernlybedpidPFSdtn-romizedpheIItrilwhichhvedictimpcndrugdevelopmentfciltgmomeddeignfurrvlidtiromizedtrilInUnedSttelungcncermotcommcuecncer-lteddethly205%5-yeroverllurvivlrteLowlungcncerurvivlrteflectlrgeproptiptient(57%)dignoeddtntmettewhich5-yerltiveurvivlrte5%N-mllcelllungcncer(NSCLC)motcommtypepentg85%lungcncerceTwentytypercentNSCLCptientdevelopbrmettrhtperiodprimrytumdignoTheglycnSilylLewX(SLeX)expicedcncercellcompdnmlepililcellduetumhypoxiClicltudiehvehownptienttumexpghighlevelSLeXhveignificntlyhigherrkdevelopgvimettthnptienttumexpglowlevelthntigenWehowfirttimeSSL11medecellmotilyrtducgdheivibdgSLeXThepropertiebdgglycnSLeXhibgcellmotilySSL11mkenppelgdeliverypltmgtcncerthvexpSLeXPeudomexoxA(PE)nADP-riboyltgABxuedctructimmunoxtrgetgcncerntibodieplcementcepr-bdgdomPEA24kDtrunctedmPE(PE24)wfuedvrietyimmunoxctivteeEF-2cncercellwhichhhownpromgultgtmultiplecncerWehypoizefuiproteSSL11-PE24compoedSSL11PE24providenovelrpygtcncerovexpgSLeXFproprciplewetetwherSSL11-PE24exhibnticncerctiviehumnlungcncerWeengeerfuiproteSSL11-PE24chrcterizeglycn-bdgpecificy(im1)WeexplovrticncereffectSSL11-PE24humnlungcncercellovexpgSLeX(im2)TheoutcomethtudyprovidepotentilnovelrpeuticpprochbedbcterilxgtcncerepecillycncerpremettABSTRACTTheroletum-mcrophgehybridcellprottecncermettARignlghibir(ARSI)commlyuedttcurntprottecncerwhoegrowthdependARctivieHoweverARSIcnultelectiveputrnigAR-dependenttumAR-dependenttumExtenivetudiehveveledignl-wchgmechnmwhichARSIexertphenotypictrniledgmettticctrti-tntprottecncer(mCRPC)Aprteignlgcircumventihewepropoetum-mcrophgehybrid(TMH)cellnovelcellulrctriburmCRPCOurplimrydtuggetTMHcelldoptmcrophgechrcterticevdeimmuneurveillncethemodynmictvcultudtntcoliztiInddiTMHcelltricllyexpverylowAR/AR-trgetemblgndenocrcom-immuneubtypemCRPCtARSIThepecificimueytem-levelpprochemechnticllydeferoleTMHcellmCRPCInAim1wedemtrteTMHcelllevergebundntc-MycpntlcncercellupgulteM1/M2polriztilociderivedpntlmcrophgeThuniquetrncriptimcherynobervedeirpntlcellgexploedcfoundhotimmuneytemenhncgimmunoevivefetuTMHcellInthgrdc-MycctnimmunoevivedrivernotprimrilyncogenicdriverpereTMHcellInAim2wehowultcellulrfuiTMHcellundergotrncripmicwirgARctromeledgttmenttnceARSICequentlyecellovertkeAR-dependentcncercellpopultimlignnutgrowthInAim3weevlutewhertegr-mededmechnotrnductiTMHcelltngnirtncefluidhertbloodcircultiTheignlgccdeenhncemeenchymlfetuTMHcellendowgmhighervibilymotilythncircultgtumcell(CTC)Theeourpropoedtudyhighlightnoverlookedcell-tricfcrctrigmCRPCFurrmoenumertimoleculrprilgTMHcellpentnewtypeliquidbiopyprottecncerptientProjectSummryThebroderueT-cell-bedrpietillhdedchllengeltedidentictipeptide-trgetbothimmunogenic(cpblectivtgT-cell)fe(dottrigger-trget/f-tumf-trgetxicie)Thprtduepertentdependencydequence-bedmethoddepecentbkthroughtructurlmodelgmchelerngcouldlevergedupptnewwkowidentictum-ocedntigen(TAA)ToddthuefoterdeigntterT-cell-bedimmunpiewepropoenewcomputtilenvirment(HLA-n20)tegrteextgITCRourcenewbiomticmethodtructurlmodelgnlykeycellulrimmunyceprnmelyT-cellcepr(TCR)HumnLeukocyteAntigen(HLA)ceprOurwkghypocombtimulti-omicdtlrge-cletructu-bednlycnovercomemotlimtiextgpipeleTAAdcoveryeenblgdeigntterferT-cell-bedimmunpieTotetthhypoweimplementnewwkowtructu-guidedTAAdcoverytegrtgHLA-AnpVACol(ITCR-fundedpckgeequence-bednetigendcovery)CroDome(nRpckgef-trgetxicypdicti)IncollbtiercherMDAnderCncerCenterPIdeveloptetwkowddextgneedT-cell-bedimmunpyWefocutwodiffentcncertypepentdiffentchllengecncerimmunpyIncollbtiDrLizewenchmrkourtructu-guidedTAAdcoverywkowugimmunopeptidomicdnmelnomWelunf-trgetxicypdictiidentifyfetmg10potentillyrpeuticT-cellcletrgetgtwomelnom-derivedTAASLC45A2MelnomtypeolidtumwhichgteruccehenobervedimmunpyttmentOnhcutemyeloidleukemi(AML)typebloodcncerwhichevectiimmunpyhveenobervedInthctextwewkDrAbbexmetrncripmicdtet(bulkgle-celldt)AMLptientimgtuncovergTAATCRocedeffectiveimmunepeAMLFllyweueCroDomeextgdnknownTAAdevelopTheCncerf-trgetToxicyAtl(TCTA)FechknownTAAthnewdtbectltpotentilf-trgethouldtetedwhentrgetgeTAAimmunpiePdictedf-trgetnnottedddildt(egtueexpiHLA-bdgimmunogenicyetc)Allmethodmdevilblecommunythroughuer-friendlywkowfciltgdeigntterferT-cell-bedimmunpienumeroutypecncerThepropoedmethoddeeplytegrtedITCRnetwkctgmnyopptuniefutucollbtiInddilg-termgolpropoederchwelllignedNCImichievemoeffectivelexiccncerttmentehelpgpeoplelivelgerhelthierliveProjectummry/btrctFmultiplecncertypeepidemiologicldtexhibtrgcltitweenehcidencedeeeverywhendignoedclicloutcomehncetrlbckgroundptientThwell-documentedphenomentrglyuggetlktweenbiologygeneticcncerndividuldividulgeneticncetryIndeedcenterchcncergenomicbothpn-cncercncertype-pecificpotgeneticphenotypicdiffencetweentumoccurrgptientpopultidifferggeneticncetrieneedmodtcollectipowerfurrtudythItpurpoethpropolfcilteuchdtnlymuchgtercleenblggeneticncetryfencedictlycncer-derivedmoleculrdtoutneedptientcncer-fegenotypeelf-decldrceothnicySuccefulcomplethprojectunlockvtmountuchdtncetry-ientedtudiecncertwomjourceOnebodydtdSequenceRedArchiveimilrmivediglpoirieder106cncer-derivedmoleculrprileThebodyrchivltumtuecromultiplemediclcentermilliwhichmoleculrdtmygenertedWedeveloptwolgeneticncetryfencemultipletypecncer-deriveddtnmelyDNAequencedtwholeexomewholegenometlowcovergetrgetedequencepnelRNAequencedtATAC-eqbulfe-cvertedequencedtTheoldevelopeddeliverfencegloblgeneticncetrytub-ctentllevelolutincetrldmixtuloclncetryTheeoldptiveendowedbilyoptimizeirpermnceechputcncer-derivedmoleculrprileThdptbilychievedugimulteddtcombgputcncer-derivedprilencetrlbckgroundpentgwell-defedpopultigroupAultefencemethodpermctentlyquntifibleccurcycrorngeprilgdepthquliemigtecncer-lteddmgegenomeAnopen-ourceuer-friendlyFAIR-complinttwimplementtiemethodmdevilbleerchcommunythroughnumrchnnelcludgGHubBiocducrGlxyTrgcommunyoutchthtwprovidedcollbtiITCRTrgNetwkABSTRACTThedetectichrcterizticell-feDNA(cfDNA)cglygueddetectcncerthmodlyfquentlyferdliquidbiopyEpigeneticchrcterizticfDNAnemerggpprochenivedetectiquntificticncerburdenTndcncergrowthevidentcfDNAmgptientdvcedmettticcncerhoweverignificnttrnltilneeddevelopmenterly-tgecncerevenp-cncerdetectiyviliquidbiopyMlignnttumcellhedDNAbloodtmcncerptientcfDNAcommlymnucleoome-izedfrgmentThebrodtetcfDNAmethylticncerbiomrkermodlyrnggtrgetedbiomrkerpnelwhole-genomechrcterizticfDNAmethylomeFdetectg5mCmethylticfDNAcurntlyproceedbulfeenzymticcveriunmodifiedcyeurcilwhichdetectedht-dequencerThpprochtroduceuchGCkewoxidtiveDNAdmgePCRmplifictiblignmentrtifctChrcterizgcfDNAmethylomeptientmchllenggprticulrlycventilequencgpprocheWecentlydemtrtednovelpprochgle-moleculemethyltinlycfDNAthvercomeeueWedevelopednnopo-bedequencgpprochefficientlychrcterizgmethyltiprilecfDNAcncerptientThepgemethyltedDNAthroughnnopogenerteuniqueelectriclignlcompdunmodifiedDNAoutcyecveriwhichcnnclifiedmchelernglghmWegenerteduphunddmillidpercfDNAmplecoloctlcncerptientglennogrmlenlyteperptientInthprojectweeekextendourwk(1)chrcterizeerly-tgecoloctlcncercfDNAmethylomelcpe(2)developclifictimodelerlydetecticoloctlcncerUgcfDNAmpleptienttStndCncerIntute(SCI)PLCOclicltrilwegenertecfDNAmethylomebbiomrkerigntucoloctlcncerdetectiInAim1wederivecfDNAmethylomeprilecfirmedp-dignoticCRCchrcterizehowcfDNAmethylomeffectedtumubtypetgeWelodecvolutecfDNAugmtchedprimrytumimmunecellfenceInAim2ugequencedcfDNAwebuildmchelerngmodeldetermettticllyignificntchngecfDNAmethyltitweencncerptienthelthyctrolThemchelerngmodelloquntifytumburdenwherlikelympledictivecncerWeueSCIPLCOptientdependentcohtpermtrgvlidtiProjectSummry/AbtrctThefieldcncererchttmenthgtlydvncedduebkthroughDNAequencgtechniqueTheedevelopmenthveccelertedidentifictidependencygenepvedwypcimediceMnyencodeddependencyprotehowevernotknownbdendogenoumllmoleculecequentlymodifficultgugetermirpotentiltrgetgchemiclproBdg-firtpltmcludgActivy-BedProtePrilg(ABPP)technologyhvevelednumeroucyteeemenblemll-moleculebdgHoweverunclerwhereligbleeimptntprotefuncticouldervetrtgpotmllmoleculedrugdevelopmentToddthchllengeIhvecentlynovtedbeedg-ABPPpltmeeeentilyligblecyteecncerdependencyproteNotblyIhveuncovedeverlhighlyligblefunctillyimptntedependencyprotecludgTOE1InthpropolIutilizebiochemtryequencgchemiclproteomicmethod1)dectmechnmhowcovlentproffectTOE1ctivymodelRNAtercti2)explocequenceTOE1hibidetermntenivycncerIlodecriplnctuedtechnologynovti3)identifynovelfunctilcyteecncerdependencyproteugprimeedgInlg-termIpictefirt--clrpeutictrgetgligblecyteeStrglySelectivecncerdependencieDurgwrdperiodIimprovemycommunictiwrgcientifickilllernnewlbtechniquecludgeCLIPequencgprimeedgThepropoedtudiepermedtScrippReerchIntute(TSRI)p-rnkgtutinownedtegrtitte---rtchemtrybiomediceerchMymenrDrBenjmCrvttledgfiguchemiclbiologychemiclproteomicco-menrDrGeneYeopieerRNA-bdgproteerchDrDvidLiulederfieldgenomeedgprovidemevlubleguidnceIlocollbtemoleculrbiologtDrLykke-AnderenmediclcologtDrPrktUCSDCollectivelytherchpildevelopmentplnfermecruciltrgdurgrnilpheupptmelunchgmyownlbryerchuniveryPROJECTSUMMARYOyocedncedrklpecutelymphoblticleukemi(ALL)motcommchildhoodcncerWehveuncovednovelmechnmwhichfttuemymkeALLmoggivehrdercuALLcellfounddipoetuemouemodelhvehigherexpiRANKL(ceprctivrnuclerfcrkpp-Blig)thnALLfoundmrrowExpogALLcelldipoetueexvivoloceirexpiRANKLRANKLknownctrieALLcellexpnivivowellvicentrlnervouytem(CNS)InpentgrntwevetigtepthwywhichdipoetueceALLexpiRANKLWeexplothfdgugtrnltilpprochexperimentrnggnchmoueevluticliclmpleWeelucidtewhichdipoetue-derivedignlpibleALLcellRANKLexpiWeexmewheroyceALLRANKLexpimicecliclmpleexploltihiptweenRANKLexpidenyCNSvichempyttmentpeFllywetetnFDA-pprovedttmentdenoumbmiceeewherimpirgRANKLignlgcnimproveALLttmenutcomeTheetudiemyprovidenoveltrtegyALLptientducelofrctuduceCNSvipotentillyimprovechempyttmenutcomePROJECTSUMMARYLungcncerledgcuecncerdethlungcncerceng(LCS)cnducelungcncer-ltedmtly20%Howeverly5-10%eligibledividulhveceivednilLCSexmBlckHpnicdividullelikelycenedmolikelyufferdelydignottmentctrighighermtlylungcncerCommunyhelthwker(CHW)neffectivetrtegypromotecengmigtedpriecncerettgWherCHWcneffectivectextLCSddkeybrrierceivgLCSmunknownThegolthtudydeveloppilottetfour-prtCHWterventiimproveLCSuptkemigtedpriewhichclude1)ptienutch2)ptient-centedhddeci-mkg3)mokgceticounelg4)nvigtilogticlbrrierOurcentrlhypobedourqultivewkmedexpedHelthBeliefModelpoCHWcnddkeymodifiblefcrimproveLCSwneenggementbrrierccegcledgcedLCSuptkeoverllmgBlckHpniccommunieOurimJotlytrncteCHWterventiceLCSuptkemgptientervedcommunyhelthcenter(Aim1)cductpilotromizedctrolledtrilCHWterventi(Aim2)obtempiricetimteeffectizeLCSbccottmentutilizti(Aim2b)WefirteekjotlytrncteCHWterventiourcommunydvybdcompdkeytkeholderLCSptientlivedexperiencepplygTrnctiFrmewkCommuny-EnggedBehvilInterventiReduceHelthDprieThenwecductpilotromizedctrolledtrilCHWterventBytteHelththecommunyhelthcenterWeromize80LCS-eligibledividul(40echrm)eirCHW-ledterventienhnceduulc(iemiledLCSeductilmteriluulLCSperprimrycprovider)PrimrypiloutcomefocuedfeibilycludgprticipntcrumentmeucompletentifidelycceptbilyWelocductnevlutiecdrytriloutcomecludgLCSbccottmentutiliztiwellexplopotentilmedir(egknowledgefciltilogticlbrrier)Thepropoedctivieprovidemecrucilkillhelthequyerchimplementticienceclicltrildeignlunchmycerclicin-cienttdedictedddghelthdprieThwklolygroundwkubequentR01grntcductgfullypowedromizedctrolledtrilCHWterventidictlyddeppriiePidentCncerMohotNCImidevelopmulti-levelterventifcilteequbleccecncercengducelungcncermtlyAbtrctBiocducrcrucilourcettticlnlydtmngementcncergenomicerchprovidgmothn2200open-ourcetwdtpckgeThtwecoytemupptedcodtclemethodprovidecvenientpenttiefficienpertimnykdhigh-throughpumicdtRecenttechnicldvnceenblecglyolvedtudymoleculrbiologycncertgle-celllevelthroughcomdygDNAequenceepigeneticgeneexpiprotepectevenptilmtiTheedevelopmentpentnewchllengecomplexyizeterptbilydtnlyTheoverrchggolthprojectmtexpcoBiocducrtwfrtructumeetechllengethroughfollowgimFirtwemtexpfrtructumultimodlexperimentptiltrncripmiccnectR/Biocducrecoytemn-RimgenlyolfciltettticlnlyhpthologyimgectextptiltrncripmicmoleculrdtSecdwetrniBiocducrdtnnotti-hrgolfedertedlnguge-gnoticytemfciltectriiextenicommunyimprovefdbilyenbleumtedimprovementmetdtenhnceutilyn-RuerThirdwectecurtedtegrteddtpoiriemkekeydtetmofdbleubledrivedevelopmentplnnednewdt-hrgytemFllywedevelopprogrmuertrgnewoutchpprocheuppttrguerdevelopercludgctilrgelngugemodel-bedchtbotcloud-bedpltmpertentdkcourewkhopByfotergknowledgedemtiprcticltrgweimempowererchernecerykillourcelevergeenhncedcpbilieBiocducrdvncedcncergenomicerchPROJECTSUMMARYANDABSTRACTRtileDepenovelchempiehveignificntlyimprovedprognomelnomptientdrugtnceoccurevblytumprogicomeexblepentgnunmeturgentneednovelrpeuticterventiMotmelnomhrbcogenicBRAFV600EpiveBRAFV600E-pecifichibirdbrfenibMEKhibirtrmetibhoweverptienteventullycquitncemlydueMAPKctivti/counterctiphophooide3-ke(PI3K)WhileubtntilefthveenmdemigterpytnceugPI3KhibirhenlckuccenoPI3KhibircurntlycpbleervgthpurpoePI3KhfourfunctillydivergentctlytickePI3K///DrugblockllfourkedividulPI3K//hvehowncliclnefelicednotblemetbolicimmune-ltedxicieSuchcliclchllengedrugggPI3K//hfueledtetPI3KrpiehoweverPI3KATPcompetivehibirGSK2636771TGX-221AZD6482notclicllyeffectivenottgirpromgpcliclnti-cncerctivieThperhpcueATPcompetivehibirterctwell-cervediduetmotifpivotlexecutgkectivyPI3K///mkgmnotPI3K-electivedeidRgthchllengewehvecentlyidentifiedn18-iduemotifdubd18thccurlyPI3KnotPI3K//Selectide-18rg18cell-penetrtgpeptidedrtPI3KcomplexectivtePI3KlowdowngrowthBRAFV600EmelnomexpghighlevelPI3KlowlevelPI3K-ntgizgphophtePTEN(deigntedPI3Khyper)enizerpy-tntPI3Khypermelnomcelldbrfenib/trmetibOurfurr-iliclyehveidentifiedSelectide-9htveriSelectide-18whichlyct9iduederivedS18motiftilltmecyxicctivieSelectide-18HypoWehypoizeSelectide-9electivelydegrdectivtePI3KovercomgrpytncePI3KhypermelnomSpecificAimWeuepprocheetblhedPIlbrytetbovehypoInAim1wetethowSelectide-9degrdectivtePI3KelectivelyugbiochemiclimggtechniqueInAim2wetetwherSelectide-9uperiATPcompetivehibirovercomgrpytnceugtwohumnBRAFV600Eptient-derivedxenogrftleimmunodeficientmiceTheWM4701-6673lehlowlevelPI3Kcurnt/rpy-tntWM4701-7329tumderivedWM4701-6673ttedBRAFV600EhibirWedetermeifWM4701-6673enivewhiltWM4701-7329tntdbrfenibtrmetibifSelectide-9mopotentthnGSK2636771rgenivydbrfenibtrmetibMooverweidentifygeneigntudefgrpy-tntPI3Khypermelnomuggle-cellRNAequencgImpctOurwklygroundwkupptfututudiegdeeperightrpytncemelnomidentifynnovtivepprochcircumventgthtncePROJECTSUMMARYImmunecheckpothibir(ICI)prticulrlythoeblockgPD-1/PD-L1pthwyhveimprovedttmentn-mllcelllungcncer(NSCLC)upptgpmeeviimmunedetructictrieNSCLCpthogeneNeleNSCLCEGFRmuttitenexhibtriccquidtnceICIemphizgcriclneeddefgmechnmdriveimmuneevidevelopggentcircumventmWkgeneticllyengeedmouemodel(GEMM)hdemtrtedEGFRmutntNSCLCcellctivtePD-1/PD-L1pthwyceproductiproflmmrycykeuppTcellctivytummicroenvirment(TME)AmechnticbthoefdgwefoundthncogenicMUC1-CprotewhichimptnceNSCLCprogictrieductiPD-L1expiprogrmimmuneuppiOrtudiehowedtrgetgMUC1-CimmunocompetentNSCLCtummodelvereuppiimmunecognidetructiTheefdghvecollectivelyupptedpmeMUC1-CctrienimmunouppiveNSCLCTMEpotentiltrgetdvncgNSCLCttmentAccdglywegenertednovelntibodiegtn-hedMUC1-Cextrcellulrdomunderdevelopmentntibody-drugcjugte(ADC)WhtneedednowtletprtmopcelydefehowMUC1-CpromoteimmuneevidvnceimmunpyEGFRmutntNSCLCdetermewhertrgetgMUC1-CeffectivevergimmuneuppitnceICINSCLCttmentTheimthpropolidentifynovelrpeutictrtegieugnti-MUC1-CADClecombtiICItrprogiNSCLCthroughctivtgnti-tumimmunyOuroverllhypoMUC1-CplynimptntroleimmuneeviEGFRmutntNSCLCwhichddedtudie(i)humnNSCLCcellle(ii)GEMM(iii)NSCLCtumpecimenTheobjectivepropoedwkdvnceourundertghowMUC1-CctivteimmunouppivepthwyEGFRmutntNSCLCtrgetgMUC1-CADCbedourplimryfdgcouldprovidenewopptunieimprovgNSCLCimmunpyPROJECTSUMMARY/ABSTRACTReerchCncerecdledgcuemtlywldetimtehigh19millinewdignoe06millidethUnedStteltyerTrillinmllyneficilmicrotermedmicrobiotctuoulycolizemmmlinteteemerggevidencedictekeyroleemicroimpctgcncerThcludebothpromotgtumgrowthprogiloupptgpeimmunpiergexcgpoibilymnipultemicrobiotcombtcncerhowevermechnmwhichmicrobiotfluencecncerprogiimmunpiempolyunderodBedmypublhednewplimrydtIhypoizehot-microbiottercti(i)promotetumgrowthlimgmetboleprovokenti-tumimmuny(ii)hpeytemicnti-tumimmunyoutcomeimmunpyntigen-pecificpegutmicrobiotvicrotlkRORgt+lymphocyteTheetudiedefetwovelpthwywhichmicrobiotterctmmmlinhotimpcttumgrowthprogiimmunpypethuprovokgnovelopptunieterventiCergolMyoverrchggolcomendependentvetigrtncdemictutiwheIvetigtemechnmwhichhot-microterctimodultenti-tumimmunyimmunpypettmentcncerFurrIpicomenpirtilproductivemenreeentilpectgndependentvetigrCerDevelopmentPlnTocomeuccefuldependentvetigrIfurrdevelopvriouerchpilperlkillTheecludefurrcquirgexpertecncerbiologymicrobiologytechniquewellfotergcollbtidevelopgkillwrgcommunictgtechgmenrglbrymngementMyhotlbryWeillCnellMediceprovidenouttgcdemicenvirmentwhetecnfulfilecrerifotergcientificcollbtienrollgcouredevelopkillpeciltcientificperldevelopmentlbrymngementThemenrhipIceivehighettrdFurrddimymenrco-menrIhveuppttemdependentvetigrexteniveexpertegtlyfciltecompletiexperimentpropoedmycertrnidependenceCerDevelopmentEnvirmentIpermK99phelbryDrGgySnenrgtWeillCnellMedicewhichprovidenouttgenvirmenttermourcefcilievilbleWeillCnellMedicenidelenvirmentdevelopdurgK99pheIprogcomeuccefuldependentvetigrThelbryhccelltrumentfcilienecerycompleteexperimentpropoedthpplictiProjectSummryColcncerm3rdmotcommlydignoedcncer3rdhighetcncerltedmtliebothmenwomenTumtenectedlettmenptivilblethoedignoedltertgeImmunpyhhdmixedultcolcncerthunewrpeutictrtegieneededimproveoutcomeprticulrlyltetgeptientWehveenexmgmucolocedvrintT(MAIT)cellubetTcelldplynteeffecrquliepotentilhrneedHLA-dependentimmunpeuticgentWehvefoundMAITcellhvepotentildecetumgrowthhveidentifiedpotentilmechnmwhichMAITcellenhncenteimmunecellpederpromotenti-tumimmunyBedournovelplimrydtwepropoetethypoMAITcellhvecpcynti-tumeffectthroughbothdictcyxicyTcellcepr-dependentmnnerdictmechnmthroughcrumentnteimmunecellTotetthhypowepropoecfullydeignedexperimentexmepotentilMAITcellrpeuticpotentilugprimryhumncellgnoidmodelmouetumrpeuticpprochepcliclmodelFurrmowetetthrpeuticpprochcombticheckpotrpyenhncenti-tumcyxicctivyDtcollectedthprojectcouldlednovelimmunpypprochgtrotetlcncerPROJECTSUMMARY/ABSTRACTRenlcellcrcom(RCC)ccountmothn430000cecncerwldwidebout180000cncer-lteddethechyerClercellRCC(ccRCC)motfquent(75%80%)ubtypeRCCTrdilchempyrdirpylrgelyeffectivettmentllRCCubtypeThedevelopmentmulti-trgetedtyroekehibir(TKI)immunpeuticgentnotblychngedttmentprdigmdvncedkidneycncerHoweverdeperpeuticprogcompletedurblepehveennotedlyfewceFurrmopevilblerpeuticgentmunpdictbledividulccRCCptientWehvehownpvioulyLDLcholeterolcompromentumefficcyclicllylevntTKIOurcentfdghowmjlipoprote(ieLDLHDLVLDL)equllyeffectiveupptggrowthccRCCcellcounterctgntumctivyTKIInctrtnmlcellccRCCcelllrgelydependexogenoucholeterolupplyThetrcellulrtrffickgexogenoulipoprote-derivedcholeterolpperdtctmovementendogenoulyynizedcholeterolDenovoyntizedcholeteroltrnptedendoplmicticulumdictlyplmmembrnecyl-CoAcholeterolcyltrnferewhelipoprote-derivedcholeteroldtriedthroughNPC1-dependentendoomltrffickgytemNPC1plycriclrolemtgdequtecholeterolupplycellcnnotproduceendogenoucholeterolExpiNPC1cedccRCCtmRNAprotelevelhighexpiNPC1ocedpoprognobedTCGAdtnlyImptntlytrffickgdenovoyntizedcholeterolnmlcellnotffectedphrmcologiclgenetichibiNPC1ctrttrffickgexogenouly-derivedcholeterolOurcentfdgupptthobervtihowgccRCCcellprticulrlyeniveNPC1hibiGivenccRCCcellhvedundntmechnmcholeterolcquiwehypoizethnlyccomnttrgetgllourcecholeterolcquicommroutetrcellulrcholeteroltrffickgwoulddeprivetumcellcholeterolupplyToteurhypoelucidteroleNPC1novelrpeutictrgetpotentilprognoticbiomrkerccRCCwepropoefollowgSpecificAim(1)EvluteNPC1potentilrpeutictrgetccRCC(2)DetermeifexpilipidbiomrkerclteclicloutcomeccRCCAcriclunmetneedprottecncermngementpventdeedvncectrti-tntchempy-ertlethltgeWeexplovelnti-cncerpprochgtctrti-tntprottecncer(CRPC)entilctivtipro-drugcjugtepecificllytumtueledgcncercellbltioutimpogf-trgetxicyThepprochbed2021ptTnk&colleguedrug-cjugtedrylzidectendogenoucrolemoleculebundntcncernotnmltueThbiothoglcticncercellbedclickchemtryledrrngementctiproductdrugleeWeutilizethdrugleeprciplepclicltudytrgetCRPCcellBO-264mopotentderivtivewhichmll-moleculenti-cncergent&drugcidtedocetxel&cbzxel-chempydrugcliclCRPCAcrole3-crbunturtedldehydecopioulyproducedcncercellduebnmlmetbolmoxidtivetBO-264identifiedchemicllibrrycenhibTACC3centroome-ocedprotewhichgultechromoomeeggtiTACC3elevtedprottecncerolidtumThprojectcollbtiPIlbCo-PIynticchemtrylbNovelrylzidecjugtebiologicchempeuticynizedCo-PIlbexmedimpctCRPCvrovivomouexenogrft&llogrftPIlbPlimdthowdoe-dependentcguceptibilyPC3CRPCcellzidecjugteBO-264ynized-houeN-cncerRWPE-1prottecellweunffectedPC3cellhowed~7-foldhighercrolethnRWPE-1SpAim1Synizethighyieldrylzidecjugtebove-notednti-cncerbiologic&txneugnovelyntrtegiechrcterizeendproductTheproductchrcterizedNMRIRHRMSX-ryDerivtiveBO-264notvilblecommercillyynizedSpAim2Invetigtectivteddrug/biologicleedcjugteeffecthumn&moueCRPCcellCRPCxenogrft/llogrfttummiceCjugte-ttedcellcultutumyedprolifertipopmigrtiviEMTARAKT&ERKctivtiFrogencepr(AR)-poiveCRPCcomdeffectenzlutmide(ARhibir)nzidecjugteprodTumvolumemettexmedcltedtumcrolelevelMethodEngeergcelltblyexpAkLuciferepterbiolumecenceimggetumvolumemettNMRIRHRMSX-ryCellvimigrtiWeternIHCgle-cellRT-qPCRAcroleyFACSSttticCliclimpct1)Highclicltrnltipotentil2)Novelzidecjugtenti-cncerbiologic&CRPCdrug3)Tum-electivelee&ctivtidrugbiothoglctibedclickchemtrypplicblecncer4)Druglee&ctivtinimmune-tctllogrfttummicroenvirmentclicllylevntPROJECTSUMMARY/ABSTRACTAdvnceourundertgdeebiologydevelopmentnewtechnologiehvemdedividulizedttmentlymnyptientcncerSuchimprovementhveeneluivedolecentyoungdult(AYA)rcomTtmentediverercomtencludetenivemultigentchempyurgeryrdiyetmnyptienttillufferlpediedeeSurvivleftdebiltglteeffectcludgfertilyhertdeeecdrycncerOutcomecncerhveenvtlyimprovedugbiomrkerdeletedeeub-groupevluteperpydetectlpemximizgchncecumimizglteeffectInctrtnovlidtedbiomrkerAYArcomfciltetetgrk-trtifiedrpyThcientificgppentmjbrrierimprovgoutcomeMylg-termobjectiveimproveoutcomeAYArcomthroughbiomrker-medclicltrilCircultgtumDNA(ctDNA)nexcgcidtebiomrkerthpurpoeholdpotentilbrodpplicticromjyAYArcomIhvedemtrtedelevtedctDNAburdentdignoocedncedrkdeelpedethptienttwomotcommrcomffectgthpopultiEwgrcom(EWS)oteorcomBrodlyllhigh-grdercomcndividedfui-poivercomlikeEWSfui-negtivercomhighlevelneuploidylikeoteorcomctDNAholdpotentilprdigmhiftgttmentAYArcomleverggegenomicchrcterticmrk-trtifictiWehveembledlrgeptientcoht(n>700)twofui-poivercom(EWSynovilrcom)twofui-negtivercom[oteorcomundiffentedpleomphicrcom(UPS)]permvlidtitudieetblhctDNAprognoticthholdtdignofollowgilrpyToecliclimpctturnultclicinIhvelunchedpilottudyugcommercilliquidbiopytetgfuidetectidurgdeeurveillnceptientEWSIevlutecentrlhypoctDNAburdenclicllymtivercomffectgAYAcnmtrilrk-dptedrpynerfutuddgfollowgim(1)DetermectDNA-bedprognoticthholdrklpefui-negtivercomtbele(2)DetermectDNA-bedprognoticthholdrklpefui-poivercomtbelefollowgilttment(3)EvlutecliclimpctctDNAtetgdeeurveillnceEWSAtccluhprojectwehvevlidtedctDNAprognoticbiomrkermultiplecliclettgpoiedthbiomrkerimmedetegrtipropectivetrilTheultimtegolimproveoutcomeAYArcomthroughdevelopmentrk-trtifiedrpyPROJECTSUMMARY/ABSTRACTThe293milliptientceivgcUSFederllyQulifiedHelthCenter(FQHC)hvemuchlowercerviclcncercengrtethnntilvergeOnly53%eligibleptientweup--dte2021COVID-19pemicexcerbtededprieSelf-mplghumnppillomviru(HPV)nevidence-bedcerviclcncercengmethodhighpotentilducecengbrrierSelf-mplgkcndtriedtclicmiledptienthomeDepewidepdterntildoptiHPVelf-mplgncentUSLtledtvilblemimplementgthpventiveervicelow-ourceettguchFQHCOurtwo-phepilotprgmtictrildptevlutetwoprogrmtegrteHPVelf-mplgFQHCOurtrilccountctextcpcyourceFQHClevergeFQHC-MedicidprtnerhippromotethpventivecervicePhe1milene-drivenplnngpheWeuecommuny-bedprticipryerchtkeholderputdptpilot-tet2multilevelterventi2FQHCdtrigHPVelf-mplgkclicclicpludictmilgPhe2cluter-romizedprgmtictril42OgWhgnFQHCclicevlutecomprtiveeffectivenecot-effectiveneterventiClicromizedUulC(UC)-clicdtrii(ClicOnly)-clicplumileddtrii(Clic+Mil)F-clicdtriiproviderferelf-mplgt-pertelehelthencounterThemiledcompentdmtedMedicidhelthplnTheprimryoutcomeproptieligibleptient(30-64yerdue/overduerouteceng)whocompletecengCo-primrycompr(1)UCvClicOnly(2)ClicOnlyvClic+MilTomimizechcomprcludedtctbuverlppgptientpopultiCompr1cludellptient(Medicidn-Medicid)clicencounterdurg12-mthtudyperiodCompr2trictedMedicidptientwhoenrolledclicdoenotquiclicencounterdurg12-mthtudyperiodCot-effectivenecompClicOnlyHPVelf-mplgterventiltiveUCClic+MilltiveClicOnlyWeueRE-AIMfrmewkPRISMeproviderclichelthplncceptbilyevlutedpttiimplementtitrtegiethroughmixedmethodOurprgmtictrilfirtUSdetermeeffectivenecot-effectiveneHPVelf-mplgcgcerviclcncercengFQHCettgReultourcomprevlutiimplementtitrtegiembrod-cleimplementtiHPVelf-mplgcroFQHCfety-netclicUSducecerviclcncercengdprieProjectSummry/AbtrctThepropoedwkdevelopfirt---kdtrnptblemticolPopultiCncerAementSurveillnceEnge(Pop-CASE)tegrteptient-levelcncergtrydtpopultigrnulrcommuny-leveldttrdizeddtmodelwhileprovidguer-friendlyqueryolfciltequickerchgerchercommunyoutchpilBrodengcceetypedterchertkeholderdvncepcebdthcncerdprieerchctlyzectiducedprieBuildgwknextgprotypegogputntiwideSteergCommteeweim1)buildPop-CASEdtbecomputtillyerugnextendedetcommunyhelthytemdtourceemddgddilclculticpbilie2)builduer-friendlyterfceexptcpbilie3)developnImplementtikfeturgtwcterctglocti-pecifictncePop-CASEnimplementtiguideTheeimccomplhedfirtctgltildtbePotgSQLtblederivedNthAmericnAociCentrlCncerRegtry(NAACCR)trdcdmtUSCenuAmericnCommunySurveydtHelthPilShtgeA(HPSA)dtmlletimteBehvilRkFcrSurveillnceSytem(BRFSS)cncercengrkhvicombidyburdenmeuNtilProviderIndex(NPI)FoodDrugAdmtrti(FDA)providerfcilyloctimtihricldlgdtflectgdcrimrylendgprcticeourceguidedourSteergCommteeAcomputtillyerlogicgedjutmentdtnceclculticlculticommdicedpryddvntgecodedPythAuerterfcebuiltJvcript-bedfrmewkenblepecificticomplexquerieoutputtvriouuer-electedgeogrphicleveloptiptexptllemddedcpbilietiedccemllnumrcountptient-leveldtetAmoderncterfrmewkueddevelopPopCASE---boxtwcterllowgcncercentercncergtriecceptient-levelgtrydtcteeculocti-pecifictncePop-CASEInflprojectyerUniverySournClini(USC)projecttemmemruePopCASEcterimplementPopCASEtncebedLoAngeleCountycncergtrydtknownLA-CASEPopCASEprovidenewolcncerctrolercherplce-ctextulizedcncerdttfegeogrphiccleItcnloprovideCommunyOutchEnggement(COE)pilcncercenterlederwkgcurbcncerdprietlocllevelnunpcedentedlypowerfulctchmentdtolABSTRACTWepurugfirtnti-tummllmoleculectpecificllygthumnSicHhproteuproceguniquebioynticeventnecerydrivecogenichedgehog(Hh)ligdependentcell/cellignlgSicHhproteuprocegvolvepcurmHhpiblelirtgmtuSicHhignlgligwhilelomodifygligtermlcrboxylgroupcholeterolThelg-tgchllengehendcovermllmoleculepecificllyntgizethkeyctumcellTofciltedcoverywehvedevedfirt-cellyytemcenntgthumnHhuprocegthighthroughputOurycoupletrcellulrSicHhuprocegextrcellulrectibiolumecentpterenzymeWecentlymurizedthy1536-wellplteplimrywkcompleteduccefulpilotcengtLOPACHewepropoetwo-yerhighrk/gtrtegytegrte(AIM1)In-cellqunttivehighthroughputcengcollbtiNtilCenterAdvncgTrnltilScience(NCATS)dcoverfirtbioctivedrug-likentgthumnSicHhuproceg(AIM2)P-cliclevlutinti-tumeffectthoenovelHhuproceghibirwrdhumnmultiplemyelomhumncolcncercellwhichexhibHh-ligdependentgrowthWehypoizepecificntgtSicHhuprocegdepleteextrcellulrSicHhligTumpopexpectedultthligdeprivtitrtegyInummryugnnovtiveynovelnti-HhpprochwepoedddignificntgpfieldHhignlgwhilepurugnewclcncerrpeuticPROJECTSUMMARYDurgtumevoluticncercellcncquiphenotypicheterogeneyenblgmgrowmoggivelyvdeneighbgtueevdeimmuneytemrpeuticchllengemettizedtnteThebilycncercellchngeirphenotypecnbrodlydefedcncercellplticywhichcnfluencedboumtricextricfcrHoweverunderlygmoleculrmechnmgultecncercellttetrnithroughouttumevolutimpolyunderodAcompheniveundertgemechnmuncoverkeygenenetwkpotentillymnovelrpeuticpprocheStudygcncercellttetrnivivohenchllenggduelckoltrckgcelllegeltihipthigholutiToovercomethIhvecentlyctrieddevelopmentnevolvglegetrcerlevergeCRISPR/C9technologyimultneoulyptechcncercelllegehrytrncriptilttevivoBypplygtholwell-chrcterizedKrTrp53(KP)uchthoumouemodellungdenocrcomIwblectructentumevolutihrymeucncerplticyquntifygcellttechngephylogeneticlly-ltedcncercellBuilnthnovtiveytemthpropolimvetigtemechnmunderlyglungcncercellplticybothcell-unomoun-cell-unomouLeverggmyexpertecncerbiologyevolvglegetrcgmodelIqunttivelytrckcncercellttetrnintivemicroenvirmentSpecificllyIdeletecell-unomougulrcncercellplticyCRISPRknockoutputtivegulrplticyidentifyplticy-ocedtummicroenvirmentlfcrdectn-cell-unomougultiplticyugptiltrncripmicexploleplticytncedevelopmentnti-cncerrpieAddgefundmentlquetiprovidenewightbiologycncercellttegultiMooverexperimentlcomputtilfrmewkthpropolcnpplicbletudygcncerplticygeneticperturbtirpeuticctextervggenerltemplteundertgmoleculrbcncercellplticytumevolutiMydivereexpertecncerbiologymouemodelgtechnologyglecellgenomicpoimeexecutepropoedprojecthelpmecquiimptntplimrydtpplyfutuerchgrntAprtthgrntIemblendvytemtmytutiupptmytrnicerdevelopmenttrgctivieoutledthpropolIlotkedvntgevriedourcetmypotdocrltutitutiwheIecundependentpoidevelopkillltedmenrhipcommunictierchethicOverllIlievemyfocuederchplndetiledtrggoltrgdvytemfcilteuccefultrnidependenceSUMMARYWhilelt15yerhvebroughtmrkbleclicldvncemelnomrpycurnttrd--ctrgetedimmunerpiehvehceilgmutovercomefurrimproveptienutcomeTheidentifictinoveltrgetholdtmendoupromedevetrtegieddourcliclrmmentriummelnomrpieCncercelldptirmetbolmmeetmetbolicquimentutedproliferterctummicroenvirmenutgrowdemtedecdryeMetbolicenzymekeyrolecncercellenviedctiblevulnerbilieOneuchenzymephophoglycertedehydrogene(PHGDH)whichmedefirtrte-limgtepSeynpthwyPHGDHplynimptntrolemelnommtimettIntetglycombgPHGDHhibiextrcellulrSetrvtidetrimentlcolcncercelluggetglimgSevilbilymytrtegytrgetcncercellHowevercurntPHGDHhibirnotubleclicluemylocueytemicxicieThulterntivepprochelimSevilbilytrgetmelnomcellneeddevedWedcovedthncogenicBRAFV600EignlgtimultePHGDHexpiMAPKpthwyhibidimhebeleSetrvti-ducedPHGDHlevelmelnomPlimryvrlyehowedcombgBRAFV600EhibirwixtrcellulrSetrvtiducedmelnomcelldethWeehypoizeducgPHGDHexpihibgBRAFV600EynergizedietrySetrictiducemelnomgrowthInthpropolwefirtuegeneticpprochetetifPHGDHdepletietblhedmelnomffecttumgrowthvivobencepencedietrySetrictiAddillyweevluterpeuticpotentilcombgdietrySetrictidiffentmllmoleculehibirtrgetgBRAF/MAPK/mTORxomewhichFDA-pprovedOurtudypclicllyerpeuticpotentilnewttmenttrtegymelnomcouldrpidlytrnltedclicProjectSummryGlioblmhighlymlignntvivemkgeneoplmextmelydifficulturgicllyectepropertietenulttumwhichfrcrytrdchempeuticrpieUntuntelympietrgetgknowndriverglioblmuchhyperctiveEGFRc-METRTKhveproveneffectiveuggetgdundntmechnmctivtiWehveidentifiedcirculrRNA-derivedprotewhichovexpedglioblmenovelproductcpbletimultgceprtyroekectivyledgenhncedprolifertimobilyvivechrcterticInthpplictiwepropoe1)determemechnm()circ-HGFmededctivtic-METglioblm2)clrifyrolePKA/PTBP1ignlggulticirc-HGFcirc-E-CdtrnltiiexpiGBM3)evlutenovelmllmoleculehibircirc-HGFcirc-E-CdIRES-dependenttrnlthopicGBMPDXmodelWelopropoevetigtechemicllymodifyhibirbuilddeidnti-glioblmeffectSummryCellilicifictictecellulrentietcellntetructuprotefetuhvecedtncehetpudehydrtiimprtnovelurfcepropertieTheprocecryo-ilicifictielimtexicgentcten-viblecellhvedntpropertiebiodegrdbleenblgvivtigenprocegAdptipthogen-ocedmoleculrptternuchmophophyllipidACpGoligucleotidetrnmilicifiedcellpthogenmimeticTheeimmunogeniccncercellfunctirpeuticvccectivteuppedntigenpentgdendriccellUnlikepviouvccetechnologyugirrdedcncercellilicifiedcelldotpentimmuneuppivephopholipidcellurfcecelltbledehydrtictghelf-rblevccePtclicltudieevlutgulogoullogeneicirrdedtumcellvccedemtrtedfetyfiledimproveclicloutcomeToovercomelowrpeuticefficcywepropoeplcementirrdedcncercellilicifiedcncercellurfcemkedmicrobilmoleculePclicltudieugyngeneicilicifiedtumcellchievedhighrpeuticefficcymouemodelovrincncerHewepropoeevluteefficcyllogeneiccncervccewhichdeirblebedmproductilowcotlckviveproceduhelf-deTofurrmovewrdclicltrnltivcceweevlutehumnimmunepeilicifiedcncervcceugptientmplehumnTLRgthumnizedmiceThemobjective1)Determeifilicifiedn-yngeneiccncervcceeffectivemouemodelovrincncerbtcncer2)VlidtevivovcceefficcyughumncncerimmunecellSUMMARYImmuno-cologytudiectuegrowwhicheeknewrpieleverggimmunogenicn-nmlpeptideequence(netigen)rgtum-pecificltertitgenomictrncripmicproteomiclevelN-nmlDNARNAequencemyencodenetigencnidentifiednext-genertiequencg(NGS)dtfurrpriizedirpdictedbdgclIIImjhcomptibilycomplex(MHC)ndicrimmunogenicyImmunopeptidomicenrichmentpeptide-MHCcomplexcoupledliquidchromgrphytemmpectrometry(LC-MS/MS)cncfirmextencepdictednetigenwelltum-ocedntigen(TAA)derivednmlproteequencecludgthoepot-trnltilmodificti(PTM)Thpowerfulpprochqui`immunopeptidogenomicmticoltegrteNGSMSdtnlyDepetedilygrowgnumrcncerercherpurugetudieylckcentrlizedmticourcetilodemticquimentAolutiwedevelopimmunopeptidogenomic(iPepGen)mticourceimmuno-cologyerchiPepGenlevergeGlxybiomticecoytemfergcncererchercceiblewkflowpdictnetigenNGSdtcfirmirpenceMS-bedimmunopeptidomicdtcludgtrgourcehouedGlxyTrgNetwkpromotecommunydoptiWechieveourgolthrougheSpecificAimAim1Optimizehrdenmodulrwkflowidentifygpriizgcurtgnetigencidtedetectedgenomic/trncripmicltertiAim2Optimizehrdentte---rtMS-bedimmunopeptidomicnlymoduleidentifygverifygMHC-boundnetigenTAApeptideAim3DemtetetedoptimizedwkflowenggetrgctiviepromotecommunydoptiiPepGenourceOurtembrgcomplementrywld-clexperteneceryuccedevelopgiPepGenourcePIGriffJgtphvedevelopedwidelyuedGlxy-bedmulti-omicoltrgmterilcncererchPINevizhkiiwld-lederdevelopmentcomputtilolqunttiveMS-bedproteomicpeptidomicnlyDevelopmenttetgoptimiztiolwkflowtrgmterilguidedcollbticncererchercductgDrivgImmuno-cologyProject(DIP)TheiPepGenourcefercricllyneededourcedvncegme-chnggimmunpytudieimpctgwide-vrietycncertypePtientfttyliverdeehvehighrkprogglivercncercludghepcellulrcrcomAtmoleculrleveltwomjchngeoccurhepcytecuedccumultiftliverwchenergymetbolmbedmichdridfunctiltedTCAcyclefluxbnmlepigeneticctiviecludghighexpichromtmodifygenzymeHowevercnectitweenrrnpcytemetbolmrrntepigeneticctivien-lcoholicfttyliverdee(NAFLD)n-lcoholictehept(NASH)hepcellulrcrcom(HCC)progihnotendefednrpeuticllyexploedcombnetHCCWepropoedoothpplictiWefocuetblhgmetbolicbiomrkertrgetgmetbolic/epigeneticco-vulnerbiliedurgHCCdevelopmentThertilethpprochthncogenicepigeneticJumjihnedemethyleenzymechromtmodifierupgultedHCCwhichdeletehnemethyltimrkueTCAmetbolelph-keglutrte(2-OG)co-ubtrtectlyIndeednly2-OGco-ubtrteeenzymeucctefumrtecncompete2-OGbdgthucthibirJumjictivyCurntJumjihibirwehvedevelopedwkcompetg2-OGThpentnenmouopptunyctextfttyliverdeeproggHCCcethproghuetblhenewmetbolicvulnerbilietrgetbleepigeneticcequenceWehypoizeltedcellulrTCAmetbolmfttylivertriggerrrntJumjiKDMhnedemethylelevel/ctivyeHCCetthpro-cogeniceventtrgetblethroughmllmoleculehibirJumjienzymecompete2-OGpventHCCdevelopmentWetetthhypomeurg2-OGltedmetboleliverblooddurgNAFLDHCCprogiidentifymetbolcltepeJumjihibi(im1biomrkerfocu)evlutgefficcythevilbleJumjihibirpvenrlowdownprogiNAFLDNASHHCCvivo(im2rpeuticfocu)WeueDIAMONDmiceourvivomodelceycpultehumnNAFLDNASHHCCctuumfhfullywellchrcterizedptneoulydevelopHCCyerOurtudiemfutuperlizedmedicepplictipventtmenthepcellulrcrcommkgthpropolhighlyclicllylevnttimelypotentillytrnmtilABSTRACTTumheterogeneycncertemcell(CSC)plticypentignificntchllengeeffectivettmentcoloctlcncer(CRC)SeverltudiehveetblhedLeuce-richpetctgGprote-coupledRecepr5(LGR5)mrkCSChighlyupgultedCRCPlticyLGR5+CSChenhownpromoterpytncetumprogimettCRClodependennepidermlgrowthfcrcepr(EGFR)EGFR-trgetedntibodieuchcetuximb(CTX)routelyuedttmentmettticCRCHowevercliclefficcyEGFR-trgetedttmenthenlimedubetptientdothrbKRASmuttiAntibody-drugcjugte(ADC)hveexperiencedcenturgeucceptfewyereverlhvenowenpprovedolidtumdictiTheobjectivethprojectdevelopnovelbpecificADC(BADC)dictedgtLGR5EGFRevlutentumntimettticefficcyptient-derivedmodelCRCWepropoeleverggdul-trgetgcpbilienLGR5-EGFRbpecificntibodycomdbilyADCexertpotentdrugeffectirpectivetummuttilttuwhilemimizgytemicxicyInAim1wegenerteledLGR5-EGFRBADChighpotencypecificyvroInAim2weevlutelerbilyrpeuticefficcyledLGR5-EGFRBADCubcutneouthopicptient-derivedtummodelCRCReultthtudyleddevelopmentuniquedul-trgetedADCdetermeifcnovercomerpytnceduetumheterogeneyCSCplticypventmettMoovernLGR5-EGFRBADChpotentiltrtumtypeexphighleveleirtumntigenPROJECTSUMMARYInthprojectvetigrexplofeibilyugircell-bedpltmdelivergimmunotimulryprote(IS)chievetumginvivopilotCertimmunotimulryprotehvectivygtmimldeemotolidtumHoweverirytemicdeliverydoenotpermufficientccentrtittdvnceddeeirexceocedevexicieThechllengeenbleloclizeddoethighccentrticnttdvnceddeeoutundeidideeffectThetemmihrneimmuneytemttolidtumInlethmiirobjectivethproject-cfiguircurntcell-beddeliveryytemynizeclibrtedmountimmunotimulryprotetummicroenvirment(TME)vlidtentumeffecthigh-grdeerouovrincncer(HGSOC)mouemodelThefeibilypropoedexperimentupptedourpvioupublictinewplimrydtOfprticulrlevncepentpplictiloclizedexpiimmunotimulryprotewhichhvehownexertntumeffectloxicwhendelivedytemicllyThetemhldymodifiedtumcellptgctivyircell-beddeliveryytemvrodevelopednnimlmodeletumcelleefficcyvivoThertilecell-beddeliverypltmenblehighTME-loclizeddoeimmunotimulryproteproptetumburdenThetemplnpuruethprojecttwoim1)ScleupcellengeedproduceimmunotimulryproteupengggHGSOCcell2)DemtrtefunctinHGSOCmouemodelThprojectignificntcueA)enbletrtegye-pecificdeliveryhighdoeimmunotimulryprotetrgethightumburdenB)ultprocecncledupdurgpclicltudieimmunocompetentmicewellddilIND-enblgtudiecomplincecGMPprocolWelievethprojectnovtiveubtntivedeprtuttuquocuetedttemptgimproveimmunotimulryprotebiovilbilyexogenoudeliveryducgendogenouexphnlyeffectivegtmimldeeweueourcell-bedtechnologyenhncgimmunotimulryprotedeliveryTMEThenbleufficientloclimmunotimulryproteccentrtittdvnceddeePROJECTSUMMARY/ABSTRACTChoogmoeffectiverpyimpertivebderle-ectblepncticcncer(BRPC)BRPCubctegypncticdenocrcom(PDAC)(bout20%entiPDACce)BRPCctctperipncticrterie/vehpotentiluccefullyectedfterdowntggwiffectiveneodjuvntrpyCurntlytwofirt-lerpeuticoptiBRPCptientnb-pclxelgemcFOLFIRINOXOverllperteegimencomprble(20-30%)nobutdtfvgeoverDynmicctrt-enhncedmgneticnceimgg(DCE-MRI)hpotentiln-viveolerlyevlutiPDACpechempyPDACtypicllyhypo-perfueddueignificnttumcleroctgelevtedtertilpucequentlycompgtum-feedgveelHoweverneffectiverpyducecutenecroducgtertilpucgperfuiADCE-MRIcnmeutueperfuimirgdynmicchngeMRIctrtgenttroducedtrvenoulycndetectperfuicepdgPDACemphologiclchngetumHowevervribilyqunttiveDCE-MRImeumentmccernWedevelopedperfuiphnmnmedP4(Pot--cPtblePerfuiPhnm)ducevribilyqunttiveDCE-MRImeumentTheproducibilyqunttiveDCE-MRImeument(egvolumetrnferctntKtrn)vrioubdomltuecrotheMRIcnnerignificntlycedfterP4-bederrccti(Intrclclticoefficient039v098)WedemtrtedqunttiveDCE-MRIcoulduedidentifyerlyrpeuticpePDACfterP4-bederrcctiInourpilottudyDCE-MRIwpplied20PDACptiente6-8weekfterrpyiTheKtrnpnctictumfvblypdgchempyced8426%(n=11)fterP4-bederrcctiwhilen-pdgtumdidnot(-711%)(n=9)(p<00001)Wechieved100%ccurcydiffentgtweenpdgn-pdgtumWehypoizeDCE-MRI-guidedneodjuvntchempyimprovenegtivemrg(R0)ectirteBRPCptientwhenP4uedcctgerrimggdtWepropoewchfirt-lerpeuticgimenecdeifKtrntumcemothnthholdWecompR0ectirtegroupceivedDCE-MRI-guidedneodjuvntchempyhriclctrolgroupceivedtrd--cttment(primryendpot)AlowedetermewherqunttiveDCE-MRIcnlibleolegpnctictummicroenvirmentfterP4-bederrcctiugdiglhpthology(ecdryendpot)PROJECTSUMMARY/ABSTRACTRoughly90000dolecentyoungdult(AYA1539)dignoedcncerUnedStteechyerDpriecncermtlyextmgAYAEwgrcom(EWS)oteorcom(OS)whichmyprtillydueunequlcceevidenced-bedtrdizedc(guideleccdntcGCC)MnyAYAcncerdotceiveGCCepecillythoewhoolderlimedourceMyprierchdemtrted50%AYAOSCliniceivedguideleccdntcbenceuchcnegtivelyimpctedurvivlIncgdeliveryguideleccdntcthptientpopulticouldmrkedlyimproveurvivlepecillytrdillyunderervedptient(egthoepublicurncethnWherce/ethnicy)ThebrrierdeliveryguideleccdntcnotclerlyidentifiedAYATofillthcriclgpgeentiltrgIemploynimplementtimppgprocedeveloptrtegiecedoptievidence-bedprcticeidentifybrrierfcilrdeliveryguideleccdntcdevelopnimplementtiblueprtpilotnterventiimprovedeliveryGCCAYAEWSOSThepecificim1)IdentifybrrierfcilrdeliveryGCCAYAptientEWSOS2)SytemticllydeveloptilodimplementtiblueprtdeliveryGCCcAYAptientEWSOS3)EvlutefeibilycceptbilycncercdeliveryimplementtiblueprtimprovedeliveryGCCpilottrilThelg-termgolmyerchprogrmimprovecncerhelthequyAYAptientcncerThepropoederchtrgplnupptmyneed(1)Expkillqultivemethod(iemticnly)(2)Developkillimplementticiencemethod(3)Gexperiencecductgcncercdeliverypilottril(4)ObtplimrydtnR01propolfedexpedR01cncercdeliverytrilThpropolupptednouttgmenrhiptemcientific/ctentdvycommteeubtntilexpertecncercdeliveryerchqultiveerchimplementticienceAYAcologyttmentrcomFmltrgoughtqultivemethodimplementticiencemethodwhileccurntlybuildgeentilkilllederhipCollectivelytherchpropolcerdevelopmentplnfirmlyecumypoindependentphyicin-cienttntilledernAYAcncercdeliveryercherSUMMARYUpperTrctUrolilCrcom(UTUC)rdeeccount5-10%lluroliltumnetimtednnulcidenceWeterncountrielmottwoceper100000hbntThe5-yerpecificurvivl<50%tge2-3ptient<10%thoetge4deeThpourvivlrtedemimprovementpopertivedetectiDignopopertiverk-trtifictiUTUCptientpentdtctchllengegivenlimticurntvilbleolAlthoughucylogyhncceptblepecificydetectUTUCenivyltivelylowprticulrlylow-grdecrcompelviclyceltumTheviveuterocopy(URS)biopycnenhncedignoticccurcyyetunder-grdgunder-tggrtemccernt32%46%pectivelyNowdyclicldeci-mkgprognoUTUCliehevilyTNMtgepthologiclgrdenotccurtelyvilbleuntilrdiclnephroutecmy(RNU)permedMjimprovementpdictiveolhveoccurdcentyeruniqueprmeterhveenpropoeddtguhtweenlow-high-rktumDNAmethyltiltertihveemergedpotentildignoticprognoticfcrurolilcrcomtmoleculrlevelFexmpleblddercncer-pecificDNAmethyltichngecndetecteduedimentcnuedn-vivedignoticurveillncemrkerThuperlizedmedicepprochdignoprognoUTUCurgentlyneededThegolthtudydevelopDNAmethyltibiomrkeridentifyggiveneUTUCInplimrytudyweidentifieddiffentilDNAmethyltiptternmllgroupptientwhohdexhidDNAmrkerUTUCggiveneWehypoizeblddercncerDNAmethyltimrkerpnelcnued1)chrcterizeUTUC-pecific/ggiveUTUCpecificDNAmethyltimrkerprimryUTUCpecimen(Aim1)2)vlidteemrkeruedimentUTUCptientmirgdeedignoprognocurnce(Aim2)ReultthpropolupptfurrdependentvetigtiroleDNAmethyltimrkerUTUCdignoprognoimprovetrdcpdictiveoldiffentprmeterhveenpropoeddtguhtweenlow-high-rktumprovideUTUC-pecificDNAmethyltiprileidphyicindeciPROJECTSUMMARY/ABSTRACTTriplenegtivebtcncer(TNBC)highlyggivecncerhpoprognolimedttmentduehighpropenymettticprogibencepecifictrgetedttmentAlthoughimmunecheckpothibipentbkthroughttmentdiverecncerpertePD-1PD-L1ntibodymlytbout48%-26%TNBCptientAduntgchllengeimprovgefficcyimmunpyuchPD1ntibodyrpyhowturnuppedCD8+Tcellctivtedcellftercheckpot-impoedbrkemovedOurlbhvehownpertentSTAT3ctivticricluppintumimmunyOurcenttudiedemtrtedPD-1-ligtiCD8+TcellctivteSTAT3upgulteCPT1B/fttycidoxidti(FAO)whilehibgglycoly/IFNCD8+TcellntumeffecrHowevercompromedntumeffectCD8TEFFcellhevilyimpcteduppiveimmunecellcludgCD5+BcellWeptedcncer-promotgroleBcelldependCD5-ducedSTAT3ctivtiInddiCD5+Bcellourpilottudypermedunder1R21CA241283wefoundCD5PD-1co-expedhighlymouebtcncerTcellwhichcedSTAT3ctivytumfiltrtgCD8+TcelluppTcellnti-tumfuncthroughgultgFAO/glycolyFurrmowedemtrtedtrgetgCD5TBcellenhncednti-tumeffectPD-1blockdePyMTmouemodelbtcncerHoweverhowturnupglycolytimulteIFNexpiTEFFcellimproveefficcyntumimmunerpybtcncerptientmeluiveGuidedourplimrydtwehypoize(i)CD5/PD-1-ducedSTAT3ctivtiTcellhibntumimmunepeCD8+TcellcounterctPD-1ntibodyrpypromotgFAOhibgglycolybtcncerptient(ii)effectivelyhibgSTAT3/FAOtum-ocedTcellwhichcnchievedblockgCD5fueltumfiltrtgCD8+TcellmengfullyimproventumefficcyPD-1blockdeWeccomplhouroverllobjectivepurugfollowgpecificimAim1ToewherCD5/PD-1-STAT3x-gultedFAOglycolymetbolmTcellptientbttummpleocedCD8+TEFFcellexhutifilunefPD-1-dictedrpyAim2ToentumeffectmechnmthroughwhichCD5PD-1ntibodielterTcellmetbolmenhnceCD8TEFFctivyptient-derivedtumgnoid(PDTO)micergptient-derivedxenogrft(PDX)ulogouTcellhumnimmuneytemTogeretudieprovidenewmechnticightkeypcliclevidencerpeutictncePD-1blockdeidentifynovelrpeutictrtegyovercomgtncePD-1blockdeextendnefPD-1blockderpyTNBCptientPROJECTSUMMARYOvrincncermgfiveledgcuecncerdethUSetimted20000newcemothn13000deth2023High-grdeerouovrincncer(HGSOC)motcommdedlyubtypeccount~75%ovrincncerdethAmplifictiovexpiCCNE1geneencodgcyclE1ledhyperctivticogntekeCDK2occur~50%HGSOCptientDygultedCCNE1expilofquentlyobervedggiveubtypeendometrilcncertriple-negtivebtcncerInovrincncerCCNE1mplifictiocedpoprognotncechempymotptientdvncedHGSOC(>80%)experiencecurnceultimtelyuccumbirdeeThepucyrpeuticoptiCCNE1-driventummkedevelopmentnoveldrugcounterctthrrticriclunmetneedCDK2vlidteddrugtrgettudiemnylbriecdemiphrmceuticldutryhvehowntrgetgCDK2vibleperhpidelpprochcombtcncerchrcterizedCCNE1mplifictiHowevercventilATP-e(typeI)hibirhvelrgelyfiledclicdueufficientelectivyprticulrlyftrgethibicloelyltedcommeentilkeCDK1WehvepvioulyidentifiednllotericeuniqueCDK2demtrtedmllmoleculeligoccupygthetbilizeCDK2cmtilttelefvbletercticyclWhileuchmovlentlloteric(typeIII)liglckhighbdgffyquideffectivelydruptterctiCDK2cyclE1ourcenttructurlcomputtiltudieprovidetrgevidencejognllotericlighigh-ffyATP-e(typeI)hibirpentnewmenupphyperctivtiCDK2cuedelevtedcyclE1levelTheoverllobjectivethprojectdevelopfirt--clbifunctillloterichibirtbilizeCDK2cmtilttecomptiblecyclE1bdgWehypoizeuchhibirpotentlyelectivelydruptCDK2-cyclE1complexcounterctgcogenicctivyelevtedCCNE1expiThertileunderlygtherchprovidegenerlightfeibilybivlentllotericCDK2hibirctextCCNE1-drivencncerbuildtrgcientificfrmewkwhenewrpeutictrtegiecndevelopedThecliclexperiencenti-PD-1immunecheckpothibiovrincncerhendppotgThepooutcomemytletprtduehighlyimmunouppivetummicroenvirment(TME)lowtummuttilburdenovrincnceruggetgltivelylimedimmunogenicynti-tumTcellpeTheebrriermyovercomeclicllylevntcombrilttment(i)timultenti-tumTcellimmuny(ii)lleveimmuneuppummicroenvirmentFvblecliclultcenttrilTh17-ducgdendriccell(Th17-DC)vcctiptienttgeIII/IVovrincncerprovidedtrgfoundtiTh17-DCvcce-bedcombrilpprocheimmunpyovrincncerIndeedfollow-uptudiemouemodelovrincncerhowedTh17-DCvccticoulddrmticllyimprovepenti-PD-1immunecheckpothibiSeverlleevidencehvepotedkeyroleBcellpenti-tumctivyTh17-DCvcctiInthpropolwetethypoefficcynti-PD-1/Th17-DCvcctidependennhotBcellpefollowgSpecificAimAim1)Determewherefficcynti-PD-1/Th17-DCvccticombrilimmunpydependennBcellWeevluteroleBcellnti-PD-1/Th17-DCvcce-ducedntumimmunyvivodepletiBcellID8p53-/-ID8p53-/-BRCA2-/-mouemodelovrincncerAim2)Determewherefficcynti-PD-1/Th17-DCvccticombrilimmunpyocedmtertirylymphoidtructu(TLS)WecltepvlencemphologyTLSID8p53-/-ID8p53-/-BRCA2-/-ovrintumrpeuticpenti-PD-1/Th17-DCvcctiWeloidentifyTLSgeneigntuocedrpeuticpeThepotentilynergytweenTh17-DCvcctinti-PD-1myhveciderbleimpctfutuueimmunecheckpothibirttmenvrincncerThenovelcceptefficcyTh17-DCvccti(elfnnovti)eirmpycomdnti-PD-1immunecheckpothibiultimtelydependennBcellpelohhighimpctfieldProjectSummry/AbtrctGivenhighmtlyctrti-tntprottecncer(CRPC)ultlpefterrogendeprivtirpy(ADT)novelttmenttrtegieurgentlyneededTumuppgene-phophtetenhomolog(PTEN)muttedpproximtely20%primryprottecncermny40~60%CRPCInddictivtiPI3KcogenicignlgpthwyloPTENloocedcykechemokeignlgctenimmunouppivemicroenvirmentBothdefectntigenpenttumcellimmunouppivetummicroenvirment(TME)hveenimplictedCRPCprogifterADTrpeutictnceprottecncerclicGeneticphrmcologicctivtimPI3K(p110)PTEN-deficientprottecncerhenptedignificntlyhibtumgrowthprogiAtxelngiectiRd3-lted(ATR)exhibeentilfunctictrollgDNAplictitDNAdmgepecncercellPTEN-deficientcellhveenptedmoeniveATRhibiPI3KlofunctillyocedDNAdmgepegenomictegrytumgrowthByugyngeneicgeneticllyengeedmouemodelCRPCdrivenco-deletiPTENTP53(PP-CRPC)wefoundddip110hibirignificntlyducevibilyATRhibir-ttedPP-CRPCcellMooverourplimrydthowhibip110ATRleignificntlyceMHCclIntigenpenttimouehumnCRPCcellBedenovelplimrydtwehypoizep110hibircombtiATRhibirhowpromgnti-tumctivyPTEN-deficientCRPCviducgcelldethcncercellnti-tumimmunytummicroenvirmentWelohypoizehibip110ceDNAplictitenizePTEN-deficientCRPCcellATRhibiInthtudywe1)evluterpeuticefficcyntumimmunepecomdATRhibip110hibiyngeneicPTEN-deficientCRPCmouemodel2)vetigtemoleculrmechnmcomdeffectATRhibirp110hibirplictitDNAdmge-ducedcelldethPTEN-deficientCRPCcellOurtudynlyprovidefundmentlmtrnltilerchp110hibirATRhibircncerttmentloprovidenovelttmenttrtegyptientPTEN-deficientdvncedCRPCAbtrctPtientexpoucncermmtihgrowntmendoulyReerchhhownup30%populrocilmedipotctccurtemtiMediclpilwrn77%uchpotcouldpotentillyledptientwrdhrmfuleffectiverpieThetypemmtiexggertedcomplementrylterntiverpie(CAM)fetyeffectiveneddgcncerprticulrlyccerngReerchdicteptientwhoueCAMtendexhiblowerdhencertepotentillyimpctgiroverllurvivlThepvlencetetCAMubtntilup70%ptientUScptgCAMircncercSomeptientmymmedwhenyenggeCAMup30%mexpectCAMplyubtntilrolectrollgcncerprogiDepewidepddemtiCAMmmtipvlentue20-77%ptientcncermkeCAM-lteddecioutcultgirphyicinThelckopencvertiboutCAMundermeopptunieopenmtiexchngebuildgtrutptient-providerltihipwhicheentilpromotgdhencetrdrpieTofcilteopencvertiboutCAMwepropoemultilevelterventiUnlikemotpvioutudiefocuedproviderptientlypropoedterventrgetbothprtiecvertiInmedTheyPlnnedBehvimultilevelterventiprovideptientquetipromptlt(CAM-QPL)equipphyicinwiffectivecvertitrtegiethroughwkhopfciltepoiveeffectiveCAMcvertiTheerchcomplementedfocuedtrgDrFridmnqultiveerchtkeholdenggementmethodologyevlutgmultilevelterventiDrFridmntrggolupptedmltrghercollbtinexpertqultiveerchmultilevelterventiDrElnLftnexperttkeholderenggementerchDrSmhMDDicrUrologicOncologytUNCLergerCncerCenterAtntPJohnMDnexperttudygnegtiveimpctcncerCAMmmtiThetrgenbleDrFridmnundertkefollowgtep(1)Aim1heenggeproviderptientuequltivemethoddevelopCAM-QPL(2)InAim2heetimteilefficcyCAM-QPLimplementedmultilevelterventiphyicin-fcgwkhopdevelopedexperthelthcommunictimmti(3)InAim3DrFridmncductqultiveexpltiptientproviderexperiencemultilevelterventiviThpropolddeurgentneedmultilevelterventcklecommunictibrrierboutCAMByengggopencvertiproviderptientempowednvigtecgvolumecncer-ltedmtimmtibuildtrutgltihipproviderupptirdhenceevidence-bedttmenptiPROJECTSUMMARY/ABSTRACTGlioblm(GBM)motggiveevblycurntbrtumdmlprognohighlyheterogeneouprileWhilefrt-lechemdipy(CRT)improveurvivllocomplicteementerlytumprogi(TP)Peudoprogi(PP)pentgcedenhncementdtguhbleTPcventilMRIoccurbout36%GBMptientThecurntRANOcreriquilgudlfollow-upimggexmoccillybiopymkeultimtedtcten6momthftercompletiCRTpcludgpoibilytimelypotentillymoeffectiveterventiDepedvnceophtictedphyiologiclmetbolicMRItechniquepeementmpvilgchllengecliclmngementGBMEncourgedcentfdgmuGBMxenogrftcrobtedfurrptientcethpropolimvlidteunderlyghpthologiclbebilyMRelgrphy(MRE)erlydiffentiTPptillymppgheterogenoupeGBMptientMREnMRItechniqueprovidenvivequnttivedict3DmptuevcoelticpropertievivoTheebiomechniclfcrtumhveencglycognizedhveproundimplictimlignntprogumheterogeneyttmenttnceThecentrlhypothprojectMREcnccurtelydiffentetweenerlyTPPPmppgptildtriictivetumttment-ltedchnge(TRC)knownheterogeneoutumpeTwodependentpecificimoutledtetthhypoMREfetudtctivectivetumTRCvlidtedAim1p-opertivecohtgold-trdtuecfirmtiThepprochtkedvntgehigh-pcimplgdurgneuro-nvigtilurgerieobtco-loclizedtueimggvolumequnttivecltinlyThmuch-needednevertudiedcltihumnGBMcrucilhelpelucidtepthophyiologicbheterogenouMREctrtThebilyvcoelticimggmrkerdiffenteerlyTPPPdetermedlgudlpot-CRTimggtudyAim2Thepprochlevergerobuthigh-enivyMREmethodologydevelopedtudytemigllymppgrpidfunctilchngehumnbrprovidehigh-olutimppgtuevcoelticpropertieThenblefullutiliztidignoticfetuheterogeneoubiomechniclpetummoccurtedtctiThnovtiveprojectetblhfirtevidenceroleMREcliclevluttmentpeGBMItignificntccurteerlyundertgtrueunderlygtumburdenfollowgCRTcriclguidgubequentttmentplnngimproveptienutcomeSUMMARYProttecncer(PC)motfquentmlignncyledgcuecncerdethmenUnedStteOncePCprogendvncedmettticrpy-tnttgecomelethldeeTodteundertgmechnmvolvedpthobiologylethlPCmlimedTrncriptilwirgcncercellplyfundmentlroleenblgdeeprogiGATA2mtergulrtrncriptifcrprticipteprottedevelopmentPCpthogeneInPCGATA2levelcedurgdeeprogielevtedlmotll(~100%)mettticrpy-tnttumWehvehownGATA2eentilenblerogencepr(AR)trncriptilctivywellctroltrncriptigenedependentlyARprticiptethroughdtctmechnmpthogenelethlPCMotlevntthpropolourplimrytudiepotkeyroleGATA2deeprogicferrgplticyPCcellIndeedourcomputtilfunctiltudieuggetelevtedGATA2levelcemettticpotentilPCcelltrncriptillygultgubetgenegultgmotilyvivenePCcellMooverourtrncripmicgle-cellnlyfunctiltudiedictePCcellexpghighlevelGATA2developnundiffentedtemcell-likephenotypeInddiwehveidentifiednovelrpeuticignificntlydruptGATA2trncriptilctivydemtrtevivti-cncefficcyBedupenovelplimrydtwehypoizetrncriptilwirgcuedelevtedGATA2expictriePCprogilethldeetgethmechnmcntrgetedWevetigtethhypofollowInAim1wedefeextentmechnmwhichGATA2elevtienhncePCmettfocugdefgGATA2motilygultedmoleculewelldetermeroleGATA2deeprogiugtrngeniccdilknock-mouemodelInAim2wedetermeimpctGATA2PCcellplticydeeproggle-celllevelfocugfunctillyvlidtgctromechngeducedcedGATA2levelWeloehumnmpleclicllevnceGATA2-ducedtem-likephenotypedurgdeeprogicircultgtumcellFllyAim3wevetigteefficcytrgetgGATA2combtitrdrpyp-cliclPCmodelAtcompletiultthnovtivepropolnlyenhnceourundertghowelevtedGATA2exprncriptillywicncercellctriepthobiologylethlPClohveignificntimpctidentifygnewrpeutictrtegiettthlethldeeThebundntevidencethycfercedrkvrioumcncerThecidencebtcollivercncerllcedoepopultiepidemiologicevidenceoy-btcncercnectiprticulrlytrgOneeightwomendignoedbtcncerdurgirlifetimeBtcncercidencecepproximtely10-foldwomenge60bovecompdwomen50youngerThcebtcncerrkprllelnceoyIndeedoycerktriplenegtivebtcncerp-menopulwomenetrogenceprpoivebtcncerpot-menopulwomenArrmflmmrybtcncerdrmticllyced(up5-fold)bothgroupMoimptntlyoyhtendece-feurvivlbothp-pot-menopulwomenPtientmtlybtcncerprimrilycueddtntmetteoyttimedignoocedcedrkdtntmettmtlyStudierodenthvecfirmedeltihiphowgdietry-ducedoyhigh-ftdietledcedcidencegrowumcogenecrcogen-ducedbtcncerDepethbodycltiveevidencemechnmoy-ducedbtcncerrkmpolyunderodOnepoibilythycueultncelivercueullevelctrolglucoelevelburtuecludgtummynotultntoexpoedcedulignlgIndeedwehvefoundducgultncettgomeg-3fttycidducebtcncergrowthmiceWehvelofoundtime-trictedhigh-ftdietimproveultncedepectugoynotcocidentllyhibtumgrowthButmnyimptntquetimnwedFirtlyhowdoeuldrivetumgrowth?Idicteffecntumcellmicroenvirment?SecdlydoeccticircdinrhythmtumcellTRFctrieducedtumgrowth?Thirdlyhowdutrientulgultecircdinclocktum?Ltlyweknowthylterndividulpechempynti-etrogenrpypetumltednutrilterventiuchTRF?InummryggoytrgrkfcrbtcncerwomencueovrinetrogendeclewomenhveleprotectihrmfuleffectoywhichcueflmmticeullevelTheehrmfuleffectcnveredweightloweightlothroughdietexercenotutblemoedividulWehvehownnoveldietryterventiugtime-trictedfeedgwetern-tylehigh-ftdietpventeffecydrivebtcncermicepropoedtudievetigtewherthnutrilterventicnenhncepenmlchemo-hmlrpybtcncerProjectSummryThenefMAPKhibir(MAPKi)rpymelnomhenlimedptientBRAFV600mutntmelnomScedevelopmentMEKhibir(MEKi)combtiuppcquidtncetypeIRAFhibir(RAFi)progfurrupptncehtlledSimilrlyhenltleprogdevelopmentMAPKirpy~50%ptientBRAFV600wildtypemelnomduectr-dictypeIRAFirpidtnceMEKimpyOuroverrchghypocompheniveproteogenomicundertghowfull-pectrummelnomubtypeevolveMAPKitncenewclicltetdevelopmentMAPKi-bedcombtiRecenttudiecludgourupptnotiwide-pectrum(BRAFV600MUTNRASMUTNF1-/-tripleWT)melnomhighlyddictedMAPKpthwyThelckefficcygle-gentMAPKi(egMEKi)rpyliethexquepthwyddicticuenbilyctrolphrmcologicllyMAPKpthwyctivtiThueffectivepclicltrtegiedictlytckleMAPKpthwyctivtiwelldowntmprllelphenotypecquidtncewrrntclicldevelopmentTticipteclicltnceMAPKicromelnomubtypewebuildcompheniveptient-derivedxenogrft(PDX)bnknlyMAPKi-nvemelnomloubclecquidMAPKi-tnceWecomequencg(whole-genomeexometrncripme)mpectrometry(proteomephophoproteome)coupledtemplnlytrncripmetgle-celllevelchromtcceibilyprovidemulti-omiclcperpeutictnceevolutihighlyclicllylevntpltm(MelnomRetnceEvolutiAtlMREA)functilizerpeuticvulnerbilieWeteurhypofollowgSpecificAim(1)DcoverproteogenomiclcpemelnomcquidMAPKi-tnce(2)EvlutecombriltrtegietrgetgcurntdriverMAPKi-tnce(3)Ctemulti-omicdttegrtiolidentifyrpeuticvulnerbiliecquidMAPKi-tnceMREAveri10(yer1-228PDXmodel)encompBRAFV600MUTNRASMUTmelnomwheMREAv20(yer2-4ddil60PDXmodel)encompfullpectrumcutneoumelnomubtypeTomtetnce-pecificlterti(RSA)functilvlidtivivopclicltrilwepriizeRSAbedcriclcrerihighcurncemulti-omiccvergencedruggbily/humnfetydrthoglupptlertuddilpubliccumdtbepotentilRSA-trgetgyieldynergyimmunpyMnycncerexhibrrnvexpidevelopmentllege-pecifictrncriptifcrInthprojectwevetigtepotentilexplogcogenicovexpedtrncriptifcrcecncercellproducenti-cncerrpieuggenerpytrtegyWedeignynticpromoterpecificllypivetrncriptifcrtetdiffentcnceruerpeuticvecrdrivercncerrpieApro--cceptprojectglege-pecifictrncriptifcrXctextlungcncerInlungdenocrcomhighlyexpedhomeoboxproteXgulrlyuedcliclmrkerhenhownncogenicdriverfundmentlcrcogeneThevetigtiextendlege-pecifictrncriptifcrdiffenttypecncercludgprottebtmelnombrliverhedneckgtricovrinkidneycerviclpncEwgrcomThegolourpropoedimdevelopnovelciencectrollgptilpcidrugdeliveryexplogcncertrncriptifcrlege-ddictidriveproductirpeuticlocllyOurplimryultdictecncer-pecifictrngeneexpifterytemicrpydmtrtiInourfirtimwepropoetudyeffecurgenerpycncergrowthhumnizedmumodelrpeuticpylodfelyuedytemicllyclicInourecdimwepropoedeveloppipeleunddcoveryvlidtiynticpromoterpecificllypivetrncriptifcrtetwkmoveydpro--cceptexperimentdeignggenerpytrtegierngehumncncertrncriptifcr-mededgrowthdependenciePROJECTSUMMARYLepmengeldee(LMD)mettcncercellpirchnoidcebroplfluid(CSF)devttgdeeurvivlrte4mthfterdignoLumbrpunctu(LP)cylogygoldtrdcfirmgdignoLMDhoweverhlowenivyfirtLPquirgmultipleddilmplecptucircultgtumcell(CTC)FlowcymetryCellSerchAylterntivemethoddetectiCTCCSFyhvedemtrtedhighereniviefirtLPTheepprochedetectCTCleukocyteybothexpepililcelldheimolecule(EpCAM)ddillledntibodieuchthoeCD45ybledtguhtweentwocelltypeAlthoughepprochehveignificntlyimprovedenivyqunttiveyuntuntelyquiliquidhlgtepcotlyequipmenttdpernelSmpleeneedentcentrllbwhichexpenivecntke1-2weekultwhichuncceptbleciderglowurvivlrteAddillyeLMDttmentcpdplcgCSFervoirbrjectgchempeuticdictlyventricle/CSFpcewhichcnoccur2-3timeweekSceLPcylogynotqunttivecurntlytkemthknowifuchttmenthfilednolteFlowcymetryCellSerchAycnquntifyccentrtiCTCycnnotuedl-timemirgCTCdurgttmentAnexpeniverpidequipment-feuer-friendlyycnuedtpotc(POC)lterl-flowimmunoy(LFA)whichhenueddetectpgnncyCOVID-19AlthoughLFAhmnydvntgeuntuntelylimedye/nwernotqunttiveWeepropoedeveloptwotypenextgenertipper-bedqunttivePOCdevicellowdetectiquntifictiCTCdurgLPeelimtedelydignogLMDSpecificllyedevicebledetermeccentrticellexpgEpCAMSceecellcludebothCTCleukocyteourdeviceloimultneoulydetermeccentrtileukocytethroughCD45SimilrflowcymetryCellSerchAyccentrticellexpgCD45(leukocyte)ubtrctedccentrticellexpgEpCAMetimteccentrtiCTCSuchdevicecouldloeilytegrtedttmentproceduuchedecridbovejectichempeuticettmentefficcyOurdevicetetedynticCSFctgvrygccentrtihumnbtcncercellT-cellSubequentlyplimryvlidtwotypedevicecductedcliclmplepproximtely25LMDpoive25LMDnegtiveptienttUCLAProjectSummryTrgetedcovlenthibirhveempowedpotentelectivetrgetgdrivercogenecncerBetween2011202116newcovlentdrug(12cncerdicti)wepprovedUSFDAcentnotbleexmplefirtKRAShibiribHowevermotcurntcovlentdrugdcoveryeftdictedwrdcyteewhichletbundntmocidproteome(2%)Menwhilebout6%mutntcncerledeWhileomeemuttidictlyctriecogenicignlg(egKRASG12S)cferclicltnceextgdrug(egEGFRC797SBTKC481S)TodtedictenggementemutntehvenotchievedMethodelectivelyenggemocidydcyteehighlydeirbleybridgegptweenpvlencee-cquirgmuttihumncncerlckchemicloltrgetmThprojectimdevelopnewchemtryenblecovlentenggementeidueepecillythoecquidcnceruchEGFR(C797S)(Aim1)BTKC481S(Aim2)SuccefultrgetgeproteprovidenewvenuetrgetedcncerrpyThechemtrydevelopedthprojectloervepltmdcoverynewcovlentligcurntlyundruggblecncertrget(Aim3)PROJECTSUMMARY/ABSTRACTTripleNegtiveBtCncer(TNBC)highlyggivedeeubtypecveypoptienutcomeWhiletrgetedrpieexthighlyeffectivebtcncerubtypepucytrget/trgetedgentthdeemkgcyxicchempytrdcIdentifygpprochecouldenizeTNBCtrgetedrpieeffectivebtcncerubtypemllpopultiTNBChouldprovideccelertedpprochexpgvenryttmentthdeeThpropolfocuelevergghibirNEK2mickethvexpedTNBCpotenteefficcytwoFDA-pproveddrugcleCDK4/6hibirPARPhibirUnlikebtcncerTNBCgenerllytntCDK4/6hibirInctrtPARPhibireffectiveTNBClimednumrcncerhvemuttiBRCA1geneTheefficcybothcnimprovedvrioumodelytemelevtgchromoomltbily(CIN)decgEMT(epililmeenchymltrni)NotblymickecludgNEK2cnctrolbothephenotypeuggetgymytrgtrgetimprovgCDK4/6PARPhibirefficcythhnotyetenexplodMickewethoughtidelcncerdrugtrgetcueirdruptiledmicdelydyfunctiultimtelyducgCINultcelldethenecenceHoweverdrugtrgetgeenzymehvetenfiledclicltrilduedoe-limgxicieultireentilynmlcellIdentifygleverggnovelmickemoelectivetumverunmlcellhouldgtlyimprovebilyenizeTNBCCDK4/6PARPhibirNEK2toutpotentiltrgetcueivexpedtriplenegtivebtcncer(TNBC)ocedwedeeoutcomeTherpeuticllytrgetgNEK2cnlopotenteefficcytxnetrd--cdrugthdeeoutducgxicymiceMotimptntlyunlikemickegrowthhibiultgblockgNEK2electiveTNBCnotnmlcellTogereultuggettrgetgNEK2myprovidenovelpprochimprovgCDK4/6PARPhibirpeTNBCoutcgxicyInSpecificAim1weexpourplimrydtdemtrtgpro--prcipleNEK2hibircnpotenteCDK4/6hibirpemuxenogrftmodeleimpctNEK2hibiefficcyedrugugeverlvrovivomodelTNBCflectgenomicheterogeneythdeeInSpecificAim2wedetermeifbilytrgetgNEK2ceefficcyCDK4/6/PARPhibirvolvemodultiCINEMTnewyetundcovedpthwyTogeretudieprovidefoundtidevelopgclicllyuefulNEK2hibirpirgmCDK4/6PARPhibirttTNBCptientPROJECTSUMMARYAlthoughchimericntigencepr(CAR)-TcelldrivedrmticdurblemiptientB-cellmlignnciepeolidtumhveenmochllenggThederthhighlyeffectivermgtrtegieCAR-TcellgenerteddilproteugmentCAR-Tcellfunctimodultetummicroenvirment(TME)Ourlg-termgoldevelopfeeffectiveCAR-TcellrpieolidtumTheoverllobjectivedetermeeffectlocllyectedVEGFblockdeCD70CAR-Tcellfunctifetynti-tumefficcynlcellcrcom(RCC)OurcentrlhypolocllyectedVEGFblockdepventCAR-Tcellexhutiwhileblockgngiogene/tumgrowthpthologicendolilctivtiTheunderlygrtiledetermtipcliclrpeuticefficcyocedmechnmlocllyectedVEGF-blockdefertrgcientificfrmewknewtrtegiecncerrpyTotverllobjectivewepuruetwopecificim(1)DetermeeffectectedVEGFblockdeCD70-CAR-Tcellbiology(2)DefecpcyCD70-CAR-TcellectedVEGFblockdemodulteRCCtumprolifertingiogeneendolilctivtivivoApprochgprojectcidteexmeechideimmuneynpeturn(1)defgeffectnti-VEGFglechvriblefrgment(cFv)ectiCAR-TcellthroughunderlygCD70CAR-TbiologyhgectiVEGF-cFv(prcuctrc)(Aim1)(2)determgeffectnti-VEGFcFvectiRCCtumcellngiogeneendolilctivtivivivothopicRCCtummodelcykeleeyndromemodelVEGF-blockdecrdiovculrxicymodel(Aim2)ThepplicntDrMrkLeickncologttMchuettGenerlHopl(MGH)pend80%htimetrnltilerch20%cliclprcticecrgptientcncerHehoutledfive-yercerdevelopmentplnctgcourewkcfenceemrtructudmenrgexperimentldeignmouemodelgngiogeneVEGFignlgpthwyCAR-TignlgnlcellcrcomcquinecerykillquidpermherchchhgolcomgndependentvetigrtrnltilerchHerchdictlylevntmiNCIcductcncererchdvncecientificknowledgehelpllpeoplelivelgerhelthierliveugimmunecellrpieSupervgDrLeickmenrhiptrgDrMrcelMuwldwideledercellulrimmunpyDrLeickcducttherchtMGHlevergeexceptilerchtechgenvirmenthcientificdvycommtee(MGHDnFrrCncerIntuteBethIlDeceMediclCenterBonChildnHopl)ProjectSummry/AbtrctPncticcncermotcommmpncticcncercurntlycurbleUnrvelgeentilcellulrprogrmgquidPDACdevelopmentprogifurridentifygnewdrugtrgetttdeecrucilimpcutcomeptientthdevttgdeeInthpplictiwepropoetudyfunctrnmembrneprotegultgmjnutrientupplyroutewhichcellcvengefoodfuelirgrowthItttrgetguchtrnmembrneproteblocknutrientupplypncticcncercellultcelldethBuildgourtrgexpertetudytrnmembrneprotepncticcncercellurvivlgrowthoverrchgobjectivethpropoederchgcompheniveundertgroletrnmembrneprotemedgnutrientupplyrouteevlutepotentiluchtrnmembrneprotetrgetgnodepncticcncerttmentThemjdvntgetudygtrnmembrneproteircceibilyrpeuticgentuchntibodieTochievetrnltilpotentilourtudywefurrdevelopchrcterizenovelrpeuticgentdicttrgetuchmembrneprotevriounewpcliclmodelpncticcncerUpcompletipropoederchwehvemocompleteknowledgeextentwhichpncticcncerlintuptrnmembrneprotenutrientlvgehownutrientupplymcherygultedtrnmembrneproteurfcepncticcncerwhertrgetguchmembrneprote-mededmetbolicprogrmmgmypotenterdictepncticcncercellAnwergequetiignificntlyimpcurbilydetermewherrtilpprochrpeuticllytervenenutrientupplyroutepncticcncerextFurrmoourerchignificntcuemyhvebrodimplictitypehumncncerdependgimilrnutrientupplymechnmInhttermfdgthprojectdvnceourundertgnutrientupplyroutequidutpncticcncercellprovidetrgpcliclevidencetrgetgnutrientupplyrouterpeutictrtegyttgpncticcncerInlgtermfdgourerchexpectedguidedevelopmentclicltrilchievgcliclnefptientpncticcncerWelieveultourtudiehvepoiveimpcngenerlpublicUnedSttenefgdividulffectedpncticcncerpotentillyledgimprovedoutcomeenhncedqulylifeProjectSummryAccehelthccludgclicltrilledgprdigm-chnggcncerttmentcriclhighqulycncercequyocietyDiffencerkcncerbiologymyctriedpriecnceroutcomeprticulrlyifmy/underervedgroupunderpentedclicltrilimpctnewercncerrpiemynotdequtelyevlutedepopultiCompdlterpheclicltrilerlyphetrilmocomplictedpivotldevelopmentnovelmoeffectiverpiePrticiptierlypheclicltriltenlywyptientcnccepotentillyeffectivenovelrpienotyetvilblecommercillyTheevidencedictmediclnefimprovementqulylifechievementpychologiclneferlyphetrilThechllengeengggmy/underervedpopultimoprounderlypheclicltrilygenerllymocomplextencceiblelylrgercentermetropolnInthprojectDrBrctueleddevelopmentutbletentiltrtegieextendcceceprticiptierlypheExperimentlTherpeuticCliclTrilNetwk(ETCTN)clicltrilunderpentedpopulticludgveternugrodmpbuiltlelernedNtilCncerIntute(NCI)CATCH-UP2020(CteAcceTrgetedCncerTherpyUnderervedPopulti)progrmImplementtimigounlyunmetneedefficiencyETCTNclicltriltimelyctivtrilelectipriiztienggementphyicinthroughouurctchmentctuedoptedthprojectAprojectefficientwkflowgenomicchrcteriztiptienttumllowidentifictiptientpproprebiomrker-drivenETCTNpcimediceclicltrilKUCCledEquy-FocuedCliclInvetigrTemETCTNUM1ctiumthroughexchngenovelpprochemgETCTNeenurgueprgmticpprochclicltrildeignpventunneceryburdenptmimizelodclicltrilopertiETCTNAbtrctPcimedicecologyquiccurtepdictidrugpeguideperlizedttmentdeciWedevelopedphrmcoproteomicpltmlkkomectivylivercncercelllekehibirdrugpePlimryultdictethurKI-PdicrbilyidentifydygultedkeignlghighlydependenncellulrctextToexmeoptimizeourpdictivemodelweuemplenmlhumnlivertueputevlutepermnceugddillivercellleGenomicDrugSenivyCncer(GDSC)dtetInprllelwepropoeevluteourKI-PdicrprilgkomectivyclicllivercncermpleelectgcidtekehibirtetggnotypiclicecultuderivedechdividulptienttumBycomprgpdicteddrugpeobervedpegnotypiclicecultumodelccurcylibilyKI-PdicrmodelcnevlutedThvlidtitepenbleementmodelbilycptucomplexietummicroenvirmentcludgterctitweencncercelltromlcellextrcellulrmtrixPROJECTSUMMARYWhilecncerknownheterogeneydtctubtypeobervedechgnytemourcethheterogeneyltihiptweenubtypedeficlicloutcomemctetedStudienimlmodelpncticductldenocrcom(PDAC)hepcellulrcrcom(HCC)uggetcell--igdividultumhtrgfluenceubtypedefedtrncriptillytumggivenedefedurvivlmettticpotentilInprticulrmouePDACderivedexoccrcellpdomntlyexpecliclubtypeigntulowerdevelopthnduct-derivedtumwhilemoueHCCderivedhepcytemoggivethnderivedhepcytepcurcellTheollege-trcggeneticmnipultiuedmouetudiecnnotppliedhumnptienthoweverlevgnimptntknowledgegpgrdgcellighumnPDACHCCfluencetumubtypeclicloutcomeToddegpwepropoetudyfocugcell--igcceptPDACHCCWehveobervedn-romomticmuttihighly-expedgenenmlcellctelegemrktumcellervgpermnenttrcecelligWehypoizecell--igcnervenovelbiomrkerPDACHCCpotentilimplictiptienttrtificttmentdeciInAim1weetblhequencg-bedprdigmltgcell--ighumnPDACtumubtypecliclhviByleverggextgwholegenomeequencg(WGS)RNA-eqdtwellpplygnnovtivetrgeteddeep-equencgpprochloclly-collectedmplewevlidteexpourfdgdelcr-pecificgeneocedPDACThewet-lb/dry-lbpipeledevelopedthimdictlypplicblepropectively-collectedhumnmpleAim2imdetermetimgptilpecificycell--igmuttiHCCBynlyzgextggle-cellRNA-eq(cRNA-eq)dtweidentifydenovodelliver-expedgeneThnlyhedlighntimglege-pecificdelmuttidurgtrninmllivertueHCCcnppliedPDACcncercRNA-eqnlycglyenterclicOverlltherchhignificntimplictiimprovgptienutcomelyfoundtifutuvetigtimechnmunderlygPDACHCCdevelopmenthumnPROJECTSUMMARYEpilioidhemngioendoliom(EHE)rmogeniccncercuedciproclchromoomltrnloctigenerteTAZ(WWTR1)CAMTA1(TC)fuigeneNoeffectivettmentextptientggiveEHEwhodoturviveyd2yerpot-dignoFurrnohumncellmodelEHEextmkgbothpclicltetgpotentilrpeuticmechnticundertgggivedeequechllenggTogddeproblemidentifypotentilttmentwegenertedtwogeneticllyengeedmouemodel(GEMM)EHEndolent/leggivemodelctgTCfuendogenouTzlocunggiveEHEmodelcombgTCfuicycl-dependentkehibir2(Cdkn2)cdilknockoutWeloderivedfirtEHEcellleggivetumviexvivoexpnihoweverweweunbledevelopcellleugdolent/leggivemodelTCtrncriptilcogulrpdomntlyloclizednucleueweeddrug/mllmoleculetrnlocteTCcyplmdetbilizeTCwouldducecogenicyTothendwepermedphenotypiccengbedTCimmunluocenceidentifyuchdrug/mllmoleculeWeidentifiedcycl-dependentkehibir(CDKi)dciclibpotentdrugcncueTCnuclerexdetbiliztiThtrnltedecedcellprolifertienhncementpopEHEcellcogene-ddictedTCOurlg-termgolundertEHEtumbiologyidentifyrpeuticvulnerbilyeffectivettmentEHEAim1WedetermeefficcydciclibllogrftmodelEHEelucidtemechnmctiAllphourphenotypiccencludgdciclibwetrncriptihibirpventemblyproductivetrncriptielgticomplexTheewehypoizecptgTCproductiveelgticomplexpventnuclerexTotetthhypoweevluteimmunopciptimpectrometrywherTCbdcompentthcomplexchrcterizeTCtercmefterttmenttrncriptihibirAim2EvluteeffectCdkn2troductiTClocliztitbilyvrollogrftmodeltroducgp16Ink4p19ArftwomjproteproductCdkn2ourEHEcellleviCRISPR-HDRGivenCDKhibidetbilizeTCwehypoizeCdkn2phyiologiclCDKidetbilizeTCClicllyCDKN2Aloocedlte-tgeggivedeehoweverunderlygmoleculrmechnmmunknownTheewevetigteifCdkn2deceTCtbilyInumthwkignificntcuewehvehowndciclibpotentillyfirteffectivettmentggiveEHEwehvedeciphedmechnmlkgCDKhibiTCnuclerex/tbilySUMMARYAcutemyeloidleukemi(AML)motcommcuteleukemiUS~20000newdignoe~11000dethperyerThperniciouhemlogiclmlignncyhrpidprogitrtlgmtlyunttedptientThprticulrlytrueelderlyptient(ie>65yerge)wheup70%newlydignoedptientuccumerTheeptienthveweprognoetencnnotlertemotggive(effective)ttmentcourelelikelyobtcompletemif-tertrdducticolidttmentmolikelyhveerioucomplictiideeffectUgbiomticnchpprochewefoundleukemiccellhowtrikgenivymi-chdrilxOurubequenterchidentifiedcltitweenlowercouplgefficiencymichdriAMLcellcedenivymichdrildmgeWehowedtrgynergy-tweenmultiplecombtimichdri-trgetgmoleculeknownnti-cncergentAMLnothelthycellelectivelykillgcncercellWehypoizedhemlogiclcncerccrueubtn-tilmichdrildmgeducectivtimichdrilcyclg(miphgy)likelyneftmtircelldivipotentilHoweverover-ctivtgmiphgycuecrtriggerpro-grmmedcelldethpthwyTolevergeefdgwepermedhigh-throughputcenidenti-fied8compoundcedlevelmiphgicctivrkePINK1drivgmichdrilturnoverItertivetructu-ctivyltihiptudieyieldedtwlognmedPS127BPS127ECC50AMLnMrngehelthycellurviveddrugtup20timeeccentrtiTheemoleculehib-michdrilfunctiduceoxygencumptiATPproductictivteeverlprogrmmedcelldethpthwyTheecompoundloynergizedknownAMLchempeuticweeffectivegtprimryAMLcell(cludgleukemitemcell)ducedtumburdenextendedurvivlmiceengrftedhumnleukemicellAubequentilicocenover4Mcompoundugtwopdictedctivie(popticgtthiodoxglutthieductehibi)hdmultiplecy-xicPS127-fmilymemr(mgn-cyxicmemr)identified213h93ehweclutercompoundchemiclimilryPS127fmily23weecdgrouptructurllyltedechnotPS127InthprojectwevlidtechemmticpdictiecomoundmoleculrtrgetdetermeireffectcellulrmetbolmcfirmytriggermiphgicctivtiviPINK1/PrkxmmmlincellCompletipropoedexper-imentidentifychrcterizehigh-vlueledfutup-clicltudiemumodelengrft-edptient-derivedleukemicellcludgPK/PDttmentefficcyThwklovlidtetr-getgmichdriuphgicdegrdtirpeutictrtegyAMLPROJECTSUMMARYThyroidcncercidencehigh44280newcedignoedUS2021Thyroidnodulecidencergprimrilydueceddetectinecetgmoproceduuchfeneedlepirti(FNA)biopieruleoutcncerHowevermotthyroidnodulebiopieproducenigndetermten-dignoticultpotentillyvoidbleOurlg-termgolimproverktrtificthyroidnoduleducenumrunnecerybiopiemimizeburdenthyroidcncerdignoptienthelthcytemOurcentrlhypothyroidcncergeneticrketimteimproverktrtificthyroidnoduleducenumrvoidbleFNAbiopienignthyroidnoduleSupptedrobutplimrydtcentrlhypotetedpurugtwopecificimAim1DefegeneticrchectuthyroidcncerAim2DevelopecliclutilygeneticthyroidnoduleclifierdcrimtetweennignmlignntthyroidnoduleUnderfirtimweexplogeneticocithyroidmlignncydependentnigngoerdcovernovelthyroidcncerbiomrkerdevelopclicllyuefulpolygenicrkco(PRS)Weuetwopproche1)tetgeneticocidictlyugGWASmet-nly4994thyroidcncerce20917ptientnignnodulectrol2)uecomputtilGWAS--ubtrctimethodderiveummryttticthyroidcncerfegeneticocinignnodulrgoerWeuepubliclyvilblegenome-wideocitudieuchGloblBiobnkMet-nlyInivepermourmet-nlyeugColdoCenterPerlizedMediceBiobnkBiobnkroundwldWehypoizethyroidnoduleclifierPRScombtitrdcThyroidImggReptgDtSytem(TI-RADS)ultroundchemimproverktrtificthyroidnoduleultimtelyducenumrunnecerythyroidnodulebiopieWedevelopedthyroidnoduleclifierPRSdiffentemlignntnignthyroidnodulenunderceiveropertgchrcterticcurve061Wepplythco~600thyroidnodulegenotypedptientknowncylogichpthologicdignoenigngoerthyroidcncerTheexpertphyicinetimteTI-RADSpotctegieWeevluteefficcyTI-RADSlghmlecombtiournovelPRSdtguhnignmlignntthyroidnoduleWeuepcelydefedgeneticlcpethyroidmlignncy(Aim1)improvethyroidnoduleclifierPRSThtudypvewyperlizedmngementthyroidnodulemfutumechntictudieimedttterundertgrkthyroidcncerPROJECTSUMMARYEpigeneticperturbticncerwidelycognizedpolyunderodAdetiledundertghowltentepigeneticmtictrietumigenewouldenbleutrtifyrkmgvulnerbleptientclifytumbedepigeneticttettertrgetrpeuticpprocheAnimlmodelerly-etepigeneticperturbtiferuniqueopptunytudypotentilctriiepigeneticigntupdicticncerrkceepigeneticchngepcedetumiemodelcneeprtedecdryeffecttumigeneInplimrytudiewefoundepigeneticchngeducedloepigeneticgulrKDM6A(UTX)pternlgermlemiceultelevtedlungtumburdenfprgevenwhenmutntKdm6lleleelfnotheredimplygefprgcrryilentepigeneticperturbtipdpoecncerTheemicenexcellentexperimentlmodeldefgigntuepigeneticeniztipdictcncerrkOurcentrlhypopextgdetectbleepigeneticperturbtilungtueterctgeneticdrivermuttienhncelungtumigeneultgtumhvedtctepigeneticgeneticigntuTheobjectivethtudydefeigntuepextgepigeneticchngelungmouemodeldetermeifmemythigntucndetectedlungtumAim1defetrncriptilepigeneticphenotypenmllungtueepigeneticllyenizedmiceAim2evlutemoleculrphenotypeepigeneticllyenizedlungtumugbothptneoutumtumducedctivtedKRASIfbothuccefululttwoAimcompdidentifyigntuepigeneticeniztipenthlogicllynmltueperttumWeexpectthwkvelnewmrkerepigeneticrklungtumigenedefemoleculrigntuocedpriepigeneticeniztumFutuwkdetermeextentwhichuchigntucnppliedhumnpopulticlicWhucceecncerttmentcomgmocommttgptientmettticmelnom(MM)tillgrimThedventimmunecheckpothibi(ICI)rpyprticulrlyhvolutiizedpromegenertgmodurblepehowever5-yerurvivlrteptientMMmly~23%Duerpytncepertencetum-gcell(TIC)ubpopultivlneedpdictivebiomrkerrpeuticpenovelrpeutictrgetugmentcurntttmentMMOurlbryhcentlypieedvetigtiigntufetuhumnMMcellglycomehowedcteglycnglycn-bdgfcrimpctmelnomprogiTheMMglycomechrcterizednbundncecellurfcei-lerpoly-N-cetyllcme(lerpoly-LcNAc)viloI-brnchgpoly-LcNAcenzymeGCNT2elevtiLcNAc-bdglectglect(Gl)-8InfctlowmelnomcellGCNT2/I-brnchgcpdhumnMMprogiwhedetectiGl-8erumdictlycltedignomelnomExcgpublheddthowelevtiMMcellGl-8Gl-8-bdglerpoly-LcNAcdictlyultexpikeyTICfcrnervegrowthfcrcepr(NGFR)/CD271knowndriverrpytnceMMprogiEnggementthGl-8Gl-8ligxenhnceTICpotentilpAKTctivyvivotum-mgctivyhumnMMcellOurguidghypoMMglycomehelpgovernmlignnttrcpcymelnommettizeExpiGl-8glycoproteligrglerpoly-LcNAcmyhelppdictwhichmelnommettizeevenprovidenewopptuniettptientMMInthgrntwecductmoleculrchrcteriztiMMcellGl-8ligxproroleGl-8melnomgrowthmettdetermewhermelnom-trichotGl-8impctmelnomimmunylternti-tumpeICIrpyTheSpecificAim1)ToexmefunctilroleGl-8ligxmelnomprogi2)Tlyzegrowth-mett-promotgroleGl-8melnomWeimplementg1)trgvetigrtemctgglyco-nlyticexpertcliclvetigrmelnompthologtglectbiologyexpert2)primryhumnmelnomtuetge-pecificmelnomptienterummple3)novtiveGl-8lig/glycnementmethod4)p-cliclmoueMMcellGl-8-deficientmodelimprtmotimpctfulcomphenivedtthprojectReultrnmtivepropolillumtehowMMglycomegulteMMTICfcrNGFRmelnomgrowthmettimplictgGl-8lerpoly-LcNAcbiomrkerrpeutictrgetMMprogiProjectSummrySexuldyfunctiemotcommdtgcequencecncerrpyyoungfemle(YF)cncerurvivmothn50%YFurvivptgchricexulproblem234cludgpexulctivyvulvo-vgltrophylowdeiSeveexuldyfunctihrplydimhepychologiclwell-gquly--life78YFurvivFyoungwomenwhodevelopgtrygmttimteltihipcequencecndevttg5Howeverexulhelthhbiltinotvilblemotyoungwomenuffergttment-ltedexuldyfuncti3637ToddthgpurvivhipcPIpvioulydevelopedpilotedbrief(3-hour)group-delivedkill-bedterventiclledSHARE(SexulHelthAndRehbilti)SHAREelf-mngementterventegrtette---rtexulhbiltibodywnetrgelementmdfulne-bedcogniverpydividulctiplnngIntwopviougle-rmpilottrilSHAREignificntlyducedcncer-ltedfemleexuldyfuncti15wellpychologicldtHoweverextgmSHAREqui-perttendncewhichlimccelythoetimemenbilyttendToovercomethbrrierwhilebuildgourpviouuccewedptedterventiledeliveryvivideocfencemt(SHAREle)ubequentlycductedmlptetgmterilmtSynchrouvideocfencgmthenhowneffective-pergroup61nevereueddeliverexulhbiltiyoungcncerurvivWenowpropoePheIIpro--cceptRCTexmeplimryeffectSHAREleduceexuldyfunctipychologicldtmple84YFurvivWeromize84youngfemlecncerurvivexulhelthccerneirSHAREleterventinEnhncedUulCttentictrolcdi(21)ctgeductilySexulfunctieedtbelet8-16-weekpot-terventiFeibilycceptbilycdibilycludgcdibilyctrolcdiexmedppdefiveefficcytrilWomenloceivetke-homeeductilmterilglebootertelephecll4weekpot-groupeiSHARElewdevelopedmeetneedcceibleefficientterventiyoungurvivWhemotYFurvivcurntlyhvenocceevidence-bedexulhelthhbiltiSHARElehpotentilhelpcloemjgpurvivhipcEvlutgplimryeffectSHARElecriclnexttepplnngfutuefficcytrilultimtelyenurgSHAREleneffectivewidelyvilbleterventiimprovehelthquly--lifeyoungfemlecnceruffergprouncedexuldyfunctiAdoptivetrnferTcell-bedimmunpiecheckpothibirimmunpyhvehownignificntpromettmentcncerHowevercheckpothibirrpytillfilmjyptientchimericntigencepr(CAR)-TcelleffectivegtmotolidtumInlrgeprtefiluduefctfquentlytummotlydevoidTcellTcellpennlytum-urroundgtromlrgelyexcludedtummTumtenurroundedextenivecollgen-richextrcellulrmtrix(ECM)tructuwhichimpedeentryTcelltummTcellpucyexcluumecltepoprognolimedefficcycheckpothibirimmunpieeffectiveneCAR-TcellrpygtolidtumMotcellulrtumimmunpypprochedtehvefocuedvergTcellexhuticgpertencetum-pecificTcellCAR-TcellHoweverepprochegenerllydotolveuecrumentfiltrtirpeuticTcelltumTheoverllgolthpropolengeerTcellenhnceirmigrtumceirnti-tumctivycoldtumtumexcludeTcelltummOurexplryR21propolpecificllyddeunmetneedimprovemigrtiTcelltumctgTcellcedcpcymigrtethroughtrictiveenvirmentWehvefoundFm-like-1(FMNL1)promoteefficientTcellextrvtimotilythroughcfedenvirmenttertilmigrtivivoFurrmoourplimrydtugmelnommodelhowthvexpiFMNL1ignificntlycenumrtum-pecificTcellpentttumeThuwehypoizeTcellengeedovexpFMNL1ctivemutnthvecedtrffickgtumedeeperfiltrtummenhncednti-tumctivyWeteurhypofollowgAimAim1DetermeifovexpiFMNL1ctivemutntenhncetum-pecificTcellmigrticcumultumAim2DetermeifTcellengeedovexpFMNL1hvecednti-tumctivyimproveefficcycheckpothibirrpyOverllweetblhvlidtepltmTcellbioengeergimproveTcellmigrtumecnppliedtum-filtrtglymphocyte(TIL)trnferrpyCAR-TcellrpyolidtumOurnovelpprochcnbothimprovebilyTcellextrvtettumeenhncecpcyTcellmigrtethroughtrictivetuebrrierfiltrtetummFromfututrnltiltpotnddildvntgethytemTcellfiltrtienhncementprovidedFMNL1notlimedprticulrtumntigennotMHCtrictedOverllourwkhpotentilignificntlyimprovettmentolidtumugdoptiveTcelltrnferrpiePROJECTABSTRACTDiffuemidlegliom(DMG)univerllylethlmbrcncerffectbothchildndultmotptientpgwy1yerdignofollowgtrdcrdirpyNotgledrughenFDApproveddepemultudeclicltrilmotgenttetednotdeignedpecificllythdeeThhighlightneedidentifictirpeutictrgetdictlylkedpthogenicmechnmDMGThehllmrkDMGdomntnegtivemuttihneH3keytructurlgulryctuentchromttructuwhichDNApckgedMutntH3drivetumigenepromotgtrncriptillyilentchromttpecifictumuppgenecludgCDKN2AHowtrncriptiilencedtegenomicepolyunderodkeyknowledgegpfieldOurplimrydtimplictemechnmwhichmutntH3duceilentchromtttumuppgenehijckgctivypecificcfigurtipolycombpivecomplex1(PRC1)PRC1nepigeneticilencgcomplexnumerouproteubunwhichcndopthighlyheterogeneoucfigurti(>150combti)mkgprticulrlychllenggtudyLeverggpooledCRISPRcentegrtedqunttiveproteomicwehveimplictedPRC1complexctgchromobox4(CBX4-PRC1)medirppropretrncriptililencgDMGOurcentrlhypoCBX4-PRC1co-optedDMGdrivetumgrowthtrncriptillypgtumuppgenecludgCDKN2AThegolthpropoldefeCBX4-PRC1functilcfigurtiwhichmedeppropretrncriptililencgDMGdetermewhertrgetgCBX4cncomdtrdcrdtmentDMGmodelWelevergeourtrgplimrydtmulti-dciplrytemnovelptient-derivedDMGmodelteurhypothroughfollowgim1)DefefunctillyeentilPRC1complexcfigurtiDMG2)ElucidteroleCBX4PRC1chromtcrumentilencgfunctiDMG3)EvluterpeuticpotentiltrgetgCBX4cjunctitrdcrdirpyDMGThpropollymechnticfrmewkCBX4novelrpeutictrgetDMGcurntlycurblebrcncerWevelpecificmechnmwhichmutntH3promoteppropretrncriptililencgdriveDMGgrowthdetermelevncethmechnmcroDMGubtypeguideptientelectifutuPROJECTSUMMARY/ABSTRACTDruglerntcelllimclicluccemnytypenticncerrpieDruglerncehlrgelyenocedcellheterogeneySurprglyidentifyguccefuldrugcombtihrlyendetcellpopultilevelWepropoelimeduccerpeutictrtegieduegpknowledgevulnerbiliediffentcncercellpopultiWecentlyhoweddurgilpecncerrpydruglerntcellexhibdiffencegeneexpicrodtctcellubpopultiThenlytrncriptilphenotypelungcncercelllexenogrftttedglegenthguideduuccefultrgetgdruglerntpopultiecdgentThuggetedudecribgdiffentcellpopultiuggle-cellRNAdtmyuedidentifygcbledrugpeigntuWeputwrdnnovtiveideegdruggblemodultigeneexpcellpopultilevelidentifictipotentildrugcombtiThegolfddrugechtrgetgdtctcellpopulti/lerntfirtdrugelimtellcellpcridcombttmentThidetetedtheSpecificAimdrugcgbedcellpopultiigntudrugvlidticellurvivlydrugvlidthroughchrcteriztiffectedcellpopultiThedtgle-cellRNAequencguedilicodrugpcriptipdrugcombtivlidtedvivohibggrowthpdictedcellubpopultiToenhncetrnltilvluethidewetudycellubpopultilerntttmenttrd--ccncerrpieweuelevntcncercelllemodelwedetermepplicbilyourideuglrgepn-cncercohtvilbleRNA-eqdtNodrugtrgetcncercellheterogeneyhveyetchedclicHoweverhibirvilbledtbeweueknownfetyprilehveenpprovedclicltrilcncerttmentycouldcidtehltgdruglernceThepropoederchhelpfdnewolutipprochecncerttmentItmyenblecologtccurtelytilcncercdividulptientdrugtrgetemergglerntcellpopultiPtienttrtifiedmrkerpdictivedrugpecnenterclicltrilcombtirpyProjectSummryRepertecurntimmunpiecomprblylowbtcncerptientyetptientTcellfiltrtetenpdtterToimprovepertebtcncerptientimmunpyimpertivedeveloptrtegieenhnceTcellfiltrtiIncenttudywedemtrtedcncercellcompbloodveelmettticbttumimpircrumentTcelletumLortnnntihyperteniventifibroticdrugducedextrcellulrmtrixproductimettticbttumnmlizedbloodveelpromotedTcellccumultumBedefdgwehypoizengiotenceprblocker(ARB)lortndecompetumvcultupromoteTcelltrffickgmouebtcncerTotetthhypoweuelymphnodewdowllowvivoimggtwoweekWhwdowweueopticlcohencemogrphyimggmeutuecompibloodveelfunctiprimrylymphnodetum(Aim1)InddiweuemultiphmicrocopyimggdoptivetrnfertudieteurhypolortnpromotenvecncerpecificTcellentrydecompedveelprimrylymphnodetum(Aim12)FurrourexperimentdeigneduncoverhowlortncomdimmunpyenhnceTcellfunctilederdictibttum(Aim2)WeueglecellRNAequencgflowcymetryexmecomporncriptiligntucellprogrmmedtumpdgcombtirpyFllywetetwherTcellufficienttumgrowthdelyBedplimrydtnimltudiewehypoizeueARBuchlortnbtcncerptientocedducedextrcellulrmtrixdepoumenhncedTcellfiltrtumTotudyifARBueocedepdictedoutcomeweueptientpecimenwomenenrolledBlckWomenHelthStudy(BWHS)cludgthoewhookARBttimedignoInAim3weuemultiplextgqunttivemultpectrlimggvetigteextrcellulrmtrixdepoivculrtructuimmunecellfiltrti554vivebtcncermpleAbiomticnlyRNA-equencgdbtedvivebtcncermplepermedvetigtetrncripmicigntuocedcelltummicroenvirmentWemeuwherourfdgARB-nveptientARBuertrglyoceurvivlclicopthologiclchrcterticWenticipteuccefulcompletipropoedtudieourmultidciplrytemvelcliclutilyARBpotentiltrtegyceTcellentrybttumimprovedccertgpertecurntimmunpieSUMMARYCchexiignificntctriburcedmtlyvriouchricdeecludgcncerPtientcncercchexiexperienceuntentilbodyweightlowhichcnvolvemuclelooutftmThedeclemuclemnlyimpirmuclefunctilodimhequlylifemtlyrkOurplimryerchhvelednupgultrnmggrowthfcr2(TGF2)pcedgcrumentM2mcrophgekeletlmuclecchecticmiceAddillyweoberveddepletgM2mcrophgehidtrnicchexievecchexipervgmuclemducgfibroTheedthighlightvolvementM2mcrophgectivticchexiprogitnceTGF2InthpropolwevetigteroleTGF2gfibroctivtgM2mcrophgekeletlmuclecncercchecticmiceFurrmowehypoizeM2mcrophgectpivotltrnipotdrivgdvncementevecncercchexiTheoutcomethtudymyuncovernovelmechnmnovtivetrtegiettmentcncercchexiABSTRACTLeverggneuroflmmtiimprovettmenutcomeptientglioblmchllenggcuehypoxictumimmunemicroenvirment(TIME)motlycompdimmuno-uppivetum-ocedmcrophge(TAM)mcompletelyquntifiedrpeuticllymodultedThelg-termgolccelertedevelopmentclicllymengfulimggtechnologiewydvncerpeuticpprocheptientdedlybrmlignncieTheoverllobjectivethpplictiuenovelirnnoprticleenhnced18F-fluomidzolePET/MRIderivedSeggtiExtrvculrLocliztiFerumoxylImgg(SELFI)hypoxicfrctiqunttivelydetermehowhypoxiTAMbedneuroflmmtiltettmentenivyThecentrlhyporpeuticmodultiTAMmidSELFIHypoxicFrctimelehypoxicTIMEimmunouppiledgimprovedttmenutcomeThertilepropoederchqunttiveelucidtihowhypoxicTIMEltettmenutcomelikelyprovidetrgcientificfrmewkwhenewTAMbedrpeutictrtegiecndevelopedThecentrlhypotetedpurugtwopecificim1)Defebiologicllypecificimggmeuimmuno-uppivehypoxicTIME2)DetermeeffectTAMmodulrTIMEglioblmUnderfirtimSELFIhypoxicfrctioptimizedbiologicllyvlidtedcoht27ptientIDHwildtypeglioblmneedgurgiclterventidignottmenutcomeAddillydignoticprognoticpermncedetermedthroughlgudlementhypoxicTIMEpropectivepheIIclicltril50dultptientnewlydignoedIDHwildtypeglioblmcheduledtrdrpyFecdimyngeneicptientderivedxenogrfttrcebrlglioblmrodentmodelueddetermecyxicyneuroflmmrycpbilyccurntTAMmodultictivtiAddillyTIMEltertipiblettmentefficcydefedTheerchpropoedthpplictinovtivepplicntopicueSELFIhypoxicfrctilikelyprovidenewmethodquntifygttmenutcomeThcpbilylikelydictlymirbiologiclfetuefficciourpeuticTAMmodultiThepropoederchignificntcueexpectedimproveuptrdgdolium-enhncedMRIprovidetrgevidence-bedproprciplefurrdevelopmentclicltrilrpeuticllyducedTAMbedneuroflmmtiWeeeefutuclicltrilugSELFIHypoxicFrctipecificllymirneuroflmmryeffectnovelimmunpeutictechniquePROJECTSUMMARY/ABSTRACTChildhoodbrtumurvivtignificntrkcogniveocil-emotildifficultiewhichocedducedqulylifeWhgrowgurvivpopultieftfetburdenurvivendufollowglife-vgttmentimpertiveNerlyhlfllchildhoodcncerdignoeoccurchildnunder5yergeYounggetdignomotctentrkfcrcognivelteeffectduerpidlydevelopgbrdruptierlylerngenvirmentMedulloblmmotcommmettticbrtumfntggivelengthyttmentquidcuAprimrygoltherchprogrmdevelopmentterventimigteimpctcncercncerrpiecogniveoutcomechildhoodcncerurvivCurntterventiexcluivelytrgetchildn4yerolderdepeexteniveevidencefluencgerlycognivedevelopmenthpotentilignificntcliclimpctAcgivereductilprogrm(CEP)hendeignedimproveundertgimptnceerlylerngenvirmennchildbrdevelopmentThCEPcncomdetterctiveneurodevelopmentlgme(INDG)deignedpntplyirchildntngnbrpthwypecifickillttimewhenechbrpthwyprticulrlyenivelifeexperienceStudiehvehownthCEP+INDGeffectivetechgkeydevelopmentlneurociencecceptcgiverignificntocedimprovementpnt-childterctichildproblem-olvgkillFmiliefntbrtumnideltrgetCEP+INDGgivenechildnhighlyvulnerblehvenoerchupptedterventioptievidenceterventiefficcyThehveennotudievetigtgeirterventichildnundergogcncerttmentAccdglypecificimthtudy1)ToevlutefeibilycceptbilyCEP+INDG(ieenrollmentcompletitfctirte)fntundergogmedulloblmttment2)Toetimtemgnudechngecgiver-childtercti(cnecticiprocyugvlidtedhvilcodg)followgterventi3)Toetimtemgnudechngecogniocil-emotildevelopmentocedterventiWepropoegle-bld(exmer)romizedctrolledtrilfnt(0-36mth)undergogmedulloblmttmentPrticipntromized(21)CEP+INDGtrdc(SOC)Onetwomthftergchempycgiverterventigroupprticiptetilod60muteCEPTheynceive30textpromptover3mthperiodcceINDGirphegeppropregmeelectedcncompletednyettgINDGcdfquencytimggmecceBothgroupcompletep-pot-terventi/SOCementcgiver-childterctichilddevelopmentWecruuntil40dydhvecompletedpotementStudyultmlrgerromizedtrilPROJECTSUMMARY/ABSTRACTThevtmjywomenwhodevelopdiecerviclcncerlivelow-middle-comecountrie1Inub-ShrnAfricgeogrphicequiertecerviclcncerfueledhighHIVcidencepvlencemgwomenHIV(WWH)SouthAfric(SA)rgtetHIVburdenwld2hhighetcerviclcncercidencertegloblly3SA53%llcerviclcncercettribleHIV4Whcedttentipidimptncecerviclcncerceng(whichSAtypicllycylogy-bedviPpmer)5Ppmercengrtehven201852%womenhdencened6up18-25%erliertudie7HowevercerviclcncercnlypventedifptienttedcubequentlyttedAlrmglyly26%WWHwhoceivedhigh-rkbnmlPpultcompletedmediclly-quidfollow-upmngement18mth8TocetentiWWHcerviclcncerttmentccdeimpertivewevetigtepecificfcrnegtivelyffectfollow-upppotmentttendnceenggementneceryttmentWhoutnuncedundertgbrriertenttmentcromultiplelevelWWHctuetdpropterkcerviclcncerAmulti-leveltenticterventiloduniqueneedWWHwhohvecentlyceivedhigh-rkbnmlPpulthtrgpotentilmigtemivecerviclcncerdprieWenowpropoecductmtivewknecerydevelopnovelterventiwhichlePAR-21-341modifycomplexterectgfcrctriecerviclcncerdevelopmentmgWWHInqultiveterview(1)WWH(n<10)whohdhigh-rkbnmlPpmerptixmthhvenotyetttendedfollow-upv(2)WWH(n<10)whohdhigh-rkbnmlPpmerptixmthhvettendedtlenefollow-upvweexplodividulterperlclic-leveltructurlbrrierfcilrfollow-upppotmentttendnceubequentttmentInterventipfenceloprodIneprteterviewprovider(n<8)weexploirperpectivebrrierdeliverycbrriertentiptientcpot-bnmlPpmerThequltivedtmpecifictimulti-levelterventiwhichtetedpilotromizedctrolledtril(n=60)FeibilycceptbilyprimrytudyoutcomewhicheedmgbothptientproviderWeloeignlclicllymengfuldiffence(1)proptiwomenwhottendfollow-upppotment(thoeproptiwhocompletenextphettmentwhichexplry)(2)elf-efficcyttendfollow-up/cerviclcncer-ltedppotmentIfdeemedfeiblecceptbleplimryignlefficcyterventidynR01-levelhybridefficcy/effectivenetril30-50%cncerurvivwhohvecompletedttmentcurtivetenthveunttedomniCncerurvivdiverercilethnicbckgroundexperiencehigherpvlenceomni(vn-Hpnicwhecncerurviv)yetunderpentedcncerurvivhiperchleepclicltrilCognivehvilrpyomni(CBT-I)firtleevidence-bedttmentMet-nlyeourgrouphvefoundmediumeffectizeimprovementomniyetbrrierfeibilyduecurntdeliverymodlielcktrgetedctentddgcncer-ltedbrrierleephdertentiOurtudytemdevelopedynchrouvirtulCBT-Icncerurviv4weeklyeideliveddividul(SurvivhipSleepProgrmSSP)cductedpilotromizedctrolledtrildemtrtgfeibilycceptbilyplimryefficcyvenhnceduulcup1-mthpot-terventiHoweverprticipntdeidenhncedemotilupptvigroupmrbootereiddiloutcome(emotildtwk-ltedfunctigueleepmedicti)weunchngednoteedInpePAR-21-341primryimthubmioptimizeynchrouvirtuldeliverySSP2x2fcriltril(N=80cncerurvivomni)evlute2terventideigncompentdelivery(dividulvgroup)booterei(0v3)Theprimryoutcomechngeomnieverybele(T0)1-mthurveillnce/booter1(T2)ExplryAim1chrcterizetudyprticiptileepoutcomerceethnicyFeibilynchmrketblhedourpvioupilottrilenrollment(56%enrolled/eligible)tenti(90%pertimepot)ttendnce(100%)exmedrceethnicyPrimryecdry(emotildtwk-ltedfunctigueleepmedictileepdiriectigrphy)outcomecrotimepot(T0-T33-mthurveillnce/booter3)explodrceethnicyExplryAim2chrcterizecceptbilySSPdeigncompentviextervieweedpot-SSP(T1)ugqunttivertgqultivecodechrcterizepfencechllengefutudeliverycidertiCollectivelythpropolnovtivethroughfocu1)optimizgCBT-Icncerurviv2)tetgclblevirtully-delivedynchrouterventi3)cludgkeyecdryoutcomelevntcncerurvivhip4)engggcommunyprtnerboltercrumentrcillyethnicllydiverecncerurvivThepropoedtrtegytngnedtrndciplryexperttemprtnerhiptwocommunygniztiervgdiverecncerurvivrigoufrmewkoptimizghvilterventi(MultipheOptimiztiStrtegy)nevidence-bedterventiwhichmkedpttiuequltivequnttivemethodFdgmnR01-leveltrilcommendtiddgomniftercncerPROJECTSUMMARY/ABSTRACTOverviewThegolthprojecteefficcytilodphe-delivedpoivepychologiclterventi(PATH)improvgnxietydepiympmqulylife(QOL)hempoietictemcelltrnplntti(HSCT)urvivBckgroundAllogeneicHSCTurvivexperiencehighrtettment-ltedxicieprolgedcoveryubtntilrklife-engcomplictilg-termmbidymtlyHenceHSCTurvivexperiencetmendoupychologiclympm(egnxietydepi)lowlevelpoivepychologiclwell-g(egflourhggrtude)whichundermevriouhelth-ltedoutcomeuchqulylife(QOL)HowevermotextgpychoocilterventinotcceiblemjyHSCTurvivcuey1)delived-per2)entillg60-90-muteei3)quideliverypllivecclicinpychologtextenivecotlytrg4)notfocuedpoivepychologiclwell-gToddegpwedevelopedPATHncceiblephe-delivedpoivepychologiclterventidelirteytemticctiviecultivtegrtudetngthmengInterventilikePATHcnbuffergtdtimprovenxietydepiympmQOLHSCTurviventil1520-muteeidelivedterventdiverebckgroundcludgnurgocilwkpychologyWhgleeromizedctrolledtril(RCT)PATHwehowedwfeibleplimrilyledclicllyignificntimprovementptientnxietyympmAfirtRCThowfeibilyplimryefficcytilodHSCTpoivepychologyterventinexttepeefficcyPATHnxietydepiympmQOLReerchPlnWecductnRCT400HSCTurvivtetefficcyPATHimprovgnxietydepiympmQOL(Aim#1)WeloeimpctPATHpoivewell-g(eggrtudeflourhg)elf-mngementtrget(egcopgphyiclctivy)(Aim#2)FllyweemedirmoderreffectPATHnxietyympmQOL(Aim#3)EnvirmentThprojectcductedtMGenerlBrighm/Dn-FrrCncerIntute(MGB/DFCI)DukeCncerIntuteMftCncerCenterwhichdividullycduct200-250llogeneicHSCTperyerDrAmooerchtemtMGB/DFCIDukeMfthveextenivepriciencydevelopgcductgmulti-epychoocilterventiptienthemlogicmlignnciewhoHSCTurvivenuuccefulexecutipropoedRCTcrotudyeRelevnceReerchIfefficcioutimprovgnxietydepiympmQOLPATHcnpotentillychngeprdigmpychoocilcHSCTurvivvulnerblecncerpopultiPROJECTSUMMARYExpoufirmjrkfcrdevelopmentmlignntmeoliom(MM)WedemtrtedfirduceHMGB1trnloctinucleucyplmducguphgyprotectivemechnmmeolilcellurvivlfterexpouctrigmlignnttrnmtiOurfdguphgyctutillyctivtedMMcellexplMMchemotnceAntidepntdrug(AD)wehownblockuphgyourplimrydtuggetedADwell-lerteddrughiduphgyMMcellMooverwedcovedmichdrilproteclledMcl-1blockchempy-ducedpopInhibiMcl-1cedeffectchempyfive-folduggetgcombtiADMcl-1hibirmyprticulrlyeffectivettgMMHewepropoeteurhypouphgyMMgrowthchemo-tnceADhibguphgyceenivyMMchemo-ducedpopwhichcnfurrenhncedMcl-1hibiToddthhypoweexmefollowgimAIM1TovetigtemechnmpibletnceMMcellchempyAIM2TovetigtewherADMcl-1hibirceefficcychempyMMmouemodelAIM3TovetigteugbiopieMMptienteffectADMcl-1hibirAZD-5991tumcelltummicroenvirmenteurvivlOurnoveluniquegentourcehelpuundertpecificfunctiHMGB1ltedmechnmduceuphgyfcilteMMprogiwhichmyemotclicllylevnttrgetterventiUgADMcl-1hibirhelpenizeMMchempyextmelytrnltilThtudygtimpctccelertedevelopmentmoeffectiverpeutictrtegieimproveprognothdevttgmlignncyAbtrctAntibody-drugcjugte(ADC)hvehownprometrgetedrpeuticttgcncercludgolidtumHowevernoADChgedFDApprovlttmentprottecncerMultiplefcrcludgtrgetelectiheterogeneywellufficienttumuptketrcellulrdeliverycouldhvectriedlimeduccecurntADCToovercomeelimtiimprovettmenutcomewepropoedevelopnovelbpecificADC(bADC)trgetemerggtumcellurfcentigen(CD46B7-H3DLL3)cliclvlidtiBpecifictrgetgwhichenggetwodtcttumntigenimultneoulyholdpromeovercomgtrgetheterogeneyimprovgternliztumpenetrtiUnlikecombtimocllADCbADCpoeuniquebilyexploynergticterctitweentrgetfluenceirtrcellulrfteThcceptprovidecompellgrtileexplgbADCprottecncerttmentWedcovedCD46novelprottecncercellurfcentigenpertentlyexpedcrodiffentiptternWedevelopedtrnltedCD46-trgetedADC(FOR46)pheI(NCT03575819)&II(NCT05011188)trilThCD46ADChowedgoodlerbilypromgerlyefficcyignlmCRPCptientB7-H3nemerggtrgetwidelyexpedprottecncerhentrgetedADClikeMGC018DS-7300howgcceptblefetyencourggefficcyerly-phetrilB7-H3negtivyrdenocrcommocommCRPCneuroendocfetuDLL3ovexpedeverlneuroendoctumDLL3-trgetedADC(Rov-T)hentetedneuroendocprottecncerpheItrilmkgDLL3cdentiledtrgetthubtypeWepropoedevelopbADCbedthoeemerggnoveltrgetddbothdenocrcom(B7-H3xCD46)mllcellneuroendoc(DLL3xCD46)prottecncerInAim1wedetermetrgetco-expiptternmCRPCptientmplegenertenovelhumnmocllntibodiennobodiegttrgettetctructbpecificntibodie(bAb)ugrobutIg-likerchectugenertebADCcrrygdiveredrugpylodcliclvlidtiInAim2wevetigterpeuticefficcyB7-H3xCD46DLL3xCD46bADCnimlmodelpentgdenocrcommllcellneuroendocprottecncerpectivelyWenchmrkbADCgtcurntADCgtetedclicltrilidentifyledbADCdemtrteimprovedefficcygterogeneoutumcludgtrget-lowtumenhncedurvivlnimlmodelprottecncerThepropoedtudypentnovelpprochnext-genertiADCdevelopmenthclerprnlticlicprottecncerptientwhohveprogedydcurntrpiePROJECTSUMMARY/ABSTRACTCompleteprtillochromoome7(-7/del(7q))pdpoiyndromepleukemileukemimotcommcygeneticbnmlyItocedhverllurvivlchempytnceGivenirhighpvlenceunfvbleprognonurgentneedidentifymoeffectivenovtiverpieNelepthogenerpeuticvulnerbilie-7/del(7q)mundetermedWehypoizehemizygoudeletiemohploufficienteentilgenechromoome7qpibleeffectivehempoiekprtilloriboomlprote5qdeletimyelodyplticyndrome(MDS)heredBMfiluyndromeSuchhemizygoudeletimyctepecificvulnerbiliecouldrpeuticllytrgetedfurrhibgencodedproteltedprotenocedpthwyNuclerpocomplexe(NPC)plycrucilrolegultgeverlvlcellulrproceectrollgnucler-cyplmictrffickgRNAriboometrncriptigulrdrugtrgetWecductedcomphenivettticlnlyedividulCRISPRknockoutexperimentwhichveledNUP205nNPCmemrhploufficienteentilgenechromoome7qKnockourknockdownNUP205ultgrowthddvntgecellpopdoe-dependentmnnerNUP205hemizygoudeletigle-cellcleexhibtncecytrcedenivyeleclomolctentdrugprile-7/del(7q)primryleukemimpleBetAMLcohtTheewehypoizedeletihploufficienteentilgeneNUP205ctrieBMufficiencyphenotypeoberved-7/del(7q)ptientcnrpeuticllytrgetedugeleclomol-bedttmentpecificllyelimtemlignntcellhrbg-7/del(7q)Wepropoehe(1)vetigtefunctilimpctNUP205hempoie(2)elucidtemechnmNUP205deleti-mededimpctcellulrctivychemoenivy(3)vetigteeleclomolcombtirpietrgetgleukemicellhrbg-7/del(7q)CollectivelyourtudieelucidtecellulrmoleculrmechnmNUP205deletidrivgBMufficiencyphenotypectgpecificvulnerbiliehpgdrugpeubetmyeloidmlignncieUltimtelytheftprovidebfurrtrnltilwkdevelopmentpromghibirclicltetgAddillyourtudyerveprotypeidentifygnovelrpeuticvulnerbiliechromoomedeletihemlogiclmlignncieProjectSummryArtificiltelligence(AI)ytemcglyuedrdicologytkuchimgectructigtrtiuegmenttiynticCTgenerttmentplnngHoweverAIdeignfundmentllychllengeextgqulyurnce(QA)prdigmwhichimperilqulyfetyAIcliclueAddgunmetneedQAcliclAIcriclpotentilpermncedegrdtiAIytemclichighDomhift-whendtriidtueddurgtrgdiffentdtriidtencounteddurgdeployment-criclproblemcnledignificnterrAIpermnceThcommoccurncecliclenvirmentwhecnnerpermncevrieovertimeduechngeimggprocolequenceequipmentdegrdtiplcementdiffentmkemodelMirgcliclAIytempermnceigndomhiftutmotimptnceenufehigh-qulyueDevelopmentrobutQAolprcticeverifymirpermnceAIytemecricleytementercliclnInthprojectwedevelopnewtypeQApprochmenblecloed-ourcecliclAIytemOurpprochupptedourplimrydtdeigneriedetecrwhichmirputimggdtAIytemoutputchngelkechngenctiblelerncethroughpdictimodeloutneedcceAIytemternlOuroverllhypoexpectedpermncecliclAIytempdicted5%errmirglyAIytemputoutputInSpecificAim1wedevelopQAfrmewkAIytemwhichwetdgroundtruthetlluguegmenttimodelytemWebuildcompilghmencodefetudtriiput(imge)eprtelydtriioutput(cur)ApdictimodeltkgedtriiputpdictgcurccurcybuiltWedevelopQAfrmewketextgAIytemcludgtwocommercilAIeverl-houeuegmenttilghmInSpecificAim2wefocuAIytemwhichdotuegroundtruthdurgtrgugynticCTgenertimodelytemAimilrpprochSA1ugcompibuilddtriipuutputltentfetuuedIntedpdictgccurcy(whichquigroundtruth)wedevelopmodelmirdtriioutputInSpecificAim3wedeployourqulyurncefrmewkpropectiveclicltudyvolvgmultipletutievluteeffectiveneenurgfehigh-qulydeploymentcliclAIytemWelohourfrmewkdtbrodercommunypromotetprcticeAIqulyurnceWeexpectthurQAfrmewkignificntlyimprovefetyeffectivenecliclAIytemrdicologyenurgeytemrobutdomhifrourceerrPROJECTSUMMARYLungcncer#1cuecncerdethUSThe5-yerrtecncercurncedethmhighevenptienterlytumAncompleteundertgmoleculrphyiclunderpngerlytumprogilimdvncettmentThelg-termgolidentifyfundmentlmechniclbiochemiclterctictrolprogierlyleilungdenocrcom(LUAD)TheoverllobjectiveheelucidtemechniclterctivolvedLUADprogiThecentrlhypocedtrfunctifeedwrdlooptumgrowthECMdepoipromoteLUADprogiThbedourplimrydtWecomputtillypdicttrpirticedttumodgeWelohowtumedgehcedprolifertiveignlgurroundedlveolrdemtidictivecircumfentiltrThecentrlhypotetedpurugthepecificim1)Determehowtrctrolerlylungtumgrowth2)Identifymechniclfcrmodulteviveprogi3)DetermehowfibroticECMdepoictrolprogip-cnceroulungdenomUnderfirtimwetetiftrducectivtumgrowthignlgttumedgeexpgmplifiedtrInim2wetetiflveolrwlltrducedtumexpniledwllfiluiltepviveprogiInim3wetetiffibrotictiffenglungcuehighertrmpludettumodgewhichpromoteLUADprogiThdetermephyiclmechnmctrieproginigndenomlungcncerprogiTheerchpropoedthpplictinovtivecuetetnewmodeltr-mededmechnobiologiclignlgerlylungcncerprogicueemploynewpprochettchlivelungtuequntifytrtuedmgenovelpecimen-pecificcomputtilmodelgimultipipeledetermectriitrgrowthvierlyLUADThepropoederchignificntcueprovidenewknowledgehowbiomechniclignlguchexceivetrfibroctrieerlycncerprogiSuchknowledgehpotentilprovidetrgcientificjutifictitudymechnobiologyolidtummettizelungdevelopmentneodjuvntrpieducefibrolimlungcncerprogimtlyOurnewpprochemodelgimplementedopenourceFEBiotwueubject-pecificmodeldtriedviFEBiomodelpoiryfciltgnovticienttABSTRACTRelpeleukemioccurnerlyhlfptientfterhempoieticcelltrnplntti(HCT)WhilegrowgnumrrpeuticoptileukemiclpefterHCTwelckcliclycpbleimultneoulydetectgdeetriggptientttmentwhichmotlikelynefmInthpplictiwepropoerigoulyevluteemploynovelgle-cellgenomicmethodirccompnygcomputtilpprochedetectdeetlowlevelmmechnmlpedictfuturpyInAim1weoptimizecomputtilmethoddetectgnturlgeneticvritweendcipientdignoticmneuverwelieveimproveenivydetectgmlignntcellfterHCTWenvlidteemethodugmpleptienttropectivefhiToprovideightmechnmlpewehvedevelopednovelmoleculrpprochidentifygperturbtiHLAltedgenecommmenwhichleukemievdeimmuneytemfterHCTInAim2wevlidtethmethodmnnerexplolowerlimdetectiHLA-perturdcellFllyAim3webuilddecdewkugflowcymetryeheterogeneymyeloidneoplmtegrtgourgle-cellmoleculrmeucell-urfceimmunophenotypeUgthpprochweeekdefecommmoleculrigntuleukemi-gcell(LIC)ubetcellmyeloidneoplmthoughtchemo-tntervoirleukemiThepropoedtudieetblhnewmethodurveillnceiduldeefterHCTwhichwelieveprovidedeeperlevelcfidenceightleukemiclpepot-trnplntWeexpectetudiemfoundtilpclicldtgle-cellgenomiccliclycpblerk-trtifygptienterlyevidenceleukemiclpefterHCTPROJECTSUMMARYWomenlivghricllydledneighbhoodimpctedtructurlrcmdcrimti(SRD)hvehterbtcncer(BC)curnce-feurvivl(RFS)compdwomenlivgn-hricllydledneighbhoodThdprypertfterctrollgdividulhvilifetyleenvirmentltumNtilCompheniveCncerNetwkguidele-ccdntttmentchrcterticuggetgunccountedmechnmwhichSRDimpctBCRFSOurplimrydtdicteSRDthroughneurlfluenceBCbiologymyhtenBCRFSSpecificllywelevergednovelgenomic-epidemiologicfrtructuourMimiBtCncerDprietudypropectivecohttudyclicllyurvey-nnottedbloodtuempledcoverbothobjectiveSRD[defedugIndexCcentrtExtme(ICE)]ubjectiveperceiveddcrimti[PDdefedugugExpedEverydyDcrimtiScleSurvey(EEDS)]dependentpdicr1)higherlevelmyeloidlegeimmunecellctivtiblood(ptternknownCervedTrncriptilRepeAdveryCTRA)2)moggiveBCmoleculrbiologyprile(up-gultiproflmmrytrncriptifcr(TF)NF-kBAP-1)fterctrollgdividul(eggerce/ethnicyhvilifetylecombidie)envirmentl(egirpolluti)tum(egtgeubtype)ttment(egneodjuvntchempy)fcrInddhggiveBCmoleculrbiologyprilecltedhterRFSWelodcovedbothSRDPDocedup-gultiTFCREB(mrkerSNSctivy)implictgSNSpotentilmedirSRDhterRFSthroughpro-flmmryNF-kBAP-1gultiComdourplimrydtprovidetrgevidenceourcentrlhypoSRDPDocedhterRFSprtthroughbiologicmechnmmededSNSgulti(CREB)circultgmyeloidlegeimmunecell(CTRA)ultgnggivetumbiologymoleculrprileToteurcentrlhypowepropoefollowgimlrgetocilgenomicBCtudydtectg750divere(18%n-HpnicWhe24%n-HpnicBlck58%Hpnic)BCptientenrolledourMBCDtudyAim1)DefectriiobjectiveSRDubjectivePDBCRFSAim2)VlidtebiologicmechnmmedgeffectSRDRFSAim3)EvluteptileffectcliclbiologiccltehterRFSComdefdgourknowledgepentglelrgetocilgenomicgeoptilBCerchefttudyBCRFSdpriennovtivefocu1)oltgdtctbiologicmechnmocedSRD(ICE)PD(EEDS)RFS2)geoptilidentifict-rkneighbhooddefedhvgmoSRDggivebiologyhterRFSmfutupolicytrgetedhvilrpeuticdeduceSNSctivydverythubedpriromizedctroltrilvereggivetumbiologyultimtelyimprovgBCRFShigh-rkmrglizedpopultiPROJECTSUMMARY/ABSTRACTApproximtely40%USdulthveoy(BMI>30)excebodyweightocedtlet13diffentcncer5%11%cncercemenwomenpectivelyOydproptelyimpctrcil/ethnicmylowocioecomicttu(SES)rurlpopultiplycriclrolecncerequieEvidence-BedInterventi(EBI)ddexcebodyweightphyiclctivypodieteffectivepromotgweightloducgcncerrkgrolyunderutilizedubtntildprieccemghricllymrglizedpopultiDiglEBIdeliverymodliehveyieldedoutcomecomprble-perprogrmAuchlg-termobjectiveSMARTLifeUthcechextgdiglEBIoymgrcil/ethnicmylowSESrurlpopultilowourcehelthcettgSMARTLifeUthcducted11CommunyHelthCenter(CHC)ytemctg38primrycclicSMARTLifeUthhybridtypeIIIeffectiveneimplementtideignugprgmticmultilevelthepheSequentilMultipleAignmentRomizedTril(SMART)SMARTLifeUthlevergeubiquiuhelthmtechnology(HIT)/telehelthbothimplementtitrtegieEBIdeliveryderddbrrierengggEBIImplementtitrtegietrgettwodiffentlevelcechEBI1)cliclevelHITimplementtitrtegycludeenhncedytemuppttpotc2)ptientlevelimplementtitrtegieprovidepetedopptunieenrollEBIwellmotivti/prcticlproblemolvgfcilteenrollmentThecientificpmeSMARTLifeUthbed1)EvidenceEBIoyeffectiveunderutilized2)RecommendticleupEBIchduceequieutilizgtechnologybedprogrm3)DtdemtrtgHITimplementtitrtegiecndrmticllyceenggementEBIfextgcliclytem4)DtdictgtextmeggcncechEBI5)Prierchhighlightgeffectivenetelehelth-bedptientnvigtiimprovgchEBISMARTLifeUthprovidecricldtgrdgimpctprgmticclblemultilevelimplementtitrtegiedeignedceuptkeEBIoymghricllymrglizedpopultilowourcehelthcettgItlodvncefielddemtiimplementticiencetetgkeyctructhypoizedfluenceimplementtieffectiveneugcomphenivecceptulfrmewkProjectSummry/AbtrctTriple-negtivebtcncer(TNBC)highlyggiveunimlylethlmettticettgdepecentpprovlimmuno-rpeuticthdeeOutcomecouldpotentillyimprovedcloggpourundertgimmunologiclctrolTNBCAubethumnTNBC(6-20%)trglyovexpimmuneceprVISTA(V-domimmunoglobuluppTcellctivti)whichrcloehomologydrugtrgetPD-L1ClicltrilhumnnowevlutgfetyefficcytrgetgVISTAextrcellulrdomcncerHoweverwelckmechnticundertghowVISTAignltericellPlimrydthowVISTA+TNBChveimmunologicllycoldtummicroenvirmentdecedprolifertivedexTheeeffectctrolledbothextrcellulrtrcellulrdomVISTABypurifygproteboundtrcellulrdomwehveetblhedVISTAcncruequetercyplmicclthr-dprprotecugdefectplmmembrneceprendocytrffickgCequentlyimptntimmunologiclcncergrowthceprlikeTLR4EGFRdotfunctieffectivelywhenVISTAexpedThledhypoVISTAtrcellulrdomcell-tricpmembrneceprtrffickgtrgetgbothVISTAextrcellulrtrcellulrdomcriclimproveVISTArpeuticThhypotetedthepecificim(1)TomechnticllydecthowVISTAblockceprtrffickgwechrcterizehowprotebdVISTAtrcellulrdom(2)DefemechnticroleVISTAtrcellulrdombdgprtnerceprtrffickgctivy(3)EvluterpeutictrtegieVISTA+triple-negtivebtcncerTheeimccomplhedthroughbiochemiclnlypurifiedprotecellleengeedmuttidruptclthrdprbdgVISTAtrcellulrdomAnlycludeeffectVISTAboumcellthvexpVISTAmodelhumnTNBCimmunecellnturllyexpVISTAnmlphyiologyCombtigimenexploeffectblockgbothextrcellulrtrcellulrfunctiVISTAtetedimmunocompetentmouemodeltriple-negtivebtcncerThwkhouldddneeddevelopnovelimmunomodulrygentimproveoutcomeTNBCAlthoughVISTA-trgetedrpeuticcurntlyclicldevelopmentllcurntpprocheexcluivelytrgetVISTAextrcellulrdomOurtudiehvedcovedVISTAtrcellulrdomcricldetermntceprfunctiwepropoeextenivelychrcterizectlyzeimprovedVISTA-trgetedrpiePROJECTSUMMARYGivenimptncemutticogenetumuppgenehenwidelyumedmeccumultimuttiprimryproceexplcncercidenceHowevercncerpdomntlydeeggcidencemglowuntilfourthdecdelifeundergogexpentilgrowthfterFurrmocellcrrygwell-chrcterizedcogenicmutticnfoundcronmlhumntuecnpertdecdeouteverdevelopgcncerOurcurntundertgwhtfcrgovernthdecde-lgltencyeventulfilugedtueextmelylimedAcompellgrgumentdecriuetegrytermtructufunctibothwhichdeclegecouldexpldiffentilfnecellhrbgcogenicmuttiOurignnceetuedynmicproceetemourbilypermvivlyoveruchlg-timefrmelevntmouemodelWehypoizechricliverdee(CLD)cnunderodnccelertedggliverimilrlylterfnelcpepromotgelectimuttedcellprogwrdhepcellulrcrcom(HCC)WefocuedCTNNB1encodg-ctenmotfquentlymuttedcogenehumnHCC~30%ptienthvgltertinder-ctenctutivelyctiveHoweverpcemechnmwhich-ctenmuttidriveHCCprogimunknownToddthknowledgegpwehvepermedlg-termclllegetrcghepcytergCtnnb1ctivtgmuttibothnmlchricllyjudliverBycouplgrcgytemglecellRNAeqwedcovednmlliver-ctenmuttedhepcytecpbleundertkgglecelldivitedltmthtuethroughlgprocecellulrttrielimtiwhichwehypoizeprimrilyttriedERtmldptiveUPRStrikglyctextCLDwefoundtuejuryunlehedpotentil-ctenmuttedhepcyteclllyexpdrivedevelopmentHCCtumolvglgtgcundrumfieldImptntlyugmelegetrcgytemwefound-ctenmuttedhepcytenmllivergedmicecnimilrlyundergocllexpniobervedCLDInthpropolwevetigtepecificmoleculrmechnmultdimhedcellulrfne-ctenmuttedhepcytenmllivercverelywhtmechnmhdcecellulrfne-ctenmuttedhepcytedurgchricliverdmgeByfocugemechnmweexpectlygroundwkexplogvulnerbilie-ctenmuttedhepcytefoundnmlliverwhileblockgtngthycquidurgCLDtcklethdevttgdeePROJECTSUMMARYHumncncercnclifiedccdgircellulrlegewhichtendefedpencemtergulrtrncriptifcrIneverlcliclctextopptunieexttrgetmtergulrrpeutictrtegy(egntgtAndrogenReceprdegrderIkro/Aiolo)HowevercenrioloextwhichrrntexpimtergulrcnpromotelegeplticywhichcnllowtumcellevdetrgetedrpieTheecliclobervtihighlightimptncevetigtgbiologymechnmlegemtergulrcologyOurlbcentlyptedextencetuftcell-likelegehumncrcomwhichtumdefedexpiPOU2F3Wedecridtuftcell-likecrcomn-neuroendocmmllcelllungcncer(SCLC)howeverubequenttudiehvehownPOU2F3+crcomexteverlgnwellIntherchpropolweeekdefeuniquebiologymoleculrmechnmdtguhPOU2F3+crcommhumncncerlg-termobjectivedvncgrpeuticolutithnewlyidentifiedtumlegeThefirtAimthprojectfocuvelgmoleculrmechnmbuildgupourcentdcoveryOCA-T1/OCA-T2obligtecoctivrPOU2F3tuftcelllegeFthwkweemployourltetnovtigenomeedgtechnologyepigenomicdefeeffecrPOU2F3/OCA-TcomplexPOU2F3+SCLCTheeefthvepotentilvelbiochemiclopptuniellowphrmcologiclmodultiPOU2F3cncerTheecdAimevluteuniquebiologiclpropertieneopltictuftcellvivowhichbuildupourplimrydthowgengeergcncergenemuttipulmrytuftcellledgenertiSCLC-liketumexpPOU2F3TheeuniquegeneticmodelllowuexplobiologiclquetiwouldweimpoibleughumncncercellleSpecificllywevetigte)whichpecifictumgenotypepermivemgtuftcellcrcomb)whichtumgenotypedrivelegeplticythctextprticulrlytrnitweentuftneuroendocftec)howcyxicchempyelectpecificcellulrtteettgtuftcellcrcomThethirdAimthpropoleekunderttuftcellidentyncquidttedrugtncemechnmprottedenocrcomWehvedevelopedmethodprogrmmgcrcomtuftcelltteugPOU2F3/OCA-Tco-expiwhichwecpteRpidCPmodelprottecncertudyimpcndeeprogictrtitnceCollectivelyerchoutledthpropoldvnceourfundmentlundertgbiologyrpeuticvulnerbiliePOU2F3+humncrcomABSTRACTByhrnegpowerimmuneytemttckcncercelldoptiveTcellrpy(ACT)holdtmendoupotentilovercomelimtitrdilcncerrpieprovidemoeffectiveperlizedttmenptiptientHowevereffectiveneACThdedTcellexhutidepletitemcellmemyTcell(TSCM)highlightgneedimproveTcellphenotypeIneverlACTtrilpoivepewecloelylkedpecifictrncripmicepigeneticprileCD8TcellubetmnufctudTcellproductEpigeneticprogrmmgexhutedcellhenwidelypotultedpromgtrtegyimproveACTwecurntlylckknowledgewhichgeneepigeneticprogrmmnipulteOurlg-termgolimprovecncerttmenutcomethroughepigeneticprogrmmgimmunecellToccomplhthgolwehveemblednexperiencedmultidciplrytemlevntexperteddcricltechnologiclchllengedevelopnext-genertiACTTheoverllobjectivethprojecttrnlteepigenomeedgtechnologieenblenext-genertiACTthroughprogrmmgcriclepigeneticnodegoverncomplexTcellphenotypeThecentrlhypodcoverytrgetedperturbticriclepigeneticnodecnimproveTcellfunctumctrolWeccomplhourobjective1)priizgledtrgetvihigh-throughputepigeneticperturbtiprimryhumnTcell2)identifygkeytrncriptifcrncodggulrygidrivgTcellexhuti3)vetigtgcomdeffectmtergulryfcrcomplexTcellphenotypeThpropolnovtivecuetrnltecentdevelopmentepigenomeedgtechnologiehigh-throughputtrgetedepigeneticcengdeveloppcerventiddfundmentllimtieffectiveACTCollectivelythwketblhfrmewkepigeneticengeergprimryhumnTcellprovidgightTcellgultidvncgdevelopmentnenhncedACTpltmPROJECTSUMMARY/ABSTRACTWhptienttummlignntcellurroundcomplexdynmiccollecticelltypewhichcludetrtumlmicrobiotHoweverfundmentllckundertghowmicrotummicroenvirment(TME)tercthumncompenttumhowymightctriedeeprogipentgignificntbrrierprogComprtivemicrobiomenlyhvelednenrichmentdtctvivebcterilcommunietumtuecompddjcentnmltueLrge-cleepidemiologicltudiehvedemtrtedignificntcltitweenhightrtumllodpecificcomicrouchFuobcteriumnucletumcoloctlcncer(CRC)deelpepourvivlYetwhilepn-cncertum-tuemicrobiometudiehveexpoedpervivepencetrtumlbcterilcommuniemotcncertypemotetudiedtehvecentedbulktuemoleculrnlywhichobcuptildtriiloclizedimpctmicrobiottumMytemcentlydcovedvibletrtumlbcterihveheterogenoudtriihumnlCRCtumwheymbcteril-colizedmicriche(BCM)TheeBCMmetbolicllyctivedomtednerobicbcteriumFuobcteriumnucletumchrcterizedmyeloidcellfiltrtiupgultiimmunecheckpotprotePD1CTLA4Lg3ducedT-cellfiltrtiIntrtumlheterogeney(ITH)ocedphenotypicdiverificticellulrubpopultiTMEmmjfcrcncerprogirpytnceInderunderthowTMEctriecncerprogtmenttnceimpertiveweeterctillcompenttumecoytembothmmmlinprokryoticThecentrlhypothpropolBCMtumctrigITHmodultgcncercellfunctiwellfluxptildtriiimmunecelltypecolizedtumgiInAim1undertfocltumdtriiBCMirtrom-immune-tumcellptilterctiwepropoefunctillympcellulrmetbolicfetuBCMptienttumtue-uInAim2wedeletehumncelltypeptienttumhrbtrcellulrbcteriidentythoetrcellulrbcteriirimpcnhottrncriptilprogrmtglecelllevelInAim3ugnimlmodelytemweeekexmerolecomicroFuobcteriumnucletummodelgcellulrcompentTMEMytemhbdthexperienceccomplhthprojecteekpplymulti-omicpprochedeletemicrobilhotterctiTMEOurgoldvncemechnticundertghot-microbiotterctiTMEpotentilvelnovelpprochecncerpventttmentABSTRACTN-HpnicBlck/AfricnAmericn(AA)dividuldevelopn-mllcelllungcncer(NSCLC)5yererlierthnirn-HpnicWhe(NHW)counterprtAAlohvehigherlungcncercidencemtlyrteTheroletructurlrcmdevelopmentmtennceedpriehenundertudiedOurlg-termgolchievehelthequyNSCLCthroughvetigtinefAAcommunyTheobjectivethpropoldetermeimpctrcm-ltedocio-envirmentlfcrcludgirpollutiidentileggtimutgenicproceNSCLCtumAAptientThecentrlhypomeurbletructurlrcmtducechngemuttilproceenegtivelyimpctdeeprogiAAptienterly-tgeNSCLCOurtudyrtilegenomicdtAANSCLCpecimenlckgwhichhderundertgdeeetiologyproghvulnerblepopultiFexmplely821053ptientTheCncerGenomeAtlptedidentifygAfricnAmericnInddiimpertivedetermeextentwhichrcm-ltedocio-envirmentlfcrffectdtriimuttiligntuNSCLCtumAAptientderidentifypecificpthwylkgtructurlrcmtweoutcomeyieldtrgetterventibiomrkerrktrtifictiWepropoeurvey200AAptienttgeIIINSCLCidentifiedCliniGegiCncerRegtrie100AADetrodetermeirexpoutructurlrcmtwhichwecltedtwhole-genomeequencg(WGS)irtumtueOurim(1)determeextentwhichexpoutructurlrcmovertimelkeddiffenceNSCLCtumevolutichrcterizgtypemuttiderircquictivymuttilprocee(2)defeeffecttructurlrcmterlycurnce(2yerurgery)tgeI-IIAANSCLCptient(3)determedtriigenomicnever-mokgAANSCLCcompdSherlock-LungtudyifthdtriiffectedttetThnovtivetudyefirtueWGStumevolutigeoptilnlytechniqueidentifyculpthwylkgtructurlrcmtmutgenicproceeNSCLCprovidgmuch-neededtegrtiocilciencemoleculroutcomeWeexpecttructurlrcmtducediffencetimgdrivermuttidevelopmentpromoteerlyNSCLCcurnceThtudyelucidtehowrcm-ltedocio-envirmentlfcrffectAANSCLCbiologywhichexpectedvelmechnmunderlygdprterce-bedNSCLCoutcomeultimtelyledgidentifictinewtrgetdevelopmentnovelterventiducehelthdprieProjectSummry/AbtrctHewepropoetudycnceretiologyctextDNAdmgecuedmethyltggentN-nroodimethylme(NDMA)probblehumncrcogenhenfoundwterfooddrugNDMAbothmutgenicxicouroverridghypobiologiclcequencehpedterctimgthepirpthwydictverlmmtchpir(MMR)homologoucombti(HR)OnekeyDNAleictedNDMAO6MeGwhichmpirdilythymeThedictverlproteO6-methylguneDNAmethyltrnfere(MGMT)movefendgmethylgrouprgtructuguneIntetglyO6MeGcncomexicwhenctedupMmtchRepir(MMR)lthoughunderlygmechnmmfullyelucidtedvivoNmllyMMRcognizemmtchehdplictikmovenewlyynizedtrgivecellnchncetccurteplictiInceO6MeGhenpoedMMRmovetroppoeleimggletrgpupubequentplicticyclecomebrokenk(iedoubletrbk[DSB])quiHRpirDepepvlencethmodellertuepdictedproceehveenlrgelyuntetedvivokeygplertuddedprtugn-houegeneticllyengeedmouemodelnmelyRDRwhichHRyieldfluocentignlAndvntgeRDRcnlouedlegetrcgwhichmkepoiblemircllexpniUgRDRmicewemdemrkbledcoveryMGMTtrglyuppecllexpniOuroverridghypoMMRpromotexicyflmmtiprovidgelectivepucllexpniSpecificAim1tetMMRmodelmeurgplictidependenceDSBHRelucidtepoibledependencetwocycleplictiwhichwouldctentgp-drivenkbkdownSpecificAim2quntifycllexpnileverge2-phmicrocopywhole-gn3DimggclloutgrowthpeerclloutgrowthviptiltrncripmicvelunderlygmechnmcllexpniSpecificAim3quntifyimpctMGMTMMRirterctiNDMA-ducedflmmticncerliverThepropoedwknlyelucidtewywhichterctimgDNApirpthwymodulteuceptibilyDNAdmgeloefirttudiehowDNApirhperkcllexpnifundmentllyimptnttepcrcogeneTogeretudiehveignificntltgimpctdvncgourundertgmoleculrcehpedeeimptntimplictipublichelthclicABSTRACTOnegtetdvncepedricbrtummngementhencptummoleculrfdgdignoprognotictrtificttmentptientBecuetmenptioutcomeptientpecificlterticludgtructurlvrint(SV)ultgfuihvegtlyimprovedHoweverdepemultipleerchtudiehowSVimptnttumdevelopmentmtennceprogicliclnlyegenerllylimedtrgetedgeneequencgpnel(DNA+/-RNA)trgetedfluocentuhybridizti(FISH)ThtypetetgufficientbrtumhrbclicgenomicltertidequtetumhvetypiclhlogiclmoleculrrrtitentimeultgnegtivegenomictetgInddiomeetethvelgturnroundtimeledgdelydignottmentWegtneedclicltetllowmoccurterpiddcoveryclicllyignificntSVcnuedlgequencgctettmentplnmximumnefOpticlGenomeMppg(OGM)promggenomictechnologycnhelpfillthmoleculrdignoticgpOurplimrydtutilizgbout60pedricbrtummpledemtrteutilyOGMidentifypvioulyknowndignoticSV(ieBRAF-fui)crypticSVwenotidentifiedclicltetnovelSVhveneverendecridpedricbrtumAlthoughnovelfieldpedricbrtumOGMguedclicllyCLIA/CAPcertifieddignotictetFciocpulohumerlMuculrDytrophy(FSHD)dderpvioulyquidournblottgdignoMocentlyAugutUniveryPthologyDeprtmentubmteduccefulLbryDevelopedTetpplictiOGMdignotictethemlogicmlignncieAmericnMediclAociWepropoeimplemenpticlgenomemppg(OGM)firtledignoticpprochpedricbrtumcliclettgutilizeOGMdcovergenomicSVpotentilclicllevnceThtudyfirtgenertep-cliclevidencebrtum-drivggeneticlterticnrpidlyidentifiedugOGMpotentilguidecliclttmentplnchildnetumByendtudyperiodOGMvlidtedCLIA/CAPcertifiedlbrie(ChildnNtilHoplPthologyBinoLbrieAugutUnivery)lbrydevelopedtetpplictiubmtedpendgpromgultThtudyloutilizeOGMdcoverynovelpthogenicSVlrgecohtpedricbrtummplewhichmyuedimprovedignollowtteroutcomepdictiultimtelydvncerpieffectedchildnbrtumTheultthtudyhvedictimpcncliclcoutquirgclicltrilAlthoughthtudyprimrilyfocupedricbrtumOGMcnloppliedtumtypeexpgrpeuticpoibiliechildndultdignoedecncerPROJECTSUMMARY/ABSTRACTMuttiocrtedehydrogene(IDH)enzymehllmrkvrietydedlycncercludgcutemyeloidleukemi(AML)gliomcholngiocrcomchdrorcomTcelllymphomMutntIDHenzymedrivecncerthroughnunuulmechnmyproducemetboleclled2-hydroxyglutrte(2HG)pogeneexpimcherylockmlignntcelltemcell-liketteDrughibmutntIDHenzymeducedurblecliclpeomeptientIDH-mutntcncerledgFDApprovlAMLcholngiocrcomHoweverdepeneruniverlhibi2HGproductioverhlfptientdotpdIDHhibirEvenptientwhoillypdIDHhibirmoteventullycquitncedrugWhilemechnmtnceIDHhibirmcompletelyunderodemerggevidenceuggetcquipecificco-occurrgmuttidurgtumevolutiultlodependence2HGTheeweneednewttmentpprochetrgetIDHmuttidiffentwyydimplehibienzymeWepvioulyidentifiednunuulptterntncemuttidimerterfcemichdrilIDH2wheyoccurtrn(llele)ltive2HG-producgctive-emuttiHewehowctrttrnmuttidrivedrugtncecedexpidimer-terfcemutticctive-emuttiultedmichdrildyfunctiimpidgrowthleukemicellBiochemicltructurltudiedemtrtedcdimer-terfcemuttienbledIDH2rrntlyueNADHnddilccrdrmticllyenhncedproducti2HGSeekgexploxicyexertedcdimer-terfcemuttiwepermedchemiclcenidentifiedmllmoleculecpblemimickgthrrntenzymticctivyelectivexicywrdIDH2-mutntleukemicellThuwehypoizehyperctivti(rrthnhibi)mutntIDHfernunexpectedeffectivenewtrtegytrgetIDH-mutntcncerThhyporigoulytetedtheSpecificAimAim1ueenzymeytructurlpprocheelucidtebiochemiclbmutntIDH2hyperctivtiAim2employvrovivocncermodeldefemechnmxicyrghyperctivtimutntIDH2Aim3utilizebiochemiclfunctilpprochedetermeifpprochhyperctivticnppliedcyolicIDH1muttiThepropoedtudiehpeourundertgcogenicpropertie2HGbiochemtryneomphicIDHctivtiMofundmentllythwkdemtrtefeibilynentilynovelhyperctivtipprochtrtegyhrnecogene-mededxicycouldppliedwiderngecogenecncerctextInthprojectweimtrnltefluo-19(19F)MRItechnologyvulizetumocedmcrophge(TAM)burdenptientcurnthedneckqumoucellcrcom(HNSCC)HNSCCixthmotcommcncerwldwideTAMtencompignificntvolumefrctummhighTAMburdentummicroenvirmentocedporpeuticprognoInHNSCCptientdevelopglocogillycurnrmettticdeenti-PD-1ntibodycheckpothibirrpycurntlytrdchoweverpertempo(~20%)TAMhveenocedimmunouppiT-cellexcluiwhichocedlowpertecheckpothibirThunurgentneedbiomrkerprocnn-vivelymirTAMclicltrilhelptrtifyptientrtillyoptimizerpeutictrtegieTowrdthgolwepropoetrnltgft-clergperfluocrb(PFC)nnoemuli19FMRItrceryTAMvivoFollowgtrvenoujectiizemphologynbiologicPFCnnoemulidropletmkemuceptibleendocyphgocyticimmunecellprticulrlymcrophgeTheulledcellccumultetflmmryleiultg19FMRIhot-potcnquntifiedwheignllerlyproptilmcrophgeburdenInuPFCmcrophgellghenuedmultudepcliclflmmtimodelcludgctextTAMHowevernojectblecliclPFCnnoemuliimgggentproductextdepeprovenpecificyfetyecompoiBuildgthwkpropolhtheSpecificAimAim1PerfluocrbNEmultiThimidentifyledmulticollbtectrctmnufcturggniztiproducenovelnnoemulicompoi(TAM-Sene)tlercleublePhe1trilAim2SfetyphrmcoketicbiodtriigenoxicytudieWepermvivoGLPtudieTAM-SenetwimlpecieevlutephrmcoxicologyclernceprilefollowgtrvenoujectiwellvrogenoxicyyAim3ClicltudieWecductpilotclicltril(N=12tl)imgeTAMcurntHNSCCptienttUCSnDiegoprtmentnti-PD-1ntibodieTheendpotclude(i)fety(ii)ementppntTAMburdenbiomrker(ieF-m/tumvolume)vi19FMRIhot-potquntttummWeexplopdictivetngth19FMRIfdgveruPD-L1CD68(mcrophge)immunotgbiopiemeptientMooverwepermexplrynlyecltgTAMburdenclicloutcomecludg6-mthprogi-feurvivl(PFS)objectiveperte(ORR)Thpilottudygenerteimptntfetypro--cceptbiomrkerdtneededupptdequtelypowermodefivefututrilABSTRACTChildhoodcncerurviv(CCS)experienceerlyethigherburdencrdiovculrdee(CVD)compdcommunyctrolSuchhelthdprylrgelyttriblecncerttmenttyounggeWhilecedrkhighburdenCVDmgCCShveendecridextenivelyltlemtivilblemechnticvetigtiillumteculpthwyledgcncerttmentexpoudevelopmentCVDTotterundertpthogeneCVDnurgentneederchemployntegrtedpprochunrvelfluencecomplexterplytweenprirpeuticexpouheredgeneticuceptibilymodifiblehelthhviIncurntgrntpropolwefocuevencommcrdiometbolicoutcomecludgfivemodifibleCVDrkcgcdi(bnmlglucoemetbolmoyhypertenihypertriglyceridemihypercholeterolemi)twooutcomeend-gndmge(crdiomyopthymyocrdilfrcti)mgggCCSOurerchfrmewkddrolegeneticepigeneticocicrdiometbolicrkctextcncerttmentexpoupot-ttmenthelthhviSpecificllywechrcterizerpthogenic/likelypthogenicgermlevrint(PGV)geneDNApirimmunepeepecillyflmmtipepthwydrugmetbolmevluteocitweenPGVcrriercrdiometboliccdiwhiledjutgcommgeneticvrintexpedpolygenicrkco(PRS)WevetigtevriDNAmethyltihenceltedgeneexpimechnticlktweenexpou(cncerttment/helthhvi)crdiometboliccdiFurrmowetegrtemultipleggbiomrker(cllhempoieleukocytetelomelengthepigeneticge)evlutemddilpdicrcrdiometbolicrkOurtudylevergegulrourceStJudeLifetimeCoht(SJLIFE)thetimepotlgudltudydeignnovelfdgvlidted/plictedmgurvivChildhoodCncerSurviv(CCSS)cohtOfnotemulti-omicdtgenertedthtudynlyfulfillpecificimthpropoedprojectlollowugenertefunctilgenomicdtbeencompgmethyltiqunttivetrlociexpiqunttivelociexpiqunttivetrmethyltiThfencedtbehvemengfulimpcnfutugeneticgenomictudiecductedCCSTkengerwevetigtebothntu(ieheredgenetic)nurtu(ieexpoome)comphenivelyevlutelcpecrdiometbolicrkfcr/pdicrCCSTheuccefulcomplethprojectprovidetrnltilpthwywrdurveillnceterventitrtegieimprovementurvivhipcwellgenertenewhypoefutubiccienceerchPROJECTSUMMARYEndometrilcncermotcommgynecologiclcncerUnedSttecuemothn12500dethperyerrgcidencemtlywelldeclg5-yerurvivlrteTypeI(endometrioid)tummkeup85%llendometrilcncercevtmjyetumexpetrogenceprlph(ER)AlmoteverymjrkfcrendometrilcncervolveexceunoppoedetrogendictgetrogenignlgthroughERcricldriverendometrilcncerprogiDepeclerimptnceetrogenignlgendometrilcncernimlmodeldicteexceetrogennotufficienlticueendometrilcncer98%humnendometriltumhrbtleneomticmutticommlymuttedgeneARID1AethoecommlymuttedgenehrbgmotlytrunctgmuttimjyendometrioidendometriltumtrtehigherendometrilcncerthnnycncertypeARID1AmemrcniclBAFnucleoomemodelgcomplexcomplexterctERbedlertuourdtTheloARID1AendometrilcncercellcouldhveeverleffectetrogenignlggenegultigenerlcludgncedimptnceARID1Bn-cniclBAFcomplexvrintTheechngemyctedtctvulnerbilieARID1Altedetrogen-piveendometriltumInthpropolweexplomoleculrphenotypiccrotlktweenetrogenignlgARID1AltertiwhiletkgdvntgeouruniqueourcecludgpurifiedcompleteBAFcomplexcollectiendometrilcncernmlendometrilmodelInpecificim1weprobiochemiclcequenceARID1AloBAFctivycrumentERInpecificim2wenlyzegenome-widegenegulticequencecomdARID1AltertictiveetrogenignlgInpecificim3welookuniquevulnerbilieARID1AmutntERctiveendometrilcncercelluggeneticphrmceuticlpprocheTheuccefulcomplethprojectgtlyenhnceourundertghowARID1AltertiwkgeretrogenignlgpromoteendometrilcncerhpotentiluncovernovelttmenttrtegiedepertelyneededthdeePROJECTSUMMARY/ABSTRACTAmgdividulwhourvive5yercncerdignocrdiovculrdee(CVD)ledgcuedethBlckdultcncerhvetwicerkpoCVDoutcomeWhedultcncerThdpryprtillyduehigherCVDpvlencemgBlckgenerlpopultigtercidencecrdio-xiceffectcncerrpiemgBlckwehypoizeocildetermnthelth(SDOH)(eg-leveltructurlrcmdividulocio-ecomicpoi)lopibleBlck-WheCVDdprieWehvehownhvg1dvereSDOHceerkcncermtlyBlckmolikelyhve2SDOHthnWhe(44%v24%)Aprtcncer1SDOHceerkcryhertdeetrokehertfiluUnderlygmechnmSDOHledCVDdpriecncerurvivnotwellunderodStructurlrcmhpolicyimplictiundertgroleBlck-WheCVDdpriecnpotwyolutiducedprieWeueWldHelthOrgniztiCommiSDOHfrmewkvetigteltihiptweenSDOHCVDoutcomeBlckWhecncerurvivTheobjectivethpropoldetermeroleSDOH(tructurlrcmdividulocio-ecomicpoi)CVDoutcomemgcommuny-bedcoht8000mlefemledultcncerWeeeklevergenovellktweendtREGeogrphicAndRcilDprieStroke(REGARDS)tudycncergtrieVirtulPooledRegtryCncerLkgeSytem(VPR-CLS)REGARDSntilpropectivelgudlcohttudycrued30239Englh-pekgdividultlet45yerge48ctiguouUStte(42%Blck55%femle)2003-7followprticipntdyTheVPRcodtedNthAmericnAociCncerRegtrieclude45gtriecoverg95%USThenovelcombtidtourceleverge-leveltructurlrcmmeudividul-levelmeuocio-ecomicttucncerbiologicfcrhelthhvielf-rtedhelthexpertdjudictedCVDoutcomedetermemgcncerurviv1)ocitweenSDOHCVDoutcome2)rolecncerbiologichvilpychoocilfcrltihiptweenSDOHCVD3)rolecncern-cncerheltherviceueltihiptweenSDOHCVDOurlg-termgoldeveloptrtegieelimteWhe-BlckdprieCVDoutcomecncerurvivWehveembledmulti-dciplrytemexpertCVDcncerepidemiologyheltherviceerchcrdio-cologybiottticSDOHtructurlrcmTogerwegenerteevidencemdevelopterventielimteBlck-WheCVDdpriecncerurvivhipPROJECTSUMMARYPerinelcrcom(PC)dedlietmcoloctlcncer(CRC)gtriccncer(GC)mettmedinurvivl10-18mthCRClethnthGCPCcommmmettbothCRCGCechncidencetween1050%UntuntelyfewttmentvilbleextlrgegilethnicdprieechedeeemphizgneedcederchdevelopgimprovedrpieThdevelopmentlowedbencepproprevromodelgpourknowledgehowmettoccurOurpplictifocuedimprovgthutiHewepropoechrcterizeutilizecently-developedvroPCmodel(VculrizedMicro-PerineumVMP)uerpeuticdevelopmentolThemodelbedourvculrizedmicro-tum(VMT)pltmmicrophyiologiclytem(MPS)llowdicbervtilivgcellprolifertgmetbolizgmigrtgdygcomplex3DenvirmentThpplictipeFundgOpptunyAnnouncementPAR-22-099tledCncerTueEngeergCollbtiveEnblgBiomimeticTue-EngeedTechnologieCncerReerchttedgolwhichupptdevelopmentchrcteriztitte---rtbiomimetictue-engeedtechnologiecncererchIngenerlytemiclly-deliveddrughvenotenepecillyeffectivegtPCmucherlygrowthoccururfceperineumomewhtdtntunderlygbloodveelohrdtrgethighdoedrugMotptientnowceiveneodjuvntytemicrpyfollowedcyductiveurgeryhyperrmictr-perinelchemoperfui(HIPEC)whichhultedgenerlceptienturvivlDepethimprovementmotptienttilldevelopcurntdeelethnyermjydieduedee5yerHencehugeunmetneednewimprovedrpieptientPCpurpogdrugpprovedcncermightpromgpprochOurhypoAmicrophyiologiclytempltmcnuedhelpidentifyimprovedrpieperinelcrcomTotetthhypowepuruefollowgim1Chrcterizedul-tuepltmmodelperinelcrcom2CltepltmpermncevivodtpropectiveCliclStudy3TetdrugeniviePCtumVMT/VMPProjectSummryAdultdiffuegliomhrbmuttimetbolicenzymeocrtedehydrogene1(IDH1)commyoungerdultuniverllyevdecurntggiverpiemlethlOurtemledCo-PIDrChillWkimohveidentifieduniquemetbolicdependenciecombrilrpeutictrtegieIDH-mutntgliomWehvefoundpoly(ADP-riboe)polymere(PARP)ctivtiducedlkyltgchempeutictemozolomidecnrpeuticllyexploedhibiPARbkdownenzymepoly(ADP-riboe)glycohydrole(PARG)ultgrrntPARccumulticttrophicNAD+depletiInprllelPARPtrppghibihenfoundynticlethlIDH1muttiexplogplicti-tmechnmcvergentBRCA1-mededhomologou-combtideficiencyHoweverytemichemlogicxiciehvelimedPARPhibirdoggliomptientTheegolourR01pplictidectPAR-drivenignlgpthwyIDHmutntgliomprovidgmechnticundertgmlignntgliomcellmedirenivymximizecncercelltrgetgmimizeytemicxicieultimtelyccelertgtrnltilbrydcoverieclicFoclrdirpyprttrdcgliomnenhncementnunmetneedRdiloferopptunyovercomeytemicxicieocedTMZ-bedcombtirpieAim1determehowrdirpy-ducedDNAdmgePAR-yltico-opertePARGhibiIDHmutnttummodelvrovivoEmployggeneticphrmcologiclhibiPARGwedetermerpeuticeffectmoleculrmechnmPARGhibipcliclmodelgliomMechnticllyPARignlgctivticndrivemultipledowntmmoleculrpthwycludgNAD+depletiplictitDNAdmgeAIF-MIF-drivenprthnllwhichcnctriecelldethAim2determewherignlgdowntmPARpolymerdictlyctriecelldethfterttmentlkylrPARGhibiundertmoleculrbcombtiTMZPARGhibiOurgogerchhveledgenoxicy-triggedrrntPAR-yltiperturdDNAplictitcheckpotignlgIDH-mutnttummotivtguvetigtebilypotentelectivecliclDNA-PKchibirdblerdi-ducedplictitpeAim3TheuccefulcompletiepecificimopennewvenuetrgetgpecificvulnerbilieIDH1mutntgliomdrivgpotentilcliclrpieptientetumProjectSummry/AbtrctFtigueterfencectiviemoodcogniemotpvlentdtgccerndvncedgtrotetlcncerptientAftigueterfeptientfunctigfmilycgivertenptfeelgburdenedcgpibilieEvidence-bedterventiddgcncerptientftigueterfencecgiverburdenlckgInpilottudiecceptncecommmentrpy(ACT)hhownpotentilducgympm-lteduffergcncerptientWecentlycductedpilottudytetgnoveldydicACTterventiptientfmilycgivercopgdvncedgtrotetlcncerTheterventicomcceptncemdfulneexerce(egmedtipermgctiviegterwne)identifictiperlvlueenggementctiviectentevlueThtelephe-bedterventihowedtrgevidencefeibilycceptbilypromeducgptientftigueterfencefunctigcgiverburdenThepropoedpheIItrileekmodefivelyexmeefficcyourtelephe-bedACTterventidvncedgtrotetlcncerptientmoderteeveftigueterfenceirfmilycgiverignificntcgivgburdenInril244ptient-cgiverdydromlyignedequlnumreirACTterventineducti/upptctrolcdiDydbothcdittendixweekly50-mutetelepheeiTheprimryimthtudyteteffecttelephe-delivedACTptientftigueterfencecgiverburdenSecdryoutcomecludeptientleepterfenceptientcgiverenggementdilyctiviequlylifeOutcomeeedtbele2weekpot-terventi3mthpot-terventiThtrilloexmewhercepychologiclflexibilydefedfullwnepentmomentwhilepertgctilignedperlvlueccountneficileffectACTprimryoutcomeDemtrtgACTefficcyupptdopticncercThtrillolygroundwkfurrpplictetgACTwiderngeptientcgivercopgeriouillneefunctiloutcomePROJECTSUMMARY/ABSTRACTSmllcelllungcncer(SCLC)pulmryneuroendoccncerverypoprognolimedeffectiverpeuticoptiChempyhenuedpt30yerttmentSCLCWhilemotSCLCillypdtmentnerlylllpeRecentlyimmunpiehveentroducedSCLCttmentWhileettmenthvevolutiizedttmentn-mllcelllungcncer(NSCLC)ylyeffectiveverymllubetSCLCThcicrdicommendedcourebothlimedtge(LS)extenivetge(ES)SCLCRdihenhownducedurblepeengggnti-tumimmunyHoweverrdirpywhileeffectiveomedividuldoenotlwycvertimmunologicllyn-pivecoldtumcomeimmunepivehotTheeobervtihighlightneeddevelopneweffectivettmentSCLCInmnycncerlocellcyclecheckpotgercogenectivtiledcellurvivlevenhighlevelplictit(RS)DNAdmgeCellulrpthwypdRSenuDNAproperlyplictedpventcellpmtulyentergmiHowevermotdvncedolidtumncevrietyerrdurgDNAyndruptiDNAdmgepemiccttropheThctuouhighdegeRSdependenceDNApirprovidepotentilcncervulnerbilyrpeuticopptunyThevtmjyhumntumcludgnerlyllSCLCdependenntelomereholoenzymepplictiveenecenceultgtelomehtengechcelldivhctedependencyWepropogutilizemoleculeterfefunctelomererpidlypSCLCgrowthmimlnocyxicideeffectnmltelomereilenttueInourplimrytudiewedcovedthmoleculenlycnkillcncercellcultudhcnloctivteimmuneytemwhengiventermtentlymiceWepropoedcoverhowthmoleculeenizeSCLCrdichempyttment(Aim1)Induceimmunepe(Aim2)determewhercnovercometnceextgttment(Aim3)FthgolweutilizefullyimmunocompetentmouemodelTherpiectivteimmuneytemhveenlexiccompdttmenttenprovidemodurblepeptientWehopethurtudiethmoleculegenertemtideveloprtillydeignedclicltrilwhichutilizecombtimimlxicymximumrpeuticefficcymllcelllungcncerProjectSummry/AbtrctBturgehveenhighlyuccefultdeimplementgomelow-vlueurgiclcleuccefultdeimplementgcpfence-eniveSentellymphnodebiopywomen70yerge(SLNover70)ctrlterlprophylcticmtecmy(CPM)hveendeemedlow-vluentilurgiclocietieHoweveruehmedunchngedevencedovertimePtientfquentlymotivtedpurueeoperticueperceivedprognoticvluemimizefutucncerrkHoweverwhileSLNover70CPMhvenoimpcnurvivlymyhveubtntilnegtiveimpcnpychoocilphyiclfnciloutcomeSurgeendeeopertihouldnotroutelypermedlocknowledgeperceivednefproceducnoutweighpotentilrkomewomenAcriclgpwrdupptgdeimplementtilow-vluepfence-enivecourundertghowdecimdeptient-urgeterctiBydictlytudygptterncvertioceddeimplementtiwecnundertwherptientpfencedrivgttmentplnwhtolmyhelpurgeupptptientecvertiInnR01fundedtudy(NCT03766009)weudio-cded594urgiclculttircillyocioecomicllydiveremplebtcncerptientcdtcdemiccommunycentercroUnedStteTheeculthveentrncridctentctegizedTheobjectiveuethnoveldtetundertltihiptweenwhturgeptientydurgculthowdeimplementtideciSLNover70CPMmdeWehvetheimAim1tetocitweenpermncehddecimkgdeimplementtipfence-enivelow-vluecAim2identifyptternurge-ptientterctioceddeimplementtipfence-enivelow-vluecAim3developcvertiguideuppturgedcugpfence-enivelow-vluecThR21tudygenertekeyundertgbouthowdecideimplementpfence-enivelow-vluecmdeptient-urgeterctiBycombgourightextglertuurgeptientttudeliefwedevelopmulti-fcetedtrtegyupptdeimplementtipfence-enivelow-vluecwhichcnntetedfutuR01tudyPROJECTSUMMARYTrncriptifcr(TF)mtergulrgeneexpihveenimplictedmnydeettecludgcncerOfebichelix-loop-helix(bHLH)MYCTFfmilymemrnioudrivercogenicexpiprogrmimplictedpproximtely70%llcncerTFfluencegeneexpibdgircognteDNAequencecrugppropretrncriptilmcheryctivtehibgeneexpiAlthoughTFwell-vlidtedtrgetcncerrpeuticfetulentuprote-proteprote-DNAterctiquidirfunctitnttrdildrugdevelopmentpipeleIndeedomemllmoleculehibirbHLH-TFprotehveenptedirlowpotencyunclermechnmctihvetlledirtrnlticliclueToddthchllengewehvedevelopedpltmfullyynticmodulrTFmimeticOurpprochemploytrtegicchemicltbiliztipeptideecdrytertiryquternrytructuyieldyntictrncriptilp(STR)cpblebdgtrgetDNAequencehighffypecificyTheilclSTRderivedbHLHproteMAXhibMYC/MAX-DNAbdgblockMYC-drivencogenicphenotypecellBuildgupeplimrydtthpropolimexploexpnovelSTRrchectuvlidteledSTRcpbleoppogcogenicgeneexpiprogrmphenotypenimlmodelMYC-drivencncerOurexperteynticchemtrybiochemiclprilgTFfunctiwellouretblhedcollbtilederfieldepigenetictrncripmicprilgvivoimgglevergedervicefollowgpecificim1)tructurlbiochemicloptimiztihypertbleultrpotentSTRtrgetgMYC2)enhncgcellulrphrmcologicdeliverySTRcoupledqunttivemppgSTR-progrmmgepigenetictrncripmiclcpeMYC-dependentcncercell3)evlutiledSTRvivomodelbothMYC-dependentolidtum(neuroblm)liquidcncer(lymphom)SuccefulcompletieimgenertepotentpecificphrmcologicllytenbleSTRpriizemfurrtudyMYC-trgetedrpeuticBeydthdictgolthwkprovidenewightMYC-mededgenegulticnceretblhblueprtdevelopmentSTRtrgetgTF-dependentgeneexpinetwkfutuProjectSummry/AbtrctThpplictifocuedvncedmelnomhighlyggivetypekcncerpigment-producgmelnocytebodyDepecentdvncemoleculrlytrgetedrpyimmunpeuticgentimpivepertemptientwhoeirdotpduchrpiewhoeventullylpeThe5-yeroverllurvivlrtemettticmelnomlow20%ProgivedediffentiphenotypicwchgmelnomcellundercellulrtcidedmjdriverboumprogirpytnceHowevermoleculrmechnmgovernthproceirterplygeneticleitummicroenvirmentpolyunderodTFEBmemrMiT/TFEfmilytrncriptifcrmtergulrcelldiffentipthwyOurplimrytudieidentifiedTFEBpinoveldependencycogene-drivenmelnomprogiWehowedTFEBctivtigloblly-vigtetrncriptildiffentimelnocytewhilectivtiprovokephenotypictrniwrdvivedrug-tnttteocedrrntTGF-bupgultiFurrmotrncripmicimmunecellprilgtumprimrymelnomptientcfirmeddmpenedTFEBexpifunctilocltetumimmuneevivemicroenvirmentTheefdgleduhypoizeTFEB-mededtrncriptilprogrmmgmelnomcelldiffentittepentkeymechnmdblgmelnomprogiwhichlohpetumimmunemicroenvirmentenhncednti-tumimmunyWetethypo(Aim1)defgmoleculrmechnmTFEB-mededtrncriptilprogrmmgmelnomcellplticyphenotypewchg(Aim2)vetigtgdetilvivoimpctTFEBltertimelnomprogiimmuneeviSuccefulcomplethtudyprovidemechnticighttumcell-wchgproceeholdpromedevelopmentnovelrpeutictrtegieverethprocepventielimtummettcurnceProjectSummry/AbtrctAlthoughimplementtenti-bedolhveenfoundenhncecoloctlcncer(CRC)cenguptkepritudiehvenottetedcleirimplementtirouteprimrycdeliveryettgervghrd--chpopultiuchthoelimedEnglhpriciencyOurerchgroupledPrKAGerhdevelopedtetednI2CRCdeci-mkgolvimultipleNCI-fundedtudieItddewhenwhehowdetilcengviolmpletetcolocopyInthtudywecductprllelcluter-romizedtril20clicprticiptgAmericnAcdemyFmilyPhyicinNtilReerchNetwkervgcommuniewhichtlet25%ptientpopultipferdlngugeSpnhSpecificimproject(Aim1)TocompCRCcengoutcomet6mthtweentwoimplementtipprocheourI2ol(1)implementthroughNmliztiProceThey-guidedPrticipryLerngActi(NPT-PLArm)proceveru(2)implementtiuulqulyimprovementproce(ctrolrm)primrycprcticeugprllelcluterromizedtril(Aim2)evlutefcilrbrrierimplementtipprochechtudyrmugNmliztiProceThey(NPT)frmewkMulti-dciplryclic`implementtemcludeclictffptientwhoepferdlngugeSpnhmeetmthlydurgfirt6mthclicprticiptiimtegrteI2olrouteprimrycdeliveryugNPT-PLAterventictrolpprochTheI2oldelivedvin-leRedCpurvey(ifptientpfer)ppermhencumizedueEnglhSpnhWeenrollllptientechcliceligibleCRCceng(mimum100perclic)Primry(Aim1)outcomeCRCcengderplced(clictff)completiCRCceng(ptient)over6mthptientfollow-upfterilexpouI2olAecdryimdetermewhercompletiI2cengolvrietweentudyrmFAim2llclictbelefter6mthclicprticiptiwedmterurveybedNPTctruct(NOMAD)eimplementtemmemrcompheniirroleprojectlienceourterventipprochirbuy-feibilyltergwkflowpotentilutbilyterventiircliclettgWelocductummtivequltivefocugroupdcuillclicimplementtemfter6mthclicprticipt12mthtemlederemtennceKeypernelcludeMultiple-PI(KAGerJLeMterCHeter)KUMCBiottticinBGjewkinterntilNPTexpertAMcFrlneThetudyprovideimptntmtibrrierfcilremddgNPT-PLAterventil-wldprimryccliclettgpromotecncercenguccefullyProjectSummryApproximtely200000newceovrincncer(OC)occurperyerbuverllurvivlhnotignificntlychngeddecdenovelrpieurgentlyneededHighgrdeerouOCmkeupbout70%ceItmotcommlyderivedfllopintuepiliumchrcterizednerly100%mutntTP53highexprnpobleelement(TE)NerlyhlfourgenomecompoedTEirtrncriptightlygulteddurgdevelopmentSelectTEexpedthighlevelembryictemcellmotilencedDNAmethyltipivehnemodifictidiffentedcellAprtgloblepigeneticdygulticellundergodurgtrnmtinmlcncerTEilencgcompromedTEcometrncridRecenttudieourgrouphveimplictedTEctrolnteimmuneignlgOCOurtudiecncerprogimodelhowLINE-1elementloemethyltrncridpecificllydurgcellulrtrnmtirrthnimmtliztiLINE-1lyprote-codgTEknownbletrotrnpoeLINE-1ignificntlyovexpedOCWehowedLINE-1expedfterP53muttiOCpcurleiwildtypemutntP53trncriptillygulteLINE-1OCcellleFllyLINE-1ctivtibenceP53terfeDNAplictictivteDNAdmgepecncercellWeknowLINE-1TEcomectivteddurgcncerprogiwedotunderthowthoccurimmuneeffectthctivtiTheobjectivethpplicthuuncoverbiologiclmechnmwhichepigeneticdygultiLINE-1chngeOCtummicroenvirmentWehypoizeloepigeneticgultiLINE-1ctrieOCimmuneeviWetetthhypofollowgAim1)DetermeeffectLINE-1expinteimmuneignlg2)DetermeeffectLINE-1trotrnpointeimmuneignlg3)DetermehowLINE-1expiffectOCimmunemicroenvirmentUgextgimmtlizedfllopintulewildtypemutntnullP53wetrnmleC-MyccogeneWepermgenome-widechrcteriztiLINEelementdurgtrnmtieeffectLINE-1expiDNAdmgepetumimmunemicroenvirmentTkengerexperimentdecridthpropolddourknowledgeepigeneticgultiimmunectivynundertudied20%ourgenomeLINE-1elementTheeexperimentenbleuidentifypotentilOCdrivgltertivulnerbilienovelimmunpiePROJECTSUMMARYOyphyiclctivypodietmjmodifiblerkfcrcncerledgcuedethmgUSHpnicUSHpnicyouthhvehighetrtepedricoyhowftercebodymdex(BMI)ge12<20yerthnn-HpnicWheMotHpnicdultlocrryexceweightHpnicyouthdultdottenmeetntilguidelephyiclctivydietrytkeFmily-bedterventicnimprovehelthoutcomebothyouthpnthighlylevntHpnicdueculturlvluefmilmo(fmilm)Howeververyfewextgfmily-bedoypventerventiHpnictrgetdolecentirpntthoedotdeignedfciltewidepdchAnunderutilizedpprochpromotghelthyweightttumgHpnicthroughdigl(ieeHelth/mHelth)terventiUSHpnicjutlikelyn-HpnicWheownmrtphemolikelymrtphe-lyternetuerOurtememployeduer-centedpprochdeveloppilotfmily-beddigllifetyleterventiknownHelthyJun(HelthyToger)Thnovtiveix-merventi(the-menivephethe-mthmtenncephe)groundedfmilyytemhvilieefewoypventerventiHpnicdolecentdigldeliveryIttrgetimprovementpntBMIlifetylehvifmilyfunctighelth-ltedpoivepntgprcticementhroughwhichdolecentBMIlifetylechngehypoizedoccurUnlikeextgdiglterventidolecentterventimkepntprimrygentchngepnt-dolecentprticiptemeftthroughhddeci-mkgGivenpromgfdgHelthyJunprimrygolthtudyevluteromizedctrolledtril375HpnicdolecentirpntefficcyHelthyJuncompddiglhelthferrlpubliclyvilblewebepp(ctrol)cdipventgceBMIimprovgmoderte--vigouphyiclctivy(MVPA)dietqulymgdolecentTheimtudyAIM1TodetermewherprticiptiHelthyJunpventceBMI(primryoutcome)improveMVPAdietqulypercentgebodyft(%BFecdryoutcome)HpnicdolecentAIM2ToexmewherwhtextentchngepntBMIlifetylehvimedeeffectHelthyJundolecenutcomeAIM3Toexmewherwhtextentfmilyfunctighelth-ltedpoivepntgprcticemedeeffectHelthyJundolecenutcomeWeloexploleociodemogrphic(egcculturtidolecentexweightttuneighbhooddeprivti)uerenggementmoderrwellmedgeffectdividul-levelctruct(egelf-efficcyunomoumotivti)SummryOverpttwentyyeruepcriptiopioidmgAmericnpopultihchedlrmglevelover17%AmericnugpcriptiopioidnnullyledgdeigntipublichelthemergencyIn2020InterntilAgencyReerchCncer(IARC)clifiedueopium(nturlourcemnyopioid)crcogenichumnbedevidencecugcncerlunglrynxbldderpoiblypnceophguThclifictimjccernhowugpcriptiopioidmylteubequentcncerrkycloelyltedopiumtermircompoimechnmctiPrieftelktweenpcriptiopioidcncerhumnhveenlimedlcktudiepropectivelycollecteddnbothopioiduecfounderuchbccolcoholchrichelthcdiWeedpilotpheOpioidCohtCtium(OPICO)2020overcomeextgmethodologicllimtipplyghighlynovtivemulti-dciplrypprochelevergehrmizedt(1)propectivecohttudie(2)medictidpengcd(3)helthcdtbecromultiplecountrieInthR01projectweextendOPICOlevergehrmizeextgdt19ourcecroUnedStteEuropeAutrlibuilduniqueourcehigh-qulydtmothn17millidividulcludgover385000whouedpcriptiopioidtbeleInddihrmizgdndemogrphiccfoundercncercidenceweuehelthccdeprticipntcombidieuemedictidpengcdeprticipntuepcriptiopioidtbeledurgfollow-upOPICOfirtddhypouepcriptiopioidocedcedrkopium-ltedcncercludglungblddereophgelpncticlryngelcncerAnlyeeltihipdiffentpectopioiduecludgirtngthdurtictypeWeloedoe-peltihipuemultipletrtegieelimtecfoundgdictibFurrmowepplynovelttticlmethodccounpioidoverdoedethvriugpcriptiopioidovertimeWeexpectOPICOdeliverrobutccluiveevidenceltihiptweenopioidcncergenertenterntilourcecnupptfututudieopioidirlg-termheltheffectTheefdgwouldhveignificntimpcndevelopgntilpventitrtegietrgetederlydetectipoliciemigtefutuburdencurnpioidcrAbtrctBtcncermeledgcuedethmgwomenUSWhenvilbletrgetedrpiehveignificntlyimprovedoutcomebtcncerptientUntuntelytncerpielpecommepecillymgptienttriple-negtivebtcncer(TNBC)prticulrlyggivedeewhichlimedtrgetrpyoptivilbleItcomgclerimmunouppivetummicroenvirment(TME)mjobtcleuccefullyttgggivebtcncerTumgrowthocedccumultiimmunouppivecellTMEcugcyxicT-celldyfunctumecpeFurrmotumcellctivteecpemechnmuchtriggergexpiimmunecheckpotPD-L1whichduceCD8+TcellkillgIndeedimmunpeuticgenttrgetgPD-L1immunecheckpotmoleculehvehownmrkbleefficcymetttictumfrcrytrdprocolUntuntelylymllubetptientpdeimmunpieTheenurgentneedimprovedrpeutictrtegieDcovergnewimmunpeutictrgetnovtivecombtiextgrpiettrctiveoptiexpgnefengggimmuneytemgtcncerWedcoveddurgbttumigeneHp90co-chpereUNC45AcomemuclereentilcncercelldivimdpenblenmlcellprolifertiFurrwefounduppgUNC45AmoueyngeneicTNBCtumtriggerdrticprogrmmgimmune-uppiveTMEmoimmune-piveeInddiloUNC45Ahmperbilycncercellpiriizgrdi(IR)-ducedDNAdmgeenizevivoTNBCmodelrdirpyInthpplictiwepropoeUNC45ApromgnovelimmunpeutictrgethibicombtiIRrpyduceTNBCburdenOurSpecificAim1TochrcterizeTMEprogrmmgcuedloUNC45Amlignntcell2TodefemoleculrmechnmwhichUNC45ApromotenimmunouppiveTME3TodetermerpeuticpotentilUNC45AhibicombtiIRrpyPROJECTSUMMARYMlignntpleurlmeoliom(MPM)cncercuedexpouInhledfircomeemddedlglungcughrmfulflmmtipleurultgMPMMotptientMPMdieyerfterdignoMPMquetntrpyMotptientceivetrdchempycplt/pemetxedcombtiwhichlyextendurvivlnvergebout11weekAlterntiverpiehvefiledignificntlyextendurvivluntil2021whenFDApprovedcombtiimmunecheckpothibir(ICI)nivolumbipilimumbnlterntivefirt-lettmentMPMICIhrneptientownimmuneytemfightMPMcncercellICIhveextendedlifeexpectncyomeptientboutfourmthcompdtrdilchempygimenFptienttumlimedeidecheturgiclectichempyhvelgeturvivlOurgroupcentlycompletedfetyfeibletrilwhichwedmtedICInpermedurgiclmovlMPMtumTheptientdidprticulrlywellewecurntlyopenglrgertrilwhichwedmtereirICIchempyICInpermurgeryHoweverdepeddiICIttmenptittmentpelyoccurubetptientlg-termoutcomeptientMPMmpogrdlettmenttrtegyThufdgnoveleffectivetrtegiecerpeuticpeICIcricllyunmetneedAwell-knownproblemttgcncercncercelldeveloptncedethwhenttednydrugAprtcellpibletgttmentmichdriwhichctlikeengeprovidgllenergytumgrowwhileprotectgcelldethInourpriwkwefoundpecificproteMyeloidCellLeukemi(Mcl-1)ttchemichdriprotectdethWhenweueddrugblockedMcl-1chempymichdrinolgerpventedtumcelldeumdiedMcl-1extmelyuntbleultgrpidexpidetructiwhichmkehrdttTheetrgetgprotegulteMcl-1myclicllyeffectivetrtegyInourpriICItrilwefoundpecificpthwymichdriclledmethiemetbolicpthwywcedAprotepthwyProteArgeMethyltrnfere(PRMT)5determewherMcl-1blockcelldethInthpropolwetudywhertrgetgPRMT5Mcl-1drugtumcellenivydrugttmentThelg-termgolthpropolttckmichdriovercomerpeutictnceoptientcntthdeeThtudyhighlytrnltilwerpidlypermclicltrilbedeultThegolthtudyccelertedevelopmentmoeffectiverpieimproveurvivlptientMPMABSTRACTMlignntprimrybrtumpentmotfquentcuecncerdethchildnyoungdultccountmodeththncncerkidneymelnomGlioblm(GBM)unimlylethlcurntrpyn-pecificproducemedinoverllurvivl<21mthMooverptientGBMplguedducedytemicTcellcountductiecdrylymphgncellulrycedmtuTcellequetedmrrow(BM)dyfunctilntigenpenttumdrglymphnodeThcombtiBMequetrtiTcellheterogeneountigenexpiledtumecpeprogiDendriccell(DC)rgtumntigencndelivedvccemigrtedrglymphnode(DLN)triggermtipotenttum-pecificcyxicTlymphocyte(CTL)cpbleerdictgtumwhilelevgnmltueunhrmedHoweverdepedividulcemrkbleptientpentumDCvcctioverllobjectivepeerlypheclicltrilhvemedunder15%Wehvefoundpotdendriccell(DC)vcctibothlg-termurvivlmigrtiDCdependennchemokeCCL3IntetglyCCL3cnenhncemigrtibothexogeneouDCvccelymphnodeendogenouDCttumeSeprtelyccurntlyTcellequetrtiBMloveredCCL3dmtrtiHeweimbuildthdtpclicllydetermeoptimlCCL3doeDCmigrtidetermemechnmCCL3TcellequetrtidetermeefficcyCCL3combtiDCvccenti-heterogeneougliompeWehypoizeytemicdmtrtiCCL3cemigrtibothexogenouendogenouDCmtcedlevelctivtedTcellytemicllyTMEelimtgequetrtiThpropolpromotedevelopmentCCL3novelnti-cncerdrugenhncepotencydiveryimmunepegenertedDCducentigenecpeimprovectroldiffuelyheterogeneoutumAbtrctInterleuk-2(IL-2)nimmunotimulrycykeplycentrlrolentumimmunyprticulrlyctivtiprolifertiTcellnturlkiller(NK)celltumerdictiProleukfirtFDApprovedimmunpydrugcurblepeubetnlkcncerptientHoweverignificntimmune-ltedxiciehthlf-lifedvertentctivtiimmunelerntgulryTcell(Tg)trictwideclicldoptiProleukrpyPleotropiceffectIL-2ctivtibothimmuneuppiveTgtumkillgCD8+TcellNKcelldrovedevelopmentIL-2muteuperkepolrizedffywrdCD8+T/NKcellMoovertumcidyhenhowndectivtewildtypeIL-2whichpurddeignlowpH-tntIL-2muteLgcircultgIL-2hloendevelopedfuiFclbumproteIL-2Depeexteniveeftmotprote-engeedIL-2tillencounterignificntytemicxicielimdoeefficcycncerrpyThelg-termgolthpplictietblhtum-ctivtbleIL-2muteuperkennoprticlentegrtedprdigmIL-2rpyWeimcomnnoprticleengeergproteengeergmimizeytemicxicywhilemtgntumefficcycidictummicroenvirmentInptdecdeourlbventedlibrryultr-pHenive(UPS)nnoprticlecoopertivemicelle/unimerphetrnipepecificpHthholdPlimrydthowUPSdeliverywildtypeIL-2Fcgtlyducedytemicxicie(eg>100-foldducterfer-level)whilemtgntumefficcyIL-2FcOurcollbrDrToYuelbcentlyidentifiedlowpH-tntIL-2uperke20-foldhigherbdgIL-2cepr(R)thnwildtypeIL-2whilemtghighctivytpH64whewildtypeIL-2lotctivyInthpplictiwetetcentrlhypotum-ctivtbledeliveryR-tropiccidy-tntIL-2uperkeultr-pHenivennoprticleeffectivelymkytemicxicynmltuewhilechievgrobutctivticyxiclymphocytetumefficciourpyWecrryoutthepecificimAim1Etblhcidy-tntIL-2uperke-UPSnnoprticletblelodgpH-ctivtbleleeAim2InvetigtefetyntumofficcyIL-2Fcuperke-UPSnnoprticletum-rgmiceelucidtetropmCD8+T/NKcellctivtioverTgAim3InvetigteynergyodiumlcttettmentIL-2FcuperkennoprticlerpyWenticipteuccefulexecutipropoedpplictilednewprdigmterleuke-2rpyimprovedfetyntumefficcyoutcomePROJECTSUMMARY/ABSTRACTPeoblmefmilychildhoodcncercnthroughmuttimicroRNAproceggeneDROSHADICER1ItunknownwheretumdevelopthroughhddtcncogenicpthwynowyrpeuticllytrgetuchmuttiTounderthowemutticuecncerwedevelopedmouemodelpeoblmbltgDrohDicer1developgpelglTheemicedeveloptumemblehumnpeoblmTheyhighlyprolifertiveyexhibnexpiigntuembryicpelglyovexpmicroRNAtrgetgeneAmgmicroRNAtrgetgeneovexpedetumetdevelopmentltrncriptifcrcludgOnecut2FurrmobdgequencecognizedetrncriptifcrenrichedgiopenchromtepeltumInthprojectwevetigteroleOnecut2developgpelglpeltumdevelopmentInAim1wetetwherOnecut2necerytumdevelopmentInAim2wevetigtehowOnecut2terctneurodevelopmentltrncriptifcrInAim3weexplowherONECUT2quidptient-derivedmodelpeoblmIfuccefulthprojectwoulddemtrtemuttiDROSHADICER1cnrtdiffenthroughdevelopmentltrncriptifcrimpirgctivyetrncriptifcrcouldfuturpeutictrtegyABSTRACTHedneckqumoucellcrcom(HNSCC)7thmotpvlentcncerglobllyultg930000newce467000dethnnullyAlgidebccolcoholuehumnppillomviru(HPV)fectictrieHNSCCdevelopmentRegrdleirclicltgeloctietumexhibignificntheterogeneygeneexptmentpeWhileimmunpyhvolutiizedttmentpprochemnycncerimpcnHNSCCmlimedThuggetpectHNSCCtumimmunologycludgroleHPVplyimmunedygultinotwellunderodThuobjectivetherchdevelopvlidteimplementdvncedcomputtiltumphenotypgtechniquechrcterizeHNSCCtmultiplelevelbiologiclgniztiOurpprochvolvehigh-throughputnlyqunttivefetubothrdiologyimge(ierdiomic)diglpthologyimge(iepthomic)genertemultcledepictiHNSCCphenotypeWehypoizetum-pecificrdiopthomicexpiptternHNSCCcnectedfundmentlbiologiclimmunomoleculrproceedrivgrpeutictnceInAim1prognoticvluerdiomicevlutedbothHPV+HPVHNSCCptientttedrdipyprtpvioulycductedpropectiveclicltril(NCT01908504)Chngerdiomicexpifteril20GyquntifiedvidtimiltiPET/CTimggchticmodeltumdynmicInAim2tumimmunemicroenvirmenteptientchrcterizedvipthomicnlySgle-cellterctimeudtweendiffentimmunecompoicompdgle-celltrncripmicdtgmechnticightgenedrivgpthomicexpiRdiomic(Aim1)pthomic(Aim2)echexperimentllycfirmedmechnticllyvlidtednovelcrcogen-ducedgeneticllyengeedmouemodelco-evolventctimmuneytemwhewedectmechnmttmenttnceterrogteimmunedygultimiceptneoulydevelopHPV+vHPVHNSCCInAim3ourcientificfdgdependentlytetedngogpropectiveterventiltudy(NCT04667585)evluterdiopthomicexpipotentilbiomrkerguidedptiverpyHPV+HNSCCCidtebiomrkeridentifiedNCT01908504dependentlytetedNCT04667585providenundevlutiirprognoticvlueThertileetudieenhnceundertgHNSCCbiologyguideimprovedttmentpprochethurgentunmetcliclneedByleverggnovtiverdiopthomictrtegienovelclicltrildtcomplementrymechnticterrogtiourpropoederchnimptntdvncementcomputtilcologypctmentHNSCCWenticiptethurultimproveourundertgHNSCCttmenttncebridgeknowledgegptweenbtrctimgepenttibicbiologyPROJECTSUMMARY/ABSTRACTThegolthpropoltledMirgpeneodjuvntrpyprimryblddercncerughyperpolrized13CMRIdevelopmetbolicimggbiomrkereneodjuvntchempy(NAC)mucleviveblddercncer(MIBC)pvioulyunexplodtrnltilopptunyThccomplhedugnovelqunttivehyperpolrized(HP)13Cpyruvtemgneticnceimgg(MRI)echngeglycolypenti-cncerrpyugptientderivedxenogrftderivedpvioulyunttedtumNAChenocedpthologicpe40%ptientcompletepeup25%ignificnverttmentn-pderIdentifygptientwhochemoenivewouldnlyprovidenefmwouldpunneceryxicypoiblyftldelyrdiclcytecmyptientwhochempytntAlthoughcro-ectilimggcnernemngementptientMIBCtiltggdurgfollow-uphnotenpplieduccefullymirgpeNACLckpecificeniven-vivemenmirpecurntlylimcliclpplictivlueNACMIBCInAim1weemploy6PDXknownpegemccpltmotcommlypcridNACgimenevlutebilyqunttiveimggmrkerkPLppntrtecveripyruvtelctteflectgglycolymirpeidcombrilchempyugHPMRIAim2lygroundwkprovidgbiologiclbvluekPLnimggbiomrkerttmentpetncelopdictivemrkerAddillyweexploblmetbolepthwymtivettmenteffectdevelopcomplimentryimggmrkerfutuGivenrpidlyexpgclicltudieHPMRIpoivepcliclultcnwiftlytrnltedclicltrilPROJECTSUMMARY/ABSTRACTBlddercncer6thmotcommcncerUS4thmotcommcncermleEchyermothn80000peopleUSdignoedblddercncerover17000dieThevtmjy(74%)pentn-mucleviveblddercncer(NMIBC)NMIBCholdetmedingetdignoteniveurveillncequimenthighcurnceprogirte(up80%)egtetlifetimettmentcotllcncerTtmenptifollowgcurncehigh-grdeNMIBCcludeeirBST(bldderprgrpieignificntrkcncercurnce/progi)rdiclcytecmy(life-ltergblddermovlurgeryubtntilht-termmbidymtly)HoweverptientircgiverclicinmutmkethcomplexttmentdecibedlimedevidenceceblddercncererchmunderfundedltivecommcncerblddercncerepidemiologycohtuncommRCThveprovenchllenggcductrktrtifictimodeldequteThucriclneedhigh-qulyerchcurnthigh-grdeNMIBCcrofullpectrumoutcomemttmentdeci-mkgAcentlyetblheduniquecohtcnlevergedddeevidencegpSpecificllyPCORI-fundedComprIntrveiclTherpySurgeryTtmentOpti(CISTO)Studylrgeprgmticmultetudyptientcurnthigh-grdeNMIBCptientwhohveelectedBSTrdiclcytecmymngeircncerTheCISTOcohtuniqueourceblddercncerchpotentilervefoundtiddgcriclquetilevntoptimlptient-centedmngementHoweverlger-termfollowupCISTOcohtquidfullyecomprtiveeffectivenehrmmngemenpticurnthigh-grdeNMIBCInddicptgmoleculrfcrocedblddercncerprogihpotentilimproveclicltggugmentrkpdictimodelFllyfncilimpctnewBSToptinimptntcidertiptientwhtldyemotexpenivetypecncerttTheewepropoeBESTCARERecurntNMIBCtudy1)Tocomplg-termoutcome(cliclptient-pted)tweenptientundergogBSTrdiclcytecmy2)Todetermewherpdictiprogimucle-vivemettticblddercncerimprovedmoleculrtgg3)ToevluteimpctnewlypprovedBSToptifncilxicyWeimfillubtntilknowledgegpboutlg-termcologicqulylife(QOL)outcomepecificllyddgctuedrolerdiclcytecmyIfrdiclcytecmyocedtterlg-termclicloutcomelefncilhrdhipimilrlg-termQOLBSTctextddilmtifedthroughmoleculrtggthwouldimpctfulcliclNMIBCprcticeThePRKACAgeneencodectlyticubunprotekeA(PKA-C)Recentge-nomicefthveidentifiedeverlgle-emuttiertirrntfuidictlylkedendocdeeSpecificllyfewomticgermlemutti/ertihveenlkeddenom-ocedCuhgyndromeocedcrdicmyxomAddillytwochimerdriverfibrolmellrhepcellulrcrcom(FLHCC)trductlcocyticppillryneoplm(IOPN)pncbileductRecentler-tuourplimrytudieuggetdyfunctilptiotemplgultiloubtrtepecificyPKA-Cmypentcommtrprogied-eeHowevernoccluivemoleculrmechnmunderlygprogiedeeWehypoizeePKA-Cvrintdruptllotericcoopertivydriveembly/demblygulrycomplexeunlehgctivePKA-CWepro-poeuette---rtliquid-tteNMRtechniquecoupledbiophyiclbiochemi-clpprochechrcterizeterctitweenPKA-CgulryubunendogenougulrPKIWeehowmuttiertifuichimerPKA-Cdrupttr-ter-moleculrlloteryledgrrntgultideeUndertggulrymechnmPKAhelpdetermemoleculretiologyedeeidfutudeigntrtegiepcelyctrolrrntctivykeABSTRACTTherpy-ltedmyeloidneoplm(tMN)cludgmyelodyplticyndrome(MDS)cutemyeloidleuk-emi(AML)evetenrpidlyftlmrrowdderthccurmllfrctiolidtumptientwhohveceivedcyxicttmentOvrincncer(OC)urvivhveehighetci-dencetMNmgllcncerptientflectgbothncedrkduepltumexpoucentlycognizedfurrcerkPARPhibir(PARPi)rpyCollectivelyePARPi--ocedmyeloidneoplmpproximtelyfquentcutepromyelocyticleukemirAMLub-typepvioulyhdhighftlyrtehcomemgmotcurblemyeloidneoplmthroughccertedefterchcommunyInthctexurtemhctriedtudiehowgdproptenumrPARPi-ocedtMNOCptienthvebillelicctivtiTP53tumuppgeneLikeTP53-mutntmyeloidneoplmtMNOCptientceivgPARPpdpolycventilchempylpequicklymedinurvivl4-8mthhigh-lightgneedimprovedrpieInplimrytudiewehvehownplicticheckpotmod-ulrcludghibirkeCHK1WEE1ATRexhibntileukemicctivyAMLcelllexenogrftprimryAMLmplecludgTP53-mutntAMLThctivyflectTP53-dependentductipoptrpeuticllychievbleccentrtithroughtlettwodtctpopticpth-wyewhichvolveleukemicell-trictrnctivtiTNFgenefollowedTNFcepr-dependentcpectivtiwhichvolvemichdrilpopticpthwylecompletelydefedTheeobervtiledhypoplicticheckpotmodulrdm-tedmpycombtihventileukemiceffecttMNdevelopOCptientTofurrdvncetudyegentwenowpropoedefeecdpthwywhichplicticheckpotmodulrducepopTP53-mutntAMLprovidgdeeperightdetermi-nnttMNenivythemerggcldrug(Aim1)determenteoplticeffectplicticheckpotmodulrvrolecombtihypomethyltggentBH3mimetic(twoclecurnttrd--cAMLgent)mplePARPi-emergenttMNOCptient(Aim2)eefficcyplicticheckpotmodulrvivolecombtihypomethyl-tggentBH3mimeticptient-derivedxenogrftgenertedPARPi-emergentAMLOCp-tient(Aim3)Collectivelyetudiedeignedprovidenewightnteoplticctiplicticheckpotmodulrimultneoulypoiourmultidciplrytempermfutuerlypheclicltrilplicticheckpotmodulr-bedrpyOCptientPARPi-emergenttMNPROJECTSUMMARY/ABSTRACTBckgroundAgenthibAndrogenRecepr(AR)ignlgtrd--cttmentprottecncer(PC)ptientUntuntelyeentillyllptientdeveloptnceARtrgetgrpie(ART)WepvioulyfoundrobutB7-H3(CD276)expimettticPCptienttntARTInourcentpheIIclicltrilwefoundB7-H3trgetggentimprovedclicloutcome66%PCptientunknownWeeprtelyexmedmechnticgulrB7-H3expicomputtillbrypprocheWeplimryfoundB7-H3expiwgultedARco-gulr(FOXA1HOXB13)tfourtrncriptigulryeAlgerwehypoizeARctivygulteB7-H3exphupeB7-H3trgetedrpieSpecificAimStudyDeignWepropoedetermemechnmB7-H3expiexmgneceyllB7-H3trncriptifcrgulrePC(AIM1)ThcludeARco-gulrHOXB13FOXA1wellfourB7-H3enhncerewehyperctivtedmettticPCcompdprimrydeeWelodetermehowrogenARTwhichuedclicllyimpctuceptibilyARTtnttumcellwrdB7-H3trgetedrpie(AIM2)WeutilizeglecellRNA-equencgpltmidentifygeneignlgprogrmocedpeB7-H3rpieglecellLtlyweimidentifycliclmoleculrchrcterticPCptientpdictedpeB7-H3trgetedrpie(AIM3)Weuecomputer-modelgolchrcterizeomticchngecliclfetuptientpvioulypdedB7-H3trgetedrpyWenpplythpeigntu~7000ddiltumidentifyignificntcliclmoleculrfetupdictivepeAnticiptedOutcomeWenticiptecidtetrncriptifcrgulryeB7-H3ctrolB7-H3expiPCtumFurruchchngecellurfceB7-H3expigtlyimpcttum-mgcpcyARTtnceWelticiptecliclmrogenARTlterB7-H3exphuimpctpeB7-H3trgetedrpieLtlyweexpectidentifymnyddilcliclmoleculrfetuocedB7-H3expgtumFutuDictiImpctWenticiptethtudyuncovermechnticightB7-H3expifurrundertgPCptientpeB7-H3trgetedrpieWehllloidentifymechnmwhichB7-H3gulteARTtncetummticellignlgLtlyourfdgimpctptienttrtifictimethodupcomgB7-H3clicltrilwhicheentildevelopmentdeploymentfutuB7-H3rpeuticPCptientSummryThegolthprojectdevelopnovelhtripydevicen-vivettmentheterogeneouoteorcomtum(OS)OSmlignnttumdevelopbothchildndultLg-termurvivlrteptientmettticn-mettticOSround20%70%pectivelyhighlightgdevttgntuthdeeLimblvgeurgerymputtifirt-lettmentprimryppendiculrOSemocedhighcomplictirtedecedmobilyfunctiNovelttmentOSneededimproveoutcomeHtripyn-viveultroundrpymechnicllybltetumcellulrdebrvictrolledcouticcvtiHtripycntue-electivewheneurovculrbundleveelcnpervedwhiletumcompletelydruptedcellulrdebrHtripypperwell-uedOSbilyerven-urgicllimblvgettmenptipromgultnotedplimrytudieDepethpromeOSttmenripypentuniquechllenge1)OStumexhibhighter-tr-tumlheterogeneyvrygproptilyticprolifertivettuetumprolifertiquirgoptimizedttmenttrtegiecompleteunimbltillOSphenotype2)OStumgrowcloecricltructuWhilehtripyhenhowntue-electivepplictimneeddevelopmethodelectivelybltgOStumwhilepervghelthynerveveelcnectivetue3)Htripytypicllyguidedl-timeultroundimggwhichnotfeibleubetOStumdueobtructiquirgimprovedtrgetgmirgtechniqueInthpropolwedevelopntegrtedimge-guidedhtripyytempcetrgetgbltiOStumTheytemctphedrrytrnducertrnm-ceivecpbily3Dcvtimirgimge-furgetg(CT/MRI)fullyumtedroboticttmenttechniquetrtegiechievgunimcompletebltiheterogeneouOStumWepropoefollowgtheimAim1DeignctructntegrtedhtripyOSytemctgnrrytrnducertrnm-ceivecpbilie3Dcvtiimggimge-furgetgAim2Developptientpecificttmentmethodoptimizedprmetercompleteunimtue-electiveOSbltiAim3TetvivofetyefficcytegrtedOSytem(Aim1)optimizedprmeterunimfettmentOS(Aim2)cneOSptienttVirgiTechAnimlCncerCReerchCenterThprojectulthumnprotypehtripyytemuniquettmentmirgcpbiliewellprmeteroptimizedOSThecneptienttlrgenimlmodeltetfetyefficcyhtripyccelerteclicltrnltiveterryttmentnpplictihtripyOSrpyeFDApprovlhumnuePROJECTSUMMARYHopicegoldtrdqulyend--life(EOL)cAcompdde-fcoptidyghoplhopiceimprovequlylife(QOL)duceEOLcexpenduimprovecgivervemenutcomeAlthoughmotptientwhodiecncerceivehopicecdultbloodcncerglrgexceptilethn25%ceivghopiceerviceThefewwhoenrollhopicetypicllydooltfewdylifenegtgmotnefLckccebloodtrnfuiprimebrrierhopiceuethptientpopultiRefrcrynemhrombocypenicommflpthwymnybloodcncercuedebiltgftiguehtnebthbleedgTrnfuiplleeympmimproveQOLyetmothopicedotprovideccetrnfuineprovidehometrnfuiFcedterriblechoicectugQOL-pervgtrnfuiccegqulyhome-bedhopicecmotptientopngogtrnfuiAultmotbloodcncerptientultimtelydiehoplubjectedpfulunnecerymediclterventieprtedhomepeopleycmotboutlifeInpethgtneedwehvedevelopednovelmodelhopicecHEmlogy-ModifiEdHopice(HEME-Hopice)tructudputbloodcncerptientircgiverhemlogiccologtThroughuniqueprtnerhiplrgehopicegniztincdemictrnfuierviceHEME-Hopicecomcoelementhopice(egvgnurehomehelthideocilwkerchpl)hometrnfuitriggedympm(egftiguehtnebthbleedg)medlbryprmeterWepropoeprllelcluterromizedtril350hopice-eligibledultptientbloodcncerclutedhemlogiccologttetefficcycceHEME-HopiceveruuulcprimryoutcomehopiceenrollmentSecdryoutcomecludelengthhopiceenrollmenthigh-tenyhelthcueexpenduptient/cgiver-ptedQOLmoodqulydethWehypoizecceHEME-HopiceulthigherrtehopiceenrollmentcompduulcWelticipteultductihigh-tenyhelthcuenerEOLlowerexpenduimprovedQOLmoodptientircgiverThpplictiferopptunyrigoulyddcriclbrrierultmnyptientbloodcncerdygoutnefhopicecUltimtelytherchhpotentiltrnmhopicecdeliveryimproveEOLcbloodcncerptientABSTRACTSomen-combutiblebccoproductuchvrioummokelebcco(ST)cnpoeignificntlyfewerrkdividuluerthntrdilcigttecludgthoeeverltypecncerAlthoughnotfeeproductmightferpotentilhrmductidultwhomokecigttewhocompletelywchmRecognizgeueFoodDrugAdmtrti(FDA)developednewpthwywhichbccocompniecnpplymodified-rkbccoproduct(MRTP)ttulegllymkemodifiedrkclimboutirproductInMrch2023FDAnnouncedCopenhgenp-ellgSTbrUScouldlegllymkemodifiedrkclimdvertgcompletewchgcigtteproductducerklungcncerFDAhdpvioulyuthizedcomprbleclimnSTbrGenerlSnuboutducedrkmultipledeeTheFDAuthiztieSTclimnotblegivenpviouimplichelthclimtcticuedbccodutrymrketgcigtte(notblylightcigtte)nowbnnedFDAGivenltivecencyeSTclimuthiztiltletillknownbouthowuchclimmyimpctcumerhvihelthEffectmydependeverlfcrcludgwherprticipntexpoedclimfdmlievbleperuiveAnopennovtivequetiwhernewlyuthizedclimmokelebccoproductwhichmkeexplichelthfencemyimproveexpectncieboutubjectivertgemokeleproductwhenugmIndeedpvioutudiehowbccomrketguchpckggcolmrketgdecripr(egmooth)cnimpctubjectivertgthoeproductwhenuedThimptntgivennegtiveproductperceptiltedubjectiveuechrctertic(uchttetfctilikg)hveennotedbrrier/whymokerhvenotwchedeproductptAnegtiveenyexperiencemyundermecfidenceducedrkclimledduceduetentiwheenjoybleenyexperiencemyledevlutiliefbouthrmfulnewhichturnmycefututentiueOverllcurnttudyeekexplocumerpennouncementimplementtienewmodifiedrkclimugeriecomplementrynovtiveerchctiviecludgnleurveyexperimentnexperimentluctin-perproductuelbtudyTwopecificimexplo1)cumerexpouctiuthizedmokelebccoMRTPclim2)wherMRTPclimfluencemokelebccodemenyevlutiProjectSummry/AbtrctThegolthpropoldeveloppltmcteddvncedbiomterilenblenovelvetigtiphyiochemiclroletummicroenvirment(TME)igcoloctlcncerColoctlcncerledgcuecncerdethUScgcidenceVirtullylletumdenompolypwhoeprogicncerdrivenphyiclchemiclchngeTMEccertgeneticmuttiAlthoughmuchknownboutgeneticcolcncerltivelyltleunderodbouthowphyicochemiclpropertieurroundgTMEmtriximpctprocecnceriCurntevidencedoeuggeteTMElterticricldenommtiprogicncerTodvnceourundertgthprocenterdciplrygroupterntillynownedvetigrexpertemterilciencebioengeergopticlpltmtetltemcellbiologycologyhenembledcte4D-tunblehydrogeltudyhoweTMEltertiimpctdevelopmentcoloctlcncerAdvncedlight-ctivtedhydrogelirfbrictimgnccurtemodelcolicrchectutmicrcleextenivelyoptimizedchrcterizedThelightctivtblebiomterilctrollblephyiochemiclpropertienmfoundtilcompentcolmicrophyiologicytem(MPS)Humntetlcellidenewbiomtrixcffoldgpoegpho-ctrolledtiffnebothpcetimeupptgmtichemiclgrdientTotkefulldvntgenewbiomteriloletcumizedlight-heetpltmimggcettecomptiblepplictigrdientgrowthfcroxygendevelopedupptlivgcolictuethbioengeedcffoldThepltmenblehigh-qulyimgglrgenumrcoliccryptgenertedtetufficientizettticlcomprhypotetgThhumnizedrchecturllyphyiochemicllyccurtebiomterilpltmnuedvelkeychrcterticTMEfluencehllmrkcncerdemtrtgutilyedvncedbiomteriltudiecolcncertypeAbtrctTheenzymtictrnittetructummmlinpunucleoidephophyle(PNP)weolvedexperimentllythlbrycombtricketicopeeffect(KIE)computtilquntumchemtryTheultgbdgeometryelectrotticpotentilmpenbleddeignyntrnittenlogImmucill-H(kBCX1777FodeeMundee)hibhumnPNPpicomolrffyThePNPblockdecuedGTPccumultipopticcelldethpecificllyctivtedmlignntTcellFodeeentedclicltrilwpprovednlrpyfrcrylpedperipherlT-celllymphomJpn2017Approximtely10%wefrcryptientttedFodeerpyundergocompletemiOrhowtbledeenopeGenomicnlyFodeepdervn-pderT-cellcncerptientveleddrugefficcyverelyproptilSAMHD1expi(terilelphmotifHD-dom-ctgprote1)SAMHD1dNTPtriphophohydrole(dNTP+H2OdNuc+PPPi)pventgdGTPcculultiducgpoptrgetedcncerTcellTheecombtiSAMHD1hibirFodeeexpectedextendrpeuticprilehumnPNPhibirynticlethlterctiDrugdeigntrnittenlyextendedSAMHD1rtriphophohydrolectivySAMHD1hibihpotentilenhnceT-cellnticnceroutcomeTheprivilidgedenzyme-ctntgeometryttrntitteenltedehibirdeignelementDrugcidtedeignedtblizeSAMHD1protegeometryttrnittepowerfulhibirChemiclcengfrgmentlibrrieomecovlentpotentilcoupledclickchemtrieuedcombrilhibirdeignnlterntivepprochSAMHD1hibiruedcombtiFodeeexpectedprovideimprovedrpeuticpprochepectrumT-cellmlignncieSAMHD1dockedtrnittedefeenzymticcvyttrnitteuedgrowcomplimentryprote-tbilizgtructulibrryfrgmentmimictrnittecfigurtiSAMHD1cmtiltrptrnittegeometrytight-bderABrx-bednovelptient-derivedcncerT-celllibrrytetedcultumouexenogrftSAMHD1hibirexplocopeynticlethltercticrogeneticllydefedhumnT-cellcncerTheprogrmchievedpecificim1)olvetrnittetructuSAMHD1ctntctlyticeperpective2)dcoverSAMHD1hibircmtiltrnittetbiliztifrgmentcenggrowthctlyticecvytructurlbiologypproche3)uecellcultumouexenogrftchrcterizebiologicleffectthynticlethlterctiABSTRACTMocllB-celllymphocy(MBL)pcnceroutteffectg8-10millidultnoextgcncerctroltrtegieApcurchriclymphocyticleukemi(CLL)MBLchrcterizedpencemocllB-cellcleperipherlbloodwehelthydividulErlyevidenceupptMBLcerkdvereclicloutcomecludgprogiCLLquirgrpydevelopmenrhemlogiclolidcncerhopliztidueerioufectiducedhumlimmunepevcctiHoweverclediveryMBLtudiecurntlylimedneedflowcymetricnlyperipherlbloodmuclercelldignoeMBLTheebiopecimenrlyvilblelrgebiobnkgcohttudiecouldwellowmocomphenivewell-powedvetigticuecequenceMBLepecillypopultidiverencetrieWepropoeovercomeelimtidevelopgvlidtgtrtegypdictMBLttu(Aim1)Inbriefwepropoeugextggenotypgrrydtdilyvilblemnybiobnkidentifymoicchromoomllterti(mCA)whichffectlrgeegmentDNAcludegloecopynumr-neutrlloheterozygoyeventRecentwkbiobnktudiehetblhedmCApotentrkfcrlymphoidmlignncieMBLlomjrkfcrlymphoidmlignnciethuquetihowmCAlteMBLunknownWehvecollectedlrgetcohtdividulMBLgeneticdurplimrynlyewefounduomlmCAocedrkMBLnoddrtio505(95%cfidencetervl365-706P=134x10-152)highdcrimtiAim1vlidteeultdeveloppdictivemodelknownrkfcrMBLnexmegenerlizbilymodeldividultrgfmilyhrylymphoidmlignncydividulAfricnncetryWefurrhypoizemCAdriverB-cellclegrowthInAim2wefirtquntifycidencemCAchngecellfrctimCAovertimeerilperipherlbloodmplehveloencenedMBLWenevluteltihiptweenmCAgrowrjecrieB-cellcledividulMBLSuccefulcompletieimunlockbilytudyMBLlrgetcohtwldenblgfututudieMBLtnunpcedentedcleAwectueimproveundertgcequenceMBLrktrtifictidividulMBLeentilThpropollogenbleuchtrtifictichrcterizgMBLclltrjecrieTogereimctlyzefututudieMBLimproveundertgmetiologicfcrrktrtificthpvlentpcncereventulcncerctrolPROJECTABSTRACTThemngementmettticbldder/uppertrct(urolil)cncerhentrnmedoverptfiveyerFDApprovlnti-PD-1/PD-L1ntibodienFGFR-electivekehibirmotcentlytwtibody-drugcjugte(ADC)DepeedvncemotptientmettticurolilcncertilldieirdeeTheHER2ceprtyroeke(encodedERBB2gene)implictedpthogeneeverlcncertypedrugtrgetHER2hvenetblhedrolemngementbtlungeophgogtriccncerWhileHER2mutti/mplifictipentpproximtely20%mettticurolilcncerolderHER2-trgetedntibodiekehibirhdlymodetcliclctivyurolilcncerUnpcedentedcliclctivywcentlydemtrtednewgenertiHER2-dictedADCbtlungcncertntolderHER2-trgetedrpiecludgHER2-lowbtcncerERBB2-muttedlungcncerThecurntpropolbed1)plimrydtdictgfquentmuttildcdnceERBB2pidprimrymetttictumcollecteddividulptienturolilcncer2)durblepeecd-genertiHER2-dictedADCubetptientHER2-expgurolilcncerWehypoizep-extgHER2expiheterogeneycommmechnmtnceHER2-trgetedADCurolilcncermoleculrimggcnidentifythoeptientmotlikelychievedurblepeTotetthhypowelevergelrget---kdpropectivemoleculrchrcteriztieftnovelmoleculrimggpltm(89Zr--pertuzumbPET)defepvlenceHER2expiheterogeneyurolilcncerociERBB2muttilttuimpcnHER2-trgetedADCpeWeccomplhetrnltilobjectivethroughthebrodpproche1)Wepermmoleculrnlyepidprimrymetttictumcollectedptienturolilcncer2)Weexploextentlei--leiHER2heterogeneymettticurolilcncerugpokeHER2PETimggpltm(89Zr--pertuzumbPET)3)Weue89Zr--pertuzumbPETtumcollectedettmentttimedeeprogiHER2-trgetedADCtudyimpctHER2heterogeneydurbilypethnoveldrugclMechnmHER2ADCtncefunctillyexplodugptient-derivedurolilcncergnoidxenogrftmodelGivenpromgcliclctivyHER2-dictedADCptienturolilcncerwepdicttudiepropoeddictlyfluencedeignfutuclicltrilHER2-trgetedrpieptientetblhcliclutilyHER2PETpdictivebiomrkerpeptienturolilcncergcidedHER2-trgetedrpyPROJECTSUMMARY/ABSTRACTM-eggtedchromoomeentrppedmicrucleiuceptiblecttrophichttergthroughprocetermedchromothripTheultgDNAfrgmentubequentlyundergoerr-pre-ligturngenertgcomplexgenomicrrngementdetectedpproximtelye-thirddiveretumtypeChromothripdrivepunctutedevoluticncergenomerpidlyrrnggdividulchromoomefewcellcyclewhichcnimultneoulyctivtemultipletumuppgenegenertecogenicgenefui/mplifycncer-ocedgenecirculrextrchromoomlDNAelementTheecompletemechnticundertgetiologychromothrippentcriclneedwrddefghowcncercellcquicomplexgenomicltertiAlthoughchromothripmyprtillytriggedDNAdmgemicrucleidurgterphecentevidenceupptecdwveexteniveDNAdmgeflictedupmicentryThemechnmunderlyguchmicDNAdmgectriichromothrippolyunderodToddthknowledgegpwelevergedchromoome-pecificmicrucleuchromothrippltmcductpooledCRISPR/C9centrgetgmmmlinDNAdmgepeWeunexpectedlyidentifiedmultiplecompentFncinemi(FA)pthwyquimentchromothripAlthoughFApthwynmllygenome-protectiveDNApirmechnmourplimrytudiedictefunctibnmllydurgmicentryduceextenivefrgmenttiunder-plictedchromoomemicrucleifollowedmicDNAynWehypoizepthologiclctivtiFApthwytriggerchromothripdurgmithroughclevgecompleteDNAplictermedeccumultemicrucleiTotetthcentrlhypowepropoethecomplementryimdefemoleculrmechnmdrivgmichttergmicrucletedchromoomeFirtwecomphenivelychrcterizetricdefectocedmicruclerDNAplictidetermecellcycletgedurgwhichy(Aim1)NextwevetigtehowFApthwyfunctihttermicrucletedchromoomedurgmicludgidentifygtructu-pecificnuclee()volvedducgwidepdmicchromoomeclevge(Aim2)LtlyweexmeroleFApthwygenertgcomplexgenomicrrngementextrchromoomlDNAexperimentlmodelchromothripFAptientcncergenome(Aim3)SuccefulcompletieimprovidedetiledmechnticundertghowmicerrtigterpidkryotypicchngecncergenomeTheetudieeekprovideprdigm-hiftgighthowdefectiveDNAplictictivtenunchrcterizedfunctiFApthwytriggergchromothripcncergenometbilyABSTRACTInerpcicologymoptientlivglgerdvncedcnceryetmnynewtrtegiequiyerftigugttmentWhilecognivehvilrpy(CBT)neffectivettmentftigueerly-tgecncerdvncedcncercentCochrnemet-nlyfoundfewtrilverylow-qulyevidenceendurgnefinftiguetfollow-upItlounknownifddgftigueimprovedhencecncerttmentFllygivendvncedcncertypicllyquigogttmentmolticducenegtiveterfenceftiguequlylife(ftigueterfence)thnelimteftigueelfThufullypowedtrilpromgterventiftigueterfencecricllyneededimproveoutcomedvncedcncerurvivOvrincncerpentnidelctexttetuchterventimotptientdignoeddvnceddeefterilttmentpcridlpolyADP-riboepolymere(PARP)hibir2-3yerPARPhibirwhichcglyuedtrcncercuelife-terfergftiguenerlyhlfptient(ltiveplcebo)ToddelimtiwedevelopedfedpilotedREVITALIZEtelehelerventiddftigueterfencemgptientdvncedovrincncertkgPARPhibirBedAcceptnceCommmentTherpy(ACT)CBTvrintwell-mtchedctextdvncedcncerREVITALIZEhptientidentifyducectriburftigueydPARPhibirclrifylignirhviirvlueuectivecceptncetrtegieduceftigueterfencedilylifeInpilotromizedtril(N=44)ltiveenhnceduulc(EUC)REVITALIZEducedftigueterfencet12-weekfollow-upp=008lrgeeffectimprovedftigueeveryelf-efficcycttrophizgqulylifeledfewerdoedelyductiWepropoecductfully-powedromizedctrolledtrilcludedhenceoutcomelgerfollow-upcrobothcommunycdemiccncerclicervediverecommuniecomprgREVITALIZEEUC(N=240)eedtbelemid-terventi(emechnm)pot-terventi4-6-mthfollow-upAim(1)ToevluteREVITALIZEvEUCeffectftigueterfence(primryoutcome)ftigueeveryelf-efficcycttrophizgqulylife(ecdryoutcome)(2)ToeeffectREVITALIZEvEUCobjectivePARPhibirmthlydhencedoeterruptiductipertenceugWepillmedictimirgdevicechrtview(3)Toey-drivenmechnmREVITALIZEctivecceptncelignmenthvivlueexmgmedirREVITALIZEeffectcompdEUCIfefficciouREVITALIZEprovideclbletelehelerventiimproveurvivhipdvncedovrincncercndilydptedddftiguemggrowgcommunydvncedcncerurvivPROJECTSUMMARYPhenotypicplticyepigeneticprogrmmgttwotewthycncerhllmrkLegeplticyprticulrhencognizedkeymechnmenblecncercellevdetrgetedrpieProttecncer(PC)epecillymotggivemmettticctrti-tntprottecncer(mCRPC)exemplifielegeplticy-bedtnceAndrogenRecepr(AR)trgetedrpieThtnceignificntlyctrptientclicloutcomendergmCRPCcurbleundercgcricldemelucidtgmechnmtnceidentifygctiblerpeutictrgetovercometnceWeidentifiedZNF397pivotlcoctivrARexpieentiltrncriptilprogrmgoverngAR-drivenlumllegevrioucncerZNF397deficiencypvlentevenberved25-40%PCptientenbletrnicncercellnAR-drivenlumllegeTET2-drivenlegeplticttecequentlyledgARrpytncePlimryultlouggetbothgeneticphrmceuticlctivtiTET2erdicteARtrgetedrpytncehighlightgTET2potentilrpeutictrgetcombtARtrgetedrpytncedvncedPCcludgmCRPCTheeOverllObjectivethtudycomphenivelydeciphermoleculrmechnmZNF397-deficiencypromotglegeplticyAR-trgetedrpytncegoldevelopnovtiverpeuticpprocheovercometncenefptientuffergthdevttgdeeWepropoedtheimtethypofquentlyobervedZNF397-deficiencymoleculrdriverpromotetrnicncercellnAR-drivenlumllegetteTET2-drivenlegeplticttewhichubequentlycomen-piveAR-trgetedrpyInAim1wecomphenivelyeeffectZNF397-deficiencyPCtumigenerpypivenelegeplticyugouruniquelygenertedGEMMZNF397-KOwellglecellRNA-eqptiltrncripmicInAim2weelucidtemoleculrmechnmTET2-drivenepigeneticwirglegeplticyZNF397-deficientPCInAim3weepdictivepotencyZNF397expibiomrkerARtrgetedrpypeexmeefficcytwoveltrtegieovercometnceZNF397-deficienttumTET2hibirZNF397-DUBTACThepropoedimcplizeourlbryexpertethurcollbrcomphenivelydefemoleculrfunctiZNF397ComplethprojectnlyfeourundertgmechnmpropellgAR-trgetedrpytncelolednewpdictivebiomrkertwovtiverpeutictrtegiecombtthlethlcomplictimoderntrgetedrpieimprovgclicloutcomeptientProjectSummryWidepdimplementticle-uputbilyculturlly-ppropreevidence-bedprogrmcriclducgignificntdpropteburdencncermgBlckwomenCommuny-enggedLyHelthAdv(LHA)progrmhighlyuccefulducghelthequiecncerOnemotrobutevidence-bedntillydemtedLHAcncerpventi/cengprogrmTheNtilWneProject(NWP)NWPefewequy-focuedLHAprogrmbothlgevyevidenceimpctBlckcommunientillyDepeimpctNWPctuetcechllengeutbilylg-termdeliveryprogrmAdvncgcienceutbilyurgentequiecncerchllengeutbilyevidence-bedprogrmweexcerbteddurgCOVIDpemicReerchcricllyneededutbilyprticulrlymglow-ourceettgcommuniefcehriclgogtructurlytemicbrrierhelthmkeprogwrdrcilequycncercengoutcomeOurtemuniquelypoedleddvnceerchthBuildgfourwkutbilylg-termprtnerhipNWPwepropoentilmixed-methodpropectivetudyfollowgimFirtim1wefeub-mpleNWPentilly(n=6)pckgeutbilytrtegieuppngogdeliveryNWPtclelg-termgolddgcncercengequiemgBlckwomenWefocutrtegiebuildgcpcyprtnerhipenhnceutedimpctdeliveryNWPuppttentiLHA(egnovelcurricul/trgtilodtechnicltnceCommunyPrcticemodelhlecroe)golenhncgcpcy1)buildgprtnerhip/identifygchmpitcdemic/helthccenterlevergegniztilource2)buildgbueceprogrmvlue3)dptgloclcommunyneedctextInAim2wepropoedeliverexmeimpctthfedpckgeutbilytrtegiemultipleutbilyoutcomennullyoverfouryercro16NWPentillyugp-potcluterpropectivedeignFllyim3weplnpplyccurntmixed-methodpproch(n=200urvey50-65-deperview)exmeuptkecceptbilypproprenefeibilyimpctutbilytrtegiemg16NWPeexploproceethroughwhichtrtegiebuildcpcyfluenceutbilyequy-focuedEBIcommunyettgover4yerTherchtimelyprovidgkeyopptunydvncecientificundertgtrtegiepromoteutbilymggenerlizblentillydemtedprogrmFdglygroundwkenhncgutbilytrutedcommuny-ledprogrmmkgprogwrdrcilequycncercncercengAbtrctEwgSrcom(ES)ecdmotcommpedriccncerIntenifiedchempygimenhvelycmentllyimprovedcurnrmettticESoutcomemotivtgerchdevelopmentnewttmenpticombtthdedlydeeTheccumultilrgeglycogengrnuleclicllyknownPeriodiccid-Schiff(PAS)poivecliclhllmrkESHoweverigpthologyES-glycogenmcriclknowledgegphnotenpuruedrpeutictrgetRecentptcludgourownvelcriclrolecomplexcrbohydrteuchglycogenN-lkedglycntumprogiWedevelopedrobuthighlyenivewkflowclledMALDIimggcomplexcrbohydrte(MICC)unerglecellptilolutiUgthwkflowweterrogtedcomplexcrbohydrteover1000tumpecimenprottelungcolESptientOurdtdemtrte1)highglycogenuniquecliclhllmrkES2)thedependenttrtegie(ieCRISPRknockoutmllmoleculehibigenetic-expi)leddrmticductiESglycogenultedbluntedEStumgrowthvivothymicmouemodel3)glycogenynthehibirynergizedmetmtimprovgAMPKctivypventgtumigeneCollectivelyeultprovidetrgevidenceuppurhypoglycogenuniqueclicllyctiblehllmrkEScnlevergedclicbothdignoticrpeuticterventiTheobjectivethtudydeferoleglycogenESclicloutcomecncermetbolmlevergeglycogentrgetgtrtegierpeuticoptiESTochievethweDefedignoticpdictivepotentilglycogenEScliclcoure(Aim1)ThenweDefeptio-cellulrroleESglycogenutiliztiupptcncergrowth(Aim2)FllyweeGlycogennESrpeutictrget(Aim3)OurtudypentpieergtegrtedpprochexplodtctEShllmrkexceiveglycogenugpowerfulmethodologielikempectrometryimgguniquecliclcohtEStumThpropolbuildfoundtiexcgplimrydurtrndciplrytemexpertedefeEScliclcoureundertEStummetbolmimprovettmentdocumenteddeeOurfdgubtntillyenrichknowledgebepurrgdevelopmentperlizedrpieESptientwhocurntlylyolelycventilchempieOurgolimprovgptientcoutcomeprovidetterttmenptichildnuffergESBlddercncer(BC)ccount80000newcncerdignoe20000dethnnullyUSRecentlrge-cletudiehvecomphenivelymppedgeneticlcpeBCyetmedinurvivlptientmettticBCly14mthTheenurgentneedmechntictudiemednewgenomicdtdeferolepecificltertiBCbiologyguidenovelrpeutictrtegieArrntctivtimigen-ctivtedproteke(MAPK)pthwycommfetucncer~20%blddertumhrbMAPKctivtidrivenRAF1(CRAF)mplifictinctivtgHRASmuttiPeroxomeproliferrctivtgceprgmm(PPARG)nuclerceprtrncriptifcrgultelipidglucoehomeotPPARGlohnimptntroleurolilcelldiffentiubetBChvegenomicPPARGltertiledgcedPPARGignlgnimmune-excludedluml-likephenotypedriventletprtchngeNFkB-mededgeneexpiWecentlyfoundMAPKPPARGpthwyltertico-occurubetBCcentrlhypothpropolrrntMAPKPPARGignlgcoopertedriveuniquephenotypeeMAPK/PPARG-ltedtumFurrmowehypoizetrgetgMAPKignlgnovelMAPK-dictedgentuchRAFdimeriztihibirprovidedulrpeuticnefdictlyhibgcogenicMAPKignlgwelltrgPPARGignlgpromotgimmunefiltrticedenivyimmunecheckpothibiInAim1wedectignlgterplytweenMAPKPPARGmeurgeffectMAPKpthwymodultiPPARGphophyltictivtittewellPPARGlumlgeneexpiprogrmMAPK/PPARGltedn-ltedBCcellleptient-derivedmodelWelodefetrncriptilnetwkthrchetrteMAPK-PPARGignlgBCcellInAim2wevetigteimpctMAPKpthwyctivyNFkB-mededcykeignlgmcrophgepropertieBCmodelWetetwherMAPKignlgBCcelldrivemcrophgepolriztividicrprcmechnmwedefeimpctMAPKpthwyperturbtiBCcykegenetrncriptiInAim3wevetigtecomdctivyMAPKhibiimmunecheckpothibi(ICI)multipleMAPK/PPARG-ltedimmunocompetentBCmodelWemeuttmenteffecntumgrowthurvivldefeimpctMAPKpthwyhibiimmunectextuFllywevetigteocimgPPARGignlgMAPKignlgttmenutcomeICI-ttedunttedcliclBCcohtTogeretegrtedtudiedefemechnm()throughwhichMAPKpthwyctivygulteuniquetumcelltricimmunemicroenvirmentlfetuMAPK/PPARG-ltedBCpotentillymgnovelrpeuticpprochethubetBCABSTRACTWehypoizeroom-tempertu360ocentricprrpygntryfideLcvultkMi-GntryThwouldenblecverweighbgLcvult(eMi-Gntryeccelerr)nultr-compctprrpycentercecceibilyprrpyepecillyurbncenterextglerccelerrvultwhepcectrtExtgprrpygntrielrgerthn24dimeterTheprgntrietMchuettGenerlHoploccupy3rieTheIBAProteuOnegntry25dimeterNeeftypicl12highbementhigh-buildgquicum-deignedpceTheimoptimizeprmximumenergyttmentfieldizeMi-Gntrywhilemtg12dimeterproducedeignTheftdetermefeibilyMi-GntrycceptwhichteppgnepublictigrntptentprotypeprtnergprrpyvendCtproprietrymtiBCliequetnotleedperoutidegovernmentexceptpurpoeviewevluti_PROJECTABSTRACTRurlApplchincountiehvehighetcncercidencemtlyrteUnedStte(US)WhilemotcncerdprienrrowgtweenApplchinn-ApplchinUSdprielunglcncerwidengAhighpvlencecigttemokg(ie>30%mnyrurlApplchincountiev115%ntilly)primrilyctrieedprieAculturlfcrdeficiencierurlApplchinhelthcytembccodutryctihveundermeduccebccoctrolpprocheproveduccefulelewhewepropoenewpprochducepvlencecigttemokgrurlApplchiOrlnicotepouche(ONPegZynOn!)whichctnicotenobccohveimilrxicntprilemediclnicoteplcementrpy(NRT)motcrcogenxicntlowlimdetectiONPdelivernicoteimilrlyNRTlozengebouthlfexpenivemrketedmokerourplimrydtdicterurlApplchinmokerfdmmoocillycceptblethncigttemopltblethnNRTWepropoe6-mwo-rmmoteromizedwchgtril1000dultmokerwholiverurlApplchiPrticipntromizedeirnONPnNRT(ptchlozenge)rmDurg2-weekSmplgPheprticipntmpleproductirlevnttudyrmrngeflvnicoteccentrtielectflv(ONPrm)nicoteccentrti(ONPNRTrm)uedurgSwchPheDurg12-weekSwchPheprticipntttemptpmokgcigttecompletelywchirtudyONPNRTugtudyproductprovidedfeDurg14-weekObervtiPheprticipntnolgerceivetudyproductfollowedevlutelger-termwchgoutcomePrticipntelf-ptmokgtudyproductueleurveychngecigttemokgcfirmedugmotecrbmoxideementThignificntnovtivetudyfirtevlutewherONPubleubtutecigttemokgmgrurlApplchindultIfourtudyfdONPprticipnthvegterucceducgqutgmokgthnNRTprticipntultprovidefoundterventigultiupptwchgcigttemokgONPueIfourtudyfdONPprovideme(we)effectmokgoutcomeNRTultuggetpublichelthprctiergulrclicinhouldteermokerwyONPfvNRTAbtrctThehnecetyltrnfereCREB-bdgprote(CBP)prloguep300protekeytrncriptilco-ctivrttrctiverpeutictrgethumnprottecncertypehumncncerDevelopmenthighlypotenrllyctivemll-moleculedegrderCBPp300protepentpromgnewrpeutictrtegyOurplimrydtdemtrtethurdeigneddegrderhighlyeffectiveducgrpidcompletedegrdtibothCBPp300protetumcelltub-xnnomolrccentrti>100-timemopotenthibicellgrowhnCBP/p300hibirOuroptimizedCBP/p300degrderchieveexcellentphrmcoketiclbiovilbilymiceOrldmtrtiouroptimizedCBP/p300degrdertrglyhibtumgrowthnimlmodelhumncncertwell-lerteddoe-cheduleCollectivelyourplimrydtprovidecompellgdtupptfurrevlutioptimiztidevelopmenrllyctiveCBP/p300degrdernewnticncerrpyPROJECTSUMMARYImprovedttmentcoloctlcncer(CRC)quitterundertgkeygulrurvivlprolifertetlepililcellircrotlkimmuneytemUpgultihyperctivti-TrCPE3ubiquligeunderlieCRCpthogenepopechempyWhiledictlyhibg-TrCPprovedprcticllydifficulthewepropoetrgetkeygulr-TrCPCRCcludgprotetbilizemRNA(IGF2BP1)prote(PARP11)OurpublhedplimrydtdicteIGF2BP1PARP11ctmlignntcellwellnignimmunecelltummicroenvirment(TME)timultecoloctltumgrowthprogilimirpechempeuticgimenTheedtupptnoverrchghypotrgetgIGF2BP1PARP11houldelicpotentnti-tumeffectimproveefficcynti-cncerchempieWetetthhypothedependentyettegrtedSpecificAimInAim1wedetermeroleIGF2BP1cncercellpro-tumigenicTMEperpyWeutilizegeneticmodultiIGF2BP1expiCRCcellcellTMEundertroleIGF2BP1tumgrowthmetteenivyFOLFOXgimenwhichtrdcchempyCRCptientMechnmgoverngIGF2BP1expiTMEwellmechnmTME-dependentvolvementIGF2BP1enivychempyvetigtedAim2determeimptncePARP11growthprogetltumwellirpenti-tumrpyWeuegeneticmoleculrphrmcologicpprochemodultePARP11coldenocrcomcelln-mlignntTMEcelldetermeimptncePARP11pro-tumigenicphenotypevrobilymthopictumlivermettevivoPARP11-dependentmechnmunderlygctrolmlignntcellnti-tumimmuneytempivenetumchempyvetigtedAim3exmeeffectphrmcologicltrgetggulr-TrCPimprovepecoldenocrcomtumchempyWedetermenti-tumeffectnovelpotenthighlyelectivehibirIGF2BP1(AVJ16)PARP11(ITK7)mo-gentirbilyimprovepeFOLFOXgimenCompletietudiehouldgighnimptnceIGF2BP1PARP11coloctltumgrowthmettchrcterizeegulrpotentilvulnerbiliewhichcouldexploedimprovgchempyCRCABSTRACTSmokgcglyccentrtedocioecomicllyddvntgedpopultimightnothveenchedpoliciecommunicticmpignmedegemoproperougroupInrpidlychnggmedilcpenewpprochedevelopgtetgmegeneededThprojectuennovtivecombtiqultiveeyetrckgqunttive(dctechoiceexperimentromizedclicltril)tudiedevelopevlutebccoeductimegetrtegiedeliveddiglchnnelcommunictecomplexcientificcceptpublicprticulrlypriypopultiTheetrtegiedevelopedctextFDA-propoedbnmentholcigtteflvcigrproduct(flvbn)FlvbnhpotentilvehunddthoulivecnundermedmmtimperceptiLtleerchhytemticllydocumentedmperceptidevelopedmegecctmOurprojectpropoeddthimptntgpdevelopgtetgtrtegiechpriypopultimegediglchnnelThprojectprovideerchpurugepecificim(1)Identifyeffectivemegettriediglchnnelugco-ctipproch(2)Quntifyltiveimptncediffentttriediglmegeugcombtidctechoiceexperimentneye-trckgtudy(3)TetimpctmegehviloutcomectextdiglocilmediromizedclicltrilntillypenttivempleflvodcombutedbccoproductuerTheulthelpelimtebcco-lteddprieceeffectivenebccoeductilmegemgpopultiwhomnti-bccomegehvenotenoptimllyeffectivePROJECTSUMMARY/ABSTRACTAdefectDNAdmgepirtriggergenometbilyhllmrkcncerexploedttmentuchiizgrdipltumchempypoly(ADP-riboe)polymerehibir(PARPi)PthogenicgermleomticvrintDNApirgeneBRCA1fquentlydetectedtriplenegtivebtcncer(TNBC)BRCA1-muttedTNBCcntrgetedPARPichievecliclpeElucidtgmechnm()whichBRCA1ocedprtnerolveDNAleiprovidenewighthowgenometbilypromotecellulrtrnmtiidentifynewrpeutictrgetInthpropolwevetigtefunctiATR-METTL3-BRCA1xR-loopocedDNAdmgeuttblegenomePertentuncheduledR-loopctetructurlbrrierwhenycollidecollpedplictikdoubletrbk(DSB)elicgenometbilyOurplimrydtfoundMETTL3protepromotgRNAm6AmodifictiwhenR-loopmdurgtrncripticruedpirDNAleitctivetrncriptieMETTL3phophyltedATRkeykeR-loopocedDNAdmgeignlgthphophyltipromoteociBRCA1WefoundBRCA1bothneceryufficientMETTL3crumentDNAdmgeeWeidentifiedeverlbtcncerocedMETTL3muttifoundtwoctlyticllyctivemuttiimpedeHRpirbolhgociBRCA1OurproteomicnlyhidentifiedDNA/RNAheliceolveR-loopeffecrATR-METTL3-BRCA1xFurrmohibiMETTL3ctlyticctivymllmoleculeducedefecthomologoucombtienhncePARPenivyTNBCcellleWehypoizeATR-METTL3-BRCA1xcriclR-loop-ocedDNAdmgepirbtcncerdevelopmentfernewrpeutictrgetTNBCWetetthhypofollowgpecificimInAim1weelucidtemechnmwhichMETTL3Se43phophyltipromoteDNA/RNAhelicecrumentolveR-loopocedDNAdmgeInAim2wedetermeroleATR-METTL3-BRCA1xbtcncerdevelopmentmouemodelInAim3wetrgetATR-METTL3-BRCA1xMETTL3hibirTNBCOurtudieunrvelnovelfunctiMETTL3DNApiridentifyMETTL3promgrpeutictrgetTNBCPROJECTSUMMARYAnimmunouppivetummicroenvirmentpentignificnthurdlectrollgtumgrowthActivtitimulrterfergene(STING)proteenteimmunepepotentillyovercomgtumimmunouppielicgpotentntumimmunepeHoweverclicltrilSTINGgtrpyhencountedproundtumtncemechnmmunclerTheignificntgpourundertgnegtivegulryeffectSTINGntumimmunyunderlietncedevelopmentSTINGgtrpySTINGcrucilnteimmuneenene23-CyclicGMP-AMP(cGAMP)producedCyclicGMP-AMPynthe(cGAS)ctivteterfer(IFN)ignlgWhcomplextummicroenvirment(TME)extrcellulrcGAMPcnimptedvrioucelltypecludgmyeloidcellNturlKiller(NK)cellfibrobltducgSTING-mededIFNignlgelicgpotentntumimmunepeHoweverourerchhdemtrtedcGAMPimpttum-filtrtgTcell(TIL)cndverelyduceSTING-mededcelldethTcellthnimptntmechnmwhichtumevdeimmunedetructimouetummodelThuSTINGctivtiTMEbothpoivelynegtivelygultentumimmunyTheeultledupropoehypotumevdeTcellmededimmuneurveillncethroughcGAMPimpttum-filtrtgTcellduceSTING-mededcelldethpthwydependentlyIFNTheobjectivethprojectelucidtemechnmcGAMP-STING-mededTcelldethdeveloptrtegieblockgSTING-mededTcelldethGivenSTINGgtnowdevelopmentuecncerrpeuticdictgctivtiSTING-mededIFNignlgwhilevoidgSTING-mededdethTILimproveucceSTINGgtrpyAim1identifycGAMPimpterIFN-ducedmedirfciltgcGAMPimpttiTcellAim2elucidtemoleculrmechnmunderlygcoopertivectivtiSTINGTCRignlgtriggergTcellpyropAim3developnovelimmunpieviblockdeSTING-mededTcelldethThepropoedtudieheelucidtenovelmechnmwhichcGAMPimptedtum-filtrtgTcellctivteSTING-mededcellpyropWenticipteightgedourtudiehveignificntimpcnSTING-bedcncerimmunpiePncticductldenocrcom(PDAC)nggivedeepoprognochrcterizeduniquemicroenvirmentevelydepletedmocid(AA)DietryAAterventiuche/glyce(Ser/Gly)-fedietcnducePDACtumburdenHoweverPDACcellcngultevrioupthwydptgrowurvivepeAAtrvticludgtrncriptimRNAtrnltielgtimRNAtrnltiefficiencie(mTE)codBygultgmTEcodPDACcellllowelectivemRNAtrnltiquiddpttinutrientpomicroenvirmenttumTheewepropoetrgetgpthwygultemTEcodcnprovidenovelrpeuticvenueimproveoutcomeptientPDACcncerIpvioulyfoundSer-deprivtidecemTEtwooutixSercodTCCTCT(TC[C/T])electivelyupppromoteynTC[C/T]-rich-pogenepectivelyIntetglyTC[C/T]-pogeneignificntlyenricheddptivepthwyquidurvivluchcellcycletrncriptiectedfcrWheuppiTC[C/T]-richprotecnpromoteimmuneecpeByblockgmTEdiffenceSer-deprivedcdiwewouldblepventctivtimultipledptivepthwyquidurvivlupSer-limtiPDACtumHowevermechnm()gultemTESercodpeSer-limtinotknownMyerchfocudeciphergultieffectrolehumnSercodmRNAtrnltidurgPDACtumigenehrneefdgidentifynovelrpeutictrtegiettmentPDACcncerUgwholegenomeCRISPRcenwehveldyidentifiedELAC23p-tRNAprocegenzymekeymTEgulrSer-codPDACcelltrvedSerHeweelucidteuptmignlgccde()eneSer-trvtiltermTESercoddetermedowntmmechnm()ctrolmTEdiffenceeimptncemTEgultiSercoddurgPDACtumigeneByelucidtguptmignlgccdedowntmmechnmfunctidetilwegcompheniveundertgrolehumnSercodmRNAtrnltipenutrientenvirmentdurgPDACtumigeneWeidentifymultiplerpeutictrtegieblockmTEdiffencellowctivtiSercod-drivendptivepthwydurgPDACtumigeneThwklovelmechnticightpthogenehumngeneticdeeuchtellectuldbilieocedELAC2TPRKBmuttiAcompheniveundertgroleSercodmRNAtrnltipenutrientenvirmentcnetblhnewprdigmtumnutrient-codpfencenAchilleheeldurgtumigenePDACcncerProjectAbtrctFibrolmellrhepcellulrcrcom(FLC)rtenlethlmlivercncerprimrilyffectchildnyoungdultoutcirrhoThenopprovedytemicrpieFLCuullyfrcryttmentpprochedevelopedmlivercncerAchimerictrncripttweenDNAJB1PRKACAwidentifiedigntugenomiceventFLCledctivtiPKAcHoweverphrmcologiclhibiPKAcFLCtrdilmllmoleculehibirhenfeibledue-trgetxicyOurplimrydtderivedpcliclmodelFLChumnFLCtumhowDNAJB1-PRKACAfuiultmetbolicwirgtumcellledgglutmedependenceInductiDNAJB1-PRKACAfuipcliclcellleocedenivyglutmentimetbolerpyGlutmedependencyFLCultnutrient-depletedtumimmunemicroenvirment(TiME)enrichedimmunouppivemetbole(egmmicido)impirgntumimmunyInnvivomodelFLCcombtiglutmentimetbolerpyplunimmunecheckpothibir(ICI)vereTcelldyfunctumimmunemicroenvirment(TiME)ducentumimmunyultgrobuttumctrolWetrnltgepcliclfdgclicltrilglutmentgt(irpiglentt)combtiPDL1hibir(durvlumb)InAim1wecductclicltriltetfetycliclctivyirpiglenttcombtidurvlumbchildndultdvncedFLCInAim2wedetermewherttmentirpiglenttcomddurvlumbuppeglutme-dependentproceecenumrctivtedFLC-pecificTcelltummicroenvirmentInAim3weidentifymoleculrmechnmpecificmetbolicperturbtithroughwhichDNAJB1-PRKACAfuiduceglutmeddictiimmuneuppiThwkdvncepromgnewttmentpprochdvncedFLCtumtypecurntlycfermedinurvivllyeyerUncovergctivypecificpthwymkeFLCglutmedependentetblhmocompleteundertgmetbolicbiomrkerglutmeddictivelynergticvulnerbiliewhichmytrgetbleevenmoeffectivettmentpprocheWenticipteevenuequirylikelygenerlizblecleglutmeddictedtumSUMMARY/ABSTRACTPncticductldenocrcom(PDAC)nggivecncer5-yerurvivlrtely~12%TheecriclunmetneednewttmenptiChimericntigencepr(CAR)-Tcellhveledprdigmhiftttmentomehemlogiccncerefficcyolidtummlimedprtlyduelckhighlypecifictrgetimmunouppivetummicroenvirment(TME)MoovertimequidhighcotmnufcturgnulogoucellproductxicyCAR-TcellcllnovelproductuniverlfepotentCAR-NKcellhveemergedpromgcellrpycncerdueNKcellntebilykilltumcellirfetyllogeneicettgInfirt--humntudyourgrouphowedfetyefficcycdblood(CB)-derivedCAR-NKcelltrgetgCD19B-lymphoidmlignncieThpropolimbuildthpltmdevelopnext-genertiNKcellrpiePDACenhncgNKcellpotencypertencethroughoptimlco-timulryignlgcykermgcheckpothibiWehveidentifiedTROP2promgrpeutictrgetPDACdevelopednoveltrtegytrgetTROP2geneticllymodifygCB-NKcelltrovirlvecrencodg(i)humnizedRS7cFvtrgetgTROP2(ii)DAP10nNK-pecificco-timulrydom(iii)IL-15upptirurvivlproliferti(iv)duciblecpe-9(iC9)fetywch(iC9/TROP2CAR/IL-15)OurdthowefficcyfetythpprochvrovivouppttrnlticlicInddiwehvedevelopedrobuttrtegycryopervtiCAR-NKcellenblggenertibiobnkf--helfengeedNKcellcouldthwedfuedtdidethuducgcotcgcceibilyWehvemnufctudcryoperved125ptientdoeGMP-grdeiC9/TROP2CAR/IL-15NKcellclicltudytetfetyefficcythf--helfproductPDACwcentlypprovedFDA(Procol2022-0687IND29348)FllywehvedevednoveltrtegytrgetimmunemetboliccheckpotCREMmodultemetbolicfnepotencyCAR-NKcellPDACTMEWehypoizetrgetgTROP2iC9/TROP2CAR/IL-15NKcellgtlyimproveoutcomePDACdeletgmetbolicimmunecheckpotCREMwecnfurrenhncefnepotencyNKcellWeteurhypothepecificimInAim1wecductPheI/IIclicltriltetfetyefficcytrperinellydelivediC9/TROP2CAR/IL-15NKcellptientTROP2+PDACInAim2wepplynovtivegle-celltrncripmicptilproteomiccomphenivelychrcterizeftedoptivelytrnferdCAR-NKcellirtercticellTMEuncoverkeymechnmefficcytnceInAim3wevetigtemechnmwhichtrgetgCREMenhncentumctivyiC9/TROP2CAR/IL-15NKcellnthopicPDXmouemodelPDACFtercoveryducedhopltyquickerturnnmlctiviemotevidentdvntgelprocopicurgeryMothn13millilprocopicprocedupermedeveryyerLprocopicurgeryhcometechniquechoicevirtullyeverykdbdomlurgeryRobottedlprocopicrdiclprottecmymotcommurgiclpprochpermedprottecncerHowevercurnncologicloutcome(undetectbleprottepecificntigennoevidencecncercurnce)functiloutcome(coveryctenceectilefuncti)lychieved6270%prottecncerptientUntuntelyendocopeuedcurntlprocopicroboticurgerydoenotllowtropertiveementtuedetermeifidultummBecuepoivetummrgcncercurnceevblyledneedfurrttmentwhichexpenivewellmbidThoughfluocenceimggvidocynegenhprovidedighttueperfuiimprovedtuectrtdurglprocopicurgerydrwbckcludehthlflifebloodtmquimentctrtgentjectiAultnunmetneeddevelopllfeimggtechniquecndetectcnceroutueltimedurglprocopicroboticurgeryTheobjectivepropoederchdevelopllfehyperpectrllprocopicteoimggytemroboticurgeryHyperpectrlimgg(HSI)providenlyhigholutiptilimgelopectrldttechpixelBothpectrlptilmticnuedidentifyvrioutypetuecludgmlignnttumTherchbeducceugourlrgeizeHSIytembothfhurgiclpecimenhumntuevivimlWhourdvncedmchelerngmethodwechievedenivy889%pecificy971%cncerdetectifhurgicltuepecimenmothn200humnptientHowevercurntHSIytemobulkyirimgecquipeedolowtropertiveueInthprojectwepropoetegrteltimenphotHSIcmer3Dteoendocopetetytemprotte93humnptient(Aim1)Wedevelopevlutedvnceddeeplernglghmumticllydetectmlignnttuehyperpectrlimge(Aim2)WetegrteourhyperpectrlendocopicteoimggytemdVcirobotIntuiveSurgiclpermrobottedlprocopicurgerypclicltudy(Aim3)Thenewcpbiliepropoedhyperpectrllprocopicimggytemcludei)cpbilydiffentemlignntnigntuedurgurgeryii)cpbilymptueoxygenturti(StO2)nerfrdperfuidex(NIRPI)gnhemoglobdex(OHI)tuewterdex(TWI)IntherchutiliztiqunttivehyperpectrlimggrobottedlprocopicurgerypentmjnovtimimllyviveurgeryThecdemicdutrilprtnerhipmgUTSouthweternUTDllIntuiveSurgiclwktrtegicllinceutilizeuniqueourcetecheenutrnltihyperpectrllprocopicteoimggtechniquecommercildVcirobotbrodpplictiimprovedurgicloutcomeProjectSummryFmotolidtumhigh-qulyurgerypentgtetpotentilcuWhilemnycncerqulyimprovementefthvefocuedcengdignoticproceetimelydeliverydjuvntrpieltivelyltlettentihenpidcncerurgerytechniclqulyToddthgpAmericnCollegeSurge(ACS)publhed134opertivetrdcro15cncertypeOpertivetrdttemptdefecriclelementoptimlcncerurgerycnuedqulyurnceolprcticgurgeTheCommiCncer(CoC)centlyimplementedixetrdccdtihoplexpectedch80%dhence2024ACoCccd>1400hoplervg>70%cidentcncerptientthprogrmpotentillyimpctupemilliptientnnullyTheeverlmechnmwhichopertivetrdmyimproveoutcomeburcenriomylednoeffecrfleoutcomeignlOpertivetrdcouldimprovetechniclqulythroughhvilmechnmuchclicineductiHwthneeffecrudfeedbckAddillymnytrddictedtlymphnodeevluticncertggtrdmyimprovetggppropredeliverydjuvntrpieOnhopertivetrdmyfilimprovecnceroutcomeifydictedttechniclcompentldypermedthighrtetcompentnotdictlyimpctgoutcomeifytrgeutcomeloweventrteFllyptgometrdlyelf-ementopertgurgeInthceopertivetrdmyfilimproveoutcomeifurgecctlyeetrdoutchngetechniclqulyUndertgwhercurntlteopertivetrdimproveoutcomecriclWell-deignedtrdhvepotentilducetechniclvriimprovequlyInctrteffectivetrdwouldplcecotlyunnecerydmtrtiveburdenclicinCoChoplpotentillydtrctclicinhoplhigh-qulycledmoexteniveurgerydoenotnefptientWepropoeevluteimpctixCoCopertivetrdht-termcnceroutcomeleverggnturlexperimentimplementtimeleplnnedCoCcheduledCoCeveimplementtitrdp-extgdtcollectiNtilCncerDtbe(NCDB)TofullyevluteltihiptweenCoCopertivetrdoutcomeweemployCoCSpecilStudycollectcncercurnceoutcomenotcurntlycollectedNCDBFurrwepropoeevluteimplementtioutcomecludgourceburdencrodivereCoCepotentillyexplnyobervedheterogeneyimplementtioffectPROJECTSUMMARYMelnomdevttgkcncerkillnerly8000ptientUSnnullyPtientthickermelnomvdgdeepercloerlymphticbloodveelmolikelyhvemettgillymphnode(LN)FptientoutclicllyevidentLNmettepenceoccultmetteentelLN(SLN)firttum-drgLN(TDLN)motimptntprognoticfcrHoweverwhymelnommettizeLNomeptientnmpolyunderodecricldetermefcrgultgmettmdevelopmentnovelrpeuticpprochepventtrgetmettWedemtrtednlygutmicrobiomecriclmodulrpeimmunecheckpotblockde(ICB)lofvblegutmicrobiomecnugmentnti-tumimmunytdtntecludgkWehveloidentifieddiffencegutmicrobiomemelnomptienterly-tge(0-II)compdlte-tge(III-IV)deeThegpknowledgeeffectgutmicrobiomenturlevolutimelnomtprimrytummettgilLNOurhypomicrogutmelnomptientfluenceprimrytumdevelopmentrkLNmettuchtrgetedmodultigutmicrobiomecnpventmelnomLNmetteTotetthhypowe1)IdentifygutmicrobilimmunologicfetuocedtumprogiLNmettmelnomptientWecompgutmicrobiomeprilepidtueimmuneprileugGeoMxdiglptilprilgchrcterizeimmunemicroenvirment(IME)primrymelnomSLN16Sgenemplicequencg/wholemetgenomicequencgnlyzefeclmplemelnomptient11)Low-rkvHigh-rkprimrytum12)NegtivevPoiveSLN13)CliclStgeIIImelnomceivgneodjuvntICBSttticlcltinlyeppliedidentifygutmicrobilfetuocedimmunemodultimelnomprogimett2)DeletetrtegiemodultegutmicropventmelnomprogiLNmettWevetigteculltihiptweengutmicrobiometumprogiLNmettugnduciblemodelmumelnom(cKERT2BrfV600EPtenfl/fl)eg21)ImpctFMTpdern-pderptientprimrytumprogiLNmett22)IMEbothprimrytumSLNidentifymicrobiome-dependentimmunologiclmechnmtumprogi23)EffectperturbtigutmicrobidevelopmentgilLNmettTheimpctthwkcognigutmicrobiomecricldetermntmelnomprogprimrymettgilLNidgdevelopmentnextgenertipprochepventLNmettmelnomcncerPROJECTSUMMARY/ABSTRACTCurnttrdtri-modlyrpy(chempyrdiurgery)locllydvncedctlcncerocedhighmbidylycudeebout75%ptientWehypoizebiomrker-drivenpprochgivemtchedtrgetedrpyptienterlyttmentlocllydvncedctlcncerledhighnti-tumctivyprovidechncevoidrdi/urgeryocedmbidieWehveldypieeduchnpprochmmtchpirdeficientlocllydvncedctlcncerwhecliclcompletepeweenllptientwhocompleted6mthupfrtttmentimmunecheckpothibir(23/23100%completecliclpe)llowgomirdi/urgeryInthpropolwefocuptientHER2-mplifiedctlcncerhypoizeductirpyHER2-trgetedttmentledtumgimodifyneedtri-modlyrpyWepropoenvetigr-edpheIItudy(NCT05672524MSKIRB#22-185)centlyopenedenrollmentllptientceivetuctibplutrtuzumbductiHER2-trgetedrpy6weekctuetuctibplutrtuzumbdditrd--cchempy4mthfolloweddeeementetrdchemdieurgeryPtientcliclcompletepeductiHER2rpylecomdchempycombtifollowedchemdiundergoobervtichncengn-prgmngementpprochOurcentrlhypoprimrytumhighlyeniveHER2-trgetedrpylecombtitrdchempyledghigherfquencycliclcompletepethntrdtlneodjuvntrpyTtmentctlcncerptientprovideuniqueopptunyobn-ttmentlgudltumbloodmpleevlutemechnmpetnceWehypoizelevelHER2expicequentdependenceHER2homodimerunderliedrugpedetermeHER2expibiopymple89Zr-trtuzumbPET/MRIclteperteprogi-feurvivlCircultgtumDNAtetedbiomrkerpeEtblhednewlygenertedptient-derivedHER2-mplifiedcoloctlcncergnoiduedmodeltudycquidtncetkgdvntgeourtemexpertegenertgethe-dimenilmulti-cellulrtructuwhichbothcpultebiologyctlcncerprovideneededourceexplimedHER2-mplifiedctlcncermodelcurntlyvilbleWehypoizekeytncemechnmctdecedHER2expiecdryltertictivteERKhifttumtrncriptilprogrmTogerwedefeefficcybiologicleffectbiomrker-dictedrpyimtrnmttmentptientHER2-mplifiedlocllydvncedctlcncerPROJECTSUMMARY/ABSTRACTApproximtely50%ptientovrincncerhrbdeficiencieDNAdmgepirwiirgermle/omticmuttiBRCA1/2homologoucombtideficiency(HRD)nefmtenncerpypoly(ADP-riboe)polymerehibir(PARPi)followgdjuvntpltum-bedchempyUntuntelymoteptienthvedeecurncedeveloptncePARPrpynultimtelyn-curbledeeHowevernovtivecombtitrtegiecnutilizedovercometncewellproviderpeuticnefimprovgliveourptientWehveidentifiednovelfirtclgentcirtuvivtdemtrteglegentctivyovrincncerpotenteuniquemechnmovercomePARPtnceynergizePARPrpyPARPtnvrincncermodelCirtuvivtCDC-likeke(CLK)dulpecificytyroeke(DYRK)hibirupectedmultiplenti-tummechnmctiOurpcliclwkhdemtrtedthedtctmechnmctivycirtuvivt1)cglterntiveplicgevent2)hibgWnttrncriptilctivy3)cgR-LoopmtiAlterntiveplicgnmlphyiologicfunctillowcellchngem-pecificproteproductipeextrcellulrtrcellulrtimuliAltertiimplictedtumigenemettCirtuvivtlterlterntiveplicgWntgeneOurwketblhedPARPtnthighgrdeerouovrincncercelldplyhyperctivtiWntignlgcedTCFtrncriptilctivyledgPARPtnceWeeetblhedrtilecombtiWnthibiPARPrpyovercomeWntdriventnceAddillywedemtrtecirtuvivtduceDNAdmgeR-LoopmtiovrincncercellleR-LoopDNA-RNAhybridctedDNAdmgepirIncedmtiR-LooplenduceptibilyPARPdependentDNAdmgeFllyynergyPARPhibicirtuvivtwdemtrtedpnelPARPtnvrincncercellleBedthrtileAim1evlutePheIclicltrilcombticirtuvivlprib(PARPhibir)pltumtnvrincncerptientgermleomticBRCA/HRDdeficiencywhohvepvioulyenttedPARPiWeevlutefetylerbilythcombtigoletblhgcommendedphe2dogAim2focuedevlutiCLK/DYRKhibiductiR-LoopDNAdmgeubequentuceptibilyPARPhibiWetriveelucidtemechnmynergyetwodrugtroducemviblerpeutictrtegyignificntptiovrincncerptientPROJECTSUMMARYDypneemotcommdtgympmocedcnceroccurrgnerly70%ptientdvncedcncerDypneocedimpidfunctidecedqulylifehtenedurvivlPvioutriluggetextgplliveterventiuchlowflowupplementloxygenopioidhvelimedefficcyDuepucyhigh-qulyevidencecurntlynoUSFoodDrugAdmtrti(FDA)-pprovedttmenptiMultiplegnizticludgIntuteMediceNtilHopicePlliveNureAociidentifieddypnepriyerchThelg-termgolourerchdevelopevidence-bedrpiepllidypneptientcncerTheoverllobjectiveourpropoedhighrkhighimpcttwo-rmprllel-groupw-ltctrolromizedclicltrilcompefficcypirryrpt(RT)-ledStructudPerlizedOxygenupptTherpiedypneONcologyptient(SPOT-ON)terventiwhnceduulcdypneBedourplimrydtwehypoizeperlizedRT-ledterventicptgtime-limedtriloxygenupptrpiewouldeffectiveducgdypnecutelyillhoplizedptientcncerThetwoprimrypecificimthtudycompeffectSPOT-ONenhnceduulcchngetenydypnet24hhoplizedcncerptienthypoxemi(PrimryAim1)outhypoxemi(PrimryAim2)ThethirdimcompeffectSPOT-ONenhnceduulcptienutcomeover72hcludgdypnetenydypneunplentnedypnepevlignympmburdenhelth-ltedqulylifedvereeventptterndeviceuehoploutcomeThefourthimefcrocedefficcySPOT-ONterventicludgptientdemogrphicpfencelevelugeoxygendeliverymodlieAfterobtgmedcentRTdmtertructudtudyterventimirprticipntcloely72hourThtudyhighlynovtivecue(1)firtclicltrilpecificllyexmeRT-ledterventipllidypne(2)exmehowtime-limedtrilcnuedperlizedypnemngement(3)providettmentbedptientpfencetedphyicinpcripti(4)teteffectvriouoxygenmodlieptientouthypoxemi(5)doptperlizeddypnegolnovelpecreri(6)employnnovtiveperlizedtrildeignSuccefulcomplethdefivetudyexpectedidentifyoptimltrtegyducedypneoxygen-bedupptrpieReultthtudyexpectedenhncequlylifeptientdvncedcncertrnmmngementdypnehiftprdigmympmerchProjectSummry/AbtrctMcrophgeemjcellulrelementtummicroenvirment(TME)Tumocedmcrophge(TAM)mrkedlyoutnumrdendriccell(DC)pentpromentpopultintigenpentgcell(APC)TMEAementirnumrdtriihumnolidtumprovideeluiveprdoxiclmtigrdgirrolehumntumimmunyBedtudiemuytemmcrophgehricllyclifiedM1M2ubetHoweverphenotypechrcterticfunctimcrophgedetermedenvirmentlmilieuwhichmcrophgeideLikePD-L1/PD-1pthwyweimtidentifictipvioulyunknownimmunetncetrget()whichmypotentillytrgetblepecificmocllntibody(mAb)HencewehvettemptedexploltihiptweentrnmembrneproteAPC(tumcellwell)ICBefficcyptientcncertumrgnimlmodelWedcoved()membrne-pnng4-domubfmilyAmemr7(MS4A7)wpdomntlyexpedTAM(b)MS4A7ctriedponti-tumimmunycltedimmunetnceICBbothhumnmice(c)MS4A7terctedpventedTREM2(Triggergceprexpedmyeloidcell2)clevgeultgducedexpikeyfunctilgene(uchMHCCD86)mcrophgenimpidmcrophge-mededphgocyducedTcellctivtiBedeurprgnovelfdgourcentrlhypoMS4A7endowTAMphenotypehpeICBefficcyblockgMS4A7pthwycouldprogrmTAMTheeMS4A7myeloidcellocedpvioulyunknownimmunetncemembrneprotepotentilnovelICBtrgetInthpplictiwepropoetwopecificim7ubimtetthcentrlhypomechnticllyfunctillytrnltillyengggbiomticgenomicproteomicimmunologiclolnovelMS4A7-neutrlizgntibodieAim1teurhypoMS4A7ctrieTAM-mededimmuneuppiAim2teurhypoMS4A7-TREM2xctrolTAMtumimmunyThepropoldeferoleMS4A7tumimmunyunderlygmoleculrmechnmbothhumnmouecncerettgeexplolikelycncerimmune-levntmembrne-pnngfmilymemrprovideproprcipletrgetgpecificmembrne-pnngprotemyugmenttumimmunyenizeICBefficcyPROJECTSUMMARYThemTORpthwymtergulrnutrientmetbolmcellprolifertipeenvirmentlcueIthlgenviewednimptntdrivertumigenenidelcncerrpeutictrgetMultiplemTORhibirhveentetedmothn500clicltrileirglegentcombtichempycncerttmentHowevermgnerly200completedtrilfewhowpoiveoutcomechllenggutilymTORneffectivecncerrpeutictrgetAntegrrextrcellulrignlcellulrpemTORpthwycriclcellulrdpttienvirmentlchngeInprticulrmTORhibiduceembryicdipueveribledmncyttedevelopmentpeunfvbleenvirmentcueWenlogouroleembryicdipuemTORhibimyducendptivedipue-likedmntttecncerledgpertenceidultumfollowgchempyInlethnoticenttudiehvedeedptedmrkedlyducedmTORctivyidultumHoweverculltihiptweenmTORhibumpertencehnotenetblhedvetigtedIntegrtgmultiplette---rtpprocheourcenttudiehowmTORhibideedducedipue-likeperterttetumcellWecfirmthpn-cncerphenomenugtumdiveretueigdemtrteperterttecpulteidultumptientfollowgchempyImptntlyourtudieidentifyferropkeydruggblevulnerbilyperterBuilnecompellgfdgwehypoizemTORmtergulrdipue-likeperterttetummodultgurvivldmncyThecurntpropolimvetigtemechnticgultiperterttetetrpeutictrtegietrgetidultumpcliclmodelultimtegolpventtumcurnceptientAbtrctCerviclcncerhighlypventblewhendetectederlymngedpproprelydymottendignoedunder-ceneddividulfterfilufollow-upbnmlcengultCerviclcncercengmngement(CCSM)complexbothcengmodliemngementguidelehvecentlyevolvedThe2018USPventiveServiceTkFcecengguidelecommend3trtegiecencerviclcncerPptetoptiflexhumnppillomviru(HPV)tetgPp/HPVco-tetgHPVleThe2019AmericnSocietyColpocopyCerviclPthology(ASCCP)guidelemnggbnmlultflectprcipleequlmngementequlrkpromotghighlyperlizedmngementyncurntpriultmximizenefcncerpventiwhilemimizghrmover-tetgover-ttmentYetcomplexyecurntevidence-bedcliclguidelemkechllenggclicinimplementprcticeLcktegrtiASCCPlghmelectrichelthcd(EHR)nimptntbrriermngementAultcompletecctfollow-uppentngoggrowgchllengevolvgcomplexterctimgptientprimrycprctierpeciltImplementgperlizedrk-bedcerviclcncercengquiddgbrriertdividulbothptientprctierlevelwelltctemhelthytemlevelWepropoedeveloptetdemtehelthmtechnology-enbledmultilevelteppedcterventigroundedprimrycPREDICT(PerlizedRk-bedFollow-upCerviclCncerScengPrctice)cerviclcncercengctuumPREDICTdeignedhighlyclbleugnopenourceCCSMoltegrtedugntildttrdended21tCenturyCuActFlRuleKeyPREDICTcompentcludeytemdeignpromoteidentifictrckgEHR-tegrticliclguidelepromotebothv-bedpopultimngementuedividulptientprctiermderolpromoteenggementenhncetemcodthroughnefficientteppedcpprochTheeffectiveneimplementtiPREDICTevlutedcductg3-rmcluterromizedctrolledtril(trdcvv-bedmngementvpopultioutch)dividul4primrycnetwkThedeignllowuexmemrglcumultiveeffectiveneterventicompentprimryeffectiveneoutcomeceiptppropreCCSM120-dycomgduecGuidedImplementtiEvluti(RE-AIMQuEST)Determti(CFIR)frmewkweechcceptbilydoptiimplementtimtennce/utbilyterventiProjectSummry/AbtrctThprojectimdevelopcompctfixedmleoluticptgFixed-FieldAlterntgGrdient(FFA)technologynovelultr-ftenergydegrderultr-rpiddoedeliveryprrpyBylevergguniquecpbiliethytemweeekenhncequlyprrpyptientignificntlyducettmenttimecotprrpyInprticulrdelivergechfieldfewecdthytemenbleeffectivemoefficientttmentmovgtrgetAtmetimehigherptientthroughputignificntlyducedcotfciliehotgthcompctytemimprovecceibilyprrpyUnedSttewldwideMooverup50%hterttmenttimeignificntlyimproveptientcomtTheprojectcompoedthepecificim(1)Ultr-ftmdelivery(2)Bemtrnptfglettmentroom(3)TechnologyvlidtiSpecificAim1focuechievgultr-ftdoedeliverydeigngvlidtgnultr-ftenergydegrderytemcpblerpidmenergychngeAfull-izeprotypedegrderengeeddutrilprtnerPyrmidTechniclCultntThfolloweddeignFFA-bedmtrnptenblgefficientenergywchgrpiddoedeliveryTheFFAltticemodeledimulteddetilPyrmidTechniclCultntlodevelopftpencilmcnng(PBS)ytemwhichtegrtedmledeignWeertivelyoptimizeentimtrnptoluticidergcliclquimentmqulySpecificAim2enumtrnptytemfglettmentroomThvolvedeigngopticmextrctiegmentenblgcomptibilycompctttmentroomizeLINACvultTwooptittmentroomvetigtedcludgcompctceilg-mountedynchrotrupercductgcyclotrpidourytemSpecificAim3focuevlidtidevelopedtechnologyExperimentltetgcductedvlidtedegrderprotypeftPBSytemegirpeedccurcydoedeliveryFurrmodown-cledFFAmgneticmletlleddemtrteytemfeibilynchmrkoutputmprmetergtdetiledprticletrnpttrckgimultiSuccefulcompletieimpvewytrnltiFFAtechnologycomdnultr-ftenergydegrderp-commercilprotypecompctmlefergpromgolutiexpedettmentimproveptienutcomeddlimedvilbilyhighcotprrpyPROJECTABSTRACTTobccouehlrmglyhighrtemgpeopleHIV(PWH)43%compd15%generlpopultiDuedevelopmenthighlyeffectivettmentHIVultgcedlgevymgPWHthpopultinowloemolifeyermokgthnHIVfectielfNoveleffectivemodeldeliverwiderchgmokgceterventiPWHhighlyneededdictedpriyNIHDiglrpeutic(DTx)mynovelclblehighlyvilblepprochengggttgmokgthpopultiHoweverlthoughDTxmokgcetihveenhowneffectivegenerlpopultinolrgetrildtehexmedeffectivenetilodDTxmokgcetiPWHnoimplementticiencewkhexmedbrrierfcilrimplementtiDTxmokgcethpopultiInprierly-phewkwedevelopedLTQ-Huer-centedmokgcetiDTxtilodneedPWH(R21CA243911)ThnovelDTxbedmentlhelerventi--AcceptnceCommmentTherpy--henhowneffectivettmentmokgcetiLTQ-HloprovidecommendtiUSCliclPrcticeGuideleWetetedLTQ-HmotepilotromizedctrolledtrilCtentourcceptulmodelultdictedignificnteffectpilotprimryoutcome(1)highlevelobjectiveuerenggement(2)dhencemokgcetictent(3)fetueffectivelyddedourtrgetedcompent(egmentlhelthcognivedeficHIVtigm)LTQ-HqurtewehighcompdprimobilehvilmokgceterventithpopulthoughtrilwnotpoweddetectmokgoutcomediffencectrolgroupThetrilcrueddemogrphicllydiverempleptient9UStteetblhedltihipeverlHIVcliceternUSInthprojectwecducttype1hybrideffectiveneimplementtrilmedColidtedFrmewkImplementtiReerchThetrilim(1)compeffectiveneLTQ-HQuGuidenevidence-bedDTxgenerlpopulti(2)evlutecceptbilypproprenecotfeibilyDTxmokgcetimgPWHHIVclicThetrilfocuetwohigh-priyerchNIHStrtegicPlnHIV-ReltedReerchCncerMohotReerchInive(1)cptitte---rttechnologyimproveccehrd--chpopultiettg(2)ueimplementticienceddcncerhelthdprieThtudygenerteneceryclicleffectivenedtimplementtitrtegiegenerlpplictiDTxfututype3hybridtrilPROJECTSUMMARY/ABSTRACTMicrohveenimplictedcoloctlcncer(CRC)pthogenedefiveknowledgewidentiectrigmicroirbiologiceffectThecriclneedfillthknowledgegpcuedvnceundertgrolemicroCRCpthogenefernewighthowCRCproglghighlightgpotentilnewpprochepventttCRCtrgetgmicrobilpthwyIthenptedelectedlmicroenrichedgutptientCRCThfdgimplictepotentill-gutxCRCWepvioulyfoundthrlflmmtiuchperiodtducerrntexpnilpthobwhichcntrnloctedtlgtrotetltrctecpicllycolizeCtentpotentilpthogenicrolelflmmtigtrotetldeephenotypelrgehumncohttudyveledperiodtldeerkfcrCRCAkeylg-termgolthprojectdefepecificlmicroocedCRChibirctriiCRCWehveexmedfluenceperiodtlflmmtidevelopmentCRCugmouemodelddgbothperiodtCRCOurplimryultdemtrtefollowg(i)periodtfciltecolictumigeneAOM/DSScol-ocedCRCmodel(ii)periodtledrrntccumultigenoxicbcteri(colibct-producgpk+Echerichicoli)lcvy(iii)medlgenoxicpk+Ecolimytrnloctegutecpicllycolize(iv)gutcoliztilpk+EcolipromotedevelopmentCRCthroughcolibct(v)lStpcoccupecieco-exppk+Ecolidurgperiodtlflmmtipromotegutcoliztilpk+EcoliBedeplimryultoverrchghypothprojectpoly-microbilterctitweenlmicropromotecolictumigeneWeplnfurrexplothhypopurugfollowgtwopecificimInAim1wedetermemechnmwhichlbcteriocedperiodtlflmmticoopertivelypromotetumigenecolWehypoizelStpcoccupeciepromotecoliztipk+EcolicolicepiliumledgenhncedtumigeneInAim2weclrifyrolecolibctecpicgutcoliztilpk+EcoliWehypoizecolibctquidmximizefneEcolidurglflmmtitbilybcteriumdurgnicheloctiecpicgutcoliztibcteriumThecompletipropoederchyieldimpctfulighthowlpthobctrieCRCpthogenefdgclrifyhowdevelopnewrpieCRCpventtmenttrgetgl-gutxProjectSummry/AbtrctFerropuniquetypeprogrmmedcelldehtducedexceivelipidperoxidtiEmerggevidenceuggetferroppentvulnerbilycerttypecncerhvecquidtncerpieHoweverignlgmechnmcnhrneedpromotecncercellferropfunctilcequencetummicroenvirment(TME)progrmmgpolyunderodInthPropolweimtudypvioulyuncognizednti-ferropticeffectimprtedmichdrilclciumignlgwhichmyloctrieetblhmentimmunouppiveTMEMichdrilclciumunipter(MCU)highlyelectiveclciumchnnelloclizednermichdrilmembrnewhichpromoteproductimetbolecetyl-coenzymeA(cetyl-CoA)trgetgpyruvtedehydrogene(PDH)InplimrytudiewedcovedMCU-mededcetyl-CoAgenertiblockbothcncercellferropntumimmunyWefoundgeneticbltiMcu(Mcu/)bolhedcetyltiglutthieperoxide4(GPX4)criclgtekeeperferropwhichcltedimpidGPX4ctivyenhncedenivyferropductiMooverMcudeficiencycncercellignificntlybluntedirgrowthimprovedntumimmunepeTheeblockdeMCUfunctimypentpromgrpeuticgimencncerThegolourpropoederchpropolexmefunctimechnmMCU-mededcetyl-CoAmetbolmGPX4-ctrolledferropimpcnntumimmunyWehypoize1)decedcetyl-CoAproductibenceMCUenizecncercellterropdueGPX4hypocetylti2)elevtedferropticcelldethMcu/cncercellpromoteproductype1terfertrtumlmyeloidcellvicyclicGMP-AMPynthe(cGAS)-dependentDNA-engpthwyledgenhncedntumimmuny3)phrmcologiclhibiMCUMCU-i11ynergizeprogrmmeddeth-1(PD-1)blockdelimgtumgrowthRepenttiveyngeneictummodelhighlowimmunogenicyemployedexmeeffectMCU-mededferropntumimmunySgle-cellRNAequencgnlytum-filtrtgimmunecellpeMCU-i11ttmentpermedundertwherMCUhibipromotentumimmunyReultetudieprovidenovelightductifunctiferropjuventgntumimmunywhichcnpotentillyledidentifictinewrpeutictrgetcncerttmentProjectSummry/AbtrctCol-ocedcoloctlcncer(CAC)emotdedlytypecoloctlcncer(CRC)cuemotmbidymtlyptientflmmryboweldee(IBD)TheerlydetectidyplticmlignntleiptientulcertivecolchllenggwhichulteddelyeddignolimedrpeuticefficcyCACBilecid(BA)erlydietryencriclmedirgutphyiologyprtlyffectgirmterceprFrneoidXRecepr(FXR)ctivyBAoverproductiimplicteddirrheocedIBDCACwhichfunctiFXRevelycompromedTheBA-FXRxcvergentpotgeneticdietryrkfcrCRCInddiFXRcrucilmodulrpro-nti-flmmrypetetlepiliumIntetlmcrophgectutelrgetpoolmcrophgebodyhveemergedcrucilentelgutmicrobiomemetbolecogniHoweverdueexceptilplticygutmcrophgedurgcncerprogimjlckmechnticundertghowgutmcrophgeeneBAhowFXRgultegutmcrophgefunctimedetercticelltypeCACOurplimrytudieveledepiliumdmgetetlflmmtiultedloBAhomeotcompromedFXRignlgCACmicemodelOuroverrchghypodygultedBA-FXRxfurrducepthologiclimmunelcpechngeepecillymcrophgewhichcrotlkedTh17cellgerpromotgtumigeneThpropolimevlutemechnmcti(MOA)FXRgmcludgFDA-pprovedOticholiccid(OCA)gutmcrophgediffentifunctivrovivocludgexpninimltetgdeletebdhnti-cncerefficcybothcolCACnimmunomodulrdrugThepecificimpuruedAim1vetigteimpctflmmti-tum-ducedhot-microbil-derivedBAmcrophgecrotlkTcelltetltemcellAim2vetigtegutmcrophgedependenceFXRmodultgfunctiCACmicemodelAim3thpropoldetermerpeuticutilyctivtiFXRgutmcrophgettmentCACBeidewelovlidtecombtirpiemximizeefficcycncerttmentcludgrtilcombtinti-IL23FXRgtWelievevetigtgroleBA-FXRxflmmti-ducedtum-filtrtedMcrophgefcilteourundertgetiologycol-ducedcolcncerThepropoedtudyFXRlightendevelopmentnovelrpeuticthdebiltgmotlethlcoloctlcncerPROJECTSUMMARYThelotumuppgeneSMARCB1comemrSWItch/ucroen-fermentble(SWI/SNF)chromtmodelgcomplexdefegroupmlignnciechrcterizedprticulrlyggivecliclcourepromentmetttichviRenlmedullrycrcom(RMC)motcommlydignoedSMARCB1-deficientnlmlignncypdomntlyfflictyoungdividulAfricndecentcrrygicklecelltrSMARCB1-deficientnlmlignncieextmelychllenggdeefilpdtrd--crpeuticgimenuednltumInourcentwkwefoundSMARCB1-deficientnlmlignncieuchRMCchrcterizedhighlyflmedphenotypeyetdemtrteccelertedtumprogi(hyperprogi)petrdimmunecheckpothibi(ICI)Ourplimrydtpropectivelycollectedtuepecimenimmunocompetentgeneticllyengeedmouemodel(GEMM)RMCuggetthhyperprogifollowgICIdueenggementmyeloid-ffiledtrncriptilprogrmtumcellOuroverrchghypohijckgmyeloid-ffiledtrncriptilcircuSMARCB1-deficientnlmlignnciemjmechnmdrivgICI-ducedhyperprogiwhichcnpventedtrgetgmtermyeloidgulruchS100A9CEBPB/p300complexInfirtimwepermimmunogenomicprilgtudietgle-celllevelourclicltriltuepecimenimmunocompetentGEMMdetermehowICIugnti-PD-1lecombtieirnti-CTLA-4nti-LAG-3modultetumimmunemicroenvirmentdrivehyperprogivienggementmyeloid-ffiledtrncriptilpthwyInecdimwepermtrnltilgenomicphrmcologicexperimentourGEMMRMCdetermewhertrgetgS100A9CEBPB/p300complexcnduceenivyICISMARCB1-deficientnlmlignncieInthirdimweutilizefirt--cltechnologyenbletrievlICIrpy-tntclevetigteclldynmicourGEMMdetermeroleSMARCB1loenggementmyeloid-ltedtrncriptilpthwyubequenthyperprogumcellfollowgICIttmentThprojectlticfeiblepropoedtimelebudgetcueutilizetechnologytuemplemodelSMARCB1-deficientnlmlignncieldyvilblemultidciplryerchtemexpertdedictedtrnltilpipeleledPIDrPvloMouelOurpprochcnprovidefundmentlmtiboutmechnmICI-ducedhyperprogiSMARCB1-deficientnlmlignnciewhichubtntillyimproveourundertghowoptimllyelicntumimmunepethuopennewrpeuticvenueedeedrivenloSMARCB1ubunSWI/SNFchromtmodelgcomplexMicrobiomeimpctcncerdevelopmentrpeuticefficcyInddigutmicroidediffenttuefluencgpthophyiologytuemicroenvirmentTheetue-identmicrolrgelyttriedtrnloctigutmicroInbtuchpgetermedgut-btxhelpgetblhmicrobiotbttuemilkNeverlegut-btxhenmotlycceptulizedroundpgnncycompletelyunknownwherthxdeedextoutidepgnncyimpctbthelthcrcogeneOurlg-termgoldecthowmicrobiomectriebtpthophyiologyEpecillyobjectivepenttudydetermei)whergut-btxoccurgulrbii)wherthvolvedcteetbcterihelthycohtvcncerptientiii)whtirroleOurcentrlhypogut-btxtkeplcegulrbvolvgdtctetbctericfernti-tumeffecthelthycohtvpro-tumeffectcncerptientThepropoederchbedourplimrytudiellowguhrvetpecificgutmicrobiottum-protected-uceptiblenimlWeptedupplementgepipter(SEP)endogenoupcurtetrhydrobiopter(ccrnricoxide(NO)ynthe)nmlizedrgemetbolmimprovedimmunogenicyHER2-poivemmmrytumWenllyppliedSEPmicepreHER2-poivemmmrytumwtrgtumpventiTheemicelohowedceNOlevelNO-producgbcterigutBeideextrctegutbcterictivtednteimmunecelluggetgroleegutbcterinti-tumimmunyHewedetermewheregutbcteriphyicllytrnloctebtexerttumpventtiveeffectOurhypotetedthroughtwoSPECIFICAIMS1)Determewhergutmicrobiot)tum-protectedvb)-uceptiblemiceexertnti-tumvpro-tumeffect2)determewherdtctetgutmicrotrnloctedmmmryglexertnti-tumvpro-tumeffectInAim1wetrnplntgutmicrobiot)tum-protected(SEP-tted)b)-uceptible(DMSO-tted)HER2micecipientgiveveredrugttmentWetetwhertrnplntedmicrobiotntgizettmentInAim2gutmicrobiot)tum-protected(SEP)vb)-uceptible(DMSO)micediffentillylled5050mixtugivencipientundergogSEPDMSOttmentLledmicronlyzedirgut-bttrnloctiirrtiobtctriibtmicrobiotdrugeffectThepropoedtudynovtivecuethfirttimecrobtegut-btxctriibtpthophyiologyThetudyignificntcuehvepoivetrnltilimpctjutifygdevelopmentnewbtcncerttmenrpventitrtegyfocuedbtmicrobiotPROJECTSUMMARY/ABSTRACTOverviewThegolthtudyexmeefficcynoveldiglpplicti(pp)improvgqulylife(QOL)pychologicloutcomeptientdignoedcutemyeloidleukemi(AML)BckgroundPtientnewlydignoedAMLcfrtuddenlife-engdignoquirgnimmededruptiirlifenurgent4-6-weekhopliztietenivechempyDurgthhopliztiyenduubtntilphyiclympmdueide-effectchempywhichnegtivelyimpctirQOLImptntlyptientloexperienceimmenepychologicldtytrugglebrupnetillneuncerttygrdgirprognophyiclociloltidurghoplizticompletelodependenceDepewell-decridpychologiclequleptientAMLexperienceterventiupptmdurgthchllengghopliztilimedMooverlimedvilbilypllivecmentlhelthclicinfurrhderclbilydemtiupptivecterventiddneedllptientAMLWedevelopedelf-dmtednoveldiglpp(DREAMLAND)ptientAMLundergogtenivechempyDREAMLANDcludefourmodulefocu1)upptivepychpyhelpptientdjuthockdigno2)pychoeductimngeillneexpectti3)pychoocilkill-buildgpromoteeffectivecopg4)elf-cWecentlycompletedpilotromizedtrildemtrtgfeibilyDREAMLANDpromgefficcyimprovgptient-ptedQOLnxietydepiympmwellelf-efficcyympmburdencompduulcBedefdgDREAMLANDceivednFDABkthroughDeviceDeigntipromgdiglrpeuticAMLReerchPlnWepropoecductmulti-eromizedtrilDREAMLANDveruCERENA(phy-iclhelthpromotictrolpp)200ptientAMLundergogtenivechempyteteffi-ccyDREAMLANDimprovgptient-ptedoutcomelrgemodivereptientpopultiWeloeimpctDREAMLANDptientlg-termQOLpychologicloutcomewellexplomedirmoderrterventieffecnptient-ptedQOLEnvirmentThprojectcductedtMchuettGenerlHoplDukeCncerCenterFdHutchCncerReerchCenterTheeehveupptivecerchleukemiexperiencefrtructuproceecductrilTheMGHerchtemhexpertedevelopgtetgplliveupptivecdiglhelerventiptientolidtumhemlogicmlignncieenuuccefulimplementtirilcrolltudyeRelevnceReerchDtthprojectuedobtFDApprovlDREAMLANDdiglrpeuticcnpcridddimmeneneedptientAMLProjectSummryAfricnAmericn(AA)menhvencedrkbothprottecncer(PC)cidencemtlyAlthoughocio-ecomicttuenvirmentlculturlfcrlikelyctriethrcildpryemerggevidencehhownnimptntrolegeneticepigeneticfcrpthogeneAAPCAndrogenrogencepr(AR)-mededignlgpthwyplycentrlroleprottetumigeneTheARlig-ducedtrncriptilfcrctnN-termltrnctivtidom(NTD)TheNTDhumnARpoeepolymphictrucleotidepetCAG(cyedenegune)whichcodepolyglutme(PolyQ)trctThelengthCAGpethumnARgenehenhownverelycltedrkdevelopgPCgedeeetrkdvncedPCtdignoIntriguglyAAmenrhterCAGpetignificntlymofquentlythnCucinAmericn(CA)menlkglengthpolyQtrctpthogenePCAAmenAddillyignificntco-ctivtirogenWntignlgpthwyhenveledftgrowgerlyetPCpecificllyenrichedAAPCmpleMooveremerggevidencehhownnicheroletromlARupptprotticepililcogeneHoweverdepeetrigugfdgptcientificprogcogenicroleltedmoleculrmechnmAR-mededignlgpthwyPCtumigenepecificllyAAPCrcildprymeluivelyOnebottleneckehtflllckbiologicllylevntnimlmodelcncpulterrntARctivtipromotgPCdevelopmentprogimimickgutiAAptientTodictlyddthchllengewepropoeerieexperimentugournewlevntnimlmodelhumnPCmplegle-cellRNAequencgdvncedpprochedictlyteurcentrlhyporrntctivtiARrghtpolyQtrctbothprotticepilitrompromotePCiprogihmefrcAAptientSuccefulcompletipropoedtudyhoulddictlyimpctcurntprdigmleddevelopmentnewpventiverpeutictrtegieimproveclicloutcomeAAPCptientProjectSummry/AbtrctWholebrynpticdenyimggqunttiveporemimogrphy(PET)hdemtrtedcriclightundertgneurodegenertivedderepilepyepecillyettgnmlnmiclMRIWepropoeuequnttivewholebrPETnovelynpticdenytrcerchrcterizeynpticdenychngeettgtrgetedrdirpyrodentcltecognivechngethccurfterrdirpyWhilerdirpylife-vgtrdcttmentcentrlnervouytem(CNS)mlignnciebothdultchildncognivedecleemjcomplictihentiedmultifcrilmechnmwhichcludeloynpewhemtterdmgeendolilcelldmgectivtineuroflmmrymrkerhippocmpup-frtlctexHippocmplprgrdirpyledgpprochpervecognivefunctiptientquirgrdirpyUntuntelyevenfterhippocmplprgrdiover50%ptientdevelopdebiltgcognivedecleWhcelgtermurvivlptientCNSmlignnciecriclneedundertmechnmhdrdiducedbrjurypiecntrgetedpventpot-rdicognivedecleCurntlynoetblheddrugpvenrttequelerdinbiomrkermircellulrdmgeAvilbilyecoulduedmodifyttmentprocolpridevelopmentevecognivedecleChrcteriztiwholebrdynmicchngeynpehowyltedwhemtterdmgehvenotenevlutedupnowcueoltudywholebrynpticdenyhvenotendilyvilbleTochrcterizemechnmhdrdiducedcognivedecleweuenovelPETtrcerhenetblhedmeuynpticdenyqunttivePETmodelgquntifictiynpticdenydiffentgihumnbrWeembledtemexpertfieldqunttivePETrodentqunttiveMRIrodentrdirpyrodentneuropthologycogniveementdetermetimecoureynpticdenychngediffentgibrhowltepthologiclementynpticdenywhemtterdmgeneuroflmmtiThehttermgolthprojectchrcterizehippocmplextr-hippocmplynpticdenychngertftertrgetedhlf-brrdiThelgtermgoluethmodelchrcterizemoleculrmechnmrdirpyducedCNSdmgehumnptientmutundergdtmentbrtumComplethprojectchrcterizenoveln-vivebiomrkerrdiducedcognivedeclecntrnltedclicltriluedmirgynpticdenychngeperlizettmentProjectSummryAdoptivecellrpy(ACT)chimericntigencepr(CAR)TcellhdemtrtedimpiveperteBcellmlignncieACThnotmededutedpeolidtumCD19CARTcellrpyhchedup80%perteclichowevermideeffectcykeleeyndrome(CRS)immuneeffecrcell-ocedneuroxicyyndrome(ICANS)whichoccur3783%bout25-35%ptientpectivelyFurrmoemjobtcleACTheterogeneytrgetedntigenlpeduentigenecpeRecentlywecenedcoht16FDA-pprovednti-flmmrydrugidentifiedclzime(CLF)pcidtedeidbifunctileffectnti-CRS/ICANSnti-ntigenecperoleAim1determeroleCLFducgmcrophge-derivedROScurtilCRS/ICANSAim2determeroleCLFdrivgdRNA/dDNAignlmcrophgeerdictumWeexpectthtudydemtrtebilyCLFpotentgnti-ntigenecpecpcyACTcurbgtrctbleCRSmylofilldepertecliclneedimprovedmlptienturvivlICANSThtrtegypurpogclicllypprovedCLFmyholdgtpromeovercomecriclobtclelizgfullpotentilACTCAR-TcellThtrnltillylevntwkcouldnlyfoundtifutuclicltrilABSTRACTThU01pplictiim(1)developrobutprocouticdoimeter3DvivodoimetryprFLASHrpywhicheentilcliclpplicticceptnce(2)mmulti-dciplrymulti-tutilerchprtnerhipcptgbothcdemicdutrilentiehtenctiimplementthnovtivedoimetercliclugeenug5-10yerMothnhlfcncerptientceiverdirpy(RT)irttmentjourneyThecentRTmethodFLASHugnultr-highdoertenotedbilymimizenmltuedmgewhilemtgtumctrolPrrpyemerggpromgdeliverymethodFLASHEnurgpciprFLASHdeliverycriclgivenhighrkuchttmentErrultr-ftdeliverycnignificntlyffectdoedeliverytumhelthytueAultnurgentneed3DvivodoimetervlidtiguidncectuldoedelivedFLASHThneceytemfctcurntdoimetercnthleultr-highdoerteFLASHlckvivovolumetricdtThudevelopg3DvivodoimetrykeypcedeliveryprFLASHRTOurpropolvolvectinovelProcoutic/UltroundDul-modlyImggSytem(PUDIS)meetthpgneedPUDISueprocouticimggdoimetryvlidtiwepieerexplgrdi-ducedcouticimggrdidoimetryRecentlywevehownpotentilugprocouticignlvivodoimetrygleprpuleHowevermowkneededexploechnologyunderFLASHdoerteignificntlyenhnceimgequlypce3DdoimetryWeimccomplhhroughfollowgobjectiveAim1ChrcterizebprocouticimggFLASHdoimeterhumn-izephnmAim2Developrobutprocoutic/ultrounddul-modlyimggytem(PUDIS)doimetry/nmyverifictinimlmodelvivoAim3EtblhPUDISqunttive3DdoimetryytemFLASHrpyOutcome/ImpctThgrntultrigoulyvettedPUDISprotypemrkgfirttroducti3DvivodoimetryprFLASHRTBckedtemcro-tutilcdemicdutryexpertwenticipteuccefulprojectPUDISvivo3DdoeverifictictlyzepceprFLASHRTunlockgFLASHfullpotentilThccelerteerchpplicticceptncetmentultimtelynefgcncerptientvulnerbleRT-ltedxiciePrciplInvetigrRortErleSProgrmummryApproximtely20%llhumncncerocedviruefunctibiologiclccrdrivgecncerSomeeviruemyhvedictrolemedgecncerceHIV-ltedcncerwhichcludeKporcompleurleffuilymphomlymphoprolifertivedeeThelcenumrHPV-ltedptientexmpleimmunocompromedptientwhoHAARTrpyhedneckqumoucellcrcomTheTumVirologyTrgProgrmtUniveryPennylvniervecentrlumfciltgterctimgvetigrvolvedcncer-ltedvirlerchPenncmpuwhichprovidemodictedtrgteProgrmmemrhveexperteEBVKSHVHPVHCVHIVtrovirueThebiomediclcommunytPennwouldlikectuemomentumrgprogrmTumVirologytrgpdocrlpotdocrltudentThe21trthprogrmllwhomcommtedtrgppotdocrlfellowbiomediclerchcerThefcultyhvewell-fundedNIHprogrmuppteddiffentNIHfundgmechnmGovernmentprivtefoundtifundgThetrgprogrmeekctueuppt2pdocrl4potdocrltudentnnullyech5yerfundgThenumrtelbtrthprogrmhenctentlycgwenticiptendctugcomgyerThuwewouldlikehvevilblelotctuedcenumrpdocrlpotdocrlcidtevilbleprogrmVirlltedcncerexpectedcetechnologyidentifygegentimproveWectueprovidentmophecollbtitweencliclbiccienttourtewhohveopptunymulteidewhichledbictrnltiltudiegmtgcoheivegrouptumvirologyThecedcidencevirlocedcncercommmenttrtutiwell-gnizedtrgprogrmctueprovidenouttgtrgenvirmentp-potdocrlcidtetumvirologyOVERALLSUMMARYHepcellulrcrcom(HCC)primrymlignncyhepcytedignoblekoutcomeWhlrmgglobloycidenceoy-ducedn-lcoholictehept(NASH)comgledgcueHCCHCCuullydignoedtndvncedtgewhentumunectbleThemoteffectiveFDA-pprovedttmentdvncedn-ectbleHCCcombtinti-PD-L1(tezolizumb)nti-VEGF(vcizumb)ntibodieprovidgnoverllperte27%Aprtimmunpyytemicrpytyroekehibir(TKIuchfeniblenvtib)providelymodet(~3mth)ceoverllurvivlcuedrugtnceixmthRecenttudiedocumentimmunpymyleeffectiveptientNASH-HCCthnHCCptientvirlheptThununmetneeddevelopnoveleffectivemodliettmentdvncedHCCThP01propolExpLogErpeuticVulnerAbiliehepTocEllulrcrcom(ELEVATE)whichvolvefourprojectndmtrtiveco(Co1)mouemodelpthologiclnlyco(Co2)biottticbiomticco(Co3BBC)imterrogtemoleculrchngeHCCexplomdevelopcombrilttmentpprocheepecillytrgetedNASH-HCCTheoverllobjectivecludeterrogtimoleculrmechnmgultgNASH-HCCdevelopmentnovelcombrilttmentpprochebedidentifiedmoleculrbnmlieevlutipprocheimproveefficcypprovedimmunpyugnunticNASH-HCCmouemodeldevelopmentevlutinovelpprocheenggeimmuneytemcounterctHCC(flmmryNASH-HCC)TochievethobjectivethP01compexpertnetblhedhryhighlytegrtedterctiHCCbiologymouemodelgliverphyiologypthologymediclchemtrycncerimmunpypthologicldignonnoprticledeliverybiomticbiottticSuccefulcompletipropoedtudieignificntlydvnceourundertgmoleculrmechnmHCCpthogenenovelrpeuticgenertetrnltillylevntdtp-cliclmodelhvgpotentilrdicllytrnmmngementHCCptientfciltgprolgedurvivlThuthnovtiveP01grnthhighmechntictrnltilignificnceELEVATEbrggerexpertehighlytegrtedtemprovidgynergticoutcomemynotdelivedechprojectleInvetigtgroleIkrovrintmultiplemyelompthophyiologydrugenivyMultiplemyelom(MM)complexheterogeneoudeewhichmlignntplmcellgrowccumultemrrowcugend-gndyfunctimbidyAlthoughurvivlMMhimprovedignificntlycquitnceMMptientultlpeledgchllengedeemngementThutterundertgmoleculrmechnmunderlygdeequididentifictinoveltnce/enivyprognoticmrkerTheilimpctMMttmentcmetroductilenlidomideLenlidomidecueelectiveubiqutidegrdtwolymphoidtrncriptifcrIkro(IKZF1)Aiolo(IKZF3)CeblubiquligeThetblheddependencyMMcellIKZF1irutedprolifertiurvivlAloIKZF1criclgulrlymphocytedevelopmentdiffentiItknownctbothctivrpgenetrncriptiWhileexmgdiffence3endRNAprocegtweenMMptientnmlplmcellwurprgfdnmlplmcellexphighlevelnIKZF1vrintwhichlotgroupMMptientPtientexhibgthlolohdhterprogi-feurvivlAthvrintgenertedcombtilterntiveplicgerlyclevgepolydenyltrgeneferdIkrotricclevgepolydenyltim(IKZF1-IPA)IKZF1-IPAlckfive3excttwolternte3exthudiffer3codggi3untrnltedgi(3UTR)compdIKZF1-full-length(IKZF1-FL)TheencodedIKZF1-IPAhdtctC-termuwhichignificntlyhterthnIKZF1-FLlckllknownDNAbdgwellhomo-hetero-dimeriztidomBedefdgwell-etblhedcogenicroleIKZF1-FLhypoizedloIKZF1-IPAcouldctrieMMpthogenecgcogenicIKZF1-FLlevellotumouruppivectivyIKZF1-IPAAnhypoMMcellexhibdiffentenivelenlidomidettmentpencebenceIKZF1-IPAThuAIM1howloIKZF1-IPApromoteMMpthophyiologyvetigtedAIKZF1-IPAexhiblimedimilryknownIKZF1mlckundertgboutbdgprtnerIKZF1-IPAlocliztipfenceIdentifygbdgprtnerprovideightboutmoleculrmoduoperiIthendemtrtedterctitweenIKZF1-FLIKZF1vrintimpctchromtmodelgctivyThuAIM2roleIKZF1-IPAhpgepigeneticlcpebdgprtnerlocliztipfencevetigtedUndertgfunctilroleIKZF1-IPAMMdvnceknowledgebouttnceenivypthwyMMItlollowdetermeifIKZF1-IPAcnerveprognoticmrkerMMttmentpeGivencentrlroleIKZF1developmentdeettmentknowledgegedthtudycnextendeddeemlignncieSqumoucellcrcomhedneck(HNSCC)complexdderctmultiplecellpopultimkgdifficulttudyntucellulrfunctideleteltihipmgubpopultiThenlygloblgeneexpiglecelllevelhevolvedtnundgpceptfewyernowchgophtictedlevelolveheterogeneycomplexgnToundertgvivotummicroenvirmentlrgecle(~10000cell)glecellgeneexpiycnelucidtetrnilttedeleteltihipmgubpopultiThegolthpropolchrcterizedtctpopultiHNSCCtromlprogenirexplocellulrmechnmwhichecellgultetumprogiultimtelytrnltefdgcliclcncerrpieUggeneticolSCCnimlmodeldthengenerteddemtrte1)uniquepotntlGli1+tromlpopultifoundcrnicilgi2)Gli1+cellhveprogenirunderhomeotticdeecdivivo3)tumprogiupptedtromlcompentelevtedHNSCCmicroenvirmentervechemo-ttrctnttumvi4)3Dcultuprimrytumkercytecncerocedfibroblt(CAF)howedtrtifiedgrowthcellprolifertidiffenticomprbletweenco-cultuirpectiventivetuewhileylrgelydiffedcultuoutCAFWehypoizeGli1+cellctdtctubpopultitromlprogenircrnicilgiGli1+cellplynicheroleupptgHNSCCproghroughmodelgepililmphogeneDurgthpropolweexplowherGli1+cellnicheupptcncerprogimettthroughlegetrcgGli1CERT2TdTommicediphri-mededlo--functiGli1CERT2DTAmice(Aim1)Subequentlythpropoluetrncripmicptilmoleculrnlygle-celllevelcomdcomputtilnlyfunctilvlidtiidentifyuniquevivotromlpopultimouehumnHNSCCelucidteirmoleculrpthwyigntuWevlidteeuniquecncertromlubpopultivetigteirfetugulrymechnmfunctiptilmoleculrchrcterticBedfdg3Dgnoidmodelgnovelvculrizedgn--chiptechniquenewlyidentifiedtumpecifictromlprogenirpopultiutilizedgenerte3DvculrizedSCCgnoiddcovernovelrpeuticvenueHNSCCmngement(Aim2)SuccefulcompletipropoldvnceourundertgntuvivotromleffecttummicroenvirmentdevelopnewttmentHNSCCPROJECTSUMMARY/DESCRIPTIONSmll-celllungcncer(SCLC)ccountgbout15%llcelungcncerwldwidemotlethlmlungcncerDepenillyhighpertechempychemoimunpymjySCLCptientextenivetgedeevriblylpeeyerAlthoughSCLCcurntlymngedgledeepltum-bedchempymgcnernettmenttudiehveidentifiedSCLCdplyboer-tr-tumlheterogeneydtcttrncripmechngeHoweverpecificmoleculrdetermntpemunclerepecillytumevolvenvechemo-pivettencquidchemo-tntttefollowgchempyEffectiverpeutictrtegieurgentlyneededimproveclicloutcomeWeddthknowledgegpoverllAim1undertghowcricldetermntchemoenivySchlfenfmilymemr11(SLFN11)mdegechemo-piveneSCLCubtypeInoverllAim2wetudyhowdiffentplictitpepthwyplictikmodulrwkccertgultechemo-enivyFllyoverllAim3wetegrteightgedwkpermeduppverllAim12developtrtegietrgetplictitpepthwycombtgcquidchemo-tnceSCLCyielddeepermodurblepeimprovedlerbilyTheerchwkhighlycodtedProgrmProjectfrmewktheCofcilieTheexperimentprogdicticienceechProjectmidfeedbckviAdmtrtiveCoAEtblhmentdiffentSCLCcelllePDXGEMmodelupptedCoBAdvncedmicrocopycomputtilpprocheechprojectupptedCoCTheProject/ColederhvecomplementryexperteJohnPoirier(functilgenomicProject1CoB)TyHung(moleculrbiologyProject2CoA)EliRrg(biophyicProject3CoC)DvidFenyo(computtilbiologyCoC)Kwok-KWg(cncerbiologyProject4CoB)Thenemblecomplementryexpertefotercro-fertiliztiideneficilwholetemmkewkpoiblecnlyccomplhedProgrmProjectgrntThtemloldyhlgtrckcdproductivecollbtiTheultobtedthProgrmProjectprovidefundmentldvncementundertgmoleculrmechnmunderpngDNAplictitSCLCrpeuticpvewydeignnovelcncerrpytrgetglpedSCLCptientPROJECTSUMMARYOverhlfptientttedcncerptccernltedexulhelthIfunddeduchccerncncueubtntildtcompromeptienthelthoverllwell-gAlthoughcliclguideleunimlycommendcologtdcuexulhelthirptientevidenceuggetexulhelthoverwhelmglyneglectedptientroutecncercOncologtlckknowledgekillwhicheffectivelydcuexulhelthlrgelycuemothveceivednolevnttrgAcenturveyhemlogy-cologyfellowhipprogrmUSourtemfoundmjyferltlenomltrgexulhelthThefilueductehemlogy-cologyfellowexulhelthfcepvlentcncer-ltedexulproblemciderbleptientdtctutecriclgpppdnecologywkceUSAtrgcourefellowddgcncer-ltedexulhelthlikelybothhighlycceptbleimpctfulcuewould()fwelleductilettgfellowhipprogrm(b)providefoundticlicin--trgdevelopeffectivecliclprcticeptterntegrtegulrcommunictiboutcncer-ltedexulhelthTheewepropoedevelopnovelvirtulcoureclledSexulHelthIntegrtiveFellowhipTrg(SHIFT)()provideeductikilltrgcommunictiboutcncer-ltedexulhelthhemlogy-cologyfellow(b)guidedyignificntplimryqultiveterventierchprojecttemctivevolvementdiverePtientAdvyBdkeytkeholderBecuecertcncerptientubgroup(egexulgendermyptient)myhveuniquecncer-ltedexulccerncommunictineedSHIFTcludectentfciltefelloweffectivecommunictiboutexulhelthdivereptientpopultiAim1projectdevelopSHIFTcourewhichweexpectimprovehemlogy-cologyfellowknowledgeliefbedocilcognivey(ieelf-efficcyoutcomeexpectncieexulhelthcommunicti)cliclcommunictioutcome(iecomtcommunictiboutexulhelth)Aim2evlutecceptbilyimpctSHIFTknowledgeliefexulhelthcommunictimgtwocohthemlogy-cologyfellowFoxCheCncerCenter(primrye)Dn-FrrCncerIntuteWenfecoureplndemtiThepropoedtudyfirtdeveloptettrgcouredeignedequipfellowcologyddexulhelthircncerptientThtudypentlogiclnexttepngogbodyerchcentergdevelopmentevidence-bedterventiimproveptient-clicincommunictiboutexulhelthcncerTheoverrchggolthlewkimprovehelthqulylifeptientcncerthroughtegrtgeffectivecliclcommunictiboutexulhelthirroutecncercOVERALLABSTRACTDiffuelrgeB-celllymphom(DLBCL)nggiveclicllyheterogeneoumlignncyderivedB-celltrnggermlcenter(GC)ctiIndeedbiologiclheterogeneyDLBCLlignctuumdevelopmentltteubequentGCctiThegenetichllmrkDLBCLomticmuttichromtmodifiertrncriptifcrgeneimmuneynpeignlgmedirExmgmechnmctiemuttihprovidedightdctecell-tricproceedegultedDLBCLdotccounthowemuttifunctiwhenyoccurgermelymphomcellhowyhpelymphommicroenvirmentLMEhowLMEfluencelymphomhowcriclhotfetuuchgefluencedefentuelymphomirLMEDLBCLthucomplexentieytembiologyimmunologicltpotprdigmhifurthkgboutetumneceryrrivetdefiveundertgdeepthogeneeffectivepcerpeutictrtegieToddthchllengewehveembledtemexpertdtctpheexperteuecuttgedgetechnologiepowerfulphyiologicllyccurtemodelytemTheyhvewkedgertemdevelopcompellgbodyplimrydtupptgcceptulfrmewkthpropolhvedevelopedcriclourceuchhdgenomicdtbeprimryhumnPDXpoiriegeneticllyengeedmouemodelcomputtilpipelegrphicluerterfceTheyddcentrlhypoei)chromtkeytegrrrheottexecurcell-triccell-extricpthwygultgkeyGCcellftedecidowntmimmuneynpeignlgii)DLBCLflectctuummlignnttteechtumligngemopotlgGCB-cellepigenetictrjecrieiii)GCBABCDLBCLdefedcrotlktweenirchromtlcpeimmunepopultihpeLMEiv)echromtLMEeffectvrypecificwymuttiprilegggev)rtiltrgetgDLBCLmuttkeccountpecificllyntgizeepecificchromt-immuneynpe-LMEcenriochievelgtermtumdictiABSTRACTDNAdouble-trbk(DSB)occurupexpoucelliizgrdichemiclenvirmentwhenDNAplictikcomeimpededleiobtclenubequentlycollpeTwomechnticllydtctDSBpirpthwynmelyhomology-dictedpir(HDR)n-homologouDNAend-jog(NHEJ)piblemovlmjyDSBWheHDRmotlyccurteNHEJwhileefficienttenentilloDNAequencedurgpircnlogenertechromoometrnloctiplictikfuiFiluNHEJHDRledheightenedenggementlternteend-jog(AltEJ)gle-trnnelg(SSA)highlymutgenicwempthwypirolAuchchoiceDSBpirpthwyhmjimpcnmtenncegenometbilypventgneopltictrnmticellcogeneOurProgrmProjectbrggerevenledgNIH-fundedlbriehighlycollbtiveynergticlmdeletemechnmHDRplictikmtenncehowHDRnegtivelygultedfvueNHEJDSBpirolWehveembledtheShdReourceCoprovidette---rterviceproductihighqulyprotepprtimechnticexperimentbiophyicltructurlnlyeprote-ligterctipcemeumentbdgctntlocellulrnlyeDSBpirplictikmtennceAlgerweexceptillywellpoedlevergeourdeepknowledgeDSBpirmechnmlederhipunderthowtumuppBRCA1-BARD1BRCA2functipromoteHDRovercomeHDRtrictivectiepigeneticmrkder53BP1ocedfcruchDYNLL1hetero-trimericCTC1-STN1-TEN1complexAuchourProgrmProjectnlyexertmjimpctelucidtgmechnmDSBpirpthwychoicecncerdrugtnceloidentifynoveltrgetpthwypivotpotguidedevelopmentnewrpeutictrtegiettclcrntbvrincncerPROJECTSUMMARYWilmtum(WT)ecdmotcommolidpedriccnceruullydevelopyoungchildnege5WTencompthemcelltypeepiliumtrombltermWTtypicllyttedcombtiurgerychempyrdipyAlthoughurvivlrteWTptientgenerllyfvbleprognoptientbltemdomnthlogympoPtientbltemdomnthlogymotncechempyhvehigherrtecncercurnceeunmetcliclneedimproverpyThemjobtcledevelopgnovelrpielckcelllenimlmodelpentghigh-rkbltemlWTBecuebltemlWTpentrrntESCweprogrmmedWiT49WTcellepililigducedpluripotenttemcell(iPSC)trnplntediPSCkidneymiceThetummettizedliverlungThuWiT49-iPSCpentfirtbltemlWTmodelublemechntictudieundertmoleculrchngedtguhgepililbltemltypeWTcnuedcenFDA-pproveddrugfdtterttmentchildnggiveWTBecueWiT49-iPSCcquitemcellmrkerwellmetttictrcompdWiT49wehypoizeWiT49-iPSCervebltemlWTmodelublemechntictudiedrugcengdevelopnovelrpiemettticbltemlWTInthpropoedtudywe(1)progrmWiT49-iPSCpermtermydetermetemcellpotency(2)identifyepigeneticchromtigntudtguhgbltemlepililtypeWT(3)developnovelrpeutictrtegiettmentWTWecenWiT49WiT49-iPSCcellgtFDA-pproveddrugepigeneticcompoundidentifydrugeffectivegtWiT49-iPSCveruWiT-49cellSuccefulcomplethprojectexpectedhvegtimpcnundertgbiologykidneycnceretblhgvlubleexperimentlpltmdevelopmentfermoeffectiverpieWilmtumABSTRACTBtcncermotcommcncerecdledgcuecncermtlywomenUSApproximtely75%btcnceretrogencepr(ER)poiveThecurnttrdcpotmenopulwomenER+btcncervolvechoicenupfrtromtehibir(AI)tmoxifen(Tm)-AIAI-TmwchtrtegyTmfirtlerpypmenopulwomenecdlepotmenopulwomenchemopventivegentllgegroupThuTmctuemnimptntelectiveERmodulrttmentER+btcncerptientHowever~30%ER+ptientdotpdTmcuedenovotncemotwhodopdeventullycquiTmtnce(TmR)BtcncerptientwholpeTmtfunctilERignlguggetgendoctncevolvegticfunctiTmetrogendependentERctivyCrotlktweenERgrowthfcrcepr(GFR)ignlgpthwylievedctrieendoctnceHoweverclicltrilGFRhibirhveyieldedmixedultdictgcomplexERbiologyvolvementnovelcrotlkddil/lterntemechnmendoctnceInthpplictibedourdtogenicmodelcquiddenovoTmRwepropoenoveltrncriptiprogrmmgducedmechnmTmRenueER-dependent/Tm-ducedupgulti-cten/TCF-mededtrncriptilctivyThfurrupptedourdthowecpic-ctenexpiTm-eniveER+btcncercelltrnmTmnntgtngtultntER-dependentTm-ducedtrncriptilctivti-cten/TCF-pivegeneRd6B(kUBE2B)nubiqucjugtgenzyme(UBC)tbilizectivte-ctenK63-lkedpolyubiquti(polyUb)lye394idueubiqutieventprotect-cten26SproteomldegrdtiRd6Belf-ctentrncriptiltrgetthuctgvicioupoivefeedbcklooptweenRd6Bgeneexpi-ctencogenicctivtiBededtwehypoizeRd6B-meded-ctenpolyubiqutrncriptilctivtidriveTmRfciltgTm-ducedubiquted--cten/ERcomplexmtrncriptilprogrmmg-cten/TCFgenetrgetHencehyperctiveRd6B/-ctenxwoulddrivecellTm-eniveTm-frcryttewhehibiRd6Bctlyticctivyhib-ctenubiquti/ctivtiuncoupleTCF/-cten/ERcogultedtrncriptilprogrmultgrtiTmenivyWetetthhypotwopecificimSpecificAim1EtblhcutiveroleRd6Btmoxifen-duced-cten/TCFtrncriptilprogrmmgTmRbtcncerdevelopmentprogiSpecificAim2Identifychrcterize-cten/ERcomplexgultedtrncriptilnetwkunderlygltertiepigeneticlcpeocedTmReirvulnerbilyRd6B-ctenhibiThtudyuncovermoleculrunderpngnovelprdigmhiftghypohpotentilimpctcliclmngementendoctntbtcncerItlyfoundtetgnewnxictrtegyttgTmRbtcncerwellidentifymrkerdignotic/prognotic/rpeuticpotentilABSTRACTThtrggrntpplictieekfundgDukeReerchTrgProgrmSurgiclOncologyDukeUniveryDeprtmentSurgeryThenewubmicludetructurlgniztiourlg-runngprogrmdermolevntpiveevolvgtrgneedurgiclcientturgiclcologyTheprogrmhendeignedprovidefutuurge-cientterchmethodkillnecerypuruedependentlyfundedcdemiccerimprovehelthoutcomeptientpmlignnrmlignntcdifoculocl/gildeeThetrgprogrmcomubtntilcdemicrigDukeUniverySchoolMediceDukeDeprtmentSurgerylg-tgcommmenttrgnextgenertiurgiclercherTheprogrmledtemurge-cientthryfundederchexperteurgiclcologySupplementedn-urgemenrexpertebictrnltilcliclerchthmultidciplrytempnbdthurgiclcologyerchdderchlocl/gildeeTumInviMettBiomrkerPrognoTtmentSelectiRegilCncerImmunpyTheprogrmuppt4erchfellowechyer(2echyer2yer)progrmprticipntcturgiclidentcruedoutideDukeSurgiclReidencyProgrmTeelecttwomenrprimryn-clicincientificmenrhighlyexperienceddiveregroup14ercherwhodictirtwo-yererchfellowhipenenudcliclurgiclcologtwhoguideircerthroughoutidencytrgirilcdemicfcultyppotmentLedirmenrteechdevelopexecuteerchprojectwhichbfutucerdevelopmenrdependenterchwrdpplictiArobuterchfrtructuubtntilourceprovidedbothDeprtmentSurgeryDukeCncerIntuteprovide100%neceryuppttethufciltgircductpublictiiglvetigtioubligticliclerviceSpecifictructechniclpecturgiclcologyvetigtiprovidedmenrhipcientificwrgpublictiethicclicltimemngementTheunifygobjectiveprogrmtrfutuntilledercdemicurgiclcologyProjectAbtrctRdipy(RT)uedttmenver50%cncerptientDepemjtechnologicldevelopmentRTtillcricllylimednmltuexicycurtivettmenttrictedloclizedtumPervivedprieloextcceRTUSAgloblhelthduettmentcotdtnce-timebrrierculturlfrtructu/technologybrrierTheedprielofundmentllyflectedrdipywkceThenowemerggtrnmtiveRTerchivecnddxicylimtiubtntilwyextendRTcurtivettmentbothloclmettticdeeducedprienovtiducettmenttimecotenhnceptientcvenienceignificntlyceurvivlqulylifeptientSomeexcgemerggtrnmtiveRTerchcludeRdio-ImmunpyFLASHRTArtificilIntelligence(AI)RTmrtRTbiomterilMRI-guidedRTnewtechnologypprochegloblhelthlltmendoupotentilenggetudent/tefcultydvncenovtiducedprieTheeemerggexcggtneedccertedccelertedefttrgdiverenextgenertierchledereToddthunmetneedoverllgolnovthprojectetblhpmierCREER(CncerReerchEductiExcellenceRdipy)progrmtrnextgenerticientttechnologtphyicinkillederchemerggtrnmtiveRTnovtifocuddgRTdprieThepropoedCREERprogrmlevergetrgtutilenvirmenttJohnHopkcollbtifcultytHricllyBlckCollegeUniverielikeHowrdUniverygloblhelthprtnerttrcttignificntnumrunderpentedmiewhoempowedpuruecerhighereductiprogrmvolvgcncererchThehighetignificnceCREERprogrmexpectedccertedtrgdiverenextgenertiledernewlyemerggtrnmtiveerchrdipydrivenovtiovercomgcurntRTlimtiducgdprieSUMMARYSurge-cienttnunderpentedpopulticdemicmedicefederllyfundedphyicin-cientt-lederchhendecleoverptdecdeSubtntilchllengefcedurgiclteeekgerchtrgImptntlyurgiclidenttrgprogrmmpleprotectedtimededictedexperientilerchtrghveeffectivelyctriedpipeleuccefuldependentlyfundedurge-cienttTheeercherhvemengfullyimpctedurgiclcologyptientccientificknowledgeThepropoedSurgiclOncologyReerchTrgtIndin(SORTI)progrmbrggerextenivemultidciplrycologicexpertetIndinUniverySchoolMedice(IUSM)SimCompheniveCncerCenterctemultidciplrytwo-yererchtrgprogrmctg(1)HelthServiceOutcomeReerch(HSOR)Trck(2)BicScienceTrnltil(BTS)ReerchTrckTheSORTIprogrmdrwupDeprtmentSurgery30-yexperiencetrgBTScologyerch15-yerurgiclcologyHSORidenttrgcollbtitweenSurgiclOutcomeQulyImprovementCenter(SOQIC)RegentriefIntuteAmericnCollegeSurge(ACS)CncerProgrmSce2011SOQIChtd44urgiclerchtewhohvegecology-focuedcdemiccerDurgtwo-yertenivetrgperiod(100%protectedtime)teSORTIprogrmimmeredmultidciplryexperientilerchtrgugtemciencepprochtilodmenrhipfocueddidctictechg(Mterdegethoeoutpridvnceddege)EchtehvenexperienceddivereMenrTem(ctentmethodologiclexpert)tilodirtrgneedTheSORTIprogrmcocurriculumcludecouretudydeignnlyticpprochetprcticeethicerchcommunictgerchcerdevelopmentTeprticiptewkhopemrerchtrgopptunietIndinUniverytlevnturgiclcologicpilocietieTedeignexecuteerchprojectculmtepenttitmjntilcfencepublictihigh-impctjournlCtuoumirgertiveprogrmimprovementchievedenggementhighlyccomplhedExternlAdvyCommteerobutevlutiIndinUniveryCenterEvlutiPolicyReerchTheultimtegolSORTIprogrmcenumrvetigrwhouccefullychievecdemiccerdependentlyfundedurgiclcologiccienttIndinUniverySchoolMediceuniquelypoieduucceSORTIprogrmctugdevelopfutuurgiclcologycienttledermenrABSTRACTTumntigen-triggedTcellcepr(TCR)ignlgcyplmtrncriptil/epigeneticctrolnucleucentrlCD8+Tcell-dependentntumimmunyHowevertrgpertentntigentimultiledimmuneexhutiCompdtumdrgelymphnodetummicroenvirment(TME)cthighermounttumntigenirprolgedpenttum-filtrtgCD8+TcellcnexcerbteTcellexhutiimmuneeviExceptco-hibiryceprlrgelyunknownhowTcelldptntigen-richmilieuTMEBetterundertgmechnmunderlygTME-uniquegultiTcellfuncticouldmnovelrpieimedtvigtgntumpotentilexhutedCD8+TcellTheoverrchgcientificobjectiveourpropoedwkdetermehownegtiveelgtifcr(NELF)knownfunctiRNApolymereII(PolII)puggulteCD8+TcellctivieTME-uniquemnnerOurplimrywkuggetNELFbothneceryrte-limgpromotgntumctivyCD8+TcellOfnotethNELFfunctiuniqueCD8+TcellTMEnottumdrgelymphnodeFurrmoourpublhedunpublheddtpotpotentildulctidtctubcellulrpoolNELFwhilenuclerNELFprticiptetrncriptilepigeneticprogrmcyplmicNELFttenuteTCRignlgWehypoizecomdctiNELFlikelyctrietrgerTcellmemyleTcellexhutiBuiltuprigoucientificpmemultidciplryexpertewevlidtethnovelhypodeciphergTME-uniquefunctiNELF(Aim1)terrogtgdulmoleculrctinucleucyplm(Aim2)explgutilyNELFovexpibootgefficcynticncerimmunpie(Aim3)ThecceptNELFhTME-uniquefunctintumimmunynovelFurrmopropoeddulctiNELFclerlydevePolIIpug-excluiveprdigmNELFbiologyThepropoedwkthmulti-PIR01propolpromehedlighnpvioulyunppcedgulrTME-uniquefunctitum-filtrtgTcellpotentilutedimpcnundertgntumimmunyFromtrnltilperpectivedcoveriethprojectcouldmmoeffectivepprochebootTcellmemyovercomeTcellexhuthuhelpgddignificntbrrierunmetcliclneednticncerimmunpiePROJECTSUMMARYNtiveAmericn(NA)endudpropteburdencoloctlcncer(CRC)cidenceCRC-pecificmtlyScengneffectiveerlydetectitrtegydecepventbleCRC-lteddethNAhveomelowetCRCcengrteInOklhomly51%NAupdtecengcompdnerlytwo-thirdeligibleUSdultEftducedpriecengrtehvefocuedcgccehomeolcengHoweverpproximtelye-hlfNAOklhomnbnmlhomeoltetdotcompletequidfollow-updignoticcolocopyAtimecolocopyfternbnnlhomeoltetocedgterdignolte-tgedeeCRCmtlynovtivetrtegieneededcertetimelydignoticcolocopyfollowupmgNAOklhomThepropoedtudylevergenextgltihipCheyenneArphoTrico-developpilottettwodigloutchterventicertedignoticcolocopyFirtmobilehelthoutch(mHelthSMStextvideomege)ttemptcemotivticheduledignoticcolocopyInddiceivgmtiltextbouthowwhychedulecolocopyprticipntloceiveculturllyenivevideoueperlnrrtiveNAptienthigh-ttuCheyenneArphoTriblmemr(egelder)SecdcurntclicwkflowquiCheyenneArphoptientvcolocopycliclfciliebothp-vppotmentctulproceduThprocequimimumtwoundtripcolocopyfcilyover90milemotptientWetetwherp-vtelehelthculttiducetrnpttibrrierOuroverrchghypoculturllyenivedigloutchterventicemotivtiducetructurlbrrierthuimprovertedignoticcolocopyThefirttudyimco-developtegrteculturllyenivedigloutchterventitrtegieclicwkflowguidedNAptientcommunydvybdAmg140NAptientecdimdetermechfeibilypotentilefficcyterventitrtegieug2x2fcrildeign(OutchTypeFcr1)mHelthoutchvmtilpmphlet(CulttiTypeFcr2)telehelthv-perp-vcolocopyculttiTheprimryoutcomepotentilefficcymeudrtedignoticcolocopy60dypot-romiztiThethirdimexplopenetrticceptbilyclbilydigloutchterventitrtegieIfeffectivethfirt---kdhighlyclblepprochferubtntilpublichelthimpctducevoidbleCRCmbidymtlymgNAptientcgrtedignoticcolocopyFdgupptnR01HybridType1effectivene-implementtrildetermeclicleffectivenetterundertctextimplementticulturllyenivedigloutchterventicroourTriblprtnerOklhomProjectSummryOuroverrchggolcertecerviclcncer(CC)cengmgIndigenouwomenUSThpopultiexperiencedproptelyhighrtecerviclcncermbidymtlyTheytwicelikelydevelopdieCCcompdn-HpnicWhewomenTheytendignoedtltertgewhichmkeuccefulttmenturvivlmochllenggErlydetecthroughgulrCCcengveliveignificntlyducehumnppillomviru(HPV)-ltedfectiubequenthelthrkCCmtlyup80%Howeverpproximtely45%IndigenouwomenmuncenedToddthueimproveCCcengrteweimdeveloptetefficcyfeibilyy-drivenculturlly-tilodmultilevelmultimedimobilewebppterventi(clledwPp)pecificllytrgetgIndigenouwomenYnknSiouxTri(YST)ReervtiSouthDkotWecduct2-rmromizedctrolledtrilugcommuny-bedprticipryerchmultiplemethodologieover4-yerperiodWecru120YSTwomenged2565yerromlyignmeirwltctrolgroup(n=60ceivgprtedeductilmterilCCcengguidele)wPpterventigroup(n=60ceivgculturlly-tilodperlizedmultilevelmultimedimegethroughmobilewebpp)ThewPpterventidmted7dyWecductementtbele1-weekpot-terventi6-mthfollow-upurveyfocugroupAim1identifydividulocioculturltructurldetermntCCCCcengthroughqultiveementThemtigdguidedevelopgwPpterventiAim2developmultilevelmultimediwPpterventipromoteCCcengIndigenouwomenAim3evlutefeibilyefficcywPpterventicgCCcengrtemgIndigenouwomenEvluticrericludeterventifeibily(iecceptbilytfcti)efficcy(ieceiptCCcengchngeknowledgettude/liefboutcengelf-efficcytentundergoCCceng)ByddgbrriercengwPpterventihpotentilcecceibilyutbilyevidence-bedpventivecultimtelyducghelthdprieIndinCountryTheulthvewidepplicbilyervgmodelimprovgcncer-ltedhelthoutcomeerlyterventypecncerIndigenouwomencrogeogrphiclgitriblcommuniePROJECTSUMMARYBlddercncerpible80000cncerdignoe20000dethnnullyUSApproximtelye-fourthblddercncerptientdignoedmucle-viveblddercncer(MIBC)nggivepotentillycurbledeetteInUSmotcommttmentMIBCblddermovl(ierdiclcytecmy)bldder-prgpprochugccurntchemdipy(CRT)ocedimilrdeeoutcomeimprovedquly--lifeMIBChrbnumeroucurntgeneticlterticludgfquentltertiDNApirpthwygeneprticulrlynucleotideexcipir(NER~15%tum)homologoucombtipir(HRR~10%tum)wehvehownNERHRRdeficiencycferuniquebiologiclpropertierpeuticenivieInpttwoyertwtibody-drugcjugte(ADC)hveenpprovedttmentchempy-frcrymettticblddercncerentumbvedot(EV)comnect-4trgetgntibodymicrotubulepovedotwhecuzumbgovecn(SG)comtrop-2trgetgntibodytypeIpoomerehibirgovecnMultipleEVSGclicltrilnow-gogmultipleblddercncerettghoweverterctiADCRTblddercncerhnotenvetigtedOurcentrlhypordiupgultenect-4trop-2expiblddercncercellecombgEVSGrdicompellgynticcombtitrtegyMIBCttmentOurhypoupptedplimrydtblddercncercellledemtrtgrdi-ducedcenect-4trop-2expiwellynergticcellkillgwhenEVSGcomdrdiHowevercomphenivenlycropcliclmodelpentmoleculrdiveryMIBCcurntlylckgTheoverllgolpropoedwkvetigteimpctrdiexpinect-4trop-2blddertumdefectivyEVSGrdicromoleculrlynnottedhumnMIBCpcliclmodelInAim1wemeurdidoe-time-dependentchngenect-4trop-2tgeneprotelevelcroblddercncercellleptient-derivedxenogrftmodelWelotetcomdeffectEVpluRTSGpluRTcellulrpropertietumpevrovivoInAim2wetetimpctNERHRRdeficiencyenivyEV-SG-bedttmentugueogeniccellulrytemvilbleourlbGivenknownmechnmvedotgovecnweexpectNERHRRdeficiencyceenivySG-notEV-bedrdicombtiTogerweexpectetudievelnovelcompellgynticcombtitrtegyugADCRTeffectivelytrgetblddertumWelieveetudiedictlymdeignnovelclicltriltetgEV-SG-rdicombticouldimprovebldder-prgttmentMIBCPROJECTSUMMARYHepcellulrcrcom(HCC)motcommtypelivercncerccountover30000dethechyerUnedStteleRegttblycurntrpieprovidelimedcliclnefptientdvncedHCCThunewmoeffectiverpieHCCurgentlyneededMotdrugtrgetdcoverievlidtipprocheemploycellcultu-bedcengmethodvivoimmunocompromedimmunodeficientmouemodel(egnudemiceNSGmiceetc)Howevermultiplecellcultultedrtifct(eg2-Dcultuhighccentrtigrowthfcrmedietc)ueimmune-defectivemouemodellimrigouidentificticlicllylevntdrugtrgetultimtelynegtivelyimpctirtrnlticlicToovercomeelimtirigoulyidentifynovelrpeutictrgetHCCwecomdtwotte---rtpprochenmelynvivoepigenome-wideCRISPR-bedfunctilgenomiccenghumnizedmouemodelfunctilhumnimmuneytemUgeytemweidentifiedchromtmodifierNSD3fcrpromotedHCCtumgrowthmettmicefunctilhumnimmuneytemMechnticllyNSD3lopromotedNKcell-mededHCCerdictihighly-electiveefficciouhibirNSD3BI-9321blockedHCCtumgrowthmicehumnimmuneytemBedeultwehypoizeNSD3-mededuppiNKcell-medednti-tumimmunyneceryHCCtumgrowthmetttrgetgNSD3pentnovelrpeuticopptunyttgHCCTheoverllobjectivedetermevivoleNSD3drivgHCCtumgrowthmettviuppgNKcell-medednti-tumimmunyevlutevivophrmcologicltrgetgNSD3HCCttmentInAim1wefirtdetermevivoleNSD3fciltgHCCtumgrowthmettNextwedetermemechnmuppiNKmedednti-tumimmunyNSD3rolegultiNSD3-mededHCCtumgrowthmettTwerequetiweuenovelliverfibromodelwehvedevelopedtudyHCCtumgrowthmettcjunctiimmunocompetenthumnizedmicetrnplntedhumnimmuneytemAddillyuggn-pecificthopicptneouHCCmettmodelwetudyroleNSD3HCCmettInAim2werigoulycomphenivelyteteffectiveneNSD3hibir(BI-9321NSD3-pecificProteolyTrgetgChimer(PROTAC))eirlenti-cncergentHCCttmentvivoTheetudieutilizeetblhedHCCcellleHCCptient-derivedxenogrft(PDX)uehumnizedmicetrnplntedhumnimmuneytemCollectivelyetudiedetermeroleNSD3driverHCCetblhefficcyNSD3hibirttgdvncedHCCPROJECTSUMMARY/ABSTRACTReltivegenerlpopultiHIV-fecteddividulhve60200-foldhigherltiverkdevelopN-HodgkLymphomcludgplmblticlymphomprimrycentrlnervouytemlymphomprimryeffuilymphomdiffuelrgeB-celllymphomTheylohven810-foldhigherltiverkdevelopHodgkLymphomcompdunfecteddividulMnyemlignnciedrivenEpte-Brrviru(EBV)ultpoimmunectrolvirudrivenHIV-dependentimmunedyfunctiThufeeffectivevccepventEBVfectielimteEBV-ocedcompentrkcouldhveignificntcliclnefource-powheHIV-1endemicTheclteprotectimotuccefulvirlvcceneutrlizgntibodiePvioulyourlboltedfirtnti-EBVmAbcouldpotentlyneutrlizefectibothBcellepililcellWefurrdemtrtedpivetrnferAMMO1protectedbothhumnizedmicerheumcqueexperimentlEBVfectiTheeulttrglyuggetntibodieimptntifnotufficientprotectgtEBVfectiprophylcticvccehouldeekelichighterAMMO1-likentibodieTothendwedevelopedtetedeverlgH/gLvcceAllgH/gLvccewetrglyimmunogenicylyhowedprtilprotectigtexperimentlEBVfectihumnizedmicemcqueEpipemppgtudieveledvcce-elicedgH/gLntibodietrgetgAMMO1epipeweubdomntrwhilentibodietrgetgn-neutrlizgepipegH/gLweimmunodomntThegolthpropolobthigh-olutintigeniclcpegH/gLglycoprotedefemotcriclevulnerbilyWenuehmtiemploytructuguidedEBVvccedeigntendedimmunocuntibodypeprotectiveepipelikeetrgetedAMMO1evluteirbilyprotectgtEBVchllengehumnizedmicemcqueABSTRACTMettctrievtmjybtcncerdethcurntrpiedemteddeehvelimedefficcyignificntideeffectImmunecheckpotblockde(ICB)rpyhouttgpromebtcncerltetgecurntlylypprovedtriple-negtivecncer(TNBC)tpoivePD-L1proteeptiently~25%hownilpeAlthoughcuedivergentpemultifcrillieved-eductgimmunouppiveimmunepopultitumceperteHoweverpprochemodultecellprimrilybedytemicllydmtedimmunotimulrydrugwhichhveeveideeffectThprojectdeveloptrgetedrpydeliverimmunotimulrydrugimmunouppivemcrophgemettticbttumwhilemimizgeffectf-trgettueWhmotmcromoleculrdeliverytrtegievtmjyntrvenoulydmteddoeccumulteliverpleenWedcovedcertnnocrrierliverpleenuptkecnblockeddjuvntnocrrierccumultemcrophgethopicTNBCtummouemodelWedetermedthtrtegycouldueddelivercompoundducedtumburdencombtiICBrpyThefedruglepotentlyimmune-timultgoxicytemicttmenthumnRemrkblynnocrrierblockercombtiduceerumcykelee37-foldltivefedrugThennocrrierblockercompoedhighlybiocomptiblemterilroutecliclueThprojecptimizecompoiegentbiodegrdtielimtimximizepotentilclicltrnltifurroptimizedogchedulgdeliverycombtiICBrpyAtccluhprojectwehvedeignednoptimlpprochdeliverimmunemodulrelectivelymettticcnceroutuemcrophgetuemximizeefficcywhilemimizgideeffectThtrtegyhpotentilvolutiizecncerrpyimilrhownb-pclxel(Abrxne)himprovedbtcnceroutcomethroughtrgetedrpySummryPOPBIOgolcommercilizetertilchemo-phpy(I-CPT)newrpeuticoptilocllydvncedlivercncerDoxubic(Dox)cnctivelylodedlgcircultgerum-tblepphyr-phopholipid(PoP)lipoomeleed665-nmlerlight(PhoDox)ThpprochledvtlyenhnceddrugccumultiirrdedtueultgultrpotenttumbltiInpheISTTRweemployedthdoimetry-ttmentplnngpltmguidelightdmtrtiI-CPTPhoDoxWedemtrtedtmentplnnglightdoimetryeffectivebltglrgethopichepcellulrcrcomtumrtThepheIISTTRfocueoptimizgttmentplnnglightdoimetryuglrger(~50cm3)tumwoodchuckwelldevelopgGLPxicologypckgeprtnFDAINDubmibedourp-INDmeetgPOPBIOhpvioulygenertedn-GLPxicydtPhoDoxrtcludgcuryetblhmentmximumlerteddoeIn2019POPBIOheldp-INDmeetgFDAwhocfirmedubily505(b)(2)routecompentPhoDoxprovidedguidnceboutquidxicologicltudiequidprifirt--humntudieThexicologyprogrmlogenerteermpletwimlmodelneednlyzedLC/MS(quetthpplicti)InthCommercilRedeProgrmpplictiwepropoefurrdvnceI-CPTPhoDoxwrdnINDenblgfutuclicltudieegphrmcoketicDoxdoxubicol(Dox-ol)mjmetboleDoxPP-lipidphoctiveexcipientPhoDoxwelltbilyPhoDoxunderccelertedrgecdiTheetkquidFDAprurINDpckgeTheermpleephrmcoketichveengenertedprtpntPheIISTTRwrdGLPxicologyprogrmUnderGLPcdiugLC/MSerccentrtifeDoxlipoomeentrppedDoxDox-olPP-lipidmeudSubequentphrmcoketicnlyprtthpplictipermedRowellPrkBilyticMetbolomic&Phrmcoketic(BMPK)ShdReourceTheultthpplictigenertidtdictlyuedPOPBIOINDpckgegenertiIfuccefulI-CPTPhoDoxtnefmjynewlivercncerptientwhohveoperbleproblemticprimrytumPROJECTSUMMARY/ABSTRACTGtrotetltromltum(GIST)teneffectivelyttedFDA-pprovedfirt-lerpieuchimtibvpribHoweverthtrtegyeffectiveprticulrubetGISTptientthoeGISTcuedheredlo--functimuttipdicepigeneticilencggeneencodgucctedehydrogene(SDH)complexTheeSDH-deficient(SDH-def)GISTexhibquevriblebiologyrnggdolenttumrpidlyprogivedeequicklyleddeenmgdolecentyoungdultWecentlyptedttmentSDH-defGISTtemozolomide(TMZ)ultedfvblepemllptientcohtefdgledmulticenterpheIItrilvetigteefficcyTMZSDH-defGISTptientWelodevelopedfirnlyptient-derivedSDH-defGISTcellcultubiopoirywhichweutilizeddcoverTMZduceexpidethcepr5(DR5)TRAILceprInhibrxIncLJollCAhdevelopednentilynewrpeuticgtbdDR5ceprcollbtivelywehveuedegerTMZepopducecellvibilyvroThilfdggermjnewplimrydtwenowpentuggetynergtictrtegycombgDR5gmTMZmyledmoeffectivettmenutcomeSDH-defGISTptientthuddthunmetmediclneedTheoverllobjectivethpropoedU01uneNIHtrmurlextrmurlSDH-defGISTclicinercherexpertedultpedricmediclcologyurgiclcologybictrnltilcienceptientdvoctendutryprtnerddtwolg-termgol(1)ccurtelydtguhSDH-defGISTptientwhohvedolentbiologythoewhohveggivebiology(2)identifytetfeeffectiverpeutictrtegiettgSDH-defGISTptientepecillythoemoggivemthcncerwhowedieSupptedourplimrydtwehypoizeSDH-defGISTpoeunderppcedtumheterogeneyhencecpdglycomplexbiologyquicombtirpiechievedeectrolByccomplhgourimwetterundertbiologyetumidentifynimprovedttmenttrtegythdeeWepropoelevergeourextgNtilSuccteDehydrogene-DeficientGISTTrnltilReerchCliclTrilCtiumlguniqueNIHCliclCenterource(1)evlutefetyefficcyTMZINBRX-109(potentDR5gt)mgptientprogiveSDH-defGISTPheI/IIclicltril(2)ctecentrlizedbiobnkwell-nnottedSDH-defGIST(3)developnetwkerchlbriedevelopimprovedpcliclmodelvetigtedivereSDH-defGISTbiology(4)developcliclolpdictSDH-defGISTprognoOurprojecthpotentilimmedecliclimpctmngettSDH-defGISTptientprovidemuch-neededner-termhopeeptientirfmiliecgiverABSTRACTThe2023SoClGenomeStbilySympoiume-dycfenceheldtUniverySournCliniLoAngeleThecfencefocugenomictbilyDNAmutgeneenvirmentlmutgenDNAdmgeignlgmechnmDNApiririmplicticncerrpieIncentyermnynovelcncerrpiehveendevelopedtrgetDNApirpthwyTheenewrpiecurntlymovglbclicwepoedrpidexpniDNApirpthwy-trgetgdruguedttdiffenttypecncerAtmetimettmentcnduceDNAdmgeccumulticncercurnceThuundertgmechnmDNApircellpeDNApir-trgetgchemiclneceryimprovettmentAtcfencegrdutetudentpotdocrlfellowlbrieloctedSournClinipentirgogunpublhederchThegolobjectivecfence1)expoetudentpotdocnewfrtierrpidlyproggerchcricllyimptntddgcncer2)providemlpltmpenttitenopptunyceivefeedbckirerchprog3)timultenewcollbtitweenlbriecrodiffenterchtuti4)ctlyzeopptunieyoungcienttnetwkdiveregroupcienttcludgceivgmlmlmenrgopengfutupotdocrlfcultypoiopptunie5)providentmophecluirigteprticiptgympoiumTheympoiumenhnceterctimgtudentpotdocrlfellowllgenderbckgroundigcludghricllymrglizedgroupuchthoeunderpentedrcilethnicgroupdividuldbiliedividuldiffentexulienttidividulocioecomicllyddvntgedbckgroundBroderwnefieldgedthroughloclmeetguchthprticulrlyimptntppteirnextcertgepotdocrlfellowprciplvetigrcercienceIMATR61AbtrctInddiwell-cognizedroleneurlcomputticrdicctrctivoltgecroplmmembrnehenimplictedfundmentlgulrdiffentiprolifertiTheccurntgultiprolifertitemcellttemembrnevoltgectrienmltuemphogenedevelopmentdeeuchcncerMembrnehyperpolriztendpromoteceddiffentiducedprolifertiwhiledepolriztiocedimmtuprolifertivetem-likecelltteOfclicllevncecncercellcncertem-likecellexhibdepolrizedmembrnevoltgevluecompdnmldiffentedcellwhichyDepetrgocitweenvoltgecncercellphenotypevoltgemodultihnoteneffectivelyexploeddrugtrgetgtcncerlrgelyflectgtechnologiclchllengemembrnevoltgemeumentphyiologicllylevntctextCurnttechniquemeumembrnevoltgecludgelectroderryvoltgeenivedyehvelimtinumrexperimentlobervtipoiblecomptibilycomplementryphenotypicdoutdurtimplgbilypermlgudlcellnlyeTheetechnologicchllengemotivteourhypotegrtigeneticllyencodedvoltgecellcycleenproviderobutnovelhigh-throughputpltmidentifymodulrmembrnevoltgecellprolifertiWepropoedevelopoptimizevlidtecell-bedtechnologypltmtegrtgJEDInovelvoltgedicrFUCCIcell-cycleenenbleltimehigh-throughputnlyccurntchngevoltgecellprolifertilivgcellTobuildpltmwepropoedemtrtehigh-throughputimggvoltgedynmic(Aim1)cellcyclette(Aim2)glioblmtemcellWenextpropoedeployetechnologiehigh-throughputquntifictiimpctichnnel-modultgdrugmembrnevoltgecell-cyclechnge(Aim3)Thnovelpltmexpectedfirttimeprovideoll-timelivecelldoutccurntchngemembrnevoltgecellprolifertiBeideimplictittmentcncerwenticiptethpltmhvefrchgbiccienceclicltrnltilpplictineurociencetemcelliPSCbiologycell-bedrpiecrdiovculrdeeProjectSummry/AbtrctTheIntuteHelthPromotiReerch(IHPR)MyCncerCenternNCI-deigntedcncercentertUTHelthSnAnnioprtnercloelyvetigtecueolutiunequlimpctcncerchricdeemgLSouthTexntiglobllyAlthoughhenubtntilprogcncerpventicengdignottmenverpteverldecdeproghnotkeptpcemgcertpopultigrdghelthdprieuchdiffencecceclefquentueprovencengtethigherrtedvncedcncerdignoehighermtlyrteLmggrouphighetrtenewcncerceUnedStteInpeedprieugurlAdvncgScienceCncerL(ASCL)cfencewheld2018FeedbckugurlubequentASCLcfence(201820202022)henverypoiveercherhveppcedopptunyenggeerchertetedducgLcncerhelthdprieTheproundpowerwhenercherundertLculturlnuncebrriercomegerimproveLhelthoutcomeThe2024ASCLcfencehotedSnAnnioTextweenFebrury21-232024ThegolcfencecveneercherphyicinhelthcpilptientdvoctetudentcommunymemrenggeopendilogueummrizeerchdvncementidentifygpdevelopctiblegoltrnlteerchclicltprcticeeffectivecommunyterventipiltrgprogrmelimtecncerdprieLTochieveth2024ASCLcfenceupptfollowgim1Exploterectihelthequybiologycncerctrolpventtment2PromotecollbtimgttendeeddcncerhelthdpriemgLColdSprgHrbLbryCfenceThePARPFmilyADP-riboyltiApril362024ABSTRACTThpropoleekupptmeetgThePARPFmilyADP-riboyltiheldtColdSprgHrbLbry(CSHL)April362024ADP-riboyltipottrnltilmodificti(PTM)proteRNADNActlyzedfmilyenzymeknownPARP(17humn)PARPuenicotmidedeneducleotide(NAD+)ctlyzeADP-riboyltiAcurioucricllyimptntfetuPARPirbilyctlyzetwomADP-riboylti(i)mo-ADP-riboylti(MARylti)whichvolvetrnfergleunADP-riboe(ii)poly-ADP-riboylti(PARylti)whichvolvetrnfermultipleunADP-riboeSimilrPTMADP-riboyltiveribleIndeedenzymeverePARylti(egPARGTARG1)MARylti(egMcroD2ARH3)hveenidentifiedInerlydyPARPfieldfocuwolelyPARP1whichveledcriclrolePARP1DNAdmgepe(DDR)TheetudieultimtelyledvlidtiPARP1rpeutictrgetttmentDDRdefectivecncerTodtefourFDA-pprovedPARP1hibirubetbvrincncereverlmopipeleIneverlcePARP1hibirttmentulteddtntdee-feurvivldemtrtgirtmendouclicluccehowfieldhtrnltedfundmentldcoverierpeuticAndwejutgettgtrtedRecenttudiehveexpedourundertgnlyrolePARP1outideDNApirloleleer-underodPARPfmilymemrdiverecellulrproceecludgpot-trncriptilpot-trnltilgultiprotedegrdtinteimmuneignlgTheetudiehveendvnceddventnewtechnologicldevelopmentfieldepecillychemiclbiologytructurlbiologympectrometrySeverlPARPydPARP1hveemergedrpeutictrgetnlycncerloflmmtifectioudeeIndeedhibirPARP7PARP14curntlyclicldevelopmentTheedeedexcgtimePARPADP-riboyltifieldboermexpninewphyiologydeenovelrpeuticdevelopmentThmeetgemblelederfieldgerjunifcultypotdocrlfellowgrdutetudentpentviewdcucurnterchPARPADP-riboyltiCricllythuniquetimelymeetgbrggercienttbothcdemidutrywkgvrioubiologychemtrydcipleenhncgcientificdiveryprovidggoodblncetweenfundmentltrnltilerchEcheichidtwoledgcienttfieldbothcdemidutryLgermrlpenttigivendtguhedcienttwellrgtrfieldShtermrlpenttigivencienttelectedbtrctecludegrdutetudentpotdocrlfellowjunifcultyimgmximlcluiyoungvetigrimptntlycienttgrouphricllyexcludedunderpentedbiomediclcienceWeexpectbout175peoplettendvtmjypentgpotertlkOverllthmeetg-pmiermeetgPARPfield-upptrobutexchngeidepromotecollbtiPROJECTSUMMARYHPV-ocedmlignnciecludecncercervixophrynxnuvulvvgpenTheycuethoudethUnedStteechyerTtmentmettticdeerlyprovideltgpllihvemimlcurtivepotentilFirt-lerpycglycludeimmunecheckpotblockdecombtichempylimgoptiubequentttmentHencecompellgneedmoeffectivettmentdvnced-tgedeeHPV-ocedcncerhrbcogenicHPVE6E7proteTheentigenttrctivetrgetimmunpydueirunimexpumbenceexpihelthytueThexpiptternpermtrgetgHPVcoproteoutxicytentelimtecncercellcuptientSpecificimmunpeutictrgetgHPVcoprotecncervccehnoteneffectivelikelydueprtlincevccehotTcellwhichvrypcurfquencyfunctilvidyWehvedevelopednewtypettmentHPV-ocedcncertrgetE7coprotedmterghigh-vidyulogouTcelldictedgtE7gene-engeedT-cellcepr(E7TCR-Tcell)E7TCR-Tcellrpyhdemtrtedfetycliclctivyttment-frcrymettticHPV-ocedmettticcncerInpheIclicltrilnodoe-limgxicywidentifiedCliclctivycludedgiwidepdbulkycncercompletegimottumomeptientcludgimmunecheckpotblockde-frcrytumTrnltilerchidentifiedimmunomoleculrmechnmtncewhichnowpermcengptienttnlythoewhoetumdemtrtenbencetncemrkerThprojecttwo-centerpheIIclicltrilE7TCR-TcellrpymettticHPV-ocedcncerThtrillevergetngthRutgerCncerIntuteNewJereyNIHCliclCenterimplementnovelimmunomoleculrcengnext-generti(two-week)engeedT-cellmnufcturgcrumentttmentptientdiveregeogrphicgibckgroundTheht-termgolthercheperteE7TCR-TcellrpyttmentmettticHPV-ocedcncerThelg-termgoldevelopnewtrtegyttemlignncieimcgurvivlcurgomeptientAim1determeperteE7TCR-TcellrpycductgpheIItrilTherchlurrchrcterizefetyprilettmentAim2cducttrnilerchvelmechnmwhichE7TCR-Tcellmedetumgielucidtetumevimechnmcnguidenext-genertirpeuticpprochebiomrkerdcoverySUMMARY/ABSTRACTTheSocietyReerchNicote&Tobcco(SRNT)lycientificocidedictedexcluivelyuppterchercdemicttmentpilgovernmentemployeeprtnerfieldnicotebccoerchWhmemrmothn40countrieSRNTtrulygloblchTheSRNTAnnulMeetgmvenuepenttinovelfdggloblbccoctrolerchnetwkgmgcienttfieldTopromoteterntilmiSRNThlgtgpolicywivggtrtifeeprovidgtrvelwrdlow-middle-comecountry(LMIC)ercherenupenttigloblbccoctrolciencemeetgprogrmTheSRNTGloblReerchNetwk(GRN)upptSRNTmemrLMICprovideguidnceSRNTBdcommteenecerymdcuiroundueltederchercherLMICenhnceSRNTmipromotgencourggutedvolvementgloblbccoctrolcienceFoverdecdeLMICerchercrogeogrphicgiexteniveerchexperiencepilnetwkcroLMIChveenGRNChirhveledGRNcommteeDepeSRNTupptgloblbccoctrolLMIC-bedcienceunderpentedtnnulmeetgepecillygiven80%wldbccouerliveLMICFurrpromotiimplementticiencedepertelyneededcloecriclimplementtigpgloblbccoctrolSRNTeekcfencegrntelevtevibilygloblbccoctrolerchimplementticiencetSRNT2024AnnulMeetgheldEdburghScotlThloctillowprticiptierchergitypicllyhvelepencetnnulcfenceWemGRNSteergCommteepuruefollowgpecificim1)Orgnizep-cfencewkhoppidentilympoiumpromotebidictillernggloblbccoctrolimplementticience2)Incebtrctubmigloblbccoctrolciencehighlightdvncefotercientificdcuidebtetimultecollbtimggloblbccoctrolercher3)OffertrvelcholrhipLMIC-bedercherpentgpicltedNCICenterGloblHeltherchpriie4)Supptpot-cfencerticleubmiledLMICvetigrNicote&TobccoReerch(SRNTjournl)focuimplementticiencegloblbccoctrolMeetgpropoedimbolterhowSRNTnnulmeetgfciltebidictillerngopptuniemgLMIChigh-comecountry(HIC)vetigrwkggloblbccoctrolbuildgcpcycductimplementtierchlevntimpctfullowourcectextABSTRACTSupptquetedKeyneSympoicfenceentledEpigeneticMechnmTtmentCncergnizedDrTyKouzrideRbPrjhMrBrlomeiThecfenceheldSntFeNewMexicoFebrury4-72024ThKeyneSympoiEpigeneticcfencehighlightltetdvnceundertgepigeneticdrivercncerltethcurntepigeneticttmentdeeOneuniquecompellgpectthcfenceterecticdemidutryAcdemicpenterhighlightbicerchepigeneticpthwycncer(iewhtdriverhowywkhowdoedierenvirmentffecthernceuceptibilymutticcumultiwhtepigeneticmechnmcncertncemetttumplticy)Indutrypekerlteirltetefttrgetcncerperlizedmnnerpnemerggdevelopmentnti-cncerrpiecurntlyhedgclicAddillynemphexmplewhecdemic/clicinhvetkenirerchwrdclicthroughcollbtiphrmceuticlbiotechcompnieItnticiptedthcfenceprovidenopptunycdemicclicldutrycienttmeetcollbteInddiyoungvetigrhveopptunylernhowbicerchcvertedcctettmentcncerptientcgdvntgethkgboutptientnefdutrilprtnergirerchFllyderhelpfcilteircerchoicewkhoppneltcdemidutryflectgirchoiceexperiencewellpnelwomencienceProjectSummryThemjybtcncerlteddethoccurultmettOncecncercellmettize5-yerltiveurvivlrtebtcncerptientdrticllydropDurgmettcomplexerieeventedchngeextrcellulrmtrix(ECM)compoirchectudtnttuewhemettticcncercelltkerootmecdrytumTheedtctchngepmettticniche(PMN)fciltetumcellcoliztiphenotypicheterogeneycellpopultictriedrugtncefquentlyobervedmetttictumUgnengeedmodelPMNwehvedemtrtedextrcellulrveicle(EV)fciltedynmicchngepmetttictueblockgkeyeventdurgPMNmtidruptmettticproceOurplimrytudiedicteECMprotetrnglutme2(TG2)fibrect(FN)plyignificntroleetblhgPMNthroughnEV-dependentmechnmHoweverfundmentlgpmidentifygcricleventnichefciltemettticcoliztumcellcellulrplticydrugtnceTheoverllgolthpropolidentifyhowdynmicchngemettticnichemkedtnttuehopblemettticcncercellAim1ueournovelmodelPMNidentifyhowpecificchngePMNfciltecoliztidemtgcellAim2focuedoltgpecificeffectECMdynmiccellulrctuentPMNimpctphenotypicheterogeneyimmunogenicygivggrowthpermivegrowtrictiveenvirmentAim3identifymechnmwhichkeymtrixcompentnicheprotectmetttictumcellrpeuticgentOurcro-dciplrytemencompeexpertebiomediclengeergmettimggEVbiologyThepropoedtudieetblhnovelmechnmwhichPMNfciltebtcncermettneentiltepwrduccefulttmentdruptmettticproceAbtrctThemtenncecellulrtuehomeotlietightgulticellgrowthprolifertiThgultipdomntlyctrolledtwoevolutirilycervedpthwymmmlinTrgetRpmyc(mTOR)pthwyHippopthwyDygultibothmTORHippopthwypromoterrntcellprolifertueovergrowumdevelopmentElucidtghowmTORHippoignlgpthwycodteirctivieevllyimptntyetpolyunderodcellcncerbiologyOurlbpvioulydemtrtedSTK25e/thekefunctinuptmctivrHippoignlglimcellgrowthUgundpprochewehvenowgenertedtrgplimrydtuggetgSTK25kelofunctiimpirmTORC1ignlgWehvefoundgeneticdepletiSTK25ledbothmTORC1pthwyctivtiHippopthwyctivtiTheedtuggetSTK25myplycriclrolegultgcellprolifertumuppicodtgctiviebothmTORC1HippoignlgpthwyHowevermechnmwhichSTK25gultemTORC1unknownInthpropolwehypoizeSTK25dictlygultephophyltekeygulrycompentmTORC1ignlgpthwyultimtelyttenutgmTORignlgFurrourplimrytudieSTK25knockoutmicedemtrtecdildepletiSTK25ufficientducetumigenewhichcgruentbiomticevidenceSTK25ignificntlyfocllydeletedvrietyhumncncerCombgthourvrofdgwelohypoizeSTK25deficienttumdependennYAP/TAZ/mTORC1ctivygrowthurvivlTheehypoetetedtwopecificimInAim1weuecellbiologiclbiochemiclpprochemechnticllydeferoleSTK25kegultgmTORC1ctivychrcterizgdictphophyltedubtrteInAim2weuecdilSTK25knockoutmouewehveldygenerteddetermeifSTK25lofciltetumigenethroughcedYAP/TAZ/mTORC1ctivySuccefulcompletieimdvnceourundertgmTORC1HippoignlgvelignificntnewightunderlygmechnmdrivgtumdevelopmentMooverpropoedtrgplngtlyenhncemyperikillmicrocopyimggtechniquemoleculrcellbiologymouecncertudieliquidchromgrphympectrometry(LC-MS/MS)nlyAlgerthfciltedevelopmentmycientificexpertefieldmTORHippoignlgcncerbiologyquiduccendependentcienttPROJECTSUMMARY/ABSTRACTEpigeneticmodifictiplycrucilrolemmmlindevelopmentcellulrdiffentidee5-methylcye(5mC)gmotwell-tudiedepigeneticmodificti5mCglobllypegeneexpihignificntgene-gulryimptncevrioudeeTheten-eleventrnlocti(TET)fmilyenzymecnoxidize5mC5-hydroxymethylcye(5hmC)whichtblemrkerglobltrncriptilctivtiWhilepvioutudiehvechrcterizedrole5hmCmodifictihelthyhumntueevlutedplmcell-feDNA(cfDNA)biomrkerpotentilvrioumlignncieucfDNAhnotyetentudiedUpentn-viveeilycollectibleproximlbiluidnumrGUdeeAtpentunclerhowucell-feDNA(cfDNA)5hmCprileflectnmlphyiologiclcdimirrcompoineighbgtueReercherwderwherucfDNA5hmCprilemightferuperilterntiveplmcfDNAcurntgoldtrdliquidbiopydignoGUcncerlikeblddercncerToddequetithpropoleekchrcterizegenome-wide5hmClcpehelthyudevelopbiomrkerettgloclizedblddercncerThepropolimchieveeobjectivethroughtwopecificimThefirtimfocueidentifygourceunwntedvrichrcterizggenomicepigenomic5hmClcpeferrgtue--igcell-feDNA(cfDNA)derivedhelthyumpleToccomplhthimbiomticpipeleoptimizedproceg5hmCprileucfDNAThe5hmCgultiucfDNAchrcterizednlyzgctivygenebodiepromoterenhncervriougulryepigenomicgiThimlopropoectioldetermetue--igucfDNAcfirmenrichmentGUtuecompdplmcfDNAhighlightgpplicbilyucfDNAGUctextTheightgedAim1providefenceevlutgdevi5hmCdtriiucfDNAvrioucncern-cncerdeetteTheecdimfocuedevelopgrobutdignoticpdictivebiomrkerloclizedblddercncerThetudydemtrteutilyucfDNA5hmC-prileblddercncerdignottmenturveillncecomppermnceplmcfDNA5hmCprileAddillymulti-omicclifiermodelcptg5hmCcopynumrtrgetedmuttildtctedvlidtedpdictgmimliduldeeblddercncerptientwhounderwentcurtive-tentblddermovlurgeryTheultAim2generte5hmCigntucnuedpdicnetloclizedblddercncerpdictmimliduldeeUltimtelydtAim2coulddeliveretnewgeneenhncertrgetmyerveexcgrpeutictrgetpventtmentblddercncerPROJECTSUMMARYCncer-ocedcchexidebiltedyndromehdrmticimpcnqulylifeoutcomeptientCncercchexioccurmrkblyhighcidencepncticductldenocrcom(PDAC)ptientCncercchexichrcterizedprogivedepletimuclekeletlmwhichtenculmtegenerlgndyfunctiptientdethTheedeeperundertgunderlygmechnmcncercchexiwouldultimtelyledidentifictinovtiverpeuticimprovemngementmuclewtgcncerptientOurcenttudiehvehownpnc-pecificbltiTgif1geneKrG12DbckgroundleddrmticccelertiPDACmiceQuetriguglydepehvgthevePDACphenotypeemicedotdplynypromentigncncercchexiuchprogiveweightlodecedmuclemfunctiThctrtourpvioutudyugtwodiffentmouemodelhumnPDACKPC(KrG12DheterozygoudeletiTrp53)KICLuc(KrG12Dhomozygoudeletip16Ink4)whichctentlymnifetevecncercchexidurgPDACprogiTheefdghttpoibilyTGIF1mightfunctiPDACcelleeventculmtemuclecchexiIneftprothpoibilywegenertednewmouemodelllowcdilovexpiTgif1foundencgTGIF1expipncticepiliumwufficientducemuclecchexiSubequentmechnticexperimentvelednbilyTGIF1duceexpiFN14whichfunctitrnmembrneceprcncercelldriveflmmtiledgmuclecchexiEncedTGIF1expiloducedexpimembrne-boundmtrnmggrowthfcrlph(TGF)whoeovexpipnclodrivenflmmryphenotypeimilrwhtweobervedmicecdilovexpiTGIF1Inpidetrigugfdgwectednewbpecificntibody(B-14)imultneoulyneutrlizepro-cchecticctivieFN14TGFThtmendouprogpromptedudeignvrietynovtivegeneticntibody-bedphrmcologiclpprocheprovideirfutblepro--prcipletrgetgFN14TGFdowntmTGIF1couldfernovtiverpeutictrtegiecurbcncercchexiOverrchgpecificimSpecificAim1ExproletrnltilpotentilTGIF1PDAC-drivenmuclecchexiSpecificAim2)ExplomechnmwhichTGIF1fciltePDAC-drivenmuclecchexiSpecificAim3)TetrpeuticefficcymocllbpecificntibodietrgetgFN14TGFignlgPDAC-mededmuclecchexiAuchcomplethhighlynovtivepropollikelyculmteprdigmhifurundertgttmentthlethlwtgyndromePROJECTSUMMARY1CncerurvivuebccotgterrkexperiencgnegtivehelthoutcomeWhilemny2cncerurvivquugbccottimedignovilbleerchdemtrtemny3lpe(eg13-60%)TheSocilEcologiclModel(SEM)providecceptulfrmewk4undertgtrperlfcrterperlfcrmyctriebccouelpe5Howeverdtefewtudiehveidentifiedtrperlterperlpdicrbccouelpe6mgthptientpopultiFurretudieutilizeurveydeignunbleexme7fcrimmedelypcedebccolpeThultivelyunknownhowtrperl8terperlfcrltebccolpectextcncerurvivhipl-time9Thepropoedtudyimddthcriclgpdvncecncerpventictrolcience10throughugmultipleurveymethod(ieecologiclmomentryementlgudlurvey)11exmemomentrylg-termocitweentrperlfcr(iecncerwrynegtive12ffect)terperlfcr(ieocilupptocilctrt)bccolpehviCncer13urvivdemtrtegterrklpe(egnewlydignoedcentlyquugbcco)(N=122)14cruedVCUMeyCncerCenterkedcompletebeleurvey3-mth15follow-upurveyexmetrperlterperlpdicrbccouelpe(iectued16bccoue>7dy)Aubet40prticipntlocomplete14-dyecologiclmomentry17ement(EMA)vetigtemomentrytrperlterperlpdicrgterbcco18lperk(defedhigherurgeuebccolowermotivtibtbcco)Specificlly19pplicntim(1)exmedilyocitweentrperlfcr(iecncerwrynegtive20ffect)bccolperkcro14-dyperiod(2)exmedilyocitweenterperl21fcr(ieocilupptocilctrt)bccolperkcro14-dyperiod(3)exme22ocitweenbeletrperlterperlfcrbccouelpetfollow-up23ThepropoedtrggolthNRSAfellowhip(1)cepplicntknowledgefcr24ctriebccouebccolpemgcncerurviv(2)enhncetrgdvnced25qunttivettticlmethod(3)improvetrnltilerch-ltedkillThtrgplnvolve26vrietyerchdidcticpildevelopment-ltedctiviefcilteucceful27completipropoedprojectequippplicntkilletneededledcern28dependentercherFurrpplicntmenrhiptemcludeexpertfieldcncer29pventibccoctrolwhomthrycollbtiOverllultthprojecthve30potentilmdevelopmentfutubccottmentprogrmcncerurvivPROJECTSUMMARYAcutemyeloidleukemi(AML)nggivebloodcncerchrcterizedccumultibnmlmyeloidprogenirrteddiffentiItmotcommmleukemimgdultecdmotcommmgchildnDepeciderbledvnceourundertgthdeeprognoAMLptientmdmlfive-yerurvivlrtelnguhgt<30%depeuetenivechempyThucompellgneedidentifynovelmoleculrvulnerbilieAMLhelpguidedevelopmentmoeffectivetrgetedrpieTheRNAheliceDDX6emergedpromenthiurCRISPRdropoutcenimedtidentifygpecificAMLdependencieDDX6petrnltrgetmRNAugATP-dependenthelicectivyequetermP-bodiecyplmicribucleoprotegrnuleOurplimrydtdicteAMLcellovexpDDX6hrbmoP-bodiecompdnmlhempoieticprogenirWefdloDDX6triggergP-bodydoluttenuteelf-newlAMLcellpromoteirdiffentivrohltleeffecnnmlhempoieticprogenirCgruentlywelofdloDDX6brogteexpniAMLcellvivoBypurifygtctP-bodieAMLcellwefoundenrichmentpotenttumupp(egKDM5BTLE4TRAF6)mgmRNAequetedDDX6P-bodieTogeredtleduhypoizeDDX6pecificAMLdependencyutAMLequetergtrnltillypgmRNAencodgtumuppWetetthhypothroughtwoSpecificAimInAim1wedefefunctilquimentDDX6AMLugnovelmouemodelWeexpectDdx6lomuttihelicectivypvenrdelyAMLetvivoCverelyweexpectDdx6ovexpiccelerteAMLetvivoInAim2weelucidtemoleculrmechnmwhichDDX6utAMLWepdictwefdmRNAencodgtumuppenrichedP-bodieAMLcelltrnltillypedWenticipteloDDX6de-pemRNApromoteirtrnltiproteexpiCollectivelyeexperimentunveilRNAheliceDDX6potentilrpeutictrgetAMLetblhgpecificAMLdependencydeciphergmechnticbthdependencyThtudyloprovidefirtevidencencogenicroleP-bodiectexthemlogiclmlignnciemyuncovernoveltumuppmgDDX6trgetcnpotentillyexploedgtAMLGlioblm(GBM)mbrcncernocufive-yerurvivlrtelow10%Immunpieuchimmunecheckpotblockde(ICB)hvehowngtpromeolidtumhvedemtrtednocliclnefGBMptientInprtduehighlyimmunouppivetummicroenvirmenthibTcellctivtifiltrtiThecequentlynurgentunmetneedengeernewimmunpieGBMReiccid-duciblegeneI(RIG-I)promgtrgetcncerimmunpyRIG-InRNAengptterncogniceprcyolleddowntmproductypeIterferwhichcnledCD8+TcellfiltrtumHoweverRNAdeliverycyolchllengecuenegtivechrgeRNApventternliztiTherpeuticctivteRIG-IhveendemtrtedimprovepeICBeverlpcliclmodelolidtumhveyetexplodGBMThpropolimdeigntetbiomterilrpylocllydeliverRIG-Igt5-triphophylteddouble-tdRNA(3pRNA)vipolymericnnocrrierelicpro-flmmrypemouemodelGBMRIG-InuntudiedtrgetttgGBMwedeliveruniquetem-loop3pRNA(SLR)ctivtepthwySLRdelivedpHpivennocrrierdetbilizeendoomeleeSLRcyolAn-CD11bnnobodycjugtednnoprticledriveuptkentigenpentgcellcludgidentmicroglifiltrtgdendriccellmcrophgeWepropoetwopecificim1)EngeerRANGBMimmunpy2)determeirimmunologiclcequenceWetetimugfollowgexperimentAim1)SLRcovlentlycjugtedpolymericnnoprticlefollowedclickchemtryttchn-CD11bnnobodyWeverifyRNActivyuptkevrougterferptercelllemrrow-deriveddendriccellTheefficcyourengeednnoprticletetedGL261CT2AimmunocompetentmodelGBMugtrcrniljectinnoprticleWedetermeifcombtirpyICBledenhncedefficcyRIG-IctivtgnnoprticlectemoimmunogenictummicroenvirmentAim2)StudiedetermeimmunologiclmechnmttmentWeevluteimmunecellfquencyctivtittetumbrWedetermeTcelldependenceiffiltrtgTcellneceryefficcyifrpyctememyTcellbrWehypoizethurpolymerrpeuticctivtentigenpentgcellledgCD8+TcellfiltrtumThprojectimproveknowledgefieldneuroimmunologythroughightgedboutroleRIG-IctivtiGBMItloenhnceknowledgefieldmterilengeergcuewelernmtiboutbrpepHctivepolymerwhichcnppliedfuturpiePROJECTSUMMARY/ABSTRACTMnyptientdvnced-tgecncerdevelopmettticdeebrMotptientwhodevelopbrmett(BM)uccumbdeeDepeuchpooutcomeBM-pecificrpiecurntlylckgRecentclicltrilhvedemtrtedBMmypdimmunecheckpothibirHoweverpeBMtendledurblethnthoeeenextrcrnilmettewrrntgfurrvetigtihowimmunpiecntterlevergedgtBMRecentfdgourgrouphveuggetedmyloidt(A)protewell-etblhedroleAlzheimerdeepthogenefcilteimmunouppiBMmicroenvirmenthibcncercellphgocymcrophgepermtgtumoutgrowthLikeweetudyglioblmfoundueBACEhibir(BACEi)whichtll-ecteenzymevolvedAproductidecetumburdencgcncercellphgocyflmmryignlgmcrophgeWehypoizeAdriveimmunouppiBMmcrophge-dependentmnnertrgetgAledprogrmmgmcrophgepromotgnti-tumimmunyBMmicroenvirmentInAim1wepermnovelchrcteriztiABMmicroenvirmentugimmunocompetentmouemodelFollowgthchrcteriztiwedetermeifttmentBACEilecombtinti-PD1hiboutgrowthevenducegiBMAim2unpckmechnmwhichAterctmcrophgehibcncercellphgocyfcilteirimmunouppivechrcterticWelotudyhowthA-mcrophgeterctifluencedowntmTcellphenotypeCollectivelythwketblhApotentilrpeutictrgetBMuncovernovelmyeloid-bedmoleculrcidtenext-genertiimmunpieThetrgplnthfellowhippn25yerdurgwhich15yerdedictederch1yerdedictedclicltrgTheerchdetiledbovellowmeetblhmteryfieldcncerbiologyimmunologypoigmewellchievemygolcomgpetblhgmyowntumimmunologylbryInddivetigtgimmunologicfunctiABMIttendpenttmultudeternlemrterntilmeetgTodevelopmymenrhipkillIenggeeverlopptuniemenrhighchoolundergrdutetudentAddillyIctuemyvolvementNYUCliclTrnltilScienceIntutetermydevelopmenttrnltilcienttLtlyIupptmyclicltrgttendgOncologyTumBdHemlogy/Oncologygrroundhdowghevilyerch-focuedcologtcompletgmymediclchoolcoclerkhipcurriculumPROJECTSUMMARY/ABSTRACTTrgetedcncerrpeutichvetrdillyfocuedhibgctivtedcogenicignlgpthwyWhileuchpthwyhibirhveultedcliclucceeimprovedptientperteprogifeurvivlmotceyhveyetyieldcurtivepedueeventuldrugtnceEmerggevidenceuggetctext-dependentlethlyducedpthwyctivtipentpromgunexplodpprochcncerrpeuticpotentilovercometnceThemgolthprojectdemtrtecncerdevelopgtncetrgetedrpygcedenivyn-cro-tntpthwy-hyperctivtiSpecificllythprojectfocumelnomwhecogenicERKMAPKpthwyctivtimotivteddevelopmentMAPKpthwyhibirBRAFhibir(BRAFi)MEKhibir(MEKi)uedcombtitrdctrgetedrpyBRAFV600EmelnomptientHowevercurntttmenpticludgetrgetedrpieimmunpierlychievecompletepeduetriccquidtnceAlthoughtnceMAPKpthwyhibipdomntlymededMAPKctivtrtumlheterogeneytncemechnmcomplictecurtileftcombttnceInceduceptibilyMAPKhyperctivtioccurthroughmemechnmmkecelltntBRAFi/MEKiuggetgcyclgttmentMAPKhibifollowedMAPKctivtiwouldducecollterlenivyvoidtncedevelopmentThpropolemployhighcomplexycellulrbrcodetrcgwellBRAFi/MEKitntxenogrftmodelvetigteefficcydrivgtumcllevolutiwrdBRAFi/MEKitncemximlenivylethlMAPKhyperctivtiultgtumerdictiFurrmodul-knockoutCRISPRcengtrtegieemployedidentifymoleculrmechnmmedgMAPKhyperctivtilethlyThepropoedrpeuticpprochbed1)plimrywkobervgelectiveenivyMAPKitntmelnomlethlMAPKhyperctivti2)n-crotncemechnmMAPKhibihyperctivtiByexplgynergytweenetblhedtrgetedrpytrtegiepvioulyunppcedpthwyctivticncerdependencieetudieimetblhnewrpeuticprdigmcncerttmentThpprochlikelybrodlypplicblekeycogenicignlgpthwycncertypeddeefundmentllimtitrgetedrpiePROJECTSUMMARY/ABSTRACTColoctlcncer(CRC)ecdcuecncer-ltedmtlycuemettticdeepentedliverperinelmettThdeelrgelyenivemodernimmunpielimedcurtiveoptiImmunemechnmgultgCRCtummicroenvirment(TME)notwellunderodlikelyholdkeytterimmune-bedrpieWeurprglyfoundlevelInterleuk(IL)27cykecedhumnCRClevntmouemodelCRCcedlevelcltepoprognoAprtplimrydtwefoundgeneticctivtiIL27R(cepr)neutrliztiIL27cykepdicCRCmodelducetumgrowthprogimettThpropolimunderthowIL27gulteCRCTMEdurgmettdevelopmenthowctivtidriventi-tumimmunyexertedntedptivermimmunepeOurhypoIL27uppednti-tumimmunepemededdptiveimmuneTcellpoiblecellnteimmunyWeuegeneticmodelIL27/IL27RdeficiencywellneutrliztiIL27cykecomdcuttgedgepcliclmodelCRCpdmetthlogiclcuttg-edgeimggmoleculrbiologicl/dvncedtrncripmicmethodmouehumnCRCPropolbedthetercnectedSpecificAim1)ExmeeffectIL27immunouppiveTMECRCliverperinelmett2)UncovercelltypepecificyIL27ignlTMECRCmett3)TetwherIL27neutrlizticnidimmunpeuticmodlieprticulrlyfocuectivtidptive(nti-PD1/nti-LAG3)ntemyeloidcellnticncerimmunepe(nti-CD47)OurexperimenteetblhnuniqueroleIL27ignlgliverrlytudiedperinelCRCmettuncoverunderlygmoleculrcellulrmechnmetblhtetrtilefeibilyIL27pthwyblockdefciltenti-cncerimmunydifficult--ttdvncedcncerSUMMARYThemicrotubulepopclxel(PTX)trd--cbtcncerttmentllbtcncerubtypebotherlytgemettticdeeHowever~50%btcncerptientdotnefPTXThoughPTXcuemicrtthighccentrticellcultuourdttwobiomrkertudiedemtrtePTXlevelptienttumolowcuemicrtIntedPTXcuebnmlmultipolrmicpdleDivimultipolrpdlecueunequlchromoomeeggti(termedchromoomltbilyCIN)WhilelowrteCINcommtumcgrteCINbovemximllylertedthholdlethlScePTXceCINedtupptmodelwhichPTXeffectivewhenceCINovermximllylertedthholdOurlgtermgoluethnovelmechnticightcvertPTXgenericchempypcimedicedevelopg)biomrkerpdictwhichtumpdPTXb)method()enize~50%tntcncerBedourplimrydtwehypoizetwomjdetermntPTXenivyFirttumhveendogenouCINcloemximllylertedCINthholdmoenivePTXSecdometumcnfocuPTX-ducedmultipolrpdlener-nmlbipolrpdlemidmidrmticllyducePTX-ducedcyxicyevenwhenPTXffectpdleerlymiScePTXttmentcecidencemultipolrpdleerlymithimplictemidmifocugPTX-ducedmultipolrpdleecdmechnmPTXtnceAim1tethypop-ttmentCINcltePTXpeprimrybtcncerdetermedngogbiomrkertudyneodjuvntgle-gentPTXtropectivenlyI-SPY2mpleAddillyAim1tetwherexperimentllyducgCINenhncePTXpeAim2enblette---rtqunttivemeuCIN)employggle-cellDNAequencg(cDNAeq)quntifyllchromoomeb)ccountgdropouthighlyneuploidcelltumpopulthroughtechniqueknownApproximteByeinComputtiAim3experimentllytethowpolefocugctrolPTXpeAddillytethypolertibnhibirAurkAcnpventpolefocugPventgpolefocugexpectedenizetumtntPTXcgcellundergomultipolrdivimrkedlyelevtgCINFllyCRISPRcenuedidentifygenecferthmechnmprimrytnceAgeneigntupolefocugcouldimproveCIN-bedpdictivebiomrkerPTXpeTogerrnltilwkbedcceptuldvnceprovidedourpvioutrnltiltudieprovidebicknowledgebiologiclmechnmgultgcelldethpecnernenti-cncerttmentThprovideoundbfutudevelopmentpdictivebiomrkerPTXtrtegieenizgPTX-tntcncerProjectSummryPncticductldenocrcom(PDAC)motpvlentneoplticdeepncexpectedcomeecdledgcuecncerlteddethovernextdecdePDAChnmlprognoly10%ptienturvivgmothn5yerdignoIntetglyover90%PDAChrbctivtgmuttiKRAScogenemotcommKRASmuttieenPDACG12DG12VG12RG12DG12VmutticommlyfoundlungcolcncerhoweverG12RmuttilrgelytrictedPDAC15-20%PDACcrryG12RmuttimjypcliclnimlmodelfocuKrG12DmuttiwhichflectlethnhlfKRASmuttieenhumnPDACTheplimrydthownthwkoverllpropolimdetermeifKrG12RmyfunctillydtctKRASdrivermuttihowthffectdeeiprogiApvioulydecriduunlikeKrG12DKrG12Rmuttidotdriveprogip-neoplticPnINleicrcelltedymtlleddurgcr--ductlmetpli(ADM)ddimutntp53lleledoenotccelertedeemtimiceHoweverwehvefoundundertwopecificctextKrG12R/p53MUTductl-derivedgnoidtrnplntedmicemicep53mutntllelelop53llelecogenictrnmtihppenultPDACmtiWehvelodecriddecedPI3K/AKTignlgKrG12RwhencompdKrG12DThpropoedwktethypocelllege/coopertggeneticeventPI3KpthwyimpcncogenicpotentilKrG12RmuttipnccncerMypropolpentignificntctriiundertgmoleculrunderpngdeeiprogiKrG12RInpropoedtudieweimdetermeifhowcell--igimpctdeeiprogihowimmedeutedmoleculreventfollowgKrG12RctivtiffectiprogiWeloimelucidterolePI3KmuttiffectdeeiprogibothvrovivoToddequetiweuelegetrcgmouemodelcdillymrkcellducemutntKrG12Rp53muttipncInddiweueCRISPR-C9genomeedgtechnologiemkecomplementrygnoidvivomodelPIK3CAmuttiPTENdeletihelpelucidterolePI3KKrG12RPDACWeplnuediffenthlogiclmoleculrtechniquedectmoleculrunderpngKrG12RdrivenPDACWenticiptetterundertgKrG12RltedcellulrmoleculrproceefurrelbteKRASheterogeneyfoundPDACwellprovidevenuedevelopmenttrgetedrpeuticptientpopultivrygKRASmuttiTITLEBiochemiclpropertieimplictiNRASmutnt-pecificBRAFterctimelnomABSTRACTExtrcellulrgrowthfcrpromotecellulrprolifertimotilyurvivlthroughcomplexnetwkignltrnductipthwyThumuttiepthwycncuepproprecellulrprolifertileddeeuchcncerRASntrcellulrhubmultipleignlgpthwymutted20-30%llhumncncerWhiletheRASm(H-K-N-RAS)hhighdegeimilryechRAS-drivencncertypeenrichedmuttipecificRASmcod(121361)mocidWedotfullyundertmechnmdrivgthobervedelectivylthoughechRASmutnthdtctbiochemiclfunctilpropertieElucidtgmechnmunderlygemuttilpfencecouldhelpidentifyfetucogenicRASquidecncerdiffenttuetypeToddthknowledgegpwehvefocuedelectipecificNRASmutntmelnomOurwkhhowncommmelnom-ocedNRASmutnt(Q61RK)promoteMAPKignlgthroughcedctivtiBRAFhomo-hetero-dimerNewmoleculrdynmicimultiuggetcmtilpropertiepecificNRASmutntdrivemelnomfcilteBRAFbdgHeItethypotructurldiffencetweenNRASmutntdetermeirbilyoutcompeteuhibiryBRAFterctidriveenhncedMAPK>ERKctivtilterpotencyRAFhibirTotetmyhypoIuevrietyvrobioencell-bedignlgymouemodeldefemutnt-pecificfetuNRASfcilteBRAFtercti(Aim1)howtructurldetermntdiffentNRASmutnt-BRAFterctifluenceBRAFhibirenivy(Aim2)SuccefulcompletietudieenhncemyknowledgetructurlbiologyrpeuticdevelopmentmouemodelcncerIloidentifymutnt-pecificNRAS-BRAFterfceguidedeignnovelrpeuticpprocheNRAS-mutntcncerprovidemtilevntcliclimplementtinext-genertiRAFhibirAbtrctWehvehownbltumwhichcomp<20%PDACtumtntfirt-lechempygimenFOLFIRINOXWehowbltumignificntlyenrichedceprtyroekecludgEGFRWhileEGFRhibirhveenctentlydppotgPDACournlytwoclicltrilwheptientwettedgemccombtinEGFRhibirhownegtiveultverylikelydrivenpvioulckknowledgeubtypeInbothclicltrilptientbltumignificntlynefEGFRhibirttmentItnotewthyurvivlptientblubtypetumignificntlywethnptientclicltumWehowveryfirttimeblptientwhoceiventi-EGFRrpynefEGFRhibirrpy(ptientcliclubtypetumdot)cnchieveequivlenutcomecliclptientOurfdgtrglyupptpoiveubgroupnlyblptientexpledhigherEGFRkeexpifoundbltumTheedttrglyuppurhypotrgetgubtype-pecifickekeypromgpcicologypprochekehibirPDACWepropoemulti-dciplrytemtrnltilercher(Yeh)komeexpert(John)mediclcologt(Somundrm)tkenexttepdetermgifEGFRhibirhouldpurpoedptientblubtypetumlevergetrnmtivehighenivymethoddefgkomelowputmpleuchbiopieidentifytrgetedpprochepecificllyblubtypetumPROJECTSUMMARY/ABSTRACTDethrtehvedecedcromnycncertypeowgimprovederlydetecttmentmethodmedlrgelytgnnvrincnceroverltfourdecdeHighgrdeerouovrincrcom(HGSOC)motcommdedlyubtypeccountglmot70%llovrincncerce70-80%dethHGSOClikelydevelopecrycellfllopintuepilium(FTE)neopltictrnmtypicllyproducehighlymetttictumcellp53mutnthomologoucombtidefectiveApop(progrmmedcelldeth)fundmentllyimptntprocemovgdmgedmlignntcellevipophllmrkcncerThetricpoppthwyctrolledBCL-2fmilyprotewhichtendygultedcncercellcferurvivldvntgeWehvecentlydetectednupgultiBCL2L1genewhichencodepro-urvivlproteBCL-XLHGSOCcompdnmlfllopintuepiliumThupgultiproducedependencythpro-urvivlprotemytrgetedrpeuticllyFmyF31erchpropolIhypoizeHGSOCcellhvecedpro-urvivlproteexpiprticulrlyBCL-XLbuffergtcedpro-popticignlgocedneopltictrnmtiwhichcnrpeuticllytrgetedcetumcelldethIpropoetetheim1)certpopticgultipro-urvivlprotedependencep-mlignntmlignnttgetrnmti2)ueHGSOCptientderivedxenogrft(PDX)mouemodeleefficcycombgpro-urvivlprotetrgetgdrugfirt-lechempeuticenhncetumcelldeth3)elucidtehowhmefolliculrfluidexpouffectpopticgultifllopintuepililcellnir-liquidterfcecultuThetrgplnthpropoldeignedgivememenrhipexperiencekilletneededobtpotdocrlpoiultimtelytrnindependenterchcerwkgfieldgynecologiclcncerbiologyBegmendmypDrKrpherSroiekDvidChrtiniwkgcloecollbrpecilizeovrincncererchllowmelernnecerylbrytechniquegubjectmtterexpertepopovrincrcogenecncerrpeuticenvirmentlhelthltecncerrkTheScienceAdvyCerMenrgcommteeIhveetblhedprovidefurrguidncemygrowthuccefuldependentcienttIpublhmnucriptttendcfencepentmyfdghemywrtenverblcientificcommunictiUltimtelythF31providemetrgexpertenecerycercncererchpotentillynopptunypoivelyimpctlivewomendignoedovrincncerPROJECTSUMMARY/ABSTRACTObjectiveTheoverrchggolourerchplceviverdiclprottecmytrgetedmi-mllyviveimge-guidedfoclectiprottecncerWepropoeccomplhthcombgnovellow-eldMRItechniquenewkdurgiclrobotcpbledelivergtweedle-izedmnipulrprottethroughtrdtrnuthrlendocopeSignicnce18mendignoedprottecncerirlifetimeecdlylungcncernumrmenkilleveryyerUSAThegoldtrdttmentrdiclprottecmyvolvecomplicticludgllthoemjurgerywellhighrteimpotencectenceRecentlypieergurgehvenotedpromeptient-pecictrnuthrlfoclectiducecomplictirteHoweverpprochcurntlyfundmentllylimedfctcnceroutuecnnotvullydiffentedhelthytueendocopeimgecgurgeguewhecncerbedmemypopertiveMRIimgeUltround-MRIfuicnnotimprovethgceultroundprocompeprottewhichcollpeuthrpcludetrnuthrlterventiWepropoeelimteguewkenbleccurtepceperlizedfoclectifughigh-olutipopertiveMRItropertivelow-eldMRInovelroboticytemInnovtiThecentrlnovthprojectenbleueemergggenertiexpeniveptbleopenlow-eldMRIcnnerguidefoclprotteectiAddilnovticomeroboticytemwhichenblepceccurteueimggmtiTherobotrtMRI-cdilrobotbledelivermultiplemnipulrthroughnendocopeItfetuneedle-izedtentcle-likemnipulrdeploymprottethroughtrd-dimetertrnuthrlendocopepceectrctueThmkefoclectiprocemucheiermoccurteurgeccomplhApprochWecteourMRI-guidedroboticytemthroughtheSpecicAimAim1chieveft-tropertiveimggupdteurgeimgeguidncedplyymovetueInAim2webuildnovelMRI-cdilrobottegrtelow-eldMRIcnnerInAim3wevlidtetegrtedytemnthropomphicphnmurologicurgeNoteclicltrnltiourytemrpidtuccefulccluhR01ThprojectcludetwodutryprtnerPromxoIncwhichhcentlyleednFDA-pprovedlow-eldprotteMRIcnnerVirtuooSurgiclIncwhichde-velopg(n-MRI-cdil)trnuthrlrobotltedmrkettimethR01ccludeThuuccefulcomplethR01pvewycommerciltrnlticlicltrilenblgurpidlybrgnettherchdocrirptientPROJECTSUMMARY/ABSTRACTAcutemyeloidleukemi(AML)nggivebloodcncer5-yerexpectedurvivlrtelethn30%Internltemduplicti(ITD)Fm-liketyroeke3(FLT3)commmuttiAMLmoleculrdriverimmtubloodcellprolifertiDepedvncedevelopmentFLT3kehibirmiht-livedIhvepvioulyhownhibiepigeneticgulrlye-pecificdemethyle1(LSD1)enhnceefficcyFLT3hibirFLT3-ITDAMLThedrugcombtiduceleukemiccelldethdruptggulrybdgtMYCblood-pecificuper-enhncercomplex(BENC)ultgloctivyexpiMYCpro-coproteInAim1Iueglecellchromtcceibilyequencghigh-olutiepigeneticprilgprimryAMLmpledefetrncriptifcrgulrMYCBENCFLT3-ITDAMLInAim2IuectivtgCRISPRtechnologydrugenivyyidentifydividulMYCBENCenhncermodulecriclctivycomdFLT3LSD1hibiSuccefulcompletietudiedetermemoleculrctrolMYCBENCFLT3-ITDAMLnomtgnoveltrgetenblgperliztidulFLT3LSD1hibiptientFLT3-ITDAMLMygolmngendependentytembiologyerchgroupvetigtemoleculrleukemibiologytrgetedleukemirpiewhileimultneoulyprcticghemlogncologttncdemicerchtuteThpplictipropoecompheniveterdciplrytrgplnpromentcdemicmediclerchtutiemlelytegrteerchpropolprovideeentiltrgcomputtilmoleculrcncerbiologyIceiveguidncedrugenivyfunctilgenetictechniquewellcceelrgetAMLptientbiopoiriewldmypDrBrinDrukerpieerfieldtrgetedleukemirpyDicrKnightCncerIntuteIupptednlyglecellequencgdtmyco-pDrEmekDemirSectiHedComputtilBiologytKnightCncerIntuteIlernpplyhigh-olutiepigeneticprilgtechniquevetigteepigeneticgulrymechnmleukemimyco-pDrTheodoBrunphyicin-cienttAtntPHemlogy&MediclOncologyItdueglecellchromtcceibilyequencglederglecellequencgtechnologieDrAndwAdeyIlernuetegrtiveytembiologytechniquetudytrgetedleukemirpiemydvycommteememrDrLurHeerIlerndeigntetmyhypoectextrpeuticpecncermydvymemrDrNokiOhimiPROJECTSUMMARYThprojecttrnltennovtivechimericntigencepr(CAR)Tcellrpyptientpncticductldenocrcom(PDAC)WepoefficcyCARTtrgetgmeol(levntPDACntigen)cnenhncedue1)newubetexpgCD26(cotimulrymoleculeenzymticpropertie)termedCD26+Tcell2)nnovtiveexpniprocolcptephophtidyloilke-3hibir(PI3Ki)duvelibimproveCARTpertencemetbolmOurtemptedCD26+CD4+TcelldictedMeo-CARwepolyfunctilelicctivygtPDACtummiceOuroverllhypoPI3Ki-expedCD26+CD4+TcellnideltempltefelydictgimmunyPDACWhileCD26+CD4+TcellpolyfunctilyfullydiffentefterexpniwhichducepotencyHoweverourdthowCD26+Tcelldiffenticnducedugduvelibdurgmnufcturgthuutgelf-newl(ietemne)whileenhncgvivocylyticctivygrthopicKPCtumThProjectpuruethepecificimAim1teurhypoCD26+CD4+CARTcelldegrdechemokeduceuppivemyeloidcellfvblyltergcellcompoummicroenvirmentuglevntmuPDACmodel(thopicmetttic)immunecompetentmiceFunctilimpctMeo-CARTendogenouTcelltetedprlleltudieRAG2KOturrdefemechnmefficcyAim2vetigteterctitweenDuvelib-expedCD26+CD4+CARTcellcventilCARTcelltrgetgPDACAloleCD26efficcyevlutedugCD26+CD4+MeoCARTcellexpgenzymticllyctivectiveCD26ttgmiceelectiveCD26hibir(glipt)TheeffectCD26enzymemodulticrumentmyeloidcellPDACTMEtetedbothhumnmuvivoytemInAim3wecductnovelfirt--humntrilptientdvncedPDACevlutefetypertencefteco-fuedDuvelib-expedCD26+CD4+cventilCD3+MeoCARTcellWefemnufcturggenertefoundtilfeibily/producibleCMCdtnINDpplictiAphe0/1clicltriluelowdoenumrDuvelib-expedCD26+CD4+Meo-CARTcellfolloweddoeecltiDuvelib-expedCD26+CD4+Meo-CARTcellcombtidiffentillybr-codedcventilCD3+Meo-CARTcelldefefetyclicllyeffectivedoethnovelACTrpyEngrftmentpertenceCARTproductbloodptienttumbiopietetedptilmoleculrimggmulti-prmeterflowcymetrytudyCARTmetbolic/effecrpropertieCollectivelythwkdefepropertienovelDuvelib-expedCD26+CD4+CARTcellnimlPDACmodeldetermefetypertenceCD26+CD4+CARTcellptientOurultenbleubequenttrilCD26+CD4+Meo-CARTcellndividulrpycompentcomdcellrpyPDACPROJECTSUMMARY&ABSTRACTAbtrctAmotcommmlignncyurrytrctmgmenwomenblddercnceretimtedurp80000newce17000deth2023Accountgmotblddercncerceurolilcrcomhdmlurvivlrtepproximtely5%mettticettgAPOBEC3A(A3A)APOBEC3B(A3B)memrfmilycytidedemeenzymectlyzemovlnmogroupcyenucleotidegenertgurcilplceerveourcemuttiA3AA3BenzymecommlyovexpednumeroucncertypecludgurolilcrcomAPOBECmuttiigntueenmotcethcncertypeDueirmutgenicctivyA3AA3BhveenimplictedlterggenomiclcpeurolilcrcomtumovertimeTheeltertihvepotentilugmenttumcellcllycnlednenrichmentcellfrcryttmentdrivedeeprogiCurntlyunclerifbothA3AA3BdriveAPOBEC-ducedmutgeneifeenzymeplylrgermutgenicrolethnThpropoleekddhypoA3AA3Benzymediffermutgenicctivyledgdiffencepromotrtumlheterogeneypenti-PD-1immunecheckpotblockdehibiToddthhypotwomoueblddercncercellleentledBBN963BBN976penttivehumnmucleviveblddercncerdevelopedexpeirHA-epipetggedA3AA3BdoxycycleduciblemnnerUtilizthmodelllowdictcomprA3AA3BducedmutgenicctivytumcellcllydiverifictimodultipettmentExperimentdetiledAim1elucidtedriverAPOBECmuttiligntuurolilcrcomug-vroynlyzepdictedtrgetequenceAPOBEC3enzymeSubequentlyAim2ueDNAbrcodgtechnologycomppromotrtumlheterogeneyA3AA3BLtlyAim3determefluenceA3AA3Bttmentpenti-PD-1rpyroleeenzymeplyltergtum-immunemicroenvirmentutilizgn-vivopprochCompletiwkoutledeimultidentifictidriverAPOBEC3mutgeneurolilcrcomhighlightpotentiltrgethibicombtirpyimmunecheckpotblockdeptientelevtedAPOBEC3mutgenicctivyABSTRACTColoctlcncer(CRC)thirdmotdignoedcncerUnedStteWhcgpublicknowledgecncerrkfcrcengcidenceCRChtedilydeceddividuloverge50overlteverldecdeHowevercidenceCRCyoungerpopultihenIndividulunderge50cglyfflictedlight-t-nightexpounight-hiftwkerrticetgptternwhichknowndruptcircdinclockImptntlydrupticircdinrhythmknownrkfcrCRCTheelikelydrupticircdinclockctrigfcrlrmgceerly-etCRCceThemergglktweencircdinclockcncerhenmoupotentilcncerpventitrtegieWhilecullkclerunderlygmechnmhowcircdinclockimpgentumimmunyctepermiveenvirmenttumigeneunknownThegolthprojectunderthowbothgeneticenvirmentlcircdinclockdruptilterimmunelcpepromotetumigeneOurplimryfdguggetdrupticircdinclockpromoteflmmtilterhotimmunyBedefdgwehypoizeclockdruptipromoteflmmtictenimmunouppivemicroenvirmentublecnceriprogiThcentrlhypoddedfollowgSpecificAimAim1determehowclockdruptiltervivoimmunelcpethroughctivtiMDSCuppicyxicCD8+TcellAim2defemoleculrmechnmhowclockdruptiimpcthotimmunyccelertetumigenethroughWntignlgpthwyMYCTheoutcomeourfdgdefemechnticunderpnglkgdrupticircdinclockltedhotnti-tumimmunyThelg-termgolthtudyimprovecncerpventtmentthroughlifetylephrmcologiclmnipultilktweencircdinclockimmuneytemPROJECTSUMMARYAdoptiveTcelltrnfer(ACT)rpymedepotentimmunyomeptientggivemlignnciemnydividuldotpdlpeOnerpyfiluduelckTcellpertenceToovercomethproblemweimedgenertecellproductledlgtermimmunyggivelygrowgtumOurtemptedntigen-pecificCD4+TcellecteIL-17termedTh17cellpertlgtermcnerdictelrgeolidtumwhenfuedmiceWefoundtumdrglymphnodemicettedTh17rpywvtductigeneMHC-IIpthwywellkeycykecotimulrycuetrncriptifcrknownupptBcelldiffentimturtiFurrmohotBcellweurprglycriclutgdurbleimmunyirdepletiimpidurvivlInmicedeficientBcellIL-21IFN-gproductiTh17cellwimpidImptntlyourfdghowfirttimenctiveroleBcellACTBedourfdgwepropoecentrlhypoIL-21IFN-genhnceTh17BcellcoopertivyturnutglglivedpeviMHC-IIdependentpthwytumpecificntibodieTotetthhypoAim1weexmehowIL-21IFN-gupptTh17-BcellcoopertiTh17celldeficienrufficientIL-21RIFN-gRfuedmelnom-rgmiceoutIL-21RIFN-gRwetethowIL-21IFN-gignlggovernTh17Bcellelf-newlprolifertimturtinetwkgInAim2wedetermehowtrnferdTh17cellynergizehotBcellmedetumimmunyToddthwedetermeifTh17cellcndictlykilltumnMHC-IItrictedmnnerpermgvrokillgyTh17cellgtmelnom(outMHC-IIexpi)FurrTh17celltrnferdmicedeficienrufficientMHC-IIexpgBcellrgmelnom(outMHC-IIexpi)tetidebothMHC-IItumBcellneededutedimmunyAddillywetetifntibodieducedTh17cellrpytumpecificTotetthwetrnferntibodieTh17cudmicettmentnvemicechllengedlungmetttetifentibodiecnprotecttummtiTheevetigtiexpectedexpoemechnmhdTh17BcellntumcoopertivyturnmgdevelopmentnovelrpiebolterimmunygtggivetumevdecurntttmentProjectSummry/AbtrctAdoptivecellulrrpie(ACT)hvemdemrkbledvncettmenthemlogiclmlignncieHowevermrkbleoutcomecfedubetptientbloodcncerhvenotenchieveddividulolidtumwhichccount90%dultcncerTheenovtivepprocheovercomeelimtieentilddubtntilunmetneedeffectivecellulrrpieWehypoizenwermycomenunlikelyourceTcellneoplmTcellTcellneoplmhvedevelopedgeneticmenimproveTcellfneovercomeomemeobtclefcedrpeuticTcellOurgrouphpieedpipeleuglymphoidneoplmmuttimethodddobtclefcedrpeuticTcellWefoundnovelgenefuiCARD11-PIK3R3drmticllyceccumultieffecrfunctinti-tumefficcydoptivelytrnferdcellnntigendependentmnnermultipleTCR-trngenicTcellmodelTheeulthveendemtrtedfullyimmunocompetentmumodeloutlymphodepletinoevidencelymphomgenexiceffectPlimrydtourgroupuggetefuiexpgcellhveuniquecykeprilecedeffecrfunctivroHowevermechnmwhichyenhncenti-tumimmunyvivotillunclerTheethpropolweimmechnticllydectpthwygovernthuniquephenotypetrgnti-tumimmunyOurplimryvivodtuggetefuiexpgcellhvecedtemnepolyfunctilybletTcellexhutiInAim1weutilizevivomodelglecell-omicdetermetrncriptilepigeneticmetbolicmechnmllowCARD11-PIK3R3expgcelltexhutiInAim2weIdentifyhowCARD11-PIK3R3Tcellffectimmunepopultitummicroenvirmentpromotenti-tumimmunydetermewherthoepopultineceryufficientcerpeuticefficcyfuiPlimrydtmourlbhldyhownenhncedcrumentcertcellpopultiCARD11-PIK3R3ttedtumUgmultipletrngenicmouemodelelectivelydepletecertcellpopultiweuncoverimptntterctitummicroenvirmentMyoverllcergolcomeuccefuldependentphyicin-cienttTherigoutrgplnpropoedthfellowhipllowmechievegolggerchkillknowledgecellulrimmunologycncerignlgpthwyepigeneticmetbolmImendDrJehyukChoinexpertrole-modelphyicin-cienttwhohdevedrigoutrgplndevelopllneceryerchkillcommunictikillpromotemypildevelopmentThfellowhipbrodenourundertgTcellphenotypeignlgidentifypotentilnovelrpeutictrtegieimprovedoptivecellulrrpiewellprovideneceryfoundtimyfutucerphyicin-cienttIntropertiveidentifictimettticleichllenggdueunpdictblelocticovergenmltueIntropertivemoleculrimgg(IMI)uetrgetedrdioope/fluophoguideurgecncertuedtguhtummrgnmlurroundgtueRdioctiveopener-frd(NIR)fluophocomplementechdul-lledproprovidgbothdepthdetecti(rdioope)vuldeletumbder(fluopho)commclicllyuedhhelddetecrMettticoteorcometypecncercouldnefIMIimprovedectigivendifficultyidentifygleitummrgOteorcom(OS)motcommprimrycncerchildndolecentnoverll5-yer-urvivlrte60-70%loclizeddeely20%mettticdeeMcrocopicllycompleteectiprimrymettticleiocedlgerurvivlmkgtropertivedetecticriclNetypercentOSmetteoccurlungthoughpopertiveCTmemllpulmrymetteFurrleidifficultdetectlowlungurfcenecetgnvivethcomyplpteleiwhichuntuntelycntillmedFluocentgenthvehownpromeidgOSmettectihvelimeddepthdetectiThecriclneedmethodimprovecompletenemetttictumectideceviveneurgeryGD2tumntigenweklyexpednmlCNStuemelnocytehighlyovexpedmultiplecncercludgneuroblmprimrycurntmettticOSTheFDA-pprovedchimericntibodydutuximbtrgetGD2mtenncerpyneuroblmOurgroupcentlyctructedDTPA[111In]-dutuximb-IRDye800CW(111In-dutuximb-IR800)compoeddutuximbtrgetGD2DTPA[111In]detectprimryneuroblmtup5cmdepthhheldgmmproIRDye800CWvulizecncerhheldNIRcmerAfterpromgneuroblmxenogrfttudiemice111In-dutuximb-IR800poedclicltrnltiprimryGD2-expgcncerhnotyetenevlutedmettticdeeWehypoize111In-dutuximb-IR800cndevelopedcliclueprimrymettticpedrictumectiInAim1weoptimizectencymnufcturgtudyphrmcologyxicologytbilyprileenblecliclueInAim2wetetbilydetectOSmettevivoThelg-termgolthprojecttrnltethIMIgentclicltrilueectineuroblmmettticOSGD2-expgtumWeueulteimppnINDdeignnerlypheclicltriltropertiveue111In-dutuximb-IR800urgiclectiprimryneuroblmoteorcommetteProjectSummry/AbtrctMerkelcellcrcom(MCC)motggiveftlcncerce--cebrpidlyrgcidenceApproximtely80%MCCcecuedMerkelcellpolyomviruwhichexpetwovirlcogeneknownlrgeTntigenmllTntigenquidcllcrcogeneNotblylthoughMCChighlyggivepproximtely50%ptientttedimmunecheckpotblockde(ICB)pdttmentWhpproximtelyequlnumrpiveptienttntptientmllhdnetigenperivirupoive(VP)MCCervemodelTcellpecncerItunknownwhyomeptientpdICBwhiletttmentAcriclunmetneeddevelopttmentptientprimrycquidtntICBToelucidtethmechnmidentifybiomrkerICBpewehvecollectedlrgetclicllynnotteddtbeprimryMCCmplettedICBWehveidentifiedubetTcelldriveICBpeInthprojectweelucidtemechnmwhichecellmedepeICBWeptillyfunctillyidentifywhichcepr-ligterctimotcricltriggergpeeTcellNextweidentifypecificTcellceprcognizetumntigenFllywechrcterizenti-MCCTcelltummicroenvirmentcugthpeTheeultvlidteprognoticpotentilecellidentifymechnmwhichdriveICBpeVPMCCMyoverllcergolcomeuccefuldependentphyicin-cienttTherigoutrgplnpropoedthfellowhipllowmechievegolggerchkillknowledgecellulrimmunologybiomticImendDrJehyukChoinexpertphyicin-cienttMCCwhohdevedtrgplndevelopllneceryerchkillcommunictikillpromotemypildevelopmentThfellowhipbrodenourundertgMCCimmunologyidentifypotentilnovelrpeutictrtegiewellprovideneceryfoundtimyfutucerphyicin-cienttABSTRACTSupptquetedKeyneSympoicfenceentledTumMetbolmgnizedDrGDeNicolRuhikPerDvidShckeldThecfenceheldBnffAlrtCndFebrury12-152024CncermjcuemtlywldwideIncedundertgmechnmdrivecncerprovidenewvenueducecidencettdeeArrntmetbolmcriclhllmrkcncercellenbledpttivrietyexternlternltThuidentifygtrgetgkeymetbolicdependenciecncercellmnimptnttrtegyblockgcncerprogiTheethcfencebrggerercherfocugidentifygcncercelltricmechnmltermetbolicttehowepthwytegrtediffentilctivykeymetbolicgnelleuchmichdrilyoomeTheter-cnectitweennutrientcquiutiliztichngetummicroenvirmentloexplodAncgppcidiffencemetbolicdependencieprimryverumettticdeeemergethcfencelofocudcuguniquemetbolicvulnerbiliemettticcellyeedgrowecdrygneThecfencelobrggervetigrtcuttgedgenewimggqunttiveolmeurgtummetbolmvrovivoFllyprogrmexploltetdevelopmenttrgetgtummetbolmnexttepquideffectivelytrnltgpcliclfdgptientThenumerouhttlkopptuniebkftpicdcuihelpfoterdcuicollbtitweenvetigrtllcertgePROJECTSUMMARYThegrowgevidenceneurlctivyctriegliomprolifertiprogimoleculrmechnmwhichthoccurnotwellunderodMooverhenlimedtudyhowendogenouneurlctivycludgptneouepilepticctivyenytimulu-evokedctivyffectgliomcellAclermechnticundertggliompeneurlctivycriclidentifynovelrpeuticvenueAcequenceneurlhyperctivyeizuATPleeThepurgicceprP2RX7expedhumngliomctivtedhighccentrtiextrcellulrATPultgclciumfluxClciumfluxhenbrodlyimplictedgliomprogihownfunctillylevntcequenceneur-gliomcrotlkHoweverroleP2RX7gliomhnotenwellelucidtedroletum-promotgcrotlktweenneurgliomcellhnotentudiedThpropolvetigtepurgicignlgmenwhichneurlctivyledgliomprogfiltrtivecticlmrgAim12utilizegliomcellgeneticllyengeedexpfluocentpterclciumflux(GCMP6)extrcellulrATP(GRABATP10)InAim1vroimgggliomcellexvivoimggelectrophyiologycutetumlicepermeddetermefunctipurgicceprgliomcellclciumpeneurlctivyAim1lovetigteeffectpurgicignlggliomcellprolifertieP2RX7expihumngliomtfiltrtivemrgAim2employnthopicdiffuelyfiltrtgGCMP6gliommodelelicneurlpthologycludghypexcbilyeizuInvivotwo-phimggtwo-colwidefieldopticlmppgneurgliomcelluedeeffectneurlctivycludgepilepticeventtimulu-evokedctivygliomcellclciumctivyprogiInbothimpurgicignlggliomcellperturdP2RX7knockourbr-permebleP2RX7hibirBrillintBlueGvetigtefunctineur-gliomcrotlkgliomcellprolifertiprogiAprtcomphenivetrgplnthprojectcductedtColumbiUniveryIrvgMediclCenterundermenrhipmypcollbtinterdciplrytemphyicin-biccienttwhoprovidellexperteourceneededmedeveloptrgfoundtibrtumbiologyexvivoelectrophyiologyvivobrimggnenhncedbilythrougherchchllengeClicltrgoccurtNewYk-PterinHoplhomeHerrtIrvgCompheniveCncerCenterNeurologiclIntuteNewYkIntegrtederchclicltrgprovideightcliclpplictibicbrtumerchfciltemenrhipdedictedgroupcliclerchfcultyThfellowhipupptlg-termgolcerndependentphyicin-cienttwkgtterectineurocienceneuro-cologyPROJECTSUMMARYLivercncercidencemtlyctuenewrpeutictrgetneededThfellowhippplictiexplohowenzymehnedecetyleeleven(HDAC11)drivelivercncertetHDAC11potentilnewtrgetrpyHDAC11ctprimrilylyefttycid(KFA)hydrolenenzymemovefttycidprote(de-KFA)HDAC11expedtlowlevelmothelthytuecedlivercncerhighlevelignificntlycltedpoptienutcomeProteomictudiehveimplictedHDAC11lterntivemRNAplicgwhichpvlentmotcncerTheoverllgolthpplictiundertroleHDAC11livercncerepotentilnewhighlypecificHDAC11mllmoleculehibirIntwoimthpplictethypoHDAC11promotehepcellulrcrcomthroughde-KFAplicgfcrSF3B2hibgHDAC11blockhepcellulrcrcomprogiInAim1SF3B2untictednHDAC11ubtrteetblhedhepcellulrcrcomcellleugclickchemtry-bedpprochPlimrydtcfirmfeibilyechniqueetblheSF3B2cnlyefttycyltedPropoedtudietetifHDAC11-mededde-KFASF3B2chngenuclerlocliztichnggbilygulteRNAplicgnucleuultglterntivemRNAexpiTodetillterntiveplicgoutcomedrivenHDAC11mRNAmpecificlgdequencgcductedThebundncempecificlterntivemRNAHDAC11wildtypeveruknockouthibir-ttedlivercncerquntifiedInAim2HDAC11pecificmllmoleculehibirtetedetblhHDAC11hibipotentilcncerttmentpprochPlimrydthowHDAC11hibipecificllydececolymticedrugenivyledgfenceHDAC11mypromotecncercelltemnechrcterticuchelf-newldrugtnceOncogenevivotetedfollowgwildtypeknockouthibirttmentdeeprogimidlumecenceimggThtudyprovidenewknowledgemoleculrfunctiHDAC11lterntivemRNAplicglivercncerprogievlutecliclly-levntmllmoleculehibirpotentillivercncerttmentCompletipropoedprojectdevelopneceryerchpilkilleentilcercncervetigrProjectSummryCombrilcenchrcterizemoleculrpthwycellidentifygterctitweenperturbtiQuntifygterctiquinotin-tercti(ienullterctimodel)whichwell-etblhedcombrilcenmeurgcellurvivlimplephenotypeHowevercentdvncegle-cellomicumtedmicrocopyhveenbledcombrilcenhigh-dimenilphenotypicprileTheephenotypicprilectfetuunknownn-lerhviuchgeneexpiimgefetuAultnowell-defednullterctimodelcombrilcenhigh-dimenilphenotypeThegolmypropoletblhnullterctimodelhigh-dimenilphenotypeMypprochtermedDENIM(Dt-drivenEtimtiNullInterctiModel)imuerobutetimtimodellernnddivepenttinullperturbtiimprovequntifictercticrocombrilcendtetInddhfrmewkhkeypplictidrugtrgetidentifictienblgccurtepriiztichemicl-geneticterctimicrocopy-bedphenotypicprileMycentrlhyponullterctimodelwhichccurtelymodeldiverehvihigh-dimenilfetucnubtntillyimproveterctidetectiInAim1IdevelopcricllyeDENIMugbothimultedl-wldcombrildtetgeneexpihigh-ctentimggdoutIevluteDENIMgtextgbelebilyccurtelyterctitngthimultiwellcpulteknownterctitweengenepirdrugpirPlimrydtimultidemtrteDENIMcnccurtelyidentifylernn-lerperturbtrjecriewhichledimprovementpermnceltivetrdbele(ievecrddi)InAim2IlevergeimprovedpriizterctiprovidedDENIMpermdrugtrgetidentifictiThtrgetidentifictipltmquilrge-clegeneticperturbtitudychemicl-geneticterctiTothendplimryulthowlrge-clegeneticperturbticnccurtelycductedugpooledgeneticcengfolloweduequencgguidedemultiplexgMooverInlyzedpilotcenwell-etblhedMEK1/2hibirwheIccurtelycovedtrgetpthwycompentimilrpermnceugdrug-levnrdrug-gnoticbiomrkerTogercomplethpropolultrigoufrmewkhigh-dimenilterctinchmrkgnullterctimodelnovelpltmchemicl-genetictrgetidentifictiugmicrocopy-bedphenotypicprileABSTRACTMerkelcellcrcom(MCC)polyunderodcutneoumlignncyvirletiologyMotMCCtumfetumoclltegrtiMerkelcellpolyomviru(MCV)whichexpevirlT-Antigen(T-Ag)SmllT-ntigen(T-Ag)cttrncriptilco-gulrwhileLrgeT(LT-Ag)prcipllyfunctiequeterblmprote(RB1)de-gultecellcycleTheT-AgpibledrivgtumigeneT-Agexpg(T-Ag+)MCCtumfewmuttipentT-Ag+MCCtumcludgtumuppRB1TP53whoectivietedpedfunctiT-AgLtentMCVfectidoentultT-AgproductifoundubtntilptihumnpopultihoweverMCCoccurlyrlyMuchwhccurtweenltentfectipperncefull-blownT-Ag+MCCtumhnotenexplodduelckvivoMCCtumigenemodelAmgunnwedquetihowMCVT-AgducetumtrncriptilprogrmfetumrkermultiplecelllegecludgbothepidermltemcellneuroendocftePviouerchourlbrydetermedSOX9-expg(SOX9+)hirfolliclecellwhichgivemechnoenyMerkelcelldurgfetldevelopmentloMerkelcellprogenirdultkHypoizgT-AgprogrmcellMerkelcelllegecueMCCIgenertedtrngenicmiceexpT-AgblteRB1mimicLT-AgSOX9+cellTheemicedevelopedtumwenotb-fideMCCexpedneuroendocmrkermkgemicevlublemodelwhichtudymechnmT-AgmededprogrmmgAnlytumterlytimepotveled-progrmmgoccurdlypecificub-popultiSOX9+cellprogrmmedcellwehighlypopticTheeIhypoizedpecificlcpegenecceibilyquidT-Agduceprogrmmgnigcelluppgp53mededpopquidMCCIpropoelevergemodelSOX9-derivedT-AgdrivenneuroendoctumgenertenovelightmechnmT-AgmededprogrmmgIuetegrtedepigenetictrncripmicequencgnlyechrcterizegenecceibilytrncriptillcpequidT-AgmededprogrmmgoccuridentifyntivecelltypecompetentundergoprogrmmgFurrmoItudyhowp53uppiwhichcommlyobervedMCCtumctriedvncgprogrmmgAlgerpropoedtudieetblhmodelT-AgmededprogrmmgvivodcoverfcrenbleT-AgprogrmcellTherchnlymkevlublectriifieldMCCerchlomytrgexpogmemoleculrtechniquegenomicepigenomicnlyefoundtilndependenterchcerPROJECTSUMMARY/ABSTRACTAuimmuneRegulrgene(AIRE)pventuimmunypromotgthymicdeletielf-ctiveTcellWhilemottudiedthymuAIREloexpedecdrylymphoidgnwhethoughtctrieperipherllerncethroughterctideletielf-ctiveTcellHoweverAIREroleextrthymicAi-expgcell(eTAC)likelymomulti-fcetedthnthymuWecentlyidentifiedAIREexpimultiplemyeloidpopultitummicroenvirment(TME)Theecludedendriccell(DC)mocytepdomntlycompoedtumocedmcrophge(TAM)whichknownhibnti-tumimmunepeWhiletumocedeTACwelycentlydcovedourgrouppriwkimplicteAIREhibgnti-tumimmunyRecentlyvilbleoltudyAIREmicehvefciltedvetigtiperipherlAIREexpiTMEWehvefoundtumocedeTACeverlcommolidtummodelexpgmyeloidlegemrkerbothflowcymetrymcymetry(CyTOF)CricllywelodemtrtedbltiAi+celldrmticllylowtumprogiThplimrydtgerrpeuticpotentiltrgetgeTACTMEimprovecncerimmunpymkethpopultideervgthoughfunctilvetigtiThpropoltethypotumocedeTACnimmunouppivepro-tumlcellpopultiAim1thpropoldefephenotypictrncriptilpriletumocedeTACwellirptilgniztiAim2determemechnmwhichAi+cellcnpromotetumprogiAim3defeignldriveAiexpielucidtecell-tricroleAumocedeTACTherchpprochcrriedoutugvrietymethodcludgglecellnlyviRNA-eqCyTOFflowcymetryvivoyutilizgnovelgeneticmouemodelTheepropoedtudiefirtchrcteriztiAIREexpinytumidentimmunecellfurrourundertgfunctiperipherlAIRE-expgcelltypeThcouldultdcoverynovelpthwylevntrpeutictnceimproveourundertggloblAIREfunctiTrnltillythwkmyidentifynovelimmunetrgetcncerrpieTherchprojectfellowhiptrgcductedtp-fundederchtutiUniveryCliniSnFrncco(UCSF)lbrieDrJmeGrdnerDrMtwSpzerexpertmenrhipDrVilNtrnoDrGrdnerhexpertetudyperipherlAIREmouemodelgenertiDrSpzerhexperteytemimmunologytumfiltrtgmyeloidcellbiologyDrNtrnohexpertecomputtilnlyglecelldtetOverllthfcilytemproviderichtrgenvirmentcompletherchdevelopmentpilkillnecerycercdemicerchPROJECTSUMMARYGenemplificticogeneMycocedcedmetttncettmenverllpoprognourvivlcroeverlcncerInccdncerolepro-growrncriptifcrMycupgulteproteynglobllydrivgexpiriboomlRNAriboomlproteprotetrnltiifcrThceproteyncpcypumedpromotecncercellgrowthprolifertiloleddygultedignlgmt-pepthwyuullyocedimpidproteottrnltiltKeykevolvedepthwycludememrtegrtedtpePERKGCN2nundertghowMycexpictivteetpepthwymundexplodOnemechnmhowevermythroughriboomecollinrrnttrnltieventctivteGCN2lgMAP3KZAKtriggereirtrnltipipventddilcollieventpopeveceRiboomecolliultvrioutrnltiltoccurwhennelgtgtrilgriboomectcheupcollidetlledledgriboomenmRNAtrncriptGivent-pepthwydowntmcollimyhyper-ctivecellhighMyclevellikelyriboomecollioccurthigherrteMycovexpicelllecompdcelllowerMycexpiAultecellmymouceptiblecellulrtduceriboomecolliwellThecentrlhypothpropoleupgultrnltictivyMycovexpiledcedpoppenceriboomecolli-ducgdrugIpropoeddthhypothroughfollowgimAim1InvetigteeffectMycexpiprotetrnltidynmicAim2AehowMycffectriboomecollifquencyenivytrnltitAim2bDetermeiftrnltitcepopcncerhighMycexpiTheeimchievedutilizgmylbryexpertetudygriboomefunctigultivibiochemiclequencgnlytudytrnltilctivycolli-ducedignlgcell-bedmodelMycovexpicncercellleknowndiffentilMycexpiReultthwkcouldvelbothnovelrpeutictrtegiecombttgmnycncerubtypewilevtedlevelMycuniqueighthowcedproteyndemffecttrnltidynmiccncerSUMMARYEpidermlgrowthfcrcepr(EGFR)-trgetedrpyEGFRtyroekehibir(EGFR-TKI)prticulrlycurntthirdgenertimutti-electivegentuchoimertib(AZD9291TAGRISSOTM)hchievedgtucceprovidedignificntcliclnefptientEGFRctivtgmuttiHoweverdevelopmentunvoidblecquidtncehcomemjobtcleptientchievglg-termmiHencenurgentunmetneedclicdevelopmenteffectivetrtegieovercomecquidtnceEGFR-TKIprticulrly3rdgenertigentTheperoxomeproliferr-ctivtedcepr-(PPAR)coctivr-1(PGC1)functicoctivrcodtectivytrncriptifcruchPPARmodulteenergymetbolmlipidmetbolmcellulrproceeBothPGC1PPARhveenimplictedpromotgtumigenemedgchemotnceOurRNA-eqnlyveledexpibothPPARGC1B(encodePGC1)PPARG(encodePPAR)geneweignificntlydecedoimertib-ttedEGFRmutntNSCLCcellefdgwecfirmedtprotelevelwellMooveroimertib-tntcellpoeedelevtedlevelPGC1PPARwhichwetntmodultioimertibImptntlyhibibothPGC1knockdownPPARknockdowndiffentchemiclntgtdenivieoimertib-tntcellleoimertibTheedtuggetcriclrolePGC1/PPARxmedgrpeuticefficcyoimertibEGFRmutntNSCLCcellThuwehypoizeeffectivehibiPGC1/PPARxcricleentileventmtglg-termrpeuticefficcyoimertib3rdgenertiEGFR-TKIttmentEGFRmutntNSCLCThhypotetedccomplhgfollowgpecificim1)TodemtrtebiologiclignificncePGC1/PPARmodultigultgpeEGFRmutntNSCLCcelloimertibcludgdevelopmentcquidtnce2)ToelucidtemoleculrmechnmccountgdowngultiPGC1PPARoimertibEGFRmutntNSCLCcell3)TodevelopefficcioutrtegieovercomgcquidtnceoimertibtrgetgPPARTheobjectivethpropolfullydemtrtemechnmwhichoimertibnegtivelygultePPARGC1BexpiEGFRmutntNSCLCcellvelcrucilrolePGC1/PPARmedgpeEGFRmutntNSCLCcell3rdgenertiEGFR-TKIcludgdevelopmentcquidtncedevelopeffectiverpeutictrtegiedelyovercomeoimertibcquidtncetrgetgthxThpropolllowugnewknowledgedeepundertgbiology3rdgenertiEGFR-TKIdevelopnovtiverpeutictrtegiemnggcquidtnce3rdgenertiEGFR-TKIProjectSummry/AbtrctRhbdomyorcom(RMS)commggivepedricttuercomDepemnyrigouclicltrilurvivlrtehigh-rkptienthnotcedthedecdeFurrmopedricRMSptientceivenggivecombtiurgerychempyrdiledglife-lgttmentltedcequenceundercgneedundertbicbiologyRMSidentifynewmoleculrtrgetRMScommlyviewedthroughlenmucledevelopmentwhegeneticllycruptedkeletlmucleprogenirfiltermllydiffenteToundertRMSpthologyeentilundertroleRMSgenenmlmyogeneTodetermegeneteurlbcompdRMScotrncriptifcr(TF)RMSeentilgenegeneovexpedourRMSgeneticlly-engeed-moue-model(GEMM)identifiedtheTFwepentedPx7MyoD1Sox8PAX7MYOD1plyknownrolemyogeneRMSroleSOX8bothproceemunclerMypropoedprojectfocuedetermgroleSOX8myogenerhbdomyorcomgeneTodetermeroleSOX8myogeneIperturbSOX8primrymyobltcultuytemwellvivothroughournovelSox8FloxmouePlimrydthowSOX8deficientmyobltdilydiffentewhennotprompteduggetgSOX8imptntmtgmucletemcellfteInlyzebilySOX8deficienver-expgmucletemcellpthroughmuclediffentimfunctilmuclecompentTheecdpectmyprojectidentifyroleSOX8RMSIutilizehumnRMScellourRMSGEMMdectSOX8roleRMStumigenicytumrncriptilprogrmthroughbothlo--functig--functiexperimentFllyIdetermeSOX8tercmehumnRMScellgmechnticightSOX8trncriptilgultihumnRMSUndertgroleSOX8myogeneRMSceourundertgmyogeniccellcruptivelpotentilcoTFerverpeutictrgetRMSStJudeChildnReerchHoplHtleyLbfullyupptmytrggolupptmytrgplnlerncientifictechniquemyprojectdeignrigouwell-roundedexperimentcientificcommunictimyfdgmenrhipthoeroundmeTheHtleyLxperteRMSGEMMmoleculrbiologyidmytrggolAddillyupptgrnedthroughCoFcilieAcdemicProgrmOfficetStJudeChildnReerchHoplfurrupptmybilypermpropoedexperimentcommunicteulteffectivelyThebovecomdupptRuthLKirchtePdocrlIndividulNtilReerchAwrd(F31)providenexcellentlunchgpdmycergolcomendependentcdemicvetigrPROJECTSUMMARYOn-trgettncemll-moleculehibirrpymjchllengecncerttmentWhiledeignnovelcompoundmnimptntlg-termtrtegyobtgelectivepotenthibiemutntfurrtumevolutitncemyoccurTtmentmultiplehibirco-hibmerpeutictrgethgungtrctivibleclicltrtegyduceemergencetnceMeenchymlepililtrnifcr(c-MET/MET)ceprtyroekencogenicdrivermnytumtypenotblyn-mllcelllungcncer(NSCLC)melnomMETmplifictiloervenecpemechnmfollowgttmentEGFRALKKRASG12ChibirdefgMETcriclrpeutictrgetSomeclicllypprovedkehibir(KI)hvectivygtMETHowevercliclly-obervedMETmuttipromotetncecertKIubtypepfentillybdctivectivekecmtiDefgwhichKIhoulduedttptientpentgpecificMETmuttipgcliclneedCombgfewtwotheKIhdctivygttrgettetmximize-trgetelectivydilutgechhibirf-trgeteffectInddimximizg-trgeteffectMETleMETrpeuticco-trgetcombtihibirdiffentbdgmodecoulddeceprobbilytnceemerggthroughfurrmuttiTheobjectivethtudydefeelectivyprileclicllypprovedKIgtclicllyobervedMETmutntclculteKIcombtiwouldmotelectivelyhibthoemutntThtudyvetigtehypocombticlicllypprovedKIcnclcultedmximizeelectivyMETmutntMET/EGFRMET/ALKibMET/KRASG12Cco-trgetdeceprobbilytnceemerggThhypotetedmeurgelectivyprileKIclicllyobervedMETmutntpdictgKIcombtitetgcombticellyngeneicthopicmouemodellungdenocrcomTheprimryrtilethwkprovidenctiblerodmpMETmutti-pecifictrgetedKIrpycliclcohtCombtitwotheclicllypprovedKIdiffentbdgmodehveenelectedmximize-trgetctivypentnctibletrtegycerpeuticpotentildeceprobbilyfurrKItnceemerggProjectSummry/AbtrctImnMD/PhDtudentlbryDrSunneWelltCcntiChildnHoplMediclCenterUniveryCcntiCollegeMediceThpropoloutleerchprojectdeignedppmecomddul-degecerpthmetbolmcncerbiologyTheoverllerchgoldetermehowloFnciAnemi(FA)DNApirpthwyledmetbolicprogrmmgtumprogiInheredlo--functimuttiFApthwypromotedevelopmentuniquelyggivehedneckqumoucellcrcom(HNSCC)progipoprognoWhileup20%pdicHNSCCtumhrbmuttiFAgeneunclerwherpdicloFApthwylopromoteggivetumprogiTognwerthquetiIhvegenertednvivoxenogrftmodelwheFA-deficientknockdown(vpricientctrol)pdicHNSCCcellwejectedcheekmucoimmunodeficientmiceFA-deficienttumwemoprolifertivevivehighergrdethnirFA-pricientcounterprtPviouvrotudieWelllbryidentifiedpotentilmechnmephenotypedcovergtwodriverviFA-deficientHNSCCcell(1)ctivtin-homologouendjogocedDNA-dependentproteke(DNA-PK)dependentdowntmtimultiGTPeRc1(2)ccumultiglycophgolipidGM3gnglioideRc1ctivticnupgultefoltepotentillyltedmetbolicpthwylike1-crb(1C)metbolmInturn1CmetbolmcnctrieGM3gnglioideyncncer-drivgproceeMyexperimenthvedetermed1CmetbolmwdeedupgultedcromultipleFA-deficientHNSCCcelllecpti1ChibirenizedFA-deficientHNSCCcelltumpheroiddecedgrowthcompdFA-pricientcounterprtThuFApthwylo-dependentctivtiDNA-PKRc1mytimulte1Cmetbolm1CmetbolmturnmydriveggivetumhviFA-deficientytemAim1tetwherDNA-PK/Rc1ctivtiFA-dependenttimulr1CmetbolmIexpectdetectctivtiDNA-PK/Rc1dependentupgulti1Cmetbolecromultiple2D3DtumpheroidgnotypicrftmodelFA-deficientHNSCCcellTheeexperimentedefenovelmechnmwhichloDNApirpthwypromoterrntmetbolictimultiAim2defefunctilrole1CmetbolmFAdeephenotypetetgenzymemetbolecidterpeutictrgetIexpecthibir1CmetbolmuppcncerphenotypeuchmigrtivivropventgrowthprogiFA-deficientHNSCCtumvivoTkengereexperimentdefenovellktweenFApthwylocncermetbolmthuexplopoiblemetbolicnutrilterventipventi/ttmentlethlcncerFAgenerlpopultiPROJECTSUMMARY/ABSTRACTProttecncerecd-motdignoedcncerecdledgcuecncerdethAmericnmenErlydetectiloclizeddeecommfollowedmochllenggtkprognoghighlyvriblecliclcoureLoclizedtumtendolentnotlwyCurntcliclrk-ementchemecptgerumbundnceprottepecificntigen(PSA)tumize&extenttumgrdebedbiopylimedccurcyoverqurterptientover-ttedThegolthpropolfillurgentneedttermrkerdcrimtgdolentggiveloclizedprottecncerAnimprovedmethodrktrtifictimyliehedryfcrProttecnceremottrglyhered(h2=57%)ccumultgevidenceocgrvrintcommvrintgeneticncetryclicloutcomeTheoverllhypothpropolvrintttuDNAdmgepir(DDR)geneprottecncerpolygenicrkgeneticncetryimprovecliclrktrtifictiprottecncerToddthhypoimthpropolfocutwoclicloutcomepentgkeydecipotmngementdeeSpecificllyimvetigtebiomrkerpotentildecridgermlefcrpdict(1)progictiveurveillnceptientmgwheryhoulddeferttment(2)biochemicllpefterrpyptientmgmotpproprettmentcoureFbothimgermleDNAmplecohtptientdignoedloclizedprottecncerextenivecliclfollow-updtequencedugtrgetedequencgpprochApokebiomticwkflowuedderivegermlegenomicendpotpthogeniclikelypthogenicDDRvrintgenomicrkcogeneticncetryFechimexplryunivremultivrenlyevlidteocitweengenomiccliclendpotctrolcliclprognoticfetuMultivreCoxproptil-hzrdgimodeltdvlidtedevlutedpdictivepermnceetblhutilygermlegenomicbiomrkerprottecncercliclrktrtifictiTheultthpropolhvepotentiltrnmtrd--cmngementthdeethuubtntillyctrieenhncghumnhelthqulylifeAbtrctMotcncer-lteddethcequencemettticdeeYeurundertgunderlygmechnmpiblemettepecillyimmuneytemrolemodultgmettticprogimrudimentryMyplbcentlydcovedtumvilymphnode(LN)evokeductigulryTcell(Tg)cferytemictum-pecificimmunelerncepermtgdtnt(gn)metteWhilebothhumnmutum-volvedlymphnodetuehvedemtrtedcerveddomntmechnmquirgTgmettticprogiunderlygmedirgovernirdevelopmentmenigmticthuwrrntfurrvetigtiInlenotipilntigen-pentgcell(APC)criclntigen-pecificTcelldevelopmentmyplimrywkveledpilAPCdiffentillyenrichedtum-volvedlymphnodemiceHoweverwhichAPCpopultipiblepromotgtum-pecificTgdevelopmentwhertumimmunelerncemcherycnrpeuticllyovercomemvetigtedToddegpknowledgeIpropoefollowgim1)identifyAPCpotenteLNmett-ducedtum-pecificimmunelernce2)erpeutictrtegieprogrmAPCcurtilmettticprogiUghigh-dimenilmultiplexedimgg(CODEX)gle-cellRNA-equencgvriouvivocell-depletimouemodeldoptivecelltrnferywellvroco-cultuexperimentIytemticllydectkeyAPCpopultiIhypoizepiblemedgtum-pecificTgdevelopmentTpeuticllyprogrmAPCwylernceductiIdevelopimmunotimulryntibodycjugtedrLNtetmmouemodelmelnompncticductldenocrcomThepropoedwkimdeleteAPCpopultipiblemedgtum-pecificTgductidvncedevelopmentimmunpeutictrtegiettmettticdeePROJECTABSTRACTMettmjcuemtlycncerptientccountbout90%cncerdethwhichhnotchngedpt50yerThdicteignificntneedfurrtudymettpthwyfdnoveldruggbletrgetOurlbtudieEwgrcom(ES)whichnggivechildhoodcncerthccurttueThefive-yerurvivlrteEwgrcomptientdignoedmettticdeetillly25%mkgESgoodmodeluemetttudyTodcovergenewhoectivtiledcedmettgenome-wideCRISPR/C9trncriptilctivticenwpermedzebrfhxenogrftmodelThegeneINAFM2wchoenfurrtudywovexpedixdiffentcncercellle(fourESehepcellulrcrcomemchdenocrcom)OvexpiINAFM2cuedcedcellmigrtichemotxvrocedmettzebrfhxenogrftINAFM2knockdownfourcncercellle(twoESeclercellnlcellcrcomemchdenocrcom)decedchemotxcueINAFM2expidcellbilymigrteAnlyptienttumRNAequencgdtmnydiffenttypecncerveledcltitweenINAFM2expibothncedmettticphenotypepoptienturvivlThprovidetrgevidenceubtntilroleINAFM2cncermettHowevernomticurntlyvilblebouthumnINAFM2proteThgrntimddgpknowledgethnovelprotepurugfollowgtwopecificimThefirtmjimthpropoldcernmoleculrpthwymederoleINAFM2promotgmettugvrovivomodelTodetermemechnmunderlygINAFM2mett-promotgfunctiIpermedRNAequencgEScellfollowgovexpiknockdownINAFM2whichveledignificntenrichmentMAPKWntpthwymgItudyepthwyvrovivougINAFM2ovexpiknockdowncellleIldygenertedTheecdmjimthpropoldcoverchrcterizefunctilignificncedictprotebdgprtnerpot-trnltilmodificti(PTM)INAFM2Ipermproximy-dependentbiotyltimpectrometry(MS)identifybdgprtneruetemMS/MSidentifyglycoyltiphophyltieINAFM2OverlletwoimfullycfirmnovelproteINAFM2rolecncermettdetermemechnmfunctipotentillyvelgrpeuticvulnerbiliedeignfutudrugrpieProjectSummryArrtichromtmodifygenzymefquentlyfoundwidepectrumhumeeAmgmhneH3K4methyltrnferemixedlegeleukemi(MLL1loclledKMT2A)henextenivelytudiedcncerMLL1rrngementcommcutepedricleukemiwhichtrnloctieMLL1llelegivencogenicfuiproteOrMLL1mutticludgmplifictiovexpicommlyfoundmultiplecncerunknownetiologyMLL1idemulti-ubuncomplexcervedcompenthdmgKMT2fmilyenzymegerygultegloblhneH3K4methyltiWhilemottudiefocuMLL1roletrncriptivicniclH3K4methyltiMLL1lohn-cniclfunctigultgimptntcellulrproceeWeuemultidciplrypprochegnewmechnticighthowMLL1ffectcncerdevelopmentthroughtrncriptidependentdependentctivieevlutepotentilrpeutictrgethepcellulrcrcomAbtrctTrncriptiefirttepgeneexpimnyprotefcrvolvedmuttightlygultedcctlycrryoutcellulrproceeTheIntegrrcomplex15-ubunmetz-pecificcomplexwillydcovedcrucilpropertrncripticertn-codgRNARecentlyhenfoundIntegrrbrodtrncriptilgulrroletmnyprote-codgn-codggeneIntegrrctnegtivegulrRNAPolymereII(RNAPII)trncripthroughpromoter-proximltermticnlterfunctilypetuchDNAdmgectiveoxygenpecieDepecriclrolefe-tungtrncriptilgultinotyetunderodhowIntegrrembledgultedpentgknowledgegpfieldOurplimryexperimenttrikglyveledkeyfcrvolvedDNAdmgepir(DDR)ocegloblgulrRNAPIIctivythuprovidgpvioulyunknowncnectitweenetwoproceeSpecificllyBRCA1-ATMctivr1(BRAT1)oceIntegrrubun11(INTS11)enduclee-ctgubunIntegrrcomplexBRAT1cyplmicprote-loclizenucleuupDNAdmgectcffoldtweenedmgepirproteOurcryo-EMnlyINTS11-BRAT1heterodimervelBRAT1mcirculrtructuroundINTS11uethecervedC-termliduebdINTS11ctiveepventgclevgeRNAAddillycryo-EMnlyhowedINTS9cnbdmnINTS11-INTS9-BRAT1heterotrimeruggetgterplytweenBRAT1nhibirINTS11memrIntegrrcomplexThegolthpropolexmefunctimechnmctietwouniquecomplexeToexmefunctiourlbgenertedBRAT1nullcelllerpiddepletiytemugux-ducibledegr(AID)tgllowquickdepletiINTS11IniltudieelehowBRAT1loultnINTS11depletiphenotypepentgupgultigenenegtivelygultedIntegrrOverlledtpentmodelwheBRAT1couldgulteIntegrrctivythroughociINTS9/11ThehypoBRAT1ctlicengfcrfciltgemblyIntegrrcomplexprovidgpcegultiwhichepecillyimptntdurgcellulrtuchDNAdmgeTotetthhypotheimpropoedFirtterctitweenBRAT1INTS9/11biochemicllydefedfurrprotructuNextimpctBRAT1cniclIntegrrcomplexfunctidetermedFllyimpctINTS11-INTS9-BRAT1durgDNAdmgepirelucidtedSuccefulcompletieimprovidemothoughundertggultiemblyIntegrrcomplexPROJECTSUMMARY/ABSTRACTSignificnceOver15000childnged<20yerdignoedcncer2023duedvncementttmentrpie85%echildnexpectedjogrowgpopultichildhoodcncerurviv(CCS)curntlylivgUSOnvergeCCSexperienceover17chrichelthcdige50ctrighelthcomplicti(phyiclmentlpychoocil)erlymtlyAccepecilizedlg-termhelthcbrrierchievgequyqulylgevylifeepecillyddvntgedpopultithbrriermgnifiedpopultiCCSctueexpExtgerchhhownproximyprovidercferdvntgefquencyctterhelthoutcomeHoweverprtillyttriblevilbilydequtedtetetudiehvelyexmedroledtnceltecncercidencerrthnpot-ttmenturvivhipFCCSepecillydolecentyoungdult(AYA)urvivcommunictitween/fluctuticproviderddcomplexyutedhelthcttmentcrolifecoureAimThproject(1)chrcterizeproximyAYAurvivChildnOncologyGroup(COG)urvivhipccroUS(2)determeocitweendtncecerlymtlyexmewherthfluencedocioecomicttu(SES)/rce/ethnicyAYAurvivApprochThepropoedecdrynlylevergeAYAcncerptientdtCOGChildnCncerReerchNetwk(procol#ACCRN07)Pviouwkgeocodeptientidencecomplete(p-pot-digno)identilhryhllowedtudyptientidenceltiurvivhipcAim1nlymeudtncecchrcterizeptientidentilenvirment(dividul--levelchrctertic)Pogiuedenumrurvivhipcctctperun(deny)Aim2eltihiptweendtncecerlymtly(<5yerpot-digno)ugCoxproptilhzrdmodeldjutggeexMedinlyuedexplofluenceSESweevluterce/ethnicycfounderFellowhipInmtiThepplicntPhDtudentEpidemiologytUniveryMneotpdocrlteNICHD-fundedT32trgprogrmPopultiHelthScienceThroughcourewkmenrgpedriccncerepidemiologygeoptilnlyhelthdprielgguidncecommunictgfdgwrggrntpropoedtrgplnbuildMThomextgerchkillThtrgenhnceherbilycompleteherderttierchcomendependentcncerepidemiologyercherexpertechildhoodcncerurvivhipPROJECTSUMMARY(ABSTRACT)BcterilcncerrpyhextedceDrWillimColeyemployeddelirtebcterilfectumovercenturygofirtknownexmplecncerimmunpyBcterigeneticllytrctbleelf-plictgrpeuticwhichcntuneddelivervrioupylodmodifypecificydeceideeffectAddillytrvenoulydmtedbcteri(prticulrlyEcherichiSlmell)tricllycpbleelectivelycolizgtumtuemouemodelhowgducedcoliztirpidclerncegnTheepropertiemkebctertrctivepotentilvehicledelivergcncerrpyHowevererlyclicltrilhveentymiedlowcoliztirtehumnptientThoughmuchwkhendedeveloprpeuticpylodbcterildeliverycomprtivelyltleknownboutmechnmwhichbctericolizetumdeliverepylodAtpentltlep-extglertuugcompheniveundcenidentifypthwytum-pecificbctericoliztiTheecenurgentlyneedednlyidentifyeentilpthwytumcoliztibcteriloidentifypthwywhichmymnipultedcetum-pecificcoliztibcteriThmticnlevergedbothidentifypthwyeentiltumcoliztideveloptrcedtumpecificyByidentifygegenethprojectimundertmechnmwhichEcolipecificllymigrtegrowtumidentifytrgetwhichcnmnipultedtunecoliztiefficiencypecificyUltimtelythwkdvnceproductilivgmedicecncerrpyThetrgcommunyimmunologtynticbiologtbiomticinupervgtewkupptthfellowhipThroughoutwrdtenefouttgtrgenvirmenttColumbibotherchcliclcompentwelltegrtwodtctdcipletrgphyicincienttdevelopfundmentlkillcomgndependentphyicinvetigrThecurntyegHER2wef--purpoe(over25yergo)identifyHER2ovexpi/genemplifictinotbuiltubclifyunmplifiedHER2expicncerApplygelegcyyulthighter-rterdgementrteHER2-negtivevHER2-lowce(up75%dcdnce0v1+/2+)WhemergencenewrpyoptiHER2-lowcncernmelytrtuzumbderuxtecn(T-DXd)liblecompnidignoticneededptientThecctpplictieHER2legcyyhledctroverilfdgfieldcludgprdoxicl30%objectiveperteeenIHC=0btcncerDAISYtrilThpropolimccurtelytrtifyptientHER2-low/negtivebtcncerugournlytichigh-enivyHER2(HS-HER2)ydeveloplghmelectimotpproprerpybtcncerptientSpecificllypropolhtwoimAim1ferighnclicllymeurblepthologic&ptilprmeterfluenceteffectocedenewerlkerclevblentibodydrugcjugtelikeT-DXdSpecificllythimfocuequntifygptilheterogeneyHER2expiptternlgideHER2tumccentrtiultimtelypdictT-DXdpeIhypoizeubclifygHER2expibtcncerqunttiveptilheterogeneymetriccluter-typegle-cellmoic-typeptternfurrexplwhyly~30%IHC=0nefT-DXdDAISYtril(lthough~70%IHC=0cehvedetectbletmole/mm2HER2ccentrtiourHS-HER2y)IpropoevetigtelrgetropectivepropectivebtcncercohtourHS-HER2ywellcohtHER2-lowbtcncergogT-DXdclicltrilAim2eekexploifnH&E-bedvirtulHER2tcnpdictlowHER2expittuOurlbhveillutrtedHER2genemplifictioceddetectblemphologiclchngeH&EimgeleIhypoizeHER2-lowbtcncerlohvedtctmphologicocicndcovedThetudypropoebuilddtetHS-HER2H&EligneddjcenterilectiwholelideimgeThentrtte---rtcomputervirchectuH&Eimgemulti-tkmulti-imgep-trgmixed-upervimultipletncelerngtrtegypdictlowHER2expittu(defedHS-HER2ytmole/mm2)ThimvelH&EmphologicfetubtcncerocedlowHER2expiT-DXdpeOverllthpropolddecriclunmetcliclneedccurtelyegHER2expibtcncerptientpropoetwovtiveimdeveloplghmT-DXdptientelectiProjectSummry/AbtrctSuccefulnti-tumimmunepequicodtitweenrmimmunygtmultipletumntigenhownthroughtudienimlmodelhumnimmunepeKeycncercellelimtiTlymphocyteprticulrcyxicCD8TcellwhichervecognizentigenpentedtumcellnHLAclImoleculethroughirTcellcepr(TCR)CpdglycentdvnceimmunpygedtbootgTcellcyxicythroughimmunecheckpotblockde(ICB)hvetrnmedttmentlcpemnyptientuffergolidtumHowevermelnomICBducenobjectivepelyround40%ptientThelimedefficcyICBhenpvioulylkedpencedyfunctilTcelltummicroenvirment(TME)pertgttetermlexhutiThethupgneedtterundertdetermntTcellpegttumTovetigteemechnmourlbhextenivelychrcterizedlcpenti-tumTcellfiltrtgmelnomRCCbiopieetblhgtum-pecificTcellfoundoverwhelmglyexhutedTcellcomprtmentStillquidntigenicdiveryptilterctiuchtum-pecificTcelldetermgnti-tumpevivopolyunderodAddillyltiveimptncentigenclprticulrlynetigentum-ocedntigen(TAA)effectiventi-tumTcellpecompletelyunderodInSpecificAim1Ithupropoegenerteptient-derivedxenogrft(PDX)mumodel3melnomptienttumtetquiddiveryTCRchoentum-filtrtgTcellugmrkerocedtumpecificyexertimmunepuheterogeneoutumlikemelnomByfugTcelltrnducedvrygnumrputtiveptienttum-pecificTCRctroln-tum-pecificTCRIbleediveryTCRquidctroltumgrowthFurrSpecificAim2IvetigterolentigencltumctrolugeemelnomPDXmodelcombticell-brcodgytemtrckltiveimmune-ducedelectumTCRpecificgteirnetigenTAAvivoFllySpecificAim3IutilizeptilequencgtechniquetudylocliztiCD8TcellfirtmyTcell-chllengedPDXmodelchrcterizetum-tricimmunouppiveterctifiltrtiTcellmyPDXmodelInvetigteterctiocedphenotypetum-pecificTcellntiveTMEptientmelnombiopiecurnttumAchievementeimledpipelecouldolteputtivetum-pecificTcellthroughcellulrmrkeridentifyirTCRfollowed-expieputtivetum-ntigen-pecificTCRn-exhutedTcellprimednoptimlcellttenti-tumcyxicynulogoudoptivecellulrrpyPncticductldenocrcom(PDA)cidencergPnctictpililneoplm(PnIN)PDApcurcommympmticdultbunlyfewprogPDAThecriclgulrPnINprogiPDAmettemunknownKRASmuttioccur>92%humnlow-grdePnINPncticKrG12Dmutti(mKRAS)mice(KCmice)ducePnINmimichumnlow-grdePnINfilprogPDAHighftdiet(HFD)pncticP53mutti(egKPCmice)promotepncticimmunouppivetummicroenvirment(iTME)PnINprogiPDAmetteKCmiceDietryfttycidnturlctivtgligperoxomeproliferr-ctivtedcepr-delt/t(PPARD)PPARDupgultedhumnPDArolePDAundertudiedWehvefound1)PPARDwupgultedhumnKCmicePnIN2)PncticPPARDknockout(KO)KCmiceuppedHFDpromotiPnINprogiPDA3)PPARDctivtiHFDdierdietctgGW501516ynticPPARDlig(GWdiet)ccelertedPnINprogiPDAKCmicegterextentKC/PdmicePPARDovexpipncticmKRAS+cell4)PPARDducedpncticepililcellproducechemokecyke(egCCL2IL-6GM-CSF)cruedimmunouppivecellmniTME5)PPARDKOKPCcell(KPC-PdKO)uppedPDAmettewhilepncticPPARDovexpiKPCmice(KPC/Pd)fedHFDpromotedmette6)PPARDplteletderivedgrowthfcrceprt(PDGFRb)expilevelwecltedhumnPDAiTMEctivtePDGFRbPDAcellpromotemettWethuhypoizectivtiupgultedPPARDmKRAS+pncticepililcellduceutniTMEpromotePDAprogimettAim1determe1)wherctivtiupgultedPPARDpncticmKRAS+cellGWdietufficientmtniTMEpromotePDAprogiKPC/PdmiceKC/PD-i-fElCERTmice(Subim1)KPCcelloutPDGFRbKOthopicllyjectedyngeneicimmunocompetentmice(B6129S)immunodeficientNSGmice(Subim1b)humnPnINderivedgnoid(PnIN-DO)trnducedTet-duciblePPARDexpilentiviruthopicllytrnplntedNSGmice(HuCD34-NSG)out(NSG)humnizedimmuneytem(Subim1c)2)chemokecykewellircelligPPARDemploymtpncticiTMEugCITE-eq(Subim1d)Aim2determeeffectpncticPPARDKOpncticiTMEPDAprogiKC/PdKO-fElCERTmicefedHFDyngeneicNSGmicethopicllyjectedKPC-PdKOcellfedGWdiet(Subim2)wellHuCD34-NSGNSGmicetrnplntedhumnPDA-derivedgnoidoutPPARDKOfedGWdiet(Subim2b)ThprojectprovideimptntightPPARDctivtitrgetPDApventiProjectSummryDygultiRNA-bdgprote(RBP)-RNAterctiimpctcodtiRNAfteeveimplictihumnhelthRBPterctdictlyRNAprocegmcherymodulteRNAlocliztidegrdtrnltidependentlytrncriptilgultiDruptiRBPirRNAbdgecnledfluctuticogenetum-uppgeneexpimlignntchngecellulrhomeotUndertgmoleculrfunctiRBPgultggeneexpinimpertivepdictgmettticprogicncerRBPmutntgeneigntuRecentwkhleddcoverythouhumnRBPmuchlehendeytemticllydecrifunctiechprotedividuldomhvegultgirRNAprtnerAddillyfunctilgniztiRBPydirdtctgenerllywell-chrcterizedRNA-bdgdom(RBD)notfullyunderodUntilcentlywumedRBPweeffectivelyn-modulroutideRBDhowevercurnttudieuggetRBPmycompoedeprbleeffecrdomterctprocegmcherypromotegulryctivyIhypoizemotRBPctdtcteffecrdompot-trncriptillygulteprotebundncethroughtercticellulrmcheryctrolRNAdecytrnltiTheBtulbhdevelopedhigh-throughputcrumentycru80mocidproteptitileynticDNAptergeneIpropoeextendthmethodologyidentifyfunctileffecrdomhumnRBPwheylomymoenivecogenicmuttiFirtIuehigh-throughputyIcentlydevelopedcrutenthouprotetileynticpterRNAevluteireffectdowntmproteexpidetermemechnmwhichygulteRNAlevelThllowmeidentifynnottedcogenicmuttithverlpeffecrdomlikelycuedeedruptgRBPgulryctivySecdcurntlydifficultpdicthowloRBPctivyffectgleboundtrncriptlrgelycueRBPbdtdiffentpoidiffentcopynumrechirmultipleprtnerRNAIqunttivelycomphowvriRBPeffecrdompoigoccupncylgtrncriptffectgeneexpieventuldiffentcncerphenotypeFllyIcductmechnticvetigtiMETTL3knownRNA-modifygenzymewhoeovexpilieveddrivedevelopmentmultiplecncerIdetermeRNAgulrypotentildependentmodifictiwrgquerydictcltitweenRNAmodifictioverllexpiThwkfirtytemticllyidentifyfunctildomRBPceundertghowdygultiRBPfunctiledcncerthroughltedtercticrucilcellulrmcheryProjectAbtrctWhdventfluocenceprotrgetgpecificcellulrubcellulreventrolefluocentimggpcliclngettgrpidlytrgerFluocencepromlyctctivecompentwhichtercttrgetptgcompentuchfluocentdyeOpertgner-frdpectrumwhichtuebptimimumeprocndetectedvivoevenifylocteddeepmiceInddidventnerfrdfluocentprotepowerfulptergeneexpitudieenhncedimptncefluocentwhole-bodyimggmllnimlOurcompnycurntlyferlygntry-bedcomdX-ryCTFluocentTomogrphy(FLT)ytemvilblemrketcnprovide3Dwhole-bodyfluocentimgemicelgnmicX-ryimgeOurmobjectivethpplictiupgrdeourcnnerugntenified-CCD(ICCD)cmermlyllowourytemprovideBiolumecenceTomogrphy(BLT)cpbilyddiFLTUtiliztinICCDcmerloenhnceFLTimprovgenivyimgecquipeedBiolumecenceimggenblevuliztigeneticllyengeedluciferegene-bedpterctructlivgnimlApplictibiolumecenceimgghgrowntmendoulypttwodecdemnyfieldcludgimmunologycologyvirologyneurociencedueunpcedentedenivyeeueBeggntrybedourupgrdedytemwouldblecquibiolumecenceimgemultipleviewctruct3DBLTimgewhichnotnoptinycommercillyvilbletrumenttmomentCpbilycquirgperfectlyco-gtedX-ryCTFLTBLTimgeplcethpropoedytemourcompnyefrpticlmoleculrmllnimlimggmrketABSTRACTTheoverllobjectivethSTTRFt-TrckprojectpppermPheIclicltrilmettticunectblepncticductlcncerdenocrcom(PDAC)ptientnewimmunpeuticpprochbedtetnucllntigendelivedbcteri(Lteri-TetnuToxoid)Gemc(GEM)BckgroundPDAChfive-yerurvivllethn10%USAietrdcGEMAbrxneFOLFIRINOX(FOLiccidFluourcilIRINocnOXliplt)lymodetlyimproveurvivlDrGrvekmperchgroup(AlrtEteCollegeMediceBrx)hdevelopeduniqueimmunpeuticpprochutilizefen-pthogenicttenutedbcteriumLterimocygeneelectivelyfecttummettevivoWehvehownmouemodelLterideliverhighlyimmunogenicntigenuchtetnuxoid[TT])immunouppedtummicroenvirment(TME)wheLteri-TTpdtumcelltumcellexpgTTByctrtLteriquicklyelimtednmltuehfewideeffectPrmountthrpypeoplehveenvcctedbootedgtTTdurgchildhoodmemyTcellTTcircultebloodlifeActgnetigenurrogteLteri-TTctivteememyTcellgrdlegewhichubequentlykillfectedtumcellTofurrimproveTcellpeTMEweddedlowdoeGEMrpyPlimrydtThLteri-TT+GEMcombtigimenturnedcoldimmunologicllyhottumttrctgCD4TcellTMEproducghighlevelpergrnzymeBtwoenzymepiblekillgtumcellWehvehowntrngenicKPCmiceLteri-TT+GEMhighlyeffectivegtdvncedpncticcncer(tummetteweduced80%87%pectivelyurvivlimproved40%compdunttedmice(eeourcentpperSciTrnlMed2022)ThemgolthpropolbrgLteri-TT+GEMttmentgimenclicBrggLteri-TT+GEMclicPtentLteri-TTcllntigenccepthveengrntedUSChJpnoEuropeAllIPhenlicenedAlrtEteCollegeMediceLokiTherpeuticbrgrpyclicLokihubmtedp-INDpplictetLteri-TT+GEMPDACptientPhe1clicltrilpoivepehenceivedFDAPheIAim1GMPmnufctuLM-TT+GEMuePhe1clicltril(Mth1-12)Aim2EtblhpthologyxicologyprileLM-TTmice(Mth1-12)Aim3SubmnINDpplictinIRBprocol(Mth1-12)PheIIAim4EtblhfetyxicypeprileLM-TT+GEMPDACptient(Mth13-36)ProjectSummryTheprimryobjectivethpropoederchprogrmevluteclicltrilimprovementclicloutcomeuetwupptgphyicindurgpercutneoumicrowvebltilivertumcnultInpercutneoumicrowvebltineedle-hpedbltiproertedtumentergbodythroughkThetipprocnemmicrowvehettuekillgcertvolumetueroundtipproThegolkillcompletelytumpermgglebltimllertumplcgprotmultiplepoipermgmultipleblticoverlltumvolumeDurgproceduptientlieCTcnnereverlimgecquidvulizepoiprotumItchllenggthoughphyicinevluteeimgewhichprttumhenkilledwhichnotcequenceprocedumighttermtederlythkgllmlignnttuehveenttedwhilemllptitumprcticeleftunttedDependgtumizethcnhppen20%(mediumtum)50%(lrgetum)ceNEScientifichdevelopedtwwhichbleimultephyictkgplcedurgprocedudetermewhichtuekilledbedimultiThekilledtueetimtedbedimultihighlightedCTimgedurgproceduophyicinlwyknowwhichprttummighttillneedkilledThcomputerizedidphyicinhouldultmuchlowerrtecompletebltiThetrilprtthprogrmmirrtetumcurnce(rgcompleteblti)84ptientwhichundergomicrowveblttglivertumIftriluccefulmicrowveblticomdcomputerizedguidncemimllyvivecncerttmenptiwhichdoenotpentideeffectchempyrdipyABSTRACTOverltdecdecellbedlivgmedicelikechimericntigencepr(CAR)-TcellimmunpiehveledmirculoucudvncedggiveleukemlymphomchildndultPriirtroductiecncerwethoughtvirtullyunttbleyetmultipleclicltrilhvenowhowndmtergCAR-TrpycnevenmoeffectivethnchempytrdcDepegtpromemnybrrierctuelimpotencyCAR-TrpiettgolidliquidtumtillnotclerwhichbiomrkerhvemotclicllevnceUnlikemoleculrrpieuchmllmoleculedrugbiologicwhichcnhomogenoulyproducedbtchbtchcell-bedrpiehentlyheterogeneoutillmnyunknownboutwhichpecificubpopultictedelivgmedicectrieoverllrpeuticpotencyClicldthctentlyhownthverllimmunepetendomtedltivelyfewCAR-TclebothkilltrgetrpidlyprolifertefterfuiHoweverdtehnotenpoiblefurrquntifyekillerprolifertiveubpopultidueourbilymeuediverefunctiimultneoulytlevelechglecellToprovidemocompheniveolutinlyzgCAR-TpotencyCelldomcommercilizgpltmcnmeufunctilpropertie>100000CAR-Teffecrcellco-cultumtgleexperimentnueefunctilmeumentmkeltimedeciboutwhichcelltrievegenomicchrcteriztiOurpltmueproprietrymicrowellplteoltedcteglecellco-cultuugimplewkflowvolvglyliquidhlgolcentrifugtiWehvebuiltnimgercnmtvibilyco-cultuovermnydywhilectuoulymirgmultiplephenotypicprmeteruchcyxicyctivygrowthrteWhupptthpropolweimcludeddilmeumentcykeecticellurfcemrkergeneexpiInderchievethgolweneedlizecombtechniclengeergmileneimmunologiclydevelopmentmileneOurengeergobjectivepplyvideocticognimodelimproveccurcycylymeumentcocultudetectietblhl-timeimgecquicomputervidtnlypipelellowclepickedimmedelytendexperimentOurydevelopmenbjectiveerngelimdetecti3cyke3urfcemrkerddeelecticrericleoltiWefurrimtrievehighpriyclepecificmicrowellnlyzetrncriptilttecllydiffentub-popultiOncellecpbilieplceCelldomhvemotcomphenivepltmmrketmeurgfunctilmoleculrpropertiedividulTcellwhichcnhelpidentifyfurrtudyubpopultidomtevivopePROJECTSUMMARYWhilechimericntigencepr(CAR)TcellrpyhdrmticllyltedcncerrpylcpeuceptibilyCARTcelluccumxhutipechrictimultumntigenmmjchllengeStrtegieovercomeCARTcellexhuticricllyneededpentkeyerchpriyEpigeneticgenectivtgprogrmhveemergedimptntfcilrCARTexhutidemtrtedobervtiCARTcelllckgDNA-modifygenzymeTET2pertfcechricntigentimultipviouknowledgeTET2veregeneilencgprogrmducedDNAmethyltiTkengereightuggetctivtipecificgenemyufficientnecerypromoteexhutiThpropolimidentifyuchgenewhichpentttrctivetrgethibigenertemodurbleCARTcellAim1focuectgfirtpl-engeedCRISPR/dC9-guidedepigenomeedirTheeTET-bedtechnologie(eEE)duciblyctivteunderctrolmllmoleculeenblgctrollblectivtrgetgenemnnercpultedynmicduciblentuepigeneticprogrmmgAim2eekidentifyTET-gultedgeneimplictedCARTcellexhutifirtemploygnovelducibleTETovexpictruct(eTET)decipherdynmicepigeneticlcpechricllytimultedCARTcellnlevergguniquepropertieeEEcengenevolvedducgCARTcellexhutiCidtegenetrgetedctivtiultgimpcnCARTcellphenotypeevlutedvelgctibletrgethibitrtegyimproverpeuticefficcyCARTcellThepropoederchulttroductinovelepigenomeedgtechnologieprovidekeyightepigeneticCARTcellexhutihightrnltilpotentilImptntlytherchlotrnMD/PhDtudentcomewell-roundeddependentphyicin-cienttIncjuncticliclimmerictiviePelmnSchoolMediceMediclScienttTrgProgrmopptuniecollbticientificcommunictibothideoutidePennpecilty-pecificcerdevelopmentctivieerchpermedunderthfundgopptunypptudentuccefulcerphyicin-cienttfocuedextenicell-bedimmunpieepigeneticprognotictitrtegievrioudeegtrotetltrctSUMMARYSmllcelllungcncer(SCLC)lethltumtypechrcterizedexquepechempyfollowedrpidemergencechemotnceAddiPDL-1hibipltum/epoidechempyledimprovedcliclpebunlymllubetSCLCptientnefDtctubetSCLChveenidentifiedcludghigh-neuroendoclow-neuroendoc(NE)ubtypeHigh-NESCLCexpghighlevelASCL1(SCLC-A)NEUROD1(SCLC-N)tunderodgeneticllyengeedmouemodelvilbleHoweverourundertglow-NEubtypepoowgprtlckmouemodelAlow-NEimmuneflmedubetSCLC(SCLC-I)exhidcedpeimmunecheckpotblockdehighexpiRE-1SilencgElement(REST)uppneurlneuroendocgeneexpiAim1tethypoeRESTovexpimouemodelSCLCultlow-NESCLCRESTceimmunogenicyWeueglofunctitudiedectctriiRESTSCLCmodellow-NESCLCRNA-eqnlyeuedtmoueGEMmodelogeniccellleRESTperturbtiidentifygenectentlygultedRESTwhileCUT&RUNidentifydicttrgetRESTWepermglofunctitudieepthwythroughwhichRESTlterbiologySCLCnilfocuhowRESTctrolexpiMHC-IAim2buildourplimrydtimplicteRESTexpidrivgchempytnceWepermednvivofunctilCRISPRctivti(CRISPR)cenidentifygenewchchemoeniveptientderivedxenogrft(PDX)modelcomechemotntwhenovexpedmgpcenhwRESTWetudyimpctRESTperturbtichempypeteurhypoRESTexpicuewchchemotnceWepermimmunohchemtrymoleculrnlyechrcterizepeREST-perturdPDXmodelchempyvivoWhcedppcilow-NESCLCpoundertgunderlygbiologycriclthimptntubetSCLCmodelledunderodThpropolprovidenewvivoGEMPDXmodellow-NESCLCwhicheentilgentlkbiologicllydtctSCLCubetmotpromgrpeuticpprocheProjectSummryHigh-grdeerouovrincrcom(HGSOC)ccount75%ovrincncerdignoebout80%ptienthvemettticdeeupdignoMettticHGSOCtypicllyttedrdiclurgicldebulkgcyxicchempy~80%ptientdeecur3yerledgmedinoverllurvivlly40mthTrgetedrpiehvedemtrtedlymrglimprovementoutcomeHGSOCnewrpeuticpprocheurgentlyneededImge-guidedtrgetedlph-prticlerpy(lph-TRT)hemergedneffectiveterventieverlcncercommerciliztinlph-TRTmettticHGSOCignificntcueucceoureftimproveoutcomethouptientdotneflpefterfrtlerpieTheoverllgolthpropolcommercilizenewlph-TRTcnimproveoutcomethoumettticHGSOCptientwhomllrpiefllhtTochievethgolwecomPerpectiveTherpeuticproprietryrdiuclidechelti212Pbopeproductechnologiennovtivecucurb[7]uril-dmntne(CB7-Adm)hotguetptrgetgpltmdelivernimge-guidedlph-TRTrpeuticugelementlly-mtchedrdiuclide203Pb(imgg)212Pb(rpy)Thrpeuticpprochtrgettumocedglycoprote72(TAG72)well-etblhedbiomrkerthvexpedmjyHGSOCtumInPhe1thFtTrckSTTRprojectwedemtrtefeibilyptrgetgpprochlph-TRTughumnizedTAG72mocllntibody(huCC49)mouemodelHGSOCdemtrtgdoimetry-derivedrpeuticdexmeetcognizednchmrkeffectiveTRTAddillywevlidtehuCC49thdictipermgimmunohchemtry(IHC)humnHGSOCmpleInPhe2weoptimizeourptrgetedlph-TRTmicedetermgdoe-dependenttumgrowthhibiurvivlpotentilxiciepprochSimultneoulyweoptimize212Pbrdioligynmultietblhoptimlmulti(helflife)dtriiclicleCMCpprtiFurrmoweynizepurifychrcterizeufficientmterilpermGLPxicologycoldmllmoleculerdioligccdgFDAguidnceInumwehveoptimizedprocolproducgdelivergimge-guideddoimetry-bedptrgetedlph-TRTmicemrigoubhumnHGSOCrpyThuucceourSTTRprojectAimPerpectiveppdFDAfilg(CMC/IND)upptPheIclicltrilfncedugprivtecplcompnyhdepviouprogrmProjectSummryKercytemelnocytegermepidermlmelnunwhicheentilprotectivetnngpefterultrvioletrdi(UV)expouKercytepdUVlegprcfcrducemelnocytecemelnproductidendricyMylbhowedkercyte-pecificdemoomlcdherdemogle1(Dg1)whichtemprilylotpecuteUVexpouplyrolethprotectivetnngpeAcuteexpoumelnocytecdiedmediDg1-deficientkercytecemelnectidendricyHowevermelnocytechricllyexpoedDg1-deficientkercyteexhidfetutrnmticludgpgeidmelnocyWefoundcentlymelnomcellcdiedmediDg1-deficientkercyteexhidcedmigrtiduetletprtCXCL1/CXCR2ignlgWhenkercytewecultudmelnomcdiedmediDg1wdowngultedlgtrncriptilctivrGryhedlike1(Grhl1)whileectiptientmelnomtueDg1wlotkercyteurroundgmelnomOverlledtledmehypoizemelnomcellctivelytrgetDg1downgultikercyteirownnefledgcedproductiprcfcrturnpromotemelnomprogiOurRNAequencgultuggetmelnomcellcultudDg1-deficientmediupgulteneurlcttemcell(NCSC)-likeigntuexhidmelnomcellpopultienhncedmigrtividrugtnceHeIpropoe1)determehowlokercyteDg1ledprogrmmgmelnomcelldoptmopro-tumigeniccellfte2)determehowmelnomcelldowngultekercyteDg1elucidtguptmgulrmodulteDg1expimechnmwhichmelnomcelltrgetDg1kercyteTowrdthendIcultumelnomcellDg1-deficientkercytecdiedmediueRNAequencgglemoleculeRNAFISHidentifychngetrncriptiligntutweenmigrry/n-migrryvive/n-vivemelnomcellpopultiTodetermeifmelnomcelldjcentkercytelckDg1exhibnceNCSC-likemrkerIuehumntueectitNCSC-likemrkerToidentifymelnomectedfcrcnhibDg1kercyteItkeprllelcidteundpprochfocuggrowthfcrcnctivteErk5whichwidentifiednuptmgulrDg1RNAequencgFcrlterDg1expikercytegeneticllymnipultedmelnomcellultgcdiedmedicollectedKercytecultudmelnomcdiedmedidetermeifloidentifiedtrgethibDg1loOverlletudieelucidtenovelprcignlgtweenkercytemelnomcellidentifymoleculrmechnmwhichmelnomcellcnctrolkercyteectipro-melnomfcrProjectSummrySoLLChdevelopedqRT-PCR-bedmicrluidic7-geney(CATOS-LU)pdictcurnceprogimettn-mllcelllungcncer(NSCLC)ptientwhohundergeectitge1cncerouthigh-rkfetuttimeurgiclterventiIntropective/rchivedlgudlclicltudieourywhichwdevelopedutilizgnovelrtificiltelligence(AI)methodvlidtedviourqRT-PCRnext-genertiequencg(NGS)proteomicccurtelypdicted1)rktumcurnceerly-tgeNSCLCptient(n>1600)cludgptientromizedpheIIIclicltrilJBR10(CliclTrilgov)2)cliclnefdjuvntchempyeptientTheeultupptthurtechnologycn1)identifyerly-tgeNSCLCthighrktumcurnce2)pdictcliclnefchempytge1NSCLCouthigh-rkfetuerlierimplementtidjuvntchempycouredeemngementydcurnttrdcWehveccomplhedeverlkeymilenehelpdemtrteerlypro--cceptdurgildevelopmenurproductWehveubmtedetcompheniveptentpplictitngnourIPourtechnologyddgcliclutilyCATOS-LUptientnp-frozenml-fixedprff-emdded(FFPE)tumwhichwehvelodcuedFDATohelpcommercilizeourtechnologywetendoptimizeCATOS-LUFFPEcliclmpletterfurgery/pthology/cologywkflowInthPheISBIRprojectweetblhqRT-PCRybedupourAI-defed7-genepnelfocugtge1NSCLCouthigh-rkfetu(n=200)pdicticurncerkToenhncecliclpplictimrketvlueourCATOS-LUtrddignoticcwedevelopourCATOS-LUFFPEtumCAP-ccdedlbryTheprojecttetfeibilytegrtgourpropoedqRT-PCRyFFPEtumextghoplwkflowcot-effective-houetetgThepropoeddtnlyfollowFDAtructiwehveceivedultgenertedthprojectubmtedgencypprovlWehveenggedtrtegicprtnercludgcommmentmtchthprojectpendgwrdPheIWequetPheIuppttetfeibilyourprojecptimizeourtetidphyicinidentifygehigh-rkptienterliettgeNSCLCUltimtelywetendobtCMScoverge/imburementnLDTfollowedFDApprovlourdignotictetniddignorkcoementptientthighrkcurnceNSCLCtge1outhigh-rkfetufollowgprimrytumectiProjectSummryAbtrctRdirpy(RT)hprovencdefficcyttgmnympedricbrtumHoweverocedlg-termideeffectduedmgeurroundghelthytueThepecillyimptntpedricdevelopgbrwhelg-termdeficcneencognivedevelopmentTomigteedefichenhiftwholebrirrdimotrgetedttmentugdoeptgtenymodultedrdirpyHoweverueetechniquemomtineededbouthowgivgrdinmlbrtructuclledgn-t-rk(OAR)ffectoutcomeboermbrnmyfunctiVoxelHelthcLLC(VH)developerClickBrnumticpedricMRbregmenttioluecloud-beddeeplerng(GoogleTenFlow)technologyrdiologyclicldeciupptScecepthtwweextendedClickBrClickBrRTytemcomClickBrpttmentbrtructuegmenttioutputrdiplnngcomputedmogrphy(CT)/mgneticnce(MR)imggclcultedoeOARClickBrRTloegmentlgudlMRItrckoutcomevivolumetricchngeInpviouprojectwecltedputprmeteruchOARdogdemogrphictumtypegrdeOARtumvolumetricmeumentOARvolumetricoutcomeugdtbebrMRIgermcelltumptientHeAim1wemodifyourpdictiughybriddeeplerngmchelerngmethodpdicttmenutcomeOARWeloimprovgouruegmentlghmThetumimgeextrctedMRICTimgecctentedptientpecificdemogrphicmti(gegender)trghybridneurlnetwkrchectuImggfetuentnuencodercvolutilneurlnetwk(CNN)whiledemogrphicmtientdenelycnectedmulti-lyerperceptr(MLP)netwkAfterdividulfetuextrctihpgycctentedentMLPmodelttmentltecogniveeffectpdictiMgdtpotynizedugmodifiedPix2PixGenertiveAdverrilNetwk(GAN)method3InAim1bwebuildourcurntterfceprotypewhichueclicldemogrphicvrible(gechempydoetumtypegrdelocti)beleimggpuutputpdictedoutcomeOARWeupgrdeterfceprovidefullfunctilycomptibilyextgcommerciltweeptgfiletweenytemOurextendedvlidtiAim2focunextglrgedtbebrodrngebrtumptientcquidprttrd--cpvioutudietChildnHoplLoAngeleOurlg-termgolClickBrRTtrmchelernglghmprovideoptimizedcommendedOARdogerngebedptienthrytummtiOurtwllowrdicologtoptimizettmentvtlyimprovelg-termqulylifepedricbrtumurvivPROJECTSUMMARY/ABSTRACTProblemLungcncerthirdmotcommcncerUSnetimted238340newce2023projectedbout25timemodedlythnnycncertype2023(127070deth)The5-yerurvivlrtedvncedmettticlungcncerly7%ThehugeunmetmediclneedttmentptienttnrfrcrytrgetedrpiecentlypprovedimmunecheckpothibirTheverytrgevidencehigherlevelolubleMICAMICBclevedcncercellurfceledimmuneecpedictlycltedpoptienturvivlrteTheedeigngnntibody-bedrpyblockMICA/BclevgepentnttrctiverpeuticopptunyTechnologyAkhBiologicdevelopgnovelfirt--clMICAXMSLNbpecificntibodyttmentdvncedmettticlungcncertnrfrcrycurntttmenptiTheMICAXMSLNbpecificntibodycomthecrucilcompentglegentbrggynergyNKcellctivti(I)nnti-3dom-pecificMICA/BbdgrmblockproteolyticclevgeMICA/Bimmuneurveillnce-engggMICA/B(vi12MICAdom)NKG2D(II)nengeedFcvrintenhnceADCCctivycompdWTFc(III)nnti-MSLNbdgrmenhncepecificyefficcyAkhBiologichidentifiednADCCenhncedFcengeedlednti-MICAntibody(AHA-1031)pventheddgMICA/BWedemtrtedthurFcengeedntibodydrmticllylowhibtumgrowthcompdnchmrkCLN-619ntibodyPhe1clicltrilTofurrbootefficcypecificywectructedolbpecificntibodycompourlednti-MICAFbrmimmunectivtgrmnnti-MSLNdAb(lertu)TAArmnenhncedADCCFcvrintAexpectedweobervedmuchhigherpecificcellkillgbpecificntibodycompdmocllpntntibodyWihknowledgewenowplnembleourownADCC-enhncedbpecificMICAXMSLNntibodyThegolcurntpropolcenidentifytbpecificntibodydemtrteuperumgrowthhibimultipleNSCLCmouetummodelcompdnchmrkntibodieSuccefulcompletipropoedtudieupptPheIISBIRpplictihelpucompleteptiIND-enblgtudieOurflgoltkethbpecificntibodyclicltrilpotentillyprovideimprovedttmenptiptientdvncedNSCLCProjectSummry/AbtrctBtcncermotdignoedcncerwomenUnedSttepopultibtcncerurviv(BCS)growgCncer-ltedftigue(CRF)motcommlgtermideeffectbtcncerdeettmentCRFocedpoqulylifedecedphyiclpychologiclwell-gTheeidentifygtrtegiemngeCRFbtcncerurvivhipcriclStrgevidencedictecedphyiclctivyprticiptiocedlowerCRFlevelBCSeffectuperiphrmcologicterventiTheephyiclctivycommendedfirt-lettmentCRFHowevermotBCSdotmeetphyiclctivyguideleelevtedCRFocedlowerphyiclctivylevelBCSMobilehelth(mHelth)terventimypromgterventideliveryolBCSCRFcueircedcvenienceflexibilyclbilypotentildecedburdenHowevernoextgmHelthphyiclctivyterventihvepecificllytrgetedBCSCRFThepurpoethtudyuepprtipheMultipheOptimiztiStrtegy(MOST)exploeffectdiffentphyiclctivypromoterventicompentBCSCRFtterundertmulti-levelterventicompentpfencethpopultimfututerventidevelopmentThprojectcludeecdryqunttivedtnlyeF2ThrivetudynmHelthphyiclctivyterventiBCSuedoptimiztipheMOSTAnlyeexplowherfeibilycceptbilyfidelyphyiclctivyoutcomevriedubgroupBCSprticipntelevtedCRFNextneedement(quetiniemi-tructudterview)emulti-leveltkeholder(BCSftigueexpertcommunyprtner)perceivedbrrierfcilrmHelthphyiclctivyterventiuptkeBCSCRFThfellowhipferignificnttrgopptunymHelthhvilterventideigndemtiqunttivequltivedtnlyThepropoedimctenevidence-bedfoundtideigndevelopmentfutumHelthphyiclctivyterventiBCSCRFpromotehelthwell-gthroughouturvivhipProjectSummryAulogouchimericntigenceprT(CART)cellrpypoelogticlecomiclchllengedepecurtivepotentilD-derivedllogeneicf--helf(OTS)cellrpiehvecomeholygrilcellrpyycnm-producedimmedelyvilblecncerptienttfdblepriceHowevercurntOTStrtegievolvecomplexmnufcturgprocegene-edgfetyccernuchcrcogenerkN-Tcell-bedOTStrtegieuchNKcellhvepotencyccernylckpertencedurbilyImmunebroTherpeuticdevelopgimplenovelpltmtechnologyproduced-derivedTcell-bedOTSproductnmedenggerTcellEnggerTcellengeeddTcellexpgectgnrtificilmodulrprotecn1)trgetdTcelldeidcncertrget2)curbdTcelllloctivyducggrftveruhotdee(GvHD)DderivedenggerTcellimpleolutiOTSTcellrpyneedgeneedgItvolvewell-etblhedmuchlecomplexmnufcturgprocecomprgeneededOTSCARTcellcurntlydevelopmentPlimrydthvedemtrteddderivedCD19-trgetgenggerTcellhvelowxenogeneicGvHDrkefficciouttgxenogrftCD19+leukemimouemodelHoweveride--idecomprCD19enggerTcellferi2ndgenCD19CARTcellefficcyduelckco-timultiAefficcycrucilgulrycommerciluccenydrugcidtethpropolimgtdevelopgenhncedCD19enggerTcelllowGvHDrkSpecificAim1developenhncedCD19enggerTcelletrngeneexpiectiThetrtegieuedproduceenhnceCD19enggerTcell1)co-expgCD19CAR2)co-expgTcellpromotgcykeIL153)co-expgcotimulryfcr4-1BBLCD80SpecificAim2demtrteemoenhncedCD19enggerTcellhvelowxenogeneicGvHDrkimmunedeficientmiceSpecificAim3demtrteemoenhncedCD19enggerTcellhvecomprbleefficcy2ndgenCD19CARTcellByendPhe1wkImmunebrohveenhncedCD19enggerTcellfirtproductprotypebuiltimplenovelOTSpltmThpltmcnuedbuildrichpipeleOTSTcelltrgetgvrietycncerlecomplexmnufcturgferprilecomprbletterefficcythngeneededOTSCARTcellcurntlydevelopmentPROJECTSUMMARYChromoomlIntbily(CIN)lohtrmchromoome17(17p)terltedltivelycommchrcterticmnydvncedmettticcncerThoughegeneticltertilikelyctrieynticlethliegeneticdependencieultgCIN17plohvenotenextenivelyidentifiedexplodAwhole-genomeCRISPR/C9cenpermedourlbcomprgprimrymetttic-derivtivecellleveledmetttictumwhichpoehigherrtechromoomltbilymoenivehibimicgulrocedchromoomeeggtiKnockouneuchgulrNDE1electivelyhidgrowthmettticCIN-highcelllevrovivoIntetglydependenceNDE1highlycltedlo17pcrocellleDepMpdtbedictgbothCIN17plomyctrieNDE1enivyWehypoizehibgNDE1myneffectivewytrgetcncerhrbg17plocedCINthroughuniquedulctimechnmvolvgbuilduperrfhfulchromoomeeggtiynticlethlynNDE1prlogbdgprtnerbothwhichlocted17pTotetthcentrlhypoIpropoedefgltihiptweenNDE1dependence17plochromoomltbilychrcterizgroleNDE1properchromoomeeggtiegrpeuticpotentiltrgetgNDE1ctextCIN17ploPROJECTSUMMARY/ABSTRACTTriple-negtivebtcncer(TNBC)ubtypebtcncerhighlyvivehlimedttmenptiprecurncemettThetrdcTNBCptientvolveneodjuvntchempyfollowedurgeryrdipyEvencentdvnceimmuno-cologicl(I-O)ttment5-yerurvivlrtemettticTNBCly12%Mooverlyome(~20%TNBCptient)eligiblechemo-immunpycombttmentoignificntptientmgpopultinotnefcurntttmentTheenoveleffectiverpeuticpprochemutdevelopedcomplementtrdttmentTNBCenhnceimmunepeTomeetthurgentcliclneedwedevelopgn-phrmcologiclwerblen-vivecommercillyviblemedicldevicettgmettticTNBCUgducedelectricfield(iEF)technologyelectromgneticfieldtermedefquency(<500kHz)lowteny(V/cmmV/cm)wehveldyhownpcliclTNBCmodelimmunocompetentmiceiEFttmentultignificntdecedtntmettelungprimrytumburdenfiltrtipro-metttictumocedM2-likemcrophgecedfiltrtictivtedcyxicTcellprimrytummicroenvirment(TME)ThnoveliEFrpyelicpotentneficilelectivebiologiclpemodifygendogenouelectricfield(potentildiffence)extbotuecellulrleveltroducgexogenouvoltgeelectricfieldhdertumgrowthmettlungBothourvrovivodtuppurhypooverllgolthpplictrniourpromgultcloeryetcliccombgiEFttmentmouemodeltrdcchempydvncedTNBCWeccomplhthgol(1)determgetblhgfetyprileiEFrpyegnydvereeffectiEFrpywild-typeimmunocompetentmiceidentifygnyobervbleeffecttrdnlytebloodnly(2)determgbilyiEFrpycomdtrdcchempeuticgentetblhedmouemodelcpultebtcncertumgrowthprogipulmrymettWedetermevivoefficcytleIEFrpydecgtumgrowthpulmrymettneefficcycombgiEFttmenttrdcchemo-mpie(pclxelcpec)hrkgprimrytumpventgpulmrymettCollectivelythwkhpotentilvgliveptientmettticTNBCwhotpivecurnttrdcctrieleengmbidycurntttmentpotentillylowergquiddoechempeuticgentProjectSummryLungmett2ndmotcommmettccount30%llmettticdeehumncncerptientPtientlungmettehveveryhturvivltimeFexmple5-yerurvivlrtecoloctlcncerptientlungmetteifleftunttedly5%Surgicllungmetteecti(pulmrymettecmy)curtivettmentcncerptientlungmetteFexmplepulmrymettecmyce5-yerurvivlrtecoloctlcncerptientlungmette503-66%Howeverpulmrymettecmycurntlypermedlyverymllpopulticncerptientlungmetteduerk-ltedhighlyelectivecreriFexmplely5%coloctlcncerptientlungmettettedpulmrymettecmyAneodjuvntrpycneffectivelyducelungmettenumr/izeeexpectedignificntlyceeligibleptientpopulthlife-vgpulmrymettecmyChemMedImmuneIncdevelopgIFNA2-LNP001lipidnnoprticle-encpultedIFN2-encodgmi-plmidDNAttmentptientlungmetteIFNA2-LNP01dmtedclicllyneodjuvntettgwhectivtetypeIterfer(IFN-I)ignlgpthwylungmetteceexpiTcellchemokeCXCL9CXCL10ultgenhncedTcellcrumenttumeduceizenumrlungmetteAkeydiffentgfetuIFNA2-LNP01dmtrtineodjuvntettgwhichnecerygiveptienttchncefightirmetttictumhedlerpiecnnegtivelyffectTcellIFNA2-LNP01deignedbedourcentpublheddthowgloIFN-IexpifunctimjmechnmunderlyglungmetteimmuneevigrowthTwoimpuruedthproject1)determeefficcyIFNA2-LNP01uppumlungmettevivo2)determeIFNA2-LNP01biodtriixicologyvivoThprojectexpectedgenerteufficientefficcyxicologydtPheIIIND-enblgtudyIFNA2-LNP01PROJECTSUMMARYOvrinCncer(OvC)fifthledgcuecncerdethwomenocedverylowurvivbilyCurntttmenttrtegieOvClrgelycludeurgerychempyChempywhichtenvolvepltum-ctgdrugtxnecneffectivehowevermnyptientexperiencecomplictidueideeffect/tncechempyAlterntiveoptineededprovideeffectivettmenttrtegieOvCptientImmuno-cology(IO)drughvehownimprovettmenutcomeomecncerenblgptientimmuneytemlunchnimmunettckgttumHoweverefficcycurntIOdrug(egimmunecheckpothibir(ICI))lowdueirbilygenerteimmunogenictumCurntIOdrugpimmunouppilycncercellimmunouppiimmunouppcelluchMyeloidDerivedSuppCell(MDSC)mtctutgnimmunouppivetummicroenvirmentWhileelimtgMDSCperceivedtrtegyovercomgimmunouppiclicltrilhvehownelimtgMDSCleufficientducetumburdenCurntdrugcnelimteMDSCunubleylckelectivytrgetMDSCn-pecificllydepleteimmunecellHencetumpecificelimtilyMDSCwhiltelimtgcncercellmjunmetcliclneedTRIOPhrmceuticl(TRIO)fulfillgneeddevelopgnewclcncerdrugferdTRAILBodywhichdeignedelimtebothcncercellMDSCelectivectivtiTRAIL-R2mededpopoutengggimmuneeffecrcellcjugtedxTRAILBodietrgetcncercellbdgtumpecificntigentrgetMDSCbdgFcRIITRAILBodieelimtebothcncercellMDSCTRAIL-R2mededpopupengggtumpecificntigenFcRIIpectivelyInthSBIRpropolTRIOdevelopgTRAILBodyOvCFOLR1TRAIL-R2ferdTRIO-628TRIO-628deignedimproveOvCttmentefficcygenertgimmunogenictumvielimtgcncercelltrgetgFOLR1(ovexpedOvC)elimtgMDSCtrgetgFcRIIPlimrytudiehvehownhighdegeelectivyFOLR1TRAIL-R2trgetenhncednti-tumctivycomprlextumumbThegolPheIprogrmetblhTRIO-628nOvCdrugThgolmetthroughexecutwoSpecificAimwhichvolvevroementelectivyTRIO-628depletgMDSCenhncgtumimmunynvivoefficcytudyTRIO-228ugpltumtntptient-derivedxenogrftmodelSuccefulcompletiPheIprovidecriclvivopro--cceptdtugTRIO-628ttOVCAupptPheIIpropolfocuedfetylerbilytudietrnltitudiedvnceINDeftSUMMARYTheDNADmgeMuttiCncerGdReerchCfence(GRC)ledgterntilcientificcfencefocueddvncgciencethroughpentticuttg-edgeunpublhederchpriizgtimedetileddcuifterechtlkfotergmlterctimgcienttllcertgeThecfencefivedylgheldncceiblelocti(VenturCAwhichhuttlerideLoAngeleInterntilAirpt)TheloctidjcentchwhichlendelfleuctiviefotermlterctiimptntgecientificcommunieAfternofetimecommunlmelloupptuchterctitwodnerhveThemeTblewhichvolvetehvgopptunyignuppecifictblehveenignedpekernotblettendee(egenicienttdutrycientificedir)TheprogrmcludedivereetvedpekereverlddillothttlkelectedubmtedbtrctelecticommteeInddipekgpenttieicfencehubtntildeigntedtimepotereidividulllcertgeThecfencell-cluiveemphizeteprticiptiydocedGdReerchSemr(GRS)p-meetgtepcedeGRCThePowerHouretendeellcertgeguideddcuiupptgrowthwomencienceupptllunderpentedpopulticienttpectwk/lifeblnceFllynmenrgcompentwequetlleichirpriizequetitejunifcultydurgdcuieiThecientificfocuprogrmerchdefgbicmechnmDNAdmgepe(DDR)leverggthmtrnltilerchcncerbiomrkerrpeuticTheDDRcentrlcncerbiologyInddiimptncemutgeneetiologycncermnyttmentmodlievolveDDRegclgenicchempeuticrdipyynticlethlyviPARPhibiremerggtrgetlikeDNApolymeretAccdglyprogrmcoverrngetructurlbiologykeyplyerDDRmechnmmutgenechromoomlrrngementcncerDDRDNAplictimechnmltemechnmrpeuticmuttidegultiDDRcncerInddiceimptnceDDRcncerltedterplyimmuneytemehpicFllyeiDDRbrwhichimptntundertbothneurodegenertiwellmlignnciemettbrTheeicludenewpprochetechnologieprovidettendeegrpcurntlcpeerchmechnmDDRthroughpplicthknowledgeimprovecncerttmenutcomeGlioblm(GBM)motcommprimrybrcncerdultOver10000peopleetimteddieyerlyGBMdepeggivettmenthennoubtntilimprovementGBMptienturvivlmothnfourdecde(5-yerurvivlrtemid-19704%v7%dy)emphizgneednewrpieAhllmrkGBMncidictummicroenvirmentwhichpromotetumprogiGPR68pr-engG-prote-coupledceprctivtedpencidicmicroenvirmentimplictedcncer-ltedproceePrBioco-founderidentifiedfirtclpecificGPR68hibirogmphpotentlykilldiverepnelGBMcellthroughferropnovelmir-dependentgultedcelldetheventhoetntfirt-lerpytemozolomideprovidgfoundtihypotrgetgGPR68pentnovelrpeuticpprochgtGBMWhilepngmphhdpophrmcologiclpropertiepcludedvivovlidthhypotructu-ctivyltihipnlyyieldedimprovednlogThenloghveenelectedledcidteTheobjectivethPheIprojectelectledogmphpermcriclpro--ccepttetgthopicGBMptient-derivedxenogrft(PDX)Tochieveeobjectivefollowgthepecificimpurued1)defevrophrmcologiclpropertieogmphledcidte2)determedetiledPK/brccumultiprileogmphledcidte3)demtrtepro--ccepttrgetgGPR68ledogmphefficciougtGBMvivoInAim1theledcidtecompdide--ideplmprotebdgcychromeP450hibimicroomltbilyhERGhibiInAim2phrmcoketicbrpenetrtiledcidtedetermedfollowgldmtrtiCD-1miceFromdtgenertedAim12ledogmphelectedInAim3criclpro--cceptefficcytudiepermedugthopictemozolomide-enivetemozolomide-tntGBMPDXmodelTtmenteffectmidurvivlMRInlytumgrowthhlogyimmunohchemtrySuccefuletblhmentpro--cceptvlidteGPR68rpeutictrgetGBMmoveledogmphdevelopmentThedevelopmentGRP68hibirrpeuticcouldpotentillyvolutiizeGBMttmentfllybrgboutwelcomehift5-yerurvivlGBMptientProjectSummry/AbtrctCncercellenterbrdifficulttttrdtrvenoudmtrtichempiedueblood-brbrrierIntrcldmtrtiMethotxteTopotecnchempiehveenuedptovercomebr-bloodbrrier(BBB)enhncedoedelivedubrchnoidpcethoughultpotuedtriuepenetrtennotdeeptueToddthEnClerctedpltmtechnologyccecebroplfluid(CSF)deliverrpeuticgentctrollgcircultgdoedCSFtweenlumbrubrchnoidpcelterlcebrlventricleThenhnceddeliverytendedctroldoedeliverythroughoutcebroplpcetrgettetInctrtpivetrcldeliverylienturlcircultiCSFdeliverchempythroughoutubrchnoidpceWhrpidturnoverCSF(4-5timehumn)drugcledquicklypivediffuiCSFThepurpoethPhe1grntdemtrtefetyfeibilyoptimldeliveryTopotecnlrgenimlmodelInpurugimthgrntwe1)FurrdevelopoptimizepcliclCSFextrcpolflowytemubrchnoidchempydelivery2)Tetpcliclytemnch-pflowloop3)DemtrtefeibilyfetyourenrryEnClerpclicldeliveryytemmipiggliomtummodelTopotecnttmentInPhe2wedevelopfldevicebrgthroughdeignverifictiexpnimlefficcycncermodelpermGLPnimlfetytudyppnecerytetgnInvetigtilDeviceExemptipplictiFDApermfirt--humntudyAbtrctOncogenetrgetedrpieferfeeffectivepprochuppcncerceedrugphelthytueelectivelytrgetgdrivermutticncercellDepetrgilpeerpiehoweverptienteventullyproglpemthttmentdueurvivlidultumcellTheeiduldeecellcrucilerdicteceecelltenerveervoirtncelpeHoweverbiologiclimmunologiclpropertieidultumcellpolyunderodWetudiedimmunologiclpropertieidulcncercellmoleculrmechnmgoverngUgBRAFmutntmouemelnommodelwefoundidulcncercellurvivevroBRAFrpyexhibimmuneevivivoOurplimrydtuggetidultumcellevdeimmuneytemtrgetgmcrophgeimmuneytemthroughupgultidtetmemrkeruchCD47(cluterdiffenti47)OurfdgproduciblehumnBRAFALKKRASmutntcncercelllellhowCD47upgultiupttmentpectivetrgetedrpieImptntlyCD47blockdehenhownhvenntumeffectmnymouetummodelcurntlyundervetigticlicltrildetermeefficcyhumnptientThuourplimrydtlkgcogenetrgetedrpieCD47upgultihignificntimplicticombgerpiecliclprcticeTofurrvetigteourfdgwepropoeerietegrtivetrncripmicfunctilgenomicpprocheuncoverpotentilmechnmtrgetengeerimmune-mededclernceidultumcellPROJECTSUMMARY/ABSTRACTAcutemyeloidleukemi(AML)devttgdeectuehvepoprognolethne-thirdptientchievgcuirdeeWhileidentifictigenomicubtypehenbledomerktrtificticglyevidentvricelltteAMLprticulrlypenceleukemiprogenirco-opthempoietictemcell(HSC)progrmppercferprticulrlypoprognoDepeerobutdecriptiveobervtihowevermoleculrdriverehigh-rkgeneexpiprogrmltercellttehvemedlrgelyundefedOurerchgroupcentlychrcterizedgenenetwkgultedHSCmtertrncriptifcrMECOMco-optedhigh-rkmAMLHoweverwetilllcknundertgmechnmwhichMECOMgultethnetwkhowcnrpeuticllyhijckedimprovettmentleukemTotterterrogteMECOMdictfunctiAMLweengeednAMLcell-lemodelwhichMECOMcnrpidlyctrollblydegrdedddimllmoleculeAementchngetrncriptichromtcceibilyimmedelyfollowgcompleteMECOMdegrdtiimplicteMECOMnepigeneticppro-myeloiddiffentiprogrmImptntlymjyediffentillycceiblechromtgilodictlyboundMECOMbencedegrdtiuggetgeobervedchngedictcequenceMECOMbltiTheobervedpivefunctiMECOMloctentptedterctiCtBPfmilyco-pivefcrHoweverfundmentlknowledgegpbothidentyMECOMdicttrgetcroprimryAMLmechnmunderlygpivefunctibothwhichcouldrpeuticllyuefulThtudycttwoimvetigte(1)identygenetictrgetdictlygultedMECOMfunctihigh-rkAML(2)epigeneticmechnmwhichMECOMpediffentiprogrmmtAMLprogenircellFthF31wrdPIhdeignederchtrtegytrgprogrmprovidehim(1)fundmentlexpertegenomicbiomticcncerbiology(2)nexpertgroupmenrcollbrpromotenlyerchexpertelocer-lgcdemickillcludggrntmnhipcientificcommunicti(3)experiencepermgrigoumechnticfoundtilbiomediclerchpprtihcergolncdemiccienttThpropoltkeplcerichcollbtiveHrvrdMediclSchoolBonChildnHoplerchenvirmentComplethwkexpectedidentifydicttrncriptiltrgetMECOMhigh-rkAMLelucidteepigeneticmechnmwhichMECOMdriveleukemogeneTheeulthveproundimplictirtilepuruhigh-cfidencetrctbletrgetcnrpeuticllymnipultedttmentmyeloidmlignnciecurntlydmloutcomePROJECTSUMMARYAnnullypncticcncer(PC)hgloblcidencemothn495000cemtlyrtelmot460000ceMoteptient(~80%)ceivelte-tgedignoewhenirtumcnnoturgicllyectednecetgphrmcpyAmjyPCptient(81%)hvedenefibroutromtueurroundgirtumwhichnegtiveprognoticDepettmentPChlowet5-yerurvivlrtellcncerNnomedicehveendevelopeduecologyducexicyimproveefficcyIndeeddruglikeprote-boundpclxelnnomedice(Nb-PTXAbrxne)lipoomlirotecn(Nl-IRIOnivyde)hveleddrmticimprovementpertecnceruchbtlungleukemiHowevernnomediceefficcygPChvefllenfrhtthoeeendictiThtemprtPCtromltueblockextrvtipenetrtilrgennomedicelikeNb-PTXNl-IRI(>100nm)ToovercomedeliverychllengeextgnnomediceDuoOncologydevelopgDUO-207nultrmllnnoprticle(<30nm)compdcopolymer-cjugtedgemc(PGEM)encpultepclxel(PTX)DUO-207fixeddoecombtideliverctivemoietieGEMNb-PTXcurnttrdc(SoC)dvncedPCDUO-207ctfournovtiddgpthSoCrpyoptimizefetyefficcycvenience1)Theptent-pendgpolymerchemtryhdPGEMprotectGEMrpidctivtivicytidedemebloodliverClicllylrgedoeGEMdmtedcompenterpidctivticedrugbiovilbilytumtuethpprochctriedoelimgxicy2)InDUO-207GEMcjugtedpolymerfciltgctrolledgrdulleeprovidgprolgedexpouGEMwhichhenocedimprovedcliclefficcy3)ThebdlkGEMpolymerenivethecdicommtummicroenvirmentidgleeGEMdjcentcncercell4)Ltlyournovelpolymerchemtryllowelf-embly14nmPGEMmicellecnccommodtehighdruglodgPTXgleivfuiDUO-207ultrmllizelloweffectivepenetrticcumultumtuedemtrtedourpcliclthopicmodelPCuggeneticllyengeedKr-Pdx1-C(KPC)cellproducedenetromInthpplictiwepropoepermmuxicologytumgrowthtudiebuildfetyefficcyprileDUO-207compdcurntSocUltimtelynovtiDUO-207improveurvivloutcomexicyprilequlylifeptientuffergdvncedPCABSTRACTBtcncermotpvlentcncerwomenecdledgcuecncerlteddethApproximtely20%btcncercetriplenegtivebtcncer(TNBC)chrcterizedtumnegtivethecepretrogenprogeterehumnepidermlgrowthfcrcepr2(HER2)mkgpecifichmentibodytrgetedrpieeffectiveduelckirrpeutictrgetTtmentTNBCvolvebothloclrpie(urgeryrdi)ytemicrpie(chempy)HowevercompdtypebtcncerTNBCmotchllenggmbtcncerttprecurncemetthpo5-yerurvivlrteepecillyltertgeNotblydvncedBCdtntmettecurntlycidedcurbleMuttitumuppgeneTP53geneoccur80%ceTNBCocedlpemotggivettmentmtlyMenemuttip53(proteencodedthgene)ledproducticcumultimutntp53proteouttumuppcpbilieAnyrpycouldtumuppfuncticcumultedp53protewouldprovidenouttgrpeuticopptunyturnevenmotggivecncerhrbgp53muttiveryttbleegoodprognoThehricexmplethprdigmTheidentifictiBCR-AblchricmyeloidleukemiPML-RARApromyelomocyticleukemiirelectiverpie(Imtib/Reiccid)pectivelyturnedceuncurblecncercurbledeeWerwxBiotechnologiedevelopgnovelproprietryhighlynovtivedrug-dcoverypltmidentifybifunctilmolecule(BFM)ctivtetumuppfunctip53mutnrmBFMnewclmll-moleculebiliemodultedrugtrgetgtlyexceedthoetrdilrpeuticThcueBFMdtlydictbdgmodultedrugtrget(trddrugdo)IntedycruendogenoumodifierprotebdlterprotetetGivenbrodrngepot-trnltilmodificticleenzymectlyzeupproteco-optgectlyticcpbilieBFMcnenblemechnmctiunpcedentedefficcyTheobjectivethprojectproducehighqulyBFMolcompoundled-likepropertiecpblectivtimutntp53UtilizgWerwxknowledgegederlycengBFMtherchidentifyhcompoundelectivelyducecelldethlyp53mutnttumcellUtilizgprllelchemtrylibrryBFMcompounddeignedynized(SpecificAim1)followedelectihmodifierprotehowgbiologiclmodultip53ctivycellulo(SpecificAim2)Fllythroughtructu-ctivyltihipADMEhighqulyhighffyBFMproduced(SpecificAim3)(lthoughydcopethgrnt)cnnmovedpclicltudieABSTRACTDurbletumgiimmunecheckpotblockde(ICB)henobervedmllcohtcncerptientICBefficcyvriewidelyndividulbICBlrgelytrgetcyxicCD8+TcellmechnmgultgCD8+TcellpeICByetelucidtedCX3CR1+CD8+Tcellmhighlycyxicprolifertivetummicroenvirmentgle-cellRNA-equencgCX3CR1+CD8+TcellICBpderexhidctentdeceexpiDulSpecificyPhophte2(DUSP2)nuclerphophtecompdCX3CR1-CD8+TcellPeripherlhumnCD8+TcellDUPS2knockdown(KD)cedtumcyxicyvrowheovexpi(OE)tndedwrddecedectieffecrmoleculeGrnzymeBInterfergmmRecentpthveddillydocumentedcedvivti-tumcpcyDUSP2KOmicehvelooelymdecnectitweenDUSP2CX3CR1expi6roleDUSP2CD8+TcellICBpepecificllyctextnotyetexplodFurrmoignlgpthwyhumnprimrycellhveyetveledOurplimrydtedgoluncoverDUSP2mechnticroleICBpehopeppotgrpeutictrgetmyimproveICBperteThpropolvetigtehypoDUSP2expiCD8+TcellnegtivelygulteeffecrfunctipeICBThepropoedpecificimthpropol1)chrcterizeimpctDUSP2expiCD8+TcellICBpe2)determegulrymechnmDUSP2trncriptiCD8+TcelldowntmpthwymodultedDUSP2TodetermeimpctDUSP2ICBpetumizeketicwellCD8+TcellphenotypenlyzedCD8+TcellDup2cdilknockout(cKO)miceceivgtumICBjectiTheDUSP2ignlgnetwkuncovedpromoterpull-downygle-cellprilgRNA-equencgnlyehumnCD8+TcellDUSP2KDOEIdentifiedpthwymodulted(blockedctivted)humnCD8+TcellvrodmtrtipthwyhibirgtDUSP2expiubequentlymeudqunttiveveretrncriptiPCRweternblotflowcymetryCD8+Tcellphenotypedflowcymetrycludedtumco-cultucyxicyyThepropoedvivoexperimentexpoeDUSP2rolegultgICBpeUncovergDUSP2tercmehumnCD8+TcellcnprovidenoveltrnltillyignificnpptunyimproveICBpecologyptientlimedrpeuticlterntiveN-geneticcquidtncehenimplictedrpyfilumultiplecncertypeTheehveenignificnteftuncovermechnmgultguchdrug-tntcellulrttehowettemyperturdpromotecncercelldethcurbdeeprogiWhilehenmuchprogundertgchrcterizgdrug-ducedcellulrtteltleknownboutwhtctrolhernceettedughtercellUndertgherbilydrug-ducedttenlyuefuldetermedogfquencylocricldeigngeffectivecombttmentgimenExtgpprochechrcterizecelltteherncefllhtthgolcuefetuneededdefecellttecceibletemplwdowneededobervettetrniexceedglylgcellulrthroughputneededrobutlydouteffectytemticperturbtiprohibivelyhighHewepropoehernce-Seqnewmethodenblequntificticelltteherbilymeetneednpprochundertherbilydrug-ducedtteInhernce-SeqcomCRISPR-bedgeneticlegetrcgphenotypgmicrocopyuequencg(ISS)enbleclblemeumentphenotypehernceytemticpooledgeneticperturbtiexplomechnmphenotypictrherncecellInpropoedwkwedeignimplementgenerlfrmewkquntifyherbilycellttevlidtepermncehernce-Seqidentifygknownfcrgultgherncedrug-ducedmetbolicttechngeOVCAR8cellfollowgcrbopltttmentProjectSummry/AbtrctMottumnothomogeneourrcompdhighlydtctheterogenoucncercellpopultiAdjcentcelltummyhrbdiffentgeneticltertihvediffentphenotypeThucomplextummothnumirprtwhichctrieggivenemettticpotentildrugtnceThcomplexytrtumheterogeneymjchllengecncerrpyInctrtnmlcellwhichchromoomeeggtightlyctrolledmtdiploidchromoomeetcncercellfquentlyneuploidIndeedbnmlgloechromoomemgtmotcommchrcterticcncercellnerlyllolidcncerexhibgometypeneuploidyAhighdegetumneuploidylocltepoclicloutcomeAlthoughthtrgcltitweenneuploidycncerwellknownculltihipcompletelyunderodEpecillynmltuedurgerlytgecrcogenechromoomeeggtierrrtrnienteventnioulydifficulttudyTodvnceourundertghowchromoomeeggtierrdrivecnceridevelopmentevolutiheterogeneyenblenoveltypemodelytemexmpleexpleuploidyrpeutictrgetptient-derivedcncergnoidthpilotprojectpropoedevelopmoleculrimggolkobervemnipultechromoomeeggtidynmichighptiltemplccurcythe-dimenilmodelptient-derivedcncergnoidInAim1wedevelopmethodidentifycounttrckpecificchromoomedurgmultiplecelldivicncergnoidTwopropoedpprochevolveenduclee-dectivteddC9comdgRNActeuniquechromoome-pecificpectrlbrcodeugdC9imggpetiveDNAequencegenertechromoome-pecificfluocenceptternlg-termgolenblglivekryotypgcncergnoidugdeeplerngnetwkInAim2wedevelopthelterntivetrtegiectrolchromoomedynmictegryugopgeneticThepropoedopgeneticcturcludelight-ctrolledkecho-microtubuleterfcenopgeneticchromoometrpimmobilizepecificchromoomedurgcykephoctivtedC9producecentricchromoomermducechromothripTheeffectiveneetrtegieevlutedmmmryepililbtcncermodelgolundertghowcutelyducedeggtierrchromothrippecificchromoomeffectcncercelldynmictumevolutiPROJECTSUMMARYCurntcellexpniproceduntigen-pecificCARTcellCARNKcellultcellbrodperichemokeceprUpfuiymigrtef-tumhelthytueexertxicietrgetgntigenexpedtbllevelThebilyproducerpeuticcellffymigrtetummicroenvirment(TME)criclunmetneedThevetigtgtemmihrneimmuneytemttolidtumInlethmiobjectivethR611)developprotypebiocrelectivelycultuchemotcticllycompetentcell-bedrpie(CARTCARNK-92)2)demtrteuethubetmigrtgthroughtue-mimickgbrrierkillepililovrincncercellnntigen-pecificmnnerThertiletheftdruptttuquocurntcellmnufcturgtechnologywhichgenerterpeuticcelltrfficnlytumlohelthytueThetemcductR61projectundertwomilene-drivenim1)DevelopbiocrgenertgchemotcticllycompetentCARNK-92cell2)DemtrteutilybiocrgenertgchemotcticllycompetentCARTcellInfollow-R33temuebiocrcleupproductiechemotcticllycompetentcellrpiepcliclmouetudieTheimpctbiocrmkgttmentfer(migtgf-tummigrtirpeuticcell)fdble(ducgmnulterventicloed-ytembiocr)Migtgf-tummigrtiduceburdenmnufcturgcuemotrpeuticcellchtrgetTMEeTheignificncethprojectloupptedpplicbilyimmunecell(CARNKcellCARmcrophge)curntlydevelopmenttrgetgolidtumABSTRACTCARTcellimmunpyhprovenlurdecettgfrcryhemlogicmlignnciegexplodttmentolidtumHoweverolidtumpoeomeobviouuniquechllengeOnekeydiffencetweenleukemiolidtumleukemytemicwheolidtumhighlyloclizedHenceceleukemiccetrvenoulyfuedCARTcellircnceroutrgetnevernuebothkillertrgetgpent-defultmeloctiHowevercenrioquediffentceolidtumDtourlbhowmjy(80%-90%)doptivelytrnferdrpeuticCARTcellinideletgttedotloclizeolidtumprticiptenti-tumbttleOurtudiefurrhowCARTcellunenggedperipheryvirtuedefulttntigenicencounterexhibphenotypicpropertie(TCF1HiCD127HiCD62LHiPD-1Lo)functilpotentil(IFN-gHiTNF-HiIL-2HiGzmBHi)cliclmemyTcellwhennchmrkedgtgold-trdcutevirlfecti-ducedmemyTcellHencewepropoemobilizthervoirhighlyfunctiltgmemy-likeCARTcellperipheryolidtumwouldprovidefhcementenhncedtumctrolcedynergycheckpotblockdeimmunpyToddthhypoAim1weengeertum-ducibleproductichemoketrtumlCARTcellerveloclizedcloctgfunctillypotentCAR-TperipheryenhncgtumctrolIntrtumljectiecpicexpichemokegeneticmodifictumcellhenhownceTcellfiltrtumctroloverllurvivlrtepclicltudieHowevertrtumljectinotfeiblecceibletumhthlf-lifechemokeneceteimprcticllyfquentjectiOvercomgechllengewepropoeuniqueCARbioengeergtrtegyInolidtumwhentigentrictedtummicroenvirment(TME)utiliztiNR4Apeelement(NRE)cettectivtedCAR-TcellignlgpromoteloclizedhighlypecificmechnmcgchemokelevelpecificllyolidtumInAim2wequeryimpctloclizedtrtumlchemokeexpiCARTcellpivenePD-1checkpotblockdeimmunpyThewkghypothimchemoke-mededctuedcrumentfunctilmemy-likeCARTcellperipherytumbuildtrtumlpoolleexhutedCARTcelldilypivecheckpotblockdeloprovidemocduciveimmuneenvirmentSuccefulcompletiepcliclpro--ccepttudiepvewyeydpttiduciblechemokeexpicetteextgCAR-TrpietrnmclicloutcomevrietyolidtumPROJECTSUMMARYThevergemokerttemptqumokgtlet30timeebtg12mthlgerTheettempttypicllyoccuroverdecdemokgcrcogenxicntexpouultg480000dethnnullyAhighlightedSurgeGenerlRepthelpgmokerwhocnnotqumokgwchlehrmfuln-combutiblenicote-ctgproductuche-cigttehpotentilducethhelthburdendrmticllySubtutge-cigttecombutiblecigttemighnlypoiblepertentmokerife-cigttecceibleppelgHrmductipropenthvedvoctedctuedvilbilye-cigtteflvppelidcigttemokerunblequtrdilmethodYetnopropectivetudieeffectflvilutedwchgcombutibleelectriccigtteCvergglbryepidemiologiclcliclerchuggetfru-flvode-cigttenicotemyvibleubtutecombutiblecigttemgpertentmokerThepropoedtudyeeknwertwovelquetilevntpublichelthgultie-cigtteflvgFirtdopertentmokerubtutefru-flvode-cigttemodilythntrdil-flvode-cigtte(bccomenthol)combutiblecigtte?Secdfru-flvode-cigttemowrdgcgthntrdil-flvode-cigttedoeeffectfciltewchg?Thepropoederchfillegpevidenceberomizg210pertentcigttemokerix-weekgimenfru-flvod(FFwtermelbluerryn=70)bcco-flvod(TFn=70)menthol-flvod(MFn=70)e-cigttetween-ubjectdeignBelemokgrteetblheddurgdy1-5Afterbiochemicllyverifiedovernightcigttemokgbtencelbryvdy67eflv-ocedubjectivewrdcgvlueflvode-cigtteltivecombutiblecigttePrticipntnwchcigttemokge-cigtteueixweekPrticipntcollectpentcigttefilterdilyecigttemokedperdy(cpd)ifymokeTheprimryoutcomemeulgudldilycountcigttebeleendix-weekwchperiodcigtteperdyt6-mthfollow-upecdryendpotThtudylignNCIpriieoutledNoticeSpecilIntet(NOSINOT-OD-22-023)erchhowENDSuefluencemokg(egquttemptutedbtencelpe)ProjectSummryChromtctextdefellDNAtrnctigenegultigenomemtennceChngechromtcompoihllmrkcncercellctriemlignnttrnmtihveentudiedextenivelyugwiderngeNextGenertiSequencg(NGS)pprocheHowevercventilgenome-widemppgeftlimeddetectidividultrgettetimpedgtudyirtendiverebiologiclroleMulti-ubunchromt-gulrycomplexewellproteterctihnencniclnucleiccidtructulrgelydefedthroughcltivenlyeeprtemppgeftwhichunbledetermephyiclterctiproximymeDNAfrgmenrevenpencemecellTheelimtiunderlenurgentneedimprovedctext-dependentchromtmppgchrcteriztieftInthpplictiweetblhvertilebrodlypplicbletechniquellowgenome-clenlytwo-compentterctichromtThepropolbuildourexteniveexperiencetudygenome-widechromtpeDNAdmgewellexperteco-InvetigrDrMichelSeidmnnlyvulizticloe-proximymoleculrterctictextDNAplictitAim1comthcomplementryexpertedevelopProximy-bedChromtImmunopcipti(ProxiChIP)olchrcterizefunctilubetgivenchromtfetubedterctgprtnerhiftgcurntChIPprdigmwrdcombrilfetumppgUgwell-chrcterizedterctgchromtbdgproteproprciplewecvertmethodcurntlytrictedimgg-beddetectiprotetercti(proximyligtiyPLA)brodlypplicblebiochemtryolubleimmunopciptidivereetdowntmpplicticludgNGSInAim2wepplythmethodologydvnceepigenomicchrcteriztipthologiclRNADNAhybridcomplexpolyunderodfetumnycncergenomethoughtctrieDNAplictitcncergenometbilyrpypeRNADNAhybridhveenmppedgenome-wideugDNARNAimmunopcipti(DRIP)ltedmethodHoweverextgpprochefildtguhtweenphyiologiclpthologiclRNADNAhybridubetProxiChIP-bedmppgRNADNAhybridctextplictitexpecteddefegenomicfetuunderlypthologiclRloopmtiwhichpentneentiltepwrdundertgirimpcngenometegrymlignnttrnmtiABSTRACTOf6500knownrdeelybout5%hveUSFoodDrugAdmtrti-pprovedttmentIncncerrtumccountpproximtely20%cncercidencetenlcketblhedrpeuticgimenHenceggmoleculrundertgrtumkeydevelopmenteffectiverpieThmulti-vetigrpropolvetigtecogenicmuttictivteprotekeA(PKA)promotedefectivecellignlgrendocheptictumTrgetedrpeutichvetrnmedcptientrcncertrgetgcogenicmuttiprotekePKAc-drivencncerchllenggtrgetthwycuethbrodpecificykectrolmyridphyiologiclproceeCequentlyelectivePKAchibirhveenlegtedroleolcompoundrrthnclicllyvibledrugThulterntivetrtegiemutdevelopedttPKAc-drivencncerOurplimryprilgcogenicPKAcmutntprovidecompellgevidencePKAcenggedowntmprotekeccdeimpcttrnltidnlheptictumWeloobervedcedmRNAtrnltinemergghllmrkePKAcdrivenmlignncieTheefdghvegedwkghypoPKAc-drivencncercnttedtrgetgdowntmeffecruchRNAheliceeIF4ArrthnglobllyblockgctlyticctivykeThepecificimtetrnmtivepme1)ProteomictrncripmicprilgcellexpgcogenicPKAcvrintunderlieCrneycomplexCuhgdenomfibrolmellrcrcomelucidtedowntmignlgelementimpgemRNAtrnlti2)MoleculrpprochevetigtenewpropertieimprtedDNAJ-PKAc-chimerickefibrolmellrcrcommycfertncechemicllyducedpop3)ClicllylevntcompoundnovelbivlenthibirdectmechnmeIF4AdependencePKAc-drivenmlignncieptientderived(PDX)modelfibrolmellrcrcomThpropolnlybuildolidfoundtiPKAcerchlofdnunprlleledopptunydcoverdevelopvlidtedrugtrgetgroupptientdineedPROJECTSUMMARY/ABSTRACTMgultinucleop(NUP)eentilctuentnuclerpocomplexe(NPC)dyfunctiN6-methyldenoe(m6A)ignlghveendividullylkedcncerAlthoughhenptedNPC-mededmcromoleculrtrnptcoopertem6AmodifictictrolmovementmeengerRNA(mRNA)outnucleuctriiuchcoopertipthogeneprogicncermobcuOurproteomictudyNPC-ocedccrveleddictterctitweenm6AmethyltrnfereMETTL3eNUPproteclledNUP93everlcncercelllecludgprottecncer(PC)AlthoughechprotehendictedvolveprogiometypehumnmlignncieirfunctimoleculrmechnmctipolyunderodPCletleirterctiOurimmunohchemtrynlyhowedbothMETTL3NUP93proteupgultedmettticctrti-tntprottecncer(CRPC)lethlmdeecompdprimrytumirnmlcounterprtDruptgMETTL-NUP93complexgeneticmuttiiduemedgerctibrogtedprolifertimigrtiCRPCcellTheeultuggetMETTL3-NUP93complexmyplynimptntrolePCprogictrtitnceunderlygmechnmwthyfurrvetigtiCidergbothNPCm6AmcheryctrolnucleocyplmictrnptmRNAwepermedfrctiRNA-eqidentifymRNAmoleculewhoenuclerbundncechngedupknockdownMETTL3NUP93PCcellAlrgegroupmRNAweignificntlytednucleibothknockdowncelluggetgMETTL3NUP93cogultenuclerexptemRNAThemRNAcrgoMETTL3-NUP93complexpfentillymethyltedllowgmelectedcomplexviociMETTL3IntetglyubetemRNAcrgofunctillyvolvedbioynexhmerogenwellknownctivtemdriverPCprogirogencepr(AR)Indeedovexpiwild-typeMETTL3NUP93notmutntmterruptgnewmRNAtrnptpthwycetrcellulrrogenlevelPCcellupgulteexpiARtrgetgeneevenoutddiligcferrogen-dependentgrowthPCcellimplygdevelopmenthme-frcryphenotypeAlleeffectcnllevedphrmcologiclhibirteroidogenicenzymeencodedtrgetmRNAMETTL3-NUP93complexSoourhypoUpgultiMETTL3NUP93promotePCprogifciltgnuclerexptmRNAubgroupwhichencoderogenbioynenzymetriggerctivtiARignlgCRPCInthpropolweddthemechnticllyclicllyimptntquetifieldRNAmethylticncerbiology(1)HowMETTL3-NUP93complexelecttrgetmRNAexpedeirnuclerexpt(2)HowmRNAexptmededMETTL3-NUP93complexchetrteARctivyunderctrticdi(3)HowwecngeneticllyphrmcologicllyblocknewmRNAtrnptpthwyttCRPCWelevergeourexperiencegenome/trncripme-wideprilgm6A-edgolwellthurcollbrhigh-olutimicrocopyetblhmentpcliclmodelelucidtefuncticrotlktweenNPCm6AmcherycncerexplomechnmunderlygdevelopmentCRPCugcellulrnimlmodelThefive-yerurvivlrtemettticbtcncer(MBC)mlethn50%nerlyllptienteventullyuccumbdeeeundertgpro-mettticmechnmdjuvntrpytntbtcncer(BC)mcriclunmetneedfieldOurlg-termgolelucidtedptivechngeenbleBCcellpertcurmettticdeevelnewrpeuticvulnerbilieThetrdcdjuvntrpyetrogenceprlphpoive(ER+)BCpotmenopulwomen(motcommmdee)etrogen(E2)-deprivtichievedthroughromtehibir(AI)AIrpyblockcverirogenE2effectivelydecgE2producticecircultgtr-tumlrogenTheRicherlbryhpublhedextenivelymechnmwhichrogencepr(AR)terctdrivgpthwythemBCubtypeRecentlyYulbrydependentlydcovedARuppttumcellurvivlundercellulrtcurdE2-deprivti(imultgAIrpy)ctiveoxygenpecie(ROS)curdnchgedependencemyfciltelpemettticdeeIndeedtwolbdependentlydcovedARfurrelevtedBCcellERhotpotmuttiexcluivelydetectbleMBCfollowgtnceAIrpySceurvivgE2-deprivtirpynchgedependencecriclmettticprogiER+BCundertgroleARecdihighlylevntMBCItknowncriclbrriercircultgtumcell(CTC)urvivldurgmettovercomehighlevelROSnchgedependentcdiTheedtledourhypoARpromoteductiROSCTCurvivlpromotemettWecomexperteARignlg(Richer)mett(Yu)uemutntERBCcellleptientderivedCTCleptientderivedxenogrft(PDX)muyngeneicmodeltetfollowgimWeevluterolemechnmARupgultidurgetrogendeprivtinchge-dependenturvivlERmutntBCcellexmgROSlevelimpctedARctivyARbdgpriledowntmtrgetvrowellmechnmARupgultinchgedependentcdi(Aim1)WeexmectriimechnmARmededpro-mettticignlvivovievlutgimpctARhibimettticpotentilmutntERcellARlevelCTCmettwellbdgprileARroledowntmtrgetpromotgmette(Aim2)ThpplictiimeddetermehowARupptERmutntBCttecurddurgmettticprogigoldevgtterrpeutictrtegieducemtlyMBCThegoltherchchrcterizeR-drivenKSR1-dependentmechnmmodultetumidrugtnceepilil--meenchymltrni(EMT)coloctlcncerTumgcell(TIC)ubpopultumcelldefedirbilyelf-newgenerteentiheterogeneoutumpopultilievedervoirdrugtntpertercellEMT-likehvictrietumivimettPrtilverlEMThybridtteneceryefficientTICmtimettticcoliztiInturnTICloeclogenicyelf-newlcquivivehvimeenchymlcelldriveirdemtiWhiletercverumcellmigrryvivemeenchymlcellelf-newgTICnecerymettltleknownboutmechnmdicttumcelltweenephenotypeWecomdtrgetggeneencodgkeyeffecrRignlgpolyomeprilgcomputtilnlydcovermoleculrcffoldKSR1medetnceclicllypproveddruggulteTICmtiEMTviRNAbdgproteSRSF9OurplimrydtuggethypoKSR1-dependentignlgKRAS-muttedCRCpromoteplicgtrnltimRNAcriclCRCtumidrugtnceEMTUggeneticllymodifiedCRCgnoidmouemodelcellynergticexperteourtemchrcterizeenovelpthwyctrollgCRChvivrovivo1)ChrcterizgKSR1-dependentpthwy()necerytumitnce2)DefgKSR1-dependentmechnm()drivgcellprtilEMTwrdvivemeenchymlhvi3)DetermghowKSR1-dependentplicgpromotetrnltiprotecriclEMTCompletherchvelnovelmechnmmytrgetedimproverpeuticpehibtumimettABSTRACTWhnerly45000ctlcncerdignoed2023mjcliclquetetidentificthoeptientwhochieveutedcliclcompletepe(cCRnodetectblemcrocopictum)truepCR(pthologiccompletepeveryfew/notumcell)Whcentcptioptiuchtlneodjuvntrpy(neodjuvntchempychemdi)ecompletepderptientcncompup~50%popultiIfetruecompletepeptientcouldliblyidentifiedycouldvoidmjcomplictictlecti(nmoticlekgepelviceputericjury)quly--lifeue(permnenmyfeclctence)noimpcniroverllurvivlHowevernovlidtedobjectivedignoticcreri(ugendocopyMRIdiglctlexm)erum/blood-bedmrker(egcrcoembryicntigenCEA)cefivelyidentifytruecompletepdergn-pervgtrtegien-opertivemngementctlcncerQunttiven-viveimggmrkerccurtelychrcterizepthologictumgictlcncerfterneodjuvntrpycouldhugelyimpctfulelectgcompletepeptientwhocnfelycommendedgn-pervtivprtil/n-pderwhoquiurgeryTopecificllycptuubtlepthologiccueMRIultgdemoplticfibrotumpefterchemdi/TNTwehveidentifieduniquecomputer-extrctedimgefetugrdientpemphologicldruptilei(wlltum)peri-leienvirment(lumenperumlft)ThR01buildeexcgfdgdevelopvlidteRdiomicTumRepe(RdTR)clifierccurtelyidentifycompletepderfterneodjuvntrpyctlcncervirouteMRITheRdTRclifierddillycptenovelptildiverydecriprcptumcro-cletuegniztitromlcompoibiologiclhllmrkcompletepeUgmulti-tutilcoht~900ptientourvlidtiRdTRclifierfocuthekeycreri(i)ToenblecliclterptbilywecductdetiledhmphologiclevlutiRdTRfetuviptillymppedMRIwhole-mountctlpthologypecimen(ii)FcfirmgdignoticlibilyRdTRclifiercomphenivelycompdgtcliclevluticreri(endocopyMRIdiglctlexm)wellmulti-dertudycfirmpermnceimprovementidentifygCRviMRI(iii)TowrdenurgequypopultipermncefutuclicldeploymentRdTRclifiervlidtedcromultipletutipopultiugntilclicltrilcohtTNTctlcncer(NRGGI-002)Toclicllyctiblecommendggn-pervgttmentctlcncerRdTRmodeltrget50%improvementenivyidentifygcompletepewellenurg95%pecificyidentifygprtil/n-pCRptientneedgurgeryPROJECTSUMMARYSenecencelikepopnetblhedtumuppivemechnmprotectgtcncerdevelopmentducgutedprolifertivertApopenecencecommftecncerrpybothctriecliclpeWhencncercellceivelethldoecncerrpeuticytypicllyexecutepopCverelycellulrdmgeultub-lethldoeduceenecentfteAlthoughrpietriggertbleenecence(pro-enecent)neficilcueyuppprolifertienecentcncercellcnumeprolifertenmobiologicllyggivefetuedurbilyenecencenimptntphrmcologicpropertyWehvedeignedynizedcgenertxne-etubulmolecule(+)-dcodermolide(DDM)potentlyducecelldethANDenecencetxne-frcrytriplenegtivebtcncermodelPleglyenecentphenotypeducedenlogignificntlymodurblethnpntmoleculeTxolcyxicdrugimprovgpotentilprolgednti-tumefficcyUgX-rycrytllogrphywectueevolvechemtryDDMtterenggeundexplodiduetxnephrmcophoddwherdiffentiloccuptiDDMcgenerimpctphrmcologycellftemetbolictbilyWelogenertefluocentDDMmoleculetrckdtriilgevyDDM-tbilizedmicrotubuleugtime-lpeimggMultiplexeddoe-pemodelgtxne-frcrycncercellleprimrilyguideelectiledDDMmoleculevivlyeInAim2weueX-rycrytllogrphyCryo-EMdecipherDDM-tubulDDM-microtubuleterctiledDDMcgenerTheeultfeedbckAim1guidemoefficientchemicloptimiztipotentillyprovidemechnticightdurbleenecenceDDMmoleculeInAim3weevluteoptimldogvivofetyledDDMmoleculeC57BL/6micefocughemlogicneuropthichvilmetricwellhpthologicnlyeAnti-tumofficcymodelTxol-tnceugptient-derivedbtcncerxenogrftloevlutedThterdciplrycollbtiveprogrmemploychemiclyntructurlbiologyphenotypiccengtcticdevelophighlyefficcioumetbolicllytbleDDMnlogmobilizebothpopenecencecellftemximizetumuppivecpbiliePROJECTSUMMARYWepropoennovtivepprochntgizerogencepr(AR)dplygARligpepidcffoldThnewfmilymoleculeclledmultivlentpepidcjugte(MPC)potentlypgrowthprottecncercelltntttmenttrdnti-rogengentuchenzlutmidePepidmllprote-likechunlikepolypeptideyproteetntthuexhibimprovedphrmcologictbilyfvbleolubilycellpermebilychrcterticmkgmnttrctiveoptidrugdevelopmentOurpublhedplimrytudiehowMPCdeterprottecncergrowthntgizgprolifertivepeARWepropoeMPCpromotenovelARcmtidrivediffentptternAR-mededgeneexpicompdDHTzlutmideultgblockcellprolifertigloARoccupncytelectgenomiceWepermChIP-eqRNA-eqChIP-mpecidentifyMPCtrgetgenecogulryfcrctrollgirexpicompdenzlutmideDHTenzlutmide-tntcellInddiMPCcnpromoteimmunecellfiltrttedxenogrftprottetumwhichcouldpotentecyxicTcellpeenhnceefficcyimmunecheckpotblockde(ICB)llowgptientimmuneytemfighttumgrowthThedequcyvilbleimmunecheckpotblockdetrtegienobtclettgdvncedprottecncerWedetermewherMPCcnpromotenti-tumimmunyenizetumICBttmentTheengolthpropolewherMPC309cnynergizeICBntibodiettgCRPCWelocductX-rycrytllogrphytudieetblhmechnmctiMPC309ARThprovideightmoleculrterctitweenMCP309ARuedguidedeignmopotentelectiveMPCoptimizedARntgmThuMPCcnpgrowthprottecncercellhvedptedttmentdevelopgdrugtncehvepotentilleddevelopmentnoveleffectiverpieptientdvncedprottecncerGlioblm(GBM)motlethlllbrmlignnciemnyptientdieeyerdignoTheepooutcomedrivenGBMggivegrowthloclvibothdenovpiddevelopmentrdipychempytnceGBMuelterntiveplicggenerteuniquemRNAprotepromoteprolifertiviHewevetigtepecificlterntiveplicgprogrmtetifirmnipultihpotentilvelnovelrpeutictrtegieoppoeggivebiologythdedlydeeEtrogen-ltedceprt(ESRRB)nphnnuclercepr-notboundetrogenUpgultedexpicedESRRBgenecopynumrbothocedlgeroverllGBMurvivlThet2mESRRBproducedlterntiveplicgcurntevidenceimplictge/rge-richplicgfcr6(SRSF6)keydrivertheventBet2ctivtiynticESRRBgtDY131ducepopGBMcellBet2loclizecyplmterctctctnctbdgprotececellmotilyctrollgctmodelgveicletrffickgImptntlyynticESRRBgttbilizet2/ctctterctiledgloGBMcellmotilyeffectwepropoelkedntumeffectt2Inthpropolwehypoizet2mESRRBctpotenthibirGBMterctgctcthibmotily/viWefurrpropoephrmcologiclupgulti/ctivtit2myultimtelyfernovelpprochGBMrpyInSpecificAim1wetetifSRSF6promoteESRRBplicgcet2expilevelifdictupgultit2SRSF6hibGBMmotily/viWecomplementefocuedmechntictudietetgtwovelplicgmodulrydrugirbilycet2productiGBMInSpecificAim2weidentifyhowt2/ctctterctihibGBMmotilySpecificllywetetift2uppeGBMmotilyhibgctct-mededctbrnchgmodelgveiculrtrffickgGBMInprllelwepermnundcenidentifynovelcyplmicbdgprtnert2tetirroleuppgGBMmotilyWhilethgrntfocuedfoundtilmechntictudieyprovidepowerfulpcliclevidencefutunovelrpeutictrtegyGBMThelg-termimpctuccefullyetblhgnewttmentgimenupgultectivtet2wouldmjneffieldwhich1)curntfirt-letrdc(urgeryccurnttemozolomide+rdipydjuvnttemozolomide)hmedeentillyunchngednerly20yer2)nowidelycceptedecd-letrdcABSTRACTGlioblm(GBM)hcomplexfiltrtgtummicroenvirmentwhichextendwellydvibleenhncgtummrgplyubtntilroleGBMcurncepooutcomeUntuntelybencepceptilmptumextenttendifficultdiffentefiltrtgtumvogenicedemcliclMRIdurgrdi/urgiclplnngTheunttedfiltrtgtumultimtelyctrieover90%GBMcurnceAnequllypgchllengedifficultydtguhgcurnttumttment-effectfollowgchemdiDuehlogicllydiverelcpepot-ttedleittment-effecttenco-exttumcurncemimicppernceimggInbencelibleol15-20%ptientGBMcurncecctlydignoedduemplgerrocedtrcrnilbiopyThudevelopgn-viveptilmpGBMtumextentcnliblyidentifyfiltrtg/curnttumcfoundgpthologie(ttment-effect/edem)hveignificntimplictirdi/urgicl-plnngpot-ttmentmngementRecentlywedevelopedRdiomic-Imge(Rd-I)mptumextentuecomputtilfetucpdgmicro-rchecturlimgemeumentdderlocltenygrdient(iegrdiententropy)TheilveriRd-Imphenevluteddtguhcurnttumveruttment-effectpot-ttmentGd-T1wMRIn85%ccurcyn=75tudiedtguhfiltrtgtumveruvogenicedemp-ttmentMRIcn94%ccurcyn=42tudieInthR01projectwepropoeimproveourilveriRd-Impcptg(1)ddilnmicl(T2wFLAIR)functilMRequence(perfui)(2)novelleicomplexyfetuwhichcptugniztilchngetuecompoivigrph-oticpprocheMRIcnOvercomglimtipertgmllcohtlckptillymppedex-vivohlogyvlidtiRd-Impextenivelyvlidted(1)lrgemulti-tutilMRIcohtco-loclizedhpthology(2)PRESERVEclicltrildeignedcptuGBMheterogeneyvimultipleco-loclizedtuemple/leiTheecohtlollowetblhgociournewrdiomicfetuunderlyghlogicl/moleculrtumchrctertic-pqueclicldoptiLtlyRd-ImpevlutedtumbdurveyddclicllychllenggproblemdtguhgcurnttumveruttmenteffectCreriucceRd-Impytletn-fericcurcyteotcticbiopie(85-90%)identifygtumnichecpdg()vible/filtrtgtumvedem(b)curnttumvttmenteffectMulti-tutilvlidtiend-uer(tumbd)feedbckfurrcfirmutilyRd-Impnvivelterntiveurgiclbiopiepvgwyrdi/urgiclpot-ttmentmngementGBMtumProjectSummryDruptinmlmichdrilbioenergeticoxidtivephophyltipentnerlyeventdurgcogenechnggenergymetbolmpcnceroucnceroucellPhenethylothiocynte(PEITC)nturlcompoundpentcruciferouvegetblehenhownhibdevelopmenteverltypecncernimlmodelPEITChenhownhibixidtivephophyltiducecncercellpopthroughmichdri-dependentmechnmROSmtiuggetgrolemichdrilbioenergeticfunctidoxhomeotcogeneThprovidertilecjugtgPEITCtrgetggentdrivemichdripecificllytudyrolemichdrilfunctiROSmtilungcncerdevelopmentceefficcyPEITCPlimrytudiedemtrtemichdri-trgetedPEITC(Mi-PEITC)ignificntlymopotenthibirlungcrcogenemiceWehypoizelungcogenemettdependmichdrilpirtiMi-PEITCnovelpotenthibirlungcrcogenemettctgprimrilythroughmichdrilmechnmThhypotetedugthepecificimAim1evlutepventivepotentilmechnmctiMi-PEITCvroWeueMi-PEITClungcncercellgeneticllymodifiedexpimemrmichdrilelectrtrnptchdeciphercogenicmechnmevlutemechnmctiMi-PEITCAim2determepventiveefficcyMi-PEITClungtumiprogiA/JmiceAim3determevivomechnmefficcyMi-PEITChiblungcncerbrmettWeuette---rtvrovivoycludgmllnimlimggtechnologymirgrowthprimrytum(mgneticnceimgg)engrftmentmettticcellInnovtivepprochevivomirgchngecncercellbioenergeticcellulroxidntproducti(biolumecenceimgg)employedDefgmichdrilmechnmlungcogenebrmettdevelopgnovelwell-lertedefficciougentpventtmentlungcncerhighlyignificntPROJECTSUMMARY/ABSTRACTPromotghighqulycommunictieriouillnepgntilpriyHowevertrdilpprochemeurgcommunictinturlcliclettgcumromeexpenivenotcfidentiltime-cumgInderundertdemteupptcentivizehighqulycommunictiweneedmeumentmethodcncledlrgerclicltudieroutehelthervicequlyptgThpropollevergeextrdrydtwehveurdpolourtemexpertemchelerngumticllymeufetueriouillnecommunictiqulynturlcliclettgWefocuepodeCnectilSilencethccurtweenclicinptientcueemomentmrkereffectiveltengenggedhddeci-mkgcompepenceThePlliveCCommunictiReerchInive(PCCRI)multi-ecohttudydiverepopulti240hoplizedptientdvncedcncer54pllivecclicinPrticipntpentdiverygegenderrcilethnicbckgroundligiouffililevelfncilecurylguticperiperlyttmentpfenceThecohtdtclude363udio-cdedpllivecptientcultticomprgmothn10000mutecverti180000pekerturn14milliwdWehvecompletedfollowgPlimryStudiepprthpropoedwk()developedupervedmchelernglghmidentifyover28000cvertilpuepekgmidnoyhoplenvirment(egoxygenmkIVpumptelevihllwyvoiceetc)(b)developedlibleHumnCodgpprochidentifygCnectilSilencedtcttypecvertilpue(c)uccefullytdplimrydeepneurlnetwkbothlexiclounddturroundgpuePCCRIdtOurtemwellpoiedovercometrdilbrrierdictmeumentcommunictiqulyhelthcettgdvncemchelerngtechnologynlycliclcvertiultimtelyimprovecommunictillerioulyillpeopleWepropoecompletefollowgovertwo-yerwrdperiodAimOne)trDeepNeurlNetwkuelexiclfetuimmedeurroundgcverticcurtelydtguhmomentCnectilSilencetypepueAimTwo)Ugde-identifiedpectrlimgeoundurroundgcvertilpuedevelopntegrteddeeplernglghmuebothlexicproodypeechdtdtguhmomentCnectilSilencetypecvertilpueExplryAim)identifyfetucommunictiurroundgCnectilSilenceocedptientfeelgmoHerd&UnderodProjectSummry/AbtrctThpropolfundnetblhedpot-docrltrgprogrmclledColumbiCncerReerchTrgProgrmReident-Invetigr(CAPRI)focuedtrgphyicin-cientttrnltilcncermedicetColumbiUniveryIrvgMediclCenter(CUIMC)Overpt5yergogtutiluppurCAPRIprogrmwehvetd11ident-vetigr(RI)6diffentclicldeprtmentcludg2identunderpentedmized(URM)bckgroundFthubmiweexpCAPRI24RIperyerwefoculrgetidencyprogrmmjynothvgbuilt-erchyerWehveuccefullycruedidentmultipledciplelevergedourceHerrtIrvgCompheniveCncerCenter(HICCC)tCUIMCcludg36NIH-fundedfcultybicclicl/trnltilpopulticiencerichtrgenvirmentWhgogexpnitutilcommmentcologywehveddedover20dependentvetigrourpoolerchpcepr(RP)whoprovidedictuperveThroughnewlederhiptCUIMCmticerchourCncerCenterfocupcimedicecncerhelthdprieRecentiveuchHICCCCncerReerchTrgEductiCodti(CRTEC)coprovideddilopptunietrgcerenhncementctivieident-vetigrIndercediverycdemicwkcewehvepecificllyddedCommteeDiveryEnhncementfotereeftCAPRITheprciplimCAPRIprovidecomphenivetrgdeigncducttte---rterchhighlymotivtedphyicin(MDMD-PhD)dedictedcdemiccercliclcncermediceWhnemphmulti-dciplrytemcienceourgolfciltedevelopmenttrnltilercherdrwn5CUIMCidencyprogrmcludgMedicePthologyPedricRdiOncologySurgeryCAPRIprovideRIdvncedkillnecery1Deigncductrigouhypo-drivenerchencompecncercctuumpventicengdignottmenturvivhippllivecgolducgmbidymtlythdeeducghelthdprie2Trnltepromgp-cliclobervtilfdgcncerclicltrilpropectivelyevlutebiologiclcliclendpot3Cductcliclcncererchmulti-dciplrytemettgwhichphyicin-cienttbiccienttpopulticienttcollbteterctexpedeccelertetrnltierchfdgcliclettgOurfocutrnltinovelmicrocopypprochfemecdpump-promicrocopywhichourplimrydthowcndetermewhich(nomlly)erly-tgeprimrymelnomtedmettticcncerThimptntcuecurntcliclgoldtrdtgg(hpthologyentellymphnodebiopy(SLNB))cnignerly(n-metttic)tgetumwhichlymettticcncerwhichdelyttmentcotliveInfctmopeoplediemelnomfterilStgeItumdignothnfterdignonyhighergrdeTodydjuvntrpiehvemdegttride(lte-tgetum)llFDA-pprovedrpietrictedmetttic(tgeIIIIV)melnomcueignificntttment-lteddvereeventcommWelievedjuvntrpiecouldmoeffectivelexicifpplieduppoedlyerlytgetumwhichhveldygenertedundetectedmetteSucherlydjuvntrpycouldhvegtnefdeectrolducedxicyducedhelthcotthquigoodmrkerdecidgwhicherly-tgeptienthouldgouchrpyextgmrkerhvelimedvlueOurplimryulthowwecnidentifyuchptientpump-promicrocopyTheultimtegolrouteidentificticctlyclifiederly-tgeleitlettgeIIB/CpferblyerliertgewelloptientcnttedterruptdeeprogiSpecificAim1focueoptimizgmulti-prmeterpump-proimggccentrteclicllylevntctrtThepprtudeignfetumodultichemekeepppliedpowerctntwhiletgcompletectroloverpulepolriztidelypludetectichemengulrolutiDemtrtitrtmelnmodelytemmelnomcellmovebiopiechrcterizgdictilpolrizticompentpump-prodecymximizeignlcltichemiclcellulrmelndegrdtiSpecificAim2focuemximizgdignoticutilyugptientbiopieDukeBiopoirytropectivelydignoemettticmelnomtetpermnceimprovedclicllylevntctrtThwkcloelycnectedpthologyweviewtechnologycomplementgextgdignoticprocolBedourveryencourggplimryultmchelernglghmpylrgeroleourementdignoticutilyWeexpectdemtrtetletStgeIIB/IICtum(7000ceyer)pump-proimggcnliblyegmentthpopultiidentifyptientwholmotcertlyneedttmentydexciPROJECTSUMMARYInUnedSttecoloctlcncer(CRC)mtlymrkedlyhigherAfricn-Americn(AA)ptientthnnyrcilethnicgroupTtmenptiocioecomicttu(SES)combidietumchrcterticctrieurvivldprieTumchrcterticfocuedmetbolmmicrobiologyhveenrlytudiedltiCRCmtlyrcil/ethnicgroupthuquifurrvetigtiMetboleubtrteproductmetbolmquidtumcellgenegultigrowthimmunepeTheycnmodultemetbolmefficcychempeuticdrugelkedCRCttmentpemtlyrteDiffencelifetylefcr(iedietphyiclctivy)ocildetermnthelthenvirmentlexpouexttweenrcil/ethnicgroupffectmetboleproductiCRCInddicolmicrobiomemjmodulrmetbolehenimplictedCRCGivenmetboleuceptiblemodultilifetylefcrdiffertweenrcil/ethnicgrouptumchrcterticctriedprieCRCmtlywehypoizediffenceCRCmetbolemicrobiometweenrcil/ethnicgroupccountdprieclicloutcomeOurobjectiveddlckknowledgethpermgdcoverymetbolomicpprochidentifylientfetuCRCmetbolmhentrceWeloexmehowmicrobiomemetbolomechngedurgctuumCRCcocettmentpeffectedSESInpecificim1weueuntrgetedmetbolomicmetbolicpthwynlymoleculrnetwkgpprocheidentifyCRCtumtuemetbolepecificAAtrtifictiextgeSESThgenertefirtevermetbolicigntuCRCAAcludeexogenoumetbolederivedenvirmentlexpoumicrobiomeFpecificim2weidentifyimpcturgerychempeuticttmentCRColmicrobiomeWeidentifymicrobiotuniqueAAptientdetermeiffcrltedSEScludgdietphyiclctivybodymdexmycfoundthociWeultimtelydetermehowpettmentdiffertweenAAn-HpnicwheptienttterundertmechnmcedmtlyAACRCTheimmedeoutcomethpropol1)genertifirtmetbolicigntuCRCrce2)identifictinovelmicrobilenvirmentlmetboleCRCrce3)firtchrcteriztimicrobiomemetbolechngetcruciltimepotlgctuumCRCc(egdignourgerychempy)ociSESThdtgenertenewhypoegrdgtumchrcterticcnceroutcomeOurlg-termgolimproveptienutcomeidentifygkeymetbolicpthwymicrobiotdiffertweenrce/ethnicySESmyexploeddevelopmentmoeffectiverpeuticterventiPROJECTSUMMARY/ABSTRACTTheburdencncerrgAfricmtlyrtehighAmjy(70-80%)ptientpenttdvncedtgecncerccurubtntilfncilcotfmiliehelthcytemEvenpotentillycurbleptienteffectivettmentdeliveryhmpedlowdhencetenticInthctextptient-centedcommunicti(PCC)fernimmedeopptunyimprovettmenutcomeoptimizeourceutiliztilleveuffergPCCmenpdgdividulptientperpectiveneedvolvgptientdecimkgprovidgemotilupptPtientclicinmnyAfricnettgcludgRwhveidentifiedcricldeficPCChveclledculturlhiftwrdptient-centedcEmpowergptientthroughptient-ptedmeuclicinthroughcommunictikilltrghpotentilbrodlyimpctfulimprovementPCCAkeybrrierprogPCCerchAfricncncercbencectext-ppropremeucommunictiqulyCurntlynomeucliclcommunictihveenvlidtednAfricncncercctextThpropolddethgpdptgvlidtgpilotgptienturveycommunictiqulyRwSpecificllyDrDeBoerim(1)dptnextgptienturveyPtient-CentedCommunictiCncerC(PCC-C)bedputRwntkeholder(2)etblhpychometricpropertiedptedPCCptienturveyRw(3)cductfeibilypilottrildptedPCCptienturveyevlutecommunictrgterventiclicinRwTochieveeimDrDeBoerlevergeherextgerchprtnerhiptButroHoplRwherpriwkdptgPCCclicintrgterventiRwnctextThepropoederchultctext-ppropremeucnuedevlutePCCclicintrgterventifutuR01cluterromizedtrilRwThK08wrdupptdvncedtrgimplementticiencecerdevelopmentgloblcologygnizedroundfourtrggol(1)tkeholder-enggederch(2)progrmevluti(3)terventiltrildeign(4)cerdevelopmentgloblcologyFechgolDrDeBoercompletecourewkfulfillgUCSFCertificteImplementtiSciencewellmendturilexperientillerngerchimAnexceptilmultidciplrytemmenrnoptimlblncecomplementryexperteguideDrDeBoerchievghergolThtrgpoiDrDeBoeruccefuldependenterchcernimplementticienttlederemerggcdemicfieldgloblcologydvncgDrDeBoerultimteobjectivepromotggloblcncerequyimprovgqulycptientEtAfricyd1ABSTRACTN-mllcelllungcncer(NSCLC)highlyggivedeedmlprognoocedhighrtettmenttncedeecurnceInltdecdefirtleNSCLCttmenthenubtntillycedtroductiimmunpytrgetgimmunecheckpotuchprogrmmedcelldeth1(PD-1)ligPD-L1PD-1/PD-L1immunecheckpotblockde(ICB)howverypromgcliclprileyetlg-termdeectroloccurlethn25%NSCLCptientUndertgmechnmttmenttnceeentildddineedtroducgnovelynergticrpietrgetfrcrydeeimmune-privilegedNSCLCtumExperimentlevidencehowNSCLCtumlggmgmothypoxictumtypedplyporteimmunecellfiltrtiimpidTcelleffecrfunctihypoxictumgiThuggetlowoxygenmyctrieimmuneprivilegepopettmentNSCLCIntetglytumhypoxihenocednti-cncerttmenttncedecdeyetrolecliclmngementNSCLCmlrgelyunexplodRecentlertuuggetpertentntigenictimultum-filtrtgCD8+Tcellhypoxictummicroenvirment(TME)duceTcellexhutidyfunctilttechrcterizedprogiveloTcelleffecrfunctiIncurntK22TrniCerDevelopmentAwrdpplictiwepropoevetigteroletumhypoximodulrimmuneprivilegemuNSCLCmodelWehvepvioulyidentifiedmichdrilhibirppve(PPV)experimentlderivtiveSMV-32cnveriblyelevteprtiloxygenpumuNSCLCtummodelup90%OurplimrydthowPPVSMV-32-mededTMEoxygentipridelivergPD-1ICBledignificntenhncementtumgrowthdelymoueyngeneicNSCLCtummodelcompdPD-1mpyRepetedttmenteirdrugledidnotffecttumgrowthWelohowhypoxiledenrichmentdyfunctilCD8+TcellpopultivrovivothxygentipromoteelevtiPD-1ICB-piveprogenirexhutedTcellpopultiwhiledecgtermllyexhutedTcellpopultiTheoverllgolK22propolelucidteTME-pecificmechnmhypoxicimmuneprivilegeNSCLCtumgdvncederchexperiencepildevelopmentquidtrniuccefuldependentvetigrPROJECTSUMMARYNnoprticle-bedrpiehvemnypotentildvntgettgcncercurntlynocliclbiomrkerpdictwhichptientmotlikelynefnnpeuticovercventilnticncergentToimproveefficcynnoprticlecncerttmentIvetigtennoprticledrugdeliveryctextSLC46A3lipoome-pecificbiomrkercentlyidentifiedmivelyprllelpooledcncercelllecenBedtrgplimrydtIhypoizeSLC46A3plyrolephopholipidmetbolmcncercellmkgrpeuticllylevntbiomrkerlipoomlnnpeuticThpropolimetblhroleSLC46A3phopholipidhomeotdictlycnectSLC46A3expirpeuticlipoomedeliveryvivougpedricneuroblmmodelytemTheultimtegolprojectvlidteSLC46A3cliclbiomrkerlipoomlnnoprticledeliverydeveloprigoupclicldtmotivtebiomrker-trtifiedclicltrilbothextgFDA-pprovedlipoomeexperimentlmultiImpedriccologteekgK08upptmendtrgperiodunderco-menrhipDrPulHmmdtMchuettIntuteTechnology(MIT)DrKimrlyStegmiertDn-FrrCncerIntute/BonChildnHopl(DFCI/BCH)Mylg-termcergolndependentphyicin-cientttudygnno-bioterfceterctigoldvncgnnomedicecliccncerptientMyprierchexperiencehveetblhedmykillnnomedicedrugdeliveryImnowwellpoiedetblhneceryexpertecncermetbolmfunctilgenomicthroughcriclmendK08wrdTheDFCI/BCHMITBrodIntuteMITHrvrdterntillycognizederchprogrmnumrexpertercherfunctilgenomicmetbolmnnomterilmgTheDFCIDiviPedricOncologyhdtguhedcdtrgyoungphyicin-cienttlederhiprolepedriccncererchIhveemblednexcellentmenrgdvycommteectgDrMtwVerHeiden(MIT)DrAngelKoehler(MIT)DrStevenDubo(DFCI)whoguidemyerchtrgexperiencelgmymenrWhtructudmenrgeductilcientificplnIcquineceryexpertecomeuccefuldependentvetigrtrnltilcncernnomediceProjectSummry/AbtrctIncedriboomebiogenehllmrkcncerflectcedperviveproteynticneedcncercellTrgetgthprocecurbgrte-limgtepRNApolymereI(PolI)trncriptiugpecifichibirbrogtgthctivypromgtrtegycncerrpyBMH-21firt--clmllmoleculehibPolItrncriptilrge-clecncercelllecendemtrtedpotentefficcycrobrodcncerlegeHoweverheterogeneoupewobervedemphizgpencemechnmdmpengrpeuticpeGenome-widepoiveelectiCRISPRC9knock-outcenwepermedhumncoloctlcrcomcellidentifygenecuetnceelectivehibiPolIThecenidentifiedllkeypoivegulrmTORC1pthwyccountgtncemTORmjdriverriboomebiogenecellulrtrnltilprogrmcidedeentilcncergrowthThectivtimTORtncemechnmcountertuivethmechnmquiducedtrnltilttecncercellctivtwokeypthwyenblgproteynTheeunexpectedfdgledhypocncercellevdeeveriboomebiogenetwchgfmTOR-dependenttrnltilpthwyThpmetipultepmechnmhveevolvedtciltetrnltieentilproteurvivlgrowthwhencncercellfceobtcleprotetrnltiThccepttetedugphrmcologiclgeneticpprocheblockmTORThegolprojectgknowledgemechnmenbleunbtedriboometrnlticncercellThefollowgimimplementedchievethgolAim1IdentifygenedrivgtncePolItrnltihibirAim2InvetigtetrnltilctivymtedundertrnltitcncercellAim3IdentifygulrriboomectivyuppturvivltrnltitByexecutgeimwegknowledgehowcncercellurviveevetrnltiltmechnmthecpeTheetudieidentifycriclproceeprotequidurvivlhowirtrnltimtedlimedriboomenumrTheefdghveimplictirpeutictrtegietrgetriboomebiogeneproteyntrnltipprochedeigneduethknowledgedevelopnewcombtitrtegieovercomeetncemechnmProjectSummry/AbtrctDepeexcgdvncelungcncermledgcuecncer-lteddethUnedStteAcriclgpourundertghowlungcncercellcomemetttictntourttmentHricllylungcncererchhfocuedgeneticdrivermculprdeeButcentlrgeDNARNAequencgtudiehvehowngeneticchngeccounnly50%lungcncerprogitrglyuggetgunidentifiedn-geneticmechnmdeeprogiThePIplimrydthidentifiedpropemetbolmmetbolicpthwypvioulynotknownplyrolecncerdygultedn-mllcelllungcncer(NSCLC)Indeedirdthowmethylmliccid(MMA)keymetbolicproductpropemetbolmcnpromoteepilil--meenchymltrni(EMT)elevtedlungcncererumptientmettticdeeMooverPIhidentifiedMMAcnctivtebdG-protecoupledcepruncovergnovelignlgxHplimrydtlohowMMABkeygulrygenepropemetbolmundexpedNSCLCknockgdownMMABpromoteEMTdrugtncelungcncercellTheetudiehveledcentrlhypopropemetbolmdygultipromotelungcncerprogidrugtnceNSCLCnimptntn-geneticmechnmdeeprogiThegolpropoedtudieunderti)mechnmwhichMMAignlii)effectMMABloNSCLCiii)vivoeffectMMANSCLCugmouemodelSuccefulcompletipropoedwkimproveourundertgmetbolicpthwylungcncerpolyunderodpotentillyidentifynewpthwycouldtrgetedrpeuticllyThpropoldecrifive-yertrgprogrmlunchndependenterchcerfocugmechnmNSCLCdrugtncemettThecidteDrBobkPrngmediclcologyfellowtWeillCnellMedicewhohentrgcomephyicin-cientvertenyerHehoutledcerdevelopmentplnbuildhtrgbckgroundcncerbiologycliclcologyprovidgrigoutrgnewkillmoleculrbiologymetbolomicmouemodellungcncerHepermpropoedtudieundermenrhipDrJohnBlenwldnownedexpertmoleculrbiologycncermetbolmcellulrignlgrichtutilenvirmentWeillCnellMediceWhmenrhiptemhehembledhtrgcliclcientificbckgroundhtrgplnDrPrngidellypoieddevelopndependentlbry-bedphyicincienttR01fundgPROJECTSUMMARYTriplenegtivebtcncer(TNBC)motggivembtcncer(BC)whichoccurmofquentlyyoungerwomentendignoedcedeehldymettizedInlyBCubtypewheimmunecheckpothibir(ICI)pproveduebunlymyptientpdcurntICIttmentOnemechnmtncelowexprtumlchemokeCXCL9CXCL10eentilttrctgnti-tumCD8+Tcelltummicroenvirment(TME)PychoociltexperiencedmnyBCptientcnenhnceimmunouppi-dnergicceprblockdehhownhigherurvivlnefTNBCptientcompdBCubtype(obervtiltudie)uggetgpoibilyympticoverdriveTNBCHowevermechnticrolepychoociltttmenttnceICImgTNBCptientmunknownWehvehownchrictmedirepeph(EPI)nopeph(NE)driveimmunouppiTMEdecgCD8+TcellcgmyeloidderiveduppcellgulryTcellOurubequenttudyhowedproprnololpn--blockerimprovepeICImettticmelnomptientWelofoundEPIcnmedeductiprotglE2(PGE2)BCtueWehvehownPGE2hibterfer(IFN)-ducedCXCL9/10ectiThuIhypoizechrictpromoteimmunouppiTNBCcgPGE2hibgIFNpthwyultgdecedCXCL9/10Ipropoetetthhypofollowgim1)ExmeNE-ducedchngeTNBCtuetetrpeuticmeuexvivo2)Studyimmunechngep-vpot-ttmenttumtuebloodmettticTNBCptientceivgproprnololICI3)CltevlidtedmeupychoociltexpiIFNCXCL9/10BCtueTochieveegolIutilizeTNBCtueptientexvivotudiecductpropectiveclicltrilexmeltihiptweenelf-ptedtcltetumimmunybnkedmpleTogmechnticundertgcomplementrytte---rtmultiplextueimggtechniquecludgcfoclmicrocopyimggmcymetryptiltrncripmicutilizedCompletipropoedwkprovidekeynovelightmechnticrolePGE2-IFN-chemokepthwyt-ducedTMEimmunouppihelpmnewpprochetrnltedenhncedrpeuticnefTNBCptientThprojectdvncemydevelopmentndependentcliclcientttrnltilercherdvncgpciimmuno-cologyttmentTNBCThccomplhedrichcdemicenvirmenttRowellPrkCompheniveCncerCenterUniverytBufflounderguidncenouttgmenrhiptemcomplementryexpertebtcncerimmuno-cologyTME-ocedchemokeprotglIFNpychoociltProjectSummry/AbtrctExplgSGLTThernoticTrgetCncerMettCncerquiubtntilenergycommlyprovidedcedglucoetrnptmetbolmClicllythevlutedugPorEmiTomogrphy(PET)imgg18F-lledglucoenlog2-fluo-2-deoxy-D-glucoe([18F]FDG)[18F]FDGentercellprimrilyvifciltiveglucoetrnpterknownGLUTwhichovexpedomehumncncer[18F]FDGcnnotuedproodium-dependentglucoetrnpter(SGLT)diffentfmilytrnptercncerInfctroleSGLTbtprottelunghed/neckbrpnccolcervixovrylynowtrtgcognizedGivenSGLTexpievenhighermettthnprimrytumwepropoeycouldrnotictrgetmettticdeeSGLTbleccentrteglucoenlogtrcellulrlymnyfoldirextrcellulrccentrtiToevlutethwectedbrnewcompoundclled6FIGA(FluocentIodtedGlucoeAnlogmodifiedt6poicrb)whichelectivelytrnptedSGLTItcnmderpeuticrdiuclide131IdeliverlethlrdicncercellwhilehvglowytemicccentrtimimizexicieFurrSGLTfunctirpyplnngcouldmedPETimggugchemiclly-identiclgentmde124IopeInddiwehvemdetbleiodefluocentyimggpnngmicrocopymuvivotudieHewepropoeuethnoveltrifunctilgentevluteSGLTrnotictrgetcncermettSignificntlytrgetedrdiucliderpycouldolveefficcyproblemduetumheterogeneyRdiigtgSGLT-expgcellpenetrtemultiplecelllengthevenkillneighbgcelllckSGLTOurplimrywkhow6FIGAtrnptedelectivelySGLTpenttivemettticbtprottecncercelllenvivomuflnkhumnprottecncertumdemtrted6FIGAccentrtglowf-trgetuptkeInthexplryprojectweue6FIGAexploSGLTpotentilrnotictrgetviim1Evlutetimecourebiodtrii[124I]6FIGAvivomettticmodelmeurgtumnmltueccentrtimecoureoceddoimetryWehypoize[124I]6FIGAySGLTctivyprovidediffentmthn[18F]FDG2Cductpro--ccepttrgetedttmentug[131I]6FIGArdiucliderpyegoverllurvivlimggperpyCltivetudiepermedcludgimmunohchemtryexvivofluocenceimggderquntifyltitweenuptkeproteexpilevelThuwedemtrtepotentilSGLTrnotictrgetPROJECTSUMMARY/ABSTRACTTheprimrygoltherchpropolprovideDrONeilfouryertrgerchexperienceimplementticiencemixed-methoderchtechniqueupprnigndependentercherfocuedimprovgerlydetectibtcncerbtcncercmobrodlylow-middle-comecountrie(LMIC)BtcptientLMICfcefrhighermtlyptientUSAprtcuelckcengmmmogrphyultmothn50%gdignoedtgeIIIIVcncerBtcncercengugcliclbtexmhenhownnerlyeffectivetdetectgerlyBCmmmogrphycpbledecgBCtgetdignomtlyHowevercengCBE(CBE)hnotenwidelyimplementedLMICcludgSouthAfricDrONeilpropoeueImplementtiMppgprocecollbtivelydeignpilotettrtegieimplementgCBEprimryhelthcenter(PHC)SoweSouthAfricInAim1heenggeproviderptienttkeholdertfourprticiptgPHCcductbeleneedementidentifydetermntimplementtichngeobjectiveelectpplicbletrtegienproduceimplementtimterilDetermnttrtegyelectignizedugCOM-BhvilwheelchngefrmewkInAim2DrONeilcductfeibilypilottudyCBEimplementtimefourPHCugtrtegiedevelopedAim1ThtudyllowfementtrtegieprimryoutcomecompceiptCBEmgeligiblewomenefterimplementtiTheeultecdryultRE-AIMfrmewkprovideplimrydtupptgnR01propollrge-clehybridtrilmeurgeffectiveneimplementtiucceCBEimplementtipckgedevelopedheDrONeilhubtntilexperiencetudygbtcncercqulybrriercub-ShrnAfricHtrgplnddfoundtiemphizgnewkilleentilctullyimprovgcmltructiiemethodimplementticiencemixed-methoderchHmenrgtemcludeexpertbtcncercliclerchimplementticiencegloblcologywhouniquelyqulifieduperveDrONeilerchprogrmhelphimexphcdemicgloblcologynetwkDrONeillolevergghlgtgproductiveprtnerhipbtcncererchertUniveryWwterrJohnneburgwhoenthuticcollbrpropoedwkprovidevlupptThwkfirttepwrdclg-uptudygbtcncercengthroughoutSouthAfricLMICpublichelthgolpotentildecegloblbtcncermtlyItlopoiDrONeiluccefulcerndependentgloblcologyimplementticienttProjectSummry/AbtrctProttecncerledgcuecncerdethAmericnmenTheNtilCncerIntuteetimtedwould~268490newceprottecncer~34500dethprottecncerUnedStte2022Depedevelopmentecd-genertihmlrpie(egenzlutmide)trgetedpoly(ADP-riboe)polymere(PARP)hibir(egolprib)mtlyprottecncermhightriccquiddrugtncecommllegentmnyptientdevelopcurblemettticctrti-tntprottecncer(mCRPC)23yerAccumultgevidenceourplimrydthowmCRPCcelldeficienthomologoucombtipir(HRR)ctivieduegeneticmuttiDNApirgeneuchBRCA1/2dueenzlutmidettment-ducedBRCAnetteprticulrlyvulnerbledruptiDNA-dmgelerncepthwyuchmutgenictrnleiDNAyn(TLS)TLSfundmentlcellulrdefenemechnmenbleDNAplicticroleieunderplictitderpromotecellurvivltcotplictifidelyTheeukryoticY-fmilypolymereRev1neentilcffoldgproteTLSterctitweenC-termldom(CTD)trnleipolymerezbolutelyquidfunctiAidedourtructurlelucidtiRev1-bridgedtrnleiomecomplexTLSwehveidentifiedfirt--clvivoctivemllmoleculehibirJH-RE-06druptTLSdictlybdgRev1CTDblockRev1terctiRev7compentpolymerezJH-RE-06uppeptneouttment-ducedmutgenecellenizecncercellvrietyDNA-dmgggentbothvromuxenogrfttummodelRecentlywehvehownmCRPCcellBRCAnetteprticulrlyvulnerbleJH-RE-06hibiThegolthpropolfurrchrcterizeJH-RE-06derivtiveprottecncercelloptimizeirpotencyfetyphrmcologiclpropertiedemtrteireffectivenettgmCRPCuppgcquiddrugtncemutummodelTheuccefulexecutipropolproundlylterextgprdigmlethlprottecncerttmentprovidgeffectivemenovercometriccquiddrugtncethuimprovgoutcomeptientlethlprottecncerPROJECTSUMMARYMylg-termcergoldevelopndependenterchprogrmfocuedevlutinovelcellulrrpiedeignedimprovelg-termoutcomepedricptienthigh-rkmlignncieThK08pplictidecricerdevelopmentplnerchpropolprovidemequetructudmenrhipcourewkh-cliclerchexperienceprotectedtimenecerydevelopuccefuldependentcliclvetigrMyerchplncenterhyponovelCD19-CART-cellpprochecludgllogeneicpltm/hncementulogoutrtegiecnovercomelimtiulogouCART-cellrpyimproveptienutcomeTotetthhypoIcductPheIclicltril(MEMCAR19NCT04881240)evlutgnllogeneicCD19-CART-cellproductugdmemyT-cellmimizerkgrft-veru-hot-dee(Aim1)IevivochrcterticeCARTcellthroughtenivecltivetudiecductedcjunctimycollbrfurrourundertgCART-cellbiologymupfuturpeuticpproche(kveretrnltiAim2)AddillyIdevelopnewclicltrilevlutgnovelCART-cellproducttendedduceutedmhroughdul-ntigentrgetg(CD19/22)enhncedCART-cellpertencethroughepigeneticmodificti(DNMT3Aknockout)(entledPERSISTAim3)Imptntlywhiletherchfocuepedricptientlped/frcryB-cellhemlogicmlignncieknowledgegedthwkprovidevlubleightCART-cellbiologycntrnltedpprochehigh-rkmlignncieToupptmytrnindependentvetigrIhvedevelopedrobutmenrhipdvtemcomplimentryexpertetrgtrckcduccefulerchmenrhipjunivetigrMymenrdvIhvedevedcomphenivecerdevelopmentplnwhichcludei)cquimltrgclicltrildeigncludgcourewkbiottticMterCliclInvetigtiii)expnimytrgimmunologythroughtrgetedwkhopiii)dvncementmylederhipkillTherigoutrgprovidedthwrdppmecerdedictedimprovgcellulrrpiepedricptienthricllycurbledeeUpcomplethK08AwrdIexpecthvegednecerytrgdvncedclicltrnilerchmethodupptmytrnindependentvetigrLikeweIexpecthvegenertedufficientdtjutifydevelopmentddilcellulrrpytudiethroughfutucliclR01pplictiPROJECTSUMMARYDiffuemidlegliom(DMG)devttgchildhoodbrtumwhichnoeffectiverpieWhilehnemuttithoughtcricltumgeventyufficientgliommtico-occuromticltertipthwycludgMYCgrowthfcrceprignlgIhvecentlydcovedubetDMGrrntlyexpkhedtrncriptifcrFOXR2FOXR2ufficientenhnceDMGmtiloquidFOXR2-expgDMGFOXR2DNA-bdghighlyenrichedtE26trnmti-pecific(ETS)motifFOXR2pecificllyctivteETStrncriptilcircuMooverFOXR2-expgDMGlckmplifictigeneticeventgrowthfcrceprpthwyuggetgfunctildundncyIndeedphophoproteomicevidencehowFOXR2-expgcellctivteMAPKignlgTheefdgprovidertiletudyhowrrntFOXR2expicooperteETStrncriptifcrenhnceDMGmtictivtgdowntmpthwycludgMAPKignlgTodvnceourundertgFOXR2-expgDMGthpropolpuruefollowgtwoSpecificAim1)TethypoETStrncriptifcrquidFOXR2-mededcogene2)TethypothncogenicphenotypeFOXR2mededthroughMAPKignlgImcurntlynIntrucrPedricPedricNeuro-OncologttDn-FrrCncerIntute80%mytimeprotectederchImfullycommtedcerphyicin-cienttgolelucidtgDMGdeemechnmdvnceptientcThepurpoethcerdevelopmentwrdfillcriclgpmytrgenblemegpecifickillvivimlmodelgpedricbrtumhigh-throughputgeneticperturbtipprocheIhvechoennouttgmenrhiptemDrPrtiBopdhyyDrMyleBrownDrBopdhyynetblhedlederpedricbrtumgenomicDrBrownnterntillederepigenomicchromtbiologyexteniveexperiencemenrgphyicin-cienttMycientificdvycommteecludeexpertflectgkeymytrgplnDrEricFcher(proteomic)TimothyPhoenix(mugliommodel)KehLig(immunohchemiclnlyemumodel)KimStegmier(pedriccncergenomichigh-throughputgeneticperturbtiy)ImoovercollbteDrJohnDoench(high-throughputgeneticperturbtimethodnlye)gexperteUndermenrhipmyco-menrcommmentmycientificdvycommteeItrtimultgenvirmentDn-FrrCncerIntuteBrodIntutebothouttgtutitmendouourceTheK08wrdfermefurrmenderchtimeeentilcerdevelopmenttrgultimtelyemergendependentphyicin-cienttvetigrfieldPedricNeuro-OncologySUMMARY/ABSTRACTMultipleclicltrilhvehowncombgnti-etrogenrpyCDK4/6hibirrpyimproveprogi-feurvivlER+/HER2-btcncerptientHowevermnyptienttntCDK4/6hibircquitncefirtfewmthttmentIntetglyhlogicltgttedtumvelmllctentpopulticellprolifertivephecellcyclephenomenweferfrctiltnceItcriclundertmechnticbfrctiltncecuepcefrctiprolifertgtumcell(eg2%veru15%)trgpdicrptienutcomeRecentgle-celltudiehvehowndividulcellcntkedtcttrjecriepththroughcellcycledefeduniquecombtimoleculrtteovertimeWehypoizefrctiltncebttumoccurcuecellcntkemultiplepththroughcellcyclebunlyomeeptheniveCDK4/6hibirTotetthhypowehvedevelopedpowerfulnewmethodprile>50cellcyclegulrproteglecellBylkggle-cellttegercomputtillythpprochhveledhowdividulcelltkelterntepthevdecellcycle-trgetedrpyInAim1weducefrctiltncepnelbttummodelpplygcgdoeCDK4/6hibirendocrpygrdullyelimteubpopultiprolifertgtumcelldefgrngemoleculrttecellcnchunderdrugttmentPlimrywkuggettntcellmuttkeprticulretpthtG1/Strnichrcterizedhighrtiocycl(egcyclD/E)CDKhibir(egp21/p27)ltedCDT1expielevtedE2F1levelWevlidteepdictithroughtime-lpemicrocopyAim2tkenundpprochdetermechngegloblprotelcpepecgdoeendoc/CDK4/6hibirrpyUgdeepqunttiveproteomiccommiveflepeptidefrctemmtgllgwedetermechngeprotelcpepeCDK4/6hibivlidteechngebiochemicllyimggdetermeimpctmoleculrttechngeenivytnceendoc/CDK4/6hibirrpyNewplimryulthowmultiplecidtegulr(egCDKN3UHRF1)cellcycle-dependenrexpedfrctillytntubpopultiAim3identifytntpthectedhumntumtechniquedevelopedoururgicltemInddiwetetfrctiltncehypotheER+/HER2-PDXmodeleextentfrctiltncelgtermphyiologicllylevntmodelOverllthprojectprovidenewknowledgehowheterogeneycellcyclehviledfrctildrugtnceER+/HER2-tumidentifynoveltncefcrpvewydevelopmentnext-genertibiomrkercptuuniquecellcyclehvidrugeniviecncertypeProttecncerecdledgcuecncerlteddethAmericnmlelthoughdethrtehvedecledtillmotdignoedcncermleHvgtterundertgprottecncerhelpdeceerteClticul(CRT)nEndoplmicReticulum(ER)identchpereproteknownexpedgultedrogenprotticepililcellCRThenfoundmigrtecellurfcecidencecncerwhepromotephgocyticuptkecncercellimmuneytemAlthoughurfceexpoedCRTccentrticeeverlcncertypebothupdowngultihenptedprottecncerTheeegolthprojectvetigteurfceexpoedCRTexpiprottecncerThemethodCRTtrffickgcellurfceunknowncellulnvirmentpot-trnltilmodifictimyctrieAproteome-widetudyfoundnumerouprotecetyltedprottecnceryetnotudiehvefocuedcetyltiCRTprottecncerTheenobjectivepropoederchprojectevluteroleCRTcetyltitrffickgcellurfceprottecncerMyplimrydtuggetCRTtructuchngeupbdgcetylgroupdItlohowdoubleexpilyecetylticlticulpenttcellurfceprottecncercellprottecncertuempleTheeIhypoizeCRTcetylticetrffickgcellurfceprottecncerTotetthhypoIpropoetheSpecificAim1)InvetigtetrffickgCRTmprottecncercellugfluocentlytggedwildtypeCRTKDELdeficientCRTCRTmuttedcetyltie2)UndertmethodprtnerCRTtrffickgugprotepulldownyfolloweddvncedproteomicnlymtroducedprottecncercellle3)IdentifyexpiloctiCRTprottecncertueugimmunohchemiclnlyCRTcohtprottecncerptientThK01propoldeignedbuildupmytrgbckgroundprotetructu/functichngeupligbdgexpmykillknowledgetrnltilcncerdprieercherMycientificdvycommteecompoedccomplhedcienttexperteprottecncercncerhelthdprieproteomicmoleculrbiologytummicroenvirmentTheprogrmoutledthK01propolpropelmendependentcientificcerthroughrigoucerdevelopmentctivietilodmypecificerchcergolPROJECTSUMMARYAdoptivecellulrrpie(ACT)uchchimericntigenceprT-cellrpycomplexttmentptienthemlogicmlignnciePtientceivgACTcnexperiencelife-engxiciewhichulttmendouympmburdencteubtntilburdenircgiverMooverptientceivgACTexperiencetenehelthcutiliztendlife(EOL)50%dyghoplThuterventineededoptimizequlylife(QOL)EOLcptientceivgACTimproveQOLircgiverPritudiehvehownvolvgpeciltypllivec(PC)clicincptientolidtumhemlogicmlignncieimprovewiderngeoutcomeptientircgiverYetPCclicinrlycultedcptientceivgACTFurrmoeptienthveuniqueneedillnetrjecrypriPCterventicologynottilodthpopultiWecentlycompletedlgudltudycomphenivelydeleteneedptientceivgACTutilizededtdevelopPCterventi(PEACE)tilodthpopultiThpropoldetilfive-yerplnfepilottetPEACEddunmetneedptientceivgACTircgiverSpecificllyimthproject1)fePEACEbedfdgnopenpilottudy(N=15)ptienthemlogicmlignncieundergogACTircgiver2)determefeibilycceptbilyPEACEcductgpilotromizedctrolledtril(RCT)(N=80)3)exploplimryeffectPEACEimprovgQOLphyiclpychologiclympmprognoticundertgEOLcommunictiptientceivgACTQOLpychologiclympmprognoticundertgircgiverThwklyfoundtidemtrterolePCimprovgqulyclivedexperienceptientceivgACTThpropollodetilplncidteDrPCnJohnmediclcologtphyicin-vetigrpecilizgACTgmenrhipdidctictrgcerdevelopmentfciltehtrnierchdependenceDrJohnlg-termcergolcomelederupptiveccologyerchpecilizgdevelopgevlutgterventiimproveQOLcptientceivgACTThpropolcludeDrJohnplnggexperte1)fgtetgupptivecterventi2)dptgPCterventiuniqueneedptientceivgACTircgiver3)cductgevlutgoutcomeupptivecclicltrilHechievergthroughexperientillerngledgpropoedprojectguidncehmenrDrAejEl-JwhriledgexpertPCerchcientificdvytemexpertePCerchqultiveerchmethodACTcliclcerchEOLcommunictimirgterventifidelyRCToutcomeevlutiHegddilkillthroughcourewkPCRCTdeigncductThprojectpoiDrJohncompeteR01-levelfundglunchndependentcerledgerchprogrmtterfceupptivecACTPROJECTSUMMARY/ABSTRACTThNCIK08MendCerDevelopmentAwrdppDrDnielRichrdcomendependentR01-levelvetigrptient-centedcncercdeliveryptientcutemyeloidleukemi(AML)AMLttmentprdigmchnggolderptientAfterlmot40yeroutnynewttment10newrpiehveenpprovedce2017Theepprovlhvetroducedcliclequipoettmentdeci-mkgmnyolderptientChoogtttmenptendependwhtechptientvluemoptimizgqulylifeprolggurvivlClicinptientcnenggehddeci-mkgclrifyptientvluehelpptientrrivetmedpfenceboutrpyMultipletkeholderhveclleddevelopmentnewolupptptientclicinthcomplictedproceDrRichrdplnwkunderguidncehmenrevlutenovelvlueelictiolclledPRIME(PfenceReptgImproveMngementExperience)PRIMEgenerteperlizedvlueptl-timemhddeci-mkgbedt-wtclg(BWS)impleyetrobutvlueclrifictimethodThpropolbuildDrRichrdpviouerchhmenrdevelopvlueelictiurveyAMLptientTheobjectivethpropolevlutefeibilyugPRIMEimprovettmentdecioptimizeimplementtiRCTevluteefficcyTheimthtudy(1)determefeibilyugPRIMEimprovettmentdeci-mkg(2)identifybrrierfcilrimplementgPRIMEcliclwkflowmdevelopmentppropreimplementtitrtegieSuccethprojectdvncenovtiverigoumethodcptuptientvluemyhvebrodpplicbilycrocologyThprojectlopromoteDrRichrdlg-termerchgolimprovgtegrtiptientvluettmentdeci-mkgDrRichrdupptedmenrhiptemexpertevlueelicti(JohnBridgePhD)implementticience(StephnieWheelerPhD)cncercdeliverytril(EthnBchMDAnniBennettPhD)AprtthK08wrdhedevelopexpertecncercdeliverytrildeignexecutivlueelictimethodologyimplementticienceProjectSummryThegolthK08ppPIceiveh-experienceimplementtidemtideigngledgromizedctrolledtril(RCT)pllivecimprovegrntwrgkillcomendependentR01-fundedvetigrHpnic/Ltx(H/L)communieexperiencedprtegenerlhelthoutcomemolikelydignoeddvncedcncerwhencompdn-H/LpopultiH/LptientexperiencgdvncedcncerircgivertncedrkunmetpychoocilneedthK08llowPIfocuthimptntgpmyhelthcTheerchgolthpropolfepilotnterventledCgiverPtientSupptLtxCopgAdvncedCncer(CASA)five-ei60-muteechteleheltherieptient-cgiverdydThelg-termtrggolthpplictienblepplicnt(PI)comendependentvetigrculturldpttiexpernpychoocilterventihelthdpryerchThertilethprojectlygroundwkRomizedCtrolTril(RCT)tetgefficcyCASAItloeimplementtinnovtivemethoddeliverCASAterventiThtudyimuecollbtiveterventiplnngfrmewkORBITmodelmodifyefeibilyplimryeffectCASAterventiTheoverllimpctthtudyimproveccepychoocilculturllydptedterventimgH/LptientcgivercopgdvncedcncerTheSpecificAimfollowAim1UecollbtiveterventiplnngfrmewkprovidercommunytkeholderfetudyprocedupriimplementtipilotromizedctrolledtrilAim2TotrcommunymemrptientcruercliclpychologydocrltudentterventCASAterventiAim3ToimplementpilotromizedctrolledtrilevlutefeibilycceptbilypotentilefficcyCASAterventiHpnic/LtxdydcopgcncerProjectSummry/AbtrctMlignntprimrycentrlnervouytem(CNS)tumcurbletumchrcterizedhighympmburdenpourvivlInddiympmchllengecommptientdvncedcncerptientdignoedmlignntprimryCNStumfceuniquetltedeffectcncerirnervouytemInneftcopedtboutirpoprognoneurologicldyfunctieptientcommlyenggevoidnthvimyultimtelyheightenirdtledociloltidvereeffectirmoodqulylifeThpropoldetilfive-yerplnfepilottetupptivepychoocilterventicpteelementAcceptnceCommmentTherpyddunmetupptivecneedptientprimrymlignntCNStumlleveirdtSpecificllyimthproject1)fepopulti-pecificpychoocilterventibedterviewtkeholder(N=15)nopenpilottudy(N=10)cptgdpttiptientcognivecommunictideficcommmgeptient2)permpilotromizedctrolledtril(N=100)evlutefeibilytudyprocolcceptbilyterventietimteplimryeffectterventerventrget(copgkillvlue-drivenhvi)propoedoutcome(prognoticdtmoodqulylifeocilolti)ThpropollodetilplncidteDrDebhFtneuro-cologutcomeerchergmenrhipdidctictrgcerdevelopmentfciltehertrnierchdependenceDrFtlg-termcergolcomendependentphyicin-vetigrlederupptivecerchneuro-cologyWihprojectDrFtgeentilexperiencekill1)developgpychoocilterventi2)dptgupptivecccommodteneedptientcognivecommunictidefic3)cductgupptivectrilerioulyillptientSheceivergthroughcombtiexpertmenrhipcourewkcfenceprticiptideignexecutipropoedprojectDrFthembledtemmenrwhoexpertdeigngcductgupptivectril(DrJenniferTemelprimrymenr)fgpychoocilterventi(DrLrTgerco-menr)heceiveddilguidnceupptcientificdvexpertecognivedyfunctiptientCNStumcognive-lgutichbiltineuro-cologytrilbiottticDrFttrgupplementedtructudcourewkprticiptipertentwkhopcfenceThK08wrdppDrFtcomendependentR01-fundedvetigrlederupptivecneuro-cologyfocueddevelopmentnovelevidence-bedpychoocilterventiimproveoutcomeptientmlignntprimryCNStumvulnerblecncerpopultiPROJECTSUMMARY/ABSTRACTDepechrcterticdolentcoureubtntilubetfolliculrlymphom(FL)ptienthnerlylpepooutcomeThufreftidentifyfcrpdicturvivlhveenunuccefulHoweverwehvedemtrtedprognoticlevncetummicroenvirment(TME)FLprovidedilevidencerolepecificgeneticltertihpgdiffentenvirmenthighlydimilrcliclcoureYetcrotlktweenmlignntBcellimmunecellTMEpolyunderodrolemoleculrltertimodultgerplyThundercourgentneedimproveourundertghowtum-immuneterctimydrivelymphomgenepentrpeuticvulnerbilieThroughmivegenetictrncripmicequencgwefoundFLptientcedexpiIRF4nNF-kBtrgetcriclroleBcelldiffentidplydygultedimmuneigntunimmunouppiveTMEpoprognoWehypoizecedIRF4expidruptimmuneynpetweenBcellTfolliculrhelper(TFH)cellwhilepromotguppiveTfolliculrgulry(TFR)cellprtpventgductielectimoleculeuchCD40PDL1prtwirgcykeleeToteurhypowepropoethepecificimInAim1weuenoveltrngenicmouemodelovexpideletiirf4vetigtewherhowIRF4ctroltumimmunynmlmlignntBcelltegrtggle-celltrncriptiltrnltil(CITE-eq)nlyInAim2weuehighdimenilcymetry(CyTOF)ptillyolvedproteomic(CODEX)CITE-eqmemouemodeldefeeffectBcelldiffentIRF4ttuTFHcellInAim3weuegle-celltrncripmicproteomicolelucidteroleTFRcellpeBcelldiffentlyexpgIRF4ThefdgllimvlidtedhumnFLmpleBuildgherubtntilprilbrycliclexperienceBcelllymphomDrPtriziMdelloledetudieunderdulmenrhipDrStephenAnelllederimmunpyTMElymphomtMyoClicDrLurPqulucciwldexpertgeneticepigeneticBcelllymphomtColumbiUniveryMyoClicfernexceptilenvirmentcultivtgdevelopgcertrnltilcncererchTochievelg-termgolcomguccefuldependentvetigrDrMdellohdevelopedtructudcurriculumctivieimedtbrodengherknowledgebeexpghertechniclperidevelopglederhipkillShehloembledndvycommteeledgcienttIncompletgherpropoedplnemDrMdelloppdcompeteR01fundglunchtrnltilerchprogrmtudygdygultirpeutictrgetgchromtmodifiertrncriptifcrireffecnTMElymphomProjectSummry/AbtrctThprojectdeigneddevelopnewpprochmirpdictttmentpeptientpncticductldenocrcom(PDA)ughyperpolrized(HP)13CpyruvteMRmoleculrimggPDAmgdedlietcncernticiptedcome2ndledgcuecncer-lteddethUS2030MotPDAptientpentnectbledeewheytemicrpylylife-prolggttmentInmyptient(~30%)whopentloclizedpotentillyectbledeeneodjuvntrpy(NAT)followedurgerynemerggpprochimproveptienturvivlbunlyneficilifelectedNATeffectiveFllPDAptienteffectiveytemicrpyglemotimptntfcrfluencgirurvivlHowevercurntpeementolcludgMRICTerumtummrkerCA19-9providepoerlyementpeptientrpidlylethldvncedPDAuboptimlelectgptientmotlikelynefhighlymbidurgeryfterNATTheecriclunmetneedmotimelyccurtedicrrpypePDA1)promptlydctueeffectivettmentwchlterntivettmentpotentillyttefficcy2)tterguideclicldecigrdgurgeryfollowgNATMetbolicprogrmmgwrdcedglycolyhllmrkPDAInprticulrover-expilcttedehydrogeneAmocrboxyltetrnpter14ulthighlevelpyruvtecverilcttewhichplycentrlrolePDAprogirpytnceSuchprogrmmedglycolyticmetbolmcnnvivelyterrogtedugHP13CpyruvteMRInemerggmoleculrimggmethodprovidedynmicpthwy-pecificmetbolicmtinotvilblecurntimggmethodcludg[18F]fluodeoxyglucoeporemimogrphy(FDG-PET)OurplimryptienttudiedemtrteprogrmmedglycolyticmetbolmPDAugHP13CpyruvteMRIcedcverilctteducedcverilnetumcompdnmlpncOurplimryultlouggeterlymetbolicchngemeudHP13CpyruvteMRIcnpdicttumperpyBuildgeexcgultwepropoevetigtefirttimevlueHP13CpyruvteMRIrpypemirgPDAptientInAim1wedevelopfeHP13CpyruvteMRIcquipot-procegnlytrtegieoptimizedPDAmetbolicevlutiInAim2wemirerlyrpypeugthimggpprochptientdvnced/nectblePDAInAim3wedetermewherHP13CpyruvteMRIcnpdictpeNATthroughcltipthologicpeptientectedPDASuccefulcomplethprojectprovidefirtdnHP13CpyruvtemetbolmPDAperpyoverrchggoltterguidgclicldecimkgimproveurvivlptientthdedlydeePROJECTSUMMARY/ABSTRACTAmjhurdlecliclmngementpncticdenocrcom(PDAC)proundtncechempeuticexhidetumPDACchemotncemededtummicroenvirment(TME)oltedPDACcellcultudexvivodilypdrpiewhilePDACcelltumdotThuidentifygTMEfcrmechnmwhichTMEgultedrugpePDACcriclgbleeffectivelyttthdeeTowrdgolidentifygTMEfcrgultgPDACbiologywehvetkentrtegymeurgphyiologiclprmeterPDACTMEctgecdiexvivotudymechnticdetilhowPDACcellimpctedTMEphyiologyAprtthpprochwecentlydevelopedtechniqueoltetertilfluid(loclperfute)PDACtumqunttivemetboleprilgtechniquemeuvilbily~150mjnutrientPDACTMEThprovidedufirtqunttivetlnutrientvilbilyPDACwefoundloclnutrientbundnceetumwtrikglydiffentthnbulkcircultihelthytueTotudyhowbnmlccenutrientTMEcouldimpctPDACcellwedevelopednovelcellcultumodelwhichPDACcellcultudpcelevel~120mjvmnutrientyencounterntiveTMEUgthmodelwefoundPDACcellexpoedTMEnutriexhibtncewiderryclicllyuedchempieidentifygbnmltumnutrientvilbilycriclTMEfcrmedgchemotncethdeeFurrnlyTMEnutrient-ducedchemotntphenotypedicted(1)cedvilbilymocidglyceTMEcuePDACcellcomehighlychemotnce(2)TMEglycedoenotendowPDACcellbilyevdectichempierrbilylertedmgeducedrpeuticchllengeBedeplimrytudiewedevelopedhypoTMEglyceimpirbilyPDACcellundergocelldethpechempeuticultthuenblgPDACcelllertechempeuticttmentInthpropolwedeterme(1)metbolicbhowglyceccumultePDACTMEiftrgetgTMEglycevilbilycnenizePDACtumchempy(2)mechnmwhichPDACcellglerncechempeutictiftrgetgelerncemechnmcnynergizechempyTherpytncemjctriburpoprognoPDACptientOurwkddethkeyrpeuticchllengedeemuchunmetcliclneedcouldidentifynovelrpeuticoptiPDACptientProjectummry/AbtrctPclxel-ducedperipherlneuropthy(PIPN)ocedneuropthicpignificntdvereeffectexperiencedcncerptientwhoceivedpclxelfuiItcndverelyffectdilyctiviequlylifeometimeceupentmentwhichcnnegtivelyimpcturvivlHowevermechnmunderlygpthogenePIPNuncerthdergdevelopmenteffectiverpiethcombidyThepropoedtudieimidentifymoleculr/cellulrmechnmgPIPNPtientcutepdurgpclxelfuihvehigherrkdevelopgPIPNuggetgcuteexctienyneurlkeddevelopmentPIPNOurcenttudydictepclxelexceenyneurhibgKCNQchnnelbundntenyneurxNeurlover-exctiultquickATPdepletiTrnpttimoleculewrdwyomnATP-dependentprocecriclmichdrilemblyclernceWehypoizecuteover-exctiprimryenyneurducedpclxelledATP-dependenttrnptimpirment(cludgmichdrimiphgoome)xultgpthologiclltertiextmieckgglovedtriiInpropoedtudywefirtdetectwhererlyover-exctiDRGneurducePIPN-likeltertiGeneticoluedtimulteenyneurmirPIPN-likechngeSimultneoulywelouegeneticolhibenyneurdetermeifcnpventdevelopmentPIPNTheltihiptweenATPlevelmichdrimovementxobervedlive-cellimggTheptiotempldtriibnmlmichdrimiphgyctivylgperipherlfirfterpclxelexpouobervedvivoevluteroleneurlhypexcbilypthogenemichdrildyfunctiwhichcricldevelopmentPIPNltihipckgglovedtriienydyfunctiTheeffectctenATPbuffermichdrimiphgyloobervedFllyefficcyctetiggimePIPNnimlmodeldetermedctextmetttictumburdenTheethtudymyledtterundertgmechnmunderlygPIPNwelldeletenoveltrgetttmentPIPNPROJECTSUMMARYMettprimrycuecncermtlyyetfewbtcncerdrugeffectivelyhibmettBtcncercelluecollectivemigrtimodellignurroundgextrcellulrmtrix(ECM)fibrilwhichfcilteviAlignedtumtrompogrphycnducecluterbuddgdemtibtcncercellThegolthprojectidentifychempeuticdrugugengeedbiomimetictumvimodelevluterpeuticfeibilyhibgtrgetgenevolvedbtcncerdemtiTochievethgolwedevelopedqui-3Dnnopogrphicllyptternedubtrtecptgnnoptternedimpednceelectroderry(nnoIEA)quntifycollectivecellmigrtiprolifertil-timethigh-throughputWevlidtg3DlignedcollgenfirhydrogelmodelctroloverfirlignmentcpultefirdimeniienttivivobttumtromTheemodelmrkedlypromotebtcncercluterdemticetncechempyInourplimrytudywehveidentifieddiffentillyexpedgeneviRNA-eqtweendemtedtumcellclutern-demtedtumcellugqui-3DmodelWepuruetheimlevergeourexpertecncermoleculrbiology/genomic(Ahn)tueengeerg(Kim)mchelerng(ML)-bedimgenly(Lee)cncergnoid/mett(Ewld)phrmcology/drugdevelopment(Liu)Humnbtcncerptient-derivedxenogrft(PDX)cellcluter/gnoidvetigtedthprojectInAim1weevluteeffectfollowgdrugcollectivecellmigrtigrowthugnnoIEA[]23cologydrug(out147drugweteted)whichmotignificntlyhidvibilybtcncercellqui-3Dmodel[b]73n-cologydrugwhichhidvibily22btcncercellletlet4-foldcventil2Dcultu[c]95hibirtrgetgene(CYP1A1CYP1A2CYP1B1)InAim2wechrcterizephenotypicpebtcncercell/gnoididentifieddrugcidteAim1uglivecellmicrocopyMLnlyePhenotypicchnge(egmotilymphology)quntifiedctrtubpopulti(n-vivevvive)drug-ttedcellvunttedInAim3weevluterpeuticfeibilygultgtrgetgenehibcncerviWedetermeexpitrgetgenetprotelevelPDXgnoidnclteegnoidvivene3DmodelWendetermehowhibrgetgenefluencechemoenivyPDXgnoiduppeirviveneThprojectceourundertgmechnmpogrphy-ducedbtcncerdemtietblhourtumECM-mimeticnnoIEAMLimggnlypcliclcncervimodel/ychrcterizeheterogenoucellpopultidiffentmettticphenotypeidentifychempeuticgentdictlyhibbtcncerviSUMMARYWepvioulyptedvibilyomebtcncerdependhnedecetyle6(HDAC6)Welodevelopedbiomrker(HDAC6-covlidtedNYCLIAcertifiedtet)identifycncerdependHDAC6functiBynlyzgover3000primrybtcncerwehvecentlyfound~30%llbtcncercnneftrgetedrpygtHDAC6ThuwedeignedclicltrilprtnerhipAcetyl/CelgenevetigteledgHDAC6hibir(HDAC6iRicolott)plunb-pclxelbtcncerrpy(NCT02632071)NotblywehveobervedthgimenwelllertedcliclctivyidentifiedptientmettticdeeMoleculrlywehvefoundHDAC6de-cetyltecMychibiHDAC6promotehypercetylticMycdegrdtiproteomeFurrmowelkedductiMycexpidueHDAC6hibinticncerctivyHDAC6i(mnucriptcceptedNtuCncer)ObjectiveInthgrntpropolourultimtegolundertmoleculrmechnmmedenticncerctivyHDAC6i/uethmtiimproveHDAC6-bedbtcncergimenInthgrntpropolwepurueeobjectivetwodependentcomplementryimAim1DefecliclpceHDAC6hibirbtcncerttmentwehypoizecludgHDAC6i/rpeuticgimentHR+HER2+ptienthighHDAC6cohveuperirpeuticimpct-Aim1EvlutepehighlowHDAC6-coHR+/HER2-cncercellcombtiHDAC6i/trdcytemicrpy-Aim1b-Aim1bEvlutepeHDAC6-cohighlowHER2+cncercellcombtiHDAC6i/trd--cytemicrpy-Aim1cMoleculrchrcteriztumpettum-tummicroenvirment(TME)levelugc-RNAeqptiltrncripmicAim2InvetigtemechnmtnceHDAC6i/btcncercellDepeuccetrgetedrpietncettmentcnemergeHewepermbothcidte-drivenundcomphenivenlytuempleptientourtrilplucelllePDOctlogfunctillytetmoleculrdiffencetweenenivetncecncer-Aim2Prilepot-trnltilmodificti(PTM)c-MYCHDAC6i-tnteniveBC-Aim2bEvlutetedy-ttelevelproteomlctivyHDAC6i-tnteniveBC-Aim2cNetwknlyHDAC6i/enivetntBCcell-Aim2dIncepecificyHDAC6cotncedtProjectSummry/AbtrctDemogrphicchngecommercillyudpopultifollowgimplementtiAfdbleCAct(ACA)pecificllyimprovedenrollmentner-pothoechriccombidie--myhveprdoxicllymgnifiedproblemunderurnceurnceleveperthighrkfncilhrdhipcgpfollowgillneThecentrlobjectivethtudyundertextentwhichcommercillyudcncerptient--prticulrlyner-pothoechriccditrkhtfllcdverefnciloutcomeOurwkghypounderurncecuggpcfncilhrdhipubtntilproptivulnerblecncerptientcommercilurncepot-ACAerToddourobjectivehypoweutilizenovelper-lkedpopulti-leveldtbeclude1)WeternWASEERcncergtrydtcncerptientdignoed2009-20222)WAttevotergtrtifiledt(n-cncerctrol)3)Enrollmentclimcdttelrgetcommercilpyer(RegenceBlueShieldPmerBlueCro)4)LgudlfncilcdcdTrnUni5)WhgnSttebnkruptcycd6)MedicidenrollmentcdUgthuniquedtbeupdtednnullyourfirtimunderthowneighbhoodchrcterticfncilhelthcliclchrcterticcommercillyudcncerptienthvechngedfollowgACAimplementtiDueexpedeligibilycommercilurnceunderACAwehypoizegterpropticncerptientdignoedpot-ACA(2015-2022)liveocioecomicllyddvntgedneighbhoodfncillyfrgile(lowercdhigherdebtdelquentpyment)hvemocombidiethnp-ACA(2009-2012)ptientOurecdimetimtepot-ACAtndout--pocket(OOP)cotexpouunderurnceemphvulnerblepopultiWechrcterizetndvribilyOOPexpourkunderurncecncerptientcroemployer-bedACAmrketplceplnOurthirdimdetermeextentwhichcommercillyudvulnerblecncerptientdignoedfterimplementtiACAexperiencedpriecoutcomecompdlevulnerbleptientInddiwemeultihiptweenOOPcotexpoudvereoutcomeechpopultidefedgpqulycfncilhrdhipdenrollmentcommercilurnce/enrollmentMedicidfollowgdignoThuniquetudygogcollbtinexternlcommuny-bedmulti-tkeholderdvygroupprovidecrucilevidencemcliclpolicydcuiimedtidentifygducgdpriettmenutcomemgcommercillyudcncerptientpot-ACAerABSTRACTChimericntigencepr(CAR)T-cellvolutirycncerttmentprticulrnefgenertgmemyT-cellcnltyeruppcncerlpeCAR-expgCD8+T-cellhveenhownculeukemicncerclicltrilgtucceHowevermnychllengemeCAR-bedimmunpycncomewidelydoptedprticulrlyolidtumAmjproblemCART-cellcomeexhuteddyfunctildplydecedrpeuticeffectivenewhenubjectedprolgedntigentimultummicroenvirmentElevtedcyolicclciumocedT-cellctivtiuchclciumignlgctivycnuedqunttivemeuT-cellfunctidyfunctiThehryclciumignlgoverhtlgperiodtimeencodemtiboutcurntfunctilcpcyT-cellnumrtumcellencountedptcnuedbothevlutepopultidividulcleelectcletntexhutiHoweverimggclciumignlgctivyvivougtrdilgeneticllyencodedfluocentdicrpentuniquechllengeT-cellhighlymobilecelltypeepecillywhenmedium-lg-termctivytrckgquidThecurntlynofcilemethodimgeclciumignltgle-cellleveloverlgtimeperiodtrckclciumctivyhryuchhighlymobilecellpopultieirvrovivoInthprojectweueeverldtctvrietiephoctivefluocentprotecoupledfmilyhigh-ctrtbiolumecentclciumengenerteOpticlRecderClcium(ORC)cpbleptght-medium-lg-termclciumignlghrieCART-celluppetedexpoutrgettumcellWeddillyengeermllmoleculeubtrteuedtime-gtehrycdgimprovedbiovilbilycellpecificydiverifywvelengthlightemtedbiolumecentendomeproTheengeedORCultimtelyued(1)trckexhutittuCART-celloverlgperiodpetedexpoutrgettumcell(2)enrichexhuti-tntpopultiCART-cellCRISPRknockoutlibrrie(3)qunttivelynchmrkexhutitnceCART-cellcleTheeproddillyvlidtedCART-cellvivoubcutneoumouetummodelUltimtelywenticipteORCfirtbrodnewclgeneticlly-encodedprocpblecdgpecificbiochemiclignlhryn-vivelymnydeemodelrpeuticterventiPROJECTSUMMARY/ABSTRACTHnedecetyle(HAT)zc-dependentenzymectlyzemovlcetylgroupepilmelyeidechTheeprotehveenwidelypuruednti-cncerdrugtrgetrpeuticdevelopmenthenlrgelyunuccefulgiveneentilntumnyHDACproteRecentlywedcovedynticlethlltihiptweenHDAC1HDAC2whichcuedcurntchromoomldeletiulthemizygoudeletiHDAC1neuroblmHDAC2multiplemyelomAultHDAC1deletineuroblmcellhyperenivedruptiHDAC2vicevermultiplemyelomUgdTAG-mededdegrdtiCRISPR/C9-bedgenedruptiwedcovedtrgetgHDAC1/2ynticlethly(egdegrdgHDAC2neuroblmcellhemizygouHDAC1deleti)ultdociNuRDchromtmodelercomplexwhichHDAC1/2memrDocicomplexultdegrdtiNuRDubunelectivelyquidneuroblmmultiplemyelomurvivluggetgHDAC1/2ynticlethlycnlevergedtrgetubun-pecificNuRDvulnerbiliecncerWehypoizeHDAC1deleticueNuRDubunHDAC2/MBD3/MTA3eentilneuroblmwheHDAC2deleticuevulnerbilieloirprlogHDAC1/MBD2/MTA2multiplemyelomHeweddthhypoexplotrnltilpotentilevulnerbiliedevelopgmll-moleculemodulrtrgetNuRDtructu/functiInAim1we(i)DetermewherMBDMTAvulnerbiliecuedHDAC1/2deletiugCRISPR/C9ducibleRNAidTAG-bedpprochevrovivo(ii)RevelwherloNuRDubunquidcncercellurvivlleddoci/degrdtiNuRDcomplexugundproteomicpproche(iii)EtblhifHDAC1/MBD2/MTA2HDAC2/MBD3/MTA3mdtctNuRDub-complexeultHDAC2HDAC1deletipectivelyTheeexperimentdetermeifubun-pecificNuRDvulnerbiliecuedHDAC1/2deletiimplyexploedHDAC1/2ynticlethlyInAim2wedevelopmllmoleculetrgetgNuRDcomplexexploNuRDvulnerbiliegeneticllydefedcncerub-typeSpecificllywe(i)developprlog-electivePROTACdtguhtweenHDAC1HDAC2(ii)determepotentilcovlentligMTA3-Cy532druptNuRDtructu/functiMTA3-dependentcncer(iii)developMTA3-trgetedPROTACbedligcovlentlyenggeMTA3-C532AlgeruccefulcompletieimdetermemechnmunderlygNuRDvulnerbiliecncerdvncenovelchemicloldrugtudymDeperpeuticdvnce5-yerurvivlrtemetttictriplenegtivebtcncer(TNBC)hnotimprovedignificntly30yerAuchignificntnefptientdvncedbtcncerultdevelopgnovelrpiewhichtrgetdvncedmettticbtcncerToddthneedwecenedmettticcncergenewhichcouldctriemettFromthcenweidentifiedMDA-9/Synten-1/SydecnBdgProte(MDA-9)gulrcncercellmettPublhedplimrytudieugeverlmouemodelmettcfirmhibgMDA-9pventmettenizeprogivemetttictumchempieledgimprovedurvivlTheeultuppthypotrgetgMDA-9hibirledcombrilrpeuticpprochimultneoulyhibbothdemtigrowth/urvivlprogiveTNBCWedevelopedneffectivemllmoleculehibirMDA-9clledPDZ1iAdmtergPDZ1ieverlmouemodelmettticcncereffectivelypventmettenizemetttictumchempieupptgourhypoInthpplictiwepropoeexperimenttterunderthowPDZ1iexertnti-tum/mettticeffectifthmticnuedmkePDZ1itterchempyInSpecificAim1weeekmultePDZ1icliclpplictibuildgupourplimrywknovelnnocrytltechnology(PDZ1i-Nno)chrcterizen-cell-unomoumechnmwhichPDZ1iuppetumgrowthFocuimmuneytemprticulrlyfiltrtieffecrimmunecellpePDZ1i-NnottedtumcellExperimentemployTNBCmettticmouemodelhumnptient-derived(PDX)tumhumnizedmiceThepceimpctthcrumenntumgrowthctrolevlutedthimInSpecificAim2genomewidedtetueddefeignlgpthwygulrytrncriptifcrdown-tmgenetrgetgultedMDA-9promotecellmotilyvromettvivoInSpecificAim3PDZ1i-Nnocomdtrdc(SOC)chempypclxel(Txol)improverpymouemodelTNBCTheetudiecludeugPDZ1i-NnobothndjuvntneodjuvntettgmenpventgpperncemetteExperimenttudyhowPDZ1i-NnoenizeTNBCcellhotcelleffectchempieimprovetumgrowthctrolwhichquidPDZ1iprogclicltrilBecuePDZ1imllmoleculehibirhilfvbledrugchrctertic(ADMEphrmcoketicxicytetg)permwellmouetummodelcncomdFDApprovedSOCchempieulttherchprogrmcouldledentrypheIclicltrilducglgtimeuntilnefcouldlizedbtcncerptientSUMMARYChempyducedperipherlneuropthy(CIPN)motpvlentneurologiclcomplictiltrvenouchempyApproximtely5090%ptientunderchempyffectedCIPNrhighrkchricy(pprox3040%)LimedympmticliefprovidedopioidnlgeicntidepntnticvulntUntuntelypthogeneCIPNtilllrgelyunknownSeverldiffentclenticncerdrugctgthroughdiffentnteoplticmechnmcnduceCIPNHoweverenyimpirmentlwyeirlypdomntdvereeffectuggetgextencecommmechnmpthogeneTubulbuildgblockmicrotubulewell-etblhedtrgetmultiplenticncerdrugcnpromoteCIPNThectriubulchngeetCIPNnotwellunderodtrglyimplicteddetermgfcrTubulmicrotubuleplycrucilroleenyneurlfuncticludgdtriicrgodtlginerveTRPchnnelctivygultimichdrildynmicTheoverllhypothpropolCIPN-promotgdrugmyhnunderlygmechnmpthogenebedmodultubulpot-trnltilmodifictitprodromltgedeeWefurrevlutewherccumultidelt-2tubulnirveriblemodificti-tubulwhichwecentlyfoundmedexldegenertinti-cncerdrugbtezomibplycommpthogenicroleneuropthicdmgeflictedunltedCIPN-promotgdrugFllyweexmectriimichdrilTRPchnneldyfunctixopthyducedccumultiD2DRGneurOurpropolbedourpublheddtdevelopmentrobutcellulrpcliclmodelCIPNgenertedngogcollbtitweenPIDrYldMoyedico-vetigrthpplictiCollectivelyourtudieprovidemechnticightunifygmodelpthogenedevelopmentCIPNbedtubulmodifictidictlyexmeunexplodpotentiltubul-modifygenzymedrugrpieimedtpventgxljuryneuropthicpCIPNTheylopvewynlyzepthogenicrolemodifiedtubulerchempy-lteddvereequeleuchnephroxicyoxicywellidiopthicheredmperipherlneuropthyddiCIPNABSTRACTSurvivchildhoodcncertcedrkchrichelthcdi(CHC)erlymtlytrtetypicllymgdividuldecdeolderuggetgnccelertedggphenotypeHoweverlimedtudiepplygmoleculrbiomrkerquntifyccelertigglg-termurvivchildhoodcncerHewepropoepplyepigeneticgemeubiologiclggvetigtetrjecrieepigeneticggrkfcrhelthoutcomethpopultiOurpropolbuiltupourpvioutudieptgepigeneticgeccelerti(EAA)ignificntlyhigherurvivchildhoodcncerthndividulouthrycncerocedttmentexpouunfvblehelthhvipenceCHCTofurrourerchwetkedvntgerichourceStJudeLifetimeCohtStudy(SJLIFE)whichclude42635+yerurvivchildhoodcncerwhohveenchrcterizedgenome-wideepigeneticprilg(MethyltiEPICBedChip)ugperipherlbloodmuclercell(PBMC)collectednetimepot(T1)welldocumentedcncerttmentexpouhelthhviocildetermnthelth(SDOH)wellcomphenivecliclementCHCWelomeuEAAet1804urvivPBMCcollectedtecdtimepot(T2)1000urvivthirdtimepot(T3)ntervlpproximtely5-yertweendjcenttimepotInddiwelevergetwogogNIH-fundedterventrilTelehelth-bedterventiimprovefne[CA246570]eHelerventilteeffectchildhoodcncer[CA239689]whebiopecimencollectedefterterventiundergoepigeneticprilgTheoverrchggol1)exmeeffecthelthhviSDOHfcrrtechngeEAAdurgfollow-upSJLIFEcoht2)evluteocitweenrtechngeEAAubequentlg-termoutcomecludgpvlence/every/cumultiveburdenCHCmtlydurgfollow-upSJLIFEcoht3)determeimpcthvilterventiphyiclfneleepqulychngeEAAOurnoveltudyencompobervtilterventilcompentechlgudlpetedmeuEAAtupthetime-potenbleevlutichngeEAAFdgn-HpnicWheurvivevluteddiverepopulticludgn-HpnicBlckHpnicurvivwelln-cncerctrolnexplryfhiSuccefulcompletipropoedtudyubtntillydvnceourundertggenertenewightccelertedggphenomenmdevelopmentnovelterventilowdownccelertedggpvenrmedege-ltedCHCfciltefutuclicltrnltiEAA/ggbiomrkerptientcwhichcricllyneededggurvivchildhoodcncerPROJECTSUMMARY/ABSTRACTTtgKRASmutntlungdenocrcom(LUAD)mmjchllengecliclcologyApproximtely20%KRASmutntLUADtumcrrylo--functimuttiKEAP1negtivegulrNRF2whichmtertrncriptilgulrendogenountioxidntpeUgCRISPR/C9-bedomticedggeneticllyengeedmouemodelKRAS-drivenLUADwedemtrtedloKep1hyper-ctivteNrf2drmticllyccelerteKRAS-drivenLUADCombgCRISPR/C9-bedgeneticcengmetbolicnlyewehowedKep1mutntcelldependenncedglutmemetbolmthpropertycnrpeuticllyexploedthroughphrmcologiclhibiInthpplictiwefocuchrcterizgmoleculrmechnmrpeuticpotentiltrgetgglutmemetbolmKRAS-drivenKEAP1mutntLUADThpplictiim1)AerpeuticpotentilnovelglutmentgtbothhumnmuKRASG12D-KRASG12C-drivenKEAP1mutntLUADp-cliclmodel2)Providertileub-trtifictihumnlungcncerptientKRAS-KEAP1-NRF2mutnttumlikelypderglutmentgtdetermerpeuticpotentilcombgclicllylevntKC-IDRP-1043)ChrcterizemetbolicmechnmunderlygglutmentgtenivyKRAS-drivenKEAP1mutntLUAD4)IdentifymechnmtnceglutmedependenceOurtudieprovidertileub-trtifictiptienthyperctivtiNRF2pthwyttmentpderDRP-104novelglutmentgtclicltrilwhichpertentgolpcimedicePROJECTSUMMARYEndemicBurktlymphom(eBL)outcomechildndvncedtgedeemrkedlyferhoechildnerly-tgedeeeBLemotrpidlygrowgtumAultdignoticdelydy--weekctrieltepenttidictlyffecttgecurbilydeeBLmotcommchildhoodcncerUgAchildlrgejwmdilycognizedhvgeBLtypicllyttedehlogiccfirmtiHoweverchildleerjwwellgnbdomlmmyttedempiricntimicrobilobervedweekEvenfterprocedupermedupectedBLflhpthologytypicllynotvilblentwoweekEBVctentlyocedeBLdetectblebloodliveBLptientAlthoughEBVDNAholdpromenerlydetectimrkereBLdignoticutilylimedpopecificyEBVDNAnotltedtumpentbloodmllfrctiltentlyfectednmllymphocyteEBVvirimypentplmEBVvirilofquentlydetectblelivWehypoizepecificymlignncywouldmrkedlyenhncedenrichgpecimencircultgtum-derivedEBVDNAThmyccomplhedmodifygpnlyticlvriblepecimenpprticludgupfrtcelltbiliztilimvirlDNAlekgeltentlyfectedcellelimtinmllymphocyte(epililcellliv)myhrbltentEBVDNAenrichmentCpGmethyltedDNAwhicheffectivelyduceviriDNAceneverCpGmethyltedEnrichmentmethyltedEBVDNAprticulrlynovtivepprochimproveypecificyWetetehypoetwoimInAim1(blood)PBMC-derivedvirlDNAducednlyzgplmoppoedwholebloodbuffycotcellcollectedcell-tbilizgtumimizeexvivocelllyViriEBVDNAexcludedviCpGmethyltedDNAeprtiTheeffectpecimentrnpttempertutimepnlyticlvriblecell-feDNA(cfDNA)coveryEBVDNAmeumentevlutedInAim2(liv)collectechniquemimizelepililcelllymphocytemimizeexvivocelllylgexcluiviriEBVDNAeedTheeffectpecimentrnpttempertutimeddivecell-feDNA(cfDNA)coveryEBVDNAmeumentloevlutedTheetudieimdefeoptimlpecimenpprtimethodfeibleAfricnettgelewhecnervebfututrdbiopecimenciencecommunytlrgeImproveddignoticpecificyEBVDNAmeumentchievedoptimizgpnlyticlproceduhouldtrnltedictlyerlierdignoehighercurteeBLImprovedpecimenhlglohpotentilimproveeBLttmentmirgcouldextrpoltedigno/mirgEBV-ocedmlignncieWhenpcliclerchfilplictehumnbiologycientificprogtllclicltrilflterptientctueufferWhilemnyfcrctrieefilulckttentip-nlyticvribilyemlueWecentlyptedevenht-termexpoumbientirufficienttriggerignlgchngetumn-mlignntbiopecimenThoechngeturnlterirbiologypivenetrgetedrpieOxygen(O2)tenivriougnrnge3-9%wheO2mbientir21%UgtrngenicmodelbtcncercicfluidptientovrincncerwedemtrteddiffentilexpivriouignlgmoleculecludgYAP1NRF2/KEAP1WNT/b-CATENINwhenbiopecimencollectedproceedunderphyioxi(3-5%O2)compdmebiopecimencollectedproceedundermbientirWeloobervedbldrug-ducedignlgnetwkdetermecellulrpetrgetedrpieimpctedexpoumbientirKeyignlgmoleculeffectedcludepEGFR(Y1068)pPDGFRb(Y751)pAKT(S473)pERK(T202/Y204)DNMT3ATET2BRD4BedeultwehypoizeexpoubiopecimenmbientirdurgcollectiprocegcctlyetimtelevelmnyignlgmoleculeuedbiomrkerdefetumchrcterticdetermepotentilneftrgetedrpieTheeffectmbientirexpoudurgcollectiprocegextendbiopecimennmltueimpctgchrcterizticell--igirocedcncerExperimentdeignedtheimtetehypoeInfirtimwecollectbttumbiopiemlignntcepleurleffuiunder135%O2flectgvribleO2tenumnpermcomprtivenlyoutubequentexpoumbientirignlgmoleculeltedboveSceourplimrytudiehvehowneffectmbientirexpoulevelDNMT3ATET2twomjdetermntDNAmethyltiim2vetigteeffectmbientirexpouDNAmethylometrncripmeInthirdimuguniquetutilourceKomenTueBnkwldlypoirynmlbttuedtedhelthywomenuppterchwechrcterizeeffectmbientirexpoulevelbiomrkerAim1trncripmeSuccefulcompletietudiechngehowmplecollectedproceedenurgO2expoumimicO2ccentrtignlimtroductimbientirO2-ducedchngeInddhwkcedevelopmentnewcollectidevicelimexpoubiopecimenmbientirWhpectthpecificFOAthpropolddethemjpicimprovgcliclbiomrkeryttmentdeciddglimedtrnltip-cliclfdgclicevidence-bedtrdiztibiopecimenhlgproceduPROJECTSUMMARY/ABSTRACTProttecncermotcommecddedlietn-kcncerAmericnmenccountg26%newcncerdignoe9%cncerdethmenActiveurveillncerdiclprottecmyrdipycommlyuedttmentclicllyloclizedprottecncerHowevercurntrktrtifictimethodcnnotuedeffectivelyvoidubjectgptientclicllydolentcncerunneceryterventicugignificntmbidycotTheprimrycompentcurntlyvolvedcengdiglctlexm(DRE)erumbiomrkeruchPSAPCA3PHI4KcoUntuntelydepedvnceetetoverdignommjproblemduelimedpecificyAult90%ptientdignoedprottecncerceivettmenteventhoughup60%thoeptientcouldcidtectiveurveillnceSuchttmenttenultlg-termductifunctiloutcomeTheerchobjectivethR01developnovelmrkermodelbothmoccurtelydetectggivecncerectrrivlUglrgecohtptientwefirtplnidentifynovelpthomicgermlefetudictepenceggivecncerpcurWenplnimplementntegrtivegrphcvolutilnetwk(GCN)comdcvolutilneurlnetwk(CNN)genertenewmulti-modlpenttiunderlygcncertteentiprotteThefrmewkcommultiprmetricmgneticnceimgg(mpMRI)diglhlogyimgegermlefetubiomrkerpdicrWeloimplementbelenomogrmrkmodelcomprwelleverlnewnomogrmmodelcpteournewlyidentifiedfetuAbtrctProttecnceremotcommcncermgmenlthoughcnuccefullyttedomemendeveloptncerpiecnlpeThuprudentdcovernewrpeutictrgetdeveloprpeutictrtegieutilizeldydevelopedrpieexpededevelopmentnewttmenptiprottecncerptientProttecncercncuedtgeneticepigeneticlevelNlydoepigeneticmodificticludeunwdggene(ieDNA)oycnexpedRNAthepigeneticgulticnloedRNAOneepigeneticmodifierproteenzymeenhncerzethomolog2(EZH2)nmllymodifiehneH3K27tightlywdgDNAilencggeneexpiOurpviouwkhowedEZH2upgulteddvncedprottecrcommettticprottecncerprottecncerptientwhohvehigherexpilevelEZH2hvehterurvivltimethnprottecncerptientlownoexpiEZH2SurprglywecentlydcoveddygultiEZH2lterRNAedgwhichtllydiffentwell-knowncniclfunctiprotemodifierRNAedgcnffecttbilyRNAducevrimuttitrunctiRNAwhichlterimptntgultiRNAprotetrnltifidelyTheerrnteffectRNAltertiRNAedgocedcncerprticulrprottecncerTheevetigtgthnovelEZH2n-cniclfunctiRNAedghelputterundertprogidvncedprottecncerAlthoughdevelopmentEZH2hibirhennctivevetigtimultiplebiotechphrmceuticlcompniehveendevelopguchdrugEZH2hibirlehvenotproveneffectivemotolidcncerThuidentifygnewrpeutictrgetleddevelopmentnewdrugcncomdldydevelopeddrughenceexpedgdevelopmentnewttmenpticncerOurdthowfirttimeEZH2dictlyterctADARwhichnRNA-pecificdenoedemeetwoenzymepibleedgcvertgdenoeoeRNAMotdvncedprottecncercellhvehigherexpilevelEZH2ADARcompdthoenignprotteepililcellerlytgeprottecncercelluggetgimptncebotheproteprottecncerprogiInpropoedprojectweidentifypcelyhowEZH2ADARterctedubtrteprottecncerNextwetudyhowEZH2ADARwkgerpromoteprottecncerprogiUndertgemechnmledfutudeignnewhibirEZH2ADARTheeourwkprovidenovelrtiletrgetbothADAREZH2wepdicthibibothADAREZH2killmocncercellthnhibgeirADAREZH2leProjectSummry/AbtrctProteomehibir(PI)drugturnedunttblemultiplemyelomttbleignificntlyimprovequlylifemultiplemyelomptientThetheFDA-pprovedPIdrugInddilmultiplemyelom(MM)PIdruglopprovedttmntlecelllymphom(MCL)myloidlightch(AL)myloidoWldentrmmcroglobulemilttertwcurblerdderltedplmcellNeverletnceevblyoccurAllthedrughveeriouxicieAhighpercentgeptientufferneuropthydebiltgdvereeffecttwopeptidebtebedPIdrugbtezomibixzomibAnPIdrugcrfilzomiblohcrdiovculrnlxicyNotblynePIdrughowedltlecliclnefttgptientolidtumnumerouclicltrilStudiehvehownupttmentPItrncriptifcrNRF1ctivtedexpmoproteomenderPIdruglen-effectiveRecenttudiehowwhenchymotryptic5tryptic2proteomeimultneoulyhidNRF1tedctivtimgggteddrmgbilytumcelltpoptictducedproteomehibiBecuetrikgdiffencetweenchymotrypticproteolyticpfence5clevefterhydrophobiciduetrypticpfence2clevefterbiciduechllenggdevelophibircntrgetboth25imilrpotencyBeideuch52trgetghibirwouldlohvepcidic1ctiveubunvoidnpecificcyxicyNouchhibirhveenptedpeptidebtepeptideepoxykenecleThetheknown52-hibirclellmirveriblecrrygunpdictblexicieWehvenowdeignedchrcterizedgroupmcrocyclicpeptidebteimultneoulyhib52not1TheecompoundelicmrkedlyleNRF1ctivtriplenegtivebtcncercell(TNBC)thnBTZWenowimctueourtempprochdvncetructu-guideddevelopment52hibircncerttmentimprovgirpecificyphrmceuticlpropertieevluteirvrticncerctivyvivoefficcynimlmodelTNBCInAim1thpropolwecducttructu-guidedledoptimiztiimprove52-hibirpotencypecificyphrmcoketicpropertieInAim2wetet52-hibircyxicygtbtcncerlecellAim3tetefficcy52-hibirnimlmodelTNBCProjectSummryOyrkfcrpncticductldenocrcom(PDAC)cncerhdml5-yerurvivlrteduelimtipventtmentOypromotePDACtumigenewenurvivlcgytemicflmmtimetbolicdyfunctichempytncemechnmdrivetumigeneoyunknownDeletglipocl2(LCN2)oegeneticllyengeedmouemodel(GEMM)PDACdeceflmmtummicroenvirmentceurvivlLCN2cnbdlipidliglikefttycid(FA)whichdygultedplmdipoetueoePDACubjectLoleiccidcnupppro-flmmryignlthrougheverlpthwycludghibgLCN2bdgmtrixmetlloprotee-9WeoberveloleiccidwlowerplmrchidiccidlevelhighlybundntdipoetueoePDACptientArchidiccidcnderivedloleiccidncvertedpro-flmmryprotglenzymecyclooxygene2(COX2)WehvepvioulyhownhibgCOX2oePDACGEMMSducePDACThroughmetbolicpthwyloleiccidcnmetbolizednti-flmmryprotglTheeundertghowLCN2loleiccidCOX2functiflmmtimetbolmoymyhelpimprovepventtmentPDACOurlg-termgoldetermehowexcedipoyflmmtidueoyctriePDACidentifytrgetnovelpventtmenttrtegieHYPOTHESES1)SignlgdipoeimmunecelloydrivetumdevelopmentthroughchngeflmmtiFAmetbolmdipoetummicroenvirment2)TrgetgFAmetbolmlowdevelopmeny-ocedPDACdecedipoetueflmmtiToteurhypowepropoefollowgimAIM1DetermedipoetueimmunecellctriiLCN2ignlgoy-ocedPDACWehypoizecgLCN2ignlgexcedipoetue/immunecellctrieoy-ocedPDACdevelopmentprogigrowthmodultgFAmetbolmflmmtumdipoemicroenvirmentAIM2Determewhertrgetgfttycidmetbolmhiboy-ocedPDACWehypoizecgdietryloleiccidlevelhibgCOX2upptummodifygKRctivyprotglbioynpromotenti-flmmryignlgPDACIMPACTWeelucidteignlgmechnmunderliehowchngedipoetueoedividulcndrivedevelopmentprogioy-ocedPDACUndertghowdipoe-derivedfcrctrieoy-ocedtumigenelednoveltrgetimprovgPDACpventtmentprovidemodelfutuwkoy-ocedcncerProjectSummryLungcncerledgcuecncerdethUSccountgpproximtely22%llcncerdethAnnulcenglow-doecomputedmogrphy(LDCT)commendeddultged50-80yerwhohvehrypck-yer20curntmokerqupt15yercengLDCTmctroverildueveryhighfle-poivertecedrdiexpoucotMoovermnydultdignoedlungcncerwhoteligiblecengIn2021USPSTFcommendtittementtkceidentifiedFutuReerchNeedwhichcludecductgmoerchbiomrkernotgBiomrkercouldpotentillyuedidentifyhigh-rkcidtecengLDCTFthprojectwepropoemeuDNAmethyltilevelbloodleukocyteobtedmplewecollectedpriceng(tmultipletimepot)prticipntNtilLungScengTril(NLST)Ourfirbjectivedevelopp-cengolwouldclifyhigh-rkprticipntddilrkctegieducenumrcnneededOurecdobjectiveexmewherdiffenceDNAmethyltimrkercndtguhprticipntpoivecengultwhodevelopedlungcncerthoeflepoive(iedidnotdevelopcncer)OurthirdobjectiveexmewherdiffenceDNAmethyltimrkercndcrimteprticipntwhohdnegtivecnwedignoedlungcncerdurgfollow-upthroughend2014thoenegtivecnwhodidnotdeveloplungcncerUgNLSTrchivedmplellowuefficientlyevlutewherDNAmethyltimrkercnimprovemodelrktrtificthuduceunnecerycnneededpermedwellpotentillytidentifygtruepoiveflenegtiveLDCTcnPROJECTSUMMARYOverptdecdedevelopmentimmunecheckpotblockde(ICB)melnomtumtypehtrnmedttmenptivilblemnyptientcncerHowevermelnomlypproximtelyhlfptientexperiencedurblepettmentweultmortumtypeWehveidentifiedtrtegieenhncenti-tumimmunyenizen-pivemumelnomtumICBtrgetgdRNAptterncognicepr(PRR)TheetrtegiecludegmdRNAenRIG-IloAdenoeDemeActgdRNA(ADAR1)WehowedADAR1nntehibirycheckpottumcelllimnti-cncerimmunytrgetgrpeuticllycntriggermultipledRNAPRRenizetumimmunpyBothRIG-IgmtrgetgADAR1ultedenhncedcykeleemutummicroenvirmentimprovedcrumentctroltumTcellIncentwkwehveuncovedevidenceco-trgetgmultipledRNAengpthwyducecoopertiveeffectenhncenti-tumimmunycompdtrgetggleenHowevereverlgpknowledgelimtrnltietrtegieeffectiverpieptientTheecludei)defgoptimlrpeutictrtegytrgetgdRNAPRRii)undertgmechnmwhichdRNAengtumprogrmimmunecellfunctiiii)identifygptientmotlikelypddRNA-trgetgrpeuticToteteffectdRNAPRRtimultiptienttumimmunempleexvivowedevelopednovelperturbtilglecellRNAequencgpprochApplygthtrtegywefounddRNAtimultiptienttumimmunecellducedtctTcellprogrmctivtiurvivlepprochemymoteffectivetumhighp-ttmentlevelterferignlgdenoe--oedRNAedgInAim1thpropolwetethypoco-trgetgADAR1RIG-Ienhncectivtiprolifertifunctinti-tumTcellWeexplomechnmthfdgmouemodelcludgcedcrumentctivticro-penttumntigendendriccellInAim2weeekidentifytumdetermntrpeuticpetrgetgADAR1uncoverightfciltedevelopmentmllmoleculenucleiccidrpeuticIfuccefulwkdecridthpropolhelpdeferulewhichtumTcellpddRNAtimultidvncedevelopmentdRNA-trgetgtrtegiemelnomtumAbtrctThgolthprojectdevelopcomputerimulticombtirpyggivelymphompplymundertptpoivenegtivetrilenblemodel-guideddeignnewgimenTheoticlmodelcncerdrugpetnceevolutihveprovidedmnycceptulightmodel`penttivetumhvenotenblepdictpedtriiheterogeneouhumnpopultiWecentlydevelopedimultiwhichueclicllyoberveddtriigle-drugpepdictdtriimulti-drugpeTheemodelhveenvlidtedccurtelypdictgmnytrilultolidcncer(9FDApprovl)buurprimodelweoimpledecricurtivettmentcueylckedtr-tumheterogeneyketicHewepropoecceptultechnicldvncemodelcomplexycurtiverpieugDiffueLrgeB-CellLymphom(DLBCL)cetudyOurimultimulti-drugpeciderter-ptienttr-tumheterogeneylerbilydogettmentchedulepeketicdrugterctiWedoptcceptulpprochpopulti-phrmcoketicwheechprmeterhdtriidecribgvrincemgptientWepplythpprochtumdrugpecidergb-tumter-ptientvriPrmeterdtriimedouxperimentldtcletrcgliquidbiopiequntifycllheterogeneypeketicdigiztidecdetrildtAim1nlyzeptcurnttrildrugcombtifirt-leDLBCLtetwhercliclefficcydrugcombtipdictblegledrugefficcyPlimrydthowpt20yernovelcombtrilfirt-leDLBCLcfirmmodelccurcywepropectivelypdictedfirtucce2decdeThimproducepdictivemodelcnhelpdeignfutudrugcombtiAim2vetigteexplntinegtiveulttrilddedtrgetedrpyibrutibtrdchempyWemodelfluencelerbilydoeductienrollmentbttmentchedulecomprgmodeloutputl-wldnlyehowefcrffecutcomeByundertgcuetrilfiluthimcnhelpfututrildeignovercomeeproblemInAim3wecollbteECOG-ACRINtrilgrouppplymodel-guideddeigntrilpcicombtirpyfirt-leDLBCLTheLymphoMtchtrilimmtch5ubtypeDLBCL5trgetedrpiecomdtrdchempyWeueclicldngledrugefficciecombtilerbilyubtypeprognoeccurcyubtypebiomrkerdrugenivieecttrilultooptimizedeigngimenendpotTherchdelivernovtivemulti-clemodeltumheterogeneyolvechllengedeignnovelcombtirpieclicltrilimcumocelymphomPROJECTSUMMARYAemotcommdedlycncertypewldwidequmoucncercnoccurdiveregnecludglungeophguupperdigetivetrctcervixkCurntttmentqumoucncermlylimedggiveurgerieunpecificchempierdipiewhilebiomrker-guidedtrgetedrpielrgelymgThemjyqumoucncerocedovexpiSOX2geneencodgnSRY-boxtrncriptifcrSOX2plyimptntrolepecifygqumoulegedrivequmoucncermtiwhenhyperctivtedDepeimptnceSOX2qumoucncerSOX2trncriptifcrdifficulttrgetmllmoleculeIdentifictilterntiverpeutictrgethdedourlimedknowledgemechnmSOX2cogeneInprticulrtwokeyquetimlrgelyunknown1)howSOX2cogenetrncriptillyctivted2)howSOX2trncriptifcrgultetrgetgenequmoucncerWeddequeti3Dgenomectexteentilpromoter-enhncerterctigenegultihenlrgelymedtrdillergenomicpprocheBedourplimrydtwehypoizeSOX2cogenetrncriptillyctivtedgulrboundtdtlenhncerthroughlg-rngechromtloopencodedSOX2trncriptifcrturnbdenhncercoopertgcohecomplexco-fcrgulte3DgenomerchectucogenictrncriptilprogrmWecomfunctil3DgenomicmyridCRISPRtechnologietetthhypoInAim1wedetermegulrymechnmunderlygovexpiSOX2cogenequmoucncerFocugqumou-cncerpecificenhncerweidentifiedprcipldriverSOX2ovexpiweutilizemotifnlydC9-APEX-mededproteomicidentifytrncriptifcrchromtgulrpibleSOX2ovexpiInddiweueepigenomeedgpprocheterfechromtloopcnectgenhncerSOX2promoterdetermeroleSOX2trncriptilctivtiInAim2wedetermehowSOX2trncriptifcrgultecogenictrncriptilprogrmqumoucncerWepply3DgenomicidentifychromtloopcnectgSOX2bdgeirdicttrgetgeneWenpriizefunctillychrcterize10SOX2-trgetgeneWelodetermeroleSOX2cohecrumentchromtloopgFurrmoweidentifyddilSOX2co-fcrcooperteSOX2trncriptilgultiTheuccefulcomplethpropolvelnovelmechnmSOX2cogenequmoucncerThefdguncoverlterntiverpeutictrgetSOX2-drivenqumoucncerdiveregneProjectSummry/AbtrctNeuroendocprottecncer(NEPC)ftlprottecncer(PC)ubtypeggivecliclfetupoprognoAlthoughrlyoccurdenovottment-ducedNEPChowignificntlycgcidencefterwidepduemopotentntirogenttmentctrti-tntprottecncer(CRPC)centyerctutgup25%dvncedrpy-tntCRPCCurntlyNEPCmcurblemedinoverllptienturvivllethnyertimedignoTheedmlfctundercopgcliclneedidentifynewmoleculrdetermntNEPCpthogeneprogidevelopneffectivetrgetedrpyprolgurvivlInplimrytudiewefoundtrypphnhydroxyle1(TPH1)rte-limgenzymepiblebioynperipherlerknownneurotrnmterenrichedneuroendoctumcliclneuroendocbiomrkercricllyquidmtgNEPCdiffentidevelopmentgrowthGeneticphrmcologiclhibiTPH1NEPCcellproundlypeneuroendocmrkercellprolifertivixenogrfttumgrowthmiceImptntlyourdthowedTPH1upgultedhumnNEPCCRPCcrrygneuroendocfetultiveprotticdenocrcommultipledependentptientcohtMechnticllyourtrncripmicbiomticbiochemiclnlyedemtrtedTPH1ctivtemTORignlgubequentlyE2F1NEPC-promotgcogenictrncriptilprogrmmededynergticllyFOXM1TAZTheenewfdguppurhypoTPH1plynctiveroledrivgNEPCpentrpeutictrgetNEPCTotetthhypoAim1deletemoleculrmechnmTPH1ignlgNEPCpecificllydectghowTPH1ctivtemTOR-FOXM1/TAZ/E2F1ignlgxhowthxcferNEPCgrowthdvntgeneuroendoctrctextTPH1WeloetblhclicllevnceourmechnticfdgeirprognoticvluelrgecollectihumndvncedPCmpleAim2defefunctilbiologiclimpctTPH1NEPCdiffentigrowthprogiugerievrovivophenotypicphrmcologiclycoupledcomplementryhumnmoueNEPCcellgnoidcellle-ptient-derivedxenogrftmouemodelTRAMPtrngenicmiceSuccefulcomplethprojectgtlydeepenourmechnticundertgNEPCdevelopmentprogiprovidecompellgrtilepurpogclicllyvilbleTPH1hibirNEPCrpyquicktrnltilpotentilneflte-tgePCptientnerfutuDevelopgPARP-1PETcompnueypciolguidePARPirpyPROJECTSUMMARYWhenwegivephrmceuticlptientcncerydeervetpdictivemeuwecnemploytellmwherrpyhignificntlikelihoodkillgtumextendgirlifeNoehouldhveufferdrugxicyoutnefIfthpropoluccefulwedevelopnvivepdictivebiomrkerenivyPARPhibir(PARPi)couldpotentillyuedl-timedoemodultiwellptientelectiWhileourvetigtiimpctPARPinytumtypewelrgelyfocubtcncerwhePARPicurntlyuedettgmettticdeedjuvntettgHebilypdictpewouldloprovidecricllyneededbiomrkertrtifyptientclicltriltetgneodjuvntPARPi/chempycombtiepecillytriple-negtivebtcncerpopultiBRCA1/2HRDtetgdictlyelecttummyuceptiblePARPileverggcceptynticlethlydotdictlymeudrug-trgetdenyThedevelopmentimgg-tuemrkerPARPibdgPARP-1expinovtivectextcurntlyuedcompnidignoticPARPiuegenomicyPlimrydtbvrincncerhowytrget(PARP-1)bdgPARPimeudrug-trgetenggementprovidecomplementrymtipperddpdictivevlueInthpropolwedevelopcltivetueypromgPARP-1rdiotrcerugimggimmunohchemtryvrdioligbdgy(Aim1)tetypdictivevluehriclclicltriletptientwhoceivedPARPiknownclicloutcome(Aim2)dictlyevlutehypotrceruptkepdictpenimlmodeldee(Aim3)Thevlidtedimgggenttuecompnidignoticwouldhveplnnedcliclueimilrfluoetrdiolimgg/etrogenceprementClicincouldvoidfutilerpycewhetrgetnotexpedlopotentillyidentifyddilptientwhowouldnefPARP-1trgetedrpycombtitrtegiePcimediceourchneedemployedggivebtcncerIfuccefultherchcouldlednewwyfunctillychrcterizebtcncerguidetrgetedrpyelectierpeuticpetnceThenewimggproimmedelypplicbleptienturcenterproductihentrdizedfciltemulti-centeruePROJECTSUMMARYBtctructiftermtecmycriclcomphenivebtcncerttmentcuecnqulylifebodyimgewhichtenimpidftermtecmyHowevermnyptientnotfedctructiepecillythoewhoidentifyBlckHpnic/LtMnyptientlckknowledgeboutbtctructirkirchoiceboutctructenmlignirpfenceWehvedevelopedbtctructideciidclledBREASTChoicedemtrtedefficcyeffectivenetwomizedctrolledtrilPtientclicinfoundBREASTChoicehighlyublequetedveriycoulduemobiledeviceeilyhfmilyfriendLikemotdeciidBREASTChoiceimplementtihenlimedcliclettghdlimeduptkeFdemtideciupptuccefulmutmkedeciupptvilblehowwhenwhepeoplewntueDemthroughocilmedilecommuniecouldbrodenchBREASTChoicedeciolMotAmericnueocilmedi(81%)ueternethelthmti(72%)Evenmolderdult(60%)ueternetBtcncerurvivepecillyenggedocilmedilecommunieOurplimrydtuggetbtcncerurvivwouldenggeBREASTChoicethroughocilmediGuidedDeigngDemtiprdigmprtnerhip3cncerurvivtwoclicingniztiwepropoedptBREASTChoicedemtethroughocilmedilecommunieAim1AdptBREASTChoicemobileueledemtiGuidedADAPT-ITTmodelwecductertivephetetgbtcncerurviv(n=45)qultiveterviewpiclexpert(n=10)webeprogrmmgchngeAdpttitrckedugFRAMEAim2DeigntetocilmedimegedemtiBREASTChoiceGuidedDiffuiInnovtiTheyweenggekeycommunyprtnergrdgpotentildoptidechngeeocilmedidemtictextcludgdiglopilederpltmdeveloptetocilmedimegeAim3DemteBREASTChoicebtcncerurvivleverggocilmediUgdptedoltetedmegewerolloutocilmedicmpignover12mthWetetcmpignexpouchenggementterruptedtimeerienlyBREASTChoiceeffectivene(urgerychoicedeciqulydecilcflicttfctideci)throughlgudluerurveyUpcompletieimwehveovercomemjcientificgplimeddoptideciidhvedevelopedwidelypplicblepprochdemtgdeciidoutidecliclctextABSTRACTEchyernetimted275000newcevivebtcncerdignoedUSDepemjdvncegmdeimprovebtcncerttmentdeetillccountover40000dethnnullyReerchptdecdehhelpedidentifyheredBRCA1BRCA2pthogenicvrintTheevrinttenocednggivembtcncerwellovrincncerAlthoughttmentvilbleBRCA1-mutntbvrincncermotbtcncerptientlpe9mthrpyduetncettmentTheemottmenptineededWehvecentlyetblhedcnectitweenBRCA1proteUnfoldedProteRepe(UPR)WefoundBRCA1nE3ligeendoplmicticulum(ER)FurrmoourtudylovelUPRtenPERKIRE1endogenouproteubtrtetrgetedBRCA1ubiqutiOurdthowbothPERKIRE1proteexpedtmuchhigherlevelBRCA1-deficient(def)cncercellthnBRCA1-pricentcncercellprobblydueunder-ubiqutilckfunctilBRCA1proteSubequentlywedcovedBRCA1-defcncercell(vro)BRCA1-deftum(vivo)cntrgeteddepletgpecificcompentUPRignlgpthwySceourpropoedttmentmoteffectivetrgetgBRCA1-defcncereimpertiveidentifyptientmotnefttmentCurntlynodefivemenidentifyloE3ligefunctiBRCA1vrintWihnewmtiourtudyweplnexplopotentilugproteubiqutiubtrteBRCA1(egPERKIRE1)biomrkeridentifyptientwhohvenE3lige-deficient(E3D)BRCA1OurtudyhowPERKIRE1protectentlyovexpedBRCA1-defcncercellowehypoizeweblediffenteBRCA1-pricientBRCA1-deftumexmgqunttivedenimetrictgtenydiffenceproteexpiprilePERKIRE1viimmunohchemicltgELISA/MSpectrophometricnlyifflhfrozenmplevilbleWeexmeprotelevelPERKIRE1compentUPRignlgpthwyptienttumbiopecimenevlutewhernymcnuedvlidbiomrkercenptientwhohveBRCA1vrinthcuedloE3ligefunctiBRCA1proteInthtudywepropoenexplrymeutegryE3ligefunctiBRCA1prilgexpiptternPERK/IRE1proteWelotudycltitweenhighUPRctivytumpiveneUPRtrgetrpyWeddfollowgquetithpropol(1)HowdoeBRCA1medeprotehomeotcncercell?(2)CnwepplyUPRen/effecrbiomrkerdiffenteBRCA1-pricientBRCA1-deftum?(3)HowdoweidentifyUPR-dependentcncer?ProjectSummry/AbtrctBtcncer(BC)2ndledgcuecncer-lteddethAmericnwomenmettmjBC-ltedmtlyHrnegimmuneytembttlecncerviimmunpyhemergedpowerfulpotentillyvolutiizgtrtegyttgcncermettAlthoughcncerimmunpytrtegiehvehownuccettghemlogiclmlignncieiruedetroygolidtumneedfurrimprovementTheimmunouppivetummicroenvirment(TME)keyfcrctriepoclicloutcomeimmunpyolidtumCryourgeryhenpropoedpromgtrtegymodulteTMEItdefezgcueicemti(iefrot)tumwhichmyledimmunogeniccelldethhpenimmune-ctiveTMEprovokentumimmunyUnlikehyperrmicrpywhichirveriblevculrtoccurdurghetgtempry(fewhour)perfuumfterthwgfrozentumicebllThenhnceimmunecellfiltrtumftercryourgerycompdhetgHowevercryourgeryleufficientctivtepotentimmunepegtcncervimodultgTMEMoovercryourgeryhenuedclicttgcncerepecillyBCThcuemimllyvivemimlcometicdmgecompdurgiclectihypechoicfrozenBCtumicebllcncvenientlymidltimemediclultrogrphyUntuntelytempertu-20Clowerneededcompletecelldethwhiletempertuperipheryfrozentumicebll>-20CThmyultcompletetumkillgcncercurnceThucombgcryourgeryrpiecludgimmunpyhentudiedimprovecncerkillgperipherlgifrozentumicebllAlthoughthpromgkillloclizedtumneffectivebcopl/immuniztieffectcryoimmunpygtdtnt/metttictumhnotenptednnomterilhenuedenhncecryoimmunpyuntilcenttudyuInthtudywedevelopedcold-pivennoprticle(CRNP)trgetcncercellctivelyleepylod(chempyimmunpygent)pecificllycyolpivecoldtempertuperipheryfrozentumicebllcombgcryourgeryThducepotentcryoimmunepegtnlyprimrytumfezglodtntchllengedmetttictumoutcryourgery(iebcoplimmuniztieffect)Wehypoizeefficcyfetynovelcryoimmunpytrtegycnfurrimproved1)developgCRNPctivelytrgetbothcncercelltumvcultu2)delivergchempyimmunpygentbothpermirrpeuticfuncticyolThenoveldul-trgetgCRNP-potentedcryoimmunpymyvlublecombtgmettBCcncerSummryTumknownducemtiuniquemicroenvirmentdtnrgnfcilteeedgurvivlgrowthmettticnoduleTheeeknownp-mettticnicheemergepecomdytemiceffecttum-derivedfcrhedextrcellulrveicleAidepmettticnichedtntltertiwenmltuecncer-rgubjecthvenotenidentifiedWhileevlutgytemicvcultutum-rgmiceweendipiulyfoundpencecerttypecrcomimplntedubcutneoulyhvedeleterioueffecntetllymphticbloodveelThurprgfdgwdictlycltedeveweightloprogiveductikeletlmuclemcdiknowncchexiImptntlycncerptientcchexihmengfulnegtiveimpctirbilypdcoverrpythuidentifictidividultrkeffectivettmentverethcdiimpertiveBlockgcchexifernlyignificntimprovementqulylifeeptientloimprovelerncepecncerttmentmeurbleceurvivlrteAlthoughcliclcequencecchexipoiveperpywellknownd-outerlydignoeffectivettmentmchllenggOurplimryfdguncovedtumhighcircultglevelpecificflmmrycykeducedvculrlymphticbrrierdyfuncteteInprticulrcpillriecentrllymphticlcteltetlvillihowedprolgedexcerbtedlevelVEGFR2/3ignlgTAK1phophyltiltertiyieldcompromedjunctilcomplexeInturnwedocumentedchngefoodbptidepeunltedlevelfoodcumptiocedweightloCollectivelyfdgdictecncer-ducedltertivculo-lymphticcomprtmenttetlvillictrieperhptriggerdevelopmentcchexiffectgirbilybblipidThegolthprojectdetermewherdeficiencielymphticvculndoliumignificntunderlygcuecncer-ducedcchexicntrgetedverecdiOurtwoproguedpprochdelvefurrundertgunderlygmoleculrmechnmwhilepurugp-clicltrilmouemodeltetrpeuticvenueimedtcctgvculrdeficiencieThectriivcultunimptntculprcchexihnotencognizedcouldtrnmtivemyfernunpcedentedopptunyterventerlytgefocugwirgendolilbrrierblockgthdevttgcdiProjectummryEukryoticprotekegulteimptntcellulrproceethroughirbilyphophyltemelveubtrteproteOnephophyltieventcommmotprotekephophylthccurtctivtiloopThphophyltieventtenoccurviu-phophyltilthoughhownctivekechievephopho-trnferctiownctivtiloopetilluncler[2]Wecentlyptedctivtidulpecificytyroe-phophylti-gultedke1A1B(DYRK1ADYRK1B)quiprolyl-hydroxyltioxygenengprolylhydroxylePHD1DYRK1ctivtiprolyl-hydroxyltitigteequenceeventwhephophyltiID2DYRK1leeID2mededctrtVHLubiquligetumuppcomplexthugultgdegrdtiHIFprotebrtumcncertemcellOurmotcentwkidentifiedprolylhydroxyltiPHD1generlmechnmquidtrnprimeprotekeCMGCfmilyuphophyltictivtiBeideDYRK1CMGCkecludeCycldependentke(C)Migenctivtedproteke(M)Glycogenyntheke(G)CDC-likeke(C)Inthpropolwefollowlg-tgtetlbmoleculrpthwyfvneurlcellelf-newldurgbrdevelopmentrrntlycrueddurggliomgenevetigtemodegultiglycogenyntheke3(GSK3)centrlhubctrolbrfuncticogeneGSK3hmemrCMGCkefmilyhighlycervedCMGCertdomWefoundthdomhrbL/xGxPmotifhighlycervedproleiduePro-276whichtrgetedhydroxyltiprolehydroxyleenzymePHD1necerykectivtiTheeobervtiledupropoecombtimechnticgenetictudiedefedynmicGSK3/bkemturtiducedPHD1terctiignlgmechnmgulteGSK3kectivyTheignificnceprolehydroxyltigliomgenevetigtedknock-mouemodelProAlmuttiGSK3/b(Pro-339Pro-276pectively)MouetumnlyzedugproteomicphophoproteomicctructctivywildtypemutntGSK3keGivenuncertroleGSK3kecncerglioblm(promoterupp)fdgledtterundertgpotentilnef/hrmGSK3hibircurntlypropoedttmentglioblmPROJECTSUMMARYHepcellulrcrcom(HCC)5thmotcommmlignncywld4thledgcuecncerdethUSReectrnplnttiolepotentillycurtivettmentHCCbunly10-15%ptientcidteNivolumb(humnnti-PD-1mAb)wFDApproved2017HCCptientpvioulyttedfenibRecentclicltrildemtrtepotentilimmunecheckpotblockde(ICB)ntibodiegtprogrmmedcelldeth1(PD-1)ligPD-L1ttmentHCCHoweverimmuneuppivetummicroenvirment(TME)HCCledtnceICBimmunpyimmunelteddvereeffect(irAE)thuefficcyICBimmunpymynotufficientelicdurblecliclnefCombtilICBimmunpiepirgimmunogenicloclrpiepromgpprochttmentHCCRecentlyp-clicclicltrilhvetetedPD-L1ICBimmunpycombterventilloclbltirpiepromeenhncgoverllrpeuticeffectOnelimticcountcompromedefficcyytemicICBimmunpycombtilowtumpecificcceibilyf-trgetbdgICBntibodienmltueupytemicdmtrtiTumepecificdeliveryICBenhncetumlimmunecheckpotblockgeefficcyvoidgytemicn-pecificctivtiimmuneytemultgirAELocllydelivedICBcjugtednno-crrierhveenbledemergencepltmfelydelivergeffectivedoeICBtumWepropoecter-dictedtr-rteril(IA)fuiientednti-PD-L1cjugtedferumoxylugZ-dom(PD-L1-Z-Fer)ynergticcombtiICBimmunpyimmunogenicirveribleelectropti(IRE)loclrpyAnengeedZdomimmunoglobulG(IgG)Fcdom-pecificbdgprotepropoedenhnceimmunecheckpotblockgefficiencyPD-L1FDApprovediroxidennoprticle(ferumoxylFer)OurcentultdemtrtedZ-domdprprovidedcvenientctrolledPD-L1ICBcjugtiFer(PD-L1-Z-Fer)ubequentenhncementimmunecheckpotblockdeefficiencyOurpropoedIAfuiPD-L1-Z-FerpermfurrefficienttrgeteddeliveryimmunotimulryPD-L1llowncedogeimprovedfetyprilefterimmunogenicterventilloclbltirpyuperirpeuticoutcomeMRIviblePD-L1-Z-FerMRimgeguidncehouldlopermmir/trck/quntifydeliveryPD-L1-Z-FertrgetedtumtuettednimmunogenicloclrpyThroughcollbtiveprojectbuildgupourtngthnno-immunpyterventilcologyrdiologyweeekdeveloppowerfulnewpprochimge-guidedcombtilIAfuedPD-L1-Z-FerimmunogenicloclblttmentHCCProjectSummryThecurnttrdcevlutiurveillncegilmettticdeedvncedtgehedneckqumoucellcrcom(HNSCC)18F-FDG-PET/CTcnwhichhighlyenivenotpecificultidentifieignificntnumrdetermteleiInterrogtieleiledunneceryproceduoverdigno/uptggptientnxietycedcotpoiblettmentdelydueneedpetimggToddthwevetigtewherPETimggugrdiollednti-EGFRntibody(89Zr-pnumumb)cnueddetectcncerhighpecificyWeue89Zr-pnumumbPET/CTeHNSCCptientdetermtefdg18F-FDGPET/CTdetermepoivepdictivevlue89Zr-pnPET/CTdetectimettticdeeThenpecificntu18F-FDG-PET/CTlolimuefulnedetectgmllprimrytumptientophryngelcncerThtudyeeffectivene89Zr-pnPET/CTimggdetectgunknownprimrytumptientpentgnenlrgednecknodeoutidentifictiprimrytumexmcventilimggSuccefuldetectiprimrytumug89Zr-pnPET/CTwouldvoidvivebiopietypicllyquidlocteprimrytumeptientThenovelimggmodlydevelopedthtudycouldovercomelimtimetbolic18F-FDGPET/CTimggducgnumrviveproceduvoidgdelyttmentduedetermtefdgSummryMerkelcellcrcom(MCC)highlyggivekcncerncidence3000USAce/yerMCCcrrie2-yermtly40%clerunmetmediclneedMjy(65%)MCCviru-poiveTheMerkelcellpolyomviru(MCPyV)mdriverviru-poiveMCCtumVirlTntigenhighlyimmunogeniccueyeignimmuneytemVirlpoiveMCCcnthunidelettgdeveloptrgetedimmunpiecludgcncervcceSeverlchllengecfrurbilydevelopTcell-bedMCCvccei)lckknowledgecervedimmunogenicMCPyV-derivedTcellepipebddiverehumnHLAlleleprovideimmunyii)lckvccepltmgenertgpertentmemyTcellgtcncercellToovercomeebrrierIhveledeftimmunopeptidomenlyledggenertimollelicclIexpgcelllecro95diffentHLAlleleUgthourceweidentified>185000HLAclI-bdgpeptidewhichwetdhighlyccurteepipepdictilghm(HLAn)67Wedevelopedrobutprocoletblhptient-derivedMCClepplictiHLAnelehyieldednewMCPyVepipewhichwecfirmedLC-MS/MSnly(LeeJCIp)FllycollbtiDrMowedevelopedlipidnnodcimmuniztrgetpilntigen-pentgcell(APC)cpblergmucolmemyCD8Tcelljecttum8Wehypoizecncer-drivgMCPyVvirlntigencnyieldhighlyimmunogenicepipeWeexpectuchknowledgecnfueldevelopmentneffectivef--helfcncervccegtMCCOurimthuAim1SytemticllydetermeclIpentedMCPyVepipecrohumnHLAllelecouldprovidegloblpopulticovergeTcell-bedcncervcceWehvegenerted95gleHLAllele-expgB721221cellleprovidegloblHLAcoverge7WetrnfectMCPyVLTSTeekidentifyclIHLA-pentedMCPyVepipeLC-MS/MSnlyWelopdictepipeugHLAnEpipeidentifiedMSnlypdictifurrnlyzedidentifycervedpromcuouepipewhichcouldcidteuniverlf--helfTcell-bedMCPyVvcceAim2CfirmimmunogenicycidteMCPyVepipeImmunogenicvlidtichrcteriztiMCPyVepipeenbledcoverycidteprotectiveMCC-ctiveTcellepipeWeutilizeldybnkedHLAtypednveMCCptienthumnPBMCetudiedetermeTcellimmunememyde-novoTcellpeTCRvidycyxicctivygtMCCtumcellleAim3TetimpctTcell-bedrpiedictedgtMCPyVvivomodelWedevemulti-epipevcceugnnodcpltmTheecidteMCPyV-trgetgvccetetedMCCGEMmodeltumctrolWefurrchrcterizeMCCGEMmodeltummicroenvirment+/-vccePROJECTSUMMARYThelg-termobjectivethpropolimproveprognoptientcoloctllivermette(CRLM)Only15%eptientcidteurgiclectiduenumrizeloctiirlivermetteEvenecticidteurvivlrtemdmlImprovedpprochedepertelyneededttthdevttgcglypvlentdeeIthencognizednerobicbctericnprolifertelyhypoxicgiolidtumubequentlylygtumcellultgmrkedde-bulkgtencompletegiThefiluchempiebrodrngetumetiologiecludgCRLMhledjuventedtetdevelopmentbcteriolyticpprochettmentolidtumMotcentlymodifiedneroClotridiumnovyi-NTwidentifiednideltrbcteriolyticrpyP-cliclnimlmodeltudiehvedemtrtedtrikgpotentilCnovyi-NTerdicteolidtumRecentclicltrilhvevetigtedebcteriolyticpprochettmentptientbrodrngetumetiologieInilultetudiehveenhighlypromgHoweveretudiehveloidentifiedcriclquetimutddedmximizeefficcybcteriolyticpprocheprticulrlyttmentCRLM1)Sytemictr-venou(IV)dogCnovyi-NTpocnproducepoivepeidultumtuenmoxicocedxicielowtrgetgefficcyquimentextendedgimenntibioticpot-rpymyproblemticFCRLMelectiveliver-dictedtrnctertr-rteril(IA)dmtrtihouldfeibleFurrmogivenpfentilrterilbloodupplyCRLMhypoxielectivenerogermticouldcceivblyenhncedvifollow-upfuiembolicmterilblockbloodflowemetteThelientcombtiltterpprochewehvenowdubd`trnrterilbcteriolyticembolizti(TBE)2)ObligteneroCnovyi-NTpogermtelyhypoxicgidetroytumcellvectilipeproteeAccurtedeliveryCnovyi-NTpoehypoxicgiubequenttumcolizticriclchievepoiveoutcomeImggdynmicdtriiCnovyi-NTpogermtednero(trncterIAdeliverytumubequentcoliztum)houldcricllyperm)tr-procedurloptimiztidurgtrgeteddmtrtib)erlypdictilgudloutcomeThroughthcollbtiveprojectbuildgupourter-dciplrytngthnno/bioterfcennomediceterventilcologyrdiologyweeekdevelopnewnno-functilizedcybgCnovyi-NTpowerfulnewpprochimge-guidedtrn-rterilbcteriolyticrpyPROJECTSUMMARYCncer-ltedcogniveimpirment(CRCI)pentnimptntcliclueffectgup75%peopleedurgfterdignottmentUndertgcognivetrjecrieocedcncercncerttmentprticulrlyimptntmgolderdult(ge65)whomymouceptibleCRCIHoweverolderdulthveenunderpentedpvioutudiehveenlimedpdomnceht-termfollow-upfocubtcncerlckmechnticvetigtiTheoverllobjectivethpplictidetermerkuceptibilybiologiclmechnmlkgcncercncerttmentcognivefunctigWelevergedtASPREE(ApirReducgEventElderly)obervtilfollow-uptudy(ASPREE-XT)ASPREEwtril19114dividulged70yer(65USmie)enrolledAutrli(n=16703)UnedStte(n=2411)whichprticipntweromlyllocteddilylow-doe(100mg)pirplceboAtenrollmentprticipnthdnohrydignoeddementicrdiovculrdeeignificntphyicldbilymjcogniveimpirmentRepetedmeumultipledomcognivefunctiwepermedcludgmemyexecutivefunctipychompeedeedtbeleevery2yer(2010-2017)nnnullydurgfollow-up(2018-2024)WeuepropectivelgudltudydeignexmefollowgpecificimAim1DetermeimpctcncercncerttmennlgudltrjecriecognivefunctigWeexpcncerttmentdtetcludettmentdtllcnceventthrough2024furrvetigtewherhotfcruchgetdignoignmentpirplceboeductilttmentAPOErkgenotypedementipolygenicrkcop-dignoticcllhempoiedetermntignificnce(CHIP)biomrkerocedAlzheimerDeelteddement(ADRD)neuropthology(Ap-tuNfLGFAP)impctrkAim2DetermeimpctcncercncerttmennCHIPADRDbiomrker(Ap-tuNfLGFAP)vetigtepotentilmedgeffectpectcognivefunctigThtudyignificntcueddehighunmetneedelucidteltihiptweencncercncerttmentcognivefunctigolderdultchrcterizep-dignoticfcrcferuceptibilyidentifymechnmunderlieociInodogenbleerlydetectihigh-rkdividulItdictlyddepriieoutledNOT-CA-21-031Thtudylevergeuniquetudypopultilgudlmeucognivefunctieftercncerdignovetigtecognivetrjecriecludemultiplecncertypefocueolderdultdvncemechnticundertgcncer-ltedcogniveimpirmentTheimpcthelpidentifydividulthigherrkCRCImodifibletrgetterventiultimtelyimprovgqulylifedependentlivgProjectSummryAlthoughcncerimmunpyhenproclimedbkthroughmnytypecncerpncticductldenocrcom(PDAC)pdpolyimmunecheckpotblockde(ICB)rpyPDACclifiedimmunologicllycoldtumprouncedpenceimmunouppivemyeloidcellTheedevelopgnovelpprocheprogrmPDACtumimmunemicroenvirment(TiME)promotgimmunpeuticefficcydrticllyneededAkeyknowledgegpundertgPDACTiMElckolvulizemireimmunouppivemyeloidcelldurgtumprogtmentMoleculrimggpprocheprovideuchnopptunythroughpecificcell-trckgtrtegytrgetgurfcemoleculeexpedimmunecellInplimrytudiewedemtrtedyet-derivedwholeb-glucnprticle(WGP)pdomtelytrfficpnccemivefiltrtimyeloidcelltdimmunyphenotypeledgductiPDACtumprogiprolgedurvivlTdimmunydefednteimmunepecndptdevelopmemy-likephenotypepvioufectivcctiDepeeucceemicettedWGPeventullydiedevencombtinti-PD-L1rpyTheoverrchggolthpropoldevelopntegrtedvivoimggimmunophenotypgpprochundertPDACimmuneevimechnmdevelopmoefficciourpyPDACTheAimpropoedAim1determeifductdimmunyprogrmpncmyeloidcellthuhpgirfunctiPDACTiMEWeutilizerdiolledWGPnnti-CD11bprotrckWGPtrffickgfluxmyeloidcellpncWelotethypobundncepnctueidentmcrophge(TRM)meudlymphticveelendolilhylurncepr(LYVE-1)propdictivemrkerPDACimmuneeviprogiAim2determewhercombgtdimmunynti-CD47/nti-EGFRmAbrpypromotemyeloidcellphgocytic/tumicidlctivymximizententumimmunyTrgetedvivoimgguedmirphgocyEGFRlevelPDACTiMEAim3determebilyductdimmunycrutimultedptiveTcellpncWelodetermewhercombgductdimmunynti-CD47mAbrpyfurrpotententi-PD-L1rpeuticefficcyPADCImmuno-imgguedtrckCD8+TcellfiltrtifunctiPD-L1expiPDACTiMETheuccefulcomplethpropollikelyprovidenovelightundertgmechnmPDACimmuneevtmentpetnceProjectSummry/AbtrctTheInterntilWkhopRetrovirlPthogenenow33rdyerhlgervedumexchngenewerchfdgcceptllpecttrovirlpthogenemoleculrmechnmimmunologiclprmeterhot-viruterctiThecfencectuetrdimteenggedcientificterctillpecttrovirlpthogenetrgemphnimltroviruemodelhumndeeRetrovirlpthogenhumnnimllltrovirlgenerubjectcientificpenttivibrntdcuiTopictwkhopcludetroviruentrytegrtiplictitrictiemblyimmunepecogenepthogenenewemerggpthogenendogenoutroviruenimlmodeldeeApproximtely100prticipntnticiptedcludgprciplvetigrpotdocrltegrdutetudentPlnnedDecemr4-72023TnItlymllizemtcfenceupptccentrtedterctideepcientificenggementThecfencefoterpildevelopmentjunivetigrfdgmopptunypentircurntwkpnelenggedcollegueerveSeiChirTheoverrchggolcfenceprovideumfoterctuedcientificenggementledgnovtivecceptuldvnceerchtrovirlpthogenebrodlydefedThecfenceddthgolthroughthepecificim(1)Brggerntilterntilcientificlederfieldgerjunivetigrpotdocrltudentte(2)Provideopptuniefourvedkeynotecientificpenttidcuigroupterperedmotimteopptunydcuercti(3)Providepltmopptuniejunivetigrwomenunderpentedmycholrthroughcientificpentti/deigntiSeiChir(4)ProvideWrgWkhopcovergpicuchhowfrmeerchfdgpublictitepmnucriptgoethroughedirilprocemechnicwrgerchpublictiethicPROJECTSUMMARYTelomepecilizedprote-DNAtructuprotectendlerchromoomemtgenomictbilyMtenncedequtetelomelenghueentilcellulrimmtliztumigeneWhilemothumncncerchievehroughtelomerectivti~5%-10%mdoptcombti-bedmechnmtermedlterntivelengngtelome(ALT)elgteirtelomeAlthoughALT-drivencncergenerllyggivepoprognocurntlynotrgetedrpieInhumncncerALTtrglyocedgeneticltertiffecthneH33chpereATRX-DAXXcomplexWepvioulydemtrtedATRX-DAXXcomplexeentilnmltelomemtennceWehowedATRXDAXXlowhilepromotgtumigenepotentgALT-drivenimmtliztiloctepertenttelomeplictidyfunctiWeehypoizeALT-immtlizedcncermuthvedoptedpecilmechnm()fetirntetelomeDNAplictidefectthuwouldelectivelyvulnerblehibhoecompenrypthwyBycombgouruniqueogenicALT-immtliztimodelytemcumizeddom-focuedCRISPRcenpltmwehveuncovedltelectivemoleculrvulnerbiliecludghnelyedemethyleKDM2AALT-dependentcellWedemtrteKDM2A-mededH3K36me2demethyltiquidALT-dictedtelomemtennceInctivtiKDM2AimpirALT-pecificmultelomecluterdolutiledgchromoomemeggtimiccelldethTheobjectivethpropoldeletemoleculrmechnmunderlygALT-dictedtelomemtennceidentifymechnm-bedrpeutictrgetgtALT-drivenhumncncerTomeetthoegolwepuruefollowgthepecificimInAim1wevetigtemoleculrfunctiKDM2AALT-dictedtelomemtennceInAim2wedefepotentildvereeffectf-tumxiciefutuKDM2A-trgetedrpieInAim3weetblhnvivopltmexployntic-lethlterctiALT-drivenATRX-mutntmlignntgliomCompletipropoedtudieuncovermoleculrmechnmcricldependencieunderlygALT-dictedtelomemtenncethudrivedevelopmentnovelmechnm-bedrpeuticgtALT-dependentcncercludgATRXmutntmlignntgliomProjectummryDiffuelrgeBcelllymphom(DLBCL)n-HodgklymphommotcommhemlogicmlignncyUnedStteoccurbothdultchildnApproximtely40%dultDLBCLptientlpefrcrycurntfrtlerpyThhighlightnurgentneednewrpeuticoptiDLBCLMnyDLBCLcelllehighlyenivecompoundcueplictivet/hibDNAdmgepe(DDR)Thuwechoedevelopnovelnucleoidenlogp-cliclDLBCLrpeuticcethcompoundcltypicllyduceplictivethighlyctivehemlogiclcncerNucleoidenlogmotwidelyuccefuldrug-clhveenpprovedttghemlogiclcncermgdictiUgphenotypiclchemiclbiologycomdhigh-throughputmultiplexed930cncercelllecenweidentified4-ethynyl-deoxycytide(EdC)highlyeffectiveuniquep-cliclrpeuticDLBCLEdCexhibnnomolrpotencyDLBCL(GCBABCubtype)hrbgltertiepigeneticfcr(KMT2DEZH2)BCL2/MYCgeDLBCLtummice3-5dyoutweightloxicyInctrttrdilnucleoidenlogEdCuniquelyctmophophteduceplictivethibgdenovodCTPynTofurrchrcterizedevelopEdCuniquehighlypromgp-cliclrpeuticDLBCLweplndevelopfollowgAim1ElucidtemechnmctiEdC2ChrcterizebiomrkerDLBCLenivyEdC3InvetigteefficcyEdCDLBCLvivoThpropolexpectedfurlucidtemechnmbiomrkervivoefficcyEdCnewp-cliclcidteDLBCLProttecncer(PC)mncurbledeeceprogimettticctrti-tnt(mCRPC)tteoccurkillg>30000USmen/yrUntuntelyechFDA-pprovedgentmCRPCproducelymodetceoverllurvivlfollowedemergencetntmoggivephenotypeThuurgentunmetneednovtiverpienovelmechnmctillowdcrimtitweennmlPCcellHeweputwrdnnovtivetrtegyelectivelyexploelectivevulnerbilieneuroendocprottecncer(NEPC)highlyggivevrintmCRPCpoprognougnlly-doedhighlypecificlye-pecificdemethyle1(LSD1)hibirbomedemttclicldevelopmentunlteddictimximizener-termptientnefThepvlenceNEPCcgmCRPCptientfollowgprolgedttmentpotentrogencepr(AR)x-trgetedrpie(egbirtereenzlutmide)ndptivemechnmtnceComphenivegenome-clenlyetegrtedphrmcogenomicpipeleproviderichmechnticundertggeneticepigeneticfetuunderlygenivydiffentiltweenNEPCAR+prottecncer(ARPC)ubtypeLSD1hibi(LSD1i)IthouldnotedlthoughNEPCmoeniveLSD1ilohignificntctivygtARPCtumwhichhimptntcliclimplictigrowgnumrdvncedmCRPCptientheterogeneouleiencompgmixedmoleculrpthologiclubtypeLSD1-depedentvulnerbilieidentifiedguideptientelectipcimedicepprochAddillycombtirpytrgetgLSD1-ducedynticlethluceptibiliertillydeignedprovidemopotentdurblepeextendcliclutilyewell-lertedcliclly-tetedgentfvblefetyphrmcoketicprileOurpropoedwkhbothcceptultechniclnovtiWe1)vlidteLSD1trgetNE+AR+tumvicomphenivemechnticterrogtiuguniqueptient-derivedxenogrfrgnoid(PDX/O)model2)comppdervn-pdercroubtypemptientelectifutubiomrker-drivenclicltrilugtte---rtgenome-wideprilgtechnologie3)dectfunctileffectLSD1idvncedpcliclmodelytemugemedvncedprilgtrtegie4)identifyrtilcombtirpiebedLSD1i-ducedynticlethlvulnerbilieproducedurblepeughigh-throughputPDOcengpltm5)ueclicl-grdedrugmximizener-termrpeuticpotentilgtthhighlyggivelethlmCRPCvrintemerggtncemechnmtrd--crpiecgfquencyAbtrctOurobjectivedevelopolimproveerlydignoytemiclight-ch(AL)myloidodeecuehertkidneyfiluerlydethptientmoldergmultiplemyelomdeewhichptientmkeimmunoglobulfelightchltivelyympmticBedtropectivetudymemrUSArmedFcewhodevelopedAL1015yerpcurperiodpriptientpentgtmedinge63ympmALduexicfelightch(FLC)myloiddepoInimilrtudieptientmoldergmyelomweknow2%mdevelopALmeng2%hveFLCmrkedlybnmlOverhlfnewALptientpenthertvolvementfiludignoeerlyunderlieir20%mtly6mthInthpplictiweeekupptcenptientmoldergmultiplemyelomundignoedALrkALugeriecrericeourknowledgelikelihoodhvgundignoedALgtrkALOnlyeftdignoeALdetermerkALpcurphedeeduceerlymtlyrteOurgoldeveloplikelihoodlghmundignoedALrkALmoldergmyelomptientourimthpplictictenetwkenroll340ptientmoldergmultiplemyelom(SMM)collbtivetudyquirgmrrowbloodpecimencollectidttrgetlikelihoodttticplnfutuvlidtitudyvlidtennextgenertiequence(NGS)yidentifieIGVLgenecllplmcellThecllIGVLgeneALcetrictedAL-ltedetgeneThelikelihoodlghmemploy5prmeter(1)penceSMM(2)diffencetweenvolved(pthologic)unvolvedFLC>23mg/L(3)cllplmcellcygenetichowgt(1114)g1q(4)AL-ltedIGVLgeneNGS(5)NT-proBNP>332pg/mLAllubjecthveircllIGVLgeneidentifiedNGSenblgctivlidtilbrydevelopedtetpcimedicelbrycertifiedundergultiCliclLbryImprovementAmendment1988(CLIA)Ourlg-termgolovercomecurntbilyptientSMMeffectivelyepenceoccultALetimtelikelihooddevelopgALBydetermgvlue5prmeterwectetrgetnlghmetimtelikelihoodhvgproggALbledeignvlidtitudyWehveembledcollbtivetemvetigrtcentercroUSApurueourimnexpertupptgroupddopptuniechllengeptientcueWehveputgertemexpertcollbroverdozencdemiccenterexpertcultntmyelomALmyloidomoleculrbiologyprotebiologyderpurueeimlizgcomplexyendevdemechimDepeimprovementoverllurvivlmotcncerurvivlptientpncticcncermdmllylowdueltedignorpidpdgUndertgpncticcnceriprogigtimptncedevelopmenteffectiveterventitrtegyMouemodelcpultghumnpncticductldenocrcom(PDAC)hveengenertedthroughctivticogenicKrcomdvriougeneticmuttidiffentpncticcelltypetudieugmouegeneticuggetbothcrductlcellcngivePDACcellulrigpecificgenemuttimydetermepcurleiiprogiwellmoleculrubtypePDACNotchignlgpthwymtergulrcellftedecidiffenticriclpncticdevelopmentdygultedpncticcncerWecentlydcovedexpiNotchmodulrLunticFrge(Lfng)cfedubetcentrocrcellnmlpncLfng-expgcentrocrcelluniquelyuceptiblecogenictrnmtideletiLfngblocktumiecellLfngupgultedcrductlcell-derivedpcurleideletiLfngdecelertetumdevelopmentetwocelltypeThuLfngexertcogenicroledevelopmentPDACthedtctcellulrigcentrocrcrductlcellAmplifictiupgultiLFNGnotedhumnPDACocedpourvivlTheewepropoedectroleLfng-dependentNotchignlgpncticcncerugmultiplepprochecludggnoidcultulegetrcgtempllege-pecificgeneticmnipultidiffentilgeneexpinlywellfunctilnlycidtegenehumnPDACcellleddfollowgSpecificAim1)determeroleLfng-dependentNotchignlgpncticcncerdevelopmentLfng-expgcentrocrcell2)determeroleLfng-dependentNotchignlgcr-ductl-derivedPDACpthogene3)chrcterizeLfng-expgpncticcncercellidentifygenediffentillyexpedecellpotentilrpeutictrgetWehopedemtrteLfngcricliprogipncticcncerrgdiffentcelltypepncLfngmrkpncticcncertemcellthoughtpibledrugtncecncerlpeIdentifictigenedowntmLfng-dependentNotchignlgmyleddevelopmentbiomrkertrgetedrpythprticulrlydedlydeePROJECTSUMMARYThebrecommgnbtcncercurnceBtcncerbrmettcglycomgignificntcliclproblemduergcidencelimedefficcyextgytemicrpieMettcequencefvbleterctitweenvdedcncercellmicroenvirmentdtlgnTocncercellbrhmotuniquemicroenvirmentcetromlcellbrdotextnygnThexplwhyrpeutictrtegiewhichefficientlydimhprimryn-brmettticbttumeffectivectrollgetblhedbrleiOurcurntwkimundertuniquebrmettmicroenvirmentdeletehowfciltemettticoutgrowthTypeIterfer(IFN)ignlgwell-cognizednti-tumpthwyHoweverexperimentournimlmodelhowtypeIpetrocyteuniquebrtromlcellhpro-mettticeffectbrBedefdgwefurrddfollowgqueti1)DefeunderlygmechnmhowtypeIIFNpetrocytemedebrmettWetethypoctivtedIFNpetrocytehelpcrumentpecificimmunecellbrlei2)VlidtetypeIIFNctivtdiffenttgebrmettWepplyp-notchimggtechniqueourmouemodeldictlyvulizecellulrmoleculrchngeyoccurl-timevlidteeobervticliclmple3)InvetigterpeuticeffecthibiimmunecellcrumennbrmettWenlyidentifydruggbletrgetlooptimizerpeuticwdowourp-cliclmouemodelOverllouridethnceweknowhowbrmicroenvirmenthelpcncergrowthbrwecnfocuoureftppgOurerchpropolyieldlctibletrgetbrmicroenvirmenttedcncercellttbrmettMoimptntlyourtudietrckgdynmicchngedurgbrmettticprocehelpidentifyoptimlrpeutictrtegieeffectivelyttbrmettmimizepotentilideeffectProjectAbtrctThecentFDApprovl(LutrAzedrPluvic)wellpromgexperimentlgentclicltrilundercourggenthumvetigtemoleculrlytrgetedrdipy(TRT)ttmentmodlycncerHowevertumpeTRTtentrnient/vriblemgptientThunurgentunmetneeddevelopnewtrtegiemximizerpeuticnefTRTcncerptientFpteverlyernuclermedicefieldhpriizeddevelopglowMWmllmoleculepeptiderdiolig(RLT)rpidlyexbloodtmmimizehotxicyHowevertumlpeRLTlimedeverlfcrcludgheterogeneoutrgetexpimgtumdocidegrdtilig/ceprcomplexecompletetrgetturtiduelowmdoefquentpetdogThuexplgnewtrtegieydRLTtumldeliveryrdioopewthwhilegolWehvepprochedthchllengedevelopgnewclrdiophrmceuticltermedtrictedterctipeptide(RIP)whichleruntructudlowMWpeptideternllyclevedtumendoproteetetunmkrdiolledheliclmembrnebdgpeptideOncelirtedrdiolledheliclpeptideimmedelyirveriblyttchenerphopholipidmembrnetumUgPETwehvefoundRIPmyhveeverlpropertiedvntgeouTRTcludgctlyticmplifictumuptkelgpertencerdioopetumduetbilypeptide/lipidmembrneterctiThuRIPfernunuulcombtideirblefetyprilechrcterticlowMWRLThightumluptkemotypicllrgeMWTRTCollectivelyefdgprovidetrgcientificrtiletetfirttimeifrdiolledRIPcneffectivelylevergedtttumOverthepecificimweevlutentumeffectnovelRIPtermedFRIP2couplgpenttive-(Lu-177)lph(Ac-225)emterFurrmowetrnlte64Cu-FRIP2ptienttetfetydoimetryphrmcoketicpltmwhileloevlutgfeibilytumtrgetgInummrythprojectpentfirtuecdillyctivtedmembrnebdgproTRTwhichmyovercomewelldocumentedhtcomgcventilRLTSUMMARYOycerknumeroucncercludgcoloctlcncer(CRC)Whgrowggloblepidemicoygterundertgoycncer-lkcludgunderlygbiologydverefluenceptienutcomecricllyneededOurbilyttptientoptimllyhenhmpedprttrdiluebodymdex(BMI)defeoyBMIfiltkeccountimptntdimenibodycompoiuchftdtrii(egvcerloy)muclem(egrcopeni)AclicllypplicblepprochchrcterizgoybodycompoicomdnundertgCRC-oybiologydvnceourbilytilttmentterventidruptdvereimpctoyttmentxicyptienutcomeWepropoenterdciplrytudyddebothgpknowledge(1)pplicticuttg-edgertificiltelligence(AI)-powedfullyumtedCTcn-bedpltmgenerteccurtedividulizedvolumetricmeudipoetuecomprtment/keletlmuclem(2)tetgrolethromboflmmtinovelbiologicpthwyvetigtectexy-CRCoutcomeThromboflmmtittechrcterizedcedplteletctivtiytemictum-pecificequeleplyrolemetthcentlyeprtelyenocedoycncerhoweverhnevereenvetigtedbiologiclterfcepotentiltrgetterventioy-CRClkOurtudylevergeuniqueourcelgudlCTimgeclicldttumplmupopultiN=1200tgeI-IIICRCptientenrolledNCI-fundedColoCStudyInAim1wepplynovelAI-powedfullyumtedrdiologic3Dbodyegmenttitwgenerterobutvolumetricdipoymuclemprileexmeocittment-ltedxicyclicloutcomeInAim2weexmethromboflmmtibiomrkerbloodutumltivcerloyurvivloutcometetwherthpthwymedeAim1ociTogerwedcerndiffencercefcr(eggeextgetume)Thepropoedprojecttkepowerfulrigoutemciencepprochddkeyquetiimpctbodycompoidipoy-promotedthromboflmmtiCRCttment-ltedxicieurvivlUeglelrgetudyptientpopultinexceptiletunimlyvilbleCTcndtbiopecimencot-effectivemximllymtiveOurtudynlyyieldclicllymengfulprognoticmeubodycompohromboflmmtiloprovideightoy-CRCbiologypotentilidentifynovelperlizedttmenttrtegiePROJECTSUMMARYThecompoimicrognmhbgutknowngutmicrobiomehentrglyocedpthogeneeverldeecludgcncerditemultiplecleroNotblyeverlhigh-priletudiehveptedcompoigutmicrobiomecltedpeimmunecheckpothibir(ICI)humncncerptientWhileetudiehvepropoedeverlmechnmccountgthphenomenpecificetcellulrmoleculrterctiexplepemelucidtedOnepoiblemechnmthroughimmunologiccogniproductmicrobilmetbolmMucol-ocedvrintT(MAIT)cellnbundnthighlycervedubetnte-likeTcellcognizeproductmicrobilriblvynpentedn-polymphicHLA-likemoleculeMR1MicegrowngermfecdihveignificntductiMAITcelltroductibcterihighproductiriblvdrticllyceMAITcellfquencyctivtiOurplimrydtdicteMAITcellfoundhumnmelnomtumFurrmowefoundptienttgeIII/IVmelnomhveignificntlydecedfquencieMAITcellmgtirPBMCwhichcnveredupnti-PD-1immunpyttmentpiveptientnotn-piveptientMottrikglyweobervedptienthighfquenciecircultgMAITcellhdignificntlyimprovedoverllurvivlcompdthoelowfquencieFurrmowehvefoundtumpdgptienthvecedexpiMR1mRNAcompdn-pderIntetglypiveptientlohowcedltivebundnceriblv-ynizgbcteriirgutmicrobiomecompdn-pderAddillyournovelMAITcelldeficientmouemodelyngeneicmelnomtumgrowignificntlyfterntumimmunyignificntlydimhedcompdwildtypemiceKeyquetieobervtiFirthowriblvbioynMAITcellfunctifluencedICIttment?AddillywhtroledoMAITcellplytumimmunywhtrpeuticnefcnMAITcell-dictedrpieferwhencomdICIttment?WehypoizeMAITcellquidnti-melnomimmunyctivtedMAITcelllkmicrobiometumimmunythroughmicrobilriblvynThhypoddedfollowgSpecificAim(1)DetermemechnmunderlygocitweenMAITcelldynmicriblv-ynizgmicrogutmicrobiomedurgimmunecheckpothibirrpy(2)DefectriiMAITcellICIrpypeShouldthtudyvelroleMAITcellnti-tumimmunydependentmicrobiomemodlieimedtexpg/ctivtgMAITcelldurgrpymyprovideubtntilcliclnefmelnomptientAbtrctCerviclcncerledgcuecncermbidymtlymgwomenlow--middle-comecountrie(LMIC)uchAfricwhecengvulpecticeticcid(VIA)primrytrtegyAlthough2021WldHelthOrgnizti(WHO)commendedhumnppillomviru(HPV)tetgpferdcengtetllettgVIAmmotcommcengteteeeblefutumnyLMICmtrigetetftertrniHPVcengHowevercompletevuliztrnmtize(TZ)cervix(Type3TZ)whichccountbout15%womenundergogcerviclcncercengocedmedleidurgVIATheeterventicecompletevuliztiTZ(iecveri)ducgType3TZtVIAmpriycerviclcncerpventiProtglE1(moprol)cerviclmodultgeffectpromgterventiduewidevilbilylowcot($1/doe)glevgldoenignideeffectmlltriluggetgefficcyHowevermoprolefficcymuncertunclerwhervrydurtimoprolge/menopueprypvioupcncerttmenrwheruchprogrmcceptbleprticulrlyAfricgihighetrkcerviclcncerToddegpbuildgourplimrydtwepropoedouble-bldRCT(N=420)evluteeffectivenecceptbilymoprolcvertType3TZptientttendgcengprogrmCmeroTheultimtegolpventcerviclcncermbidyimprovgdetectip-/cncerouleiAim1Teteffectivenevglmoprol600mcgvplcebocvertType3TZHypo1InwomenType3TZmoprolgivenup6hrpriVIAcertecveriover50%(primryoutcome)detectmocerviclp-/cncerlei(ecdryoutcome)SubAim1IdentifyoptimltimgmoprolplcementprimedyevlutioptimizeefficcyfcrfluencertecveriType3TZHypo1Cumultivelycverirtet4-6hourftermoprolnotmterillyhigherthnt2-3hourcverirtevrymternlgepryprip-cncerttmentmenopulttuAim2ExmecceptbilytfctegrtgmoprolType3TZcerviclcncercengprogrmAfricptienthelthcwkerperpectiveHypo2PtientType3TZcliclproviderhvehighcceptbilytfctirtethpprochCmerolow-ourceettghighburdencerviclcncerhVIA-bedcomphenivepventiprogrmwhichprovidefrmewkpropoedtudyIfuccefulthimpleexpeniveterventiducerkmedcerviclleiimproveerlyttmentpventicerviclcncerProjectSummryDiffuegliommotcommprimrymlignntdultbrtumLowergrdegliom(Grde2)evblycomemlignntprognoftlKeycliclchllengeclude1)ignificnttr-ter-tummoleculrheterogeney2)limticurntimggtechniquedtguhgtruetumcurnce(TTR)peudo-progi(PP)rdinecro(RN)followgurgiclectidjuvntrpyDicttuemplgvivemynotcptuentimoleculrlcpetumN-viveimgg(egMRI)fildetectmllcurncelimedolvgdiffentildignoedurgimggfollow-updoenotcptutummoleculrevolutiRecentlyliquidbiopyproximlfluidhgedpopulryytemictumIngliombothbloodcebroplfluid(CSF)vibleourceproximlfluidWhilecquibloodleviveCSFphyiologicllyexpecteduperienrichedervoirtum-pecificbiomrkerThuCSFcnlevergedmodicttrgetidentifictiwhichcnubequentlyextendedbloodyMotmoleculrnlyeglioblmhvefocuedgenomeepigenometrncripmeproteomicnlyeloquidunderttumfunctilphenotypelikeperpyWehvecductedhotgunproteomicltle30LCSFptientglioblmprimrycentrlnervouytemlymphomdetectgubtntilccentrtidtctidentifygdiffentillyenrichedpthwyechtumclWehypoizetegrtiCSF-bedproteogenomicnlyecnimproveourdignoDGfeourmngementdurgtumurveillnceferightpotentilnoveldrugtrgetWepropoecductmulti-centertudyfocuedCSFlrgetpropectivecohtetblhed-dteThprojectvlidteourplimryfdgwhileetblhgnoveldignoticproteomicigntubedCSFWeloetblhfirteverCSFglycoproteomeDGwhichgtvluedrugtrgetdevelopmentSuccethpropolhveignificntimpcndiffuegliommngementthroughimprovgpopertivedignoticpciubequenturgiclplnngenbleerlyterventiTTRwhileelimtgpotentillyunneceryurgeryRNetblhtempltedrugtrgetdcoveryfututudieTtmentcncerngogprocedurgwhichclicinmkeeriedecitcriclpotptientdeeynizgbeleevolvgptientmtigoloptimizgexpectedlg-termptientnetWeuetermttmentferbrodlyrpeuticgentupptivehvilterventimigtedvereeffectrpieympmwellter-ventifocuedpventicengAnevidence-bedpprochoptimizgdecimkgtudyentiequentilttmenttrtegiewhichcnmlizedttmentgimeAttmentgimeequencedeciruleechwhichocedkeydeciueccruedmtiptientelectttmenptimgfeibleoptiptientAnoptimlgimeemximizeexpectedptientnetpopultiSequentilmultipleign-mentromizedtril(SMART)whichubjectromizedtecheverlkeydecipotteiblettmenptibedirccruedmtiidellyueddcoveryevluttmentgimenumrSMARTcncerhveencductedAtmetimegtnovtihveenmdecncerclicltrilpltmpe-dptivetrileekop-timizettmentbothprticipntfutuptientllowcptinewoptielimtieffectiveopticglygcductedThepotentilSMARTdvnceop-timlequentildecimkgcncerttmentthuquinextgenertideignnlymethodSMARTcpteimilrnovtimocomplexettgmultipledecipetedromiztiubjectddcurntcncererchpriieThegolthprojectdevelopcomphenivettticlfrmewknext-genertiSMARTcncererchrttepwrdwhichweundertkethroughfourpecicimOurrtimdevelopmethoddeignnlypltmSMARTuepe-dptiveromiztifvoptimlttmentignmentllowtroductinewttmentdctutieffectivettmenttnyde-cipotAim2developmethoddeignnlySMARTvolvgmulti-compentmulti-modlttmenttechdecipotOurthirdimpropoenoveltrilfrmewkmergeSMARTmicro-romizedtrilllowjoptimiztiequentilrpeuticdecielec-tiupptivemHelerventidddverecequencecncerrpywheupptiveterventichoenmximizeuccerpyInAim4wedevelopfrmewkterimnlySMARTwhichltlemethodologyvilbleThemethodhlebryctuoucenodtime--evenutcometetcncererchAtwpckgedevelopedtuerdeignnlynext-genertiSMARTPROJECTSUMMARY/ABSTRACTCpltfquentlyuedttqumoucellcrcom(SCC)fquentlycombtidrugiizgrdi(IR)Tumcurnceduerpeuticfiluoccurpproximtely8%ptient5yerttment5-yerurvivldividulcurntdeemround55%depecenttroductrgetedimmunpieThemechnmgultgcplttncempolyunderodpentgignificntgpknowledgehighclicllevnceThpropolelucidtenovelmechnmcplttnceSCCthuopengnewvenuemuchneededttmenttrtegiechemotntHNSCCenblgrpiddvncementfieldNp63pro-cogeneimplictedcplttnceovexpedSCCkhedneckcervixlungWepvioulypublhedTIP60cetyltrnferedictlycetyltetbilizeNp63promoteSCCcellprolifertiOurplimrydtdicte()chemotncecpltcltehighNp63TIP60levelHNSCCtumkSCCcellle(b)TIP60hibubiqutidegrdtiNp63whilecgcetylti(c)ilencgTIP60hibgHATctivyugTH1834downgulteNp63ducecetylticecellpopenizecellcplt(d)wedemtrtedncedefficcycplt-IRttmentIR-TH1834combtidemtrtgTIP60hibiceenivyIRWehypoizeTIP60promotecSCCHNSCCproliferticplttncevienhncedtbilyNp63functiTotetthhypowe(Aim1)determehowcetyltiNp63TIP60impctubiqutiproteomldegrdtiNp63(Aim2)vetigtehowTIP60mededcetyltiNp63ltertrncriptilctivyimpctpopDDRultimtelycplttnce(Aim3)elucidteroleTIP60/Np63xSCCprogirpeuticpeutilizgcellderivedxenogrftmodelefficcytudieHNSCCPDXmodeldetermeeffectiveneTIP60hibirpotentilrpeuticdjuncttrdcchemdi(cpltIR)ttmentTogercomdueg-lo--functivrlyevivoxenogrftPDXmodelcplt-tntSCCprovidettticllyrigouchrcteriztiTIP60/Np63ignlgcplttncepopDNAdmgepeSCCepotentilnovelrpyThididentifictiddilpotentilrpeutictrgetttmentSCCepililcncercludgnophryngellungcrcomprovidecriclightrpeuticpotentilcetyltrnferehibirSUMMARYTrngender(TG)men(ignedfemletbirth)TGwomen(ignedmletbirth)compvulnerblepopultiwhoehelthlrgelyundertudiedApproximtely75%95%TGdividulueexogenouhmeprtgender-ffirmgcGender-ffirmghmerpycommunypriyTGpeoplecncriclprotectivefcrimprovggenerlhelthwell-gHoweverexogenouhmeuedoublerkbtcncer(BC)cgender(exignedtbirthligngender)womenYetunknownwhergender-ffirmghmerpymodifieBCrkTGdividulDepethlckevidencecurntBCcengguideletteTGmenwomenhouldfollowcgenderguideleepecillyify50yeroldifTGwomenhveuedhme5yerWehypoizegender-ffirmghmerpymodifieBCcncerrkteroidmetbolomeflectthWeteurhypoourSPECTRUM(StudygPRIDEEnhnceCncercengguideleTRngenderUergender-ffirMghme)StudypeNoticeSpecilIntetNOT-MD-19-001Wecrudividul(ged25-50yer)cropectrumgenderidentievryghmeuethroughnncillrytudyPRIDEelrgetntiwidecohtexul/gendermypeoplewhom33%TGWeuethcohtcductfollowgimAim1)Quntifyhmeuecrogenderidentypectrum(n=5000)exmeocitweenhmeueteroidmetbolomeubet(n=1200)Aim2)Evlutelgudlchngeteroidmetbolomebedgegender-ffirmghmeuegdvenryTGmenwomen(n=600)Aim3)IncptehmlevidencecengguideleugDelphimethod10expertUntilgenderidentydtcollectedytemticllyTG-enhncedcohtprovidevlubleourceundertrolegender-ffirmghmerpyBCrktmoleculrlevelSuchknowledgelckgyetcouldgtlyimprovecengcommendtiwhichnowimplyextrpoltecgenderguideleTGpopultiGivenhighpvlencegender-ffirmghmerpynefprovidetermmentlgenerlhelthTGpopultideerveknowwhthmeuementermircncerrkPrctierwhoerveSGMpeoplecencncerleedguideleevidence-bedgender-ffirmgProjectSummryWehveidentifiednovelmodeunomouprogrmmedcelldehtctrolledp53mllcelllungcncer(SCLC)motdedlymlungcncerWecplizedgeneticllyengeedmouemodelwectedgulteendogenoup53ctivtitempllyctrolledctivtietblhedmouemodelSCLCWefoundp53ctrolcniclenecenceprogrmpproximtelyhlftumn-popticcelldethprogrmtThemechnmcelldethdtctknownmprogrmmedcelldethdependennmultiplememrcyclophilprotefmilypeptydyl-prolylomereWedemtrtep53gultedtcttrncriptilprogrmdygSCLCtumnotctiveenecgSCLCMooverctivtirncriptilprogrmbolhedmllmoleculehibircyclophilInim1ourprojectweterrogtemoleculrunderpngthp53-cyclophilterctiAtcellphyiologicllevelp53-mededSCLCcelldethocedfetuprppolydefedmodecelldethnotpvioulyocedp53chrcterizedexceiveccumulticyplmicvcuolecellwellgplmmembrnedyfunctiAddillyweobervedmiveductinendoplmicticulum-dicteduphgyprogrm(ER-phgy)durgp53-mededSCLCdethInim2ourprojectweterrogtemoleculrfetudectmoleculrdetermntprpER-phgythctextFllywepentcomprtivegenomicimplicte`cliclmoleculrubtypeSCLCpentedSCLCtumdiefterp53rti`vrintmoleculrubtypeSCLCpentedSCLCtumenecefterp53rtiInim3ourprojectwedetermeifeffectp53rtidtctbedeircelligcollectidrivermuttiecheimpctmoleculrubtypedevelopSCLCTogerourprojectelucidtenimptntmoleculrmechnmctrollgSCLChedlighntrgetblevulnerbilieidentifypecificubetSCLCptientmyuceptibleuchpprochePROJECTSUMMARY/ABSTRACTInpePAR-22-072MeuMethodAdvnceReerchMyHelthHelthDprie-ReltedCtructthprojectSmokgCncer-ReltedHelthDpriemgSexulGenderMyAdultpropoetegrtemultipledependentntildtetetimtepvlencemokghvilowdoecomputedmogrphy(LDCT)lungcncercengeligibilyuemokg-ltedoutcomemgexulienttigenderidenty(SOGI)my(eglebingyxultrngender)dultWhilegrowgbodylertudocumentlrgedpriebccoueSOGImypopultipterchfocugSOGImydultdetermemokg-ltedhelthdpriehenevelyhmpedgeogrphydequtempleizeprticulrlyexmeheterogeneySOGImyubgroupThulckerchexmepvlenceuniquerkfcr(iette-levelSOGI-pecificpolicie)ocedcigttemokgLDCTlungcncercengmokg-ltedhelthoutcomemgSOGImydultugntillypenttivedtThebencedequteexplnryfrmewkfurrhderbilyeffectivelycenpvenrttlungcncer-ltedhelthhvit-rkpopultiuchSOGImydultTheoverllfive-yerurvivlrtelungcncerly17-19%urvivlubtntillyimproveerlydetectiTothendpropoedprojecttegrtefourntildtetcludedultged18yerolderUSThetegrtiedtetwhichhvecommmeuSOGIcigtteuemokg-ltedhelthoutcomeprovidedequtempleizeexmepvlencerkfcrmokghvicnnotdequtelyddededtetleThtudyim(1)evlutelterntivette---rttechniquecombgetimtefourdiffenturveypecificfocuSOGImypopulticigtteuemokg-ltedhelthoutcomeLDCTeligibilyue(2)ughrmizeddtbedfourdiffenturveyeelf-ptedcigtteuemokgpck-yermokg-ltedhelthoutcomeeligibilyueLDCTlungcncercengmgdultexulientti(SO)genderidenty(GI)(3)exmehowtte-levelpolicyenctmentimplementtiltedSOGIocedmokgLDCTlungcengeligibilyuemokg-ltedhelthoutcomewhilectrollgtte-levelbccoenvirmentWecplizeuniqueopptuniefdedtegrtiedtetlrgempleSOGImieheteroexulcgendercomprgroupnovtivemethodologiclpprochecombgetimtemultilevelnlyette-levelpolicieltedSOGIProjectAbtrct(Summry)Medicllyunderervedpopultidproptelyffectedcen-pventblecnceruchcoloctlcncer(CRC)EntieuchUnedSttePventiveServiceTkFceAmericnCncerSocietycommendfeclimmunochemicltetg(FIT)neffectivehome-bedmethodCRCcengAnnulFITwhenfolloweddignoticcolocopypoiveultcnduceCRCmtlypopultilevelCRCcengtrdillydelivedprtmediclvHoweverduehtvtimecompetgdemmgproviderptientlikeptienteventhoewhogulrlyttendmediclvmymouncengputtgmthigherrkerioudeeFITcneilydtriedn-trdilhelthcettgcnhelpbridgegpcunderervedpopultiCommunyphrmcieholdpromeeCRCcengcueircceibilyphrmctexpgroledelivergpventiveerviceBedourmtivepilotwkdemtrtgcceptbilyfeibilyplimryeffectiveneFITdeliveryphrmcieourobjectiveevluteeffectiveneimplementtiphrmcy-bedFITterventiclledPhrmFITThroughcollbticommunyprtneruchNthCrolNetwkCtium(NCNC)WhgnWyomgAlkMtnIdhoPrcticeReerchNetwk(WPRN)CommunyPhrmcyEnhncedServiceNetwk(CPESN)ourim1)evluteimpct2)eimplementti3)etimtecotPhrmFITterventiWecductromizedctrolledtrileimpctPhrmFITCRCcengrteeligibleprimrycptientwhotupdtePtientdividullyromizeduulcrmPhrmFITrmwedetermewherttticllyignificntdiffenceCRCcengrteCcurntlyweuemixed-methodpprocherngeplimryimplementtioutcomeidentifybrrierfcilr(iedetermnt)thoeimplementtioutcomeFllyweclcultecotPhrmFITugcollbtiveproceflowdigrmmgmmicro-cotgbudgetimpctnlyWehypoizePhrmFITterventiceCRCcenguptkeoveruulcprovidgtterccemoopptuniepventiveervicethroughcollbtivephrmcy/primrycpprochPROJECTSUMMARYThecentdvncementteotcticbodyrdipy(SBRT)enblehighlyfocueddoedeliverytumwhileprgurroundgnmltueEmerggcliclevidencehowguperumctrolptienturvivluggetSBRTplyncglycriclrolelivertummngementHoweverrdi-ducedxicyepecillydoe-enivenmllivertuepoelgergchllengeliverrdipySBRTPrrpyuniqueBrggpekllowimultneoutumdoeecltinmltueprgpvgwybootefficcyfetyliverSBRTUntuntelypcelydelivergplnnedprdoelivertumignificntlychllengedtr-ttmentlivermotiepecillycglydomntpencilmcnng(PBS)techniqueCurntmotimngementtechniquecludgbdomlcompim-cnngpirrygtghoweverlluffervriouourceuncerttieccurcyultglimedce-dependentefficcyMotrckgtechniquetrckl-timetummoticcdglydjutmdeliverycnytemticllyfundmentllyddmotichllengeHoweveruchtechniquenotyetvilblecurntlyfcgthemjchllengeeliver1)Thepirti-ducedftlivermotiquil-timeimgghunddmillecdwhichultextmelylimedmplgmke3Ddemblemotrckgchllengg2)Thelowctrtlivertumgturroundgnmlliverpnchymddnlyeruncerttytummotrckg3)Them-trckgtechniquepulygeometry-guidedwhichquiftenergywchgdifficultchievecurntprytemItlofilcidercumultivetrckgerrcuedytemltencymotipdictierrdoechngeduenmicldemtiTheoverrchggolthprojectdevelopl-timeimggprplndptti(RIPA)ytemcompoedtwoub-ytem(MehBioNetMAO)olvel-time3Ddemblemoti(MehBioNet)imultneoudoeclculticcumulti--flyprplndptti(MAO)MehBioNetueArtificilIntelligence-drivenmethodolvel-time3Ddemblemotiglex-ryprojectiMAOfetufirtcloed-loopdoimetry-guidedfrmewkctivelymirdptprdoeenumtchgplnneddoeoutquirgtrckg-ltedftenergywchgWehvetheSpecificAim1)Developoptimizel-timeimggub-ytem(MehBioNet)2)Developoptimize--flyprplndeliverydpttiub-ytem(MAO)3)TetRIPAvip-cliclmoti-enbledphnmtudytropectiveptienttudyTheuccefulcductprojectultfirtend--endytemimprovedeliveryccurcyprrpyliverunlehfullpotentilprrpyepecillyviSBRTdvncgliverdeecPROJECTSUMMARYOncoprotedrivetumdevelopmentggivegrowthdygultgignlgpthwyvolvedcellgrowthurvivlprolifertiTrgetgcoprotedictlyirdowntmpthwyhultednovelrpiecurntlyguedttmentdiffentcncerubtypeTheRASfmilygunoetriphophte(GTP)hydrole(GTPe)groupcoprotehverolecnceriprogitncerpieFurrmomuttigeneencodgcliclRASproteveryfquentcncerRASprotecycletweengunoediphophte(GDP)ctivemGTPctivemInGTP-boundcmtiRASprotepromotectivtidowntmignlgpthwyctriegrowthproliferticellThnucleotidecycletedcceyprotectlyzelodghydrolyGTPdygulthmechnmlofquentcncerEmerggevidencehhownn-cliclRASproteloplycriclrolecncerbiologyhoweverirmechnmgultumigenenotwell-underoddiffercliclRASproteWehvecentlydcovednovelmechnmgultin-cliclRASproteRIT1MRASmededubiqutiproteomldegrdtictiveGDP-boundmOurwkidentifiedLZTR1novelprotebdRIT1MRASmcomplexE3UbiquligeCull-3(CRL3LZTR1)Cncer-ocedmuttiRIT1LZTR1druptirterctiledccumultin-cliclRASGTPectivtidowntmignlgInthpplictiwepropoetudycriclpectgrdggulthnovelcomplexctriumigenepotentilphrmcologicltrtegieprotedegrdtiInAim1weuebiochemicltructurlpprocheundertdetermntLZTR1electivywrdn-cliclRASGTPeRIT1MRASfunctiprotedomInAim2weplnelucidteignlgmechnmgulteCRL3LZTR1ctivycellhowepthwycnctrietncepecifictrgetedrpieInAim3wedevelopnovelmouemodeldrivenncogenicRIT1muttitntLZTR1-mededproteomldegrdtinlyzemoleculrigntuetumInddiwedeveloppro--cceptphrmcologiclttmentRIT1-drivencncerOverllourprojectddmjknowledgegpmechnmgultin-cliclRAScoproteprovidenovelpcliclmodelrpeutictrtegieecncerThewkdecridthpplictifirttepdevelopmechnm-bedpcemedicetrgetgecogenicpthwycncerAbtrctThpropoldeegnoticptientcentedfocugympmocedideeffectimmunecheckpothibir(ICP)AlthoughICPeffectivettmenteverlcn-cerrkimmune-lteddvereevent(irAE)dueuntdctivtiimmuneytempentignificntchllengeSeveirAE(grde3higher)cndevttgmnywyTheympmocedeveirAEcndebiltgultgfquenthopliztiTheirimpcnqulylifecnignificntenoughmtedctutinICPihvgneficilnti-tumctivyultgprogideedecedoverllurvivlInbenceprompt-terventieveirAEmycuelife-engdeclegnfunctipotentillyftlOurti-tuti(MDAnderCncerCenter)hhownerlydetecttmentirAEimprovett-menutcomeHoweverbiomrkerpdictptientrkirAEcouldhelpdevelopgurveil-lncetrtegieerlydignomngementirAElckgpentggpknowledgeTheoverllobjectivethpplictibuildvlidterk-pdictimodeldevelopcliclolpdictrkeveirAEptientttedICPInplimrytudiewefoundpoly-mphmgermle-encodedT-cellceprt(TCRB)vrible(TRBV)geneervepdictivebiomrkereveirAEWeloobervedchngeympmptedugMDAnderSympmInvenry(MDASI)-Immunpymeufirt3weekimmunpyipdictiveubequentdevelopmenteveirAEGuidedourplimryfdgwehypoizetegrtiTRBVpolymphmerlychngeMDASI-Immunpyympmemp-dictiveeveirAEToteurhypoweevlute500ptientttmentICPtMDAnderNtilCncerIntuteInAim1wepermlg-mplicTCRBperiequenc-gRNAextrctedbeleperipherlbloodmplepdictrkeveirAEbedTRBVpolymphmInAim2welgudllydmterptient-ptedoutcome(PRO)meudeter-meympmfunctihelthttuchngepdictrkeveirAEFllyAim3com-bgTRBVpolymphmPROchngelevntdemogrphicocioecomicttmentcli-clfcrwebuildpdictivemodelvlidtemodelndependentcohtptientTotrnlteourultcliclprcticewelodevelopweb-bedpplictipdictrkeveirAEdurgttmentICPOurctriiignificntcerkementugnovelimpleweb-bedolenbleptientirttgphyicinmulteperlizedirAE-mirgcplnmigteirAEThmultidciplrypprochfcilteerlydetectipromptmngementirAEwhichducechnceprogilife-engftleventPROJECTSUMMARYThegolthpropoldevelopcompheniveundertgcopekeydriverrcilethnicdprieopioidmngementcrocncerctrjecryuethundertgdeignmulti-levelcncerpequyterventifututetgPcommdblgympmcncerffectghlfptientttmennethirdurvivovertwothirdthoedvnceddeeDepeirrkopioidmcnernemnggcncerpCncerptientcolceivelepotentnlgeicthnWheptientcequentlyexperiencemoevedebiltgpYethveenfewpopulti-bedtudieopioidequiemgcncerpopultimuchmunknownboutmgnudecopeptientcommuniemotffectedltivefluencephyicinprcticehelthytemneighbhoodfcrInplimrywkexmgover300000MedicneficiriepoprognocncerwefoundBlckHpnicptientceivedfewerlepotenpioidthnWheptientBlckptientwemolikelyundergoudrugcengnerend--lifeDpriedproptelyffectedBlckmenthoelivgurbnundercgneedtterundertneighbhoodfcrubpopultimotimpctedHewepropoecomphenivenlyequieopioidmngementmgBlckHpnicAinn-HpnicWheMedicMedicid-udptientcropot-opertivectivettmenturvivhipend--lifephecncercBylkgdmtrtivedtcomphenivemtiboutphyicinprcticehelthytemneighbhoodweexmercilvricroveruelevelelucidtgkeymechnmwhichrcmundermeequblepmngementTheprojectmednexpliclynti-rcmfrmewkledtemexpertemultilevelnlyehelthcqulyequyguidedlgudlenggementptienttkeholderlggcommuniecolAfteridentifygpopultiettgtgtetrkchiefdriveropioidequieweuerigou4-pheerchprocedeignmulti-levelcncerpequyterventrgetgmotpotentmutbledrivercliclettggtetneedThprocegroundedmultilevelmodelbedupRcmFundmentlCueInequlieHelthguidedqultivefeedbckcncerptientcgivercolclicintffgniztillederdiverecncercytemThpropolyieldcompheniveundertgcoperootcuercilequiecncerpmngementtril-dyterventiddetrtegicourceequietmultiplelevelOurfdglohveclerimplictipolicymkerurhelthytemledercommtedprovidgequbleccncerptientTriple-negtivebtcncer(TNBC)nggivemoleculrlyheterogeneouubtypebtcncerfquentlyexhibtncechempyledgpoclicloutcomeAfricnAmericn(AA)womenUnedSttenlyufferhighercidencerteTNBCcompdirEuropenAmericn(EA)counterprtyloendupourvivloutcomeRcildprieTNBCoutcomemultifcrilnotfullyexpledttmentvriocioecomiclequlieAuchvetigtihowpthophyiologyTNBCdiffertweenAAEAwomenmyfernewightmnnerthroughwhichbiologicocio-demogrphicfcrcvergectgoutcomedprieTNBCByequencgtrncripmeprimryTNBCtumobted3dependentptientcohtwedetectedrrntctivtiMIZ1~70%AAtumneventwtrglyocedpooverllurvivlolelyAAptientBedecompellgfdgwehypoize(i)MIZ1ctivtiunderliedprteoutcomepooverllurvivlrteAAwomen(ii)trgetgmechnticvulnerbilieMIZ1ignlgprovidenovelrpeuticpprocheignificntlyimproveAATNBCoutcomeTotetthhypoelucidtemoleculrmechnmwheMIZ1governTNBCggiveneAAptientweendevpermfollowgSpecificAim(1)determemechnmwheMIZ1driveAAtumigenicy(2)determemechnmwheMIZ1impctcellulrheterogeneymcrophgepolriztiAATNBCtum(3)determeociAfricnncetryMIZ1ctivtiAATNBCdeferoletheventTNBCprogiThprojectmrkfirtefthrnemechnticvulnerbilieMIZ1ctivtifunctiimproveclicloutcomeAATNBCptientCollectivelyournovtiveccepthighlyimpctfulcouldpotentillydefecliclprcticettgAATNBCptientdogodevelopgnovelbiomrkernewdrugdrugtrgetimproveclicloutcomeAATNBCptientPROJECTSUMMARYMyelibro(MF)hemlogicmlignncychrcterizedctutilympmplenomeglymrrow(BM)fibrohighrktrnmticutemyeloidleukemi(AML)MFmgmotggivechricmyeloidneoplmmedinoverllurvivl(OS)lethn4yerSomticmuttiJAK2CALRMPLgenecomm~85%MFptientpclicltudiehvehownemuttiultctutivectivtiJAK/STATpthwyledgchricflmmtiBMfibroAccdglyFDAhpprovedtheJAK2hibirRuxolibFedrtibPcribbedircliclimprovementctutilympmplenomeglyOSHoweverubtntilfrctiMFptientlckJAK2-ctivtgmuttiMooverJAK2-ctivtgmuttipertptientundergogJAK2hibirrpieubgroupptienthveuboptimlpeJAK2hibirundercgurgentneeddevelopgnewrpeutictrtegieimproveclicloutcomeMYCtrncriptifcrctrolcellprolifertiurvivlmetbolmAlthoughMYCplyimptnncogenicrolemyeloidmlignncieuchAMLroleMFpthogeneunknownNotblyourcenttudieveledMYCcopynumrgfquentlyoccurMFptientthocedcedlevelMYCproteexpiptientBMcellImptntlywehvehownctivtiMYCexpimouehempoietictemcell(HSC)ufficientprovokeMFdependentJAK2CALRMPLmuttithquiupgultiS100A9nlrmDngerAocedMoleculrPttern(DAMP)proteplypivotlroleflmmtinteimmunyAccdglyMYC-S100A9xunderliecomplexnetwkflmmryignlgvolvevriouhempoieticcelltypeBMnicheFllywedcovedMYCloduceexpnimeenchymltromlcell(MSC)knownmyibrobltctrigMFpthogeneTheefdguppthypoectivtiMYC-lrmpthwydriveMFdependentJAK2/CALR/MPLmuttihibgMYCtrgetlrmimproveclicloutcomeMFptienthvgcedMYCexpiTotetehypoeweepcliclctivyphrmcologicgenttrgetgMYC-S100A9xMFdetermemechnmMYC-dictedupgultiS100A9(Aim1)FurrweeroleMYC-S100A9circuctivtiexpnimyibrobltirctriiMFdevelopment(Aim2)FllywedeferoleMYCtrgetlrmMFdrivenJAK2pthwymutti(Aim3)CollectivelytherchprovideimptntightnewmoleculrcircucnectgMYClrm-mededflmmtetifMYC-lrmxpentnovelrpeuticvulnerbilycntrgetedimproveclicloutcomeMFPtientmettticcoloctlcncer(mCRC)hveubtntillyweoutcomethnthoeprimryloclizedCRCOver80%CRCmetteoccurliverwhichhuniqueendolilcell(EC)-richmicroenvirmentDtctpcedentECtudiefocuedngiogenevculrmodelgwedcovedliverECecteolublefcrpromotemCRCdevelopmentprcfhiSpecificllywefoundhumnepidermlgrowthfcrcepr3(HER3loknownErbb3)keymedirEC-ducedmCRCgrowthliverHoweverwefoundliverECctivteHER3dependennlyknownHER3ligneugulHewemdeprdigm-hiftgdcoveryleucerichlph-2-glycoprote1(LRG1)ectedliverECnovelHER3ligctivteCRC-ocedHER3promoteCRCcellgrowthMooverytemichibiLRG1ttenutegrowthCRCubcutneou(ubQ)xenogrftcemoueurvivlnthopicmCRCmodelTheGOALthpropoldetermeroleLRG1novelHER3ligpromotgmCRCdevelopmentelucidtemechnmwhichLRG1bdctivteHER3WeHYPOTHESIZELRG1novelHER3ligLRG1-HER3ignlgxplycriclroleCRClivermettedevelopmentWetetthhypotwoSPECIFICAIMSAim1determeroleEC-ectedLRG1promotgmCRCioutgrowthclicllylevntmCRCmodelEC-pecificLRG1knockoutmiceLRG1neutrlizgntibodyptient-derivedxenogrftgnoidAim2elucidtemechnmwhichLRG1bdctivteHER3determedcltitweenHER3ctivtimCRCptienutcomeINNOVATIONSthprojectcludedetermtinovelroleLRG1promotgmCRCdevelopmentidentifictiLRG1novelHER3ligelucidtimechnmLRG1ctivtgHER3SuccefulcompletipropoedtudieloidentifyHER3ctivtipotentilprognoticbiomrkerptientmCRClyfoundtidevelopgnewrpeutictrtegietrgetgLRG1menblecompent()LRG1-HER3ignlgccdePROJECTSUMMARY/ABSTRACTRdirpymyduceevedvereevent(AE)ultignificntdetrimentptientqulylifeepecillyhedneckuchbrnecro(BN)otediecro(ORN)etcItimptntdevelopferrdirpydeliverymodelmimizerkAESpotcnngprrpy(SSPT)provideuchnopptunydueuniquephyicchrcterticieBrggpekButlotroduceddilcomplexieceprdepomotenergyhtdtnceultghighlerenergytrnfer(LET)compdtrdilphrpyTheeltivebiologicllyeffective(RBE)doemyvryignificntlyevenmedelivedphyicldoeHowevercliclueLETlimedcueuncerttiedcpncieRBEmodellgclcultiThucurntSSPTplnevlutiexcluivelyliephyicldoeignocriclLETmtiInthprojectwepropoenoveloldoe-LETvolumehgrm(DLVH)vulizedoeLETtructuvolumee3DurfceplotWhilevoidgprmeterlrgeuncerttieRBEmodellgweclteAEwell-defedquntiedoe/LETetblhdoe-LETvolumectrt(DLVC)rgnlevelThefollow-upmediclimge(CTPETMRIetc)howedthnlymllptigi(eedpot)tAEeigtedynergticeffecthighdoeLETTheeeedpotnexpnervoxellowdoe/LETduebiologiclproceemAEeidentifiedlterfollow-upimgeThecluievoxellowdoe/LETtroducelotnoedtnlyThuimptntfilterenoetrueignlifwewntundertdoe-LETeffectAEiliztiWepropoenovelvoxel-bedmethoddoimetriceedpotnlytudygdoe-LETeffectupAEiliztvoxellevelSeedpotnlykptch-bedmethodmediclimgenlyidentifieeedpotEmpiriclAEmodeldevelopedvidoimetriceedpotnlycriclvoxelelectedpopulti-bedDLVCTheter-ptientvricidedtwo-levelmixedeffectlogticgimodelThenmltuecomplictiprobbilymodeletblhedbedDLVCppliedcliclprcticeplnevlutiwendevelopDLVH-bedttmentplnngugDLVCSSPTpropectivelymimizepoiblecidenceAEThepropoedprojectcrriedoutexpertMyoClicMDAnderNewYkPrCenter/MemilSlKettergUniveryGegiOurprojectfillcricltechnologyvoidSSPTelrget-vivooutcome-driventudievetigteimpctLETTheuccethtudycomemjdvncementcurnttrdcSSPTplnevlutioptimiztiugphyicldoeleledgpcirdirpyimprovedclicloutcomePROJECTSUMMARY/ABSTRACTSmllcelllungcncer(SCLC)nextmelydedlycncercurntchemo/rdirpielckdurbleeffectImmunpyimmunecheckpotblockdeeffectively~13%SCLCptientrlyultutedpeextenive-tgeSCLCTrgetedrpydevelopmentSCLCchllenggSCLCtumtypicllyhvefewctibledrivertedmlydrivenlo--functimuttiRB1TP53(>90%)fquentloctivtipotentiltumuppcludgetepigeneticgulrNeverlecentdcoverieSCLCgenomicprovidenewfrmewkundertgbiologySCLCidentifygmoleculrvulnerbiliedeeFunctilchrcterizticurntmuttiputtivetumuppgenecrucildefgmechnmtumigenewhichfciltedcoverybiomrkertumpventerventiWecentlyidentifiednewtumuppgeneCRACD(CppgprotehibgRegulrACtDynmicKIAA1211/CRAD)CRACDencodeprotebdhibcppgprotefciltgctpolymeriztiCRACDfquentlymuttedtrncriptillydowngultedSCLCptienttumCrcdknockout(KO)promotetrnmtipneoplticpcurlungepililcellCrcdKOloignificntlyccelerteSCLCdevelopmentnuchthoumouemodelwhichtumiduceddeletiRb1Trp53Rbl2tripleKOmouemodelCrcdKOSCLCtumhrbdtctrootcellcluterrrntcelllegetrjecrieimpidntigenpenttiSgle-celltrncripmenlyhfurrtrtifiedSCLCptientCRACDctivtintigenpenttipthwyimpirmentIntriguglybltiCrcdleducehyperplineuroendoccellrrntcelllegeplticymouelungTheeultledhypoCRACDctivtiducerrntneuroendoccellplticyepromoteSCLCtumigenevidygultednuclerctdynmicubequentepigeneticprogrmmgThepropoedtudyunveilbiologySCLCiprogidetermecell--igirlevntcelllegeducgneuroendoccellplticyprovidgnovelightSCLCtumigeneAddillythtudyetblhnewmodelytemSCLCiprogroducenovelomticengeergytemwhichtechnologicllynovtiveCompletgthtudylolyolidfoundtidetermewherCRACDlomoleculrigntupecificSCLCptienttrtifictiimmunpypepdictiwhichcceptullyclicllynovtivePROJECTSUMMARY/ABSTRACTUnpcedentedcliclucceept12yerimmunecheckpotblocker(ICB)uchnti-CTLA-4nti-PD-1-tigtetrgtetcentyertudyterplytweenrdipy(RT)immuneytemlg-geobervtiRecentemleftmnygrouphowRTlegdngerignlnovelnetigendrivedendriccellmturturncroprimeTcellmedenti-tumimmunepeHoweverTcell-tricmechnmRThveeneluivedepedpenbleroleTcellgoverngRTefficcyMooverturngtumuperlizedvccedebulkgICB-tntlrgetumdependentdictkillgIFN-RTpentnidelrpeuticoptiovercomeICBtnceocedtumloIFN-ignlgmjmechnmtnceICBwecentlyidentifiedThtudylogicllybuiltupourplimrydthowgthurRTgimenctivtemTORdowntmtrgethypoxi-duciblefcr1(HIF1)tum-filtrtgTcell(TIL)pecificdeletiHIF1TcellbolherpeuticeffectRTImptntlylthoughnotpotentWTtumourRTgimentillbleduceignificntuppumlckgfunctilIFN-ignlgWeehypoizemTOR-HIF1xTILmjmechnmundercgrpeuticimmunologicleffectRTwhichcnutilizedovercomeICBtnceInAim1weetblhTcell-tricmTOR-HIF1xctrolRTefficcyInAim2wedetermecellulrmoleculrmechnmwhichctivtedHIF1chetrtenti-tumimmunyelicedRTInAim3werigoulyteurRTgimeneirlecjunctrgetedchempie/ICBbothhumnmumelnomlckgfunctilIFN-ignlgnoverllgolovercomethmjmechnmICBtnceOurtudievelfirttimeTcell-tricmechnm()RTSceourtetedcompoundclicllypprovedourfdgfcilterpidnchdidetrnltiFurrmoourrtillydeignedRTRT+ICBgimenmyguidefutuclicltrilPncticductldenocrcom(PDA)ledgcuecncer-lteddethUSwhichttmentmbicllyunchngedptthedecdeAlthoughptienttendiemettticleinopecificdignoticmrkerrpeutictrtegieimedtttgmetteprticulrlyduenlmotcompletelckknowledgemoleculrdrivermettticprogiUgdiffentilgeneexpinlymtchedprimrytummettgeneticllyengeedmouemodelPDAnovelfunctilt-grcenubequentvlidtitudiehumnpecimenweidentifiednovelglutthie-ltedmetbolicpthwypecificllyctivtedmettticcellCricllyduciblebltwokeyfcrpthwyGtt1(glutthieS-trnferet1)mocidtrnpterSlc384pecificllyexpedmettticleicompletelyhltedgrowthmetteoutffectgprimrytumegenelyexpednmllivercelluggetgmettticcellco-optthpthwypurpoemetbolicfnefurrmoplimrydtdicteuchdpttidrivenovelcjugtgctivy(glutthyylti)mtrixprotecludgfibrect1(Fn1)llowmettticcelltterexpextrcellulrmtrix(ECM)llgerdictgeleievolvecquirgn-geneticdpttiInthpropolwetkedvntgebiochemtrycellbiologygeneticlly-engeedmouemodelmplehumnptientdermoleculrlychrcterizeefcrpotentilchngettmentthdevttgdeePROJECTSUMMARY/ABSTRACTChempy-ducedperipherlneuropthy(CIPN)evedoe-limgxicyffectover65%ptientceivgtxne-pltum-bedchempybrgtrotetlcncerNlydoeCIPNcemtlylimgdoechempyCIPNffectwlkgwrgetgdgvinumbnetglgpcoldenivycrmpghfeetThenoFDA-pprovedttmentCIPNcueweneedgterundertgpthophyiologyCIPNhumnThprojectmotivtednnovtiveperpectiveCIPNympmnotdueimplyperipherlnervedmgerrCIPNympmwenedchngebrcludgteroceptibrprocegentibodyThnobervtillgudlcohttudy120ptientbrgtrotetlcncercheduledceivetxnepltumchempylg60ge-mtchedhelthyctrolTheptienteed2weeketrtgchempylethnemthftercompletgchempyixmthftercompletgchempyCtroleedtmtchedtimetervlEchementclude(1)meuneurlubtrteterocepti(brMRIcnngei)(2)ptient-ptedcliclfetuteroceptiperipherlnervefuncti(3)ptient-ptedCIPNeveryOurimechngeteroceptilgcncerchempyctuumcompdhelthyctroleltihiptweenteroceptiCIPNptientThfirttudyegteroceptiefterchempycompdhelthyctrolletlehowteroceptictrieCIPNcommevedoe-limgxicyenigmticmechnmBycludgtxne-pltum-ducedCIPNwecnddtwocommneuroxicgentexhibdtctignympmmechnmxiciemypddiffentlygiventtmentOurultmournoveloticlfrmewkCIPNltedteroceptimgfollow-upclicltrilugterocepti-bedbiomrkerprophylcticttmentCIPNexmpleugexercemedtiphrmcologiclgentThwkultimtelyhelplleveburdenchempyptientcncerCebrlcvernoumlmti(CCM)vculrleicentrlnervouytemffectg~05%popultiCCMptientexperiencedebiltgneurologiclproblemwhichwenleiexpprogCCMtriggedendolilcellgermle/omticmuttie3gene(ieKRIT1CCM2PDCD10)encodecompentCCMcomplexDruptiCCMcomplexendolilcelldrivecllexpninepilil--meenchyml-liketrniultgCCMmtiSympmticCCMuullyttedurgiclmovlwhichviverkyPhrmcologiclttmentCCMgtetedHoweverignificntphyiclbrrierexttrnptytemiclly-dmteddrugCCMmicroenvirmentepecillyo-clledbiologicwhichtypicllyexceed1KDmoleculrweightIndeedhumnCCMhveltlenovculrcceviCCMlumenGrowgCCMdocrumicrovcultufernlterntivedrugcceroutehowevertignificntblood-brbrrier(BBB)functiwhichlimdrugdeliveryHewedevelopMRimge-guidedtrtegietrgeteddrugdeliveryCCMvrnientpermebilizthperileilmicrovcultufocuedultround(FUS)microbubble(MB)ToetfoundthprojectwepvioulydevelopedchrcterizedtrngenicmouemodelCCMcpultehllmrkhumndeeoptimizedlgudlMRimggmirCCMprogicfirmedviMRIperileilmicroveeltbrrierfunctiInnewerplimrytudiewedeployedMRI-guidedFUS+MBfelypermebilizeperileilmicroveelFurrmowedetermedmrkblyCCMexpoedFUS+MBlechricllytbilizedprovidgpowerfulpltmmyferrpeuticynergyugmenteddrugdeliveryGiventhpmeeplimrydtwewell-poiedpropoethepecificimInAim1wedeveloprobutMRimge-guidedpprochfeeffectivedeliverydrugCCMmicroenvirmentFUSMBWedefeltihiptweencouticfeedbckctrolytemctrtgentdeliveryfetyInAim2welevergethmtidefeCCM-drugexpoucurventi-ngiogenic[Anti-VEGF-A3TSR(Thrombopd-1frgment)]nti-neuroflmmry(Anti-CSF1R)biologicwehypoizeefficciouctrollgCCMugImmunoPETimggInAim3wectrolCCMprogiocedneuroflmmtiviFUS+MB-mededdeliveryebiologicBedImmunoPETmeumentAim2wetilimplementprocoldeliveryechdrugCCMmicroenvirmentCCMprogineuroflmmtioxidtiveturvivlexmedGivenourFUSfrtructuexpertewellourexperiencetrnltgFUSttmentclicltrilweexceptillywell-poiedtrnlteuccefulultclicOurcentrlhypotrgetggulrygenecncerprogiimpedetumgrowthpventdeecurnceOurtudygoltwo-folddcovercncergulrygeneHER2/Neu-expgDiveryOutbd(DO)F1micetetterventitrtegiedictedtctibletrgetuchLILRB4myeloidntigen-pentgcell(APC)checkpotmoleculeThedevelopmentptneoummmrytumHER2/neu-trngenicmicecptuubtntilterctimgtumtromlimmunecellprovidetrnltilerchpltmWeue(BALBxDO)F1NeuTmice(FVBxDO)F1d16HER2miceencompcompletebiologiclproceHER2/Neu-ducedtummicedividullydtctgeneticbckgroundTheR-bedR/QTLlghmocetumgrowthphenotypeechmoueuniquehplotypevelQunttiveTrLoci(QTL)CidtegeneQTLidentifiedourbiomticpipelevettedhumnclicloutcomedtActibletrgetelectedtegrtgcRNAtrncripmicfdgfunctilpthwynlyLILRB4emergedpnelcidtemoleculecueexpedmyeloidntigenpentgcell(APC)cltedpourvivlhumnbtlungcncerptientAntigenpenttifoundtiimmunectivtinunder-utilizedopptunymodifygnti-tumimmunyLILRB4ctivtibluntntigenpenttimcheryignlproductiimmuneuppivemoleculeLILRB4blockdemyenhncemyeloidcellntigenpenttiprimeexpTcellunlockgirnti-tumctivyToteurhypotrgetgcncergulrygenedeectrolweAim1Identifycidtegenegultecncerprogi1AIdentifyvlidteQTLgultetumetgegrowthrte(FVBxDO)F1d16HER2mice1BIdentifyvetcidtegeneechQTLugetblhedbiomticpipeleAim2Defecidtegeneexpiprileelectctibletrget2ADecvolutegeneexpiprilemouemmmryftpdcRNA-Seq2BIdentifyctibletrgetgenetegrtggeneexpiprilefunctilpthwynly2CAoceenhncercceibilydiffentilgeneexpicptuddilcidtegeneAim3TethypoLILRB4blockdeexptumimmunyimpedetumgrowth3AEvluteroleLILRB4tumimmunygeneticknockourntibodyblockde3BTetnti-tumimmunectivticombgLILRB4blockde-HER2mAbrpyctivevcctiWepropoetudyextrcellulrveicle(EV)novelmedirpthogenerdicyt(RC)whichffectpproximtely15%prottecncer(PC)ptientttedrdipy(RT)BldderrdioxicyimpctlivePCurvivmotnotblyolderptientnopdictivemrkerocedcidencendurblemoleculrrpiecpblepventgRCThenurgentneeddevelopmenteffectivemediclcountermeugtRCidentifictimoleculrdignoticidmigtgthdebiltgttment-ltedcomplictiEVlipid-boundnnoprticlemedetercellulrcommunictidelivergcrgomoleculeneighbgdtntcellStudiehvehownRTduceEVleeltercompoieEVHowevermoterchdtehencductedcelllelimedpclicltudienohumnerchUgpervedmplecollectedgenome-wideocitudy(GWAS)weptedfirttimelktweenurryEV(uEV)levelfutuethemturiprovidgpromgbiomrkermyenblemotimelyttmentt-rkptientmigtedevelopmentltebldderxicieTheprognoticutilyEVerumwlerobutThfurrupptednnimltudyhowgcltiuEVprticlecountRT-ducedbldderxicyCricllypot-RTuEVderivedPCptientwhodevelopedltehemturiducedubtntiloxidtivetnmlblddercipientcellfurrupptgfunctillktweenEVrdioxicyProteomicnlye12uEVmpleveledthoeEVcrgoproteweproundlyltedRTNotblyweidentified60RT-xicyigntuuEVprotecludgmnyfunctiocednteimmunyneutrophilctivyhighlightgpotentilmechnm()ctiBedetudiewehypoizeRTduceleeEVlterircompoiultntRT-EVcrryimmunologicllyctivebiomoleculeducgddilcellulrdmgeTheketicRT-EVleeRT-EVcrgomoleculecnervepdictivebiomrkerRT-ducedxicyllowerlyterventimigteRTxicyWepropoetheSpecificAimAim1Todeferolerdi-ducedextrcellulrveiclemedgRT-ducedbldderdmgevrovivoAim2ChrcteriztiRT-EVcrgomoleculeirrolemedgrdioxicyAim3Toetblhbodyfluid-derivedEV-bedpdictivebiomrkerRT-ducedxicyAccomplhgpropoedtudiedefefunctilroleRT-EVmedirRTxicyRT-ducedEVleeketicltertiEVcrgopentenivenviveu/blood-bedEVbiomrkercnpdictclicllylevntRToutcomeeetltexiciePROJECTSUMMARYLungcncerledgcuecncer-lteddethmenwomenWeterncountrien-mllcelllungcncer(NSCLC)ccountg~85%lllungcncerceRepertechempynewertrgetedrpieimmunecheckpothibir(ICI)mpymuntfcrynewttmentneededNSCLCElevtedlevelctivtiignltrnducerctivrtrncripti(STAT)3trncriptifcrervemtergulrcnceroccurmotNSCLCtumocedweurvivlICItncemededprtthroughctimyeloidderiveduppcell(MDSC)tummicroenvirment(TME)STAT3ctivtilomyctrieICI-mededimmune-ltedevedvereevent(irSAE)TheTwerdygroupwkgclicl-tgebiotechnologycompny(TvrdiTherpeuticInc)uedcomputer-beddockgled-compoundoptimiztitrtegieidentifyTTI-101potentn-xicllybiovilblehibirSTAT3TTI-101htrgetblockedtumgrowthplimrytudieugCC-LRK-rmutntmouemodelNSCLCpublhedtudienudemicergxenogrftLKB1-nullhumnNSCLCcellleA549APhe1doe-ecltitudyTTI-101mpyptientdvnced/frcryolidtum(NCT03195699)completedenrollmentQ32022velednodoelimgxicieftlttment-lteddvereeventidentifiedRP2DTTI-101dmtrtiducedlevelctivtedSTAT3tum57%wneficil2139(54%)evlubleptientcludg5cfirmedprtilpeBedeultTTI-101wgrntedFDAFtTrckdeigntihemergedmotpromgmll-moleculeSTAT3hibirclicldevelopmentttcncerOurlg-termtrnltilgolimproveoutcomeptientcurnrmetttic(RM)NSCLCThemobjectivehedetermeifSTAT3trgetgTTI-101neficilttmentRMNSCLCThepecificimdeignedchievethobjective1)determeifTTI-101lecombtinti-PD-1mocllntibodyeffectivettmentNSCLCK-rmutnt(CC-LR)mouemodel2)determenti-tumefficcyimmune-modulryeffectTTI-101lecombtinti-PD-1immune-competentmouemodelK-rStk11/Lkb1(KL)co-muttedNSCLC3)determefetynti-tumefficcySTAT3hibiTTI-101combtipembrolizumb(nti-PD-1)pvioulyttedptientKRASSTK11/LKB1(KL)co-muttedRMNSCLCPheIB/IIclicltrilWeobttumbiopiep-pot-ttmentPheIItrilpermcltivetudiecludedetermgltihiptweenphrmcoketicphrmcodynmicTMEcliclpeptientmiceNSCLCttedTTI-101lecombtinti-PD-1rpyIfuccefulourerchimproveurvivldecexicyptientRMNSCLCAbtrctDNA-trgetgdrugmtmrpycncercomgcleromeirnti-cncerctivyduenlyDNAdmgelochromtdecdentiwhichwecllchromtdmge(CD)MooverhenhownomedrugcuelyCDoutDNAdmgeeCD-lydrugpotentnti-cncerdrugcompoundcugbothCDDNAdmgelckxicyocedDNAdmgeThefocuourtudyunderthowCDctivteIFNhowthpropertycnuedclicgugepotencyCDdrugOurultimtegolourerchhowCDuperimechnmDNAdmgenextgenertinti-cncerchempywhichmoeffectivelexicmopowerfulctivtgnnti-tumimmunepeTochievethgolwehvedevelopednewgroupCD-lychemiclcurxThenti-cncerctivycurxcliclledCBL0137hendemtrtedmultiplemouemodelPheItrilhhownmngeblexicieevidencentumctivyTheetudiecfirmedductiIFNignlgCBL0137micehumnNotblycurxcuetrgerfterIFNducthnDNAdmgggentDNAmethyltrnferehibirHDAChibirItwelletblhednowIFNductiignificntlyimproveirnti-cncerefficcyDNAdmggrpyCDcueIFNductividiffentmechnmbuurdthowedIFNctivtienhncenti-cncerefficcyCDTheewepropoenti-cncerctivyCDgentmededvivovwocomplementrymechnmdictkillgtumcellenggementnti-tumimmunettckThpropolfocuehypoIFNignlgtum/n-tumcellducedCDvimechnmdiffentDNAdmgepotententi-cncerctivyCDdrugWefocutriplenegtivebtcncer(TNBC)chllenggdeettdueggivehvilckctibletrgetOurpecificim1DetermeimpctIFNctivtumn-tumcellnti-tumctivyCDrpy2DefemechnmIFNctivtiCDgent3Developtrtegievergimmuneuppiveenvirmenttriple-negtivebtcncerugCDgentPROJECTSUMMARY/ABSTRACTEophgelqumoucellcrcom(ESCC)ccountover80%eophgelcncercehpoprognolrgelyduebenceympmerlytgeAlthoughnerlydignoESCCmyledtteroutcomettmenterlydetectichllenggceESCCigteblcelllyervdelmpropriTheeundertgbiologyESCCidevelopgmodelytemcpulteESCCneoplicrucilCurntlymechnmESCCiimmunelcpemodelgdurgESCCumigenemunclerWehveetblhedgeneticllyengeedmueophgelgnoidmodelytemhhownignificntpotentiltudyESCCiThroughCRISPR-bedgeneticmnipultimueophgelgnoidweidentifiedkeytumuppgenemotfquentlydeletedESCCptientetblhed32eophgelgnoidleTrncripmicneoplticgnoiddictedtrncriptiligntuctentESCCptientgle-celltrncripmicidentifieddtctcelllegemultiplerootcellcriclguluchneoplticgnoidIntetglylypecificneoplticgnoid-derivedcelldevelopedtumimmunocompetentmiceOurplimryultuggetlotumuppgenecrucileventESCCiducgeophgelneopli(cell-unomou)modelgimmunelcpe(n-cell-unomou)TheewehypoizecombrillotumuppgeneeESCCducgeophgelneoplicellplticyimmuneeviThhypotetedthroughtwopecificimAim1TodetermegenetictrncriptilnetwkgESCCugnewmodelytemAim2TodetermeimpcttrgetgESCC-drivenimmunelcpemodelgESCCumigeneThetudyfillcurntknowledgegpunveilgbiologyESCCiprovidgnewmodeldevelopgviblerpeuticpplictierlyESCCBckgroundAnti-EGFRgenthveenhownnefcoloctlcncerptientexceptptientwhoetumcludeKRASmuttiDtmultipleclicltriluggetthmycctColoctlcncerptientKRASG13Dppernefnti-EGFRgentCtroveryurroundthobervticuectrdictwell-etblhedmechnmEGFRignlgRmuttiWehvevetigtedproblemnovelexperimentl-ytempprochRignlgvelgn-tuivedependencyEGFRfollowdiffencehowKRASmutnttercttumuppneuribrom(NF1)fluencewild-typeRASctivtiMooverwehveidentifiednddil10mutntotbdNF1cferenivyEGFRhibiHewepropoetudymgmutntmkeupover90%RASmuttiCRCFurrmowehvedevedtrtegyelectivelytrgetWTRAStntRASlleleenizeCRCEGFRhibirOverrchgHypoWeplnchrcterizeemutnthypodrivendependentimAim1FunctilmechntictudietetRAScidtedetermedirbilybdNF1EGFRhibirenivyAim2PhrmcologicllytrgetWT-RASCRCcellhrbmutntKRASllelecfertrictnceEGFRhibirAim3Levergedomnt/negtiveeffectcyolicNRASmutntEGFRhibiLgtermgolItcglylievedcombgexperimentlcomputtilmethodquidmtchptientttmentOurwkdemtrtehowytempprocheenblemechnm-bedfenceccernghowmuttifluencepettmentOurcurntfdguggetwecnidentifymocidteenizetntlleletrgetgWT-RASprocegThpotentillycouldcenumrptientEGFRhibircurntlycnnotceivethrpyAbtrctMultiplemyelom(MM)ecdmotcommhemlogicmlignncy(ftern-Hodgklymphom)USOverptdecdedepedventnovelrpiehimprovedlifeexpectncyptientMMMMtillcurblePtienutcomevriewidelyoverllurvivl(OS)rngglethn1yergterthn10yerThelrgevribilyptienverllurvivlultghighheterogeneoumicroenvirmentMMheightenneedrk-dptedttmentlg-termctrolwhichlrgelyliedccurteementtumevolutiurvivlpdictiTheInterntilMyelomWkgGroup(IMWG)guideleeverldiffentprognoticmodelhveenuedettmenutcomeTheeytemutilizediffentubetlbryvlueclictetementcreriwhichmynotdictefullextenttumburdenMRIgoldtrdimggmodlydetectimrrowvolvementItprovidegloblpenttumburdenevenptientn-ecryhypo-ecryMMWehypoizetegrtgmultimodlmtidelivedtimeerilnviveMRimggclicltetprovidemobutccurtemodelgMMevolutidurgfterttmentthucnpdictttmenutcomemoliblytnerlytimeOurgoldevelopfrmewkdeciupptytem(DSS)tegrteMRimgeclicltettphyicinmkgmeddecitilgttmentndividulMMptientThepropoedtudyim(1)InvetigteeffectiveneMRIrdiomicfetuchrcterizgMMfiltrtiircltittmenutcome(2)InvetigtecircumtncehowcombtiMRIrdiomicclicltetcomplementechmopowerfulerlypdicttmenutcomeTochieveeimwetropectivelycollectlrgedtetMMcebelefollow-upMRIcnclicltetdevelopmentvlidtiDSSytemWeutilizedvncedrtificiltelligence(AI)techniquecludgcurntneurlnetwkcementlerngtrpdictivemodeltimeerilMRIclicldtcquidtmultipletimepotwhichllowtdmodeldeployedflexiblyechdividultimepotttmentementtcilteerlypdictiFurrmoedvncedAItechniquecnlerntertempldependencievilbledtcompentemgdrexmtgletimepoterilexmwhichmyoccurl-wldcliclutiWhflexiblemodulrrchectudeignourDSSytemwevetigteter-tr-ltihiptweenMRIlbryvribletterundertgircomplementrychrcterizgtumburdendurgMMttmentiroctmenutcomeAfltepugndependentmulti-tutiltetetwevlidtepermncedevelopedDSSpdictgcurncerktnerlytimepotdurgttmentProjectSummryTtmenutcomeptientcutemyeloidleukemi(AML)hvectuedlghdoutcomeptedhemlogiclmlignncielikecutelymphoblticleukemi(ALL)prtcueltivelylowdevelopmentimmunpy(cludgimmunecheckpothibir[ICI])compdALLHowevertrnlticurntlyvilbleimmunpieAMLttmenthenchllenggnovelAML-trgetgdrugimmune-timultgctivygtlyneededThecGAS-STINGignlgmjpthwypromotenextrictypeIInterfer(IFN-I)pewhichpotentlyprimeTcellimmune-coldcncercludgAMLMylbryhenctivedefgfunctiprotergemethyltrnfere(PRMT)leukemiHeourplimrytudiebprimryAMLcellwellmuAMLmodelvelnnti-AMLimmunectivtieenfterhibiPRMT9motcentlydefedPRMTSpecificllyPRMT9hibitimultedleukemi-triccGASevidencedcGAMP(nimmunotrnmter)productiducedleukemi-elimtgIFN-IpemuAML-microenvirment(ME)WhencomdnICI(PD1hibir)-houePRMT9hibirLD2erdictedAMLnimlmodelThuwehypoizePRMT9ctivyllowAMLcellevdeimmuneurveillncepgcGAS-STINGctivyMELD2lecomdnICI(PD1hibir)elicTcellctivyelimteAMLcellExtrcellulrcGAMPwhichhydrolyzedENPP1STINGctivtihotimmunecellptedlyeentilimmunyThuAim1ugtwoAMLtrnplntmodelwedetermewherdowngultgcGAMP(vieirENPP1-ovexpicGAS-knockout(KO)AMLcell)STING-KOimmunecellcomprtmentcipientmicewouldverePRMT9hibi-ducedAMLgiInAim2wedetermemechnmunderlygcncer-triccGASctivtieenfterPRMT9hibiSpecificllywedefePRMT9trgetwhenunmethyltedunderliecGASctivtiInAim3weenti-AMLctivyLD2lecomdPD1hibirugAMLmouemodelMooverdefepotentilhiftimmunecelltype/ttefterPRMT9hibiwepermgle-celltrncripmenlyAMLPDXcellhumnizedmouettedLD2combtiWefirtidentifyPRMT9druggbleimmunectivtrgetgtcncerIfuccefulthwkwouldupptcombgPRMT9hibirICIrpyAMLwhichgleICIrpyhverylimedeffectPROJECTSUMMARY/ABSTRACTCRISPRtechnologyhvemivelyexpedourbilyterrogtegeneticmechnmcncerdeferpeuticvenueTechniquehveevolvedoverptfiveyergenertimivecleCRISPRgeneticcenlkedglecelltrncripmicHoweverbilypermuchcenvivogeneticllyengeedmodelmcumromeOverpteverlyerwehvepieednelectropti-bedomticmuttimethodrpidn-viveomtictrngenehighthroughputvlidtumdrivergeneugmoicnlydulcombe-mededcetteexchnge(MADR)ThecentrlmethgrntpplictigenerteoptimizevlidteMADRPerturb-eqnoveluegeneticolfciltemiveclegeneticcenctextbothvivomuomtictrngenewellducibleedghumniPSC-derivedgnoidWeexploiurexperienceelectroptibedmodelgrpidlyoptimizeempiricllytetMADRPerturb-eqTheoverllobjectivepropolpermdvnceddevelopmentthcomdMADR-CRISPRpprochllowgenerlizeduediveretumctextedemtrtepotentilechnologytrnmcncererchWepropoecrryoutthwktheprtThefocuSpecificAim1OptimizeCRISPRelementORFmoleculrbrcodeueomtictrngenicptient-derivedtumigntuvlidtegeneticolenblgmultiplexgeneticcennfhelfCRISPR/C9moueThemgolSpecificAim2vlidteMADRmultiplexgcengvivotcleFllyAim3weengeerpprochehighlymultiplexedgeneticcenugMADRcomdducibleelement/virlly-delivedMADRelementhumnengeediPSCSuccefulcompletieexperimentyieldunpcedentedcpbiliegeneticllycengtummechnmpotentilrpeuticwekneeABSTRACTAccelertedundertgnervouytemfuncticncerhledcncerneurocienceevolvgnewfrtierdcoverycncerbiologyrpyThepropoedhybridCncerNeurocienceAnEmerggHllmrkympoiumheldboth-etTheUniveryTexMDAnderCncerCentervirtullycognicompheniverolenervouytemplycncercludgigrowthpdApltmuchthenurtuterdciplrydcuimgcologtneurocienttimmunologtcncerbiologtnunmetneedBedhighlyuccefulfirt---kd2022CncerNeurocienceSympoiumcludedmothn1200prticipnt70countriewepropoectepltmcro-fertiliztidjcentdciplelg-termgolimprovgcncerttmentervicetrgetedcluivribleoutcomecncerneurocienceerchimgducedpriebedrceexgendergeWeeekgprtilupptenblergpotdocrlfellowtejunifcultyttendCncerNeurocienceSympoiumThepropoedprogrmfetukeynoteeicommunictitweencncernervouytembrnkeynoteeieterctiperipherlnervouytemThecientificprogrmcludepieergultimpctcncercentrlperipherlnervouytemneurlgulticncercro-tlktweennerveimmunecellnerveglilcellcncergrowthpdcommunyptientdvoccybrhelthdurgcncerrpieneurljurycncerptientOuroverllgollevergedvnceneurociencefertilizeidekeyopiledercncerbiologywelllevergedvnceimmuno-cologyclicllylevntfieldfocu(egbiologygg)Tochievethgolweim1)enblettendeeCncerNeurocienceSympoiumgknowledgeboutcncerneurociencevetigtimethodologiefotercollbticro-tutimenrhipdvncefieldcncerneurocienceroundwld2)cruvepekerttendeediverebckground(ierceexgender)prticipteCncerNeurocienceSympoiummkeignificntimpcnfieldfutudicti3)encourgevetigrtveryerlytgeircerfurrpurueterdciplrycncerneurocienceerchlg-termcer4)providefncilgtrtrvelupptenbletetudentpentirerchtCncerNeurocienceSympoiumfepubliccientificenvirmentThcllrmpurerchhelpfillcriclgpcropectrumcncerptientcttmenttrtegieTheCncerNeurocienceSympoiumtledgedgeterectiexcgnewbkthroughwldneurobiologydcoveriefundmentlcncerbiologybkdownbrrierhveeprtedefieldptLungcncerprimrycuecncerdethweterncountriecludgUnedStteKentuckyledntibothlungcncercidencemtlyLungcncer-ltedmtlymlyduemettDurgmettmlignnttumccumultecollgenfibrildrivecncercelldemtiimpedefluxnti-tumimmunecellThelg-termgolourlbrydetermerolecollgencollgen-modifygenzymemettmnewrpeuticdevelopmentTowrdgolwefoundcollgenlyylhydroxyle2lglterntivelyplicedmb(LH2b)crrygnextrmotifencodedex13pvioulyundetectedcollgenglucoyltrnfere(GGT)GGTplymjroleLH2pro-mettticctivyHighexpilevelLH2bpdictweprognowhileexpilevelLH2htlterntivelyplicedm(LH2)outex13notprognoticTheefdgprovidenovelbobervtimdeourgroupmnyhighLH2expihpo-prognoticvluedrivegrowthmettmultiplecncertypecludglungcncerbtcncerrcomThuLH2GGTnewrpeutictrgettetHoweverhowLH2GGTdrivecncermettunclerLH2GGThibirnotvilbledeficienciecnddedlyggmechnticighttructu-functiLH2GGTToelucidtehowLH2GGTenzymticctivytructurllygultedweolved3collgenGGTtructucludgLH2GGTmimivirlhomologOurultuggetedLH2bmdimerctuoucollgen-bdgebdUDP-glucoecoopertivelyBedefdgwehypoizedLH2buniquetructurlfetullowmodifytumtromdrivemettBytetgthhypowegight1)whtextentLH2bovexpiLH2b-mededcollgenglucoyltihppenhumnlungcncer2)whyLH2bdrivetumprogi3)howLH2bGGTfunctigulted4)whtLH2bGGTpro-metttictructurlfetuThefdgthwkdvnceundertglevncemechnmLH2btumprogiidentifytructurlfetuLH2bGGTdrivecncerprogiSuchightmLH2bGGTcncerbiologyhibirdevelopmentPROJECTSUMMARYWhilecncercchexidevttgyndromechrcterizedprogivemuclewtgflmmtimetbolicdruptiunderlygmechnmmpolychrcterizedThecurntlynottmentcchexiCncercchexidrivenytemicflmmtipro-flmmrycykepop(cellulrdebr)Aprdigmhiftemerggundertgolutiflmmtinctivebiochemiclproceourdcoverynovelpecilizedpro-olvgmedir(SPM)ucholvendogenouolutiprogrmSPMtimultemcrophge-mededclerncedebrpromotetue/muclegenerticounter-gultepro-flmmrycyketnnogrmdoeoutimmunouppiDepepprocheblockytemicflmmtinocurntpro-olvgrpiecncercncercchexiMooverimpctcncercchexieiconoidnovelpro-olvglipidmedirbothkeyendogenougulriolutiflmmtiunknownThpropolbuildourcentfdgtimultgolutiflmm-tipventtumgrowthcounter-gultgpro-flmmrycyke/eiconoidclergdebrTheeoverrchgmeelucidteunderlygproceefiledolutiflmm-tidrivecncercchexiWelyetetblhedexperimentlytemcludggeneticphrmcologiclmnipultiSPMirceprnimlmodelmcrophgeWehlltetthmulti-prgedpprochInSpecificAim1mechnmdygultedoluti-flmmticchexivetigtedWeprilelipidutcoidmedircludgeiconoidSPMteurnovtivehypofiledolutiflmmtineceryufficientcuecchexiwhichducerpideiconoidrmdygultedSPMlednun-ctrolledcykermWeevlutepro-olvglipidmedirterventiltrgetc-chexiInSpecificAim2weoptimizedeliverySPMmimetichumnizednno-pro-olvgmedice(NPRM)crrygSPMcrgocchectictuedetermewherSPMcnpventchempy-ducedcchexiTheetudiecomplementSpecificAim3whicheekp-ventcncercchexivitimultiolutipcinutriPrbiotudiedetermewhercncer-ducedcchexicuedneffecnprimrytummettticemotptientcchexidiemetteTheetudiecnfernewnimlytemevlutecchexnerlytgeWecnecurpcliclfdgclicldeephenotypeugcomputtilfrmewkundertfiledflmmtioluticchexiSceSPMhveprovenfeeffec-tivehumnflmmrydderetudiehllprovidebrpidtrnltioluti-dictedttmenthumnnewdictipotentillypvent/verecncercchexiPROJECTSUMMARYMngementprottecncermduntgchllengeMnymenprottecncernotdieevenoutnyterventieirduecompetgrkdethcuedolentntuirtumYetloecdmotcommcuecncerdethmenOngoguncerttyboutwherhowttdeehultedtmendouvrimngementnoutizedfluencen-cliclfcruchfncilcentiveAtrikgfetucurnthelthclcpecgcolidtiphyicinprcticeTherpidhiftwrdbothverticl(iehopl-phyicinprtnerhip)hiztl(iephyicingroupcombgmlrgergroup)tegrtiurologyprcticelmotcertlyfluencehowprottecncermngedthoughimplictiuncertThroughcentrlizticecomieclebootfrtructuourcehelthcdeliverycolidtimyultttercodticfocuedervicelerobutqulyimprovementeftFmenprottecncerthcouldhelpenuctentimplementtiguideleccdntctiveurveillncecppropremirgtrgetedrpiedvnceddeeButcolidtilovriblyducemrketcompetillowguchprcticenegotehigherthird-prtypyment(iecommercilprice)TheultgfncilcentivemypromoteutiliztifotergphyicinhvipilloverMedicpopultiIndependentntucolidtiimplicticceprottecncerclouncertOnehcolidtimyimpircce(egquirglgerdtncetrvel)menpvioulyervedcquidrurlprcticeOnhmyimprovecceemenhigherqulyhighvolumephyicinhoplWeepropoetudytterundertltihiptweenurologyprcticecolidtiprottecncercfollowgim1)Tomeueffectverticlurologyprcticecolidtiqulyprottecncerc2)Toeeffecthiztlurologyprcticecolidtiqulyprottecncerc3)TodetermeeffecturologyprcticecolidticceprottecncercThtudyhedlighnltihiptweenphyicinprcticecolidtideliverycnexceedglycommcncerTheeuehveenvirtullyuntudieddtehveimplictipeciltycdcipleexperiencgimilrtndcolidtiFdghvel-wldimplictiptientwhturllytetedgettgtprottecncercAbtrctDiglywhichultr-enivemoleculrmeumentmdepermgmilliprllelexperimentpicolerdroplethvegenertedmuchcententhumdueirglemoleculeolutiRNADNAproteirrobutnecticdiTheeyhveenmoupotentildignodifficultdignoedeeuchpncticcncercurntlycfedlbryettgduecumrometrumenttinecerygenertectrolmeutenmillidependentdropletToovercomethchllengewedevelopghybridmicroelectric/micrluidicchipunlockdroplet-bedycliclueOurmicrodropletmegcledetecr(MD)cngenertedetectfluocencemillidropletperecd(1000fterthnextgdiglpproche)whilechievg1000xgterenivythncventilELISAddPCRuglycventilcellphecmerThekeynovtiourpprochbrowedtelecommunictidutrywhewemodulteexctilightpeudomequenceenbledividuldropletolvedwouldweoverlpduelimedfrmertediglcmerBuildgucceourR21wepropoedeveloppltmtechnologyultrenivelyquntifyprotectDNAgleEVntegrteddevicedictlyptientbloodddcricluemultimodldignoticIncollbtiAbrmCncerCenterbuildgpriwkgermulti-modldignoticwefocuourttentiPncticductldenocrcom-thirdledgcuecncer-lteddethUnedSttenoverll5-yerurvivlly9%PROJECTSUMMARYArrntplicgmjmechnmledgprogicncernewlyemerggexperimentlcomputtilpprochevelcricllyimptnthigh-olutiviewheterogeneycncermotdictlyppotbiomrkerdrugtrgetnetigenimmunpieCurntgene-trgetedcncerrpieprimrilyhmpedextmegeneticheterogeneyobervedcroptientpopultiOnegeneefunctiedeemodelcnnotccilecomplexydiffentmuttimegenetenleddiffentphenotypeAcentpn-cncerchrcteriztirrntplicgwecductedveledthoupotentildrivermuttilterctivyplicegulrygiirtrgetprotemIncentptgenomeexomeequencgprojecthveidentifiedthougeneticmutticncerptientcludgomticgermlemuttiTodtemotlertuhfocuedtudygmuttiffectencodedprotemocidequenceRecentevidencehemergeddictepoiblefunctiilentmuttiwhichctdegultelterntiveplicgledgproductirrntlevelidentiedtctprotemHewepropoeetnovtivebrodlypplicbletechnologieytemticllylkilentcncermuttiplicgeventfunctilimpctircequentprotemSpecificllywepuruefollowgtwoim(1)SyMp-SpliceAntegrtedytempprochcoupledlg-dequencgdcoverchrcterizefull-lengthprotemdrivercncer(2)Cn-IoPPIAnenhncedpltmvetigtefull-lengthplicem-mededPPIwirgcncerbedffypurificti-mpectrometryTogerourtegrtivepprochbothnovtiveignificntcueprovideightpriizgcncer-cuggenotypehvedictimpcnprotemexpiptientcricltepwrdm-olvedperlizedpcimedicedrugtrgetnetigendcovery1AbtrctImmunpiecncercludgAdoptiveCellTrnfer(ACT)chimericntigencepr(CAR)TcellrpyImmuneCheckpotBlockde(ICB)hveeengtcliclucceHoweverytilllimedcotvribleefficcytncelckqulytrgetTechnologietrckimmunepeprticulrtum-pecificTcellpewouldhelpercherclicintterundertvriblepeptientdeignttertrgetrpietrckptienthelthoutcomeInthpropolweimdpurnovelhydrogel-bedimmunecellexpniytemdetectchrcterizerneo-epipepecificTcellperipherlbloodThpltmtermedrtificilTcelltimultimtrix(TM)hyluriccidhydrogelcjugtedignl1(peptide-MHC)2(nti-CD28)3(cykeuppt)InderctenTM-bedhigh-throughputdetectiytemwefirtvetigteeffectphyicl(ietiffne)biochemicl(iectivtimoleculecyke)cueTMexpnineo-epipepecificnti-tumTcellmiceWeteptimizedTMbtchedexpnibulkmuplenocytederctehigh-throughputytemNextwedevelopprocedetectexptum-ocedntigen-pecificTcellperipherlbloodhelthydcompthcurntgoldtrdntigen-pecificTcelldetectiFllycuedeettumyimpcurbilydetectrTcellweverifyytemcnueddetectineoepipe-pecificTcellperipherlbloodmelnomptientAccebloodptientlollowudetermehowICBttmentffectimmunepetumvetigtiexpedneo-epipepecificTcellphenotypefunctiefterrpyThedevelopmentTMhigh-throughputdetectiytemneo-epipeptient-pecificTcellpellowp-cliclcliclerchertudyimmunepecncerimprovecncerimmunpiebrggpowererpiemoptientPeripherlT-celllymphom(PTCL)derivedmtuTcellggivemlignnciewhichextgrpieuboptimlmedinoverllurvivlptientlped/frcrydee<6mthTheedmloutcomeexpledtletprtntrictncecventilchempeuticpprochepoundertgcurntrpeuticllytrgetblecogenicdriverDepeirgeneticmoleculrheterogeneymotPTCLmdependentupirmicroenvirmentctuenttummicroenvirment(TME)promotegrowthurvivlchempytncemlignntTcellthroughtrophicfcrTheeimprovedundertgtrophicfcrvilblePTCLTMEcellprovidemmyunveilnovelrpeutictrtegieNotchignlgtriggedligpentedn-hempoietictromlcellplycricllyimptntroledevelopmentdiffentifuncticventil(n-mlignnt)TcellUtilizglevntcomplementrygeneticllyengeedmoue(GEM)modelprimryPTCLpecimenwehvedcovedNotchctivtihighlycurntPTCLnwepecified(PTCLNOS)WhenctivtedNotchignlgocedignificnttrncriptilprogrmmgPTCLprolifertiTMErichfibroblticticulrcell(FRC)whichpecilizedtromlcellquidpenttiNotchligcventilTcellecdrylymphoidgnOurplimrydtutilizgcomplementryphrmcologic(ientibody-bedthuclicllytrnltble)geneticpprochedemtrteNotchignlgncogenicdriverPTCLTheeouroverllobjectivethpplictiboltedourplimrydtidentifycogenicNotchlig()tromlcellpentmfurrchrcterizetrncriptilprogrmytigtePTCLThobjectivechievedddgourcentrlhypon-muttiltromlcell-lig-dependentNotchignlgignificntrpeuticllytrgetblecogenicdrivermtuT-celllymphomSUMMARYCncercueddynmicgenomewhichultimtelytrnlterrtiproteomectutgmjfunctiltructurlcompentcellTheproteomecomphighlevelcomplexydrivenpectuchpot-trnltilprotemodificticcurtelygultedprotedegrdtifunctilgulthroughprote-proteterctinetwkItlocidedcloetmoleculrlkbiologiclytemphenotypeMpectrometrymgmotimptntolchrcterizeproteomevertilywelluedmtchproteomecomplexyIteurprgmtiundertgdignogcncerprovidedcncerproteomelmotentilyuntppedclicltudieAmgthlckmplethroughputmpectrometry-bedproteomicwhencompdgenomictechnologieThtrnltehighernlycotducedcceproteomicOuroverrchgimthpropoldevelopnovelmpectrometry-bedproteomicdtcquimethodcemplethroughputdeepproteomemppg(>2000protebloodplm>8000protetuemple)comprcurntmethodfcruptenfold(10mpermple)Themethodbedmultiplexedobricproteomicbrcodgtechnologycurntlyllowimultneounlyeup18mpleThenovelpectuertificiltelligence(AI)drivedtcquiproceTheproteomiccommunyhtrtedcpteAIirwkflowdtnlyhnotyetenuedimprovgdtcquiOurAIytemdictmpectrometerl-timeoptimizenlyglobllytrgetgllproteumedmpletftrteProteomempledigetedpeptidecombtineurlnetwktdmillimpectrometrypectruedpdictl-timepeptidenlytehvioptimizenlyticlpeedthighnlyticldepthAplimryverimethodllowmppg1300plmprote10mpermpleWepropoeAim1furrimprovementmethodthroughddilneurlnetwkenblgmoenivel-timepeptideidentifictiimultneouidentifictimultiplepeptideOurgolgenertemethodroutelyquntify2000protehumnplm10muteThemethodcptedpltmlocludelow-cotumtedmplepprtichievenoverllnlycot<$100permpleWepropoeevlutemethodAim2mppgproteome500cliclplmproteomemplelungcncerptientdiffentpthologiclcncertgeOurplimrydtnlyhowhighpdictivepowermpectrometry-bedproteomicdetectgerly-tgelungcncerweueevlutivlidtedetectipowercroerlyltetgeWelievethurnovelAI-drivenmpectrometry-bedproteomemppghhighpotentilovercomecurnthurdleugdeepcovergeproteomiccliclettgProjectSummry/AbtrctTheoverrchggolStephenCncerCenter(SCC)OklhomTriblRurlUrbnCncerScengTril(OKTRUST)ACCESSHunhncecpcycgcncercengtrilccrulprticiptimgtriblrurlurbnpopulticroOklhomOKTRUSTdeignedpecificllyccruelrgenumrprticipntegrouptriblrurllow-comeurbnpopultihvedproptelyhighcncerrtelowrteprticipticlicltriltntillevelToceclicltrilcceibilyrurlloctiOKTRUSTAffileOrgnizticludelrgerurlfederllyqulifiedhelthcenter(FQHC)evenprimryclictwurlTriopertg10triblprimrycclicnrurlTricloelyocedtheIndinHelthServiceclicAcceibilyclicltrilloffectlow-comeptientlivgurbnOKTRUSTcludetwolrgeurbnFQHCloctedOklhomCyeopertg21clicervgpdomtelySpnh-pekgptientopertg7clicervgmnyBlck/AfricnAmericnptientUniveryOklhomclicOklhomCyTulloervelrgenumrBlck/AfricnAmericnptientOKTrutlocludeOklhomCyIndinClic-lrgeturbnIndinhelthcfcilyntiIngggte80000perged4570yerceivehelthctOKTRUSTAffileOrgniztiGivenhricldtruttweenAmericnIndincommuniecdemicerchercenternotbleeverlTriAmericnIndin-ervgcliclfcilieprticiptgprojectcollectgbiologicldtTheeprtnervolvedcueyundertimpctnewcncercengtetmyhveducgcncerdpriemgAmericnIndinpeopleTheyloundertrobutgovernncetructuguideuehrgdtvolvgAmericnIndinprticipntcueTrioveignntihverightuniquemgunderpentedgroupUnedStteSpecificllyOKTRUSTimplementprocee1)ProvidelederhipdmtrtiveupptneededcductCSRNtrilcrotriblrurlurbnffilegniztiOklhomctchmentprticiptehpgCSRNemerggerchgendProvidelederhipdmtrtiveupptenhncefrtructuneceryenuCncerScengReerchNetwktrilvilbilyprticipticrodivereettriblrurlurbnAffileOrgnizti2)ExpcceceenrollmentcncercengtrilfergVngurdtudyfututudieprticipnthomecommuniehelthcfcilie3)LevergeSCCntillycognizedexperteproviclicltrilcludegulryopertilupptcncercengtrilfedtriblrurlurbnloctittewideProjectSummry/AbtrctCncerecdledgcuedethUnedSttewhedelydignottmentledcedmtlydvnced-tgedeeDevelopgrtificiltelligence(AI)deeplerng(DL)pprocheumticchrcteriztimlignntdeecnfcilteerlydetectidignoprognottmentcncerRdiomicDLpprocheextrctqunttivemtivulfeturdiologicldtglenightptientdeeTrdilrdiomicpprocheufferproducibilyueduemlldtetizediffenceimggcnnerctructimethodoperrvribilygitetegmenttiDLmethodqurglrgedtetnnottedgroundtruthwhichdifficultobtduelimedvilbilyphyicin-defednnottihpthologiclgroundtruthRdiomicDLmethodtentddtetencomppecificmlignncywhichddillylimirgenerlizbilyoverllutilyNuclermediceimggmodlieprovideimptntfunctilmtigrdgrdiotrceruptkenignmlignntpthologiecnhelpmdignottmentTheignificntunmetneeddeveloperchcliclolddchllengeenblglrge-cleAI-bedpipelenuclermediceAim1buildlrgedtbecliclporemimogrphy(PET)/computedmogrphy(CT)imgephyicin-nnottedgroundtruthAim2developphyic-guideddeepgenertivemodelgpprochgenertelticimultedPET/CTdtknowngroundtruthAim3quntifyrobutnerdiomicfetuugbothimultedcliclPET/CTdtAim4developvlidteimulti-bedtrnferlerngpprochumtedleidetectiegmentticlifictkAim5developvlidtemultiprgedpprochcomrobutrdiomicDLenemblemet-lerngpdictclicloutcomePET/CTimgeptientcncerInK99trgphethgrntDrKevHLeungcductpropoederchunderguidnceDrMrtGPomperupputtgdvycommteememrexteniveexperterdiologycologyPETCTmediclimggphyicThemjobjectivemenderchphectelrgecliclPET/CTdtbeencompgwiderngecncerdevelopphyic-guidedpprochgenertelticimultedPET/CTdtflectcliclpopulti-levelchrcterticThetechnologydevelopedK99pheexpeddependentR00phegenerlizedpltmenblelrge-cleAInuclermedicewiderngemediclimgenlytkTherichourcetrgcollbtivilbletJohnHopkprovidenideltrgenvirmentcompletelyupptivepropoederchcdemicdvncementDrLeungPROJECTSUMMARYNewcncercengtechnologiegtpromeducgcncerdethemerggTheetechnologiequilrge-clectrolledclicltrilevluteireffectiveneefeibilydoptgimplementgmrouteprcticeifeffectiveFurrmoNtilAcdemyMediceUSPventiveServiceTkFcehveidentifieddozenevidencegpcurntcncercengpprocheneedimilrlrgecleromizedctrolledtrillgudltudie1-3ToddthNtilCncerIntute(NCI)ctgCncerScengReerchNetwk(CSRN)netwkAccrulEnrollmentScengSe(ACCESS)HubcpblecductgclicltrillgudltudiecentrlSttticDtMngementCentercentrlCodtgCommunictiCenterWepropoecteVirgiCSRNACCESSHublg-tgter-tutilprtnerhiptthimptntntileftTheeprtnerhipclude1)thehelthytemVirgiCommwelthUnivery(VCU)HelthInovHelthSytemSentrHelthc2)twomediclchoolVCUEternVirgiMediclSchool3)twocncercenterMeyCompheniveCncerCentertVCUnNCI-deigntedcomphenivecncercenterInovHelthSchrCncerIntutewhichcludecentlylunchedSvilleCncerScengPventiCenter4)NIH-fundedWrightRegilCenterCliclTrnltilScience5)tte-wideprimrycprctice-bederchnetwk(VirgiAmbulryCOutcomeReerchNetwkACORN)TheeentiehvenetblhedtrckcdwkggerdecdecollectivelycizbleproptitteidentcludglrgetfetynethelthytemprovidgbothurbnrurlervicemjyVirgcommuniedemtrtedexpertecrugtgmrglizedunderervedptientcommunietrilntilexpertecncerpventimticcommunyenggementdemtiimplementticienceTheVirgiCSRNACCESSHubillycruttlet1600prticipntNCI-codtedthe-rmromizedctrolledVngurdtudytettwovelmulti-cncerdetecti(MCD)tetcompduulcncercengcWemeuucceequblecluivecrumenttimeledhencedignoticwkupttmentprocolprticiptillntilCSRNeftAddillywecductnovelmixedmethodnlyourwkugcolidtedfrmewkimplementtierchctructudemtrteourhubfeibilyutbilyfutuCSRNtrilefcrnecerywidepddoptiMCDtetifproveneffectiveOurhubmengfullyctrieVngurdtudybrguniqueprtnerhipnequylendemtiimplementtiexpertebroderCSRNeftPROJECTSUMMARYOverview18millipeopledielungcncerechyercrogloImmunpyprticulrlyugimmunecheckpothibir(ICI)hvolutiizedlungcncerttmentoverltyerprojectgignificntimprovementcncerprognohoweverperteICIly15-25%whichprtduelowerlevelfunctilimmunecellufficientfiltrtiimmunecelltumFurrmobout70%ptientNSCLCceivgICIexperienceimmunpy-lteddvereevent(irAE)(egmetbolicdygultimylgicrdiopulmrydee)AneffectiveterventicnenhncettmentpewellmeleirAEwouldignificntdvncecliclcptientNSCLCICIExercehenemerggnovelpprochcnenhncepeimmunpyduceirAEExercecncefiltrtineutrophiltrgetcellcircultglevelTcellNKcellwellducetumngiogenepcliclettgwhichhpotentilducetterpeICIcnceruppiFurrmoexerceprovenfeibleptientlungcncercecrdiopulmry/muculrfnemetbolicgultiwhichlouggetpotentilnefexerceduceirAEHowevernoexerceclicltudiedtehveencductedptientlungcncerceivgICIAlounclerwhichexercepcriptiprticulrlygrdgexercetenywouldyieldtterimmunologiclttment-ltedoutcomeTheeIpropoemulti-levelcliclerchwhepilotromizedclicltril(K99)exploplimryefficcymechnmdiffentexercetrgimmunefunctiwhichmlrgerPheIItril(R00)exmeeffectexerceimmunpyperteirAEReerchPlnTheK99tudythe-rmpilotromizedclicltrilcomphigh-tenytervltrg(HIIT)vmoderte-tenyctuoutrg(MICT)vuulc(UC)exploplimryefficcyexerceimmunefuncti(Aim1)providepro--cceptmechnmnlyzgbiomrkerimmunefunctiexerce-ducedcykecncerprogi(Aim2)TheefdgmR00tudywhichtwo-rmpheIIromizedclicltrilexmeeffectexerce(motefficcioutrgK99)immunefuncti(Aim3)tumbiomrker(Aim3b)immunpypeirAE(Aim3c)CerDevelopmentPlnThepropoedcomphenivetrndciplrytrgvolvgcourewkmenrhiperchvolvementemr/meetgenbleme(1)obtfundmentlexpertenecerycomphendroleexercelungcncerimmunpy(2)comendependentercherwholederchgrouppieerfieldExerceImmuno-OncologyPROJECTSUMMARYThecriclneedttmentpprochecvenientlydeliverevidence-bedterventicounelgphrmcpywiderngemokerddcomplextimelecettemptfilu-ttemptTheobjectivethpropolidentifytdividulizedphrmcologiclttmenttrtegieuedbothilmokgceticuerpymgthoewhofilquirlpeThetrilueSMARTdeign(SequentilMultipleAignmentRomizedTril)etimtecomprtiveeffectivene(1)nil6-weekcoureeirtrddoevnicledulnicoteplcement(ourtwotpermgphrmcpie)(2)mgthoemokerwhoillyfilqufterfirt6weeketimteeffecteirctugmemedictin6weekwchgmedictiydidnotceiveillyugmentgcurntphrmcpycgdoeddgddilFDA-pprovedcetimedictiAllttmentoccurvivirtuldeliverymethodenurgwidetpoiblepplictifewetbrriercludebothdynmicphrmcpycounelgdelivedunifiedenvirmentenhnceuptkeeffectiveneptientexperienceThepropoedtrilclude2000dultprticipntthroughoutTexwhoeekgqumokgPrticipntillyromlyignedeourtwot-permgmokgcettmenteirdulnicoteplcementrpy(NRTnicoteptchplulozenge)vnicle(2mg/twicedily)After6weekmokgbtermircurntttmentn-bter-romizedeir()wchrpie(ieceivettmentnotgivenfirt6week)(b)ugmentircurntrpy(chngedoge/ddmedictiegbupropi)(c)ctuememedicti6moweekThettmentfuncticomprrechtelectedtimepotpecificechttmentpheOurprimryoutcomebiochemicllyverified(crbmoxide<6ppm)ctuoumokgbtencetWeek6tend--ttment(EOT)+30dyOurecdryoutcomeclude6-mthbtencedrwlcrvgpoivenegtiveffectdepiveympm(nhedi)Week6tend--ttment(EOT)+30dyOurultmptient-providerdcuioptimlttmentpprochfutudemtiourfdgThddecriclgpttgnicotedependencecuewhilemjymokerlpetwoweeknilcettemptltleempiriclevidenceguideclicinptienttubequentttmentenhncelikelihoodcetiOurtudymplepenttivegenerlpopultimokerdrwgvolunteerdiverecommunyourcewellddvntgedpopulti(Medicideligiblerurlunud)ABSTRACTDevelopmentcovlentdrugcncerrpyliehevilyidentifygfullpectrum-f-trgetproteomelgpecificehibirbdgechtrgetCurntlywecnnotpdictettrgetblecyteegivenhibirnpotentilcovlentllgf-trgetprotewhichcnleduntendedxicieTheelimtiimpedetrgetdcoverydurgdevelopmentnewcovlenthibirSimilrlycepecificprotetrgethenidentifiedgelectivelyboundnhibir-cidtetetdifficultcertfrctrgetmoleculecelltuecovlentlyboundcompound(trgeccupncy)TrgetdcoveryoccupncydtcncomdxicologyphrmcoketicultbuildmomtiverkprileenuthnlymotpromgdrugcidtedvncedultimtelynomtedclicltrilTheobjectiveourterdciplrytem(JutKimchemtrychemiclbiologyJrrodMrprotebiochemtrychemiclproteomic)ynizetetfirt-genertigentdeigneddvncecovlenthibirtrgetdcoverytrgeccupncytudieAchievgourobjectivevlidteourpprochpvewynteniveertivecmpignproynpidchemoproteomicnlyytemticllyoptimizeourgentInfullnetimeweenvicompleteuechemoproteomicy-pecificgentfciltetrgetdcoverytrgeccupncytudieAim1Tooptimizenewbiothoglgentproteome-widehibirtrgetidentifictiInthimwefurrdevelopourbiothoglchemtryrtillyexpourlibrrylkyltgcffoldublecyteeprilgexperimentWeytemticllyepermnceourprotrgetdcoveryugcentlychrcterizedcovlenthibirkedeubiqutgenzymeAim2TodevelopmultiplexedpterprorpidlyquntifycovlenthibirtrgeccupncyWelevergeelectivefrgmenttiourpterprocffolddevelophigh-enivyhigh-through-puttrgetedmpectrometryyquntifyoccupncycovlenthibirirprimryprotetrgetWecfullyepermnceourcyteelkyltgprouniverlgentpull-down-bed(PD)trgeccupncynlycludgleryccurcylimdetecti/quntifictiSuccefulcompletiourobjectiveprovideniletgentnexteniblefrmewkupptfutuprooptimizticmpignufieldCollectivelyoutpuurprogrmccelertedevelopmentnewcovlentdrugcncerrpyPROJECTSUMMARY/ABSTRACTMuttihumngenomegivemnyhumndeecludgcncerMuttiloneficilproceecludgevolutidptiveimmunyHoweverltleknownboutmoleculrbmutgeneOnemechnmledtroductimuttimcptinucleotideDNApolymeredurgDNAplictipirThefocuourpplictideoxynucleoidetriphophte(dNTP)ubtrteelectiDNApolymeret(Pol)PolfunctibeexcipirprocehevolvedpiroxidtiveDNAdmgeTheetypedmgegenertedcellendogenoumetbolmwellexogenouourceuchiizgrdiUVlightchempeuticgentDurgbeexcipir20000-50000pdomntlyoxidtiveDNAleienzymticllymovedlevgmllgpDNAfilledPolIncctubtrteelectiPoldurgbeexcipirhpotentilultgenomictbilyWehvecentlyhownPollofunctiDNAgpfillgdurgmicrohomology-mededend-jogVDJcombtiwheplynimptntrolegenertgimmunediveryOurbrodlg-termobjectiveunderthowDNApolymerechooecctubtrtecptiDNAPolnexcellentmodeltudygpolymeremechnmcueltivelymllizeeepurifygprotegrowgcrytlTheimthpplictiunderthowPolelectcctdNTPwhyometimechooecctdNTPcptiDNAWeemploypowerfulcombtibiochemicltructurlbiophyiclcomputtilbiologiclpprochethmulti-vetigrprojectWedetermehowPolelectcctubtrtecptiDNAhowmechnmdiffermutrvrintPolOurerchultchrcteriztirolemocididueelectiubtrtedurgPolctlyOurfdgfundmentlimptnceundertgmoleculrbubtrteelectiPollikelyhvebrodpplicbilyDNApolymereMulti-cncerdetectiyfernewopptuniecenmnydiffentcncercurntlyhvelimedoptierlydetectiTheCncerScengReerchNetwk(CSRN)cductdefiveclicltriltudieevluteeyDeignimplementticengtrilvolvemnychllengeCncercidencedethreventnvergerkpopultiTrildeignmutblncecengfquencytrildurtimpleizechievetrilobjectivecot-efficientmnnerImplementtimutnticipteueuchn-dhencen-complincectmtiAnlymutccommodtedeignwhiledptgcircumtnceimplementtiTheSttticDtMngementCenter(SDMC)CSRNferrigouytemCSRNtrildeignmngementnlyomtigenertedCSRNtrilmoundbntilcncercengpolicyOurtembrggerttticllederclicltrilmngementexpertexperiencemjclicltrilnetwkcludgWomenHelthIniveCliclCodtgCenterSWOGSttticDtMngementCenterErlyDetectiReerchNetwkDtMngementCodtgCenterWehveexpertlydeignedimplementednlyzedptedcncercengpventtmenttrilThwkhquiddevelopgproceduproceeexpertexecutrilproductilibleultIthnecetedctgcloecollbticlicincienttptientdvocteubjectmtterexpertAndprticulrlycecengtrilhpiddevelopmentnovelttticlmethodhvecomeetblhedfieldOurgolpromoteexcellencellpectttticldtmngementCSRNToddcriclquetigrdgpotentilnefrknewcncercengmethodologieCSRNclicltrilmutdeignedimplementedgttegryefficiencyproducemotknowledgepoiblelticctrttimeourceTottegolSDMCCSRNhfourpecificim(1)IntegrteSDMCCSRNcompent(2)Providerigouhigh-qulydeignnlyCSRNtudie(3)Buildtte---rtdtytemenudtqulytegryCSRNtril(4)DevelopttticldtmngementpprochelrgeCSRNcengclicltrilwouldbuildupVngurdtudyMCDtetgpentpotentilprdigmhiftcncererlydetectiSuccefulexecutieimenuCSRNproducevlidliblequnttiveultccerngefficcynef-hrmtrdefcidteproductupptevidence-bedpolicieccerngirueProjectSummry/AbtrctAcutemyeloidleukemi(AML)ctuehvedml5-yerurvivlrte<25%chempyInddhoewhourviveufferlifelgcequenceduecomplictichempyugn-trgetedcyxicdruguchcytrnthrcycleThunurgentneeddcoverdevelopnoveltrgeteddrugmoeffectivelexicimprovettmentAMLStudiehvefoundhumnMDM2cogenefquentlyovexpedAMLhighlevelMDM2expioceddeeprogipottmenutcomeItknownthnecogenicfunctiMDM2bdtumuppp53whichhibp53-mededtrnctivtinucleuledgcncerpromotiMDM2loplyp53-dependentrolecogeneterctggultgmoleculeFtnceMDM2terctgulte/tubulcyplmwhichmyplyp53-dependentrolecogeneThnotiderivedourobervtinoveltubulhibirtermedVERU-111cnpecificllytrglyhibMDM2expioutocedctivtip53SignificntlywehvefoundAML-celldethducedVERU-111cltedexpilevelMDM2AMLcellleukemiccellhigh-levelMDM2expiveryeniveVERU-111IC50vlue25~5nMwheMDM2-negtiveAMLcelltntgrdleirp53ttu(wildtypemutntp53)Bedeobervtiwehypoizenimptntp53-dependenncogenicroleMDM2gultimicrotubulenetwkthroughterctubulledgltedmicrotubuledynmiccrcogeneWefurrhypoizeVERU-111blockMDM2-tubulterctibdgcolchicee/tubulterfceledgdowngultiMDM2vicedubiquticncercelldethThegolthpropolueVERU-111proAMLcellmodelteurhypopermpclicltudievlidtetrgetgMDM2-microtubuleignlgpthwyVERU-111novelttrctiverpeutictrtegyMDM2-expgAMLSpecificllyweelucidtep53-dependentroleMDM2terctggultg/tubulAMLcellgrowthdeeprogi(Aim1)WedetermewherMDM2-/tubulterctrgetVERU-111(Aim2)AddillywevetigtefeibilytrgetgMDM2-/tubulignlgpthwyVERU-111pciperlizedttmentfrcry/MDM2-ovexpgAML(Aim3)SceVERU-111welldevelopedlvilbilyexcellentPKpropertiemimlxicyhlopedexteniveIND-enblgtudiecurntlytubulhibirPhe3clicltrilmettticprottecncerknowledgegenertedpropoedtudyhouldhvener-termcliclimpctprovidgrtileexpedediVERU-111nAMLPhe-1clicltrilProjectSummryMulti-cncerdetecti(MCD)tetwhichevlutecell-feDNAbiologiclcompentgleblooddrwnewfrtiercncercengprticulrlycncernoeffectivecengmethodDepecommercilvilbilyltleknownboutirfeibilycceptbilyeffectivenecrodivereettgpopultiToddthevidencegpNtilCncerIntute(NCI)ctgCncerScengReerchNetwk(CSRN)cductrigoumulticentercncercengtudieInpeRFA-CA-23-020wepropoeCSRNACCrulEnrollmentScengSe(ACCESS)HubcruprticipntilVngurdtudyKerPermnente(KP)cro21ociodemogrphicllydiveremediclcenterurbnuburbnemi-rurlCliniclude~145millidultge45-70yercnefficientlyexpfollow-upCSRNtudie36mediclcenter~3milliceng-eligibledultOurunderlygpopultiVngurdtudycludelrgenumrAinPcificIler(311959)Blck(100910)Hpnic(285287)dultcovedMedicMedicidcommercilurncellowgovermplgcluiunderpentedgroupEfficientlylkeddmtrtiveclicldtytemntegrtedhelthcytemKPACCESSHubwell-uedchieveCSRNgolOurettgprovidecompheniveprimrypeciltycctuoulgudltrckghelthcutilizticludgtrdccncercenghlowlofollow-upduehelthplndenrollmentcptucompletel-timemtiptientencounterferrldignoeprocedutetultttmentoutcomeexteniveelectrichelthcddtytemcludglbrypthologyrdiologycncergtrydtbeTheKPACCESSHubledmultidciplrytememddedKPcliclopertierchtructuThetemhdecdecliclcientificimplementtiexpertecncercengprovenexperiencecrugprticipntlrge-volumetrildtmngementpecimencollecticludgueovermplgtrtegieoptimizgprticipntdiveryenggementDrwgecollectivetngthourpecificim(1)Recruenrolltfollowociodemogrphicllydiveremple2400ympmticverge-rkdultge45-70yercludgundertgbrrierprticiptiunderpentedgroup(2)DevelopeproceeeffectivelycommunicteMCDtetultprticipntprovider(3)IdentifyevlutedignoticpthwyfollowgpoiveMCDtettimelyfollow-upc(4)Collecttrnferhigh-qulydtpecimentudycrumentthroughcloeoutllneededendpotIncloecollbtiCodtgCommunictiCenterSttticDtMngementCenterACCESSHubNCIKPACCESSHubcnmevlutiMCDtetcrodiverepopultiPROJECTSUMMARYGermlepthogenicmutticommvrinthveenimplicteddevelopmentclercellnlcellcrcom(ccRCC)SimilrlycurntomticltertikeyccRCCpthogenedtctclicltteCombtigermleomticmutticndictlyterctdruptmegeneccRCCtrdillyexemplifiedbillelicpthogeniccodgmuttiVHLNovelcombtidiffentgeneltertypegermleomticgenomemyloctriepthogeneclicltte(cvergence)howevertudygeltihipmmjchllengecncergeneticfieldFexmpleexpgcopegermleomticeventncodggimotwhichhveuncertfunctilimpctignificntlycomplictedcoverygenedygultecvergentbiologiclproceeAddillywherltedgermleomticeventpromotetumheterogeneywhichmyloimpctclicloutcomelrgelyunknownhricllydifficulttudygivenlckppropremethodologiecohtFllycertgermleomticltertype(egtructurlvrint)mpolyunderodccRCCdetermtiirimpcnctiblegenenecerymximizepcicologypprocheOurtemhdevelopedtrtegieovercomeeignificntchllengeourubequentplimryfdgdicteccRCCexhibpvioulyunppcedmcvergenceTheecludecombtigermleomticevent(i)ltertrncriptilttebiologicllyltedgenethroughncodgvri(ii)impctchromtgulrycomplexeultclicllylevnthlogicheterogeney(iii)dictlydruptctiblegenethroughnoveltructurlmechnmBrodlyhypo-drivenvetigtieuncventilgermleomticltihipmymhowypromoteccRCCpthogeneuniquehpthologicttedtctclicloutcomeBuildgourexteniveplimrydtlgtgexpertecomputtilfunctilcncergenomicoverrchghypothprojectnovelbiologicllycvergentgermleomticltertictrieccRCCpthogeneecvergentpropertiejotlyhpetumheterogeneyclicltteWeevlutethhypothroughfollowgdependentSpecificAim1)Determecvergentgermleomticncodgeventctriecogene2)Defegermleomticltertijotlyfluenceclicllylevntptilheterogeney3)DectcliclctibilygermleomtictructurlvrintcluivecohtThhypo-drivenpropolvelltihiptweengermleomticeventtumheterogeneycliclctibilyccRCCviuenovtivecro-dciplrypprocheOverllthpropolenblenewundertghowgermleomticgenomejotlyhpetumievoluticcRCCpotentillycrocncerPROJECTSUMMARYColoctlcncer(CRC)mettmjcuemtlyyetdtctlckrpietrgetgmettAmgmjmodifibleexternlfcrknownffectCRCrkdieyhoweverunlikecncerihowpro-oyhighftdiet(HFD)cnimpctcncermettmneentilquetiOurundertgbiologymettticcellignificntlyimpededlck-vivoCRCmodelcpultemettticdeeThpropollevergeourthopictrnplnttimodelCRCwhegeneticlly-engeedCRCgnoidhrbgcommmuttifoundhumnCRCtrnplntedvicolocopycipienthotcolmgtumltermettizeliverUgthytemwehveguntudyhowCRCdiffentdrivermuttiuchAPCKRASp53mettizedptlivermicroenvirmentdietducedoyWehveoberveddietducedoyceCRCmettliverOurilglecellRNA-SequencgnlyeprimrycollivermetttictumhveidentifiedtumtricextricchngepenoogenicHFDTumtricpeHFDcludecedYAP1ignlgtum-pecificvivltemcellvSClikepopultiInourAIM1mendK99pheugCRISPRmededknockoutmodeluntrgetedmetboleprilgweidentifyroleHippo/YAP1ignlgtummettmetbolicdpttipro-oyHFDInourAIM2(K99phe)leverggptermouemodelglecellRNA-SequencgweidentifyctriivSCmettticeedgroleYAP1genertiveignlgmedgvSClikephenotypeoyInourAIM3dependentR00pheweidentifytumextricnichefcrctriecedmettHFDInourplimryglecellprilgtumnicheHFDweoberveevolutipecificSpp1Cxcl1expgcncerocedfibroblt(CAF)collivermettticnicheAIM3pecificllychrcterizeigroleterctieCAFpopultiTheK99trgmlyfocucncertemcellnichemodelgglecellnlyetummetbolmThccomplhedtrgprimrymenrDrOmerYilmzexpertetetltemcellirnichecoloctlcncergtrotetlpthologymenrgtemDrAlexShlek(glecellcomputtilnly)DrAlplnTdognMtwVerHeiden(tummetbolm)DrJcqueleLee(cncertemcell)ThupplementedcfencecourewkwkhopMetbolomicMettBiomticmenrhiptechgexerceppfutucdemiccerdependentR00pheSuccefulcomplethtudyidentifymechnmtegrlemtmettvelgtrgetblevulnerbiliewellprovideightguidedietryterventiPROJECTSUMMARYHumnppillomviru(HPV)cutivegentgrowgpropticidentcehedneckqumoucellcrcom(HNSCC)HPVtype16pibleover90%HPV+HNSCCdignoedUnedStteTheHPV16E7ntigennttrctiveimmunpeutictrgetHPV-ocedcncerceuniqueviru-pecificcoprotectutivelyexpedllcncercellTcellgeneticllyengeedexpnHLA-A*0201-trictedTcellcepr(TCR)cognizeHPV16E711-19epipecnmedegiHPV16-ocedcncerpcliclmodel1Aphe1firt--humn(FIH)multi-centertudydemtrtedfetyefficcynulogouHPVTCR-engeedTcell(TCR-T)rpywhichtrgetHPV16E7bdgepipeHLA-A*0201-expgHPV+cncerptient(NCT03912831)2Howeverlizedchllengedoptivecellrpy(ACT)i)highcotocedmnufcturbilymirgmnggxicieupr-phyiologiclboluACTproductwhichcomdytemicIL-2dmtrtiii)limedvivopertenceduelckpproprentigen-pecifictimultiduepotr-tumlTcellcrumentolidtumHewepropoenovtivepro--ccept(PoC)experimentdetermewherlowdoedoptivelytrnferdHPV16E711-19TCR-TcellcnexpentillyexpedudmtergnovelbiologicfuiproteCUE-101whichdeliverHPV16E7ntigen-pecifictimultiloclizeddeliveryhighdoeIL-23-5FurrmowedetermewherHPV16E7TCR-Tcellpertencetrnltenenhncednti-tumeffectpcliclHPV+tummodel(Aim1)LtlywebuildupourtemdcoveryroleCXCR6CXCL16xcrumentperipherlcircultgCD8+TcellperivculrnichetumpopultedCXCL16-expgCCR7+DC3whichcnuturvivltum-pecificCD8+Tcell6ThuweewherefficcyHPV16E7TCR-TcellcnimprovedthroughengeergtrtegietroduceCXCR6TCR-Tcellwhichcnfciltetr-tumlcrumentprolifertiurvivlu(Aim2)ThecompletieimgenerteupptgrtilefutuclicltrildmtergHPV16E7TCR-TcellCUE-101HPV+cncerptientTheeeftcnpotentillytrnmourcurntpprochedoptivecellrpyAbtrctTourvivenutrient-oxygen-deprivednichecncercellundergodrticmetbolicprogrmmgwheyupgulteirendogenoulipidynexogenoulipiduptkePopulti-widempectrometrylipidnlyevelmountlipiddegelipidturticyl-chlengthprovideurvivldvntgemkgcellmetbolicllydependentexternlourceenergyprotectggxidtivettimultgimmunepeuppiHencecncercelllipidprilgemergepowerfuldignoticolfundmentlerchgolHowevercurnttechnologielckgle-cellolutidotprovideptilmticpblelkgcncercellphenotypelipidcompoiHewedecriuniquepltmimultneoulipidprilgmultiplecelltypetcttuempletub-cellulrlevelprobghentmoleculrvibrtiugpectrlcohentnti-SkeRmnctterg(CARS)microcopyItprometrnmtivemtihowlipidprilehpeddiffenttummicroenvirment(TME)bothcncercellcncer-ocedcellltethqunttiveptilmtiptternprotegeneexpiWecomcumumticllytunblelerytemcommercilcfoclmicrocopeenblecvenientmppgrngemoleculrvibrtie(i)mountlipidub-femlerpci(ii)degelipidunturtglecrbdouble-bdpci(iii)cylchlengglemethylenegrouppciwhichcncledupprogrmmblemultipotmeumentmultiplempleFurrimplementgimultneougle-cellRNAimggmetbolicprilecnlkeduptmRNAtrncriptctrollgcellmetbolmcludgknowncogeneFthpurpoewedeignerienovelRNAproechnope-pecificnrilegroupwhichcntrgetedhighpecificythroughdtctmoleculrvibrtitimultedRmnexcedfluocence(SREF)ThnkmultudepoiblecombtiopellgthnovtivepprochllowimultneoudetectihighernumrRNAtrncriptthncndecurntfluocence-bedRNAllgtechniqueoutdturbglipidlcpeSimultneoulytrdfluophocnuedprocell-typemrkertprotelevelcventilimmunocychemtryAultmultipleRNAtrncriptcnmppedimultneoulylipidprileproteprilemultiplediffentcelltypeThedevelopmentcductedcollbticncerbiologtcncermetbolmexpertclicinenurgbiologiclclicllevnceourpprochdtnlyPROJECTSUMMARY/ABSTRACTEvenlrgetlungcncercengtrildteNtilLungCncerScengTril(NLST)ufficiennownnwerquetibouteffectivenelungcncercengdiverecliclettgFdgNLSTmynotgenerlizenewpopultiduehighlyelectedtrilpopultihigherleveldhencecengtrtegiedotflectcurntprcticeClimdtetcenggtriepropectivetudieferopptunieevlutglungcncercengtrtegiel-wldpopulticurntmethodttempttegrtethevidenceufficientStrdmet-nlyeimultimodeluemtimultipletriltudieproduceetimtedothveclerculterpttinytrgetpopultiThepropoedprojectbridgegptweenvilbledtpolicylevntqueticombgdiveremtidevelopgnewmethodetimtecengtrtegiehveculterpttintillypenttivetrgetpopultiOurlg-termobjectiveducelungcncermtlycombgmulti-ourcedtlernbouptimllungcncercengtrtegiel-wldpopultiWetketepwrdthobjectivechievgfollowgpecificim(1)Uemtidivereourcetrnpteffectlungcncercengtrtegietrilntillypenttivetrgetpopulti(2)Identifydividulntillypenttivetrgetpopultiwhomotlikelyneflungcncercengcludgdividultrdillyunderpentedtriljotlyevlutgeffectheterogeneyovermultiplechrctertic(3)Modeldhenceptternlungcncercengtrtegiel-wldettgueemodeleeffectlungcncercengtrtegieunderdiffentleveldhencentillypenttivetrgetpopulti(4)Etimtentillypenttivetrgetpopulticomprtiveeffectivenelungcncercengtrtegiewhentrtegiehvenotendictlycompdmetrilhveenevluteddiffenttrilgtcommcomprr(5)UemtidivereourceputimultimodelcompcengtrtegiedifferthoeuedtrilntillypenttivetrgetpopultiThprojectprovidenewightcomprtiveeffectivenelungcncercengtrtegieTrgcncerpventittticlkilllunchmycerndependentercherdtcienceepidemiologydevelopculttticlimultimethodproduceevidenceledimproveddeci-mkgcncerctroltrtegieABSTRACTEndometrilcncer4thmotcommcncerdignoed6thledgcuecncerdethmgUnedStte(US)womenTodymothn891000endometrilcncerurvivUSmkgecdlrgetcncerurvivgroupmgwomen(fterbt)BlckwomenmolikelythnWhewomenhveendometrilcncercurtwicelikelydieDprieendometrilcnceroutcomemultifcrilctriburlikelycludenotlimednequbledtriiwe-prognobiologicubtypevriympmcogniceiptguidele-ccdntcncerttmentdiffentilurvivhipcWepropoecomphenivepprochundertunderlygrcildprieoutcomepopulti-bedendometrilcncerurvivhipcohtTheCrolEndometrilCncerStudy(CECS)propectivelycruwomennewly-dignoedendometrilcncerNthCrolugttewideCentrlCncerRegtryrpidcecertmentprogrmBlckwomenovermpleddeignderenroll~667Blckwomenplnnedcoht~1700womenBeledtcollecticludetrievltumprffblockmediclcddetileddignoticttmenthrycollectibucclmpledmtrtiquetinifedwrtenphelemtWecductfollow-upterviewevery18mthtrievemediclcdnyddilendometrilcncerttmenrpteddeecurnceOurimclude1)ToevridtriiendometrilcncerhlogicmoleculrubtypeocedpoprognomgBlckWhewomenevlutedcentrlizedpthologyview2)Toevripentgympmceiptguidele-ccdntendometrilcncerttmentmgBlckWhewomen3)Toevriexperienceproviderementguidele-commendedympmurveillncevurvivhipcmgBlckWhewomenThepropoedcncerepidemiologyurvivhipcohtuepopulti-bedpltmcomdetiledtumbiologyptient-ptedurveydtvetigteendometrilcncerbiologymediclcexperienceWecollectdetiledmtidividul-levelmoleculrtumchrctertichvillifetylefcrcncerttmentfollow-upccurncemtibtrctedmediclcdhvenetblhedfrtructulkprticipntcddmtrtiveurnceclim-levelocildetermnthelthhelthytemfcrThemultidciplryvetigtivetemptientdvoccyupptfciltevetigtinlypropoedimcteourcefrtructugogerchdvncecienceendometrilcncerurvivhipPROJECTSUMMARYCncerurvivoverweighroy(ow/ob)dplycedmbidymtlyevenftermelideeImprovementdietryphyiclctivyptterncnmigtethrkcnupptedthroughcomphenivemultiplehelthhvichnge(MHBC)terventiYettrnltiMHBCterventicliclprcticelimedprtcuetrdilttmentpckgepprochenoptimizedl-wldimplementtiIntegrtimulti-omicdtcncptulifetyleexpoubiologiclpeprovidgpotentiltngnccluiovercomelimtiextgementmethodThpprochcouldelucidtebiologiclunderpnghowchngemodifiblehvifluencedividulphenotypedurgurvivhipSuchknowledgewouldhelpidentifytilterventicptiurvivhipcYetthhnotencductedpogcriclerchgpMygolcteutbleclbleMHBCprogrmcombgdietexerceuppturvivow/obimprovehelthurvivhipThuoverllobjectivethNCIerlyK99/R00wrd(1)developurvivhipnutrerventiBfedBwellimplementtinextgcliclexercecologyprogrm(2)determeimpctterventidiethelhroughtegrtimulti-omicpprocheInK99pheIutilizeMultipheOptimiztiStrtegy(MOST)frmewknengeerg-bedpprochefficientlyytemticllydevelopoptimizeevlutehvilterventitettheocilcognivey-bedcompent(1)11counelggteddietin(2)hvilkilldevelopment(3)groupupptdeliverylgidecutrieducticurriculumcliclexercecologyprogrmPot-ttmenturviv(n=80)ow/obcomplete12-weekcluter-romized2^3fcriltriltetcidteterventicompentfeibilycceptbilyidentifyetcompentdemtrteptternefficcyceddhencelifetylecommendtiweightloimprovementcrdiometbolichelthInR00pheIutilizetrgetedmetbolomicmeuchngebiomrkerdietryexpouthroughnlyprticipntbiopecimencollectedefterterventiInpermtegrtednetwknlyugmulti-omic(metbolomeproteomemicrobiome)exmeeffectterventicrdiometbolichelthMyK99menrhiptrgplnprovidekillhvilweightlotrilMOSTtudydeignmulti-omictegrtiurvivhipTheR00phedvncemyfoundtilknowledgeIcomenexpertidentifygterptgmulti-omicfdgtegrtgmhvilterventipdictevlutedividulpeCompletieimlygroundwknR01-leveloptimiztrilledgdvncecwhilepnnghvilbiologicldomdeveloppcicologynutritrtegieimprovedurvivhipProjectSummryPeoplecncerhvehigherrkfectigenerlcuevulnerbiliergircncerttmentThepecillytruenovelcviruSARS-CoV-2PeoplecncertwicelikelydieCOVID-19compdgenerlpopultiomeubgroupppergfmuchweThepemichloledignificntdrupticncercengdignottmentwhichnticiptedledndictcembidymtlythpopultiThutudygCOVID-19peoplecncerhighlywrrntedInthU01projectTheCOVID-19CncerCtium(CCC19)RegtrywelevergeetblhedCCC19gtry(NCT04354701)whichlrgetgtrydultCOVID-19cncerNthAmericnwernumrimptntcientificquetiInAim1weevlutehownticncerttmentnti-COVID-19ttmentvcctiimptntlyirterctimodifyht-lg-termcomplictiWeexplowherrceethnicyociodemogrphicfcr(egurnceccettment)ocedoutcomeWeexplowherdt-drivenfetuelectimche-lernglghmveluncognizedociInAim2wehypoizemeurblechngecncercurnceprogiptientwhourviveCOVID-19Welovetigtewhernticncerttmentmodifictiwhichwehveoberved40%ptientwhowenticncerrpyttimefectiffectlger-termprognoInAim3wedevelopmethodmeucertmentcolliderwhichomemotimptntourcebgtry-bedtudydeignAlgeimwectueupptmtCCC19gtrypromoteuegenerlcommunyfollowgFAIRprcipleABSTRACTReltivemtchednmltuecentlrgecleequencgeftdictecoloctlcncer(CRC)tumpecificllyenrichedlofunctimuttimichdrilDNA(mtDNA)howeverignificncefunctilcequencehighmtDNAmuttilburdenCRCmunknownGivenmtDNAencodecriclubun4out5complexeelectrtrnptch(ETC)highmtDNAmuttilburdenuggetCRCcidence/pthogenedependenndruptimichdrilpirtiOnctrryimpirgtummichdrilpirtiviphrmcologiclETChibirdeletigenequidfunctipirrycomplexeblunttumgrowthcromnytumtypecludgCRCTogereeemglyctrdicrydtethighlightntrigugprdoxhowdoccumultedmtDNAmuttiupptCRCtumigeneifmichdriloxidtivemetbolmhentlyquidtumgrow?GenertgtrgetedefficientCRCrpeuticdependennnwergthquetiInplimrytudieugpurifiedhumnCRCmichdriwecfirmedltivemtchednmlCRCtumhvemomtDNAmuttidcovedfunctilbioenergeticdeficiencieexcluivelyloclizemichdrilcomplexI100%(12/12)cliclCRCtumdplygprtillo--functicomplexIctivyTomodelhumnCRCbioenergeticdeficienciemoueweducedcomplexIctivy50%colugtue-pecificdeleticomplexIcceyubunNDUFS4PrtilcomplexIhibicedboumnumrizefollowgCRCiAOM/DSSducedprouncedgrowthdvntgetum-derivedgnoidTheeultdemtrteprtilcomplexIlofunctiprovidegrowthdvntgeufficientccelerteCRCoutgrowthSurprglydeperolegcomplexETCcomplexIdeficientCRCtumpidnmllylthoughtexpenecedmtrixNADH/NAD+AddilbioenergeticnlyveledCRCtumcircumventNADH/NAD+hyper-ductiutmichdriloxidtivemetbolmuncouplgpirtiATPynThuourplimrydtdicteCRCmichdriexhibuniquemetbolicwirgllowpirtiproceeddepeprtilcomplexIhibiThegolthprojecttethypoprtilcomplexIdeficiencyducecedNADH/NAD+/pirryuncouplgccelerteCRCgrowthSuccefulcomplethprojectetblhmechnmwhichcomplexIdeficiencyccelerteCRCGivencomplexIgenemotfquentlymuttedmtDNAgenecrotumtypeefdgprovidebroderighnterplytweenmichdrilfuncticncerMetropoln-DetrobedHenryFdHelth(HFH)hover20yerexperienceuccefulcductmulti-ecncercengpventiclicltrilerchAntegrtedhelthcdeliveryytemervgrcillyocioecomicllydiverectchmenurcncercengtrilexperiencecludeelectrichelthcdidentifictienggementt-rkpopulticrumentlg-termtentierchprticipntcomphenivefollow-upbnmlfdgThexperiencecludeuccefulcrumentNCIProtteLungColoctlOvrinCncer(PLCO)trilNtilLungScengTril(NLST)HFHenrollednerlyhlf(46%)llprticipntPLCOwhoweBlckrce/ethnicyMocentlyHFHhuccefullyenrolleddivereptientGRAILIncpodtudieSTRIVEPthfder2vlidtrilnovelmulti-cncererlydetectet(MCD)GlleriHFHlodtctrigePopulti-bedReerchOptimizeScengProce(PROSPR)IItwolgtermNIH-podcohttudieAllUCnectCncerPventiHFHcludeevenhopl41mbulryclicHenryFdMediclGroup(HFMG)CncerIntute(HFCI)HFH-MichignStteUniveryHelthScienceCenter(HFH-MSUHSC)Fover50yerHFMGphyicinhveprovidedcCommunyHelthAndSocilService(CHASS)CenterFederllyQulifiedHelthClicTheHFCIttover14000cncerptientnnullyTheHFHDeprtmentPublicHelthScienceover250fcultytffignificntexperiencecductgexternllyfundedcliclepidemiologiclheltherviceerchhomebeourmulti-dciplrytemwhichhexperiencebrbtcoloctlhednecklunglymphomprottecncerwelldprieerchptientptedoutcomeHFH-MSUHSClohwld-clbic-cienceerchprogrmdevelopgnewcncercengtechnologieWelevergeeextgource1)cductVngurdpilottudydetermemoteffectivemethodcrugtgdivereprticipntMCDcengtril2)ctullyimproveextgwkflowfollow-upprticipntpoivefdgetblhlg-termfrtructucductghighqulyprgmticcncercengtrilcluiveocioecomicllyddvntgedhricllymizedpeople3)etblhcollbtiveltihipCodtgCommunictiCenterSttticlDtMngementCenterledimpctfulclicltrilwhichuemotpromgnewemerggcncercengtechnologieutilizehigh-qulyefficientptient-centeddtcollectimngementtrtegieTheHFH-MSUACCrulEnrollmentScengSeourdivereurbnpopultivetigrexperiencedmulti-ecncercengprgmticclicltrilhelplunchCncerScengReerchNetwkthnewfrtiercncercengProjectSummry/AbtrctReerchPlnTrgetedprotedegrdtiugmoleculrglue-mllmoleculebrgprotetetproximynE3lige-emergedpromgrpeutictrtegycncerepecillyprotehveenhricllychllenggtrgetcventildrugdcoverypprocheHoweverdevelopmentmoleculrgluedegrderpentmidblechllengeduebenceytemticmethodologyidentifygecompoundCurntlymotmoleculrgluedegrderemployedclicettghveenidentifiedthroughendipiudcoverylimgirpotentilpplictitrgetgtrctblecogenicproteToddthchllengeIhvedevelopednovelchemoproteomicpprochferdLyteIPwhichenbleidentifictinovelmoleculrgluectiviemllmoleculeInmyplimryvetigtiugthmethodIdcovedlenlidomidenFDA-pprovedmoleculrgluedegrderduceASS1crumentCRBNdoenotultASS1degrdtiGivenexteniveuelenlidomideclicCRBN-bedPROTACcrucilexmellpotentilctivielenlidomideelicTheedurgmendK99pheIpropoevetigteimplictiASS1crumentCRBNlenlidomiderolelenlidomidetncemultiplemyelom(Aim1)InubequentdependentR00pheItendutilizedevelopedLyteIPylrge-clemultiplexedidentifictinovelmoleculrgluegtunexplodE3ubiqulige(Aim2)prtnticncerdrugdcoveryproceTheprimryobjectivetherchytemticllyidentifychrcterizenewmoleculrglueultimtegolexpgmllmoleculeolboxtrgetedcncerrpyCerDevelopmentPlnIhvected5-yercerdevelopmentplnenblemettmygolcomgndependentvetigrcncerbiologyMyextenivebckgroundchemiclbiologymediclchemtryhpoiedmeuniquepoiccomplhgoloutledthpropolSupptednterdciplrytemdvcollbrcludgDrBenjmErtEricFcherScottArmtrgAmChoudhryIimcquinovelpriciencierngecludglrge-clechemiclcengmpectrometryomic-cledtnlyvulizticomphenivecncerbiologyAddillytutilupptBrodIntutewellthroughmlcourewktrgIetblhndependentcncer-ienteddrugdcoveryprogrmgolexpgrngedruggbleproteugmllmoleculeSUMMARY/ABSTRACTThepromeerlydetectiduceburdencncerneilyunderodhighlydeidterventipotcncerctuumRecentdevelopmentmulticncerdetecti(MCD)technologiehvefueledldytrgtetiruewelldvncecompellgdtdecribgimpctMCD-bedcengcncermtlyInddilimeddtvilbleenivyledtimeeeMCDtetcomplexieimplementgml-wldcliclenvirmentquicfulevlutiefquencychievgolutipoiveMCDtet(iepecificcncerdigno)ntutimelecotthoeprocedupotentilcecncerwryhelthequieTohelpddecriclcpdtCncerScengReerchNetwk(CSRN)coopertivegrouptructuexpertefrtructucceppropreptientpopultineededprovidehighqulyevidencevlueMCDtetl-wldettgThegolVngurdphedeigncductromizedctrolledfeibilytriltwopromgMCDtetTheCSRNCommunictiCodtgCenter(CCC)cjunctiCSRNSttticDtMngementCenter(SDMC)NCIledupptthcriclntileftOurpecificobjective(1)ProvideexceptilcientificcliclexpertedeignimplementtimulticentercncercengtrilprticulrlyromizedtrilevlutgMCDy(2)DevelopgniztiltructudmtrtiveltihipuCSRNucce(3)DevelopmteffectivecommunictichnnelmterilpromoteCSRNucce(4)SupptCSRNACCESSeircrumenttentieftByeeftCSRNefeibilyetblhcofrtructuneededcductfutufull-cletrilMCDtetcncercengtudieThrougheftVngurdpheCSRNctefrtructudtlerngneededupptfull-cletrilddilobervtiltudiemotpromgMCDtetcncercengpprochePtientlivglgermettticlungcncer(iemetviv)duerpeuticdvncefceignificntchllengeMotmetvivultimtelydiecncermutnvigtedulylivgwhiledygUnurprglymetvivendehighpychologicldt(egnxietydepiillnen-cceptnce)highympmburden(egftiguedypnep)poqulylifePychoocilterventicnimproveoutcomeextgprdigmnotdeignedhelpmetvivnvigteemotilturbulencelivgmettticdeeDilecticlBehvilTherpy(DBT)SkillTrgnevidence-bedttmenttecheptienttrndignoticey--uekillbothcceptthgy(mdfulnedtlernce)chngethgirctrol(emotigulterperleffectivene)tternvigtelifechllengeHoweverDBTSkillTrghrlyenppliedptientchricillneWedptedDBTSkillTrg(egterventidoedeliveryctent)ptientlivgmettticlungcncercteLiveWelln8-eiSkillTrgprocoldelivede--evivideocfenceBuildgplimrydtlignedORBITmodelhvilterventidevelopmentfirtphethtudy(K99Aim11yer)imertivelyfeLiveWellug1)qultiveexterviewdtpro--ccepttudy2)ndvybdtetedprtie3)DynmicSutbilyFrmewkimplementticience4)uertetg(n=10)TheK99pheproducetrdizedprocolproceduR00Theecddependentphetudy(R00Aim23yer)PheIIBromizedpilottriltettudyfeibilycceptbilyoutcomeptternuggetgefficcyLiveWellcompdEnhncedUulC(EUC)Lungcncermetviv(n=80>20%n-Whe)ceivgctNCI-deigntedcenter(N=2e)endgdt>3/10romizedLiveWellEUCWehypoize1)LiveWellEUCprocolproceduhowevidencefeibily(ccrulN=80/20mth>80%dhenceterventiement<20%ttri)cceptbily(>3/5tfctitudyprocedu>3menterventitfctiLiveWell))2)LiveWellimprovequlylife(primryoutcome)ducepychologicldt(depinxietyillnecceptnce)ympmburden(ftiguedypnep)(ecdryoutcome)belepot-ttmentcompdEUCWeexploemotigultimechnmchngeTheobjectivethErlyK99/R00provideDrHyllimedddilmendtrgnfciltehertrnindependentvetigrwkgdeveloptetimplementnovelpychoocilterventicncermetvivFdgthtudymnR01ubmicductPheIIIefficcytrilLiveWellIfuccefulLiveWellimprovemetvivqulylifeprovidepromgpychoocilterventiprdigmmetvivptientchricillnePROJECTSUMMARY/ABSTRACTAlthoughevidence-bedcncercengprocolexteverlcommcncertypenetimted70%cncerdethduecncerwhichnoerlydetectetyetvilbleMulti-cncererlydetectet(MCD)eekfillthgpugdvncecell-feDNAdetectiidentifymultiplecncertypegleblooddrwThnewpprochcncercenghpotentilvolutiizeerlydetectiducecncermtlyMCDrpidlymovgwrdgenerlcommercilvilbilytudieurgentlyneededimproveourundertgrknefocedetethowtimplementmpproprelyeffectivelyToddegpNtilCncerIntuteeekcteCncerScengReerchNetwk(CSRN)AtUniveryNthCrolLergerCompheniveCncerCenterwehvemedmulti-dciplrytemhighlyqulifiedegerjoNCICSRNCSRNNthCrolHub(CSRNNCHub)OurexteniveerchexperiencecncercengtrilNCIclicltrilfrtructuourcengerchffilibothUNCHelthourttewidehelthytemFederllyQulifiedHelthCenter(FQHC)demtrteourcpcyenrollhricllyunderpentedcommuniecludgpecificllyBlckHpnicAmericnIndinpopultiOuroverrchgimccelerteerchemerggcncercengtechnologieprtnerhipCSRNInthpplictiwepropoe(1)etblhCSRNNCHubfrtructulkgebuildcpcyfutulrgertudieMCDnovelcncercengtet(2)enrolldivereptientpopulticductVngurdfeibilytril(3)cductplimryqultiveerchelicperpectivediverecommuniegrdgMCDcengWebuildpopulti-bedrcillydiverecrumenthubNthCrollevergegeogrphicdemogrphicdiverytteFVngurdtrilweenroll2000prticipnttwoelectedUNCHeltheeFQHCugmixnovtivecrumenttentimethoddemtrtedeffectiveourpritudieBedptexperiencewelieveCSRNNCHuxceptillywell-poiedupptcriclCSRNgolcrugdivereceng-eligiblepopultipenttivercilethnicrurl/urbndtriibothNCUSAprtCSRNNCACCESSHubignificntlyctrierpidevlutiemerggcncercengtechnologiefututudieMCDnovelcengtechnologieyieldhighqulyevidencemueetetcliclprcticecrodivereUSpopultiTobrgequyprcipleerchprcticecncercengerlydetectiwebuildCSRNACCESSHubtSemnCncerCenterImprovgerlydetecticriclducggrowgburdencncerourocietyhpotentilducecncerhelthdprieFthhppenerchmutnlycludegroupwhohvetrdillyenmrglizedunder-pentederchwemutciderthoecommunieerchdeigncductReerchcductedtSemnCtchmentHubpriizerigequydiverycluiunder-pentedpopultiWepentcollbtiSemnCncerCenterevencommuny-bedhelthcytemMouriIlloLednexperiencedmulti-dciplrytemourtime-teteddmtrtivetructuenggepenttiprticiptgecommunyprtnercommuny-bedclicintutilexpertthendevWedrwdeepcliclerchfrtructuuppttSemnCncerCenterWhgnUniverySchoolMedicegnizedourHubfourcoAdmtrtivePrticipntStudyProcolDtWefoundedtentiltegrtienggementtrnpntcommunictitrtegieThepecificimourCenter(1)CtriecientificdevelopmentCSRNerchcludgnilMulti-CncerDetectiVngurdtudycluivediverepopulticiderhelthequypproch(2)RecrutdivereprticipntCSRNtudiepentticrorurlurbncomeurncercilethnicbckground(3)ImplementCSRNprocolcludgdignoticfollow-upneededBuildgourexperiencecductgerchcludegrouptrdillyunder-pentederchwepropoeenroll2000dividulcroourgiVngurdtudytlet50%rurl25%rcilethnicgroupunder-pentederchpurpoefulcluilow-comeunder/un-uddultWewkcloelycommunyprtnerupptcrumentenuprocolcceiblediveredividulTheSemnCtchmentHubheverlnotbletngthnovtiFirtweervecommtedpopultimedicllyunderervedunder-pentedcliclerchSecdourmultidciplrylederhiptemdedictedequycluihdeepexperiencecncercengerchclicltrilThirdweenggegniztilprtnercommunyprtnerHublederhipFourthwehvetrgtutilupptfrtructuupptcducttherchccequlydtrigourpprochWeneedoundevidencemdvncecncercengerlydetecticludgcidergfeibilycceptbilyfutuimplementtidivereettgpopultiTheSemnCtchmentCSRNHubdeliverneedABSTRACTRecurnceerly-tge(tgeI/II)primrymelnomtenundetecteduntilympmticmettccountmotmelnommtlyCurntprognoticoldequteidentifyptientthighrkcurncemettttimedignolimgbilyprovideimprovedurveillnceperlizedttmentAddillybiologiclmechnmdrivgerly-tgemelnomcurncemundertudiedpvioutudiehveextenivelyfocueddvncedmelnomIhypoizetteterctiptilltihipcellmelnommicroenvirmentwelltrncripmicigntuplycriclroleerly-tgemelnomcurncecnfurrmpdictivemodelTotetthhypoIpropoelevergecentdvncemultiplexedtueimggptiltrncripmicrtificiltelligencerobutlyquntifyknownprognoticfcrdcovernewbiomrkerdevelopexplblemche-lerngmodelpdictgerly-tgemelnomcurnceThetegrticliclhpthologicmultiplexedimgggle-celldtfciltedevelopmentccurtelibleprognoticolwhichcndeployedcliclettgfollowgdependentvlidtiInAim1(K99)Idevelopcomputtilpprocheidentifyquntifybothknownprognoticfetunovelbiomrkerthroughmulti-modlnlyemultiplexedimggptiltrncripmicdtInAim2(K99)ugnefficientmulti-modlimggmethodIgenertemultiplexedcventilhpthologichemxyleo-tedimgemetueectilrgecohttegrtemelectrichelthcdbuildterptblemche-lerngmodelpdictgmelnomcurnceInAim3(R00)IvlidtemchelerngmodelndependentcohtpplypipeletgeIIImelnomcurncecncerettgMyPhDcomputerciencegogpotdocrltrgcomputtilbiologygenomicbiomediclmticputmeuniquepoiccomplhthpropoederchDurgK99pheIupptednouttgterdciplrytemmenrdvcollbr(DrSemenovDrSgerDrYuDrShlekDrToDrLinDrNemeth)expertellpectpropoederchIcquinewknowledgekill()cncerbiologyimmunology(b)computtilnlyemultiplexedtueimggptiltrncripmicTogermlcourewkpiltrgtutilupptMchuettGenerlHoplHrvrdMediclSchoolIbridgemyknowledgegpcomputtilcncerbiologypilkilllederhipvltrnindependentpoietblhhighlyimpctfullbryfocugdevelopmentcomputtilmethodologieytemticllydeciphermechnmcncerdevelopmentprogiPROJECTSUMMARY/ABSTRACTThepychologiclympmclutercommproblemimpctwomenceivgbtcncerttmentocedeverlnegtiveoutcomecludgducedfunctilttuqulylifeUntuntelymechnm()underliethcluterunknownwhichlimdevelopmenttrgetedterventiMountgevidenceuggetdividul(eggeeducti)communy-leveldetermnthelth(egneighbhooddeprivtipolluti)cepychologiclympmwomenbtcncerWhileexercecnimprovepychologiclympmwomenbtcncerunknownifdividulcommuny-levelfcrimpctthltihipGivenexercedividulcommuny-levelfcrcnlterDNAmethyltievlutiepigeneticgultimyprovidenewmechnticightInvetigtiepigenomicdividulcommuny-levelfcrocedpychologiclympmcluterwomenbtcncerctextromizedclicltrilmoderte-tenyerobicexerceterventiclrifyeltihipmdevelopmenttrgetedterventiTheoverrchggoltherchlleveympmcncerptientwhicherchpriyNCIDiviCncerPventiTheimK99tudy(1)tethypoeepigenomicdividulcommuny-levelfcrocedpychologiclympmclutereveryprilewomenbtcncerpritrtromtehibirrpy(2)tethypoeepigenomicdividulcommuny-levelfcrocedwengpychologiclympmclutereveryprilefollowgixmthromtehibirrpywomenbtcncerwhileexerceepigenomicfcrmigtetheffectThecidteextendthleerchimmunpywhichrpidlyemerggndjuvntrpybtcncerThedetiledtrgplnexceptiltemmenrerch-teniveenvirmentUniveryPtburghprovidecidtemendtrguppterchexperienceneededcducttherchThroughrgplncidtedeveloppriciencyepigenomiccompetencynlybiomticlgudlepigenomicdtpriciencyevlutiocildetermnthelthympmcienceexpertemechnmimmunpy-ltedympmknowledgekillpilcerdevelopmentTheimR00tudy(1)identifyympmcluterprilewomenbtcncerceivgimmunpyovertime(2)evluteepigenomicdividulterperlcommunyocietl-levelfcrocedympmclutereveryprilewomenbtcncerceivgimmunpyovertimeFdgeprojectprovidenewknowledgeguidecliclementdevelopmenttrgetedterventimigteeverycommympmcluterPROJECTSUMMARY/ABSTRACTPncticductldenocrcom(PDAC)devttgdeepoprognoccountupwrd95%llpncticcncerWhcidencePDACoecdledgcuecncer-lteddethUnedStteDepecentprogdevelopmentmoeffectivecombrilchempyttmenturvivlhmedpocuechempy-ocedxicyhenrcquidchemotncelckbiomrkermtchptientpecificchempeuticgentOncolyticvirpy(leprtcombttment)ltivelynewnticncerpprochutilizeplicti-competentviruefectdetroycncercell(outdmggnmltue)throughviruplictiviru-ducedntumimmunepeVeiculrmtviru(VSV)euchcolyticviru(OV)ldypheIclicltrilgtdiffentmlignncieInourpvioutudiewenlyzedvriouVSV-bedOVgtmnyPDACcelllemdenilchrcteriztiPDAClegrdgirgenerlcellulrchrcterticpermiveneVSVOurtudiedemtrtedVSVeffectivegtmjytetedhumnPDACcellleHoweveromePDACcelllehowvrioudegetnceVSVOVmlydueidulupgultedJAK/STATntivirlignlgefficientttchmentvirueomePDACOurgoltterunderttrgetfcrdetermgucceVSV-bedOVrpyenhnceOVefficcyovercometncePDACOVbrodenpectrumPDACphenotypewhichtmentcnuccefullyppliedThpropolbedourcentlypublhedplimrytudieugnexperimentlevolutipprochUgthpprochwehvegenertednovelPDAC-trgetedcolyticVSVvrinttterblefectkillPDACcellouthrmgn-mlignntcellInAim1wedetermemoleculrmechnmpibleimprovedcoelectivyenovelvirueInAim2weexmeefficcyfetyourtte---rtviruVSV-p53-CCSUIT-2lecombtiFDA-pproveddrugRuxolib(JkfielectiveJAK1JAK2hibir)/nti-PD-1ntibodyugcliclly-levntimmunocompetenrthopicmouemodelPDACThetriple[VSV-p53-CCSUIT-2/Ruxolib/nti-PD-1ntibody]combtiexpectedcenlyVSVplictiviru-mededdicncolyviRuxolib-mededhibiTypeIIFNntivirlignlglti-PD-1immunpyefficcyviRuxolib-mededhibiJAK-STAT-mededtum-protectivepeOurtudieleddevelopmentmoeffectiveVSV-bedcolyticrpiebrodenpectrumPDACphenotypewhichtmentcnuccefullyppliedWhilethpropolfocuedVSVgtPDACourdcoverielolevntOVtumytemProjectSummryCncergovernedevolutiryprciplewheequentilchngetgeneticepigeneticlevelenbleprolifertiimmuneevidrugtncemettAnouttggolcncerbiologyundertptiotemplproceeunderpngthevolutiTodoowouldgtlyimproveourbilyctemoeffectivettmenttrtegieecttumdevelopmentfrfutuHoweverthgolmeluivedueourcompletectlogmoleculrproceedrivgevolutilckmoleculrcomputtilolholticllyprilgtumOneemerggdriverextrchromoomlDNA(ecDNA)FoundpproximtelyhlfcncertrglyocedpourvivlecDNAuniquemcogenemplifictiyideoutidechromoomeexhilevtedcopy-numrgeneexpichromtcceibilycompdchromoomlmplifictiNewevidencehundercodimptnceecDNAdynmicheterogeneydrivgtumprogifirtecDNAymmetricllyeggtedurgmiledgccelertedcopy-numrgrpiddpttitfulcdiSecdeverlvrietieecDNAcnextglecellwheymcoopertivetermoleculrhubDepethppciefetuecDNAhvemedeluivetudyduecrcyolprilgirvterogeneychticevolutirydynmicInthprojectIdevelopquecomputtilolprilgecDNAvribilyevoluticncerueeolmothoughlyvetigtehowecDNAheterogeneyctedmtedlevergedpetrgetedrpieFirtIbuildbkthroughlg-dequencgdevelopolenbleundmulti-omicprilgecDNAvribilycrobiologiclcdi(Aim1)SecdIlevergenewmoleculrtechniqueferphylodynmicpropertieecDNAlegelernmoleculrfnelcpeecDNA(Aim2)ThirdIexploco-evolutiryprcipleecDNAcombgevolutirymodelgCRISPR-bedcen(Aim3)TogeretudieillumtepropertieecDNAevolutinomtenewrpeutictrtegieprovidenovtivecomputtilolgtercientificcommunyThwkpermedexcellenttrgenvirmentStndUniveryundermenrhipDrHowrdChngnexpertepigenomicecDNAAndvycommteelederfieldecDNAcncerbiologybiomtictumevolutiprovideddilexpertemenrhipThefirthlfechimcompletedpdomntlydurgK99phewrdprovidgolidfoundtiimR00pheeventullyndependentR01pplictiInvivemlignntmelnomhncidencedecdeDermocopyiddetectierlietmotcurbletgemelnomThelgledtimequidppotmentpecilttddermocopylckdermocopytrgmid-levelprctiertenfirtencountermelnomctriedelymelnomdetectmotcurbletgeRecentdvnceclifierrchectucomputgpowerhveenbleddevelopmentdvncedimge-procegolimprovedignoticccurcyexceedgdermlogtExtenivecollectidermocopyimgevilbleenblettertrgdeeplerngcomputtiltechniqueHoweverumtedmethodtillneedprovideufficientccurcyliblemelnomceng-pervirtulculttiComputtiltechniqueleuccefullimeddtetuchthoepecificfetuOurhypoAnnotticriclkleitructumll-cledtetmultipleexpertenbleumtictructudetecticnimproveumticleidcrimtibilyTovetigtethhypopropoedthe-yerprojectcollbtilrgetpubliclyvilblekleiimgerchivectepltmpromoteterntilprticiptidtetnnotticurtivlidtifciltedvncekleinlyerchThpltmllowgloblexpertnnottevlidtedermocopickleiimgedtetidentifyegmentcricltructuprovidgnrchivetegrtedpubliclycceibleInterntilSkImggCollbtive(ISIC)imgecollectiSkleifetunlyvlidtitudiecductedidentifycriclfetuctrigimprovedmelnomdcrimtinignmimicThepropoederchvetigtefuiextgdeeplerngtechniquebedentikleideeplerngtechniquetdugloclizednnottimtiguideddeeplerngpecifickleitructufetuextrctidignoWepermttticlnlyedetermelevntnnottedkleimll-clefetuetizeignificncefetudetectidignoticrtetweentrddeeplerngtechniquetrgetedloclizedfetuet-bedguideddeeplerngtrgfued(comd)ulthypoementHypo-drivenfetudetectidignoultthtudyimpctmll-cledtetnlydeeplernglghmdevelopmentAprtpropoedprojectemrprovidedp-collegetudentthroughSTEMprogrmuchProjectLedWyFurreductiltrgopptunieprovidedundergrdutetudentpurugp-medbiologiclciencedtciencebiomediclengeergprogrmthroughemrummercmph-menderchopptunieABSTRACTInddipivotlrolegultgcellcyclertpopDNApirmetbolmp53tumupphendemtrtedmodultenteimmunedptiveimmunepethroughcrotlkkeygulrimmuneignlgpthwyThedygultiInterleuk17(IL17)cykefmilyceprhenocedmnyhumndeenotblyflmmticncercdgircrucilrolenmlhotimmunepePrticulrlyInterleuk17ReceprB(IL17RB)henfoundovexpedvrioucncerthroughctivtiNFBAKTERKignlgpromotetumigeneOurplimryultdicteIL17RBp53prgetpiIL17RButp53peAddillyctivtip53nutl-3IL17RBdepletideceexpipro-flmmrycykeIL8ducedlipopolycchride(LPS)Thegolthpplictitudyrolep53-mededIL17RBpumuppiflmmtihibiWeetblhedytemIL17RBpiovexpictivtienblebiochemiclcellulrchrcteriztiwell-depthgeneexpinlyeelucidtectriiIL17RBpumuppiveflmmtihibiryfunctip53ThepropoedwknlyllowugtterundertghowIL17RBlkp53crotlkignlgpthwyhowp53ttenutecogeniceffectchricflmmthroughpgIL17RBloprovidemechnticbdevelopmentnovelnti-cncertrtegiewellflmmtihibirInddhprojectenhnceerchenvirmenttStJohnUniveryprovidgundergrdutegrdutetudentnumerouopptunielernfundmentlbiomediclerchProjectSummry/AbtrctTumimmuneexcluipdictponticncerrpeuticpeptienutcomeThemechniclbrrierbuilttercellulrjuncticnectiextrcellulrmtrixmtimmuneexcluiimmune-privilegedgnHowuchbrrierdictteimmunefiltrticncermlrgelyunknownMyprrgcergolfocuedunmetneedcomphenivelyundertwhtmechniclbrrierutilizedtumhowytigteimmuneexcluievdeimmuneurveillncehowrtillydeignnovtiverpiebkdownmechniclbrrierunlehfullpotentilntumimmunyScejogEllenLbtMchuettGenerlHopl/HrvrdMediclSchoolIhvefocuedmymechniclbrriertudietightjunctiltedmoleculeTROP2whichovexpedthoughtplyroleprogimultiplecncercludgggivetriplenegtivebtcncer(TNBC)LikeprlogEPCAMTROP2eetmechniclbrriermoleculelkedlcktumfiltrtgimmunecellAddillymyplimrybiomticnlyhowTROP2hignificntnegtivecltikeyntumimmunemrkermultiplebtcncercohtThuIhypoizedTROP2myencemechniclbrrierdeterntumimmunefiltrtibtcncerImptntlyTROP2trgetprotemultiplecentlydevelopedntibodydrugcjugte(ADC)cludgScuzumbGovecn(SG)SGfirtFDApprovedADCTNBCcomTROP2-trgetedntibodypoomere1(TOP1)hibircyxicpylodWhileSGprovghighlyuccefulpcirpymechnmmpolyunderodFurrmocyxicpylodSGTOP1hibircldrugknownelicimmunogeniccelldehuprovidgtrgrtileundertmechnmwhichtrgetgTROP2lectextSGmodultetumimmunemicroenvirmentthuenizgtumimmunecheckpothibirThpropolemploybiochemtrymouetummodelgeneticcenwellmulti-omicptilimggnlyptientpecimenThetudyimdectmechnmTROP2-mededimmuneexcluiTNBC(Aim1)dcovermechnmSG/nti-PD1combti(Aim2)ytemticllyuncovernoveltigrbttumimmuneexclui(Aim3)Myextenivebckgroundbtcncerimmunemicroenvirmentterdciplryexpertemymenr/dv/collbrtemmkemewell-uedcrryoutthnovtivepropolytemticllyunrveltum-tricmechnmimmuneexcluiTogertutilupptMchuettGenerlHopl/HrvrdMediclSchoolthwrdhelpmegddilknowledgetrgtummodelptilmulti-omicnlyCRISPRcenwellcerdevelopmentkillwhichultimtelyhelpmerpidlytrnifrufulimpctfuldependenterchcerABSTRACTLeverggdecdeNCIvetmentclicltrildtfrtructucncercengerchI-SCREEN(ImprovgStrtegieCncerReducthroughErly-detectiENggement)ACCESSHubwell-poiedefficientlyeffectivelyddpgueroundemergencenewtechnologiecncercengTheecludeevlutgnefhrmnewcncercengtechnologieirimpctcncer-ltedhelthdprieWebuildUniveryColdoCncerCenter(UCCC)uccefuldmtrtilrgecncercengtrilcludgProtteLungOvrin&Coloctl(PLCO)CncerScengTrilNtilLungScengTril(NLST)lgirwell-etblhedColdoCncerScengProgrm(CCSP)ttewidecncercengnetwkchgunder-ourcedcommunieUCCCnetwkrurlhelthcentercomplementedKerPermnenteColdo(KPCO)cluiHpnicmemrColdoFrtRngeextendextgcollbtitweenUCCCKPCONCI-fundedColdoImplementtiScienceCenterCncerCtrol(COISC3)WelobuildynergytweenKPCOKerPermnenteHwii(KPHI)lytwoeNCIPopulti-bedReerchOptimizeScenProce(PROSPR)CtiumloprtCnectNCICohtIniveKerPermnente(KP)ReerchBnk(KPntilbiobnk)bothcrughelthyptientcollectgbloodbiopecimenTheI-SCREENCtiumctnNCI-deigntedCncerCentertwotegrtedcdeliveryytemefederllyqulifiedhelthytemerurlcriclccehoplytemI-SCREENcruomemotunder-pentedpopulticlicltrilcludgHpnicNtiveHwiin/PcificIler(NH/PI)AinubgrouprurlpopultiOurlg-termgolducecncer-ltedmtlyrpidlyvetigtgemerggnovelcengtechnologiediveretudycohtenuefficciounewtechnologiehvebrodchhelpdecenotwidencncer-ltedhelthdprieToccomplhthgolwe1)collbteNCICSRNCenterACCESSHubbuildnecoytemevlutenewcncercengtechnologietrtegiediverecliclettg2)DevelopcengexecuteVngurdfeibilytudymdeigntrilevlutenewtechnologiecncerunder-pentedpopulti3)ceimpctCSRNcollbtgNCIbuildrobutdt/biopecimenpoiryvilbleCSRNvetigrexternlvetigrThroughcentrlizedAdmtrtiveRecrumentBiopecimenEnggementDtCoweenuACCESSHubcollbticommunictiprogwrdCSRNdeliverbleI-SCREENmodelhigh-impcttrnltilerchtetemerggcncercengtechnologieducedpriecncermtlyPROJECTSUMMARYPltum-bedchempygimenimproveurvivlptientmucle-vive(MIBC)mettticblddercncer(BC)thpprochmrpeuticcnernethdee(mnyolidtumtype)WhilewehvegununderthowcertmoleculrproceeMIBCtumpromotetnceuchthoevolvgDNApirimmunemicroenvirmentltrncriptilprogrmmgdiveryeterctgpropertieirmechnticunderpnglrgelyunknownOurtemdvncenovelvrovivoblddercncermodelytemenbledictterrogticidtemechnmwhenpidptient-centedglecellptilprilgtrtegie(lkeddvncecomputtillghmdectedttumevolutiprciple)provideplimryightmotivtiguidethhypo-drivenpropolOuroverrchghypodtcttumimmunecellulrprogrmcoopertepromotetncepltumchempyMIBCwecnuniquelyvetigtethhypothroughfollowgSpecificAim1)Defefluencetum-triccellcycleDNApirpthwyltertipltumtnceMIBC2)DectimpctpltumexpoumcrophgeprogrmmgMIBC3)Invetigtemechnmtum-mcrophgecrotlkpromotgpltumtnceMIBCFecheAimwepermdictedmechnticexperimentuglevntBCmodelpirouruniqueclicllytegrtedptientcohttegrtivemoleculrnlytrtegie(cludgwholegenomeglecellptiltrtegiedictlyimplictedourmoleculrhypoe)Tkengerthhypo-drivenpropoldefeltihiptweenpecifictumimmunecellulrterctiMIBCtumpromotepltumtnceugnoveluefunctilcomputtilcro-dciplrypprocheBrodlythprojectprovidentegrtivemoleculrcellulrexperimentlfrmewkundertgclicllybiologicllylevntmoleculrunderpngtumimmuneterctideeprogicrotumtypeSummryRecenttudiehowwholegenomeduplicti(WGD)fquenteventcncerevolutipromotechromoomltbilyneuploidyWGDtumhveweprognoelevteddrugtncecedmettticpotentilwhencompdner-diploidcounterprtHowevermechnmdrivgWGDdurgcncerevolutimunclerThcueeventledWGDoccurynchroulytlowfquencymkgmdifficultcptuugtrdilpprocheuchfixedendpotpprocheMylbhpieedgeneticllyencodedbioenimgenlytechniquebiochemicllychrcterizethoudividulcellmultipledyygothroughnmlrrntcellcycleUgepprochewehvefoundWGDoccurpecommtcdiuchomotictDNAdmgeriboomecolliThprocevolvetwotepfirtcellgoG2G0outentergmi(iemicp)SecdomecellecpecellcyclertenterS-phe-duplictgirgenomeFurrmoourdthowDNAdmgecuedcommlyuedchempeuticpromoteWGDcncercellrgquetiboutrolechempy-ducedWGDcquiddrugtnceThprticulrlyimptntmettticTripleNegtiveBtCncer(mTNBC)whichDNAdmgggenttillmtmttmentdevelopmenttncectuedevttghelthcproblem(medinurvivlrte<18mth)HeIpropoeueourlivegle-cellpprochechrcterizecuecequenceWGDcncerprogicquiddrugtnceInAim1wecomlivecellimgggle-cellequencguncoverhowphyiologicltetriggermicpWGDn-trnmedcellInAim2wetudymechnmchempy-ducedWGDcncercellInAim3weuehumnbtcncergnoidptientderivedxenogrftdeferolechempy-ducedWGDcquiddrugtnceOverllourwkpvewywrdchrcterizgcell-cycledynmiccncercellidentifyuniquevulnerbilietrgetrrntcellcycledrivetumigenePROJECTSUMMARY/ABSTRACTAdecemuclemfunctiknownrcopenihighlypvlentcncerptienttenleddecedendurncecedftiguefllpoqulylife(QOL)cedmtlyProttecncer(PC)2ndmotcommcncer2ndledgcuecncerdethmenwldwidegtlyimpctgurvivlQOLeptientAndrogendeprivtirpy(ADT)trdttmentdvncedmettticPCUntuntelyADTexcerbtercopenictrigympmburdenpooverllQOLDepelevncenopprovedphrmcologiclttmentrcopeniSeverlgpourknowledgeimpededevelopmentrpiercopeni1)Thenogemennpecificoleclicllylevnutcome2)Theunderlygmechnmnotfullyunderod3)livedexperienceemenhvenotencerted4)wecurntlyunblepdictwhodeveloprcopeniuptrtgADTTheOverllGolthpropoletblhclicloutcomepdicrrcopeniPCptientundergogADTchrcterizepthwymechnmledgthphenotypecludgrolemichdriWepropoepermclicltrilcludg70mendignoPCtrtgADTPrticipntfollowed12mthChngebodycompoimucletngthphyiclpermnceptientptedoutcome(PRO)cludgftigueQOLmeudirclicllevncecertedBloodmplemuclebiopieobtedtbele6mth12mthvetigtegeneprotemetboleltedADTetblhpdictivevlueebiomrkerclicloutcomercopeniugcomphenivemulti-omicpprochTheSpecificAim1)EtblhclicllevncediffenutcomemeuercopeniPCptienttrtgADTWehypoizeADTcueclicllymengfuldeceppendiculrlenbodym(LBM)mucletngthphyiclpermnceQOL2)IdentifypriizemoleculrpthwymedgeffectADTeoutcomeugmulti-omicpprochOurhypoADTltergeneexpiprotemetbolelevelmucleplmmeudcomphenivemulti-omicpprochthocedrcopeni3)Determerolebelebiomrkerlevelpdicrrcopeni4)PermmechntictudiemucletuedeferolemichdrildyfunctiADT-ducedrcopeniWenticiptepecificpthwyprodplmmucleimpirmentmichdrilfunctbelepdictdevelopmentrcopeniuptrtgADTWelochrcterizeexperienceemengrdimpcnQOLThedtgenertedprovideeentilknowledgemtiveolmeuclicllylevnutcomeADT-ducedrcopeniidentifynoveltrgetclicllymengfulpdictivebiomrkerthmbidcdiCombgimmunecheckpothibirBRAFMEKhibirhenbledignificntimprovementttgmetttickcutneoumelnompoectivtgmuttiBRAFgene(BRAFmutntmelnom)Inctrtctiblepecifictrgetmettticcutneoumelnomctwild-typeBRAFgene(BRAFWTmelnom)hveyetdcovedhdergdevelopmentmoeffectivetrtegiettgetumHewepropoeddknowledgegpvlidtgcidtetrgetBRAFWTmelnomtrtegierpeuticterventiPublhedplimrydthveledfollowghypoERBB4muttielevtedERBB4trncripticeignlgERBB4-EGFRERBB4-ERBB2heterodimerultgcedPI3keignlgcoopertiNF1RASgenemutticedprolifertiBRAFWTmelnomWetetpectthhypotwopecificim(1)WhichERBB4mutntfoundBRAFWTmelnomcuecedprolifertiBRAFWTmelnomcellle?(2)IEGFRERBB2PI3KpthwyquidprolifertiERBB4-dependentBRAF-WTmelnomcellle?Weetimtepdictedoutcomeetudieledeffectivetrtegiettgpproximtely30%mettticBRAFWTmelnomvolutiizgcptientcrryeggivekcncerPROJECTSUMMARYGlioblm(GBM)dedlydeenoeffectiverpyocedewt5-yerurvivlrtellhumncncerCurntttmentwhichcludeggiveurgiclcrdipychempyeffectiveprtcuehighlydptblentuGBMwhichfcilterpyevipertentevolutideeRecentwkhveledcrucilroletummicroenvirment(TME)gultgtumcellplticyledgeftctetrgetedTME-dependentttmentcombtGBMprogiHoweverduecomplexntuTMElimedundertglevntpromoterdeeemddedthmilieuprogidentifygpromgrpeutictrgetmchllenggWhTMEbiophyiclcuecludgmtrixtiffnecompoihveemergedignificntgulrGBMcellggiveneFocuedvetigtibiophyiclmechnmgultgGBMcellggivenepentnovelpprochdevelopeffectiveGBMTMEtrgetgrpieTheemergencebiophyiclltertiTMEmpolyunderodproceTMEtuemodelggnunderppcedpectGBMprogiCurntvetigtidicteltertihyluriccid(HA)ectidigetimyffecttumproghroughtwomjprocee1)hpebiophyiclchrcterticevolvgTME2)ducemeenchymlhiftledceddygultiECMecticedvivenecedprolifertiThpropoleekclrifyctriimechnmECMmodelgquntifygECMltertitumcimdectgmechnotrnductivemechnmunderlygHA-dependenttumigenicctrolTodothwetetfollowghypoe1)CoECMmodelgledelevtedHActentcetuetiffengduecedHAS2HYAL2ctivymeenchymltumgi2)IncedmechnicltiffneHApenttiynergticllypromotemeenchymltrniledcedHASedecedHYALledgccumultiHAvrygmoleculrweightubequentbiophyicllterti3)IncedHAtiffneceCD44mechnotrnducthroughCD44clutergERMctivyledgupgultedpro-meenchymlignlgviSTAT3-NF-BLOX-Twt1LMWHAectiThepropoedtudiefirtytemticllydectECMcompentvriouptientmtchedgiGBMtumtudyirctriibiophyiclchrcterticmeenchymltrniHA-CD44mechnotrnductiProjectSummry(30le)High-rkNeuroblm(HRNB)nextrcrnilpedriccncerwhichup65%ptienttntrpieRecentbiomedicldvncehveimprovedttmenpticncerptientYetnoeffectivettmentlpedHRNBptientwhohveundergettmentexperiencedtumcurnceOurlg-termgoldevelopmoeffectivettmenttrgetlpedHRNBAkeyfetuHRNBdrivedeeprogirrntclcium(C2+)ignlgThfertrgetedrpeuticpotentilC2+chnnelhibirOrgrouphvemdeprogctgidentifygC2+chnnelhibirmyuedcncerttmentOurgrouptkgnlterntivepprochtrgetgC2+ignlpromoteNBprogiuniquelpedHRNBThepropoedprojectlevergeelevtedlevelcyolicC2+lpedHRNBdrivenenhnced-opertedC2+entry(SOCE)promotemichdrilC2+overlodpopThehypoctivtiuphgypventmichdrilC2+overlodpoplpedHRNBthrwemightprepopdueelevtedSOCETheecombttmentcompoednoveldrug249nuphgyhibireffectivelykilllpedHRNBTrgetgmichdrilC2+trnptergultepopmyfernewrpeuticpprochttglpedHRNBvrietycncerAdetiledundertgmtC2+ignlgllowtrgetgdeedtueoutdeleterioueffecthelthytueInddhwkcludeundergrdutegrdutetudenterchercludgthoeunderpentedmygroupTheethwktrnextgenertierchercediverybiomediclwkceProjectSummryThelg-termobjectivethprojectdevelopDrRomno-Nnclcpcycducttudietegrtedietrylifetylefcrmulti-omicdttrdilbiomrkertterundertbiologiclpthwyunderlygetiologyggivembtcncerdvncefieldpcinutricncerpventiThepropoederchcomomicmethodologiedvncedttticltechniquevetigterolechricflmmtietiologybtcncerChricflmmtihenidentifiedpoiblerkfcrdevelopmentbtcncercludgetrogenceprnegtivebtcncerwhichubtypebtcncerocedpoprognolepivehmlrpieThefoundthpropolbedourcentfdgwhehigherdhencenEmpiriclDietryInflmmryPttern(EDIP)co(mopro-flmmrydiet)wocedcedbtcncerrkprticulrlytumlckgetrogenceprexpiLevergguniquedeignwelthourceNureHelthStudy(NHS)NureHelthStudyII(NHSII)peteddietrymeupdignoticplmpecimenthpplicticomdietryomicdtmultiplebiologicldimenicuttg-edgeepidemiologiclbiomticmethodologieexmeltihiptweenchricflmmtivivebtcncerrketrogenceprubtypeInAim1(K99)heexmeociplmmetbolomicprileEDIPubequentrkbtcncerNHSNHSIImg1997ceirmtchedctrolInAim2(R00)heuengnoticpprochidentifyociplmproteomicrkbtcncerNHSNHSIImg200ceirmtchedctrolInAim3(R00)hetegrtemulti-omicdtcludgmetbolomicproteomictrncripmicchrcterizeroleflmmtibtcnceretiologyTherchprovidenovelevidenceenhnceourundertgbiologiclmechnmvolvedbtcnceretiologyhelpidentifynewpventitrtegiemoggivemdeeDrRomno-Nnclcientificimupptedthetrgobjectivellowherdvncehertrjecrywrdcomgndependentvetigr1)gle-omicmulti-omicmethodologiedvncednlytic2)proteomictudydeignexecuti3)btcnceretiologypthophyiologyThetrgenvirmenttBrighmWomenHoplprovideexceptilupptDrRomno-NnclhepurueedevelopmentcientificgolShehemblednouttgterdciplrymenrgtemexpertecncerepidemiologymulti-omicbiomticbtcncerpthologyproteomicmetbolomicThK99/R00wrdhelpDrRomno-NnclcquiknowledgeexperiencenecerylunchhercerndependentvetigrModerndrugnlytechniquentegrlprterchhelthcdyRegttblycurntpprochmplecollectictlerllymovgpieceptienrexperimentlniml(wherbloodmpletuebiopy)entlbrynlySuchprocedupoeethicluehelthrkmediclpernelcveniencevetigtedg(ptienrlbniml)FurrmolthoughhencognizedtueccentrtimopdictiveclicloutcomethnplmccentrtiementdrugdtrirgetephrmcoketicverydifficultcuelckppropremethodologyPot--cdevicemeurgelectrolytecrdicmrkereverlmllmoleculenowideemergencyroomeventptientdide-noclicldeviceftmirgdruglevelbodyfluidtueTheneeduchdeviceevengterdifficultttdeeuchneoplmInpecurntchllengefceddrugnlyphrmcoketicphrmcodynmicrpeuticdrugmirgwepropogpplynovtivemicromplgpprochemeurpeuticntibodyccentrtitumoutcollectgphyiclmplevetigtedgnmTheemethodfetulibleclibrtifedompumpnoomoticeffectignificntimprovementenivyFurrmoyftermoecomiclthnclicleThenewmethodppliedfirttimemeutumccentrtiimmunecheckpothibirctblockgprogrmmedcelldethceprTcellThepropoederchutilizebiocomptiblemplgdevicedictmicroextrctintibodydrugtumTheedeviceppdcovergflexiblemedicl-grdemetlwibiocomptiblepolymerhighffyextrctivepheTheextrctednlytequntifiedchromgrphympectrometryferhighpecificylowlimdetectiFqunttieverlclibrtimethodpplieduchexternltrddiffui-bedclibrtiketicclibrtiThedtuedbuildphrmcoketic-phrmcodynmicmodelpenttiverpeuticntibodyuchpembrolizumbThenewvivomplgmethodvlidtedcomprlrgepomicrodilyItexpectedmicroextrctiprovidetterenivyccurcyletuedmge(duemllerize)ptbilycvenience(nopumpfluid)PROJECTSUMMARYQunttivelypdictgdrug-tntmuttiimprovepcicologyMywkbuildwrdmechnticllymedpprochmodelpdictdrug-tntkemuttienhnceptientttmentgimenProtekeimptntignlgenzymetendygultedcncerirphrmcologiclvluedrugtrgetexemplifiedcliclueover75FDA-pprovedhibirUntuntelymultipleclicllyobervedkemutntthibirdrticllyduceptienturvivlrtePcicologypprochemtchgpecifictumprileoptimllyrpiehveprovenuefulthnktumequencgmuttiprilgHowevermchllenggidentifydrug-tntmutntprtmentdevelopgimencircumventmAlckmechnticmtidecribgclicllyobervedkemutntmkedifficultpdictwhermuttitcnicllyuedkehibirKemuttimydecedrug-bdgffycekectivytunehibirenivyprilenycombtiemechnmStructu-bedmethodpromehelppdictimpctkemuttiIhypoizekehibirutilygtdrug-tntmutntexpedugphyiclqunttivepropertieliketructurlttepopultibdgffieMywkqunttivelyeeimpctcliclkemuttihibirtnceenivyuceptibilySpecificllyIdevelopmodelpdictwhercliclkemuttiperturbhibir-bdgcekectivytbilizgctivecfigurtienizekelterntivehibirInthpropolIdrwupcliclmuttidtbetudymutti-hibirpirc-MetketrgetN-Smll-Celllungcncer(NSCLC)buildguppvioutudietncemuttiAblkeAmentee(K99)Iuebdgfe-energyclcultipdicthowcliclmuttiducec-Methibirffy(Aim1)AItrnidependence(K99/R00)Iuemoleculrimultibiophyicllyevlutewhercliclmutticekectivyhiftgkepopultictlyticllyctivecmti(Aim2)Updependence(R00)Itudywhercliclmuttienizekerlyuedlterntivehibir(Aim3)TheecomputtillyteniveclculticntentkeyercollectufficientdnnmlcomputerIntedIrunclcultiplnetry-cleFoldg@homedtriedcomputgpltmcollbtihigh-throughputbiophyiclexperimentmeukectivyhibirbdgffyOverllmypropolfutulbbuildwrdpci-cologypltmhelpclicinplnttmentgimenProjectSummry/AbtrctBtcncerecdmotcommtypecncerdignoedwldwideloecdledgcuecncer-lteddethmgwomenoverllWhilemuchproghenmdedignottmentbtcncertrdilchempeuticttmentcnleddevelopmentchempeutictncemmjchllengeoverllptienutcomeThectivtiPgnneXRecepr(PXR)numerouendo-xeno-bioticcludgeverlchempeuticdrugknowngultemnymetbolicpthwyoceddrugmetbolmtnceThelg-termgolunderttrncriptilmetbolictrgetPXRhumnbtcncerpplythknowledgeirttmenrderimproveptienutcomeTheobjectivethpplictielucidteeffectPXRexpictivtrncripmephenotypicchngehumnbtcncercellleThecentrlhypowhichmultedPXRknownroledrugmetbolmhelthypthogenictuewellplimrydtPXRctivticexenobioticmetbolmviductiPheIIIenzymewellPheIIItrnpterddilterticellcyclepopbtcncerThertilepropoederchthncetrncriptilphenotypicltertipePXRctivtiidentifiedphrmcologiclgentgimeterfeepthwycoulddevelopeddecechemotncebtcncerTheobjectivethprojectccomplhedtwopecificim(1)Identifygloblgeneexpichngehumnbtcncerocedpgnnexceprexpi/trncriptifcrctivtiAnRNA-eqbedpprochuedidentifychngetrncripmepeendogenouexogenouPXRexpictivti(2)ExmeeffectPXRexpictivtimodelbtcncercellurvivlchemotnceIn-vrobedyexmgeffectPXRvrioupectcellcycleurvivlpopviveneutilizedThtudynovtivecuehiftfocuPXRrolenmllivertetldrugmetbolmderfilllrgevoidourundertgPXRfluencebtcncerpotentillymnytypecncerwellThepropoedprojectignificntcueuncovergenemetbolicpthwycricldevelopmentchempeutictncebtcnceridentifygnewpotentilrpeutictrgetProjectummryEndocrpy(ET)tncemettmjobtclecurgptientdvncedER+btcncer(ER+BC)UpgultedcogenicERctivyplycriclroledvncedprogiER+BCOneeentilmechnmgultgERignlgubiquti-dependentproteomldegrdtiERco-ctivruchteroidceprcoctivr3(SRC-3loknownmplifiedbtcncer1)OwgdicteffecttrgetgERdegrdtifulvetrnnlyFDA-pprovedelectiveetrogenceprdegrder(SERD)firtleendocgentmettticlocllydvncedbtcncerecdledrugdvncedmettticbtcncerhprogedftertmoxifenromtehibirttmentUntuntelyeirdenovocquidtncefulvetrnccurmjyptientdvncedER+BCThemoleculrmechnmunderlygfulvetrnttncetilllrgelyunknownThepropoedtudyimtetntrigughypoF-BoxproteFBXL16timultecogenicERctivyupgultgtbilyexpilevelERcoctivrSRC-3promotgbtcncerdevelopmentmettticprogiendocrpy(ET)tnceTwopecificimpermedAim1determeroleFBXL16gultgtbilyexpilevelERERLBDmutntAim2determeroleFBXL16ER+bttumgrowthmettendocrpytnceBycductgvrietybothvrocell-bedyvivotummouemodelexperimentweexpectelucidtehowFBXL16upgulteprotetbilyERER-LBDmutntdetermeroleFBXL16bttumdevelopmentmettETtnceOurultimtegoldefeFXBL16newprognoticmrker/rpeuticdrugtrgetttgdvncedER+BCprticulrlyptienteirdenovocquidtnceSERDcludgthoeERLBDctivtgmuttiPROJECTSUMMARY/ABSTRACTMotpplictigenomicmoderncologyfocuomticmutticquiddurgtumovolutielectgdrugtrgetetum-pecificmuttiWhileeffectiveepprocheuullydotciderbroderctextptienthered(iegermle)geneticwhichmjourcecncerrkcnmodifyeffectomticmuttilterrpeuticpeThfocuomticmuttilomjlimticncerdrivenRAScogenefmilywhichclcrntvirtullylltrgetedrpieSomticRASlterticommmnycncerepecillypncticcoloctlklungtum(hefterRAS-drivencncer)difficulthibphrmcologicllyTheecncercomp39%llcncer-lteddethUSAechyermnywhichcouldpventedifircncerweterceptedterliertgeThflectnurgenpptunyducecncer-ltedmtlyunifyggermleomticgeneticpriizehigh-rkdividulcengerlyterventiidentifynoveltrgetrpeuticdevelopmentInthpropolIoutletrtegydectimpctgermlegeneticRAS-drivencncerDurgK99pheIdcovergermlefcrmodifyRAScogenicyuniquecollectiomticgermleclicl/trncripmicdt>35000dividulDurgR00pheInucletendependenterchprogrmroundcomphenivecomputtilfrmewkgenome-widedetectigermlerkfcrcncerpnngfullpectrumvricceiblegenomeequencgnemphundertudiedclevriliketructurlrncodgvrintIpplythmethodytemticllympgeneticrkfcrRAS-drivencncerdivereet>10200ptient>17100cncer-fectrolMylg-termcergoluhernewerpventtivepcicologyunlockgpotentilhumngenomicillumteherblecuecnceriprogiMymenrIhvedevelopedcomphenivetrgplncncerbiologymediclcologymyK99pheppmelunchuccefuldependentcertterectigenomiccncerdtcienceR00pheMypotdocrltrgupervedDrEliezerVnAllenwhowld-ledercomputtilcologyIlonefcomplementryexpertetwoco-menrDrAlexerGuev(tttic)KevHig(RASbiology)whotDrVnAllenmenrhipenuIbuildwell-roundedkilletdurgmendK99phelyfoundtihighlyproductivedependentR00pheFllymypropoederchplnfciltedouttgcientificenvirmenttDn-FrrCncerIntutewhichidelecoytemupptmypotdocrlphePROJECTSUMMARY/ABSTRACT80%ptientPncticDuctlAdenocrcom(PDAC)developcchexiwhichultdprop-tekeletlmuclemloltiveclicdeficCchexicuefunctilimpirmenteli-gibilynti-tumrpeuticterventiledgdrticllylowerptientqulylifecedmtlySupplementlnutrinotufficientpventtuelonbjectlcktrgetednti-cchecticrpeuticThlrgelyduencompleteundertghoweffecruchter-leuk6(IL-6)driveccheximechntictudiepolyflectcliclcenrioPDACurvi-vhipImprovgqulylifeurvivhipptientPDACquiweddfund-mentlknowledgegpmechnmcchexipertenceftercncercoveryOurcentwkhowytemicflmmtiPDACpventliverdptgkegenicmetbolmdurgnutrilcrcywhichledmucleloLohepticignltrnducerctivrtrncripti3(STAT3)ufficientkegenicpotentilpventmucleloPDACmiceThwkfirthowimprovghepticfttycidoxidtipventcchexiprogiToimprovetrnltiefdgwemutddtwounmetneed1)mechnmSTAT3-drivendowngultilipidoxidti2)tudieddcchexicoverycncerurvivBedourpriwkwehypoizeSTAT3ignlgctliverducemetbolicchngepertftercncercoverytdetrimentmucleThprojectnovtivecueuedvncedepigenetictechniquecomdnovelmouemodelPDACurvivhipclerlydefeepigeneticprogrmmgeventpertftertumclerncecevulnerbilymuclenutriltTheignificncethprojectliep-clicltetgmetbolicterventiprotectmucledurgPDACcoverydefgpvioulyundecridctiSTAT3hepticmetbolmctrollkglg-termmetbolicdyfunctiepi-geneticprogrmmgdurgPDACcchexiThelg-termgolourerchimprovequlylifedignothroughurvivhipptientcncercchexhroughmechnticundertgter-gnmetboliceventAbtrctMoleculroxygen(O2)plycrucilrolehpgErthbiopheItgenerllycceptedthxygentmopheledlivgytemevolveophtictedpirrychwhichllowedgnmhrvetenergyoxidtivephophyltiOxygenndpenblepecteukryoticlifectntmnyenzymticctiydoxidtivephophyltiHoweverhfquentlyennoverlookedvriblebiochemiclcellulrtudieRecentlycgevidencethxygentenicrucilprmetertuecellulrevenubcellulrmetbolmOxygen(O2)ccentrtidictlyfluencephyiologydoxignlgmnifettiwiderngepthologiewelldevelopmentldiffentiprogrmeukryoticcelltueAignificnbtclecompheniveundertghowdiffentO2tenictrolmodulteephenotypebencevertilelibletechnologymiroxygengrdientlivgcellThpropolimddechnologiclgpdevelopgprote-bedfluocencebioenmirO2levelmmmlincellBedcurntlyvilblebiochemicltructurlmtiweengeercjugtetweennturllyoccurrgheme-bedprotecffoldbdoxygenveribly(engun)fluocentproteUnG(pterun)TheenctructdeignedoUnG-bedptgunlyvulizecmtilbptichngeoccurrgupO2bdgheme-bedengunOurpprochtkedvntgefctmturtichromophoUnGnoxygendependenteUnGcnuedpteruntvriouoxygenteniBioencidterigoulychrcterizedugbiochemiclpectrocopicimggpprochebothpurifiedcombntprotewellmmmlincellcultuytemFllywepplyourgeneticllyencodedbioenelucidtetrcellulrO2ccentrtidependentmetbolicmodelgnlcncercellleeirtcrdeficientvHippelLdutumupp(VHL)geneOverlltechnologywedevelopgprovidetrnmtiveopptunieundertgroleO2metbolmcnceryddictlyvulizgoxygengrdienttub-gnellrolutilivgcellABSTRACTPncticDuctlAdenocrcom(PDAC)highlylethldeeexpectedcomeecdledgcuecncer-oced-dethUSyer2025TrgetedrpeutichvefiledprovideignificnturvivldvntgeovertrdcWhntenifiedfocuimmunpyimmunecheckpotblockde(ICB)rpielehveenufficientPDACwhichtendplyn-immunogeniccoldtumphenotypelckcyxicTlymphocyte(CTL)filtrthucpblevokgnimmunepeTothpotwehvelernedmultiplebiologiclmoleculrpectPDACctrieICBefficcycludgntigenicyimmunogenicytummicroenvirmentFdgtrgetedrpeuticceepectimmunycetrtumlTcellfiltrtieentilimprovgimmunpeuticpplictiPDACOypromentrkfcrdevelopmentPDACwellmodvnceddeeOywellevidenceddrivelocldipoeflmmtiloctrieytemicflmmtiOurcentfdgdictedipoederivedcykedictlymodultetrncriptilprilePDACcellSpecificllywefoundtimultiPDACcelldipoecdiedmedipromotednti-immunogenicchemokeectum-derivedCXCL5whichligCXCR1/2ceprtypicllygultemyeloidcrument/ctivtiWhileclicltriltrgetgCXCR1/2ceprphrmcologichibirhveentedclicltrilirefficcyPDACquetibleduebrodceprexpicflictgultIncomprourtudiehvedemtrteddepletgtumderivedCXCL5emnyCXCR1/2ligufficientpromotetrtumlCTLfiltrtiprimetumcheckpothibiettgoyIngenerltrgetgpncticcncercell-pecificbiomrkerhpentedchllengeercheromebiomrkerPDAChighlyexpedn-cnceroutuelimgdrugdeliveryn-cnceroutueeentilmimizgideeffectThePlectprotepentnidelbiomrkertrgetedrpeuticdeliveryInhelthycellPlectmtcyplmiclocliztiwhehiddentrgetedrpeuticAlterntivelyPlectexcluivelyexternlizedpncticcncercellwheprovidenoptimltrgetdrugdeliveryProprcipletudiehvevlidtedPDACpecificbdgPlecttrgetedAAVvirlprticleWeplnpckgehRNACXCL5Plect-AAVprticlecpulteourCRISPRtudieduceuceptibilyICBrpynoeettgABSTRACTT-celllrgegrnulrlymphocyticleukemi(T-LGLL)ncurbleunderdignoedproliferticllCD8+cyxicT-lymphocyteulteveneutropeninemiultntcurrgfectitrnfuidependencedethThenoFDA-pprovedrpieT-LGLLcurntimmune-uppivebedrpiehvemrglefficcyEvenifpettedcurntrpieptienthifttweenimmune-uppivegentubjectdvereeffectedrugthoenyeffectdeferpyquidUrgentvetigtipthogeneT-LGLLdevelopmentrtiltrgetedrpieneededT-LGLLcyke-dependentdeedriventerleuk-15(IL-15)whichhenidentifiedmterwchcrucilducepotenteT-LGLLIL-15ducepthogeneT-LGLLthroughup-gultiSTAT3ultntdeceF/F-LigmededpopultntT-LGLLproliferticypenWeevlutedBNZ-1c-hibgpeptideblockIL-15ptientT-LGLLlyecdmjmulticentertrilcompletedT-LGLLCliclpeweoberved20%ptientvivodtvelednerlyllptienthddrmticpopT-LGLLcell24hourpot-BNZ-1thoughpoppertedlypdgptienttdy29Theeult(viBlood)providevivoproBNZ-1duceT-LGLLcellpopT-LGLLcelldependennIL-15vivoptientToevlutemechnmtnceIL-15deprivtiducedcelldethwepermedgle-cellRNAequencg(cRNAeq)mplen-pderWeidentifiedemergenceuniqueT-LGLLub-popultidy29cpdgup-gultinti-popticpthwyPI3KNF-kBimplictgup-gultielterntepthwyT-LGLLkeymechnmtnceT-LGLLIL-15deprivtiYetvlidtilrgermpleetneededcfirmefdgidentifyrpeutictrgetToddetrnltilcliclgpwepermcRNAeqgle-cellT-cellceprequencg(cTCReq)mgclicllynnottedmple3pder3n-pderBNZ-1trilteurhypotnceIL-15deprivtiBNZ-1cuedexpnitntT-LGLLpopultiupgultinti-popticpthwy(egNF-kBPI3K)InAim1wepermcRNAeqteriltimepot(bele24hourpot-BNZ-129dypotBNZ-1)identifykeynti-popticpthwygenerpeutictrgettntpopultiInAim2wepplycTCReqevluteT-LGLLcllpopulti(clotype)determeimpctIL-15deprivtigeneexpinti-popticpthwyegroupUpcompletiwegcrucilmechnticightcriclgenenti-popticpthwyT-LGLLledtnceIL-15deprivtiidentifyrpeutictrgetfutuNCIR01propolBNZ-1combriltrilPROJECTSUMMARY/ABSTRACTCliclignificnceTriplenegtivebtcncer(TNBC)motggiveubtypebtcncerpent15-20%newce(1)GivenTNBClckmoleculrexpihmlceprHER2mplifictichempymgo-ttmenpti(2)TheprognoTNBCptientgrimfterilurgery/chempyptienttenlpemettelungbrliver(3)UndertgmechnmgovernTNBCprogimettcnvelnewtrgetrpeuticterventiwhichnurgentunmetcliclneedthptientpopulti(45)RtileAuphgymetbolicprogrmhighlyutilizedTNBCcellurviveprticulrlyupexpouchempy(6)Whilegentuchchloquecnblockuphgyircliclimpctyetlizeddueunknownmechnmctixicy(78)HoweverfocugpecifickeynodegulteprogrmhighlyelectivehibirpoibleInvetigtguptmiruphgyprogrmemerggevidenceourgroupdemtrteUnc-51likeke3(ULK3)expioppoedmocommlytudiedULK1clteTNBCggiveneFurrgeneticnlyecfirmkeyroleULK3ctrollgTNBCuphgyurvivlNoULK3hibircurntlyextexcglywehvegenertednovelULK3electivehibireffectiveplimryvroexperimentHeweplnfocuourledULK3hibirRF1024teurhypoULK3trctblerpeutictrgeteffectivettmenttriplenegtivebtcncerPropoedtudieInAim1weeefficcyRF1024limgTNBCgrowthvrougimmtlizedcelllevivougtwopcliclmettticTNBCmodel(4T1SUM159)InAim2wedetermeULK3expiTNBCptientWelovetigteuphgyttuULK3levelpe/prognobiomrkerrobutdtetTNBCptientbiopieWepropoedetermetropectivetudy(ptientmple2010-dte)TNBCptientpecimencollectedtMftpurpoevlidtefirttimeULK3protepoiblebiomrkerAtccluiourtudieweexpecthvefullyterrogtedefficcynovelULK3hibircnrpidlytrnltedcliclettgttmentTNBCptientPROJECTSUMMARYOteorcom(OS)nggivemlignntprimrycncerhighpropenylungmettScedevelopmentggivechempyurgery5-yerevent-feurvivlrten-mettticptienthtted70%Inctrutcomepulmrymettticoteorcom(pOS)mpo5-yerevent-feurvivlhnotimprovedignificntlyoverpt3decde(20%)TheettgpOSeffectivelymchllengeTrnmggrowthfcr-(TGF-)emotpotentimmuneuppivecyketummicroenvirment(TME)cnpromotemettolidtumTGF-producticederOSptientThceTGF-producticltedhighgrdeOSocedpencelungmetteTheetrgetTGF-newrpeuticpprochttmentOSInthpropolwedemtrterpeuticeffectnovelhibirTGF-ignlgTEW-7197OSgrowthvrovivoocedimmunepeOSTMETEW-7197(Vcertib)firt--clmllmoleculehibirTGF-typeIRecepr(TRI)kecurntlyPheIclicltriltUHSeidmnCncerCenterMultipleMyelomndeehighTGF-(#NCT03143985)TEW-7197llyvilble(tkenqDBID)welllertedmimlideeffectOurplimrydthowblockgTGF-ignlgTEW-7197hidOSprolifertivroldmtrtiTEW-7197OS-rgmiceignificntlyducedetblhedpOSvivoOurplimryobervtihultednOrphnDrugDeigntiuthiztiFDAAugut2021wellFt-trckINDunceJnury2023ueTEW-7197OSMocentlymulti-centerpheI/IIclicltrilugVcertibmpyttmentdvncedoteorcomptientge14upengnizedplnnedccrulprg2023(#NCT05588648)t21ecroUSEuropeAiRecentlywehvemdeddilobervtiTGF-ducedc-MycexpiOScellthoeductiwecompletelyhidTEW-7197OScellc-Mycmjpro-cogenewhichhighlymplifiedOSc-MycovexpihumnOSclteggivetumcellvimettwenoverllptientcliclprognoTheeenewultuggetc-MycgultiTGF-mynimptntrpeutictrgetOSWehypoizeTGF-ignlghibimyneffectiverpeutictrtegygtmettticpOSmodifygtum-tricignlg(c-Mycgulti)extricimmune-ltedTMEchieveoptimlimmune-effecrfunctimximlcliclpepOSTocfirmthhypoweutilizevrioumouehumnOScelllePDXmodelvrovivoTwopecificimpuruedccomplhoverllobjectiveSpecificim1DetermeeffectTGF-hibic-MycgultiOScellvroSpecificim2DetermewherdilyldmtrtiTEW-7197uppepOStumprogiyngeneichumnizedmouemodelAfullyhumnizedmouemodelemployedterrogteTEW-7197effectcellulrimmunepepcliclhumnOSTMEvivoTherchetblhcriclroleTGF-ignlgpOSprogiprovidecientificrtiletrgetgTGF-ignlgllyvilblemllmoleculehibirhoulddevelopedviblerpeuticrenlpOSptientPROJECTSUMMARYThettmentprdigmnewlydignoeddiffuelrgeB-celllymphom(DLBCL)hlrgelymedunchngedunimlyppliedgimen6cycleruximbcyclophophmidedoxubicvcrtepdne(R-CHOP)Anewergimentermedehigh-rkptientplcgvcrtepoltuzumbvedot(R-pol-CHP)hcentlyhownimprovedefficcyTheromizedFLYERtudydemtrtedhtengfrtlerpyptientyoungerthn60limed-tgelow-rkDLBCL6cycleR-CHOP4cycleR-CHOPfollowed2cycleruximblepoibleequlefficcydecedxicyHowevereligibilythpprochbedp-ttmentrkementpplicblemyptientStrtifygptientdvncedtgeDLBCLlowrkirterimpecouldnewwyidentifyptientttmentde-ecltiFrgmentcircultgtumDNA(ctDNA)ctgcncer-pecificequencecnoltedptientperipherlbloodNextgenertiequencg-bedydetectctDNAhvehownpromeliquidbiopieDLBCLllowgmoleculrpeementdetectimimliduldee(MRD)Howeverechnologyhnotyetenuedl-timeAlltudiectDNADLBCLhveentropectiven-terventilthdtevolvgequencgrchivlmpleoutclicltegrtiPhedvrintenrichmentdetectiequencg(PhED-eq)whichvolvedetectifrgmentctDNAhrbgmultipleomticmuttibotlowetlimdetectivilbletechniqueIntropectivepropectivenlyeptientwhoweMRDnegtivePhED-eqfter2-3cyclefrtleDLBCLrpyexperiencedlgtermmi>90%cePtientdvncedtgeDLBCLchieveterimMRD-negtivylikelyovertted6fullcyclerpyctDNA-guidedde-ecltipprochcouldtillledcuwhileprgptientunneceryxicyttmentDemtrtgfeibilyl-timectDNAequencgdurgDLBCLrpyneedededoptgidpprochroutecliclprcticeOurcentrlhypofeiblepermterimctDNAequencgdurgtrdfrtleDLBCLrpydetermewhichptienthoulddctuechempyerlyThepropoedgle-centerpilottudyenroll8ptientnewlydignoedtgeII-IVDLBCLtended6cycleR-CHOPR-pol-CHPPtientMRD-negtivePhED-eqftercycle23de-eclteruximblecycle5-6whilellptientceive6fullcycleWevetigtefollowgim1DetermefeibilyctDNAementl-timeguidedecimkgdurgfrtlerpyDLBCL2AeoutcomeptientwhocomeundetectblectDNAdurgfrtlerpyDLBCLdctuechempyerly3Evlutefetyprileocedde-ecltedcourefrtlerpyDLBCLSUMMARYEophgeldenocrcom(EAC)motpvlenthlogicltypeeophgelmlignncyUSmnyWeternntiThtummdedlypproximtely80%ptientdignoedtdvncedtgehvelowfive-yerurvivlrteGtroeophgelfluxdee(GERD)etrgetrkfcrEACInGERDptientepilillgeophguexpoedgtroeophgelflux(GER)ctgtriccidfquentlymixedduodenlbileTheeophgelepililcellundergoeevedmgeexpoucidbileltThexpoulopromoteflmmtiwhichcnexcerbtetuedmgeleddevelopmentBrtteophgu(BE)BEpneoplticcdidpoedmlignnttrnmtiThemoleculrmechnmeophgeltumigenecdieophgelfluxjurympolyunderodWehvedevelopednnovtivehypovetigtehowolevugl(oLG)lipidderivtivedductmultipleprotecdieophgelfluxfciltetumigenicproceeprotedductiIoLGmedferdiclducedperoxidtilipidcyclooxygene(COX)highlyctivelyewellcellulrmeIoLGbdcovlentlyprotemoleculeflictdmgeegcognizedcellulrdefenemechnmInourexperimentlcdieophgelfluxp63foundemotdductedproteoLGP63mtergulreophgelepilildevelopmentwhichlogultebrodpectrumgenevolveddiffentcellulrproceeuchDNApirtemneprolifertidiffentiOurplimrydttrglyuppthypoprovidgevidenceltertip63protedductiInim1ugvrocellytemthpropolexmeuniquemechnmgultgp63ignlgpthwyprotedductibiologiclimpctcdieophgelfluxjuryInim2wetudyp63protedductivivomicemodeltetvriouphrmcologicloptiverethproceIfuccefulthtudyprovidenewrpeuticpprochpventpro-tumigenicltertieophgelcncerPROJECTSUMMARY/ABSTRACTThecentrlKRAS-ERKignlgxctivtedmothumnpncticdenocrcom(PDAC)AttempttrgetERK1ERK2ignlgn-electivekehibirhveproducedlylimedefficcyclictcotdoe-limgxicyOurbkthroughdcoverythpropolERK2notERK1neentildriverpncticcrcogenedpenblen-trnmedpncticepililcellBedthERK2pentnewpotenttrgetrpeuticterventiPDACThpropolbuilnultourcenttudiegeneticmodelmyeloidneoplmwhichwehveetblhedERK2centrlcogeniceffecrviuniqueubtrteterctidomInourERK2knock-mouegeneticmodelDdomERK2promotecncerprogiwhileERK2DBPdomoppoeprogiduceenecencecogene-trnmedcellHoweverroleERK2-DDBPdomdrivgKRAS-edPDACtumigenehnotenvetigtedHenceourcentrlhypopncticcrcogenedrivenmutntKRASdependenndom-pecificfunctiERK2WepropoefollowgimAim1ToeoppogfunctiERK2-DDBPdompncticcrcogeneOurplimryultdictecdildeletiERK2(Mpk1gene)KPCmodeldrmticllyimpedePDACdevelopmentWetercroKPCmicewhichwildtypeMpk1geneplcedD-DBP-dommutnt(knock-modelldyvilbleourlb)ppotwhichubtrtebdgpocketcriclpncticcncerdevelopmentprogiAim2DetermemechnticbwhichERK2-DDBPdomexertirdtctfunctiWegenertevromodelERK2deletiplcementD-DBP-dommuttiRNAiCRISPR-trgetgERK2PDACcellleeeffectcellgrowthMAPKpthwyignlgTheemodeleentildcoveryolfutuproteomictrncripmenlyeppotERK2domtercreentilexertgKRASmlignntphenotypellowudeciphermoleculrboppogfunctiERK2DDBPdomThrougheeftweexpectbrgnewightroleERK2ubtrtebdgmodulegultgpncticcncerprogihowexplothmtirpeuticllyGlioblm(GBM)motggivebrcnceruullyftlyerfterdignoCurntttmentpprocheprovidelymodetfewmthlifeexteniTumfiltrtgmyeloidcell(TIM)providetrgimpcntumgrowthdperlttmenttnceThecurntunmetneedGBMttmentddTIMctriumgrowtmenttncettmentprocolThegoltudyidentifymoleculrtrgetGBMttmentpprocheimedtmodultumimmunemicroenvirmentOurcenttudieidentifiedignificntup-gultiProle-RichTyroeKe2(Pyk2)GBMtumcompdhelthybrtuewellpoivecltitweenPyk2ctivtumcellcykeexpiprileTIMAddillyboumectemozolomidettmentup-gultePyk2GBMtumffectctivtitteTIMThidentifiedPyk2cidteprognoticmrkerimmunetteGBMtummicroenvirmentPlimrytudieGL261gliomcellidentifiedcellknockedoutPyk2dotleepopultiEVdimeterbiggerm600nmduceexpimocytechemottrctntprote(CCL2)CCL12vculrendoliumgrowthfcr(VEGF)EVfrcticompdPyk2WTcellCpdglyceCD86+/CD206+flmmrymyeloidcellCD8+lymphocytepopultiwefoundTIMpurifiedPyk2KOtumcompdPyk2WTtumGL261/C57Bl/6mouegliomimplnttimodelBedefdgwehypoizePyk2volvedignlggultileeflmmrycykeCCL2CCL12CCL5throughEVmechnmledgmodultiTIMcellpolriztiInthtudyweutilizemouegliomimplnttimodelprimryhumnGBMcellcultuhighlowlevelPyk2expicoupledcellbiologypprochedectrolePyk2gultibiogenecykectentgliomcellderivedEVWeloexmemouehumnvromodelmodultictivtittemicroglilcellthroughgliom-derivedEVmechnmThepurpoeprojectidentifymechnmterctitweengliomTIMcellrolePyk2ignlgthcommunictiToteurhypowepropoefollowgpecificimSpecificAim1TovetigterolePyk2leecykethroughEVmechnmGBMcellSpecificAim2TovetigterolePyk2gultict-ltedleeEVpopultiSpecificAim3ToeroleveiculrPyk2EVternliztimicroglilcellABSTRACTBtcncer(BC)complexheterogeneouneoplticdeehighcidencemtlyBCcndividedcliclhpthologicmoleculrubtypeTriple-negtivebtcncer(TNBC)ccountpproximtely15%llbtcncercechrcterizedtumdotexpetrogencepr(ER)progeterecepr(PR)humnepidermlgrowthfcrcepr2(HER2)TNBCthoughtmotggiveubtypeocedpoprognowellhighrkdtntcurncedethfirt35yerfollow-upThebenceeceprnderTNBCtntttmenttrgetgthoepthwyThuTNBCtillmneoplticdeeunmetcliclchllengeOurlbryhpvioulydemtrtedntegrltum-tricroleTAZ(trncriptilco-ctivrPDZ-bdgmotifloknownWWTR1)whichkeycompentHippoignlgpthwyfoundTNBCprogi/mettNewplimrydurlbrydictetumTAZexpihibtumprogimouemodelTNBCcellimmuneytemtctmicethudictgTAZexpiloplynunderppcedextricroleTNBCbiologyWefurrveledTAZgultecrument/functiimmuneuppivecelluchmyeloid-deriveduppcell(MDSC)mcrophgegulryTcell(Tg)TheoverllobjectivethpropolundertunderlygmoleculrmechnmwhichTAZexpumcellgulteimmuneuppivecellTNBCOurcentrlhypotumTAZexpigulteTMElcpevicro-tlktweencncercelln-cncerimmuneuppivecellOurlg-termgoldecipherTAZgultedcrotlktweenbttumcellimmunecompenttummicroenvirment(TME)uncovernewprognoticrpeutictrgetTNBCTochieveegolwepropoefollowgtwoim1)Todetermeimpcttum-tricTAZexpiimmune-TME2)ToundertmoleculrmechnmTAZexpidrivenimmuneuppivecellcrumentTMEAmjimpctthtudyidentifypvioulyundecridTAZ-mededmechnmunveilnewbiomrkermnovelrpeuticterventidvncedTNBCCncerimmunpyugcheckpotblockde(CPB)hvolutiizedcncerttmentprovidgdurblecucceptblexicyomecncerptientHoweverlyfewcncertypepdevenpdgtumtypepetenlimedmyecncerwhichquetiwherdictlytrgetgTcellufficientwherpectimmunycnexploedtimultebootntumimmunyInflmmryimmunogeniccelldethemerggnimptntimmunenodebridgentedptiveimmunytimultentumimmunywellpotenteCPBWhilenteoplticgentcurntlyuedhumncnloometimeduceflmmrycelldethhelp-etblhimmuneurveillncetummicroenvirmentegentdotpdictblyduceimmunogeniccelldehuledgvribleoutcomeThehypowepropoethprojectcnfundmentllychngethcenrioducgpdictbleimmunogeniccelldehroughtrgetgkeymoleculeknowngderm(GSDM)prticulrGSDMDwhichwidelyexpedcncercictlyduceimmunogeniccelldethupctivtiGSDMDmedepyropcykeleedowntmflmmomewhichuprmoleculrcomplexectivteflmmrycpe(cpe-1/-4/-5humncpe-1/-11mice)Activtedcpe-1proceeIL-1fmilycykeirctivemllflmmrycpecleveGSDMDproducenN-terml(NT)frgmentmpocellmembrneducepyropleeIL-1fmilycykeflmmrymedircludgATPHMGB1WepecificllypropoeidentifymllmoleculegtGSDMDdictductiimmunogenicpyropcncercellwhichmyloynergizeimmunemodulrwellCPBGSDMDwidelyexpedcncerWhileGSDMDloexpedomenmltueneedlymllfrctumcellundergopyroplertimmuneytemmymkeGSDMDgmn-xicevenwhendmtedytemicllyABSTRACTTcellplyimptntrolecncercellimmunouppiCncercellcnterctimmunecheckpotproteexpedeffecrTcellcueTcellexhutifciltegulryT(Tg)celluppieffecrTcellUndertgTcellimmunynimptntgolcncerimmunpyAlthoughimmunecheckpothibirCAR-Tcellrpiehvehowntmendoupromecurntimmunpielyneffrcticncerptientnewpprochemechnm-drivenimmunemodultineededbrodenrpeuticneflepiveptientTrgetgTgcellctivteeffecrTcellcombtcncernemerggcceptcncerimmunpyWhileytemicdepletiTgcellcncueexceiveTcellctivtiledguimmunyproperductiTgcelltbilyoutideeffectuimmunepemyopennewvenueimmunemodultiInplimrytudiewehvefoundheterozygoudeletiRhoGTPeCdc42TgcelldidnotffectTgcellhomeotnultuimmunepecueddetbiliztiTgcellelicednnti-tumimmunyPhrmcologicltrgetgCdc42mllmoleculehibirCASINmimickedCdc42heterozygoudeletidetbilizgTgcellggnnti-tumTcellimmunyCASINpotentedeffectimmunecheckpothibirtumuppioutdetectbleuimmunymiceThprojecthypoizertildeignedmllmoleculetrgetgCdc42ctivycndetbilizeTgcellmodultenti-cncerimmunpyoutflmmryideeffectInAim1determemoleculrphrmcologyCASINctiwedefemechnmctiCASINimproveCASINefficcyWecrryoutfurrmediclchemtrytudievlidteCASINderivtivepropertrgetenggementexmepotentilxicyTcellcelltypeInAim2wedemtrteprocceptCASINderivtivetrgetgCdc42mouemodeltriggernti-tumTcellimmunyWedetermexicyphrmcoketicphrmcodynmicCASINderivtiveexmeirpcliclefficciedetbilizgTgcellelicnti-tumTcellimmunylecombtiimmunecheckpothibirOverllourwketblhnovelcceptpentuefulpprochnti-cncerimmunomodultiPROJECTSUMMARY/ABSTRACTLynchyndrome(LS)motcommheredcuecoloctlcncer(CRC)ffectg~12milliAmer-icncrrie3-8xhigherlifetimeCRCrkthngenerlpopultiColocopytrtgerlydulthoodpetedyerlybiennillylycommendedurveillncetrtegywhichtrnlte~25-50lifetimecolocopieThtenivecolocopyurveillncenotidelcue)CRCrkvriewidelyLSgenegeb)colocopievivecotlynotdilycceiblellptientc)dhenceuboptimlPerlizedurveillncetrtegieLStegrten-vivetetcol-ocopywouldddlimtibrriercurntcliclprcticehvenotenpvioulytudiedToddegpthmulti-centerpropectivetrilexmepermncefeclimmunochemicltet(FIT)LSptientundergogcolocopyurveillnceInddimeurgFITtetchrctertic(pecificyenivynegtivepoivepdictivevlue)thtudyexmeLSptientttudecceptbilyn-vivetet(Aim1)ThepropolevluteperlizedurveillncetrtegieLStegrten-vivetetcolocopyugimultimodelg(Aim2)Animptntdeliverble1twell-nnottedpropectiveLSbiobnkUSfututudiepromgbiomrkerclicloutcome(Aim3)ThtudytimelycueuniqueopptunyhrmizedtUKFITLynchtudygncrument2023derevluteFITpermncelrgeterntilLScohtTkengerpropolignificntcuehpotentilchngeprdigmCRCurveil-lncederimprovelivelgevyLSptientPROJECTSUMMARY/ABSTRACTMentlideeffectchempyducequlylifettmentdogcgmtlyCurntupptivecttmenteffectivethuidentifygnewterventipvenrduceedvereideeffectcrucilWehvecentlyhypoizedgutdybiomyctriehvilideeffectchempyOurlg-termgoldevelopnovelmicrobil-bedttmentdevttgideeffectlrgegrowgpopultichempy-ttedptientThegutmicrobilcommunydrmticllyltedchempyhcentlyenhowncommunictebrffecthviIndeedwehvepvioulypublhedltedcompoigutmicrobiotduechempymicedrivecentrlytemicflmmtiultgelectivehvilideeffectThuoverllobjectivehedetermepotentilfeibilyugfeclmicrobiltrn-plnt(FMT)nterventichempyhvilideeffectThepecificimpropoedtudythobjectiveugourmuchempymodel(Aim1&2)feibilypilotclicltrilbtcncerptientceivgchempy(Aim3)Aim1quntifyefficcyhelthyFMTmelgicknecognivehvidurgchempyEfficcyuFMTlloFMTledelivedpventtiverpeuticprdigmicknecognivehvieeddurgchempyttmentmiceftermmmrytumectiAim2identifyytemicneurobiologiclclteFMTterventidurgchempyTheefficcyFMTttmentytemiccentrlflm-mryignlpecificrolemicroglieeddurgchempymiceftertumectiAim3pilotfeibilyvetigtgrpeuticpotentilFMTllevehvilgtrotetlchempyideeffecterly-tgebtcncerptientAmllgroupptientceivgchempyunderguFMTtrdcSideeffecteedefterFMTThepropoederchcceptullynovtiveourterdciplrytemfirtuenovelrpeuticFMTchempy-ducedhvilideeffectcomdbiccliclpprochTherchprojectprovidenecerymechnticcliclfoundtifutupro-polfocuedlrgercliclFMTtrilThfirtteplgmicrobilerchrchpotentillterhowcommchempydrugdmtedPROJECTSUMMARYActivtedCD8+TcellcpblepdgtumnetigencnidclerncetumIndeedCD8+Tcellcriclneficileffectimmunecheckpotblockderpiethoeptientpduchrpie(mAbCTLA-4PD-1/L1LAG3)InddiCD8+TcellmelvecndeployedrpiemCAR-TcellomehemlogiclmlignncieOrrpeuticpventtivemodlietillunderctivetudycludeexpnifuum-filtrtglymphocyte(TIL)vcctiAllepprochequieirpencetumpecificCD8+TcellwhoefuncticnugmentedknowledgebouttumnetigencndictlytrgetedrpeuticllyDepedvncetillignificntgpknowledgegrdghowtum-pecificCD8+Tcellprimedhowycrued(excluded)tumhowycomedyfunctiltummicroenvirmentOurundertgruleTcelldevelopmentfunctintigendcrimtihveengtlyenhncedugTcellceprtrngenic(TCRTg)miceTheemodelprovidetrceblepoolntigen-pecificTcellcntudiedovercourenfectiMnyvetigrhvelotkendvntgeTCRTgTcellmodelpetumntigenexpgcogntentigen(egLCMVGPOVA)trnplntbletumlegenetictummodelOnelimtiuchtudieyhvemotlyemployedn-tumntigenirpectiveTCRwhichtenpenthighffyoutlierTCR-ligpirgThethuneedddilmodelemploynturllyrgtumneo-ntigenmtchgTCROnemotcommlyuedtrnplntblemuyngeneictumleC57BL/6bckgroundMC38colcrcommodeligllyderivedC57BL/6micettedmethylcholnthneAcenttudyptedidentifictumneo-ntigenMC38modelmuttedmriboomlproteRpl18ferdhefterRpl18*pentedH-2KbWehvenowvlidtedthpentmjTcellepipeC57BL/6micergMC38tumWehveloidentifiedTCRcognizethepipecfirmedeTCRcnmedeTcellctivtieffecrfunctiWenowpropoeuetwoTCRwehveidentifiedgenerteTCRTgmouelecnuedfututudyTcellnti-tumpemouemodelTleHeterogeneougeneticrchectulungcncerrkProjectSummry/AbtrctLungcncermultifcrildeedrivenenvirmentlexpouheredgermlegeneticvrintnccumultiomticgeneticeventMotlungcncercettriedcigttemokgApproximtely10%lungcncercehvefmilyhrytlenefirt-degeltiveGenome-wideocitudie(GWAS)hveidentifiedbout45uceptibilylocidictlyfluencglungcncerrkThegeneticrchectudividulfmilyhrylungcncerdifferthoepdiclungcncerlthoughcommgeneticlocifluencgbothceThemgnudeocitweenmokglungcncerrkvriefmilyhryttuThelofmililcompentmokghviwhichmycfoundocilungcncerrkmokghedryceEchlocuhoweverexertlymodeteffectmotherbilymunexpledNewpprocheeneededddproblemmgherbilySceltivelywekignlgeneticrkfcrdifficultdetectnimprovementwouldjotlymodelmultiplegeneticfcrdetermeimpctrkUgmche-lernghigh-derterctimodelmgnumerougeneticfetuubetcedefedccdgfmilyhryttulocidergmokghvicnhelpillutrtehowegeneticvrintechtrtifiedubetjotlyfluencelungcncerrkTheoverrchgimthpropolchrcterizehddtctgeneticctriilungcncerdevelopmentprovidetterighthomogeneouheterogeneougeneticrchectulungcnceretiologycrofmilyhryttudiffentpopultiThepecificimpropoederchidentifyhierrchiclcombtimultiplegeneticvrintlungcnceruceptibilyugmche-lerngexplodepthimpctgeneticfcrlungcncerGWASEuropen-Africn-ncetrypopultiThpropolcplizeextgwellgenotype-phenotypepoiriepdicfmilillungcncerugubet-bedmche-lerngocimethoddiffentpopultiThpropolddecomphenivepprochimproveourundertghowhomogeneouheterogeneougeneticrchectubiologiclmechnmctrielungcncerdevelopmenthowpecificgeneticeffectddivedomnrceiveexpllungcncerrkFllywecnidentifyubgroupdividulthigh-rkbeddividulgeneticchrcterticpotentilimplictipventicengmngementlungcncerProjectSummry/AbtrctMnynti-cncerdietpromotedpopulrcultucncerpventtmentflectgenthumptientclicinercherlikeugdietimproveptientprognoMnyedietrycommendtihoweverpolyupptedcientificevidenceWhiledietknownctriburcncerrkhowdietfluenceurvivlptientwholdyhvecncerpolyunderodThkeydtcticuemnyptientlymotivtedmkedietrychngefterceivgcncerdignoMoovercuedietrydviceptientmutgivenctexrttmenttrtegieimptntdetermehowdietmightenhncentgizetrd--cemerggcncerrpieTheecriclneeddefemoleculrmechnmunderliedietryeffectcncerprogirpyepoibletegrtedieteffectivelycncerttmentUncovergemechnmtrnmpcinutrirpeuticpprochewhichimtildietrychngeprticulrrpietrgetpecifictumtypeRecentwkcncermetbolmhhownchngenutrientleveltummicroenvirmentkeydetermgimpctdietryterventitummetbolmgrowthperpyInterctitweenwhole-bodytumlipidmetbolmhvecentrlrolelkgdietcncerprogiLipidynizedfttycidwhichcnturtedmounturtedpolyunturteddependgnumrdoublebdyctCellulrfttycidturtightlygultedmtmembrnetructucellulrfunctiPvioudthowdietrymnipulticnlterblncetweenturtedunturtedfttycidtumThepropoederchdefemechnmwhichdietdygultetumfttycidturtittefluencetumprogirpypeMouepncticlungcncermodeluedexme(1)howclictrictidietltertum-tricpolyunturtedfttycidmetbolmdefgdietryctextunderwhichthpthwycnrpeuticllytrgeted(2)howexceiveturtedfttycidcumptiducelipoxicttumgenertetncecncerrpyverlwhichcouldtrtegyenhncerpype(3)howmnipultgfttypedietltertummetbolmgrowthpdictblemnnerprovidgtumdiffentltivemountturtedmounturtedpolyunturtedfttycidledgdietryfttype-ocedmetbolicdependenciecnrpeuticllyexploedTheetudiedefemetbolicmechnmunderlyghowdiet-ducedchngewhole-bodytumlipidmetbolmterctcncerrpieTheexpectedoutcomeetfoundtiimproveddeignfututrnltiltudieuedietryterventintiverpycncerttmentLungcncerledgcuecncer-ltedmtlyUnedStten-mllcelllungcncer(NSCLC)compover80percentlltypelungcncerThetummicroenvirmentplynimptntrolecncerprogumendolilcell(TEC)criclcompentthmicroenvirmentTEChrbmoleculrbnmliekeepmpertentctivtedttelochricllytimultedcyketummicroenvirmentInthpropolwetudyignificncemoleculrbnmlyTECducedvculrendolilgrowthfcr(VEGF)gultelevelmicroRNA(miRNA)MiRNAmll(21-22nucleotide)ncodgRNAgultegeneexpicrugmeengerRNARNA-ducedilencgcomplex(RISC)MiR-1flghipexmpletumuppmiRNAWehvepvioulyhownmiR-1levelTEColtedNSCLCptientignificntlylowerthnendolilcelloltedn-cnceroulungtueMooverovexpimiR-1pecificllyendoliumdecedtumburdenvculryKRAS-mutntP53knock-out(KP)micehowgdowngultimiR-1criclNSCLCtumngiogeneprogiAmechnticvetigtimiR-1downgultiendolilcellhowedVEGFdowngultemtumiR-1outltergtrncriptiproceglodgpcurRISCiedegrdemtumiR-1OnemmechnmelectivemtumiRNAdegrdtimodifictrimmg3endThproceproduce3miRNAvrint(omiR)AmllRNAequencgnlyVEGF-timultedendolilcellveledemergenceunique3-denylted-trimmedomiRecelluggetg3-denyltriggermiR-1degrdtiInccdthfdgVEGFtimultielectivelycedexpermlnucleotidyltrnfere2(TENT2)menzymeknowndenyltemiRNA3endTENT2expiwlocedfterVEGFtimultiTEColtedNSCLCptientWeplimrilyeedroleTENT2miR-1gultingiogenetetgeffectknockdownTheeexperimenthowedTENT2knockdowncemiR-1levelhibendolilcellprolifertidecetumburdenKPmiceBedefdgwehvehypoizedTENT2triggermiR-1degrdtiTECvin-templtedddidene3endthroughthmechnmgultetumngiogeneprogiNSCLCTotetthhypowepropoefollowgimAim1TodetermeroleTENT2miRNAdenyltidegrdtumendoliumAim2TodetermeroleendolilTENT2NSCLCtumngiogeneprogiSUMMARY/ABSTRACTRelpedpedricT-cellcutelymphoblticleukemi(T-ALL)tenfrcrycventilrpyoceddmlurvivlrtelethn25%ThudevelopmentnovelrpielpedT-ALLpentnurgentunmetmediclneedchildnAdenoedemectgRNA1(ADAR1)medecveridenoe(A)oe(I)mmmlintrncripmeMlignntADAR1ctivtiover-edgwptedextenivelypteddultcncertypeAultntenetetundertmechnmwhichADAR1-dictedA--IRNAedggultegeneexpihoweedgeventfluencetumigeneHoweverglobllcpeA--IRNAedgpedriccncerhnotenytemticllychrcterizedFulfillgthknowledgegpllowmechnticfunctiltudieeRNAedgmodificticnultimtelyidmultgnewrpeuticpventivetrtegieWedcoved70%T-ALLptientexhibhighexpiADAR1thocedignificntlyweclicloutcomeOurRNAedgnlyover260T-ALLptientveledwide-pdA--IRNAmuttilpedT-ALLcohtStrikglywefoundhibgADAR1impirmlignntT-ALLprogenirpropogtiTheedcoverieneedvlidtedlrgecohtT-ALLptientfurrdeletecriclRNAedgmuttiocedlpeTheoverllobjectivethtudylevergelrgempleizeKidFirtProgrmfullyundertheterogenouRNAedglcpeT-ALLpthogeneOurcentrlhypoADAR1promoteuniqueA--IRNAedgchngeT-ALLwhichdrivedeelperpeutictnceInthpropolwe1)defeADAR1-ctrolledA--IRNAedglcpe1304T-ALLptientcombgKidFirtNCITARGETdtet2)identifynovelRNAedgeventpdictdeeoutcome3)compRNAedglcpevrioumoleculrubtypevelnycricllktweenRNAedggeneticbckgroundOurplimrytudiepropoedwkgerprovidefirtcompleteA--IRNAedglcpeT-ALLhdpedricerchcommunyInddiweprovidenewightmechnmfunctiADAR1T-ALLpthogeneubtntillydvnceourundertgeprncripmicgultipedricmlignncieTheuccethwkvelcompheniveevlutiRNAedgnetwkprovidedvntgeleukemiexpniRNAhyper-edgeventwhichmyerventtrctiverpeutictrgetPROJECTSUMMARYMechnmfunctilcequencedietrylipidlegepecifictumgrowthcohnegliomDiffuemidlegliom(DMG)motggivebrtumchildhoodMlignntgrowthH3K27MDMGlkedducedctivyhnemethyltrnferepolycombpivecomplex2(PRC2)dimhedH3K27trimethylti(H3K27me3)pivechromtmrkH3K27M-ducedcfigurtichromtrchectuuppediffenticyclgglilprogenircelldevelopgbrThfurrccompniedcedPDGFRAignlgupptgexpnieprogenircellNeverletumcelltomeltentdiffentipotentilWehvehownthpotentilcnunmkedttmenterumphrmcologicmodelgchromtwhichdrivediffentietumcellmomtuglilcelllegeduceirtumigenicpotentilInplimrytudiewehvefound(i)diet-derivedlipidmn3-polyunturtedfttycid(n3-PUFA)quiderum-duceddiffentiH3K27DMG(ii)n3-PUFAeffectthettgocedcedH3K27me3mrkenrichmentmodiffentedglilcellpopultiducticyclgglilprogenircellpopultiThuggetpvioulyunppcedlktweenedietrylipidepigeneticmodulticelllegepecifictiAgtthbckdropourcentrlhypoPUFApthwy(pecificllyn3-PUFA)modultecellftedeciepigeneticprogrmlevntH3K27M-mededgliomgeneWetetthhypoddgthefundmentlquetiFirtwhtfunctilrolen3-PUFAelf-newllege-pecificdiffentiH3K27Mglilprogenir?Aim1ddethqueterrogtgcullktweenn3-PUFAH3K27Mgliomcellttepecificthroughcombtilo-g--functinutrientcueygle-celltrncripmicrigoulyexmefunctilctriielipidcellfteSecdwhtbiochemiclmechnmwhen3-PUFAfluenceecelltte?Aim2ddethquetichrcterizgmechnticlktweenelipidH3K27MDMGchromtlcpeexmgchromtcceibilylocipecificdtctcelllegeterrogtgPRC2ctivyPDGFRAignlgbiochemicltrgetn3-PUFAThirddoPUFAenrichmenttrtegiehverpeuticpotentilDMG?Aim3ddethquetetgnti-tumeffectn3-PUFAdietgeneticctivtiPUFApthwyH3K27MDMGPDXmodelTheetudielignedPAR-23-051ytetn3-PUFAdietryvriblemechnticllylkepigeneticmodifier/progrmH3K27MDMGcellftedecitumigenicpotentilPROJECTSUMMARY/ABSTRACTBtctructicriclcompentbtcncerttmentcuequlylifebodyimgeftermtecmyIthcomemocommpt25yergrowg340%mtecmyceHoweverSpnh-pekgLtwomenwhoundergomtecmyletlikelyundergoctructimeetctructiveurgeceiveenoughmtiboutctructiThoewhodothvectructiexperiencehighetrtedtfctigtboutirdeciHpnicLpeoplelrgetmypopultiUS(19%populti)Mot(73%)primrilypekSpnhthomemny(15%)feeluncomtbleEnglhPerdignoedcncerwhoprimrilypekSpnhidentifyLtAmericnlelikelyceiveguidele-ccdntcncerttmentShddecimkgdeciupptcnimprovettmentdecipfenceenive(rightchoicedependperpfence)TheyulthigherptientknowledgegterccdncetweenpfencettmentUntuntelymotdeciidUSEnglhdevelopedfewLtxpeopleWehvedevelopeddeciidbtctructiclledBREASTChoiceprovenefficcyeffectivenetwomizedctrolledtrilBREASTChoicewdevelopedextenivetkeholdenggementcluderkpdictimodelperlizedetimticomplictirkPtientclicinhighlyupptiveBREASTChoicehvekedSpnhlngugevericnhdeilyAim1AdptBREASTChoiceSpnh-pekgLtbtcncerurvivWeterviewSpnh-pekgLtbtcncerurvivcommuny-bedkeymntculturllydpttrnlteBREASTChoiceOurcommunyprtnerLivgBeydBtCncerLtCtrCncerhelpuidentifyprticipntThedptedolprogrmmedmobile-friendlywebeAim2AeubilyefficcydptedBREASTChoicemgSpnh-pekgLtbtcncerurvivWecductp-potevlutimgSpnh-pekgbtcncerurviv(N=50)whoueolcompleteurveyefterugSurveyeknowledgeboutbtctructidptedolubilyThtudyultfirtculturllylguticllylevntdeciidbtctructiSpnhpekgLtbtcncerurvivThedeciidmtmobilefriendlywebepoiwiderdemtiimplementticueptbledptbleThepprochweuethtudywidelypplicbledeciidodeciupptcnchSpnh-pekgLtxpopultiSummryAntibody-drugcjugte(ADC)hvedrivenvoluttmentbtcncerhoweverlg-termnefptienttillheterogeneouADCduceimmunogeniccelldethcncercellledgnticncerimmunythplykeyrolentumpeADCTherpy-ducednticncerimmunytenlimedimmunouppivemechnmpoedtummicroenvirment(TME)Ttmentbtcncercelltrtuzumb-emtne(T-DM1)nADCcueextrcellulrATPleewhichecrumentnteimmunecellprimgntumimmunyHoweverextrcellulrATPTMEquicklydegrdedimmunouppivedenoeviccertedenzymticctivieCD39CD73dmpengnticncerimmunyWehypoizeATP-pivedeliveryCD39/CD73hibirbiccid(BA)-ctgnnoprticleenblecomplementtiADCctiNPdeliveryledgynergticnticncerctittwolevelFirtlycncer-trgetgADCgenerteATPtriggerleeCD39/CD73hibirNPlytumepventgf-trgeteffectnmltueThefterleedenzymehibirpventcveriATPAdoenhncgprolggimmunogenicctiADCledgdurbletumpeWehveppdBA-ctgnnoprticleATP-pivedrugdeliveryCD39hibirARL67156(ARL)nucleotidenloguelodednnoprticlethroughterctiBAThenucleotidedrugcnleednnoprticlethroughplcementATPnucleotideInplimrytudiettmentbtcncercellT-DM1followedNP-ARLcedextrcellulrATPccentrtiducedpencedenoeCombtirpyT-DM1NP-ARLEO711/HER2-rgmicemodeledTMEnimmunotimulrylcpeThchngeimmunelcpeledexcellentimmune-medictedtumpethyngeneicmouemodelbtcncerInthpropolweexplomechnmimmunectivtiproducedATP-pivedrugdeliverynenhncenticncerctivyourpprochprovidgneffectiveferpyHER2-lowbtcncerThprojectcndictlytrnltednovelcncerimmunpyttgBCggivehighlyimmuneheterogeneouStudiethprojecttetfeibilyugBA-bednnoprticlenewdeliveryytemdrugtrgetgthuopennewerchhizdeliverynucleotide/nucleoidedrugcnttvrioudeePROJECTSUMMARYBrtummotcommmcncerchildntween0-19yergeUnedSttelrgetcuecncer-lteddethOurlgtermgolimproveoutcomechildndignoedbrtumchrcterizggermleomticeventdrivgtumigenetilevidence-bedrpiecndevelopedOurobjectivehepermntegrtivegermle-tumnlyGbrielMillerKidFirt(GMKF)X01CA267587pedricbrtumcohtidentifybothhereddenovopthogeniclikelypthogenic(P-LP)geneticvrintmyexplobleubtypgrkpdicti/rpeuticterventiDtGMKFcohtcomdwixtntequencgdtPedricBrTumAtl(PBTA)yield3849germleDNA4438tumDNA/RNAequenceThecomdcohtpneventeenbrodhlogiecluderobutly-nnottedptient-pnttrid/dyd(n=771)OurcentrlhypobothhereddenovoP-LPgermlevrintfluenceiprogipedricbrtumHeweteurhypoccomplhourobjectivetwopecificimAim1)IdentifyeherbilyrP-LPvrintpedricbrtumtriddydRglenucleotidevrint(SNV)erti-deleti(INDELS)vetigtedthroughwell-developedcomputtilpipelePthogenicyeedugourAmericnCollegeMediclGenetic(ACMG)-guidedpprochTrid/dydtudiedewhervrintheredcquiddenovoRvrintburdentetgpermedthroughcomprmultiplecncer-fecohtClicltum-biologiclcltivetudieurvivlnlyeundertkenAim2)Permtegrtivetum-nmlnlyeelucidtefunctillevncegermleP-LPvrintSomticecdhtgenepthwyleveleedenticoht(N=2558)Nextugpedrichigh-grdegliom(pHGG)modelnexpedtegrtiveilicoevluticurnrgggtegermleeventugmtchedtumDNARNAequencgpermed(N=367pHGG)Germlecopynumrvrint(CNV)identifiedherbilyeedTumequencgdtproceedthroughOpenPBTAomticwkflowdeignedevluteSNVINDELStructurlvrint(SV)muttiligntuDNAccountexpiprilemfuinoveltrncriptRNAThroughtegrtiX01CA267587pedricbrtumcohtextntchildhoodcncertructurlbirthdefectdtweexpectdvnceourundertggeneticbdivererrypedricbrtumighthegpplicblegeneticbchildhoodcdiMooverweddfirttimewherpedricbrtumgeneticrkfcrheredcquiddenovoComplethprojecthveutedpoiveimpcnfieldidentifygclicllyctiblegeneticltertieimptntcncerABSTRACTThetrgrtilepriizebccoctrolpolicyterventicommuniethighrkbccoproductexpoulowerccephrmcieocedhelthdpriePolicyeftcecceNRTquirgleigngecommunytilercouldddmultiplepublichelthTodtehveenlimedeftceNRTvilbilybccotilenvirmentGrowgoutcognicvenienceellmotbccoproductltleNRT2022NJcmefirtUSttequibccotilerellNRTWhilelwquirgNRTtpotleholdpromefurrducebccoueextentwhichthnewlwcouldhvepoiveequyimpctunknownThexplryR21projectuemixedmethodpprochundertimplementtiht-termimpctnewttewideNRTlweekgexpevidencebefocurcil/ethnicgroupctextdiverebccoenvirmentSpecificllywe1)determewherNRTcomplincevrieneighbhoodchrcterticugudcductgptilnlyeexmeocitweencomplinceneighbhooddemogrphicbccotilerdeny2)exploht-termdicrNRTlwimpctexmgtndNRTproductleNJQuleclltween20212023ThelevncepropoederchpublichelthbilyimproveextgfutuNRTpoliciewycouldpromotehelthequyducebcco-lteddpriePROJECTSUMMARYImmuneeffecrcell-ocedneuroxicyyndrome(ICANS)cluterympmocedimmunpydidnothowupp-clicltudiehenfound40-90%peopleundergogimmunpyprtcncerttmentThepurpoeICANSdetectipromptttmenthltICANSprogimimizerkbredemhernimotfedequeleICANSultgevecogniveympmcomICUtytubtipotentillydethCurnttrd--cpprochemirgICANSctbriefneurocogniveementultgnimmuneeffecrcell-ocedencephlopthy(ICE)codictiveeverycogniveimpirmentHowevercentwkhownopptunydetectICANStnerliertgethncurntlypoibleICEmirgubtleerlychngepeechlngugeuchdecedfluencycohencewdfdgdifficultiecedpetivenepeechWehvedevelopedStAffectLngugeSpeechAnly(SALSA)ytemdeigneddmternlyzepeech-bedneurocognivetetovertelepheSALSAcductcvertiptientcoudioceivedptienteverlmrkerpeechfluencyverblfluencywkgmemydeficOurlg-termgoldevelopvlidtenend--endAI-bedolutihightenylowptientproviderburdenneurocognivecengerlymnifettiICANSbedSALSApltmTheht-termobjectivepropoedtudyexmefeibilyfetybilySALSAdetectICANSpecificyenivyequltterthntrdcpropectiveclicltudy7ProjectummryProteprotetercti(PPI)plypivotlrolegultgplethbiologiclproceeirmgultihveenocedvrietydeeModernproteomicolenbledover600000PPIidentifiedpotentiltrgetwhichcnvlidtedtncdiblepceprogrmmblegene-edgpot-muttimmmlincellGivenetechnologicldvncemodultr-extrcellulrPPIhemergedemotexcgtrtegiewrdnext-genertirpeuticYetdevelopmentPPIhibirlgggfrhduccefuldrugmodlie(ntibodiemllmolecule)duechllengeocedlrgehllowtendynmicwter-expoedbdgterfceTheewepropoetudynovelPPIhibirmodlievi-hirppeptidefeturglrgebdg-urfcepidlgn-cniclloopmgntibodyprpeOurgolpervehigh-ffybdgpecificyntibodiemimickgbdg-competentcmtiCDR-H3loopequencedruptPPITherchpropoeexplo-hirpcffoldynizedourlbctentibodyloopcceptullynyequencelengthcmtilplticy(im1)Apro--ccept(PoC)tructu-guidedpprochX-rycrytltructuprotentibodydrugcomplexefollowedrtillydeignPPIhibirprogrmmedcelldeth1(PD1)immunoceprlig1(PDL1)IndeedPD1/PDL1terctihibT-celleffecrfunctiproceknowntumimmuneeviblockdehprovenneffectivetrtegyT-cellprolifertidiffentcncer-typeTovlidteourPoCcovlenthibirdeignedcrftgelectrophilicwrhedtpecificlooppoimotpotent-hirpbder(im2)Overllourtrtegycomyn-hirprgtdloop(N>12-idue)cloelymimiclrgebdgctctntibodieCDR-H3loopctehigh-ffyhibirpoigelectrophilicwrhedcovlentbdgtPPIterfceAerienovelelectrophilicwrhedevlutedtrgetdtctivelyeidue(K131)loctedtcenterPD1bdgepipeAtructuctivyoptimiztilochievedlne-cnngvlidtemotpromgcell-penetrtghirppeptidelivgcell(PBMC)ThtrtegyCDR-H3mimicrycovlent-hirpcouldpotentillygme-chngervgpeptidedrugnotblebdtightlyelectivelyextr-/trcellulrprotetenddurgpclicltudieduelckvivoctivyAultlrgenumrprotetrgetocedvrioudeecouldcomedruggblefernewpoibiliepcePPIhibirdrugdcoveryPROJECTSUMMARYFocuedUltround(FUS)powerfultechnologynowFDApprovedeverlbltivebrrpiehdemtrtednimpivefetyefficcyprilettgdeeucheentiltmBeydbltierlyhumntudiedemtrteefficcyfetynvivemicrobubble-mededblood-brbrrier(BBB)druptiFUSdvncedrpeuticpplictiInthhigh-rkhigh-wrdbiomediclengeergprojectwehveembleduniquelyqulifiedtemexplovelpplictiFUSimproveChimericAntigenReceprTcell(CAR-T)rpyglioblm(GBM)ttmentCAR-TpromgnewttmentpltmllowdictedtrgetgkillgtumcellLocllydmtedCAR-ThvedemtrtedpromgefficcygtGBMHoweverlikechempeuticgentytemicllydmtedCAR-TufferlimedccebrWehvedemtrtedpplictifocuedultround(FUS)FDApprovedmicrobubblemplifydepoiultroundenergytueducgvrietybiologicleffectUndercertultroundcdiFUScntemprilyveriblylterpermebilyBBBdeliverexogenoucompoundbrwhichhendemtrtedpcliclmodelerly-tgeclicltrilhumnWehvedevelopednultroundimge-guidedFUSrpeuticpltmpecificrodentcpblectentccurtetrgetgBBBdruptideliveryrpeuticbrneceryquimentpropoedtudieFurrmowehveidentifiedimmunogulryproteB7-H3nttrctiveCAR-TtrgetwhichhighlyexpedcliclGBMoltenotnmltueWehvedevelopedbothmuB7-H3CAR-TwhichdemtrteefficcyxenogrftmodelhumnB7-H3CAR-Twhichcurntlygevlutedphe1clicltrilfetyntumctivyurfcilyOurtemeuniquepoitudypotentilpplictiFUSimproveCAR-TrpyGBMSpecificllywehypoizeFUS-mededBBBdruptiultcedtrffickgytemicllydmtedB7-H3CAR-TGBMtumFUSrpyimproveoverllnti-tumefficcyB7-H3CAR-TmodultgimmunouppivetummicroenvirmentTheehypoedded1)firtetblhgeffectFUSvrygprmetercetrffickgB7-H3CAR-TGBMtum2)determgB7-H3CAR-TbiodtriiprolifertipertenceovertimefollowgytemicdmtrtiFUSrpyflly3)pilottudydetermeimpctFUSrpytumimmunemicroenvirmenthowthoechngeugmentB7-H3CAR-TefficcySuccethbiomediclengeergprojectwouldpvewyfurrtechnologydevelopmentwellexplticlicltrnltiynergyetwoltivelynewpowerfultechnologiemkeubtntilimpctliveGBMptientProjectSummryRectiveOxygenSpecie(ROS)producedproductoxidtivephophyltifoundelevtedmotcncerInderpventROSmededcellulrxicycncercellupgulteproductiROSdexifygenzymeuchGlutthiePeroxide4(GPx4)EentilctlyticctivyGPx4ctlyticelenocyteeiduecptedthroughpecificprogrmmgUGA-STOPcodtRNA-elenocytee(tRNASec)tRNASecquichemiclmodifictinticodtRNAmethyltrnfereAlkBH8propercognidecodgbilyUGAcodOurplimrydtdictehighlevelAlkBH8cltedweprognoticoutcomecoloctlcncerloAlkBH8ducegrowthrtducetummgbilyeverlcoloctlcncercellleHowevertpentlmotnothgknowngrdgroleAlkBH8tRNAmodificticncercellgrowthurvivlTheetudiepropoedhetendedfillcriclvoidourundertgtRNAmodificticncerFirtweuenducibleknockdownmodelAlkBH8vetigtemechnmfollowgloAlkBH8ledgrowthrtvetigtewherthmechnmcerved-vivoxenogrftmodelSecdweutilize-vrlycombntAlkBH8derdecvolutectriiechdomctlyticctivyThemtigenertedthroughetudieeeketblhnovelrpeutictrgenemotfquentlydignoeddedlietcncercrowldAbtrctPropoeddevelopmentdilyvilbleolrdiochemtrybedtetrzeligtibiothoglctirpidketichentudiedoverdecdeuniquelypowerfulolrdiochemiclllgbiomoleculeLimticcegtetrzetrn-cyclooctene(TCO)llgpcurppropreketicphyicochemiclpropertiehvepventedbroderpplictiechnologyThpropolbuildeverltechnologiclnovtictichemtryhveendevelopedgroupPIcludgmethodologytroducg18FromticmoleculeviphoctlyviC-Hctivtiromticubtutinewmethodologyprcticlclbleyntrn-cyclooctenefvbleketicphyiochemiclpropertienewmethodologiepprtifunctilizedtetrzeThroughthcollbtivetechnologypropolourgrouplevergeemethodologiedevelopmentnewolefficientrdiollgprotee-electivefhipplictieolvroInAim1wedevelopimprovedmethodyn18F-lledtrn-cycloocteneblncedctivyhydrophilicytbilyLte-tgephoomeriztilouedobthighlyctive18F-TCOwedevelopmethodologye-electivettchmentC-termucncer-trgetgproteInAim2rpidmildmethodpprti18F-lledtetrzepterdevelopedugphodoxrdilutictiPETproctructiInAim3wevlidtenewlydeveloped18F-TCO18F-tetrzeughydrophilicFAPIlighydrophobicSR142948AproteThebrpermebily18F-TCO/tetrzepterloevlutednmlrtBecuethpplictifocueolelydevelopment18F-llgtechnologietudieAim3primrilytendedprovideimptntfeedbckAim1-2whichultdeign18F-TCO18F-tetrzehighutilybroderrdiollgcommuny(wdcompheniveevluti/chrcteriztipecificpronotpermedthpplicti)Inummrywedevelopggenerlllgolboxgenerte18FlledPETgentWeimdevelopllgpcurcndilycommercilizedodevelopedtechnologiewidelyuedefficientimplellgmethodmodifybiologicllyctivemllmolecule/peptide/prote/drugwhichcouldhveignificntimpcnmediclimggdrugdcoverydevelopmentPROJECTSUMMARYImmunecheckpothibir(ICI)rpyrpeuticpprochblockpthwyhibnti-tumimmunyctivteimmuneytemfightcncerAlthoughICIrpyheenignificntucceomeptientuntuntelymoteligibleptienttillfilpdttmentSeverltudiehvehighlightedmodulrycpcymicrobilcompoigutmicrobiomewellcerrgnmdictptientpeICIOurplimrydthowhumngutcommenlBcteroideovtu8483hcpcyenhnce-PD-L1(ProgrmmedDeth-Lig1)rpygerm-fe(GF)ntibiotic-ttedmiceThelipooligocchride(LOS)Bovtumjcellurfcemoleculecomprgbout50%urfcethmicrooutermembrneTheLOSextnturllyeverldiffenttructurlnlogWehvefoundmgmnynloglipidAproducedBovtunllydelivedtetr-cyltedmophophyltedlipidA(4A-MPLA)cnpotentlyenhnceefficcy-PD-L1micewouldwefilclertumWepropoedetermewher4A-MPLAcouldervenovelrpeuticenhncgcurntcncerimmunpyrenlOurlg-termgolue4A-MPLAcombtiPD-1pthwyblockdettcncerptientprticulrlyn-pder-PD-L1leOvercourenexttwoyerweimundert1)celltypeignlgpthwywhich4A-MPLAfluenceloclytemicimprovement-PD-L1pe2)underttypecncermypdtmentGivenourplimrytudiedemtrtgeffectBovtucolicgulryTcell(Tg)wehypoizeBovtuffectgperipherlTgcoldruptgirbilytrntumimmunyTotetthhypowecompimmuneprilecelleverltuecludggutlmproprimeentericlymphnodetumdrglymphnodetumelfgnobioticntibiotic-ttedpecific-pthogen-fe(SPF)micetted4A-MPLAcompdctrolTgwelllevntcomprtmenttummicroenvirment(TME)uchCD8+CD4+TcellNKcellNKTcellBcelldendriccellM1M2mcrophgemocyticgrnulocyticmyeloid-deriveduppcellnlyzedmouetummodelimmunologicpe-PD-L1rpyout4A-MPLAFllywedetermewhichmutummodelpdthrpytterpdictcliclpplicbilyABSTRACTRomizedctrolledtril(RCT)goldtrdegterventipventgttgcncerirexternlvlidylygurnteediftrilprticipntrommpletrgetpopultiUntuntelymotcncer-ltedRCTuecveniencemplenotprobbilymplediffencetweentrilmpletrgetpopultilikelyextIfediffenceltedeffectivenettmentgtudied(effectmodifier)trilultfilgenerlizeWhileobervblediffencemyeedpotentillydjuted(egunderpentticertdemogrphicgroup)ediffencehveenhownnotcompletelyexplo-clledefficcy-effectivenegpWepounmeuddiffencetweenwhochooeprticiptenRCTwhodoenotmynimptntctriburfiluometrilultgenerlizeInthprojectwepropoedevelopttticlfrmewkquntifygpotentilimpctunmeuddiffencetweentrilmpletrgetpopultrilultTheultgenivynlyboundpotentilbttmenteffectetimtewhengenerlizgtrilmpletrgetpopultiThemethodologybedourpriwkdevelopgenivynlyeurveynpeelectibwhichimilrlycideruediffencetweenwhotudymplewhotThwkhvebrodpplicbilyydcncertrilgenerlizbilyuniverlccernromizedtrilcropplictiPROJECTSUMMARY/ABSTRACTLungcncerecddedlietcncerDepepvlenceunfvblecequencecurntrpeuticpprochelimedThepropoedtudyimundertbiologylungtumigeneueknowledgelyfoundtideveloppotentilttmentgimenlungcncerNmlcellundergofedivimquiecentThedimeriztiprtnerRB-likeE2Fmulti-vulvlclB(DREAM)complexcellcycle-gulrymultiprotecomplexthrchetrtecellquiecencecellcycleInociRBL2/p130(blm-likeprote2)E2F4DP1(E2Fdimeriztiprtner1)DREAMcomplexloclizedpromotercellcycle-gultggenepgirtrncriptiducgcellquiecenceviG0G1rtHoweverdygultiuchprocecuecellquiecenceex-entrybnmlcellprolifertilikelyledgtumiprogiNelemechnmhowDREAMcomplexrrntlygultedcncercellmeluiveComphenivepprocheemployggeneticllyengeednimlmodelundcenguggetPAF(PCNA-ocedfcr/KIAA0101/PCLAF)plycogenicrolen-mllcelllungcrcom(NSCLC)modelgDREAMcomplexIntriguglywefoundrrntlygultedclciumignlgenhnceDREAMcomplex-mededgenetrnctivtiDepeimplictiC2+ignlgcncercogenicroleC2+ignlglungcncerwepolyunderodBedplimryultwehypoizedygultedclciumignlgctrieNSCLCtumigeneviDREAMcomplexwhichppertrgetblevulnerbilylungcncerThehypotetedpurugtwopecificimAim1TodetermerpeuticimpctNFAThibirlungtumigeneAim2TodectmechnmNFAT-mededlungtumigeneCompletgpropoederchexpecteddvncedevelopmentnewpprochttglungcncerbednoveltrgetblemoleculrmechnmvolvedlungtumigenePROJECTSUMMARYLungcncerledgcuecncerdethUnedStten-mllcelllungcncer(NSCLC)gmjubtypeccountgpproximtely85%ceEffectivettmentNSCLCcurntlylckgduecomplexymoleculrubtypecompleteundertgunderlygmechnmRNAN6-methyldenoe(m6A)modificticglycognizedgdegultedhumncncerhoweverpecificm6AeventNSCLCyetidentifiedWefoundelevtedm6Amodificti7SKmllnuclerRNANSCLCcellNSCLCmouemodelTrgetedductim6A-7SKhibNSCLCcellgrowthtgrcolymtiy7SKgulteRNAPolymereII(PolII)trncripticentrlplyerctrollgPolIItrncriptilpugelgtiTheem6Amodificti7SKmyunderlieNSCLCmtiphenotypeThegolthtudydectmoleculrpthwygultem6A-7SKdeciphermechnmwhichm6A-7SKffectgenegulrynetwkNSCLCThefirtimidentifym6Aeugl-timePCR-bedm6Adetectiyidentifywrerererenzyme7SKhthirpRNAknockdownTheecdimdetermehowm6A-7SKfluencegeneexpiNSCLCmtiCRISPRdCRx-ALKBH5fuiproteuedmodultem6A-7SKNSCLCcellcellprolifertimigrtiyemployedTodetermemoleculrdetilm6A-7SK-mededgenegultiSHAPE-MPequencgprotructum6A-7SKncentRNA-eqChIP-eqPolIIChIRP-eq7SKpermedurveytrncriptilprogrmNSCLCcelldiffentlevelm6A-7SKTheultthtudyvelnovelmoleculrdetilm6Amodificti7SKhowygultecncergeneexpiThmtiprovidebfutuerchdevelopnovelNSCLCrpeuticltergRNAm6AlevelLungcncerledgcuecncer-ltedmtlyUSccountgpproximtely15cncer-lteddethApproximtely80%lungcncerttriblecigttemokgAnnulLow-DoeComputedTomogrphycenglungcncer(hefterferdLungCncerScengLCS)commendedUSPventiveServiceTkFce(USPSTF)DepeevidenceeffectiveneUSPSTFcommendtiimplementtiLCScliclprcticehenexceedglylimedly65%eligibledividulcened2020mjhelthequieLCSltedrce/ethnicyocioecomicttuThelg-termgolthprogrmerchcechLCStclemglowourcehelthcettgpopultihveenhricllymrglizedThepropoedprojectLungSMARTUwopheSequentilMultipleAignmentRomizedTril(SMART)cductedUthCommunyHelthCenter(CHC)Uthh14CHCytem50primrycclicEchUthCHCFederllyQulifiedHelthCenterprovidgcompheniveprimryc>160000ptientnnullyUthCHCptient50%L8%NtiveAmericn38%tervedlngugethnEnglh61%<100%federlpovertylevel45%unud41%clicrurl(RUCC>4)LungSMARTUthguidedcomphenivecceptulfrmewkdeigneddictlyddLCSimplementtichllengeenuequbleimplementtiducehelthequieLungSMARTUthutilizePopultiHelthMngement(PHM)frmewkwhichclblecceibleutbletelehelerventiuedenggeptientLCSPhe1SMARTlevergeubiquiutechnologieenbleCHCptienteedLCSeligibilyenggeShdDeciMkg(SDM)ifeligibleferdLCSPhe2SMARTtettelehelerventideignedddlogticlbrrierhencyroundcompletgLCSmgferdptientLungSMARTUthlevergemrtphe/ternettechnologiewhenvilbleloupptptientwhoelytelehelthcnectivycellpheAcentrlizedHunbleeligibilyementSDMclicldeciupptcengferrlcenglogtictncetclehelpovercomenumerouocildetermnthelhtimpctlowourceettghricllymrglizedpopultiAlltudyproceduterventicductedEnglhSpnhbedptientpferdlngugeInumLungSMARTUthcductedl-wldctextcromultipledependenthelthcdeliveryytemlimedource(ieCHC)mghricllymrglizedpopulti(ielowSESrurlL)LungSMARTUthprovidecriclevidence-belrge-cleimplementterventideignedducehelthequieLCStCHClowourceettgntiwideActivtiwild-type(wt)p53tumuppufficientkilltumcellevenifgenedefectpentCpltp53-dependentdrughevilyuedttgcncerHowevereverlcncerhrbgpdomntlywt-p53nefifnyht-livedFtncepertecpltClerCellovrincncer(OvC)ub-typelow25%ultgnoverllurvivlly10%ThucplttnceignificntimpedimentthhctednunmetneedidentifynoveltrtegiewouldledtrgetedrpeuticoptirtildevelopmentgtfrcryOvCdeeAmjfcrtncelop53functinotnecerilythroughmuttiThpropolfocuedwt-p53cenowcutewneourwkthoethgenotypeubiquiumnydvncedclicllytntcnceruchmeoliomoteo-rcomInthpropolourfocufrcryOvChrbgwt-p53whichgenotypepentpdomntly(~90%)rOvCub-typectutg30%llovrincncerImptntlyeub-typeoccurtnerliergeedethobervedyoungerwomenButcurntrpyeub-typemempiriclduelrgelyproundknowledgegpextthdeeWehveetblhedtumcellcometntcpltwhenthdrugfilctivtewt-p53dueilencgpecifickevlp53phophyltip53-dependenttrnctivtifunctiNmllywt-p53mtednctivetteendogenounturlhibirThectivyprtillyleedp53throughphrmcologicltrgetguchhibirhoweverufficientexceedcriclthholdpopticfunctiScep53phophyltivlfullyfunctilizgp53popticfunctiwepropoenovelhypotrgetedductiMDM4fullyleep53llowccecriclp53-eendogenouctiveke()ducephophyltiWetetthhypothroughtwopecificim1)Etblhblphophyltip53trgetgMDM4frcryOvCub-typetummodelvrovivo2)Identifyctivekephophyltep53epotentilrolerpyWeutilizephrmcologicoldefetumenivyfollowgMDM4modultibiochemiclmoleculrolidentifymodultekedeletebverlcplttncegrphicllymodelntumeffectrtilcombtietblhynergyThhigh-rkprojecthpotentiletblhcceptulfoundtirpeuticctivtiwt-p53rOvCenblefollow-uptudielikelychngetrjecryttmenutcomelrgenumrptientdignoedcplt-tntOvCub-typeImptntlyhighpotentilthutcomepropoedtudielikelytumgnoticubtntillyimpctwiderpectrumwt-p53cncertntdrugAbtrctPncticcncerlow-growgdee5-yerurvivlrtepproximtely9%Itfourthledgcuecncer-lteddethUSCurntlyuedpncticcncerdrugnotveryeffectiveexhibeveideeffectPtientdevelopdrugtnceultimtelycncerlpeduegenerticncertemcell(CSC)whichplyignificntroletumipromotimettchempyfiluThunurgentneeddevelopnewn-xicdrugimprovepncticcncerptientoutcomeSpecilAT-richbdgprote2(SATB2)nuclermtrixprotectkeygulrgeneexpichromtmodelgSATB2highlyexpedpncticcncercellCSCnothumnpncticnmlductlepililcellNnogtrncriptifcrhighlyexpedmouehumnpluripotenttemcellNnogovexpihendetectedcncerCSCcltedcellprolifertumcurnceclogenicdevelopmenttumigenicyvivenetncechempySTAB2plyignificntrolepluripotencyelf-newltemcellhibpncticcncercellgrowthSATB2gulteexpipluripotencymtgelf-newlfcr(Oct-4Sox-2NnogcMycKLF4)FurrmoovexpiSATB2geneducemlignnttrnmtihibiSATB2expihRNAhibpncticcncergrowthuggetgcogenicroleSATB2pncticcncerUntuntelynomllgnicmolecule-bedFDA-pprovedSATB2hibirmrketThemobjectivethpplictiidentifyvlidteSATB2hibirttmentpncticcncerugmoleculrdockgmoleculrdynmicimultivrocellcultupprocheOurhypoSATB2hibiruppepncticcncergrowthhibgNnogexpiAim1TopermmoleculrcengdockgtudiefdelectiveSATB2hibirAim2ToexmemoleculrmechnmwhichSATB2hibirupphumnpncticcncergrowthvroMoleculrdockgtudiemoleculrdynmicimultiQikPropnlypermedidentifyn-xicdrug-likeelectiveSATB2hibirBidgidueSATB2whichterctpecificcompound(SATB2hibirmllgnicmolecule)loidentifiedTheeffectSATB2hibirbdgSATB2proteNnogtrncripticellvibilypoppheroidcolymtiepilil-meenchymltrni(EMT)exmedTheeffectSATB2hibirexpipluripotencyelf-newlgene(Oct-4Sox-2KLF-4cMycNnog)temcellmrker(CD24CD44CD133)meudqRT-PCR/weternblotnlySATB2bdgprtner/trgetidentifiedChromtImmunopciptiSequencg(ChIP-eq)Inccluiourtudiehighlynovtiveferignificntpcliclnefdevelopgn-xicSATB2hibirttmentpncticcncerAbtrctImmunpypromgrpeutictrtegymnycncerAnti-tumimmunepeelicedgtnetigengeneticltertitumcellgiveperipeptideimmuneytemcognizen-elfttckkillgtumcellhrbgmCncerhighmuttillodgenerllynefimmunecheckpotrpyomeolidmlignncielikepncticcncerhvelowmuttilburdenhmperimmunpyOnetrtegyovercomethlimtideliverexogenounetigencncercellHewepropoenpprochuetumpenetrtgpeptideiRGDdelivernetigenpnctictumUnlikecventilRGDpeptideiRGDnlybletrgettumvcultuthroughvtegrloextrvtepenetrtetumtuevineuropil-1delivergcjugtedco-dmteddrugpeptidePncticcncerlgtermurvivtenhvenetigenmimiccommvirlepipeuggetgpoibilyedividulnefednimmunepegtnetigenmimicvirlcompentWepoiRGD-mededdeliveryentigenpnctictumdictp-extgntivirlimmunygtmFthpurpoeweuepeptidectivtgcymegloviru(CMV)-pecificTcellCMV-herpevirufect>60%popultielictrgimmunepeccountg>10%llcircultgCD4CD8TcellOurplimrydthowmiceltentlyfectedCMVctgthopicpnctictumpdttmentiRGDpluCMVpeptidetumgiocedcednecromrkedTcellfiltrtiHewepropoeexperimentdetermenthopicpnctictummouemodelwhttnetigenoptimlttmentcdichievglgltgtumgi(Aim1)WeloepenceCMVpecificTcellhumnpnctictumnecerytepwrdeventultrnltbilythpproch(Aim2)PROJECTABSTRACTHodgkLymphom(HL)cncerwhoeprciplrpieocedncedrkcrdiopulmrycomplicticebrovculrdeewhencompdiblgReducedcrdiopulmryfunctilervelungmbidyocedponeurocogniveoutcomeThepthophyiologyhowHLttmentcrdiopulmrycomplictiltedcedcebrovculrneurocogniverknotwellunderodWehypoizeimpidgulticebrlbloodflow(CBF)whichprimrilydrivenoxygencrbdioxidelevelbloodcuedimpidgdiffuilungducedcrdiopulmryfunctifunctilerveThepecificimtherch1)evlutehowCBFoxygentichngedurgexerceurvivcompdctrol2)exmeifCO2clerncedifferurvivcompdctroldurgtexerce3)exmeocimgCBFducedcrdiopulmryfunctilervecrdiopulmryfunctineurocogniveoutcomeHLurvivThtudyutilizecro-ectilementcommunyctroldulturvivHLwhowettedbleomyc/chetneckrdiPrticipntcruedStJudeLifetimeCoht(SJLIFE)tudyAprtthtudyyundergocompletepulmryfunctetechocrdiogrmneurocognivetetgInddhtrdtetgCBFeedimmedelypridurgcrdiopulmryexerceugwerblenerfrdpectrocopyytemPrticipntcompletemximl(100%pdictedhertrte)crdiopulmryexercetetgctuou12-ledelectrocrdiogrm(ECG)mirgExpidgcollectedtwo-wyn-brvlvemidctuoulyugbth--bthgnlyytemevlutecrdiopulmryfunctilervelungventiltigdiffuimeuDemogrphicttmentfcrcompdcrdiopulmryfunctilerveoutcomeGdiffui(ETCO2/DLCO)CBFcompdtweenHLurvivcommunyctrolidentifieddiffencefencedchempychetneckrdidoepulmryfunctetECGneurocognivetetgThtudyimproveourundertgltihiptweencrdiopulmryhelthfunctilerveCBFgultilte-etneurocogniveimpirmentHLurvivThcntrnltedimprovedcengmirgdevelopmentterventiducecncerltedlte-effectProjectSummry/AbtrctSynticlethlycenholdgtpromecncerrpyceyenbleidentifictichemiclcompoundelectivelytrgettumcellwhileprgnmltueThpprochpumecncercellhrbgpecificmuttimoenivemnipulticertpthwythnnmlcelllckmuttiThevHippel-Ldu(VHL)tum-uppgenefunctillylotbout90%ClerCellRenlCellCrcom(ccRCC)BecueVHL-deficientccRCCtcurntrpiefquentlymettizeidentifygeffectivenewrpiecrucilchievglg-ltgpeThprojectlg-termgolrpeuticllytrgetVHL-deficientccRCCugynticlethlypprochmovemotpromgrpeuticclicltrilHewepropoevetigtecycl-dependentke(CDK)hibirynticlethly-bedrpeutictrgetgccRCCWehvevlidtedmulti-CDKhibirDciclibrpeuticcidtepotentvivoctivyptient-derivedxenogrft(PDX)-bedthopicmouemodelccRCCOurplimrydtdicteeverlpecificCDK9hibir(CDK9i)AZD4573NVP-2KB-0742mimicDciclib-duceddethVHL-deficientcellvroCDK9pentpromgrpeutictrgetce(1)n-cniclCDKgultgRNApolymereII-mededtrncripti(2)multipleCDK9ihveendevelopedeverlundergogclicltrilcncerthnccRCCAccdglyourgolevluteAZD4573potentilrpeuticccRCCOurobjectivedectmechnmynticlethlyvroeAZD4573efficcyvivocludgeffectnti-tumimmunyWepropoefollowgSpecificAim1)DectmechnmynticlethlyCDK9hibiVHLlovrowhewetethypocro-tlktweenVHLCDK9pthwyffectgechctivyWelotetvolvementeverlcidtepthwydowntmCDK9(MCL-1Bfl-1pro-urvivlprote)VHL(HIF-1HIF-2)ynticlethlydetermebiomrkertumpe2)EvluteCDKhibirAZD4573potentilrpeuticnthopicPDX-bedimmunocompetentmodelccRCClttercductedcombtiimmunecheckpothibir(ICI)nti-PD1ICIpentcurntfrt-lettmentccRCClertudicteCDKhibiDciclibpecificCDK9iducenti-tumimmunypotentgirnti-tumeffectAccdglyourwkghypoCDK9ilowtumgrowthimmunodeficientmodelcuetumgiimmunocompetentmodelepecillywhencomdICISuccefulcompletiexperimentlplnprovidenefficientrpeutictrtegyVHL-deficientccRCCCDK9i+ICIcombttmentDectgmechnmynticlethlyllowptienttrtifictipotentilpdern-pderOvrincncerdedlietgynecologiccncer~20000newcepdicted2023Althoughfirt-lettmentpltumcompoundtxneyieldpertemothn80%dvncedovrincncermedintimeprogi-feurvivlly18mthRettmentcnpermedfterlpechemotncecomemjueTheenewoptittmentbothprimrylpedovrincncerurgentlyneededTheNotchignlgpthwygultecellprolifertidiffentiArrntNotchctivtiplyroleiprogichemotncevrietycncertypeDtTheCncerGenomeAtlvelNotch-pthwyrrtioce22%high-grdeerouovrincncerNotchpthwydrupticnenizeovrintumcellpltum-bedrpyAccdglydrughibNotchignlggtvluettmentNotch-ocedovrincncerTodteutilyNotch-pthwyhibirlimeddoe-dependentf-trgetxicieMotNotchhibitrtegiehvefocuedlevelNotchceprctivtiWehypoizedmodultgterctiRBPJoleNotchtrncriptileffecrgenetrgetwouldprovidementervenellNotch-ocedcncergrdlemechnmrrntpthwyctivtiWedcovedFDA-pproveddrugurnpotentNotchpthwyhibirMooverwefoundurnterctynergticllycpltpfentillyducgvibilyhighNotch-expgovrincncercellInthpropoedtudyweuediffentpcliclmodeltetutilyurncpltcottmenttrgetedovrincncerrpyWeuecollectiovrincncercellleexmehowleveldiffentNotchceprligimpcturnpeWeloueptient-derivedtumgnoid(PDO)ptient-derivedxenogrft(PDX)mouemodelexmeurncpltynergy3-DcultuperinelenvirmentWelotudyhowurnimpctcncertem-cellexpnicncerlpeTheimpctetudieifuccefulignificntourpropolhpotentilpurpoenFDA-pprovedgentimmededeploymenttrgetedrpybothprimrylpedovrincncerNotch-dependentTRANSLATIONOFNONINVASIVEMETABOLICBIOMARKERSTOTARGETEDTHERAPYFORCANCERPROJECTSUMMARY/ABSTRACTThegeneticmuttimkelivgcellcomecncerproducefultyignlgccdeltercellmetbolicproceemetboleThmetbolicprogrmmgclledWrburgeffectpentmotcncerItdemtrtedprimrilycedlcttemtiglucoedepeproperoxy-gentifunctilmichdriInddimcromoleculepcurfvgcellgrowthdiviloced(eglneproteyn)Notblynewcncerrpietrgetefultyc-cdeThuuccefulttmentetrgetedrpiemutmodifymetbolectenttumFexmpleBruntyroeke(BTK)hyperctivemntlecelllymphom(MCL)lterB-cellceprignlgccdeThuhyperctiveBTKfvcncerproceecludgWrburgeffectTheeBTKhibi(BTKi)potentilttmentchoiceMCLOurpclicltudiehowedlcttelneductiBTKi-enivehumnMCLcelllecul-tuMCLxenogrftIncomprMCLmodelunpiveBTKidothowemetbolicchngeNotblyemetbolicchngedurgeffectiveBTKirpypcedeobjectiveevidencetumperpy(ieductivibilycultudcellletumvolumexenogrft)OuroverllgoleclicltrnltbilyourpclicltudieThuourcentrlhypotteltedtumctentlcttelneBTKi-enivetumMCLptientpcedeductumburdenupptgirpotentiluepdictivebiomrkerpeHoweverteurhypoweimefeibilymeurglcttelnetumMCLptientOurgrouphhelpeddevelopimproverobutmgneticncepectrocopicimggmethodHdmrd-electivemultiplequntumcohence(Hd-Sel-MQC)WedptedthmethodmeulcttelneelectivelymkgimplifiedevlutiWrburgeffectAddillyHd-Sel-MQCnmicllyloclizelcttelnellowgirnviveementtumirplcebody(ieu)FurrmowehvetrnferdHd-Sel-MQCcliclwhole-bodymgnetico-nnceimgercentlyimprovedpplictihumnubject(Lee2022doi101088/2057-1976/c57dLee2022doi101016/jmri202208020)Wetudy15helthyvolunteer30MCLptientthfeibilyprojectOurpecificgolenuMRSIexmchieveproperlocliztumignltpectrlquly(ieimprovedB0-himmgwterlipiduppi)irpectivebodyprttudiedInddiwepypecilttentumroehowcrdicpirtimovementffectexmdetermetwymimizeireffectAmjimpedimentttmentglioblm(GBM)extenivetrtumlheterogeneyEchGBMtumheterogeneoupectgeneticimmunemicroenvirmenttumcelltteInprticulrgle-cellRNA-equencg(cRNA-eq)hveledechGBMmixtudiffenttypetumcellechdiffentbiologiclpropertiecelltteCequentlymyneceryttechptientperlizeddrugcombtiAlthoughcRNA-eqhenbleduundertcomplexyGBMcliclpotentillrgelyuntppedThprtlycuedifficultphyicllyoltetudycelltypedcovedugcRNA-eqInpviouwkwehowedcellurfcemrkeridentifiedthroughcRNA-eqcnuedpurifytumubpopultiugflowtgBuildgthwepropoenovelpprocholtgGBMcellpopultitudygirrpeuticvulnerbilieidentifygperlizeddrugcombtitrgetmultiplecellpopultiimultneoulyOurpprochbedCITE-eq(CellulrIndexgTrncripmeEpipeSequencg)nextenicRNA-eqenbleuefficientlydefetumcellpopultioltemugflowtgWetetdrugenivieechcellpopultinidentifycombtidrugmoeffectivelyerdictetumThpprochdevelopedthroughtwoSpecificAim(1)WeoltechrcterizeGBMubpopultiugCITE-eqflowtgUgourplimrycRNA-eqdtweidentifiedpnelcidtecell-urfcemrkerknownGBMubpopultiUgoligo-cjugtedntibodieeputtivemrkerwepermCITE-eqprimrytummtchedcellledetermewhichmrkerclenlydtguhmgtumcellpopultiUgmotpromgmrkerweteptimizeourbilyeprteGBMmpledtctubpopultiugflowtgIndogowetethypoexttbleGBMcellttepertfterflowtg(2)Wepermdrug-cengflow-tedGBMubpopultiidentifyperlizeddrugcombtiTothendweolteeverlubpopultiechfivecellleugflowtgntetechubpopulti(wellflow-throughuntedcellle)enivyech960FDA-pproveddrugcludgtemozolomide(curnttrdc)pecificcombtiTheultgdrugenivymtrixnlyzedugclutergmchelerngtechniqueidentifydrugwhenuedcombtrgetmultipleGBMubpopultichievegterefficcythngledrugleIfthpprochpromgpilotexperimentweultimtelyhopeexpdptclicowecndilyidentifydrugcombtinydividultumPROJECTSUMMARYFewrpiehveyetchievedurblemidvncedtgetriplenegtivebtcncer(TNBC)OnepromgpprochimproveclicloutcomecommultiplechempietimultenntumpeAnunderlygpmethpprochelectchempieenhnceTNBCimmunogenicytimultgnti-tumimmunepeimprovgtumgrowthctrolWihtrtegymdwehvedcovedhibgepigeneticgulrBPTFnucleoomemodelerNURFeirgeneticllyphrmcologicllynovelpprochimprovgTNBCimmunogenicyInthpropolwenowhowugtwodiffentTNBCtummodelwhenBPTFdepleticomdDNAmethyltrnferehibir(DNMTi)Gudec(Gud)wefurrtimultetumcellimmunogenicydrmticllyimprovetumgrowthctrolimmunecompetentnotimmunecompromedmiceGenomewidenlyhowcombtirpyenhnceimmunetimulrypthwynenrichmentimmunetimulrycykeThuugnovelcombtipprochwehypoizeBPTFdepleti/hibiynergizeimmunetimultgrpietrgetgepigeneticfcr(Gudec)TNBCttmentimprovgrpeuticoutcomeInAim1identifyimmunectiveeffecrcellquidntumeffectGud+BPTFdepletiugmoueE0771TNBCtummodelAddilflowcymetryexvivoimmunecellychrcterizefurrdefeimmunecellquidentumctivieTheBPTFhibirBZ1+GuduedprlleltumtudieugE0771modeldetermeifhvivoctivymoleculrtudie(RNA-SeqATAC-Seq)FACStedE0771tumcelldetermeifhimilreffectBPTFKOHumnizedmouemodelTNBCPDXmplevlidtetrnltbilyefdgInAim2weoptimizedrug-likepropertieourecdgenertiledBPTFhibirVlidtgrpeuticpotentilBPTFhibihenignificntlylimedduelckpotenthibirBPTFOurfirtgenertiBPTFbromodomhibirAU1whileeffectiveilvlidtiBPTFhibicellvivopophyiochemiclpropertiemodetctivyvivohvelimedfurrvlidtiBPTFdrugtrgetUgtructu-beddeignwehvenowdevelopedecdhighlypotenthibirerieHewefocuoptimizgdrug-likepropertieugbotblhedbiophyiclcell-bedytrnlteourfdgourvivomodelytemAim1ThecompletieAimdeepenourundertgcncercellepigeneticcncercellimmunogenicychrcterizgeffecthibgchromtfcrNURFcombtiDNMTiOurpprochfurrdeignedenhncentumimmunyTNBCimprovgrpyducedtumimmunogenicythroughcombtiepigeneticrpyABSTRACTBloodcncerccountpproximtely10%llmlignnciellogeneicmrrowtrnplntti(BMT)pferdcurtiverpyeerioucdiWhilerpeuticpotentilthproceduliegrft-veru-leukemi(GVL)effectwhichdTNKcellerdictehotmlignncyBMToutcomelimedtrnplnt-ltedcomplictimlygrft-veru-hotdee(GVHD)whichdTcellttckhotnmltueopptunticfectiIndeed15-20%BMTptientdevelopeveGVHDftlprticulrlywhenvolvggtrotetltrcthoweverlpeprimrymlignncytillhigheventullypiblemjy(40-60%)trnplntfiludethCurntpventtmentGVHDwhichlybroduppiTcellbteGVLeffectThuimmunologiclterventimimizeGVHDpromotgGVLunmetneedBMTTheimtenncedTcellpedependennlltigenpenttintigen-pentgcell(APC)AlthoughcentlytypeAPCduceenhnceGVHDimmunologiclmechnmhveenelucidtedirroleGVLpenceGVL-pecificAPCmunknownInthpropolwefocuGVL-quirgAPCenhnceGVLpcentleukemilpeInprticulrwebuildourplimrydttethypodTcellprimedtextrmedullryemigrteBMwheirnti-leukemiccpcymtedvilltigenpentticipienttromlAPCWeutilizecuttg-edgemechnticpcliclmutudieugdvncedflowcymetrymultiplexedimmunluocencemicrocopyRNASeqREAP/CITE-equndertntigenpenttiquideffectiveGVLlpepventiFllywetetnovelttenutedynticIL-18tntIL-18bdgprote(decoytnt(DR-18))henfuedCXCR4nnobodyCD117ntibodyelectivelyenhnceIFNgntigenpenttilocllymrrowThepropollednewclicllytrctblepprochelectivelypromoteGVLpventlpefterllogeneicBMTPROJECTSUMMARYAnlcncerpentpproximtely~10%llolidcncermgpeopleHIV(PWH)pible~4%llmtlythgrouppentgmjmbidyburdenthpopultiScengnlpcncerouleittgetumhenprovenpventvivecncerfercliclopptunyddgthemerggdeeHowevertrdcengtet(nlcylogyhigh-rkHPVtetg)hveverypopecificyledgburdenomevivecfirmrytetgToddthwehveidentifiedgenomiclterticnidentifynlhigh-grdequmoutpilillei(HSIL)immedepcurvivecncerpotentillygterccurcytlowercotthntrdcengtetHoweverpplicthpprochcenghnotyetenvetigtedTheSpecificAimtherchpropol(1)comppermncecybruh-bednovelgenomictetdetectiHSILtrdcpropectivecohtpeopleHIV(PWH)thighrknlcncer(2)identifygenomicltertiocedggiveHSILleidevelopclifierpdictleimolikelycurToddeAimweenrollpropectivecoht250PWHnlcncercenglgudldtcollectiThprojectvlidtegenomicpnelidentifyHSILcomptrdccengwellidentifybiomrkeroceHSILcurnceThpplictiloupptDrRichrdSilvercerdevelopmentndependentptient-ientedvetigrfieldnlcncermgpeopleHIVDrSilvercergolcomelederdevelopgnoveltrtegieidentifictipventinlcncermgPWHThepropoedcerdevelopmentplntegrte-depthmenrgtemenicienttclicindvncedcourewkerchdeignnlycncergenomicbiomrkerdevelopmentexperientillerngthroughcductpropoederchhighlyupptiveenvirmentThemenrhiptemwhichcludedependentvetigrexteniveexperteerchcncermgpeopleHIVwellgenomiccncerguidecidteerchcerdevelopmentAtccluhprojectDrSilverwellpoiedcomendependentphyicin-vetigrtudygbiologiclcliclueltednlcncermgpeopleHIVSummryStrd--cttmentmotrcomchildhoodcncercludehigh-doenthrcycleprticulrdoxubic(DOXO)DOXOcueirprbledmgenmltueepecillyhertlte-etcrdiomyopthyeledgcuedethmgchildhoodcncerurvivInddilpecommptientrcomfewerthn20%ptientwholpecncudExperimentlrpietenirlyopticrdioxicyprimryrpyctemjcliclchllengeeptientvetigtildrugdrugcombtilpeddeecnnotcurddilcrdioxiceffectUntuntelypriiknowledgeboutpotentilcrdioxicyvetigtilgentcombtilmotnevervilbleThucriclneeddeveloppcliclmodelcnliblyecrdioxiceffectexperimentlrpieeydvncedclicltrilptientInthpropolwecomourmulti-dciplryexpertecologycrdiologydeveloplecrdioxicttmenptiptientlpedEwgrcom(EwS)Wecommouexenogrftmodelzebrfhmllmoleculeceng(1)improveourbilypdictcrdioxiceffectcombtirpie(2)ccelerteidentifictrnltieffectivecombtidrugrpie(3)identifymllmoleculecombtinti-tumctivydecedcrdioxicyEwSnggivetumpekdolecenceTumcricllydependennepigeneticprogrmmgbundntpclicldtourowngrouphvehownpromeepigeneticmodifiervetigtilgentEwSptientHoweverepigeneticgentnoteffectiveglegentcombtipprocheneededThepotentilcrdioxiceffectmotepigeneticdrugeirlecombtiyetunknownStudiethprojectfocutetgepigeneticgentlecombticlrubic(ACLA)mimllycrdioxicnthrcycleequivlentnti-tumefficcyDOXOThecombtibromodomhibi(BETi)ACLAvetigtedpriybothmouezebrfhAnti-tumefficcypecificllyevlutedmicecrdioxicyeedbothnimlmodelDemtrtiddednti-neoplticctivybenceddedcrdioxicyupptdvncgBETipluACLAclicltrilptientlpedEwSBeydBEThpropoltkedvntgelrge-clecengzebrfhytemticllytetlrgeepigeneticmllmoleculelibrrycrdioxicycombtinthrcycleBycro-vlidtgctivieepigeneticcompoundourtwovivomodelweccelertepthclicltrilcelikelihoodnewpotentildrugrpiehvelecrdioxicycedimpctptientTheefficcycurntcncerimmunpielimedtermupfrtpiveneubetttedptientdurbilypeSignificnteftgmdeceupfrtpivenemoptientcombtirpieHoweverenhncgdurbilypectueignificntcliclchllengeThedurbilypecncerimmunpielimedmtiimmunologiclmemyourundertgimmunecellbiologyufficientlckgfeeffectivewyenhnceTcellmemyphenotypeCD4+Tcellplyimptntrolemedgnti-tumimmunepetermhelpercyxicimptntlymemyfunctiInprticulrCD4+Tubetuchcentrlmemy(cm)CD4+TcellwelletblhedpromotgimmunologiclmemydurgpthologiclcdiuchfecticncerLowmemyTcellpopultimjunderlygtrnientnti-tumimmunypeimmunpieEftimedtpecificllycgmemyCD4+TcellpopulticludedoptivecelltrnferwhichvolveexvivotgtrtumlmemyTcellfollowedfuiptientHoweverthpprochlimedbelepucytrtumlTcellSfeeffectivewycebundncefnectivymemyCD4+TcelllckgpentnurgentunmetcliclneedWecentlydcovedthrldmtrtidietryugrL-fucoe(L-fuc)melnom-rgmicecetrtumlimmunecellupptumgrowth(Leteretl2023NtuCncer)Wedeletedkeymechnmunderlygthimmune-medednti-tumctivylL-fuccefucoyltum-expedMHC-IIproteHLA-DRB1promotgcellurfceccumultriggergCD4+Tcell-mededcetrtumlimmunecelltumuppiNotblylL-fucltertrtumlCD4+TcellprilepecificllycgcmCD4+TcellpopultiquidtumuppiInelicgeeffectwhencomdimmunecheckpotblockdegentnti-PD1L-fucenhnceefficcydurbilynti-PD1-mededtumuppiOurdtdicteL-fuctimultepotentnti-tumimmunycgtrtumlcmCD4+TcellpopultiWepropoeteurhypoL-fucfucoyltilterignlgCD4+TcellkewgtrtumlubpopultiwrdcmCD4+Tcellpromotgdurblenti-tumimmunememypeInthprojectwedeletehowL-fuclterbiologyCD4+TcellcedevelopmentexpnicmCD4+Tcellgle-cellRNAequencgWefurrdetermeifL-fucdeedenhnceimmunologiclmemyblocktumcurncevivoPROJECTSUMMARYCncermetbolicprogrmmgkeydpttumirhrhmicroenvirmentElevtedLDbundncetumfquentlydetectedgcognizedcommfetuirwidmetbolmLipiddropletmultifcetedgnelleprticiptecrucilcellulrfuncticludgmetbolmmembrneynhomeotignlgprotetrffickgWehvehownhypoxitimulteLDccumulticeddepletiLDimpedetumgrowthInderdcovernovelgulrlipiddropletturnoverwepermedgenome-widelofuncticenbedCrprengeergEdedcellweeprtedbedirLDbundnceequencedOurpprochidentifiedGFPT1(glutme-fruce-6-phophtetrnme1)cidtepoiveLDgulrGFPT1ctlyzefirtrtelimgtephexomebioynThehexomebioynticpthwyueglycolytictermedeglutmeproduceUDP-GlcNAcwhicheentilO-GlcNACyltiglycoyltiprotemcromoleculeFluxthroughhexomepthwygultedcogeniceventnutrientvilbilyputnutrientenlikeAMPKInturnHBPimpctcrucilignlgfunctimetbolicproceeCncerhveelevtedHBPctivygeneexpidependennthctivyurvivlgrowthmettticdemtiBrodrngephrmcologiclhibirHBPhvehownpromgultrpeuticpprochhowevernoHBP-dictedcncerrpiecurntlypprovedOurplimryfdgGFPT1poivelygultelipidrgepromptuhypoizeccurnthibiHBPneutrllipidynultmocompleteLDdepletienhncedtumctrolInim1wedeletelipidmetbolicproceeimpctedgeneticGFPT1bltimllmoleculehibiHBPPDACmodelvroWeuncovernutrilquimentLDturnoverundernmoxihypoxictextHBPhibiquntifyxicycomdHBP-lipidmetbolmhibiFurrwemechnticllylkGFPT1AMPKvipot-trnltilmodifictidurgnmoxichypoxicLDccumultiInim2weevlutevivoefficcyHBPmetbolichibirthopicPDACmodelmeuimpctenewttmentchemetummicroenvirmentlchrcterticSuccefulcomplethpropoluncovernewcnectitweentwocncer-promotgmetbolicprogrmdevelopnewchempeuticprdigmcncerttmentABSTRACTMelnombrmett(MBM)dedlypolyunderodcequencemelnomwhichptientneedimprovedttmenptiIntegrtgproteomictrncripmicdtdependentptientcohtCNDP1widentifiedcommlyupgultedgeneMBMCNDP1crnoedipeptide-1clevecrnoecompentmocidL-htide-lneCrnoebundntmucleliverbrwheexertneuroprotectiveeffect5Whilecrnoeelfthoughtexertnti-tumigeniceffectroleCNDP1cncermvtlyunknownToprofunctilroleCNDP1MBMweeedeffectCNDP1depletiMBMvrovivoCtutiveCNDP1ilencgducedmelnomcellbilycolizebrpnchymducibleuppiimpidgrowthetblhedMBMpcliclmouemodelMechnticllyourplimrytudieuggetddicrnoeclevgeCNDP1mygultecellulrmocidpoolmocyl-tRNAvilbilyprotetrnltiprticulrlymichdrilproteOurfdguggetpoibilyhigherCNDP1levelllowmelnomcellthighcrnoeleveloxidtivetdurgbrmettThpropolim1)olidifyvluepecificyCNDP1novelMBMtrgetugpcliclmodelgeneticphrmcologiclpproche2)dectmechnm()ctiPROJECTSUMMARYDepeproghumnppillomviru(HPV)vcctiuptkeboutthemilliwomentilldignoedpcnceroucerviclleiechyerUSMotptneoulygyerlyfollowupviveprophylcticc(egendocerviclcuttgecerviclbiopy)tillquidnotclerwhichmyprogcerviclcncerSceBlckwomenhvemopertentHPVfectipcncerouleiwellhighercidencecerviclcncerthnwhewomenydproptelyimpctedeviveprophylcticproceduirequele(egpbleedgcrrgfertilyfutumcrrigeptermbirth)Thevglmicrobiome(VMB)henimplictedutgHPVfectidevelopmentpcncerouleiHPV-poivewomenwomenpcncerouleiBlckwomenmolikelyhveuboptimlVMBhightxomicdiverydepletiLcbcillupp(bothfetuvglflmmtidybio)loocedweprognopcncerouleiMyplimrydthownoptimlLcbcillupdomntVMBprotectivegtrkpcnceroucerviclleiwhenotBlckwomenSceVMBuceptiblehotmicromcroenvirmentpluibleediffenceoverrideprotectiveeffectVMBBlckwomenAtmicroleveldiffencepecie-pecificmetbolicprilemightctrigleiprognodturbgvglhomeotAtmcrolevelpychologicltwhichdproptelyexperiencedBlckwomenmyfluencgVMBthroughclpthwywhichhenbiologicllyimplictedVMBdynmicknowndygultedBlckwomenpetInthK01pplictiItethyporcildiffencedilyexperiencetpectiveclpeultVMBchngefluencediffentilpcncerouleigirceImeuVMBchngepychologicl(ecologiclmomentryement)phyiologiclt(livrycl)mg75Blck75Whewomendignoedcerviclleieeddurgcricltimetweenirrouteppcenbnmlfollow-upThepropoedmenrhiptrgerchgivemecriclkillbiomticttticlmoleculrbiologyterrogtepluiblemechnmthroughwhichVMBmightunderliercillydiffentiletiologiep-cnceroucerviclleiThetrgdecridthpropolppmecomendependenttrnltilvetigrledgidentifictiprcticlolutiducticnceroutcomedpriePROJECTSUMMARY/ABSTRACTCANDIDATEImpotdocrlerchocelbryDrYuChenHumnOncologyPthogeneProgrm(HOPP)tMemilSlKettergCncerCenterMyPhDtrgtBonUniverySchoolMediceunderuperviDrSmThiglgmllowedmedevelopcellulrmoleculrbiologiclkillfunctillychrcterizecidtegenevolvedcncerprogivetigterpeuticvulnerbilieMycurnterchfocueutilizgptient-derivedgnoidmodeldefeepigeneticubtypectrtitntprottecncer(CRPC)determgdependencytrncriptifcrmedegrowthlegeidentyMypropoederchmenrgplnprovidemetrgfoundtiwrdcomgndependentvetigrcdemiMylg-termcergoldvnceperlizedcncermedicepecifictetdeemodelgfunctilchrcteriztidriverlegeplticyevlutirpeutictrgencogenicdependencyTochievethgolIhvedevelopedcerplnenumyuccecomgndependentvetigr1)boltergmycientificknowledgetechniclexperte2)emblgndvycommteeovereemytrgprog3)improvgmycommunictikill4)expgmypilnetwk4)pprgmeledgmenrgfututeRESEARCHProttecncerdependrogencepr(AR)ignlggrowthurvivlThedventrpietrgetgARignlghdrivendeewrdAR-dependenceUgfunctilgenomicpprochwehveidentifiednewepigeneticubtypeCRPCclledtemcell-like(SCL)whichdrivenFOSL1lckrpeuticoptiGeneticperturbtiFOSL1coopertgfcrYAP/TAZledimpidcellgrowthloSCLlegeuggetgCRPC-SCLcelldependennFOSL1urvivlBuildgedcoveriethpropolIim1)DeferoleFOSL1medglegeplticytnceenzlutmideprottecncer2)EvluterpeutictrgetYAP/TAZ/TEAD/FOSL1pthwytemcell-likeubtypeprottecncerENVIRONMENTTheYuChenlbryprtHOPPunderlederhipDrChrleSwyertMemilSlKettergCncerCenterp-tiertutecncererchTheprimrymenrDrYuChenpieerdevelopgprottecncergnoidptientnexperttudyepigeneticrrntlyctivtedtrncriptilprogrmFurrmomydvycommteecollbrprovideddilupptpropoederchcerdevelopmentplnProjectSummryLivercncerthirdledgcuecncer-lteddethoceddivererngecogenicltertiTheedrivermuttiimpctclicloutcomedeeprognoperpyTtmenptilivercncercludefewmulti-kehibirurgiclectiprovidglylimedurvivlnefTothendgenotype-guidedrpeuticpprocheurgentlyneededclicMetbolm-focuedpprochehvecentlygedtetexplodnti-cncerrpyHoweverpolyunderodhowpecificcogenicltertiimpcttummetbolmwhichtumwouldnefmetbolm-bedrpieGivencomplexcellulrnutrilcompoumtudygtummetbolmtcellulrolutiquechllenggInthtudyIpropoewyovercomethchllengeemploygngnellepull-downtechnologyprilgmichdrilmetbolecncercellhighlyheterogeneoutumtueInmyplimrywkIfocuedmichdricentrlbioyntichubcellulrmetbolmppliedmichdrilimmunopciptimethod(mi-IP)cptucncercellmichdrivivotrnmedlivertumdrivendiffenncogeniclterticludgc-MYCp53-/-KrG12Dp53-/-ThpprochenbledmichdrilmetboleprilgLC/MSidentifiedmetbolechngepecificechcogenicltertiInprticulrIfoundenrichmentctemetbolmtermedegunidocettecte(Cr)phophocte(P-Cr)pecificllyKrG12DtumMichdrilproteomiccrobtedefdgveledupgultiGtmrtelimgenzymectebioynKrG12DtumBuildgupefdgthpropolItetcentrlhypothncogeneimpoedtctmetbolicltertimichdriwhichcnexploedtrgetedrpieIfirtteteentilyctemetbolmKrG12D-mutntlivertumgrowthThenIdetermepcemechnmwhichctemetbolmctrieKrG12D-driventumigeneFllygivenuccemyvivomi-IPpprochImodelfquentlivercncermuttimpdiffentillygultedmichdrilmetboleproteidentifylimgmetbolicctithroughundgeneticcenByddgimthpropolwegmechnticightdowntmmetboliceffectcogenicltertipotentilgenotype-trgetedmetbolicrpietrgetglivercncerCollectivelyeimprovidefoundtimyfutuerchprogrmcommtedundertghowcogene(geneticdetermnt)ltercncercellmetbolmvivogolexploguchltertigenotype-trgetedmetbolicrpiePROJECTSUMMARYTheoverllurvivlrtechildnhigh-rklivercncercludgmettticlpe/frcryhepblm(HB)hepcellulrcrcom(HCC)HBHCCfetu(HBC)low50%TheddurvivlptientecncercompleteurgiclectinegtivemrgthnotchievbletdignomotptientIntedhigh-rkptientttedcombtichempyurgerywhechempyuedducetumburdeneurgeryelimteidulcncercellfterurgeryThelowurvivlrtehigh-rklivercncerocedchemotnceimprovgeurvivlrtequilterntiverpietrgetchemotntcncercellcombtichempyWepropoecomphenivepprochchrcterizechemotntcncercellchildnhigh-rklivercncerdeigntechnologiedetectecncertdignodcoveretblhrpietrgetechemotntcncercellueptient-derivedmodeltetperlizedttmentcombtiepcribgmhigh-rkptientWepropoeproceedtheimFirtweetblhchemotntmodelmoleculrlyclicllychrcterizemSecdweuemoleculrdtenbleidentifictichemotntcncertdignoutilizgpropectivelycollectedpecimenmjclicltrilWeueperlizedmodelpdictttmentpepropectivelyenrolledcncerptientdetermeifchemotncecndetectedtdignoFllyweidentifyvetigtetrgetedcombtirpieptient-derivedmodelCceptulnovtiourpropolcludebuildgpedriclivercncertlmoleculrlyclicllychrcterizedcelltypecoulduedpdictptientperpytdignowellmppgoutdriverchemotncepedriclivercncerThetudyevlutelrgetcohtptient-derivedmodelpedriclivercncerutilyemodelp-clicloldevelopevluterpiechildnhigh-rklivercncerIfuccefulthtudyhelpefttrnmdignottmentchildnhigh-rklivercncerledgdrmticllyimprovedoutcomePROJECTSUMMARYGlioblm(GBM)mlignntprimrybrtumdultStrdcvolvemximlfeurgiclectirdichempytemozolomideNovelrpielounderdevelopmentGBMptientHoweverphyicinhmpedirefteffectivelyttGBMptientirbilyliblymirtumgrowthvivoSpecificllydeeprogtmentpeGBMptienttypicllymidn-vivemgneticnceimgg(MRI)methoduchctrt-enhncedMRIHoweverctrtenhncementflecttegrybloodbrbrrierrrthnnytricbiologiclctivytumAultcomedifficultliblydetermeperpyTumprogrmirmetbolmgenertebioynticpcurneededprolifertiPhophtidylcholemtructurlcompentllcellulrmembrnebioynupgultedmotcncerduehighmembrneturnoverocedunctrolledprolifertiThedietrynutrientcholecvertedphophochole(PC)whichubequentlycptedphophtidylcholeExpikeyenzymethpthwycholeke(CK)elevtedtumltiveurroundgnmltuecludgGBMN-vivemethodimggCKctivyprovideuniqueopptunyvulizetumtricbiologiclctivyvivoDeuteriummgneticncepectrocopycentlyemergednnovtiveclicllytrnltblemethodimggmetbolmtblen-rdioctivedeutertedmoleculevivoOurgoldetermewhermppgCKctivyugdeutertedcholeenblen-viveementGBMperpyvivoWeexmebilydeutertedcholeptillympCKctivy(Aim1)providedoutGBMperpy(Aim2)vivotcliclfieldtngth3TFbothimweuecomplementrybiochemiclycfirmourDMRSdtcltetumbiologyOurpropolnovtiveimpctfulcuevlidtedeutertedcholepecificfen-rdioctivetrcerimggGBMgrowthvivoBydogoourpropolenblepciimggignificntlyimproveoutcomequlylifeGBMptientAbtrctOvrincncermmotlethlgynecologiclmlignncyduelckhighlyenivepecificcengoldetectierly-tgedeeThegolpropoedtudyexplovibilynovelPiwi-terctgRNA(piRNA)-beddetectiolerlydetectiovrincncerPiRNAnbundntclmll(26-32nt)ncodgRNAover30000knownhumnmemrplypivotlrolemtenncegenomictbilyviepigeneticilencgtrnpobleelement(TE)RecentevidenceourgrouphuggetedpiRNAcnloduceDNAmethyltn-TEprotecodggenecludgcncer-ltedgeneomticcellOurgognlyehveobervedmrkeddiffenceexpieverlpiRNAtweenovrincncertuenmlovrintueAnovelgroupmllncodgRNAnopublhedwkhexmedpotentiluepiRNAerlydetectiovrincncerThepropoedtudytethypopiRNAcnervenovelgroupblood-bedbiomrkererlydetectiovrincncerWepermpiRNAequencg(piSeq)nlydetecver-expedpiRNAcidte1)erlytge(I-II)ovrintumtuecompdfllopintutuectrolubject(Aim1)2)erummpleerlytge(I-II)ovrincncerptientcompdmtchednmlubject(Aim2)Thexplrytudyprovideprocceptfutulrgepopulti-bedtudiefurrvetigtetrnltilrolepiRNAovrincncerwhichwouldccelerteourundertgrolepiRNAovrintumigeneprovidenewvenueerchfciltedevelopmentnovtivedignoticbiomrkerovrincncerPROJECTABSTRACTThpplictifocueddevelopmentnewrpeuticpedrichigh-grdegliom(HGG)cludgrubetknownDiffueIntricPteGliom(DIPG)DIPGrbrcncerprimrilyffectgchildnpproximtely200-300newnnulceUnedSttelethn2percenturvivlt2yerlimedperpeuticrdi(RT)RecentlypublhedtudiepcliclgliommodelhveveledRTultprogiveccumultimocytederivedmcrophge(MDM)ctivtedmicroglihibicrumentMDMdelygliomcurnceTheubtntilevidencedemtrtgkeyrolechemoke(C-Cmotif)lig2CCL2loknownmocytechemottrctntprote-1(MCP-1)RT-ducedflmmticludgcrumentMDMbrtummicroenvirment(TME)TheetudienlyhowRTducetrnientelectiveupgultiCCL2hourexpoulodemtrtedruptiCCL2ignlgdurgimefrmeleufficientttenutechricmicroglilctivtillowcoveryneurogeneweekfollowgrdiHoweverdeperteneednewgentnlypotenthibirCCL2productiignlglofedmtrticombtiRTTheynticolennetrerpenoid(SOT)evlutedthpplictimeetecreriTheerchtempurueground-bkghigh-rkhigh-gtudieddourcentrlhypochricytemicldmtrtinewlydevelopedSOT(CDDO-2P-Im2P-Im)enhncerdipeDIPGthroughmechnmcludeuppiRT-ducedcrumentctivtimyeloidcellbrpotentillolimRT-ltedxicyPlimrydthow900nnomole2P-Im/kgbrt6hourfter1moledoegiveneirtrperineljectilgvgemice2P-ImhibCCL2productictivtedhumnmcrophgetpicomolrccentrtivroTheprojecrgnizedroundthepecificim(1)defeeffect2P-Im(bothlecombtiRT)vroclogenicurvivlDIPGcelllecludgthoehrbghneH33Ly27--methie(K27M)muttiltihipdictmoleculrtrget2P-Im(AIM1)(2)determedoe-time-dependenteffect2P-ImRT-ducedcrumentMDMmicroglilctivti(AIM2)(3)demtrtevivoefficcyctivy2P-Im(dmtedrodentdiet)etblhedthopicPDXmodelDIPGcludgcpcy2P-ImenhncerdipeDIPGxenogrftvivo(AIM3)Dtgenertedthpropolpoi2P-ImdvncementcriclIND-enblgtudienovelllybiovilblerpyhighlyggivefrcryrchildhoodcncerPROJECTSUMMARYGlioblm(GBM)nuncurblemprimrybrtumextmelypoprognoDepemulti-modlrpycludgurgeryirrdichempyllptientexperiencetumprogiNotrdcetblhedcurnrprogiveGBMTheidentifictineurlcellulrtteGBMmodiffentedtteenrichedtcurnceperipherytumprovidenewighthowneurlctivygultetumviDecvolutinmlcelltypegle-cellRNAeqbulktumveledneurltteGBMocedhighfiltrtin-mlignntcellThetricteynpticcommunictitweenneurbrtumcellcrucilgliomprogitncetrdrpiewhichupptedmpledtrpidlyemerggfieldcncerneurocienceHowevermoleculrmechnmdrivgenhncedneurlctivytcurncemunderodDectgptiotempldynmicgliomeco-ytemdurgevolutineceryidentifyrpeuticvulnerbilycurntGBMHeproteogenomicgle-nucleiRNAeqprilgmtchedprimrycurntGBMIDHwild-typeuggetevolutirytrnimoprolifertive-progenirwrdneurltteGBMgultedbothgeneticpot-geneticmoleculreventpotentilfunctilterctitweenmlignntn-mlignntcellInAim1developmentmultiomic-bednetwkdiffuipprochenlightenubnetwkprote/phopho-proteignificntlyffecteduptmgeneticeventdrivgctivtineurlprogrmdurgprogiGenertiilicoknock-outnetwkcentegrtivenlyproteomicphrmcologicldtcncercelllepriizelethleentilproteubnetwkidentifypotentilrpeuticvulnerbilieneurl-curntGBMInAim2gle-nucleiptiltrncripmicprilgmtchedprimrycurntGBMIDHwild-typeidentifyfunctilcnectitweenneurodevelopmentltumcellulrttecelltypetummicroenvirmentThedevelopmentptilmedcellcellcommunictilghmctructercellulrignlgnetwkferkeyfunctilterctitweenneurodevelopmentltumcellulrttecelltypetummicroenvirmentlgpotentileffecteterctidowntmgulrymoleculrpthwyTheetudielyfoundtimyfutuerchprogrmdvnceundertgmoleculrmechnmmedggliomcnecmedrivggliomviTheetudiedvnceneurociencefieldthroughdcoverytrgetblepthwyproteprovidgrpeuticopptuniecurntGBMPROJECTSUMMARY/ABSTRACTThehnemethyltrnfere(HMTe)EZH2wproveddrivemlignntphenotypevrioutypecncercellcludgetrogencepr-negtive(ER-)btcncerTheeelectivemll-moleculehibirEZH2hveendevelopedllwhichblockenzymticctivyHoweverccumultgevidenceuggetHMTectivyEZH2whichexecutedC-termlctlyticSETdommynotpentnideltrgetnticncerdrugcertutiFirtmultiplegenetictudieuggetHMTectivyEZH2plytumuppiveroleometypecncerSecdEZH2mypromotetumigenecncerprogidependentHMTecompetenceTheecientificdcoverieexplwhyomecncercellquiEZH2irtumgenicyenivecurntEZH2hibirwhyecdrymlignnceweometimenotedptientceivgtzemettfirtFDA-pprovedHMTehibirEZH2AllecliclfiluwrrntdevelopmentnewEZH2hibirblockgHMTe-dependenncogenicfunctiEZH2whichmyexhibtrgerntumpotencyfewerideeffectwidercliclpplictiRecentlynN-termltrnctivtidom(TAD)wfoundmedetum-promotgeffectEZH2vigenectivtitedHMTectivyInER-btcncercellwedemtrtedmlignntphenotypeuchprolifertimigrtiweunffecteduptzemettttmenrovexpiSETdom-deletedEZH2drmticllyhdedwhenTADdomwtrunctedwhencriclidueproperprotefoldgTADdomwemuttedMoimptntlygroupgeneeentiltummigrtiwpecificllyctivtedfunctilTADdomnotgultedSETdomAlleultuggetthprticulrN-termlTADdomrrthnmethyltrnferectivycurntEZH2hibirblockquidcogenicfunctiEZH2ER-btcncercellBedefdgwecrriedouthigh-throughputcengchemiclpecificllyterctthTADdomcidtecompoundwthuidentifiedTheledcompounddictlybdTADdomEZH2downgultegenepromotecncercellmigrtibrogteggivephenotypeER-btcncercelloutterfergmethyltrnferectivyEZH2Computer-idedtructurlnlyuggetcriclidueeentiltructufunctilyTADdommydictlyterctthprotypecompoundBedeplimrydtweimdevelopnewclEZH2hibirtrgetN-termlTADdomfurrchrcterizeirchemiclbiologiclfetupropoedtudyUndertructiCo-InvetigrDrDohgZhouCollbrDrYxiYunwetudytructu-ctivyltihipourledcompoundfurrbuildbdgmodeTADdomWelowkCultntDrStnnMcHrdydeignynizenlogprotypecompoundFllywecrryoutphrmcoketictudienewEZH2hibirtnceCultntDrNicholClnnevluteirefficcyelucidtemechnmctiecompoundER-btcncercellwellxenogrftmouemodelbtcncervivoRNA-eqChIP-eqproteomicnlyewhichpermedCollbrDrZhoZhngAlgerthtudyyieldfirt--clnticncergenttrgetdiffentfunctildomEZH2hibcogenicfuncticerttypecncercelldotpdcurntEZH2-trgetgdrugDetectgReverlApopCncerCellMiceProjectSummryTrgetgpopticpthwyemotimptntrpeutictrtegiecncerttmentprimrycncertenexhibdrmticilpeuchttmentHowevermotmettticcncerevblycurledgttmentfiluThecliclviewpophlgumedthnceedthcelluicideproceirveribleChllenggthumptiourcenthighlyigldcoverypopcnveribleeventltetgemultiplehumncncercelllevroWenmedthcellcoverymechnmntwhichmenrglifeGekRemovldethtimuluufficientllowntoccurthudictgntntriccoveryphenomenWehypoizentnunexpectedecpetcticuedcncercellurvivecell-deth-ducgcncerrpycugcncercurnceIfthhypotruentwouldnovelrpeutictrgetuppgcncercurnceprogiHoweverntcncercellvivohyetdemtrtedcequencentmundcovedTodetectntlivenimlwehveuccefullydevelopednewbioenllntticcellfrufliefluocentlytgggcellhveveredpopThpermnenttguniqueoldetectgfollowgcequencentvivoHewepplyimilrtrtegydetecttrckntcncercellmiceBycptgbioen-expghumncncercelltheclicllylevntxenogrftmouemodelcncerlpewedetermewherntoccurcncercellvivoifidentifiedwherctriecurncefternti-cncerrpyOurultlytrgfoundtidevelopgnt-trgetgnti-cncerrpygenertgeentilnimlmodeltudygcequencentvelgrpeuticpotentilhrnegntuppcncercurncePROJECTSUMMARYCpefmilycyteeproteewhichcncleveprotectgclevgeeflexiblegriggercelldehroughpoppyropRecentlybifunctilmllmoleculeuchproteolytrgetgchimer(PROTAC)lyoometrgetgchimer(LYTAC)uphgytrgetgchimer(AUTAC)hveemergedpotentilrpeuticmodliehijckgubiqu-proteomeytem(UPS)lyoomeuphgydegrdeprotetet(POI)Cpeclevgee-tepprocetntlytermteprotefunctiHewedcovedpiperlgume(PL)dietrynturlproductcncrucpe()cleveBcl-xLwhencjugtedBcl-xL/2hibirABT263ThfdgmotivtedufurrdevelopbifunctilmllmoleculetrgetedproteclevgecrugcpewhichcouldupericomplementryknowndegrderWetermedthkdcompoundcpeclevgetrgetgchimer(CACTAC)Inthpropolwepplyeriette---rttechnologiefdcpe()cruedcurntPL-bedBcl-xLCACTACcfirmmechnmctiInddiwebuildHlo-FKBPytemfurrgeneticllyexplopotentilCACTAC-mededtrgetedproteclevgevrioucpeThecpe-clevgeepirytemticllyidentifiedmfutuCACTACdeignWelofurrdevelopnewcpe-2cruerthroughPLnloglibrrycengtructu/computermodelg-bedoptimiztiMoCACTACtrgetgPOIynizedtetedexppplictiCACTACTheCACTACpltmpropoedhefervolutirywepgncoprotecncerrpyPROJECTSUMMARYTrgetgAndrogenReceprBldderCncerEnhnceSenivyImmuneCheckpotBlockdeUp70-80%ptientblddercncerdemtrtedenovotncePD-1/PDL-1immunecheckpotblockde(ICB)OfthoeptientillypdICBmotultimtelydeveloptnce[1-5]TheedtupptvetigtiddilcoopertivetrgetwhichmyenizeblddercncerimmunomodulryrpieAndrogendeprivtirpy(ADT)trdcttmentprottecncerptientHoweverADThloprovendelyprogiARpoiveblddercncerthuferpotentillyvibleco-trgetenhncgctivyclicllypprovedPD-1/PDL-1trgetggentEmerggevidenceprottecncerupptnAR-dependentmechnmgultgICBpewheTcelltricexpiARblockTcellctivydiffentiWehypoizeclicllypprovedADTcludggdlctrtiARtrgetedhibirpromotefunctumfiltrtgTcellwhileccomntlyhibgrogeneniveepiliblddertumWehvedevelopedpcliclmouemodeltechniquetetimpctADTerlylte-tgeblddercncerprogiWelevergeetblhedmethodglecelltrncripmicundertmechnm()howADTcouldlterimmunemicroenvirmentenizetumICBTofurrundertcelltricroleARwelevergenetblhedpcliclmodelMulholllbrygeneticllydruptARexpipecificllyTcellOurtemWeueneffectivecollbtitweenexpertfieldcncermodelgcologyurologybiomticttticThetrnltilerchtemctDvidMulhollPhD(pcliclmouemodelg)MtwGlkyMD(GUcology)JohnSfkinoMD(urgiclurology)ErneGucciePhD(biomtic)MdhuMzumdrPhD(biotttic)ImpctIfuccefulourexplrytudiegenertedthighlyimpctfulblddercncerptientwhopolypivetrdcimmunomodulryrpieABSTRACTTum-ocedmcrophgecriclgulrtumdevelopmentprogimettFcrtummicroenvirmentducetum-ocedmcrophgedopttum-upptivephenotypeuppeimmunepeTheccumultum-upptivemcrophgetumocedccelertedtumprogipoptientprognoMcrophgeenepdirenvirmentexpgpttern-cognicepruchCl-AScvengerRecepr(SR-A)InplimrydtwehowSR-Abdglycnexpedbtcncercellnn-cncercellFurrmowehowSR-AexpipromotedevelopmentplpbletumlungmettemouemodelptneoulydevelopbtcncerImptntlyultgeneexpiprilgdictetum-ocedmcrophgedoptnimmune-uppivephenotypeSR-A-expgmicenotSR-Aknock-outmiceTheefdgupptnovelccluiSR-Abdgtum-pecificligducepolriztum-filtrtgmcrophgewrdnimmune-uppivephenotypeenhncebtcncergrowthmetteItlogicllyfollowhibgSR-AterctitummyprovidennovtivepprochpolrizeTAMnntumphenotypeimproveeffectivenenti-tumimmunepehibbtcncerprogiThugolpropoedexperimenti)identifyligbtcncercellbdSR-Aducemcrophgepolriztiwrdprotumphenotypeii)demtrtentgizgSR-Apolrizemcrophgewrdtum-hibiryphenotypeenhnceimmunepeprolgurvivlpcliclmodelbtcncerShowgntgizgSR-Atercticenti-tumimmunectivyprolgurvivlnimlmodelcfirmrpeuticpotentilthpprochttbtcncerInddiidentifygtum-ocedligterctSR-Amyuggetddiltum-pecifictrtegiehibgeterctiAbtrctUltr-highdoerte(UHDR)rdideliverytermedFLASHrdipy(FLASH-RT)hpotentilducenmltuedmgeignificntcliclcncerttmentrmifictiCurntevidenceuggetFLASH-RTducefunctildmgenmlbrcollungktmedoevlueAlthoughctroverilometudiehowthductuedmgegt40%depetuetypelph/trtiotldoemignificntunknownfcrMoturprglytumtuepperunffectedFLASHrdiprguggetgrpeuticrtiochievedthroughFLASH-RThigherthncventilRTThepotentilchievehigherrpeuticrtiomkeFLASH-RTveryttrctivefutuhumnueddrdiotnttumwouldweultexceiverdioxicydurgcventilttmentDepeclicltrnltiFLASH-RTlrgenimlhumntudiegurgentlywrrntedmjypcliclwkFLASH-RTmmllnimlwheccerngrdgdoedoertehomogeneiecnnotdequtelyeedAmjbrrierwrdtrnltilFLASH-RTthptimizttmentplnlrgenimlhumnlrger/deepertuecomplictedgeometriemchllenggInderdemtrtehypoizeduperiyFLASH-RTeentilcducttudieFLASH-RTtudieunderctrolledcdiclicllylticwkflowThgttmentplnngytem{TPS)cpblegenertgdelivergcomprbleplnFLASH/CONV-RTmimllymodifiedcliclettgIncurntpropolwecommteddevelopguchTPSfirttimemkgourtwvilblecientificcommunyWechievethfirtgenertgmmodelFLASH-cpblelcTheemmodelnuedimplementdvncedplnngdeliverytechnologyutilizgpivetenymodultiNextwedeveloptumctrolprobbilynmltuecomplictiprobbilymodeldeploybleTPSLtlyourwkculmtedemtrtguccefuldeliverieoptimizedplncomphenivechrcteriztiplndeliveryugqulyurnceytemuniquelyvilbletDrtmouthDueurgencytrnferthprdigm-hiftgrpyhigh-rkfirtiveexplrydevelopmentlntupropolR21grntmechnmlevergedjutifiedTheuccefulcompletipropoedwkdvncette---rtFLASH-RTbridggextenivegptweenbiccienceFLASHcliclneedFLASHtrnltihumntrilThetemhledgexperterdiphyicmticrdicologyupptedextgFLASH-cpblelcTPSprotypeuniqueUHDRdoimetrytechnologieventedtDrtmouthcnepilottrilfutuhumntrilplnngledgdutrilprtnerTkengertemidellypoedcductpropoedwkexplrydevelopmentlntuProjectSummry/AbtrctNewtrtegiepventbtcncerurgentlyneededcuei)btcncercidencertekeeprg05%peryerbout13%18USwomengogdevelopvivebtcncerirlifetimeii)endoc-trgetedgentER+btcncerpventidotducebtcncermtlyiii)pventitrtegyER-btcncerwhichhhighermtlyrtetillnotvilbleyetOurcenttudy(publhedCncerCell2022Jn1040(1)36-52)uncovedhighlevelplmhtmehtmeceprH1(HRH1)expum(mlymcrophge)ignificntlycltedducedcyxicimmunecellfiltrtidevttgTcellfunctiptientbtcncerOnctrrybtcncerptientwhookH1-ntihtmedurgimmunpyttmenthdevidentlyimprovedurvivlImptntlyocitweenntihtmeuptketterclicloutcomewlyobervedptientttedimmunpienotchempieuggetgH1-ntihtmemyctrientumimmunyIndeedwefoundH1-ntihtmettmenrHRH1knockoutbootedCD8+cyxicTcellctivieenhncedimmunpypeeverlmmmrytummodelMotetglyourltettropectivenlyelectrichelthcdMDACCptientcohttge01btcncerveledptientwhookH1-ntihtmehdignificntlyducedtumcurncecompdptientwhodidnottkemPtientwhoceivedrpiethnurgeryweexcludeduggetgducedcurncenotdueenhncedrpeuticpeTheenewfdgleduhypoizeblockghtme-HRH1xH1-ntihtmeenhnceimmuneurveillnceterceptbtcncerdevelopmentWepropoetwoSpecificAim1)TeteffectH1-ntihtmeterceptgmouemmmrytumdevelopmentWeteti)wherH1-ntihtmecntercepterly-tgemmmrytummouemodelmimicptienterlytgebtcncer(iecohtnly)ii)wherH1-ntihtmepvent/delybl-likebtcnceri/progigeneticllyengeedmouemodelwhichcpultenturldevelopmentbtcncer2)Determeimpctblockghtme-HRH1xytemicimmunelcpetumimmunemicroenvirmenterlytgemmmrytumWeexmei)brodeffectH1-ntihtmebloodimmunecelllcpeCyTOFii)impctH1-ntihtmeloclimmunyegptilterctimmmryepililcelldivereimmunecellpopultiIntegrtgbovedtweidentifykeychngeimmunecelllkedntihtme-mededimmunopventiThepropoedtudyexplewtrtegybedourltetfdgddunmetchllengebtcncerpventiIfultpromgourfdgcouldtrnltedclictrilimmunopventibtcncerepecillywomenthigh-rkABSTRACTTumocedmcrophge(TAM)keycompenttummicroenvirmentocedimmunouppipoprognondequtepeimmunecheckpotrpy(ICT)diffenttypetumReprogrmmgTAMwrdmophgocytictype1pro-flmmryphenotypecnimprovetumctrolThueverlmoleculeocedimmunouppivephenotypeTAMhveentrgetedboummodelptientlecombtiICTRecentlywehowedhumnhibiryceprILT3loknownLILRB4nttrctivetrgetTAMprogrmmgtumrpyWefoundILT3highlyexpedTAMvrioutypecncerMooverwedcovedILT3cognizefibrect(Fn)whichubiquiulyexpedextrcellulrmtrixenrichedvriouprimrytummettticeILT3-FnterctipolrizemcrophgemyeloidcelluchdendriccellmocytewrdnimmunouppivettewhichdebilteircpcytimultectivteTcellThuILT3-Fnxmechnmunderlygtroml-drivenhibinti-tumctivypentpromgtrgetpromoteprogrmmgTAMmyeloidcellgenerlcncerInthgrntpplictiwepropoedetermeimpctILT3blockdectrolprimrymetttictummodelvivopecificmocllntibodymAb1blockILT3FnterctiSceILT3humnceprdtntlyltedmoueprloguetudygfunctivivohendifficultTodteevidenceILT3immunouppivectivybedexpidthumnmplevroywhilevivoimpctILT3myeloidcellfunctinti-tumctivymelucidtedToovercomethuewegenertedtrngenicmouecrriebcterilrtificilchromoomeencompgptihumnchromoome19ctILT3genegerputtivegulrygiAnlyILT3exphmouedemtrtedptternctenthumnmgdiffenttueInpecificim1wetetimpctILT3blockdetumgrowthnti-tumimmunepetwomodelrcomcoloctlcrcomvivoWefurrtetbilyILT3blockdeneffectivepeICTmodelICTtnceInpecificim2wetetimpctILT3blockdecompoip-mettticmettticnichetwomodellungmetteultimtelymtimettticleiThpropoldvnceourknowledgemechnmgultgimmunelcpeprimrymetttictumvlidtenti-humnILT3mAbrpeuticgentcnbroughtcliceirleociICTMycoFungoide(MF)clldderk-identmemyTcellmotcommmcutneouT-celllymphom(CTCL)InerlytgeMFTcellideprimrilyklyfewcirculteperipherlbloodHoweverignificntnumrptientdeeproge10yertumcellpdgebodyledgftloutcomeDignoMFdifficultetblhepecillyerlytgecueympmhlogicfetumimicnignflmmrydermepecificmrkermlignntlymphocytelckgcequentlyMFmymdignoedttedpproprelyultgpoclicloutcomeWehvecentlyhownmlignntTlymphocyteerly-dvnced-tgeMFkleiproducehighlevelcykeIL-13ignificntlyyloexpIL-13-pecificceprIL-13R1unlikehelthyhumnTcellFurrwedemtrtedIL-13ctnucfcrtumlymphocyteimplictedIL-13ignlgviIL-13R1SignlTrnducerActivrTrncripti-6(STAT-6)BedeultourcentrlhypoIL-13R1expimlignntTlymphocyteerly-tgeMFkleipropectivemrkererlydignoMFInthpropolweteurhypovetigtgcltitweenIL-1R1expiTcellmlignncyptientchrcteriztiWeemployCellulrIndexgTrncripmeEpipeequencg(CITE-eq)meuimmunophenotypetrncripmeimultneoulythoudividulcelllrgeheterogeneoupopultiuchptientbiopyPrllelhigh-olutiprilgTcellimmuneperiidentifyexpedmlignntTcellcledictlyMFptientkmpleWeimidentifyIL-13-pecificpthwymlignntIL-13R1+Tcellerly-tgeMFkleicomprdjcentunffectedkhelthyctrolkkffectednignflmmrydermInecdfocumulticolimmunohchemiclmethoduedbnkedmplePROCLIPIpoiryeexpiIL13R1TcelltropectivecltiocedclicldbtedlgudllyoveryerThwkvelocitweenIL13R1expiTcellMFtumigeneprogiSuccefulcompletiprovidefrmewkevlutgIL13R1cidtebiomrkermydevelopeddignotictetbedmulticolimmunoh-chemtry/immunluocencewouldublecliclettgABSTRACTEchyer50000womendignoedductlcrcomu(DCIS)USDCISn-vivembtcncerwhichpectnturltuebrrierbtenotlife-engHoweveromeeDCISleioverrulenturltuebrrierimpoedhelthybttueledgvivemettticbtcncer(IBC)life-engdeeThecurntlynowypdictwhichDCISprogIBCcugllwomendignoedDCISttedviveurgeryytemicrpycugoverttmenthrmfulideeffectpychologiclburdenwhilelougvlubleourcehelthcytemOnecvetcliclDCISerchnturlprogiwhichcnnotfollowedovertimelmotllptientttedurgiclexciwhenleidetectedTheedynmicnturlcoureDCISgrowthvivetrnmtimpolyunderodToolvethlckdynmicmtiPIScheeletVIBgercollbtglbtNerlCncerIntutehdevelopedfirtlivgbiobnk>100ptient-derivedxenogrft(PDX)modelDCISdictlyderivedhumnmplethroughthopicjectiThbiobnkfullpenttiptientpopultipentllDCISmoleculrubtypemphologiclgrowthptternhlogiclfetugrdehighccdnceiglptientmplePIScheeletemlodevelopedwynlyzeDCISprogiug3Dwhole-glimggtechniquetudyleiizeloctigrowthptterntcttuetteregrowthptterndiffentleiUgthpprochtemhhown3Dgrowthptternprovidemuchtterpdictiviveproghncliclmrkerderived2DhpthologyTheVIBtemhidentifiedllDCISleicnclifiedtwodtct3DgrowthptternplcementgrowthexpnivegrowthOnlyexpnivegrowthptterntrglyclteviwheplcementleineverprogvivedeeHowevermechnmwhichegrowthptternprogevivebtcncerwhegrowthptternmdolentmunknownAddillyuncertifePDXderivedgrowthptternoccurptientmplewherhlogiclnlyllowidentifyegrowthptternPIScheelepropoeeeuncerttiefurrvetigtegrowthptternDCISundertghowDCIScellcnoverrulenturlbrrierimpoedhelthybttueUguniquecohtDCIS-PDXmodelcomdopticlbrcodg3Dimgglgudl(trvl)microcopyVIBtemimbuilddetiledptio-templ(xyzt)mpDCISgrowthprogiFrome4DmpDCISgrowthprogemimextrctpdictivebiomrkeruchmphologiclfetumrkergeneexpicndcrimtelow-rkhigh-rkDCISprivicliclpthologyprcticePROJECTSUMMARY/ABSTRACTSeplife-engmediclcdichrcterizedhighlevelflmmrymrkermulti-gndmgeDepetrdttmentepmledgcuembidymtlycricllyillptientepecillycncerptientRecentlyhenhowncupunctucnducedopmeproductiuppflmmtiduceepnimltudieSeverlromizedctrolledclicltrilhvehowncupunctumyducemtlyepptientHowevertrilweunbldedtrkbHewepropoefillknowledgegpcductgromizedctrolledptientevlurbldedphe2trilcupunctu(ACTIONStril)ughmcupunctuctrolptienttrkepThepecificAim1)generteplimrydtetimtedeffectizecupunctuducgmtlyICU(InteniveCUn)dmiepptientdetermefeibilycductgromizedctrolledtrilcupunctuhoplizedptientwhotrkep2)explowhercupunctucectecholmeduceflmmrycykemothnhmcupunctuSeventy-eightptienttrkepromizedtruehmcupunctudily10dyuntiltrnferICUdethdchrgeFeibilyendpotcludeccrulrteterventideliveryrtettrirtedtcompletirteEfficcyendpotcludemtlyrteICUdmiBiomrkerendpotplmlevelctecholmepro-flmmrycykemeudefterfirtcupunctuttmentIfthtudyhowcupunctudeemedfeibleetimtedeffectizewrrntlrgertudyweplncductromizedctrolledphe3tudyevlutedefiveefficcycupunctuimprovgoutcomeepptientThepropoedtudywouldfirnecupunctutudyepughmcupunctuctrolThedtlohedlighnmechnmcticupunctuThprojecthpotentildevelopgcupunctunnovtivecliclpprochmngementepItchllengecurntcliclprcticeprdigmcnledductidethdueepProjectSummryProttecncermotcommmlignncyecdledgcuecncer-ltedmtlymenUnedStteTheAmericnUrologiclAocicommenduemultiprmetricmgneticnceimgg(mpMRI)dignodeemngementllmenthighrkprottecncermpMRIloneficilmen1)ncgprotte-pecificntigen(PSA)followgnilnegtiveprottebiopy2)durglgudlfollow-upctiveurveillncebiopy-provenlow-rkprottecncer3)guidncelocllytrgetedrpiecludgcrypyhightenyfocuedultround(HIFU)MR-guidedtrnuthrlultroundblti(TULSA)emerggrdioligtrgetedttmenttermedehigh-rkcncerTheecommendtilylizblethroughccurtelocliztichrcteriztidividulprotteleiMRIwhichignificntlychllenggmenpelvicmetlimplntThimptntcecidenceprottecncerceubtntillyover50yergeprllelpvlencehipplcementurgerylocegegroup(etimtedch~4milli2030US)MotmetlimplntcurntcliclueMRcomptiblehoweverydrtloclmgneticfield(B0)cugignificntignlloimgedrtiThprticulrlyproblemticecho-plnrbeddiffui-weightedimgg(EP-DWI)ndergeimgen-dignoticThmjlimticeDWIccdgprotteimggptgdtytem(PI-RADS)clifictipivotlequenceleidetectichrcteriztiperipherlzewhe70-75%prottecncerToddthunmetcliclneedwepropoeetblh3Dturbopecho(TSE)bedDWIrobutcnwidelyimplementedcrollMRcnnerThbuiltupourcentlytroducednovelcquictructitrtegyutilizgvribledenyCrteincquipirlprilederg(VD-CASPR)Thevolumetriccqui3DVD-CASPR-DWIprovidehigherignlnoertioTSEdoutimproverobutneB0homogeneieThprovideuperiimgequlyenblevuliztientiprottegloutimgedrtifciltgccurtedetectichrcteriztiprotteleimenpelvicmetlimplntWeoptimizenovel3DVD-CASPR-DWIphnm-vivoprotteimgghelthyvolunteerWenvlidteechnique20ptientout20ptientpelvicmetlimplntevlutedknownupectedprottecncerTheuccefuloutcomethprojectnoptimizedmpMRIournovel3DVD-CASPR-DWIprovidepertentcliclmtittermngementprottecncerptientubequentlyimproveirqulylifeoverllurvivlPROJECTSUMMARYOnehllmrkcncertumbilyevdeimmunedetectielimtiImmunecheckpothibir(ICI)nttrctiverpeutictrtegymnycncerAftermnyclicltriltrgetgvriouolidcncertypehoweverly15-40%ptientnefedICIrpyShockgly4-29%n-piveptientdevelopedhyperprogivedee(HPD)cdichrcterizedccelertedtumgrowthrpidclicldeteriVeryltleknownboutwhtcueHPDhowpventcentwkuggettumhyperprolifertinimmune-lteddvereevent(irAE)AprtVAI-SU2CEpigeneticDmTemwedcovedctivtgrylhydrocrbcepr(AHR)pthwydowntmtrgetgeneCYP1A1prognoticdicrhyperprolifertive-irAE(HP-irAE)HP-irAEblddertumhowmetbolicwchwrdfttycidxenobioticmetbolmAHRknownhvencogenicroletumigeneimmunedyfunctiwhichledwkghypoAHRctivtieICIrpypcdicncercelltummicroenvirmentrpidprolifertiwheHP-irAEntriggedtrcellulrPD-L1ignlgimmunecell/cncercellfterICIrpyTotetthhypowefirtueNnoStrgGeoMXpltmptillyprileRNAproteexpiCYP1A1-poiveblddertummicroenvirmentolveptilheterogeneyimmunecncercelldependencie(Aim1)InAim2wedetermehowICIttmentAHRctivtrncriptillymetbolicllyprogrmblddercncerimmunecellTheeexperimenteprtecncer-tricimmune-ltedmetboliccequenceAHRPD-L1ignlgprovidepowerfulmodelfutugenetic-drug-cengtudieFlly(Aim3)weueblddercncermouemodeldefehowAHRICIttmentimpctevolutummicroenvirmentvivoTheedtprovidevlubleighthowAHRctivtimightfluenceICIefficcydvereeventTheK99phethprojectprovidevltrgptiltrncript/proteomicmetbolomicmultimodlgle-celltechnologiehowprocetegrtehigh-dimenildtundert(bldder)cncerevolutiirAETheftguidednouttgmultidciplrydvycommteeledDrPeterJetVnAndelIntutemlgmtebictrnltilciencecrocncerbiologyimmunologyepigeneticmetbolmfieldTheetrgnewkilletlevergedultimtelytrnindependenterchcer(R00phe)vlidtevrofdgvivomouemodelTogerthprojectprovidefirtmechnticighthowAHRpthwyexcerbteblddercncerpeICIttmentwhichprovidenewopptuniefutudrugdcoverypcimediceeftmimizeHP-irAEICI-ttedptientPROJECTSUMMARYAmgmotpowerfuluccefulnewrpieentercncerclicCAR-TcellrpyCAR-TcellrpyhenmrkblyeffectiveptientcertfrcryprogivehemlogiccncerultgeverlFDA-pprovedCAR-TcellrpieHoweverthrpyhnotenuccefulolidcnceruchcoloctlcncer(CRC)flectgneedublentigentrgetechdeewellptienttumimmunefcrepecillypofiltrtiolidtumCAR-TcellThedevelopmentcellulrrpiecnppliedCRCoutxicywouldhvemrkbleimpcnlcpeolidcncerrpyHewetethypoCAR-TcellcnengeedhomeCRCtumleverggindogenouchemokemilieucgntumefficcyovercventilCAR-TcellWehveidentifiedchemoke+chemokeceprxmtnimmunouppivetummicroenvirment(TME)CRCUgvlidtedhumnCRCmodeltrgetntigenweengeerCAR-TcellexpchemokeceprdictedtthCRCchemokeexplofetyefficcythpprochmouemodelAim1defetumhomgefficcychemokecepr-engeedCAR-TcellvrovivoughumnCRCcellleAim2defefetyimpctmicecuethpprochmycehomgCAR-TcellnlytumlmltueultgxicyTogeretudieproducenecerypro--cceptdtdevelopthrpeuticpprochtrnlticlicltrilptientdvnced/mettticCRCABSTRACTThehumnbodycompoedtlet400diffentcelltypeechdtguhbledtctcellulrmrkerCncercellloexpdtctcellulrmrkerdiffentgmirpcurcell-typeprimlignnttrnmtiAccdglybrodgolcologytrgetedtum-pecificrpiedeignedmximizerpeuticefficcywhilevoidgundeidf-trgeteffectThcognizedmjobtclepplicticurntgeneedgtechnologiePropoedhetrtegytum-pecificgeneedgvolvgcomduechimericdeno-ocedviru/phge(AAVP)vecrgerclutedgulrly-terpcedhtpldromicpet(CRISPR)/CRISPR-ocedprote(C)geneedgytemcollectivelyferdAAVP-CRISPRThetue-pecifictrgetgpectcrriedoutphgecpidAAVPwhichcnmodifieddplytrgetgpeptidelig-dicteddeliverydeidtrngeneAAVPfirttroduced2006well-chrcterizedgenedeliveryolhenexplodnumeroutummodelHeweplntroducetwoeprteCRISPR/CytempvioulydemtrtedgeneedgefficcyAAVPvecrThefirtctructctcventilCRISPR/C9ytemwhileecdctructctmocentlydcovedhypercompctCRISPR/CytemferdAAVP-CRISPR/C9AAVP-CRISPR/CpectivelyThetwoctructengeeddplyRGD4Cwell-knownclicllyvibletum-trgetgpeptidecrryvriougeneedgguideRNA(gRNA)combtiGeneedgugtwoctructfirtpermednvroettgcfirmctivyelementechCRISPR/CytemcludgceprbdgcellternliztiCgeneexpigeneedgctivySeverlgRNAcfigurtitetedvroAAVP-CRISPRctructctgledggRNAcidteevlutedtumtrgetgCexpigeneedgctivyvivoSuccefulcompletipropoedtudieprovideightefficcyAAVP-CRISPRtum-pecificgeneedgctriedevelopmentmuchneedednovelrpeutictrtegiecncerProjectSummryThedurbilycliclpeimmunecheckpothibirtrgetgPD1hgenertedtmendoutetimmunpycncerHowevernotllptientdemtrtecompletedurblepethuneeddevelopddilrpeuticntibodie(mAb)trgerimmunepthwycnuedcombtinti-PD1rpieThoughmjyfocudtehenhibirypthwyuchCTLA4TIGITcentdevelopmenthveuggetedrolemAbtrgetgco-timulryceprllowgtroductirpienlyleeproverbilbrkeimmuneytemlopplyggetimmunepemovgOneuchcotimulryceprGITR(TNFRSF18)TNFRuperfmilymemrurfceceprupgultedctivtedTcellendogenoulyexpedbothTgNKthoughblexpiNKcellciderblylowerAmnytimulryceprGITRquiceprclutergchctivthholdignltrnducticellulrctivthumnytudievolvggticnti-GITRntibodiefiledhowignificntcliclnefhumnThoughmutntntibodyFcdomhveendevelopedenbleptneouhexmeriztiupcellurfcebdghexmeriztiloenhnceC1qbdgcomplementdepoiledgnimmunodepletgmoleculepotenteffecrfunctiTobrodenpplictithpltmourlbhuedtructuguidedengeergpprochidentifyddilmutticnbrogteC1qbdgledghexmerizgntibodynegligibleeffecrfunctieubletrgetgctivtgtimulryceprInvroluciferebedbioydemtrtedwhencomdhexmerizgFcdomourgticnti-GITRntibodydemtrteignificntlyenhncedtimultiuniqueynergticeffectGITR-LigThefirtimthpropollookexmevivoefficcythgtichexmerizgnti-GITRntibodyugmentedtimulrycpbilieugnetblhedwellchrcterizedthopicnlcellcrcommodelhumnizedmoueAddillydvncednlyticltechniquecludgglecellRNAequencgimmunohchemtrymultiprmeterFACSenble-depthevlutimechnticcellulrdiffenceultgrpeuticuehexmerizgntibodietrgetgtimulryceprTheecdimfurrdvncerpeuticpotentilthntibodyengeergtetgvivohexmerizgbpecificntibodytrgetbothGITRPD1ThmoleculebothcueexhutedimmunecelltimultectivtedTcellllowgmodelgtummicroenvirmentrtinti-tumimmunyThpropolnlyevluterpeuticpotentilnovelFcdombpecificntibodyloprovidevlubleightmechnticdiffenceultgenhncedceprignlgcombtirpiePROJECTSUMMARY/ABSTRACTUvelmelnom(UM)motcommprimrytroculrtumdulthoodrdi-bedrpiemtyttmentmotmllmediumomelrgeUMDepehighrtelocltumctrolovertwo-thirdptientleftfunctilbldnettedeyeduerdi-ducedideeffectRdiopticneuropthy(RON)prticulrlydevttgduetrgociproundvuldeficlckeffectivettmenptiWecentlyidentifiedpotentilnovelopptunyterventibedtropectivetudyidentifygrkfcrRONInourcliclprcticeweobervedomeptientRONmnifetedccurntneurotlrimthng(NRT)BedthobervtiwenlyzednumrpotentilrkfcrRONptientttedplquerdipyUMfoundhigherbeletroculrpu(IOP)wocedncedrkRONTheedtupptedhypopvioulypropoedglucomuopticneuropthieSpecificllypuenivecompentopticnervejurywhichocedcnectivetuettrtlmcribroultcuppgNRTFewnimlmodelccurtelyplictethpecthumnnmyduelckwell-developedlmcribroHowevertehwhimilrdtctlod-rglmcribrorpidlycomgnnimlmodeltudiecdicludgglucomopticneuropthieGivenourcliclobervtigrowguetehwmodelopticnervepthologyourCentrlHyponovelmodelRONcndevelopedugtehwbedlod-rglmcribrowhichplictechrcterticfetuhumnpthologyllowtetgnovelrpeuticpecificllythoeltedIOPductiEtblhgpenttivenimlmodelhvepotentilccelertenewttmentpprocheptientRONWeevluteourcentrlhypovwopecificimAim1vlidteuetehwmodelRONpermgrigouementtructurlfunctilphenotypetehwmodelRONAim2exmeroleIOPgultieveryRONBedtrgclicldtwhichmthhypoeimuppurlg-termgoldevelopgnovelttmentpprochecludgIOPductiducerkRONpventbldneptientquirgexpourdiTleDevelopghumnizedNutCrcommouemodeldevelopgNUTM1trgetedrpieProjectSummryNUTcrcom(NC)highlyggivecncernoeffectivettment(mediumurvivltime~6mthdigno)AlthoughcidedrdecimlprognoNCclldevelopmenttterttmentClicllyNCtrglyocedchromoometrnloctiledmtifuigenetweentet-pecificgeneNUTM1vrioufuiprtnercludgBRD4(70%ce)BRD3NSD3ZNF532etc(t30%ce)FunctillyknockdownBRD4-NUTM1fuigenehumnNCcellleuppeirprolifertiuggetgtrgdependencyBRD4-NUTM1NCHowevercueecpicexpiBRD4-NUTM1n-NCcellleunequivocllyxiccogenicctivyfuigenehnotenprovedpvioulyRecentlywedevelopedfirtgeneticllyengeedmouemodel(GEMM)NCcpultgBrd4-Nutm1mgchromoometrnloctiblcellepililtueThemouemodeldevelopedhighlyggivelowdiffentiqumoucellcrcomimilrhumnNCOurGEMMtudyprovidedfirtfunctilproBRD4-NUTM1cogenicdriverNCThehighdependencyNCBRD4-NUTM1fuigenebothcnceridevelopmentpentednideltrgetrpyMoovertet-pecificexpiprilewouldmkerpeutictrtegietrgetgNUTM1highlypecifichighrpeuticdexBecueNUTM1ndprproteprimrilyctedlow-complexyequencenoppnttrgetemllmoleculrhibirNewrpeuticmoduletrgetDNA(egCRISPR-bedgenerpy)mRNA(ntenerpy)equenceetrgetproteynticffygent(egnnobody-dictedProteolyChimer(PROTAC))wouldlikelyneededDuelimedcervtigenomicDNA(~3%)peptideequence(66%)ourNCmodelbedmouegenenotideldevelopgNUTM1-trgetgrpeuticWepropoehumnizeNCGEMMplcgmoueNutm1genecompenthumnNUTM1codgequence(Aim1)chrcterizeNCtumgenertedthhumnizedmodel(Aim2)Weexpectthwell-chrcterizedhumnizedNCGEMMervevlublepcliclmodeldevelopgNUTM1trgetgrpieNCOverllImpctThprojectproducehumnizedGEMMNCByllowgpclicldevelopmenthumnNUTM1trgetgrpieournewmodelcntrnmlcpeNCrpydevelopmentnefNCptientMobrodlyknowledgeroundtrgetgNUTM1humnizedNCmodelfotercnprovidecriclcluedevelopgNUTM1trgetgrpieNUTM1rrngedcnceruchchildhoodleukemircomPROJECTSUMMARYAdulturvivchildhoodcncerfcelifetimehelthrkdueptcncerttmentnetimted80%experiencgtleneevelife-engchrichelthcdige45Toceivecommendedlifelgurvivhipcyoungdultchildhoodcncerurviv(YA-CCS)needdevelopkillmngeirowncygeTridiccommunictimgYA-CCSpnt/cgiverclicineentilYA-CCSlernboutircncerhrydevelopekillhowevercommunictgbouturvivhippiccomplexevenmochllenggfmiliewhopferlngugethnEnglhLngugebrrierocildetermnthelth(comeeductirce/ethnicy)ctriehelthdpriemgchildhoodcncerurvivyetveryfewterventihveddededprieBilgulcommunyhelthwkerhelpcnectunderervedcommunieerviceuchcncercenghvenotenwidelyemployedcncerurvivhipettgNewtrtegiecricllyneededducecommunictibrrierimproveurvivhipcmgYA-CCStrkhelthdprieToddegppplicntDrSmhlevergeherprtnerhipcommunygniztiervgpdomntlyHpnic/L(Ltx)fmiliechildncncergiClinilowocioecomicttuhighrten-EnglhlngugepfenceThepropoedtudydeveloppilottetfeculturllylguticllytilodfmily-centedcommunicterventiLtxYA-CCSpnt/cgiverSpecificllytudyim1)Evluteurvivhip-ltedcommunictigplguticculturlcommunictipfencemgLtxYA-CCSpntthroughEnglhSpnhfocugroup2)Developcommunyhelthwker-ledterventifciltecommunictimgYA-CCSpntclicinpplygprciplecommuny-bedprticipryerchvolvecncerurvivpntcommunymemrnertiveterventideignproce3)Pilottetcommunicterventievlutefeibilycceptbilymg18YA-CCSpntdydfeterventibedfeedbckThroughledgthtudyDrSmhdevelopdvncedkillcommuny-enggederchfmily-centedcommunicterventicienceShedoothroughtructudtrguppttrgmenrhiptemexpertecommuny-bedprticipryerchcommunictihvilterventicncerurvivhipDrSmhmenrhiptrgplncomdStndrobuttutilupptcommuny-enggederchnticiptedlunchDrSmhdependentcerledgptient-centedcommuny-enggedcliclerchtudieducehelthdpriemgchildhoodcncerurvivTherchfillnimptntgpvolvgnovelpopultivulnerblehelthdprie(LtxYA-CCS)ddgnovelterventrget(tridiccommunicti)ProjectummryDepecentprogundertgbiologiclunderpngcutemyeloidleukemi(AML)dvncettmentptientAMLfewerthnethirdptientchievedurblecuTheedeepermechnticightdriverAMLleddjunctivetrgetedrpiedepertelyneededRecentlyIelucidtedgeneexpinetwkgultedtrncriptifcrMECOMeentilhempoietictemcellmtenncehijckedhigh-rkAMLtrncriptilepigeneticco-gulreentildowntmeffecrMECOMnetwkunknownInthpropolItethypoMECOMdictlygulteelectgroupgenemodultgcriclepigeneticpthwyubetthoeMECOMtrgetgeneeentilAMLmtennceItethroughettwodependentpecificimIeek1)mechnticllydefeeentilco-gulrdicttrgetMECOMctivymtgAMLprogenir2)identifydpenbledowntmeffecrMECOMuncoverrpeuticvulnerbilieAMLImnIntrucrPedricOncologytlet80%protectederchtimeeekgpplyighttemcellbiologyuncovertrgeteentilpthwyAMLMycergolcomendependentphyicin-cientttudygtrncriptildygultileukemipurpoethcerdevelopmentwrdupplementmyexpertetemcellbiologyrigoutrgvivomodelgleukemicomputtilnlyIhvenouttgmenrhiptemDrVijySnkrnScottArmtrgwhohveetblhedtrckcdhighimpctcientificoutputexemplrymenrhiptewhoferhighlycomplementryexperteDrSnkrnnnovrledermodelggeneticvrihempoieticdiffentitemcellmtennceDrArmtrgnuthydevelopmentlgeneexpiprogrmAMLMydvycommteecollbrcludeexpertflectgkeymytrgplnDrKimStegmier(AMLgenomic)StuOrk(hempoieticgulti)MnuelGrr(biomtic)AnderHnen(chromticbiology)SethGoldmn(trncripmic)MrkMden(AML)Mymenrco-menrdvtuticommtedmyerchtrgcerdevelopmentprogindependentphyicin-cientttccluhwrdIcductthwktwld-cltutiBonChildnHoplDn-FrrCncerIntuteBrodIntuteprovidenenvirmentcientificrigexceptilmenrhipWhmenderchcerdevelopmentfedthroughthK08wrdIidellyuedetblhmydependentcerphyicin-cienttpedriccologyProjectSummry/AbtrctRecentbkthroughtumimmunologyleddevelopmentcncerimmunpiewhichhveenuccefullyppliedrngehumncncerAmgimmunecellulrytummicroenvirmenttum-ocedmcrophge(TAM)tenmotbundntimmunecellplycriclroletumimmunourveillnceRecentprogdemtrtecncercellupgultenti-phgocyticdtetmeignlelf-protectivemechnmgtmcrophgeurveillnceWheneignlblockedmcrophgecpbleelimtgvrioumlignnthempoieticolidtumcellthroughcellulrphgocyInducgcncercellphgocydemtrteignificntnticncereffectrpeuticpotentilpcliclmodelcentclicltrilTyroephophyltidephophyltimededprotetyroeke(PTK)protetyroephophte(PTP)neentilmechnmunderlygignltrnductivolvedmultiplecriclbiologiclfuncticludggultiimmunepePTPuchSHP1/SHP2hveenhownvolvedhibiryignlgmcrophgeTcelldectivtgimmunectivieDepeimptncehoweverunderlygmoleculrmechnmmcrophge-mededcncercellphgocytillunclercriclcompentmedgthproceddicellurfceceprhvemlymedunidentifiedInthpropolwefocugfunctirolePTPmcrophgeimmunourveillnceThroughCRISPR-bedlo--functicengmcrophgewehveidentifiedn-ceprPTPcidtenegtivelygultephgocyWhenirexpiuppedphgocyticbilymcrophgewrdcncercellignificntlyenhncedOurcentrlhypouchPTPfunctihibirygulrmcrophge-mededcncercellphgocythuirhibicnpromoteefficcymcrophgephgocy-bedcncerimmunpyInthpropolwefirtvetigtewhtextentdeficiencyhibiryPTPmcrophgepromoteefficcycncercellphgocymultiplepcliclmodelSecdwedectmoleculrmechnmhowdeficiencyPTPmcrophgeugmentcncercellphgocyFllyweexmenticncerefficcyuppgPTPmcrophgevivocncermodelThecomplethtudyidentifyetblhrolenewgulrcncercellphgocypidevelopmentnewrpeutictrtegieenhnceefficcymcrophge-bedcncerimmunpySummryChimericAntigenRecepr(CAR)-TcellrpiehvechievedunpcedenteduccettgbloodcncertnttrdilrdichempieHoweverefficcyCAR-TrpyolidtummlimedMjchllengecludepofiltrtiTcelltumexhutilowpertenceTcellunderhotiletumenvirmentTotckleeproblemweimeeklterntivecellcrrierCARMtcellpenteverldvntgetrgetgolidtumyidetumtuecnliveupyerTheycnpetivelykilltrgetcelloutexhutiTheyloleecykecncruireffecrcellkillcncerInthprojectwedeignCARpecificllyctivtemtcellkillolidtumugmelnomcolcncermodelOureftexpectedlycientificfoundtibr-newcellrpyprovidertilegenertegentmovgwrdfurrp-cliclclicltudieABSTRACTDurgtumprogilocellcelldheidetchmentextrcellulrmtrixducedynmicgnizticykelenmtivdopodumcellctivtiepilil--meenchymltrniThenbledtungmoleculrprogrmderdptlottchmentMerlencodedNF2genememrezr-rdix-moeprotefmilylkmembrneprotecticlctcykelengultedheimigrticell-cellctctprolifertiignltrnductiMerlcricllyvolvedctct-dependenthibigrowthWefoundMerlprotelevelducedmjycefiltrtgductlcrcommettticbtcncertueDecedMerlproteexpiwloeendvncednodlvolvementbtcncerIndercriclicllevncewe-cpultedloMerlbtcncercellMerldeficiencyelicedmrkedlyvivephenotypemphologicllyprogrmmticllyevidentepilil--meenchymltrniInderovercomechllengeembryiclethlytlNf2-knockoutwegenerteduniquemmmry-pecificNf2-knockoutmouemmmrytummodelTheemicehowmrkblyccelerteddevelopmenttumInthR21pplictiourobjectivetrgetpotentillibilieMerl-deficientmmmrytummigteirmett-cducivetumptfolioUgmultipleMerl-deficientmmmrytumytemtum-derivedgnoidwevetigte(i)trgetgrrntlyctivtedHhignlgMerl-deficienttum(ii)potentiltrgetdegultedtrypphnmetbolmMerl-deficienttumOurpprochen-overlppgcomplementryOutcomeourwkpenttwounpcedentedtrtegietrgetpoiblelibilieMerl-deficientbtcncerefdgcnexped/trnltedtumtypehrbMerldeficiencyPROJECTSUMMARY/ABSTRACTChimericntigenceprT-cell(CART)hvevolutiizedcncerrpyHoweverCARTcuetwocommevexicieCykeReleeSyndrome(CRS)ImmuneEffecrCellAocedNeuroxicySyndrome(ICANS)CRSICANSoverlppgphenomenthccurpectrumeverymildlifeengEffectiverpieCRScurntlyextevefrcrycetilloccurEffectiverpieICANSlckgThepthophyiologyCRSICANShvenotyetenfullydefedpcludgdevelopmenttrnltinovelrpieInprticulrrolehotnteimmuneytemecdipolyunderodThepecificobjectivethprojectidentifycellulrcykeirCRSrolecomplementflmmomebiologyICANSInSpecificAim1cidtedetermenumrtrncriptilctivtittediffentmocyten-mocytepopultiocedCRSugglecellRNAequencg(cRNAeq)tetrolenovelmocyteproducedcykeprimgiCRSInSpecificAim2cidtedectroleflmmomecomplementdygultidevelopmentICANStetdividulcomdpprocheflmmomecomplementblockdepventgttgICANSThecidtepedriccologtcommtedundertgimmunedygultidderthccurcequencecncerimmunpyThepropoedtrgplnerchprojectcductedtChildnHoplPhildelphi(CHOP)UniveryPennylvni(UPENN)CHOPUPENNledercellulrimmunpiebiccliclimmunologyprovidenouttgenvirmentwhichcductpropoederchThroughoutperiodwrdcidtemendDrDvidTecheyverytrgdvycommteecludgDrEdBehnMrcelMuWenchoSgStephnGruppThelg-termgolcidtedeveloperchprogrmdevotedundertgrolenteimmuneytemimmunedygultiltedcncerimmunpieimprovghelthptientfciltgtrnltilexicmoeffectiveimmunpieCompletipropoederchprojectcomplementrytrgplnproviderobutfoundtichievethgolProjectSummryTriple-negtivebtcncer(TNBC)highlyggiveocedpoclicloutcomeTNBCmjcuedethmgbtcncerptientlyubtypebtcncertillhfeweffectiverpeuticoptiThtudyddethcriclmediclneedco-trgetgpoly(ADP-riboe)polymere(PARP)STAT3bothBRCA-mutntBRCA-pricientTNBCcellTNBCfquentlyhrbBRCAmuttiwhichultdyfunctilDNApirmechnmPARPhibicjunctiloDNApirviBRCA-dependentmechnmultedynticlethlyugmentedTNBCcelldethInddicentptdictePARPhibircombtifewdrugcnduceBRCAnephenotypeloeffectiveBRCA-pricientcncercellHoweverttmentgle-gentPARPhibirnotdurbleledgtncerpydeeprogiTNBCcellleectehighetlevelInterleuk-6(IL-6)compdubtypebtcncercellleIL-6/STAT3ignlgcfertncenti-cncerdrugInddiournovelplimryultdemtrtePARPhibirtlzopribcnduceIL-6phophyltedSTAT3levelTNBCcelltlzoprib-ttedTNBCcellcouldpotentillycomemotnttlzopribrpyugmentgIL-6/STAT3xtrgetgSTAT3mypotenteTNBCcelltlzopribrpyThupptedSTAT3iRNAcnenizeTNBCcelltlzopribOurcentrlhypodulhibiPARPSTAT3tlzopribLLL12BcombtilrpyneffectivepprochhibtumgrowthcurncemettbothBRCA-mutntBRCA-pricientTNBCcellThhypoupptedournovelplimryult(1)STAT3hibirLLL12BSTAT3iRNAcnduceBRCAnephenotypeBRCA-pricientTNBCcellupptgPARPhibirrpeuticutilyBRCA-pricientTNBCwellwhencomdLLL12B(2)combtlzopribLLL12BynergticllyhibcellvibilyignificntlyhibcellmigrtiBRCA-mutntBRCA-pricientTNBCcellWetethypotwopecificim(I)EvlutectivytlzopribLLL12BcombtihibgBRCA-mutntTNBCtumexpnicurncemettugthopicmouetummodelvivo(II)EvluteefficcytlzopribLLL12BcombtihibgBRCA-pricientTNBCtumgrowthcurncemettugthopicyngeneicmouetummodelvivoThtudynovelignificntcueeekextendcurntPARPhibirttmentwhichlylimedBRCA-mutntTNBCynergticllyco-trgetgPARPSTAT3bothBRCA-mutntBRCA-pricientTNBCIfuccefulourlg-termobjectivetrnltgthnovelrpeuticpprochtlzopribLLL12BcombticliclevlutihpotentilimproveptientcurvivlwomenffectedBRCA-mutntBRCA-pricientTNBCPROJECTSUMMARY/ABSTRACTLimticheckpothibircncerttmentcludepciptiuimmunytnceimmunpyFomecncernotblyprottelymphocyteunblefiltrtecncermicroenvirmentTheenewpprochetrgetquidHewepentCD6cellurfceglycoproteexpedmotT-lymphocytehumnnturlkiller(NK)cellenggecell-cellterctibdgligCD166(ALCAM)CD318(CDCP1)CD6-/-CD318-/-micehelthytntductiTcelldependentuimmunemodelmultipleclerouverheumidrthrMooverCD6-humnizedmicemocllnti-humnCD6ntibodywedevelopedtermedUMCD6trikglyeffectivettmenteuimmunecdiBothCD166CD318twoligCD6highlyexpedmnycncerexpiCD318clteggivenemettmnytypehumncncercludgprottecncerCD318cnlohedcncercellolublem(CD318)chemotcticNKcellTcellWehvecentlyfoundprottecncercelllehyper-exphyper-hedCD318ctggrdienthltlymphocytemigrtiprientrytummicroenvirmentAddillywetetedeffectblockgCD6-CD318xUMCD6bilyhumnlymphocytekillhumnprottecncercellWefoundUMCD6enhncedlymphocyte-mededprottecncercelldethducedcncercellurvivlWehypoizeUMCD6ctdictlyCD8+TcellNKcellcnproducecompletepevivohumnprottecncerimmunedeficientmiceWelopropoeUMCD6chetrteprottecncercelldethexteniveltertigeneexpiNKcellCD8+TcelllicengecellkillcncercellmoggivelyWeevluteefficcyUMCD6ugpeteddmtrtiUMCD6humnlymphocytetthumnprottecncerxenogrftedcid-igemiceWelodemtrtehighccentrtiCD318hedprottecncercnexcludelymphocyteentergprottecncervivounleCD6ternlizedToverifyvivomechnmnticncereffectUMCD6flectptternltedgeneexpilymphocytevrowepermglecellRNA-eqmulticolflowcymetrytum-filtrtglymphocyte(TIL)WeloeignificnceupgultedtimulryceprugblockgntibodiegteceprcncercellkillgyTheeexperimenttructudprovidecompellgrtiledvncgCD6-trgetedimmunpyclicltrilhumnprottecncerHepcellulrcrcom(HCC)motcommprimrylivercncerpentecdmotcommcuecncer-lteddethwldwideInddilivermotcommemettticcncerTrnrterilchemo-rdio-embolizti(TACE/TARE)unectbleHCCexploheptictumbloodupplyvihepticrteryelectivelydeliverembolicgentrpeutictrgetedgiliverHoweverettmentlrgelypllivedictvuliztideliveryfterctrtwhoutnotpoibleThunewrnoticmodlieurgentlyneededAlph-emtgrdiophrmceuticlrpy(RPT)emergghighlypotentttmenteffectivelytrgetglecellmimliduldeemicromettticleierdictecncercellexhibtncecventilttmentTodddiffui-limedpenetrtidepthRPTmyultprtiltumirrdiwepropoedevelopdulmodlyimgg-vibleexoome-mededrdinoticpltmnlphemterdeliveryInSpecificAim1weevluteimggvibilytrgetgbilyrdiolledexoomecellmolyer3DvculrizedpheroidAelectedRPTmultitetedecpicthopicHCCmouemodel(Aim2)llowguevlutebiodtriiefficcyfetyvrtumltrrterildeliveryThepropoedtudybrguniquecombtiexperterdioyndoimetrymediclimggnimlmodelcncerddcriclchllengeeffectiveHCCttmentSuccefulcompletipropoedctiviehvevtrmifictidvncgdevelopmentexoome-mededRPTttgHCCcncerPROJECTSUMMARYInhibirgtmutntKRAScogenecedeemedundruggbleimpivelyhowgtumctrolpclicltetgentergclictetgvrioumlignncieceKRASG12ChibirSibggFDApprovlMRTX1133KRASG12Dhibirnowentergphe1clicltetgpenthopeptientrgKRASmutticludgignificntnumrnevermokern-mllcelllungcncer(NSCLC)56%whomhveKRASG12D-mutntcncerMTRX1133likelyultprdigmhifteNSCLCptientMooverNSCLCpdwellimmunpythuefficcycombgKRAShibiimmunecheckpotimmunpy(ICI)expectedevengterHowevermnymoleculrlytrgetedrpietnceelpecommThhenobervedptientttedSibccerntnceMRTX1133KRAShibirlodevelopRetncetenlkedmodelgtummicroenvirment(TME)thunimpertiveneedhemergedundertthmodelgprocedurgterventumcurnceguidedevelopmentfuturpeuticttmentprdigmlg-termpeOurnlyTMEuniqueKrG12DducibleveriblemouemodelNSCLCugglecellRNAequencgdthowKrG12D-dependentctrolTMEUpgKrG12DexpiPDL1decedubetmyeloidcellpotentillydictgptientmutntKrG12DunlikelypdimmunecheckpotrpyugPD1/PDL1hibirIntetglywhenKrG12DwturnedOFFexpiPDL1cedprovidgtrgrtileco-ttmentKRAShibirICIeptientThuwehypoize)ctivticogenicKrG12Ddvncedtumenizelungcncernti-PDL1ntibodieb)rpeuticterventitrgetgKrG12DultmodelgtummicroenvirmentToteurhypowedetermetumgiurvivlnefKrG12DhibiwhecogenicKRAShideirgeneticllyMRTX1133combtinti-PDL1ImptntlywelotudytumcurnceNSCLCduerpeutictnceourmodel(Aim1)Toddurgentneeddeveeffectivettmentlg-termpeundertterctitweencogenicKRASexpgcellurroundgTMEdurgttmentlpewethoughlyevlutefibrobltimmunettulpedKrG12D-drivenlungcnceremiceThetrictemechnmKRASG12D-gultedTMEprticulrlyfibrobltcelllocrutizedptientderivedgnoidmodelugMRTX1133co-cultumtchgfibroblt(Aim2)Succefulcomplethpropolprovidectiblebiomrkerrpeutictrgetlpedtumdevelopglg-termrpeuticolutiTriplenegtivebtcncer(TNBC)tntcventilrpieledgpodee-feurvivlhighcurncerteHoweverctrtbtcncerTNBChvemotumfiltrtglymphocytemkgmubletrgetimmunpyWhileimmunecheckpothibircombtichempyrdirpyimmunpydrughvedemtrtedclicllylevntimprovementoverllperteTNBCptientpetilllimedubetptientOverptdecdeimmunogeniccelldeth(ICD)hencognizednimpertivetepnti-tumimmunyICDpecificcelldethpthwyducedcellulrtultgexpouectieverldmge-ocedmoleculrptterncykewhichfciltecro-penttumntigenCD8+TcellICDductihcomencglypopulrttmenpticombtirpiepcliclclicltudiedemtrtgchempycnctnICDducerTNBCHowevernewICDducerneededcombtytemicxiciecogenicideeffectchempyFocuedultround(FUS)n-xicn-iizgdilyclicllytrnltbleoptin-vivetrgetedtumdetructiImmunpynemerggpplictiFUSrmlFUShenhownduceleetcttum-ocedntigenhet-hockprotendicrICDbtcncerHoweverICDductifterrmlFUSpplictihnotenthoughlychrcterizedfunctirmldoeThpropolchrcterizeductiICDfterFUSrmlttmentvetigtemountgdptiveimmunymuTNBCtummodelTwmlFUSmechnm(hyperrmirmlblti)evlutedtwopecificimAim1quntifyICDductifollowgrmlFUSptilgtrtimultipleximmunluocenceMRI-derivedrmldoebiomrkerAim2quntifydptiveimmunepefollowgrmlfocuedultroundducedICDTheuccefulcompletipropolmhowrmlfocuedultroundcnfluenceimmunogeniccelldethubequentdptiveimmunymutriplenegtivebtcncermodelTheevlutedFUSexpoucndilytrnferdfutuclicltrilptient-pecificttmentmirgMRI-bedrmldoebiomrkerldyutilizedgogFUSbtcncerclicltrilAbtrctTcellplycentrlrolenti-cncerimmunepeEngeergdmtrtgtum-pecificTcellhveuccefullyttedometypecncerCompdchimericntigencepr(CAR)-TcellrpieTcellcepr(TCR)-TcellenggetumcellthroughengeedTCRbdpeptidepentedhumnleukocytentigen(HLA)TheepeptidecnderivedtumntigennycellulrcomprtmentmkgTCR-TnttrctivepprochdevelopgnovelengeedTcellrpieIdentifygubletum-pecificTCRmotcricltepdevelopgTCR-TrpieHoweverlymllnumrTCRcognizehdtumntigenhveenidentifiedwhichmjbottleneckdevelopgnovelTCR-TrpieHewehveidentifiedtwotum-filtrtglymphocyte(TIL)mpleptientcndrmticllyctivtedthedependentccRCCcellledictgeTILctTcellcognizghdtumntigenWefurrfoundccRCC-TCR1wdomnteTILwhdllctivtedTcellThccRCC-TCR1HLA-B0702trictedwhichcrried~26%AmericnInvrokillgyhowedeTILhighlycyxicccRCCcelllenMHC-I-dependentmnnerTheedtcollectivelyuggetedhigh-ffyTCRpotentillycognizewidelyhdccRCCtumntigenWepropoetwoimdevelopTCR-TrpyccRCC-TCR1ttkidneycncer1)determentigenpecificyccRCC-TCR12)determevivtumctivyccRCC-TCR1TcellByidentifygntigenccRCC-TCR1evlutgntumctivyvivnltilprojectpvewyfutucliclpplictiAtcompletiprojectexpectedoutcomehvetum-hdntigenidentifiedmovewrdcductddilp-clicltudieppeclicltrilccRCC-TCR1TrpyProjectSummry/AbtrctNeuroendoctum(NET)clicllypthologicllyimilrdplyignificntdiffencedeeprogirpeuticpeoverllurvivlThelimedccurcycurntprognoticbiomrkermjunmetcliclneedprticulrlytumtyperpidlyrgpvlencecidenceWhilegeneticdriverhveenidentifiedegeneticltertilimedcncercelldotprovideytemticementmtiencodedtcttummicroenvirment(TME)cludgroletumrchectuptillygnizedimmunologiclproceeFexmplewhileemerggevidencepropoekeyroletum-ocedmcrophge(TAM)chetrtgnimmunouppiveTMEptient-pecificfcrmedecell--cellterctiloclizedchemokecykeignlgNETcurntlyunknownToddthknowledgegpwkourgroupgle-celltrncripmicprilgNEThetblhedTAMdplyndverectuumcelltte(ienoteprtedhriclM1M2groupg)whileexpgtum-pecificchemokecykevolvedgultgkeyimmunepthwyOurfdghighlightignificntheterogeneymyeloidcomprtmentNETprticulrlyTAMmyferpotentilpromgtrgetprognorpyHoweverunlockgthpotentilquiytemticundertgptildtriiterctiediffentmcrophgecellpopultibothcncercelllymphoidcellpopultiwhichger-multi-cellulrytem-dictteimmunouppictivtiTheetricteptilighttillmjlylckgobtgmlycentlypoibledventnewptiltechnologieToundertunderlygproceedriveNETprogiwellvelpotentilrpeuticvulnerbilieweteurhypocrotwomutullycgimInAim1weidentifyexctptilcompoirchectucellulrcrotlktumTMErchivlNETcnecbtedmtimcrophge-centricignlgproceeInAim2wedetermeifytemticptildtriiterctimcrophgecellpopultiNET-pecificchemokeprileoceddeeoutcomeNETTheuccefulimplementtipropoedtudiecouldprovidenovtivedt-drivenightcomplexmcrophgebiologyccurntlyetblhhigh-dimenilprilgTMEcliclbiomrkertrnmgprognotictrtificticliclmngementptientNETpotentillyidentifygnoveldruggbletrgettumwholeHewepropoenewEpigeneticDNApirGenomic(EDGe)TrgProgrmCnceruppt4p-docrltudentperyerEDGetkedvntgemtictetfieldDNApirepigenomicterectiefieldctextcncerprovideopptunieterdciplrytrgterctimgtudentdedictedtrgfcultyTheUTHelthSAIntegrtedBiomediclScience(IBMS)grduteprogrmterdciplrymnytudentpecilizecncer-lteddciplecludgCncerBiologyBiochemiclMechnmMediceCellBiologyGeneticMoleculrMediceWhethedcipleprticulrtrgtetbothDNApirepigeneticctroltrncriptiprogrmltecncerbiologythoughwenotlimethedcipleAnfocucricllyimptntterfceDNApirtrncriptigultichromrgniztielucidtebcncerdevelopmentidentifypotentilrpeutictrtegieThT32trgprogrmtkedvntgefcultyexperte(25+experiencedmenr)multi-dciplrylederhiptructuvilbilycurriculumfrtructulevntpiccnprovidecro-dciplrytrgcncerbiologyournextgenerticncerbiologtThehighlyterctivefcultymenrbrgtrgexpertecriclpectDNApirepigeneticbiochemicltructu/functicellbiologybiomtictrnltilpprocheThefirttwoyerIBMSgrduteprogrmcludecompletgtwoyercourewkbothgenerlIBMScourecodciple-pecificcoureStudentppotedpropoedT322yerfterpgirqulifygexmfollowgrigoucompetiveevluterviewAprtthEDGeTrgProgrmwequecquicro-dciplrytrgtngnirundertgcncerbiologyDNApirepigeneticcludgcncerbiologycocourebiomticTeloquidtkentutilcourepiblecducterchvolvedte-gnizedeventplnngprticipteddilenrichmentctivieuchTex-wideGenomeIntbilyGroupemrerieTheyloexpectedprticipteT32-pecificmeetgcomprgerch--progpenttittendMyCncerCenternnulttAmy-ervgeductiltutediverytrgmjcompenurprogrmeekgpromotecrumenttentidiveretudentwhilewkgenhnceoutcomecgcompetivecrerielectiugmentgmenrgEDGeevlutednnullynExternlAdvyCommteequrterlyExecutiveCommteemeetgThT32propolhbrodtutilupptflectedfncilcommmentGrduteSchoolLgSchoolMediceMyCncerCenterOfficeVicePidentReerchSUMMARYThegolthprojectctenovelimmunpeuticdrugcidtegvrincncer(OVCA)OVCAledgcuedethgynecologiclmlignncyUnedSttepourvivlrtedueltedignochemo-tntftlcurntdeefterfirt-ledebulkgurgerychempieImmunecheckpothibirhvethufrfiledhowignificntcliclnefduehighlyimmunouppivetummicroenvirmentpofiltrtiTcellThudevelopmenteffectiveOVCAimmunpyquinoveltrtegieToddthproblempropoedprojectctenovelimmunpeuticprotebedAvnlectItmll14-kDcombntproteengeedPIlbrynturlcmycetelectwhichelectivelycognizecluterhigh-mnnoeglycnpvlennurfceenvelopedviruemlignntcellAfuiprotectgAvnlecthumnIgG1Fc(AvFc)wpvioulyhownexhibpotentntivirlntumctivieoutxicyvrovivimlmodelBedgrowgevidencedictghigh-mnnoeoverccumultilooccururfceOVCAcellwehypoizeAvnlectcnutilizednovelOVCA-trgetgtrtegieOurplimrydthowAvFcefficientlybdOVCAnotdjcentnmltueAvFcelicedpotentntibody-dependentcell-mededcyxicy(ADCC)gtOVCAcellleFurrmoAvFcttmentexhidmoderteyetttticllyignificntefficcyextendgurvivlnimlyngeneicthopicmuOVCAmodelugID8cellleBuildgedtthprojectwecteimmunotimulryvrintAvnlectcntrnmOVCAmoimmunologicllyhottumexhibgpotentimmunpeuticefficcySpecificllyweengeertrnltilfuiprotectgAvnlect/AvFcnntumcyke(lectike)InAim1wegenertelectikefugvrintIL-2devoidCD25bdg(IL-2v)IL-15AvFcwhichproducedNicotinnthminplntugtrnienvexpiytemAfterthoughpurifictiweeirmoleculrpropertieOVCAcell-bdgffycykefunctibtterybiochemiclbiophyiclcell-bedyInAim2weevluterpeuticeffectlectikecomprAvFcmuID8OVCAmodelDeeprogimidthroughbdomencircumfencebodyweightlivenimlbiolumecenceimggImmunophenotypgperinelcellpermedflowcymetryWenticiptelectikeelicignificntefficcythroughcedimmunectivtummicroenvirmentSuccefulcomplethpilotprojectetblhnilpro--cceptgenertecompellgdtetfurrvetigtidevelopmentfirt--clOVCAimmunpyTleAnoveluteleiomyorcommouemodelrpeuticdevelopmentPROJECTSUMMARYUteleiomyorcomnextmelyrclicllyggiveutecncerrgmoothmucleuteruEchyeretimtedoccur6outevery1000000womenUnedStteThevergegetdigno51womenuteleiomyorcomhvepoprognoCurntrpieuteleiomyorcomnotveryeffectiveprimryttmentuteleiomyorcomurgeryDuetricrrythdeepropectiveromizedclicltrilexmgoutcomedividuluteleiomyorcomlimedMooverpoundertgpthogenethdeelomjknowledgegpdevelopeffectivettmenttrtegieThupclicluteleiomyorcommodelcpultehumndeedepertelyneededupptclicltrildeHomozygoup53muttihomozygouPtendeletihveenobervedpproximtely61%19%humnuteleiomyorcompectivelygeneticmouemodelp53homozygoumuttihomozygoudeletiPtengeneticllylevnthumeeHowevergenertehomozygoup53muttipvioulydevelopedcdilTrp53mutntllele(uchLSLp53-R172H)micenotfeibleItcuemicehomozygouLSLp53-R172Hllelep53nulldiemlylymphomt4-6mthgeHoweverTrp53wm-R172HTrp53wm-R245WllelecentlydevelopedurIntuteexpfunctilwild-typep53evenmicehomozygougenotypeThuenovelllelellowhomologoumutntp53expiPtendeletigenertedupAmhr2-C-mededcombtiOurplimrydthowedmouehomozygoup53muttihomozygoudeletiPtendevelopedmettticuteleiomyorcomround24weekgeRNAeqGeneSetEnrichmentAnly(GSEA)dictedgeneexpiuteleiomyorcomemicelikehumnuteleiomyorcomThuwepropoeturrundertmechnmunderlygiprogiuteleiomyorcomugemouemodelwhichledmtildrugdevelopmenttetgScep53muttiPtendeletiloverycommcncerwhtwelernemouemodelpotentillyneftudycncerheterozygouhomozygoup53muttirpeuticdevelopmentPROJECTSUMMARY/ABSTRACTAdvereevent(AE)criclcompentclicltrilfetydtprotectptientunneceryrkdevelopfetypriledrugnef-rkementMenwhilevrioutudiehowedociAEclicloutcomelungcnceruchhyperteniimmune-lteddvereeventimprovedurvivloutcomehighneutrophil--lymphocytertiocltedweurvivlHoweverduecomplexyAEdthenunderutilizedub-optimlAEptg(egwtgrdemethod)efficientlyeptientfetyefficcyprileWhileextgpprochehvetriedimprovechrcteriztiAEprilelimtihvepventedirbdpplictidueeirlimggleAEnlylckfullutiliztiAEprmeterdifficultyterpttiuncerttyclicllevnceThhighlytrnltiltudyimchngeprdigmAEdtugedecriptiveummrymodernmtiveAEbiomrkerfulfillpcimediceWehypoizeAE-derivedbiomrkerhveclicllypdictivevluelungcncercuebilyextenivelyegrdettmentltedneoccurncefquencydurtiWelolievecompheniveAEdtnlymoderntrtegyoverllAExicyctegyAEdividulAEfciltedevelopmenttegrtiveAEbiomrkerigntupdictgclicloutcomeTwovtiveerchAimpropoedchieveoverlltudyobjectiveAim1evluteAEbiomrkerpdictivevlueclicloutcomelungcncerGivenpromgAEplimrydtwefirtteurnewfrmewkidentifygAEoctmentpeurvivloutcomeuniqueetnewtudycohtn-mllcelllungcncer(NSCLC)ttedimmunpy(Aim11)WefurrevluteAEbiomrkercliclociNSCLCttedchempypcirpy(Aim12)Aim2buildmodernAEnlyolfcilteidentificticlicl-ocedAEbiomrkergenertiumtedmtiveAEptWedevelopnewclicllylevntAEnlyfunctienhncedtnlyAEpt(Aim21)WentegrtedevelopedAEnlyfunctiuer-friendlyoltmledtnlyumtedptgenerti(Aim22)IfuccefulAE-derivedbiomrkercouldhelpclicinerlydetermewhohouldtytrilttmentnef(egttment-ltedlow-grdeAE)whohoulddctueddueeffectivettment(eghigher-grdeAE)ThemtiveAEnlyolcouldlevergedcliclerchcienttdcovernovelAEbiomrkerfciltevtmengfulAEerchhypoeABSTRACTThecentrlgolthR50ClicinScienttAwrdpplictietblhfeproceefcilteclicltrilcncerterceptTheUniveryKnCncerCenter(KUCC)uniquegoldiffentmjyR50pplicntwhichfocucncerttmenttrilCncerpventinmedcncerterceptiiectiverrthnpivecncerpventidruptcncerpthwyerlynNCIpriyTheKUCCNCI-deigntedcomphenivecncercentergilledercologycCncerPventiCtrol(CPC)erchprogrmgnized2019hldyhdtmendouucce69%CPCmemrprciplvetigrfundedcncer-ltederchgrntcludg29%fundedNCICPCmemrpublhed309rticle2022Imgtroenterologtphyicin-cienttfocucncerpventi/terceptiIjoedKUCC2017buildourgtrotetl(GI)cncerpventiprogrmmjgilneedgroundupTheprogrmhgrownexpentillynowloervecduccrulcncerpventibiomrkerimggtrilOneuchexmple14-centerNCItrilAPheIICliclTrilMultrgetedRecombntAdenoviru5(CEA/MUC1/Brchyury)Vcce(Tri-Ad5)LynchSyndrome(NCT05419011)wheIerveLedPIStudyChirTheKUCCCliclTrilOffice(CTO)huccefullyupptedcncerttmenttrilhowevermnyCTOproceecncerterceptrilcntillimprovedCncerterceptrilhvediffentchllengecompdcncerttmenttrilcueptientpopultidoenothvectivecnceredoenotterctdictlycncercenterUnlikettmenttrilecncerpventiprticipntmynotexperienceimmedenefHencecrumenttentitrtegyneedemddedcliclctructuwhichprovideimmedevluecentrlidehdmyGIcncerpventiprogrmIpropoeimproveKUCCCTOproceei)hirgprojectnvigrfciltetudypprovlPIn-cologydeprtmentoutideKUCCii)trgerchcodrpventriliii)etblhgproceeourcehrgtweenKUCCn-cologydeprtmentiv)tmlgnlytrnltilendpotv)improvgmycrumentviJunhomegrowncenterpromoteLhelthvi)expgextgTheKnPtientProviderEnggedPventiReerch(KPPEPR)NetwkimprovecceunderervedrurlpopulticncerpventrilIuemyctiveprticiptwoNCI-upptedErlyPheCliclCncerPventiCti(NthweternUniveryUniveryMichign)brgcncerpventrilKUCCtrjunifcultymemrutgrowhprogrmIhveetblhedltihipledgvetigrfielddevelopnewerchcpbilieuchmeengerRNAcncervccecncerterceptiPROJECTSUMMARY/ABSTRACTHodgkLymphom(HL)hfirtcidencepekdolecentyoungdult(AYA)yerDepeuccechempyrdiyoungerchildnolderdulthengpurvivlAYAInddhgrouptrkdecedcceclicltrilWhvilbilyntibodydrugcjugteimmunpiecnttHLpromewecnducembidyhricchempyrdigimenlimlgtermoverllurvivlfurrAYAblckHpnicptientInherroleScientificChirHLcommteeChildnOncologyGroup(COG)DrCtellogolccelertecptiimmunpyCD30-trgetedcellulrrpychildnAYAthroughcollbtivetrilNCTNgroupbothilrpylpedfrcrydeeSheloplndelivertrildeigncpteemerggtum-microenvirmenthotbiologyHLtterrktrtifictipe-bedpprocheOnntillevelhelopropoedvncethroughlederhipNODALdtcommthroughnlyelkgtrildtextntepidemiologicdtpotttmentfollowupAttutillevelProgrmlederLeukemiLymphomtAflcCncerBloodDderCenterWhipCncerIntutehepropoeledytemticqulyiveenhncetrilenrollmentAYAptientunder-pentedrceethnicyGegiHerlederhipleukemilymphombiopoirycnextendedctgfrtructubnklymphomtuewhichcnenhncetrnltilwkwrdpcrildeignlpedHLrlymphomTheeftupptthroughR50wrdwouldllowhertimeccelertetrillymphomntillyenhnceAYAccrullocllyHerexperienceproductivydtepoiherucceroleR50CliclReerchpeciltAbtrctMnynti-tubulgentuchpclxel(Txol)hveenuedextenivelyttmenteverltypecncercludgovrinlungbtcncerDepeirwideuecncerttmenthoweverptientpehighlyvribledrugtncemmjcliclueIteeentilidentifyprognoticmrkerpdictptientpeenhncedrugenivyProtetyroeke(PTK)plyignificntrolecncerdevelopmentmnyPTKhibirhveenwidelyuedttmentmlignncieclicltrilWecductedPho-tg-bedbiochemiclcengdetermegultifunctiPTKdurgTxolchempeuticInpeTxolttmennemotignificntchngePTKfmilymrkedprotedegrdtifibrobltgrowthfcrcepr4(FGFR4)InddiFGFR4ctrolTxolchemoenivyovrincncercellImptntlyFGFR4expilevelelevtedcurntpot-chempyovrincncerptientTheeplimryultprovidetrgpmeuppurhypoFGFR4ignlgfunctirpeutictrgetpclxel-bedchempeuticttmentdrug-tnt/curntptientWeteurcentrlhypotwopecificimAim1DetermehowFGFR4gulteddurgTxolttmentAim2TrgetgFGFR4overcomepclxelchemotnceovrincncerTheidentifictinewgulr/ignlgpthwytriggednti-tubuldrughedlighnmechnmunderlygchemotnceOurtudyidentifieFGFR4ignlgpotentilrpeutictrgetcurnvrincnceruggetcombgelectivehibirFGFR4(clicldevelopment)Txolhveenhncedefficcyttmentchemo-tnt/curntptientPROJECTSUMMARY/ABSTRACTGuidedmy16yerexperiencelederhipNCI-podclicltrilnetwk(NCI-CTN)thR50ReerchSpeciltwrdfercriclupptwouldllowmefullyenggehigh-yieldctiviecropectrumeductillederhipclicltril-ltederchendevFundmentlechpropoedctivyctentfocuducghelthdpriepromotgdiverymodernclicltrildevelopmentIwouldctueprovidetrglederhipmyrolememrNCI-CncerPventiSteergCommteeViceChirNCI-GtrotetlRectl-AnlTkFcepirgubminovelcceptrigouequbleviewenhncgdiverycommteememrhippnelptientdiveryourclicltrilAPrciplInvetigr(PI)rce/ethnicllydivereNCI-NCORPPheIIIclicltrilS0820/PACES(PventgAdenomColEflnheSuldc)Imcommtedcompletgllerchctiviefive-yerperiodthgrntyieldghighetqulydtmengfulterpttiourultGivenextgtrgntiwidecollbtithR50grntenblemectueenggenovelmycrumenttrtegieNCI-netwk-bedclicltrilwebuildupourpriromizedtrilevidenceIwouldlevergeprotectedtimeprovidedthR50grntmenrdiveregroupjunifcultycliclfellowvrioucncer-lteddcipleurtuti(UCIrveChoFmilyCompheniveCenterUCI-CFCCC)NCI-CTNerchMooverthR50grntwouldprovidemeunomydvncenewlederhippoicomevilbleovernextfiveyerloclly(tUCI-CFCCCwheIcurntlyerveViceChirDtSfetyMirgBd)ntilly(SWOGvriouNCISteergCommtee)LtlygivenUCIhrictngtherlyphecncerpventiclicltrilthgrntctenexcgopptunyourCncerCenter-enggeNCI-DiviCncerPventiCliclTrilNetwk(CP-CTNet)ASePIIpropoeledUCICP-CTNetAffileOrgniztiexpgcceourctchmentdiverepopultierlyphecncerpventiclicltrilPROJECTSUMMARYOver25millikcncerdignoednnullyUnedSttemothnllmcncercomdErlydignocriclthuwepropoedeveloptwerblemgneelticmicreedleptch(MMP)n-viverpidkcncercengItcouldpermftcnngptiltiffnekleidepthup5mmThcceptetblhedbPIpriuccedcoverggintmgneelticeffecttmtter(NtMter2021201670)WhfundmentllynewwkgmechnmpropoedtMMPcncoverlrgedetecti(77cm2)hvehighptiloluti(1mmtduper-olutilghm)highfrmerte(2000Hz)ultrhighenivy(<2kP)WehypoizepropoedtMMPenbleftn-vivecnngktiffnebothleibderptillywhichcnuedexperimentlly/clickcncererlydignocenglgudlmirg/guidgcncerexciToteurhypowepropoetheimAim1SclbledeignoptimiztitMMPftptiltiffnemppgAim2VlidtetMMPvitiffnemppgmicemodelkcncerAim3VlidtetMMPvitiffnemppgexcedhumnkcncerPROJECTSUMMARY/ABSTRACTRelpeddeekeychllengecncerbiologymediceCncercelldynmicextflexiblytercvertgepigeneticlly-pecifiedttegultedmtertrncriptifcr(mTF)TheemTFdetermetrncripmeultntmlignntphenotypecludgctrollgtrikgdiffenceenivychempieThepencecellulrheterogeneytumdrivenepigeneticctrolcellttemechnmwhichtumcellmyecpettmentThhenchllenggtudycetumcommlymrkedhighmuttillodwhichmyobcuctriicelltteIntriguglypedrichigh-rktumneuroblm(NB)heterogenoulethltumocedepigeneticlly-plticcellttemrkedlowmuttilburdenThmkeNBnidelytemtudyctriicellttechemoenivyOurlg-termgolueepigenomicctrolcellttedevelopmechnticlly-bedtrgetedcncerrpieTheobjectivethpropolterrogtehowmTFctrolcellttechemoenivyNBOurcentrlhypochemotnceenivyctrolledmTFetblhNBtrncripmecelltteThhypomultedbedplimrydtugnewytemcludgcelltteptergenomeengeergcoupledchemiclbiologydecteflexibly-tercvertgcellttetermeddnergic(ADRN)meenchyml(MES)tteThertilethwkMESADRNNBcellttedplydiffentilenivychempieflectmechnmwhichNBcellevdecventilrpydrivglethltumlpeThhypotetedtwoprllelpecificim1)InterrogtgtrncriptilctrollerMESNBtteleverggthrpeuticnef2)DectgtrncriptilmtennceADRNtteFirtweueourptergeneedg-expimodeldetermehowcidtemTFemtMEStteWeidentifyterrogteMES-pecificctlytictrgetdruptthchemotnthigh-rktteSecdweuechemiclbiologypprochenewmodelADRNNBdecthowmTFmtADRNchemoenivetteUgepigenomicncenttrncripmicwedetermevlidtetrgetgultedechmTFetblhchemoenivyTheepprochenovtiveyuenewpprochecludgcellttepterchemicldegrdtidectcelltteheterogeneyNBillumtemechnmcellttechemotncectrolAultweexpectidentifynewvulnerbiliechievgnewerchhizThpprochignificntcueexpourundertghowmTFctrolcellttechemotnceNBidentifynewcell-tte-pecificvulnerbilieThhpotentilchngemngementchildnNBwhileloimpctgourundertgchemotntcellttegultibrodlycncerPROJECTSUMMARY/ABSTRACTDepettmentdvnceoverptdecdemettticprottecncer(PC)mftldeeAuchncuteneedddilttmenptiThedevelopmentrpeuticpecificllytrgetcellurfcentigenpentnttrctivepprochPSMAcellurfceglycoprotehighlyexpedPCcuePSMAltivelytrictedprottictuepentnidelrnotictrget(ieuefulbothrpydignotic)177Lu-PSMA-617PSMA-dictedrdioligwcentlypprovedFDAWhilethclerlywelcomettmenptimedinPFShenpted<9mthobjectivepelyoccur~50%ptientAuchtrtegieugmentefficcyPSMA-dictedrpieneededGivenp-cliclclicldthhownhighunimexpiPSMAocedoptimloutcomeepprochugmentctivy177Lu-PSMA-617woulddmterdrughowncePSMAexpiOurplimrydtUniveryWhgnRpidAupy(UW-RA)progrmhhownubtntilproptimenwhodiemettticctrti-tntPC(mCRPC)hrbtumhvemimlnoPSMAexpiMechntictudieexplgmedirPSMAexpihvedemtrtedepigeneticmodifictipentkeygulrPSMAexpiDNAhypermethyltiFOLH1(PSMAgene)cloedchromttteocedPSMAnegtivetumImptntlywehvedemtrtedepigeneticchngeultgPSMApiveriblettmentvrietyHDAChibirultrobutcePSMAexpivrovivoInthpropolwecductfirtfieldclicltriltetgnovelepigeneticprimgtrtegydeignedcePSMAexpiWeuenovtivetechnologieuniquebiopecimenfeourprimgtrtegydevelopertivepprochemximizecliclnefPSMA-dictedrpieInAim1weevluteeffectHDAChibirvotnPSMAexpidetermedPSMAPETimggWelocductdetiledcltivewkeimggbloodtue-bedpdictivebiomrkerInAim2wefeourepigeneticprimgtrtegycductpclicltudiemertiveclicltrilFllyAim3weutilizeUW-RAprogrmcollectmetttictuemenwhodiedmCRPCceived177Lu-PSMA-617ThenbleudetermegulrPSMAexpidetermemechnmtnce177Lu-PSMA-617ImptntlycueeptientlohvebelePSMAFDG-PETimggwebleevlutedependencyPETimggfetumoleculrphenotypeCollectivelyetudieimptntguideclicldevelopmentPSMArnoticprovidenovelpprocheovercomeprimryecdrytncePSMA-dictedrpieSUMMARYChimericntigencepr(CAR)Tcellrpiepentmjdvncementcncerimmunpy(IOT)fieldhvehownmrkbleucceprticulrlyttghemlogicmlignncieDepeirmeteicelivgdrugfcenumrchllengehvelimedirwidepdutily(epecillyolidtum)cludgbilydcerncellftefterfuiGrowgvetmentdevelopgnewCARTcellrpiedeioptimizeextgehighlighturgentunmetneedtechniquepermn-vivelgudlmirgCARTcellfteAnimggmethodenbleenivedetectictivtedTcellcludgCARTcellvivohpotentilvelmechnmunderlygfiluthuenhncgourbilydeignoptimizeIOTImmuno-poremimogrphy(immunoPET)rpidlyexpgmoleculrimggcomultr-pecificntibodientibodyfrgmentPETrdioopehenmoupotentilhedlighnvivoptiotempldtriifunctilttuCARTcellUntuntelynoclicllypprovedgold-trdimmunoPETrdiotrcerimggtechniquetrgetTcellctivtimrkerRecentlyweidentifiedOX40ICOS(twocell-urfcentigenhighlypecificllyupgultedctivtedTcell)promgbiomrkerimggTcellpeSubequentlywedevelopedfirtPETrdiotrcerimgemuOX40ICOSrdiollgmocllntibodie(mAb)64Cu89ZrdemtrtedirutilyquntifygtrckgctivtedTcellvrietycncerIOTmodelWeloverifiedbothOX40ICOSignificntlyupgultedctivtedhumnmuCD19-CARTcellICOSimmunoPETenblevuliztilttervivoInthR01wepropoebuildourpromgpclicldtdevelopgfirthumn-pecificrdiotrcerOX40ICOSutilizgmAbF(b)2frgmentWehvepermedplimry89Zr-rdiollghumn-OX40-ICOSmAbdemtrtedirpecificyhumnctivtedTcellAddillywehvecquidhighlyencourggvivoimggtbilydurnovelhumnOX40-mAbrdiotrcerAim1volveoptimizgrdiollgICOSOX40mAbgenertgllgF(b)2frgmentddhoughlyegtbilyffyimmunoctivyllfournewrdiotrcerWenvetigtepotentilbiologicleffectvivobdgerdiotrcerctivtedhumnTcell(Aim2)CARTcellltterengeedtrgetliquidolidtum(Aim3)FllyweefetyerdiotrcerCARTcellimgg(Aim3)Completgeexperimentprovidevlublednenivypecificywellpotentilbiologiceffectllfourimgggentguidgiroptimiztiourlg-termgolclicltrnltiSuchOX40ICOSPETrdiotrcerfdnewpprochmirgCARTcellIOTgtpotentilceirclicluccePROJECTSUMMARYOurlg-termobjectiveundertexpifunctimocyte/mcrophgeFcceprgolimprovgntibody-bedrpiedeeuchchriclymphocyticleukemi(CLL)WehvedemtrtedCD20ntibodieimproveoutcomeCLLptientceivgbothchemoimmunpycentlyttmentecdgenertiBTKhibirclbrutibMocyte/mcrophgeplycriclrolentibody-mededdepletumcellyuppedtteCLLInprticulrmcrophgeCLLptientunuullylrgeizeplymjroleupptgurvivlprolifertiCLLcellTheemcrophgehveencllednure-likecell(NLC)WehvefoundctivtgtrcellulrceprNOD2mocyte/NLCubtntillyduceexpinegtivegulruchoilphophteSHIP1hibiryceprCD31CverelywewupgultictivtgFcRIoced-chThledignificntceFcR-mededcykeproducticludgthoectivteNKcellAlguchcykewupgultiNKcellctivtgurfceligmocyte/NLCttedNOD2gtIndeedco-culturgttedmocyteNKcellenhncedNK-cellmturticyxicyCollectivelyeultuggetNOD2gtmyneffectivedjuvntttmentCLLImptntlyNOD2gtMTP-PE(mifmurtide/MePACT)henubjectptcurntclicltriloteorcomwpprovedEuropenMediceAoci(EMA)combtenivechempyoteorcomnimmunedjuvntOverllmifmurtidehncceptblefetyprilewelljutifygnlterntivetrtegyclicldevelopmentBedboveobervtiwehypoizeNOD2gtctivtemocyte/NLClodictlydictlyctivteNKcellTotetpdictithhypowepropoefollowgtheAim1)InterrogtemechnmfluenceNOD2timultimocyte/NLCfunctiloutcome2)ExmemechnmfluenceNOD2timultiNKcellcludgctct-dependent/dependentquimentNK-cellmturticyxicbily3)VlidtecentrlhypovivoNOD2ctivticnledphenotypicfunctilchngemocyte/NLCwellNKcellledgtrgerntumctivyAtcompletietudiewehveetblhednentilynovelmechnmctivtimocyteNKcellCLLthuenhncgefficcymocllntibody-bedrpiePROJECTSUMMARY/ABSTRACTPncticductldenocrcom(PDA)crriedmlprognoUndertgmechnmleddevelopmentpncticcnceridentifymrkerdtguhtweenn-cnceroucncerouleigtethopeerlydetectierlyttmentptientThpropolfocueidentifygerlydetectimrkerwouldllowectumttimepotwheytillloclIurhypopnctichigh-grdeleiignificntlydtguhlow-grdeleiexpgPADI1WefurrhypoizePADI1crulltedubtrtecndetectedpncticbiopymympnelmrkerpecificerlydetectiPDATotetthweverifyPADI1pecificmrkerHGleitetpenceliquidbiopie(SpecificAim1)chrcterizecrulltedfibrogenPADI1ubtrtemrkerpncticcncer(SpecificAim2)identifypnccncerpecificPADI1-crulltedubtrte(trcellulrected)leiliquidbiopy(SpecificAim3)Succefulcompletiourprojectidentifyectedprotemrkerdetectbleeilycceibleliquidbiopy(blooderum)dtguhtweenpncticn-cncerouleiPnIN3(crcomu)PDAleiPROJECTSUMMARYThededlietmdvnced-tgeprottecncerttment-tntmettticctrti-tntprottecncer(mCRPC)whichoccur~35%ptientfterexpourogencepr(AR)-dictedrpieuchAbirtereEnzlutmideultgdmlmedinurvivlly~55mthUntuntelydetecttment-tntdeetypicllyoccuroltewhenptientldyproggAR-dicteddrugfterwhichyuccumbrpidlyirdeeTheecriclneeddetectARtncemoenivelyerlierdeecoureToddthourtemdeignednovelcell-feDNAyclledEnhncerNeighbgLociAndrogenReceprSequencg(EnhnceAR-Seq)builtupCncerPerlizedPrilgdeepSequencg(CAPP-Seq)pltmdemtrteduperbenivydetectgARgenebodyenhncerlocultertiplmcollectedmCRPCptientNotblyweppliedourEnhnceAR-SeqtechnologymCRPCptientplmhowedultcltetrglyclicllyverifiedtnceAR-dictedrpyignificntlyoutpermcircultgtumcell(CTC)AR-V7detectiBuildgupthcurntpropolevlutewherourEnhnceAR-Seqtechnologycnuedpdictboth(Aim1)p-ttment(Aim2)-ttmenttnceAR-dictedrpymCRPCptientFurrAim3wevetigtewhertegrtgEnhnceAR-Seqgenome-widemethyltiequencgcngrnulrlyfeourbilypdictttmenttncemirbothcllphenotypicevolutimCRPCWeuniquelypoiedccomplhhroughourterdciplrytemcompdcell-feDNAgenomictbiomticincologtttticinOverllthtudyhignificnttrnltilimpctetblhgcell-fegenomicepigenomicbiomrkertumevolutitnceAR-dictedrpymenlethlprottecncerAbtrctBtcncermotdignoedcncerecdledgcuecncerdethwomenUSAImmunecheckpotrpy(ICI)volutiizgrpynumrmlignnciecludgtriplenegtivebtcncer(TNBC)Therpeuticblockdeimmunecheckpotuchnti-PD-1movetum-eduppiimmuneytemunleheprolgednti-tumimmunyDepeencourgguccemnyptientdevelopeveometimelife-gdvereeffectmnylofilnefimmunpyExtgimmunerpypepdictivemrkerhvelymodetpoivepdictivevluenoclicllyuefulmrkerxicyOurpropoedtudyfocucompheniveevlutierologiclu-ntibodie(AAb)potentilpdicrimmunelteddvereevent(irAE)nefrpySerumbedbiomrkerexploeymplecceibilydictlymeuimmunepeOurpltmcnrpidlydoptedcliclueOurtudylevergecollbtitweenexpertimmunoproteomicbiomrkerdcoveryphyicincienttpecilizgbtcncerOurtudynlyzemothn3000lgudlerummplecollected1195ptientenrolledromizedpheIIItril(SWOGS1418)tetefficcyeyerglegentdjuvntpembrolizumb(nti-PD-1ntibody)rpycompdobervtihighrkTNBCSerummplewecollectedtbelet1355weekftertrtgrpyllmplennotteddetiledxicyoutcomemtiwecollecteddurgthFDAgtrtrilWeemploytwocomplementryhigh-throughputntibodyprilgtechnologiecludgNucleicAcidProgrmmbleProteArry(NAPPA)MultipleInSolutiAntibodyAy(MISPA)wedevelopedNAPPAllowdetectintibodiegttenthoufhlyproducedfulllengthprotehunddmplewhileMISPAenblemopcequntifictihunddntibodiethoumplecouldcledcliclueOurpprochvolve(i)dcoverytepugNAPPArryterrogteerummpleAAbgt18000humnprotedcoverycoht(ii)verifictitepidentifiedoutcome-pdictiveAAbugMISPApltmugdcoverympleelectfletcidtemrker(iii)bldedvlidticidteAAbugMISPAheldoutvlidtietIdentifictibiomrkercnpdictcliclly-levntimmune-lteddvereeventcurncehenceefficcyrpywouldhelptteretimterknefrtioeveryexpenivepotentillyxicrpiePdicrdvereeventcouldlofluenceptientmirgllowerlierrpeuticterventiThelelernedthpropoedtudyTNBClikelyimpctbrodpectrumcncercedvereeventnotcncertypedependentProjectSummryBtcncertillmotcommmlignncywomenwldwideDepecdibledvncemdeptdecdewrdelimtgbtcncernerlyllwomenmettticbtcnceruccumbdeeTheewedepertelyneednewimprovedpprochewrdelimtgbtcncerThepropoedwkfocuewidelydocumentedcliclfdgnoknownunderlygmechnmbluntedcircultgglucocticoidrhythmptientbtcncerCricllyptientflrbluntedcircdinrhythmcircultgglucocticoid(egcl)ptlowerqulylifediecncererlierthnptientnmlrobutcircdinrhythmGlucocticoidrhythmlrgelyctrolledccertedterctimghypothlmupurydnlgl(ieHPA-x)ctgultediverephyiologiclproceeeentilhelthcludgimmunecelltrffickg/polriztienergymobiliztiroulynchriztiperipherlcircdinclockOurplimrydtdemtrtepcliclmouemodelbtcncerloexhibthbluntgglucocticoidrhythmthccompniedrrntctivyhypothlmicneurgulteHPA-x(iePVNCRHneur)Addilly-etblhgrobutglucocticoidrhythmvichemogenetictimultieneurwewebleignificntlyimpedeprimrybtcncergrowthmouemodelInpentpropolweytemticllydetermewhelgHPA-xdyfunctioccurpebtcnceridentifymechnm()drivgthdyfunctinuethoglpprochemnipulteemechnmcfernef(ducedtummettticburdenenhncedpecheckpotblockdeimmunpy)mouemodelbtcncerTheetudiepentignificnttepwrdourundertghowmlignntproceefluencehothowhotpedicttecncerprogirpeuticefficcyTheedtfurrmdeignnovelrpeuticpprochewrdelimtgbtcncertrgetgHPA-xAbtrctCncermgledgcuedethwldwidehot-bcterilmicrobiotterctiproundlyfluencetumigenecncerprogiperpieNeverlerolefungi(mycobiot)eproceemlrgelyunexplodmgpotentilopptunydevelopgnoveldignoticpventtiverpeutictrtegieAcropopulticoloctlcncer(CRC)thirdmotcommcncertypeInddibcteriwecentlydecridpencelivetrncriptillyctivefungicoloctlcncerHewepetfurrevidencepencectivemycobiotcoloctltumexperimentldtupptghypofungiplynimptntrolecolcncergrowthperpiethroughterctifunglmetbolevirulencefcrtummcro-micro-envirmentWeuenovelmethodologievivomodelgllowgdetermefunglpeciefcrfluenceCRCWedetermepecificimmunemedircellimmuneytemterctfungumppotmechnmwhichpecificfungltrfluencetummicroenvirmentimpcttumgrowthWefurrchrcterizefungumptientmicedetermeutilymycobiomepdicrcncerprogiurvivlperpieTheultetudiectriewrdtterundertghot-mycobiottercticncermightprovidebnoveldignoticrpeuticco-rpeuticnticncerpprocheCRCtrgetgfunglrmmicrobiomeMyeloidneoplmuchchricmyelogenouleukemi(CML)myeloprolifertiveneoplm(MPN)myovertimetrnmchricphe(CP)pectivelybltcr(BC)ecdrycutemyeloidleukemi(AML)BothecdipolypivecurntlyvilblerpienovelpprocheurgentlyneededTothendwehvetudieddtctmechnmBC/AMLtrnmtidcovernewtrgetdevelopcpdgrpeuticpprochepventcudeetrnmtiAcommgollletudieelimteleukemitemcell(LSC)driveleukemigrowthBC/AMLtrnmtiInddimechnmBC/AMLtrnmtricLSCwehvecentlygedightthoeextricLSCvolvetrnmtinmlmrrow(BM)microenvirment(niche)leukemiceHewefoculeukemogenicmechnmduceTcellloctivyexhutiultimtelydriveLSCecpeTcellntileukemicimmuneurveillnceTothendmicroRNA(miRNA)mlln-codgRNAtrgetmeengerRNAgultelevelcpdgproteMIR142highlycervedgeneencodemiR-142whichvolveddevelopmentgultihempoientivedptiveimmunyInhumnMIR142henfoundmuttedlymphomAMLnotCMLMPNWecentlyhowedmiR-142downgulti(defic)occurCD34+CD38-LSCBCCMLptientcompdthoeCPCMLptientledgupotultectriievolutiCP-LSCBC-LSCWhilevetigtgefdgmouemodelweobervedcompdMir142+/+BCR-ABLmoue(CPCMLmodel)Mir142/BCR-ABLmoue(BCCMLmodel)pentedproundTcelllymphopeniignificntductiTcellctivyTothendweloobervedducedmiR-142levelctivyTcellBCCMLptientcompdthoeCPCMLptientbnocimiR-142deficcedPD-1expiTcellexhuticcctimiR-142deficnovelynticmiR-142mimic(CpG-M-miR-142)whichdntileukemicctivyTcellbothhumnmuBC/AMLmodelThuwehypoizehemiR-142deficcquidTcelldurgBC/AMLtrnmtictriephenotypicevolutiCML/MPNBC/AMLvimechnmllowLSCecpeTcellntileukemicurveillnceToproveourhypowepropoethepecificim(SA)SA#1TodetermeroleTcellmiR-142deficBC/AMLtrnmtiSA#2TodectmoleculrmechnmthroughwhichmiR-142deficmedeTcellloctivydurgBC/AMLtrnmtiSA#3TotrgetmiR-142deficTcellderpvent/cuBC/AMLtrnmtiOurultimtegolobtIND-enblgevidenceCpG-M-miR-142noveltrgetgrpeuticTcellimmunyturnelimteBC/AMLLSCAbtrctRB1tumuppgenefquentlymuttedvrioutumcludgblmmllcelllungcncertriple-negtivebtcncerprottecnceroteorcomInddiRB1emotpvlenttumuppgenedrivgmettDepeextenivetudiepRbfmilyproterpeuticpprochpecificllytrgetdefectumuppcurntlynotvilblepentgcriclknowledgegpneederchlterntivetrtegiettgcncerctivtedRB1Synticlethly(SL)pentviblepprochtrgetRB1-muttedtumApirgenecndefedhvgSLterctiwhenperturbtieirgenelenotlethlimultneouperturbtibothgenelethlWepvioulypermedgeneticcenSLprtnerRbDroophileyencfirmedvlidyidentifiedtrget(plicgmcheryRANeIF4A3)humncncercellleptienttummpleMooverwedemtrtedeSLterctipervedpenceddiltrgcogenicltertiuchctivtiRloPten(Prkhkoetl2021)Wehypoizecomdtrgetgtwoynticlethlprtnerlggdiffentpthwywouldhvenddive/ynergticeffecnprolifertiRB1-deficientcellgrowthxenogrfttumInthpplictiwepropoetetmlllibrrydrugtrgetgidentifiedSLtrget/pthwylepirweogenicpirRB1-levntcncercellle(Aim1)tetwhercomdtrgetgtwoSLprtnerelectivelymoefficientlygledruglowdowngrowthxenogrfttum(Aim2)WeexpectthurpropolhvehightrnltilimpctwepriizeFDA-pproveddrugcneilytrnltedhumnclicltrilprovideperlizedpprochRB1-muttedcncerInddiwegetnewightbiologyRB1-deficientcelllgpmottenmutnttumuppgenecncercellTleDevelopgextrcellulrveicle-mededtrgetedmicroRNAdeliveryytemEGFRcncerProjectSummryTrgetedrpyctwell-defedmoleculrmechnmdeepthologietuecellHowevermnyclicltrilencountedufficientefficcyfetyuedueccumultgunwntedgnf-trgeteffectOneuchmoleculemicroRNA(miRNA)mlln-codgRNAplycriclroletumbiologycludgtumprogidrugtncemettthroughequence-pecifictrnltilgultiWhilemiRNAholdpromgrpeuticpotentildvereeventultgeveimmunogenicpetermtedclicltrilThunefficientdeliveryytemeentiletblhgmiRNArpyThprojectimetblhtrgetedrpeuticmiRNAdeliveryytemugengeedcell-derivedextrcellulrveicle(EV)EVbodynturlbiomoleculrtrnptercouldovercomevriouueocedextgdeliveryytemSpecificllyweengeerEVurfcentibodymimetic(mobody)trgetEpidermlGrowthFcrRecepr(EGFR)cncerdelivertumuppmiRNAWehypoizeEVcnefficientlydelivermiRNAEGFR+cellwhemiRNAexertpowerfulnti-tumeffectFollowgEVgenertiwedemtrteemiRNApckggEVhveEGFRtumpecificynti-tumeffectThbuildfoundtiEV-bedtrgeteddeliverymiRNA-bedrpieWeexpecurpprochfernewpoibiliecncerttmentutilizgEVlowimmunogenicycyxicyefficientmiRNAleeTheevlidtiempowerccelertedevelopmentEV-bedtrgetedrpeuticdeliveryPROJECTSUMMARYClercellovrincncer(CCOC)emotchllenggubtypeovrincncer(OVCA)tttnttrdchempyocedpooutcomeCCOClikelyendometrioupptgiruniquemoleculrlcpeARID1A-ctivtgmutti(ARID1Amut)gmotpvlent(50%)OurpropoederchcplizehighpvlenceARID1AmutCCOCugnovelynticlethlpprochprovidenewttmenptiptientddgclicllyunmetneedOurplimrydthowARID1AloenizeCCOCtumcombtiATRBETfmilyprotehibi(ATRi-BETi)ATRi-BETtmentynergtickillgCCOCcellptient-derivedxenogrft(PDX)tumcompdmpienARID1A-dependentmnnerTheeulthveledPheIBvetigr-edclicltrilrunthroughNRGcoopertiveclicltrilgroupevlutgnext-genertiATRi(M1774)BETi(ZEN-3694)curntCCOCTheoverrchggolerchpropoedhedevelopARID1AbiomrkerATRi-BETtmentidentifynewfunctillylevntbiomrkerfcilteptientelecthrpyCCOCfutuclicltrilTheegollizedthroughuehumnmplecollectedthclicltrilcomplementedueCCOCPDXmodelpedtwhichemployedvlidteARID1AmutpdictivebiomrkerpehelpidentifynovelbiomrkerfurnhnceeffectivenethcombtiNovelpdictivebiomrkeridentifiedugmulti-dimenilmoleculrprilgpprochtegrte1)muttigeneexpilterticltepivenehumnnimlmodeldetermedcomputtilmodelg2)fcrimpctpedrugttmenttmoleculreBETi-ATRictigenomeDNAplictikThpprochdeigneddcovermechnticllylevntbiomrkerpdictperpyOuroverrchghypoARID1AmutddilmoleculrltertiervebiomrkerpeATRi-BETiCCOCInummryepropoedtudie1)providenewttmenptiCCOCddgclicllyunmetneed2)determeifARID1AlobiomrkerpeATRi-BETi3)identifyddilmechnticllylevntbiomrkerpeguidefutuclicltrilABSTRACTApproximtely120000AmericnneuribromtypeI(NF1)ufferctellticliclmnifetticludgrrntprolifertineurltueledgmlignntperipherlnerveheum(MPNST)MPNSThighlyggivercomhighrkcurrgpdgultg5-yerurvivlrtelethn25%ErlydignoterventiferutcomeHoweverlckcvenientpecificdignoticolmjbrrieroptimlrpeuticterventiCventilimggmodlieuchcomputedmogrphy(CTcn)18F-fluo-d-glucoeporemimogrphycn(PETcn)ufficientlypecificFurrleibiopieextmelypfulhvelimedvluedueheterogeneyetumTheeccurtebiomrkerdignopot-ttmentmirgMPNSTcricllyneededThelg-termgolthpropoldeploycfDNA-bedbiomrkerptientNF1routecliclueimproveerlydetectimlignnttrnmtimirperpyTheobjectivethpropoletblhdignoticpnelDNAmethyltimrkercfDNA-derivedtumfrctineuploidyprilecltecomplementimgg-bedmodlieclicllyeffectiveoldtguhpenceMPNSTpleximneuribromOurcentrlhypoMPNSTrgptientNF1hveuniqueDNAmethyltiomticchromoomlcopynumrprile(neuploidy)cndetectedplmervecliclbiomrkererlydignoguiderpeutictrtegieWepropoe4SpecificAim1)DemtrtemethyltiprilebiomrkerMPNSTplmmple2)EtblhneuploidytumfrctibiomrkerMPNST3)EvluteroledvncedMRIerlydetectiMPNST4)DetermefeibilycfDNAbiomrkerpdictmlignnttrnmticurntdeeUpccluiwenticiptedevelopmentvlidticfDNAmethyltimrkercfDNA-derivedtumfrctineuploidyprilecncomplementimgg-bedmodliecnhelpphyicinerlydetectiMPNSTOurtudieignificntcueyfcilteerlyccurtedignoeggivetumcequentlyexpedepproprettmentimprovgptientqulylifecludgurvivlSpecificAim(Reved1-29-2024)Fttgovrincncerpclxelfrt-ledruguedcombticplt/crbopltlouedledoedenechedulecurntcncerAhighlyeffectiventi-microtubulegentpclxellocuedoe-limgdvereeffectInprticulrmny80%ptientceivgpclxeldeveloplopeciwhichevelyimpctptientqulylifeWehvedcovedbriefexpoulow-tenyultroundcnprotectvrioutypeprolifertgcellcyxicctivypclxelcelldethvrotrnientlydruptgpclxel-ducedmtirigidtbilizedmicrotubulebundleWehypoizethroughthmechnmlow-tenyultroundmypventlopeci(loclly)outcompromgefficcyytemticcncerrpyTheobjectivepropoltethypoughumnclphirfolliclegncultuublemouemodelTheilbicexperimentupptednDODpilotfundgR01upptfurrextendgolwkolidifyultccluiwhichguideoptimldeignprocolclicltrilnerfutuSpecificAim1Invetigtemechnmbkgdrug-tbilizedmicrotubulecellulrmechnmcountergpclxelctivySub-Aim1-1Incell-feytemwevetigtefrgmenttipolymerizedmicrotubulelowtenyultroundoutpencepclxelSub-Aim1-2InhumnclphirfolliclegncultuwetudyultroundimpctmicrotubuleirbkggggtifrgmentdegrdtiuphgylyoomeSub-Aim1-3Inhumnclphirfolliclegncultuwetudyultroundcugcelldethpclxel+crbopltcombtiwhichcommlyuedttmenvrincncerSub-Aim1-4WeloverifybilyultroundcounterddiltxnecludgdocetxelcbzxelwhichuedttmentmettticbtprottecncerpectivelySub-Aim1-5Wetudyerioutimecoureimmede(5m)lgterm(7dy)effectpclxel/ultroundhumnclphirfolliclegncultuThehirfolliclegncultuytemenbleourtrictenlyeugmicrocopycellbiologypprocheterrogteboemprypermnentpclxel-duceddmgethimidentifyunderlygprotectivemechnmultroundrpySpecificAim2VerifypventihirfollicledmgetudymechnmultroundcountergpclxelcyxicylivemiceSub-Aim2-1WecrryoutextenivenlyeverifybiologymechnmlivemiceSub-Aim2-2Inhumnclphirfolliclegncultuwetudyultroundcugcelldethpclxel+crbopltcombtiwhichcommlyuedttmenvrincncerSub-Aim2-3WeloverifybilyultroundcounterddiltxnecludgdocetxelcbzxelwhichuedttmentmettticbtprottecncerpectivelySub-Aim2-4SglecellRNA-eqtechnologyuednlyzehirfollicledetermeoverllexpiprilevrioucelltypeimpctedpclxel/ultroundSub-Aim2-5Thetudymouemodellodetermelgterm(36mth)impctdrug(crbopltpclxel)ultroundhirfolliclekmicedetermenypotentilideeffectultroundttmentSpecificAim3Determebilyultroundpventpclxel-cuedhirfollicledmgelomouemodelgrftedhumnclphirlg-termcequenceSub-Aim3-1WehveetblhedhumnizedlopecimouemodeltrnplntghumnclphidkimmunecompromedmiceWetetifultroundexpoucnpventhirfollicledmgehirlocuedpclxelttmentmodelSub-Aim3-2Inddinlyzecute(17dyfollowgdrugultroundttment)effectexperimentlocludelgterm(36mthfterprocedu)effectverifymechnmuncovedmouemodeldetermeifnypotentilideeffectfetyultroundttmennhumnhirfollicleSub-Aim3-3WhddilcourewebletudyncenumrmiceimplntedhumnhirfollicleobttrgttticlultThlollowucompdetermepotentildiffentilpehirfolliclepclxel/ultroundcltigendergercilncetrldetermeifbiologicldiffenceextTheimexperimentpropoedprojecthelptrnltedevelopbicciencedcoverycliclprcticeetblhprocedupventhirlocncerttmentIfuccefulprojecthvemjimpctqulylifeuecncerptientPROJECTSUMMARYAndrogencepr(AR)ignlgmjdriverprottecncer(PC)progiPertentctivtiARduerrnttrtumlrogenyn(ITAS)plypivotlroletncerpienext-genertiARignlghibir(ARSI)uchbirtereInctrtedmleiderogenproduceddenovoyncholeteroldnlteroiddehydroepirotere(DHEA)DHEA-ulfte(DHEA-S)mjpcurITAS3-hydroxyteroiddehydrogene-1(3HSD1)encodedHSD3B1genekey3HSDenzymectlyzecveridnl-derivedteroidDHEADHEA-StetereCHD1nepigeneticderelectivelycognizemethyltedhneH3lye4uchH3K4me3trncriptictivechromtmrkTheCHD1genedeleted9-11%bothprimrydvncedPCtglevncelofunctiCHD1PCpthogeneprogiIthenhownloCHD1promoteARctromedtriintirogentncePCcellhoweverunderlygmechnmmeluiveOurplimrydthowedCHD1terctSIN3AcopproteSIN3AloCHD1duceelevtllevelpnhnecetylticedexpiteroidogenegeneITASWelohowedupgultiteroidgenecludgHSD3B1ducedCHD1loocedcedexprncriptifcrHOXC13FurrmowedemtrtedbirterettmentprtillyhibgrowthCHD1-deficientcelltheffectbolhedccomntdepletiHSD3B1BedournovelplimrydtwehypoizeCHD1functitrncriptipterctgSIN3AcopmedgtrncriptipiHOXC13trncriptifcrdowngultirogenegeneHoweverloCHD1ulttrncriptilde-piHOXC13whichturnducerrntexpirogenegenebnmltrtumlrogenyntnceARSIrpiePCArrntlyelevted3HSD1cedrogenepentctiblevulnerbilieeffectivettmentCHD1-deficientPCcellTotetehypoewedetermemoleculrmechnmextentwhichCHD1terctSIN3AmodultehnecetyltrncriptiloutputPC(Aim1)determemoleculrmechnmfunctilimptnceHOXC13upgultiteroidogenegenectrti-tntgrowthCHD1-deficientPC(Aim2)determecliclignificncent-cncerefficcyp-cliclrpeutictrgetgdegultedCHD1-HOXC13-3HSD1ignlgxPC(Aim3)FdgthpplictihednewlighnnoveltrncriptipifunctiCHD1pivotlroleHOXC13-HSD3B1xrrntrogenynctrtitnceCHD1-deficientprottecnceridentifictinewctibletrgeteffectivettmentthubtypeprottecncerPROJECTSUMMARYTheloendogenoutumuppnobligryteptumetprogiunderlygmechnmeluivebdthirtrgetmotlyunknownWehvenowdcovedPrkmichdri-ocedE3ubiquligebillelicllyltederly-etPrkDeefunctinoveldulmodetumuppThvolvehibrictumtrcellmotilymetbolmloprogrmmgnntumimmunemicroenvirmentInthpthwyPrkcrumentmichdriprimeimmunogeniccelldethctrolleeDmge-AocedMoleculrPttern(DAMP)ctivtekeccdetrncripterfergeneflmmrycykedependentlymiphgyTheultenhncedtrtumlfiltrtiCD8+TcellducedmyeloidimmunouppihibiprimrymetttictumgrowthBecuePrkepigeneticllyilencedllhumncncerdulmodetumuppiuniverlbrriergtmlignncyTheehypoPrktumuppibridgemichdrilctivterferignlgimmuneprogrmmgmicroenvirmentcnmultedctutefocupentpplictiThecomplementrymultidciplrypecificimelucidterolePrknteimmunytumuppiInfirtpecificimwechrcterizehowPrkprimeimmunogeniccelldethelucidteroleERtuphgymichdrilnecropmpcellulrbiochemiclquimentDAMPleeTheecdpecificimdectignlgquimentPrkctivtinteimmunypectcyoliccGAS-STINGflmmomectivtimichdrilRIG-I-MAVSengemblySTAT1-gultedISGF3trncriptilcomplexTcellctivtidendriccellfunctiInthirdpecificimwetetimpctPrknteimmunypcliclthopictrngenicmodelprimrymetttictumgrowthvivomodultintumvcctitrtegiediffentilenivycventilimmunerpieThepplictibuildexpniveplimrydtnovelcceptdulmodePrktumuppidictimichdrilnteimmunypvioulyknownvirlfectintumpeTheultmyprcticechnggApropoedheelucidtiPrknteimmunyidentifynewtrtegienntumimmunemicroenvirmentdmpenmyeloidimmunouppienblebrodermodurbleptientpecventilimmunerpycludglte-tgedeePROJECTSUMMARYCncerimmunpyprcticehrnegctivyimmuneytemcombtcncerImmunecheckpotblockde(ICB)typecncerimmunpyunlehectivycyxicTcellblockgterctihibiryceprTcellligexpedtumcellICBhenneffectivettmentmnyultgdurbleevencurtiventi-tumimmunepeHowevermotcncertypelethn50%ptientpdpurrgeftundertgeneticmoleculrigntuocedICBpewellrpiecnuedcombtiimproveICBefficcyRetropectivetudiehvehownmuttiARID1AgeneenrichedmgptientpdICBpn-cncercncertypepecifictrilARID1AubunSWI/SNFchromtmodelgcomplexwhichutilizeenergyderivedATPhydrolymovenucleoomelgDNAGeneencodgubunSWI/SNFcomplexfquentlymuttedhumncncerARID1AgmotfquentlymuttedubunthirdmotcommlymuttedtumupphdTP53CDKN2AARID1AmutticouldthuervenimptntbiomrkercncerimmunpypotentillyffectgttmenthunddthoucncerptientItnotknownwherARID1AmutticulhowARID1AmuttienizetumICBttmentIndeedARID1Amutticommlyfoundmicrotelleuntble(MSI)tummuttiburden-high(TMB-high)tumwhichmelvedependentpdicrICBpiveneHoweverARID1AmuttineficildependentMSITMBttuddiveptientMSITMB-hightumItwfoundArid1mutnttumgrowmolowlythnogenicwild-typelemumodelcedimmunefiltrtiTcellctivtiFurrArid1mutntcncercellupgulteubetgeneTypeIInterferpecludgchemokentigenpenttiproceggeneMechnticllygeneticphrmcologichibiARID1AultcedRloopwellcyplmicccumultiRNADNAhybridDNAThpropolutilizegeneticdeletimllmoleculehibirARID1Adeterme1)howARID1Adeficiencycuecyolicnucleiccidlee2)pthwywhichflmmrygenectivtedARID1Adeficientcell3)roleRloopdrivenflmmrypeARID1Amutntnti-tumimmunyICBpeThccomplhedugARID1AmutnthumncncercelllemouemodelArid1mutntcncerFllytudiepieergvivouemllmoleculehibirARID1AcombtiICBpermedTheetudievelmoleculrmechnmwhichARID1AmutntcncerpdICBpotentilimproveptientelectiICBugmentICBefficcyARID1AhibirProjectSummryPncticductldenocrcom(PDAC)chrcterizedextenivedemopliultgoccupncymottummdenetromctgfibrobltmcrophgeextrcellulrmtrix(ECM)FibrillrcollgenuchtypeIcollgen(ColI)mjECMcompentweptedexertpolyunderodtimulryhibiryeffectPDACgrowthmlignncyItwloobervedptientwhoetromfibrolytichighctentclevedcollgenfrgmentgenertedmtrixmetlloprotee(MMP)howpooverllurvivlfterectiwheptientnerttromrichtctcollgenfirhveciderblyimprovedurvivlThemechnmunderlygecliclobervtitumtimulryhibiryeffectColIweheunknownUguniquecultuytempcliclmodelcliclpecimenwedcovedtct(i)ColIfirMMP-genertedcleved(c)ColIfrgmenthvedimetricllyoppoedeffectPDACmetbolmgrowthdueirdiffentiltercticollgenceprDDR1WhecColI(MMP-clevedcollgen)ctivteDDR1downtmeffecrwhichcludetrncriptifcrNF-kBNRF2timultePDACmetbolmmichdrilbiogenepirtiiColIdoenotctivteDDR1tedduceubiqu-dependentproteomldegrdtihibgNRF2ctivtiPDACmetbolmOurgolunderthowMMPclevgeenblebdgcColIDDR1determeifbdgDDR1quidductidegrdtiiColITofullyunderthowcColIDDR1ignlgctrolPDACmetbolmgrowthwhyColIbltinothibirypventiColIclevgewetetwherdiffentileffectcColIiColIDDR1expictivtipplyfibrillrycollgen(ColIII)defeunderlygbiochemiclmechnmenbleDDR1bdgNextwevetigtehowiColItriggerDDR1ubiqutiproteomldegrdtirolenewlyuncovedDDR1E3ligeFBXW2thproceTheetudiecludeidentifictimechnmwhichiColItimulteDDR1ubiqutiFBXW2developmentlige-crugolcompoundduceDDR1degrdtiwhoebiologicleffectevlutedcultudcellmouemodelThfollowedtudygroledividulMMPozymeexpedPDACcncercellcncer-ocedfibrobltmcrophgecollgenmodelgPDACmetbolmgrowthWedetermeubilydividulcollgenclevgMMPdrugtrgetttmentcColIenrichedPDACWelodetermemechnmpibleMMPductiPDACmicroenvirmentymyprovideddilrpeutictrgetThepropoedtudieemploycuttg-edgetechnologienovtiveECMbedPDACcultunewgeneticllymodifiedmouetrllowevlutibothprimrylivermettticPDACcliclpecimenPROJECTSUMMARY/ABSTRACTChildndvncedneuroblm(NBL)hvepooutcomedepeggivemultimodlrpynewrpeuticpprocheneededRecenttudiehvedemtrtedtrgeted131I-MIBGrdiophrmceuticlrpycombgmodulromticepigeneticprogrm(vott)GD2-trgetedimmunpy(dutuximb)howubtntilrpeuticpromeAlthough131I-MIBGemoteffectiverpiedvncedNBLnotllptientpdthrpypdictivebiomrkerttmentpemechnmtncehvenotenidentifiedOurplimrywkNBLhowmimllyviveliquidbiopytrtegiedetecticircultgtumDNA(ctDNA)circultgtumcell(CTC)cell-feGD2levelcnuccefullyemployedlgudlmpleoutlinceurgiclproceduthvulnerblepedricpopultiInthpropolwepplyetechnologiemplecollectedromizedphe2trildeignedidentifyoptimlgentcombti131I-MIBGlped/frcryNBL(NANT2021-02[N21-02])lunchgoPtientromizedeir(A)vott+131I-MIBG(B)dutuximb+131I-MIBG(C)vott+dutuximb+131I-MIBGOuroverllhypocircultgbiomrkerlevelocedttmentpeechcombtigtetedrilWefurrhypoizeelectimuttichngechromtigntudowngultintigenexpioceddeeprogiInAim1weprileerilplmmpledetectquntifyctDNAlevelmeuocitweenctDNAlevelperpyechrmN21-02FurrmoweidentifymuttioceddevelopmentttmenttncethroughdeepequencgctDNAmpleInAim2wevlidteourextgchromtcceibilygeneexpiigntuocedvottttmentpcliclmodelvott-ttedptientmpleWenlevergeerilliquidbiopympleptientenrolledN21-02ttedoutvottdetectductivottigntudetermewhereigntuocedpevott-ctgrpieFllyAim3welgudllymeuolubleGD2levelurfceexpilevelCTCmplecollectedptientdutuximb-ctgttmentrmcompGD2levelptientnotceivgdutuximbrpyWetetociolubleGD2levelpeGD2-dictedrpydetermewherchngeGD2expiCTCoceddevelopmentdeeprogirpyAtendthwrdweexpectidentifybiomrkerpemechnmttmenttnceptientlpedNBLTheefdgledoptimizedttmentelectinewcidterpiepventemergencetntdeeptientNBLProjectSummryHigh-rkneuroblm(NB)pible~15%pedriccncer-lteddethnerlyhlfechrcterizedMYCNmplifictiTheddinti-GD2ntibodieidmtenncerpyhimprovedoutcomeeptienttillmothn50%perhOmictudieNBtumhveledmotNBdrivenndnergic(ADRN)cogulrycomplex(CRC)trncriptifcrcndrivenMYCNcludeGATA-3TBX2HAND2PHOX2BISL1ASCL1GenomicllytrgetgCRChendemtrtedhighlyeffectivehoweverphrmceuticlwytrgetCRCprticulrewouldlertedptienthnotendevelopedHewedemtrtemrkblerpeuticvulnerbilyMYCN-mplifiedNBSUMOyltihibiWeprovideevidencexicyvolvedruptiADRNCRCwhichquipenceMYCNThpthwyhcomectibledventSUMOyltihibirTAK-981(Subumtt)nowmultipleclicltrilThuwepropoewehveuncovednADRNCRChibitrtegyeffectiveMYCN-mplifiedNBuggetglrpeuticwdowSpecificAimSpecificAim1Tetdivereetwell-nnottedhigh-rkptient-derivedxenogrft(PDX)modelefficcyfetySUMOyltihibineuroblmlecomdmtenncerpySpecificAim2Invetigtemechnmdnergic(ADRN)cogulrycomplex(CRC)druptifollowgSUMOyltrgetgStudyDeignWefurrchrcterizehighenivyTAK-981high-rkMYCN-mplifiedNBptient-derivedxenogrft(PDX)modeleirlecombtinti-GD2rpydutuximbThrougheriegenomicproteomictudiewefurrctegizemechnmenivySUMOyltihibiATAK-981duceNKcellctivtirtilducgprtnernti-GD2immunpydutuximbWelovetigtethcombtiNBmouemodelInllwettemptgrpcliclevidenceTAK-981houldclicllyevlutedMYCN-mplifiedNBptientPROJECTSUMMARY/ABSTRACTMycliclerchprogrmfocueimprovglivellwomengynecologicmlignncieIerveledclicltrilprogrmGynecologicOncology(GYO)tutilPrciplInvetigr(PI)NRG/NCTNMypoiUniveryVirgiCompheniveCncerCenter(UVACCC)UVASchoolMedice(SOM)uniqueIpend50%myeftprcticgGynecologicOncologtcliclercherwheImtthrivgurgiclchempyprcticeThe50%myeftpentAoceDenCliclReerchSOMInthroleIovereebuildgmtenncellcliclerchfrtructucludgCliclTrilOfficewhicherveentiSOMImeuniquelypoiedcductcliclerchwellbuildcriclcliclerchfrtructuUVACCCentiSOMThwrdllowmedecemyurgiclctivyfocufollowgthegol(1)InceUVACCCccruldepthbdthNCTN/ETCTNclicltrilidentifygovercomgbothproviderptientbrrier(2)InceUVAlederhipcollbtinewclicltrilthroughNCTN/ETCTNmechnmvimenrhipprtnerhiptrnltilerchermulti-dciplrygroup(3)CplizemyroleDenficemyowncliclerchexpertetmleclicltrildevelopmentviewctivtiSOMIchieveegolleverggmydultngthcliclerchmenrgyoungvetigrlgmydmtrtiveroleDenficewhichenblemebuildddilfrtructuchool-wideTheectivieceUVAvolvementNCTN/ETCTNtrilnefllptientttedtUVACCCPROJECTSUMMARYTertirylymphoidtructu(TLS)TBlymphocytegggtintigenpentgcellfibroblthighendolilvenuleobervedomechricllyflmedtueTLSmtumcncerptientocedimproveddptiveimmunefuncticedoverllurvivlInurgicllyectedhumnpncticductldenocrcom(PDAC)ignificntproptiptientmptneouTLSirprimrytumOrgrouphvedemtrtedimilrfdgnoevidencecurntlyexthowgTLSdictlyfluenceTcellimmunyInthpplictiwepropoevetigteifTLSenhnceTcellimmunyctextPDACtumigenemechnmhowthoccurOurplimrydtTLS+mouehumnPDACtumhowTCF1+tem-likeTcell(T-tem)enrichedpecificllyTLSltiveurroundgtumtromWepoTLSPDACtumupptdevelopmenttem-likeTcellphenotype(T-tem)dependennterleuk-21ignlgTheeuniqueTcellubethvepvioulyenhownutcellulrimmunydurgchricfecticncerprovidgctulpletimemyeffecrtermllydiffentedcellfollowgntigeniccllimmunecheckpotblockdettmentWemodelthbiologyugpnelmouePDACcelllederivedtrngenicmouetumcdillyexpmutntKRp53motcommdrivermuttiPDACencodemodelMHCI-trictedntigentrcktumntigen-pecificpeTheecncercellledepehrgimilrgeneticmuttilbckgroundducetumuniquephenotypeheterogenoutummicroenvirmentWedeploynovelmethodduceTLSemouetumthroughlymphoxtcepr(LTBR)gmwheomeourmouetumlepermiveTLSmtitntWetetifTLS-mededgenertiT-tempibleimprovedtumctrolCD8cdilTCF1-knockoutmiceWedetermeifinrichmentTLSdueIL-21ignlderiveddictlyTLSpromoteirmtidependentlymphticvolvementutilizgcombticelllegetrcggeneticllymodifiedmouemodelWecomplementetudievetigtgtummplePDACptientphenotypicpthwyuniquepecificgietumWechievethpermgptiltrncripmichumnPDACtumectinlyzednnovtivelghmtrnmptilvriblegenefunctiltuemoduledetermegi-pecificimmunephenotypeloclizedTLScompdn-TLSgitumoutTLSThpprochidentifiemechnmhowTLSupptTcellfunctiunticmouemodelTLS+PDACtrnlteefdghumncncerptientovelimmunpyoptideignedelicctivteTLScnfedptientttmenttntmlignncySummryTheRAS/RAF/MEK/ERK(RAS/MAPK)ignlgpthwynetblheddrivermnycncercommlyhyperctivtedgeneticltertiRASBRAFRAFMEKhibir(RAFiMEKi)hveenclicllyuccefulBRAF-mutnt(BRAF-MUT)tumircliclefficcyRAS-mutnt(RAS-MUT)tumhenofrmodetlimedxicieBedexperienceBRAF-MUTtumwepocliclefficcyRASpthwy-trgetghibirquielectiveMAPKhibiRAS-MUTtumoverRAS-WTnmlcellTochieveuchRAS-MUTtum-electivepotencyRASpthwyhibirweneedtterundertghowRASctivtiffecttrgetdrugbdgMAPKhibicellThegolthpropolccomplhtterundertghowcellulrctextffecttum-electiverpeuticpotencyRAFiMEKigoldeigngmoeffectiverpeutictrtegieRAS-MUTcncerOurplimryfdguggetRASctivtidiffentillyffectRAFibdgRAFprlogwellirprotetbilyWehvefurrevidencelthoughRAFiuppMAPKpfentillyRAS-MUToverRAS-WTnmlcellcombtiRAFiMEKiultimilrMAPKhibwoctextythupdictedpromotedoe-limgxicieOurhypoRASctivtiffectproteexpilevelcmtiRAFprlogMEKultgdiffentilbdgRAFiMEKidetermgtum-electiveMAPKcellgrowthhibiedrugThhypotetedtheAimAim1chrcterizediffentilRAFibdgRAFprlogRAS-MUTnmlcellug-cellbdgytructurlbiophyiclpprocheAim2defeeffectRASctivtiRAFprlogprotetbilyexpiAim3chrcterizebiochemicllybiophyicllyvivocombtidivereRAFiMEKidetermewherlcktum-electiveuppiMAPKignlgRAS-MUTtumoverRAS-WTnmlcellcexicylimefficcycomdRAFi+MEKiThepropoederchdevelopexperimentlolcceptdeletemechnmdetermgdiffentilpotencyRAFiMEKiRAS-MUTovernmlcellulrctextDefguchmechnmhouldenblertildeignmoeffectiveRASpthwy-trgetgdrugdrugcombtittmentRAS-MUTcncerProjectSummryThe5-yerurvivlrteptientdignoedpncticductldenocrcom(PDAC)11%Thpooutcomeduemultiplefcrcludgrpidprogimettticdeepocliclpetrdcrpienoeffectivetrgetedimmunpeuticpproche1ThettmentfrcryntuPDAClikelydueprtproundlyfibroticimmuneuppivetummicroenvirment(TME)hllmrkthdeeTwomjdriverthTMEcludedenefibrotictumtromrobutfiltrtum-upptivemyeloidcellPDACctphenotypicllydiverecncerocedfibroblt(CAF)ubetTheeubetcludemyibroblt(myCAF)flmmryfibrobltmllubetntigenpentgCAFRecentlyhenpropoedomevetigrmyCAFmyhvetumtrgpropertiewhilevetigrhvefoundmyCAFcnpromotetumprogtmenttnceWhtclertumtrgtumpromotgfetulikelyphenotypectextdependentWepropoehecellulrenecencemydtguhedtum-promotgtrgCAFubetOuroverllhypoStromlenecenceplykeyroledrivgtumprogiltergtumimmuneECMpropertieToddthhypoweuettertbiophyiclimmunologicltechniquehumnPDACpecimenttertgeneticllyengeedmouemodelbothPDACtudyenecentcellevlutefollowgimAim1DetermehowbiophyiclpropertieextrcellulrmtrixgulteductifunctienecentCAFAim2DetermeimpctenecentCAFmyeloiddendriccelldrivenimmuneurveillnceAim3DetermegnpecificimpctenecentCAFmettticprogiSignificnceUndertghowPDACTMEgultetumimmunycriclemploygtromlmodulryrpyenhnceimmunpeuticThcceptcentrletudieABSTRACTChromoomerrngement(tructurlvrint)commcncerydrivetumdevelopmentltergexpifuncticogenetumuppgenecopynumrltertimticogenicfuiltertiDNAelementpiblegultgcncergeneWehvedevelopednnovtiveCRISPR-bedpprochpecificllytrgettructurlvrintjuncti(SVJ)cncercellouthrmgnmlcellThpprochclledKLIPPbedueplenzymepprochctgctivteddC9fuedenducleeFok1(Fok1-dC9)ToctivteFok1enducleetwoFok1-dC9complexebroughtgertSVJugSVJ-trgetgguideRNAledgductixicDNAdoubletrbkWehveobtedtrgpro--cceptthpprochblddercncercncercellytembothcellcultuvivoInthpropolwepermp-cliclefficcytetgPciKLIPPTherpypprochnthopicmouemodelblddercncerThepmetrgetgblddercncerthpprochfirtlocllyviveblddercncercommdedlydeefewimpctfulrpeuticoptiSecdblddercncertypicllyhowgenomictbilymnyhunddSVJcouldtrgetedourpprochThirdbldderidelloclter-veicledeliveryCRISPRgentcuebilychievehighloclccentrtivoidgytemiceffectWethpplictipuruethepecificimAim#1CRISPRcenmppotentilFok1-dC9bdgxicygenome-wideAim#2DeliveryCRISPRgentblddercellcultuAim#3AementefficcyPciKLIPPTherpyp-cliclHGSCmouemodelWihR01fundgwebledvncethprojectpotplnnghumnclicltrilPROJECTSUMMARY/ABSTRACTBRAFctivtgmuttioccurpproximtely10%mettticcoloctlcncer(CRC)ocedweprognoduenferipetrdchempieCurnttrdcptientmettticBRAFV600ECRCwhohveceivedprirpyBRAFhibir(BRAFi)pluEGFRtmentUntuntelypenotdurblemedinoverllurvivlptientceivgcombtirpymdmltroughly9mthTheeimprovgpeBRAFipluEGFRirpymettticBRAFmutntCRCpentcriclunmetcliclneedWhuemopotenttrgetedrpiehiftcellidentydueepililcelltrndiffentinemerggcuerpytnceInubetlungprottecncerlegetrnidenocrcomneuroendocphenotypemechnmtnceEGFRinti-rogentrgetedrpiepectivelyHoweverphenomenrpy-ducedtrndiffentihnotenexmedCRCItwcentlydetermedBRAFmutntCRCuniquelyctenteroendoccell(EEC)progenirpromotecncercellurvivlviectedfcrdiffentitteetumgultedlyedemethyleLSD1InnewplimrytudieBRAFilecombtiEGFRihownfurrcenumrEECprogenirBRAFmutntCRCBRAFtmentlofoundduceignltrnducerctivrtrncripti3(STAT3)terctLSD1ultgEECprogenirenrichmentCequentlyhibiknockdowneirSTAT3LSD1blockBRAFi-ducedenrichmentEECprogenirEECtetlneuroendoccellfdgthpopultiexpfterBRAFiprovidetrgcientificpmeoverllhypothlegepromoterpytnceBRAFmutntCRCIthypoizedBRAFipromoterpytncetrndiffentiBRAFmutntCRCnEECprogenirttethroughSTAT3LSD1ctivtiItfurrhypoizedhibgLSD1promgtrtegyblockBRAFi-ducedtrndiffentiimprovedurbilytumctrolBRAFipluEGFRtmentInAim1mechnmwhichBRAFipromotetrndiffentiBRAFmutntCRCdetermedfocughowLSD1STAT3terctgultedowntmgeneexpipthwyInAim2clicllylevntLSD1hibiruedyngeneicmouemodelmettticBRAFmutntCRChumnPDXmodeldetermeeffectLSD1hibiBRAFipluEGFRi-ducedtrndiffentumimmunemicroenvirmentefficcytrgetedrpyvivoOverllpropoedwkhpotentildevelopnepigenetichibir-bedpprochblockrpy-ducedtrndiffentiprolgrpypeimproveclicloutcomeptientBRAFmutntCRCPROJECTSUMMARY/ABSTRACTDNAcyemethyltiyieldg5-methylcye(5mC)mjepigeneticmodifictivolvedgultichromttructugeneexpiMmmlinDNAmethyltictlyzedtheDNAmethyltrnfere(DNMT)lggtwotructurllyfunctillydtctfmilieDNMT3ADNMT3BetblhilcyemethyltiptternwheDNMT1mtptternnewlyplictedDNACncercellexhibrrntDNAmethyltiptterncludggloblhypomethyltiwhichocedlowmtennceefficiencygilhypermethyltiwhichmlyduebnmldenovomethylti/deficientdemethyltiAlthoughdemethyltggent5-zcytide5-z-2-deoxycytide(dec)hveenpprovedFDAttgomehemlogiclmlignncieenucleoidenlogcpteDNAledgubtntilDNAdmgecellulrxicyeffectivettgolidtumRecentlyGlxoSmhKle(GSK)pteddcoverynewcldicynopyride-ctgDNMT1-electivehibirrpeuticpotentilThelg-termgoltherchdevelophighlypotentelectiven-nucleoideDNMT3A/3BhibircncerttmentTheobjectiveth2-yerexplryprojectidentifyemopromgledfurrdevelopmentThertilemedyghypermethyltihibgDNMT3A/3BwouldctivtebnmllyilencedgenecludgtumuppgenethuproviderpeuticnefcncerptientThepropolbedplimrydtgenertedpplicntlbriehowgomedicynopyride-ctgderivtivequole-bedderivtivecnelectivelyhibDNMT3A/3BThepplicntpropoepermbiochemicltructurltudieimprovepotencyelectivyDNMT3A/3Bhibir(Aim1)vlidtecompoundirpotencyelectivyugwild-typeDNMT-deficientmoueembryictemcell(mESC)determeirnti-cncereffectugcncercellleoutmutticompentDNAmethyltidemethyltienzyme(DNMT3ATET2IDH1/2)eircyxicyuguntrnmedcellle(Aim2)Thepotentilimpctidentifygn-nucleoideDNMT3A/3BhibirlikelyveryubtntilPROJECTSUMMARYThpropolimelucidtemoleculrcircurylimefficcychimericntigencepr(CAR)-engeedTcellCARynticprotewhenexpedTcellcnmedepotentctivygtcncerThemotuccefulcliclpplictiechnologytrgetCD19urfceBcellleukemilymphomWhilecurtiveomedurblemieenlethnhlfptientttedEmerggdtpotCARTcellfiluoppoedcncercelltncedriverpooutcomedeeprogiTheefdghighlightundertghowCARdictTcellfunctidyfuncticriclimptnceThemTcelldyfunctitunderodexhuticellttedevelopultchrictimultiendogenouTcellcepr(TCR)ettgchricvirlfectiAllCARctprimryignlgdomTCRwellnddilcotimulrydomenhnceTcellctivtiOfixCARproductpprovedcliclueUSfourctcotimulrydom41BBwhiletwoctdomCD28ToidentifyCAR-ctivtedmoleculrpthwypibleTcellfiluwedevelopednvroytemduceTcelldyfuncthroughchricCARtimultiWeobervedwhile41BBCD28-bedCARTcellbothloefunctiultchrictimultieceprctivtedivergentmoleculrcircuryyloefunctiCD28-bedCARTcellphenotypicllytrncriptillyepigeneticllyimilrexhutedTcellInctrt41BB-bedCARTcelldotrhllmrkclicexhutidtcttlllevelprogrmmgWeobervedctivthuniquetrncriptiligntu41BB-drivendyfunctiCARTcellfiledctroldeeptientWefurridentifiedtrncriptifcrFOXO3highlyctivedyfunctil41BB-bedCARTcelldeletiFOXO3improveCARTcellfunctiBedeobervtiwehypoizechrictimulti41BBtriggerignlgpthwyrrntlyctivteFOXO3FOXO3ctivteeverldtctprogrmuppCARTcellfunctiInpropoedtudieweuebiochemicltechniquehigh-olutimicrocopyidentifytermedeignlgprotelk41BBFOXO3(Aim1)uecdilexpiytemdetermehowFOXO3uppeTcellfuncti(Aim2)identifyengeedTcellrpievulnerble41BB-drivendyfunctilprogrm(Aim3)Collectivelyetudieelucidtehowchricctivti41BBlednoveltteTcelldyfunctievlutetrnltilly-levnttrtegiedvncedengeergthvercomethdyfuncti-ducgcircuryGenomicbeAfricngeo-ethnicprottecncerhelthdpryPROJECTSUMMARY/ABSTRACTWhnoknowncuemodifiblerkfcrprottecncer(PC)chrcterizedignificntgeo-ethnicdpryMenAfricnncetry/AfrictgtetrkggivedeeCompdn-AfricnAfricnAmericnment255-foldcedrklethlyHeweddifthgeo-ethnicdprydrivenethnicy(genetic)geogrphy(envirment)combtiOurpprochuepowerwholetum/bloodgenometerrogtiidentifyctriggeneticn-geneticfcrGeneticfcrcludeheredrpthogenicmuttituecquidcncerdriverCverelyn-geneticfcruchenvirmentlcrcogenlevecomputtillyderivedptternomticvrint(muttiligntu)developgtumAddillymotlydcrdedn-humnprottegenomicdtholdunmetpotentilidentifyctrigpthogen(bcterilvirue)cncerfetudchricflmmtiHoweverPCwholegenomedtlckgcroAfricndpWhilemuchwkethnicocedPChelthdpryhddedctriifcrcommgermlevrintocioecomicetudiehvelmotexcluivelyenlimedUnedSttemunderdebteGlobllylethlPCexpertedAfricnncetrlgicludgSub-ShrnAfricSouthAmericrte2516-foldgterthnUnedSttepectivelyOurwkghypogloblcluiprovideuniqueopptunyclteethnicgeogrphicimilriediffencemenAfricnncetrypentggtetgeneticdiverywhilelopentggiignificntenvirmentldiveryWhilenefdiverycluienhncggenomicmedicewellunderodnefboltercientificknowledgehenleppcedIn2022emgenertedfirtAfricnncetrlPCwholegenomedtprovidgightrnggnovelAfricn-pecificcncerdriveridentifyglrgerpectrumomticmuttiligntuwhiledecribgclicllylevntAfricn-pecificmoleculrtxomyOurtudyprovidedfirttntlizgevidencebothethnicgeogrphicctriiAfricnncetrlPChelthdprieHeweexpthplimrywkcludeAfricnncetrlpopultiUS(Chicgo)BrzilSouthAfricThroughwholegenomeprilg700menirtumweidentifyAfricn-levntheredpthogenicvrintcncerdrivercludggermle-omticterctiidentifyn-geneticigntucomplextumgenomethroughomticvrintptterncogniocedgeogrphyoverethnicycludgournewlydecridGloblMuttilSubtypgwhilewehrnepowerhotgungenomicterrogtiprovidenovelightpotentilrolefectioupthogenUltimtelyidentifygunderlygcuePChelthdpriehignificntimplictidvncgourundertgetiologyerlydetectipventtmentlethlPCllmenABSTRACTPncticductldenocrcom(PDAC)ededlietmlignncieFulltrncripmedefeclicllylevntubtypedeebl-likeubtypePDACoceddvncedtgemetttncettmentpoptienturvivlThemechnmwhichtummicroenvirmentdrivePDACubtypediffentimunchrcterizedUndertgcncer-extricfcrtummicroenvirmentpromotebl-likettecoulduncovercncervulnerbilieleddevelopmentnewrpeuticpprocheWefoundctivtihnedemethylegeneKdm8progrmPDACcellhighlymetttictteMphologicllyKdm8ctivtiduceexpigenedefgcliclPDACubtypedriveproundlodiffentigeneticllyengeedPDACmouemodelImptntlyenzymticfunctiKdm8quimoleculroxygenhypoxidimhedphenotypicchngeducedKdm8ctivtiWenotedgloblupgultihne3lye27(H3K27)trimethyltiupctivtiKdm8upptgvolvementdemethylefunctigultgchromtcelltteInhumnPDACKDM8-gultedgeneigntunexceptillygoodpdicrdeeubtypeOurplimryultuggethypoxummicroenvirmenttrictdemethylefunctiKdm8uppgcliclPDACubtypewhilepromotgbl-likettemettthroughepigeneticprogrmmgWehypoizehypoxi-KDM8-chromtxplycriclrolePDACubtypedetermtimettticbilyInpropoedtudyweimdetermemechnmwhichKdm8ctrolPDACubtypemettticprogimechnmwhichhypoxiuppeKdm8functipromotechromtprogrmmgPDACmettOverllourtudyfillmjgpourundertghowhypoxiPDACtummicroenvirmentpromotebl-likemoleculrubtypemettOurmechntictudyuncoverfundmentlightroleKDM8ubtypedetermtimydcovernovelvulnerbiliebl-likePDACtteThelg-termobjectivegtterundertgkeycell-extricfcrtummicroenvirmentpromoteggivebl-likePDACubtypePROJECTSUMMARYThettmentvriouqumoucellcrcom(SCC)uchSCChedneckhveenvolutiizeddevelopmentimmunpieHowevereventhoughmnyttedptientcnevokerobutilpemotSCCptienttenexperiencerpidtumlpentuwhichtillpolyunderodSuchhurdlehighlightdineeduncovernovelmechnmdrivgimmunpytnceUndertgtumlpefterimmunpyvldvncgclicloutcomeThubroderchobjectivethpropolundertmoleculrnetwkdrivgtumlpecncerimmunpyCncerimmuneevihighlycomplexprocemededbothnimmuneuppivemicroenvirmentcncercell-trictncemechnmRecentlygeneticllyengeedmouemodelSCCweveledgroupTGF-pdgtum-gcell(TIC)hijckmnymoleculrfetudulttuetemcellImptntlyecellpperroottumlpefterimmunpyttmentendoweduniqueprogrmfcilteirmrkbleimmunetnceThkeyfdgdimptnceidentifygcriclmoleculrfetueTICdrivgimmunetnceSCCInthtudyweidentifiedpivotlroleSox2mtertrncriptifcrchetrtgTIC-pecificimmunetnceprogrmHeweemploynultround-guideduterolentivirlgenedeliverypprochchieverpidgeneticmnipultiTICdictlyptneouSCCtumWihpowerfultechniqueweimfirtidentifySox2-ctivtedtrncriptilnetwkhpgimmuneuppivemicroenvirmentSecdwedectmechnmhowSox2enhncetricimmunetncetum-gcellCollectivelyourpropoedtudydvnceourundertgimmunetncemechnmpecificTIChowemechnmpromoteSCClpefterimmunpyttmentUltimtelydefgblueprtTIC-pecificimmuneevivemechnmopennewvenueovercomeSCCcurnceimproveefficcycurntcncerttmentABSTRACTCurntcncerrpeuticvcceutilizebothCD4CD8TcellnetigentimulteTcellimmunythroughdendriccell/mcrophge-mededntigenpenttiirnticncerefficcyHoweverdepeomepromgultcertcncertype(egmelnom)pcliclclicltudiemotevccehveyetchievelg-termefficcycrodiffenttypecncerInctrtroleBcellimmunycncervccehenubjectdebteeverldecdethurpeuticcncervccehvenottrdillyendeignedctivteBcellimmunyHowevercentclicltudiehveuggetedBcell-ntigen-pentti-mededB/CD4TcellcrotlkcrucildurblenticncefficcyimmunpyHowevermotcurntnetigencncervccedotctivteBcell-ntigen-pentti-mededB/CD4Tcellcrotlkdue(A)evccectglyCD4/CD8TcellepipeoutBcellepipecouldnotpromoteBcell-mededntigenpenttiB/CD4Tcellcrotlk(B)evccedothveoptimizeddeliveryytemenhnceBcellepipebdg/crolkBcellcepr(BCR)quidBcelluptkentigenpenttiCD4TcellAevidencedourplimrydtwehypoizeVAM-B/CD4netigenvcceenhnceBcell-mededntigenpenttictivteB/CD4Tcellcrotlkpromotelg-termnetigen-pecificmemyB/CD4/CD8TcellimmunychievedurblenticncerefficcyInddiourplimrydtlouggetB/CD4crotlkVAM-B/CD4moimptntdurblenticncerefficcythnBcellepipeducedntibodyproductiTheewefurrhypoizepromcuouvirlBcellepipeVAM-B(virl)/CD4(netigen)couldpromotebdg/crolkBCRwhichenhnceBcell-mededntigenpenttictivtequidB/CD4TcellcrotlkdurblenticncerefficcyThpropolnovtivecueVAM-B/CD4netigenvccetimulteBcellntigen-pentti-mededB/CD4Tcellcrotlkpromotelg-termntigen-pecificB/CD4/CD8TcellmemydurblenticncerefficcyThdtctcurntTcellcncervcceugCD4/CD8epipethroughDC/mcrophgemeded-ntigenpentti(B)VAM-B/CD4uevirlntigenclutermimicrypogrphyenhncebdgBCRpromoteBCRcrolkBcelluptkentigenBcellmededntigenpenttiThdtctnnodeliveryytempromoteDC/mcrophge-mededuptkentigenpentti(C)VAM-B/CD4vccecouldlouepromcuouvirlBcellepipecncernetigenpromoteB/CD4crotlkThprojectmyhveignificntlypoiveimpctchievelg-termdurblenticncerefficcymnytypecncerProjectSummry/AbtrctVcctipotentgulrimmuneytemmucherchgcductedunderthowntigen-pecifictimulticnuedducedictnti-tumimmunyOurtemdevelopcncerimmunpyprogrmugnovelAAVvecrdeliverntigenbothdictlycro-penttintigenpentgcellOptimiztinturllyoccurrgAAVerotypenovelmethodAAVproductinecerywrrntwideueevecrcncerimmunpyThemimthpropoldetermefetyefficcyournovelAAV-bedvcceprtpclicltudieugcompnidoglmelnomIncentyerwehveundertkentudiegtterundertgunderlygmoleculrmechnmAAVhotimmuneytemterctivihighefficiencytrnductiDCWehvemdefollowgcientificchievementwhichmbcurntpropolIdentifiedmutgenizedcriclurfce-expoedetheidueAAVcpidvolvedtrcellulrtrffickgviruhotcellDemtrtedrtilmodifictiAAVexpicetteultntigenprocegdendriccell(DC)ledgtrgerprolgedntigen-pecificimmunepeDevelopednextgenertihighlyefficientAAV-vecrexpedtum-ocedntigen(pmelnoomeprotegp100(loknownPmel)tyroe(Tyr)tyroe-ltedprote1(TRP1)dopchrometumere(TRP2)TetedenovelAAVvecrirbilytimultepecificT-cellcleprolifertiprotectiveimmunepemllnimlmodelInthpropolwetetbilyourcentlydevelopedoptimizedAAVcpidexpicettewhoeuniquepropertieenhncecellulr/humlimmunepewrdvecrencodedtumntigenSuccefulcompleticurntpropolultProductihighterrpeuticAAV-bedvcceIdentifictinoptimlAAV-beddoevccticnuedlow/elimteprogimelnomcncerlrgenimlmodeluchcompnidog-ptientptneoucncerMechnmnovelcncervccefunctimotpproprenimlmodelTheoptimizedAAVvecrcnpotentillyuedvccepltmttmentcncercnehumnPROJECTSUMMARYIn202053millipeopleUServedfmilycgiverprtnerltivefriendwhoprovidetnce(iephyiclemotil)ptienttenlife-engcurbleillneeCgivercglytkedpibiliecepermedmediclpilvilbilyhelthupptivecgivermocriclthneverAgrowgnumrcgiverprovidecptientdvncedlife-limgcncertkedcriclptientcpibilieplyignificntrolehelthccommunictidvncedcplnnghelthcproxieTheburdenepibiliegtdrivenlrgelyextentildtwhichctrienxietydepipoqulylifementlhelthchllengevementCcurntlycgivgnopptunyexperienceproundenemengpurpoecgivgllowliztinewtngthcpciehelgltihipfementlifegolWhenextentildtddedcgivercnexperiencenenhncedenewell-gdepeirchllengeWhilemnyterventihveendevelopedupptcncercgivernedictlytrgetextentildtOurgroupdptedMeng-CentedPychpy(MCP)highlyeffectiveterventidecgextentildtenhncgwell-gmgptientdvncedcncercncercgiverMeng-CentedPychpyCncerCgiver(MCP-C)tkeholder-mednovtivemnulizedterventideignedtcgivercnectmengpurpoelifedepechllengecgivgReultourpilotromizedctrolleddemtrtedMCP-Cfeibilycceptbilyuperiyimprovgmengnef-fdgdepipirulwellgInpropoedtrilwemigoulyevluteefficcyMCP-Cthroughromizedctrolledtril200cgiverptientdvnced(StgeIII/IVolidtum)cncerwhoceive7eiMCP-CSupptivePychpyCgiver(SP-C)trdcommuny-bedcgivercPrticipntundergoementmengpirulwellg(primryoutcome)nxietydepineffdgcgiverburdenociluppt(ecdryoutcome)tbelepot-ttmentt6-12-mthfollow-upBevemenutcomecludgp-pot-logriefppdnelogtloevlutedtechtimepotWepdictMCP-CultgterimprovementprimryecdryoutcomeenemenglifemedettmenteffectWelopdictMCP-Culttterppdneloimprovedp-pot-logriefgtOurultenhnceourcpcypowerfullytrgetextentildtcgiverptientdvncecncerexteniimproveircpcyprovidecriclcptienttend--lifePROJECTSUMMARYBckgroundMmmlinmodelcncerhveentrumentldevelopmentmnytrgetedrpieIthoweverdifficultetblhemodeluchptient-derivedcellcultu(PDCC)xenogrft(PDX)AultmotcncertypehvelylimednumrmodelvilblewhichdotccurtelyflectdiveryhumncncerllifeInnovtiThemjyptient-derivedmodelwedevelopedugunttedprimrympleplentytumtueThenextchllengetummodelgquimuchmodifficultmpleuchmuteidultumfociptientprtilchempypeEventhoughcncerdeeuncheckedcellgrowthbodynmlcellprdoxicllyprolifertefterthnmlignntcellcellcultuAultmjyPDCCmodelcncercelleventullydpperTodduenmlcellovergrowthwectgtum-pecificmedium(TSM)uppenmlcellprolifertiPlimrydtApro--cceptwepublhedtwenty-fivenewovrincncercell(OvC)letedmoleculrhlogicoutcomefetuptienttumObjectiveOurgolctenovtiveimplecultumethodenblectiptient-derivedcellcultuPDXmodeldeveloptprcticevlidtgemodelSpecificAimWewkgfivemjolidtumtype(lungbtprottekidneyovry)liquidtum(leukemi)illutrtethurytemcndptedcultufullpectrumtumtypeAim1Ptient-DerivedCultuSolidTumWeetblhptient-derivedlungbtprottekidneyovrydenocrcomcultucompirmoleculrprileiglptienttumAim2)Ptient-DerivedCultuSolidTumWeetblhptient-derivedAMLcultucompirmoleculrphenotypicprileiglptienttumReerchStrtegyWecompgenometrncripmeproteomeechcellleiglptienttumextgcellletumdtetInnovtiByuppgexpninmltromlcellnmlepiliumTSMcultuytemcnmtcncercelllelg-termoutfeederlyerdrugextrctImpctPdictgdrugctivyclichlwyendifficultugtrdilculturlmodelTheehvgccebiologicllylevntlungbtprottekidneyovryAMLcelllecouldvolutiizecncerdrugdevelopmentProjectSummryPcliclmodellungcncereentilolercherundertcncerbiologydeveloprpeutictrtegieChoogmotcot-effectivepcliclmodelnwerpecificcientificquetiquicfultudyextgmoleculrpthologiclchrcteriztidiffentmodelhumntummoleculrprilgvelchetrtibiologiclproceepthologiclchrcteriztimptilcompoummicroenvirmentWhilepcliclmodellungcncerhveenextenivelychrcterizedmoleculrdtmcttedpthologydthverlyendepoednoolextevlutemoleculrpthologiclgementtweenpcliclmodelhumntumWehvepvioulybuiltlungcncerexplwhichprovideuer-friendlytegrtivenlyticlolexplogeneexpiclicldtover6700ptient56publheddtetLeverggptientlungtumpthologyimgerchivewedevelopedlghmpipelepermhpthologydigltgfetuextrctiH&EimgeidentifiedtetgpthologyfetupdicutcomepetrgetedrpyExtendgeeftpcliclmodelthpropolimdevelopnmticpltmtegrtgmoleculrpthologydtvrioulungcncerpcliclmodelptienttumepcliclmodelfidelythroughcomprtivenlyeSpecificAim1hrmizemoleculrprilgdtetvrioulungcncerpcliclmodelSttticlmethodcro-tudyvlidtiqulyctrolimplementedenucomputtilcomptibilyelectppropredtetnlyModel-pecificwebpplictibuiltupptdtexpltinlySpecificAim2permhpthologiclptiltrncripmicchrcteriztumvivomodelWenetwklungcncerpcliclmodelvetigrolicctriipthologyimgempleetblhgpublicimgerchiveptilmoleculrprilgexperimentEffectivelghmpipelepcliclmodelpthologyimgenlyeetblhedSpecificAim3tegrtedtcollectedhrmizedAim12ctructnmticpltmcro-modelcomprlignmenthumntumThpltmllowuerviewdownlodourproceedmoleculrpthologydtetcompmoleculrpthologyprilepcliclmodelptienttummultiplefcetWeheourcelungcncererchcommunyolicfeedbckimproveourpltmTheuccefulimplementthprojectemblecttedmoleculrdtetetblhlrge-clepublicpthologyimgeptilmoleculrprilgourceetblhuer-friendlytegrtivefidelyementpltmlungcncerpcliclmodelABSTRACTT-cellcutelymphoblticleukemi(T-ALL)nggivehemlogicmlignncythccurprimrilychildncnlooccurdultDepecentdvncettment20-50%ptientdohowprimrytncelpefterttmentultimtelydieirdeehighlightgneeddcovernoveltrgetedrpeuticpprocheThedetectihighlypvlentNOTCH1ctivtgmuttiT-ALLeen~60%ptientleddcoveryNOTCH1ignlghibiruchgmm-ectehibir(GSI)blockcriclproteolyticlclevgetepquidNOTCH1mturtictivtiGSIcurntlygexplodclicltrillped/frcrycehoweverpeobervedglegentttmenthveengenerllylimeduchidentifictinoveltrgetcombtirpiecpbledelivergtrgynergticntileukemicpeptientemoturgentgolT-ALLfieldOurlbhpvioulydemtrtedrpeuticneftrgetgmetbolicrouteT-ALLInthctextmyplimryulttrglyuggettrgetgglycolyticenzymepyruvteke(PKM)htrgntileukemiceffectownignificntlyynergizeGSIttmentvivoStillrolePKMT-ALLmlrgelyunknownNotblyPKMhtwodiffenrmPKM1PKM2wehveldygenertedcdilknockoutleukemechpecificmwellbothmccomntlywhichllowuexquelynlyzeeffectpyruvtekeleukemiprogiperpyvivoThuimthprojectmechnticllydectfunctiPKMT-ALLugcombtigeneexpimetbolomicprilgepigeneticprilgexperimentlrpeuticvivotkgdvntgeouruniquegeneticolOurulthedlighnmechnmwhichNOTCH1ctrolcncercellmetbolmvelPKMputtivenoveltrgetttmentT-ALLSUMMARYBtcncerccountnerlyqurterllcncerwomenmecdledgcuecncerdethUSdepeubtntilchngetrdcttmentIdentifygevolutirymechnmnturllyprotectpeciedevelopgcncercomgncglyppcedpprochdeveloprpeutictrtegiebothefficientn-xicWecentlyidentifiedcncer-uppgmechnmbedectibioctivefcrnti-cncerctivymmmrycell(kmmmophe-derivedepililcellMDEC)dometictedmmmrycncer-prommmlSpecificllyebioctivefcrwehown(i)ducetriplenegtivebtcncer(TNBC)celldethoutffectgnmlhumnbtcellvro(ii)ducetumigenicyxenogrftTNBCmouemodelvivoTheefdgledourcentrlhypoMDECecmemmmrycncer-prommmlhignificntpotentildevelopmentnoveleffectiven-xicrpiett/pventbtcncerepecillyggivehmerpy-unpiveTNBCWenowpropoefollowupetetgfdgfurrchrcterizgnti-cncerctivyMDECecmegterdepth(Aim1)evlutgrpeutic/pventtiveeffectMDECecmemouemodelTNBC(Aim2)Theignificncethpplictilienoveltypprochguedidentifyn-xicefficientbtcncerrpeutic/pventtiveterventifocugbioctiventi-cncerfcrproducednmlmmmrycellmmmrycncer-prommmlThepropoedexperimentceourknowledgenovelcncer-uppgmechnmprovideolidbdeigneffectiven-xicrpiecnuedfightggiveTNBC/developmentprotectivefcr-bedrpeuticelimteduceTNBChigh-rkpopultiPROJECTSUMMARYThemechnticTrgetRpmycComplex1(mTORC1)mtergulrcellgrowthmetbolmDygultimTORC1obervedpdicfmililcncermTORC1hibinetblhedttmentnlcellcrcom(RCC)DepegtefttrgetmTORC1cncerdvereeffectlimuemTORC1hibirclicRecentwkourlbcollbrhveledextencetructurlbubtrte-pecificgulrypthwymytrgetedgterpchnhemTORC1ctivtedurfcelyoomepenutrientignlcverinucleotidetteRgGTPective(RgA/BGDP-RgC/DGTP)ctive(RgA/BGTP-RgC/DGDP)TheRgtrgetedlyoomeRgulrcomplexRgttetercvertedRgC/DGAPFLCN-FNIPRgA/BGAPGATOR1SubunecomplexeRgmuttedcncerRgA/BGTPGATOR1ctivtiquidphophyltillmTORC1ubtrteRgC/DGDPFLCN-FNIPctivylyquidphophyltin-cniclubtrtewhichcludeTFEBkeytrncriptilgulrlyoomebiogeneuphgyCryo-EMtudieRgRgulrFLCN-FNIPpthwyourlbryprovidedtrt--fhtructurlexplntipictivtiFLCNGAPctivytrvtifeedgTheetudiectrieddcoveryRgC/DGDPuniquelygulteTFEBMiT-TFEtrncriptifcrwhichturnexpledtumuppctivyFLCNBirt-Hogg-Dub(BHD)yndromeThpthwyhnowenlkedRHEBctivyTurouScleroComplex(TSC)WendemtrtedextencedetermgtructufunctimTORC1-TFEB-Rg-RgulrmegcomplexctgfullmTORC1dimertwocopieTFEBfourcopieheptmericcomplexctiveRgRgulrhowghowRgC/DGDPpecificllycruTFEBInim12weexplewvenueopenedupnlymegcomplexWedetermehowmegcomplexturnedoverfollowgTFEBphophyltiwherprcipleubtrtepecificctivtieenTFEBRgClopplycniclubtrteFdgfollowedupBHDTSCcellleBHDmouexenogrftmodelWhilewenowhvetrt--fhtructurlmppgFLCN/RgC/DpthwytillmyteriougulrymechnmopertgGATOR1/RgA/Bpthwyelucidtedim3cncerimplictiexplodknock-outGlioblmcellleABSTRACTRectlcncercommcncerledgcuecncerdethThemjyctlcncerptientdignoedtgeIIIIIlocllydvnceddeeNeodjuvntchemdipyfollowedtlmeoctlexcitrdcttgeptientHoweverpeneodjuvntrpyhighlyheterogeneouWhilepproximtely20%ptientchievepthologiccompletepelg-termdeectrolover30%ptientdevelopdtntmettdepemultimodlyttmentBecuetlmeoctlexciocedignificntmbidypoqulylifegnpervti(iewtchfulwgouturgery)commendedptientwhodeemedchievecompletepeOnhptientthighrkcurncetlneodjuvntrpyductichempycglyuederlyerdictimicrometteimprovecurteTheuccefulimplementtietwohighlypromgttmenttrtegie(gnpervtlneodjuvntrpy)hgepceknowledge(1)whichptienthvepthologiccompletepe(2)whichptientdevelopdtntmettUntuntelycurntcliclolrrcrudedotllowccurteoutcomepdictindividulbledgover-ttmentomeptientunder-ttmenrThepgunmetneedlibleprognoticpdictivebiomrkerguideperlizedttmentctlcncerToddthunmetneedwedoptrtilpprochprognopdictidevelopgrdiomicdeeplerngmodelmedguidedetblhedknowledgetumpthobiologyAddillywepropoenovelpprochenlyzeerilimgepdictgpthologicpeneodjuvntrpyFurrleverggcomplementryvlueimggblood-bedbiomrkerwectructtegrtivemodelimproveoutcomepdictiToetblhcliclvlidyweuelrgetropectivedtetmodeltrgcductrigoupropectivevlidtiIfuccefulthprojectledrk-dptivepe-drivenperlizedttmenttrtegiewhichmyultimtelyimproveoutcomeptientctlcncerPROJECTSUMMARYTherpeuticpprochecncerrpiehveevolveduehighlyxicchempygentpcimedicewell-defedtrgetmimlxicieWhilepcimedicehighlydeirbleeffectivenedependpencectivtggenttypicllytrgetglepthwywhichcducivedevelopmentdrugtncewhenlterntivepthwyfeedbckmechnmuedTheelimtitexemplifiednti-cncerrpietrgetgprotetrnltigulrmmmlinTrgetOfRpmyc(mTOR)AlthoughehibirhowclernefomecnceruchmntlecelllymphomRenlCellCrcomTurouScleroComplex-ltedtumyhvelimedefficcyglegentmorcncerduecompenryfeedbckmechnmInddrgetgcompentgenerlprotetrnltilmcheryloeentilnmlcellfunctiwouldlikelyctrienmltuexicyAgentcouldtrgetimultneoulynumrlimedkeypthwyeentilcncercellprogiurvivlwouldthuexpecteddecexicytnceTothAimwehveidentifiedfirtclmllmoleculehibirhnRNPA18gulrprotetrnlticncercellhnRNPA18trgettrncriptvolvedcncerprogimettngiogenenti-poptumimmunecheckpotOurwkghypomllmoleculehibirhnRNPA18hibtrnltipecificRNAtrncriptdevotedcferrggrowthdvntgeimmuneprotecticncercellToverifythhypothecomplementrypecificAimhveendeignedAim1DeignynizeimprovemllmoleculehibirhnRNPA18Aim2PriizecompoundthroughvromethodcludgRNAbdgcellpteryprolifertixicyAim3Determevivti-tumADMETpropertieledcompoundemploygxenogrftyngeneicPtientDerived(PDX)tummodelAmultidciplrytemexpertcompoedmediclchemttructurlbiologticlchemtcncerbiologtimmunologtncologthenembleddevelopoptimizethnewclnticncergentultimtegolbrggmclicAbtrctEpigeneticbnmliecommhumncncerplycriclroletumigenevidygultigeneexpiffectgchromtfunctiNuclerceprbdgSETdomprote3(NSD3/WHSC1L1)lgfmilyNSDhnemethyltrnferectlyzemo-di-methyltilye36hneH3(H3K36me1/2)NSD3genelocted8p11-12gimplifiedpproximtely15%ptientbtcrcomthmplifictiignificntlyoceddee-pecificurvivldtntcurncebtcncerptientNSD3henidentifiedkeycogenicdriver8p11-12mplicknockdownNSD3ultproundlogrowthurvivlbtcncercellHoweverNSD3complexmultidomprotedepemultipleeftnotudieunmbiguoulyvlidtedwherctlyticSETdomeentilcogenicctivyNSD3HewepropoeeimptnceNSD3SETdomcogenedevelopgmllmoleculechemiclproThpprochhighlynovelnoNSD3hibirtrgetgctlyticSETdomweptedlertuTodteweidentifiedclmllmoleculecompoundbdelectivelyNSD3SETdomnotcloelyltedNSD1NSD2InplimrytudieourhibirpecificllyblockgrowthbtcncercellmplifictiNSD3ThegolthpropolfurrdevelopecompoundvlidtewheroptimizedchemiclproblockgctlyticctivyNSD3wouldimpirdevelopmentprogibtcncervivoToccomplhthgolweemployextenivemediclchemtryimprovepotencyelectivyphrmcoketicpropertieourNSD3hibirEfficcymotpotentcompoundevlutedxenogrftPDXmodelbtcncerWecfidentthurcompheniveplnleduccefuldevelopmentpotentNSD3chemiclproexpltiNSD3biologybtcncertum8p11-12mplifictiPROJECTSUMMARYProttecncer(PC)motcommlydignoedmlignncyeffectivettmentctrti-tntPC(CRPC)mmjchllengeclicSPOPubtrte-bdgdprCULLIN3-RBX1E3ubiquligecomplexSPOPgenemutted10-15%primryn-ctrtemettticPCNotblypproximtely50%SPOP-muttedPCmtntrogencepr(AR)pthwyhibiruchenzlutmide(Enz)enurgentneedelucidteunderlygmechnmtncedevenewttmenttrtegieOurplimrytudiedemtrtedSPOPmutti(SPOPmut)co-occurdrrntctivtiMAPKpthwy(MAPKlt)uchgenomiclterticompentRAS/RAF/MEK/ERKignlgxtwoleicoopertedduceprottecogeneprogimiceWefoundSPOPmut/MAPKltPCcellctrti-tntcultumiceMechnticllywedemtrtedSPOPmuttiducedtbiliztiGLPG9proteugmentedMAPKlt-ducedexpiDNAmethyltrnfereDNMT1promotgDNAhypermethyltiepigeneticilencggrouptumuppgene(TSG)cludgAR-terctgproteuchKDM6AWecfirmedhypermethyltiKDM6AgenelocudowngultiTCGASU2CPCptientmplecultudPCcellhigh-levelERK1/2phophylti(MAPKlt)WefurrhowedKDM6AterctARSPOPmutticeARprotemethyltimnnerdependennKDM6AWehowedco-ttmentMEKhibir-enizedSPOPmut/MAPKltPCcellEnzBedenovelplimrydtwehypoizeSPOPmutticooperterrntlyctivtedMAPKpthwyducerrntGLP/G9protetbiliztiDNMT1upgultiwhichturnpromoteDNAhypermethyltlociTSGuchKDM6AcedARprotemethyltiARignlgprogrmgctrti-tntprogiPCpentgvibletrgetovercomentirogentnceSPOPmut/MAPKltPCWedetermemoleculrmechnmextentwhichKDM6AgulteARprotedemethyltiARctivieSPOPmut/MAPKltPCcell(Aim1)determemoleculrmechnmunderlygdegultiGLP/G9/DNMT1-KDM6Axirimpcnctrti-tntgrowthSPOPmut/MAPKltPCcell(Aim2)determemechnmdeelevncepcliclrpeutictrgetgfunctilcoopertitweenSPOPmuttirrntctivtiMAPKpthwyPC(Aim3)FdgthnovtivepropolnlyhednewlighnourundertgtumbiologySPOPmuttimoleculrmechnmntirogenrpytnceSPOPmuttedPCloledidentifictinewrpeutictrgettrtegieeffectivettmentPCfluencgPCfieldbothcientificllyclicllyPROJECTSUMMARYTheobjectivethmulti-prciplvetigrpplictilevergecomplimentryexpertevetigrdevelopcdentilmultiplenewmouemodelhigh-rkpedriccutemyeloidleukemi(AML)TheecludebothhumnmoueAMLgenotypecelligmedl-wldptientdtpentundertudiedhigh-rkmoleculrubtypedeeThpropolddpgcliclcientificneedChildnAMLctuehvenoverllpourvivlltivepedriccncerptientAdvncetrgetedrpiehveenlowdevelopup-frtttmentprocolhvemedmrkblytgnntpt4decdeEftderivenewrpiehvelggedprtduemrkedgeneticheterogeneypedricAMLIndeedwehveetblhedthver20uniquemoleculrubtypepedricAMLflectuniquedrivermuttiexpiigntuPedricAMLlohrbecdrymuttifurrexcerbtegeneticheterogeneyThurpiemightnefptientegeneticubtypepedricAMLcouldhvelimedvluediffentptientpopultiUntuntelycurntmodelpedricAMLdotflectmrkedgenomicdiveryobervedptientCurntpprochecommlyfoculimedubetmoleculrubtypetypicllyvoidgrhigh-rkubtypeyeirdotco-modelecdrymuttiyimplementmuttilcombtinotflectedptientThumclerunmetneeddvncepedricAMLmodelgmenexpgeneticllymedrpeuticoptiWeddthneedthroughcompletheAimexplouniquekillechvetigrdependenterchprogrmexceptiltutilfrtructutbothStJudeChildnReerchHoplWhgnUniverySchoolMediceAim1Developnovelyngeneicmouemodelhigh-rkpedricAMLAim2DevelophumnmodelrpedricAMLptient-medcoopertgmuttiAim3CdentiletblhednewlydevelopedAMLmodelgnenprimryhumnpecimenTocteAMLmodelwedeployeverlnovtivegenetictrtegiecludgnovelpprochgenertegeneticllycomplexmuAMLducedpluripotenttemcelldictedghumncdbloodprogenirCdentilgvolvedictcomprprimryptientmterilgeneticllymtchedmuhumnmodelbedtrncripmicepigenomicproteomictrtegieThehigh-rkpedricAMLmodeldevelopedthroughthcomphenivecro-peciepropolprovidecientificcommunynunprlleledcollectiextenivelychrcterizedpecimenfutuvetigtideemechnmrpeuticvulnerbilieABSTRACTThecliclnefcncerimmunpiecludgdoptivecelltrnfer(ACT)chimericntigencepr(CAR)TcelllimedwhenuedgtolidtumTheimmuno-uppivetummicroenvirment(TME)enrichedcellulrcompent(gulryTcellmyeloidderiveduppcelltum-ocedmcrophgeetc)cellulrfcr(hypoxideficnutrientcidodenoeetc)decevibilytumicidlctivienti-tumntiveCD8+cyxicTlymphocyte(CTL)rpeuticCARTcellTherpeuticneutrliztiefcrcompentchllenggcueirdiverydundncyIntedweimidentifythwrtkeymechnmwhichTME-derivedfcrcdiundermevibilynti-tumctivieCARTcellWefocuTME-triggeddowngultypeIterfer(IFN1)ceprIFNAR1whichnmllyupptvibilyctivyntiveCTLCARTcellOurplimrydthowMAPKActivtedProteKe2(MK2)mo-ADP-riboyltrnferePARP11coopertedowngulteIFNAR1trtumlCAR-rgTcellledgirctivtirpidcelldethIFNAR1loleddowngultiIFN1-duciblecholeterol25-hydroxyle(CH25H)CH25HctlimeffecrtrogocytweenmlignntcellpecificCARTcellInbenceufficientlevelCH25Hproduct25-hydroxycholeterol(25HC)rogocyundermectivieCARTcellexpoemfrtricidlkillgTheeexcgplimryultuggetnoverrchghypotrgetgTME-drivenPARP11/MK2/CH25H-dependentmechnmgultevibilyctivyCARTcellhouldenhnceirnti-tumctivieceefficcyCARTACTTotetthhypowedeterme(i)roleTME-ducedPARP11ctivtiCARTcell(ii)imptnceMK2ctivyupprtumlCARTcell(iii)ctriidowngultiCH25HCARTcellctivtidecedefficcyCARTACTCompletietudiehouldgightimmunoupprtumlCARTcellhelpdevelopnovelCARctructCARTp-ttmentwellcombrilpprocheceefficcyCARTACTProjectSummry/AbtrctTumprogicludgtncerpymettcurncepiblemjycncerdethUndertghowcncercellurvivettmentpddtntepertdmntidulcelleventullycureentilimprovgttmentthdeeThelg-termgolmyerchgroupidentifypthwygulteeproceederpvenrtttumcurnceTochievethweugcdilgeneticllyengeedmoue(GEM)modelbtcncerllowmechnticdectiproceedmncycurnceUgemodelwehveidentifiedfunctilroletumuppPr-4gultgurvivlcurncebtcncercellfterrpyPr-4downgultedcurnttumtheGEMmodelthdowngultibothneceryufficienttumcurnceSimilrlywomenbtcncerlowPr-4expiocedpopeneodjuvntrpyncedrkcurnceWehvechrcterizeduptmpthwygultePr-4expifunctidurgdmncycurncewelldowntmpthwyPr-4gultehibdmntcellurvivlcurnceThpropolbuildthwkfurrexplomechnmwhichPr-4cttumuppTheoverrchghypopropolPr-4promotecelldethprtthroughducgcmyoctrctilythctrietumuppivefunctiWeexplothhypoctextPr-4roleidulcellurvivlurvivlvivelobulrcncercellOurwkvelnewmtihowPr-4functigultedmntidulcellurvivlmyuncovernovelopptunierpeuticterventielimtgidulcellpventgcurncePROJECTSUMMARY/ABSTRACTOVERALLProttecncerecdledgcuecncerdethmenUnedStteplceignificnthelthburdenocietyTheoverrchggolUCSFProtteCncerSPOREddthburdenducgmbidymtlyocedprottecncerthroughleverggdeepundertgdeetrnltebiologiclfdgcliclimpctTheSPOREtempprochthmrndciplryerchhighlycollbtivetrnltilthroughfourpecificimA)InvetigtemoleculrdriverggiveprottecncerB)DevelopbiomrkerguidettmentptientdvncedprottecncerC)Trgetrpeutictncemettticctrtitntprottecncer(mCRPC)whichlethlmnifettidvnceddeeD)AccelertetrnltilerchcropectrumprottecncerToddeimUCSFProtteSPOREpropoethecientificprojectechvetigtgggiveprottecncermechnticbiomrkerrpeuticperpectiveProject1CombtiimmunpyrdioligrpymettticprottecncerProject2InvetigtgCliclBiologiclImplictiNovelHypermethyltedSubtypemCRPCProject3DeciphergRoleTrnltilOncogenicProgrmProtteCncerTheepropoedtudieidedhiztlcollbtiProtteSPORESNCIivemoleculrdignoticcompniewellverticlcollbtiNtilCliclTrilNetwk(NCTN)DODProtteCncerCliclTrilCtium(PCCTC)phrmceuticlcompniemggniztiAddillyeprojectcomplementedtrggogtutilcommmentmeypcewell-ourcedCerEnhncementDevelopmentlReerchProgrmthecoAdmtrtiBiotttic/BiomticPthology/TueThefrtructuoutledunderthSPOREpplictideignedencourgepromotetrnltinovtiveimpctfulideupptgpromgnewprojectprovidgccecriclourcench--didetrnipgterdciplrycollbtiprovidgneffectivefrmewkmenrg/nurturgnextgenertrnltilcienttBybrgggerdiveremulti-dciplrygroupvetigrthProtteCncerSPOREccelertehighlyimpctfultrnltilerchpotentilignificntlyimproveclicloutcomemenggiveprottecncerSUMMARYTheInterntilSkImggCollbti(ISIC)overrchggollevergetechnologyducekcncermtlymbidyTheISICArchivectedledMemilSlKettergCncerCenterce2016ledgpubliclyvilblekimggpoiryWh>240000imge>6000gteduer17-21milliimgedownlodpermthISICArchivehmdemjctriidermlogytechgdevelopmentrtificiltelligence(AI)kcncerdignoISIChloencentrldevelopmentdoptitrdkimggpromotequlyteroperbilyISIChhoted5mchelerngGrChllengehotctuouLiveChllengeugISICArchiveimgeISICChllengehvettrcted6818prticipnt25326ubmiISIChdictlypublhed21cientificpperwhilen260peerviewedpper3060techniclpthveliedISICdtHewepropoedevelopISICArchivenevengterourceerchthroughmjenhncementfocumkgISICArchivefullycomplintFAIRprciple(fdbilycceibilyteroperbilyubily)whileexpgArchiveddilupptbrodlyueddtmt(egDiglCommunictiStrdMedice[DICOM])kimggmodlie(cliclimggtlbodyphogrphy[TBP])WepropoelevergeISIClederhipDICOMcommunyimprovetwupptetblhedkimggtrdwhilepublhgnewtrdTBPimprovequlyteroperbilyeimggmodlieWehvegnizedkeymilenethpropolunder4pecificim(1)brgISICArchiverigoucomplinceFAIRprciple(2)overcomechllengegetghrgcliclimgepenttiTBPwhilemtgptientprivcyddgenivy(3)tngnteroperbilyISICdtthroughueDICOM(4)implementpprochefcilteclgdemtgutgISICdtpoiryTheultgISICArchivemocientificllyrobutimpctfulutbleourceISICctuepromoteueArchiveenggedermlogycomputerciencecommuniethroughChllengewkhoppublictiBypromotgupptgercheffectivelylevergekimggAIdignoekcncererliermoccurtelyweveliveducembidyocedunnecerybiopiettmentdvnceddeeOverllProjectSummry/AbtrctProttecncerhcomemotfquentlydignoedcncermenUnedStte(US)mjcuecncermbidymtly33000Americnmen(~90everydy)dygnnullydeeCiderbleprogoverltdecdeultedpprovlmultiplenewhmlcyxicrpieechproducgmodetimprovementurvivlYetdepebrodpletterpeuticoptiemerggpromeimmunpycumettticprottecncerhmedeluiveHoweveroverpttwodecdededictedprottecncererchccomplhedJohnHopkProtteCncerProgrmvetigrercherledmrkbleccumultiknowledgeboutmoleculrmechnmwhichhumnprottecncerprogTheetudieidentifieddptiveugultirogenceprctivymuttiltertiDNA-pirpthwynimmunouppivemicroenvirmentfundmentlchrcterticprottecncerproducgtncehmlDNA-trgetedimmunebedrpiellowgprogieventullyenlifeTomkeignificntdvncementttmentprottecncergolthnewProtteSPOREpplictrnltenewightboutroleplyeddptivechngehmlxDNA-pirimmuneytempthobiologyprottecncernewhypoetetedclicltrilThetrncendenverllobjectiveJohnHopkProtteCncerSPOREduceprottecncermtlyvifocuedpurutrnltilerchprottecncerPROJECTSUMMARYUtecncer(UC)cidencedethrtebothignificntlycgUnedStteMotUCendometrilcncerwhichnerlguterudefedeverldiffenthlogicubtypemotcommwhichendometrioidAddillyurvivloutcomeweblckwomenBecuewengurvivlwomendvncedlpedendometrilcncerthP01grntfocuedtrgetgplictit(RS)derimproverpeuticoutcomeeptientRSdefedlowgtllgplictikprogidurgDNAynwidelycognizedignificntcuegenomictbilycriclfetucncercellThP01grntvetigte3diffenttrtegietrgetgRSUCgoltrnltgeeffectivelvgerpiewomendvnced/lpedUCWehveembledtemterntillycognizedercherDn-FrrCncerIntuteBrighmWomenHoplbothBonMAmultidciplryexperteUCDNApirRSimmunpypcliclmodelbiottticcomputtilbiologygynecologicpthologydrugdevelopmentclicltrilThP01grntgledDrPngiotKtnpouloJoyceLiuUrulMtulwhocognizedterntillederfieldgynecologiccncerendometrilcncererchThP01grntct3Project4CoThelederhiptemechProjectcompdpidvetigrcomplementryexpertebiccienceclicl/trnltilerchProject1focuetudygmechnmWEE1hibicurntUSCp53-muttedUCcltiWEE1ctivyfunctilimmunohchemicl(IHC)meuRSBedupultclicltrilWEE1hibirdvoertibwhichpvioulydemtrtedignificntcliclctivyUSCthprojectlevergecollectiptient-derivedxenogrft(PDX)ptient-derivedgnoid(PDO)geneticllyengeedmouemodel(GEMM)p53-mutted/nullendometrilcncerexmeeffectWEE1hibifunctilIHCmeuRSvrovivoettgAddillythroughbiopy-drivenvetigr-edprocolWEE1hibirZN-c3USCProject1exmeeffectWEE1hibimeuRSco-cliclPDOcltiemeucliclctivyProject2focuehypohibiPI3KpthwycnceRSecteynergyATRhibirInpvioulypermedPRISMCRISPRcenhibiPI3KignlggerATRhibiwidentifiedpotentillyynergticubequentexperimenthvedemtrtedynergmtweenPI3KhibircopnlibATRhibirelimuertibProject2exmePDXPDOGEMMmodelytempotentilynergytweenATRPI3KhibiexplocliclctivythcombtiPhe1bdoeeclticlicltrildoeexpniuteerouARID1AmuttedutetumbothenrichedccomntPI3KpthwyltertigenomicltertiocedhighRSProject3focuefurrvetigtgplimrydthowgtrgetgRSpethroughhibiDNAdmgecheckpotkeATRWEE1ledcedDNAdmgectivtiSTING/TBK1/IRF3pthwyultgenhncednti-tumimmunyimprovedpeimmunecheckpothibi(ICI)Bedenoveltrtegypropoedextendnefimmunpymmtchpirpricient(MMRP)cncerugDNAdmgecheckpotkehibircombtiICIThemhypoprimgimmunologicllycoldMMRPUChottumugDNAdmgecheckpotkehibicomdICIovercometum-mededimmunouppiledeffectiventumimmunygtMMRPUCThe4CothgrntcludeAdmtrtiveBiottticComputtilBiologyPcliclModelSytemPthologyReviewourP01grntexternlProjectCotemoccurthroughnExternlAdvyBd(EAB)nInternlAdvyBd(IAB)ndvoctecoPROJECTSUMMARYGtrotetl(GI)cncerwhichcludemlignncieeophgumchpnccoloctummllteteliverctuteplurlycncerdethUnedSttewldwideWhileubtntilproghenmdedeletgunderlygmoleculrmechnmtrnltipventichemopventierlydetectiprognorktrtifictirpyurvivhipkeygpmbiologiclunderpngpthogeneGIcncerFurrmollGIcncerdpriettmenutcomedverelyimpctunder-pentedpopulticludgAfricn-AmericnHpnic-AmericnGivencomplexydtctetiologicrpeuticfetuGIcncerGIcncererchmhighpriymnyyercomeThumpgneedtrnextgenerticienttcductGIcncererchnnovtiveproductivemnnerColumbiUniveryIrvgMediclCenter(CUIMC)NCIdeigntedHerrtIrvgCompheniveCncerCenter(HICCC)helrgetgroupNIH/NCIfundedvetigrwkgGIcncer(iecriclmmenr)AddillytrgprogrmfcultymenrpermerchcropectrumtrgdciplecludgbicciencetrnltilerchcliclepidemiologicltudiewellbiomticBuildgthwehvedevelopedrigoupotdocrltrgprogrmmultipleuniquefetutngth1)FocuGIcncerGIcncerpibleplurlycncerdethUnedSttewldwideyetprogrmimedpecificllytdevelopgfutuvetigrfocuedGIcncerlckg2)BdrgInddibictrnltilciencewellclicl-epidemiologiclerchmethodourprogrmcludetrgbiomticbridgebic/trnltil/cliclerchuniquepectNCItrgprogrm3)CommmentpromotgdiveryWehveetblheduniquecollbtiveprogrmUniveryPuerRicoSchoolMedicecrupdocrltudentourpotdocrltrgprogrmInddiwehvedevelopedextenivecommtedeftbothpecificthprogrmleverggextgprogrmurtutienhncepromotediveryfutuGIcncerercherTheeductilgolProgrmervepmiertrgentiwideemerggercherGIcncerTheprogrmimdvnceourundertgGIcncerlg-termgolducgmbidymtlyemlignncieAnimptntgolourprogrmcediveryfutucienttenggedGIcncererchTochieveegolweidentifycrudiverepooltefermrigoudividulizedcurriculumprovidemerchexperiencewkgeournumerouexpertexperiencedfcultymenrvetigrtColumbiUniveryOVERALLABSTRACTLeverggObervtil(RelWld)DtAdvncePciOncologyPrciplInvetigrChrleSwyerMemilSlKettergCncerCenterPcicologyfirmlyetblhedpillrprcticecncermedicewenowcognizenewchllengebrodimplementtiTheeclude(i)heterogeneypepcicologydrugptientidenticldrivermutti(ii)diffencedrivermuttifquencieptientdiffentethnicieimplictienurgoptimlttment(iii)cedubtypgcncerhunddrdeeultnpertilchllengeclicltrildeignexecuti(iv)limedundertghoweffectivelylevergeobervtil(lwld)dtddechllengeThevetigrthP01Progrmhvehdlgtgcollbtioverpt8yerhelpgbuildlrge(>148000ptient)terntilclico-genomiccncergtryknownAACRProjectGENIEWehvecomegervetigteeuepropoefourhighlytegrtedprojectltedemeProject1eekovercomemethodologicbrriernlyobervtilclico-genomicdtProject2ddrolegeneticncetrypcicologyoutcomepotentilequiehowpcicologydignotictetdevelopedProject3uelwldevidencemclicldecittmentcncerptientcnnotddedugcventilclicltrildtetoptimizeptgefdgugOncoKBknowledgebeTheprojectupptedCurtiSttticlAnlyCo(dtbtrctibiottticuppt)MoleculrPthologyBiomticCo(moleculrprilgdtcptu)AdmtrtiveCo(cptgextgGENIEfrtructudthrgcommunictidmtrtiveuppt)Ourpropolhighlyynergticbrggermulti-tutiltemdtguhedvetigrpopulticiencepopultigeneticcncergenomicexperimentlrpeuticubtntiltrckcdcollbtiveterctiwhowkgerddeimptntpicpcicologyPROGRAMSUMMARYRecentepidemiologicevidencehighlightignificntunmethvilhelthneedcncerptientUnedStteAtrgevidencebenowupptuediglhelechnologieeffectivelyextendchimpctcncerclicinimprovequlycHowevertrgtegrtieolutiprcticeeentilovercomebrrierenutprcticeuccefullyddpccerncncerptientdiglverilg-proventtmentThepropoedR25progrmtrfrtlecncerclicin(phyicindvncedprcticeproviderpychologtpychrtnureocilwker)t-prcticeimplementtechnologycncerupptivecOuroverllgolpromoteeffectivetegrtievidence-beddiglheleleheltholutietblhedcliclterventicpprochecncer-ltedftigueomnipdepinxietyWechievethgolthroughthepecificim1)Toimplementmultimodltrgcurriculumeducte600cncerclicintechnology-ugmentedcTrgprovidedthroughlewebrkill-bedwkhopbothdidcticexperientillerngpot-wkhopterctiveleupptbothdictlyprogrmfcultylolerngcommunytepeercollegue2)TocetebilyuccefullyimplementuediglheltholuticliclprcticeTelernevlutediglhelerventitermirempiriclfoundticliclutilydetermehowmtchterventipecificpopultiobteffectivelyueptientmtidigldevice(egleepqulyphyiclctivyvlign)enhnceclicloutcomeddchllengeltedcedvilbilyptientdt3)ToeeffectivenetrgprogrmFmtiveummtivennulfive-yerevlutieteknowledgegedcfidencetechnologyimplementtitfctioverllprogrmwellpecificcompentThpropoluppteducceourfourpriR25ivepivehighleveltetexpedpotentilteidentifiedthroughcently-cductedneedementInddileferg-perwkhopfedNewYkCyDenverPdenfciltetettendncecroUnedStteProgrmfcultypillyculturllyrcillygeogrphicllydiveretewhobckgroundunderpentedmediceceivepriycceprogrmenrollmentCMEcdprovidedlleligibleprticipntTokeepcotgbrrierprticiptiupptprovidedtewhoptfncilneedpfencegiventhoeunderpentedmediceToourknowledgenotrgprogrmddourmiABSTRACTTriple-negtivebtcncer(TNBC)nggiveubtypebtcncerdefedpooverllprognoggiveerlyptternmettelckttmentleduteddeectrolThecriclneedmoleculrtrgetedttmentptientTNBCmoeffectivehveducedideeffectdecemtlyocedTNBCMuc-1(MUC1)ovexpedunderglycoylted94%TNBCceprdenyextmelyhighThecombtimodifictiglycoyltiovexpillowtumocedMUC1dtguhbletrgetblenmltueTrgetedrdiucliderpy(TRT)moleculrtrgetedttmentpecificllyuerdiolledmoietiebiologicltrgetgvecrtendeddeliverloclizedcyxicrdicncercellthvexppecificceprouthrmgnmlcellWepropoecomubilyMUC1rpeutictrgetTNBCpromgtechniqueTRTdevelopnovelrnoticpeptidedignoticimggTRTTNBCTheimthpropoldevelopMUC1trgetedpeptidecnuccefullyppliedTRTexhibgpropertieubleclicltrnltiThedvntgepeptideoverpvioulytudiedntibodyrdioopecomplexecludeuperiphrmcoketiclowimmunogenicyeeynwidepdpplictiInAim1wedetermemechnmpecificypeptidebdgoptimizecptimetlchelrthroughvrioupcermoietieemploydiffentcycliztitrtegieimprovepeptideffytbilyInAim2werdiollthepeptideequencepromgbdgffiegllium-68lutetium-177WecompletecomphenivenlybdgternliztiTNBCcelldetermevivotumtrgetgpropertiebiodriimouemodelTNBCInAim3wedvncemotpromgpeptideequenceidentifiedthroughqunttivemetricrpeutictudiedetermebilyMUC1TRTttTNBCmouemodelWeddillycompleteplimryfetyementThroughetudieweloundertnyueltedproceedgclicltrnltiMUC1rnoticpeptidepplictiTNBCGivenmbidymtlyocedTNBCcriclneedtrgetedttmentthMUC1TRThvehighimpctttmentmngementTNBCWeprovideprocceptMUC1vlidrpeutictrgetTRTcneffectivelyttTNBCWetendourultlyfoundtiubequentdevelopmentromizedctrolledclicltriltetthpromgttmentptientTNBCIfuccefulthignificnttepwrdducgmtlyocedTNBCProjectSummry/AbtrctOverllProgrmGenetictetgbothgermleomticmuttihimprovedourundertgbicbiologycrcogeneidentifiedhigh-rkpopultitrgetedpventicengidentifiedtrgetnewttmenttrtegiehledomemotignificntrodducgcncerburdenYettillmuchlernboutroleheredgeneticuceptibilycncerignificntbrriercceggeneticcounelgtetgerviceprticulrlyunder-pentedpopultiWehveembledelrgetpopultiAfricnAmericncncerurvivdtetudygeneticuceptibilythpopultiTheDetroReerchCncerSurviv(ROCS)(U01CA199240)cohtcludeprticipntcidedtprticulrlyhigh-rkduefmilyhrycncergetdignodignoecdprimrycncerfrtructuuedexpprticiptiTheProgrmcludetheprojecttwoconoverllgolimprovgidentificticliclmngementhedrymultipleprimrycncerAfricnAmericnwhocurntlyunderpentedgeneticerchTodothwe1)UebiomticnlyefmilytructugeneexpiomticltertiidentifyAfricnAmericncncerurvivmotlikelyhrbhigh-penetrncegeneticvrintcurntlyclifiedpthogenichvguncertignificnce2)ChrcterizepectrumgermlegeneticvriAfricnAmericnmultipleprimrycncerltiknownpthogenicmuttie-pecificpolygenicrkco(PRS)lrgelymodifiblen-geneticrkfcr3)DevelopnleculturllydptedeductilterventiceccegeneticcounelgmtimgmedicllyunderervedAfricnAmericnuptkerk-ppropregenetictetgmgthoetcedrkowepoedtrnltenovelgeneticdcoveriecliclprcticePROJECTSUMMARY/ABSTRACTTheoverrchggolthR21propolexplopotentilnelfvirwidelyuedntivirlgentmodulrignificntlyugmentefficcydoptivecelltrnfer(ACT)rpygtmelnomMelnomemotggiveftlneoplmpibleover80%kcncer-lteddethDepecentdvncettmentthdevttgdeecludgurgiclectrgetedrpychempyprognoptientmelnommdmlCellulrrpyugACTpprochpentprticulrlypromgtrtegyttmentthmlignncyyetrpeuticoutcomemeluiveduevrietyfcrlimnti-tumimmunyWecentlyveledcriclroleeukryoticelgtifcr-2ke(eEF-2K)promotgurvivlcycidlctivyCD8+TcellugmentgntumctivyCAR-TrpyuggetgpotentilmnipultgthkebootgimmunpygtmelnomeEF-2Klgfmilytypicl-kenevolutirilycervedgulrproteynThkephophylteeEF-2100kDprotepromoteriboomltrnloctiAP-ectiducemovementmRNAlgriboomedurgtrnltiPhophyltedeEF2unblectlyzeriboomltrnloctihibgpeptideelgtiNotblytudiehowedeEF-2KcnctivtednelfvirnllybiovilblentivirlgenthveenwidelyuedcliclttmenthumnimmunodeficiencyvirufectiuchHIVAIDSctivtieEF-2KtumcellpromotetumcelldethuppetumprogiThubedourobervtiroleeEF-2KvigticyxicCD8+TcellwellbovetudiewehypoizephrmcologicctivtieEF-2KnelfvircnexploednoveleffectiverpeuticpprochubtntillyugmentefficcyACTgtmelnomAddgthhypowouldprovideprocceptrtileimprovgefficcycurntnti-melnomrpiethroughtrgetgeEF-2KuenelfvirTotetthhypowechrcterizeeffectnelfvircyxicTlymphocytecludgTcellfunctipertencetbilyevluteimpctnelfvircgefficcyACTgtmelnomthroughuevrovivomelnommodelSuccefulcomplethtudymyproviderpidpthenterclicltrilnelfvirttmentptientimmunepo-pivemelnomyieldgnewrpeuticopptunieignificntlyimprovecurntmelnomttmentthroughuenelfvirNobtrctvilblePROJECTSUMMARYAdoptivecelltrnferugtum-pecificTcellpromgopticncerttmentmotpowerfultum-killgeffecrTcellCD8+type-1cyxicTcell(Tc1)WehvehownIL-9-ectgCD8+Tc9cellmedetrgerlg-ltgntumeffectvivocompdcliclIFN--ectgTc1HoweverunderlygmechnmmunclerRecentlywedcovedwhenwechllengedPmel-1Tc9-Tc1-ttedmicectrlterlflnkgp100-knockout(KO)B16tumcellecellrpidlygwetblhedtumTc1notTc9-ttedmiceSimilrlylpedgp100B16cellcovedPmel-1Tc1-ttedmicerpidlygwetblhedtumfter-implntgPmel-1Tc1-notTc9-ttedmiceuggetgTc9-notTc1-ttedmicedevelophotimmunygr(thncognte)ntigenexpedlpedtumImptntlyignificntlylrgernumrCD4+notCD8+Tcellwedetectedlte-tgetumchllengedtumtum-drglymphnode(TDLN)Tc9-ttedmicecompdTc1-ttedmiceTheeCD4+TcellexpedhighlevelIFNgrnzyme-Beffectivelykilledwild-typeB16gp100lpedgp100-KOB16tumcellHenceenovelfdgtrglydictedoptivelytrnferdTc9notTc1celleffectivelyducehotCD4+TcellpegtlpedtumTodetermemechnmunderlygTc9cell-ducedhotCD4+Tcellpewepermedplimrytudieexmeimmunecelltummicroenvirment(TME)Weoberveddendriccell(DC)weenrichedTc9-ttedprimrytumchllengedtumTDLNMoimptntlyTc9cellectedhighlevelIL-24Tc9-ttedtumuperntntctedbundntIL-24AourplimrytudiehowedIL-24ttrctedDCmigrtivrowepeculteTc9cellducehotCD4+TcellpethroughIL-24-DCcircuWehypoizetum-pecificTc9cellmyuperbT-cellubetcncerimmunpydueircpcyelichotCD4+TcellpeuppgrowthlpedtumToteurhypoAim1determeroleimptnceTc9cell-ducedhotCD4+TcellpecognizgelimtglpedtumcellAim2determerolemechnmIL-24-DCcircuTMETDLNelicgtum-pecificCD4+TcellpepventgcurncetumCompletgthprojectuncovernovelmechnmTc9cellmedglg-ltgntumctivyTMEducghotCD4+Tcellcognizetum-ocedntigennetigenviIL-24-DCcircuuppgpventgtumcurnceTc9-ttedmicePROJECTSUMMARYCidteDrJenniferFoltzdocrlpot-docrltrghfocuedimprovgnturlkiller(NK)cellrpytypentelymphocytehhowncliclefficcyclicltrilcutemyeloidleukemi(AML)DrFoltzeektegrteherwet-lbcomputtiltrgdeletemechnmtnceNKcellrpyHerlg-termcergoltrnlteefdgclicReerchCerDevelopmentPlnDrFoltzpurugndependenttenutrckvetigrpoiDurgthprojectheexpherexpertegenomicerchenhnceherkillledermenrwhichneceryeffectivelyrunngerchlbryShettendlevntgenomicepigenomicemrjournlclubprticipteerlyvetigrnetwkggrouplederhipcouregrntwrgwkhoppenthererchtntilterntilcfenceReerchProjectThelg-termgolherpropoldefenovelmechnmunderlyggultiNKcellnti-leukemifunctrnlteefdgclicthroughheretblhedcollbtiRecentlyNKcellrpiehvecludedNKcellpoememybilymemrprictivticulmtgmpidpricientpeupecdrychllengeCyke-ducedmemy-like(ML)NKcellgenertedthroughbriefIL-12/15/18ctivtifolloweddiffentivrovivoAMLptientcomeMLPtientttedMLNKcellhveimprovedclicloutcomecompdcNKcellhowevernotllptientpdBeduppvioulertuourplimrydtwehypoizeMLNKcellexertuniqueimmunepuAMLdrivgdiffentilAMLtncemechnmuniquectivtiMLNKverucventilNK(cNK)cellThterrogtedfollowgimAim1WeelucidtetrncriptifcrepigeneticchngeunderlygcNKveruMLNKcellnti-leukemifunctilyHewedetermeroleTOXtrncriptifcrMLNKcellfunctiugCRISPRlo--functi(LoF)WelodefehowAMLmodulteepigenomeMLcNKcellmultiomicpprocheAim2WedetermehowMLNKcelledphenotypeleukemiHewedeletehowAMLtnceMLNKcelldtctAMLtntcNKbedupdiffentilKIRenivyLAG-3expiuggenomicnlyflowcymetrymechnticLoFvromuxenogrftmodelTogerefdglygroundwkDrFoltzerchcermechnmunderlygNKcellcliclefficcyProjectAbtrctProtekectuteelrgetenzymefmiliehumnirrrntcrcogenicfunctivtrrycncerwellknownHoweverdepenowknownhentdruggbilythenzymecllypproximtelytwodozenkehveenuccefullyexploeddrugtrgethighlightgneedmjnovtifunctilchrcteriztidrugdcoveryMoovernerly200kempoly/completelyundertudiedtimeycncideddrkkomeduelckenivemeumentpltmirvetigtiThegolthpropoldevelopnext-genertimplemultiplexg-bedproteomictechnologietrnmkomeerchAccomplhgthgolllowuliblymeultivebolutekebundncecrohunddcncermplehedlighnirfunctielucidtemechnmunderlygkehibirtnceidentifycompoundpotentilkedegrderSpecificllyIpropoei)developtrgetedkomeyenbleimultneouboluteltivequntifictifullhumnkome(Aim1)ii)developtmledpltmcptgumtedmplepprtienblehigh-throughputkome-focuedcompoundlibrryceng(Aim2)iii)permcompoundlibrrycengidentifynewkedegrder(Aim3)Theendultpropoedtudientegrtedprdigm-hiftgpltmelevtehumnkomeerchInotepltmcneilydptedchrcterizeentiprotectegie(egtrncriptifcr)levntcncerpthologyMooverdtthpplictigenertemultiplefirt--ir-kdourcecludgkomeexpimpcrodiffenthumncncercelllekomepempknownkehibirkedegrdtimpcompoundlibrrieThpropoldrwmytrgchemtryproteomicbiomticDurgmypotdocrlerchIhveuccefullyppliedmyknowledgeundertvrietybiologiclpthologiclproceecludgpltum-tnvrincncertue-pecificmcheryggimpctgeneticvriproteexpilipidmetbolmmyloidpcurproteprocegendo-lyoomlytemAcncereledgcuedethwldwidemycergoldeveloperchprogrmfocumechnticundertgcncerrpeuticdevelopmentttmentIimcomelederkebiologyugproteomicchemiclbiologypprochewhichdtguhmydependentwkmymenrPROJECTSUMMARYTheobjectivethpplictidevelopcerDrBynefciltghtrnitbledependentpheetblhgherchprogrmHepuruerigoucerdevelopmentplnfurrhtrg(i)extrcellulrveicle(EV)biology(ii)immune-cology(iii)pildevelopmentProgedomccomplhedthroughcourewkttendncepekgtcfencewkhopwrgltuthppermenrgledgtemeftThetrgenvirmentexceptilcollbrwld-clTheK22AwrdgivePIprotectedtimegenertedtnR01propolwhilelunchghdependentfcultypoiOnceglioblm(GB)progefterfirt-lerpyttmenptilimedmnggcurntGBmchllenggWhilenewlydignoedGBptienthvelifeexpectncy~15mthduced69mthfterlpeRecentlyloclizeddeliveryterleuk-12(IL12)hhdpromgnti-tumleffectptienthigh-grdecurntGBextendgurvivl~17mthOurplimrydthowtrtumlIL12gerloclexpicotimulryfcrcyxicTlymphocyte(CTL)-4-1BBLcnduceutednti-gliompeTheobjectiveourtudiedevelopclicllylevnttrtegycombgefcrwhileexpgourundertgimmune-uppivetncegtIL12-ducednti-gliomctivyInAim1weetblhdruptivetechnologypentgcombtiimmuno-modulryfcrglennocrrierIneencedendriccell(DC)-derivedEVdeigneddplyIL124-1BBLnetigenMHCcomplexInleourfdgGB-ttedmiceIL12/4-1BBLcombo-compdIL12mpywenticipteimmunpeuticEVtrnlte~68%improvementurvivlGB-rgmiceInAim2tncemechnmducedGBgtIL12ttmentexplodWehveobervedmyeloidcellubetenentumimmunyctivtedIL12Bycombggle-cellRNAequencgnlymultiprmetricflowcymetryIL12-ttedGBmouemodelweuncoverpro-cogenicignlgultgPD-L1ce4-1BBLdeceInturnetrgetmidpetrtumlEVttmentnticiptgttenutiGBtnceAim3vetigteCTLDCcrotlkdrivgIL12ttmentCTLpibleIL12-ducednti-gliomctivyhownourCD8depletiexperimentHoweverltleknownboutDCnIL12-timultedGBbrTrngenicmouemodelidumrkgdepletglevntDCtumtudygnti-tumctivyourengeedEVThuniquepropolddecruciltimelyunmetneedfieldWeplnenggerpeuticpotentilEVrtGBprogiThwkundoubtedlyprovidetrgfoundticidtedependentlederhipbrtumerchAbtrctChromoomltrnloctivolvgLyeMethyltrnfere2A(KMT2A)genecommlyfoundhigh-rkubtypecuteleukemiproducepotenncoprotethccupychromtcuem-gultidevelopmentlgenevolvedhempoieImmunpietrgetgcellurfceproteCD19hvevolutiizedttmentB-cellAcuteLymphoblticLeukemi(B-ALL)HoweverKMT2A-rnged(KMT2Ar)B-ALLfquentlycvertB-ALLnAcuteMyeloidLeukemi(AML)phenotypedowngulteexpiCD19evdetrgetedrpyGenome-wideequencgdicteeB-ALL--AML-lege-wchgeventcnoccurbenceddilmuttiuggetgn-geneticchngetumgultictriethphenotypichiftWeidentifiedgroupKMT2Acoprotetrgetgenehowdivergentptterntrncriptillyctivedevelopmentllypedchromtglecellmeleukemi(JnenDHetlNtuGenetic2021)MocentlyIdevelopedgle-cellcombrildexgCUT&Tg(ciCUT&Tg)ppliedthmethodprilechromtlcpethoucellprimryfntKMT2ArB-ALLwellfntKMT2ArB-ALLderivedcellleKOPN-8Iidentifiedcollecti18coprotetrgetgenehowmedivergentgulryprogrmcroheterogeneoucelltypebothprimryfntKMT2ArB-ALLKOPN-8cellleTheeptternuggetKMT2Acoprotectivtedtctgrouptrgetgeneltedleukemicellprovidgfirtglimpehowecoprotectrien-geneticheterogeneyKMT2ArleukemiThpropol(1)ddhowKMT2AcoprotectrieB-ALL--AML-lege-wchgevent(2)identifynovelrpeuticpprocheeffectivelyidentifyttKMT2ArB-ALLlege-wchgpotentilInfirtimIlevergeKOPN-8cellleidentifycoprote-gultedgenepromotetr-tumlheterogeneyhigh-rkKMT2ArB-ALLInddiIidentifyclicllyvilblemllmoleculepotentiluedcombtiCD19-dictedimmunpiepventlegewchgInecdthirdimIpplyciCUT&TgchrcterizechromtlcpecollectiprimryKMT2ArB-ALLwellnmlhempoietictemprogenircelltypeUgcomprtivegenomicIidentifynovelbiomrkerllKMT2ArB-ALLcelllege-wchgpotentilcnpotentillyuedtrgetthpopultivinovelimmunpieThpropolppliegenomicmethodDrDekJnendevelopedpotdocidentifynovelttmenttrtegietrgethigh-rkKMT2ArB-ALLetblhlg-termcollbticomputtiltrnltilbiologtwellcliclercherhetrniprciplvetigrroleetblhendependenterchprogrmttieretutiPROJECTSUMMARY/ABSTRACTDepedvncedevelopmenthighlyeffectiverogencepr(AR)-dictedrpiettmentmendvncedprottecncercquidtnceultimtelyenueLegeplticyhenpropoedemechnmrpeutictncewheptienttntdeedevelopAR-negtiverogenignlg-diffentprottetumloeirlumlidentydplyneuroendocfetu(neuroendocprottecncerNEPC)WhileNEPCtumhmnygeneticltertiprottedenocrcompotentildriverlegeplticymundertudiedUgnovelgeneticlly-engeedmouemodelfhfullycpultetrniNEPCIhveetblhedngnoid-bedllogrftpltmmenblegeneedgtechnologieUggle-cellbedpprocheFurrmoIhveidentifiedpvioulyundecridtumubpopultiuniquetrncriptilgulrmypentntrnitweendenocrcomNEPCFpropoedtudieImodulteexpilevelidentifiedtrncriptilgulrugCRISPR-bedgeneedgovexpitrtegieprottegnoiddetermehowtrniNEPCffectedIloeenivyumubpopulticliclly-levntttmenpticludgrogendrwlAR-trgetedrpyFllyIvelhowtrgetgepigeneticmodifierchngecompoumubpopultiveredevelopmentrpeutictnceAlgideecientificimIueperiodupptenhncemykilletdevelopndependentercherThroughcompheniveplncludgwkhopcourewkcliclcecfencettendncetemrcientificcfenceIplndevelopdeeperundertgbiomtictglecelllevelexpmyexpoucriclbrrierfcgclicinprottecncerptientuccefullyctuemytrnindependenterchpoiTheenvirmenttWeillCnellMedicemgcloelylignedneighbgtutiidelmecompletepropoedtudiehelpfotermyctuederchcerdevelopmentuccePROJECTSUMMARYCidteDurgmytrgIhveenhighlymotivtedunderthowcyxiclymphocytecnuedndoptiverpyhowimmunecellgulteddurgimmunpyIhveervedfirtco-cpdguthnumerouhigh-impcriglerchrticlepentgdvncebictrnltilcliclimmunologyIhveuccefullycompetedcerdevelopmentwrdhvellowedmectuemyerchtetMylg-termerchgolundertmechnmimptntNKcelleffecrfunctihowNKcellctrieimpctedimmunomodultihowhotimmunepecnpromotelimirNKcellneffectivecellulrrpyhumnmuytemReerchCerDevelopmentPlnAIgmydependenterchprogrmIutilizeeductilerchourceimedpecificllytjunifcultytWhgnUniverytngnmycerdevelopmentWhileIhvecientifictrgexpertepermpropoedtudieIutilizeopptunietWUSMppmytenu-trckpoiSpecificllypectmngementmenrhiplerngdmtrtivepibilierunngerchlbry(nimlprocoltutilpprovlbudgetmngement)ReerchProjectThelg-termgolthprojectimproveourundertgmechnmopertiveucceefilunteimmunerpyMemy-likeNKcellwefirtidentifiedmiceoverdecdegotudieexmgirpertencenti-tumpemetbolicdpttitummicroenvirmenthvelidgroundwkbothhumntrilcurntlyopenenrollmenttudiepropoedheOnecurntbrrierfieldtrnltgenovelimmunepprochewhichhvehdomuchuccettghemlogicmlignncieucceettgolidtumWehypoizeMLNKcelldiffenticomdchimericntigencepr(CAR)-trgetgimproveNKcelltrffickgeffecrpefnebothllogeneiculogouimmunpeuticprdigmWeevlutethcceptgtcncerfectiTheetudiemyvelnoveltrtegierpeuticterventiNK-cellbedrpielikelybrodlylevntcellulrrpieCompletietudielycientificgroundwkbothfutuR01pplictiuccefulcertudygterctidoptivecellrpyhotimmuneytemProjectSummryANGEL2nRNA-bdgprote(RBP)memrctbolepi4(CCR4)fmilyprotewhichvolvedmodultimRNAtbilytrnltiWhcliclignificncedecedANGEL2expicro17diffentcncertypecltedbothpooverlldee-feurvivlHowevermoleculrmechnmwhichANGEL2modultetumigenehveyetdetermedGeneexpicltinlyveledfunctilltihiptweenANGEL2tumuppTP53CtentlyANGEL2deficiencycuedubtntilloTP53expiultedmulticellulrtumpheroiddoptgtellte/vivemphologyInddinANGEL2-derivedpeptidecedTP53expidecedmulticellulrtumpheroidgrowthTP53trncriptifcrtenwhichplyntegrlrolemtggenomeInctivtiTP53occurmothn50%humncncerhllmrktumprogichemotnceItewidelycognizedlowild-typeTP53expi/functidrivertumprogiCequentlydetermgkeymodulrTP53prmountundertgtumigenedevelopmentnovelrpeuticpprocheThprojectimelucidteroleANGEL2TP53-dependenttumuppidetermeifthpthwycntrgetedenhncewild-typeTP53expiupptumgrowthUtilizgANGEL2knockoutcelllecoupledxenogrftptient-derivedgnoidmodeleffectANGEL2TP53expiTP53-dependenttumuppidetermedMooveruemoleculrbiophyicloldeignmodifyANGEL2-derivedpeptideupgultewild-typeTP53expiexplodrpeuticpprochmlignnciewhichcrrywild-typeTP53TheetudieguidecerdevelopmentDrChrpherLuccheiprovidglevntknowledgekillobtedthroughcollbticouremoleculrbiophyicltechnique3D-gnoidtummodelgpeptidedrugdeigntrnltilerchlederhipkillDrLuccheiloprwelthvilbleourcetUCDvequiphimnecerykilletchhcergolThroughtrgthcollbtiveOneMediceenvirmentDrLuccheicompetivedependentvetigrlederuccefulproductiveerchtemPROJECTSUMMARYShenqqg(Stn)GuPhDnexperimentl-computtilbiologtwhoecergoldevelopperlizedtrtegieoptimlcombtiimmunpycucncerTledEnhncgefficcyimmunpyoptimlueSMACmimeticpropoedercheekelucidtectextdependencieSMACmimeticeffectexmeoptimlcombtiextgimmunecheckpotblockderpyCerdevelopmentplnDrGucipientSrElizthOBrienTrutFellowhipHpviouwkhfocuedgulticncer-immuneterctiugvrioupprochecludgclltrcgdtmggenome-wideCRISPRcengwhichhveppdhimcductpropoederchDrGuhoutledpecifictrgctivieexphkilletfour1)Tcellbiology2)mchelerng3)gle-celltechnologie4)lederhippilkillThkilletneceryucceedmydependenterchcerCollbr/EnvirmentDrGucollbtememblewld-ledgexpertcncerimmunologycomputtilbiologytrnltilcliclerchmelnomgle-celltechnologyLeverggextenivecollbtiourcetDFCIHrvrdNCIccelrgemountcliclmpleDrGuuniquelyplcedidentifyoptimlugeSMACmimeticenhnceefficcyimmunpycncerReerchOurpviouerchidentifiedSMACmimeticcnupgulteMHC-IomecncercellpotenteimmunpyunclerwhichubetcncerptientcnnefSMACmimeticttmentTofcilteeffectiveueSMACmimeticclicthpropolterrogteSMACmimeticgrdgoptimlctextgenegultirtilcombtiimmunecheckpotblockdeAim1tegrtegenetic/epigeneticfetuelectifunctilvlidtiidentifyctextdependencieSMACmimeticeffectcncercellAim2tegrtemulti-omicprilgtgle-celllevelexmeeffectSMACmimeticttmennimmunecellAim3evluteefficcydiffentchedulgcombtiSMACmimeticICBugvroco-cultuvivotrnplnttimodelOutcome/ImpctThprojectvelgenetic/epigeneticctextdependencieSMACmimeticeffectelucidteireffectimmunecellexmeoptimlcombtiimmunpyDtthtudycnhelpimprovedeignclicltriltetgSMACmimeticcncerptientThedevelopmentcertrniwrdenbleDrGucomeledernewfielddevelopgperlizedcombtiimmunpytrtegieSummryN-mllcelllungcncer(NSCLC)eledgcuecncerdethwldwideKRASmotfquentlymuttedcogenelungdenocrcommotcommubtypeNSCLCApproximtely30%ptientlungdenocrcomhrbKRASmuttiG12CG12VgmotfquentmDicttrgetgKRASwhricllydifficultuntilcentdevelopmentKRASG12CpecifichibircludgAMG510MRTX849Theehibirhvehowntrgnti-tumoffectKRASG12C-muttedlungdenocrcomptientexemplifiedcentFDApprovlAMG510(Sib)DepethbkthroughKRASrpeuticSibdemtrte32%perteptientlungcncerptienttendeveloprpidtnceFurrmopecifichibirKRASG12VecdmotcommKRASmuttiNSCLCTheenurgentneeddevelopnewtrtegieimprovecliclpeKRASG12ChibirwelltckleKRASG12VlungdenocrcomPROteolyTArgetgChimer(PROTAC)-mededprotedegrdtihemergedpowerfulytempecificllytrgencogenicdriverUtilizgthPROTACytemwehvedevelopedvertilepprochknowndegrdtg(dTAG)ytemrpidlydepletenytggedtrgetprotevrovivoOurplimrytudydemtrteddTAGpotentlydegrdecogenicKRASvrintbolhelungtumvivodriventi-tumimmunythroughcgCD8+TdendriccellctivyMypropoedprojectlevergedTAGytemnovelKRASG12CG12Vpcliclmodel(gnoidgeneticllyengeedmouemodel(GEMM))furrevluteKRASdegrdtinewrpeuticpprochFurrmoKRASG12ChibirimmunpyclicltrilunderwyevlutgvivpeuticcombgKRASdegrdtiimmunpyhighignificnceOverllAim1comphenivelyevluteefficcytrgeteddegrdticogenicKRASvrintlecombtiimmunpyvivoAim2decttummicroenvirmentltertiupdegrdticogenicKRASmutntlecombtiimmunpyAim3chrcterizeunderlygcncertricimmunologiclmechnmctrientumimmunyFdgmyerchferevidencefurrevlutiprotedegrdtrgetgKRASmutntcncerclicltrilTochieveeimIdeigned3-yerplncludeprticipticientificcerdevelopmentmeetgwkhopcourewkfurrdevelopmycncerimmunologycomputtilbiologyexperteThcertrniwrdgtlyfciltemygolledgmultidciplryerchlbryfocuedddgchllengettmentlungcncercdemicenvirmentnNCI-deigntedcomphenivecncercenterProjectSummry/AbtrctTobccomokgcullyltedtlet12cncertypeQutgmokgftercncercriclimprovedttmenutcomehoweverovertwo-thirdmokerctuemokeftercncerdignoSmokgftercncercerkmtlyocedpocncerttmentefficcyttmentcomplictidevelopmentecdprimrytumcncercurnceCtuedmokgloplceptienttgterrkn-cncerltedhelthcequence(egcrdiovculrdee)ducedqulylifeThumokgcetiextmelyimptntcncerptientgrdlecncertypeHoweverourpviouerchdemtrtedptientn-mokgltedcncer(egbt)cncernotwidelyknownmokg-lted(egbldder)ptlowermokgcetimotivtipocetirtecompdptientcncerwhichmokgwell-etblhedrkfcr(egthcic)ThuimmyytemticdependenterchlecemokgcetimotivtiultimtelyenhncemokgbtencertemgptientcncernottypicllylkedmokgWhNCIR03fundgIdevelopedfivebriefbooklettrgetedcncertypecemotivtiqumokgmgptientcncernotmokglted(iebtmelnom)notwidelycognizedmokglted(ieblddercoloctlgynecologicl)Thepropoedprojectctueytemticdevelopmenterventipilotgtetgromizedctrolledtril(RCT)proceduegctextulfcrmfutuimplementticologyttmentettgWecducttwigoutudieInStudyIweromize100ptienteementiedcncerdigno(20percncere)ceiveuulc(briefdvice+QuilteEHRferrl)vuulcpluourtrgetedelf-helpterventiexmefeibilyRCTprocedu(iecrumentrteromiztidhencettmentfidelyttricceptbilycdibily)etblhcfidencetervletimtedefficcyourterventicgmokgcetimotivticompduulcSimultneoulyStudyIIugequentilmixed-methodpprochwecollectqunttivequltivedtclicledertkeholdercologyettg(egphyicinnurebccottmentpecilt)whocouldvolvedprovidgmokgcetitnceidentify(1)terventideliverymodlyource(2)potentilbrrierfcilrimplementti(3)commendedimplementtitrtegieemletegrtiroutec(4)curntprcticeptterngniztildechngeThtudycodtipropoedtrgplnophtictedtudydeignimplementticiencecomplexdtnlyprovideneceryplimrydtexperteneededuccefulcerndependentvetigr', 1)]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: return rows with project titles with \"MATCHMAKERS\"\n",
        "\n",
        "df_matchmakers = df2[df2['Project Title'].str.contains('MATCHMAKERS', case=False)]\n",
        "df_matchmakers.head(50)\n",
        "\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "-kZUxJOE-tob",
        "outputId": "f289813d-0d77-47d3-9a02-3f20d7e368d4"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                        Project Title Contact PI Person ID  \\\n",
              "25  MATCHMAKERS - Solving TCR recognition and desi...             11974674   \n",
              "33  MATCHMAKERS - SOLVING TCR RECOGNITION AND DESI...             15788314   \n",
              "34  MATCHMAKERS - Solving T-cell receptor recognit...             14226120   \n",
              "35  MATCHMAKERS - large-scale generation of reacti...             14981981   \n",
              "42  MATCHMAKERS: Solving T-cell receptor recogniti...              1887701   \n",
              "44  MATCHMAKERS - Creating and training AI tools f...             10293339   \n",
              "46  MATCHMAKERS - Solving T-cell receptor recognit...             10661907   \n",
              "49                                        MATCHMAKERS              1955169   \n",
              "50  MATCHMAKERS: SOLVING TCR RECOGNITION AND DESIG...              6472797   \n",
              "52                                        MATCHMAKERS             11746917   \n",
              "54  MATCHMAKERS: Large-scale generation of TCR-pMH...             79629683   \n",
              "\n",
              "   Contact PI / Project Leader  \\\n",
              "25        SGOURAKIS, NIKOLAOS    \n",
              "33            OLWEUS, JOHANNA    \n",
              "34      DEKOSKY, BRANDON JAMES   \n",
              "35            QUEZADA, SERGIO    \n",
              "42          ELLEDGE, STEPHEN J   \n",
              "44          BIRNBAUM, MICHAEL    \n",
              "46        BRUNO, PETER MICHAEL   \n",
              "49               BAKER, DAVID    \n",
              "50   GARCIA, KENAN CHRISTOPHER   \n",
              "52            SCHUMACHER, TON    \n",
              "54                BUSCH, DIRK    \n",
              "\n",
              "                                     Project Abstract Public Health Relevance  \\\n",
              "25  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "33  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "34  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "35  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "42  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "44  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "46  ABSTRACT: UCSFUnderstanding how T cell recepto...                     NaN   \n",
              "49  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "50  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "52  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "54  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "\n",
              "                    Department Organization ID (IPF)  \\\n",
              "25                 Unavailable               1499101   \n",
              "33                 Unavailable              10005923   \n",
              "34                 Unavailable               4907701   \n",
              "35                 Unavailable               3527409   \n",
              "42                 Unavailable               1080401   \n",
              "44               MISCELLANEOUS               4911501   \n",
              "46                     UROLOGY                577508   \n",
              "49                BIOCHEMISTRY               9087701   \n",
              "50  INTERNAL MEDICINE/MEDICINE               8046501   \n",
              "52                 Unavailable               5802601   \n",
              "54                 Unavailable               8227001   \n",
              "\n",
              "                           Organization Name Organization City  \\\n",
              "25           CHILDREN'S HOSP OF PHILADELPHIA      PHILADELPHIA   \n",
              "33  OSLO UNIVERSITY HOSPITAL, RIKSHOSPITALET              OSLO   \n",
              "34            MASSACHUSETTS GENERAL HOSPITAL            BOSTON   \n",
              "35                 UNIVERSITY COLLEGE LONDON            LONDON   \n",
              "42              BRIGHAM AND WOMEN'S HOSPITAL            BOSTON   \n",
              "44     MASSACHUSETTS INSTITUTE OF TECHNOLOGY         CAMBRIDGE   \n",
              "46   UNIVERSITY OF CALIFORNIA, SAN FRANCISCO     SAN FRANCISCO   \n",
              "49                  UNIVERSITY OF WASHINGTON           SEATTLE   \n",
              "50                       STANFORD UNIVERSITY          STANFORD   \n",
              "52              NETHERLANDS CANCER INSTITUTE         AMSTERDAM   \n",
              "54            TECHNICAL UNIVERSITY OF MUNICH            MUNICH   \n",
              "\n",
              "   Organization State         Organization Type Organization Country  \\\n",
              "25                 PA     Independent Hospitals        UNITED STATES   \n",
              "33                                  Unavailable               NORWAY   \n",
              "34                 MA     Independent Hospitals        UNITED STATES   \n",
              "35                                  Unavailable       UNITED KINGDOM   \n",
              "42                 MA     Independent Hospitals        UNITED STATES   \n",
              "44                 MA  ORGANIZED RESEARCH UNITS        UNITED STATES   \n",
              "46                 CA       SCHOOLS OF MEDICINE        UNITED STATES   \n",
              "49                 WA       SCHOOLS OF MEDICINE        UNITED STATES   \n",
              "50                 CA       SCHOOLS OF MEDICINE        UNITED STATES   \n",
              "52                                  Unavailable          NETHERLANDS   \n",
              "54                                  Unavailable              GERMANY   \n",
              "\n",
              "   Total Cost Total Cost (Sub Projects) Funding IC(s) Direct Cost IC  \\\n",
              "25     248155                                     NCI         139413   \n",
              "33      74043                                     NCI          74043   \n",
              "34     233863                                     NCI         140038   \n",
              "35     169280                                     NCI         156741   \n",
              "42     289171                                     NCI         168227   \n",
              "44     681176                                     NCI         484249   \n",
              "46     160333                                     NCI          98013   \n",
              "49     327039                                     NCI         282715   \n",
              "50     214343                                     NCI         138823   \n",
              "52     167757                                     NCI         167757   \n",
              "54     191844                                     NCI         191844   \n",
              "\n",
              "   InDirect Cost IC Total Cost IC  \n",
              "25           108742        248155  \n",
              "33                0         74043  \n",
              "34            93825        233863  \n",
              "35            12539        169280  \n",
              "42           120944        289171  \n",
              "44           196927        681176  \n",
              "46            62320        160333  \n",
              "49            44324        327039  \n",
              "50            75520        214343  \n",
              "52                0        167757  \n",
              "54                0        191844  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-c5ec2e41-02de-4afb-8714-a1449afd6839\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Project Title</th>\n",
              "      <th>Contact PI Person ID</th>\n",
              "      <th>Contact PI / Project Leader</th>\n",
              "      <th>Project Abstract</th>\n",
              "      <th>Public Health Relevance</th>\n",
              "      <th>Department</th>\n",
              "      <th>Organization ID (IPF)</th>\n",
              "      <th>Organization Name</th>\n",
              "      <th>Organization City</th>\n",
              "      <th>Organization State</th>\n",
              "      <th>Organization Type</th>\n",
              "      <th>Organization Country</th>\n",
              "      <th>Total Cost</th>\n",
              "      <th>Total Cost (Sub Projects)</th>\n",
              "      <th>Funding IC(s)</th>\n",
              "      <th>Direct Cost IC</th>\n",
              "      <th>InDirect Cost IC</th>\n",
              "      <th>Total Cost IC</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>25</th>\n",
              "      <td>MATCHMAKERS - Solving TCR recognition and desi...</td>\n",
              "      <td>11974674</td>\n",
              "      <td>SGOURAKIS, NIKOLAOS</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>1499101</td>\n",
              "      <td>CHILDREN'S HOSP OF PHILADELPHIA</td>\n",
              "      <td>PHILADELPHIA</td>\n",
              "      <td>PA</td>\n",
              "      <td>Independent Hospitals</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>248155</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>139413</td>\n",
              "      <td>108742</td>\n",
              "      <td>248155</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>33</th>\n",
              "      <td>MATCHMAKERS - SOLVING TCR RECOGNITION AND DESI...</td>\n",
              "      <td>15788314</td>\n",
              "      <td>OLWEUS, JOHANNA</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>10005923</td>\n",
              "      <td>OSLO UNIVERSITY HOSPITAL, RIKSHOSPITALET</td>\n",
              "      <td>OSLO</td>\n",
              "      <td></td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>NORWAY</td>\n",
              "      <td>74043</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>74043</td>\n",
              "      <td>0</td>\n",
              "      <td>74043</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>34</th>\n",
              "      <td>MATCHMAKERS - Solving T-cell receptor recognit...</td>\n",
              "      <td>14226120</td>\n",
              "      <td>DEKOSKY, BRANDON JAMES</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>4907701</td>\n",
              "      <td>MASSACHUSETTS GENERAL HOSPITAL</td>\n",
              "      <td>BOSTON</td>\n",
              "      <td>MA</td>\n",
              "      <td>Independent Hospitals</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>233863</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>140038</td>\n",
              "      <td>93825</td>\n",
              "      <td>233863</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>35</th>\n",
              "      <td>MATCHMAKERS - large-scale generation of reacti...</td>\n",
              "      <td>14981981</td>\n",
              "      <td>QUEZADA, SERGIO</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>3527409</td>\n",
              "      <td>UNIVERSITY COLLEGE LONDON</td>\n",
              "      <td>LONDON</td>\n",
              "      <td></td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>UNITED KINGDOM</td>\n",
              "      <td>169280</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>156741</td>\n",
              "      <td>12539</td>\n",
              "      <td>169280</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>42</th>\n",
              "      <td>MATCHMAKERS: Solving T-cell receptor recogniti...</td>\n",
              "      <td>1887701</td>\n",
              "      <td>ELLEDGE, STEPHEN J</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>1080401</td>\n",
              "      <td>BRIGHAM AND WOMEN'S HOSPITAL</td>\n",
              "      <td>BOSTON</td>\n",
              "      <td>MA</td>\n",
              "      <td>Independent Hospitals</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>289171</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>168227</td>\n",
              "      <td>120944</td>\n",
              "      <td>289171</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>44</th>\n",
              "      <td>MATCHMAKERS - Creating and training AI tools f...</td>\n",
              "      <td>10293339</td>\n",
              "      <td>BIRNBAUM, MICHAEL</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>MISCELLANEOUS</td>\n",
              "      <td>4911501</td>\n",
              "      <td>MASSACHUSETTS INSTITUTE OF TECHNOLOGY</td>\n",
              "      <td>CAMBRIDGE</td>\n",
              "      <td>MA</td>\n",
              "      <td>ORGANIZED RESEARCH UNITS</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>681176</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>484249</td>\n",
              "      <td>196927</td>\n",
              "      <td>681176</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>46</th>\n",
              "      <td>MATCHMAKERS - Solving T-cell receptor recognit...</td>\n",
              "      <td>10661907</td>\n",
              "      <td>BRUNO, PETER MICHAEL</td>\n",
              "      <td>ABSTRACT: UCSFUnderstanding how T cell recepto...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>UROLOGY</td>\n",
              "      <td>577508</td>\n",
              "      <td>UNIVERSITY OF CALIFORNIA, SAN FRANCISCO</td>\n",
              "      <td>SAN FRANCISCO</td>\n",
              "      <td>CA</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>160333</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>98013</td>\n",
              "      <td>62320</td>\n",
              "      <td>160333</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>49</th>\n",
              "      <td>MATCHMAKERS</td>\n",
              "      <td>1955169</td>\n",
              "      <td>BAKER, DAVID</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>BIOCHEMISTRY</td>\n",
              "      <td>9087701</td>\n",
              "      <td>UNIVERSITY OF WASHINGTON</td>\n",
              "      <td>SEATTLE</td>\n",
              "      <td>WA</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>327039</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>282715</td>\n",
              "      <td>44324</td>\n",
              "      <td>327039</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>50</th>\n",
              "      <td>MATCHMAKERS: SOLVING TCR RECOGNITION AND DESIG...</td>\n",
              "      <td>6472797</td>\n",
              "      <td>GARCIA, KENAN CHRISTOPHER</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>INTERNAL MEDICINE/MEDICINE</td>\n",
              "      <td>8046501</td>\n",
              "      <td>STANFORD UNIVERSITY</td>\n",
              "      <td>STANFORD</td>\n",
              "      <td>CA</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>214343</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>138823</td>\n",
              "      <td>75520</td>\n",
              "      <td>214343</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>52</th>\n",
              "      <td>MATCHMAKERS</td>\n",
              "      <td>11746917</td>\n",
              "      <td>SCHUMACHER, TON</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>5802601</td>\n",
              "      <td>NETHERLANDS CANCER INSTITUTE</td>\n",
              "      <td>AMSTERDAM</td>\n",
              "      <td></td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>NETHERLANDS</td>\n",
              "      <td>167757</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>167757</td>\n",
              "      <td>0</td>\n",
              "      <td>167757</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>54</th>\n",
              "      <td>MATCHMAKERS: Large-scale generation of TCR-pMH...</td>\n",
              "      <td>79629683</td>\n",
              "      <td>BUSCH, DIRK</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>8227001</td>\n",
              "      <td>TECHNICAL UNIVERSITY OF MUNICH</td>\n",
              "      <td>MUNICH</td>\n",
              "      <td></td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>GERMANY</td>\n",
              "      <td>191844</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>191844</td>\n",
              "      <td>0</td>\n",
              "      <td>191844</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-c5ec2e41-02de-4afb-8714-a1449afd6839')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-c5ec2e41-02de-4afb-8714-a1449afd6839 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-c5ec2e41-02de-4afb-8714-a1449afd6839');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-8bd182c3-ca97-4c57-8f33-a4574a7a0dfd\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-8bd182c3-ca97-4c57-8f33-a4574a7a0dfd')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-8bd182c3-ca97-4c57-8f33-a4574a7a0dfd button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df_matchmakers",
              "repr_error": "0"
            }
          },
          "metadata": {},
          "execution_count": 12
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: remove rows with duplicate abstracts but keep 1\n",
        "\n",
        "df2 = df2.drop_duplicates(subset=['Project Abstract'], keep='first')\n",
        "df_matchmakers = df2[df2['Project Title'].str.contains('MATCHMAKERS', case=False)]\n",
        "df_matchmakers.head(50)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 455
        },
        "id": "7JpBH8bw_YZy",
        "outputId": "85e5630c-64a3-4381-b743-54a56beb44d9"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                        Project Title Contact PI Person ID  \\\n",
              "25  MATCHMAKERS - Solving TCR recognition and desi...             11974674   \n",
              "33  MATCHMAKERS - SOLVING TCR RECOGNITION AND DESI...             15788314   \n",
              "34  MATCHMAKERS - Solving T-cell receptor recognit...             14226120   \n",
              "46  MATCHMAKERS - Solving T-cell receptor recognit...             10661907   \n",
              "\n",
              "   Contact PI / Project Leader  \\\n",
              "25        SGOURAKIS, NIKOLAOS    \n",
              "33            OLWEUS, JOHANNA    \n",
              "34      DEKOSKY, BRANDON JAMES   \n",
              "46        BRUNO, PETER MICHAEL   \n",
              "\n",
              "                                     Project Abstract Public Health Relevance  \\\n",
              "25  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "33  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "34  AbstractUnderstanding how T cell receptors (TC...                     NaN   \n",
              "46  ABSTRACT: UCSFUnderstanding how T cell recepto...                     NaN   \n",
              "\n",
              "     Department Organization ID (IPF)  \\\n",
              "25  Unavailable               1499101   \n",
              "33  Unavailable              10005923   \n",
              "34  Unavailable               4907701   \n",
              "46      UROLOGY                577508   \n",
              "\n",
              "                           Organization Name Organization City  \\\n",
              "25           CHILDREN'S HOSP OF PHILADELPHIA      PHILADELPHIA   \n",
              "33  OSLO UNIVERSITY HOSPITAL, RIKSHOSPITALET              OSLO   \n",
              "34            MASSACHUSETTS GENERAL HOSPITAL            BOSTON   \n",
              "46   UNIVERSITY OF CALIFORNIA, SAN FRANCISCO     SAN FRANCISCO   \n",
              "\n",
              "   Organization State      Organization Type Organization Country Total Cost  \\\n",
              "25                 PA  Independent Hospitals        UNITED STATES     248155   \n",
              "33                               Unavailable               NORWAY      74043   \n",
              "34                 MA  Independent Hospitals        UNITED STATES     233863   \n",
              "46                 CA    SCHOOLS OF MEDICINE        UNITED STATES     160333   \n",
              "\n",
              "   Total Cost (Sub Projects) Funding IC(s) Direct Cost IC InDirect Cost IC  \\\n",
              "25                                     NCI         139413           108742   \n",
              "33                                     NCI          74043                0   \n",
              "34                                     NCI         140038            93825   \n",
              "46                                     NCI          98013            62320   \n",
              "\n",
              "   Total Cost IC  \n",
              "25        248155  \n",
              "33         74043  \n",
              "34        233863  \n",
              "46        160333  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-3f24a32e-fab7-4b8c-8829-f7648d52bce0\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Project Title</th>\n",
              "      <th>Contact PI Person ID</th>\n",
              "      <th>Contact PI / Project Leader</th>\n",
              "      <th>Project Abstract</th>\n",
              "      <th>Public Health Relevance</th>\n",
              "      <th>Department</th>\n",
              "      <th>Organization ID (IPF)</th>\n",
              "      <th>Organization Name</th>\n",
              "      <th>Organization City</th>\n",
              "      <th>Organization State</th>\n",
              "      <th>Organization Type</th>\n",
              "      <th>Organization Country</th>\n",
              "      <th>Total Cost</th>\n",
              "      <th>Total Cost (Sub Projects)</th>\n",
              "      <th>Funding IC(s)</th>\n",
              "      <th>Direct Cost IC</th>\n",
              "      <th>InDirect Cost IC</th>\n",
              "      <th>Total Cost IC</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>25</th>\n",
              "      <td>MATCHMAKERS - Solving TCR recognition and desi...</td>\n",
              "      <td>11974674</td>\n",
              "      <td>SGOURAKIS, NIKOLAOS</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>1499101</td>\n",
              "      <td>CHILDREN'S HOSP OF PHILADELPHIA</td>\n",
              "      <td>PHILADELPHIA</td>\n",
              "      <td>PA</td>\n",
              "      <td>Independent Hospitals</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>248155</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>139413</td>\n",
              "      <td>108742</td>\n",
              "      <td>248155</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>33</th>\n",
              "      <td>MATCHMAKERS - SOLVING TCR RECOGNITION AND DESI...</td>\n",
              "      <td>15788314</td>\n",
              "      <td>OLWEUS, JOHANNA</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>10005923</td>\n",
              "      <td>OSLO UNIVERSITY HOSPITAL, RIKSHOSPITALET</td>\n",
              "      <td>OSLO</td>\n",
              "      <td></td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>NORWAY</td>\n",
              "      <td>74043</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>74043</td>\n",
              "      <td>0</td>\n",
              "      <td>74043</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>34</th>\n",
              "      <td>MATCHMAKERS - Solving T-cell receptor recognit...</td>\n",
              "      <td>14226120</td>\n",
              "      <td>DEKOSKY, BRANDON JAMES</td>\n",
              "      <td>AbstractUnderstanding how T cell receptors (TC...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Unavailable</td>\n",
              "      <td>4907701</td>\n",
              "      <td>MASSACHUSETTS GENERAL HOSPITAL</td>\n",
              "      <td>BOSTON</td>\n",
              "      <td>MA</td>\n",
              "      <td>Independent Hospitals</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>233863</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>140038</td>\n",
              "      <td>93825</td>\n",
              "      <td>233863</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>46</th>\n",
              "      <td>MATCHMAKERS - Solving T-cell receptor recognit...</td>\n",
              "      <td>10661907</td>\n",
              "      <td>BRUNO, PETER MICHAEL</td>\n",
              "      <td>ABSTRACT: UCSFUnderstanding how T cell recepto...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>UROLOGY</td>\n",
              "      <td>577508</td>\n",
              "      <td>UNIVERSITY OF CALIFORNIA, SAN FRANCISCO</td>\n",
              "      <td>SAN FRANCISCO</td>\n",
              "      <td>CA</td>\n",
              "      <td>SCHOOLS OF MEDICINE</td>\n",
              "      <td>UNITED STATES</td>\n",
              "      <td>160333</td>\n",
              "      <td></td>\n",
              "      <td>NCI</td>\n",
              "      <td>98013</td>\n",
              "      <td>62320</td>\n",
              "      <td>160333</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-3f24a32e-fab7-4b8c-8829-f7648d52bce0')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-3f24a32e-fab7-4b8c-8829-f7648d52bce0 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-3f24a32e-fab7-4b8c-8829-f7648d52bce0');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-c36f38f4-4e39-4739-99e1-882174c1e764\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-c36f38f4-4e39-4739-99e1-882174c1e764')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-c36f38f4-4e39-4739-99e1-882174c1e764 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df_matchmakers",
              "repr_error": "0"
            }
          },
          "metadata": {},
          "execution_count": 13
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: count of rows in df2\n",
        "\n",
        "print(len(df2))\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "t0EiBFs__ueI",
        "outputId": "192782df-d072-4670-ba41-5b7022dc38b3"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "1448\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Assuming 'Project Abstract' contains information about cancer types\n",
        "cancer_counts = df2['Project Abstract'].str.lower().str.findall(r'\\b(breast cancer|leukemia|liver cancer|tumor)\\b').explode().value_counts()\n",
        "\n",
        "# Create the bar graph\n",
        "plt.figure(figsize=(10, 6))\n",
        "cancer_counts.plot(kind='bar')\n",
        "plt.xlabel('Cancer Type')\n",
        "plt.ylabel('Count')\n",
        "plt.title('Count of Cancer Types')\n",
        "plt.xticks(rotation=45, ha='right')\n",
        "plt.tight_layout()\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 413
        },
        "id": "2xUKDDzjAI6P",
        "outputId": "7a383369-4b30-4269-ea96-5c5bfd33b47b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: export column headers and descriptions\n",
        "\n",
        "import pandas as pd\n",
        "# Get the column headers and descriptions\n",
        "column_headers = df2.columns.tolist()\n",
        "column_descriptions = [df2[col].dtype for col in df2.columns]\n",
        "\n",
        "# Create a DataFrame with headers and descriptions\n",
        "header_description_df = pd.DataFrame({'Header': column_headers, 'Description': column_descriptions})\n",
        "\n",
        "# Export the DataFrame to a CSV file\n",
        "header_description_df.to_csv('column_headers_and_descriptions.csv', index=False)\n",
        "\n",
        "# Optionally, you can print the DataFrame to see the content\n",
        "print(header_description_df)\n",
        "\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "paMB1uvjTMw4",
        "outputId": "8a95de15-58c3-4aa2-bdbd-66d7f08d7ba0"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "                         Header Description\n",
            "0                 Project Title      object\n",
            "1          Contact PI Person ID      object\n",
            "2   Contact PI / Project Leader      object\n",
            "3              Project Abstract      object\n",
            "4       Public Health Relevance      object\n",
            "5                    Department      object\n",
            "6         Organization ID (IPF)      object\n",
            "7             Organization Name      object\n",
            "8             Organization City      object\n",
            "9            Organization State      object\n",
            "10            Organization Type      object\n",
            "11         Organization Country      object\n",
            "12                   Total Cost      object\n",
            "13    Total Cost (Sub Projects)      object\n",
            "14                Funding IC(s)      object\n",
            "15               Direct Cost IC      object\n",
            "16             InDirect Cost IC      object\n",
            "17                Total Cost IC      object\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Assuming 'Project Abstract' contains information about cancer types\n",
        "cancer_counts = df2['Project Abstract'].str.lower().str.findall(r'\\b(Bladder Cancer|Breast Cancer|Colon Cancer|Rectal Cancer|Endometrial Cancer|Kidney Cancer|Leukemia|Liver|Lung Cancer|Melanoma|Non-Hodgkin Lymphoma|Pancreatic Cancer|Prostate Cancer|Thyroid Cancer)\\b').explode().value_counts()\n",
        "\n",
        "# Create the bar graph\n",
        "plt.figure(figsize=(10, 6))\n",
        "cancer_counts.plot(kind='bar')\n",
        "plt.xlabel('Cancer Type')\n",
        "plt.ylabel('Count')\n",
        "plt.title('Count of Cancer Types')\n",
        "plt.xticks(rotation=45, ha='right')\n",
        "plt.tight_layout()\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 805
        },
        "id": "KvAA_QJSWVzW",
        "outputId": "104d90d5-97d5-43cf-a07c-07c696adc4a5"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "error",
          "ename": "IndexError",
          "evalue": "index 0 is out of bounds for axis 0 with size 0",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mIndexError\u001b[0m                                Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-19-4d301aae9139>\u001b[0m in \u001b[0;36m<cell line: 6>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[0;31m# Create the bar graph\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0mplt\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mfigure\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfigsize\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;36m10\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;36m6\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 6\u001b[0;31m \u001b[0mcancer_counts\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mplot\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mkind\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m'bar'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      7\u001b[0m \u001b[0mplt\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mxlabel\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'Cancer Type'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      8\u001b[0m \u001b[0mplt\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mylabel\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'Count'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/plotting/_core.py\u001b[0m in \u001b[0;36m__call__\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1029\u001b[0m                     \u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mcolumns\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mlabel_name\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1030\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1031\u001b[0;31m         \u001b[0;32mreturn\u001b[0m \u001b[0mplot_backend\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mplot\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mkind\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mkind\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1032\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1033\u001b[0m     \u001b[0m__call__\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m__doc__\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0m__doc__\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/plotting/_matplotlib/__init__.py\u001b[0m in \u001b[0;36mplot\u001b[0;34m(data, kind, **kwargs)\u001b[0m\n\u001b[1;32m     69\u001b[0m             \u001b[0mkwargs\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m\"ax\"\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mgetattr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0max\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m\"left_ax\"\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0max\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     70\u001b[0m     \u001b[0mplot_obj\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mPLOT_CLASSES\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mkind\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 71\u001b[0;31m     \u001b[0mplot_obj\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mgenerate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     72\u001b[0m     \u001b[0mplot_obj\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdraw\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     73\u001b[0m     \u001b[0;32mreturn\u001b[0m \u001b[0mplot_obj\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mresult\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/plotting/_matplotlib/core.py\u001b[0m in \u001b[0;36mgenerate\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m    458\u001b[0m         \u001b[0;32mfor\u001b[0m \u001b[0max\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0maxes\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    459\u001b[0m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_post_plot_logic_common\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0max\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 460\u001b[0;31m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_post_plot_logic\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0max\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    461\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    462\u001b[0m     \u001b[0;34m@\u001b[0m\u001b[0mabstractmethod\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/plotting/_matplotlib/core.py\u001b[0m in \u001b[0;36m_post_plot_logic\u001b[0;34m(self, ax, data)\u001b[0m\n\u001b[1;32m   1755\u001b[0m             \u001b[0mstr_index\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m[\u001b[0m\u001b[0mpprint_thing\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mkey\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mkey\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mrange\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mshape\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1756\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1757\u001b[0;31m         \u001b[0ms_edge\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0max_pos\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m-\u001b[0m \u001b[0;36m0.25\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mlim_offset\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1758\u001b[0m         \u001b[0me_edge\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0max_pos\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m-\u001b[0m\u001b[0;36m1\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0;36m0.25\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbar_width\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mlim_offset\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1759\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mIndexError\u001b[0m: index 0 is out of bounds for axis 0 with size 0"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: Create a similar bar graph with these words Bladder Cancer\n",
        "\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "# Assuming 'Project Abstract' contains information about cancer types\n",
        "cancer_counts = df2['Project Abstract'].str.lower().str.findall(r'\\b(acute lymphoblastic leukemia\\acute myeloid leukemia|anal cancer|adrenocortical carcinoma|breast cancer|brain cancer|bone cancer|bile duct cancer|colon and rectal cancer|colorectal cancer|cervical cancer|endometrial cancer|kidney cancer|leukemia|liver|lung cancer|melanoma|medulloblastoma|non-hodgkin lymphoma||pancreatic cancer||prostate cancer|skin cancer|thyroid cancer)\\b').explode().value_counts()\n",
        "\n",
        "# Create the bar graph\n",
        "plt.figure(figsize=(10, 6))\n",
        "cancer_counts.plot(kind='bar')\n",
        "plt.xlabel('Cancer Type')\n",
        "plt.ylabel('Count')\n",
        "plt.title('Count of Cancer Types')\n",
        "plt.xticks(rotation=45, ha='right')\n",
        "plt.tight_layout()\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 607
        },
        "id": "pyfh2VJiWiNv",
        "outputId": "28a5908e-e158-46dc-8d3f-ac9db033fb33"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: now with this list: Adenoid Cystic Carcinoma\n",
        "# Adrenal Gland Cancer\n",
        "# Amyloidosis\n",
        "# Anal Cancer\n",
        "# Ataxia-Telangiectasia\n",
        "# Atypical Mole Syndrome\n",
        "# Basal Cell Carcinoma\n",
        "# Bile Duct Cancer\n",
        "# Birt Hogg Dube Syndrome\n",
        "# Bladder Cancer\n",
        "# Bone Cancer\n",
        "# Brain Tumor\n",
        "# Breast Cancer\n",
        "# Breast Cancer in Men\n",
        "# Carcinoid Tumor\n",
        "# Cervical Cancer\n",
        "# Colorectal Cancer\n",
        "# Ductal Carcinoma\n",
        "# Endometrial Cancer\n",
        "# Esophageal Cancer\n",
        "# Gastric Cancer\n",
        "# Gastrontes\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "cancer_types = [\n",
        "    \"Adenoid Cystic Carcinoma\",\n",
        "    \"Adrenal Gland Cancer\",\n",
        "    \"Amyloidosis\",\n",
        "    \"Anal Cancer\",\n",
        "    \"Ataxia-Telangiectasia\",\n",
        "    \"Atypical Mole Syndrome\",\n",
        "    \"Basal Cell Carcinoma\",\n",
        "    \"Bile Duct Cancer\",\n",
        "    \"Birt Hogg Dube Syndrome\",\n",
        "    \"Bladder Cancer\",\n",
        "    \"Bone Cancer\",\n",
        "    \"Brain Tumor\",\n",
        "    \"Breast Cancer\",\n",
        "    \"Breast Cancer in Men\",\n",
        "    \"Carcinoid Tumor\",\n",
        "    \"Cervical Cancer\",\n",
        "    \"Colorectal Cancer\",\n",
        "    \"Ductal Carcinoma\",\n",
        "    \"Endometrial Cancer\",\n",
        "    \"Esophageal Cancer\",\n",
        "    \"Gastric Cancer\",\n",
        "    \"Gastrontes\"\n",
        "]\n",
        "\n",
        "# Create a regular expression pattern to search for these cancer types\n",
        "pattern = r'\\b(' + '|'.join(cancer_types) + r')\\b'\n",
        "\n",
        "# Find the occurrences of each cancer type in the 'Project Abstract' column\n",
        "cancer_counts = df2['Project Abstract'].str.lower().str.findall(pattern).explode().value_counts()\n",
        "\n",
        "# Create the bar graph\n",
        "plt.figure(figsize=(10, 6))\n",
        "cancer_counts.plot(kind='bar')\n",
        "plt.xlabel('Cancer Type')\n",
        "plt.ylabel('Count')\n",
        "plt.title('Count of Cancer Types')\n",
        "plt.xticks(rotation=45, ha='right')\n",
        "plt.tight_layout()\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 903
        },
        "id": "5_QC_i9tXlk-",
        "outputId": "bd1721bb-bed0-4756-c0e0-724815568670"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "error",
          "ename": "IndexError",
          "evalue": "index 0 is out of bounds for axis 0 with size 0",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mIndexError\u001b[0m                                Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-31-26e15765a7af>\u001b[0m in \u001b[0;36m<cell line: 58>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     56\u001b[0m \u001b[0;31m# Create the bar graph\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     57\u001b[0m \u001b[0mplt\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mfigure\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfigsize\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;36m10\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;36m6\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 58\u001b[0;31m \u001b[0mcancer_counts\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mplot\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mkind\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m'bar'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     59\u001b[0m \u001b[0mplt\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mxlabel\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'Cancer Type'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     60\u001b[0m \u001b[0mplt\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mylabel\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'Count'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/plotting/_core.py\u001b[0m in \u001b[0;36m__call__\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1029\u001b[0m                     \u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mcolumns\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mlabel_name\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1030\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1031\u001b[0;31m         \u001b[0;32mreturn\u001b[0m \u001b[0mplot_backend\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mplot\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mkind\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mkind\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1032\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1033\u001b[0m     \u001b[0m__call__\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m__doc__\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0m__doc__\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/plotting/_matplotlib/__init__.py\u001b[0m in \u001b[0;36mplot\u001b[0;34m(data, kind, **kwargs)\u001b[0m\n\u001b[1;32m     69\u001b[0m             \u001b[0mkwargs\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m\"ax\"\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mgetattr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0max\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m\"left_ax\"\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0max\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     70\u001b[0m     \u001b[0mplot_obj\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mPLOT_CLASSES\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mkind\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 71\u001b[0;31m     \u001b[0mplot_obj\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mgenerate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     72\u001b[0m     \u001b[0mplot_obj\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdraw\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     73\u001b[0m     \u001b[0;32mreturn\u001b[0m \u001b[0mplot_obj\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mresult\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/plotting/_matplotlib/core.py\u001b[0m in \u001b[0;36mgenerate\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m    458\u001b[0m         \u001b[0;32mfor\u001b[0m \u001b[0max\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0maxes\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    459\u001b[0m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_post_plot_logic_common\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0max\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 460\u001b[0;31m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_post_plot_logic\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0max\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    461\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    462\u001b[0m     \u001b[0;34m@\u001b[0m\u001b[0mabstractmethod\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/plotting/_matplotlib/core.py\u001b[0m in \u001b[0;36m_post_plot_logic\u001b[0;34m(self, ax, data)\u001b[0m\n\u001b[1;32m   1755\u001b[0m             \u001b[0mstr_index\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m[\u001b[0m\u001b[0mpprint_thing\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mkey\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mkey\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mrange\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mshape\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1756\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1757\u001b[0;31m         \u001b[0ms_edge\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0max_pos\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m-\u001b[0m \u001b[0;36m0.25\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mlim_offset\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1758\u001b[0m         \u001b[0me_edge\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0max_pos\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m-\u001b[0m\u001b[0;36m1\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0;36m0.25\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbar_width\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mlim_offset\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1759\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mIndexError\u001b[0m: index 0 is out of bounds for axis 0 with size 0"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: create a bar graph checkng for these words acute lymphoblastic leukemia\\acute myeloid leukemia|anal cancer|adrenocortical carcinoma|breast cancer|brain cancer|bone cancer|bile duct cancer|colon and rectal cancer|colorectal cancer|cervical cancer|endometrial cancer|kidney cancer|leukemia|liver|lung cancer|melanoma|medulloblastoma|non-hodgkin lymphoma||pancreatic cancer||prostate cancer|skin cancer|\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "cancer_types = [\n",
        "    \"acute lymphoblastic leukemia\",\n",
        "    \"acute myeloid leukemia\",\n",
        "    \"anal cancer\",\n",
        "    \"adrenocortical carcinoma\",\n",
        "    \"breast cancer\",\n",
        "    \"brain cancer\",\n",
        "    \"bone cancer\",\n",
        "    \"bile duct cancer\",\n",
        "    \"colon and rectal cancer\",\n",
        "    \"colorectal cancer\",\n",
        "    \"cervical cancer\",\n",
        "    \"endometrial cancer\",\n",
        "    \"kidney cancer\",\n",
        "    \"leukemia\",\n",
        "    \"liver\",\n",
        "    \"lung cancer\",\n",
        "    \"melanoma\",\n",
        "    \"medulloblastoma\",\n",
        "    \"non-hodgkin lymphoma\",\n",
        "    \"pancreatic cancer\",\n",
        "    \"prostate cancer\",\n",
        "    \"skin cancer\"\n",
        "]\n",
        "\n",
        "# Create a regular expression pattern to search for these cancer types\n",
        "pattern = r'\\b(' + '|'.join(cancer_types) + r')\\b'\n",
        "\n",
        "# Find the occurrences of each cancer type in the 'Project Abstract' column\n",
        "cancer_counts = df2['Project Abstract'].str.lower().str.findall(pattern).explode().value_counts()\n",
        "\n",
        "# Create the bar graph\n",
        "plt.figure(figsize=(10, 6))\n",
        "cancer_counts.plot(kind='bar')\n",
        "plt.xlabel('Cancer Type')\n",
        "plt.ylabel('Count')\n",
        "plt.title('Count of Cancer Types')\n",
        "plt.xticks(rotation=45, ha='right')\n",
        "plt.tight_layout()\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 607
        },
        "id": "2OzQdViEbkMi",
        "outputId": "0f98dab3-78a1-4691-acd0-30efe1d38087"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: show counts of each bar and add color gradient\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "import numpy as np\n",
        "cancer_types = [\n",
        "    \"acute lymphoblastic leukemia\",\n",
        "    \"acute myeloid leukemia\",\n",
        "    \"anal cancer\",\n",
        "    \"adrenocortical carcinoma\",\n",
        "    \"breast cancer\",\n",
        "    \"brain cancer\",\n",
        "    \"bone cancer\",\n",
        "    \"bile duct cancer\",\n",
        "    \"colon and rectal cancer\",\n",
        "    \"colorectal cancer\",\n",
        "    \"cervical cancer\",\n",
        "    \"endometrial cancer\",\n",
        "    \"kidney cancer\",\n",
        "    \"leukemia\",\n",
        "    \"liver cancer\",\n",
        "    \"lung cancer\",\n",
        "    \"melanoma\",\n",
        "    \"medulloblastoma\",\n",
        "    \"non-hodgkin lymphoma\",\n",
        "    \"pancreatic cancer\",\n",
        "    \"prostate cancer\",\n",
        "    \"skin cancer\"\n",
        "]\n",
        "\n",
        "# Create a regular expression pattern to search for these cancer types\n",
        "pattern = r'\\b(' + '|'.join(cancer_types) + r')\\b'\n",
        "\n",
        "# Find the occurrences of each cancer type in the 'Project Abstract' column\n",
        "cancer_counts = df2['Project Abstract'].str.lower().str.findall(pattern).explode().value_counts()\n",
        "\n",
        "# Create the bar graph with counts and color gradient\n",
        "plt.figure(figsize=(10, 6))\n",
        "ax = cancer_counts.plot(kind='bar', color=plt.cm.viridis(np.linspace(0, 1, len(cancer_counts))))\n",
        "plt.xlabel('Cancer Type')\n",
        "plt.ylabel('Count')\n",
        "plt.title('Count of Cancer Types')\n",
        "plt.xticks(rotation=45, ha='right')\n",
        "plt.tight_layout()\n",
        "\n",
        "# Add counts on top of each bar\n",
        "for p in ax.patches:\n",
        "    ax.annotate(str(p.get_height()), (p.get_x() + p.get_width() / 2., p.get_height()), ha='center', va='center', xytext=(0, 5), textcoords='offset points')\n",
        "\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 607
        },
        "id": "obH1ZnV4b2eI",
        "outputId": "e1ed5826-91c0-443e-d143-bbfb00f2c1f1"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: create bar graph like this but bars should be counts of rows containing each word\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "from collections import defaultdict\n",
        "\n",
        "def count_rows_with_word(df, column, words):\n",
        "  \"\"\"\n",
        "  Counts the number of rows in a DataFrame's column that contain each word.\n",
        "\n",
        "  Args:\n",
        "    df: The DataFrame to analyze.\n",
        "    column: The column to search in.\n",
        "    words: A list of words to search for.\n",
        "\n",
        "  Returns:\n",
        "    A dictionary mapping each word to its row count.\n",
        "  \"\"\"\n",
        "  word_counts = defaultdict(int)\n",
        "  for _, row in df.iterrows():\n",
        "    text = str(row[column]).lower()\n",
        "    for word in words:\n",
        "      if word.lower() in text:\n",
        "        word_counts[word] += 1\n",
        "  return word_counts\n",
        "\n",
        "# Example usage:\n",
        "cancer_types = [\n",
        "    \"acute lymphoblastic leukemia\",\n",
        "    \"acute myeloid leukemia\",\n",
        "    \"anal cancer\",\n",
        "    \"adrenocortical carcinoma\",\n",
        "    \"breast cancer\",\n",
        "    \"brain cancer\",\n",
        "    \"bone cancer\",\n",
        "    \"bile duct cancer\",\n",
        "    \"colon and rectal cancer\",\n",
        "    \"colorectal cancer\",\n",
        "    \"cervical cancer\",\n",
        "    \"endometrial cancer\",\n",
        "    \"kidney cancer\",\n",
        "    \"leukemia\",\n",
        "    \"liver cancer\",\n",
        "    \"lung cancer\",\n",
        "    \"melanoma\",\n",
        "    \"medulloblastoma\",\n",
        "    \"non-hodgkin lymphoma\",\n",
        "    \"pancreatic cancer\",\n",
        "    \"prostate cancer\",\n",
        "    \"skin cancer\"\n",
        "]\n",
        "\n",
        "word_counts = count_rows_with_word(df2, 'Project Abstract', cancer_types)\n",
        "\n",
        "# Create the bar graph\n",
        "plt.figure(figsize=(10, 6))\n",
        "plt.bar(word_counts.keys(), word_counts.values())\n",
        "plt.xlabel('Cancer Type')\n",
        "plt.ylabel('Row Count')\n",
        "plt.title('Count of Rows Containing Cancer Types')\n",
        "plt.xticks(rotation=45, ha='right')\n",
        "plt.tight_layout()\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 607
        },
        "id": "NMtgWSAhdiEj",
        "outputId": "34223722-85c7-448c-8d72-5cbdaad6c15a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: do this again with counts on top and gradient coloring\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "import numpy as np\n",
        "cancer_types = [\n",
        "    \"acute lymphoblastic leukemia\",\n",
        "    \"acute myeloid leukemia\",\n",
        "    \"anal cancer\",\n",
        "    \"adrenocortical carcinoma\",\n",
        "    \"breast cancer\",\n",
        "    \"brain cancer\",\n",
        "    \"bone cancer\",\n",
        "    \"bile duct cancer\",\n",
        "    \"colon and rectal cancer\",\n",
        "    \"colorectal cancer\",\n",
        "    \"cervical cancer\",\n",
        "    \"endometrial cancer\",\n",
        "    \"kidney cancer\",\n",
        "    \"leukemia\",\n",
        "    \"liver cancer\",\n",
        "    \"lung cancer\",\n",
        "    \"melanoma\",\n",
        "    \"medulloblastoma\",\n",
        "    \"non-hodgkin lymphoma\",\n",
        "    \"pancreatic cancer\",\n",
        "    \"prostate cancer\",\n",
        "    \"skin cancer\"\n",
        "]\n",
        "\n",
        "word_counts = count_rows_with_word(df2, 'Project Abstract', cancer_types)\n",
        "\n",
        "# Create the bar graph with counts and color gradient\n",
        "plt.figure(figsize=(10, 6))\n",
        "ax = plt.bar(word_counts.keys(), word_counts.values(), color=plt.cm.viridis(np.linspace(0, 1, len(word_counts))))\n",
        "plt.xlabel('Cancer Type')\n",
        "plt.ylabel('Row Count')\n",
        "plt.title('Count of Rows Containing Cancer Types')\n",
        "plt.xticks(rotation=45, ha='right')\n",
        "plt.tight_layout()\n",
        "\n",
        "# Add counts on top of each bar\n",
        "for p in ax:\n",
        "    height = p.get_height()\n",
        "    plt.text(p.get_x() + p.get_width()/2., height, height, ha='center', va='bottom')\n",
        "\n",
        "\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 607
        },
        "id": "o1MlWXujdzua",
        "outputId": "f6d0eaf6-033b-4669-ce32-18197c607f2c"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: create a similar bar graph looking for these words Biomarker testing\n",
        "# Chemotherapy\n",
        "# Hormone therapy\n",
        "# Hyperthermia\n",
        "# Immunotherapy\n",
        "# Photodynamic therapy\n",
        "# Radiation therapy\n",
        "# Stem cell transplant\n",
        "# Surgery\n",
        "# Targeted drug therapy\n",
        "# Clinical trials\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "import numpy as np\n",
        "treatment_types = [\n",
        "    \"Biomarker testing\",\n",
        "    \"Chemotherapy\",\n",
        "    \"Hormone therapy\",\n",
        "    \"Hyperthermia\",\n",
        "    \"Immunotherapy\",\n",
        "    \"Photodynamic therapy\",\n",
        "    \"Radiation therapy\",\n",
        "    \"Stem cell transplant\",\n",
        "    \"Surgery\",\n",
        "    \"Targeted drug therapy\",\n",
        "    \"Clinical trials\"\n",
        "]\n",
        "\n",
        "word_counts = count_rows_with_word(df2, 'Project Abstract', treatment_types)\n",
        "\n",
        "# Create the bar graph with counts and color gradient\n",
        "plt.figure(figsize=(10, 6))\n",
        "ax = plt.bar(word_counts.keys(), word_counts.values(), color=plt.cm.viridis(np.linspace(0, 1, len(word_counts))))\n",
        "plt.xlabel('Treatment Type')\n",
        "plt.ylabel('Row Count')\n",
        "plt.title('Count of Rows Containing Treatment Types')\n",
        "plt.xticks(rotation=45, ha='right')\n",
        "plt.tight_layout()\n",
        "\n",
        "# Add counts on top of each bar\n",
        "for p in ax:\n",
        "    height = p.get_height()\n",
        "    plt.text(p.get_x() + p.get_width()/2., height, height, ha='center', va='bottom')\n",
        "\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 607
        },
        "id": "8_sLtK4siRBE",
        "outputId": "cba8f239-8d4a-499e-c15d-b313cdc8dfaf"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Create a dictionary to store the total funding for each cancer type\n",
        "cancer_funding = {}\n",
        "for cancer_type in cancer_types:\n",
        "  cancer_funding[cancer_type] = 0.0  # Initialize with 0.0\n",
        "\n",
        "# Convert 'Total Cost' to numeric type\n",
        "df2['Total Cost'] = pd.to_numeric(df2['Total Cost'])\n",
        "\n",
        "# Iterate through the 'Project Abstract' column and find mentions of each cancer type\n",
        "for index, row in df2.iterrows():\n",
        "  abstract = str(row['Project Abstract']).lower()\n",
        "  for cancer_type in cancer_types:\n",
        "    if cancer_type in abstract:\n",
        "      cancer_funding[cancer_type] += row['Total Cost']\n",
        "\n",
        "# Create the bar graph with counts and color gradient\n",
        "plt.figure(figsize=(15, 8))\n",
        "plt.bar(cancer_funding.keys(), cancer_funding.values(), color=plt.cm.viridis(np.linspace(0, 1, len(cancer_funding))))\n",
        "plt.xlabel('Cancer Type')\n",
        "plt.ylabel('Total Funding')\n",
        "plt.title('Total Funding by Cancer Type')\n",
        "plt.xticks(rotation=45, ha='right')\n",
        "plt.tight_layout()\n",
        "\n",
        "# Add counts on top of each bar\n",
        "for i, v in enumerate(cancer_funding.values()):\n",
        "  plt.text(i, v, str(round(v, 2)), ha='center', va='bottom')\n",
        "\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 734
        },
        "id": "DStYR6cmdA-E",
        "outputId": "588b7f8e-b575-4306-b3af-ca24fb2472a7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1500x800 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    }
  ]
}